data_2ka3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ka3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 110.015 -0.802 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.11 120.12 22.37 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.54 -20.24 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.122 1.794 . . . . 0.0 109.827 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 36.6 70.56 0.16 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.933 2.893 . . . . 0.0 115.792 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 77.2 t -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.3 44.7 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 165.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -149.46 139.04 21.65 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.4 t -168.96 117.19 0.66 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.21 36.0 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -136.44 158.49 44.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.425 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -135.07 130.46 35.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -166.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 72.2 m -161.41 8.81 0.08 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -162.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 2.7 pp -29.59 147.58 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.457 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 162.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.0 -43.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 122.128 1.796 . . . . 0.0 113.487 -161.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -163.44 174.05 12.4 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.0 m -9.3 118.97 0.01 OUTLIER 'General case' 0 C--N 1.361 1.097 0 C-N-CA 130.958 3.703 . . . . 0.0 117.004 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -97.95 160.42 28.48 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 124.691 1.196 . . . . 0.0 109.478 -170.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.09 -16.67 9.73 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.815 2.343 . . . . 0.0 110.098 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.57 -137.82 2.41 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 16.5 m -64.22 145.79 55.39 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.204 1.801 . . . . 0.0 110.652 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.66 130.43 36.96 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 125.514 1.525 . . . . 0.0 110.416 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -96.18 -150.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.927 3.084 . . . . 0.0 108.954 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.58 135.52 19.99 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -117.49 -14.78 10.3 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.985 0.514 . . . . 0.0 111.828 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.29 86.82 3.28 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 118.504 0.593 . . . . 0.0 111.839 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.67 97.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.201 1.801 . . . . 0.0 106.574 168.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 50.0 mt -87.24 -37.36 17.3 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.523 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.16 126.86 1.75 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 101.591 -3.485 . . . . 0.0 101.591 162.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -175.31 60.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.494 1.497 . . . . 0.0 109.652 -168.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.72 -44.35 93.78 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -164.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.53 -28.51 11.29 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 118.99 0.814 . . . . 0.0 112.397 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -60.83 0.31 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 63.12 -80.86 0.03 OUTLIER 'General case' 0 C--N 1.356 0.869 0 C-N-CA 128.008 2.523 . . . . 0.0 114.049 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.68 119.46 32.71 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.794 1.238 . . . . 0.0 108.361 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.95 117.63 68.91 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -96.47 0.9 1.97 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 CA-C-N 125.113 2.862 . . . . 0.0 109.368 -165.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -80.31 -45.66 17.47 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -103.27 -12.61 17.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.347 1.059 . . . . 0.0 109.004 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 22.87 52.67 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 162.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 37.7 t -98.94 103.92 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.43 111.98 24.37 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.357 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 62.1 m -100.87 108.32 20.07 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.37 111.09 45.26 Favored Pre-proline 0 C--N 1.358 0.956 0 CA-C-O 117.153 -1.404 . . . . 0.0 112.016 170.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.6 1.89 3.28 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 CA-C-N 123.001 2.107 . . . . 0.0 108.946 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 39.3 mt -52.8 -51.53 60.44 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 127.9 2.48 . . . . 0.0 114.09 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 44.79 18.3 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.069 1.348 . . . . 0.0 114.023 170.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.49 -163.24 11.79 Favored Glycine 0 N--CA 1.415 -2.737 1 N-CA-C 101.212 -4.755 . . . . 0.0 101.212 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -91.98 121.35 33.48 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.287 0.2 OUTLIER -114.58 159.19 20.72 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 119.32 0.963 . . . . 0.0 108.539 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -105.53 115.41 30.2 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.555 0.742 . . . . 0.0 109.085 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.81 136.34 50.0 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 126.079 1.751 . . . . 0.0 109.178 -168.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.5 m -145.99 118.91 8.72 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 123.469 0.708 . . . . 0.0 109.608 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.3 153.66 22.41 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.99 120.64 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.3 123.17 43.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.898 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 38.5 m -79.73 131.91 36.05 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.29 1.436 . . . . 0.0 107.394 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.36 -57.26 19.39 Favored Glycine 0 C--N 1.363 2.074 0 C-N-CA 125.653 1.597 . . . . 0.0 114.713 -169.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.3 m170 34.04 73.96 0.07 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 127.696 2.399 . . . . 0.0 115.606 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -74.14 -8.3 55.68 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.227 1.411 . . . . 0.0 111.55 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -72.12 -15.58 61.99 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 125.741 1.616 . . . . 0.0 112.225 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.339 7.2 pt-20 116.15 -177.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 128.26 2.624 . . . . 0.0 108.603 173.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 104.53 134.59 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 128.244 2.618 . . . . 0.0 106.41 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 69.0 t -98.19 125.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -111.08 122.36 47.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.015 -1.902 . . . . 0.0 113.446 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.21 117.12 17.04 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.12 2.568 . . . . 0.0 108.766 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 94.5 t -87.04 113.79 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 20.3 mt -62.29 140.78 58.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.908 1.683 . . . . 0.0 110.29 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -116.06 146.78 41.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.214 1.805 . . . . 0.0 109.218 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.548 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.07 139.78 40.11 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.155 2.582 . . . . 0.0 110.13 -174.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.17 -13.62 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 129.603 3.161 . . . . 0.0 112.649 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -139.33 -26.0 0.83 Allowed 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 119.327 0.967 . . . . 0.0 111.095 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 60.54 167.01 0.08 Allowed 'General case' 0 C--N 1.361 1.105 0 C-N-CA 125.226 1.411 . . . . 0.0 111.36 -164.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -134.63 50.49 Favored Glycine 0 C--N 1.37 2.449 0 O-C-N 119.521 -1.987 . . . . 0.0 109.208 -161.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 47.4 t 57.93 75.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.235 0 C-N-CA 125.297 1.439 . . . . 0.0 110.516 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.75 114.77 27.39 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -103.01 -36.17 8.28 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.454 -171.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.28 78.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -95.32 131.55 41.3 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.145 -172.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -143.96 114.69 7.7 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.024 1.33 . . . . 0.0 107.885 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.2 84.69 0.71 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 104.529 -3.428 . . . . 0.0 104.529 167.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 110.96 174.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.2 mt -118.26 134.1 55.32 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.82 161.41 25.46 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.91 127.96 73.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -137.58 148.47 45.92 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.4 m -114.73 -44.32 3.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.427 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 26.9 tp -84.33 -50.11 8.13 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.431 1.014 . . . . 0.0 112.785 -166.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 12.6 pt -87.88 -169.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 124.688 1.195 . . . . 0.0 109.941 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.23 82.71 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -165.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.55 91.36 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 122.308 1.86 . . . . 0.0 109.592 160.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.1 142.31 49.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -94.51 156.56 16.4 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.17 123.02 21.22 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 119.533 1.06 . . . . 0.0 108.929 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.41 -11.85 71.12 Favored Glycine 0 C--N 1.345 1.082 0 C-N-CA 125.893 1.711 . . . . 0.0 111.246 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.7 175.32 5.77 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.158 0.583 . . . . 0.0 111.467 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 83.7 m -142.54 125.47 16.16 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -159.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.548 HG13 HH11 ' A' ' 914' ' ' ARG . 34.0 m -95.79 150.26 4.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.686 0.755 . . . . 0.0 109.9 171.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.7 138.91 34.59 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.684 1.994 . . . . 0.0 111.382 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.29 129.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 126.301 1.84 . . . . 0.0 106.786 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.43 131.0 54.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.168 -3.271 . . . . 0.0 102.168 170.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.04 77.55 1.77 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.3 t -160.93 99.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.4 mmm -152.4 73.89 1.05 Allowed 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 107.5 141.92 10.16 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.96 -5.88 13.17 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.256 0.623 . . . . 0.0 111.257 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.28 82.86 2.97 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.94 -175.19 3.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -122.0 159.5 26.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 16.8 t -89.01 131.19 35.3 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.69 150.03 22.55 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.41 113.36 23.29 Favored Pre-proline 0 C--N 1.356 0.869 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -98.13 174.29 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 108.54 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.75 140.91 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.46 140.58 37.33 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 119.583 1.083 . . . . 0.0 108.919 -171.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.0 mm -118.85 129.77 74.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -127.3 105.92 8.86 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 33.8 p -100.19 160.99 13.9 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.008 1.323 . . . . 0.0 110.068 170.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -179.2 109.84 0.27 Allowed Glycine 0 C--N 1.358 1.787 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.8 144.96 46.0 Favored 'General case' 0 C--N 1.346 0.439 0 O-C-N 121.416 -1.049 . . . . 0.0 113.713 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.75 123.65 24.53 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 124.591 1.156 . . . . 0.0 109.671 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 23.9 tp -98.72 -57.38 2.2 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.65 128.02 38.19 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.82 10.04 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 103.231 -3.947 . . . . 0.0 103.231 163.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -69.04 130.04 91.71 Favored Pre-proline 0 C--N 1.352 0.703 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.015 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -106.76 82.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 CA-C-N 121.885 1.709 . . . . 0.0 109.89 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 78.29 -72.28 0.09 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 130.265 3.426 . . . . 0.0 109.195 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 76.4 mt 49.93 39.0 17.55 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 129.073 2.949 . . . . 0.0 114.244 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.7 131.95 54.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -129.24 109.46 11.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.134 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 179.656 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.454 -0.801 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.69 120.41 23.01 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.5 -20.47 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.176 1.813 . . . . 0.0 110.081 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 37.95 70.37 0.2 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.926 2.89 . . . . 0.0 115.482 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 82.5 t -118.14 136.03 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.08 157.66 46.35 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -149.5 139.46 21.98 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -169.57 118.23 0.63 Allowed 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.97 153.56 34.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -138.37 158.59 43.98 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.908 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -136.06 128.1 29.65 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -167.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 73.3 m -160.33 13.0 0.12 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -167.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 2.6 pp -29.03 148.24 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 160.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.63 -43.76 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.104 1.787 . . . . 0.0 113.553 -161.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -163.41 173.83 12.7 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -8.73 118.94 0.01 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 130.952 3.701 . . . . 0.0 117.075 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -97.87 160.42 28.54 Favored Pre-proline 0 N--CA 1.44 -0.926 0 C-N-CA 124.661 1.184 . . . . 0.0 109.606 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.14 -16.69 9.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.776 2.317 . . . . 0.0 110.176 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.43 -137.71 2.37 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -64.05 145.41 55.95 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.13 1.772 . . . . 0.0 110.498 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.89 129.84 40.63 Favored Pre-proline 0 N--CA 1.438 -1.028 0 C-N-CA 125.366 1.466 . . . . 0.0 110.208 -164.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -96.82 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.797 2.998 . . . . 0.0 108.726 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.21 135.54 20.46 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -115.87 -14.05 11.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.019 0.928 . . . . 0.0 110.705 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.17 86.65 3.07 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 118.233 0.469 . . . . 0.0 112.159 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.06 97.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.247 1.819 . . . . 0.0 106.639 164.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 13.5 mt -87.75 -38.83 15.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.278 -173.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 53.3 tp -166.25 127.49 1.79 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 166.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 178.25 61.0 0.01 OUTLIER 'General case' 0 C--N 1.355 0.825 0 CA-C-N 120.331 1.423 . . . . 0.0 108.807 -164.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.13 -43.96 95.28 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.22 -29.15 10.57 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 118.741 0.7 . . . . 0.0 112.355 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.53 -60.04 0.34 Allowed Glycine 0 C--N 1.353 1.487 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 63.14 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.103 2.561 . . . . 0.0 114.148 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -95.33 119.24 33.5 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 125.007 1.323 . . . . 0.0 108.231 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -80.64 117.83 69.65 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -95.29 0.99 2.5 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 125.144 2.873 . . . . 0.0 109.589 -165.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -80.3 -44.36 19.71 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 33.2 p -105.38 -13.05 15.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.729 1.211 . . . . 0.0 108.581 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.24 47.22 Favored Glycine 0 C--N 1.362 2.009 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 163.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.7 103.44 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 -162.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.57 112.1 24.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 112.515 -2.129 . . . . 0.0 109.475 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 61.3 m -101.08 108.45 20.15 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.43 111.12 45.55 Favored Pre-proline 0 C--N 1.359 0.99 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.844 170.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -93.26 2.08 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 123.101 2.143 . . . . 0.0 108.949 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.32 -49.37 69.85 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.025 2.13 . . . . 0.0 113.888 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.32 48.18 15.38 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.747 1.619 . . . . 0.0 114.431 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.91 -164.92 20.2 Favored Glycine 0 N--CA 1.412 -2.951 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -90.79 121.38 32.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -116.42 159.54 21.85 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 119.36 0.982 . . . . 0.0 108.824 178.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -106.19 114.3 28.35 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.55 136.17 49.36 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 126.09 1.756 . . . . 0.0 108.529 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -145.02 119.31 9.54 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.167 0.587 . . . . 0.0 109.566 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.85 22.15 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.33 121.44 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.29 121.97 43.31 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.44 1.096 . . . . 0.0 108.665 -172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.3 m -79.12 132.26 36.51 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 107.749 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.15 -57.25 19.28 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.784 1.659 . . . . 0.0 114.63 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.5 m170 33.92 73.84 0.07 Allowed 'General case' 0 C--N 1.359 1.013 0 C-N-CA 127.746 2.418 . . . . 0.0 115.528 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.0 -8.48 56.28 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.283 1.433 . . . . 0.0 111.493 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -72.22 -14.51 61.81 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 125.807 1.643 . . . . 0.0 112.255 -170.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.341 7.0 pt-20 115.92 -178.27 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 128.641 2.776 . . . . 0.0 108.633 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 104.32 134.18 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 128.081 2.552 . . . . 0.0 106.635 172.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 87.8 t -98.0 126.5 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -172.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -111.98 122.8 48.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.942 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.24 116.88 16.73 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.539 2.336 . . . . 0.0 109.564 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 97.0 t -88.07 113.88 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.62 142.93 57.82 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.337 1.855 . . . . 0.0 110.249 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.7 t -116.47 147.24 41.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.298 1.839 . . . . 0.0 109.424 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.613 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.16 139.39 38.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.664 2.386 . . . . 0.0 109.826 -175.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.54 -16.94 0.03 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 129.643 3.177 . . . . 0.0 112.798 173.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -137.37 -25.5 1.03 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 119.384 0.993 . . . . 0.0 111.57 -169.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 60.44 167.35 0.08 Allowed 'General case' 0 C--N 1.36 1.062 0 C-N-CA 125.449 1.499 . . . . 0.0 111.078 -163.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.93 -133.55 49.36 Favored Glycine 0 C--N 1.367 2.259 0 O-C-N 119.664 -1.898 . . . . 0.0 109.066 -163.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 47.7 t 56.04 76.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.18 0 C-N-CA 125.64 1.576 . . . . 0.0 110.794 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.32 115.2 27.83 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -103.35 -36.83 7.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.392 -171.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.65 77.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.14 131.29 42.74 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -142.87 115.26 8.49 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.1 1.36 . . . . 0.0 107.832 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 84.63 0.73 Allowed Glycine 0 CA--C 1.486 -1.777 0 N-CA-C 104.625 -3.39 . . . . 0.0 104.625 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.644 0 C-N-CA 125.615 1.579 . . . . 0.0 111.003 175.397 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.506 -0.712 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.0 mt -116.88 134.23 55.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -142.44 162.67 27.27 Favored Glycine 0 CA--C 1.492 -1.403 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.83 130.73 73.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -137.61 150.09 47.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 54.6 m -119.19 -39.97 2.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.003 0.365 . . . . 0.0 111.91 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.56 -50.2 8.48 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-N 119.142 0.883 . . . . 0.0 112.299 -168.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 38.4 pt -84.74 -175.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 125.686 1.595 . . . . 0.0 110.14 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.38 81.92 2.81 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 -169.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.78 92.62 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.294 1.996 . . . . 0.0 110.107 162.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.85 141.85 50.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -93.5 157.19 16.33 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.162 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.92 122.8 21.43 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.808 1.186 . . . . 0.0 108.718 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.04 -11.31 72.46 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 125.667 1.603 . . . . 0.0 111.165 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.8 175.01 6.1 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.624 0.726 . . . . 0.0 110.619 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 91.1 m -142.55 125.61 16.29 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -158.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.613 HG13 HH11 ' B' ' 914' ' ' ARG . 27.2 m -96.78 151.1 4.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 121.637 0.732 . . . . 0.0 110.909 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -140.85 138.94 34.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.864 2.066 . . . . 0.0 111.454 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.71 129.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.466 0 C-N-CA 127.142 2.177 . . . . 0.0 106.964 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -107.29 130.77 54.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.633 -3.469 . . . . 0.0 101.633 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.8 77.11 1.75 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 59.5 t -160.12 100.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -151.59 71.76 1.0 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.25 141.78 9.09 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.44 -5.11 13.51 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.233 0.613 . . . . 0.0 110.994 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 37.8 tp -99.44 82.11 2.62 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.56 -174.5 3.72 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -121.97 159.76 26.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -88.62 130.52 35.26 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.81 150.11 22.4 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 113.3 23.24 Favored Pre-proline 0 C--N 1.356 0.88 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -97.75 173.88 0.61 Allowed 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 121.957 1.772 . . . . 0.0 108.492 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.95 139.53 50.54 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.42 139.63 38.99 Favored 'General case' 0 C--N 1.374 1.646 0 CA-C-N 119.728 1.149 . . . . 0.0 108.572 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.2 mm -116.82 130.4 71.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -127.78 106.03 8.85 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 982' ' ' SER . . . . . 0.484 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 34.3 p -101.22 163.02 12.48 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.086 1.354 . . . . 0.0 110.538 171.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.75 111.41 0.31 Allowed Glycine 0 C--N 1.36 1.868 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.85 145.12 45.93 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.25 123.23 23.3 Favored 'General case' 0 C--N 1.376 1.744 0 C-N-CA 124.223 1.009 . . . . 0.0 109.354 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 53.6 tp -98.3 -57.48 2.2 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.4 127.3 37.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.72 128.95 9.72 Favored Glycine 0 CA--C 1.493 -1.329 1 N-CA-C 103.053 -4.019 . . . . 0.0 103.053 163.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.76 128.91 91.65 Favored Pre-proline 0 C--N 1.349 0.567 0 CA-C-O 117.693 -1.146 . . . . 0.0 110.345 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -106.27 82.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 CA-C-N 122.08 1.779 . . . . 0.0 109.593 -168.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.0 -72.04 0.09 Allowed 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 130.201 3.4 . . . . 0.0 109.136 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 76.5 mt 49.47 40.6 19.39 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 128.984 2.914 . . . . 0.0 113.828 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -113.35 131.79 55.83 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -130.02 109.17 10.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.578 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.88 114.43 31.07 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -86.09 -23.92 1.84 Allowed 'Trans proline' 0 CA--C 1.512 -0.584 0 CA-C-N 121.697 1.642 . . . . 0.0 110.285 -171.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 38.8 67.03 0.46 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 128.602 2.761 . . . . 0.0 115.553 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.09 136.95 57.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.93 156.09 49.59 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -148.47 137.83 21.96 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.3 t -171.37 119.37 0.47 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.426 -0.796 . . . . 0.0 109.734 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.41 153.61 37.61 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.17 158.46 44.01 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.663 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -140.83 130.21 23.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 74.5 m -158.54 15.99 0.2 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.0 pp -27.25 144.33 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.517 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 160.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -79.75 -45.49 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 122.056 1.77 . . . . 0.0 113.54 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.07 174.42 12.28 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.1 m -5.02 114.83 0.01 OUTLIER 'General case' 0 C--N 1.363 1.185 0 C-N-CA 130.78 3.632 . . . . 0.0 116.901 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.87 156.55 43.67 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.01 -15.63 10.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.346 2.03 . . . . 0.0 111.259 -172.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.1 -140.48 2.96 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.0 m -65.8 144.66 56.72 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.621 1.568 . . . . 0.0 110.036 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 74.1 t -98.09 134.39 22.16 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 124.596 1.159 . . . . 0.0 110.521 -158.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -95.77 -152.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.063 3.175 . . . . 0.0 109.832 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -145.4 132.83 20.73 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -113.24 -17.03 12.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.457 0.703 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -102.9 83.42 2.23 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.194 0.521 . . . . 0.0 111.458 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.66 97.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.534 1.934 . . . . 0.0 106.649 165.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.79 -37.87 14.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.889 -173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 34.4 tp -165.02 127.22 2.16 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 174.97 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.183 1.356 . . . . 0.0 107.703 -163.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.84 -42.78 94.35 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.79 -28.32 16.4 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.744 0.702 . . . . 0.0 112.284 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.26 -58.44 0.46 Allowed Glycine 0 C--N 1.354 1.53 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 62.45 -81.28 0.02 OUTLIER 'General case' 0 C--N 1.353 0.751 0 C-N-CA 128.119 2.568 . . . . 0.0 114.654 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -95.5 120.3 35.51 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.424 1.49 . . . . 0.0 108.501 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.41 117.38 68.64 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.56 6.59 2.02 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.918 2.792 . . . . 0.0 109.768 -171.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -79.65 -45.33 19.24 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -105.26 -15.83 14.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.894 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.23 24.22 52.3 Favored Glycine 0 C--N 1.363 2.037 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 164.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.67 103.08 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 N-CA-C 101.335 -3.58 . . . . 0.0 101.335 -168.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -94.67 112.14 23.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.929 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 50.7 m -102.86 109.07 20.52 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.25 110.38 42.16 Favored Pre-proline 0 C--N 1.356 0.889 0 CA-C-O 117.221 -1.371 . . . . 0.0 111.774 169.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -92.83 1.33 3.72 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.539 2.159 . . . . 0.0 108.289 164.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 36.4 mt -54.73 -52.68 61.74 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 128.098 2.559 . . . . 0.0 113.794 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.41 67.35 0.95 Allowed 'General case' 0 C--N 1.366 1.29 0 CA-C-O 121.971 0.891 . . . . 0.0 111.177 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.97 171.22 44.11 Favored Glycine 0 N--CA 1.406 -3.307 1 N-CA-C 100.272 -5.131 . . . . 0.0 100.272 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -91.45 116.34 28.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -116.28 160.03 21.03 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-O 121.576 0.703 . . . . 0.0 110.248 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.67 112.77 25.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.39 139.36 50.98 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.142 1.377 . . . . 0.0 109.017 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.5 m -144.15 120.53 10.95 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 110.197 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.53 154.48 19.86 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.52 123.07 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.52 123.63 40.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.256 1.022 . . . . 0.0 109.341 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 49.9 m -79.63 132.7 36.32 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.66 -56.78 16.38 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 125.774 1.654 . . . . 0.0 114.432 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 32.3 71.83 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.979 2.512 . . . . 0.0 114.987 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -72.98 -9.24 58.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.554 1.541 . . . . 0.0 111.803 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -71.92 -16.5 62.11 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.98 1.712 . . . . 0.0 112.274 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 122.13 -173.1 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.571 2.748 . . . . 0.0 107.745 173.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 103.49 134.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 127.949 2.499 . . . . 0.0 106.655 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.03 123.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -104.03 130.0 51.68 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.154 1.781 . . . . 0.0 110.278 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -152.5 114.2 4.34 Favored 'General case' 0 C--N 1.358 0.965 0 C-N-CA 124.97 1.308 . . . . 0.0 110.103 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.53 114.21 27.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 125.238 1.415 . . . . 0.0 107.694 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -61.59 139.92 58.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.112 1.765 . . . . 0.0 111.421 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.1 t -117.53 144.89 44.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.059 2.144 . . . . 0.0 108.842 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.31 141.91 38.13 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 127.205 2.202 . . . . 0.0 111.003 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.6 t 99.79 -10.78 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.955 3.302 . . . . 0.0 112.179 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -141.8 -25.94 0.68 Allowed 'General case' 0 C--N 1.358 0.944 0 CA-C-N 119.275 0.943 . . . . 0.0 111.672 -172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 59.72 167.62 0.07 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.229 1.412 . . . . 0.0 111.671 -163.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.06 -131.94 52.2 Favored Glycine 0 C--N 1.373 2.595 0 O-C-N 119.498 -2.001 . . . . 0.0 109.363 -162.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 44.8 t 54.8 74.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 125.567 1.547 . . . . 0.0 111.032 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.12 114.85 27.49 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 27.7 ptt85 -97.96 -38.0 9.57 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.752 -171.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.19 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.012 -2.959 . . . . 0.0 103.012 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -97.53 131.12 44.43 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.183 0.516 . . . . 0.0 111.111 -173.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -144.05 117.06 8.86 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.475 1.51 . . . . 0.0 108.35 171.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 85.01 0.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 105.158 -3.177 . . . . 0.0 105.158 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.605 0 C-N-CA 125.168 1.366 . . . . 0.0 110.798 174.385 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 73.7 mt -122.34 134.24 54.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.96 161.63 26.75 Favored Glycine 0 CA--C 1.491 -1.467 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 28.4 m -120.8 129.64 75.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.55 150.16 48.47 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.265 -0.897 . . . . 0.0 108.775 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -115.78 -41.03 3.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.484 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 16.6 tp -90.05 -52.92 4.72 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 119.069 0.849 . . . . 0.0 111.837 -168.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.51 -177.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 125.709 1.604 . . . . 0.0 109.844 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.99 85.51 1.6 Allowed Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 87.78 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 122.543 1.944 . . . . 0.0 109.49 163.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.18 145.82 48.3 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -92.8 161.37 14.54 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 118.917 0.78 . . . . 0.0 109.721 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.51 122.67 20.87 Favored 'General case' 0 C--N 1.379 1.872 0 CA-C-N 119.907 1.231 . . . . 0.0 109.051 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.73 -12.49 69.72 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.112 1.815 . . . . 0.0 111.372 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.26 175.37 5.41 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-O 121.571 0.701 . . . . 0.0 111.45 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 93.6 m -142.68 126.65 17.28 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.965 0.906 . . . . 0.0 110.569 -159.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.44 147.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.915 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.9 t -142.04 138.88 32.1 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.984 1.714 . . . . 0.0 111.577 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 89.3 t -90.33 129.07 41.78 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 C-N-CA 126.352 1.861 . . . . 0.0 106.701 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.69 132.97 51.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 101.345 -3.576 . . . . 0.0 101.345 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.92 72.16 1.49 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.844 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.2 t -160.97 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -151.78 70.04 0.93 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.2 145.88 7.96 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -117.27 -15.8 10.38 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.044 0.938 . . . . 0.0 110.287 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -101.59 81.98 2.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.79 -161.92 1.22 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -119.61 154.15 34.41 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.6 t -89.58 132.74 34.95 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -156.5 154.41 30.3 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -128.74 120.74 20.71 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -102.49 170.96 0.25 Allowed 'Trans proline' 0 CA--C 1.506 -0.892 0 N-CA-C 107.691 -1.696 . . . . 0.0 107.691 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 8.1 mp -112.53 139.83 47.79 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.5 p -136.56 139.27 42.05 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 119.574 1.079 . . . . 0.0 108.199 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.0 131.11 68.22 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -124.91 104.87 8.83 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 982' ' ' SER . . . . . 0.427 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 31.1 p -101.88 163.45 12.24 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.357 1.463 . . . . 0.0 110.556 171.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.76 112.14 0.34 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.77 45.78 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.921 -1.341 . . . . 0.0 114.452 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.05 124.45 27.81 Favored 'General case' 0 C--N 1.379 1.875 0 C-N-CA 124.892 1.277 . . . . 0.0 109.724 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 17.1 tp -97.49 -57.09 2.33 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.809 0.338 . . . . 0.0 110.237 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -131.49 127.65 37.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.82 130.72 10.41 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 165.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -70.51 129.5 90.08 Favored Pre-proline 0 C--N 1.35 0.594 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.696 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -106.76 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.014 1.755 . . . . 0.0 109.46 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 78.45 -73.16 0.08 Allowed 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 130.034 3.334 . . . . 0.0 109.048 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.8 mt 49.79 39.66 18.52 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.911 2.884 . . . . 0.0 113.792 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -112.12 131.72 55.29 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.36 109.05 10.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.095 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 110.166 -0.744 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.03 117.89 28.28 Favored Pre-proline 0 C--N 1.353 0.748 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -89.02 -21.0 1.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 CA-C-N 121.998 1.749 . . . . 0.0 110.021 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 37.29 70.57 0.17 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 129.056 2.942 . . . . 0.0 115.493 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 81.7 t -118.23 136.12 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.19 158.11 45.2 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 164.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -150.57 143.49 24.69 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 118.924 0.784 . . . . 0.0 110.117 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.57 118.42 0.85 Allowed 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.444 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.74 154.26 37.15 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.81 157.18 45.76 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.229 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -134.45 130.17 36.35 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -166.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 39.5 p -162.99 13.38 0.07 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -161.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 3.5 pp -25.18 147.99 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.426 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 159.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.28 -45.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.111 1.79 . . . . 0.0 113.252 -164.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.95 176.1 10.5 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -173.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.55 119.57 0.02 OUTLIER 'General case' 0 C--N 1.364 1.209 0 C-N-CA 130.549 3.54 . . . . 0.0 116.148 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.96 163.7 18.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 123.98 0.912 . . . . 0.0 108.737 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.06 -13.58 13.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.886 2.391 . . . . 0.0 111.189 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.81 -144.74 4.39 Favored Glycine 0 C--N 1.354 1.563 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.5 m -64.67 137.66 57.94 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.375 1.87 . . . . 0.0 110.938 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 14.8 m -69.38 145.59 95.77 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.365 1.466 . . . . 0.0 113.292 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -101.8 -145.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.037 2.492 . . . . 0.0 107.281 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -148.11 134.07 19.16 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -117.4 -14.2 10.37 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.428 0.691 . . . . 0.0 110.42 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . 0.462 HH21 HD21 ' A' ' 872' ' ' LEU . 16.4 mmm180 -100.37 85.92 3.08 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-O 121.335 0.588 . . . . 0.0 111.427 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 74.2 t -69.2 95.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.935 2.494 . . . . 0.0 105.472 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . 0.462 HD21 HH21 ' A' ' 870' ' ' ARG . 4.3 mt -90.79 -38.08 13.23 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.875 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 55.3 tp -166.8 130.62 1.95 Allowed 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.4 p-10 172.15 62.51 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 121.012 1.733 . . . . 0.0 108.537 -172.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.34 -44.19 92.66 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -163.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.39 -31.73 9.36 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.35 -68.76 0.23 Allowed Glycine 0 CA--C 1.489 -1.557 0 N-CA-C 105.592 -3.003 . . . . 0.0 105.592 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 77.29 -67.78 0.19 Allowed 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 128.295 2.638 . . . . 0.0 112.21 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -98.35 122.12 41.13 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.31 1.444 . . . . 0.0 108.101 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.68 118.0 70.45 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 116.115 -1.898 . . . . 0.0 106.113 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.32 -0.46 4.71 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 124.637 2.692 . . . . 0.0 108.768 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.65 -41.39 27.02 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.835 1.254 . . . . 0.0 108.612 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 37.1 p -104.31 -15.34 15.48 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.57 16.81 69.96 Favored Glycine 0 C--N 1.365 2.163 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 167.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 55.7 t -101.87 105.81 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 112.37 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.236 -175.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.29 109.33 20.97 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.76 110.9 44.81 Favored Pre-proline 0 C--N 1.357 0.913 0 CA-C-O 117.172 -1.394 . . . . 0.0 111.678 169.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -93.75 0.44 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 CA-C-N 123.082 2.136 . . . . 0.0 108.602 166.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 61.5 mt -51.73 -54.39 28.96 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 127.988 2.515 . . . . 0.0 114.563 -168.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.13 66.34 1.12 Allowed 'General case' 0 C--N 1.364 1.231 0 CA-C-O 121.926 0.87 . . . . 0.0 112.166 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.27 -169.02 36.57 Favored Glycine 0 N--CA 1.408 -3.17 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -92.99 122.28 35.19 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.018 -1.091 . . . . 0.0 108.214 171.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . 0.455 ' H ' HD11 ' A' ' 954' ' ' LEU . 0.0 OUTLIER -116.56 151.68 35.69 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.94 115.83 30.87 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.867 0.867 . . . . 0.0 108.844 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -112.58 137.11 51.3 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.957 1.703 . . . . 0.0 109.758 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -145.42 119.06 9.14 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 123.634 0.773 . . . . 0.0 109.317 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.59 154.31 21.6 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.43 120.98 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.12 123.21 42.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.349 1.059 . . . . 0.0 109.22 -171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 48.5 m -83.68 132.32 34.88 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.362 1.465 . . . . 0.0 107.272 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.83 17.78 Favored Glycine 0 C--N 1.362 2.026 0 C-N-CA 125.089 1.328 . . . . 0.0 114.309 -170.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 59.1 m170 33.14 73.18 0.07 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 127.86 2.464 . . . . 0.0 115.342 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -73.91 -8.4 55.94 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.288 1.435 . . . . 0.0 111.959 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -71.17 -18.51 62.49 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.567 1.547 . . . . 0.0 112.577 -170.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.309 9.4 pt-20 123.01 -174.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 129.149 2.98 . . . . 0.0 107.915 175.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 102.32 130.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 128.162 2.585 . . . . 0.0 106.509 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 91.2 t -98.31 124.48 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -107.97 130.47 55.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.121 1.769 . . . . 0.0 110.719 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -153.97 115.1 4.09 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 125.217 1.407 . . . . 0.0 110.125 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.85 117.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.532 1.533 . . . . 0.0 107.886 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.9 mt -62.79 137.37 58.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.07 1.348 . . . . 0.0 109.145 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.2 t -116.22 147.89 41.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 126.053 1.741 . . . . 0.0 108.192 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.435 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -76.03 138.55 40.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 128.418 2.687 . . . . 0.0 110.38 -173.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 88.34 3.44 0.28 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.961 2.904 . . . . 0.0 113.012 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -149.73 -24.81 0.27 Allowed 'General case' 0 C--N 1.359 1.019 0 CA-C-N 119.45 1.023 . . . . 0.0 111.61 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 57.76 172.9 0.05 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.947 1.299 . . . . 0.0 112.117 -162.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.02 52.83 Favored Glycine 0 C--N 1.377 2.824 0 O-C-N 119.513 -1.992 . . . . 0.0 110.292 -163.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 54.5 t 55.34 75.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.266 0 C-N-CA 125.651 1.58 . . . . 0.0 111.267 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.58 116.51 28.93 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -102.27 -32.87 9.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.67 -1.605 . . . . 0.0 108.165 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.89 83.3 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.74 131.65 38.89 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.136 0.493 . . . . 0.0 110.636 -172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.0 t -143.3 115.41 8.37 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.505 1.522 . . . . 0.0 107.569 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.38 84.57 0.76 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 104.937 -3.265 . . . . 0.0 104.937 167.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.582 0 C-N-CA 124.884 1.23 . . . . 0.0 111.193 175.763 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.512 -0.504 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 56.1 mt -121.66 133.6 54.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.97 161.42 27.83 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.48 130.17 74.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -138.82 151.18 46.81 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.4 m -115.35 -43.24 3.08 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.48 -50.84 6.95 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 119.324 0.965 . . . . 0.0 112.714 -166.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.9 -172.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.799 1.64 . . . . 0.0 110.462 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.455 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -160.01 84.18 2.15 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -166.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.68 90.7 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.985 1.745 . . . . 0.0 109.089 159.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.68 142.58 50.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.8 158.72 15.3 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.06 123.09 21.31 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.745 1.157 . . . . 0.0 109.031 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.39 -11.09 72.96 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 125.886 1.708 . . . . 0.0 111.258 170.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.44 174.28 6.79 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 111.552 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.51 127.08 16.04 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -159.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.435 HG13 HH11 ' A' ' 914' ' ' ARG . 15.3 m -98.23 147.3 6.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.401 0.62 . . . . 0.0 110.865 171.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 23.4 t -142.32 137.73 30.79 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.318 1.847 . . . . 0.0 110.888 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 30.3 t -91.57 129.04 42.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 C-N-CA 125.995 1.718 . . . . 0.0 107.315 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.8 131.94 53.34 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 101.437 -3.542 . . . . 0.0 101.437 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.4 72.82 1.51 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.287 -1.779 . . . . 0.0 106.45 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 52.4 t -162.22 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 83.1 mmm -152.88 72.86 0.98 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 117.48 147.08 8.43 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.82 -28.46 7.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.1 tp -92.71 86.36 5.52 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -154.92 0.57 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -124.68 166.96 15.21 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 23.0 t -103.7 131.6 50.72 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 155.89 30.9 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.29 115.05 21.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 173.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -99.78 172.94 0.4 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 121.998 1.799 . . . . 0.0 108.05 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.64 140.97 48.69 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -138.3 140.34 39.52 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.585 1.084 . . . . 0.0 108.479 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.2 mm -116.64 130.88 70.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -126.31 106.16 9.32 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 26.9 p -100.36 160.3 14.45 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.529 1.132 . . . . 0.0 109.253 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.72 109.82 0.28 Allowed Glycine 0 C--N 1.356 1.665 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.888 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.39 143.68 47.32 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -73.35 125.96 29.05 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.955 1.302 . . . . 0.0 109.904 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.82 -57.38 2.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -131.13 127.75 38.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.9 129.98 10.1 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -69.88 128.72 91.63 Favored Pre-proline 0 C--N 1.349 0.573 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.583 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -106.94 80.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.165 1.809 . . . . 0.0 109.233 -169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 79.47 -70.51 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.936 3.295 . . . . 0.0 109.008 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 18.2 mt 50.37 38.21 17.38 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 128.729 2.812 . . . . 0.0 114.202 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -114.98 133.94 55.61 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -129.2 109.98 11.6 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.112 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.226 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.807 0 N-CA-C 110.134 -0.756 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.22 118.36 27.89 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -89.42 -21.61 1.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 122.029 1.76 . . . . 0.0 110.144 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 38.29 69.72 0.24 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 128.964 2.906 . . . . 0.0 115.455 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 79.2 t -117.89 136.21 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.05 158.3 44.7 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.5 143.58 24.81 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 118.821 0.737 . . . . 0.0 110.201 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.64 118.37 0.84 Allowed 'General case' 0 C--N 1.354 0.788 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.203 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.16 154.2 36.52 Favored 'General case' 0 C--N 1.369 1.435 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.37 157.14 46.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.405 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.99 130.21 37.29 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -166.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 39.9 p -163.07 13.1 0.06 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -161.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.5 pp -25.06 148.01 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.387 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 159.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.13 -45.66 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 122.14 1.8 . . . . 0.0 113.329 -164.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.83 176.03 10.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.64 119.63 0.02 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.507 3.523 . . . . 0.0 116.138 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -113.82 163.69 18.02 Favored Pre-proline 0 N--CA 1.443 -0.784 0 C-N-CA 124.037 0.935 . . . . 0.0 108.799 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.02 -13.55 14.04 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.875 2.383 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.79 -144.79 4.41 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -64.72 137.73 57.98 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 126.38 1.872 . . . . 0.0 110.901 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.54 145.63 95.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 113.342 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -102.21 -145.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.068 2.512 . . . . 0.0 107.285 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -148.46 134.18 18.88 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -117.0 -13.82 10.61 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.749 0.819 . . . . 0.0 110.21 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . 0.453 HH21 HD21 ' B' ' 872' ' ' LEU . 15.8 mmm180 -99.97 86.47 3.27 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-O 121.11 0.481 . . . . 0.0 111.918 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.85 95.48 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 127.763 2.425 . . . . 0.0 105.402 163.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . 0.453 HD21 HH21 ' B' ' 870' ' ' ARG . 4.5 mt -90.74 -38.14 13.22 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.726 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.5 tp -166.59 130.64 2.04 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.5 p-10 172.48 62.62 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 120.906 1.684 . . . . 0.0 108.903 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.16 -44.06 92.12 Favored 'General case' 0 C--N 1.364 1.216 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.31 -32.01 9.17 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.05 -68.39 0.24 Allowed Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 77.15 -68.18 0.18 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 128.245 2.618 . . . . 0.0 112.288 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -98.38 121.85 40.83 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.331 1.452 . . . . 0.0 108.1 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.03 118.08 70.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-O 116.149 -1.881 . . . . 0.0 106.266 167.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -90.79 -0.22 5.05 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 CA-C-N 124.6 2.679 . . . . 0.0 108.772 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.68 -41.01 27.72 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 124.921 1.288 . . . . 0.0 108.651 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 37.8 p -104.66 -15.53 15.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.67 16.98 69.24 Favored Glycine 0 C--N 1.364 2.111 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.94 105.9 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 -168.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.64 112.43 24.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.366 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.23 109.26 20.89 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.82 111.07 46.02 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.837 169.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.52 1.52 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 123.078 2.135 . . . . 0.0 108.767 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.27 -49.46 72.02 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.819 2.048 . . . . 0.0 114.26 -167.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.69 47.76 17.66 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.302 1.441 . . . . 0.0 114.704 171.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -159.63 -164.18 14.48 Favored Glycine 0 N--CA 1.413 -2.888 1 N-CA-C 101.345 -4.702 . . . . 0.0 101.345 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -89.95 121.35 31.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . 0.445 ' H ' HD11 ' B' ' 954' ' ' LEU 0.25 0.0 OUTLIER -117.17 151.94 35.82 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.901 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.9 tp -106.42 115.64 30.56 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -113.21 136.5 52.67 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.794 1.638 . . . . 0.0 109.063 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.1 m -145.93 119.23 8.95 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 123.542 0.737 . . . . 0.0 109.247 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.18 154.68 20.85 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 96.9 t -105.2 122.11 58.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.45 121.92 41.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.106 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 46.9 m -82.17 131.92 35.24 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 125.353 1.461 . . . . 0.0 107.509 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.67 18.61 Favored Glycine 0 C--N 1.363 2.062 0 C-N-CA 125.165 1.364 . . . . 0.0 114.376 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.9 m170 33.04 73.24 0.07 Allowed 'General case' 0 C--N 1.361 1.072 0 C-N-CA 127.845 2.458 . . . . 0.0 115.357 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -74.02 -8.1 54.9 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.366 1.466 . . . . 0.0 111.901 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -72.03 -15.72 62.04 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.845 1.658 . . . . 0.0 112.619 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.318 8.5 pt-20 119.36 -176.13 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 129.152 2.981 . . . . 0.0 108.192 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 103.24 129.98 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 128.158 2.583 . . . . 0.0 106.561 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.25 125.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -109.02 130.42 55.48 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.024 1.73 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.13 115.07 4.04 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.928 1.291 . . . . 0.0 110.2 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 5.0 p -84.04 117.82 30.29 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 125.494 1.518 . . . . 0.0 107.932 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 28.4 mt -62.96 137.9 58.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.453 1.501 . . . . 0.0 109.083 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.0 t -116.02 148.62 39.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.959 1.704 . . . . 0.0 108.715 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.433 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -77.06 138.19 39.41 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 127.989 2.516 . . . . 0.0 110.169 -173.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 87.6 4.67 0.31 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.863 2.865 . . . . 0.0 113.019 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -150.03 -24.67 0.26 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.438 1.017 . . . . 0.0 111.515 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 57.56 173.79 0.05 OUTLIER 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.881 1.272 . . . . 0.0 111.983 -161.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.38 -133.05 52.83 Favored Glycine 0 C--N 1.374 2.68 0 O-C-N 119.622 -1.924 . . . . 0.0 110.337 -164.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 62.0 t 55.54 75.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.22 0 C-N-CA 125.729 1.612 . . . . 0.0 111.26 172.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.56 116.59 28.99 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -173.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -102.38 -33.14 9.67 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 113.536 -1.666 . . . . 0.0 108.268 -172.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.83 83.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 164.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.35 130.77 40.53 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 121.226 0.536 . . . . 0.0 110.363 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.8 t -142.89 115.43 8.58 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.502 1.521 . . . . 0.0 107.438 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.2 84.67 0.78 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.961 -3.256 . . . . 0.0 104.961 167.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.616 0 C-N-CA 124.888 1.232 . . . . 0.0 111.285 176.184 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.19 133.76 55.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.62 161.74 27.72 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.22 130.91 73.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -138.95 151.15 46.65 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.5 m -113.85 -46.03 3.05 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.02 -49.98 8.42 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 119.221 0.919 . . . . 0.0 112.919 -166.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.63 -173.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.628 1.571 . . . . 0.0 110.455 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.445 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.77 83.86 2.23 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -166.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.7 90.69 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 109.099 159.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.65 141.12 51.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -95.49 158.45 15.45 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.19 123.08 21.38 Favored 'General case' 0 C--N 1.376 1.745 0 CA-C-N 119.805 1.184 . . . . 0.0 108.938 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.24 -10.79 73.62 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 125.867 1.699 . . . . 0.0 111.334 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.71 174.3 6.99 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-O 121.464 0.65 . . . . 0.0 111.241 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.4 m -144.43 127.03 16.06 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -159.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.433 HG13 HH11 ' B' ' 914' ' ' ARG . 15.6 m -98.35 147.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 CA-C-O 121.303 0.573 . . . . 0.0 111.397 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 23.1 t -142.76 137.86 30.05 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 126.422 1.889 . . . . 0.0 110.9 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 26.6 t -91.7 129.4 42.43 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 107.536 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.85 132.08 53.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 72.71 1.51 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 49.6 t -161.99 102.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 83.5 mmm -153.18 71.17 0.89 Allowed 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.67 146.47 7.78 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 107.571 -2.212 . . . . 0.0 107.571 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.2 -28.21 7.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 45.5 tp -92.84 86.31 5.45 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.65 -155.63 0.62 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -124.07 167.41 14.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 23.3 t -104.49 131.34 51.99 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.58 155.86 30.91 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.14 114.91 21.76 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -99.41 172.6 0.44 Allowed 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.025 1.817 . . . . 0.0 108.021 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.71 140.74 48.91 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.1 p -138.28 140.4 39.59 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 119.5 1.045 . . . . 0.0 108.49 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.66 131.21 69.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.42 106.1 9.24 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 982' ' ' SER . . . . . 0.409 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 24.9 p -99.97 160.18 14.52 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.521 1.128 . . . . 0.0 108.858 170.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.94 109.45 0.26 Allowed Glycine 0 C--N 1.356 1.643 0 C-N-CA 118.899 -1.62 . . . . 0.0 109.356 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -122.56 145.23 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 57.3 tp -72.74 126.57 30.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 124.948 1.299 . . . . 0.0 110.449 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 31.4 tp -97.45 -57.18 2.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.317 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -131.2 127.78 38.63 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -173.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 129.71 10.0 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 103.536 -3.826 . . . . 0.0 103.536 163.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.55 128.42 91.11 Favored Pre-proline 0 C--N 1.351 0.668 0 CA-C-O 117.791 -1.099 . . . . 0.0 110.342 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -106.72 82.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 122.12 1.793 . . . . 0.0 109.28 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 79.14 -70.5 0.1 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.911 3.284 . . . . 0.0 109.091 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 19.8 mt 50.08 38.91 17.98 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 128.729 2.812 . . . . 0.0 114.245 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.14 110.13 11.75 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.115 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.336 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.793 0 N-CA-C 110.175 -0.741 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.64 119.28 25.89 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.89 -19.76 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 CA-C-N 122.096 1.784 . . . . 0.0 110.102 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 36.78 71.79 0.13 Allowed 'General case' 0 C--N 1.359 1.014 0 C-N-CA 129.174 2.99 . . . . 0.0 115.388 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 75.0 t -116.85 135.32 57.58 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.43 154.37 50.81 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 163.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -150.13 141.83 23.62 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 118.536 0.607 . . . . 0.0 109.93 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 23.0 t -168.07 118.58 0.8 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.45 155.36 40.6 Favored 'General case' 0 C--N 1.368 1.405 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.1 156.13 46.02 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.743 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.34 128.33 35.44 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.467 -167.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 73.1 m -161.05 10.08 0.09 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -161.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.4 pp -27.63 146.44 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.495 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 161.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.85 -46.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 CA-C-N 122.099 1.786 . . . . 0.0 113.454 -162.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -162.28 171.16 17.73 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m 0.46 106.78 0.01 OUTLIER 'General case' 0 C--N 1.361 1.109 0 C-N-CA 131.116 3.767 . . . . 0.0 116.77 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -103.93 163.33 17.57 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 123.562 0.745 . . . . 0.0 109.316 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.7 -13.54 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.754 2.302 . . . . 0.0 111.069 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -145.35 4.47 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.9 m -65.36 139.39 58.56 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.283 1.833 . . . . 0.0 110.475 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.08 147.59 83.54 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 112.771 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -100.92 -145.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.291 2.661 . . . . 0.0 107.035 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.28 133.85 18.74 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -116.49 -16.28 10.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.501 0.72 . . . . 0.0 110.864 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -101.86 82.47 2.26 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.11 96.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 126.706 2.002 . . . . 0.0 106.511 164.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.64 -36.88 15.01 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.902 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 54.0 tp -164.06 130.3 3.08 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 100.913 -3.736 . . . . 0.0 100.913 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 175.01 60.38 0.0 OUTLIER 'General case' 0 C--N 1.356 0.865 0 CA-C-N 120.621 1.555 . . . . 0.0 107.399 -166.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.89 -44.55 95.8 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -165.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.65 -33.09 7.67 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.617 0.644 . . . . 0.0 112.212 -174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 115.86 -65.91 0.31 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 106.193 -2.763 . . . . 0.0 106.193 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 63.66 -80.52 0.03 OUTLIER 'General case' 0 C--N 1.355 0.808 0 C-N-CA 127.983 2.513 . . . . 0.0 113.598 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -94.36 120.74 35.05 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.856 1.263 . . . . 0.0 107.703 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.93 118.24 70.88 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-O 115.989 -1.958 . . . . 0.0 106.03 167.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -90.8 -4.02 4.72 Favored 'Trans proline' 0 CA--C 1.509 -0.731 0 CA-C-N 124.786 2.745 . . . . 0.0 108.795 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -79.92 -40.55 27.94 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 125.17 1.388 . . . . 0.0 108.784 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -103.8 -15.15 15.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.12 16.39 69.7 Favored Glycine 0 C--N 1.363 2.053 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 167.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.83 105.8 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 -167.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -97.28 111.67 23.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.204 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 56.3 m -101.32 109.25 21.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 170.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.69 110.51 41.98 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.491 -1.242 . . . . 0.0 111.463 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.08 -0.64 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 122.946 2.088 . . . . 0.0 108.245 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . 0.454 HD12 ' H ' ' C' ' 892' ' ' GLY . 3.7 pp -58.18 -43.55 87.57 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.333 1.453 . . . . 0.0 114.69 -166.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.72 46.71 16.84 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . 0.454 ' H ' HD12 ' C' ' 890' ' ' LEU . . . -159.03 -163.76 13.51 Favored Glycine 0 N--CA 1.417 -2.571 1 N-CA-C 101.581 -4.608 . . . . 0.0 101.581 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 46.7 ttt-85 -91.32 120.53 32.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.477 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -116.41 156.29 27.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.452 1.101 . . . . 0.0 108.798 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.9 115.52 29.96 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.581 0.752 . . . . 0.0 110.083 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 5.0 tt -116.07 136.06 53.37 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 -174.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.85 119.5 9.78 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 123.633 0.773 . . . . 0.0 109.999 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 154.75 20.94 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.2 t -105.78 122.14 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.55 122.24 41.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.28 1.032 . . . . 0.0 109.142 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 54.3 m -80.44 132.46 35.73 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 125.256 1.423 . . . . 0.0 107.997 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.06 -57.29 20.0 Favored Glycine 0 C--N 1.367 2.268 0 C-N-CA 124.819 1.199 . . . . 0.0 113.343 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 45.06 68.57 0.54 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 127.08 2.152 . . . . 0.0 114.254 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -73.14 -11.84 60.68 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.749 1.22 . . . . 0.0 112.227 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -73.13 -13.94 61.28 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.075 1.75 . . . . 0.0 112.88 -166.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.345 0.3 OUTLIER 118.26 -173.6 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 129.217 3.007 . . . . 0.0 108.398 175.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 97.24 133.44 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 128.061 2.545 . . . . 0.0 106.749 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.79 122.56 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -104.4 123.0 46.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.913 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.27 116.72 17.27 Favored 'General case' 0 C--N 1.369 1.441 0 C-N-CA 128.452 2.701 . . . . 0.0 109.434 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 97.3 t -84.0 113.95 23.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.77 148.2 43.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.021 2.129 . . . . 0.0 112.061 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.27 1.0 OUTLIER -116.34 147.07 41.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.257 1.823 . . . . 0.0 110.993 175.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 139.34 38.14 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 127.133 2.173 . . . . 0.0 108.815 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.7 t 94.74 -10.99 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.717 2.807 . . . . 0.0 112.596 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -141.44 -28.35 0.66 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.585 1.084 . . . . 0.0 111.751 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 58.38 170.7 0.06 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 124.855 1.262 . . . . 0.0 112.191 -162.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -135.52 50.16 Favored Glycine 0 C--N 1.372 2.576 0 O-C-N 119.447 -2.033 . . . . 0.0 109.997 -162.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t 56.27 76.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.248 0 C-N-CA 125.551 1.54 . . . . 0.0 111.358 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.2 115.54 28.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 37.8 ptt85 -102.38 -35.15 8.91 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.318 -172.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 93.9 t -99.56 86.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 162.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -93.93 133.54 37.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.657 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.2 t -142.21 115.47 8.91 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.675 1.59 . . . . 0.0 107.633 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.55 84.48 0.68 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 104.628 -3.389 . . . . 0.0 104.628 165.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 111.028 175.456 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 60.8 mt -120.21 133.68 55.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.22 162.38 27.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.61 130.6 74.34 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -138.07 146.44 42.94 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.4 m -107.55 -58.29 1.98 Allowed 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.028 0.377 . . . . 0.0 112.015 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.409 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 41.1 tp -77.62 -49.03 15.42 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -165.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 8.0 pt -84.84 -172.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 125.552 1.541 . . . . 0.0 110.274 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.477 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -159.61 92.04 1.81 Allowed Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -167.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.59 91.41 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 O-C-N 117.384 -1.956 . . . . 0.0 108.403 155.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.32 145.43 47.12 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -90.86 162.23 14.9 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.46 126.61 30.26 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 120.257 -1.527 . . . . 0.0 107.116 163.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.37 -1.13 64.14 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -54.65 167.93 0.32 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.574 1.549 . . . . 0.0 114.972 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.7 121.75 11.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.44 147.73 7.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -143.99 137.79 27.96 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.714 1.206 . . . . 0.0 112.059 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.14 129.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 126.929 2.092 . . . . 0.0 107.96 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.59 133.39 52.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.54 77.5 1.79 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 112.953 -1.93 . . . . 0.0 107.587 172.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 61.2 t -159.59 100.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -153.12 66.24 0.78 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 132.08 147.07 5.82 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -116.75 -16.68 10.64 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.312 0.645 . . . . 0.0 110.059 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -104.61 82.79 1.95 Allowed 'General case' 0 C--N 1.356 0.858 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.6 -167.19 2.02 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -171.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -119.94 155.06 33.51 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.6 t -93.29 132.13 37.78 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.27 151.6 23.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.91 113.7 29.94 Favored Pre-proline 0 C--N 1.355 0.814 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 172.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.0 174.81 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 122.26 1.973 . . . . 0.0 107.804 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.49 141.15 48.45 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.4 p -135.02 140.95 46.04 Favored 'General case' 0 C--N 1.374 1.67 0 CA-C-N 119.206 0.912 . . . . 0.0 108.893 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.3 mm -115.69 131.13 69.0 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -127.1 105.52 8.63 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 29.3 p -100.09 160.12 14.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.499 1.12 . . . . 0.0 109.125 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.86 108.61 0.25 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.23 145.28 45.12 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.42 126.65 30.37 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 125.015 1.326 . . . . 0.0 110.684 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 36.4 tp -98.23 -58.26 2.02 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.651 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -133.13 128.52 36.28 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.407 1.883 . . . . 0.0 106.783 -172.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.77 129.38 9.88 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 103.988 -3.645 . . . . 0.0 103.988 160.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.05 130.05 90.18 Favored Pre-proline 0 C--N 1.35 0.606 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.343 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -106.83 84.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 121.874 1.705 . . . . 0.0 109.518 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.86 -70.84 0.1 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 130.131 3.372 . . . . 0.0 109.494 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 54.0 mt 49.71 40.1 19.22 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 128.867 2.867 . . . . 0.0 113.983 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -115.14 132.48 56.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -130.49 110.53 11.52 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.219 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.758 0 N-CA-C 110.073 -0.78 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.38 120.67 24.9 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -91.11 -21.44 0.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.201 1.822 . . . . 0.0 109.585 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 34.91 71.75 0.11 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 129.258 3.023 . . . . 0.0 115.506 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.03 136.84 53.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.743 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.56 155.74 49.99 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 164.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -149.13 138.62 21.69 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.0 t -169.12 117.18 0.64 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.08 153.84 39.37 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.66 155.4 49.18 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.988 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.13 128.82 42.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -165.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 50.8 p -161.05 14.15 0.1 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -161.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 3.6 pp -20.95 143.26 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.382 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 159.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.05 -40.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 121.971 1.74 . . . . 0.0 112.481 -162.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 38.6 ptt85 -164.19 176.29 9.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 21.7 m -16.97 119.3 0.02 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 130.129 3.372 . . . . 0.0 115.481 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -119.12 147.18 42.2 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -162.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.13 -10.0 19.31 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.523 2.149 . . . . 0.0 112.695 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.5 -143.3 3.62 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 120.338 1.427 . . . . 0.0 111.265 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 32.9 m -82.68 146.82 28.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.206 1.802 . . . . 0.0 108.3 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.11 138.74 97.41 Favored Pre-proline 0 C--N 1.356 0.854 0 C-N-CA 125.491 1.517 . . . . 0.0 113.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -98.9 -149.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.805 3.003 . . . . 0.0 106.233 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -151.49 131.33 13.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -118.08 -15.02 9.92 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.947 -0.47 . . . . 0.0 111.149 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.81 85.4 2.88 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.911 -0.493 . . . . 0.0 112.005 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.52 98.64 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 126.505 1.922 . . . . 0.0 106.916 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 27.8 mt -87.64 -37.38 16.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.008 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.13 129.45 2.06 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 101.398 -3.556 . . . . 0.0 101.398 162.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -175.8 61.8 0.02 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 120.809 1.64 . . . . 0.0 109.814 -167.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -58.84 -44.78 91.03 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -166.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.08 -31.84 8.26 Favored Glycine 0 C--N 1.354 1.579 0 CA-C-N 118.949 0.795 . . . . 0.0 112.334 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.34 -58.87 0.39 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 63.58 -81.7 0.03 OUTLIER 'General case' 0 C--N 1.355 0.828 0 C-N-CA 128.204 2.602 . . . . 0.0 114.053 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -97.05 119.99 36.56 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.775 1.23 . . . . 0.0 108.35 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -78.84 117.54 67.28 Favored Pre-proline 0 N--CA 1.444 -0.756 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -92.84 2.58 3.63 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.411 2.968 . . . . 0.0 109.451 -166.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -80.74 -45.68 16.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 28.2 p -106.3 -12.89 15.55 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 109.055 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.63 38.46 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.02 103.57 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 -165.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.417 ' HB3' HG23 ' A' ' 962' ' ' VAL . 0.4 OUTLIER -101.62 112.24 24.74 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.922 -175.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 87.5 m -100.66 107.97 19.73 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.78 109.92 38.02 Favored Pre-proline 0 C--N 1.355 0.837 0 CA-C-O 117.23 -1.366 . . . . 0.0 110.916 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.12 -2.44 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.845 2.364 . . . . 0.0 108.86 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.47 -57.58 4.0 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 130.329 3.452 . . . . 0.0 114.771 -169.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.99 64.83 1.32 Allowed 'General case' 0 C--N 1.364 1.215 0 CA-C-O 121.759 0.79 . . . . 0.0 112.819 171.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.06 -166.75 32.66 Favored Glycine 0 N--CA 1.41 -3.046 1 N-CA-C 101.467 -4.653 . . . . 0.0 101.467 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -91.75 122.56 34.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.279 -0.96 . . . . 0.0 108.785 172.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . 0.528 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.2 t80 -115.3 145.73 42.19 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.14 115.69 30.19 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.391 0.676 . . . . 0.0 109.315 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.78 139.48 49.09 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.075 1.75 . . . . 0.0 108.843 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 70.1 m -144.12 119.58 10.32 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 123.363 0.665 . . . . 0.0 109.716 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.22 21.55 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.3 t -104.92 121.26 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.76 123.25 43.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.292 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 43.4 m -84.07 131.76 34.77 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 125.657 1.583 . . . . 0.0 106.936 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.56 17.85 Favored Glycine 0 C--N 1.363 2.057 0 C-N-CA 124.595 1.093 . . . . 0.0 113.53 -168.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 56.4 m170 39.39 71.44 0.17 Allowed 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.12 2.168 . . . . 0.0 114.626 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -70.87 -10.54 59.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.936 1.694 . . . . 0.0 111.957 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -73.33 -17.92 61.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.578 1.551 . . . . 0.0 112.746 -168.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.326 12.2 pt-20 124.52 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.603 2.361 . . . . 0.0 108.223 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.4 tttt 100.64 132.34 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 128.129 2.571 . . . . 0.0 107.163 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.32 124.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -108.02 123.62 48.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.163 1.785 . . . . 0.0 112.11 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.57 115.09 14.29 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.121 2.569 . . . . 0.0 109.553 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 90.8 t -87.66 113.77 25.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.578 1.951 . . . . 0.0 111.452 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER -114.44 147.28 39.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 126.671 1.988 . . . . 0.0 109.787 178.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.505 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -79.79 140.79 36.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 125.728 1.611 . . . . 0.0 110.0 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.329 24.2 p 92.61 3.86 0.07 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 129.856 3.262 . . . . 0.0 114.227 173.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -148.24 -26.18 0.34 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 119.309 0.959 . . . . 0.0 111.065 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.51 168.17 0.05 Allowed 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.729 1.612 . . . . 0.0 111.835 -162.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.86 -135.0 49.31 Favored Glycine 0 C--N 1.369 2.396 0 O-C-N 119.615 -1.928 . . . . 0.0 109.233 -161.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 41.2 t 55.96 79.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 125.952 1.701 . . . . 0.0 110.992 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.52 113.99 26.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 24.1 ptt85 -103.73 -37.1 7.62 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.014 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -99.27 87.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 166.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.06 130.43 41.74 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.688 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -143.56 115.08 8.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.353 1.461 . . . . 0.0 108.129 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.3 84.7 0.7 Allowed Glycine 0 CA--C 1.484 -1.865 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 165.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 C-N-CA 124.925 1.25 . . . . 0.0 111.302 173.741 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 61.1 mt -116.47 133.84 55.55 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -135.37 161.32 24.67 Favored Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.31 126.77 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -138.84 149.56 45.05 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 71.2 m -106.65 -54.36 2.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.456 0.302 . . . . 0.0 110.908 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.467 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 17.7 tp -83.02 -49.9 9.08 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -162.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.52 -175.97 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.381 1.472 . . . . 0.0 110.687 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.528 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -159.33 93.04 1.82 Allowed Pre-proline 0 N--CA 1.44 -0.949 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -164.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.3 92.31 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 O-C-N 116.869 -2.227 . . . . 0.0 110.152 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.85 138.93 53.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -93.21 158.03 15.97 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.843 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.98 123.11 21.28 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 119.896 1.225 . . . . 0.0 108.997 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.13 73.02 Favored Glycine 0 C--N 1.345 1.071 0 C-N-CA 126.541 2.019 . . . . 0.0 111.851 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -73.17 174.96 7.23 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.359 1.064 . . . . 0.0 110.521 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 89.7 m -142.84 125.12 15.49 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 108.821 -160.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.505 HG13 HH11 ' A' ' 914' ' ' ARG . 30.7 m -95.43 149.83 4.43 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-O 121.445 0.64 . . . . 0.0 109.627 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -141.39 138.93 33.34 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.234 1.814 . . . . 0.0 111.414 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 98.6 t -92.05 129.18 43.09 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 C-N-CA 126.484 1.914 . . . . 0.0 106.268 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.05 132.34 53.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.89 78.09 1.83 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 51.3 t -160.98 100.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.973 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -154.32 66.59 0.7 Allowed 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.16 146.89 6.91 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -114.08 -31.89 6.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -90.58 86.97 6.55 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.89 -167.18 2.1 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -122.98 157.62 32.26 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 15.7 t -91.6 133.9 35.14 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.66 151.58 22.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.52 111.16 19.24 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -98.58 173.23 0.51 Allowed 'Trans proline' 0 CA--C 1.507 -0.874 0 C-N-CA 121.742 1.628 . . . . 0.0 108.317 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.58 141.03 48.72 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 24.3 p -138.78 139.71 38.36 Favored 'General case' 0 C--N 1.374 1.66 0 CA-C-N 119.302 0.956 . . . . 0.0 108.513 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.0 mm -118.17 130.25 73.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.21 106.48 9.58 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 37.4 p -99.96 160.81 14.03 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 124.465 1.106 . . . . 0.0 109.678 171.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.97 109.49 0.27 Allowed Glycine 0 C--N 1.358 1.754 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.379 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.94 147.75 43.69 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 54.3 tp -72.43 123.29 22.79 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 126.092 1.757 . . . . 0.0 109.146 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.02 -58.0 2.01 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -133.23 127.44 33.72 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 127.053 2.141 . . . . 0.0 106.383 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.79 129.73 10.0 Favored Glycine 0 CA--C 1.496 -1.144 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 161.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -69.03 131.35 90.83 Favored Pre-proline 0 C--N 1.353 0.744 0 CA-C-N 118.435 1.118 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -105.76 82.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.68 1.636 . . . . 0.0 109.468 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.91 -72.73 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.205 3.402 . . . . 0.0 109.19 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 81.2 mt 50.87 37.68 17.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.377 3.071 . . . . 0.0 114.098 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.54 134.1 52.69 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.96 107.95 8.61 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -178.633 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 110.055 -0.787 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.03 121.01 25.38 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.63 -21.73 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 122.139 1.8 . . . . 0.0 109.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 35.46 71.97 0.11 Allowed 'General case' 0 C--N 1.361 1.079 0 C-N-CA 129.611 3.164 . . . . 0.0 115.127 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.72 136.3 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.6 155.5 50.36 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -149.54 139.79 22.23 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 26.6 t -169.11 117.8 0.66 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.51 154.28 36.85 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.29 155.4 47.76 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.905 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.59 127.72 39.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -165.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 51.3 p -160.9 13.8 0.1 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.233 -161.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.6 pp -20.82 143.45 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.456 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 158.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.35 -40.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.98 1.743 . . . . 0.0 112.48 -163.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -164.29 176.31 9.26 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 21.2 m -16.98 119.33 0.02 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.156 3.382 . . . . 0.0 115.451 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.2 147.37 42.77 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -162.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -76.27 -9.87 19.08 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.533 2.155 . . . . 0.0 112.695 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.59 -143.58 3.7 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 120.287 1.403 . . . . 0.0 111.262 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 33.0 m -81.92 147.04 29.48 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.234 1.814 . . . . 0.0 108.326 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 17.4 m -63.08 138.46 97.33 Favored Pre-proline 0 C--N 1.355 0.841 0 C-N-CA 125.413 1.485 . . . . 0.0 113.192 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -99.62 -150.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.723 2.949 . . . . 0.0 106.121 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -150.88 130.71 13.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -116.47 -14.49 10.94 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.427 0.691 . . . . 0.0 110.363 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -101.31 84.07 2.57 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 122.038 -0.414 . . . . 0.0 111.842 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.83 97.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 126.438 1.895 . . . . 0.0 106.461 166.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 12.6 mt -87.98 -38.03 15.87 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.714 -173.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.3 tp -165.3 129.3 2.34 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 101.266 -3.605 . . . . 0.0 101.266 165.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 179.03 62.2 0.01 OUTLIER 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.447 1.476 . . . . 0.0 109.214 -164.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -59.08 -44.54 91.9 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -167.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.88 -32.06 8.22 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 118.768 0.713 . . . . 0.0 112.242 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.16 -58.67 0.39 Allowed Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 63.8 -82.08 0.03 OUTLIER 'General case' 0 C--N 1.356 0.862 0 C-N-CA 128.13 2.572 . . . . 0.0 114.062 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.61 119.82 36.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 125.173 1.389 . . . . 0.0 108.308 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.27 117.92 69.09 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-O 115.459 -2.21 . . . . 0.0 105.309 171.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -91.79 2.31 4.24 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 125.507 3.002 . . . . 0.0 109.671 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -80.41 -44.53 19.19 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.606 1.163 . . . . 0.0 108.704 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 26.8 p -108.59 -13.19 14.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.085 1.354 . . . . 0.0 108.651 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.02 36.15 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 163.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 26.2 t -100.24 103.83 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.605 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 -164.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.404 ' HB3' HG23 ' B' ' 962' ' ' VAL . 0.4 OUTLIER -101.23 112.46 24.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.586 -2.097 . . . . 0.0 108.973 -176.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 88.7 m -100.79 108.13 19.86 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.96 110.13 39.87 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.138 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.95 -1.04 5.66 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.767 2.311 . . . . 0.0 108.843 165.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 129.832 3.253 . . . . 0.0 114.87 -169.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.45 58.93 2.78 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -170.23 -165.08 27.03 Favored Glycine 0 N--CA 1.412 -2.933 1 N-CA-C 102.461 -4.255 . . . . 0.0 102.461 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -92.08 121.87 34.04 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.777 -1.211 . . . . 0.0 107.868 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . 0.46 ' H ' HD11 ' B' ' 954' ' ' LEU . 1.7 t80 -116.79 146.43 42.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -173.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.8 tp -111.51 114.86 28.24 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -113.35 139.37 48.92 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.28 1.832 . . . . 0.0 108.539 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -143.79 119.74 10.65 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.194 0.598 . . . . 0.0 109.703 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.58 21.01 Favored 'General case' 0 C--N 1.364 1.224 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.49 122.02 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.4 121.81 43.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.145 0.978 . . . . 0.0 109.19 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 40.1 m -82.66 132.0 35.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.646 1.578 . . . . 0.0 107.541 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.29 -57.72 17.68 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 124.758 1.171 . . . . 0.0 113.793 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 38.63 71.74 0.15 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 127.234 2.214 . . . . 0.0 114.774 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -71.0 -10.67 60.16 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.046 1.738 . . . . 0.0 112.043 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -73.82 -15.59 61.17 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.86 1.664 . . . . 0.0 112.908 -167.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.2 pt-20 122.1 179.4 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.856 2.462 . . . . 0.0 108.107 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 101.34 131.87 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 128.074 2.55 . . . . 0.0 107.088 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.26 126.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -110.69 122.85 48.82 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.966 -1.47 . . . . 0.0 113.093 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.81 115.74 15.67 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.842 2.457 . . . . 0.0 109.596 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 76.9 t -88.48 113.88 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 148.53 43.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.093 2.157 . . . . 0.0 111.493 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.275 0.8 OUTLIER -114.6 147.9 38.85 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 126.955 2.102 . . . . 0.0 109.715 178.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.521 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.73 140.13 35.73 Favored 'General case' 0 N--CA 1.424 -1.775 0 C-N-CA 125.652 1.581 . . . . 0.0 109.718 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.327 24.0 p 92.81 1.64 0.09 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 129.85 3.26 . . . . 0.0 114.363 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -147.28 -25.98 0.39 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-N 119.527 1.058 . . . . 0.0 111.408 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.55 168.01 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 125.678 1.591 . . . . 0.0 111.692 -162.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.61 -134.54 47.39 Favored Glycine 0 C--N 1.367 2.266 0 O-C-N 119.757 -1.839 . . . . 0.0 109.142 -163.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 44.6 t 54.49 80.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 126.314 1.846 . . . . 0.0 111.008 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.28 114.2 26.67 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -103.97 -38.22 7.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 113.298 -1.774 . . . . 0.0 108.757 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.55 87.01 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.615 -3.105 . . . . 0.0 102.615 166.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.4 130.48 42.19 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.0 t -142.43 115.77 8.99 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.038 1.335 . . . . 0.0 107.813 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.19 84.58 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 103.921 -3.672 . . . . 0.0 103.921 165.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 C-N-CA 125.172 1.367 . . . . 0.0 111.289 174.209 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 62.9 mt -116.95 134.27 54.96 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.62 26.98 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.01 128.83 75.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -138.1 151.51 47.86 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 68.7 m -117.24 -38.04 3.43 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.126 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.35 -53.61 4.27 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.071 0.85 . . . . 0.0 111.947 -168.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.22 177.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.85 1.26 . . . . 0.0 109.858 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.46 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -161.08 95.13 1.41 Allowed Pre-proline 0 C--N 1.358 0.954 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -163.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.88 95.74 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.945 2.43 . . . . 0.0 111.181 161.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 9.5 mp -119.77 139.85 51.67 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -93.92 159.15 15.31 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.841 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.82 122.95 21.61 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 120.058 1.299 . . . . 0.0 108.983 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.1 -11.51 71.94 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.413 1.959 . . . . 0.0 111.681 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -73.44 174.56 8.01 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.321 1.048 . . . . 0.0 109.993 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 94.0 m -143.09 125.06 15.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -158.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.521 HG13 HH11 ' B' ' 914' ' ' ARG . 27.9 m -96.37 150.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 121.567 0.698 . . . . 0.0 110.244 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -140.95 139.02 34.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.518 1.927 . . . . 0.0 111.44 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.2 t -91.63 129.53 42.18 Favored 'Isoleucine or valine' 0 C--N 1.367 1.354 0 C-N-CA 127.261 2.224 . . . . 0.0 106.516 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.79 132.36 52.85 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.59 77.63 1.8 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 50.2 t -160.2 101.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -153.48 66.38 0.76 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.63 145.66 6.52 Favored Glycine 0 CA--C 1.492 -1.383 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -112.87 -30.92 6.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.5 86.76 6.15 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.64 -165.76 1.83 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -123.51 157.84 32.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 16.4 t -91.43 133.22 35.66 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.64 151.66 22.48 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.43 110.78 19.37 Favored Pre-proline 0 C--N 1.353 0.753 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -98.13 173.09 0.58 Allowed 'Trans proline' 0 CA--C 1.507 -0.836 0 C-N-CA 121.812 1.675 . . . . 0.0 108.172 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.51 139.28 50.21 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.8 p -138.02 138.13 38.54 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.5 mm -117.24 130.71 71.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -127.05 106.32 9.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 982' ' ' SER . . . . . 0.442 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 32.7 p -100.63 160.94 13.94 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.494 1.117 . . . . 0.0 109.771 171.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.21 109.55 0.27 Allowed Glycine 0 C--N 1.358 1.781 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.82 149.62 41.77 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.85 124.14 24.19 Favored 'General case' 0 C--N 1.378 1.836 0 C-N-CA 125.841 1.656 . . . . 0.0 109.718 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.33 -59.06 1.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -133.33 127.22 33.07 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 125.916 1.686 . . . . 0.0 106.489 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.81 130.05 10.11 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 104.311 -3.516 . . . . 0.0 104.311 161.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.12 131.27 90.71 Favored Pre-proline 0 C--N 1.351 0.652 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.205 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -105.48 81.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 121.695 1.641 . . . . 0.0 109.054 -170.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.31 -72.23 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 130.191 3.396 . . . . 0.0 109.139 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 80.1 mt 49.95 40.89 22.09 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 129.126 2.97 . . . . 0.0 113.785 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.96 133.54 55.41 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -133.34 107.78 8.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.13 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.767 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.76 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.51 114.92 29.99 Favored Pre-proline 0 N--CA 1.44 -0.943 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.24 -24.97 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 121.689 1.639 . . . . 0.0 109.826 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 41.55 66.5 0.68 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 128.192 2.597 . . . . 0.0 114.868 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.86 133.74 66.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.01 50.85 Favored 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 166.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.83 139.55 21.73 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 118.886 0.766 . . . . 0.0 109.82 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 22.7 t -169.44 120.2 0.69 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.25 -0.906 . . . . 0.0 108.8 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.51 153.05 34.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.08 158.08 44.82 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 121.685 0.755 . . . . 0.0 110.493 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -139.89 130.55 25.79 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -164.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 60.1 m -159.02 15.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.0 pp -25.8 142.79 0.04 OUTLIER Pre-proline 0 C--N 1.372 1.546 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 161.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.84 -44.05 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 CA-C-N 122.222 1.829 . . . . 0.0 113.529 -161.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -162.47 175.72 11.2 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 13.1 m -4.63 113.06 0.01 OUTLIER 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.673 3.589 . . . . 0.0 116.774 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 160.91 24.37 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.4 -17.75 7.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.418 2.079 . . . . 0.0 110.533 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -141.29 3.12 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 11.8 m -65.53 143.31 57.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.029 1.732 . . . . 0.0 110.061 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.75 132.65 25.71 Favored Pre-proline 0 N--CA 1.437 -1.098 0 C-N-CA 124.37 1.068 . . . . 0.0 110.447 -159.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.37 -151.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 124.135 3.223 . . . . 0.0 109.334 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -147.1 136.12 22.37 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -114.76 -17.78 11.52 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.669 0.788 . . . . 0.0 110.9 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -102.48 84.43 2.44 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.166 0.508 . . . . 0.0 111.125 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.68 98.22 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 126.699 1.999 . . . . 0.0 106.868 167.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.81 -39.43 17.09 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.967 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.9 tp -166.96 128.98 1.7 Allowed 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 100.598 -3.853 . . . . 0.0 100.598 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 178.71 61.91 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 108.333 -164.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.1 -44.42 94.84 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.26 -29.67 11.02 Favored Glycine 0 C--N 1.356 1.661 0 CA-C-N 118.716 0.689 . . . . 0.0 112.165 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.17 -57.76 0.42 Allowed Glycine 0 C--N 1.353 1.521 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 62.91 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.245 2.618 . . . . 0.0 113.982 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -97.53 120.64 38.28 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 125.861 1.665 . . . . 0.0 108.677 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.97 117.87 69.93 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -93.36 5.96 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 124.91 2.789 . . . . 0.0 109.887 -167.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 -46.07 17.8 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -105.67 -13.14 15.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.877 1.271 . . . . 0.0 108.327 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.98 43.63 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 162.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 70.0 t -99.53 104.22 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 102.05 -3.315 . . . . 0.0 102.05 -164.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -98.53 112.37 24.43 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 111.921 -2.4 . . . . 0.0 109.233 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 90.7 m -100.32 109.24 21.43 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.82 108.86 30.7 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.262 -1.352 . . . . 0.0 110.968 171.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -90.11 -3.86 5.28 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.528 2.152 . . . . 0.0 108.43 166.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 68.4 mt -54.51 -52.29 62.44 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 127.736 2.414 . . . . 0.0 114.418 -165.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.58 68.15 0.82 Allowed 'General case' 0 C--N 1.367 1.328 0 CA-C-O 122.076 0.941 . . . . 0.0 111.61 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.88 -167.55 34.95 Favored Glycine 0 N--CA 1.405 -3.433 1 N-CA-C 102.498 -4.241 . . . . 0.0 102.498 -171.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -92.03 121.21 33.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.275 -1.463 . . . . 0.0 108.643 172.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.537 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -117.78 145.61 44.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 51.6 tp -110.14 113.84 26.86 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . 0.416 HD12 ' HH ' ' C' ' 894' ' ' TYR . 8.8 tt -112.0 137.61 49.77 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.318 1.447 . . . . 0.0 108.925 -175.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.8 m -144.29 119.27 10.0 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.398 0.679 . . . . 0.0 109.919 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.15 153.74 22.73 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 91.1 t -101.7 122.64 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.59 121.87 40.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.026 0.93 . . . . 0.0 109.355 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.9 130.56 35.39 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -54.82 -56.84 20.71 Favored Glycine 0 C--N 1.366 2.247 0 C-N-CA 125.356 1.455 . . . . 0.0 113.354 -172.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 42.3 65.67 0.86 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.633 2.373 . . . . 0.0 114.181 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.39 -7.24 50.83 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 125.076 1.35 . . . . 0.0 112.178 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -71.38 -14.09 62.06 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.235 1.814 . . . . 0.0 112.187 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.338 6.1 pt-20 113.73 179.53 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.108 2.563 . . . . 0.0 108.051 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 109.42 137.46 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 128.56 2.744 . . . . 0.0 105.856 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 97.8 t -98.4 123.64 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -103.67 131.68 50.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.361 172.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.05 114.22 3.64 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.095 1.358 . . . . 0.0 110.519 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.27 117.74 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 125.867 1.667 . . . . 0.0 108.999 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.6 mt -62.53 143.5 57.12 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.74 1.616 . . . . 0.0 110.519 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 1.4 p -113.78 147.79 37.68 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.627 1.971 . . . . 0.0 107.795 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 137.35 37.73 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.891 173.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 2.9 t 97.93 -11.48 0.06 Allowed 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 128.797 2.839 . . . . 0.0 112.341 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.86 -27.63 0.58 Allowed 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 119.256 0.934 . . . . 0.0 111.501 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 59.04 169.09 0.06 Allowed 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.933 1.293 . . . . 0.0 112.254 -164.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.84 -130.74 51.46 Favored Glycine 0 C--N 1.376 2.79 0 O-C-N 119.702 -1.874 . . . . 0.0 110.12 -164.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 51.97 73.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.329 0 C-N-CA 126.191 1.797 . . . . 0.0 111.37 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.82 28.37 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -101.18 -30.89 11.3 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.518 -173.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.18 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 165.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -95.22 131.23 41.51 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 120.903 0.382 . . . . 0.0 111.184 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.2 t -143.88 115.07 7.93 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 125.283 1.433 . . . . 0.0 107.812 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.17 85.02 0.72 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 104.281 -3.528 . . . . 0.0 104.281 169.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.602 0 C-N-CA 125.183 1.373 . . . . 0.0 110.892 173.557 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.6 mt -122.46 134.56 54.58 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.93 163.31 27.0 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.76 132.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.46 149.81 47.12 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -121.33 -36.99 2.98 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 118.398 0.544 . . . . 0.0 111.802 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.442 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 29.0 tp -89.47 -53.77 4.39 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.533 0.606 . . . . 0.0 112.045 -165.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 25.4 pt -89.83 -162.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.846 0 C-N-CA 125.079 1.352 . . . . 0.0 108.871 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.537 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -165.26 88.15 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -166.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.94 88.18 1.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 122.422 1.901 . . . . 0.0 109.133 159.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.8 146.18 48.53 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.479 2.312 . . . . 0.0 105.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -92.71 159.98 15.18 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 119.213 0.915 . . . . 0.0 109.381 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.72 122.66 21.86 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 120.335 1.425 . . . . 0.0 108.954 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.75 71.34 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 125.95 1.738 . . . . 0.0 111.042 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.99 175.44 5.14 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.088 0.555 . . . . 0.0 111.075 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 17.1 p -141.83 127.96 19.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -157.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 17.1 m -93.41 150.19 4.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.8 t -139.72 136.5 34.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.882 1.273 . . . . 0.0 112.089 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.95 129.08 44.8 Favored 'Isoleucine or valine' 0 C--N 1.373 1.603 0 C-N-CA 126.486 1.914 . . . . 0.0 106.753 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.61 132.37 53.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 171.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.41 78.52 1.83 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.04 -1.891 . . . . 0.0 106.185 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -160.8 100.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.887 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 89.3 mmm -152.16 66.23 0.84 Allowed 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.79 143.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -112.8 -22.37 10.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.462 0.705 . . . . 0.0 109.982 -172.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 6.5 tt -98.6 86.23 3.53 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.74 -164.62 1.64 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -121.66 153.18 38.48 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 20.1 t -89.96 132.2 35.46 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -157.93 151.28 23.36 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.45 115.34 19.74 Favored Pre-proline 0 C--N 1.355 0.823 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.32 171.67 0.38 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.98 138.87 49.2 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.9 p -137.33 137.55 39.04 Favored 'General case' 0 C--N 1.376 1.746 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.0 mm -115.43 131.04 68.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.26 106.38 9.83 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 982' ' ' SER . . . . . 0.467 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 32.7 p -100.91 163.94 12.06 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.16 1.384 . . . . 0.0 110.222 172.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.91 111.19 0.32 Allowed Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.08 47.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 58.0 tp -78.18 124.42 28.05 Favored 'General case' 0 C--N 1.379 1.88 0 C-N-CA 124.516 1.126 . . . . 0.0 108.135 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 35.1 tp -97.1 -57.2 2.33 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.056 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -131.18 128.49 40.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 -174.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 131.05 10.51 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 103.412 -3.875 . . . . 0.0 103.412 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.41 131.93 88.03 Favored Pre-proline 0 C--N 1.351 0.645 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -105.84 81.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.427 0 CA-C-N 121.903 1.715 . . . . 0.0 109.847 -171.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 78.79 -72.12 0.09 Allowed 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 130.231 3.413 . . . . 0.0 109.171 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.7 mt 51.19 39.88 24.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 129.209 3.004 . . . . 0.0 113.787 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -112.62 133.49 54.64 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.86 107.86 8.59 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.453 -0.9 0 N-CA-C 110.232 -0.719 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 43.8 t -127.85 120.87 21.76 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.12 -22.23 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 122.032 1.762 . . . . 0.0 109.496 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 36.81 69.9 0.19 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.045 2.938 . . . . 0.0 115.607 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.63 136.21 56.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 160.63 37.71 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.23 139.76 22.51 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.6 t -169.27 116.56 0.61 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.61 153.02 36.11 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.02 158.54 44.22 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.21 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.81 134.72 41.14 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -167.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 40.6 p -164.25 10.1 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -163.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 2.1 pp -28.62 144.76 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.51 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 160.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -79.07 -47.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 122.324 1.866 . . . . 0.0 112.875 -162.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -162.2 170.55 18.86 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.6 m 4.03 104.05 0.0 OUTLIER 'General case' 0 C--N 1.36 1.058 0 C-N-CA 130.848 3.659 . . . . 0.0 117.463 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -96.46 163.57 20.25 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 123.174 0.59 . . . . 0.0 110.25 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.54 -14.61 12.8 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.662 2.241 . . . . 0.0 110.768 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -168.25 -142.5 3.51 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -63.83 144.46 57.03 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.714 2.006 . . . . 0.0 110.864 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 55.2 t -95.12 131.51 29.92 Favored Pre-proline 0 N--CA 1.439 -0.989 0 C-N-CA 124.841 1.256 . . . . 0.0 110.705 -162.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -95.84 -148.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.199 3.266 . . . . 0.0 108.464 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -149.65 136.86 19.79 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 41.6 p-10 -117.24 -15.61 10.41 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.909 0.484 . . . . 0.0 111.98 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -100.78 86.73 3.15 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 118.665 0.666 . . . . 0.0 112.723 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 874' ' ' ASN . 62.1 t -70.56 97.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.059 1.743 . . . . 0.0 107.123 167.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 48.0 mt -87.92 -36.46 17.12 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.969 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.6 tp -165.16 126.87 2.07 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 160.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.422 ' HB3' HG13 ' A' ' 871' ' ' VAL . 35.3 t-20 -174.88 61.86 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 120.528 1.513 . . . . 0.0 109.387 -168.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.8 -44.43 86.31 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -164.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.22 -30.6 8.61 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.946 0.793 . . . . 0.0 112.38 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.29 -60.76 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.86 -79.18 0.03 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.084 2.554 . . . . 0.0 114.111 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -95.8 120.1 35.48 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.154 1.382 . . . . 0.0 108.296 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.68 116.41 62.9 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -94.59 5.05 2.56 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 CA-C-N 125.204 2.894 . . . . 0.0 108.961 -165.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -79.82 -46.13 17.48 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 27.3 p -106.11 -12.15 15.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.902 172.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.34 25.88 41.91 Favored Glycine 0 C--N 1.362 2.015 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 163.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 44.9 t -101.36 102.83 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 100.481 -3.896 . . . . 0.0 100.481 -163.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 114.48 27.55 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 110.924 -2.853 . . . . 0.0 108.941 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 81.5 m -99.1 109.8 22.47 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.75 110.02 36.52 Favored Pre-proline 0 C--N 1.356 0.851 0 C-N-CA 125.591 1.556 . . . . 0.0 112.875 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -98.29 -8.38 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 CA-C-N 123.195 2.177 . . . . 0.0 108.653 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 26.3 mt -44.51 -58.99 2.66 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 129.963 3.305 . . . . 0.0 114.546 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.09 64.12 1.59 Allowed 'General case' 0 C--N 1.364 1.214 0 CA-C-O 121.839 0.828 . . . . 0.0 111.912 172.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.66 -174.35 39.84 Favored Glycine 0 N--CA 1.409 -3.113 1 N-CA-C 101.364 -4.694 . . . . 0.0 101.364 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -93.34 121.84 35.14 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.253 2.6 p90 -114.04 159.92 19.45 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-N 119.0 0.818 . . . . 0.0 108.936 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.82 117.8 34.95 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.759 0.824 . . . . 0.0 110.061 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.4 tt -111.17 136.54 50.09 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 126.659 1.984 . . . . 0.0 108.997 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 73.1 m -147.01 118.93 8.13 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 153.84 22.05 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.4 t -109.44 118.86 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.28 124.87 44.72 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.41 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 39.5 m -81.38 131.68 35.3 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 125.251 1.42 . . . . 0.0 107.337 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.88 -57.44 19.87 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.161 1.363 . . . . 0.0 114.066 -169.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 66.5 m170 38.15 73.01 0.11 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.13 2.172 . . . . 0.0 115.153 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -71.16 -12.84 61.71 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.784 1.634 . . . . 0.0 111.719 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -73.55 -19.99 60.75 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.299 1.439 . . . . 0.0 112.375 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.324 13.2 pt-20 125.98 -178.21 0.0 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 127.458 2.303 . . . . 0.0 108.261 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 100.72 131.19 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.074 2.549 . . . . 0.0 106.799 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.38 126.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -108.25 123.37 48.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.16 172.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.47 116.92 15.68 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 128.996 2.918 . . . . 0.0 109.892 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 99.4 t -87.91 113.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.0 141.6 57.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 126.142 1.777 . . . . 0.0 110.563 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.4 t -116.98 145.87 43.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 125.218 1.407 . . . . 0.0 111.734 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.451 ' HG3' ' HB3' ' A' ' 960' ' ' ASP . 0.0 OUTLIER -79.68 142.71 35.27 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 129.19 2.996 . . . . 0.0 111.052 -175.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 83.86 12.28 0.38 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 128.714 2.806 . . . . 0.0 112.336 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -151.79 -26.72 0.19 Allowed 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.281 -0.887 . . . . 0.0 110.628 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 57.9 167.05 0.04 OUTLIER 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.753 1.621 . . . . 0.0 112.174 -163.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.65 -134.03 49.78 Favored Glycine 0 C--N 1.372 2.556 0 O-C-N 119.217 -2.177 . . . . 0.0 109.742 -161.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 52.8 t 57.79 75.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.313 0 C-N-CA 125.79 1.636 . . . . 0.0 110.651 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.49 114.31 26.83 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -102.33 -35.17 8.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.448 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.6 83.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.728 -3.064 . . . . 0.0 102.728 167.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.59 129.36 43.99 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 121.201 0.524 . . . . 0.0 109.763 -171.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 29.7 t -143.27 115.92 8.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.506 1.523 . . . . 0.0 107.906 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.83 84.68 0.73 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 103.632 -3.787 . . . . 0.0 103.632 163.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.689 0 C-N-CA 126.24 1.876 . . . . 0.0 111.524 172.71 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.49 133.33 55.95 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.64 163.23 25.83 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -172.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 14.5 m -124.62 131.07 73.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -136.86 142.53 42.82 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.2 m -116.72 -44.49 2.83 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 33.2 tp -87.48 -53.65 4.7 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-N 119.442 1.019 . . . . 0.0 111.739 -168.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.43 HG12 ' HG ' ' C' ' 853' ' ' SER . 11.2 pt -83.73 -176.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 124.262 1.025 . . . . 0.0 108.313 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.46 83.0 2.67 Favored Pre-proline 0 N--CA 1.433 -1.284 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -163.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.82 91.95 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.535 2.156 . . . . 0.0 109.697 167.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 8.9 mp -121.78 145.89 47.6 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 126.558 1.943 . . . . 0.0 106.566 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -95.88 157.91 15.68 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.898 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.55 124.73 24.94 Favored 'General case' 0 C--N 1.375 1.705 0 CA-C-N 119.702 1.137 . . . . 0.0 109.222 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.21 69.55 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 126.306 1.908 . . . . 0.0 112.128 171.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . 0.451 ' HB3' ' HG3' ' A' ' 914' ' ' ARG . 0.9 OUTLIER -72.49 171.96 11.37 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.839 0.819 . . . . 0.0 112.116 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 85.4 m -142.28 127.81 19.02 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -157.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.83 149.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-O 121.314 0.578 . . . . 0.0 110.114 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.4 m -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 60.9 t -94.07 130.03 43.56 Favored 'Isoleucine or valine' 0 C--N 1.371 1.51 0 C-N-CA 126.623 1.969 . . . . 0.0 106.868 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -106.02 132.84 51.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 73.26 1.47 Allowed 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -163.9 103.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 86.8 mmm -153.27 74.17 1.01 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.75 151.34 9.0 Favored Glycine 0 CA--C 1.495 -1.213 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 123.726 0.811 . . . . 0.0 108.855 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.92 87.34 6.18 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.71 -166.44 1.95 Allowed 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -125.24 160.39 29.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.0 t -92.53 132.08 37.13 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.64 150.2 22.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 113.33 24.31 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -98.35 173.33 0.54 Allowed 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 121.985 1.79 . . . . 0.0 108.447 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.57 140.75 49.21 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -139.86 141.75 36.62 Favored 'General case' 0 C--N 1.375 1.68 0 CA-C-N 119.538 1.063 . . . . 0.0 108.747 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.61 129.35 75.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -125.38 105.43 9.07 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 46.0 p -101.06 161.01 13.9 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.562 1.145 . . . . 0.0 110.281 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.46 0.28 Allowed Glycine 0 C--N 1.356 1.644 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.59 144.32 47.17 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.9 124.28 26.61 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 124.906 1.282 . . . . 0.0 109.789 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.1 -57.39 2.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.36 128.01 38.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.095 1.758 . . . . 0.0 106.537 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.7 130.73 10.44 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 103.545 -3.822 . . . . 0.0 103.545 163.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.59 130.95 90.08 Favored Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.406 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -107.06 80.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 121.984 1.744 . . . . 0.0 110.293 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 77.14 -72.87 0.09 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 130.602 3.561 . . . . 0.0 109.405 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.5 mt 49.74 40.07 19.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.523 3.129 . . . . 0.0 113.94 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -110.88 130.0 55.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -128.06 109.86 11.94 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.072 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.172 -0.741 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.33 121.41 22.52 Favored Pre-proline 0 C--N 1.354 0.762 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -92.69 -22.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 122.064 1.773 . . . . 0.0 109.879 -174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 38.78 69.58 0.26 Allowed 'General case' 0 C--N 1.36 1.039 0 C-N-CA 129.189 2.996 . . . . 0.0 115.204 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.86 136.24 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.58 160.39 38.21 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -149.41 139.94 22.5 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.3 t -169.31 117.32 0.63 Allowed 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.09 153.82 34.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.47 157.72 45.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.808 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -133.09 133.39 42.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -168.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 29.7 p -163.95 8.1 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -163.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 2.0 pp -28.74 144.91 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.513 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 160.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.43 -47.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 122.242 1.836 . . . . 0.0 112.877 -163.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -162.18 170.4 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.4 m 4.06 104.3 0.0 OUTLIER 'General case' 0 C--N 1.36 1.05 0 C-N-CA 130.877 3.671 . . . . 0.0 117.563 169.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -97.07 163.65 19.54 Favored Pre-proline 0 C--N 1.353 0.731 0 C-N-CA 123.229 0.612 . . . . 0.0 110.412 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.65 -14.83 12.54 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.645 2.23 . . . . 0.0 110.94 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.92 -142.41 3.47 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.2 m -63.63 143.95 57.41 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.611 1.964 . . . . 0.0 110.703 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.45 130.99 32.01 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 124.734 1.214 . . . . 0.0 110.463 -162.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -97.03 -148.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 124.047 3.164 . . . . 0.0 108.212 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.41 136.84 20.07 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -115.17 -13.96 11.76 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.397 1.079 . . . . 0.0 110.567 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.31 87.11 3.14 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' B' ' 874' ' ' ASN . 58.7 t -70.58 97.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 18.3 mt -87.58 -38.67 15.76 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.083 -172.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 56.6 tp -165.11 127.08 2.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 100.749 -3.797 . . . . 0.0 100.749 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . 0.44 ' HB3' HG13 ' B' ' 871' ' ' VAL . 33.3 t-20 177.25 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 120.265 1.393 . . . . 0.0 108.648 -163.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -58.18 -43.66 87.6 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -166.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.15 -31.4 8.5 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 118.931 0.787 . . . . 0.0 112.479 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.22 -58.69 0.38 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 65.26 -80.36 0.03 OUTLIER 'General case' 0 C--N 1.355 0.831 0 C-N-CA 128.044 2.538 . . . . 0.0 114.406 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -97.1 119.88 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.335 1.454 . . . . 0.0 108.538 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.55 116.99 65.74 Favored Pre-proline 0 CA--C 1.503 -0.854 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -93.46 5.65 2.94 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.19 2.889 . . . . 0.0 108.986 -166.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -79.79 -44.94 19.71 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.407 1.083 . . . . 0.0 108.6 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 25.4 p -108.99 -12.48 14.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.909 1.284 . . . . 0.0 108.363 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.86 25.86 39.92 Favored Glycine 0 C--N 1.361 1.931 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 163.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 54.8 t -100.82 102.81 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 101.089 -3.671 . . . . 0.0 101.089 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.59 114.82 26.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 111.468 -2.605 . . . . 0.0 108.459 -174.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.0 m -99.17 109.78 22.42 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.15 110.45 38.39 Favored Pre-proline 0 C--N 1.357 0.922 0 C-N-CA 125.477 1.511 . . . . 0.0 113.307 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -99.42 -7.28 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 123.321 2.222 . . . . 0.0 108.931 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 16.0 mt -50.42 -51.95 41.92 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 128.618 2.767 . . . . 0.0 114.339 -168.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.8 49.09 14.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.214 1.406 . . . . 0.0 113.815 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -162.74 -166.68 21.94 Favored Glycine 0 N--CA 1.412 -2.943 1 N-CA-C 101.894 -4.482 . . . . 0.0 101.894 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -92.64 120.94 33.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 1.9 p90 -116.19 160.05 20.95 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-N 118.965 0.802 . . . . 0.0 108.841 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 54.6 tp -105.56 116.37 31.84 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.06 135.64 50.57 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 126.193 1.797 . . . . 0.0 107.827 -166.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 72.9 m -145.26 119.22 9.34 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.9 153.9 21.84 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.06 120.84 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.86 122.89 46.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.275 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.1 m -79.77 131.49 35.93 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.264 1.425 . . . . 0.0 107.936 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.73 -57.45 19.76 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.322 1.439 . . . . 0.0 114.25 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 66.4 m170 37.72 73.46 0.1 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 127.178 2.191 . . . . 0.0 115.093 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -71.48 -12.69 61.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.93 1.692 . . . . 0.0 111.544 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -74.62 -15.62 60.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.664 1.586 . . . . 0.0 112.628 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.0 pt-20 120.57 178.62 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 C-N-CA 127.911 2.485 . . . . 0.0 108.485 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 102.06 131.45 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 128.268 2.627 . . . . 0.0 106.581 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.92 131.57 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -112.02 123.42 50.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.18 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.23 115.04 13.69 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 128.426 2.69 . . . . 0.0 109.878 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.05 113.31 25.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.87 147.23 47.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.868 2.067 . . . . 0.0 111.294 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 1.9 t -117.03 147.3 42.46 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.454 1.502 . . . . 0.0 111.414 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 141.45 35.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 128.914 2.886 . . . . 0.0 110.004 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 82.97 9.68 0.62 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.31 2.644 . . . . 0.0 112.82 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -150.17 -26.23 0.25 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.81 168.02 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.476 1.51 . . . . 0.0 112.077 -163.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.29 -133.08 48.42 Favored Glycine 0 C--N 1.366 2.213 0 O-C-N 119.5 -2.0 . . . . 0.0 109.775 -164.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 60.9 t 56.04 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.215 0 C-N-CA 126.23 1.812 . . . . 0.0 111.189 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.6 114.79 27.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -103.15 -35.44 8.48 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.484 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.17 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.04 128.76 44.77 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 33.3 t -141.48 117.43 10.52 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 171.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.82 84.8 0.74 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 165.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.709 0 C-N-CA 125.356 1.455 . . . . 0.0 111.273 175.18 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.4 m . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 59.2 mt -115.3 134.29 55.25 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -168.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.55 163.94 25.73 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 124.999 1.285 . . . . 0.0 109.95 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.97 131.51 72.8 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -137.33 146.52 44.69 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 50.5 m -128.23 -27.37 2.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.364 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 33.8 tp -92.54 -55.55 3.35 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 120.071 1.305 . . . . 0.0 111.425 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.78 -177.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 C-N-CA 125.162 1.385 . . . . 0.0 108.31 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.03 82.94 2.81 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.07 93.63 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.717 2.278 . . . . 0.0 110.223 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 10.5 mp -121.39 145.34 48.01 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 125.824 1.65 . . . . 0.0 107.106 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -95.09 158.19 15.57 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.241 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.88 124.42 24.81 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 119.844 1.202 . . . . 0.0 108.713 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.81 71.04 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 125.997 1.76 . . . . 0.0 111.994 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.73 170.62 14.19 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 117.957 0.878 . . . . 0.0 110.999 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 90.0 m -143.05 127.95 18.36 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.507 -155.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . . . . . . . . . 16.5 m -96.03 150.31 4.36 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-O 121.172 0.51 . . . . 0.0 111.626 175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.7 m -141.05 137.75 33.13 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 126.794 2.038 . . . . 0.0 111.338 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.59 131.05 41.63 Favored 'Isoleucine or valine' 0 C--N 1.368 1.39 0 C-N-CA 127.947 2.499 . . . . 0.0 107.43 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -105.89 132.97 51.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 100.677 -3.823 . . . . 0.0 100.677 171.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.72 72.5 1.4 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 56.8 t -161.83 104.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.3 mmm -152.28 72.68 1.0 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 173.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.26 150.06 8.44 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -115.64 -29.38 6.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 38.3 tp -93.01 86.78 5.53 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.42 -165.95 1.85 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -125.24 159.51 31.46 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.5 t -90.97 131.93 36.28 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.87 150.33 22.5 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.94 113.1 24.43 Favored Pre-proline 0 C--N 1.356 0.889 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -97.86 172.64 0.64 Allowed 'Trans proline' 0 CA--C 1.508 -0.801 0 C-N-CA 121.93 1.754 . . . . 0.0 108.297 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.54 139.18 50.77 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.8 p -139.02 140.56 38.18 Favored 'General case' 0 C--N 1.374 1.65 0 CA-C-N 119.51 1.05 . . . . 0.0 108.499 -170.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.93 130.79 72.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -126.64 105.15 8.5 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 33.3 p -101.72 162.23 13.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.768 1.227 . . . . 0.0 110.494 170.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.14 112.09 0.32 Allowed Glycine 0 C--N 1.357 1.71 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.68 145.32 46.6 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.3 tp -73.14 124.09 24.89 Favored 'General case' 0 C--N 1.379 1.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.423 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.84 -57.52 2.21 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -131.42 127.62 37.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -173.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.81 130.61 10.39 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 103.32 -3.912 . . . . 0.0 103.32 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.11 130.64 89.49 Favored Pre-proline 0 C--N 1.351 0.66 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.569 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -106.26 81.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 122.008 1.753 . . . . 0.0 109.784 -168.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 77.3 -72.38 0.1 Allowed 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 130.311 3.444 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 75.2 mt 49.06 43.33 22.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.326 3.05 . . . . 0.0 113.569 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.52 129.6 56.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -129.0 109.41 11.2 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 N-CA-C 110.328 -0.682 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 31.1 t -122.09 114.73 30.64 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -87.95 -23.65 1.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 CA-C-N 121.649 1.624 . . . . 0.0 110.074 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 37.93 67.95 0.35 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 129.11 2.964 . . . . 0.0 115.755 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.8 136.91 58.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.09 156.84 48.33 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 165.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -148.13 138.55 22.84 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 118.767 0.712 . . . . 0.0 109.105 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 853' ' ' SER . . . . . 0.43 ' HG ' HG12 ' A' ' 953' ' ' ILE . 14.0 t -170.74 120.03 0.55 Allowed 'General case' 0 C--N 1.36 1.052 0 O-C-N 121.664 -0.648 . . . . 0.0 110.097 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.8 153.3 35.94 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.36 157.67 45.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.96 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -140.8 130.51 24.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -163.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 72.8 m -157.56 17.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.5 pp -22.44 140.13 0.04 OUTLIER Pre-proline 0 C--N 1.374 1.632 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 159.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.31 -44.76 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 122.243 1.837 . . . . 0.0 111.685 -166.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 30.9 ptt85 -163.89 170.91 16.11 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -1.03 108.73 0.01 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 130.564 3.546 . . . . 0.0 117.22 167.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.52 161.59 23.5 Favored Pre-proline 0 N--CA 1.443 -0.797 0 C-N-CA 123.708 0.803 . . . . 0.0 108.922 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.79 -12.62 14.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.848 2.366 . . . . 0.0 110.776 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.25 3.11 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.7 m -65.48 146.25 55.11 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.906 1.682 . . . . 0.0 111.037 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.21 132.63 31.78 Favored Pre-proline 0 N--CA 1.44 -0.963 0 C-N-CA 125.383 1.473 . . . . 0.0 110.281 -164.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -99.52 -148.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 124.164 3.243 . . . . 0.0 108.556 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -147.28 135.46 21.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -116.21 -18.69 10.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.264 0.626 . . . . 0.0 111.405 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -103.57 80.69 1.82 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 122.888 0.475 . . . . 0.0 111.55 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.27 99.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 126.421 1.889 . . . . 0.0 107.189 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.82 -38.32 14.71 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.856 -172.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 36.9 tp -165.3 127.54 2.11 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 176.41 61.92 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 120.234 1.379 . . . . 0.0 107.957 -163.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.84 -42.78 90.09 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -165.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.04 -29.07 13.33 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.844 0.747 . . . . 0.0 112.515 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.31 -57.73 0.49 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 62.66 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.348 2.659 . . . . 0.0 114.891 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -94.13 121.01 35.19 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 125.139 1.376 . . . . 0.0 108.885 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.69 116.92 67.04 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -94.69 7.58 2.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 124.455 2.627 . . . . 0.0 109.332 -169.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -79.34 -46.62 17.3 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 37.5 p -108.02 -10.52 15.46 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.793 1.237 . . . . 0.0 108.411 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 28.0 33.89 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 161.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.84 101.66 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 101.088 -3.671 . . . . 0.0 101.088 -166.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -95.93 112.19 23.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 112.212 -2.267 . . . . 0.0 108.941 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 58.1 m -102.12 109.15 20.78 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.02 110.87 45.15 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.583 170.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.65 1.45 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.569 2.179 . . . . 0.0 108.271 164.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 42.4 mt -53.6 -54.65 34.55 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 128.471 2.709 . . . . 0.0 113.45 -169.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.01 68.43 0.82 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.132 0.968 . . . . 0.0 111.037 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -177.16 174.13 46.79 Favored Glycine 0 N--CA 1.406 -3.348 1 N-CA-C 101.066 -4.813 . . . . 0.0 101.066 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -93.82 117.67 30.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.552 -1.324 . . . . 0.0 107.897 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -115.64 160.12 20.44 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 119.217 0.917 . . . . 0.0 110.159 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.1 tp -108.38 112.78 25.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.4 tt -116.82 140.13 49.8 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.062 1.345 . . . . 0.0 108.861 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 69.0 m -143.42 120.06 11.12 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.461 0.704 . . . . 0.0 109.571 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.26 154.4 19.83 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 95.1 t -100.84 122.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 55.5 mt -94.55 122.52 37.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.584 1.154 . . . . 0.0 109.156 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 12.2 m -81.8 132.55 35.28 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -49.77 -57.01 10.21 Favored Glycine 0 C--N 1.36 1.879 0 C-N-CA 126.159 1.837 . . . . 0.0 115.954 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.3 m80 40.22 69.95 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 127.241 2.216 . . . . 0.0 114.765 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -73.7 -8.86 57.66 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.833 1.253 . . . . 0.0 111.855 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -75.5 -4.9 42.39 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 126.338 1.855 . . . . 0.0 111.543 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.292 47.3 mt-10 96.63 -149.72 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 128.4 2.68 . . . . 0.0 107.804 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 84.12 135.27 0.05 Allowed 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.269 2.227 . . . . 0.0 108.819 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.71 128.22 51.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-O 122.499 1.143 . . . . 0.0 108.025 -171.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -111.08 131.34 55.15 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 127.315 2.246 . . . . 0.0 110.164 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -158.05 113.83 2.75 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.646 1.178 . . . . 0.0 110.716 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.07 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.084 1.754 . . . . 0.0 109.111 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 32.2 mt -62.37 143.32 57.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.261 1.824 . . . . 0.0 111.111 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.265 1.3 p -114.52 148.83 37.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 126.513 1.925 . . . . 0.0 108.598 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 137.74 37.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 125.321 1.449 . . . . 0.0 109.431 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.0 t 90.24 0.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.689 2.796 . . . . 0.0 112.694 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -145.76 -26.52 0.45 Allowed 'General case' 0 C--N 1.36 1.025 0 CA-C-N 119.495 1.043 . . . . 0.0 111.99 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 58.77 169.57 0.06 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 125.167 1.387 . . . . 0.0 111.954 -163.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.08 -127.93 46.09 Favored Glycine 0 C--N 1.374 2.667 0 O-C-N 119.741 -1.849 . . . . 0.0 110.152 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 53.4 t 49.38 72.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 126.601 1.96 . . . . 0.0 111.912 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 116.55 28.94 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -169.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -95.8 -35.7 11.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.067 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 56.3 t -99.38 81.21 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.84 131.42 40.75 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 121.091 0.472 . . . . 0.0 111.136 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -144.09 116.17 8.39 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 125.351 1.46 . . . . 0.0 108.126 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.09 84.77 0.65 Allowed Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.643 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 173.023 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.07 134.56 55.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.0 163.41 26.65 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -117.91 129.57 74.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.91 146.47 50.94 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.328 -0.858 . . . . 0.0 110.23 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.1 m -103.97 -84.06 0.48 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.716 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.32 -46.96 88.11 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.084 1.754 . . . . 0.0 114.627 -163.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.34 -179.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 124.72 1.208 . . . . 0.0 110.141 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.22 82.24 1.51 Allowed Pre-proline 0 C--N 1.355 0.836 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -168.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.92 88.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.278 1.985 . . . . 0.0 110.734 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 11.2 mp -123.59 147.46 47.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -91.33 162.53 14.57 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.358 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.71 122.74 21.15 Favored 'General case' 0 C--N 1.38 1.934 0 CA-C-N 120.954 1.706 . . . . 0.0 108.957 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.87 73.45 Favored Glycine 0 CA--C 1.496 -1.134 0 C-N-CA 125.49 1.519 . . . . 0.0 111.62 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -68.47 176.44 2.87 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.855 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 90.6 m -143.71 127.28 16.99 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.433 1.093 . . . . 0.0 110.922 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.21 147.82 6.42 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 124.802 1.241 . . . . 0.0 108.84 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 16.9 t -141.94 137.95 31.63 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.825 1.65 . . . . 0.0 111.737 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 23.8 t -90.89 129.24 42.0 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 C-N-CA 126.233 1.813 . . . . 0.0 106.169 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.68 133.5 49.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.137 -3.653 . . . . 0.0 101.137 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.53 72.64 1.45 Allowed 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.064 -1.88 . . . . 0.0 106.391 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.5 t -160.39 97.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.4 mmm -150.6 78.27 1.31 Allowed 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.98 147.53 14.1 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -113.96 -22.51 10.06 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.435 0.694 . . . . 0.0 110.135 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -98.7 85.62 3.36 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.03 -166.72 1.96 Allowed 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -119.73 150.02 41.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -88.69 130.32 35.34 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -154.95 147.93 24.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.01 115.27 26.27 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -103.73 177.22 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.7 0 C-N-CA 121.553 1.502 . . . . 0.0 108.283 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.48 138.18 51.58 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -137.81 139.95 40.26 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 119.98 1.264 . . . . 0.0 108.192 -171.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.38 131.48 67.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.47 104.92 8.69 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 35.1 p -101.83 162.89 12.57 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.942 1.297 . . . . 0.0 110.225 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.88 112.18 0.35 Allowed Glycine 0 C--N 1.359 1.818 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.28 141.95 47.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 55.8 tp -76.57 124.32 27.43 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.139 1.376 . . . . 0.0 109.439 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 16.2 tp -97.14 -56.57 2.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -131.21 127.24 37.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.51 9.09 Favored Glycine 0 CA--C 1.494 -1.27 0 N-CA-C 103.485 -3.846 . . . . 0.0 103.485 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -69.91 131.17 89.38 Favored Pre-proline 0 C--N 1.354 0.764 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.929 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -106.27 77.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 CA-C-N 122.219 1.828 . . . . 0.0 109.875 -166.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.02 -73.23 0.08 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 130.21 3.404 . . . . 0.0 108.893 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.3 mt 48.93 42.47 20.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 129.171 2.988 . . . . 0.0 113.479 -173.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -113.61 129.64 56.53 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.42 109.61 11.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.452 -0.917 0 N-CA-C 109.998 -0.808 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 118.73 24.16 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.98 -21.61 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.064 1.773 . . . . 0.0 109.875 -172.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 35.9 69.85 0.17 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.032 2.933 . . . . 0.0 115.773 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.63 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.1 155.72 49.77 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 166.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -149.62 138.77 21.27 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.0 t -169.04 117.53 0.66 Allowed 'General case' 0 C--N 1.352 0.702 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.29 152.73 36.21 Favored 'General case' 0 C--N 1.37 1.479 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.48 158.44 44.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.488 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.68 130.88 44.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -167.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.0 p -159.22 16.66 0.17 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -167.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 3.2 pp -21.92 145.55 0.01 OUTLIER Pre-proline 0 C--N 1.368 1.41 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 158.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.36 -48.0 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.927 1.751 . . . . 0.0 112.681 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -163.11 178.52 8.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.3 m -19.43 121.84 0.02 OUTLIER 'General case' 0 C--N 1.363 1.188 0 C-N-CA 129.615 3.166 . . . . 0.0 115.679 172.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -126.63 146.08 55.6 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -163.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -76.86 -10.25 18.24 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 CA-C-N 122.75 2.018 . . . . 0.0 112.937 -161.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.98 -141.12 3.04 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -63.45 145.8 54.89 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.31 1.844 . . . . 0.0 110.48 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 91.9 t -88.93 129.27 48.97 Favored Pre-proline 0 N--CA 1.436 -1.147 0 C-N-CA 125.059 1.344 . . . . 0.0 110.363 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -94.62 -153.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.056 3.171 . . . . 0.0 108.656 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -148.01 132.59 17.76 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -117.59 -11.97 10.38 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 122.707 0.403 . . . . 0.0 111.354 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -99.64 86.68 3.38 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 121.835 -0.541 . . . . 0.0 111.49 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.69 96.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 60.9 mt -87.18 -37.52 17.22 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.634 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.0 tp -166.32 127.04 1.71 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.009 -3.7 . . . . 0.0 101.009 164.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -177.0 61.13 0.01 OUTLIER 'General case' 0 C--N 1.357 0.93 0 CA-C-N 120.756 1.616 . . . . 0.0 109.618 -167.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -61.01 -44.12 97.89 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -165.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.18 -27.77 12.95 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-N 118.927 0.785 . . . . 0.0 112.614 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.25 -61.74 0.3 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 61.74 -81.79 0.02 OUTLIER 'General case' 0 C--N 1.353 0.749 0 C-N-CA 128.067 2.547 . . . . 0.0 114.125 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -94.36 119.23 32.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.358 1.063 . . . . 0.0 108.47 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.03 117.64 69.1 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -94.91 2.36 2.62 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 CA-C-N 125.12 2.864 . . . . 0.0 109.473 -166.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.46 -45.74 17.07 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.5 p -103.69 -13.97 16.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.438 1.095 . . . . 0.0 108.834 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.76 23.5 49.64 Favored Glycine 0 C--N 1.362 2.012 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 162.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.68 103.7 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.583 -3.488 . . . . 0.0 101.583 -164.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.56 111.46 23.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 112.502 -2.135 . . . . 0.0 109.496 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 57.4 m -100.43 107.89 19.74 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.33 110.91 45.94 Favored Pre-proline 0 C--N 1.356 0.87 0 CA-C-O 116.992 -1.48 . . . . 0.0 111.818 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.59 2.72 3.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 123.252 2.197 . . . . 0.0 108.91 168.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 40.8 mt -50.39 -53.44 29.26 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 128.03 2.532 . . . . 0.0 114.801 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.14 59.11 3.56 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.43 -166.7 26.95 Favored Glycine 0 N--CA 1.411 -2.978 1 N-CA-C 101.58 -4.608 . . . . 0.0 101.58 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -93.27 119.84 32.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.94 147.21 41.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.9 tp -107.63 114.9 29.19 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -112.68 139.16 48.52 Favored 'General case' 0 C--N 1.361 1.09 0 C-N-CA 126.034 1.733 . . . . 0.0 108.824 -170.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 67.4 m -143.97 118.98 10.01 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 123.422 0.689 . . . . 0.0 109.28 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.28 153.07 23.26 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.12 121.33 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 122.16 42.67 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.529 1.131 . . . . 0.0 108.682 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 10.8 m -80.6 132.35 35.62 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.83 -57.6 13.93 Favored Glycine 0 C--N 1.362 2.027 0 C-N-CA 125.852 1.691 . . . . 0.0 115.36 -167.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 2.4 m80 38.29 72.11 0.14 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 127.568 2.347 . . . . 0.0 114.855 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -72.96 -11.3 60.52 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.915 1.686 . . . . 0.0 111.341 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -72.63 -14.8 61.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.305 1.842 . . . . 0.0 112.215 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.334 7.0 pt-20 116.27 -175.66 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 C-N-CA 127.926 2.491 . . . . 0.0 108.367 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 74.9 tttt 101.59 135.93 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 127.67 2.388 . . . . 0.0 106.461 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.59 125.23 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -106.91 128.53 54.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 110.066 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.3 114.55 4.8 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.114 1.366 . . . . 0.0 109.382 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 97.2 t -88.33 115.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 139.43 58.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.121 1.768 . . . . 0.0 110.152 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.1 t -115.66 146.58 41.71 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.147 1.779 . . . . 0.0 109.339 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.602 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.99 139.26 39.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.315 2.646 . . . . 0.0 110.667 -172.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 95.9 -9.06 0.09 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.339 3.056 . . . . 0.0 112.831 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -138.46 -27.33 0.87 Allowed 'General case' 0 C--N 1.356 0.891 0 CA-C-N 119.448 1.022 . . . . 0.0 111.392 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 60.77 163.56 0.07 Allowed 'General case' 0 C--N 1.361 1.077 0 C-N-CA 125.619 1.567 . . . . 0.0 111.487 -165.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.3 -134.95 48.25 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 119.394 -2.067 . . . . 0.0 109.143 -160.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 58.05 75.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 125.284 1.434 . . . . 0.0 110.515 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.86 114.32 26.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -103.88 -33.05 9.0 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.781 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.76 77.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 166.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.35 130.32 43.49 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.418 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.9 t -144.61 114.77 7.47 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.084 1.353 . . . . 0.0 108.062 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.36 84.9 0.7 Allowed Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 104.731 -3.347 . . . . 0.0 104.731 167.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.631 0 C-N-CA 125.35 1.452 . . . . 0.0 111.212 175.052 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.42 133.76 55.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.25 161.51 25.25 Favored Glycine 0 CA--C 1.493 -1.305 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.96 127.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -138.89 149.43 44.83 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -114.57 -43.05 3.2 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.07 -52.9 5.93 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 119.733 1.151 . . . . 0.0 112.147 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.456 HG12 ' HG ' ' C' ' 853' ' ' SER . 8.3 pt -87.79 -170.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 124.601 1.161 . . . . 0.0 110.172 -174.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 85.18 1.49 Allowed Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -162.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -73.85 92.34 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 122.565 1.952 . . . . 0.0 109.781 160.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.9 142.8 49.35 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -93.89 158.24 15.74 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.092 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.16 123.88 23.18 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 119.192 0.905 . . . . 0.0 108.832 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.95 73.26 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 125.742 1.639 . . . . 0.0 111.238 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.09 175.02 5.55 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.622 0.769 . . . . 0.0 111.677 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 98.6 m -143.06 125.75 15.96 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.602 HG13 HH11 ' A' ' 914' ' ' ARG . 28.0 m -95.26 150.51 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-O 121.593 0.711 . . . . 0.0 109.544 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -142.07 138.83 32.02 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.156 1.783 . . . . 0.0 111.112 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.71 129.43 42.4 Favored 'Isoleucine or valine' 0 C--N 1.369 1.415 0 C-N-CA 126.021 1.729 . . . . 0.0 106.475 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.49 131.37 52.98 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.45 71.22 1.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.4 t -163.1 100.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.31 71.42 0.89 Allowed 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.46 143.48 7.27 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -111.02 -29.76 7.77 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.573 0.749 . . . . 0.0 108.997 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.8 tp -91.7 87.16 6.2 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.68 -164.51 1.62 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -123.93 159.26 30.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.66 133.83 35.61 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -158.91 152.2 22.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 112.39 22.35 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 172.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -98.86 174.09 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.006 1.804 . . . . 0.0 108.461 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.08 139.69 50.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.567 1.147 . . . . 0.0 108.042 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -140.12 141.4 36.12 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.984 1.266 . . . . 0.0 108.566 -170.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 30.6 mm -118.19 130.11 73.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -126.39 105.87 9.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.1 p -99.96 161.35 13.66 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.598 1.159 . . . . 0.0 109.531 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.44 109.01 0.26 Allowed Glycine 0 C--N 1.359 1.852 0 C-N-CA 119.044 -1.551 . . . . 0.0 110.675 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.95 143.41 47.05 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -74.33 124.68 26.93 Favored 'General case' 0 C--N 1.378 1.845 0 C-N-CA 125.263 1.425 . . . . 0.0 109.058 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.97 -57.94 2.06 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -132.27 128.92 38.85 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 131.85 10.82 Favored Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 103.792 -3.723 . . . . 0.0 103.792 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -69.11 129.12 92.33 Favored Pre-proline 0 C--N 1.352 0.674 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.101 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -106.57 80.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 121.873 1.704 . . . . 0.0 109.733 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 77.95 -72.86 0.08 Allowed 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 130.041 3.336 . . . . 0.0 109.2 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.0 mt 49.51 38.66 15.05 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 128.93 2.892 . . . . 0.0 114.295 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.49 132.1 54.48 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.76 107.99 10.11 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.963 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 N-CA-C 109.931 -0.834 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 119.29 24.96 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -90.24 -21.74 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 122.131 1.797 . . . . 0.0 110.085 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 37.25 69.62 0.21 Allowed 'General case' 0 C--N 1.358 0.971 0 C-N-CA 129.114 2.965 . . . . 0.0 115.587 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.6 135.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.11 155.07 50.73 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -149.33 139.61 22.29 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.26 118.25 0.56 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.89 153.1 36.35 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.16 158.4 44.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.093 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.44 129.78 43.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -168.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.5 p -158.85 15.98 0.18 Allowed 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 124.514 1.126 . . . . 0.0 108.119 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.0 pp -21.89 145.64 0.01 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 158.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.54 -48.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.789 1.659 . . . . 0.0 112.684 -169.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.09 178.46 8.26 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.5 m -19.37 121.92 0.02 OUTLIER 'General case' 0 C--N 1.364 1.218 0 C-N-CA 129.634 3.174 . . . . 0.0 115.68 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -126.71 146.17 56.11 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.01 -10.2 18.0 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 122.788 2.031 . . . . 0.0 112.978 -161.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.92 -141.03 3.02 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.3 m -63.39 145.77 54.92 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.19 1.796 . . . . 0.0 110.428 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.65 128.74 51.5 Favored Pre-proline 0 N--CA 1.437 -1.11 0 C-N-CA 125.052 1.341 . . . . 0.0 110.344 -164.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -95.29 -153.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.054 3.169 . . . . 0.0 108.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.44 132.05 17.8 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -115.5 -12.44 11.66 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.841 0.856 . . . . 0.0 110.698 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -100.56 86.42 3.14 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.215 0.531 . . . . 0.0 111.507 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.4 t -70.95 97.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 126.373 1.869 . . . . 0.0 106.29 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 20.3 mt -87.67 -38.56 15.76 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.181 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.0 tp -166.34 127.52 1.76 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.656 -3.831 . . . . 0.0 100.656 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 178.08 61.32 0.01 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.779 1.627 . . . . 0.0 109.286 -164.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.86 -43.77 97.92 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -167.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.93 -28.61 11.72 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 118.976 0.807 . . . . 0.0 112.734 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.29 -61.32 0.3 Allowed Glycine 0 C--N 1.353 1.489 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 62.12 -81.81 0.02 OUTLIER 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.018 2.527 . . . . 0.0 114.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -95.66 119.08 33.53 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 124.55 1.14 . . . . 0.0 108.283 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.7 117.9 70.07 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -93.68 2.6 3.21 Favored 'Trans proline' 0 CA--C 1.509 -0.76 0 CA-C-N 125.11 2.861 . . . . 0.0 109.728 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -80.46 -44.51 19.1 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.9 p -106.19 -13.87 15.3 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.515 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.94 24.79 43.54 Favored Glycine 0 C--N 1.362 2.018 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 162.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.5 t -100.42 103.51 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 101.711 -3.441 . . . . 0.0 101.711 -162.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.15 111.62 23.88 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.573 -175.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 57.3 m -100.73 107.78 19.46 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.5 111.16 47.7 Favored Pre-proline 0 C--N 1.357 0.922 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.88 171.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -93.43 3.3 3.27 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.267 2.202 . . . . 0.0 109.032 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -53.51 -49.6 67.2 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 126.67 1.988 . . . . 0.0 114.611 -169.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.61 48.72 13.73 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.451 1.501 . . . . 0.0 114.587 170.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.61 -165.31 18.24 Favored Glycine 0 N--CA 1.411 -2.972 1 N-CA-C 101.61 -4.596 . . . . 0.0 101.61 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -88.66 119.71 29.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.64 147.71 42.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 48.8 tp -108.7 114.22 27.83 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.57 138.45 49.33 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.965 1.706 . . . . 0.0 108.106 -171.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 73.9 m -143.46 119.13 10.44 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.21 153.33 22.85 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 90.4 t -109.13 122.28 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.13 120.65 41.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 124.557 1.143 . . . . 0.0 108.458 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 10.5 m -79.61 132.85 36.37 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.974 1.31 . . . . 0.0 107.567 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.71 13.26 Favored Glycine 0 C--N 1.364 2.111 0 C-N-CA 125.975 1.75 . . . . 0.0 115.233 -167.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.8 m80 37.96 71.92 0.14 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.558 2.343 . . . . 0.0 114.887 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -72.84 -11.54 60.64 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 126.005 1.722 . . . . 0.0 111.262 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -72.5 -13.64 61.47 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.378 1.871 . . . . 0.0 112.406 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.337 6.9 pt-20 115.69 -176.77 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.267 2.627 . . . . 0.0 108.267 174.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 101.36 135.85 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 127.568 2.347 . . . . 0.0 106.588 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.75 127.29 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -171.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -108.95 128.76 55.21 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.914 1.686 . . . . 0.0 109.969 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.49 114.39 4.7 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.817 1.247 . . . . 0.0 109.649 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.0 t -88.75 115.75 29.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 C-N-CA 125.316 1.446 . . . . 0.0 107.371 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.7 mt -62.27 141.79 58.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.744 2.018 . . . . 0.0 110.021 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.4 t -116.05 147.35 41.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 126.067 1.747 . . . . 0.0 109.506 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.631 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.02 138.81 38.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 127.82 2.448 . . . . 0.0 110.301 -173.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 96.35 -12.04 0.08 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 129.385 3.074 . . . . 0.0 112.931 173.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -136.52 -26.91 1.07 Allowed 'General case' 0 C--N 1.357 0.933 0 CA-C-N 119.453 1.024 . . . . 0.0 111.682 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 60.64 163.27 0.06 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.77 1.628 . . . . 0.0 111.317 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.48 -133.52 44.86 Favored Glycine 0 C--N 1.364 2.102 0 O-C-N 119.516 -1.99 . . . . 0.0 108.893 -162.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.3 t 55.86 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.159 0 C-N-CA 125.604 1.562 . . . . 0.0 110.813 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.45 114.72 27.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -104.16 -34.0 8.53 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.788 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 88.4 t -100.92 77.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 166.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -97.97 129.95 44.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.899 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.5 t -143.51 115.53 8.34 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.173 1.389 . . . . 0.0 107.916 169.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.93 84.71 0.73 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 168.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.691 0 C-N-CA 125.435 1.493 . . . . 0.0 111.266 175.614 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 44.3 m . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 65.0 mt -116.4 133.69 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.36 162.97 27.57 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.32 131.08 73.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -138.42 150.23 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.8 m -118.77 -39.78 2.94 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 45.7 tp -82.74 -51.64 7.5 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 119.474 1.034 . . . . 0.0 112.122 -169.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 30.2 pt -84.53 -176.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 125.663 1.585 . . . . 0.0 110.307 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.21 84.9 2.04 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -167.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.25 93.54 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.051 1.834 . . . . 0.0 110.389 163.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.56 142.23 49.54 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -93.16 158.85 15.55 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.953 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.05 123.57 23.1 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 119.46 1.027 . . . . 0.0 108.665 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.97 -10.19 74.98 Favored Glycine 0 C--N 1.344 0.984 0 C-N-CA 125.351 1.453 . . . . 0.0 111.207 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.17 174.65 6.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.869 0.867 . . . . 0.0 110.684 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 97.9 m -143.11 125.93 16.1 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -159.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.631 HG13 HH11 ' B' ' 914' ' ' ARG . 20.7 m -96.39 151.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 121.337 0.589 . . . . 0.0 110.625 172.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.2 138.95 31.85 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.236 1.814 . . . . 0.0 111.194 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.2 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 126.971 2.109 . . . . 0.0 106.892 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -105.7 131.26 53.28 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 100.835 -3.765 . . . . 0.0 100.835 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.25 70.62 1.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 58.5 t -161.52 101.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -152.39 69.61 0.88 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.7 142.9 6.63 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 107.39 -2.284 . . . . 0.0 107.39 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -110.14 -29.36 8.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -92.29 86.92 5.86 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.23 -163.17 1.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -124.62 159.22 31.23 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.02 133.33 35.82 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -159.03 152.27 22.48 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 112.39 22.52 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -98.4 173.7 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.071 1.847 . . . . 0.0 108.384 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.41 138.13 52.02 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.3 p -138.99 140.69 38.27 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.892 1.223 . . . . 0.0 108.393 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 33.6 mm -116.02 130.53 70.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -127.17 106.0 8.95 Favored 'General case' 0 C--N 1.363 1.161 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 982' ' ' SER . . . . . 0.462 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 33.3 p -101.27 162.36 12.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.738 1.215 . . . . 0.0 110.07 171.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 109.83 0.28 Allowed Glycine 0 C--N 1.359 1.825 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.131 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.41 144.17 47.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 67.7 tp -72.16 124.62 25.4 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 124.9 1.28 . . . . 0.0 109.706 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.46 -58.54 1.94 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.29 128.51 37.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.71 129.93 10.09 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 103.72 -3.752 . . . . 0.0 103.72 164.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.86 129.02 92.65 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.292 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -106.74 80.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.595 1.605 . . . . 0.0 109.103 -169.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 78.01 -72.03 0.09 Allowed 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 129.91 3.284 . . . . 0.0 109.222 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.8 mt 48.74 40.26 15.63 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 128.884 2.874 . . . . 0.0 113.936 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.51 132.14 55.24 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.88 107.63 9.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 178.717 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 N--CA 1.453 -0.885 0 N-CA-C 109.982 -0.814 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.17 114.29 27.77 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.23 -22.24 1.39 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.666 1.631 . . . . 0.0 110.296 -172.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 36.59 70.28 0.17 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.862 2.865 . . . . 0.0 115.893 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.47 137.13 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.8 155.98 49.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 164.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -148.44 137.2 21.58 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 853' ' ' SER . . . . . 0.456 ' HG ' HG12 ' A' ' 953' ' ' ILE . 18.2 t -171.67 119.8 0.46 Allowed 'General case' 0 C--N 1.362 1.147 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.629 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.54 153.36 35.51 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.81 158.71 43.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.831 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.14 130.53 29.1 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -166.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 65.1 m -158.28 16.26 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.5 pp -30.61 149.54 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.453 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 160.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -80.32 -45.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 122.212 1.826 . . . . 0.0 113.929 -161.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -162.11 178.01 9.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -171.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -15.97 125.36 0.01 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 130.39 3.476 . . . . 0.0 116.57 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.98 149.18 42.87 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -160.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.55 -16.26 19.12 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 112.111 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -138.96 2.56 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.4 m -67.47 144.98 55.43 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 109.98 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.93 133.08 28.25 Favored Pre-proline 0 N--CA 1.439 -0.987 0 C-N-CA 124.797 1.239 . . . . 0.0 110.343 -162.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -97.24 -151.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.806 3.004 . . . . 0.0 109.45 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -144.96 132.52 20.88 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -114.24 -16.53 12.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.492 0.717 . . . . 0.0 111.225 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -102.79 82.79 2.16 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.253 0.549 . . . . 0.0 111.241 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.6 97.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.61 1.964 . . . . 0.0 106.707 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.6 -37.34 13.88 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.561 -173.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.4 tp -164.99 126.61 2.09 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 101.165 -3.643 . . . . 0.0 101.165 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 174.03 61.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.139 1.336 . . . . 0.0 107.784 -163.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.28 -42.43 95.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.75 -28.49 18.64 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.802 0.728 . . . . 0.0 112.303 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.88 -58.52 0.47 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 62.53 -81.18 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 128.069 2.547 . . . . 0.0 114.525 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.44 120.1 36.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.332 1.453 . . . . 0.0 108.683 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -85.53 117.31 68.49 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.2 8.03 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 CA-C-N 125.101 2.857 . . . . 0.0 109.643 -169.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.45 -45.4 19.49 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 36.4 p -106.09 -16.45 14.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 125.456 1.502 . . . . 0.0 108.003 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.11 24.54 47.9 Favored Glycine 0 C--N 1.361 1.967 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.6 103.12 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 -166.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.61 111.48 23.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.734 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 52.3 m -102.02 107.89 19.16 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . 0.455 ' HB2' HH22 ' C' ' 914' ' ' ARG . . . -91.83 110.83 46.3 Favored Pre-proline 0 C--N 1.357 0.9 0 CA-C-O 117.262 -1.351 . . . . 0.0 111.777 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -93.06 1.43 3.57 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.557 2.171 . . . . 0.0 108.472 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 50.3 mt -53.68 -54.51 36.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.86 2.464 . . . . 0.0 114.179 -169.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.42 69.14 0.74 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 122.185 0.993 . . . . 0.0 111.166 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.82 173.4 46.23 Favored Glycine 0 N--CA 1.405 -3.379 1 N-CA-C 100.791 -4.924 . . . . 0.0 100.791 -170.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -93.32 115.72 28.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.7 -1.25 . . . . 0.0 107.741 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -117.8 160.57 21.16 Favored 'General case' 0 C--N 1.365 1.264 0 CA-C-N 119.161 0.891 . . . . 0.0 110.845 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.5 tp -108.16 113.99 27.53 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 108.131 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.7 141.68 47.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 124.795 1.238 . . . . 0.0 108.898 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.1 m -143.26 120.66 11.64 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.625 0.77 . . . . 0.0 110.241 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 154.6 20.92 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.71 123.62 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 67.6 mt -99.29 120.09 38.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.264 1.025 . . . . 0.0 109.155 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -84.87 132.78 34.35 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.67 -59.16 11.02 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 125.022 1.296 . . . . 0.0 114.095 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.2 m80 39.91 65.02 0.78 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.126 2.171 . . . . 0.0 113.899 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -71.62 -9.43 58.23 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.24 1.416 . . . . 0.0 112.12 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.07 -17.43 61.42 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.244 1.418 . . . . 0.0 112.649 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.32 9.6 pt-20 126.23 -175.61 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 128.108 2.563 . . . . 0.0 107.909 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 40.0 tttp 101.0 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 127.766 2.426 . . . . 0.0 106.741 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.4 t -99.38 123.17 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -109.3 121.65 45.64 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.366 171.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.43 116.92 17.41 Favored 'General case' 0 C--N 1.372 1.551 0 C-N-CA 128.581 2.752 . . . . 0.0 109.885 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.12 114.39 26.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.62 147.11 46.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.835 2.054 . . . . 0.0 111.688 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.269 1.2 p -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.106 2.162 . . . . 0.0 109.685 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.455 HH22 ' HB2' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.15 138.95 38.97 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.146 1.778 . . . . 0.0 109.283 174.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 5.8 t 98.0 -16.6 0.05 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 129.23 3.012 . . . . 0.0 112.409 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -136.39 -26.88 1.09 Allowed 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.105 0.866 . . . . 0.0 111.574 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 60.01 169.68 0.08 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.141 1.377 . . . . 0.0 111.308 -164.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.25 -130.98 50.31 Favored Glycine 0 C--N 1.374 2.681 0 O-C-N 119.599 -1.938 . . . . 0.0 110.117 -164.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 60.2 t 53.21 77.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.257 0 C-N-CA 125.961 1.704 . . . . 0.0 111.551 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.7 115.0 27.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -171.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -102.54 -35.7 8.65 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.626 -171.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 86.47 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.33 130.28 42.16 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.102 0.477 . . . . 0.0 110.233 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 21.0 t -142.0 115.45 8.99 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.764 1.626 . . . . 0.0 108.28 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.96 85.48 0.63 Allowed Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 104.51 -3.436 . . . . 0.0 104.51 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.723 0 C-N-CA 124.726 1.155 . . . . 0.0 110.947 170.185 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 65.5 mt -122.08 133.62 54.77 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.71 28.08 Favored Glycine 0 CA--C 1.493 -1.289 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -119.07 131.85 70.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -134.2 150.5 51.07 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 121.369 -0.832 . . . . 0.0 108.955 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 48.8 m -117.47 -42.81 2.85 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.462 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 16.8 tp -90.01 -52.62 4.87 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 121.453 -0.779 . . . . 0.0 111.913 -166.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.17 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 126.23 1.812 . . . . 0.0 109.321 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.27 85.93 1.52 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -167.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.12 89.54 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.328 2.019 . . . . 0.0 109.964 164.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.7 145.89 47.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -92.77 161.16 14.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.342 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.53 122.73 20.98 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-N 120.067 1.303 . . . . 0.0 108.877 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.33 -11.19 72.72 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 125.517 1.532 . . . . 0.0 111.377 168.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 175.56 4.04 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.67 0.788 . . . . 0.0 111.608 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.4 m -143.29 126.56 16.6 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.898 0.879 . . . . 0.0 110.412 -160.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.99 148.52 5.46 Favored 'Isoleucine or valine' 0 C--N 1.362 1.129 0 C-N-CA 123.842 0.857 . . . . 0.0 109.191 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.7 t -141.49 139.66 33.35 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 126.079 1.752 . . . . 0.0 111.451 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.44 129.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.369 1.428 0 C-N-CA 126.271 1.828 . . . . 0.0 107.574 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.02 131.53 54.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 168.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.56 77.99 1.78 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.105 -1.862 . . . . 0.0 107.032 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.9 t -159.25 99.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 N-CA-C 104.441 -2.429 . . . . 0.0 104.441 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -150.71 81.07 1.34 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.07 148.64 16.51 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -115.29 -28.56 6.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 109.274 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.4 tp -91.33 87.14 6.35 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.86 -162.56 1.31 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -123.84 157.97 32.91 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.5 133.25 35.66 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.82 150.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.64 112.61 22.75 Favored Pre-proline 0 C--N 1.355 0.817 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -101.45 -178.21 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 121.766 1.644 . . . . 0.0 108.294 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.17 137.32 53.06 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.253 1.021 . . . . 0.0 109.294 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.9 p -138.27 137.26 37.3 Favored 'General case' 0 C--N 1.376 1.719 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.24 131.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -125.14 104.45 8.53 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 30.2 p -102.51 163.72 12.07 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.313 1.445 . . . . 0.0 110.016 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.59 112.29 0.36 Allowed Glycine 0 C--N 1.356 1.679 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.29 143.04 46.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.68 125.18 27.47 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 125.556 1.543 . . . . 0.0 110.054 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 15.5 tp -98.74 -57.35 2.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 122.376 0.27 . . . . 0.0 110.362 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -131.13 128.07 39.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 131.08 10.53 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 104.174 -3.57 . . . . 0.0 104.174 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.28 128.73 91.15 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 117.768 -1.11 . . . . 0.0 111.214 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -106.71 78.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 122.029 1.76 . . . . 0.0 109.667 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 78.61 -72.74 0.08 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.852 3.261 . . . . 0.0 109.083 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.1 mt 49.19 39.46 15.58 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 128.789 2.836 . . . . 0.0 113.828 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.4 132.04 54.74 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.53 107.37 9.42 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.067 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.677 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.455 -0.777 0 N-CA-C 110.031 -0.796 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 45.0 t -126.87 119.55 22.55 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -89.84 -22.21 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.106 1.788 . . . . 0.0 109.797 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 36.92 70.01 0.19 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 129.025 2.93 . . . . 0.0 115.498 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.64 137.23 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.78 160.73 37.28 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 165.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -149.31 140.16 22.79 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.1 t -169.43 116.52 0.6 Allowed 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -122.95 153.18 40.07 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -138.64 157.83 45.38 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.24 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -131.8 130.97 42.49 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 67.5 m -160.99 8.69 0.08 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -162.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 2.9 pp -28.93 149.4 0.03 OUTLIER Pre-proline 0 C--N 1.367 1.361 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 162.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.48 -45.15 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.966 1.738 . . . . 0.0 113.672 -163.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -162.56 173.98 13.24 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.89 118.84 0.01 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 130.647 3.579 . . . . 0.0 116.759 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.7 164.44 15.19 Favored Pre-proline 0 N--CA 1.442 -0.846 0 C-N-CA 124.279 1.031 . . . . 0.0 110.271 -171.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.71 -15.5 13.53 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.751 2.301 . . . . 0.0 111.337 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.78 -140.59 3.12 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 120.176 1.353 . . . . 0.0 111.189 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.7 m -63.09 145.38 55.59 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.616 2.366 . . . . 0.0 111.454 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.7 127.1 76.4 Favored Pre-proline 0 N--CA 1.441 -0.879 0 C-N-CA 125.308 1.443 . . . . 0.0 111.59 -166.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -98.52 -150.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.429 2.752 . . . . 0.0 107.779 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -149.25 134.3 18.11 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.52 -13.4 10.3 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.029 0.532 . . . . 0.0 110.524 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -100.09 86.79 3.31 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.78 97.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.145 1.778 . . . . 0.0 106.96 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.24 -37.15 16.31 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.376 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 39.8 tp -166.38 128.3 1.83 Allowed 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 162.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -178.34 61.54 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.84 1.655 . . . . 0.0 109.386 -167.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.28 -44.37 92.47 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -165.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.51 -31.27 8.98 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.827 0.739 . . . . 0.0 112.388 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.59 -62.36 0.29 Allowed Glycine 0 C--N 1.353 1.474 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 66.9 -78.19 0.04 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.108 2.563 . . . . 0.0 113.478 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -96.36 120.53 36.82 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.309 1.444 . . . . 0.0 108.792 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.04 117.19 66.25 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -94.24 5.6 2.64 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 CA-C-N 125.43 2.975 . . . . 0.0 108.991 -168.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -80.29 -45.59 17.62 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 -13.36 15.42 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.107 1.363 . . . . 0.0 108.544 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.79 37.96 Favored Glycine 0 C--N 1.364 2.125 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 161.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 23.7 t -101.05 103.94 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 100.419 -3.919 . . . . 0.0 100.419 -163.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.49 112.44 24.98 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.298 -2.228 . . . . 0.0 108.529 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 68.1 m -100.47 108.42 20.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 167.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.41 111.18 45.88 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.85 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -94.35 1.51 2.93 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 CA-C-N 123.107 2.145 . . . . 0.0 109.196 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.49 -49.94 71.21 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.148 2.179 . . . . 0.0 114.076 -168.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 52.63 7.26 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.637 1.175 . . . . 0.0 113.749 169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -166.75 -167.3 27.22 Favored Glycine 0 N--CA 1.414 -2.771 1 N-CA-C 100.496 -5.042 . . . . 0.0 100.496 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.99 121.44 35.47 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.27 3.5 p90 -115.26 161.31 18.65 Favored 'General case' 0 C--N 1.366 1.291 0 CA-C-N 119.099 0.863 . . . . 0.0 109.127 174.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -104.7 116.94 32.9 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.62 0.768 . . . . 0.0 109.538 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -109.45 137.35 47.43 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.806 2.042 . . . . 0.0 109.136 -166.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.5 m -146.37 118.89 8.49 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 123.399 0.68 . . . . 0.0 109.218 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.06 153.55 22.45 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.28 118.86 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.44 123.56 45.7 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.497 -173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 45.8 m -79.17 131.23 36.14 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.414 1.486 . . . . 0.0 107.512 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.77 -56.47 20.33 Favored Glycine 0 C--N 1.362 2.01 0 C-N-CA 126.064 1.792 . . . . 0.0 114.897 -168.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.3 m170 33.52 74.54 0.06 Allowed 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.964 2.506 . . . . 0.0 115.897 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -72.77 -10.72 60.12 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.437 1.495 . . . . 0.0 111.355 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -73.09 -14.74 61.45 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.369 1.468 . . . . 0.0 112.228 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.363 8.3 pt-20 123.4 -168.68 0.0 OUTLIER 'General case' 0 C--N 1.363 1.155 0 C-N-CA 128.26 2.624 . . . . 0.0 108.166 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 64.9 mttt 98.29 135.54 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 128.258 2.623 . . . . 0.0 107.261 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.24 125.26 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.53 128.79 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 127.121 2.168 . . . . 0.0 109.699 176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.68 114.64 4.7 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.865 1.266 . . . . 0.0 110.06 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.7 114.68 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.51 141.67 58.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.156 1.782 . . . . 0.0 110.297 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 4.8 t -114.92 146.83 40.73 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 126.202 1.801 . . . . 0.0 109.129 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.627 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.17 138.05 38.49 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.91 2.484 . . . . 0.0 110.022 -174.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.27 -3.85 0.07 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.142 2.977 . . . . 0.0 112.809 172.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -144.25 -25.99 0.53 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 119.56 1.073 . . . . 0.0 111.245 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 58.46 166.71 0.05 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.4 1.48 . . . . 0.0 112.1 -164.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.22 -134.87 48.46 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 119.359 -2.088 . . . . 0.0 109.303 -161.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 43.8 t 57.29 73.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 125.467 1.507 . . . . 0.0 110.277 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.68 113.95 26.35 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -103.13 -35.55 8.45 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.404 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.37 78.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 168.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.32 129.09 44.63 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.5 -173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.9 t -143.43 114.56 7.84 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.57 84.51 0.75 Allowed Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.168 -3.573 . . . . 0.0 104.168 165.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.836 0 C-N-CA 124.747 1.165 . . . . 0.0 113.786 178.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.0 mt -117.89 133.8 55.57 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.44 26.99 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.01 129.46 75.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -137.75 147.51 44.78 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.7 m -115.6 -44.89 2.93 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.444 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 44.7 tp -82.27 -49.95 9.5 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 119.237 0.926 . . . . 0.0 113.038 -166.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.96 -171.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 125.955 1.702 . . . . 0.0 109.973 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.92 81.92 2.07 Favored Pre-proline 0 N--CA 1.437 -1.097 0 C-N-CA 123.442 0.697 . . . . 0.0 109.185 -165.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.75 91.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 122.509 1.932 . . . . 0.0 109.644 162.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.42 142.53 49.92 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -94.78 155.03 17.0 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.579 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.64 123.28 21.49 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 119.518 1.054 . . . . 0.0 108.93 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.75 -10.39 74.71 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 125.706 1.622 . . . . 0.0 111.297 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 175.65 5.14 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.575 0.75 . . . . 0.0 111.332 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 88.5 m -142.6 125.34 15.96 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -160.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.627 HG13 HH11 ' A' ' 914' ' ' ARG . 24.4 m -94.82 151.27 3.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 121.666 0.746 . . . . 0.0 109.692 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.05 138.3 31.69 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.446 1.898 . . . . 0.0 111.269 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.43 129.96 42.24 Favored 'Isoleucine or valine' 0 C--N 1.37 1.484 0 C-N-CA 126.589 1.955 . . . . 0.0 106.322 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -105.92 131.95 52.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.03 71.9 1.49 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 59.1 t -162.75 101.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.8 mmm -153.1 70.67 0.88 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.75 147.07 7.52 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -113.31 -30.33 6.95 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.17 87.65 6.62 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.66 -177.14 4.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -166.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -116.99 156.29 27.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -90.67 134.16 34.61 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.76 150.55 21.03 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.25 112.96 21.46 Favored Pre-proline 0 C--N 1.355 0.832 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -99.58 173.82 0.4 Allowed 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 108.586 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.78 140.1 50.16 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -139.94 141.56 36.46 Favored 'General case' 0 C--N 1.375 1.678 0 CA-C-N 119.748 1.158 . . . . 0.0 108.797 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.5 mm -119.67 130.23 74.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -125.63 104.85 8.6 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 54.8 p -101.6 162.03 13.2 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.831 1.253 . . . . 0.0 110.161 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.99 112.28 0.32 Allowed Glycine 0 C--N 1.358 1.769 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.15 144.43 46.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.1 tp -74.25 124.12 25.81 Favored 'General case' 0 C--N 1.379 1.882 0 C-N-CA 124.59 1.156 . . . . 0.0 109.675 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.61 -57.62 2.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -131.72 127.57 37.09 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.43 129.08 9.77 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 103.498 -3.841 . . . . 0.0 103.498 166.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -69.21 129.04 92.26 Favored Pre-proline 0 C--N 1.352 0.681 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.16 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -106.82 80.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 CA-C-N 122.111 1.79 . . . . 0.0 109.873 -168.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 77.98 -72.79 0.08 Allowed 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 130.149 3.379 . . . . 0.0 109.161 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 78.8 mt 49.54 39.16 16.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 129.279 3.032 . . . . 0.0 114.133 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.7 131.79 55.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.56 108.34 10.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.771 0 N-CA-C 110.006 -0.806 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.55 119.75 23.08 Favored Pre-proline 0 C--N 1.354 0.77 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -90.64 -22.24 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 122.136 1.799 . . . . 0.0 109.986 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 37.69 70.45 0.19 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 129.192 2.997 . . . . 0.0 115.196 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.26 137.46 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.64 160.02 39.4 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 165.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -148.83 139.97 23.11 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.4 t -169.28 117.52 0.64 Allowed 'General case' 0 C--N 1.354 0.765 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -124.37 153.9 41.16 Favored 'General case' 0 C--N 1.368 1.403 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.56 157.85 44.59 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.145 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -133.4 128.44 35.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -168.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.2 m -159.84 12.21 0.13 Allowed 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 124.717 1.207 . . . . 0.0 107.747 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 2.9 pp -28.68 149.87 0.03 OUTLIER Pre-proline 0 C--N 1.369 1.422 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 160.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.45 -45.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.046 1.766 . . . . 0.0 113.777 -164.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 33.6 ptt85 -162.52 173.93 13.35 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.81 118.94 0.01 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 130.692 3.597 . . . . 0.0 116.771 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.08 164.44 15.12 Favored Pre-proline 0 N--CA 1.442 -0.87 0 C-N-CA 124.325 1.05 . . . . 0.0 110.294 -171.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.77 -15.54 13.4 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.782 2.321 . . . . 0.0 111.35 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.53 -140.85 3.17 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 120.222 1.374 . . . . 0.0 111.193 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.0 m -62.93 144.62 56.59 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.473 2.309 . . . . 0.0 111.388 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.93 126.36 82.32 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.394 1.477 . . . . 0.0 111.565 -167.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -98.98 -150.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.364 2.709 . . . . 0.0 107.566 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -148.79 133.3 17.66 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -114.97 -13.96 11.89 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.333 1.053 . . . . 0.0 109.508 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.994 0.426 . . . . 0.0 111.312 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.78 97.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 126.39 1.876 . . . . 0.0 106.253 163.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.27 -38.91 14.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.659 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 54.5 tp -166.03 127.38 1.85 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 165.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 177.0 61.39 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.509 1.504 . . . . 0.0 108.524 -163.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.79 -43.75 94.26 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -165.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.11 -31.27 9.26 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 118.759 0.709 . . . . 0.0 112.366 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 110.62 -60.74 0.32 Allowed Glycine 0 C--N 1.353 1.476 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 66.23 -79.08 0.03 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.185 2.594 . . . . 0.0 113.644 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -97.01 120.75 37.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.5 1.52 . . . . 0.0 109.033 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.44 117.44 67.11 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 171.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -93.25 5.91 3.0 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-N 125.485 2.995 . . . . 0.0 109.11 -169.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -80.1 -44.17 20.44 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 108.656 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -109.16 -13.82 14.61 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.374 1.47 . . . . 0.0 108.306 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.11 27.82 32.72 Favored Glycine 0 C--N 1.362 2.027 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 162.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.44 103.58 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 -161.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -99.79 112.45 24.7 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.691 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.5 m -101.16 108.23 19.85 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 167.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.66 111.26 46.74 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 117.06 -1.447 . . . . 0.0 111.959 170.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -93.37 1.4 3.42 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 123.186 2.174 . . . . 0.0 109.183 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 31.0 mt -55.43 -49.5 72.25 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.055 2.142 . . . . 0.0 114.36 -168.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.75 52.08 7.02 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.762 1.225 . . . . 0.0 114.263 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.11 -166.41 26.15 Favored Glycine 0 N--CA 1.413 -2.871 1 N-CA-C 101.12 -4.792 . . . . 0.0 101.12 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -93.2 121.33 34.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.308 2.2 p90 -116.92 161.84 18.71 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 119.218 0.917 . . . . 0.0 109.394 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 59.4 tp -105.18 115.76 30.81 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -108.84 136.74 47.89 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 126.335 1.854 . . . . 0.0 108.194 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -145.24 118.65 9.02 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.14 153.58 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.73 120.12 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 122.82 46.26 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 41.6 m -78.58 131.75 36.87 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 125.383 1.473 . . . . 0.0 107.893 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.63 -56.47 20.05 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 126.136 1.827 . . . . 0.0 114.917 -168.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.6 m170 33.16 74.55 0.06 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.058 2.543 . . . . 0.0 115.818 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -72.73 -10.85 60.27 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.542 1.537 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.02 -13.79 61.29 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.495 1.518 . . . . 0.0 112.326 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.361 8.3 pt-20 122.98 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 C-N-CA 128.623 2.769 . . . . 0.0 108.109 172.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 62.7 mttt 97.71 135.19 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 128.211 2.604 . . . . 0.0 107.499 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.15 126.0 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.57 129.27 55.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.352 1.861 . . . . 0.0 109.819 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.8 114.64 4.66 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.566 1.146 . . . . 0.0 110.315 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 96.3 t -89.18 115.14 28.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 C-N-CA 125.569 1.548 . . . . 0.0 107.814 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.8 143.63 57.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 126.694 1.997 . . . . 0.0 110.303 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -115.32 147.43 40.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.318 1.847 . . . . 0.0 109.275 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.601 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.3 137.89 37.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.548 2.339 . . . . 0.0 109.756 -175.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.68 -6.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.196 2.998 . . . . 0.0 113.011 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -142.84 -25.68 0.61 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.716 1.144 . . . . 0.0 111.823 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 58.47 165.89 0.04 OUTLIER 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.561 1.544 . . . . 0.0 111.939 -164.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.42 -133.64 45.03 Favored Glycine 0 C--N 1.367 2.289 0 O-C-N 119.455 -2.028 . . . . 0.0 109.05 -163.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 43.0 t 55.29 74.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 110.511 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.33 114.33 26.83 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -103.84 -36.51 7.79 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.485 -1.688 . . . . 0.0 108.311 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.68 76.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.34 129.2 44.63 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.184 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -142.56 115.21 8.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.963 1.305 . . . . 0.0 107.77 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.56 84.44 0.75 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 166.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.764 0 C-N-CA 124.755 1.169 . . . . 0.0 113.893 178.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 40.1 m . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 64.4 mt -115.87 133.84 55.62 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -169.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.16 162.74 26.41 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -172.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.09 129.34 75.59 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.17 150.16 46.52 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 57.9 m -125.12 -30.28 3.22 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 119.159 -0.448 . . . . 0.0 111.751 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 29.3 tp -88.35 -51.94 5.47 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 119.411 1.005 . . . . 0.0 111.803 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.9 pt -84.94 -176.8 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 125.585 1.554 . . . . 0.0 110.011 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.32 81.15 3.26 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -167.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.02 92.22 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.328 2.019 . . . . 0.0 110.09 164.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.5 mp -120.94 142.23 49.94 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -94.62 155.96 16.64 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.342 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.56 122.67 20.9 Favored 'General case' 0 C--N 1.377 1.761 0 CA-C-N 119.874 1.215 . . . . 0.0 108.737 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.16 -9.47 77.56 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 125.51 1.528 . . . . 0.0 111.131 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.22 175.34 5.4 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.79 0.836 . . . . 0.0 110.679 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.3 m -142.83 125.5 15.91 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -158.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.601 HG13 HH11 ' B' ' 914' ' ' ARG . 18.9 m -96.13 151.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 121.5 0.666 . . . . 0.0 110.448 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.0 t -141.65 138.43 32.51 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 126.626 1.97 . . . . 0.0 111.432 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.1 t -91.72 130.01 41.53 Favored 'Isoleucine or valine' 0 C--N 1.369 1.44 0 C-N-CA 127.355 2.262 . . . . 0.0 106.531 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.94 131.98 52.59 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.795 -3.78 . . . . 0.0 100.795 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.99 71.55 1.48 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 57.3 t -161.28 102.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 91.6 mmm -152.13 69.64 0.9 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.93 146.46 7.15 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -112.53 -29.96 7.3 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -174.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.48 87.57 6.46 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.87 4.49 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -167.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -116.88 156.0 28.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.2 t -89.74 133.61 34.6 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.92 150.65 20.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.41 113.06 21.21 Favored Pre-proline 0 C--N 1.356 0.864 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -99.33 173.5 0.42 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 122.047 1.832 . . . . 0.0 108.443 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.02 138.9 51.28 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -138.43 141.19 39.54 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 119.723 1.147 . . . . 0.0 108.539 -171.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 23.6 mm -117.11 130.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -126.19 104.44 8.23 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 61.2 p -103.12 162.91 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.959 1.303 . . . . 0.0 110.722 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.45 113.76 0.37 Allowed Glycine 0 C--N 1.359 1.86 0 N-CA-C 106.684 -2.567 . . . . 0.0 106.684 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.33 145.31 46.27 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.56 124.06 24.45 Favored 'General case' 0 C--N 1.381 1.965 0 C-N-CA 124.486 1.114 . . . . 0.0 109.692 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.26 -57.52 2.19 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -131.41 127.13 36.86 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.68 128.99 9.74 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.69 -3.764 . . . . 0.0 103.69 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.15 128.63 92.51 Favored Pre-proline 0 C--N 1.352 0.687 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.771 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -106.47 79.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 122.079 1.778 . . . . 0.0 109.378 -167.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.47 -72.21 0.09 Allowed 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 130.036 3.335 . . . . 0.0 109.117 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 74.6 mt 49.09 40.62 17.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 129.162 2.985 . . . . 0.0 113.868 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -113.52 131.88 55.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -130.41 108.0 9.66 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 179.309 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.1 114.09 26.3 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.56 -21.89 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 CA-C-N 121.643 1.622 . . . . 0.0 109.859 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 39.16 70.13 0.24 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.633 2.773 . . . . 0.0 115.307 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.31 131.77 72.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -138.71 149.27 44.92 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -149.53 139.72 22.19 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.289 0.95 . . . . 0.0 110.117 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 20.4 t -169.16 119.22 0.7 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-O 118.23 -0.89 . . . . 0.0 109.519 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.27 153.96 42.42 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -174.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.23 156.23 47.22 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 122.053 0.93 . . . . 0.0 109.747 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -129.21 127.19 40.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.701 -1.59 . . . . 0.0 106.815 -165.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 47.8 p -159.82 13.0 0.13 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.017 -164.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 3.0 pp -25.93 146.24 0.03 OUTLIER Pre-proline 0 C--N 1.368 1.413 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 157.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.94 -45.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.111 1.79 . . . . 0.0 113.319 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -163.39 177.95 8.5 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 -172.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 18.4 m -13.47 119.51 0.01 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 130.101 3.36 . . . . 0.0 116.079 172.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.85 161.27 38.98 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -166.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.52 -15.23 8.76 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.408 2.072 . . . . 0.0 110.999 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.26 -144.2 4.04 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -65.49 135.55 55.32 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.86 1.664 . . . . 0.0 110.515 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 17.1 m -65.74 144.02 98.74 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 125.628 1.571 . . . . 0.0 113.184 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -99.71 -151.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 123.303 2.669 . . . . 0.0 107.295 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -146.39 129.94 16.91 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -116.23 -16.17 10.97 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 122.969 0.508 . . . . 0.0 110.705 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -102.39 81.12 2.02 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.089 0.471 . . . . 0.0 111.372 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.15 97.68 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 127.231 2.213 . . . . 0.0 106.652 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 4.9 mt -89.03 -37.3 15.26 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.465 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 45.4 tp -165.31 129.48 2.37 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 100.401 -3.926 . . . . 0.0 100.401 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 175.68 61.56 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 121.218 1.826 . . . . 0.0 108.226 -166.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.55 97.73 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -165.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.02 -28.81 12.65 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.58 0.627 . . . . 0.0 112.663 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.15 -58.71 0.4 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.79 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.588 2.755 . . . . 0.0 114.085 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -97.25 120.8 38.28 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.811 1.644 . . . . 0.0 108.203 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -83.97 116.82 66.66 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -94.22 6.06 2.58 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 CA-C-N 124.955 2.805 . . . . 0.0 109.942 -165.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -79.95 -45.43 18.53 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.7 p -106.4 -12.08 15.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.937 1.295 . . . . 0.0 108.482 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.74 21.22 54.18 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.452 161.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.42 102.44 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -162.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.45 112.06 23.84 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 111.736 -2.484 . . . . 0.0 108.997 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 80.9 m -100.57 108.05 19.88 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.17 111.41 48.43 Favored Pre-proline 0 C--N 1.354 0.798 0 CA-C-O 117.284 -1.341 . . . . 0.0 110.248 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -91.03 0.07 4.88 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.444 2.096 . . . . 0.0 108.621 166.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 87.9 mt -58.21 -50.51 73.28 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.987 1.715 . . . . 0.0 114.59 -164.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.44 68.99 0.75 Allowed 'General case' 0 C--N 1.366 1.305 0 CA-C-O 122.051 0.929 . . . . 0.0 111.738 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.8 -167.75 35.8 Favored Glycine 0 N--CA 1.406 -3.309 1 N-CA-C 102.272 -4.331 . . . . 0.0 102.272 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -92.65 121.49 34.12 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.422 -1.389 . . . . 0.0 108.493 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.514 ' H ' HD11 ' C' ' 954' ' ' LEU . 3.6 t80 -116.9 145.73 43.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -112.18 115.33 28.67 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.035 0.934 . . . . 0.0 108.648 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . 0.477 HD12 ' HH ' ' C' ' 894' ' ' TYR . 9.2 tt -112.62 140.97 46.93 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.517 1.527 . . . . 0.0 108.505 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -143.01 118.81 10.53 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.86 154.03 22.16 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.58 122.63 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 78.7 mt -97.92 122.57 41.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.309 1.044 . . . . 0.0 108.974 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.66 131.43 35.97 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.21 -56.28 24.06 Favored Glycine 0 C--N 1.367 2.261 0 C-N-CA 125.336 1.446 . . . . 0.0 112.992 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 43.72 63.08 1.69 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.772 2.429 . . . . 0.0 113.981 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -72.68 -7.48 50.63 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 112.594 -168.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 125.381 1.472 . . . . 0.0 112.294 -171.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.336 8.5 pt-20 120.89 -173.37 0.0 OUTLIER 'General case' 0 C--N 1.362 1.148 0 C-N-CA 128.253 2.621 . . . . 0.0 107.956 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.3 tttt 102.62 135.31 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 127.997 2.519 . . . . 0.0 106.524 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 93.2 t -98.39 123.29 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -104.77 129.72 52.97 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.566 1.946 . . . . 0.0 110.171 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.67 114.23 3.74 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.127 1.371 . . . . 0.0 109.943 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.27 117.2 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.818 1.647 . . . . 0.0 108.854 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.45 142.23 57.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.052 1.741 . . . . 0.0 110.204 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.26 1.3 p -113.81 148.73 36.07 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 126.427 1.891 . . . . 0.0 108.368 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.566 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -78.72 137.42 37.77 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.797 1.639 . . . . 0.0 108.364 178.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 101.65 -18.1 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 129.255 3.022 . . . . 0.0 112.281 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -137.5 -26.74 0.97 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 119.277 0.944 . . . . 0.0 111.3 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 59.93 167.17 0.07 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.31 1.444 . . . . 0.0 111.861 -164.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.5 -130.72 51.43 Favored Glycine 0 C--N 1.376 2.764 0 O-C-N 119.554 -1.966 . . . . 0.0 110.197 -163.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 43.2 t 51.8 74.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 126.317 1.847 . . . . 0.0 111.712 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.49 116.62 29.0 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -99.56 -36.66 9.46 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.782 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.85 78.12 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -94.05 132.56 38.41 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -143.55 114.56 7.79 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 125.39 1.476 . . . . 0.0 108.295 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.45 84.97 0.64 Allowed Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 104.765 -3.334 . . . . 0.0 104.765 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.727 0 C-N-CA 125.096 1.332 . . . . 0.0 110.909 172.743 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.511 -0.536 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.6 mt -121.28 134.59 55.17 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.85 162.51 26.29 Favored Glycine 0 CA--C 1.493 -1.344 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.1 130.75 73.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -137.07 150.62 48.15 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 53.3 m -117.71 -36.7 3.6 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.157 -0.34 . . . . 0.0 111.414 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.78 -54.6 3.56 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 118.525 0.602 . . . . 0.0 111.928 -166.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.6 pp -84.76 -173.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 126.463 1.905 . . . . 0.0 110.158 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.514 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -162.12 92.86 1.32 Allowed Pre-proline 0 C--N 1.358 0.942 0 O-C-N 122.02 -0.425 . . . . 0.0 109.947 -168.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.33 91.15 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 122.944 2.087 . . . . 0.0 109.797 160.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.42 142.88 49.58 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -92.43 160.23 15.18 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.75 122.05 19.97 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 120.226 1.375 . . . . 0.0 108.502 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.61 71.45 Favored Glycine 0 C--N 1.347 1.158 0 C-N-CA 125.389 1.471 . . . . 0.0 111.419 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.89 174.99 3.91 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.488 0.715 . . . . 0.0 111.471 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 19.4 p -142.96 127.98 18.48 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.435 0.635 . . . . 0.0 109.416 -161.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.566 HG13 HH11 ' C' ' 914' ' ' ARG . 19.6 m -94.69 150.28 4.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.66 137.72 33.78 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 125.047 1.339 . . . . 0.0 111.916 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.79 129.42 42.49 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 C-N-CA 125.912 1.685 . . . . 0.0 106.805 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -106.82 132.6 52.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 11.4 tp -132.28 75.26 1.62 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.196 -1.82 . . . . 0.0 107.972 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.7 t -158.59 100.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.62 75.15 1.15 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 112.89 145.6 9.51 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -113.0 -30.51 6.99 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.2 tp -92.24 87.06 5.94 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.8 -160.62 1.08 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -123.17 155.13 37.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -91.48 134.02 35.0 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -158.27 151.19 22.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -127.29 116.67 21.58 Favored Pre-proline 0 C--N 1.355 0.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -102.99 173.76 0.19 Allowed 'Trans proline' 0 CA--C 1.508 -0.817 0 N-CA-C 107.925 -1.606 . . . . 0.0 107.925 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -114.55 139.52 49.51 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -137.79 139.44 40.03 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 119.665 1.12 . . . . 0.0 108.001 -169.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.41 131.24 69.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -124.92 105.53 9.3 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 982' ' ' SER . . . . . 0.444 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 28.6 p -101.76 164.67 11.61 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.61 1.564 . . . . 0.0 109.911 172.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.15 111.81 0.35 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.06 141.53 48.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -76.7 124.45 27.68 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.386 1.474 . . . . 0.0 108.586 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 18.6 tp -98.1 -57.46 2.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.753 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.91 128.26 38.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.71 131.7 10.83 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.684 -3.766 . . . . 0.0 103.684 162.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.34 132.38 89.75 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.595 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -106.09 78.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.54 1.586 . . . . 0.0 108.954 -171.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 79.56 -71.75 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.207 3.403 . . . . 0.0 109.007 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 68.6 mt 49.87 38.87 17.01 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 129.183 2.993 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.14 131.86 54.76 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.94 107.14 9.14 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 179.544 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 109.854 -0.864 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.94 119.0 21.01 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -89.96 -20.89 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.079 1.778 . . . . 0.0 109.689 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 37.74 69.23 0.25 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.727 2.811 . . . . 0.0 115.618 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.09 137.1 54.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.2 158.84 43.32 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -149.38 138.07 21.02 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 22.9 t -170.28 117.5 0.54 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.73 153.36 34.52 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.01 157.89 45.76 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.68 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -130.75 129.32 42.33 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -166.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.2 p -162.01 14.36 0.09 Allowed 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -163.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 3.8 pp -24.86 147.44 0.02 OUTLIER Pre-proline 0 C--N 1.366 1.318 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 159.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.51 -45.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 121.918 1.721 . . . . 0.0 112.891 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -163.45 179.34 7.37 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -172.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -24.05 126.76 0.03 OUTLIER 'General case' 0 C--N 1.364 1.225 0 C-N-CA 129.364 3.066 . . . . 0.0 115.22 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -122.77 147.15 50.08 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -158.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.46 -10.35 20.45 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.505 2.137 . . . . 0.0 113.042 -172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.25 -142.01 3.33 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 120.426 1.466 . . . . 0.0 110.558 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.4 m -62.82 144.72 56.28 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 127.213 2.205 . . . . 0.0 110.813 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.11 122.77 84.75 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 125.504 1.522 . . . . 0.0 111.089 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -96.39 -153.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.96 3.107 . . . . 0.0 107.472 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -151.49 135.66 16.71 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -120.12 -11.88 9.18 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 122.146 -0.346 . . . . 0.0 111.905 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.09 87.14 3.39 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.591 0.632 . . . . 0.0 112.264 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.87 97.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 126.213 1.805 . . . . 0.0 106.882 168.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 67.0 mt -87.48 -37.82 16.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.238 -173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 32.4 tp -166.65 127.51 1.66 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 101.106 -3.665 . . . . 0.0 101.106 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 179.98 61.04 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 120.839 1.654 . . . . 0.0 108.988 -166.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 -44.03 95.84 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -166.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.72 -27.13 15.13 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 118.863 0.756 . . . . 0.0 112.456 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.77 -58.73 0.39 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 62.68 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 127.933 2.493 . . . . 0.0 114.094 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -95.97 119.54 34.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.785 1.234 . . . . 0.0 108.068 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.05 117.29 67.8 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.53 4.84 2.61 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 124.656 2.699 . . . . 0.0 109.399 -165.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.16 -45.72 17.64 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -104.31 -14.29 15.84 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 124.517 1.127 . . . . 0.0 108.746 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.26 47.65 Favored Glycine 0 C--N 1.363 2.068 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 162.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 52.5 t -100.18 103.89 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 -163.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.71 111.92 24.23 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 112.167 -2.288 . . . . 0.0 109.358 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 64.9 m -100.33 108.18 20.15 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.93 110.75 44.1 Favored Pre-proline 0 C--N 1.357 0.912 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.707 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.22 1.29 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 123.285 2.209 . . . . 0.0 108.94 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 29.9 mt -51.68 -53.84 34.61 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 128.489 2.716 . . . . 0.0 114.151 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.17 65.3 1.31 Allowed 'General case' 0 C--N 1.365 1.277 0 CA-C-O 121.901 0.858 . . . . 0.0 112.057 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.08 -177.93 45.48 Favored Glycine 0 N--CA 1.411 -3.012 1 N-CA-C 101.033 -4.827 . . . . 0.0 101.033 -173.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -93.18 121.27 34.37 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.284 1.3 p90 -114.95 161.68 17.98 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.158 0.89 . . . . 0.0 109.573 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 63.0 tp -104.17 116.45 32.22 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.421 0.688 . . . . 0.0 109.662 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.03 136.72 49.63 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 126.386 1.874 . . . . 0.0 108.916 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.8 m -147.41 119.57 8.29 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 123.318 0.647 . . . . 0.0 109.557 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.42 153.92 21.56 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.5 t -107.97 120.82 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.95 123.96 45.94 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.177 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 42.4 m -81.11 132.97 35.39 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 125.581 1.552 . . . . 0.0 107.389 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.4 -57.22 20.8 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 124.931 1.253 . . . . 0.0 113.765 -170.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.6 m170 36.1 71.48 0.13 Allowed 'General case' 0 C--N 1.36 1.043 0 C-N-CA 127.556 2.342 . . . . 0.0 115.143 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -73.03 -8.02 53.85 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 125.253 1.421 . . . . 0.0 112.028 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.82 -18.76 62.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.18 1.392 . . . . 0.0 112.605 -171.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.305 11.3 pt-20 125.13 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 127.954 2.502 . . . . 0.0 108.16 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 99.16 131.69 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.423 2.289 . . . . 0.0 107.277 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.76 123.81 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -107.97 121.71 45.35 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.015 1.726 . . . . 0.0 112.864 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -130.5 116.13 17.76 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.6 2.76 . . . . 0.0 108.615 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.3 t -84.98 114.74 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.67 141.26 58.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.841 1.656 . . . . 0.0 110.497 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.3 t -115.96 147.18 41.44 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.537 1.935 . . . . 0.0 109.373 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.611 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.68 139.49 39.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.821 2.848 . . . . 0.0 110.634 -173.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 7.2 t 97.55 -12.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 129.269 3.028 . . . . 0.0 112.909 173.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -136.9 -26.51 1.04 Allowed 'General case' 0 C--N 1.356 0.887 0 CA-C-N 119.601 1.091 . . . . 0.0 111.204 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 61.58 163.35 0.08 Allowed 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.473 1.509 . . . . 0.0 111.388 -166.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.77 -135.07 49.43 Favored Glycine 0 C--N 1.37 2.456 0 O-C-N 119.443 -2.036 . . . . 0.0 109.442 -160.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 44.0 t 57.52 78.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.169 0 C-N-CA 125.56 1.544 . . . . 0.0 110.714 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.69 114.42 26.96 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -173.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -102.86 -35.75 8.49 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.479 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -100.22 82.43 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 167.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -94.93 130.21 41.65 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.796 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -142.96 114.88 8.23 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.654 1.582 . . . . 0.0 108.631 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.3 85.12 0.65 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 103.701 -3.76 . . . . 0.0 103.701 162.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.842 0 C-N-CA 124.369 0.985 . . . . 0.0 112.133 172.206 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.52 133.28 55.99 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.13 161.58 27.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -172.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 26.5 m -122.59 127.85 75.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.7 149.32 46.42 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.0 m -115.0 -43.74 3.08 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.423 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 22.9 tp -83.71 -50.07 8.51 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 119.491 1.041 . . . . 0.0 112.775 -166.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.41 HG12 ' HG ' ' C' ' 853' ' ' SER . 7.8 pt -85.01 -174.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 110.438 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.69 81.64 2.74 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 123.154 0.582 . . . . 0.0 109.663 -166.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.24 92.24 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.593 2.195 . . . . 0.0 109.911 162.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.8 143.8 48.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -94.33 156.59 16.44 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.605 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.29 123.47 22.35 Favored 'General case' 0 C--N 1.372 1.547 0 CA-C-N 119.292 0.951 . . . . 0.0 108.861 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.11 72.92 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 125.936 1.731 . . . . 0.0 111.096 171.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.92 175.25 5.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.385 0.674 . . . . 0.0 111.528 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 13.1 t -144.4 128.68 17.8 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.825 0.821 . . . . 0.0 110.191 -164.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.611 HG13 HH11 ' A' ' 914' ' ' ARG . 23.4 m -94.53 151.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.957 172.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.54 138.5 32.76 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 126.197 1.799 . . . . 0.0 111.275 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.69 129.51 42.26 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 C-N-CA 126.102 1.761 . . . . 0.0 107.04 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -107.8 131.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 169.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -131.39 76.44 1.72 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.401 -1.727 . . . . 0.0 107.303 172.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.1 t -160.46 100.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.0 mmm -153.58 70.12 0.83 Allowed 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.05 145.8 7.33 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -113.1 -29.35 7.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.8 tp -91.37 87.42 6.44 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.62 -165.28 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -124.46 161.02 26.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -93.47 133.15 37.05 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.61 151.38 22.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.22 113.39 21.54 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -99.21 173.93 0.42 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 121.875 1.716 . . . . 0.0 108.751 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.43 139.34 51.54 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.707 1.203 . . . . 0.0 108.247 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -140.76 141.9 34.78 Favored 'General case' 0 C--N 1.376 1.727 0 CA-C-N 120.001 1.273 . . . . 0.0 108.599 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 24.3 mm -118.12 129.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -125.14 105.62 9.29 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 32.1 p -101.04 161.97 13.22 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.019 1.328 . . . . 0.0 110.379 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.54 0.28 Allowed Glycine 0 C--N 1.359 1.835 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.17 145.27 46.14 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.37 -1.077 . . . . 0.0 113.809 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.8 tp -75.19 123.09 24.66 Favored 'General case' 0 C--N 1.379 1.857 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 27.7 tp -98.61 -57.33 2.22 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -131.7 128.05 38.17 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 130.95 10.47 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 103.883 -3.687 . . . . 0.0 103.883 165.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -69.09 128.91 92.48 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-O 117.825 -1.083 . . . . 0.0 111.046 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -107.14 80.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.048 1.767 . . . . 0.0 109.814 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.89 -72.75 0.09 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 130.241 3.416 . . . . 0.0 109.315 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 73.2 mt 49.62 39.24 16.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.158 2.983 . . . . 0.0 114.169 -176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -112.1 131.43 55.44 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -128.93 108.7 10.63 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 179.318 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.55 119.19 21.57 Favored Pre-proline 0 C--N 1.354 0.771 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.25 -20.93 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 122.193 1.819 . . . . 0.0 109.905 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 39.31 69.19 0.3 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 128.783 2.833 . . . . 0.0 115.351 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 88.6 t -118.88 136.76 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.21 157.81 45.96 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 165.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.31 138.49 21.41 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -170.68 118.07 0.51 Allowed 'General case' 0 C--N 1.357 0.893 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.67 153.55 34.16 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -136.13 157.97 45.55 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.433 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -130.45 128.04 40.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -167.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.8 p -161.65 13.36 0.09 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.341 -163.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.7 pp -24.56 147.49 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.375 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 158.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.69 -45.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 CA-C-N 121.943 1.729 . . . . 0.0 112.839 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 -163.32 179.22 7.52 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -172.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.8 m -23.82 126.6 0.03 OUTLIER 'General case' 0 C--N 1.365 1.248 0 C-N-CA 129.361 3.064 . . . . 0.0 115.356 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -122.79 147.17 50.17 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -158.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.5 -10.29 20.36 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.517 2.145 . . . . 0.0 113.107 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.99 3.32 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 120.496 1.498 . . . . 0.0 110.516 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 24.3 m -62.83 144.59 56.44 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 127.086 2.154 . . . . 0.0 110.7 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 11.5 t -78.88 122.58 84.78 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 125.521 1.528 . . . . 0.0 111.004 -169.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -97.65 -153.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.932 3.088 . . . . 0.0 107.361 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -150.82 135.09 16.95 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -117.77 -10.95 10.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.604 0.761 . . . . 0.0 110.553 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -100.77 87.52 3.35 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.95 -0.469 . . . . 0.0 112.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.13 97.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.172 1.789 . . . . 0.0 106.507 164.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.05 -39.17 14.85 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.238 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 44.7 tp -166.1 126.57 1.73 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 100.6 -3.852 . . . . 0.0 100.6 165.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 177.35 60.88 0.01 OUTLIER 'General case' 0 C--N 1.354 0.79 0 CA-C-N 120.464 1.484 . . . . 0.0 108.921 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.24 -43.56 95.99 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -166.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.38 -27.82 14.46 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 118.749 0.704 . . . . 0.0 112.553 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.53 -57.89 0.43 Allowed Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 62.65 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 127.998 2.519 . . . . 0.0 114.221 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -96.86 119.13 34.76 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.926 1.29 . . . . 0.0 108.117 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.89 117.52 68.62 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.66 5.09 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 124.609 2.682 . . . . 0.0 109.529 -164.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.18 -44.6 19.55 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -106.2 -14.64 15.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.872 1.269 . . . . 0.0 108.393 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.87 25.17 42.3 Favored Glycine 0 C--N 1.361 1.917 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.54 103.89 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 -162.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -100.74 111.91 24.22 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 112.609 -2.087 . . . . 0.0 109.144 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.3 m -100.37 108.22 20.19 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 168.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.65 111.0 45.3 Favored Pre-proline 0 C--N 1.357 0.933 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.755 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -93.36 1.95 3.4 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.318 2.221 . . . . 0.0 108.929 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.14 -48.57 73.5 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 127.047 2.139 . . . . 0.0 113.951 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.29 48.89 14.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.547 1.539 . . . . 0.0 113.929 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.95 -166.1 20.08 Favored Glycine 0 N--CA 1.412 -2.902 1 N-CA-C 101.569 -4.612 . . . . 0.0 101.569 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -93.31 121.43 34.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.318 0.8 OUTLIER -117.03 161.41 19.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-N 119.26 0.936 . . . . 0.0 109.639 177.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.0 tp -105.38 115.52 30.4 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -109.72 136.46 49.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.313 1.845 . . . . 0.0 108.254 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.8 m -145.25 119.42 9.48 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.82 153.51 22.37 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 95.5 t -108.56 121.81 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.4 122.23 45.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.988 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 38.4 m -79.67 132.99 36.36 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.49 1.516 . . . . 0.0 107.853 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.02 -57.2 21.14 Favored Glycine 0 C--N 1.364 2.129 0 C-N-CA 125.057 1.313 . . . . 0.0 113.896 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.8 m170 35.84 71.79 0.12 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 127.491 2.316 . . . . 0.0 115.173 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -73.18 -7.89 53.38 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.27 1.428 . . . . 0.0 111.976 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -72.55 -15.39 61.77 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 125.46 1.504 . . . . 0.0 112.656 -169.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.317 10.2 pt-20 121.05 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.361 1.067 0 C-N-CA 128.182 2.593 . . . . 0.0 108.224 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 79.7 tttt 100.49 131.82 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 127.537 2.335 . . . . 0.0 107.46 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.76 126.23 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -111.25 122.87 48.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.498 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.58 117.34 17.82 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 128.087 2.555 . . . . 0.0 108.907 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.48 113.86 25.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.2 mt -62.59 143.29 57.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.664 1.986 . . . . 0.0 110.294 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -116.03 147.88 40.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 110.011 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.621 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.75 139.34 38.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 128.044 2.538 . . . . 0.0 110.19 -174.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 7.4 t 97.82 -16.35 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.322 3.049 . . . . 0.0 113.078 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -134.49 -26.0 1.45 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 119.599 1.091 . . . . 0.0 111.423 -170.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 61.34 162.88 0.07 Allowed 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.593 1.557 . . . . 0.0 111.176 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.35 -133.92 45.25 Favored Glycine 0 C--N 1.365 2.173 0 O-C-N 119.615 -1.928 . . . . 0.0 109.163 -162.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.13 79.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.149 0 C-N-CA 125.828 1.651 . . . . 0.0 110.823 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 114.91 27.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -103.31 -36.98 7.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.385 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.3 t -100.72 81.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.875 -3.009 . . . . 0.0 102.875 167.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -95.69 129.48 42.89 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.7 t -141.57 115.53 9.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.483 1.513 . . . . 0.0 107.714 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.64 85.0 0.69 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 104.199 -3.56 . . . . 0.0 104.199 163.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.814 0 C-N-CA 124.904 1.24 . . . . 0.0 112.029 173.204 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.4 mt -116.91 133.95 55.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 -171.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.31 162.57 27.58 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.26 130.67 73.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.28 150.6 46.82 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 55.0 m -118.89 -40.49 2.85 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 118.165 0.439 . . . . 0.0 111.918 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.44 -48.9 10.55 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 119.169 0.895 . . . . 0.0 112.646 -167.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 40.8 pt -84.29 -177.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.864 1.666 . . . . 0.0 110.389 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.28 81.35 2.91 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -169.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.35 93.41 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.602 2.201 . . . . 0.0 110.321 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.2 mp -120.5 142.52 49.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -93.21 156.97 16.51 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.616 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.02 123.27 22.42 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 119.508 1.049 . . . . 0.0 108.672 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.79 -10.46 74.52 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 125.555 1.55 . . . . 0.0 111.052 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.27 174.82 5.94 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.732 0.813 . . . . 0.0 110.458 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 14.5 t -144.42 128.76 17.86 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.745 0.783 . . . . 0.0 110.42 -161.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.621 HG13 HH11 ' B' ' 914' ' ' ARG . 17.7 m -96.15 151.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.19 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.82 138.51 32.24 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 126.281 1.832 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 90.1 t -91.21 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.331 0 C-N-CA 127.087 2.155 . . . . 0.0 107.275 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -107.41 131.54 54.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 100.77 -3.789 . . . . 0.0 100.77 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.77 75.92 1.69 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.565 -1.652 . . . . 0.0 106.948 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 61.9 t -159.21 102.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -152.8 68.86 0.84 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.76 144.98 6.82 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -111.96 -28.67 7.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -92.3 87.14 5.94 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.97 1.68 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -124.49 160.13 28.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.3 t -91.89 132.88 36.15 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.7 151.49 22.16 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.05 113.29 21.8 Favored Pre-proline 0 C--N 1.356 0.867 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -98.9 173.46 0.46 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.948 1.765 . . . . 0.0 108.693 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.71 137.71 52.5 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -139.76 140.77 36.8 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.91 1.232 . . . . 0.0 108.316 -170.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.48 129.8 72.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -125.83 105.44 8.95 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 982' ' ' SER . . . . . 0.454 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 34.4 p -102.11 163.14 12.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.104 1.361 . . . . 0.0 110.866 171.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.02 112.09 0.33 Allowed Glycine 0 C--N 1.36 1.9 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.23 145.15 46.3 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.6 tp -72.75 122.52 21.64 Favored 'General case' 0 C--N 1.381 1.975 0 C-N-CA 124.143 0.977 . . . . 0.0 109.155 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.3 tp -98.39 -57.38 2.21 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -131.46 127.43 37.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 130.25 10.21 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 103.819 -3.712 . . . . 0.0 103.819 165.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.62 128.99 91.77 Favored Pre-proline 0 C--N 1.352 0.702 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.446 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -106.62 80.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 122.029 1.76 . . . . 0.0 109.426 -168.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.16 -72.17 0.09 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 129.98 3.312 . . . . 0.0 109.199 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 68.9 mt 48.79 41.51 18.32 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 129.039 2.936 . . . . 0.0 113.696 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -114.41 131.35 56.62 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.83 108.34 10.07 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 179.096 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.454 -0.821 0 N-CA-C 109.849 -0.866 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.11 114.53 27.8 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -88.86 -21.42 1.32 Allowed 'Trans proline' 0 CA--C 1.512 -0.614 0 CA-C-N 121.723 1.651 . . . . 0.0 110.173 -172.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 35.77 71.39 0.12 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 129.039 2.936 . . . . 0.0 115.84 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.3 t -122.06 136.55 58.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 156.41 49.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 165.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 136.84 20.84 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 118.811 0.732 . . . . 0.0 109.03 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 853' ' ' SER . . . . . 0.41 ' HG ' HG12 ' A' ' 953' ' ' ILE . 15.1 t -170.86 119.93 0.53 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.321 -0.862 . . . . 0.0 109.512 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.13 153.11 36.65 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.11 157.72 44.9 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.976 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -140.23 129.44 23.74 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -163.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 69.8 m -157.06 19.52 0.3 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 1.8 pp -25.36 145.59 0.03 OUTLIER Pre-proline 0 C--N 1.373 1.596 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 160.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.6 -49.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.236 1.957 . . . . 0.0 113.463 -164.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.1 ptt85 -162.47 172.39 15.59 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -2.69 112.46 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 130.893 3.677 . . . . 0.0 117.165 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -96.1 161.46 27.14 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.702 1.201 . . . . 0.0 109.651 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.92 -15.8 11.68 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.84 2.36 . . . . 0.0 110.429 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.99 -138.74 2.58 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 10.1 m -65.17 146.76 54.56 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.85 1.66 . . . . 0.0 110.69 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.89 133.31 26.67 Favored Pre-proline 0 N--CA 1.438 -1.044 0 C-N-CA 125.447 1.499 . . . . 0.0 110.554 -162.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -96.54 -152.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.823 3.015 . . . . 0.0 109.443 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.09 134.57 23.17 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -114.44 -17.23 11.81 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.161 0.584 . . . . 0.0 111.766 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -102.92 83.21 2.2 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.519 0.6 . . . . 0.0 110.958 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.76 97.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.651 1.98 . . . . 0.0 106.51 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 6.5 mt -89.83 -37.99 14.07 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.288 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 33.8 tp -165.52 126.74 1.94 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 175.06 61.47 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 120.25 1.387 . . . . 0.0 107.72 -163.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.88 -42.51 93.91 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -165.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.95 -29.11 16.25 Favored Glycine 0 C--N 1.357 1.705 0 CA-C-N 118.736 0.698 . . . . 0.0 112.335 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.14 -58.22 0.51 Allowed Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 63.47 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.087 2.555 . . . . 0.0 114.458 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -96.16 120.69 36.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 125.329 1.452 . . . . 0.0 108.496 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -85.99 116.96 67.8 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.26 8.65 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 124.951 2.804 . . . . 0.0 109.015 -170.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -79.29 -44.39 21.78 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.3 p -107.28 -15.01 14.75 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.832 1.253 . . . . 0.0 107.932 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.62 24.74 49.13 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 164.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.08 103.66 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.95 111.83 23.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.976 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 47.5 m -102.51 108.66 20.04 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . 0.442 ' HB2' HH22 ' C' ' 914' ' ' ARG . . . -91.56 110.37 42.7 Favored Pre-proline 0 C--N 1.356 0.85 0 CA-C-O 117.261 -1.352 . . . . 0.0 111.775 170.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -93.56 3.18 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.572 2.181 . . . . 0.0 108.359 164.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.02 -51.55 67.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 127.718 2.407 . . . . 0.0 113.458 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.52 66.09 1.14 Allowed 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.128 0.966 . . . . 0.0 111.66 169.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.08 -179.36 45.59 Favored Glycine 0 N--CA 1.404 -3.442 1 N-CA-C 101.293 -4.723 . . . . 0.0 101.293 -173.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -95.64 116.71 29.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.752 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.83 160.82 20.25 Favored 'General case' 0 C--N 1.366 1.31 0 CA-C-N 119.2 0.909 . . . . 0.0 110.654 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -108.0 110.66 22.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.06 138.99 51.25 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 108.414 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 61.5 m -143.22 120.59 11.62 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.54 0.736 . . . . 0.0 110.25 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -103.65 154.87 19.04 Favored 'General case' 0 C--N 1.364 1.226 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.71 123.47 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 68.9 mt -94.92 124.32 38.9 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.631 1.172 . . . . 0.0 109.403 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.4 m -79.66 132.39 36.21 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.74 22.54 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 125.952 1.739 . . . . 0.0 114.843 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 61.2 m170 31.39 74.33 0.05 OUTLIER 'General case' 0 C--N 1.361 1.076 0 C-N-CA 128.168 2.587 . . . . 0.0 115.615 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -71.0 -11.55 61.04 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.127 1.771 . . . . 0.0 112.457 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -73.89 -5.41 40.9 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.799 2.04 . . . . 0.0 111.796 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.299 47.1 mt-10 100.09 -144.09 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.809 2.844 . . . . 0.0 107.05 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 75.3 tttt 79.12 141.39 0.07 Allowed 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.616 1.966 . . . . 0.0 109.389 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.86 126.23 59.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -110.03 129.92 55.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.908 2.083 . . . . 0.0 110.164 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.51 114.13 2.94 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.692 1.197 . . . . 0.0 110.422 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.54 117.69 30.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 C-N-CA 126.36 1.864 . . . . 0.0 109.04 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.73 137.24 58.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.129 1.372 . . . . 0.0 110.375 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.5 t -117.72 145.39 44.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.797 2.039 . . . . 0.0 107.989 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.442 HH22 ' HB2' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.33 140.37 38.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.215 2.206 . . . . 0.0 110.878 -174.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 92.25 0.86 0.12 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 128.982 2.913 . . . . 0.0 112.129 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -147.12 -25.66 0.4 Allowed 'General case' 0 C--N 1.361 1.078 0 CA-C-N 119.499 1.045 . . . . 0.0 112.101 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.5 166.99 0.06 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.422 1.489 . . . . 0.0 111.671 -164.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.7 -130.36 50.93 Favored Glycine 0 C--N 1.375 2.702 0 O-C-N 119.434 -2.041 . . . . 0.0 110.08 -164.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 47.6 t 53.6 73.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.226 0 C-N-CA 125.734 1.614 . . . . 0.0 111.586 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.89 116.1 28.62 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 25.0 ptt85 -98.93 -33.26 10.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.706 -173.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.03 79.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 166.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.88 131.71 40.48 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 120.895 0.378 . . . . 0.0 111.299 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 24.6 t -144.18 115.23 7.88 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 125.324 1.45 . . . . 0.0 108.367 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.54 85.51 0.66 Allowed Glycine 0 CA--C 1.481 -2.035 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 172.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.632 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.675 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 70.0 mt -122.31 134.1 54.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.76 162.24 27.74 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 25.5 m -118.82 130.9 73.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -136.14 150.06 48.91 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.7 t -105.12 -76.35 0.61 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.454 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 13.7 tp -61.48 -49.53 76.39 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.25 -177.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.081 1.352 . . . . 0.0 110.477 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.85 84.14 1.31 Allowed Pre-proline 0 C--N 1.356 0.848 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.59 88.14 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 122.478 1.921 . . . . 0.0 109.952 164.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.8 146.22 47.72 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.14 161.37 15.79 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.397 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.65 122.15 20.07 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.408 1.458 . . . . 0.0 108.633 172.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.2 72.71 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 125.504 1.526 . . . . 0.0 111.261 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.99 175.59 3.63 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.739 0.781 . . . . 0.0 111.673 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.9 m -142.81 127.0 17.52 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.774 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.31 147.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 C-N-CA 124.276 1.03 . . . . 0.0 109.155 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 19.6 t -142.43 137.89 30.69 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.849 1.659 . . . . 0.0 111.193 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.7 129.71 41.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -104.05 132.98 49.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.84 71.53 1.45 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.515 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.75 99.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.76 74.43 1.11 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 113.72 145.09 9.05 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -114.1 -21.13 10.68 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.595 0.758 . . . . 0.0 110.007 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -98.71 85.81 3.4 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.82 -158.66 0.88 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -172.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -120.54 169.47 10.32 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 23.2 t -108.38 130.66 55.21 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.72 154.53 30.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.0 115.41 20.44 Favored Pre-proline 0 C--N 1.355 0.813 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 172.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -103.39 176.89 0.15 Allowed 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 121.807 1.671 . . . . 0.0 108.075 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.33 138.97 50.89 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -137.54 139.2 40.33 Favored 'General case' 0 C--N 1.376 1.757 0 CA-C-N 119.931 1.241 . . . . 0.0 108.489 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 34.8 mm -115.14 131.51 67.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -125.34 104.47 8.48 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 982' ' ' SER . . . . . 0.423 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 26.6 p -102.17 163.92 11.98 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.475 1.51 . . . . 0.0 110.42 172.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.1 113.19 0.37 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.71 46.69 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.5 124.63 26.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 125.495 1.518 . . . . 0.0 109.598 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.34 -57.61 2.16 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -131.93 127.54 36.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.6 129.32 9.85 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 103.739 -3.744 . . . . 0.0 103.739 165.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.56 127.8 91.66 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.285 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -106.95 78.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.534 0 CA-C-N 121.735 1.655 . . . . 0.0 109.449 -168.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 78.86 -72.77 0.08 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 130.039 3.336 . . . . 0.0 109.063 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 66.0 mt 48.88 40.53 16.78 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 128.975 2.91 . . . . 0.0 113.576 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -112.45 131.1 55.74 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -128.85 108.3 10.34 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.265 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.509 -0.76 0 N-CA-C 109.989 -0.812 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.93 119.36 21.14 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -90.07 -22.02 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.222 1.829 . . . . 0.0 109.666 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 38.14 69.16 0.26 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 128.757 2.823 . . . . 0.0 115.408 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.79 137.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.92 159.29 41.91 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 166.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.27 117.67 0.54 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.3 153.91 33.18 Favored 'General case' 0 C--N 1.372 1.575 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -134.39 158.52 43.63 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.411 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.24 127.71 30.54 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 71.5 m -163.12 9.42 0.05 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -159.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -28.5 152.28 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.378 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 160.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -78.38 -42.26 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 121.943 1.73 . . . . 0.0 113.382 -164.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -166.23 -159.16 0.37 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.2 m -31.54 139.04 0.04 OUTLIER 'General case' 0 C--N 1.361 1.104 0 C-N-CA 129.478 3.111 . . . . 0.0 115.29 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.89 164.54 43.14 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.93 -14.15 12.53 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.591 2.194 . . . . 0.0 111.147 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.9 -139.02 2.62 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.2 m -62.93 145.4 55.33 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 126.87 2.068 . . . . 0.0 111.011 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.44 128.12 54.24 Favored Pre-proline 0 N--CA 1.437 -1.093 0 C-N-CA 125.39 1.476 . . . . 0.0 110.315 -165.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -96.26 -149.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.943 3.096 . . . . 0.0 108.361 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.96 134.17 18.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -116.81 -14.45 10.73 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 122.62 0.368 . . . . 0.0 111.719 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.55 87.8 3.46 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.658 0.663 . . . . 0.0 112.47 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.69 97.83 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.014 1.726 . . . . 0.0 106.781 168.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 78.4 mt -87.71 -37.84 16.33 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.865 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 31.7 tp -166.31 127.55 1.77 Allowed 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 163.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 179.53 60.82 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.806 1.639 . . . . 0.0 109.16 -166.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.46 -43.94 93.1 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -165.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.36 -28.04 14.0 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.733 0.697 . . . . 0.0 112.49 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.57 -58.57 0.39 Allowed Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.516 -2.234 . . . . 0.0 107.516 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 63.16 -80.58 0.03 OUTLIER 'General case' 0 C--N 1.355 0.823 0 C-N-CA 128.065 2.546 . . . . 0.0 114.286 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -96.46 119.82 35.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.678 1.191 . . . . 0.0 108.416 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -80.0 117.22 66.39 Favored Pre-proline 0 CA--C 1.503 -0.834 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -93.81 6.25 2.73 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 CA-C-N 125.45 2.982 . . . . 0.0 109.031 -167.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -80.1 -46.66 16.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 21.5 p -108.18 -10.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 108.667 173.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 27.42 38.05 Favored Glycine 0 C--N 1.363 2.028 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 162.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.13 103.26 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.578 0 N-CA-C 100.816 -3.772 . . . . 0.0 100.816 -164.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.36 112.83 25.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.19 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 61.0 m -100.58 108.48 20.4 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.83 110.69 43.53 Favored Pre-proline 0 C--N 1.358 0.966 0 CA-C-O 117.033 -1.461 . . . . 0.0 112.459 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -96.46 -1.21 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 123.109 2.146 . . . . 0.0 109.142 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.82 -50.18 66.74 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.65 2.38 . . . . 0.0 114.188 -168.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.18 47.9 13.65 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.29 1.436 . . . . 0.0 114.486 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -160.42 -165.41 17.2 Favored Glycine 0 N--CA 1.415 -2.746 1 N-CA-C 101.291 -4.724 . . . . 0.0 101.291 175.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . 0.441 HH21 HG22 ' A' ' 953' ' ' ILE . 75.9 ttt-85 -93.83 120.9 34.7 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.273 3.7 p90 -115.33 161.33 18.66 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 118.939 0.791 . . . . 0.0 109.479 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.8 tp -104.61 117.08 33.22 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.434 0.694 . . . . 0.0 109.47 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -111.26 137.38 49.06 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 126.446 1.898 . . . . 0.0 108.941 -167.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.7 m -145.58 119.14 9.1 Favored 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.63 153.35 22.5 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.38 120.43 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.62 123.87 47.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.843 -173.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 49.0 m -79.12 131.45 36.24 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 125.396 1.478 . . . . 0.0 107.37 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.19 -55.77 25.97 Favored Glycine 0 C--N 1.365 2.194 0 C-N-CA 124.571 1.081 . . . . 0.0 112.268 -169.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.41 64.91 1.56 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 126.486 1.914 . . . . 0.0 113.466 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -70.84 -9.01 56.74 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.976 1.71 . . . . 0.0 112.731 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.7 -16.8 61.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.509 1.524 . . . . 0.0 112.558 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.321 9.6 pt-20 124.2 -176.18 0.0 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.204 2.602 . . . . 0.0 107.729 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 77.3 tttt 101.49 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 127.743 2.417 . . . . 0.0 106.914 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.33 128.7 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -170.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -110.76 121.16 44.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.042 1.737 . . . . 0.0 113.316 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.37 115.68 15.16 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 128.474 2.71 . . . . 0.0 109.239 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.6 t -88.59 114.08 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.32 141.41 58.3 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.188 1.795 . . . . 0.0 110.713 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 3.9 t -116.29 146.34 42.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 126.089 1.756 . . . . 0.0 109.847 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.411 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.24 141.21 38.74 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 127.201 2.201 . . . . 0.0 110.583 -176.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.313 31.4 p 86.89 10.35 0.17 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 130.268 3.427 . . . . 0.0 114.581 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.83 -25.02 0.27 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-N 119.076 0.853 . . . . 0.0 110.751 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 58.95 166.57 0.05 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.655 1.582 . . . . 0.0 111.703 -164.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.51 51.27 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 119.387 -2.07 . . . . 0.0 109.878 -161.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 48.4 t 57.82 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 125.785 1.634 . . . . 0.0 110.646 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.84 114.14 26.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.12 -36.79 8.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.618 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 92.1 t -100.02 80.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -97.2 128.58 44.21 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.199 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -143.71 116.5 8.76 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.555 1.542 . . . . 0.0 107.369 172.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.54 84.85 0.76 Allowed Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 103.863 -3.695 . . . . 0.0 103.863 163.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.925 0 C-N-CA 124.572 1.082 . . . . 0.0 113.103 176.41 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 73.1 mt -123.49 134.2 53.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.1 161.96 26.39 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 21.1 m -124.51 127.78 73.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.18 146.57 42.86 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -114.52 -46.27 2.97 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.408 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 27.3 tp -82.17 -49.87 9.65 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.426 1.012 . . . . 0.0 112.73 -166.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.441 HG22 HH21 ' A' ' 893' ' ' ARG . 13.5 pt -84.7 -174.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.88 1.672 . . . . 0.0 110.044 -178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.7 81.72 2.73 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -167.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 91.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.294 1.996 . . . . 0.0 109.64 163.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -121.9 144.69 48.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -92.8 157.12 16.57 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.119 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.37 123.31 21.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 119.852 1.206 . . . . 0.0 109.056 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.58 -12.03 70.73 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.184 1.849 . . . . 0.0 111.223 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.65 175.57 5.53 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.717 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.8 m -142.31 125.83 16.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -160.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.411 HG13 HH11 ' A' ' 914' ' ' ARG . 4.0 m -96.8 148.5 5.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.249 0.62 . . . . 0.0 109.331 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.5 t -143.82 138.65 28.84 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.051 1.74 . . . . 0.0 111.19 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 71.4 t -91.84 130.28 41.22 Favored 'Isoleucine or valine' 0 C--N 1.367 1.364 0 C-N-CA 126.767 2.027 . . . . 0.0 107.069 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -105.52 133.11 50.81 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 101.071 -3.677 . . . . 0.0 101.071 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 1.5 tp -129.22 72.11 1.46 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.041 -1.89 . . . . 0.0 105.975 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 58.2 t -162.83 100.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.898 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 89.6 mmm -153.59 70.01 0.83 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.77 145.21 7.24 Favored Glycine 0 CA--C 1.493 -1.304 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -112.3 -29.28 7.6 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.3 tp -92.17 87.32 6.06 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.55 -165.32 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -171.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -124.19 159.67 29.59 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -91.64 131.22 37.19 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.1 149.27 22.88 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.91 112.15 22.06 Favored Pre-proline 0 C--N 1.356 0.852 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -99.59 172.33 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.117 1.878 . . . . 0.0 108.269 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.1 mp -116.85 141.17 48.57 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.72 142.33 36.85 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 119.337 0.971 . . . . 0.0 108.562 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.95 129.5 74.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.85 105.63 9.09 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.4 p -101.02 160.55 14.28 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.914 1.286 . . . . 0.0 110.212 171.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.47 110.22 0.29 Allowed Glycine 0 C--N 1.359 1.816 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.96 144.05 46.69 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 67.6 tp -74.15 123.13 23.87 Favored 'General case' 0 C--N 1.379 1.87 0 C-N-CA 124.692 1.197 . . . . 0.0 109.402 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 33.6 tp -99.0 -57.76 2.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.4 127.47 35.49 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.85 131.01 10.53 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.183 -3.567 . . . . 0.0 104.183 164.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.94 129.5 90.87 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.663 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -107.0 80.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.783 1.672 . . . . 0.0 109.823 -168.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 77.69 -72.91 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 130.303 3.441 . . . . 0.0 109.238 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.9 mt 49.6 38.76 15.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 129.288 3.035 . . . . 0.0 114.085 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.31 131.78 54.75 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.42 107.31 9.4 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 179.462 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 N-CA-C 109.99 -0.812 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.65 119.53 21.55 Favored Pre-proline 0 C--N 1.352 0.71 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -90.78 -21.97 0.7 Allowed 'Trans proline' 0 CA--C 1.513 -0.572 0 CA-C-N 122.105 1.787 . . . . 0.0 109.758 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 38.77 69.77 0.25 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.969 2.908 . . . . 0.0 115.065 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.6 136.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.9 158.1 45.14 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -149.02 138.37 21.64 Favored 'General case' 0 C--N 1.361 1.076 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.2 t -170.42 118.61 0.55 Allowed 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.88 153.81 33.94 Favored 'General case' 0 C--N 1.371 1.51 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.9 158.55 44.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.157 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -136.11 125.08 24.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -166.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.3 m -162.45 13.43 0.07 Allowed 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.959 1.304 . . . . 0.0 107.933 -164.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -27.89 152.8 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.38 0 N-CA-C 118.219 2.674 . . . . 0.0 118.219 158.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -78.04 -42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 CA-C-N 122.01 1.754 . . . . 0.0 113.438 -164.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 16.7 ptt85 -166.65 -159.01 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.0 m -31.35 139.12 0.03 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 129.392 3.077 . . . . 0.0 115.355 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -133.12 164.4 44.23 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.94 -14.1 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.618 2.212 . . . . 0.0 111.202 -175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.0 -138.99 2.62 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -62.83 145.26 55.42 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.81 2.044 . . . . 0.0 110.944 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 91.8 t -88.33 127.78 55.69 Favored Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 125.325 1.45 . . . . 0.0 110.161 -165.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.09 -149.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.952 3.101 . . . . 0.0 108.276 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.35 133.75 18.56 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -115.08 -14.35 11.8 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.747 0.819 . . . . 0.0 110.59 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.01 87.53 3.3 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.075 0.464 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.79 97.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 164.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 32.6 mt -87.92 -39.41 14.78 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.373 -173.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 46.5 tp -165.72 126.18 1.81 Allowed 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 100.492 -3.892 . . . . 0.0 100.492 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 176.25 60.58 0.0 OUTLIER 'General case' 0 C--N 1.356 0.859 0 CA-C-N 120.405 1.457 . . . . 0.0 108.514 -162.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.9 -43.53 94.78 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -165.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.07 -28.39 13.68 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 118.723 0.692 . . . . 0.0 112.518 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.09 -57.45 0.43 Allowed Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.96 -81.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.827 0 C-N-CA 128.095 2.558 . . . . 0.0 114.325 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -97.01 119.7 35.98 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 124.854 1.261 . . . . 0.0 108.495 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -79.36 117.58 67.84 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 115.481 -2.2 . . . . 0.0 105.322 171.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.92 6.03 3.11 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 CA-C-N 125.51 3.004 . . . . 0.0 109.28 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.88 -45.6 18.33 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.027 0.931 . . . . 0.0 108.888 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 20.7 p -110.05 -11.4 14.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.658 1.183 . . . . 0.0 108.435 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.63 33.22 Favored Glycine 0 C--N 1.363 2.069 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.66 102.79 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.73 113.13 25.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.014 -174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -100.83 108.48 20.29 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.57 110.92 44.61 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 117.062 -1.447 . . . . 0.0 112.825 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -95.92 -1.34 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 CA-C-N 123.301 2.215 . . . . 0.0 109.278 169.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 14.5 mt -53.67 -49.83 67.12 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 127.587 2.355 . . . . 0.0 114.358 -167.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.6 48.59 11.57 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.123 1.369 . . . . 0.0 114.676 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.18 -165.62 20.6 Favored Glycine 0 N--CA 1.412 -2.922 1 N-CA-C 101.534 -4.626 . . . . 0.0 101.534 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -93.44 120.38 33.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.298 2.4 p90 -116.92 161.29 19.57 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.132 0.878 . . . . 0.0 109.624 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -105.82 116.04 31.27 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.37 137.32 47.41 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.444 1.898 . . . . 0.0 108.251 -170.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.5 m -144.46 118.74 9.56 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 153.29 22.92 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.21 121.09 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.15 123.34 47.65 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.127 0.971 . . . . 0.0 108.522 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 43.9 m -78.61 131.41 36.71 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.204 1.402 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -56.76 22.03 Favored Glycine 0 C--N 1.367 2.271 0 C-N-CA 124.73 1.157 . . . . 0.0 112.601 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.5 65.17 1.48 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.552 1.941 . . . . 0.0 113.627 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -70.72 -9.14 56.59 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.017 1.727 . . . . 0.0 112.835 -168.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.88 -15.2 61.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.852 1.661 . . . . 0.0 112.763 -168.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.0 pt-20 122.52 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 128.575 2.75 . . . . 0.0 107.754 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 101.05 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 127.763 2.425 . . . . 0.0 107.126 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 81.2 t -99.82 128.05 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -170.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -108.57 121.18 44.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.202 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.24 115.1 13.76 Favored 'General case' 0 C--N 1.385 2.117 0 C-N-CA 128.21 2.604 . . . . 0.0 109.568 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.48 114.83 27.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 119.695 1.134 . . . . 0.0 108.273 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.24 142.77 57.52 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.84 2.056 . . . . 0.0 110.607 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 3.5 t -116.94 146.71 42.82 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.282 1.833 . . . . 0.0 109.656 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.428 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.13 140.8 37.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.936 2.094 . . . . 0.0 110.22 -177.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.31 28.5 p 87.0 8.37 0.21 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.275 3.43 . . . . 0.0 114.731 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.36 -24.93 0.29 Allowed 'General case' 0 C--N 1.356 0.865 0 CA-C-N 119.426 1.012 . . . . 0.0 111.346 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 58.87 165.12 0.04 OUTLIER 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.721 1.609 . . . . 0.0 111.767 -164.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.52 -132.71 47.61 Favored Glycine 0 C--N 1.366 2.196 0 O-C-N 119.438 -2.039 . . . . 0.0 109.599 -162.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.0 77.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.234 0 C-N-CA 126.09 1.756 . . . . 0.0 110.878 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.47 114.62 27.19 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -174.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.69 -36.84 7.74 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.8 -1.545 . . . . 0.0 108.571 -171.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.76 79.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.71 128.42 44.37 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.808 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 28.3 t -142.65 117.67 10.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.607 1.563 . . . . 0.0 107.205 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.59 84.96 0.76 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 104.312 -3.515 . . . . 0.0 104.312 165.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.898 0 C-N-CA 124.734 1.159 . . . . 0.0 113.127 176.405 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.6 m . . . . . 0 CA--C 1.508 -0.666 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.6 mt -115.75 134.2 55.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.13 26.94 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.9 129.86 74.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.86 148.91 45.83 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.1 m -120.88 -38.99 2.76 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.5 0.591 . . . . 0.0 111.995 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.1 tp -82.48 -49.09 10.3 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.351 0.978 . . . . 0.0 112.612 -168.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 42.4 pt -85.15 -175.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.699 1.599 . . . . 0.0 109.829 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 80.91 2.59 Favored Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -169.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.14 92.13 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.479 2.119 . . . . 0.0 110.026 164.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -121.44 144.46 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.95 158.36 15.85 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.828 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.84 122.78 21.33 Favored 'General case' 0 C--N 1.381 1.947 0 CA-C-N 120.147 1.339 . . . . 0.0 108.791 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.26 -11.57 71.78 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 125.868 1.699 . . . . 0.0 111.009 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.43 175.34 5.56 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.608 0.763 . . . . 0.0 110.964 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.1 m -142.56 125.71 16.39 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -159.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.428 HG13 HH11 ' B' ' 914' ' ' ARG . 4.5 m -97.5 148.62 5.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.509 0.724 . . . . 0.0 109.734 173.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -143.33 138.82 29.76 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 126.325 1.85 . . . . 0.0 111.229 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 83.3 t -91.16 130.59 40.1 Favored 'Isoleucine or valine' 0 C--N 1.368 1.413 0 C-N-CA 127.398 2.279 . . . . 0.0 107.312 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.6 133.23 50.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 100.56 -3.867 . . . . 0.0 100.56 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 1.8 tp -129.02 71.53 1.43 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.4 t -161.25 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.0 mmm -152.46 69.83 0.89 Allowed 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.58 144.51 7.09 Favored Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -111.13 -28.69 8.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.78 87.32 5.81 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.34 -164.32 1.57 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -124.55 159.42 30.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 19.0 t -90.79 130.6 36.75 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.13 149.22 22.77 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.81 112.1 22.31 Favored Pre-proline 0 C--N 1.355 0.835 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -99.32 172.36 0.45 Allowed 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 122.099 1.866 . . . . 0.0 108.139 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.1 139.3 50.44 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -138.39 140.78 39.53 Favored 'General case' 0 C--N 1.373 1.63 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.94 129.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -126.55 105.74 8.95 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 55.5 p -102.4 162.42 12.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.467 1.107 . . . . 0.0 110.989 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.53 111.35 0.32 Allowed Glycine 0 C--N 1.358 1.789 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.14 47.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -72.57 122.83 22.01 Favored 'General case' 0 C--N 1.382 2.004 0 C-N-CA 124.583 1.153 . . . . 0.0 109.387 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.9 tp -98.74 -57.84 2.09 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -131.83 127.27 36.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.65 130.67 10.37 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 165.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.87 129.0 91.45 Favored Pre-proline 0 C--N 1.351 0.674 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.532 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -106.77 78.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.016 1.756 . . . . 0.0 109.325 -167.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 77.93 -72.66 0.09 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 130.131 3.372 . . . . 0.0 109.061 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 73.6 mt 49.08 40.63 17.76 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 129.064 2.946 . . . . 0.0 113.719 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.57 131.88 55.39 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.51 106.98 8.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 179.15 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.456 -0.718 0 N-CA-C 110.038 -0.793 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.55 113.75 27.29 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.91 -22.88 1.36 Allowed 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 121.648 1.624 . . . . 0.0 110.151 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 36.8 70.19 0.18 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 128.873 2.869 . . . . 0.0 115.659 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.18 137.03 57.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.66 156.75 48.21 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -149.0 137.39 20.99 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-N 118.871 0.759 . . . . 0.0 109.23 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.9 t -171.08 118.86 0.49 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.53 153.06 37.23 Favored 'General case' 0 C--N 1.368 1.378 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.15 159.55 41.94 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.972 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.66 130.73 23.28 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -165.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.5 m -160.49 14.16 0.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.2 pp -27.5 145.9 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.532 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 161.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.64 -46.5 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 122.052 1.768 . . . . 0.0 113.634 -162.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -162.75 172.22 15.59 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.8 m -3.57 111.92 0.01 OUTLIER 'General case' 0 C--N 1.363 1.178 0 C-N-CA 130.907 3.683 . . . . 0.0 116.942 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -99.49 163.18 19.05 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 123.646 0.778 . . . . 0.0 110.56 -172.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.61 -17.2 11.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.869 2.38 . . . . 0.0 110.841 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.66 -141.45 3.25 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.3 m -66.52 146.66 54.28 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.268 1.827 . . . . 0.0 110.715 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 96.0 t -94.73 131.27 30.98 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 124.822 1.249 . . . . 0.0 111.164 -159.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -97.6 -151.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 124.087 3.192 . . . . 0.0 109.278 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -147.04 134.37 20.68 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -113.98 -16.0 12.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.353 0.661 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -102.22 84.66 2.52 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.326 0.584 . . . . 0.0 111.7 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.86 97.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.385 1.874 . . . . 0.0 106.697 163.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 8.6 mt -90.1 -38.78 13.31 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.324 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.6 tp -165.54 126.49 1.9 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 174.76 60.81 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 120.188 1.358 . . . . 0.0 107.704 -162.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.87 -42.7 94.29 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -164.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.37 -28.82 15.88 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 118.665 0.666 . . . . 0.0 112.306 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.59 -57.58 0.48 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 62.92 -81.22 0.02 OUTLIER 'General case' 0 C--N 1.354 0.782 0 C-N-CA 128.289 2.636 . . . . 0.0 114.641 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -96.02 121.02 37.32 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.534 1.534 . . . . 0.0 108.463 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.41 116.63 65.94 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -94.28 7.61 2.34 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 CA-C-N 125.167 2.881 . . . . 0.0 109.648 -166.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -79.23 -47.37 16.06 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.2 p -108.05 -9.55 15.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.932 1.293 . . . . 0.0 108.285 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.3 25.23 44.51 Favored Glycine 0 C--N 1.361 1.959 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 161.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.62 102.82 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 -163.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -94.83 111.77 23.53 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.494 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -101.8 108.21 19.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . 0.467 ' HB2' HH22 ' C' ' 914' ' ' ARG . . . -91.71 110.35 42.84 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.321 169.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -92.21 0.59 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.53 2.154 . . . . 0.0 108.21 165.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 51.6 mt -54.21 -53.23 56.41 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 127.837 2.455 . . . . 0.0 113.672 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.59 66.42 1.08 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 122.16 0.981 . . . . 0.0 110.84 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.44 170.29 43.06 Favored Glycine 0 N--CA 1.404 -3.485 1 N-CA-C 100.568 -5.013 . . . . 0.0 100.568 -167.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -93.85 115.86 28.29 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.375 -1.413 . . . . 0.0 107.968 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -116.5 160.59 20.38 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 119.088 0.858 . . . . 0.0 110.946 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 56.1 tp -107.49 113.35 26.63 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 124.685 1.194 . . . . 0.0 108.05 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . 0.405 HD13 HH12 ' C' ' 921' ' ' ARG . 7.1 tt -118.53 140.81 49.29 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.756 1.223 . . . . 0.0 109.574 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -144.14 120.28 10.79 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.923 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.0 154.22 19.93 Favored 'General case' 0 C--N 1.364 1.208 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 80.1 t -99.57 122.96 51.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.76 122.93 39.06 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.375 1.07 . . . . 0.0 109.39 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 33.8 m -80.4 131.2 35.57 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.72 20.06 Favored Glycine 0 C--N 1.362 2.018 0 C-N-CA 125.872 1.701 . . . . 0.0 114.975 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 32.44 72.65 0.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 128.18 2.592 . . . . 0.0 115.528 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -71.69 -12.72 61.47 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 126.224 1.81 . . . . 0.0 111.552 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -73.07 -17.63 61.4 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.778 1.631 . . . . 0.0 112.502 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.2 pt-20 123.44 -172.21 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 128.498 2.719 . . . . 0.0 107.917 173.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 102.19 133.26 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 128.045 2.538 . . . . 0.0 106.706 171.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 82.3 t -98.32 123.8 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -104.27 129.8 52.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.528 1.931 . . . . 0.0 109.764 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.79 114.14 3.15 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.769 1.228 . . . . 0.0 110.427 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.7 117.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 126.136 1.774 . . . . 0.0 108.809 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.1 mt -63.3 135.9 57.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.294 1.037 . . . . 0.0 109.857 172.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 8.6 t -117.49 143.94 45.55 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 126.636 1.974 . . . . 0.0 107.145 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.467 HH22 ' HB2' ' C' ' 888' ' ' ALA . 0.1 OUTLIER -79.88 140.86 36.59 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.159 2.184 . . . . 0.0 110.593 -170.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.315 25.0 p 89.49 6.52 0.13 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 130.205 3.402 . . . . 0.0 113.93 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -149.45 -25.04 0.28 Allowed 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.234 0.924 . . . . 0.0 111.622 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.39 166.92 0.06 Allowed 'General case' 0 C--N 1.364 1.237 0 C-N-CA 125.474 1.51 . . . . 0.0 111.848 -164.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.41 -131.21 51.93 Favored Glycine 0 C--N 1.375 2.737 0 O-C-N 119.441 -2.037 . . . . 0.0 110.047 -163.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . 0.252 47.6 t 54.87 73.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.244 0 C-N-CA 125.404 1.482 . . . . 0.0 111.741 173.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.09 115.9 28.47 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -172.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.405 HH12 HD13 ' C' ' 896' ' ' LEU . 11.7 ptt180 -98.83 -33.59 10.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.744 -173.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.14 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -95.35 131.32 41.59 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.922 0.391 . . . . 0.0 111.14 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -144.26 116.02 8.23 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 125.284 1.434 . . . . 0.0 108.198 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.35 85.23 0.72 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 104.566 -3.413 . . . . 0.0 104.566 169.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.671 0 C-N-CA 125.117 1.341 . . . . 0.0 111.18 172.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.4 mt -120.91 134.32 55.29 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.05 162.77 26.37 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.58 130.17 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.28 148.85 52.73 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.299 -0.875 . . . . 0.0 109.737 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.4 m -107.48 -79.85 0.57 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.566 0.746 . . . . 0.0 109.132 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.9 tp -64.1 -49.19 73.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.322 1.849 . . . . 0.0 115.008 -163.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.39 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 126.148 1.779 . . . . 0.0 110.242 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.19 88.35 0.99 Allowed Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -168.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.51 89.86 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.724 2.283 . . . . 0.0 110.121 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 86.0 mt -124.31 147.08 48.41 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.734 1.213 . . . . 0.0 108.014 -176.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.93 158.99 15.24 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.065 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.05 122.86 20.21 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 120.29 1.405 . . . . 0.0 109.516 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.56 77.15 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 126.259 1.885 . . . . 0.0 111.822 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.47 173.85 7.38 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.888 0.875 . . . . 0.0 110.057 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 12.9 t -144.15 129.13 18.51 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.271 -0.893 . . . . 0.0 111.08 -160.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 27.1 m -95.38 149.18 4.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.251 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.46 137.13 33.67 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 126.181 1.793 . . . . 0.0 111.851 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.15 129.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.376 1.739 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -105.04 133.76 49.28 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 9.2 mp -126.89 81.06 1.99 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 112.794 -2.003 . . . . 0.0 107.433 168.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.0 t -158.96 98.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.2 mmm -151.87 73.38 1.06 Allowed 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.43 145.48 10.54 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 108.139 -1.985 . . . . 0.0 108.139 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -112.52 -30.95 6.95 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -91.9 87.05 6.07 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -160.84 1.1 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -172.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -122.54 156.1 34.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.5 t -92.54 133.64 35.74 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -157.34 150.07 23.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 112.11 20.35 Favored Pre-proline 0 C--N 1.357 0.913 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -101.5 175.52 0.24 Allowed 'Trans proline' 0 CA--C 1.509 -0.766 0 C-N-CA 121.877 1.718 . . . . 0.0 108.303 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -115.84 140.58 49.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 24.0 p -137.0 140.17 41.94 Favored 'General case' 0 C--N 1.376 1.749 0 CA-C-N 119.503 1.047 . . . . 0.0 108.466 -172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.2 mm -115.94 131.26 68.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -125.56 104.78 8.59 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 982' ' ' SER . . . . . 0.408 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 33.1 p -101.62 164.07 11.94 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 125.473 1.509 . . . . 0.0 110.427 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.83 112.81 0.35 Allowed Glycine 0 C--N 1.359 1.824 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.76 45.71 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -77.01 124.47 27.82 Favored 'General case' 0 C--N 1.378 1.847 0 C-N-CA 125.046 1.338 . . . . 0.0 109.096 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.97 -57.51 2.21 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -132.19 127.41 35.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.71 129.83 10.06 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 104.051 -3.62 . . . . 0.0 104.051 166.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.1 129.33 90.82 Favored Pre-proline 0 C--N 1.351 0.637 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.937 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -106.74 76.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 121.948 1.731 . . . . 0.0 109.593 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.53 -72.81 0.08 Allowed 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 130.192 3.397 . . . . 0.0 108.989 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 49.56 38.7 15.34 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 129.151 2.981 . . . . 0.0 113.768 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -109.86 131.7 54.82 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -129.92 106.65 8.8 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.071 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.352 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 N-CA-C 109.678 -0.932 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.33 120.44 21.06 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.86 -20.31 0.86 Allowed 'Trans proline' 0 CA--C 1.51 -0.718 0 CA-C-N 122.204 1.823 . . . . 0.0 109.699 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 36.41 69.9 0.18 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 128.987 2.915 . . . . 0.0 115.898 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.19 137.05 54.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.94 160.25 38.88 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -149.2 138.92 21.84 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.0 t -169.37 117.27 0.62 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.9 152.88 36.69 Favored 'General case' 0 C--N 1.37 1.497 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.12 158.73 43.79 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.643 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -132.82 133.53 43.48 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 40.5 p -163.21 9.51 0.05 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -164.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 2.7 pp -31.42 149.21 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.483 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 160.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.39 -43.22 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 CA-C-N 122.34 1.871 . . . . 0.0 113.527 -161.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -162.52 174.13 13.08 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.679 1.127 . . . . 0.0 108.097 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.1 m -2.34 117.01 0.01 OUTLIER 'General case' 0 C--N 1.364 1.214 0 C-N-CA 131.383 3.873 . . . . 0.0 117.103 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.06 141.57 23.68 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -164.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -73.9 -11.48 23.66 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.845 2.364 . . . . 0.0 113.44 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.83 -130.37 1.17 Allowed Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 30.6 m -82.35 143.8 31.0 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.56 131.68 33.53 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 124.594 1.157 . . . . 0.0 110.631 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -93.11 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.863 3.042 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.35 135.23 20.02 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 119.248 0.931 . . . . 0.0 108.532 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -117.83 -13.52 10.12 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 122.895 0.478 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.34 87.3 3.38 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 118.574 0.624 . . . . 0.0 112.183 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.86 97.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.144 1.777 . . . . 0.0 106.894 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 49.4 mt -88.22 -37.09 16.37 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.577 -0.702 . . . . 0.0 110.709 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.6 tp -165.58 125.53 1.78 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 101.138 -3.653 . . . . 0.0 101.138 161.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -174.13 61.14 0.02 OUTLIER 'General case' 0 C--N 1.356 0.886 0 CA-C-N 120.38 1.446 . . . . 0.0 109.321 -168.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.36 -44.2 92.72 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -163.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.68 -28.38 12.6 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 118.863 0.756 . . . . 0.0 112.307 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.83 -60.55 0.32 Allowed Glycine 0 C--N 1.354 1.531 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 62.47 -80.9 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.978 2.511 . . . . 0.0 114.19 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.33 119.75 32.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 124.883 1.273 . . . . 0.0 108.919 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.72 117.43 68.51 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -96.69 1.87 1.86 Allowed 'Trans proline' 0 CA--C 1.506 -0.884 0 CA-C-N 124.986 2.817 . . . . 0.0 109.3 -165.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -79.9 -45.45 18.58 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.6 p -102.84 -13.99 16.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.103 0.961 . . . . 0.0 108.72 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 24.01 47.47 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.94 102.61 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -164.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 112.75 24.94 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 112.181 -2.281 . . . . 0.0 108.656 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 82.5 m -98.97 108.94 21.75 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.62 110.76 41.62 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.745 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.56 -4.88 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.08 2.136 . . . . 0.0 108.98 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 33.1 mt -49.06 -55.2 12.84 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 128.664 2.786 . . . . 0.0 114.612 -168.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.9 65.25 1.35 Allowed 'General case' 0 C--N 1.364 1.223 0 CA-C-O 121.926 0.869 . . . . 0.0 112.085 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.09 -175.53 42.63 Favored Glycine 0 N--CA 1.408 -3.21 1 N-CA-C 101.034 -4.826 . . . . 0.0 101.034 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.22 121.9 35.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.45 160.43 19.19 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 118.918 0.781 . . . . 0.0 108.965 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 59.7 tp -103.84 117.11 33.56 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.429 0.691 . . . . 0.0 109.698 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.87 136.3 50.11 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 126.762 2.025 . . . . 0.0 108.88 -165.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.2 m -147.17 119.17 8.18 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.597 0.759 . . . . 0.0 109.501 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 154.22 21.56 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 79.0 t -109.3 119.18 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.78 124.33 46.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.992 -173.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 33.7 m -80.48 133.27 35.81 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.34 1.456 . . . . 0.0 107.547 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.9 -57.11 21.58 Favored Glycine 0 C--N 1.364 2.137 0 C-N-CA 125.003 1.287 . . . . 0.0 114.214 -169.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 61.9 m170 35.37 72.73 0.09 Allowed 'General case' 0 C--N 1.361 1.087 0 C-N-CA 127.387 2.275 . . . . 0.0 115.266 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -73.74 -8.38 55.77 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.17 1.388 . . . . 0.0 111.72 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -71.92 -19.93 61.85 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.043 1.337 . . . . 0.0 112.49 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.319 9.3 pt-20 125.03 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.137 0 C-N-CA 128.232 2.613 . . . . 0.0 108.333 174.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 101.01 131.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.846 2.459 . . . . 0.0 106.753 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.31 124.91 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 123.512 1.625 . . . . 0.0 106.839 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -105.68 122.44 46.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.207 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.05 116.46 17.1 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 128.307 2.643 . . . . 0.0 108.769 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.62 113.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.09 142.17 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.538 1.535 . . . . 0.0 111.194 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -115.0 145.09 42.62 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 127.007 2.123 . . . . 0.0 109.086 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.52 139.22 37.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 127.791 2.436 . . . . 0.0 109.429 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.4 t 100.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.35 0.595 0 C-N-CA 129.463 3.105 . . . . 0.0 113.229 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -144.53 -24.41 0.52 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 119.486 1.039 . . . . 0.0 110.958 -175.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 60.18 167.43 0.08 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 124.886 1.274 . . . . 0.0 111.833 -164.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.6 -133.62 52.66 Favored Glycine 0 C--N 1.375 2.729 0 O-C-N 119.279 -2.138 . . . . 0.0 109.891 -161.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 46.7 t 56.6 75.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.295 0 C-N-CA 125.523 1.529 . . . . 0.0 110.99 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.57 115.22 27.71 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -103.05 -35.11 8.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.309 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 88.6 t -99.57 75.77 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.95 130.3 41.65 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.129 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.6 t -143.08 114.49 7.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.379 1.472 . . . . 0.0 108.411 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.54 84.82 0.69 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.882 -3.687 . . . . 0.0 103.882 163.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.859 0 C-N-CA 124.965 1.269 . . . . 0.0 112.708 174.42 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.443 -0.796 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 59.8 mt -117.71 133.54 55.84 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.33 161.33 26.05 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.5 m -125.25 126.3 70.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.77 149.44 43.55 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -115.02 -41.97 3.27 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.413 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 29.2 tp -82.59 -50.17 9.07 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 119.373 0.988 . . . . 0.0 113.133 -166.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.457 HG12 ' HG ' ' C' ' 853' ' ' SER . 8.2 pt -85.09 -171.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 125.371 1.469 . . . . 0.0 110.74 -175.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.25 81.52 2.57 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -168.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.18 90.84 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 CA-C-N 122.06 1.772 . . . . 0.0 109.536 160.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 8.3 mp -122.01 145.06 48.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -90.98 158.03 16.95 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.464 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.25 123.62 22.65 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-N 119.689 1.131 . . . . 0.0 108.715 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.01 69.9 Favored Glycine 0 CA--C 1.495 -1.2 0 C-N-CA 125.85 1.69 . . . . 0.0 110.999 170.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.11 175.64 5.08 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.025 0.44 . . . . 0.0 112.102 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 94.9 m -140.67 128.32 21.57 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -155.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.83 149.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -144.24 136.75 26.76 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.247 1.019 . . . . 0.0 111.65 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.21 129.75 44.06 Favored 'Isoleucine or valine' 0 C--N 1.369 1.453 0 C-N-CA 126.868 2.067 . . . . 0.0 107.245 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -107.92 132.29 53.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 168.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 21.0 tp -130.29 75.88 1.68 Allowed 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.212 -1.813 . . . . 0.0 107.045 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.8 t -160.81 101.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.06 71.79 0.92 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.71 150.57 8.3 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -119.06 -29.01 5.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.1 tp -92.25 87.07 5.94 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.5 -163.85 1.5 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -125.08 160.71 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.1 t -94.33 132.06 39.33 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -158.09 150.52 22.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.59 113.33 25.24 Favored Pre-proline 0 C--N 1.356 0.86 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -98.77 173.65 0.47 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.842 1.694 . . . . 0.0 108.365 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.43 141.49 48.27 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.6 p -139.59 142.06 37.13 Favored 'General case' 0 C--N 1.376 1.736 0 CA-C-N 119.592 1.087 . . . . 0.0 108.909 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.7 mm -119.61 129.81 74.88 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -126.15 105.77 9.09 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 44.6 p -101.25 161.92 13.26 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.816 1.246 . . . . 0.0 110.39 171.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.88 111.1 0.29 Allowed Glycine 0 C--N 1.358 1.764 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.1 144.93 46.34 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.01 123.4 25.69 Favored 'General case' 0 C--N 1.378 1.825 0 C-N-CA 124.763 1.225 . . . . 0.0 109.507 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 30.4 tp -98.23 -57.06 2.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -130.92 128.01 39.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.35 129.96 10.09 Favored Glycine 0 CA--C 1.487 -1.706 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 164.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 129.0 91.84 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -107.64 81.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 CA-C-N 121.835 1.691 . . . . 0.0 110.071 -169.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 77.76 -72.48 0.09 Allowed 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.12 3.368 . . . . 0.0 109.313 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 67.9 mt 49.41 38.81 14.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 128.841 2.856 . . . . 0.0 114.411 -176.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.86 131.09 55.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -128.09 109.41 11.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.099 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 179.321 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.961 0 N-CA-C 109.615 -0.956 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.62 121.17 22.11 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -92.45 -20.53 0.55 Allowed 'Trans proline' 0 CA--C 1.512 -0.581 0 CA-C-N 122.238 1.835 . . . . 0.0 110.037 -173.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 37.8 70.22 0.2 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 129.155 2.982 . . . . 0.0 115.532 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.94 136.82 54.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.6 40.69 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 165.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -149.22 139.19 22.03 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -169.17 117.87 0.66 Allowed 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.15 153.55 34.69 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.13 158.14 44.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.196 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -132.07 132.11 43.03 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -169.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 30.1 p -162.65 8.26 0.06 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -164.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 2.6 pp -31.44 149.94 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.441 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 161.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -81.75 -43.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.223 1.83 . . . . 0.0 113.494 -161.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -162.41 173.86 13.52 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 119.727 1.149 . . . . 0.0 108.201 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.9 m -1.77 116.81 0.01 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 131.398 3.879 . . . . 0.0 117.126 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -108.91 141.52 23.53 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -164.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -73.87 -11.57 23.75 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 122.801 2.334 . . . . 0.0 113.498 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.5 -130.71 1.19 Allowed Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 30.9 m -81.37 143.38 32.21 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.84 131.24 36.05 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 110.484 -160.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -94.15 -152.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.755 2.97 . . . . 0.0 109.248 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -148.38 135.21 19.97 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 119.156 0.889 . . . . 0.0 108.611 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -115.18 -13.22 11.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.387 1.075 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -100.77 87.62 3.37 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 118.208 0.458 . . . . 0.0 112.204 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.32 97.11 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 163.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.14 -38.69 15.15 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.31 -173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.7 tp -165.88 126.63 1.81 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 100.869 -3.752 . . . . 0.0 100.869 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 176.86 60.93 0.0 OUTLIER 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.196 1.362 . . . . 0.0 108.515 -163.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.46 -43.77 93.11 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -166.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.27 -29.68 10.99 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.889 0.768 . . . . 0.0 112.335 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.86 -59.54 0.35 Allowed Glycine 0 C--N 1.352 1.457 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 62.83 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.905 2.482 . . . . 0.0 114.408 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -96.07 119.59 34.84 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.924 1.29 . . . . 0.0 108.67 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.46 117.42 68.39 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 2.47 2.46 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 CA-C-N 125.077 2.849 . . . . 0.0 109.518 -166.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.04 -43.88 21.1 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 30.4 p -105.54 -14.29 15.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.443 1.097 . . . . 0.0 108.171 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 25.56 41.35 Favored Glycine 0 C--N 1.36 1.888 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 163.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.48 102.84 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 101.867 -3.382 . . . . 0.0 101.867 -163.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.89 113.24 25.29 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.837 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 70.6 m -99.61 109.31 21.82 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.12 111.03 42.55 Favored Pre-proline 0 C--N 1.356 0.882 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.91 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.36 -4.24 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-N 123.133 2.155 . . . . 0.0 109.192 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 21.6 mt -53.52 -49.46 67.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.184 2.193 . . . . 0.0 114.334 -167.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.56 50.61 12.55 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.627 1.571 . . . . 0.0 114.183 171.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -164.26 -165.87 22.21 Favored Glycine 0 N--CA 1.411 -3.008 1 N-CA-C 101.517 -4.633 . . . . 0.0 101.517 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -92.74 121.68 34.37 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.985 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 2.6 p90 -116.47 160.68 20.25 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 119.023 0.829 . . . . 0.0 109.269 176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.6 tp -104.72 116.0 31.28 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.26 135.7 50.61 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 126.332 1.853 . . . . 0.0 107.801 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.3 m -144.92 118.97 9.39 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.57 153.91 22.18 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 97.5 t -109.98 120.76 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.17 122.6 46.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.986 0.914 . . . . 0.0 108.812 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 32.5 m -79.29 133.35 36.64 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.258 1.423 . . . . 0.0 108.0 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.16 -57.2 21.09 Favored Glycine 0 C--N 1.365 2.167 0 C-N-CA 125.216 1.388 . . . . 0.0 114.267 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 61.3 m170 34.99 72.96 0.09 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.451 2.3 . . . . 0.0 115.186 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.66 -8.15 54.85 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.291 1.436 . . . . 0.0 111.674 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -73.18 -14.53 61.37 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.425 1.49 . . . . 0.0 112.631 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.7 pt-20 118.59 179.45 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 128.587 2.755 . . . . 0.0 108.77 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 102.08 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.057 2.543 . . . . 0.0 106.467 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.22 128.4 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -110.63 122.87 48.84 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.881 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.35 115.41 15.56 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.053 2.541 . . . . 0.0 109.932 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.47 114.18 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 O-C-N 120.216 -1.553 . . . . 0.0 106.863 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.28 144.9 56.54 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.454 1.902 . . . . 0.0 111.358 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -115.61 145.95 42.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 127.196 2.198 . . . . 0.0 109.038 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.13 138.96 35.88 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 126.828 2.051 . . . . 0.0 109.231 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.6 t 100.85 -10.82 0.03 OUTLIER 'General case' 0 C--N 1.35 0.591 0 C-N-CA 129.589 3.155 . . . . 0.0 113.383 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.44 -24.38 0.72 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 119.493 1.042 . . . . 0.0 111.293 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 60.19 168.41 0.08 Allowed 'General case' 0 C--N 1.362 1.115 0 C-N-CA 124.898 1.279 . . . . 0.0 111.541 -163.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -132.37 51.64 Favored Glycine 0 C--N 1.368 2.34 0 O-C-N 119.763 -1.836 . . . . 0.0 109.702 -164.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 48.7 t 54.74 76.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.169 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.03 115.17 27.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -103.87 -35.22 8.24 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.368 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.1 t -99.89 75.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.89 129.66 44.3 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.516 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -141.34 115.42 9.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 125.319 1.448 . . . . 0.0 107.306 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.91 84.76 0.73 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.098 -3.601 . . . . 0.0 104.098 164.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.812 0 C-N-CA 124.916 1.246 . . . . 0.0 112.808 175.484 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 56.3 mt -115.65 133.98 55.5 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -168.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.2 162.77 26.8 Favored Glycine 0 CA--C 1.494 -1.219 0 C-N-CA 124.731 1.158 . . . . 0.0 110.215 -173.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 28.5 m -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -139.55 150.05 44.62 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.7 m -123.0 -30.77 3.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.723 0.692 . . . . 0.0 112.448 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.6 tp -85.88 -51.15 6.58 Favored 'General case' 0 C--N 1.358 0.94 0 CA-C-N 119.648 1.113 . . . . 0.0 112.115 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 38.6 pt -84.8 -175.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.39 1.476 . . . . 0.0 110.133 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.06 80.9 3.04 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -170.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.24 92.32 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.271 1.98 . . . . 0.0 109.932 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 9.6 mp -121.59 144.73 48.57 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -89.91 159.23 17.04 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.334 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.45 123.48 23.19 Favored 'General case' 0 C--N 1.377 1.773 0 CA-C-N 119.769 1.168 . . . . 0.0 108.379 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.64 70.8 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 125.635 1.588 . . . . 0.0 110.92 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.36 175.31 5.53 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 121.631 0.729 . . . . 0.0 111.324 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 96.1 m -141.35 128.59 21.0 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.513 0.725 . . . . 0.0 109.095 -153.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.9 149.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-O 121.466 0.65 . . . . 0.0 109.476 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -143.99 136.67 27.08 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.724 1.209 . . . . 0.0 111.135 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.0 t -93.51 130.51 42.41 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 127.593 2.357 . . . . 0.0 107.401 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -107.25 132.12 53.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 19.7 tp -129.65 75.33 1.64 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.471 -1.695 . . . . 0.0 106.805 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.8 t -159.22 103.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.8 mmm -152.37 70.03 0.9 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 124.24 148.02 7.33 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -116.04 -27.96 6.77 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.52 86.68 5.29 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.36 -164.2 1.56 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -124.56 159.23 31.12 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.9 t -92.31 132.05 37.02 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -158.47 150.7 21.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.54 113.2 25.37 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -98.31 173.04 0.56 Allowed 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 121.853 1.702 . . . . 0.0 108.283 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.62 140.16 49.71 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.54 141.67 39.29 Favored 'General case' 0 C--N 1.374 1.647 0 CA-C-N 119.616 1.098 . . . . 0.0 108.663 -171.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 130.45 72.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -127.37 105.54 8.6 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 982' ' ' SER . . . . . 0.415 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 52.2 p -102.65 162.77 12.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.687 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.66 112.56 0.34 Allowed Glycine 0 C--N 1.359 1.825 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -121.61 145.98 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.8 tp -72.58 123.79 23.92 Favored 'General case' 0 C--N 1.381 1.971 0 C-N-CA 124.422 1.089 . . . . 0.0 109.763 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.82 -56.95 2.35 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -131.14 127.31 37.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.32 129.54 9.94 Favored Glycine 0 CA--C 1.487 -1.66 0 N-CA-C 103.379 -3.888 . . . . 0.0 103.379 163.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.41 128.84 90.9 Favored Pre-proline 0 C--N 1.349 0.555 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.122 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -107.0 81.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.782 1.672 . . . . 0.0 109.462 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 78.04 -71.73 0.1 Allowed 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 129.818 3.247 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 56.7 mt 49.16 40.49 17.81 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 128.668 2.787 . . . . 0.0 114.02 -175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -114.13 131.48 56.41 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.16 109.19 10.95 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.074 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 179.062 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.05 112.85 31.59 Favored Pre-proline 0 N--CA 1.443 -0.801 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -88.35 -21.6 1.48 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.617 1.613 . . . . 0.0 110.161 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 35.93 70.86 0.14 Allowed 'General case' 0 C--N 1.357 0.901 0 C-N-CA 129.161 2.984 . . . . 0.0 115.679 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.29 134.81 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.51 161.93 33.67 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -148.75 146.76 28.21 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 166.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 853' ' ' SER . . . . . 0.457 ' HG ' HG12 ' A' ' 953' ' ' ILE . 16.3 t -166.83 119.25 0.97 Allowed 'General case' 0 C--N 1.35 0.588 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.53 172.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.07 154.87 40.69 Favored 'General case' 0 C--N 1.371 1.531 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -143.11 155.58 44.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 122.201 1.0 . . . . 0.0 109.537 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.62 127.6 37.38 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.436 -166.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.2 m -158.8 12.78 0.16 Allowed 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -164.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.3 pp -27.71 146.18 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 160.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.78 -44.82 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 122.245 1.837 . . . . 0.0 113.332 -161.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.0 ptt85 -164.28 173.75 11.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -173.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.7 m -4.38 112.56 0.01 OUTLIER 'General case' 0 C--N 1.365 1.242 0 C-N-CA 130.826 3.651 . . . . 0.0 116.436 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.93 162.54 25.14 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -167.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.34 -14.99 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.378 2.052 . . . . 0.0 111.163 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.33 -144.2 4.05 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 28.1 m -64.96 136.14 56.46 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.986 1.715 . . . . 0.0 110.492 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 16.6 m -64.89 143.66 98.87 Favored Pre-proline 0 C--N 1.354 0.78 0 C-N-CA 125.444 1.497 . . . . 0.0 113.2 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -98.7 -151.75 0.03 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.572 0 C-N-CA 123.296 2.664 . . . . 0.0 107.478 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -146.05 130.11 17.4 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -115.93 -15.67 11.19 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.159 0.584 . . . . 0.0 111.08 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -103.23 79.71 1.76 Allowed 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.937 0.495 . . . . 0.0 111.669 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.08 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 127.063 2.145 . . . . 0.0 106.973 165.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 3.3 mt -90.75 -37.16 13.86 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.327 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 60.5 tp -164.64 128.2 2.45 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 172.34 61.96 0.0 OUTLIER 'General case' 0 C--N 1.356 0.854 0 CA-C-N 120.653 1.57 . . . . 0.0 106.973 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.32 98.02 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 116.085 1.884 . . . . 0.0 116.085 -165.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.77 -32.91 8.73 Favored Glycine 0 C--N 1.357 1.728 0 CA-C-N 119.028 0.831 . . . . 0.0 112.076 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.51 -65.01 0.26 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 64.24 -79.13 0.03 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.931 2.492 . . . . 0.0 114.517 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.59 121.87 36.59 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.804 1.642 . . . . 0.0 109.283 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -80.57 118.4 72.25 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 115.611 -2.137 . . . . 0.0 105.884 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -92.42 0.88 4.0 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 CA-C-N 125.514 3.005 . . . . 0.0 109.517 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.6 -45.66 18.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.244 1.018 . . . . 0.0 108.9 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.3 p -106.41 -13.4 15.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.702 1.601 . . . . 0.0 108.17 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 86.24 25.23 37.48 Favored Glycine 0 C--N 1.361 1.949 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.728 162.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.54 101.29 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 -165.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.409 ' HB3' HG23 ' C' ' 962' ' ' VAL . 0.4 OUTLIER -97.29 112.82 24.47 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 112.45 -2.159 . . . . 0.0 108.387 179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 67.6 m -101.11 107.83 19.36 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . 0.477 ' HB2' HH22 ' C' ' 914' ' ' ARG . . . -90.95 111.79 50.16 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.247 -1.358 . . . . 0.0 111.602 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.05 2.69 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.094 2.141 . . . . 0.0 109.067 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.01 -54.21 45.95 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.545 -167.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.8 68.5 0.83 Allowed 'General case' 0 C--N 1.366 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 111.825 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.77 36.78 Favored Glycine 0 N--CA 1.406 -3.318 1 N-CA-C 102.089 -4.404 . . . . 0.0 102.089 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . 0.424 ' HE ' HG22 ' C' ' 953' ' ' ILE . 71.3 ttt-85 -92.72 119.19 31.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.797 -1.202 . . . . 0.0 108.26 173.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.561 ' HH ' HD12 ' C' ' 896' ' ' LEU . 8.8 t80 -118.19 146.52 44.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.41 116.23 30.59 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 124.222 1.009 . . . . 0.0 109.086 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . 0.561 HD12 ' HH ' ' C' ' 894' ' ' TYR . 7.3 tt -114.42 139.77 49.23 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.016 1.326 . . . . 0.0 109.365 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.1 119.15 10.04 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.484 0.714 . . . . 0.0 109.903 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.38 154.57 21.65 Favored 'General case' 0 C--N 1.365 1.249 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.67 122.36 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.05 123.73 42.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.251 1.02 . . . . 0.0 109.617 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.0 m -83.16 131.36 35.13 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.68 -56.42 20.34 Favored Glycine 0 C--N 1.364 2.109 0 C-N-CA 125.611 1.577 . . . . 0.0 114.762 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 63.6 m170 32.04 72.34 0.07 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 127.946 2.498 . . . . 0.0 115.609 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -74.27 -9.5 58.66 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.967 1.307 . . . . 0.0 111.371 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.96 -18.33 62.01 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.297 1.439 . . . . 0.0 112.568 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.294 12.1 pt-20 124.63 -175.34 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 128.528 2.731 . . . . 0.0 107.783 174.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 100.88 131.32 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 127.696 2.398 . . . . 0.0 106.554 170.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 71.2 t -99.21 123.49 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -105.15 122.72 46.5 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.509 167.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -131.07 117.15 18.72 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.371 2.668 . . . . 0.0 109.607 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 87.1 t -90.1 113.01 25.53 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 144.6 53.58 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.796 1.639 . . . . 0.0 111.58 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.285 1.0 OUTLIER -115.31 147.24 40.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.721 2.008 . . . . 0.0 108.893 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.477 HH22 ' HB2' ' C' ' 888' ' ' ALA . 0.6 OUTLIER -80.34 138.83 36.76 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 127.301 2.241 . . . . 0.0 110.123 -177.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 94.19 -2.64 0.1 Allowed 'General case' 0 C--N 1.348 0.537 0 C-N-CA 129.21 3.004 . . . . 0.0 112.701 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -144.17 -26.41 0.53 Allowed 'General case' 0 C--N 1.358 0.95 0 O-C-N 120.904 -1.122 . . . . 0.0 111.819 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 58.89 168.31 0.06 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.197 1.399 . . . . 0.0 111.583 -162.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.72 51.4 Favored Glycine 0 C--N 1.375 2.697 0 O-C-N 119.576 -1.953 . . . . 0.0 109.855 -165.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 51.66 76.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.214 0 C-N-CA 126.197 1.799 . . . . 0.0 111.322 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.39 114.71 26.89 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -170.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -99.12 -38.69 8.83 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.413 -170.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 86.6 t -100.28 82.68 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.72 132.02 39.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.11 0.481 . . . . 0.0 110.49 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 20.7 t -142.75 115.29 8.56 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 108.631 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.25 84.54 0.7 Allowed Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 104.823 -3.311 . . . . 0.0 104.823 166.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.597 0 C-N-CA 125.89 1.709 . . . . 0.0 111.453 174.378 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -121.02 134.02 55.28 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.92 163.45 26.97 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.69 130.94 73.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.39 148.72 49.45 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -116.36 -39.77 3.33 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.415 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 31.4 tp -93.04 -55.15 3.45 Favored 'General case' 0 C--N 1.356 0.863 0 O-C-N 121.57 -0.706 . . . . 0.0 111.747 -166.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.424 HG22 ' HE ' ' C' ' 893' ' ' ARG . 2.3 pp -85.3 -161.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 C-N-CA 125.117 1.367 . . . . 0.0 109.737 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.434 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -170.72 91.55 0.47 Allowed Pre-proline 0 C--N 1.358 0.948 0 O-C-N 121.794 -0.566 . . . . 0.0 110.033 -166.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.33 90.61 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 123.247 2.195 . . . . 0.0 109.569 158.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 89.1 mt -123.36 145.83 48.43 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -95.15 159.7 14.89 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-N 118.858 0.753 . . . . 0.0 109.33 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.61 122.67 20.94 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 120.104 1.32 . . . . 0.0 109.411 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 88.79 -8.39 79.59 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 125.896 1.713 . . . . 0.0 111.923 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.14 173.75 8.1 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.946 0.898 . . . . 0.0 109.709 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 81.9 m -142.33 126.21 17.16 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -156.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.432 HG13 HH11 ' C' ' 914' ' ' ARG . 34.8 m -94.99 150.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 123.722 0.809 . . . . 0.0 109.197 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.0 t -140.13 139.46 35.79 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 125.9 1.68 . . . . 0.0 112.195 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.03 128.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.588 0 C-N-CA 126.42 1.888 . . . . 0.0 106.727 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.6 131.36 54.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 25.0 tp -131.92 76.89 1.73 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.284 -1.78 . . . . 0.0 107.617 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 58.3 t -159.03 100.0 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -149.34 83.81 1.43 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.78 149.3 16.14 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -117.4 -17.67 10.04 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.651 0.781 . . . . 0.0 110.374 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.0 tp -99.74 85.4 3.1 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.82 1.66 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -171.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -121.37 157.58 30.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.54 131.5 36.93 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.74 152.8 23.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -125.73 113.97 24.86 Favored Pre-proline 0 C--N 1.356 0.858 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -96.45 170.48 1.04 Allowed 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 121.839 1.693 . . . . 0.0 107.861 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.56 138.38 50.72 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -135.62 138.32 42.78 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 119.488 1.04 . . . . 0.0 108.299 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.62 130.59 69.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -128.9 101.18 5.97 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 982' ' ' SER . . . . . 0.413 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 24.4 p -100.68 163.83 12.15 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.6 1.56 . . . . 0.0 109.115 176.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.8 113.44 0.37 Allowed Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.0 42.62 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 66.3 tp -78.53 125.27 29.13 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.481 1.513 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 12.5 tp -97.49 -56.8 2.42 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 121.993 0.117 . . . . 0.0 110.713 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -131.09 128.36 40.03 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.41 129.34 9.86 Favored Glycine 0 CA--C 1.486 -1.725 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 163.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.47 132.11 89.65 Favored Pre-proline 0 C--N 1.349 0.563 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.478 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -106.38 79.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 121.305 1.502 . . . . 0.0 109.171 -170.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.98 -72.04 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.019 3.328 . . . . 0.0 109.056 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.9 mt 49.77 39.48 18.03 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 128.678 2.791 . . . . 0.0 113.761 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -112.32 131.42 55.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -128.34 108.97 11.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 179.206 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.455 -0.776 0 N-CA-C 110.021 -0.8 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.87 120.05 24.15 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.69 -21.0 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 122.146 1.802 . . . . 0.0 109.566 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 36.86 70.03 0.19 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 129.103 2.961 . . . . 0.0 115.631 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 87.3 t -118.78 136.5 55.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 158.81 43.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 162.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -149.44 138.56 21.32 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 28.8 t -169.1 117.15 0.65 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.5 152.36 36.09 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.67 157.58 46.53 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.537 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -131.59 131.52 43.34 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -166.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 41.7 p -160.32 16.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -165.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 3.4 pp -21.73 144.1 0.02 OUTLIER Pre-proline 0 C--N 1.37 1.464 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 159.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.8 -43.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 122.093 1.783 . . . . 0.0 111.995 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -164.28 176.67 8.94 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 17.1 m -19.22 120.21 0.02 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.651 3.18 . . . . 0.0 115.656 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -127.67 144.22 50.35 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 -163.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.66 -10.34 17.12 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 122.685 1.995 . . . . 0.0 113.586 -159.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -158.07 -142.05 3.3 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 20.3 m -63.31 145.38 55.68 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 110.47 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.1 128.79 50.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.857 1.263 . . . . 0.0 110.307 -165.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -94.45 -152.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.28 3.32 . . . . 0.0 108.489 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -149.28 135.13 18.81 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -118.33 -13.65 9.81 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 122.753 0.421 . . . . 0.0 111.608 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -100.17 86.73 3.28 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 118.609 0.641 . . . . 0.0 112.545 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 874' ' ' ASN . 54.0 t -71.92 97.65 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.831 1.652 . . . . 0.0 107.013 168.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.36 -37.21 17.3 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.946 -172.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 29.2 tp -165.4 127.64 2.09 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 101.959 -3.349 . . . . 0.0 101.959 160.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.434 ' HB3' HG13 ' A' ' 871' ' ' VAL . 26.9 t-20 -174.8 60.84 0.02 OUTLIER 'General case' 0 C--N 1.356 0.877 0 CA-C-N 120.553 1.524 . . . . 0.0 110.336 -166.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -58.87 -43.99 90.97 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -166.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.35 -27.23 12.19 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 118.928 0.785 . . . . 0.0 112.747 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -57.76 0.41 Allowed Glycine 0 C--N 1.352 1.465 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.07 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.354 0.804 0 C-N-CA 128.098 2.559 . . . . 0.0 114.746 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -96.78 119.14 34.7 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.21 116.05 62.28 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -95.95 4.88 2.03 Favored 'Trans proline' 0 CA--C 1.505 -0.93 0 CA-C-N 124.405 2.609 . . . . 0.0 109.407 -160.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -79.93 -45.81 17.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.1 p -106.01 -10.43 16.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.348 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.41 28.06 37.48 Favored Glycine 0 C--N 1.366 2.201 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 161.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 22.9 t -101.6 103.05 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 -162.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.03 111.13 23.28 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 112.434 -2.166 . . . . 0.0 109.464 -173.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 83.9 m -99.99 107.53 19.5 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.12 111.41 46.64 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 117.106 -1.426 . . . . 0.0 112.2 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.0 -1.24 5.62 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.781 2.321 . . . . 0.0 109.126 166.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -49.13 -54.82 14.49 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 128.856 2.862 . . . . 0.0 115.127 -167.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.47 48.69 14.11 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.63 -161.77 10.74 Favored Glycine 0 N--CA 1.417 -2.578 1 N-CA-C 102.636 -4.185 . . . . 0.0 102.636 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . 0.494 ' HE ' HG22 ' A' ' 953' ' ' ILE . 67.7 ttt-85 -89.92 120.89 31.53 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . 0.464 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.3 t80 -115.58 144.87 43.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -174.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -109.78 116.81 32.35 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.704 0.801 . . . . 0.0 109.871 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.1 140.02 48.83 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.091 1.756 . . . . 0.0 109.049 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -143.98 119.74 10.52 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.526 0.73 . . . . 0.0 109.812 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.47 153.95 22.07 Favored 'General case' 0 C--N 1.367 1.344 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.31 121.07 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.36 123.59 43.77 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.209 -172.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 41.8 m -83.38 131.33 35.06 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.39 -58.07 16.47 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 125.124 1.345 . . . . 0.0 114.107 -169.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 38.25 69.81 0.23 Allowed 'General case' 0 C--N 1.36 1.065 0 C-N-CA 127.085 2.154 . . . . 0.0 114.708 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -73.23 -8.97 58.12 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.161 1.384 . . . . 0.0 111.284 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.33 -19.44 61.65 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.814 1.246 . . . . 0.0 112.486 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.301 13.9 pt-20 127.56 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.161 2.584 . . . . 0.0 108.424 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.7 tttt 102.05 131.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.885 2.474 . . . . 0.0 107.386 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.7 t -99.51 125.38 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 123.306 1.527 . . . . 0.0 106.932 -172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -112.41 122.17 46.94 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.134 -1.848 . . . . 0.0 113.004 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.9 116.81 16.93 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 128.346 2.658 . . . . 0.0 108.538 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.78 112.77 23.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.08 145.67 52.57 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.647 1.579 . . . . 0.0 111.901 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.306 0.8 OUTLIER -114.81 148.87 37.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 126.588 1.955 . . . . 0.0 110.732 177.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 138.75 38.72 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.948 2.099 . . . . 0.0 109.744 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 96.85 -1.22 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 128.816 2.846 . . . . 0.0 112.319 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -147.89 -26.05 0.35 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.108 -0.995 . . . . 0.0 110.634 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 57.92 171.36 0.05 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.194 1.397 . . . . 0.0 111.521 -162.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.44 -133.6 52.63 Favored Glycine 0 C--N 1.373 2.592 0 O-C-N 119.376 -2.078 . . . . 0.0 110.104 -163.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.477 HG23 ' H ' ' A' ' 948' ' ' GLY . 58.5 t 56.32 77.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 126.036 1.735 . . . . 0.0 111.485 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.2 115.17 27.84 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -102.6 -34.09 9.22 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.601 -172.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 95.4 t -99.34 87.24 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 103.252 -2.869 . . . . 0.0 103.252 166.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -94.84 131.18 41.01 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 116.31 9.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.343 1.457 . . . . 0.0 107.714 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.41 85.03 0.71 Allowed Glycine 0 CA--C 1.485 -1.814 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 162.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.62 0 C-N-CA 124.812 1.196 . . . . 0.0 110.987 172.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.69 134.34 52.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . 0.477 ' H ' HG23 ' A' ' 919' ' ' VAL . . . -139.7 163.81 26.12 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -174.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.29 132.96 70.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.05 147.46 46.19 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 55.1 m -117.62 -40.98 2.97 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.457 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 36.4 tp -89.27 -54.21 4.21 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.666 0.666 . . . . 0.0 112.082 -165.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.494 HG22 ' HE ' ' A' ' 893' ' ' ARG . 16.3 pt -85.41 -155.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.883 0 C-N-CA 124.724 1.21 . . . . 0.0 110.278 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.464 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -170.07 85.71 0.57 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 C-N-CA 122.981 0.513 . . . . 0.0 109.934 -165.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.14 89.99 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 122.656 1.984 . . . . 0.0 109.538 159.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.78 145.83 48.07 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.568 2.347 . . . . 0.0 105.022 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -92.62 157.16 16.64 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-N 119.444 1.02 . . . . 0.0 108.705 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.27 123.83 23.15 Favored 'General case' 0 C--N 1.37 1.495 0 CA-C-N 119.749 1.159 . . . . 0.0 108.949 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.46 -13.17 67.78 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 125.884 1.707 . . . . 0.0 111.019 170.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.16 176.19 5.38 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.052 0.541 . . . . 0.0 111.697 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 77.7 m -141.74 127.17 18.82 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -157.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . . . . . . . . . 10.5 m -94.9 149.72 4.37 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 121.642 0.734 . . . . 0.0 109.909 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.6 m -139.38 137.17 35.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.139 1.775 . . . . 0.0 111.011 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 89.5 t -92.82 129.19 43.73 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 C-N-CA 126.61 1.964 . . . . 0.0 106.666 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -108.35 131.07 55.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.98 77.82 1.81 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 53.0 t -161.21 101.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.848 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -152.3 72.42 0.99 Allowed 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.04 149.42 8.55 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -117.01 -28.75 6.17 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.805 0.842 . . . . 0.0 108.748 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.2 tp -92.6 86.51 5.62 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.37 -164.13 1.54 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -125.29 160.21 29.83 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -93.22 132.07 37.72 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.57 150.01 22.75 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.23 113.58 23.71 Favored Pre-proline 0 C--N 1.355 0.844 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -97.95 172.34 0.64 Allowed 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 108.369 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.17 140.43 49.53 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -140.45 142.25 35.39 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 119.51 1.05 . . . . 0.0 108.757 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.81 129.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -125.81 106.85 9.98 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 52.1 p -99.29 160.74 14.06 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.057 0.943 . . . . 0.0 109.547 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.13 108.35 0.25 Allowed Glycine 0 C--N 1.359 1.836 0 C-N-CA 119.293 -1.432 . . . . 0.0 109.951 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.99 148.78 43.13 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 52.0 tp -72.7 123.39 23.18 Favored 'General case' 0 C--N 1.372 1.568 0 C-N-CA 125.849 1.66 . . . . 0.0 109.456 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.1 tp -99.95 -57.84 2.05 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.82 128.64 39.15 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.911 2.084 . . . . 0.0 106.466 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 130.58 10.32 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 103.979 -3.649 . . . . 0.0 103.979 161.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -69.48 133.56 89.0 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-N 118.662 1.231 . . . . 0.0 110.794 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -106.14 83.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.473 0 CA-C-N 121.469 1.56 . . . . 0.0 109.832 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.44 -72.74 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.398 3.479 . . . . 0.0 109.484 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.3 mt 49.52 40.23 18.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.27 3.028 . . . . 0.0 114.023 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.08 130.51 55.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -127.32 110.1 12.48 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.058 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.454 -0.823 0 N-CA-C 110.004 -0.806 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.2 120.67 25.15 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -92.7 -21.01 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.098 1.785 . . . . 0.0 109.83 -172.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 38.48 69.83 0.24 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 129.08 2.952 . . . . 0.0 115.315 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 78.9 t -118.7 136.42 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.24 158.34 44.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -149.52 139.21 21.74 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.3 t -169.2 117.84 0.66 Allowed 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.66 153.06 34.94 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -138.8 157.67 45.65 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.886 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.09 130.22 40.95 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -166.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 32.4 p -160.8 14.18 0.11 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.557 -163.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.2 pp -21.58 143.58 0.02 OUTLIER Pre-proline 0 C--N 1.373 1.587 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 158.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.34 -43.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 122.009 1.753 . . . . 0.0 111.936 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -164.15 176.78 8.93 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m -19.36 120.44 0.02 OUTLIER 'General case' 0 C--N 1.363 1.175 0 C-N-CA 129.706 3.203 . . . . 0.0 115.645 171.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -127.92 144.19 50.51 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -163.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.77 -10.6 16.96 Favored 'Trans proline' 0 CA--C 1.512 -0.603 0 CA-C-N 122.698 1.999 . . . . 0.0 113.645 -158.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.62 -141.81 3.25 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -63.25 144.92 56.52 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.984 1.714 . . . . 0.0 110.282 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.13 128.27 54.27 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 124.912 1.285 . . . . 0.0 110.119 -165.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -95.34 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.196 3.264 . . . . 0.0 108.382 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -147.92 133.79 19.07 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -116.48 -13.02 10.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.977 0.911 . . . . 0.0 110.696 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.26 85.7 2.86 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 121.198 0.523 . . . . 0.0 111.281 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' B' ' 874' ' ' ASN . 60.7 t -69.77 97.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 163.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 18.5 mt -87.21 -39.32 15.56 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.414 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 40.7 tp -165.23 127.25 2.09 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 101.064 -3.68 . . . . 0.0 101.064 165.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . 0.423 ' HB3' HG13 ' B' ' 871' ' ' VAL . 27.3 t-20 178.69 61.02 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 120.157 1.344 . . . . 0.0 109.146 -161.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.52 -43.56 93.38 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.59 -27.6 12.7 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 118.779 0.718 . . . . 0.0 112.669 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.92 -55.73 0.5 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 60.46 -84.11 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 C-N-CA 128.11 2.564 . . . . 0.0 114.866 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.3 118.87 34.71 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.75 116.39 63.72 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.01 5.21 2.37 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 CA-C-N 124.403 2.608 . . . . 0.0 109.73 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.95 -44.38 20.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.5 p -108.2 -10.64 15.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.957 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.79 30.13 30.16 Favored Glycine 0 C--N 1.359 1.819 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 162.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 32.3 t -101.34 102.36 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 -162.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.53 111.79 24.14 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 112.856 -1.974 . . . . 0.0 108.994 -174.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.3 m -100.14 107.67 19.61 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.13 111.53 47.32 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 117.291 -1.338 . . . . 0.0 111.93 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -89.48 0.35 5.89 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.762 2.308 . . . . 0.0 108.759 164.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -48.38 -56.44 8.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 128.914 2.886 . . . . 0.0 115.032 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.85 63.93 1.67 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 170.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.98 -166.68 31.83 Favored Glycine 0 N--CA 1.409 -3.141 0 N-CA-C 103.621 -3.791 . . . . 0.0 103.621 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -90.81 121.16 32.43 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . 0.476 ' H ' HD11 ' B' ' 954' ' ' LEU . 2.0 t80 -117.27 146.04 43.57 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -172.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.34 115.51 28.86 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.2 tt -112.08 139.83 47.27 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 126.275 1.83 . . . . 0.0 108.503 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -143.26 119.19 10.62 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 123.312 0.645 . . . . 0.0 109.43 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.65 154.46 21.42 Favored 'General case' 0 C--N 1.365 1.271 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.69 121.96 61.33 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.38 122.02 43.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.152 0.981 . . . . 0.0 109.123 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 36.4 m -81.41 132.05 35.31 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 107.781 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.01 16.7 Favored Glycine 0 C--N 1.364 2.125 0 C-N-CA 125.14 1.352 . . . . 0.0 114.405 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.5 m170 37.2 70.4 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.204 2.202 . . . . 0.0 114.976 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -73.29 -8.74 57.15 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.28 1.432 . . . . 0.0 111.442 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -73.17 -15.79 61.45 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.083 1.353 . . . . 0.0 112.564 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.314 12.2 pt-20 122.94 -179.29 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 128.568 2.747 . . . . 0.0 108.606 176.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.0 tttt 102.5 131.11 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 127.897 2.479 . . . . 0.0 107.184 170.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.08 126.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -112.52 123.13 49.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.87 174.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.56 115.67 15.75 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 128.223 2.609 . . . . 0.0 109.476 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.4 t -87.89 113.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.21 149.37 41.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.662 1.985 . . . . 0.0 112.369 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.309 0.9 OUTLIER -115.08 149.53 37.37 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 126.598 1.959 . . . . 0.0 110.524 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.71 138.71 36.35 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.593 1.957 . . . . 0.0 109.36 174.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 97.1 -5.76 0.06 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 128.92 2.888 . . . . 0.0 112.569 172.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -146.19 -25.84 0.44 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-N 119.47 1.032 . . . . 0.0 111.349 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 57.9 169.66 0.05 OUTLIER 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.32 1.448 . . . . 0.0 111.571 -162.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.03 -132.89 50.95 Favored Glycine 0 C--N 1.368 2.317 0 O-C-N 119.508 -1.995 . . . . 0.0 109.727 -165.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 53.71 78.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 126.408 1.883 . . . . 0.0 111.631 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.42 28.03 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -103.02 -35.27 8.61 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.632 -172.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 89.6 t -99.35 86.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 166.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.9 130.53 42.83 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -172.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -141.59 117.34 10.4 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.327 1.451 . . . . 0.0 107.235 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.21 85.18 0.73 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.889 -3.684 . . . . 0.0 103.889 164.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.661 0 C-N-CA 124.639 1.114 . . . . 0.0 110.927 174.309 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 CA--C 1.506 -0.747 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.54 134.07 55.42 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.67 164.68 26.0 Favored Glycine 0 CA--C 1.489 -1.545 0 C-N-CA 125.56 1.552 . . . . 0.0 109.281 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.06 133.01 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -135.66 148.51 48.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 52.6 m -122.14 -34.61 3.29 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.367 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 25.8 tp -91.31 -52.34 4.85 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.128 -168.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -86.63 -169.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 124.816 1.246 . . . . 0.0 109.353 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.476 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.62 86.42 2.1 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -168.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.31 90.88 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 117.627 -1.828 . . . . 0.0 109.982 161.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.53 145.58 48.19 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 127.083 2.153 . . . . 0.0 105.412 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -92.16 158.89 15.93 Favored 'General case' 0 C--N 1.363 1.155 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.701 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.55 123.1 22.49 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-N 120.304 1.411 . . . . 0.0 108.602 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.77 -12.02 70.1 Favored Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 125.283 1.421 . . . . 0.0 110.863 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.55 175.7 5.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.905 0.859 . . . . 0.0 110.659 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 83.2 m -142.27 127.51 18.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -154.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . . . . . . . . . 7.5 m -96.28 150.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 CA-C-O 121.464 0.649 . . . . 0.0 110.989 174.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.2 m -138.49 137.39 37.09 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 126.359 1.863 . . . . 0.0 111.035 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.04 129.44 42.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 C-N-CA 127.459 2.303 . . . . 0.0 106.564 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -107.98 130.98 55.02 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 100.886 -3.746 . . . . 0.0 100.886 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.97 77.33 1.78 Allowed 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 54.0 t -159.84 103.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -151.12 72.37 1.06 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.83 148.23 8.35 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -115.38 -27.66 7.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 35.8 tp -93.64 86.43 5.17 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.19 -163.98 1.51 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -125.2 159.29 31.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -91.38 131.13 37.06 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.58 149.99 22.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.826 -2.286 . . . . 0.0 104.826 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.06 113.29 24.12 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -97.06 172.33 0.78 Allowed 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.003 1.802 . . . . 0.0 108.173 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.4 mp -115.92 138.04 51.55 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.3 p -138.79 140.29 38.53 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 119.791 1.178 . . . . 0.0 108.261 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.8 mm -116.31 130.35 71.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -126.53 106.59 9.54 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 982' ' ' SER . . . . . 0.423 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 35.6 p -101.05 162.89 12.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.489 1.116 . . . . 0.0 110.231 171.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.75 110.31 0.29 Allowed Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.83 147.28 43.2 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.1 122.96 21.85 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 125.135 1.374 . . . . 0.0 109.091 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.1 tp -99.48 -58.09 2.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -131.37 128.39 39.54 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.897 1.679 . . . . 0.0 106.566 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.16 130.42 10.26 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 104.161 -3.575 . . . . 0.0 104.161 161.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.53 133.43 88.94 Favored Pre-proline 0 C--N 1.351 0.657 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.39 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -105.99 82.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.546 1.588 . . . . 0.0 109.195 -170.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.88 -72.28 0.09 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 130.286 3.435 . . . . 0.0 109.444 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 48.69 43.91 21.07 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 129.087 2.955 . . . . 0.0 113.671 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.0 130.23 56.72 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.08 110.2 12.25 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 179.551 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.86 0 N-CA-C 109.962 -0.822 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 34.8 t -125.4 116.52 25.22 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -90.01 -20.71 1.08 Allowed 'Trans proline' 0 CA--C 1.511 -0.638 0 CA-C-N 121.903 1.715 . . . . 0.0 109.662 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 39.16 69.8 0.26 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 128.811 2.844 . . . . 0.0 115.471 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.15 133.73 65.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -137.13 153.96 50.38 Favored 'General case' 0 C--N 1.363 1.158 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 167.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -149.71 141.7 23.87 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.916 0.78 . . . . 0.0 109.725 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.8 t -168.68 118.69 0.74 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.159 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.34 153.67 39.98 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -142.52 156.13 45.1 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.274 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -130.21 127.56 39.89 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.699 -164.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 33.3 p -162.35 11.88 0.07 Allowed 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -161.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 3.2 pp -27.62 146.86 0.04 OUTLIER Pre-proline 0 C--N 1.368 1.393 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 157.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.83 -45.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.101 1.786 . . . . 0.0 112.156 -164.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -162.17 172.64 15.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -0.43 107.17 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 130.652 3.581 . . . . 0.0 117.526 167.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -107.46 163.5 16.82 Favored Pre-proline 0 C--N 1.353 0.757 0 C-N-CA 124.249 1.02 . . . . 0.0 110.209 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.05 -13.19 14.19 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.083 2.522 . . . . 0.0 111.318 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.03 -144.39 4.28 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.1 m -64.39 136.6 57.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.364 1.866 . . . . 0.0 111.035 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.38 144.77 98.84 Favored Pre-proline 0 C--N 1.354 0.787 0 C-N-CA 125.392 1.477 . . . . 0.0 113.453 -174.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -100.96 -147.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.435 2.757 . . . . 0.0 106.67 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -147.33 134.25 20.22 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -117.59 -15.54 10.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 122.811 0.444 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . 0.41 HH21 HD21 ' C' ' 872' ' ' LEU . 11.1 mmm180 -102.33 81.52 2.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.402 0.62 . . . . 0.0 111.399 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' C' ' 874' ' ' ASN . 43.6 t -67.99 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 126.265 1.826 . . . . 0.0 107.464 162.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . 0.41 HD21 HH21 ' C' ' 870' ' ' ARG . 6.9 mt -88.47 -37.85 15.46 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 121.601 -0.687 . . . . 0.0 110.68 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.8 tp -165.86 129.77 2.21 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 168.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.417 ' HB3' HG13 ' C' ' 871' ' ' VAL . 33.2 t-20 176.42 61.69 0.0 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.828 1.649 . . . . 0.0 108.034 -165.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.32 -43.68 92.67 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -165.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.01 -28.08 11.47 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 118.896 0.771 . . . . 0.0 112.568 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.36 -57.78 0.42 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 62.38 -82.51 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.214 2.606 . . . . 0.0 114.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.0 120.05 36.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.139 1.376 . . . . 0.0 108.085 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.49 115.95 62.0 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -96.02 5.97 1.91 Allowed 'Trans proline' 0 CA--C 1.506 -0.913 0 CA-C-N 124.659 2.7 . . . . 0.0 109.702 -161.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -79.55 -45.25 19.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 29.3 p -106.72 -11.14 15.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.868 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.93 31.07 30.03 Favored Glycine 0 C--N 1.362 1.987 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 162.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 36.2 t -101.25 101.93 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 100.965 -3.716 . . . . 0.0 100.965 -164.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.26 112.09 24.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 112.127 -2.306 . . . . 0.0 108.548 -175.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 66.4 m -99.39 109.42 22.02 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.34 109.6 34.79 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 117.367 -1.302 . . . . 0.0 111.724 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.35 -4.11 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.434 2.089 . . . . 0.0 108.104 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 55.0 mt -54.54 -52.89 60.62 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 127.937 2.495 . . . . 0.0 114.009 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.56 67.62 0.92 Allowed 'General case' 0 C--N 1.366 1.32 0 CA-C-O 122.262 1.03 . . . . 0.0 111.418 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.54 -169.62 36.78 Favored Glycine 0 N--CA 1.406 -3.334 1 N-CA-C 102.156 -4.377 . . . . 0.0 102.156 -170.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -93.69 120.85 34.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.53 -1.335 . . . . 0.0 108.076 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.461 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.5 t80 -116.73 145.38 43.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -170.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 53.1 tp -109.94 114.88 28.79 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.061 0.945 . . . . 0.0 108.58 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -113.21 137.9 50.78 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.379 1.472 . . . . 0.0 108.814 -173.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -144.3 118.71 9.64 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.82 22.2 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.81 121.76 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.46 124.15 39.34 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.373 1.069 . . . . 0.0 109.837 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 55.5 m -81.47 130.62 35.11 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -50.62 -54.81 19.69 Favored Glycine 0 C--N 1.361 1.956 0 C-N-CA 126.141 1.829 . . . . 0.0 115.776 -170.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 28.7 m170 28.16 78.69 0.02 OUTLIER 'General case' 0 C--N 1.36 1.06 0 C-N-CA 128.162 2.585 . . . . 0.0 116.254 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -72.37 -13.5 61.49 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.9 1.68 . . . . 0.0 111.29 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.04 -17.43 61.43 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.661 1.584 . . . . 0.0 112.617 -168.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.2 pt-20 116.23 -179.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 128.093 2.557 . . . . 0.0 108.769 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 105.51 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 128.554 2.742 . . . . 0.0 105.136 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.8 t -97.23 125.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -101.15 130.87 47.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.086 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.75 113.54 2.8 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 125.252 1.421 . . . . 0.0 110.625 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 6.2 p -85.18 117.73 30.86 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 108.722 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.62 137.78 58.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.646 1.178 . . . . 0.0 109.81 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -117.17 144.39 44.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.609 1.564 . . . . 0.0 107.853 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.45 142.55 37.44 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 128.344 2.657 . . . . 0.0 109.591 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.33 24.1 p 88.6 3.44 0.26 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 129.902 3.281 . . . . 0.0 113.879 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -150.67 -24.26 0.23 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-N 119.453 1.024 . . . . 0.0 111.31 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 58.84 168.37 0.06 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.435 1.494 . . . . 0.0 112.116 -163.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -130.16 49.82 Favored Glycine 0 C--N 1.375 2.744 0 O-C-N 119.384 -2.072 . . . . 0.0 110.135 -163.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 49.2 t 53.48 72.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.175 0 C-N-CA 125.946 1.698 . . . . 0.0 111.974 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.66 116.37 28.95 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -99.31 -31.31 11.76 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.762 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.88 80.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -95.29 130.76 41.93 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.744 0.307 . . . . 0.0 111.197 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 117.81 9.02 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.287 1.435 . . . . 0.0 107.872 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.15 85.05 0.79 Allowed Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.713 0 C-N-CA 125.311 1.434 . . . . 0.0 110.732 172.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.51 134.69 55.24 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.73 162.59 26.24 Favored Glycine 0 CA--C 1.491 -1.421 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.88 132.98 69.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.86 148.71 45.64 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.436 -0.79 . . . . 0.0 108.957 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 63.7 m -108.31 -75.79 0.62 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.423 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 21.9 tp -66.96 -50.74 61.35 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -163.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.89 -176.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 125.94 1.696 . . . . 0.0 109.656 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.461 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -163.14 94.42 1.13 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.1 93.63 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.631 2.221 . . . . 0.0 110.015 162.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.9 mp -120.65 144.49 48.14 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -98.35 160.42 14.29 Favored 'General case' 0 C--N 1.363 1.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.43 123.41 22.31 Favored 'General case' 0 C--N 1.381 1.978 0 CA-C-N 120.329 1.422 . . . . 0.0 109.038 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -9.49 71.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 125.233 1.397 . . . . 0.0 111.794 168.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.65 171.83 4.78 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.438 0.695 . . . . 0.0 112.445 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.5 m -142.73 127.76 18.47 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -159.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.07 149.76 4.38 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 123.627 0.771 . . . . 0.0 109.295 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.2 t -142.29 136.59 29.91 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.495 1.118 . . . . 0.0 111.89 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.47 129.63 43.63 Favored 'Isoleucine or valine' 0 C--N 1.374 1.665 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.11 134.16 48.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.83 73.6 1.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.902 -1.954 . . . . 0.0 107.041 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 48.9 t -162.03 99.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.954 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -152.37 72.69 1.0 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.68 146.94 8.11 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.65 -21.56 10.17 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.413 0.685 . . . . 0.0 109.952 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -99.08 85.94 3.34 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.89 -167.88 2.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -170.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.69 156.73 33.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 15.4 t -91.12 135.53 33.7 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -160.23 154.45 23.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -127.72 115.01 20.85 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -97.57 172.96 0.67 Allowed 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 121.921 1.747 . . . . 0.0 107.894 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.8 mp -115.29 139.17 50.2 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 22.1 p -137.16 138.97 40.81 Favored 'General case' 0 C--N 1.375 1.688 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 31.5 mm -115.54 131.13 68.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -124.98 105.76 9.45 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 982' ' ' SER . . . . . 0.457 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 26.4 p -100.86 162.65 12.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 109.587 172.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 111.03 0.31 Allowed Glycine 0 C--N 1.358 1.785 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.71 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.75 142.71 47.44 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.1 tp -75.17 125.39 28.85 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.684 1.594 . . . . 0.0 108.569 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.1 -56.03 2.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -130.62 127.53 39.15 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -173.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 128.62 9.59 Favored Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 103.615 -3.794 . . . . 0.0 103.615 164.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.58 130.01 89.42 Favored Pre-proline 0 C--N 1.351 0.641 0 CA-C-O 117.461 -1.257 . . . . 0.0 111.215 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -107.03 80.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 122.519 1.935 . . . . 0.0 109.777 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 77.98 -71.99 0.1 Allowed 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 130.048 3.339 . . . . 0.0 109.414 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 64.9 mt 48.77 41.62 18.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 129.314 3.046 . . . . 0.0 113.596 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -110.0 129.55 55.66 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.94 107.0 9.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.307 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 110.015 -0.802 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.11 120.12 22.37 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.54 -20.24 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.122 1.794 . . . . 0.0 109.827 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 36.6 70.56 0.16 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.933 2.893 . . . . 0.0 115.792 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 77.2 t -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.3 44.7 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 165.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -149.46 139.04 21.65 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.4 t -168.96 117.19 0.66 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.21 36.0 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -136.44 158.49 44.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.425 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -135.07 130.46 35.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -166.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 72.2 m -161.41 8.81 0.08 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -162.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 2.7 pp -29.59 147.58 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.457 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 162.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.0 -43.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 122.128 1.796 . . . . 0.0 113.487 -161.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -163.44 174.05 12.4 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.0 m -9.3 118.97 0.01 OUTLIER 'General case' 0 C--N 1.361 1.097 0 C-N-CA 130.958 3.703 . . . . 0.0 117.004 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -97.95 160.42 28.48 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 124.691 1.196 . . . . 0.0 109.478 -170.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.09 -16.67 9.73 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.815 2.343 . . . . 0.0 110.098 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.57 -137.82 2.41 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 16.5 m -64.22 145.79 55.39 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.204 1.801 . . . . 0.0 110.652 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.66 130.43 36.96 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 125.514 1.525 . . . . 0.0 110.416 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -96.18 -150.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.927 3.084 . . . . 0.0 108.954 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.58 135.52 19.99 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -117.49 -14.78 10.3 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.985 0.514 . . . . 0.0 111.828 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.29 86.82 3.28 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 118.504 0.593 . . . . 0.0 111.839 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.67 97.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.201 1.801 . . . . 0.0 106.574 168.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 50.0 mt -87.24 -37.36 17.3 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.523 -173.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.16 126.86 1.75 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 101.591 -3.485 . . . . 0.0 101.591 162.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -175.31 60.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.494 1.497 . . . . 0.0 109.652 -168.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.72 -44.35 93.78 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -164.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.53 -28.51 11.29 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 118.99 0.814 . . . . 0.0 112.397 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -60.83 0.31 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 63.12 -80.86 0.03 OUTLIER 'General case' 0 C--N 1.356 0.869 0 C-N-CA 128.008 2.523 . . . . 0.0 114.049 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.68 119.46 32.71 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.794 1.238 . . . . 0.0 108.361 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.95 117.63 68.91 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -96.47 0.9 1.97 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 CA-C-N 125.113 2.862 . . . . 0.0 109.368 -165.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -80.31 -45.66 17.47 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -103.27 -12.61 17.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.347 1.059 . . . . 0.0 109.004 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 22.87 52.67 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 162.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 37.7 t -98.94 103.92 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.43 111.98 24.37 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.357 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 62.1 m -100.87 108.32 20.07 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.37 111.09 45.26 Favored Pre-proline 0 C--N 1.358 0.956 0 CA-C-O 117.153 -1.404 . . . . 0.0 112.016 170.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.6 1.89 3.28 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 CA-C-N 123.001 2.107 . . . . 0.0 108.946 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 39.3 mt -52.8 -51.53 60.44 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 127.9 2.48 . . . . 0.0 114.09 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 44.79 18.3 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.069 1.348 . . . . 0.0 114.023 170.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.49 -163.24 11.79 Favored Glycine 0 N--CA 1.415 -2.737 1 N-CA-C 101.212 -4.755 . . . . 0.0 101.212 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -91.98 121.35 33.48 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.287 0.2 OUTLIER -114.58 159.19 20.72 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 119.32 0.963 . . . . 0.0 108.539 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -105.53 115.41 30.2 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.555 0.742 . . . . 0.0 109.085 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.81 136.34 50.0 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 126.079 1.751 . . . . 0.0 109.178 -168.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.5 m -145.99 118.91 8.72 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 123.469 0.708 . . . . 0.0 109.608 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.3 153.66 22.41 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.99 120.64 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.3 123.17 43.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.898 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 38.5 m -79.73 131.91 36.05 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.29 1.436 . . . . 0.0 107.394 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.36 -57.26 19.39 Favored Glycine 0 C--N 1.363 2.074 0 C-N-CA 125.653 1.597 . . . . 0.0 114.713 -169.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.3 m170 34.04 73.96 0.07 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 127.696 2.399 . . . . 0.0 115.606 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -74.14 -8.3 55.68 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.227 1.411 . . . . 0.0 111.55 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -72.12 -15.58 61.99 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 125.741 1.616 . . . . 0.0 112.225 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.339 7.2 pt-20 116.15 -177.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 128.26 2.624 . . . . 0.0 108.603 173.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 104.53 134.59 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 128.244 2.618 . . . . 0.0 106.41 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 69.0 t -98.19 125.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -111.08 122.36 47.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.015 -1.902 . . . . 0.0 113.446 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.21 117.12 17.04 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.12 2.568 . . . . 0.0 108.766 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 94.5 t -87.04 113.79 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 20.3 mt -62.29 140.78 58.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.908 1.683 . . . . 0.0 110.29 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -116.06 146.78 41.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.214 1.805 . . . . 0.0 109.218 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.548 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.07 139.78 40.11 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.155 2.582 . . . . 0.0 110.13 -174.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.17 -13.62 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 129.603 3.161 . . . . 0.0 112.649 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -139.33 -26.0 0.83 Allowed 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 119.327 0.967 . . . . 0.0 111.095 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 60.54 167.01 0.08 Allowed 'General case' 0 C--N 1.361 1.105 0 C-N-CA 125.226 1.411 . . . . 0.0 111.36 -164.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -134.63 50.49 Favored Glycine 0 C--N 1.37 2.449 0 O-C-N 119.521 -1.987 . . . . 0.0 109.208 -161.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 47.4 t 57.93 75.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.235 0 C-N-CA 125.297 1.439 . . . . 0.0 110.516 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.75 114.77 27.39 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -103.01 -36.17 8.28 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.454 -171.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.28 78.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -95.32 131.55 41.3 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.145 -172.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -143.96 114.69 7.7 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.024 1.33 . . . . 0.0 107.885 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.2 84.69 0.71 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 104.529 -3.428 . . . . 0.0 104.529 167.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 110.96 174.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.2 mt -118.26 134.1 55.32 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.82 161.41 25.46 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.91 127.96 73.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -137.58 148.47 45.92 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.4 m -114.73 -44.32 3.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.427 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 26.9 tp -84.33 -50.11 8.13 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.431 1.014 . . . . 0.0 112.785 -166.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 12.6 pt -87.88 -169.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 124.688 1.195 . . . . 0.0 109.941 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.23 82.71 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -165.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.55 91.36 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 122.308 1.86 . . . . 0.0 109.592 160.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.1 142.31 49.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -94.51 156.56 16.4 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.17 123.02 21.22 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 119.533 1.06 . . . . 0.0 108.929 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.41 -11.85 71.12 Favored Glycine 0 C--N 1.345 1.082 0 C-N-CA 125.893 1.711 . . . . 0.0 111.246 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.7 175.32 5.77 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.158 0.583 . . . . 0.0 111.467 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 83.7 m -142.54 125.47 16.16 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -159.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.548 HG13 HH11 ' A' ' 914' ' ' ARG . 34.0 m -95.79 150.26 4.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.686 0.755 . . . . 0.0 109.9 171.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.7 138.91 34.59 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.684 1.994 . . . . 0.0 111.382 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.29 129.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 126.301 1.84 . . . . 0.0 106.786 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.43 131.0 54.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.168 -3.271 . . . . 0.0 102.168 170.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.04 77.55 1.77 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.3 t -160.93 99.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.4 mmm -152.4 73.89 1.05 Allowed 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 107.5 141.92 10.16 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.96 -5.88 13.17 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.256 0.623 . . . . 0.0 111.257 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.28 82.86 2.97 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.94 -175.19 3.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -122.0 159.5 26.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 16.8 t -89.01 131.19 35.3 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.69 150.03 22.55 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.41 113.36 23.29 Favored Pre-proline 0 C--N 1.356 0.869 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -98.13 174.29 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 108.54 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.75 140.91 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.46 140.58 37.33 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 119.583 1.083 . . . . 0.0 108.919 -171.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.0 mm -118.85 129.77 74.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -127.3 105.92 8.86 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 33.8 p -100.19 160.99 13.9 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.008 1.323 . . . . 0.0 110.068 170.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -179.2 109.84 0.27 Allowed Glycine 0 C--N 1.358 1.787 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.8 144.96 46.0 Favored 'General case' 0 C--N 1.346 0.439 0 O-C-N 121.416 -1.049 . . . . 0.0 113.713 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.75 123.65 24.53 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 124.591 1.156 . . . . 0.0 109.671 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 23.9 tp -98.72 -57.38 2.2 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.65 128.02 38.19 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.82 10.04 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 103.231 -3.947 . . . . 0.0 103.231 163.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -69.04 130.04 91.71 Favored Pre-proline 0 C--N 1.352 0.703 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.015 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -106.76 82.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 CA-C-N 121.885 1.709 . . . . 0.0 109.89 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 78.29 -72.28 0.09 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 130.265 3.426 . . . . 0.0 109.195 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 76.4 mt 49.93 39.0 17.55 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 129.073 2.949 . . . . 0.0 114.244 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.7 131.95 54.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -129.24 109.46 11.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.134 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 179.656 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.454 -0.801 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.69 120.41 23.01 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.5 -20.47 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.176 1.813 . . . . 0.0 110.081 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 37.95 70.37 0.2 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.926 2.89 . . . . 0.0 115.482 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 82.5 t -118.14 136.03 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.08 157.66 46.35 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -149.5 139.46 21.98 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -169.57 118.23 0.63 Allowed 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.97 153.56 34.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -138.37 158.59 43.98 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.908 176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -136.06 128.1 29.65 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -167.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 73.3 m -160.33 13.0 0.12 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -167.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 2.6 pp -29.03 148.24 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 160.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.63 -43.76 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.104 1.787 . . . . 0.0 113.553 -161.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -163.41 173.83 12.7 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -8.73 118.94 0.01 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 130.952 3.701 . . . . 0.0 117.075 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -97.87 160.42 28.54 Favored Pre-proline 0 N--CA 1.44 -0.926 0 C-N-CA 124.661 1.184 . . . . 0.0 109.606 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.14 -16.69 9.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.776 2.317 . . . . 0.0 110.176 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.43 -137.71 2.37 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -64.05 145.41 55.95 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.13 1.772 . . . . 0.0 110.498 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.89 129.84 40.63 Favored Pre-proline 0 N--CA 1.438 -1.028 0 C-N-CA 125.366 1.466 . . . . 0.0 110.208 -164.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -96.82 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.797 2.998 . . . . 0.0 108.726 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.21 135.54 20.46 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -115.87 -14.05 11.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.019 0.928 . . . . 0.0 110.705 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.17 86.65 3.07 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 118.233 0.469 . . . . 0.0 112.159 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.06 97.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.247 1.819 . . . . 0.0 106.639 164.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 13.5 mt -87.75 -38.83 15.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.278 -173.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 53.3 tp -166.25 127.49 1.79 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 166.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 178.25 61.0 0.01 OUTLIER 'General case' 0 C--N 1.355 0.825 0 CA-C-N 120.331 1.423 . . . . 0.0 108.807 -164.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.13 -43.96 95.28 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.22 -29.15 10.57 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 118.741 0.7 . . . . 0.0 112.355 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.53 -60.04 0.34 Allowed Glycine 0 C--N 1.353 1.487 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 63.14 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.103 2.561 . . . . 0.0 114.148 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -95.33 119.24 33.5 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 125.007 1.323 . . . . 0.0 108.231 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -80.64 117.83 69.65 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -95.29 0.99 2.5 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 125.144 2.873 . . . . 0.0 109.589 -165.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -80.3 -44.36 19.71 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 33.2 p -105.38 -13.05 15.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.729 1.211 . . . . 0.0 108.581 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.24 47.22 Favored Glycine 0 C--N 1.362 2.009 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 163.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.7 103.44 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 -162.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.57 112.1 24.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 112.515 -2.129 . . . . 0.0 109.475 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 61.3 m -101.08 108.45 20.15 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.43 111.12 45.55 Favored Pre-proline 0 C--N 1.359 0.99 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.844 170.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -93.26 2.08 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 123.101 2.143 . . . . 0.0 108.949 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.32 -49.37 69.85 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.025 2.13 . . . . 0.0 113.888 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.32 48.18 15.38 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.747 1.619 . . . . 0.0 114.431 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.91 -164.92 20.2 Favored Glycine 0 N--CA 1.412 -2.951 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -90.79 121.38 32.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -116.42 159.54 21.85 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 119.36 0.982 . . . . 0.0 108.824 178.195 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -106.19 114.3 28.35 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.55 136.17 49.36 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 126.09 1.756 . . . . 0.0 108.529 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -145.02 119.31 9.54 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.167 0.587 . . . . 0.0 109.566 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.85 22.15 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.33 121.44 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.29 121.97 43.31 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.44 1.096 . . . . 0.0 108.665 -172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.3 m -79.12 132.26 36.51 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 107.749 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.15 -57.25 19.28 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.784 1.659 . . . . 0.0 114.63 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.5 m170 33.92 73.84 0.07 Allowed 'General case' 0 C--N 1.359 1.013 0 C-N-CA 127.746 2.418 . . . . 0.0 115.528 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.0 -8.48 56.28 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.283 1.433 . . . . 0.0 111.493 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -72.22 -14.51 61.81 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 125.807 1.643 . . . . 0.0 112.255 -170.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.341 7.0 pt-20 115.92 -178.27 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 128.641 2.776 . . . . 0.0 108.633 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 104.32 134.18 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 128.081 2.552 . . . . 0.0 106.635 172.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 87.8 t -98.0 126.5 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -172.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -111.98 122.8 48.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.942 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.24 116.88 16.73 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.539 2.336 . . . . 0.0 109.564 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 97.0 t -88.07 113.88 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.62 142.93 57.82 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.337 1.855 . . . . 0.0 110.249 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.7 t -116.47 147.24 41.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.298 1.839 . . . . 0.0 109.424 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.613 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.16 139.39 38.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.664 2.386 . . . . 0.0 109.826 -175.106 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.54 -16.94 0.03 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 129.643 3.177 . . . . 0.0 112.798 173.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -137.37 -25.5 1.03 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 119.384 0.993 . . . . 0.0 111.57 -169.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 60.44 167.35 0.08 Allowed 'General case' 0 C--N 1.36 1.062 0 C-N-CA 125.449 1.499 . . . . 0.0 111.078 -163.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.93 -133.55 49.36 Favored Glycine 0 C--N 1.367 2.259 0 O-C-N 119.664 -1.898 . . . . 0.0 109.066 -163.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 47.7 t 56.04 76.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.18 0 C-N-CA 125.64 1.576 . . . . 0.0 110.794 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.32 115.2 27.83 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -103.35 -36.83 7.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.392 -171.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.65 77.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.14 131.29 42.74 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -142.87 115.26 8.49 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.1 1.36 . . . . 0.0 107.832 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 84.63 0.73 Allowed Glycine 0 CA--C 1.486 -1.777 0 N-CA-C 104.625 -3.39 . . . . 0.0 104.625 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.644 0 C-N-CA 125.615 1.579 . . . . 0.0 111.003 175.397 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.506 -0.712 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.0 mt -116.88 134.23 55.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -142.44 162.67 27.27 Favored Glycine 0 CA--C 1.492 -1.403 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.83 130.73 73.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -137.61 150.09 47.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 54.6 m -119.19 -39.97 2.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.003 0.365 . . . . 0.0 111.91 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.56 -50.2 8.48 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-N 119.142 0.883 . . . . 0.0 112.299 -168.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 38.4 pt -84.74 -175.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 125.686 1.595 . . . . 0.0 110.14 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.38 81.92 2.81 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 -169.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.78 92.62 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.294 1.996 . . . . 0.0 110.107 162.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.85 141.85 50.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -93.5 157.19 16.33 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.162 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.92 122.8 21.43 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.808 1.186 . . . . 0.0 108.718 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.04 -11.31 72.46 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 125.667 1.603 . . . . 0.0 111.165 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.8 175.01 6.1 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.624 0.726 . . . . 0.0 110.619 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 91.1 m -142.55 125.61 16.29 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -158.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.613 HG13 HH11 ' B' ' 914' ' ' ARG . 27.2 m -96.78 151.1 4.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 121.637 0.732 . . . . 0.0 110.909 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -140.85 138.94 34.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.864 2.066 . . . . 0.0 111.454 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.71 129.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.466 0 C-N-CA 127.142 2.177 . . . . 0.0 106.964 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -107.29 130.77 54.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.633 -3.469 . . . . 0.0 101.633 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.8 77.11 1.75 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 59.5 t -160.12 100.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -151.59 71.76 1.0 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.25 141.78 9.09 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.44 -5.11 13.51 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.233 0.613 . . . . 0.0 110.994 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 37.8 tp -99.44 82.11 2.62 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.56 -174.5 3.72 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -121.97 159.76 26.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -88.62 130.52 35.26 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.81 150.11 22.4 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 113.3 23.24 Favored Pre-proline 0 C--N 1.356 0.88 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -97.75 173.88 0.61 Allowed 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 121.957 1.772 . . . . 0.0 108.492 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.95 139.53 50.54 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.42 139.63 38.99 Favored 'General case' 0 C--N 1.374 1.646 0 CA-C-N 119.728 1.149 . . . . 0.0 108.572 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.2 mm -116.82 130.4 71.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -127.78 106.03 8.85 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 982' ' ' SER . . . . . 0.484 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 34.3 p -101.22 163.02 12.48 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.086 1.354 . . . . 0.0 110.538 171.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.75 111.41 0.31 Allowed Glycine 0 C--N 1.36 1.868 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.85 145.12 45.93 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.25 123.23 23.3 Favored 'General case' 0 C--N 1.376 1.744 0 C-N-CA 124.223 1.009 . . . . 0.0 109.354 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 53.6 tp -98.3 -57.48 2.2 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.4 127.3 37.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.72 128.95 9.72 Favored Glycine 0 CA--C 1.493 -1.329 1 N-CA-C 103.053 -4.019 . . . . 0.0 103.053 163.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.76 128.91 91.65 Favored Pre-proline 0 C--N 1.349 0.567 0 CA-C-O 117.693 -1.146 . . . . 0.0 110.345 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -106.27 82.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 CA-C-N 122.08 1.779 . . . . 0.0 109.593 -168.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.0 -72.04 0.09 Allowed 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 130.201 3.4 . . . . 0.0 109.136 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 76.5 mt 49.47 40.6 19.39 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 128.984 2.914 . . . . 0.0 113.828 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -113.35 131.79 55.83 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -130.02 109.17 10.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.578 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.88 114.43 31.07 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -86.09 -23.92 1.84 Allowed 'Trans proline' 0 CA--C 1.512 -0.584 0 CA-C-N 121.697 1.642 . . . . 0.0 110.285 -171.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 38.8 67.03 0.46 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 128.602 2.761 . . . . 0.0 115.553 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.09 136.95 57.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.93 156.09 49.59 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -148.47 137.83 21.96 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.3 t -171.37 119.37 0.47 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.426 -0.796 . . . . 0.0 109.734 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.41 153.61 37.61 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.17 158.46 44.01 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.663 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -140.83 130.21 23.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 74.5 m -158.54 15.99 0.2 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.0 pp -27.25 144.33 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.517 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 160.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -79.75 -45.49 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 122.056 1.77 . . . . 0.0 113.54 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.07 174.42 12.28 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.1 m -5.02 114.83 0.01 OUTLIER 'General case' 0 C--N 1.363 1.185 0 C-N-CA 130.78 3.632 . . . . 0.0 116.901 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.87 156.55 43.67 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.01 -15.63 10.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.346 2.03 . . . . 0.0 111.259 -172.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.1 -140.48 2.96 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.0 m -65.8 144.66 56.72 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.621 1.568 . . . . 0.0 110.036 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 74.1 t -98.09 134.39 22.16 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 124.596 1.159 . . . . 0.0 110.521 -158.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -95.77 -152.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.063 3.175 . . . . 0.0 109.832 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -145.4 132.83 20.73 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -113.24 -17.03 12.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.457 0.703 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -102.9 83.42 2.23 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.194 0.521 . . . . 0.0 111.458 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.66 97.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.534 1.934 . . . . 0.0 106.649 165.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.79 -37.87 14.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.889 -173.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 34.4 tp -165.02 127.22 2.16 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 174.97 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.183 1.356 . . . . 0.0 107.703 -163.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.84 -42.78 94.35 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.79 -28.32 16.4 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.744 0.702 . . . . 0.0 112.284 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.26 -58.44 0.46 Allowed Glycine 0 C--N 1.354 1.53 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 62.45 -81.28 0.02 OUTLIER 'General case' 0 C--N 1.353 0.751 0 C-N-CA 128.119 2.568 . . . . 0.0 114.654 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -95.5 120.3 35.51 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.424 1.49 . . . . 0.0 108.501 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.41 117.38 68.64 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.56 6.59 2.02 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.918 2.792 . . . . 0.0 109.768 -171.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -79.65 -45.33 19.24 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -105.26 -15.83 14.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.894 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.23 24.22 52.3 Favored Glycine 0 C--N 1.363 2.037 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 164.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.67 103.08 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 N-CA-C 101.335 -3.58 . . . . 0.0 101.335 -168.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -94.67 112.14 23.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.929 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 50.7 m -102.86 109.07 20.52 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.25 110.38 42.16 Favored Pre-proline 0 C--N 1.356 0.889 0 CA-C-O 117.221 -1.371 . . . . 0.0 111.774 169.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -92.83 1.33 3.72 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.539 2.159 . . . . 0.0 108.289 164.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 36.4 mt -54.73 -52.68 61.74 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 128.098 2.559 . . . . 0.0 113.794 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.41 67.35 0.95 Allowed 'General case' 0 C--N 1.366 1.29 0 CA-C-O 121.971 0.891 . . . . 0.0 111.177 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.97 171.22 44.11 Favored Glycine 0 N--CA 1.406 -3.307 1 N-CA-C 100.272 -5.131 . . . . 0.0 100.272 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -91.45 116.34 28.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -116.28 160.03 21.03 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-O 121.576 0.703 . . . . 0.0 110.248 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.67 112.77 25.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.39 139.36 50.98 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.142 1.377 . . . . 0.0 109.017 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.5 m -144.15 120.53 10.95 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 110.197 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.53 154.48 19.86 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.52 123.07 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.52 123.63 40.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.256 1.022 . . . . 0.0 109.341 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 49.9 m -79.63 132.7 36.32 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.66 -56.78 16.38 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 125.774 1.654 . . . . 0.0 114.432 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 32.3 71.83 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.979 2.512 . . . . 0.0 114.987 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -72.98 -9.24 58.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.554 1.541 . . . . 0.0 111.803 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -71.92 -16.5 62.11 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.98 1.712 . . . . 0.0 112.274 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 122.13 -173.1 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.571 2.748 . . . . 0.0 107.745 173.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 103.49 134.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 127.949 2.499 . . . . 0.0 106.655 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.03 123.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -104.03 130.0 51.68 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.154 1.781 . . . . 0.0 110.278 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -152.5 114.2 4.34 Favored 'General case' 0 C--N 1.358 0.965 0 C-N-CA 124.97 1.308 . . . . 0.0 110.103 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.53 114.21 27.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 125.238 1.415 . . . . 0.0 107.694 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -61.59 139.92 58.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.112 1.765 . . . . 0.0 111.421 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.1 t -117.53 144.89 44.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.059 2.144 . . . . 0.0 108.842 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.31 141.91 38.13 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 127.205 2.202 . . . . 0.0 111.003 -174.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.6 t 99.79 -10.78 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.955 3.302 . . . . 0.0 112.179 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -141.8 -25.94 0.68 Allowed 'General case' 0 C--N 1.358 0.944 0 CA-C-N 119.275 0.943 . . . . 0.0 111.672 -172.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 59.72 167.62 0.07 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.229 1.412 . . . . 0.0 111.671 -163.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.06 -131.94 52.2 Favored Glycine 0 C--N 1.373 2.595 0 O-C-N 119.498 -2.001 . . . . 0.0 109.363 -162.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 44.8 t 54.8 74.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 125.567 1.547 . . . . 0.0 111.032 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.12 114.85 27.49 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 27.7 ptt85 -97.96 -38.0 9.57 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.752 -171.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.19 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.012 -2.959 . . . . 0.0 103.012 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -97.53 131.12 44.43 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.183 0.516 . . . . 0.0 111.111 -173.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -144.05 117.06 8.86 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.475 1.51 . . . . 0.0 108.35 171.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 85.01 0.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 105.158 -3.177 . . . . 0.0 105.158 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.605 0 C-N-CA 125.168 1.366 . . . . 0.0 110.798 174.385 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 73.7 mt -122.34 134.24 54.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.96 161.63 26.75 Favored Glycine 0 CA--C 1.491 -1.467 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -174.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 28.4 m -120.8 129.64 75.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.55 150.16 48.47 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.265 -0.897 . . . . 0.0 108.775 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -115.78 -41.03 3.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.484 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 16.6 tp -90.05 -52.92 4.72 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 119.069 0.849 . . . . 0.0 111.837 -168.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.51 -177.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 125.709 1.604 . . . . 0.0 109.844 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.99 85.51 1.6 Allowed Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 87.78 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 122.543 1.944 . . . . 0.0 109.49 163.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.18 145.82 48.3 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -92.8 161.37 14.54 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 118.917 0.78 . . . . 0.0 109.721 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.51 122.67 20.87 Favored 'General case' 0 C--N 1.379 1.872 0 CA-C-N 119.907 1.231 . . . . 0.0 109.051 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.73 -12.49 69.72 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.112 1.815 . . . . 0.0 111.372 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.26 175.37 5.41 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-O 121.571 0.701 . . . . 0.0 111.45 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 93.6 m -142.68 126.65 17.28 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.965 0.906 . . . . 0.0 110.569 -159.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.44 147.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.915 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.9 t -142.04 138.88 32.1 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.984 1.714 . . . . 0.0 111.577 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 89.3 t -90.33 129.07 41.78 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 C-N-CA 126.352 1.861 . . . . 0.0 106.701 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.69 132.97 51.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 101.345 -3.576 . . . . 0.0 101.345 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.92 72.16 1.49 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.844 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.2 t -160.97 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -151.78 70.04 0.93 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.2 145.88 7.96 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -117.27 -15.8 10.38 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.044 0.938 . . . . 0.0 110.287 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -101.59 81.98 2.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.79 -161.92 1.22 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -119.61 154.15 34.41 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.6 t -89.58 132.74 34.95 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -156.5 154.41 30.3 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -128.74 120.74 20.71 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -102.49 170.96 0.25 Allowed 'Trans proline' 0 CA--C 1.506 -0.892 0 N-CA-C 107.691 -1.696 . . . . 0.0 107.691 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 8.1 mp -112.53 139.83 47.79 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.5 p -136.56 139.27 42.05 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 119.574 1.079 . . . . 0.0 108.199 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.0 131.11 68.22 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -124.91 104.87 8.83 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 982' ' ' SER . . . . . 0.427 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 31.1 p -101.88 163.45 12.24 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.357 1.463 . . . . 0.0 110.556 171.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.76 112.14 0.34 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.77 45.78 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.921 -1.341 . . . . 0.0 114.452 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.05 124.45 27.81 Favored 'General case' 0 C--N 1.379 1.875 0 C-N-CA 124.892 1.277 . . . . 0.0 109.724 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 17.1 tp -97.49 -57.09 2.33 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.809 0.338 . . . . 0.0 110.237 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -131.49 127.65 37.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.82 130.72 10.41 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 165.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -70.51 129.5 90.08 Favored Pre-proline 0 C--N 1.35 0.594 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.696 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -106.76 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.014 1.755 . . . . 0.0 109.46 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 78.45 -73.16 0.08 Allowed 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 130.034 3.334 . . . . 0.0 109.048 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.8 mt 49.79 39.66 18.52 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.911 2.884 . . . . 0.0 113.792 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -112.12 131.72 55.29 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.36 109.05 10.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.095 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 110.166 -0.744 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.03 117.89 28.28 Favored Pre-proline 0 C--N 1.353 0.748 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -89.02 -21.0 1.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 CA-C-N 121.998 1.749 . . . . 0.0 110.021 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 37.29 70.57 0.17 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 129.056 2.942 . . . . 0.0 115.493 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 81.7 t -118.23 136.12 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.19 158.11 45.2 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 164.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -150.57 143.49 24.69 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 118.924 0.784 . . . . 0.0 110.117 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.57 118.42 0.85 Allowed 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.444 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.74 154.26 37.15 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.81 157.18 45.76 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.229 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -134.45 130.17 36.35 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -166.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 39.5 p -162.99 13.38 0.07 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -161.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 3.5 pp -25.18 147.99 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.426 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 159.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.28 -45.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.111 1.79 . . . . 0.0 113.252 -164.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.95 176.1 10.5 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -173.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.55 119.57 0.02 OUTLIER 'General case' 0 C--N 1.364 1.209 0 C-N-CA 130.549 3.54 . . . . 0.0 116.148 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.96 163.7 18.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 123.98 0.912 . . . . 0.0 108.737 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.06 -13.58 13.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.886 2.391 . . . . 0.0 111.189 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.81 -144.74 4.39 Favored Glycine 0 C--N 1.354 1.563 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.5 m -64.67 137.66 57.94 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.375 1.87 . . . . 0.0 110.938 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 14.8 m -69.38 145.59 95.77 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.365 1.466 . . . . 0.0 113.292 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -101.8 -145.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.037 2.492 . . . . 0.0 107.281 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -148.11 134.07 19.16 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -117.4 -14.2 10.37 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.428 0.691 . . . . 0.0 110.42 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . 0.462 HH21 HD21 ' A' ' 872' ' ' LEU . 16.4 mmm180 -100.37 85.92 3.08 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-O 121.335 0.588 . . . . 0.0 111.427 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 74.2 t -69.2 95.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.935 2.494 . . . . 0.0 105.472 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . 0.462 HD21 HH21 ' A' ' 870' ' ' ARG . 4.3 mt -90.79 -38.08 13.23 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.875 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 55.3 tp -166.8 130.62 1.95 Allowed 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.4 p-10 172.15 62.51 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 121.012 1.733 . . . . 0.0 108.537 -172.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.34 -44.19 92.66 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -163.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.39 -31.73 9.36 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.35 -68.76 0.23 Allowed Glycine 0 CA--C 1.489 -1.557 0 N-CA-C 105.592 -3.003 . . . . 0.0 105.592 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 77.29 -67.78 0.19 Allowed 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 128.295 2.638 . . . . 0.0 112.21 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -98.35 122.12 41.13 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.31 1.444 . . . . 0.0 108.101 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.68 118.0 70.45 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 116.115 -1.898 . . . . 0.0 106.113 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.32 -0.46 4.71 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 124.637 2.692 . . . . 0.0 108.768 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.65 -41.39 27.02 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.835 1.254 . . . . 0.0 108.612 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 37.1 p -104.31 -15.34 15.48 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.57 16.81 69.96 Favored Glycine 0 C--N 1.365 2.163 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 167.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 55.7 t -101.87 105.81 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 112.37 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.236 -175.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.29 109.33 20.97 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.76 110.9 44.81 Favored Pre-proline 0 C--N 1.357 0.913 0 CA-C-O 117.172 -1.394 . . . . 0.0 111.678 169.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -93.75 0.44 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 CA-C-N 123.082 2.136 . . . . 0.0 108.602 166.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 61.5 mt -51.73 -54.39 28.96 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 127.988 2.515 . . . . 0.0 114.563 -168.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.13 66.34 1.12 Allowed 'General case' 0 C--N 1.364 1.231 0 CA-C-O 121.926 0.87 . . . . 0.0 112.166 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.27 -169.02 36.57 Favored Glycine 0 N--CA 1.408 -3.17 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -92.99 122.28 35.19 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.018 -1.091 . . . . 0.0 108.214 171.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . 0.455 ' H ' HD11 ' A' ' 954' ' ' LEU . 0.0 OUTLIER -116.56 151.68 35.69 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.94 115.83 30.87 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.867 0.867 . . . . 0.0 108.844 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -112.58 137.11 51.3 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.957 1.703 . . . . 0.0 109.758 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -145.42 119.06 9.14 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 123.634 0.773 . . . . 0.0 109.317 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.59 154.31 21.6 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.43 120.98 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.12 123.21 42.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.349 1.059 . . . . 0.0 109.22 -171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 48.5 m -83.68 132.32 34.88 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.362 1.465 . . . . 0.0 107.272 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.83 17.78 Favored Glycine 0 C--N 1.362 2.026 0 C-N-CA 125.089 1.328 . . . . 0.0 114.309 -170.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 59.1 m170 33.14 73.18 0.07 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 127.86 2.464 . . . . 0.0 115.342 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -73.91 -8.4 55.94 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.288 1.435 . . . . 0.0 111.959 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -71.17 -18.51 62.49 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.567 1.547 . . . . 0.0 112.577 -170.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.309 9.4 pt-20 123.01 -174.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 129.149 2.98 . . . . 0.0 107.915 175.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 102.32 130.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 128.162 2.585 . . . . 0.0 106.509 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 91.2 t -98.31 124.48 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -107.97 130.47 55.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.121 1.769 . . . . 0.0 110.719 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -153.97 115.1 4.09 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 125.217 1.407 . . . . 0.0 110.125 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.85 117.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.532 1.533 . . . . 0.0 107.886 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.9 mt -62.79 137.37 58.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.07 1.348 . . . . 0.0 109.145 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.2 t -116.22 147.89 41.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 126.053 1.741 . . . . 0.0 108.192 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.435 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -76.03 138.55 40.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 128.418 2.687 . . . . 0.0 110.38 -173.777 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 88.34 3.44 0.28 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.961 2.904 . . . . 0.0 113.012 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -149.73 -24.81 0.27 Allowed 'General case' 0 C--N 1.359 1.019 0 CA-C-N 119.45 1.023 . . . . 0.0 111.61 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 57.76 172.9 0.05 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.947 1.299 . . . . 0.0 112.117 -162.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.02 52.83 Favored Glycine 0 C--N 1.377 2.824 0 O-C-N 119.513 -1.992 . . . . 0.0 110.292 -163.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 54.5 t 55.34 75.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.266 0 C-N-CA 125.651 1.58 . . . . 0.0 111.267 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.58 116.51 28.93 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -102.27 -32.87 9.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.67 -1.605 . . . . 0.0 108.165 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.89 83.3 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.74 131.65 38.89 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.136 0.493 . . . . 0.0 110.636 -172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.0 t -143.3 115.41 8.37 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.505 1.522 . . . . 0.0 107.569 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.38 84.57 0.76 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 104.937 -3.265 . . . . 0.0 104.937 167.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.582 0 C-N-CA 124.884 1.23 . . . . 0.0 111.193 175.763 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.512 -0.504 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 56.1 mt -121.66 133.6 54.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.97 161.42 27.83 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.48 130.17 74.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -138.82 151.18 46.81 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.4 m -115.35 -43.24 3.08 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.48 -50.84 6.95 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 119.324 0.965 . . . . 0.0 112.714 -166.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.9 -172.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.799 1.64 . . . . 0.0 110.462 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.455 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -160.01 84.18 2.15 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -166.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.68 90.7 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.985 1.745 . . . . 0.0 109.089 159.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.68 142.58 50.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.8 158.72 15.3 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.06 123.09 21.31 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.745 1.157 . . . . 0.0 109.031 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.39 -11.09 72.96 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 125.886 1.708 . . . . 0.0 111.258 170.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.44 174.28 6.79 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 111.552 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.51 127.08 16.04 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -159.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.435 HG13 HH11 ' A' ' 914' ' ' ARG . 15.3 m -98.23 147.3 6.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.401 0.62 . . . . 0.0 110.865 171.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 23.4 t -142.32 137.73 30.79 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.318 1.847 . . . . 0.0 110.888 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 30.3 t -91.57 129.04 42.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 C-N-CA 125.995 1.718 . . . . 0.0 107.315 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.8 131.94 53.34 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 101.437 -3.542 . . . . 0.0 101.437 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.4 72.82 1.51 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.287 -1.779 . . . . 0.0 106.45 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 52.4 t -162.22 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 83.1 mmm -152.88 72.86 0.98 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 117.48 147.08 8.43 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.82 -28.46 7.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.1 tp -92.71 86.36 5.52 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -154.92 0.57 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -124.68 166.96 15.21 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 23.0 t -103.7 131.6 50.72 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 155.89 30.9 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.29 115.05 21.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 173.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -99.78 172.94 0.4 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 121.998 1.799 . . . . 0.0 108.05 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.64 140.97 48.69 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -138.3 140.34 39.52 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.585 1.084 . . . . 0.0 108.479 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.2 mm -116.64 130.88 70.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -126.31 106.16 9.32 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 26.9 p -100.36 160.3 14.45 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.529 1.132 . . . . 0.0 109.253 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.72 109.82 0.28 Allowed Glycine 0 C--N 1.356 1.665 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.888 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.39 143.68 47.32 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -73.35 125.96 29.05 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.955 1.302 . . . . 0.0 109.904 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.82 -57.38 2.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -131.13 127.75 38.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.9 129.98 10.1 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -69.88 128.72 91.63 Favored Pre-proline 0 C--N 1.349 0.573 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.583 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -106.94 80.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.165 1.809 . . . . 0.0 109.233 -169.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 79.47 -70.51 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.936 3.295 . . . . 0.0 109.008 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 18.2 mt 50.37 38.21 17.38 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 128.729 2.812 . . . . 0.0 114.202 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -114.98 133.94 55.61 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -129.2 109.98 11.6 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.112 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.226 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.807 0 N-CA-C 110.134 -0.756 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.22 118.36 27.89 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -89.42 -21.61 1.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 122.029 1.76 . . . . 0.0 110.144 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 38.29 69.72 0.24 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 128.964 2.906 . . . . 0.0 115.455 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 79.2 t -117.89 136.21 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.05 158.3 44.7 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.5 143.58 24.81 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 118.821 0.737 . . . . 0.0 110.201 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.64 118.37 0.84 Allowed 'General case' 0 C--N 1.354 0.788 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.203 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.16 154.2 36.52 Favored 'General case' 0 C--N 1.369 1.435 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.37 157.14 46.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.405 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.99 130.21 37.29 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -166.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 39.9 p -163.07 13.1 0.06 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -161.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.5 pp -25.06 148.01 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.387 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 159.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.13 -45.66 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 122.14 1.8 . . . . 0.0 113.329 -164.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.83 176.03 10.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.64 119.63 0.02 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.507 3.523 . . . . 0.0 116.138 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -113.82 163.69 18.02 Favored Pre-proline 0 N--CA 1.443 -0.784 0 C-N-CA 124.037 0.935 . . . . 0.0 108.799 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.02 -13.55 14.04 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.875 2.383 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.79 -144.79 4.41 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -64.72 137.73 57.98 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 126.38 1.872 . . . . 0.0 110.901 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.54 145.63 95.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 113.342 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -102.21 -145.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.068 2.512 . . . . 0.0 107.285 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -148.46 134.18 18.88 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -117.0 -13.82 10.61 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.749 0.819 . . . . 0.0 110.21 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . 0.453 HH21 HD21 ' B' ' 872' ' ' LEU . 15.8 mmm180 -99.97 86.47 3.27 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-O 121.11 0.481 . . . . 0.0 111.918 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.85 95.48 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 127.763 2.425 . . . . 0.0 105.402 163.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . 0.453 HD21 HH21 ' B' ' 870' ' ' ARG . 4.5 mt -90.74 -38.14 13.22 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.726 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.5 tp -166.59 130.64 2.04 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.5 p-10 172.48 62.62 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 120.906 1.684 . . . . 0.0 108.903 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.16 -44.06 92.12 Favored 'General case' 0 C--N 1.364 1.216 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.31 -32.01 9.17 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.05 -68.39 0.24 Allowed Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 77.15 -68.18 0.18 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 128.245 2.618 . . . . 0.0 112.288 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -98.38 121.85 40.83 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.331 1.452 . . . . 0.0 108.1 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.03 118.08 70.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-O 116.149 -1.881 . . . . 0.0 106.266 167.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -90.79 -0.22 5.05 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 CA-C-N 124.6 2.679 . . . . 0.0 108.772 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.68 -41.01 27.72 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 124.921 1.288 . . . . 0.0 108.651 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 37.8 p -104.66 -15.53 15.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.67 16.98 69.24 Favored Glycine 0 C--N 1.364 2.111 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.94 105.9 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 -168.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.64 112.43 24.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.366 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.23 109.26 20.89 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.82 111.07 46.02 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.837 169.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.52 1.52 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 123.078 2.135 . . . . 0.0 108.767 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.27 -49.46 72.02 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.819 2.048 . . . . 0.0 114.26 -167.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.69 47.76 17.66 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.302 1.441 . . . . 0.0 114.704 171.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -159.63 -164.18 14.48 Favored Glycine 0 N--CA 1.413 -2.888 1 N-CA-C 101.345 -4.702 . . . . 0.0 101.345 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -89.95 121.35 31.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . 0.445 ' H ' HD11 ' B' ' 954' ' ' LEU 0.25 0.0 OUTLIER -117.17 151.94 35.82 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.901 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.9 tp -106.42 115.64 30.56 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -113.21 136.5 52.67 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.794 1.638 . . . . 0.0 109.063 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.1 m -145.93 119.23 8.95 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 123.542 0.737 . . . . 0.0 109.247 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.18 154.68 20.85 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 96.9 t -105.2 122.11 58.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.45 121.92 41.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.106 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 46.9 m -82.17 131.92 35.24 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 125.353 1.461 . . . . 0.0 107.509 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.67 18.61 Favored Glycine 0 C--N 1.363 2.062 0 C-N-CA 125.165 1.364 . . . . 0.0 114.376 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.9 m170 33.04 73.24 0.07 Allowed 'General case' 0 C--N 1.361 1.072 0 C-N-CA 127.845 2.458 . . . . 0.0 115.357 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -74.02 -8.1 54.9 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.366 1.466 . . . . 0.0 111.901 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -72.03 -15.72 62.04 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.845 1.658 . . . . 0.0 112.619 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.318 8.5 pt-20 119.36 -176.13 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 129.152 2.981 . . . . 0.0 108.192 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 103.24 129.98 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 128.158 2.583 . . . . 0.0 106.561 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.25 125.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -109.02 130.42 55.48 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.024 1.73 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.13 115.07 4.04 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.928 1.291 . . . . 0.0 110.2 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 5.0 p -84.04 117.82 30.29 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 125.494 1.518 . . . . 0.0 107.932 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 28.4 mt -62.96 137.9 58.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.453 1.501 . . . . 0.0 109.083 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.0 t -116.02 148.62 39.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.959 1.704 . . . . 0.0 108.715 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.433 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -77.06 138.19 39.41 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 127.989 2.516 . . . . 0.0 110.169 -173.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 87.6 4.67 0.31 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.863 2.865 . . . . 0.0 113.019 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -150.03 -24.67 0.26 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.438 1.017 . . . . 0.0 111.515 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 57.56 173.79 0.05 OUTLIER 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.881 1.272 . . . . 0.0 111.983 -161.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.38 -133.05 52.83 Favored Glycine 0 C--N 1.374 2.68 0 O-C-N 119.622 -1.924 . . . . 0.0 110.337 -164.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 62.0 t 55.54 75.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.22 0 C-N-CA 125.729 1.612 . . . . 0.0 111.26 172.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.56 116.59 28.99 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -173.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -102.38 -33.14 9.67 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 113.536 -1.666 . . . . 0.0 108.268 -172.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.83 83.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 164.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.35 130.77 40.53 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 121.226 0.536 . . . . 0.0 110.363 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.8 t -142.89 115.43 8.58 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.502 1.521 . . . . 0.0 107.438 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.2 84.67 0.78 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.961 -3.256 . . . . 0.0 104.961 167.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.616 0 C-N-CA 124.888 1.232 . . . . 0.0 111.285 176.184 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.19 133.76 55.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.62 161.74 27.72 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.22 130.91 73.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -138.95 151.15 46.65 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.5 m -113.85 -46.03 3.05 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.02 -49.98 8.42 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 119.221 0.919 . . . . 0.0 112.919 -166.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.63 -173.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.628 1.571 . . . . 0.0 110.455 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.445 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.77 83.86 2.23 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -166.363 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.7 90.69 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 109.099 159.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.65 141.12 51.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -95.49 158.45 15.45 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.19 123.08 21.38 Favored 'General case' 0 C--N 1.376 1.745 0 CA-C-N 119.805 1.184 . . . . 0.0 108.938 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.24 -10.79 73.62 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 125.867 1.699 . . . . 0.0 111.334 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.71 174.3 6.99 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-O 121.464 0.65 . . . . 0.0 111.241 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.4 m -144.43 127.03 16.06 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -159.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.433 HG13 HH11 ' B' ' 914' ' ' ARG . 15.6 m -98.35 147.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 CA-C-O 121.303 0.573 . . . . 0.0 111.397 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 23.1 t -142.76 137.86 30.05 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 126.422 1.889 . . . . 0.0 110.9 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 26.6 t -91.7 129.4 42.43 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 107.536 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.85 132.08 53.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 72.71 1.51 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 49.6 t -161.99 102.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 83.5 mmm -153.18 71.17 0.89 Allowed 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.67 146.47 7.78 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 107.571 -2.212 . . . . 0.0 107.571 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.2 -28.21 7.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 45.5 tp -92.84 86.31 5.45 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.65 -155.63 0.62 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -124.07 167.41 14.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 23.3 t -104.49 131.34 51.99 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.58 155.86 30.91 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.14 114.91 21.76 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -99.41 172.6 0.44 Allowed 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.025 1.817 . . . . 0.0 108.021 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.71 140.74 48.91 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.1 p -138.28 140.4 39.59 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 119.5 1.045 . . . . 0.0 108.49 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.66 131.21 69.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.42 106.1 9.24 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 982' ' ' SER . . . . . 0.409 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 24.9 p -99.97 160.18 14.52 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.521 1.128 . . . . 0.0 108.858 170.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.94 109.45 0.26 Allowed Glycine 0 C--N 1.356 1.643 0 C-N-CA 118.899 -1.62 . . . . 0.0 109.356 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -122.56 145.23 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 57.3 tp -72.74 126.57 30.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 124.948 1.299 . . . . 0.0 110.449 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 31.4 tp -97.45 -57.18 2.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.317 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -131.2 127.78 38.63 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -173.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 129.71 10.0 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 103.536 -3.826 . . . . 0.0 103.536 163.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.55 128.42 91.11 Favored Pre-proline 0 C--N 1.351 0.668 0 CA-C-O 117.791 -1.099 . . . . 0.0 110.342 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -106.72 82.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 122.12 1.793 . . . . 0.0 109.28 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 79.14 -70.5 0.1 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.911 3.284 . . . . 0.0 109.091 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 19.8 mt 50.08 38.91 17.98 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 128.729 2.812 . . . . 0.0 114.245 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.14 110.13 11.75 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.115 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.336 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.793 0 N-CA-C 110.175 -0.741 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.64 119.28 25.89 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.89 -19.76 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 CA-C-N 122.096 1.784 . . . . 0.0 110.102 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 36.78 71.79 0.13 Allowed 'General case' 0 C--N 1.359 1.014 0 C-N-CA 129.174 2.99 . . . . 0.0 115.388 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 75.0 t -116.85 135.32 57.58 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.43 154.37 50.81 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 163.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -150.13 141.83 23.62 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 118.536 0.607 . . . . 0.0 109.93 171.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 23.0 t -168.07 118.58 0.8 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.45 155.36 40.6 Favored 'General case' 0 C--N 1.368 1.405 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.1 156.13 46.02 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.743 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -133.34 128.33 35.44 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.467 -167.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 73.1 m -161.05 10.08 0.09 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -161.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.4 pp -27.63 146.44 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.495 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 161.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.85 -46.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 CA-C-N 122.099 1.786 . . . . 0.0 113.454 -162.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -162.28 171.16 17.73 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m 0.46 106.78 0.01 OUTLIER 'General case' 0 C--N 1.361 1.109 0 C-N-CA 131.116 3.767 . . . . 0.0 116.77 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -103.93 163.33 17.57 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 123.562 0.745 . . . . 0.0 109.316 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.7 -13.54 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.754 2.302 . . . . 0.0 111.069 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -145.35 4.47 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.9 m -65.36 139.39 58.56 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.283 1.833 . . . . 0.0 110.475 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.08 147.59 83.54 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 112.771 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -100.92 -145.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.291 2.661 . . . . 0.0 107.035 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.28 133.85 18.74 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -116.49 -16.28 10.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.501 0.72 . . . . 0.0 110.864 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 11.3 mmm180 -101.86 82.47 2.26 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.11 96.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 126.706 2.002 . . . . 0.0 106.511 164.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 1.7 mt -89.64 -36.88 15.01 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.902 -175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 54.0 tp -164.06 130.3 3.08 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 100.913 -3.736 . . . . 0.0 100.913 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 175.01 60.38 0.0 OUTLIER 'General case' 0 C--N 1.356 0.865 0 CA-C-N 120.621 1.555 . . . . 0.0 107.399 -166.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.89 -44.55 95.8 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -165.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.65 -33.09 7.67 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.617 0.644 . . . . 0.0 112.212 -174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 115.86 -65.91 0.31 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 106.193 -2.763 . . . . 0.0 106.193 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 63.66 -80.52 0.03 OUTLIER 'General case' 0 C--N 1.355 0.808 0 C-N-CA 127.983 2.513 . . . . 0.0 113.598 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -94.36 120.74 35.05 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.856 1.263 . . . . 0.0 107.703 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.93 118.24 70.88 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-O 115.989 -1.958 . . . . 0.0 106.03 167.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -90.8 -4.02 4.72 Favored 'Trans proline' 0 CA--C 1.509 -0.731 0 CA-C-N 124.786 2.745 . . . . 0.0 108.795 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -79.92 -40.55 27.94 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 125.17 1.388 . . . . 0.0 108.784 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -103.8 -15.15 15.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.12 16.39 69.7 Favored Glycine 0 C--N 1.363 2.053 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 167.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.83 105.8 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 -167.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -97.28 111.67 23.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.204 -177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 56.3 m -101.32 109.25 21.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 170.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.69 110.51 41.98 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.491 -1.242 . . . . 0.0 111.463 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.08 -0.64 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 122.946 2.088 . . . . 0.0 108.245 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . 0.454 HD12 ' H ' ' C' ' 892' ' ' GLY . 3.7 pp -58.18 -43.55 87.57 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.333 1.453 . . . . 0.0 114.69 -166.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.72 46.71 16.84 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . 0.454 ' H ' HD12 ' C' ' 890' ' ' LEU . . . -159.03 -163.76 13.51 Favored Glycine 0 N--CA 1.417 -2.571 1 N-CA-C 101.581 -4.608 . . . . 0.0 101.581 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 46.7 ttt-85 -91.32 120.53 32.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.477 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -116.41 156.29 27.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.452 1.101 . . . . 0.0 108.798 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.9 115.52 29.96 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.581 0.752 . . . . 0.0 110.083 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 5.0 tt -116.07 136.06 53.37 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 -174.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.85 119.5 9.78 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 123.633 0.773 . . . . 0.0 109.999 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 154.75 20.94 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.2 t -105.78 122.14 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.55 122.24 41.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.28 1.032 . . . . 0.0 109.142 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 54.3 m -80.44 132.46 35.73 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 125.256 1.423 . . . . 0.0 107.997 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.06 -57.29 20.0 Favored Glycine 0 C--N 1.367 2.268 0 C-N-CA 124.819 1.199 . . . . 0.0 113.343 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 45.06 68.57 0.54 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 127.08 2.152 . . . . 0.0 114.254 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -73.14 -11.84 60.68 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.749 1.22 . . . . 0.0 112.227 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -73.13 -13.94 61.28 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.075 1.75 . . . . 0.0 112.88 -166.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.345 0.3 OUTLIER 118.26 -173.6 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 129.217 3.007 . . . . 0.0 108.398 175.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 97.24 133.44 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 128.061 2.545 . . . . 0.0 106.749 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.79 122.56 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -104.4 123.0 46.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.913 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.27 116.72 17.27 Favored 'General case' 0 C--N 1.369 1.441 0 C-N-CA 128.452 2.701 . . . . 0.0 109.434 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 97.3 t -84.0 113.95 23.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.77 148.2 43.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.021 2.129 . . . . 0.0 112.061 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.27 1.0 OUTLIER -116.34 147.07 41.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.257 1.823 . . . . 0.0 110.993 175.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 139.34 38.14 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 127.133 2.173 . . . . 0.0 108.815 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.7 t 94.74 -10.99 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.717 2.807 . . . . 0.0 112.596 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -141.44 -28.35 0.66 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.585 1.084 . . . . 0.0 111.751 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 58.38 170.7 0.06 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 124.855 1.262 . . . . 0.0 112.191 -162.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -135.52 50.16 Favored Glycine 0 C--N 1.372 2.576 0 O-C-N 119.447 -2.033 . . . . 0.0 109.997 -162.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t 56.27 76.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.248 0 C-N-CA 125.551 1.54 . . . . 0.0 111.358 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.2 115.54 28.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -174.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 37.8 ptt85 -102.38 -35.15 8.91 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.318 -172.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 93.9 t -99.56 86.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 162.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -93.93 133.54 37.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.657 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.2 t -142.21 115.47 8.91 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.675 1.59 . . . . 0.0 107.633 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.55 84.48 0.68 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 104.628 -3.389 . . . . 0.0 104.628 165.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 111.028 175.456 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 60.8 mt -120.21 133.68 55.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.22 162.38 27.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.61 130.6 74.34 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -138.07 146.44 42.94 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.4 m -107.55 -58.29 1.98 Allowed 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.028 0.377 . . . . 0.0 112.015 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.409 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 41.1 tp -77.62 -49.03 15.42 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -165.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 8.0 pt -84.84 -172.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 125.552 1.541 . . . . 0.0 110.274 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.477 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -159.61 92.04 1.81 Allowed Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -167.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.59 91.41 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 O-C-N 117.384 -1.956 . . . . 0.0 108.403 155.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.32 145.43 47.12 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -90.86 162.23 14.9 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.46 126.61 30.26 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 120.257 -1.527 . . . . 0.0 107.116 163.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.37 -1.13 64.14 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -54.65 167.93 0.32 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.574 1.549 . . . . 0.0 114.972 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.7 121.75 11.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.44 147.73 7.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -143.99 137.79 27.96 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.714 1.206 . . . . 0.0 112.059 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.14 129.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 126.929 2.092 . . . . 0.0 107.96 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.59 133.39 52.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.54 77.5 1.79 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 112.953 -1.93 . . . . 0.0 107.587 172.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 61.2 t -159.59 100.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -153.12 66.24 0.78 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 132.08 147.07 5.82 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -116.75 -16.68 10.64 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.312 0.645 . . . . 0.0 110.059 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -104.61 82.79 1.95 Allowed 'General case' 0 C--N 1.356 0.858 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.6 -167.19 2.02 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -171.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -119.94 155.06 33.51 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.6 t -93.29 132.13 37.78 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.27 151.6 23.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.91 113.7 29.94 Favored Pre-proline 0 C--N 1.355 0.814 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 172.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.0 174.81 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 122.26 1.973 . . . . 0.0 107.804 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.49 141.15 48.45 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.4 p -135.02 140.95 46.04 Favored 'General case' 0 C--N 1.374 1.67 0 CA-C-N 119.206 0.912 . . . . 0.0 108.893 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.3 mm -115.69 131.13 69.0 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -127.1 105.52 8.63 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 29.3 p -100.09 160.12 14.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.499 1.12 . . . . 0.0 109.125 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.86 108.61 0.25 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.23 145.28 45.12 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.42 126.65 30.37 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 125.015 1.326 . . . . 0.0 110.684 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 36.4 tp -98.23 -58.26 2.02 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.651 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -133.13 128.52 36.28 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.407 1.883 . . . . 0.0 106.783 -172.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.77 129.38 9.88 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 103.988 -3.645 . . . . 0.0 103.988 160.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.05 130.05 90.18 Favored Pre-proline 0 C--N 1.35 0.606 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.343 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -106.83 84.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 121.874 1.705 . . . . 0.0 109.518 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.86 -70.84 0.1 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 130.131 3.372 . . . . 0.0 109.494 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 54.0 mt 49.71 40.1 19.22 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 128.867 2.867 . . . . 0.0 113.983 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -115.14 132.48 56.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -130.49 110.53 11.52 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.219 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.758 0 N-CA-C 110.073 -0.78 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.38 120.67 24.9 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -91.11 -21.44 0.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.201 1.822 . . . . 0.0 109.585 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 34.91 71.75 0.11 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 129.258 3.023 . . . . 0.0 115.506 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.03 136.84 53.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.743 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.56 155.74 49.99 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 164.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -149.13 138.62 21.69 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.0 t -169.12 117.18 0.64 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.08 153.84 39.37 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.66 155.4 49.18 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.988 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.13 128.82 42.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -165.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 50.8 p -161.05 14.15 0.1 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -161.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 3.6 pp -20.95 143.26 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.382 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 159.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.05 -40.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 121.971 1.74 . . . . 0.0 112.481 -162.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 38.6 ptt85 -164.19 176.29 9.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 21.7 m -16.97 119.3 0.02 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 130.129 3.372 . . . . 0.0 115.481 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -119.12 147.18 42.2 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -162.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.13 -10.0 19.31 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.523 2.149 . . . . 0.0 112.695 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.5 -143.3 3.62 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 120.338 1.427 . . . . 0.0 111.265 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 32.9 m -82.68 146.82 28.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.206 1.802 . . . . 0.0 108.3 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.11 138.74 97.41 Favored Pre-proline 0 C--N 1.356 0.854 0 C-N-CA 125.491 1.517 . . . . 0.0 113.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -98.9 -149.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.805 3.003 . . . . 0.0 106.233 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -151.49 131.33 13.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -118.08 -15.02 9.92 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.947 -0.47 . . . . 0.0 111.149 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.81 85.4 2.88 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.911 -0.493 . . . . 0.0 112.005 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.52 98.64 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 126.505 1.922 . . . . 0.0 106.916 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 27.8 mt -87.64 -37.38 16.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.008 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.13 129.45 2.06 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 101.398 -3.556 . . . . 0.0 101.398 162.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -175.8 61.8 0.02 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 120.809 1.64 . . . . 0.0 109.814 -167.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -58.84 -44.78 91.03 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -166.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.08 -31.84 8.26 Favored Glycine 0 C--N 1.354 1.579 0 CA-C-N 118.949 0.795 . . . . 0.0 112.334 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.34 -58.87 0.39 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 63.58 -81.7 0.03 OUTLIER 'General case' 0 C--N 1.355 0.828 0 C-N-CA 128.204 2.602 . . . . 0.0 114.053 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -97.05 119.99 36.56 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.775 1.23 . . . . 0.0 108.35 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -78.84 117.54 67.28 Favored Pre-proline 0 N--CA 1.444 -0.756 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -92.84 2.58 3.63 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.411 2.968 . . . . 0.0 109.451 -166.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -80.74 -45.68 16.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 28.2 p -106.3 -12.89 15.55 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 109.055 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.63 38.46 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.02 103.57 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 -165.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.417 ' HB3' HG23 ' A' ' 962' ' ' VAL . 0.4 OUTLIER -101.62 112.24 24.74 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.922 -175.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 87.5 m -100.66 107.97 19.73 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.78 109.92 38.02 Favored Pre-proline 0 C--N 1.355 0.837 0 CA-C-O 117.23 -1.366 . . . . 0.0 110.916 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.12 -2.44 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.845 2.364 . . . . 0.0 108.86 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.47 -57.58 4.0 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 130.329 3.452 . . . . 0.0 114.771 -169.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.99 64.83 1.32 Allowed 'General case' 0 C--N 1.364 1.215 0 CA-C-O 121.759 0.79 . . . . 0.0 112.819 171.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.06 -166.75 32.66 Favored Glycine 0 N--CA 1.41 -3.046 1 N-CA-C 101.467 -4.653 . . . . 0.0 101.467 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -91.75 122.56 34.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.279 -0.96 . . . . 0.0 108.785 172.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . 0.528 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.2 t80 -115.3 145.73 42.19 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.14 115.69 30.19 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.391 0.676 . . . . 0.0 109.315 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.78 139.48 49.09 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.075 1.75 . . . . 0.0 108.843 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 70.1 m -144.12 119.58 10.32 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 123.363 0.665 . . . . 0.0 109.716 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.22 21.55 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.3 t -104.92 121.26 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.76 123.25 43.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.292 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 43.4 m -84.07 131.76 34.77 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 125.657 1.583 . . . . 0.0 106.936 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.56 17.85 Favored Glycine 0 C--N 1.363 2.057 0 C-N-CA 124.595 1.093 . . . . 0.0 113.53 -168.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 56.4 m170 39.39 71.44 0.17 Allowed 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.12 2.168 . . . . 0.0 114.626 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -70.87 -10.54 59.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.936 1.694 . . . . 0.0 111.957 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -73.33 -17.92 61.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.578 1.551 . . . . 0.0 112.746 -168.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.326 12.2 pt-20 124.52 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.603 2.361 . . . . 0.0 108.223 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.4 tttt 100.64 132.34 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 128.129 2.571 . . . . 0.0 107.163 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.32 124.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -108.02 123.62 48.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.163 1.785 . . . . 0.0 112.11 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.57 115.09 14.29 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.121 2.569 . . . . 0.0 109.553 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 90.8 t -87.66 113.77 25.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.578 1.951 . . . . 0.0 111.452 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER -114.44 147.28 39.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 126.671 1.988 . . . . 0.0 109.787 178.421 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.505 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -79.79 140.79 36.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 125.728 1.611 . . . . 0.0 110.0 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.329 24.2 p 92.61 3.86 0.07 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 129.856 3.262 . . . . 0.0 114.227 173.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -148.24 -26.18 0.34 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 119.309 0.959 . . . . 0.0 111.065 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.51 168.17 0.05 Allowed 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.729 1.612 . . . . 0.0 111.835 -162.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.86 -135.0 49.31 Favored Glycine 0 C--N 1.369 2.396 0 O-C-N 119.615 -1.928 . . . . 0.0 109.233 -161.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 41.2 t 55.96 79.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 125.952 1.701 . . . . 0.0 110.992 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.52 113.99 26.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 24.1 ptt85 -103.73 -37.1 7.62 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.014 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -99.27 87.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 166.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.06 130.43 41.74 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.688 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -143.56 115.08 8.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.353 1.461 . . . . 0.0 108.129 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.3 84.7 0.7 Allowed Glycine 0 CA--C 1.484 -1.865 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 165.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 C-N-CA 124.925 1.25 . . . . 0.0 111.302 173.741 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 61.1 mt -116.47 133.84 55.55 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -135.37 161.32 24.67 Favored Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.31 126.77 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -138.84 149.56 45.05 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 71.2 m -106.65 -54.36 2.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.456 0.302 . . . . 0.0 110.908 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.467 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 17.7 tp -83.02 -49.9 9.08 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -162.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.52 -175.97 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.381 1.472 . . . . 0.0 110.687 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.528 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -159.33 93.04 1.82 Allowed Pre-proline 0 N--CA 1.44 -0.949 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -164.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.3 92.31 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 O-C-N 116.869 -2.227 . . . . 0.0 110.152 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.8 mp -120.85 138.93 53.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -93.21 158.03 15.97 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.843 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.98 123.11 21.28 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 119.896 1.225 . . . . 0.0 108.997 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.13 73.02 Favored Glycine 0 C--N 1.345 1.071 0 C-N-CA 126.541 2.019 . . . . 0.0 111.851 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -73.17 174.96 7.23 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.359 1.064 . . . . 0.0 110.521 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 89.7 m -142.84 125.12 15.49 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 108.821 -160.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.505 HG13 HH11 ' A' ' 914' ' ' ARG . 30.7 m -95.43 149.83 4.43 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-O 121.445 0.64 . . . . 0.0 109.627 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -141.39 138.93 33.34 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.234 1.814 . . . . 0.0 111.414 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 98.6 t -92.05 129.18 43.09 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 C-N-CA 126.484 1.914 . . . . 0.0 106.268 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.05 132.34 53.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.89 78.09 1.83 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 51.3 t -160.98 100.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.973 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -154.32 66.59 0.7 Allowed 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.16 146.89 6.91 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -114.08 -31.89 6.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -90.58 86.97 6.55 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.89 -167.18 2.1 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -122.98 157.62 32.26 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 15.7 t -91.6 133.9 35.14 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.66 151.58 22.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.52 111.16 19.24 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -98.58 173.23 0.51 Allowed 'Trans proline' 0 CA--C 1.507 -0.874 0 C-N-CA 121.742 1.628 . . . . 0.0 108.317 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.58 141.03 48.72 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 24.3 p -138.78 139.71 38.36 Favored 'General case' 0 C--N 1.374 1.66 0 CA-C-N 119.302 0.956 . . . . 0.0 108.513 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.0 mm -118.17 130.25 73.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.21 106.48 9.58 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 37.4 p -99.96 160.81 14.03 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 124.465 1.106 . . . . 0.0 109.678 171.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.97 109.49 0.27 Allowed Glycine 0 C--N 1.358 1.754 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.379 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.94 147.75 43.69 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 54.3 tp -72.43 123.29 22.79 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 126.092 1.757 . . . . 0.0 109.146 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.02 -58.0 2.01 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -133.23 127.44 33.72 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 127.053 2.141 . . . . 0.0 106.383 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.79 129.73 10.0 Favored Glycine 0 CA--C 1.496 -1.144 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 161.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -69.03 131.35 90.83 Favored Pre-proline 0 C--N 1.353 0.744 0 CA-C-N 118.435 1.118 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -105.76 82.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.68 1.636 . . . . 0.0 109.468 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.91 -72.73 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.205 3.402 . . . . 0.0 109.19 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 81.2 mt 50.87 37.68 17.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.377 3.071 . . . . 0.0 114.098 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.54 134.1 52.69 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.96 107.95 8.61 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -178.633 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 110.055 -0.787 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.03 121.01 25.38 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.63 -21.73 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 122.139 1.8 . . . . 0.0 109.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 35.46 71.97 0.11 Allowed 'General case' 0 C--N 1.361 1.079 0 C-N-CA 129.611 3.164 . . . . 0.0 115.127 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.72 136.3 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.6 155.5 50.36 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -149.54 139.79 22.23 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 26.6 t -169.11 117.8 0.66 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.51 154.28 36.85 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.29 155.4 47.76 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.905 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.59 127.72 39.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -165.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 51.3 p -160.9 13.8 0.1 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.233 -161.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.6 pp -20.82 143.45 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.456 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 158.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.35 -40.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.98 1.743 . . . . 0.0 112.48 -163.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -164.29 176.31 9.26 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 21.2 m -16.98 119.33 0.02 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.156 3.382 . . . . 0.0 115.451 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.2 147.37 42.77 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -162.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -76.27 -9.87 19.08 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.533 2.155 . . . . 0.0 112.695 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.59 -143.58 3.7 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 120.287 1.403 . . . . 0.0 111.262 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 33.0 m -81.92 147.04 29.48 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.234 1.814 . . . . 0.0 108.326 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 17.4 m -63.08 138.46 97.33 Favored Pre-proline 0 C--N 1.355 0.841 0 C-N-CA 125.413 1.485 . . . . 0.0 113.192 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -99.62 -150.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.723 2.949 . . . . 0.0 106.121 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -150.88 130.71 13.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -116.47 -14.49 10.94 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.427 0.691 . . . . 0.0 110.363 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -101.31 84.07 2.57 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 122.038 -0.414 . . . . 0.0 111.842 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.83 97.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 126.438 1.895 . . . . 0.0 106.461 166.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 12.6 mt -87.98 -38.03 15.87 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.714 -173.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.3 tp -165.3 129.3 2.34 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 101.266 -3.605 . . . . 0.0 101.266 165.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 32.1 t-20 179.03 62.2 0.01 OUTLIER 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.447 1.476 . . . . 0.0 109.214 -164.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -59.08 -44.54 91.9 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -167.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.88 -32.06 8.22 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 118.768 0.713 . . . . 0.0 112.242 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.16 -58.67 0.39 Allowed Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 63.8 -82.08 0.03 OUTLIER 'General case' 0 C--N 1.356 0.862 0 C-N-CA 128.13 2.572 . . . . 0.0 114.062 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.61 119.82 36.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 125.173 1.389 . . . . 0.0 108.308 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.27 117.92 69.09 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-O 115.459 -2.21 . . . . 0.0 105.309 171.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -91.79 2.31 4.24 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 125.507 3.002 . . . . 0.0 109.671 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -80.41 -44.53 19.19 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.606 1.163 . . . . 0.0 108.704 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 26.8 p -108.59 -13.19 14.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.085 1.354 . . . . 0.0 108.651 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.02 36.15 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 163.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 26.2 t -100.24 103.83 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.605 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 -164.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.404 ' HB3' HG23 ' B' ' 962' ' ' VAL . 0.4 OUTLIER -101.23 112.46 24.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.586 -2.097 . . . . 0.0 108.973 -176.014 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 88.7 m -100.79 108.13 19.86 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.96 110.13 39.87 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.138 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.95 -1.04 5.66 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.767 2.311 . . . . 0.0 108.843 165.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 129.832 3.253 . . . . 0.0 114.87 -169.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.45 58.93 2.78 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -170.23 -165.08 27.03 Favored Glycine 0 N--CA 1.412 -2.933 1 N-CA-C 102.461 -4.255 . . . . 0.0 102.461 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -92.08 121.87 34.04 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.777 -1.211 . . . . 0.0 107.868 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . 0.46 ' H ' HD11 ' B' ' 954' ' ' LEU . 1.7 t80 -116.79 146.43 42.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -173.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.8 tp -111.51 114.86 28.24 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -113.35 139.37 48.92 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.28 1.832 . . . . 0.0 108.539 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -143.79 119.74 10.65 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.194 0.598 . . . . 0.0 109.703 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.58 21.01 Favored 'General case' 0 C--N 1.364 1.224 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.49 122.02 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.4 121.81 43.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.145 0.978 . . . . 0.0 109.19 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 40.1 m -82.66 132.0 35.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.646 1.578 . . . . 0.0 107.541 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.29 -57.72 17.68 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 124.758 1.171 . . . . 0.0 113.793 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 38.63 71.74 0.15 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 127.234 2.214 . . . . 0.0 114.774 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -71.0 -10.67 60.16 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.046 1.738 . . . . 0.0 112.043 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -73.82 -15.59 61.17 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.86 1.664 . . . . 0.0 112.908 -167.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.2 pt-20 122.1 179.4 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.856 2.462 . . . . 0.0 108.107 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 101.34 131.87 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 128.074 2.55 . . . . 0.0 107.088 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.26 126.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -110.69 122.85 48.82 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.966 -1.47 . . . . 0.0 113.093 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.81 115.74 15.67 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.842 2.457 . . . . 0.0 109.596 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 76.9 t -88.48 113.88 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 148.53 43.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.093 2.157 . . . . 0.0 111.493 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.275 0.8 OUTLIER -114.6 147.9 38.85 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 126.955 2.102 . . . . 0.0 109.715 178.5 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.521 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.73 140.13 35.73 Favored 'General case' 0 N--CA 1.424 -1.775 0 C-N-CA 125.652 1.581 . . . . 0.0 109.718 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.327 24.0 p 92.81 1.64 0.09 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 129.85 3.26 . . . . 0.0 114.363 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -147.28 -25.98 0.39 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-N 119.527 1.058 . . . . 0.0 111.408 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.55 168.01 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 125.678 1.591 . . . . 0.0 111.692 -162.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.61 -134.54 47.39 Favored Glycine 0 C--N 1.367 2.266 0 O-C-N 119.757 -1.839 . . . . 0.0 109.142 -163.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 44.6 t 54.49 80.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 126.314 1.846 . . . . 0.0 111.008 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.28 114.2 26.67 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -103.97 -38.22 7.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 113.298 -1.774 . . . . 0.0 108.757 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.55 87.01 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.615 -3.105 . . . . 0.0 102.615 166.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.4 130.48 42.19 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.0 t -142.43 115.77 8.99 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.038 1.335 . . . . 0.0 107.813 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.19 84.58 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 103.921 -3.672 . . . . 0.0 103.921 165.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 C-N-CA 125.172 1.367 . . . . 0.0 111.289 174.209 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 62.9 mt -116.95 134.27 54.96 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.62 26.98 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.01 128.83 75.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -138.1 151.51 47.86 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 68.7 m -117.24 -38.04 3.43 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.126 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.35 -53.61 4.27 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.071 0.85 . . . . 0.0 111.947 -168.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.22 177.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.85 1.26 . . . . 0.0 109.858 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.46 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -161.08 95.13 1.41 Allowed Pre-proline 0 C--N 1.358 0.954 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -163.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.88 95.74 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.945 2.43 . . . . 0.0 111.181 161.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 9.5 mp -119.77 139.85 51.67 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -93.92 159.15 15.31 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.841 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.82 122.95 21.61 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 120.058 1.299 . . . . 0.0 108.983 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.1 -11.51 71.94 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.413 1.959 . . . . 0.0 111.681 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -73.44 174.56 8.01 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.321 1.048 . . . . 0.0 109.993 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 94.0 m -143.09 125.06 15.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -158.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.521 HG13 HH11 ' B' ' 914' ' ' ARG . 27.9 m -96.37 150.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 121.567 0.698 . . . . 0.0 110.244 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -140.95 139.02 34.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.518 1.927 . . . . 0.0 111.44 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.2 t -91.63 129.53 42.18 Favored 'Isoleucine or valine' 0 C--N 1.367 1.354 0 C-N-CA 127.261 2.224 . . . . 0.0 106.516 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.79 132.36 52.85 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.59 77.63 1.8 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 50.2 t -160.2 101.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -153.48 66.38 0.76 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.63 145.66 6.52 Favored Glycine 0 CA--C 1.492 -1.383 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -112.87 -30.92 6.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.5 86.76 6.15 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.64 -165.76 1.83 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -123.51 157.84 32.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 16.4 t -91.43 133.22 35.66 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.64 151.66 22.48 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.43 110.78 19.37 Favored Pre-proline 0 C--N 1.353 0.753 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -98.13 173.09 0.58 Allowed 'Trans proline' 0 CA--C 1.507 -0.836 0 C-N-CA 121.812 1.675 . . . . 0.0 108.172 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.51 139.28 50.21 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.8 p -138.02 138.13 38.54 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.5 mm -117.24 130.71 71.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -127.05 106.32 9.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 982' ' ' SER . . . . . 0.442 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 32.7 p -100.63 160.94 13.94 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.494 1.117 . . . . 0.0 109.771 171.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.21 109.55 0.27 Allowed Glycine 0 C--N 1.358 1.781 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.82 149.62 41.77 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.85 124.14 24.19 Favored 'General case' 0 C--N 1.378 1.836 0 C-N-CA 125.841 1.656 . . . . 0.0 109.718 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.33 -59.06 1.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -133.33 127.22 33.07 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 125.916 1.686 . . . . 0.0 106.489 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.81 130.05 10.11 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 104.311 -3.516 . . . . 0.0 104.311 161.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.12 131.27 90.71 Favored Pre-proline 0 C--N 1.351 0.652 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.205 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -105.48 81.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 121.695 1.641 . . . . 0.0 109.054 -170.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.31 -72.23 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 130.191 3.396 . . . . 0.0 109.139 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 80.1 mt 49.95 40.89 22.09 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 129.126 2.97 . . . . 0.0 113.785 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.96 133.54 55.41 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -133.34 107.78 8.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.13 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.767 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.76 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.51 114.92 29.99 Favored Pre-proline 0 N--CA 1.44 -0.943 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.24 -24.97 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 121.689 1.639 . . . . 0.0 109.826 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 41.55 66.5 0.68 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 128.192 2.597 . . . . 0.0 114.868 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.86 133.74 66.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.01 50.85 Favored 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 166.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.83 139.55 21.73 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 118.886 0.766 . . . . 0.0 109.82 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 22.7 t -169.44 120.2 0.69 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.25 -0.906 . . . . 0.0 108.8 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.51 153.05 34.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.08 158.08 44.82 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 121.685 0.755 . . . . 0.0 110.493 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -139.89 130.55 25.79 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -164.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 60.1 m -159.02 15.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.0 pp -25.8 142.79 0.04 OUTLIER Pre-proline 0 C--N 1.372 1.546 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 161.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.84 -44.05 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 CA-C-N 122.222 1.829 . . . . 0.0 113.529 -161.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -162.47 175.72 11.2 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 13.1 m -4.63 113.06 0.01 OUTLIER 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.673 3.589 . . . . 0.0 116.774 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 160.91 24.37 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.4 -17.75 7.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.418 2.079 . . . . 0.0 110.533 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -141.29 3.12 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 11.8 m -65.53 143.31 57.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.029 1.732 . . . . 0.0 110.061 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.75 132.65 25.71 Favored Pre-proline 0 N--CA 1.437 -1.098 0 C-N-CA 124.37 1.068 . . . . 0.0 110.447 -159.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.37 -151.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 124.135 3.223 . . . . 0.0 109.334 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -147.1 136.12 22.37 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -114.76 -17.78 11.52 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.669 0.788 . . . . 0.0 110.9 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -102.48 84.43 2.44 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.166 0.508 . . . . 0.0 111.125 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.68 98.22 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 126.699 1.999 . . . . 0.0 106.868 167.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 8.8 mt -85.81 -39.43 17.09 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.967 -173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.9 tp -166.96 128.98 1.7 Allowed 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 100.598 -3.853 . . . . 0.0 100.598 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 178.71 61.91 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 108.333 -164.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.1 -44.42 94.84 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.26 -29.67 11.02 Favored Glycine 0 C--N 1.356 1.661 0 CA-C-N 118.716 0.689 . . . . 0.0 112.165 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.17 -57.76 0.42 Allowed Glycine 0 C--N 1.353 1.521 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 62.91 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.245 2.618 . . . . 0.0 113.982 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -97.53 120.64 38.28 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 125.861 1.665 . . . . 0.0 108.677 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.97 117.87 69.93 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -93.36 5.96 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 124.91 2.789 . . . . 0.0 109.887 -167.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 -46.07 17.8 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -105.67 -13.14 15.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.877 1.271 . . . . 0.0 108.327 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.98 43.63 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 162.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 70.0 t -99.53 104.22 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 102.05 -3.315 . . . . 0.0 102.05 -164.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -98.53 112.37 24.43 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 111.921 -2.4 . . . . 0.0 109.233 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 90.7 m -100.32 109.24 21.43 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.82 108.86 30.7 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.262 -1.352 . . . . 0.0 110.968 171.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -90.11 -3.86 5.28 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.528 2.152 . . . . 0.0 108.43 166.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 68.4 mt -54.51 -52.29 62.44 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 127.736 2.414 . . . . 0.0 114.418 -165.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.58 68.15 0.82 Allowed 'General case' 0 C--N 1.367 1.328 0 CA-C-O 122.076 0.941 . . . . 0.0 111.61 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.88 -167.55 34.95 Favored Glycine 0 N--CA 1.405 -3.433 1 N-CA-C 102.498 -4.241 . . . . 0.0 102.498 -171.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 70.4 ttt-85 -92.03 121.21 33.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.275 -1.463 . . . . 0.0 108.643 172.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.537 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -117.78 145.61 44.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 51.6 tp -110.14 113.84 26.86 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . 0.416 HD12 ' HH ' ' C' ' 894' ' ' TYR . 8.8 tt -112.0 137.61 49.77 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.318 1.447 . . . . 0.0 108.925 -175.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.8 m -144.29 119.27 10.0 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.398 0.679 . . . . 0.0 109.919 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.15 153.74 22.73 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 91.1 t -101.7 122.64 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.59 121.87 40.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.026 0.93 . . . . 0.0 109.355 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.9 130.56 35.39 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -54.82 -56.84 20.71 Favored Glycine 0 C--N 1.366 2.247 0 C-N-CA 125.356 1.455 . . . . 0.0 113.354 -172.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 42.3 65.67 0.86 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.633 2.373 . . . . 0.0 114.181 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.39 -7.24 50.83 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 125.076 1.35 . . . . 0.0 112.178 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -71.38 -14.09 62.06 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.235 1.814 . . . . 0.0 112.187 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.338 6.1 pt-20 113.73 179.53 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.108 2.563 . . . . 0.0 108.051 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 109.42 137.46 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 128.56 2.744 . . . . 0.0 105.856 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 97.8 t -98.4 123.64 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -103.67 131.68 50.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.361 172.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.05 114.22 3.64 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.095 1.358 . . . . 0.0 110.519 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.27 117.74 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 125.867 1.667 . . . . 0.0 108.999 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.6 mt -62.53 143.5 57.12 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.74 1.616 . . . . 0.0 110.519 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 1.4 p -113.78 147.79 37.68 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.627 1.971 . . . . 0.0 107.795 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 137.35 37.73 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.891 173.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 2.9 t 97.93 -11.48 0.06 Allowed 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 128.797 2.839 . . . . 0.0 112.341 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.86 -27.63 0.58 Allowed 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 119.256 0.934 . . . . 0.0 111.501 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 59.04 169.09 0.06 Allowed 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.933 1.293 . . . . 0.0 112.254 -164.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.84 -130.74 51.46 Favored Glycine 0 C--N 1.376 2.79 0 O-C-N 119.702 -1.874 . . . . 0.0 110.12 -164.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 51.97 73.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.329 0 C-N-CA 126.191 1.797 . . . . 0.0 111.37 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.82 28.37 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -101.18 -30.89 11.3 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.518 -173.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.18 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 165.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -95.22 131.23 41.51 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 120.903 0.382 . . . . 0.0 111.184 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.2 t -143.88 115.07 7.93 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 125.283 1.433 . . . . 0.0 107.812 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.17 85.02 0.72 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 104.281 -3.528 . . . . 0.0 104.281 169.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.602 0 C-N-CA 125.183 1.373 . . . . 0.0 110.892 173.557 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.6 mt -122.46 134.56 54.58 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.93 163.31 27.0 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.76 132.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.46 149.81 47.12 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -121.33 -36.99 2.98 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 118.398 0.544 . . . . 0.0 111.802 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.442 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 29.0 tp -89.47 -53.77 4.39 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.533 0.606 . . . . 0.0 112.045 -165.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 25.4 pt -89.83 -162.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.846 0 C-N-CA 125.079 1.352 . . . . 0.0 108.871 -178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.537 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -165.26 88.15 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -166.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.94 88.18 1.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 122.422 1.901 . . . . 0.0 109.133 159.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.8 146.18 48.53 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.479 2.312 . . . . 0.0 105.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -92.71 159.98 15.18 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 119.213 0.915 . . . . 0.0 109.381 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.72 122.66 21.86 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 120.335 1.425 . . . . 0.0 108.954 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.75 71.34 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 125.95 1.738 . . . . 0.0 111.042 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.99 175.44 5.14 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.088 0.555 . . . . 0.0 111.075 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 17.1 p -141.83 127.96 19.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -157.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 17.1 m -93.41 150.19 4.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.8 t -139.72 136.5 34.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.882 1.273 . . . . 0.0 112.089 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.95 129.08 44.8 Favored 'Isoleucine or valine' 0 C--N 1.373 1.603 0 C-N-CA 126.486 1.914 . . . . 0.0 106.753 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.61 132.37 53.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 171.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.41 78.52 1.83 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.04 -1.891 . . . . 0.0 106.185 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -160.8 100.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.887 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 89.3 mmm -152.16 66.23 0.84 Allowed 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.79 143.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -112.8 -22.37 10.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.462 0.705 . . . . 0.0 109.982 -172.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 6.5 tt -98.6 86.23 3.53 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.74 -164.62 1.64 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -121.66 153.18 38.48 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 20.1 t -89.96 132.2 35.46 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -157.93 151.28 23.36 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.45 115.34 19.74 Favored Pre-proline 0 C--N 1.355 0.823 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.32 171.67 0.38 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.98 138.87 49.2 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.9 p -137.33 137.55 39.04 Favored 'General case' 0 C--N 1.376 1.746 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.0 mm -115.43 131.04 68.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.26 106.38 9.83 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 982' ' ' SER . . . . . 0.467 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 32.7 p -100.91 163.94 12.06 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.16 1.384 . . . . 0.0 110.222 172.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.91 111.19 0.32 Allowed Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.08 47.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 58.0 tp -78.18 124.42 28.05 Favored 'General case' 0 C--N 1.379 1.88 0 C-N-CA 124.516 1.126 . . . . 0.0 108.135 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 35.1 tp -97.1 -57.2 2.33 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.056 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -131.18 128.49 40.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 -174.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 131.05 10.51 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 103.412 -3.875 . . . . 0.0 103.412 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.41 131.93 88.03 Favored Pre-proline 0 C--N 1.351 0.645 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -105.84 81.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.427 0 CA-C-N 121.903 1.715 . . . . 0.0 109.847 -171.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 78.79 -72.12 0.09 Allowed 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 130.231 3.413 . . . . 0.0 109.171 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.7 mt 51.19 39.88 24.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 129.209 3.004 . . . . 0.0 113.787 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -112.62 133.49 54.64 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.86 107.86 8.59 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.453 -0.9 0 N-CA-C 110.232 -0.719 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 43.8 t -127.85 120.87 21.76 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.12 -22.23 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 122.032 1.762 . . . . 0.0 109.496 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 36.81 69.9 0.19 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.045 2.938 . . . . 0.0 115.607 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.63 136.21 56.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 160.63 37.71 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -149.23 139.76 22.51 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.6 t -169.27 116.56 0.61 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.61 153.02 36.11 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.02 158.54 44.22 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.21 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -134.81 134.72 41.14 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -167.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 40.6 p -164.25 10.1 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -163.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 2.1 pp -28.62 144.76 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.51 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 160.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -79.07 -47.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 122.324 1.866 . . . . 0.0 112.875 -162.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -162.2 170.55 18.86 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.6 m 4.03 104.05 0.0 OUTLIER 'General case' 0 C--N 1.36 1.058 0 C-N-CA 130.848 3.659 . . . . 0.0 117.463 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -96.46 163.57 20.25 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 123.174 0.59 . . . . 0.0 110.25 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.54 -14.61 12.8 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.662 2.241 . . . . 0.0 110.768 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -168.25 -142.5 3.51 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -63.83 144.46 57.03 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.714 2.006 . . . . 0.0 110.864 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 55.2 t -95.12 131.51 29.92 Favored Pre-proline 0 N--CA 1.439 -0.989 0 C-N-CA 124.841 1.256 . . . . 0.0 110.705 -162.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -95.84 -148.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.199 3.266 . . . . 0.0 108.464 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -149.65 136.86 19.79 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 41.6 p-10 -117.24 -15.61 10.41 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.909 0.484 . . . . 0.0 111.98 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -100.78 86.73 3.15 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 118.665 0.666 . . . . 0.0 112.723 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 874' ' ' ASN . 62.1 t -70.56 97.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.059 1.743 . . . . 0.0 107.123 167.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 48.0 mt -87.92 -36.46 17.12 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.969 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.6 tp -165.16 126.87 2.07 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 160.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.422 ' HB3' HG13 ' A' ' 871' ' ' VAL . 35.3 t-20 -174.88 61.86 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 120.528 1.513 . . . . 0.0 109.387 -168.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.8 -44.43 86.31 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -164.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.22 -30.6 8.61 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.946 0.793 . . . . 0.0 112.38 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.29 -60.76 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.86 -79.18 0.03 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.084 2.554 . . . . 0.0 114.111 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -95.8 120.1 35.48 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.154 1.382 . . . . 0.0 108.296 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.68 116.41 62.9 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -94.59 5.05 2.56 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 CA-C-N 125.204 2.894 . . . . 0.0 108.961 -165.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -79.82 -46.13 17.48 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 27.3 p -106.11 -12.15 15.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.902 172.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.34 25.88 41.91 Favored Glycine 0 C--N 1.362 2.015 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 163.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 44.9 t -101.36 102.83 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 100.481 -3.896 . . . . 0.0 100.481 -163.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 114.48 27.55 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 110.924 -2.853 . . . . 0.0 108.941 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 81.5 m -99.1 109.8 22.47 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.75 110.02 36.52 Favored Pre-proline 0 C--N 1.356 0.851 0 C-N-CA 125.591 1.556 . . . . 0.0 112.875 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -98.29 -8.38 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 CA-C-N 123.195 2.177 . . . . 0.0 108.653 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 26.3 mt -44.51 -58.99 2.66 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 129.963 3.305 . . . . 0.0 114.546 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.09 64.12 1.59 Allowed 'General case' 0 C--N 1.364 1.214 0 CA-C-O 121.839 0.828 . . . . 0.0 111.912 172.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.66 -174.35 39.84 Favored Glycine 0 N--CA 1.409 -3.113 1 N-CA-C 101.364 -4.694 . . . . 0.0 101.364 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -93.34 121.84 35.14 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.253 2.6 p90 -114.04 159.92 19.45 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-N 119.0 0.818 . . . . 0.0 108.936 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.82 117.8 34.95 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.759 0.824 . . . . 0.0 110.061 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.4 tt -111.17 136.54 50.09 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 126.659 1.984 . . . . 0.0 108.997 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 73.1 m -147.01 118.93 8.13 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 153.84 22.05 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.4 t -109.44 118.86 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.28 124.87 44.72 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.41 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 39.5 m -81.38 131.68 35.3 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 125.251 1.42 . . . . 0.0 107.337 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.88 -57.44 19.87 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.161 1.363 . . . . 0.0 114.066 -169.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 66.5 m170 38.15 73.01 0.11 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.13 2.172 . . . . 0.0 115.153 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -71.16 -12.84 61.71 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.784 1.634 . . . . 0.0 111.719 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -73.55 -19.99 60.75 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.299 1.439 . . . . 0.0 112.375 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.324 13.2 pt-20 125.98 -178.21 0.0 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 127.458 2.303 . . . . 0.0 108.261 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 100.72 131.19 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.074 2.549 . . . . 0.0 106.799 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.38 126.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -108.25 123.37 48.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.16 172.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.47 116.92 15.68 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 128.996 2.918 . . . . 0.0 109.892 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 99.4 t -87.91 113.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.0 141.6 57.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 126.142 1.777 . . . . 0.0 110.563 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.4 t -116.98 145.87 43.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 125.218 1.407 . . . . 0.0 111.734 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.451 ' HG3' ' HB3' ' A' ' 960' ' ' ASP . 0.0 OUTLIER -79.68 142.71 35.27 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 129.19 2.996 . . . . 0.0 111.052 -175.505 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 83.86 12.28 0.38 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 128.714 2.806 . . . . 0.0 112.336 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -151.79 -26.72 0.19 Allowed 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.281 -0.887 . . . . 0.0 110.628 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 57.9 167.05 0.04 OUTLIER 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.753 1.621 . . . . 0.0 112.174 -163.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.65 -134.03 49.78 Favored Glycine 0 C--N 1.372 2.556 0 O-C-N 119.217 -2.177 . . . . 0.0 109.742 -161.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 52.8 t 57.79 75.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.313 0 C-N-CA 125.79 1.636 . . . . 0.0 110.651 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.49 114.31 26.83 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -102.33 -35.17 8.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.448 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.6 83.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.728 -3.064 . . . . 0.0 102.728 167.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.59 129.36 43.99 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 121.201 0.524 . . . . 0.0 109.763 -171.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 29.7 t -143.27 115.92 8.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.506 1.523 . . . . 0.0 107.906 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.83 84.68 0.73 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 103.632 -3.787 . . . . 0.0 103.632 163.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.689 0 C-N-CA 126.24 1.876 . . . . 0.0 111.524 172.71 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.49 133.33 55.95 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.64 163.23 25.83 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -172.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 14.5 m -124.62 131.07 73.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -136.86 142.53 42.82 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.2 m -116.72 -44.49 2.83 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 33.2 tp -87.48 -53.65 4.7 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-N 119.442 1.019 . . . . 0.0 111.739 -168.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.43 HG12 ' HG ' ' C' ' 853' ' ' SER . 11.2 pt -83.73 -176.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 124.262 1.025 . . . . 0.0 108.313 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.46 83.0 2.67 Favored Pre-proline 0 N--CA 1.433 -1.284 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -163.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.82 91.95 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.535 2.156 . . . . 0.0 109.697 167.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 8.9 mp -121.78 145.89 47.6 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 126.558 1.943 . . . . 0.0 106.566 -175.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -95.88 157.91 15.68 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.898 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.55 124.73 24.94 Favored 'General case' 0 C--N 1.375 1.705 0 CA-C-N 119.702 1.137 . . . . 0.0 109.222 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.21 69.55 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 126.306 1.908 . . . . 0.0 112.128 171.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . 0.451 ' HB3' ' HG3' ' A' ' 914' ' ' ARG . 0.9 OUTLIER -72.49 171.96 11.37 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.839 0.819 . . . . 0.0 112.116 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 85.4 m -142.28 127.81 19.02 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -157.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . . . . . . . . . 20.2 m -94.83 149.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-O 121.314 0.578 . . . . 0.0 110.114 174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.4 m -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 60.9 t -94.07 130.03 43.56 Favored 'Isoleucine or valine' 0 C--N 1.371 1.51 0 C-N-CA 126.623 1.969 . . . . 0.0 106.868 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -106.02 132.84 51.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 73.26 1.47 Allowed 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -163.9 103.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 86.8 mmm -153.27 74.17 1.01 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.75 151.34 9.0 Favored Glycine 0 CA--C 1.495 -1.213 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 123.726 0.811 . . . . 0.0 108.855 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.92 87.34 6.18 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.71 -166.44 1.95 Allowed 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -125.24 160.39 29.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.0 t -92.53 132.08 37.13 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.64 150.2 22.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 113.33 24.31 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -98.35 173.33 0.54 Allowed 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 121.985 1.79 . . . . 0.0 108.447 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.57 140.75 49.21 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -139.86 141.75 36.62 Favored 'General case' 0 C--N 1.375 1.68 0 CA-C-N 119.538 1.063 . . . . 0.0 108.747 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.61 129.35 75.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -125.38 105.43 9.07 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 46.0 p -101.06 161.01 13.9 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.562 1.145 . . . . 0.0 110.281 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.46 0.28 Allowed Glycine 0 C--N 1.356 1.644 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.59 144.32 47.17 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -173.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.9 124.28 26.61 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 124.906 1.282 . . . . 0.0 109.789 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.1 -57.39 2.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.36 128.01 38.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.095 1.758 . . . . 0.0 106.537 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.7 130.73 10.44 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 103.545 -3.822 . . . . 0.0 103.545 163.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.59 130.95 90.08 Favored Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.406 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -107.06 80.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 121.984 1.744 . . . . 0.0 110.293 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 77.14 -72.87 0.09 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 130.602 3.561 . . . . 0.0 109.405 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.5 mt 49.74 40.07 19.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.523 3.129 . . . . 0.0 113.94 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -110.88 130.0 55.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -128.06 109.86 11.94 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.072 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.172 -0.741 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.33 121.41 22.52 Favored Pre-proline 0 C--N 1.354 0.762 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -92.69 -22.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 122.064 1.773 . . . . 0.0 109.879 -174.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 38.78 69.58 0.26 Allowed 'General case' 0 C--N 1.36 1.039 0 C-N-CA 129.189 2.996 . . . . 0.0 115.204 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.86 136.24 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.58 160.39 38.21 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -149.41 139.94 22.5 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.3 t -169.31 117.32 0.63 Allowed 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.09 153.82 34.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.47 157.72 45.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.808 176.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -133.09 133.39 42.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -168.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 29.7 p -163.95 8.1 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -163.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 2.0 pp -28.74 144.91 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.513 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 160.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.43 -47.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 122.242 1.836 . . . . 0.0 112.877 -163.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -162.18 170.4 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.4 m 4.06 104.3 0.0 OUTLIER 'General case' 0 C--N 1.36 1.05 0 C-N-CA 130.877 3.671 . . . . 0.0 117.563 169.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -97.07 163.65 19.54 Favored Pre-proline 0 C--N 1.353 0.731 0 C-N-CA 123.229 0.612 . . . . 0.0 110.412 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.65 -14.83 12.54 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.645 2.23 . . . . 0.0 110.94 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.92 -142.41 3.47 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.2 m -63.63 143.95 57.41 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.611 1.964 . . . . 0.0 110.703 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.45 130.99 32.01 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 124.734 1.214 . . . . 0.0 110.463 -162.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -97.03 -148.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 124.047 3.164 . . . . 0.0 108.212 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.41 136.84 20.07 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -115.17 -13.96 11.76 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.397 1.079 . . . . 0.0 110.567 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.31 87.11 3.14 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . 0.44 HG13 ' HB3' ' B' ' 874' ' ' ASN . 58.7 t -70.58 97.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 18.3 mt -87.58 -38.67 15.76 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.083 -172.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 56.6 tp -165.11 127.08 2.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 100.749 -3.797 . . . . 0.0 100.749 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . 0.44 ' HB3' HG13 ' B' ' 871' ' ' VAL . 33.3 t-20 177.25 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 120.265 1.393 . . . . 0.0 108.648 -163.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -58.18 -43.66 87.6 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -166.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.15 -31.4 8.5 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 118.931 0.787 . . . . 0.0 112.479 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.22 -58.69 0.38 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 65.26 -80.36 0.03 OUTLIER 'General case' 0 C--N 1.355 0.831 0 C-N-CA 128.044 2.538 . . . . 0.0 114.406 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -97.1 119.88 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.335 1.454 . . . . 0.0 108.538 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.55 116.99 65.74 Favored Pre-proline 0 CA--C 1.503 -0.854 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -93.46 5.65 2.94 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.19 2.889 . . . . 0.0 108.986 -166.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -79.79 -44.94 19.71 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.407 1.083 . . . . 0.0 108.6 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 25.4 p -108.99 -12.48 14.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.909 1.284 . . . . 0.0 108.363 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.86 25.86 39.92 Favored Glycine 0 C--N 1.361 1.931 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 163.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 54.8 t -100.82 102.81 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 101.089 -3.671 . . . . 0.0 101.089 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.59 114.82 26.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 111.468 -2.605 . . . . 0.0 108.459 -174.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.0 m -99.17 109.78 22.42 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.15 110.45 38.39 Favored Pre-proline 0 C--N 1.357 0.922 0 C-N-CA 125.477 1.511 . . . . 0.0 113.307 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -99.42 -7.28 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 123.321 2.222 . . . . 0.0 108.931 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 16.0 mt -50.42 -51.95 41.92 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 128.618 2.767 . . . . 0.0 114.339 -168.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.8 49.09 14.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.214 1.406 . . . . 0.0 113.815 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -162.74 -166.68 21.94 Favored Glycine 0 N--CA 1.412 -2.943 1 N-CA-C 101.894 -4.482 . . . . 0.0 101.894 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -92.64 120.94 33.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 1.9 p90 -116.19 160.05 20.95 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-N 118.965 0.802 . . . . 0.0 108.841 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 54.6 tp -105.56 116.37 31.84 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.06 135.64 50.57 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 126.193 1.797 . . . . 0.0 107.827 -166.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 72.9 m -145.26 119.22 9.34 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.9 153.9 21.84 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.06 120.84 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.86 122.89 46.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.275 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.1 m -79.77 131.49 35.93 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.264 1.425 . . . . 0.0 107.936 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.73 -57.45 19.76 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.322 1.439 . . . . 0.0 114.25 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 66.4 m170 37.72 73.46 0.1 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 127.178 2.191 . . . . 0.0 115.093 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -71.48 -12.69 61.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.93 1.692 . . . . 0.0 111.544 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -74.62 -15.62 60.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.664 1.586 . . . . 0.0 112.628 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.0 pt-20 120.57 178.62 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 C-N-CA 127.911 2.485 . . . . 0.0 108.485 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 102.06 131.45 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 128.268 2.627 . . . . 0.0 106.581 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.92 131.57 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -112.02 123.42 50.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.18 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.23 115.04 13.69 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 128.426 2.69 . . . . 0.0 109.878 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.05 113.31 25.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.87 147.23 47.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.868 2.067 . . . . 0.0 111.294 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 1.9 t -117.03 147.3 42.46 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.454 1.502 . . . . 0.0 111.414 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.56 141.45 35.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 128.914 2.886 . . . . 0.0 110.004 -179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 82.97 9.68 0.62 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.31 2.644 . . . . 0.0 112.82 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -150.17 -26.23 0.25 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.81 168.02 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.476 1.51 . . . . 0.0 112.077 -163.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.29 -133.08 48.42 Favored Glycine 0 C--N 1.366 2.213 0 O-C-N 119.5 -2.0 . . . . 0.0 109.775 -164.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 60.9 t 56.04 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.215 0 C-N-CA 126.23 1.812 . . . . 0.0 111.189 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.6 114.79 27.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -103.15 -35.44 8.48 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.484 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.17 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.04 128.76 44.77 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 33.3 t -141.48 117.43 10.52 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 171.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.82 84.8 0.74 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 165.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.709 0 C-N-CA 125.356 1.455 . . . . 0.0 111.273 175.18 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.4 m . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 59.2 mt -115.3 134.29 55.25 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -168.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.55 163.94 25.73 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 124.999 1.285 . . . . 0.0 109.95 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.97 131.51 72.8 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -137.33 146.52 44.69 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 50.5 m -128.23 -27.37 2.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.364 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 33.8 tp -92.54 -55.55 3.35 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 120.071 1.305 . . . . 0.0 111.425 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.78 -177.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 C-N-CA 125.162 1.385 . . . . 0.0 108.31 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.03 82.94 2.81 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.07 93.63 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.717 2.278 . . . . 0.0 110.223 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 10.5 mp -121.39 145.34 48.01 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 125.824 1.65 . . . . 0.0 107.106 -177.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -95.09 158.19 15.57 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.241 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.88 124.42 24.81 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 119.844 1.202 . . . . 0.0 108.713 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.81 71.04 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 125.997 1.76 . . . . 0.0 111.994 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.73 170.62 14.19 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 117.957 0.878 . . . . 0.0 110.999 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 90.0 m -143.05 127.95 18.36 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.507 -155.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . . . . . . . . . 16.5 m -96.03 150.31 4.36 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-O 121.172 0.51 . . . . 0.0 111.626 175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.7 m -141.05 137.75 33.13 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 126.794 2.038 . . . . 0.0 111.338 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.59 131.05 41.63 Favored 'Isoleucine or valine' 0 C--N 1.368 1.39 0 C-N-CA 127.947 2.499 . . . . 0.0 107.43 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -105.89 132.97 51.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 100.677 -3.823 . . . . 0.0 100.677 171.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.72 72.5 1.4 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 56.8 t -161.83 104.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.3 mmm -152.28 72.68 1.0 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 173.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.26 150.06 8.44 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -115.64 -29.38 6.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 38.3 tp -93.01 86.78 5.53 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.42 -165.95 1.85 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -125.24 159.51 31.46 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.5 t -90.97 131.93 36.28 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.87 150.33 22.5 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.94 113.1 24.43 Favored Pre-proline 0 C--N 1.356 0.889 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -97.86 172.64 0.64 Allowed 'Trans proline' 0 CA--C 1.508 -0.801 0 C-N-CA 121.93 1.754 . . . . 0.0 108.297 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.54 139.18 50.77 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.8 p -139.02 140.56 38.18 Favored 'General case' 0 C--N 1.374 1.65 0 CA-C-N 119.51 1.05 . . . . 0.0 108.499 -170.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.93 130.79 72.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -126.64 105.15 8.5 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 33.3 p -101.72 162.23 13.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.768 1.227 . . . . 0.0 110.494 170.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.14 112.09 0.32 Allowed Glycine 0 C--N 1.357 1.71 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.68 145.32 46.6 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.3 tp -73.14 124.09 24.89 Favored 'General case' 0 C--N 1.379 1.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.423 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.84 -57.52 2.21 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -131.42 127.62 37.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -173.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.81 130.61 10.39 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 103.32 -3.912 . . . . 0.0 103.32 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.11 130.64 89.49 Favored Pre-proline 0 C--N 1.351 0.66 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.569 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -106.26 81.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 122.008 1.753 . . . . 0.0 109.784 -168.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 77.3 -72.38 0.1 Allowed 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 130.311 3.444 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 75.2 mt 49.06 43.33 22.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.326 3.05 . . . . 0.0 113.569 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.52 129.6 56.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -129.0 109.41 11.2 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 N-CA-C 110.328 -0.682 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 31.1 t -122.09 114.73 30.64 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -87.95 -23.65 1.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 CA-C-N 121.649 1.624 . . . . 0.0 110.074 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 37.93 67.95 0.35 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 129.11 2.964 . . . . 0.0 115.755 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.8 136.91 58.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.09 156.84 48.33 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 165.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -148.13 138.55 22.84 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 118.767 0.712 . . . . 0.0 109.105 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 853' ' ' SER . . . . . 0.43 ' HG ' HG12 ' A' ' 953' ' ' ILE . 14.0 t -170.74 120.03 0.55 Allowed 'General case' 0 C--N 1.36 1.052 0 O-C-N 121.664 -0.648 . . . . 0.0 110.097 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.8 153.3 35.94 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.36 157.67 45.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.96 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -140.8 130.51 24.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -163.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 72.8 m -157.56 17.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.5 pp -22.44 140.13 0.04 OUTLIER Pre-proline 0 C--N 1.374 1.632 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 159.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.31 -44.76 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 122.243 1.837 . . . . 0.0 111.685 -166.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 30.9 ptt85 -163.89 170.91 16.11 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -1.03 108.73 0.01 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 130.564 3.546 . . . . 0.0 117.22 167.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.52 161.59 23.5 Favored Pre-proline 0 N--CA 1.443 -0.797 0 C-N-CA 123.708 0.803 . . . . 0.0 108.922 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.79 -12.62 14.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.848 2.366 . . . . 0.0 110.776 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.25 3.11 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.7 m -65.48 146.25 55.11 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.906 1.682 . . . . 0.0 111.037 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.21 132.63 31.78 Favored Pre-proline 0 N--CA 1.44 -0.963 0 C-N-CA 125.383 1.473 . . . . 0.0 110.281 -164.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -99.52 -148.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 124.164 3.243 . . . . 0.0 108.556 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -147.28 135.46 21.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -116.21 -18.69 10.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.264 0.626 . . . . 0.0 111.405 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -103.57 80.69 1.82 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 122.888 0.475 . . . . 0.0 111.55 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.27 99.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 126.421 1.889 . . . . 0.0 107.189 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.82 -38.32 14.71 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.856 -172.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 36.9 tp -165.3 127.54 2.11 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 176.41 61.92 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 120.234 1.379 . . . . 0.0 107.957 -163.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.84 -42.78 90.09 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -165.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.04 -29.07 13.33 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.844 0.747 . . . . 0.0 112.515 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.31 -57.73 0.49 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 62.66 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.348 2.659 . . . . 0.0 114.891 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -94.13 121.01 35.19 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 125.139 1.376 . . . . 0.0 108.885 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.69 116.92 67.04 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -94.69 7.58 2.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 124.455 2.627 . . . . 0.0 109.332 -169.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -79.34 -46.62 17.3 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 37.5 p -108.02 -10.52 15.46 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.793 1.237 . . . . 0.0 108.411 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 28.0 33.89 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 161.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.84 101.66 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 101.088 -3.671 . . . . 0.0 101.088 -166.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -95.93 112.19 23.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 112.212 -2.267 . . . . 0.0 108.941 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 58.1 m -102.12 109.15 20.78 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.02 110.87 45.15 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.583 170.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.65 1.45 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.569 2.179 . . . . 0.0 108.271 164.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 42.4 mt -53.6 -54.65 34.55 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 128.471 2.709 . . . . 0.0 113.45 -169.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.01 68.43 0.82 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.132 0.968 . . . . 0.0 111.037 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -177.16 174.13 46.79 Favored Glycine 0 N--CA 1.406 -3.348 1 N-CA-C 101.066 -4.813 . . . . 0.0 101.066 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -93.82 117.67 30.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.552 -1.324 . . . . 0.0 107.897 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -115.64 160.12 20.44 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 119.217 0.917 . . . . 0.0 110.159 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.1 tp -108.38 112.78 25.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.4 tt -116.82 140.13 49.8 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.062 1.345 . . . . 0.0 108.861 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 69.0 m -143.42 120.06 11.12 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.461 0.704 . . . . 0.0 109.571 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.26 154.4 19.83 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 95.1 t -100.84 122.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 55.5 mt -94.55 122.52 37.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.584 1.154 . . . . 0.0 109.156 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 12.2 m -81.8 132.55 35.28 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -49.77 -57.01 10.21 Favored Glycine 0 C--N 1.36 1.879 0 C-N-CA 126.159 1.837 . . . . 0.0 115.954 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.3 m80 40.22 69.95 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 127.241 2.216 . . . . 0.0 114.765 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -73.7 -8.86 57.66 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.833 1.253 . . . . 0.0 111.855 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -75.5 -4.9 42.39 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 126.338 1.855 . . . . 0.0 111.543 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.292 47.3 mt-10 96.63 -149.72 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 128.4 2.68 . . . . 0.0 107.804 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 84.12 135.27 0.05 Allowed 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.269 2.227 . . . . 0.0 108.819 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.71 128.22 51.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-O 122.499 1.143 . . . . 0.0 108.025 -171.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -111.08 131.34 55.15 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 127.315 2.246 . . . . 0.0 110.164 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -158.05 113.83 2.75 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.646 1.178 . . . . 0.0 110.716 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.07 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.084 1.754 . . . . 0.0 109.111 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 32.2 mt -62.37 143.32 57.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.261 1.824 . . . . 0.0 111.111 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.265 1.3 p -114.52 148.83 37.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 126.513 1.925 . . . . 0.0 108.598 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.77 137.74 37.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 125.321 1.449 . . . . 0.0 109.431 176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.0 t 90.24 0.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.689 2.796 . . . . 0.0 112.694 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -145.76 -26.52 0.45 Allowed 'General case' 0 C--N 1.36 1.025 0 CA-C-N 119.495 1.043 . . . . 0.0 111.99 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 58.77 169.57 0.06 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 125.167 1.387 . . . . 0.0 111.954 -163.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.08 -127.93 46.09 Favored Glycine 0 C--N 1.374 2.667 0 O-C-N 119.741 -1.849 . . . . 0.0 110.152 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 53.4 t 49.38 72.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 126.601 1.96 . . . . 0.0 111.912 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 116.55 28.94 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -169.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -95.8 -35.7 11.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.067 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 56.3 t -99.38 81.21 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.84 131.42 40.75 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 121.091 0.472 . . . . 0.0 111.136 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -144.09 116.17 8.39 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 125.351 1.46 . . . . 0.0 108.126 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.09 84.77 0.65 Allowed Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.643 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 173.023 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.07 134.56 55.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.0 163.41 26.65 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -117.91 129.57 74.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.91 146.47 50.94 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.328 -0.858 . . . . 0.0 110.23 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.1 m -103.97 -84.06 0.48 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.716 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.32 -46.96 88.11 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.084 1.754 . . . . 0.0 114.627 -163.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.34 -179.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 124.72 1.208 . . . . 0.0 110.141 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.22 82.24 1.51 Allowed Pre-proline 0 C--N 1.355 0.836 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -168.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.92 88.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.278 1.985 . . . . 0.0 110.734 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 11.2 mp -123.59 147.46 47.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -91.33 162.53 14.57 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.358 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.71 122.74 21.15 Favored 'General case' 0 C--N 1.38 1.934 0 CA-C-N 120.954 1.706 . . . . 0.0 108.957 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.87 73.45 Favored Glycine 0 CA--C 1.496 -1.134 0 C-N-CA 125.49 1.519 . . . . 0.0 111.62 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -68.47 176.44 2.87 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.855 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 90.6 m -143.71 127.28 16.99 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.433 1.093 . . . . 0.0 110.922 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.21 147.82 6.42 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 124.802 1.241 . . . . 0.0 108.84 172.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 16.9 t -141.94 137.95 31.63 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.825 1.65 . . . . 0.0 111.737 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 23.8 t -90.89 129.24 42.0 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 C-N-CA 126.233 1.813 . . . . 0.0 106.169 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.68 133.5 49.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.137 -3.653 . . . . 0.0 101.137 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.53 72.64 1.45 Allowed 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.064 -1.88 . . . . 0.0 106.391 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.5 t -160.39 97.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.4 mmm -150.6 78.27 1.31 Allowed 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.98 147.53 14.1 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -113.96 -22.51 10.06 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.435 0.694 . . . . 0.0 110.135 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -98.7 85.62 3.36 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.03 -166.72 1.96 Allowed 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -119.73 150.02 41.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -88.69 130.32 35.34 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -154.95 147.93 24.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.01 115.27 26.27 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -103.73 177.22 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.7 0 C-N-CA 121.553 1.502 . . . . 0.0 108.283 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.48 138.18 51.58 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -137.81 139.95 40.26 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 119.98 1.264 . . . . 0.0 108.192 -171.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.38 131.48 67.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.47 104.92 8.69 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 35.1 p -101.83 162.89 12.57 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.942 1.297 . . . . 0.0 110.225 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.88 112.18 0.35 Allowed Glycine 0 C--N 1.359 1.818 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.28 141.95 47.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 55.8 tp -76.57 124.32 27.43 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.139 1.376 . . . . 0.0 109.439 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 16.2 tp -97.14 -56.57 2.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -131.21 127.24 37.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.51 9.09 Favored Glycine 0 CA--C 1.494 -1.27 0 N-CA-C 103.485 -3.846 . . . . 0.0 103.485 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -69.91 131.17 89.38 Favored Pre-proline 0 C--N 1.354 0.764 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.929 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -106.27 77.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 CA-C-N 122.219 1.828 . . . . 0.0 109.875 -166.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.02 -73.23 0.08 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 130.21 3.404 . . . . 0.0 108.893 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.3 mt 48.93 42.47 20.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 129.171 2.988 . . . . 0.0 113.479 -173.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -113.61 129.64 56.53 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.42 109.61 11.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.452 -0.917 0 N-CA-C 109.998 -0.808 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 118.73 24.16 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.98 -21.61 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.064 1.773 . . . . 0.0 109.875 -172.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 35.9 69.85 0.17 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.032 2.933 . . . . 0.0 115.773 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.63 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.1 155.72 49.77 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 166.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -149.62 138.77 21.27 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.0 t -169.04 117.53 0.66 Allowed 'General case' 0 C--N 1.352 0.702 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.29 152.73 36.21 Favored 'General case' 0 C--N 1.37 1.479 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.48 158.44 44.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.488 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.68 130.88 44.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -167.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.0 p -159.22 16.66 0.17 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -167.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 3.2 pp -21.92 145.55 0.01 OUTLIER Pre-proline 0 C--N 1.368 1.41 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 158.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.36 -48.0 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.927 1.751 . . . . 0.0 112.681 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -163.11 178.52 8.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.3 m -19.43 121.84 0.02 OUTLIER 'General case' 0 C--N 1.363 1.188 0 C-N-CA 129.615 3.166 . . . . 0.0 115.679 172.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -126.63 146.08 55.6 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -163.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -76.86 -10.25 18.24 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 CA-C-N 122.75 2.018 . . . . 0.0 112.937 -161.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.98 -141.12 3.04 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -63.45 145.8 54.89 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.31 1.844 . . . . 0.0 110.48 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 91.9 t -88.93 129.27 48.97 Favored Pre-proline 0 N--CA 1.436 -1.147 0 C-N-CA 125.059 1.344 . . . . 0.0 110.363 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -94.62 -153.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.056 3.171 . . . . 0.0 108.656 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -148.01 132.59 17.76 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -117.59 -11.97 10.38 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 122.707 0.403 . . . . 0.0 111.354 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -99.64 86.68 3.38 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 121.835 -0.541 . . . . 0.0 111.49 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.69 96.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 60.9 mt -87.18 -37.52 17.22 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.634 -173.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.0 tp -166.32 127.04 1.71 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.009 -3.7 . . . . 0.0 101.009 164.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -177.0 61.13 0.01 OUTLIER 'General case' 0 C--N 1.357 0.93 0 CA-C-N 120.756 1.616 . . . . 0.0 109.618 -167.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -61.01 -44.12 97.89 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -165.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.18 -27.77 12.95 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-N 118.927 0.785 . . . . 0.0 112.614 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.25 -61.74 0.3 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 61.74 -81.79 0.02 OUTLIER 'General case' 0 C--N 1.353 0.749 0 C-N-CA 128.067 2.547 . . . . 0.0 114.125 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -94.36 119.23 32.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.358 1.063 . . . . 0.0 108.47 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.03 117.64 69.1 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -94.91 2.36 2.62 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 CA-C-N 125.12 2.864 . . . . 0.0 109.473 -166.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.46 -45.74 17.07 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.5 p -103.69 -13.97 16.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.438 1.095 . . . . 0.0 108.834 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.76 23.5 49.64 Favored Glycine 0 C--N 1.362 2.012 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 162.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.68 103.7 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.583 -3.488 . . . . 0.0 101.583 -164.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.56 111.46 23.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 112.502 -2.135 . . . . 0.0 109.496 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 57.4 m -100.43 107.89 19.74 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.33 110.91 45.94 Favored Pre-proline 0 C--N 1.356 0.87 0 CA-C-O 116.992 -1.48 . . . . 0.0 111.818 171.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.59 2.72 3.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 123.252 2.197 . . . . 0.0 108.91 168.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 40.8 mt -50.39 -53.44 29.26 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 128.03 2.532 . . . . 0.0 114.801 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.14 59.11 3.56 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.43 -166.7 26.95 Favored Glycine 0 N--CA 1.411 -2.978 1 N-CA-C 101.58 -4.608 . . . . 0.0 101.58 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -93.27 119.84 32.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.94 147.21 41.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.9 tp -107.63 114.9 29.19 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -112.68 139.16 48.52 Favored 'General case' 0 C--N 1.361 1.09 0 C-N-CA 126.034 1.733 . . . . 0.0 108.824 -170.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 67.4 m -143.97 118.98 10.01 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 123.422 0.689 . . . . 0.0 109.28 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.28 153.07 23.26 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.12 121.33 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 122.16 42.67 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.529 1.131 . . . . 0.0 108.682 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 10.8 m -80.6 132.35 35.62 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.83 -57.6 13.93 Favored Glycine 0 C--N 1.362 2.027 0 C-N-CA 125.852 1.691 . . . . 0.0 115.36 -167.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 2.4 m80 38.29 72.11 0.14 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 127.568 2.347 . . . . 0.0 114.855 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -72.96 -11.3 60.52 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.915 1.686 . . . . 0.0 111.341 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -72.63 -14.8 61.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.305 1.842 . . . . 0.0 112.215 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.334 7.0 pt-20 116.27 -175.66 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 C-N-CA 127.926 2.491 . . . . 0.0 108.367 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 74.9 tttt 101.59 135.93 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 127.67 2.388 . . . . 0.0 106.461 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.59 125.23 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -106.91 128.53 54.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 110.066 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.3 114.55 4.8 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.114 1.366 . . . . 0.0 109.382 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 97.2 t -88.33 115.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 139.43 58.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.121 1.768 . . . . 0.0 110.152 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.1 t -115.66 146.58 41.71 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.147 1.779 . . . . 0.0 109.339 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.602 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.99 139.26 39.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.315 2.646 . . . . 0.0 110.667 -172.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 95.9 -9.06 0.09 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.339 3.056 . . . . 0.0 112.831 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -138.46 -27.33 0.87 Allowed 'General case' 0 C--N 1.356 0.891 0 CA-C-N 119.448 1.022 . . . . 0.0 111.392 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 60.77 163.56 0.07 Allowed 'General case' 0 C--N 1.361 1.077 0 C-N-CA 125.619 1.567 . . . . 0.0 111.487 -165.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.3 -134.95 48.25 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 119.394 -2.067 . . . . 0.0 109.143 -160.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 58.05 75.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 125.284 1.434 . . . . 0.0 110.515 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.86 114.32 26.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -103.88 -33.05 9.0 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.781 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.76 77.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 166.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.35 130.32 43.49 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.418 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.9 t -144.61 114.77 7.47 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.084 1.353 . . . . 0.0 108.062 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.36 84.9 0.7 Allowed Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 104.731 -3.347 . . . . 0.0 104.731 167.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.631 0 C-N-CA 125.35 1.452 . . . . 0.0 111.212 175.052 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.42 133.76 55.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.25 161.51 25.25 Favored Glycine 0 CA--C 1.493 -1.305 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.96 127.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -138.89 149.43 44.83 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -114.57 -43.05 3.2 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.07 -52.9 5.93 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 119.733 1.151 . . . . 0.0 112.147 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.456 HG12 ' HG ' ' C' ' 853' ' ' SER . 8.3 pt -87.79 -170.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 124.601 1.161 . . . . 0.0 110.172 -174.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 85.18 1.49 Allowed Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -162.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -73.85 92.34 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 122.565 1.952 . . . . 0.0 109.781 160.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.9 142.8 49.35 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -93.89 158.24 15.74 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.092 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.16 123.88 23.18 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 119.192 0.905 . . . . 0.0 108.832 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.95 73.26 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 125.742 1.639 . . . . 0.0 111.238 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.09 175.02 5.55 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.622 0.769 . . . . 0.0 111.677 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 98.6 m -143.06 125.75 15.96 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.602 HG13 HH11 ' A' ' 914' ' ' ARG . 28.0 m -95.26 150.51 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-O 121.593 0.711 . . . . 0.0 109.544 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -142.07 138.83 32.02 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.156 1.783 . . . . 0.0 111.112 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.71 129.43 42.4 Favored 'Isoleucine or valine' 0 C--N 1.369 1.415 0 C-N-CA 126.021 1.729 . . . . 0.0 106.475 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.49 131.37 52.98 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.45 71.22 1.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.4 t -163.1 100.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.31 71.42 0.89 Allowed 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.46 143.48 7.27 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -111.02 -29.76 7.77 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.573 0.749 . . . . 0.0 108.997 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.8 tp -91.7 87.16 6.2 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.68 -164.51 1.62 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -123.93 159.26 30.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.66 133.83 35.61 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -158.91 152.2 22.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 112.39 22.35 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 172.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -98.86 174.09 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.006 1.804 . . . . 0.0 108.461 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.08 139.69 50.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.567 1.147 . . . . 0.0 108.042 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -140.12 141.4 36.12 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.984 1.266 . . . . 0.0 108.566 -170.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 30.6 mm -118.19 130.11 73.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -126.39 105.87 9.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.1 p -99.96 161.35 13.66 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.598 1.159 . . . . 0.0 109.531 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.44 109.01 0.26 Allowed Glycine 0 C--N 1.359 1.852 0 C-N-CA 119.044 -1.551 . . . . 0.0 110.675 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.95 143.41 47.05 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -74.33 124.68 26.93 Favored 'General case' 0 C--N 1.378 1.845 0 C-N-CA 125.263 1.425 . . . . 0.0 109.058 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.97 -57.94 2.06 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -132.27 128.92 38.85 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 131.85 10.82 Favored Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 103.792 -3.723 . . . . 0.0 103.792 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -69.11 129.12 92.33 Favored Pre-proline 0 C--N 1.352 0.674 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.101 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -106.57 80.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 121.873 1.704 . . . . 0.0 109.733 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 77.95 -72.86 0.08 Allowed 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 130.041 3.336 . . . . 0.0 109.2 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.0 mt 49.51 38.66 15.05 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 128.93 2.892 . . . . 0.0 114.295 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.49 132.1 54.48 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.76 107.99 10.11 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.963 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 N-CA-C 109.931 -0.834 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 119.29 24.96 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -90.24 -21.74 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 122.131 1.797 . . . . 0.0 110.085 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 37.25 69.62 0.21 Allowed 'General case' 0 C--N 1.358 0.971 0 C-N-CA 129.114 2.965 . . . . 0.0 115.587 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.6 135.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.11 155.07 50.73 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -149.33 139.61 22.29 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.26 118.25 0.56 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.89 153.1 36.35 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.16 158.4 44.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.093 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.44 129.78 43.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -168.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.5 p -158.85 15.98 0.18 Allowed 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 124.514 1.126 . . . . 0.0 108.119 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.0 pp -21.89 145.64 0.01 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 158.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.54 -48.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.789 1.659 . . . . 0.0 112.684 -169.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.09 178.46 8.26 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.5 m -19.37 121.92 0.02 OUTLIER 'General case' 0 C--N 1.364 1.218 0 C-N-CA 129.634 3.174 . . . . 0.0 115.68 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -126.71 146.17 56.11 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.01 -10.2 18.0 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 122.788 2.031 . . . . 0.0 112.978 -161.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.92 -141.03 3.02 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.3 m -63.39 145.77 54.92 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.19 1.796 . . . . 0.0 110.428 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.65 128.74 51.5 Favored Pre-proline 0 N--CA 1.437 -1.11 0 C-N-CA 125.052 1.341 . . . . 0.0 110.344 -164.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -95.29 -153.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.054 3.169 . . . . 0.0 108.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.44 132.05 17.8 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -115.5 -12.44 11.66 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.841 0.856 . . . . 0.0 110.698 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -100.56 86.42 3.14 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.215 0.531 . . . . 0.0 111.507 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.4 t -70.95 97.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 126.373 1.869 . . . . 0.0 106.29 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 20.3 mt -87.67 -38.56 15.76 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.181 -174.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.0 tp -166.34 127.52 1.76 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.656 -3.831 . . . . 0.0 100.656 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 178.08 61.32 0.01 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.779 1.627 . . . . 0.0 109.286 -164.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.86 -43.77 97.92 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -167.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.93 -28.61 11.72 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 118.976 0.807 . . . . 0.0 112.734 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.29 -61.32 0.3 Allowed Glycine 0 C--N 1.353 1.489 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 62.12 -81.81 0.02 OUTLIER 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.018 2.527 . . . . 0.0 114.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -95.66 119.08 33.53 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 124.55 1.14 . . . . 0.0 108.283 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.7 117.9 70.07 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -93.68 2.6 3.21 Favored 'Trans proline' 0 CA--C 1.509 -0.76 0 CA-C-N 125.11 2.861 . . . . 0.0 109.728 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -80.46 -44.51 19.1 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.9 p -106.19 -13.87 15.3 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.515 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.94 24.79 43.54 Favored Glycine 0 C--N 1.362 2.018 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 162.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.5 t -100.42 103.51 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 101.711 -3.441 . . . . 0.0 101.711 -162.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.15 111.62 23.88 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.573 -175.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 57.3 m -100.73 107.78 19.46 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.5 111.16 47.7 Favored Pre-proline 0 C--N 1.357 0.922 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.88 171.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -93.43 3.3 3.27 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.267 2.202 . . . . 0.0 109.032 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -53.51 -49.6 67.2 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 126.67 1.988 . . . . 0.0 114.611 -169.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.61 48.72 13.73 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.451 1.501 . . . . 0.0 114.587 170.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.61 -165.31 18.24 Favored Glycine 0 N--CA 1.411 -2.972 1 N-CA-C 101.61 -4.596 . . . . 0.0 101.61 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -88.66 119.71 29.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.64 147.71 42.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 48.8 tp -108.7 114.22 27.83 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.57 138.45 49.33 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.965 1.706 . . . . 0.0 108.106 -171.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 73.9 m -143.46 119.13 10.44 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.21 153.33 22.85 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 90.4 t -109.13 122.28 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.13 120.65 41.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 124.557 1.143 . . . . 0.0 108.458 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 10.5 m -79.61 132.85 36.37 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.974 1.31 . . . . 0.0 107.567 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.71 13.26 Favored Glycine 0 C--N 1.364 2.111 0 C-N-CA 125.975 1.75 . . . . 0.0 115.233 -167.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.8 m80 37.96 71.92 0.14 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.558 2.343 . . . . 0.0 114.887 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -72.84 -11.54 60.64 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 126.005 1.722 . . . . 0.0 111.262 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -72.5 -13.64 61.47 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.378 1.871 . . . . 0.0 112.406 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.337 6.9 pt-20 115.69 -176.77 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.267 2.627 . . . . 0.0 108.267 174.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 101.36 135.85 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 127.568 2.347 . . . . 0.0 106.588 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.75 127.29 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -171.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -108.95 128.76 55.21 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.914 1.686 . . . . 0.0 109.969 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.49 114.39 4.7 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.817 1.247 . . . . 0.0 109.649 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.0 t -88.75 115.75 29.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 C-N-CA 125.316 1.446 . . . . 0.0 107.371 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.7 mt -62.27 141.79 58.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.744 2.018 . . . . 0.0 110.021 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.4 t -116.05 147.35 41.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 126.067 1.747 . . . . 0.0 109.506 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.631 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.02 138.81 38.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 127.82 2.448 . . . . 0.0 110.301 -173.299 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 96.35 -12.04 0.08 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 129.385 3.074 . . . . 0.0 112.931 173.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -136.52 -26.91 1.07 Allowed 'General case' 0 C--N 1.357 0.933 0 CA-C-N 119.453 1.024 . . . . 0.0 111.682 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 60.64 163.27 0.06 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.77 1.628 . . . . 0.0 111.317 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.48 -133.52 44.86 Favored Glycine 0 C--N 1.364 2.102 0 O-C-N 119.516 -1.99 . . . . 0.0 108.893 -162.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.3 t 55.86 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.159 0 C-N-CA 125.604 1.562 . . . . 0.0 110.813 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.45 114.72 27.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -104.16 -34.0 8.53 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.788 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 88.4 t -100.92 77.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 166.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -97.97 129.95 44.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.899 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.5 t -143.51 115.53 8.34 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.173 1.389 . . . . 0.0 107.916 169.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.93 84.71 0.73 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 168.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.691 0 C-N-CA 125.435 1.493 . . . . 0.0 111.266 175.614 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 44.3 m . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 65.0 mt -116.4 133.69 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.36 162.97 27.57 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.32 131.08 73.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -138.42 150.23 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.8 m -118.77 -39.78 2.94 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 45.7 tp -82.74 -51.64 7.5 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 119.474 1.034 . . . . 0.0 112.122 -169.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 30.2 pt -84.53 -176.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 125.663 1.585 . . . . 0.0 110.307 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.21 84.9 2.04 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -167.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.25 93.54 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.051 1.834 . . . . 0.0 110.389 163.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.56 142.23 49.54 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -93.16 158.85 15.55 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.953 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.05 123.57 23.1 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 119.46 1.027 . . . . 0.0 108.665 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.97 -10.19 74.98 Favored Glycine 0 C--N 1.344 0.984 0 C-N-CA 125.351 1.453 . . . . 0.0 111.207 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.17 174.65 6.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.869 0.867 . . . . 0.0 110.684 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 97.9 m -143.11 125.93 16.1 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -159.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.631 HG13 HH11 ' B' ' 914' ' ' ARG . 20.7 m -96.39 151.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 121.337 0.589 . . . . 0.0 110.625 172.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.2 138.95 31.85 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.236 1.814 . . . . 0.0 111.194 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.2 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 126.971 2.109 . . . . 0.0 106.892 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -105.7 131.26 53.28 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 100.835 -3.765 . . . . 0.0 100.835 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.25 70.62 1.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 58.5 t -161.52 101.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -152.39 69.61 0.88 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.7 142.9 6.63 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 107.39 -2.284 . . . . 0.0 107.39 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -110.14 -29.36 8.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -92.29 86.92 5.86 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.23 -163.17 1.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -124.62 159.22 31.23 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.02 133.33 35.82 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -159.03 152.27 22.48 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 112.39 22.52 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -98.4 173.7 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.071 1.847 . . . . 0.0 108.384 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.41 138.13 52.02 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.3 p -138.99 140.69 38.27 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.892 1.223 . . . . 0.0 108.393 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 33.6 mm -116.02 130.53 70.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -127.17 106.0 8.95 Favored 'General case' 0 C--N 1.363 1.161 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 982' ' ' SER . . . . . 0.462 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 33.3 p -101.27 162.36 12.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.738 1.215 . . . . 0.0 110.07 171.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 109.83 0.28 Allowed Glycine 0 C--N 1.359 1.825 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.131 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.41 144.17 47.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 67.7 tp -72.16 124.62 25.4 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 124.9 1.28 . . . . 0.0 109.706 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.46 -58.54 1.94 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.29 128.51 37.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.71 129.93 10.09 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 103.72 -3.752 . . . . 0.0 103.72 164.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.86 129.02 92.65 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.292 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -106.74 80.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.595 1.605 . . . . 0.0 109.103 -169.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 78.01 -72.03 0.09 Allowed 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 129.91 3.284 . . . . 0.0 109.222 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.8 mt 48.74 40.26 15.63 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 128.884 2.874 . . . . 0.0 113.936 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.51 132.14 55.24 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.88 107.63 9.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 178.717 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 N--CA 1.453 -0.885 0 N-CA-C 109.982 -0.814 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.17 114.29 27.77 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.23 -22.24 1.39 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.666 1.631 . . . . 0.0 110.296 -172.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 36.59 70.28 0.17 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.862 2.865 . . . . 0.0 115.893 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.47 137.13 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.8 155.98 49.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 164.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -148.44 137.2 21.58 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 853' ' ' SER . . . . . 0.456 ' HG ' HG12 ' A' ' 953' ' ' ILE . 18.2 t -171.67 119.8 0.46 Allowed 'General case' 0 C--N 1.362 1.147 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.629 -176.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.54 153.36 35.51 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.81 158.71 43.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.831 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.14 130.53 29.1 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -166.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 65.1 m -158.28 16.26 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -171.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.5 pp -30.61 149.54 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.453 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 160.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -80.32 -45.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 122.212 1.826 . . . . 0.0 113.929 -161.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -162.11 178.01 9.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -171.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -15.97 125.36 0.01 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 130.39 3.476 . . . . 0.0 116.57 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.98 149.18 42.87 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -160.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.55 -16.26 19.12 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 112.111 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -138.96 2.56 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.4 m -67.47 144.98 55.43 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 109.98 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.93 133.08 28.25 Favored Pre-proline 0 N--CA 1.439 -0.987 0 C-N-CA 124.797 1.239 . . . . 0.0 110.343 -162.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -97.24 -151.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.806 3.004 . . . . 0.0 109.45 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -144.96 132.52 20.88 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -114.24 -16.53 12.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.492 0.717 . . . . 0.0 111.225 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -102.79 82.79 2.16 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.253 0.549 . . . . 0.0 111.241 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.6 97.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.61 1.964 . . . . 0.0 106.707 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.6 -37.34 13.88 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.561 -173.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.4 tp -164.99 126.61 2.09 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 101.165 -3.643 . . . . 0.0 101.165 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 174.03 61.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.139 1.336 . . . . 0.0 107.784 -163.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.28 -42.43 95.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.75 -28.49 18.64 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.802 0.728 . . . . 0.0 112.303 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.88 -58.52 0.47 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 62.53 -81.18 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 128.069 2.547 . . . . 0.0 114.525 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.44 120.1 36.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.332 1.453 . . . . 0.0 108.683 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -85.53 117.31 68.49 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.2 8.03 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 CA-C-N 125.101 2.857 . . . . 0.0 109.643 -169.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.45 -45.4 19.49 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 36.4 p -106.09 -16.45 14.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 125.456 1.502 . . . . 0.0 108.003 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.11 24.54 47.9 Favored Glycine 0 C--N 1.361 1.967 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.6 103.12 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 -166.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.61 111.48 23.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.734 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 52.3 m -102.02 107.89 19.16 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . 0.455 ' HB2' HH22 ' C' ' 914' ' ' ARG . . . -91.83 110.83 46.3 Favored Pre-proline 0 C--N 1.357 0.9 0 CA-C-O 117.262 -1.351 . . . . 0.0 111.777 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -93.06 1.43 3.57 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.557 2.171 . . . . 0.0 108.472 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 50.3 mt -53.68 -54.51 36.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.86 2.464 . . . . 0.0 114.179 -169.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.42 69.14 0.74 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 122.185 0.993 . . . . 0.0 111.166 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.82 173.4 46.23 Favored Glycine 0 N--CA 1.405 -3.379 1 N-CA-C 100.791 -4.924 . . . . 0.0 100.791 -170.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -93.32 115.72 28.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.7 -1.25 . . . . 0.0 107.741 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -117.8 160.57 21.16 Favored 'General case' 0 C--N 1.365 1.264 0 CA-C-N 119.161 0.891 . . . . 0.0 110.845 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.5 tp -108.16 113.99 27.53 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 108.131 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.7 141.68 47.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 124.795 1.238 . . . . 0.0 108.898 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.1 m -143.26 120.66 11.64 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.625 0.77 . . . . 0.0 110.241 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 154.6 20.92 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.71 123.62 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 67.6 mt -99.29 120.09 38.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.264 1.025 . . . . 0.0 109.155 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -84.87 132.78 34.35 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.67 -59.16 11.02 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 125.022 1.296 . . . . 0.0 114.095 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.2 m80 39.91 65.02 0.78 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.126 2.171 . . . . 0.0 113.899 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -71.62 -9.43 58.23 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.24 1.416 . . . . 0.0 112.12 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.07 -17.43 61.42 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.244 1.418 . . . . 0.0 112.649 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.32 9.6 pt-20 126.23 -175.61 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 128.108 2.563 . . . . 0.0 107.909 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 40.0 tttp 101.0 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 127.766 2.426 . . . . 0.0 106.741 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.4 t -99.38 123.17 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -109.3 121.65 45.64 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.366 171.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.43 116.92 17.41 Favored 'General case' 0 C--N 1.372 1.551 0 C-N-CA 128.581 2.752 . . . . 0.0 109.885 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.12 114.39 26.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.62 147.11 46.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.835 2.054 . . . . 0.0 111.688 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.269 1.2 p -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.106 2.162 . . . . 0.0 109.685 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.455 HH22 ' HB2' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.15 138.95 38.97 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.146 1.778 . . . . 0.0 109.283 174.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 5.8 t 98.0 -16.6 0.05 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 129.23 3.012 . . . . 0.0 112.409 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -136.39 -26.88 1.09 Allowed 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.105 0.866 . . . . 0.0 111.574 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 60.01 169.68 0.08 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.141 1.377 . . . . 0.0 111.308 -164.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.25 -130.98 50.31 Favored Glycine 0 C--N 1.374 2.681 0 O-C-N 119.599 -1.938 . . . . 0.0 110.117 -164.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 60.2 t 53.21 77.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.257 0 C-N-CA 125.961 1.704 . . . . 0.0 111.551 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.7 115.0 27.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -171.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -102.54 -35.7 8.65 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.626 -171.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 86.47 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.33 130.28 42.16 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.102 0.477 . . . . 0.0 110.233 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 21.0 t -142.0 115.45 8.99 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.764 1.626 . . . . 0.0 108.28 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.96 85.48 0.63 Allowed Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 104.51 -3.436 . . . . 0.0 104.51 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.723 0 C-N-CA 124.726 1.155 . . . . 0.0 110.947 170.185 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 65.5 mt -122.08 133.62 54.77 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.71 28.08 Favored Glycine 0 CA--C 1.493 -1.289 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -119.07 131.85 70.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -134.2 150.5 51.07 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 121.369 -0.832 . . . . 0.0 108.955 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 48.8 m -117.47 -42.81 2.85 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.462 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 16.8 tp -90.01 -52.62 4.87 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 121.453 -0.779 . . . . 0.0 111.913 -166.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.17 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 126.23 1.812 . . . . 0.0 109.321 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.27 85.93 1.52 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -167.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.12 89.54 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.328 2.019 . . . . 0.0 109.964 164.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.7 145.89 47.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -92.77 161.16 14.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.342 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.53 122.73 20.98 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-N 120.067 1.303 . . . . 0.0 108.877 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.33 -11.19 72.72 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 125.517 1.532 . . . . 0.0 111.377 168.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 175.56 4.04 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.67 0.788 . . . . 0.0 111.608 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.4 m -143.29 126.56 16.6 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.898 0.879 . . . . 0.0 110.412 -160.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.99 148.52 5.46 Favored 'Isoleucine or valine' 0 C--N 1.362 1.129 0 C-N-CA 123.842 0.857 . . . . 0.0 109.191 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.7 t -141.49 139.66 33.35 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 126.079 1.752 . . . . 0.0 111.451 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.44 129.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.369 1.428 0 C-N-CA 126.271 1.828 . . . . 0.0 107.574 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.02 131.53 54.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 168.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.56 77.99 1.78 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.105 -1.862 . . . . 0.0 107.032 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.9 t -159.25 99.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 N-CA-C 104.441 -2.429 . . . . 0.0 104.441 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -150.71 81.07 1.34 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.07 148.64 16.51 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -115.29 -28.56 6.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 109.274 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.4 tp -91.33 87.14 6.35 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.86 -162.56 1.31 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -123.84 157.97 32.91 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.5 133.25 35.66 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.82 150.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.64 112.61 22.75 Favored Pre-proline 0 C--N 1.355 0.817 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -101.45 -178.21 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 121.766 1.644 . . . . 0.0 108.294 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.17 137.32 53.06 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.253 1.021 . . . . 0.0 109.294 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.9 p -138.27 137.26 37.3 Favored 'General case' 0 C--N 1.376 1.719 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.24 131.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -125.14 104.45 8.53 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 30.2 p -102.51 163.72 12.07 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.313 1.445 . . . . 0.0 110.016 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.59 112.29 0.36 Allowed Glycine 0 C--N 1.356 1.679 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.29 143.04 46.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.68 125.18 27.47 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 125.556 1.543 . . . . 0.0 110.054 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 15.5 tp -98.74 -57.35 2.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 122.376 0.27 . . . . 0.0 110.362 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -131.13 128.07 39.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 131.08 10.53 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 104.174 -3.57 . . . . 0.0 104.174 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.28 128.73 91.15 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 117.768 -1.11 . . . . 0.0 111.214 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -106.71 78.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 122.029 1.76 . . . . 0.0 109.667 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 78.61 -72.74 0.08 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.852 3.261 . . . . 0.0 109.083 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.1 mt 49.19 39.46 15.58 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 128.789 2.836 . . . . 0.0 113.828 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.4 132.04 54.74 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.53 107.37 9.42 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.067 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.677 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.455 -0.777 0 N-CA-C 110.031 -0.796 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 45.0 t -126.87 119.55 22.55 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -89.84 -22.21 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.106 1.788 . . . . 0.0 109.797 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 36.92 70.01 0.19 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 129.025 2.93 . . . . 0.0 115.498 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.64 137.23 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.78 160.73 37.28 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 165.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -149.31 140.16 22.79 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.1 t -169.43 116.52 0.6 Allowed 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -122.95 153.18 40.07 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -138.64 157.83 45.38 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.24 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -131.8 130.97 42.49 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -168.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 67.5 m -160.99 8.69 0.08 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -162.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 2.9 pp -28.93 149.4 0.03 OUTLIER Pre-proline 0 C--N 1.367 1.361 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 162.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.48 -45.15 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.966 1.738 . . . . 0.0 113.672 -163.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -162.56 173.98 13.24 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.89 118.84 0.01 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 130.647 3.579 . . . . 0.0 116.759 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.7 164.44 15.19 Favored Pre-proline 0 N--CA 1.442 -0.846 0 C-N-CA 124.279 1.031 . . . . 0.0 110.271 -171.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.71 -15.5 13.53 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.751 2.301 . . . . 0.0 111.337 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.78 -140.59 3.12 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 120.176 1.353 . . . . 0.0 111.189 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.7 m -63.09 145.38 55.59 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.616 2.366 . . . . 0.0 111.454 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.7 127.1 76.4 Favored Pre-proline 0 N--CA 1.441 -0.879 0 C-N-CA 125.308 1.443 . . . . 0.0 111.59 -166.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -98.52 -150.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.429 2.752 . . . . 0.0 107.779 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -149.25 134.3 18.11 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.52 -13.4 10.3 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.029 0.532 . . . . 0.0 110.524 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -100.09 86.79 3.31 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.78 97.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.145 1.778 . . . . 0.0 106.96 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.24 -37.15 16.31 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.376 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 39.8 tp -166.38 128.3 1.83 Allowed 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 162.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -178.34 61.54 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.84 1.655 . . . . 0.0 109.386 -167.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.28 -44.37 92.47 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -165.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.51 -31.27 8.98 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.827 0.739 . . . . 0.0 112.388 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.59 -62.36 0.29 Allowed Glycine 0 C--N 1.353 1.474 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 66.9 -78.19 0.04 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.108 2.563 . . . . 0.0 113.478 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -96.36 120.53 36.82 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.309 1.444 . . . . 0.0 108.792 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.04 117.19 66.25 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -94.24 5.6 2.64 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 CA-C-N 125.43 2.975 . . . . 0.0 108.991 -168.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -80.29 -45.59 17.62 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 -13.36 15.42 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.107 1.363 . . . . 0.0 108.544 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.79 37.96 Favored Glycine 0 C--N 1.364 2.125 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 161.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 23.7 t -101.05 103.94 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 100.419 -3.919 . . . . 0.0 100.419 -163.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.49 112.44 24.98 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.298 -2.228 . . . . 0.0 108.529 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 68.1 m -100.47 108.42 20.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 167.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.41 111.18 45.88 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.85 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -94.35 1.51 2.93 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 CA-C-N 123.107 2.145 . . . . 0.0 109.196 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.49 -49.94 71.21 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.148 2.179 . . . . 0.0 114.076 -168.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 52.63 7.26 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.637 1.175 . . . . 0.0 113.749 169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -166.75 -167.3 27.22 Favored Glycine 0 N--CA 1.414 -2.771 1 N-CA-C 100.496 -5.042 . . . . 0.0 100.496 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.99 121.44 35.47 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.27 3.5 p90 -115.26 161.31 18.65 Favored 'General case' 0 C--N 1.366 1.291 0 CA-C-N 119.099 0.863 . . . . 0.0 109.127 174.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -104.7 116.94 32.9 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.62 0.768 . . . . 0.0 109.538 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -109.45 137.35 47.43 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.806 2.042 . . . . 0.0 109.136 -166.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.5 m -146.37 118.89 8.49 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 123.399 0.68 . . . . 0.0 109.218 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.06 153.55 22.45 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.28 118.86 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.44 123.56 45.7 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.497 -173.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 45.8 m -79.17 131.23 36.14 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.414 1.486 . . . . 0.0 107.512 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.77 -56.47 20.33 Favored Glycine 0 C--N 1.362 2.01 0 C-N-CA 126.064 1.792 . . . . 0.0 114.897 -168.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.3 m170 33.52 74.54 0.06 Allowed 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.964 2.506 . . . . 0.0 115.897 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -72.77 -10.72 60.12 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.437 1.495 . . . . 0.0 111.355 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -73.09 -14.74 61.45 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.369 1.468 . . . . 0.0 112.228 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.363 8.3 pt-20 123.4 -168.68 0.0 OUTLIER 'General case' 0 C--N 1.363 1.155 0 C-N-CA 128.26 2.624 . . . . 0.0 108.166 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 64.9 mttt 98.29 135.54 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 128.258 2.623 . . . . 0.0 107.261 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.24 125.26 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.53 128.79 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 127.121 2.168 . . . . 0.0 109.699 176.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.68 114.64 4.7 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.865 1.266 . . . . 0.0 110.06 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.7 114.68 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.51 141.67 58.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.156 1.782 . . . . 0.0 110.297 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 4.8 t -114.92 146.83 40.73 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 126.202 1.801 . . . . 0.0 109.129 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.627 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.17 138.05 38.49 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.91 2.484 . . . . 0.0 110.022 -174.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.27 -3.85 0.07 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.142 2.977 . . . . 0.0 112.809 172.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -144.25 -25.99 0.53 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 119.56 1.073 . . . . 0.0 111.245 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 58.46 166.71 0.05 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.4 1.48 . . . . 0.0 112.1 -164.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.22 -134.87 48.46 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 119.359 -2.088 . . . . 0.0 109.303 -161.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 43.8 t 57.29 73.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 125.467 1.507 . . . . 0.0 110.277 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.68 113.95 26.35 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -103.13 -35.55 8.45 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.404 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.37 78.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 168.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.32 129.09 44.63 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.5 -173.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.9 t -143.43 114.56 7.84 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.57 84.51 0.75 Allowed Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.168 -3.573 . . . . 0.0 104.168 165.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.836 0 C-N-CA 124.747 1.165 . . . . 0.0 113.786 178.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.0 mt -117.89 133.8 55.57 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -172.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.44 26.99 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.01 129.46 75.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -137.75 147.51 44.78 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.7 m -115.6 -44.89 2.93 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.444 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 44.7 tp -82.27 -49.95 9.5 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 119.237 0.926 . . . . 0.0 113.038 -166.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.96 -171.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 125.955 1.702 . . . . 0.0 109.973 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.92 81.92 2.07 Favored Pre-proline 0 N--CA 1.437 -1.097 0 C-N-CA 123.442 0.697 . . . . 0.0 109.185 -165.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.75 91.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 122.509 1.932 . . . . 0.0 109.644 162.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.42 142.53 49.92 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -94.78 155.03 17.0 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.579 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.64 123.28 21.49 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 119.518 1.054 . . . . 0.0 108.93 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.75 -10.39 74.71 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 125.706 1.622 . . . . 0.0 111.297 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 175.65 5.14 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.575 0.75 . . . . 0.0 111.332 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 88.5 m -142.6 125.34 15.96 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -160.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.627 HG13 HH11 ' A' ' 914' ' ' ARG . 24.4 m -94.82 151.27 3.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 121.666 0.746 . . . . 0.0 109.692 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.05 138.3 31.69 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.446 1.898 . . . . 0.0 111.269 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.43 129.96 42.24 Favored 'Isoleucine or valine' 0 C--N 1.37 1.484 0 C-N-CA 126.589 1.955 . . . . 0.0 106.322 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -105.92 131.95 52.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.03 71.9 1.49 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 59.1 t -162.75 101.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.8 mmm -153.1 70.67 0.88 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.75 147.07 7.52 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -113.31 -30.33 6.95 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.17 87.65 6.62 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.66 -177.14 4.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -166.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -116.99 156.29 27.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -90.67 134.16 34.61 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.76 150.55 21.03 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.25 112.96 21.46 Favored Pre-proline 0 C--N 1.355 0.832 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -99.58 173.82 0.4 Allowed 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 108.586 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.78 140.1 50.16 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -139.94 141.56 36.46 Favored 'General case' 0 C--N 1.375 1.678 0 CA-C-N 119.748 1.158 . . . . 0.0 108.797 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.5 mm -119.67 130.23 74.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -125.63 104.85 8.6 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 54.8 p -101.6 162.03 13.2 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.831 1.253 . . . . 0.0 110.161 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.99 112.28 0.32 Allowed Glycine 0 C--N 1.358 1.769 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.15 144.43 46.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.1 tp -74.25 124.12 25.81 Favored 'General case' 0 C--N 1.379 1.882 0 C-N-CA 124.59 1.156 . . . . 0.0 109.675 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.61 -57.62 2.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -131.72 127.57 37.09 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.43 129.08 9.77 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 103.498 -3.841 . . . . 0.0 103.498 166.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -69.21 129.04 92.26 Favored Pre-proline 0 C--N 1.352 0.681 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.16 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -106.82 80.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 CA-C-N 122.111 1.79 . . . . 0.0 109.873 -168.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 77.98 -72.79 0.08 Allowed 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 130.149 3.379 . . . . 0.0 109.161 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 78.8 mt 49.54 39.16 16.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 129.279 3.032 . . . . 0.0 114.133 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.7 131.79 55.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.56 108.34 10.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.771 0 N-CA-C 110.006 -0.806 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.55 119.75 23.08 Favored Pre-proline 0 C--N 1.354 0.77 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -90.64 -22.24 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 122.136 1.799 . . . . 0.0 109.986 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 37.69 70.45 0.19 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 129.192 2.997 . . . . 0.0 115.196 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.26 137.46 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.64 160.02 39.4 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 165.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -148.83 139.97 23.11 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.4 t -169.28 117.52 0.64 Allowed 'General case' 0 C--N 1.354 0.765 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -124.37 153.9 41.16 Favored 'General case' 0 C--N 1.368 1.403 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.56 157.85 44.59 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.145 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -133.4 128.44 35.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -168.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.2 m -159.84 12.21 0.13 Allowed 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 124.717 1.207 . . . . 0.0 107.747 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 2.9 pp -28.68 149.87 0.03 OUTLIER Pre-proline 0 C--N 1.369 1.422 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 160.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.45 -45.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.046 1.766 . . . . 0.0 113.777 -164.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 33.6 ptt85 -162.52 173.93 13.35 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.81 118.94 0.01 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 130.692 3.597 . . . . 0.0 116.771 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.08 164.44 15.12 Favored Pre-proline 0 N--CA 1.442 -0.87 0 C-N-CA 124.325 1.05 . . . . 0.0 110.294 -171.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.77 -15.54 13.4 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.782 2.321 . . . . 0.0 111.35 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.53 -140.85 3.17 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 120.222 1.374 . . . . 0.0 111.193 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.0 m -62.93 144.62 56.59 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.473 2.309 . . . . 0.0 111.388 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.93 126.36 82.32 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.394 1.477 . . . . 0.0 111.565 -167.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -98.98 -150.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.364 2.709 . . . . 0.0 107.566 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -148.79 133.3 17.66 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -114.97 -13.96 11.89 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.333 1.053 . . . . 0.0 109.508 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.994 0.426 . . . . 0.0 111.312 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.78 97.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 126.39 1.876 . . . . 0.0 106.253 163.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.27 -38.91 14.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.659 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 54.5 tp -166.03 127.38 1.85 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 165.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 177.0 61.39 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.509 1.504 . . . . 0.0 108.524 -163.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.79 -43.75 94.26 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -165.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.11 -31.27 9.26 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 118.759 0.709 . . . . 0.0 112.366 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 110.62 -60.74 0.32 Allowed Glycine 0 C--N 1.353 1.476 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 66.23 -79.08 0.03 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.185 2.594 . . . . 0.0 113.644 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -97.01 120.75 37.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.5 1.52 . . . . 0.0 109.033 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.44 117.44 67.11 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 171.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -93.25 5.91 3.0 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-N 125.485 2.995 . . . . 0.0 109.11 -169.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -80.1 -44.17 20.44 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 108.656 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -109.16 -13.82 14.61 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.374 1.47 . . . . 0.0 108.306 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.11 27.82 32.72 Favored Glycine 0 C--N 1.362 2.027 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 162.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.44 103.58 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 -161.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -99.79 112.45 24.7 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.691 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.5 m -101.16 108.23 19.85 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 167.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.66 111.26 46.74 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 117.06 -1.447 . . . . 0.0 111.959 170.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -93.37 1.4 3.42 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 123.186 2.174 . . . . 0.0 109.183 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 31.0 mt -55.43 -49.5 72.25 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.055 2.142 . . . . 0.0 114.36 -168.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.75 52.08 7.02 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.762 1.225 . . . . 0.0 114.263 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.11 -166.41 26.15 Favored Glycine 0 N--CA 1.413 -2.871 1 N-CA-C 101.12 -4.792 . . . . 0.0 101.12 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -93.2 121.33 34.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.308 2.2 p90 -116.92 161.84 18.71 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 119.218 0.917 . . . . 0.0 109.394 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 59.4 tp -105.18 115.76 30.81 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -108.84 136.74 47.89 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 126.335 1.854 . . . . 0.0 108.194 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -145.24 118.65 9.02 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.14 153.58 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.73 120.12 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 122.82 46.26 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 41.6 m -78.58 131.75 36.87 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 125.383 1.473 . . . . 0.0 107.893 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.63 -56.47 20.05 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 126.136 1.827 . . . . 0.0 114.917 -168.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.6 m170 33.16 74.55 0.06 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.058 2.543 . . . . 0.0 115.818 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -72.73 -10.85 60.27 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.542 1.537 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.02 -13.79 61.29 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.495 1.518 . . . . 0.0 112.326 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.361 8.3 pt-20 122.98 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 C-N-CA 128.623 2.769 . . . . 0.0 108.109 172.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 62.7 mttt 97.71 135.19 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 128.211 2.604 . . . . 0.0 107.499 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.15 126.0 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.57 129.27 55.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.352 1.861 . . . . 0.0 109.819 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.8 114.64 4.66 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.566 1.146 . . . . 0.0 110.315 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 96.3 t -89.18 115.14 28.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 C-N-CA 125.569 1.548 . . . . 0.0 107.814 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.8 143.63 57.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 126.694 1.997 . . . . 0.0 110.303 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -115.32 147.43 40.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.318 1.847 . . . . 0.0 109.275 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.601 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.3 137.89 37.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.548 2.339 . . . . 0.0 109.756 -175.446 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.68 -6.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.196 2.998 . . . . 0.0 113.011 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -142.84 -25.68 0.61 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.716 1.144 . . . . 0.0 111.823 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 58.47 165.89 0.04 OUTLIER 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.561 1.544 . . . . 0.0 111.939 -164.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.42 -133.64 45.03 Favored Glycine 0 C--N 1.367 2.289 0 O-C-N 119.455 -2.028 . . . . 0.0 109.05 -163.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 43.0 t 55.29 74.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 110.511 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.33 114.33 26.83 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -103.84 -36.51 7.79 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.485 -1.688 . . . . 0.0 108.311 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.68 76.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.34 129.2 44.63 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.184 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -142.56 115.21 8.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.963 1.305 . . . . 0.0 107.77 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.56 84.44 0.75 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 166.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.764 0 C-N-CA 124.755 1.169 . . . . 0.0 113.893 178.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 40.1 m . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 64.4 mt -115.87 133.84 55.62 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -169.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.16 162.74 26.41 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -172.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.09 129.34 75.59 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.17 150.16 46.52 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 57.9 m -125.12 -30.28 3.22 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 119.159 -0.448 . . . . 0.0 111.751 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 29.3 tp -88.35 -51.94 5.47 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 119.411 1.005 . . . . 0.0 111.803 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.9 pt -84.94 -176.8 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 125.585 1.554 . . . . 0.0 110.011 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.32 81.15 3.26 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -167.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.02 92.22 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.328 2.019 . . . . 0.0 110.09 164.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.5 mp -120.94 142.23 49.94 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -94.62 155.96 16.64 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.342 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.56 122.67 20.9 Favored 'General case' 0 C--N 1.377 1.761 0 CA-C-N 119.874 1.215 . . . . 0.0 108.737 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.16 -9.47 77.56 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 125.51 1.528 . . . . 0.0 111.131 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.22 175.34 5.4 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.79 0.836 . . . . 0.0 110.679 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.3 m -142.83 125.5 15.91 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -158.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.601 HG13 HH11 ' B' ' 914' ' ' ARG . 18.9 m -96.13 151.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 121.5 0.666 . . . . 0.0 110.448 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.0 t -141.65 138.43 32.51 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 126.626 1.97 . . . . 0.0 111.432 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.1 t -91.72 130.01 41.53 Favored 'Isoleucine or valine' 0 C--N 1.369 1.44 0 C-N-CA 127.355 2.262 . . . . 0.0 106.531 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.94 131.98 52.59 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.795 -3.78 . . . . 0.0 100.795 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.99 71.55 1.48 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 57.3 t -161.28 102.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 91.6 mmm -152.13 69.64 0.9 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.93 146.46 7.15 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -112.53 -29.96 7.3 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -174.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.48 87.57 6.46 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.87 4.49 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -167.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -116.88 156.0 28.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.2 t -89.74 133.61 34.6 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.92 150.65 20.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.41 113.06 21.21 Favored Pre-proline 0 C--N 1.356 0.864 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -99.33 173.5 0.42 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 122.047 1.832 . . . . 0.0 108.443 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.02 138.9 51.28 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -138.43 141.19 39.54 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 119.723 1.147 . . . . 0.0 108.539 -171.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 23.6 mm -117.11 130.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -126.19 104.44 8.23 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 61.2 p -103.12 162.91 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.959 1.303 . . . . 0.0 110.722 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.45 113.76 0.37 Allowed Glycine 0 C--N 1.359 1.86 0 N-CA-C 106.684 -2.567 . . . . 0.0 106.684 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.33 145.31 46.27 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.56 124.06 24.45 Favored 'General case' 0 C--N 1.381 1.965 0 C-N-CA 124.486 1.114 . . . . 0.0 109.692 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.26 -57.52 2.19 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -131.41 127.13 36.86 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.68 128.99 9.74 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.69 -3.764 . . . . 0.0 103.69 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.15 128.63 92.51 Favored Pre-proline 0 C--N 1.352 0.687 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.771 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -106.47 79.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 122.079 1.778 . . . . 0.0 109.378 -167.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.47 -72.21 0.09 Allowed 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 130.036 3.335 . . . . 0.0 109.117 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 74.6 mt 49.09 40.62 17.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 129.162 2.985 . . . . 0.0 113.868 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -113.52 131.88 55.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -130.41 108.0 9.66 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 179.309 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.1 114.09 26.3 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.56 -21.89 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 CA-C-N 121.643 1.622 . . . . 0.0 109.859 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 39.16 70.13 0.24 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.633 2.773 . . . . 0.0 115.307 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.31 131.77 72.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -138.71 149.27 44.92 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -149.53 139.72 22.19 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.289 0.95 . . . . 0.0 110.117 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 20.4 t -169.16 119.22 0.7 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-O 118.23 -0.89 . . . . 0.0 109.519 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.27 153.96 42.42 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -174.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.23 156.23 47.22 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 122.053 0.93 . . . . 0.0 109.747 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -129.21 127.19 40.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.701 -1.59 . . . . 0.0 106.815 -165.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 47.8 p -159.82 13.0 0.13 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.017 -164.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 3.0 pp -25.93 146.24 0.03 OUTLIER Pre-proline 0 C--N 1.368 1.413 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 157.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.94 -45.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.111 1.79 . . . . 0.0 113.319 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -163.39 177.95 8.5 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 -172.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 18.4 m -13.47 119.51 0.01 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 130.101 3.36 . . . . 0.0 116.079 172.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.85 161.27 38.98 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -166.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.52 -15.23 8.76 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.408 2.072 . . . . 0.0 110.999 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.26 -144.2 4.04 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -65.49 135.55 55.32 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.86 1.664 . . . . 0.0 110.515 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 17.1 m -65.74 144.02 98.74 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 125.628 1.571 . . . . 0.0 113.184 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -99.71 -151.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 123.303 2.669 . . . . 0.0 107.295 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -146.39 129.94 16.91 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -116.23 -16.17 10.97 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 122.969 0.508 . . . . 0.0 110.705 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -102.39 81.12 2.02 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.089 0.471 . . . . 0.0 111.372 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.15 97.68 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 127.231 2.213 . . . . 0.0 106.652 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 4.9 mt -89.03 -37.3 15.26 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.465 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 45.4 tp -165.31 129.48 2.37 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 100.401 -3.926 . . . . 0.0 100.401 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 33.1 t-20 175.68 61.56 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 121.218 1.826 . . . . 0.0 108.226 -166.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.55 97.73 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -165.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.02 -28.81 12.65 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.58 0.627 . . . . 0.0 112.663 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.15 -58.71 0.4 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.79 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.588 2.755 . . . . 0.0 114.085 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -97.25 120.8 38.28 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.811 1.644 . . . . 0.0 108.203 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -83.97 116.82 66.66 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -94.22 6.06 2.58 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 CA-C-N 124.955 2.805 . . . . 0.0 109.942 -165.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -79.95 -45.43 18.53 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.7 p -106.4 -12.08 15.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.937 1.295 . . . . 0.0 108.482 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.74 21.22 54.18 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.452 161.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.42 102.44 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -162.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.45 112.06 23.84 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 111.736 -2.484 . . . . 0.0 108.997 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 80.9 m -100.57 108.05 19.88 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.17 111.41 48.43 Favored Pre-proline 0 C--N 1.354 0.798 0 CA-C-O 117.284 -1.341 . . . . 0.0 110.248 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -91.03 0.07 4.88 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.444 2.096 . . . . 0.0 108.621 166.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 87.9 mt -58.21 -50.51 73.28 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.987 1.715 . . . . 0.0 114.59 -164.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.44 68.99 0.75 Allowed 'General case' 0 C--N 1.366 1.305 0 CA-C-O 122.051 0.929 . . . . 0.0 111.738 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.8 -167.75 35.8 Favored Glycine 0 N--CA 1.406 -3.309 1 N-CA-C 102.272 -4.331 . . . . 0.0 102.272 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -92.65 121.49 34.12 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.422 -1.389 . . . . 0.0 108.493 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.514 ' H ' HD11 ' C' ' 954' ' ' LEU . 3.6 t80 -116.9 145.73 43.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -112.18 115.33 28.67 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.035 0.934 . . . . 0.0 108.648 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . 0.477 HD12 ' HH ' ' C' ' 894' ' ' TYR . 9.2 tt -112.62 140.97 46.93 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.517 1.527 . . . . 0.0 108.505 -176.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -143.01 118.81 10.53 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.86 154.03 22.16 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.58 122.63 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 78.7 mt -97.92 122.57 41.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.309 1.044 . . . . 0.0 108.974 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.66 131.43 35.97 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.21 -56.28 24.06 Favored Glycine 0 C--N 1.367 2.261 0 C-N-CA 125.336 1.446 . . . . 0.0 112.992 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 43.72 63.08 1.69 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.772 2.429 . . . . 0.0 113.981 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -72.68 -7.48 50.63 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 112.594 -168.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 125.381 1.472 . . . . 0.0 112.294 -171.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.336 8.5 pt-20 120.89 -173.37 0.0 OUTLIER 'General case' 0 C--N 1.362 1.148 0 C-N-CA 128.253 2.621 . . . . 0.0 107.956 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.3 tttt 102.62 135.31 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 127.997 2.519 . . . . 0.0 106.524 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 93.2 t -98.39 123.29 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -104.77 129.72 52.97 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.566 1.946 . . . . 0.0 110.171 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.67 114.23 3.74 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.127 1.371 . . . . 0.0 109.943 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.27 117.2 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.818 1.647 . . . . 0.0 108.854 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.45 142.23 57.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.052 1.741 . . . . 0.0 110.204 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.26 1.3 p -113.81 148.73 36.07 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 126.427 1.891 . . . . 0.0 108.368 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.566 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -78.72 137.42 37.77 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.797 1.639 . . . . 0.0 108.364 178.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 101.65 -18.1 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 129.255 3.022 . . . . 0.0 112.281 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -137.5 -26.74 0.97 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 119.277 0.944 . . . . 0.0 111.3 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 59.93 167.17 0.07 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.31 1.444 . . . . 0.0 111.861 -164.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.5 -130.72 51.43 Favored Glycine 0 C--N 1.376 2.764 0 O-C-N 119.554 -1.966 . . . . 0.0 110.197 -163.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 43.2 t 51.8 74.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 126.317 1.847 . . . . 0.0 111.712 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.49 116.62 29.0 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -99.56 -36.66 9.46 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.782 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.85 78.12 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -94.05 132.56 38.41 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -143.55 114.56 7.79 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 125.39 1.476 . . . . 0.0 108.295 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.45 84.97 0.64 Allowed Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 104.765 -3.334 . . . . 0.0 104.765 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.727 0 C-N-CA 125.096 1.332 . . . . 0.0 110.909 172.743 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.511 -0.536 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.6 mt -121.28 134.59 55.17 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.85 162.51 26.29 Favored Glycine 0 CA--C 1.493 -1.344 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.1 130.75 73.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -137.07 150.62 48.15 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 53.3 m -117.71 -36.7 3.6 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.157 -0.34 . . . . 0.0 111.414 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.78 -54.6 3.56 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 118.525 0.602 . . . . 0.0 111.928 -166.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.6 pp -84.76 -173.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 126.463 1.905 . . . . 0.0 110.158 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.514 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -162.12 92.86 1.32 Allowed Pre-proline 0 C--N 1.358 0.942 0 O-C-N 122.02 -0.425 . . . . 0.0 109.947 -168.595 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.33 91.15 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 122.944 2.087 . . . . 0.0 109.797 160.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 5.9 mp -121.42 142.88 49.58 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -92.43 160.23 15.18 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.75 122.05 19.97 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 120.226 1.375 . . . . 0.0 108.502 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.61 71.45 Favored Glycine 0 C--N 1.347 1.158 0 C-N-CA 125.389 1.471 . . . . 0.0 111.419 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.89 174.99 3.91 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.488 0.715 . . . . 0.0 111.471 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 19.4 p -142.96 127.98 18.48 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.435 0.635 . . . . 0.0 109.416 -161.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.566 HG13 HH11 ' C' ' 914' ' ' ARG . 19.6 m -94.69 150.28 4.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.66 137.72 33.78 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 125.047 1.339 . . . . 0.0 111.916 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.79 129.42 42.49 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 C-N-CA 125.912 1.685 . . . . 0.0 106.805 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -106.82 132.6 52.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 11.4 tp -132.28 75.26 1.62 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.196 -1.82 . . . . 0.0 107.972 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.7 t -158.59 100.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.62 75.15 1.15 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 112.89 145.6 9.51 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -113.0 -30.51 6.99 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.2 tp -92.24 87.06 5.94 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.8 -160.62 1.08 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -123.17 155.13 37.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -91.48 134.02 35.0 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -158.27 151.19 22.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -127.29 116.67 21.58 Favored Pre-proline 0 C--N 1.355 0.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -102.99 173.76 0.19 Allowed 'Trans proline' 0 CA--C 1.508 -0.817 0 N-CA-C 107.925 -1.606 . . . . 0.0 107.925 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -114.55 139.52 49.51 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -137.79 139.44 40.03 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 119.665 1.12 . . . . 0.0 108.001 -169.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.41 131.24 69.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -124.92 105.53 9.3 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 982' ' ' SER . . . . . 0.444 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 28.6 p -101.76 164.67 11.61 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.61 1.564 . . . . 0.0 109.911 172.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.15 111.81 0.35 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.06 141.53 48.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -76.7 124.45 27.68 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.386 1.474 . . . . 0.0 108.586 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 18.6 tp -98.1 -57.46 2.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.753 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.91 128.26 38.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.71 131.7 10.83 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.684 -3.766 . . . . 0.0 103.684 162.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.34 132.38 89.75 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.595 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -106.09 78.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.54 1.586 . . . . 0.0 108.954 -171.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 79.56 -71.75 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.207 3.403 . . . . 0.0 109.007 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 68.6 mt 49.87 38.87 17.01 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 129.183 2.993 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.14 131.86 54.76 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.94 107.14 9.14 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 179.544 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 109.854 -0.864 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.94 119.0 21.01 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -89.96 -20.89 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.079 1.778 . . . . 0.0 109.689 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 37.74 69.23 0.25 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.727 2.811 . . . . 0.0 115.618 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.09 137.1 54.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.2 158.84 43.32 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -149.38 138.07 21.02 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 22.9 t -170.28 117.5 0.54 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.73 153.36 34.52 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.01 157.89 45.76 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.68 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -130.75 129.32 42.33 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -166.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.2 p -162.01 14.36 0.09 Allowed 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -163.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 3.8 pp -24.86 147.44 0.02 OUTLIER Pre-proline 0 C--N 1.366 1.318 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 159.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.51 -45.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 121.918 1.721 . . . . 0.0 112.891 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -163.45 179.34 7.37 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -172.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -24.05 126.76 0.03 OUTLIER 'General case' 0 C--N 1.364 1.225 0 C-N-CA 129.364 3.066 . . . . 0.0 115.22 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -122.77 147.15 50.08 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -158.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.46 -10.35 20.45 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.505 2.137 . . . . 0.0 113.042 -172.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.25 -142.01 3.33 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 120.426 1.466 . . . . 0.0 110.558 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.4 m -62.82 144.72 56.28 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 127.213 2.205 . . . . 0.0 110.813 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.11 122.77 84.75 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 125.504 1.522 . . . . 0.0 111.089 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -96.39 -153.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.96 3.107 . . . . 0.0 107.472 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -151.49 135.66 16.71 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -120.12 -11.88 9.18 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 122.146 -0.346 . . . . 0.0 111.905 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.09 87.14 3.39 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.591 0.632 . . . . 0.0 112.264 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.87 97.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 126.213 1.805 . . . . 0.0 106.882 168.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 67.0 mt -87.48 -37.82 16.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.238 -173.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 32.4 tp -166.65 127.51 1.66 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 101.106 -3.665 . . . . 0.0 101.106 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 179.98 61.04 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 120.839 1.654 . . . . 0.0 108.988 -166.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 -44.03 95.84 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -166.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.72 -27.13 15.13 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 118.863 0.756 . . . . 0.0 112.456 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.77 -58.73 0.39 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 62.68 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 127.933 2.493 . . . . 0.0 114.094 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -95.97 119.54 34.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.785 1.234 . . . . 0.0 108.068 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.05 117.29 67.8 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.53 4.84 2.61 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 124.656 2.699 . . . . 0.0 109.399 -165.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.16 -45.72 17.64 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -104.31 -14.29 15.84 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 124.517 1.127 . . . . 0.0 108.746 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.26 47.65 Favored Glycine 0 C--N 1.363 2.068 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 162.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 52.5 t -100.18 103.89 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 -163.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.71 111.92 24.23 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 112.167 -2.288 . . . . 0.0 109.358 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 64.9 m -100.33 108.18 20.15 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.93 110.75 44.1 Favored Pre-proline 0 C--N 1.357 0.912 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.707 170.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.22 1.29 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 123.285 2.209 . . . . 0.0 108.94 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 29.9 mt -51.68 -53.84 34.61 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 128.489 2.716 . . . . 0.0 114.151 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.17 65.3 1.31 Allowed 'General case' 0 C--N 1.365 1.277 0 CA-C-O 121.901 0.858 . . . . 0.0 112.057 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.08 -177.93 45.48 Favored Glycine 0 N--CA 1.411 -3.012 1 N-CA-C 101.033 -4.827 . . . . 0.0 101.033 -173.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -93.18 121.27 34.37 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.284 1.3 p90 -114.95 161.68 17.98 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.158 0.89 . . . . 0.0 109.573 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 63.0 tp -104.17 116.45 32.22 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.421 0.688 . . . . 0.0 109.662 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.03 136.72 49.63 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 126.386 1.874 . . . . 0.0 108.916 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.8 m -147.41 119.57 8.29 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 123.318 0.647 . . . . 0.0 109.557 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.42 153.92 21.56 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.5 t -107.97 120.82 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.95 123.96 45.94 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.177 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 42.4 m -81.11 132.97 35.39 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 125.581 1.552 . . . . 0.0 107.389 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.4 -57.22 20.8 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 124.931 1.253 . . . . 0.0 113.765 -170.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.6 m170 36.1 71.48 0.13 Allowed 'General case' 0 C--N 1.36 1.043 0 C-N-CA 127.556 2.342 . . . . 0.0 115.143 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -73.03 -8.02 53.85 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 125.253 1.421 . . . . 0.0 112.028 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.82 -18.76 62.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.18 1.392 . . . . 0.0 112.605 -171.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.305 11.3 pt-20 125.13 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 127.954 2.502 . . . . 0.0 108.16 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 99.16 131.69 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.423 2.289 . . . . 0.0 107.277 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.76 123.81 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -107.97 121.71 45.35 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.015 1.726 . . . . 0.0 112.864 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -130.5 116.13 17.76 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.6 2.76 . . . . 0.0 108.615 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.3 t -84.98 114.74 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.67 141.26 58.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.841 1.656 . . . . 0.0 110.497 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.3 t -115.96 147.18 41.44 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.537 1.935 . . . . 0.0 109.373 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.611 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.68 139.49 39.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.821 2.848 . . . . 0.0 110.634 -173.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 7.2 t 97.55 -12.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 129.269 3.028 . . . . 0.0 112.909 173.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -136.9 -26.51 1.04 Allowed 'General case' 0 C--N 1.356 0.887 0 CA-C-N 119.601 1.091 . . . . 0.0 111.204 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 61.58 163.35 0.08 Allowed 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.473 1.509 . . . . 0.0 111.388 -166.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.77 -135.07 49.43 Favored Glycine 0 C--N 1.37 2.456 0 O-C-N 119.443 -2.036 . . . . 0.0 109.442 -160.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 44.0 t 57.52 78.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.169 0 C-N-CA 125.56 1.544 . . . . 0.0 110.714 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.69 114.42 26.96 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -173.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -102.86 -35.75 8.49 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.479 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -100.22 82.43 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 167.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -94.93 130.21 41.65 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.796 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -142.96 114.88 8.23 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.654 1.582 . . . . 0.0 108.631 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.3 85.12 0.65 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 103.701 -3.76 . . . . 0.0 103.701 162.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.842 0 C-N-CA 124.369 0.985 . . . . 0.0 112.133 172.206 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.52 133.28 55.99 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.13 161.58 27.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -172.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 26.5 m -122.59 127.85 75.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.7 149.32 46.42 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.0 m -115.0 -43.74 3.08 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.423 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 22.9 tp -83.71 -50.07 8.51 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 119.491 1.041 . . . . 0.0 112.775 -166.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.41 HG12 ' HG ' ' C' ' 853' ' ' SER . 7.8 pt -85.01 -174.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 110.438 -176.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.69 81.64 2.74 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 123.154 0.582 . . . . 0.0 109.663 -166.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.24 92.24 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.593 2.195 . . . . 0.0 109.911 162.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.8 143.8 48.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -94.33 156.59 16.44 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.605 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.29 123.47 22.35 Favored 'General case' 0 C--N 1.372 1.547 0 CA-C-N 119.292 0.951 . . . . 0.0 108.861 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.11 72.92 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 125.936 1.731 . . . . 0.0 111.096 171.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.92 175.25 5.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.385 0.674 . . . . 0.0 111.528 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 13.1 t -144.4 128.68 17.8 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.825 0.821 . . . . 0.0 110.191 -164.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.611 HG13 HH11 ' A' ' 914' ' ' ARG . 23.4 m -94.53 151.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.957 172.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.54 138.5 32.76 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 126.197 1.799 . . . . 0.0 111.275 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.69 129.51 42.26 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 C-N-CA 126.102 1.761 . . . . 0.0 107.04 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -107.8 131.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 169.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -131.39 76.44 1.72 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.401 -1.727 . . . . 0.0 107.303 172.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.1 t -160.46 100.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.0 mmm -153.58 70.12 0.83 Allowed 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.05 145.8 7.33 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -113.1 -29.35 7.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.8 tp -91.37 87.42 6.44 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.62 -165.28 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -124.46 161.02 26.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -93.47 133.15 37.05 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.61 151.38 22.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.22 113.39 21.54 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -99.21 173.93 0.42 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 121.875 1.716 . . . . 0.0 108.751 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.43 139.34 51.54 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.707 1.203 . . . . 0.0 108.247 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -140.76 141.9 34.78 Favored 'General case' 0 C--N 1.376 1.727 0 CA-C-N 120.001 1.273 . . . . 0.0 108.599 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 24.3 mm -118.12 129.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -125.14 105.62 9.29 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 32.1 p -101.04 161.97 13.22 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.019 1.328 . . . . 0.0 110.379 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.54 0.28 Allowed Glycine 0 C--N 1.359 1.835 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.17 145.27 46.14 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.37 -1.077 . . . . 0.0 113.809 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.8 tp -75.19 123.09 24.66 Favored 'General case' 0 C--N 1.379 1.857 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 27.7 tp -98.61 -57.33 2.22 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -131.7 128.05 38.17 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 130.95 10.47 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 103.883 -3.687 . . . . 0.0 103.883 165.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -69.09 128.91 92.48 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-O 117.825 -1.083 . . . . 0.0 111.046 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -107.14 80.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.048 1.767 . . . . 0.0 109.814 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.89 -72.75 0.09 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 130.241 3.416 . . . . 0.0 109.315 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 73.2 mt 49.62 39.24 16.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.158 2.983 . . . . 0.0 114.169 -176.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -112.1 131.43 55.44 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -128.93 108.7 10.63 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 179.318 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.55 119.19 21.57 Favored Pre-proline 0 C--N 1.354 0.771 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.25 -20.93 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 122.193 1.819 . . . . 0.0 109.905 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 39.31 69.19 0.3 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 128.783 2.833 . . . . 0.0 115.351 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 88.6 t -118.88 136.76 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.21 157.81 45.96 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 165.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.31 138.49 21.41 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -170.68 118.07 0.51 Allowed 'General case' 0 C--N 1.357 0.893 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.67 153.55 34.16 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -136.13 157.97 45.55 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.433 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -130.45 128.04 40.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -167.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.8 p -161.65 13.36 0.09 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.341 -163.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.7 pp -24.56 147.49 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.375 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 158.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.69 -45.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 CA-C-N 121.943 1.729 . . . . 0.0 112.839 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 -163.32 179.22 7.52 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -172.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.8 m -23.82 126.6 0.03 OUTLIER 'General case' 0 C--N 1.365 1.248 0 C-N-CA 129.361 3.064 . . . . 0.0 115.356 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -122.79 147.17 50.17 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -158.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.5 -10.29 20.36 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.517 2.145 . . . . 0.0 113.107 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.99 3.32 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 120.496 1.498 . . . . 0.0 110.516 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 24.3 m -62.83 144.59 56.44 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 127.086 2.154 . . . . 0.0 110.7 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 11.5 t -78.88 122.58 84.78 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 125.521 1.528 . . . . 0.0 111.004 -169.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -97.65 -153.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.932 3.088 . . . . 0.0 107.361 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -150.82 135.09 16.95 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -117.77 -10.95 10.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.604 0.761 . . . . 0.0 110.553 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -100.77 87.52 3.35 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.95 -0.469 . . . . 0.0 112.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.13 97.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.172 1.789 . . . . 0.0 106.507 164.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.05 -39.17 14.85 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.238 -174.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 44.7 tp -166.1 126.57 1.73 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 100.6 -3.852 . . . . 0.0 100.6 165.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 177.35 60.88 0.01 OUTLIER 'General case' 0 C--N 1.354 0.79 0 CA-C-N 120.464 1.484 . . . . 0.0 108.921 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.24 -43.56 95.99 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -166.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.38 -27.82 14.46 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 118.749 0.704 . . . . 0.0 112.553 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.53 -57.89 0.43 Allowed Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 62.65 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 127.998 2.519 . . . . 0.0 114.221 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -96.86 119.13 34.76 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.926 1.29 . . . . 0.0 108.117 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.89 117.52 68.62 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.66 5.09 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 124.609 2.682 . . . . 0.0 109.529 -164.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.18 -44.6 19.55 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -106.2 -14.64 15.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.872 1.269 . . . . 0.0 108.393 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.87 25.17 42.3 Favored Glycine 0 C--N 1.361 1.917 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.54 103.89 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 -162.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -100.74 111.91 24.22 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 112.609 -2.087 . . . . 0.0 109.144 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.3 m -100.37 108.22 20.19 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 168.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.65 111.0 45.3 Favored Pre-proline 0 C--N 1.357 0.933 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.755 171.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -93.36 1.95 3.4 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.318 2.221 . . . . 0.0 108.929 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.14 -48.57 73.5 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 127.047 2.139 . . . . 0.0 113.951 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.29 48.89 14.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.547 1.539 . . . . 0.0 113.929 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.95 -166.1 20.08 Favored Glycine 0 N--CA 1.412 -2.902 1 N-CA-C 101.569 -4.612 . . . . 0.0 101.569 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -93.31 121.43 34.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.318 0.8 OUTLIER -117.03 161.41 19.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-N 119.26 0.936 . . . . 0.0 109.639 177.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.0 tp -105.38 115.52 30.4 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -109.72 136.46 49.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.313 1.845 . . . . 0.0 108.254 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.8 m -145.25 119.42 9.48 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.82 153.51 22.37 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 95.5 t -108.56 121.81 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.4 122.23 45.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.988 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 38.4 m -79.67 132.99 36.36 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.49 1.516 . . . . 0.0 107.853 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.02 -57.2 21.14 Favored Glycine 0 C--N 1.364 2.129 0 C-N-CA 125.057 1.313 . . . . 0.0 113.896 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.8 m170 35.84 71.79 0.12 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 127.491 2.316 . . . . 0.0 115.173 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -73.18 -7.89 53.38 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.27 1.428 . . . . 0.0 111.976 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -72.55 -15.39 61.77 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 125.46 1.504 . . . . 0.0 112.656 -169.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.317 10.2 pt-20 121.05 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.361 1.067 0 C-N-CA 128.182 2.593 . . . . 0.0 108.224 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 79.7 tttt 100.49 131.82 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 127.537 2.335 . . . . 0.0 107.46 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.76 126.23 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -111.25 122.87 48.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.498 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.58 117.34 17.82 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 128.087 2.555 . . . . 0.0 108.907 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.48 113.86 25.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.2 mt -62.59 143.29 57.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.664 1.986 . . . . 0.0 110.294 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -116.03 147.88 40.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 110.011 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.621 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.75 139.34 38.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 128.044 2.538 . . . . 0.0 110.19 -174.55 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 7.4 t 97.82 -16.35 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.322 3.049 . . . . 0.0 113.078 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -134.49 -26.0 1.45 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 119.599 1.091 . . . . 0.0 111.423 -170.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 61.34 162.88 0.07 Allowed 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.593 1.557 . . . . 0.0 111.176 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.35 -133.92 45.25 Favored Glycine 0 C--N 1.365 2.173 0 O-C-N 119.615 -1.928 . . . . 0.0 109.163 -162.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.13 79.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.149 0 C-N-CA 125.828 1.651 . . . . 0.0 110.823 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 114.91 27.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -103.31 -36.98 7.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.385 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.3 t -100.72 81.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.875 -3.009 . . . . 0.0 102.875 167.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -95.69 129.48 42.89 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.7 t -141.57 115.53 9.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.483 1.513 . . . . 0.0 107.714 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.64 85.0 0.69 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 104.199 -3.56 . . . . 0.0 104.199 163.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.814 0 C-N-CA 124.904 1.24 . . . . 0.0 112.029 173.204 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.4 mt -116.91 133.95 55.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 -171.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.31 162.57 27.58 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.26 130.67 73.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.28 150.6 46.82 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 55.0 m -118.89 -40.49 2.85 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 118.165 0.439 . . . . 0.0 111.918 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.44 -48.9 10.55 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 119.169 0.895 . . . . 0.0 112.646 -167.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 40.8 pt -84.29 -177.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.864 1.666 . . . . 0.0 110.389 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.28 81.35 2.91 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -169.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.35 93.41 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.602 2.201 . . . . 0.0 110.321 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.2 mp -120.5 142.52 49.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -93.21 156.97 16.51 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.616 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.02 123.27 22.42 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 119.508 1.049 . . . . 0.0 108.672 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.79 -10.46 74.52 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 125.555 1.55 . . . . 0.0 111.052 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.27 174.82 5.94 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.732 0.813 . . . . 0.0 110.458 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 14.5 t -144.42 128.76 17.86 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.745 0.783 . . . . 0.0 110.42 -161.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.621 HG13 HH11 ' B' ' 914' ' ' ARG . 17.7 m -96.15 151.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.19 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.82 138.51 32.24 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 126.281 1.832 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 90.1 t -91.21 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.331 0 C-N-CA 127.087 2.155 . . . . 0.0 107.275 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -107.41 131.54 54.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 100.77 -3.789 . . . . 0.0 100.77 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.77 75.92 1.69 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.565 -1.652 . . . . 0.0 106.948 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 61.9 t -159.21 102.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -152.8 68.86 0.84 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.76 144.98 6.82 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -111.96 -28.67 7.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -92.3 87.14 5.94 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.97 1.68 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -124.49 160.13 28.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.3 t -91.89 132.88 36.15 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.7 151.49 22.16 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.05 113.29 21.8 Favored Pre-proline 0 C--N 1.356 0.867 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -98.9 173.46 0.46 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.948 1.765 . . . . 0.0 108.693 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.71 137.71 52.5 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -139.76 140.77 36.8 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.91 1.232 . . . . 0.0 108.316 -170.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.48 129.8 72.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -125.83 105.44 8.95 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 982' ' ' SER . . . . . 0.454 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 34.4 p -102.11 163.14 12.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.104 1.361 . . . . 0.0 110.866 171.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.02 112.09 0.33 Allowed Glycine 0 C--N 1.36 1.9 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.23 145.15 46.3 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.6 tp -72.75 122.52 21.64 Favored 'General case' 0 C--N 1.381 1.975 0 C-N-CA 124.143 0.977 . . . . 0.0 109.155 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.3 tp -98.39 -57.38 2.21 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -131.46 127.43 37.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 130.25 10.21 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 103.819 -3.712 . . . . 0.0 103.819 165.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.62 128.99 91.77 Favored Pre-proline 0 C--N 1.352 0.702 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.446 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -106.62 80.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 122.029 1.76 . . . . 0.0 109.426 -168.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.16 -72.17 0.09 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 129.98 3.312 . . . . 0.0 109.199 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 68.9 mt 48.79 41.51 18.32 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 129.039 2.936 . . . . 0.0 113.696 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -114.41 131.35 56.62 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.83 108.34 10.07 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 179.096 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.454 -0.821 0 N-CA-C 109.849 -0.866 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.11 114.53 27.8 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -88.86 -21.42 1.32 Allowed 'Trans proline' 0 CA--C 1.512 -0.614 0 CA-C-N 121.723 1.651 . . . . 0.0 110.173 -172.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 35.77 71.39 0.12 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 129.039 2.936 . . . . 0.0 115.84 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.3 t -122.06 136.55 58.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 156.41 49.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 165.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 6.8 p90 -148.8 136.84 20.84 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 118.811 0.732 . . . . 0.0 109.03 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 853' ' ' SER . . . . . 0.41 ' HG ' HG12 ' A' ' 953' ' ' ILE . 15.1 t -170.86 119.93 0.53 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.321 -0.862 . . . . 0.0 109.512 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.13 153.11 36.65 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.11 157.72 44.9 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.976 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -140.23 129.44 23.74 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -163.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 69.8 m -157.06 19.52 0.3 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 1.8 pp -25.36 145.59 0.03 OUTLIER Pre-proline 0 C--N 1.373 1.596 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 160.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.6 -49.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.236 1.957 . . . . 0.0 113.463 -164.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.1 ptt85 -162.47 172.39 15.59 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -2.69 112.46 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 130.893 3.677 . . . . 0.0 117.165 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -96.1 161.46 27.14 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.702 1.201 . . . . 0.0 109.651 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.92 -15.8 11.68 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.84 2.36 . . . . 0.0 110.429 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.99 -138.74 2.58 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 10.1 m -65.17 146.76 54.56 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.85 1.66 . . . . 0.0 110.69 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.89 133.31 26.67 Favored Pre-proline 0 N--CA 1.438 -1.044 0 C-N-CA 125.447 1.499 . . . . 0.0 110.554 -162.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -96.54 -152.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.823 3.015 . . . . 0.0 109.443 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.09 134.57 23.17 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -114.44 -17.23 11.81 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.161 0.584 . . . . 0.0 111.766 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -102.92 83.21 2.2 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.519 0.6 . . . . 0.0 110.958 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.76 97.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.651 1.98 . . . . 0.0 106.51 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 6.5 mt -89.83 -37.99 14.07 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.288 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 33.8 tp -165.52 126.74 1.94 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 175.06 61.47 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 120.25 1.387 . . . . 0.0 107.72 -163.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.88 -42.51 93.91 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -165.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.95 -29.11 16.25 Favored Glycine 0 C--N 1.357 1.705 0 CA-C-N 118.736 0.698 . . . . 0.0 112.335 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.14 -58.22 0.51 Allowed Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 63.47 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.087 2.555 . . . . 0.0 114.458 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -96.16 120.69 36.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 125.329 1.452 . . . . 0.0 108.496 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -85.99 116.96 67.8 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.26 8.65 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 124.951 2.804 . . . . 0.0 109.015 -170.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -79.29 -44.39 21.78 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.3 p -107.28 -15.01 14.75 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.832 1.253 . . . . 0.0 107.932 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.62 24.74 49.13 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 164.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.08 103.66 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.95 111.83 23.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.976 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 47.5 m -102.51 108.66 20.04 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . 0.442 ' HB2' HH22 ' C' ' 914' ' ' ARG . . . -91.56 110.37 42.7 Favored Pre-proline 0 C--N 1.356 0.85 0 CA-C-O 117.261 -1.352 . . . . 0.0 111.775 170.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -93.56 3.18 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.572 2.181 . . . . 0.0 108.359 164.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.02 -51.55 67.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 127.718 2.407 . . . . 0.0 113.458 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.52 66.09 1.14 Allowed 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.128 0.966 . . . . 0.0 111.66 169.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.08 -179.36 45.59 Favored Glycine 0 N--CA 1.404 -3.442 1 N-CA-C 101.293 -4.723 . . . . 0.0 101.293 -173.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -95.64 116.71 29.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.752 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.83 160.82 20.25 Favored 'General case' 0 C--N 1.366 1.31 0 CA-C-N 119.2 0.909 . . . . 0.0 110.654 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -108.0 110.66 22.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.06 138.99 51.25 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 108.414 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 61.5 m -143.22 120.59 11.62 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.54 0.736 . . . . 0.0 110.25 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -103.65 154.87 19.04 Favored 'General case' 0 C--N 1.364 1.226 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.71 123.47 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 68.9 mt -94.92 124.32 38.9 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.631 1.172 . . . . 0.0 109.403 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.4 m -79.66 132.39 36.21 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.74 22.54 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 125.952 1.739 . . . . 0.0 114.843 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 61.2 m170 31.39 74.33 0.05 OUTLIER 'General case' 0 C--N 1.361 1.076 0 C-N-CA 128.168 2.587 . . . . 0.0 115.615 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -71.0 -11.55 61.04 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.127 1.771 . . . . 0.0 112.457 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -73.89 -5.41 40.9 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.799 2.04 . . . . 0.0 111.796 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.299 47.1 mt-10 100.09 -144.09 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.809 2.844 . . . . 0.0 107.05 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 75.3 tttt 79.12 141.39 0.07 Allowed 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.616 1.966 . . . . 0.0 109.389 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.86 126.23 59.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -110.03 129.92 55.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.908 2.083 . . . . 0.0 110.164 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.51 114.13 2.94 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.692 1.197 . . . . 0.0 110.422 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 7.2 p -85.54 117.69 30.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 C-N-CA 126.36 1.864 . . . . 0.0 109.04 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.73 137.24 58.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.129 1.372 . . . . 0.0 110.375 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.5 t -117.72 145.39 44.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.797 2.039 . . . . 0.0 107.989 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.442 HH22 ' HB2' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.33 140.37 38.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.215 2.206 . . . . 0.0 110.878 -174.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 92.25 0.86 0.12 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 128.982 2.913 . . . . 0.0 112.129 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -147.12 -25.66 0.4 Allowed 'General case' 0 C--N 1.361 1.078 0 CA-C-N 119.499 1.045 . . . . 0.0 112.101 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.5 166.99 0.06 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.422 1.489 . . . . 0.0 111.671 -164.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.7 -130.36 50.93 Favored Glycine 0 C--N 1.375 2.702 0 O-C-N 119.434 -2.041 . . . . 0.0 110.08 -164.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 47.6 t 53.6 73.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.226 0 C-N-CA 125.734 1.614 . . . . 0.0 111.586 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.89 116.1 28.62 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 25.0 ptt85 -98.93 -33.26 10.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.706 -173.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.03 79.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 166.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.88 131.71 40.48 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 120.895 0.378 . . . . 0.0 111.299 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 24.6 t -144.18 115.23 7.88 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 125.324 1.45 . . . . 0.0 108.367 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.54 85.51 0.66 Allowed Glycine 0 CA--C 1.481 -2.035 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 172.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.632 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.675 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 70.0 mt -122.31 134.1 54.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.76 162.24 27.74 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 25.5 m -118.82 130.9 73.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -136.14 150.06 48.91 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.7 t -105.12 -76.35 0.61 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.454 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 13.7 tp -61.48 -49.53 76.39 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.25 -177.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.081 1.352 . . . . 0.0 110.477 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.85 84.14 1.31 Allowed Pre-proline 0 C--N 1.356 0.848 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.59 88.14 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 122.478 1.921 . . . . 0.0 109.952 164.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.8 146.22 47.72 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.14 161.37 15.79 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.397 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.65 122.15 20.07 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.408 1.458 . . . . 0.0 108.633 172.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.2 72.71 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 125.504 1.526 . . . . 0.0 111.261 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.99 175.59 3.63 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.739 0.781 . . . . 0.0 111.673 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.9 m -142.81 127.0 17.52 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.774 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.31 147.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 C-N-CA 124.276 1.03 . . . . 0.0 109.155 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 19.6 t -142.43 137.89 30.69 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.849 1.659 . . . . 0.0 111.193 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.7 129.71 41.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -104.05 132.98 49.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.84 71.53 1.45 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.515 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.75 99.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.76 74.43 1.11 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 113.72 145.09 9.05 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -114.1 -21.13 10.68 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.595 0.758 . . . . 0.0 110.007 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -98.71 85.81 3.4 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.82 -158.66 0.88 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -172.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -120.54 169.47 10.32 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 23.2 t -108.38 130.66 55.21 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.72 154.53 30.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.0 115.41 20.44 Favored Pre-proline 0 C--N 1.355 0.813 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 172.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -103.39 176.89 0.15 Allowed 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 121.807 1.671 . . . . 0.0 108.075 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.33 138.97 50.89 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -137.54 139.2 40.33 Favored 'General case' 0 C--N 1.376 1.757 0 CA-C-N 119.931 1.241 . . . . 0.0 108.489 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 34.8 mm -115.14 131.51 67.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -125.34 104.47 8.48 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 982' ' ' SER . . . . . 0.423 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 26.6 p -102.17 163.92 11.98 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.475 1.51 . . . . 0.0 110.42 172.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.1 113.19 0.37 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.71 46.69 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.5 124.63 26.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 125.495 1.518 . . . . 0.0 109.598 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.34 -57.61 2.16 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -131.93 127.54 36.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.6 129.32 9.85 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 103.739 -3.744 . . . . 0.0 103.739 165.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.56 127.8 91.66 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.285 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -106.95 78.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.534 0 CA-C-N 121.735 1.655 . . . . 0.0 109.449 -168.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 78.86 -72.77 0.08 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 130.039 3.336 . . . . 0.0 109.063 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 66.0 mt 48.88 40.53 16.78 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 128.975 2.91 . . . . 0.0 113.576 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -112.45 131.1 55.74 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -128.85 108.3 10.34 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.265 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.509 -0.76 0 N-CA-C 109.989 -0.812 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.93 119.36 21.14 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -90.07 -22.02 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.222 1.829 . . . . 0.0 109.666 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 38.14 69.16 0.26 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 128.757 2.823 . . . . 0.0 115.408 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.79 137.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.92 159.29 41.91 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 166.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.27 117.67 0.54 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.3 153.91 33.18 Favored 'General case' 0 C--N 1.372 1.575 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -134.39 158.52 43.63 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.411 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.24 127.71 30.54 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 71.5 m -163.12 9.42 0.05 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -159.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -28.5 152.28 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.378 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 160.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -78.38 -42.26 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 121.943 1.73 . . . . 0.0 113.382 -164.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -166.23 -159.16 0.37 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.2 m -31.54 139.04 0.04 OUTLIER 'General case' 0 C--N 1.361 1.104 0 C-N-CA 129.478 3.111 . . . . 0.0 115.29 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.89 164.54 43.14 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.93 -14.15 12.53 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.591 2.194 . . . . 0.0 111.147 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.9 -139.02 2.62 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.2 m -62.93 145.4 55.33 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 126.87 2.068 . . . . 0.0 111.011 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.44 128.12 54.24 Favored Pre-proline 0 N--CA 1.437 -1.093 0 C-N-CA 125.39 1.476 . . . . 0.0 110.315 -165.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -96.26 -149.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.943 3.096 . . . . 0.0 108.361 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.96 134.17 18.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -116.81 -14.45 10.73 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 122.62 0.368 . . . . 0.0 111.719 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.55 87.8 3.46 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.658 0.663 . . . . 0.0 112.47 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.69 97.83 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.014 1.726 . . . . 0.0 106.781 168.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 78.4 mt -87.71 -37.84 16.33 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.865 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 31.7 tp -166.31 127.55 1.77 Allowed 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 163.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 179.53 60.82 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.806 1.639 . . . . 0.0 109.16 -166.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.46 -43.94 93.1 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -165.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.36 -28.04 14.0 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.733 0.697 . . . . 0.0 112.49 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.57 -58.57 0.39 Allowed Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.516 -2.234 . . . . 0.0 107.516 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 63.16 -80.58 0.03 OUTLIER 'General case' 0 C--N 1.355 0.823 0 C-N-CA 128.065 2.546 . . . . 0.0 114.286 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -96.46 119.82 35.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.678 1.191 . . . . 0.0 108.416 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -80.0 117.22 66.39 Favored Pre-proline 0 CA--C 1.503 -0.834 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -93.81 6.25 2.73 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 CA-C-N 125.45 2.982 . . . . 0.0 109.031 -167.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -80.1 -46.66 16.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 21.5 p -108.18 -10.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 108.667 173.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 27.42 38.05 Favored Glycine 0 C--N 1.363 2.028 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 162.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.13 103.26 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.578 0 N-CA-C 100.816 -3.772 . . . . 0.0 100.816 -164.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.36 112.83 25.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.19 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 61.0 m -100.58 108.48 20.4 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.83 110.69 43.53 Favored Pre-proline 0 C--N 1.358 0.966 0 CA-C-O 117.033 -1.461 . . . . 0.0 112.459 172.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -96.46 -1.21 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 123.109 2.146 . . . . 0.0 109.142 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.82 -50.18 66.74 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.65 2.38 . . . . 0.0 114.188 -168.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.18 47.9 13.65 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.29 1.436 . . . . 0.0 114.486 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -160.42 -165.41 17.2 Favored Glycine 0 N--CA 1.415 -2.746 1 N-CA-C 101.291 -4.724 . . . . 0.0 101.291 175.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . 0.441 HH21 HG22 ' A' ' 953' ' ' ILE . 75.9 ttt-85 -93.83 120.9 34.7 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.273 3.7 p90 -115.33 161.33 18.66 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 118.939 0.791 . . . . 0.0 109.479 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.8 tp -104.61 117.08 33.22 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.434 0.694 . . . . 0.0 109.47 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -111.26 137.38 49.06 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 126.446 1.898 . . . . 0.0 108.941 -167.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.7 m -145.58 119.14 9.1 Favored 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.63 153.35 22.5 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.38 120.43 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.62 123.87 47.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.843 -173.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 49.0 m -79.12 131.45 36.24 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 125.396 1.478 . . . . 0.0 107.37 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.19 -55.77 25.97 Favored Glycine 0 C--N 1.365 2.194 0 C-N-CA 124.571 1.081 . . . . 0.0 112.268 -169.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.41 64.91 1.56 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 126.486 1.914 . . . . 0.0 113.466 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -70.84 -9.01 56.74 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.976 1.71 . . . . 0.0 112.731 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.7 -16.8 61.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.509 1.524 . . . . 0.0 112.558 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.321 9.6 pt-20 124.2 -176.18 0.0 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.204 2.602 . . . . 0.0 107.729 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 77.3 tttt 101.49 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 127.743 2.417 . . . . 0.0 106.914 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.33 128.7 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -170.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -110.76 121.16 44.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.042 1.737 . . . . 0.0 113.316 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.37 115.68 15.16 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 128.474 2.71 . . . . 0.0 109.239 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.6 t -88.59 114.08 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.32 141.41 58.3 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.188 1.795 . . . . 0.0 110.713 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 3.9 t -116.29 146.34 42.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 126.089 1.756 . . . . 0.0 109.847 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.411 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.24 141.21 38.74 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 127.201 2.201 . . . . 0.0 110.583 -176.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.313 31.4 p 86.89 10.35 0.17 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 130.268 3.427 . . . . 0.0 114.581 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.83 -25.02 0.27 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-N 119.076 0.853 . . . . 0.0 110.751 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 58.95 166.57 0.05 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.655 1.582 . . . . 0.0 111.703 -164.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.51 51.27 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 119.387 -2.07 . . . . 0.0 109.878 -161.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 48.4 t 57.82 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 125.785 1.634 . . . . 0.0 110.646 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.84 114.14 26.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.12 -36.79 8.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.618 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 92.1 t -100.02 80.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -97.2 128.58 44.21 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.199 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -143.71 116.5 8.76 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.555 1.542 . . . . 0.0 107.369 172.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.54 84.85 0.76 Allowed Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 103.863 -3.695 . . . . 0.0 103.863 163.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.925 0 C-N-CA 124.572 1.082 . . . . 0.0 113.103 176.41 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 73.1 mt -123.49 134.2 53.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.1 161.96 26.39 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 21.1 m -124.51 127.78 73.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.18 146.57 42.86 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -114.52 -46.27 2.97 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.408 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 27.3 tp -82.17 -49.87 9.65 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.426 1.012 . . . . 0.0 112.73 -166.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.441 HG22 HH21 ' A' ' 893' ' ' ARG . 13.5 pt -84.7 -174.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.88 1.672 . . . . 0.0 110.044 -178.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.7 81.72 2.73 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -167.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 91.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.294 1.996 . . . . 0.0 109.64 163.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -121.9 144.69 48.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -92.8 157.12 16.57 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.119 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.37 123.31 21.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 119.852 1.206 . . . . 0.0 109.056 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.58 -12.03 70.73 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.184 1.849 . . . . 0.0 111.223 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.65 175.57 5.53 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.717 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.8 m -142.31 125.83 16.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -160.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.411 HG13 HH11 ' A' ' 914' ' ' ARG . 4.0 m -96.8 148.5 5.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.249 0.62 . . . . 0.0 109.331 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.5 t -143.82 138.65 28.84 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.051 1.74 . . . . 0.0 111.19 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 71.4 t -91.84 130.28 41.22 Favored 'Isoleucine or valine' 0 C--N 1.367 1.364 0 C-N-CA 126.767 2.027 . . . . 0.0 107.069 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -105.52 133.11 50.81 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 101.071 -3.677 . . . . 0.0 101.071 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 1.5 tp -129.22 72.11 1.46 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.041 -1.89 . . . . 0.0 105.975 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 58.2 t -162.83 100.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.898 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 89.6 mmm -153.59 70.01 0.83 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.77 145.21 7.24 Favored Glycine 0 CA--C 1.493 -1.304 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -112.3 -29.28 7.6 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.3 tp -92.17 87.32 6.06 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.55 -165.32 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -171.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -124.19 159.67 29.59 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -91.64 131.22 37.19 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.1 149.27 22.88 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.91 112.15 22.06 Favored Pre-proline 0 C--N 1.356 0.852 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -99.59 172.33 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.117 1.878 . . . . 0.0 108.269 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.1 mp -116.85 141.17 48.57 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.72 142.33 36.85 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 119.337 0.971 . . . . 0.0 108.562 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.95 129.5 74.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.85 105.63 9.09 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.4 p -101.02 160.55 14.28 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.914 1.286 . . . . 0.0 110.212 171.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.47 110.22 0.29 Allowed Glycine 0 C--N 1.359 1.816 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.96 144.05 46.69 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 67.6 tp -74.15 123.13 23.87 Favored 'General case' 0 C--N 1.379 1.87 0 C-N-CA 124.692 1.197 . . . . 0.0 109.402 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 33.6 tp -99.0 -57.76 2.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.4 127.47 35.49 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.85 131.01 10.53 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.183 -3.567 . . . . 0.0 104.183 164.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.94 129.5 90.87 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.663 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -107.0 80.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.783 1.672 . . . . 0.0 109.823 -168.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 77.69 -72.91 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 130.303 3.441 . . . . 0.0 109.238 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.9 mt 49.6 38.76 15.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 129.288 3.035 . . . . 0.0 114.085 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.31 131.78 54.75 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.42 107.31 9.4 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 179.462 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 N-CA-C 109.99 -0.812 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.65 119.53 21.55 Favored Pre-proline 0 C--N 1.352 0.71 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -90.78 -21.97 0.7 Allowed 'Trans proline' 0 CA--C 1.513 -0.572 0 CA-C-N 122.105 1.787 . . . . 0.0 109.758 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 38.77 69.77 0.25 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.969 2.908 . . . . 0.0 115.065 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.6 136.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.9 158.1 45.14 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -149.02 138.37 21.64 Favored 'General case' 0 C--N 1.361 1.076 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.2 t -170.42 118.61 0.55 Allowed 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.88 153.81 33.94 Favored 'General case' 0 C--N 1.371 1.51 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.9 158.55 44.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.157 174.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -136.11 125.08 24.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -166.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.3 m -162.45 13.43 0.07 Allowed 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.959 1.304 . . . . 0.0 107.933 -164.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -27.89 152.8 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.38 0 N-CA-C 118.219 2.674 . . . . 0.0 118.219 158.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -78.04 -42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 CA-C-N 122.01 1.754 . . . . 0.0 113.438 -164.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 16.7 ptt85 -166.65 -159.01 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.0 m -31.35 139.12 0.03 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 129.392 3.077 . . . . 0.0 115.355 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -133.12 164.4 44.23 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.94 -14.1 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.618 2.212 . . . . 0.0 111.202 -175.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.0 -138.99 2.62 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -62.83 145.26 55.42 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.81 2.044 . . . . 0.0 110.944 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 91.8 t -88.33 127.78 55.69 Favored Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 125.325 1.45 . . . . 0.0 110.161 -165.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.09 -149.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.952 3.101 . . . . 0.0 108.276 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.35 133.75 18.56 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -115.08 -14.35 11.8 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.747 0.819 . . . . 0.0 110.59 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.01 87.53 3.3 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.075 0.464 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.79 97.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 164.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 32.6 mt -87.92 -39.41 14.78 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.373 -173.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 46.5 tp -165.72 126.18 1.81 Allowed 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 100.492 -3.892 . . . . 0.0 100.492 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 176.25 60.58 0.0 OUTLIER 'General case' 0 C--N 1.356 0.859 0 CA-C-N 120.405 1.457 . . . . 0.0 108.514 -162.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.9 -43.53 94.78 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -165.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.07 -28.39 13.68 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 118.723 0.692 . . . . 0.0 112.518 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.09 -57.45 0.43 Allowed Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.96 -81.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.827 0 C-N-CA 128.095 2.558 . . . . 0.0 114.325 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -97.01 119.7 35.98 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 124.854 1.261 . . . . 0.0 108.495 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -79.36 117.58 67.84 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 115.481 -2.2 . . . . 0.0 105.322 171.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.92 6.03 3.11 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 CA-C-N 125.51 3.004 . . . . 0.0 109.28 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.88 -45.6 18.33 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.027 0.931 . . . . 0.0 108.888 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 20.7 p -110.05 -11.4 14.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.658 1.183 . . . . 0.0 108.435 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.63 33.22 Favored Glycine 0 C--N 1.363 2.069 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.66 102.79 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.73 113.13 25.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.014 -174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -100.83 108.48 20.29 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.57 110.92 44.61 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 117.062 -1.447 . . . . 0.0 112.825 172.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -95.92 -1.34 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 CA-C-N 123.301 2.215 . . . . 0.0 109.278 169.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 14.5 mt -53.67 -49.83 67.12 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 127.587 2.355 . . . . 0.0 114.358 -167.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.6 48.59 11.57 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.123 1.369 . . . . 0.0 114.676 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.18 -165.62 20.6 Favored Glycine 0 N--CA 1.412 -2.922 1 N-CA-C 101.534 -4.626 . . . . 0.0 101.534 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -93.44 120.38 33.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.298 2.4 p90 -116.92 161.29 19.57 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.132 0.878 . . . . 0.0 109.624 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -105.82 116.04 31.27 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.37 137.32 47.41 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.444 1.898 . . . . 0.0 108.251 -170.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.5 m -144.46 118.74 9.56 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 153.29 22.92 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.21 121.09 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.15 123.34 47.65 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.127 0.971 . . . . 0.0 108.522 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 43.9 m -78.61 131.41 36.71 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.204 1.402 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -56.76 22.03 Favored Glycine 0 C--N 1.367 2.271 0 C-N-CA 124.73 1.157 . . . . 0.0 112.601 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.5 65.17 1.48 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.552 1.941 . . . . 0.0 113.627 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -70.72 -9.14 56.59 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.017 1.727 . . . . 0.0 112.835 -168.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.88 -15.2 61.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.852 1.661 . . . . 0.0 112.763 -168.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.0 pt-20 122.52 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 128.575 2.75 . . . . 0.0 107.754 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 101.05 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 127.763 2.425 . . . . 0.0 107.126 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 81.2 t -99.82 128.05 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -170.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -108.57 121.18 44.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.202 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.24 115.1 13.76 Favored 'General case' 0 C--N 1.385 2.117 0 C-N-CA 128.21 2.604 . . . . 0.0 109.568 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.48 114.83 27.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 119.695 1.134 . . . . 0.0 108.273 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.24 142.77 57.52 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.84 2.056 . . . . 0.0 110.607 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 3.5 t -116.94 146.71 42.82 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.282 1.833 . . . . 0.0 109.656 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.428 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.13 140.8 37.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.936 2.094 . . . . 0.0 110.22 -177.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.31 28.5 p 87.0 8.37 0.21 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.275 3.43 . . . . 0.0 114.731 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.36 -24.93 0.29 Allowed 'General case' 0 C--N 1.356 0.865 0 CA-C-N 119.426 1.012 . . . . 0.0 111.346 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 58.87 165.12 0.04 OUTLIER 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.721 1.609 . . . . 0.0 111.767 -164.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.52 -132.71 47.61 Favored Glycine 0 C--N 1.366 2.196 0 O-C-N 119.438 -2.039 . . . . 0.0 109.599 -162.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.0 77.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.234 0 C-N-CA 126.09 1.756 . . . . 0.0 110.878 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.47 114.62 27.19 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -174.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.69 -36.84 7.74 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.8 -1.545 . . . . 0.0 108.571 -171.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.76 79.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.71 128.42 44.37 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.808 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 28.3 t -142.65 117.67 10.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.607 1.563 . . . . 0.0 107.205 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.59 84.96 0.76 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 104.312 -3.515 . . . . 0.0 104.312 165.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.898 0 C-N-CA 124.734 1.159 . . . . 0.0 113.127 176.405 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.6 m . . . . . 0 CA--C 1.508 -0.666 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.6 mt -115.75 134.2 55.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.13 26.94 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.9 129.86 74.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.86 148.91 45.83 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.1 m -120.88 -38.99 2.76 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.5 0.591 . . . . 0.0 111.995 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.1 tp -82.48 -49.09 10.3 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.351 0.978 . . . . 0.0 112.612 -168.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 42.4 pt -85.15 -175.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.699 1.599 . . . . 0.0 109.829 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 80.91 2.59 Favored Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -169.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.14 92.13 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.479 2.119 . . . . 0.0 110.026 164.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -121.44 144.46 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.95 158.36 15.85 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.828 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.84 122.78 21.33 Favored 'General case' 0 C--N 1.381 1.947 0 CA-C-N 120.147 1.339 . . . . 0.0 108.791 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.26 -11.57 71.78 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 125.868 1.699 . . . . 0.0 111.009 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.43 175.34 5.56 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.608 0.763 . . . . 0.0 110.964 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.1 m -142.56 125.71 16.39 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -159.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.428 HG13 HH11 ' B' ' 914' ' ' ARG . 4.5 m -97.5 148.62 5.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.509 0.724 . . . . 0.0 109.734 173.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -143.33 138.82 29.76 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 126.325 1.85 . . . . 0.0 111.229 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 83.3 t -91.16 130.59 40.1 Favored 'Isoleucine or valine' 0 C--N 1.368 1.413 0 C-N-CA 127.398 2.279 . . . . 0.0 107.312 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.6 133.23 50.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 100.56 -3.867 . . . . 0.0 100.56 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 1.8 tp -129.02 71.53 1.43 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.4 t -161.25 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.0 mmm -152.46 69.83 0.89 Allowed 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.58 144.51 7.09 Favored Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -111.13 -28.69 8.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.78 87.32 5.81 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.34 -164.32 1.57 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -124.55 159.42 30.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 19.0 t -90.79 130.6 36.75 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.13 149.22 22.77 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.81 112.1 22.31 Favored Pre-proline 0 C--N 1.355 0.835 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -99.32 172.36 0.45 Allowed 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 122.099 1.866 . . . . 0.0 108.139 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.1 139.3 50.44 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -138.39 140.78 39.53 Favored 'General case' 0 C--N 1.373 1.63 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.94 129.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -126.55 105.74 8.95 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 55.5 p -102.4 162.42 12.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.467 1.107 . . . . 0.0 110.989 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.53 111.35 0.32 Allowed Glycine 0 C--N 1.358 1.789 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.14 47.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -72.57 122.83 22.01 Favored 'General case' 0 C--N 1.382 2.004 0 C-N-CA 124.583 1.153 . . . . 0.0 109.387 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.9 tp -98.74 -57.84 2.09 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -131.83 127.27 36.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.65 130.67 10.37 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 165.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.87 129.0 91.45 Favored Pre-proline 0 C--N 1.351 0.674 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.532 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -106.77 78.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.016 1.756 . . . . 0.0 109.325 -167.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 77.93 -72.66 0.09 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 130.131 3.372 . . . . 0.0 109.061 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 73.6 mt 49.08 40.63 17.76 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 129.064 2.946 . . . . 0.0 113.719 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.57 131.88 55.39 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.51 106.98 8.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 179.15 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.456 -0.718 0 N-CA-C 110.038 -0.793 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.55 113.75 27.29 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.91 -22.88 1.36 Allowed 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 121.648 1.624 . . . . 0.0 110.151 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 36.8 70.19 0.18 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 128.873 2.869 . . . . 0.0 115.659 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.18 137.03 57.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.66 156.75 48.21 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -149.0 137.39 20.99 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-N 118.871 0.759 . . . . 0.0 109.23 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.9 t -171.08 118.86 0.49 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.53 153.06 37.23 Favored 'General case' 0 C--N 1.368 1.378 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.15 159.55 41.94 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.972 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -141.66 130.73 23.28 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -165.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.5 m -160.49 14.16 0.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.2 pp -27.5 145.9 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.532 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 161.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.64 -46.5 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 122.052 1.768 . . . . 0.0 113.634 -162.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -162.75 172.22 15.59 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.8 m -3.57 111.92 0.01 OUTLIER 'General case' 0 C--N 1.363 1.178 0 C-N-CA 130.907 3.683 . . . . 0.0 116.942 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -99.49 163.18 19.05 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 123.646 0.778 . . . . 0.0 110.56 -172.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.61 -17.2 11.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.869 2.38 . . . . 0.0 110.841 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.66 -141.45 3.25 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.3 m -66.52 146.66 54.28 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.268 1.827 . . . . 0.0 110.715 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 96.0 t -94.73 131.27 30.98 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 124.822 1.249 . . . . 0.0 111.164 -159.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -97.6 -151.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 124.087 3.192 . . . . 0.0 109.278 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -147.04 134.37 20.68 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -113.98 -16.0 12.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.353 0.661 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -102.22 84.66 2.52 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.326 0.584 . . . . 0.0 111.7 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.86 97.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.385 1.874 . . . . 0.0 106.697 163.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 8.6 mt -90.1 -38.78 13.31 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.324 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.6 tp -165.54 126.49 1.9 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 174.76 60.81 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 120.188 1.358 . . . . 0.0 107.704 -162.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.87 -42.7 94.29 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -164.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.37 -28.82 15.88 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 118.665 0.666 . . . . 0.0 112.306 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.59 -57.58 0.48 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 62.92 -81.22 0.02 OUTLIER 'General case' 0 C--N 1.354 0.782 0 C-N-CA 128.289 2.636 . . . . 0.0 114.641 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -96.02 121.02 37.32 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.534 1.534 . . . . 0.0 108.463 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.41 116.63 65.94 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -94.28 7.61 2.34 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 CA-C-N 125.167 2.881 . . . . 0.0 109.648 -166.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -79.23 -47.37 16.06 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.2 p -108.05 -9.55 15.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.932 1.293 . . . . 0.0 108.285 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.3 25.23 44.51 Favored Glycine 0 C--N 1.361 1.959 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 161.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.62 102.82 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 -163.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -94.83 111.77 23.53 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.494 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -101.8 108.21 19.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . 0.467 ' HB2' HH22 ' C' ' 914' ' ' ARG . . . -91.71 110.35 42.84 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.321 169.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -92.21 0.59 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.53 2.154 . . . . 0.0 108.21 165.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 51.6 mt -54.21 -53.23 56.41 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 127.837 2.455 . . . . 0.0 113.672 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.59 66.42 1.08 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 122.16 0.981 . . . . 0.0 110.84 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.44 170.29 43.06 Favored Glycine 0 N--CA 1.404 -3.485 1 N-CA-C 100.568 -5.013 . . . . 0.0 100.568 -167.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -93.85 115.86 28.29 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.375 -1.413 . . . . 0.0 107.968 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -116.5 160.59 20.38 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 119.088 0.858 . . . . 0.0 110.946 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 56.1 tp -107.49 113.35 26.63 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 124.685 1.194 . . . . 0.0 108.05 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . 0.405 HD13 HH12 ' C' ' 921' ' ' ARG . 7.1 tt -118.53 140.81 49.29 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.756 1.223 . . . . 0.0 109.574 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -144.14 120.28 10.79 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.923 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.0 154.22 19.93 Favored 'General case' 0 C--N 1.364 1.208 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 80.1 t -99.57 122.96 51.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.76 122.93 39.06 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.375 1.07 . . . . 0.0 109.39 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 33.8 m -80.4 131.2 35.57 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.72 20.06 Favored Glycine 0 C--N 1.362 2.018 0 C-N-CA 125.872 1.701 . . . . 0.0 114.975 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 32.44 72.65 0.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 128.18 2.592 . . . . 0.0 115.528 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -71.69 -12.72 61.47 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 126.224 1.81 . . . . 0.0 111.552 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -73.07 -17.63 61.4 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.778 1.631 . . . . 0.0 112.502 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.2 pt-20 123.44 -172.21 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 128.498 2.719 . . . . 0.0 107.917 173.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 102.19 133.26 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 128.045 2.538 . . . . 0.0 106.706 171.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 82.3 t -98.32 123.8 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -104.27 129.8 52.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.528 1.931 . . . . 0.0 109.764 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.79 114.14 3.15 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.769 1.228 . . . . 0.0 110.427 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.7 117.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 126.136 1.774 . . . . 0.0 108.809 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.1 mt -63.3 135.9 57.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.294 1.037 . . . . 0.0 109.857 172.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 8.6 t -117.49 143.94 45.55 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 126.636 1.974 . . . . 0.0 107.145 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.467 HH22 ' HB2' ' C' ' 888' ' ' ALA . 0.1 OUTLIER -79.88 140.86 36.59 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.159 2.184 . . . . 0.0 110.593 -170.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.315 25.0 p 89.49 6.52 0.13 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 130.205 3.402 . . . . 0.0 113.93 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -149.45 -25.04 0.28 Allowed 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.234 0.924 . . . . 0.0 111.622 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.39 166.92 0.06 Allowed 'General case' 0 C--N 1.364 1.237 0 C-N-CA 125.474 1.51 . . . . 0.0 111.848 -164.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.41 -131.21 51.93 Favored Glycine 0 C--N 1.375 2.737 0 O-C-N 119.441 -2.037 . . . . 0.0 110.047 -163.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . 0.252 47.6 t 54.87 73.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.244 0 C-N-CA 125.404 1.482 . . . . 0.0 111.741 173.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.09 115.9 28.47 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -172.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.405 HH12 HD13 ' C' ' 896' ' ' LEU . 11.7 ptt180 -98.83 -33.59 10.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.744 -173.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.14 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -95.35 131.32 41.59 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.922 0.391 . . . . 0.0 111.14 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -144.26 116.02 8.23 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 125.284 1.434 . . . . 0.0 108.198 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.35 85.23 0.72 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 104.566 -3.413 . . . . 0.0 104.566 169.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.671 0 C-N-CA 125.117 1.341 . . . . 0.0 111.18 172.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.4 mt -120.91 134.32 55.29 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.05 162.77 26.37 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.58 130.17 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.28 148.85 52.73 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.299 -0.875 . . . . 0.0 109.737 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.4 m -107.48 -79.85 0.57 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.566 0.746 . . . . 0.0 109.132 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.9 tp -64.1 -49.19 73.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.322 1.849 . . . . 0.0 115.008 -163.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.39 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 126.148 1.779 . . . . 0.0 110.242 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.19 88.35 0.99 Allowed Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -168.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.51 89.86 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.724 2.283 . . . . 0.0 110.121 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 86.0 mt -124.31 147.08 48.41 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.734 1.213 . . . . 0.0 108.014 -176.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.93 158.99 15.24 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.065 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.05 122.86 20.21 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 120.29 1.405 . . . . 0.0 109.516 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.56 77.15 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 126.259 1.885 . . . . 0.0 111.822 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.47 173.85 7.38 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.888 0.875 . . . . 0.0 110.057 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 12.9 t -144.15 129.13 18.51 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.271 -0.893 . . . . 0.0 111.08 -160.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 27.1 m -95.38 149.18 4.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.251 175.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.46 137.13 33.67 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 126.181 1.793 . . . . 0.0 111.851 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.15 129.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.376 1.739 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -105.04 133.76 49.28 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 9.2 mp -126.89 81.06 1.99 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 112.794 -2.003 . . . . 0.0 107.433 168.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.0 t -158.96 98.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.2 mmm -151.87 73.38 1.06 Allowed 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.43 145.48 10.54 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 108.139 -1.985 . . . . 0.0 108.139 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -112.52 -30.95 6.95 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -91.9 87.05 6.07 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -160.84 1.1 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -172.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -122.54 156.1 34.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.5 t -92.54 133.64 35.74 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -157.34 150.07 23.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 112.11 20.35 Favored Pre-proline 0 C--N 1.357 0.913 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -101.5 175.52 0.24 Allowed 'Trans proline' 0 CA--C 1.509 -0.766 0 C-N-CA 121.877 1.718 . . . . 0.0 108.303 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -115.84 140.58 49.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 24.0 p -137.0 140.17 41.94 Favored 'General case' 0 C--N 1.376 1.749 0 CA-C-N 119.503 1.047 . . . . 0.0 108.466 -172.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.2 mm -115.94 131.26 68.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -125.56 104.78 8.59 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 982' ' ' SER . . . . . 0.408 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 33.1 p -101.62 164.07 11.94 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 125.473 1.509 . . . . 0.0 110.427 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.83 112.81 0.35 Allowed Glycine 0 C--N 1.359 1.824 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.76 45.71 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -77.01 124.47 27.82 Favored 'General case' 0 C--N 1.378 1.847 0 C-N-CA 125.046 1.338 . . . . 0.0 109.096 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.97 -57.51 2.21 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -132.19 127.41 35.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.71 129.83 10.06 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 104.051 -3.62 . . . . 0.0 104.051 166.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.1 129.33 90.82 Favored Pre-proline 0 C--N 1.351 0.637 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.937 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -106.74 76.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 121.948 1.731 . . . . 0.0 109.593 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.53 -72.81 0.08 Allowed 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 130.192 3.397 . . . . 0.0 108.989 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 49.56 38.7 15.34 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 129.151 2.981 . . . . 0.0 113.768 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -109.86 131.7 54.82 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -129.92 106.65 8.8 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.071 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.352 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 N-CA-C 109.678 -0.932 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.33 120.44 21.06 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.86 -20.31 0.86 Allowed 'Trans proline' 0 CA--C 1.51 -0.718 0 CA-C-N 122.204 1.823 . . . . 0.0 109.699 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 36.41 69.9 0.18 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 128.987 2.915 . . . . 0.0 115.898 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.19 137.05 54.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.94 160.25 38.88 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -149.2 138.92 21.84 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.0 t -169.37 117.27 0.62 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.9 152.88 36.69 Favored 'General case' 0 C--N 1.37 1.497 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.12 158.73 43.79 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.643 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -132.82 133.53 43.48 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 40.5 p -163.21 9.51 0.05 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -164.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 2.7 pp -31.42 149.21 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.483 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 160.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.39 -43.22 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 CA-C-N 122.34 1.871 . . . . 0.0 113.527 -161.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -162.52 174.13 13.08 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.679 1.127 . . . . 0.0 108.097 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.1 m -2.34 117.01 0.01 OUTLIER 'General case' 0 C--N 1.364 1.214 0 C-N-CA 131.383 3.873 . . . . 0.0 117.103 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.06 141.57 23.68 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -164.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -73.9 -11.48 23.66 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.845 2.364 . . . . 0.0 113.44 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.83 -130.37 1.17 Allowed Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 30.6 m -82.35 143.8 31.0 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.56 131.68 33.53 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 124.594 1.157 . . . . 0.0 110.631 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -93.11 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.863 3.042 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.35 135.23 20.02 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 119.248 0.931 . . . . 0.0 108.532 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -117.83 -13.52 10.12 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 122.895 0.478 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.34 87.3 3.38 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 118.574 0.624 . . . . 0.0 112.183 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.86 97.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.144 1.777 . . . . 0.0 106.894 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 49.4 mt -88.22 -37.09 16.37 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.577 -0.702 . . . . 0.0 110.709 -173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.6 tp -165.58 125.53 1.78 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 101.138 -3.653 . . . . 0.0 101.138 161.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -174.13 61.14 0.02 OUTLIER 'General case' 0 C--N 1.356 0.886 0 CA-C-N 120.38 1.446 . . . . 0.0 109.321 -168.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.36 -44.2 92.72 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -163.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.68 -28.38 12.6 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 118.863 0.756 . . . . 0.0 112.307 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.83 -60.55 0.32 Allowed Glycine 0 C--N 1.354 1.531 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 62.47 -80.9 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.978 2.511 . . . . 0.0 114.19 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.33 119.75 32.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 124.883 1.273 . . . . 0.0 108.919 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.72 117.43 68.51 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -96.69 1.87 1.86 Allowed 'Trans proline' 0 CA--C 1.506 -0.884 0 CA-C-N 124.986 2.817 . . . . 0.0 109.3 -165.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -79.9 -45.45 18.58 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.6 p -102.84 -13.99 16.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.103 0.961 . . . . 0.0 108.72 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 24.01 47.47 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.94 102.61 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -164.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 112.75 24.94 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 112.181 -2.281 . . . . 0.0 108.656 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 82.5 m -98.97 108.94 21.75 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.62 110.76 41.62 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.745 173.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.56 -4.88 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.08 2.136 . . . . 0.0 108.98 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 33.1 mt -49.06 -55.2 12.84 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 128.664 2.786 . . . . 0.0 114.612 -168.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.9 65.25 1.35 Allowed 'General case' 0 C--N 1.364 1.223 0 CA-C-O 121.926 0.869 . . . . 0.0 112.085 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.09 -175.53 42.63 Favored Glycine 0 N--CA 1.408 -3.21 1 N-CA-C 101.034 -4.826 . . . . 0.0 101.034 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.22 121.9 35.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.45 160.43 19.19 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 118.918 0.781 . . . . 0.0 108.965 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 59.7 tp -103.84 117.11 33.56 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.429 0.691 . . . . 0.0 109.698 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.87 136.3 50.11 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 126.762 2.025 . . . . 0.0 108.88 -165.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.2 m -147.17 119.17 8.18 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.597 0.759 . . . . 0.0 109.501 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 154.22 21.56 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 79.0 t -109.3 119.18 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.78 124.33 46.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.992 -173.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 33.7 m -80.48 133.27 35.81 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.34 1.456 . . . . 0.0 107.547 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.9 -57.11 21.58 Favored Glycine 0 C--N 1.364 2.137 0 C-N-CA 125.003 1.287 . . . . 0.0 114.214 -169.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 61.9 m170 35.37 72.73 0.09 Allowed 'General case' 0 C--N 1.361 1.087 0 C-N-CA 127.387 2.275 . . . . 0.0 115.266 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -73.74 -8.38 55.77 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.17 1.388 . . . . 0.0 111.72 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -71.92 -19.93 61.85 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.043 1.337 . . . . 0.0 112.49 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.319 9.3 pt-20 125.03 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.137 0 C-N-CA 128.232 2.613 . . . . 0.0 108.333 174.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 101.01 131.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.846 2.459 . . . . 0.0 106.753 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.31 124.91 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 123.512 1.625 . . . . 0.0 106.839 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -105.68 122.44 46.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.207 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.05 116.46 17.1 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 128.307 2.643 . . . . 0.0 108.769 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.62 113.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.09 142.17 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.538 1.535 . . . . 0.0 111.194 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -115.0 145.09 42.62 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 127.007 2.123 . . . . 0.0 109.086 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.52 139.22 37.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 127.791 2.436 . . . . 0.0 109.429 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.4 t 100.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.35 0.595 0 C-N-CA 129.463 3.105 . . . . 0.0 113.229 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -144.53 -24.41 0.52 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 119.486 1.039 . . . . 0.0 110.958 -175.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 60.18 167.43 0.08 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 124.886 1.274 . . . . 0.0 111.833 -164.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.6 -133.62 52.66 Favored Glycine 0 C--N 1.375 2.729 0 O-C-N 119.279 -2.138 . . . . 0.0 109.891 -161.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 46.7 t 56.6 75.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.295 0 C-N-CA 125.523 1.529 . . . . 0.0 110.99 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.57 115.22 27.71 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -103.05 -35.11 8.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.309 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 88.6 t -99.57 75.77 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.95 130.3 41.65 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.129 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.6 t -143.08 114.49 7.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.379 1.472 . . . . 0.0 108.411 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.54 84.82 0.69 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.882 -3.687 . . . . 0.0 103.882 163.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.859 0 C-N-CA 124.965 1.269 . . . . 0.0 112.708 174.42 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.443 -0.796 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 59.8 mt -117.71 133.54 55.84 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.33 161.33 26.05 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.5 m -125.25 126.3 70.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.77 149.44 43.55 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -115.02 -41.97 3.27 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.413 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 29.2 tp -82.59 -50.17 9.07 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 119.373 0.988 . . . . 0.0 113.133 -166.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.457 HG12 ' HG ' ' C' ' 853' ' ' SER . 8.2 pt -85.09 -171.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 125.371 1.469 . . . . 0.0 110.74 -175.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.25 81.52 2.57 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -168.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.18 90.84 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 CA-C-N 122.06 1.772 . . . . 0.0 109.536 160.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 8.3 mp -122.01 145.06 48.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -90.98 158.03 16.95 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.464 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.25 123.62 22.65 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-N 119.689 1.131 . . . . 0.0 108.715 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.01 69.9 Favored Glycine 0 CA--C 1.495 -1.2 0 C-N-CA 125.85 1.69 . . . . 0.0 110.999 170.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.11 175.64 5.08 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.025 0.44 . . . . 0.0 112.102 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 94.9 m -140.67 128.32 21.57 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -155.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.83 149.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -144.24 136.75 26.76 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.247 1.019 . . . . 0.0 111.65 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.21 129.75 44.06 Favored 'Isoleucine or valine' 0 C--N 1.369 1.453 0 C-N-CA 126.868 2.067 . . . . 0.0 107.245 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -107.92 132.29 53.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 168.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 21.0 tp -130.29 75.88 1.68 Allowed 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.212 -1.813 . . . . 0.0 107.045 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.8 t -160.81 101.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.06 71.79 0.92 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.71 150.57 8.3 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -119.06 -29.01 5.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.1 tp -92.25 87.07 5.94 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.5 -163.85 1.5 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -125.08 160.71 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.1 t -94.33 132.06 39.33 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -158.09 150.52 22.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.59 113.33 25.24 Favored Pre-proline 0 C--N 1.356 0.86 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -98.77 173.65 0.47 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.842 1.694 . . . . 0.0 108.365 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.43 141.49 48.27 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.6 p -139.59 142.06 37.13 Favored 'General case' 0 C--N 1.376 1.736 0 CA-C-N 119.592 1.087 . . . . 0.0 108.909 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.7 mm -119.61 129.81 74.88 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -126.15 105.77 9.09 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 44.6 p -101.25 161.92 13.26 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.816 1.246 . . . . 0.0 110.39 171.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.88 111.1 0.29 Allowed Glycine 0 C--N 1.358 1.764 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.1 144.93 46.34 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.01 123.4 25.69 Favored 'General case' 0 C--N 1.378 1.825 0 C-N-CA 124.763 1.225 . . . . 0.0 109.507 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 30.4 tp -98.23 -57.06 2.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -130.92 128.01 39.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.35 129.96 10.09 Favored Glycine 0 CA--C 1.487 -1.706 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 164.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 129.0 91.84 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -107.64 81.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 CA-C-N 121.835 1.691 . . . . 0.0 110.071 -169.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 77.76 -72.48 0.09 Allowed 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.12 3.368 . . . . 0.0 109.313 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 67.9 mt 49.41 38.81 14.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 128.841 2.856 . . . . 0.0 114.411 -176.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.86 131.09 55.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -128.09 109.41 11.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.099 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 179.321 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.961 0 N-CA-C 109.615 -0.956 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.62 121.17 22.11 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -92.45 -20.53 0.55 Allowed 'Trans proline' 0 CA--C 1.512 -0.581 0 CA-C-N 122.238 1.835 . . . . 0.0 110.037 -173.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 37.8 70.22 0.2 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 129.155 2.982 . . . . 0.0 115.532 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.94 136.82 54.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.6 40.69 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 165.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -149.22 139.19 22.03 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -169.17 117.87 0.66 Allowed 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.15 153.55 34.69 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.13 158.14 44.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.196 175.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -132.07 132.11 43.03 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -169.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 30.1 p -162.65 8.26 0.06 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -164.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 2.6 pp -31.44 149.94 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.441 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 161.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -81.75 -43.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.223 1.83 . . . . 0.0 113.494 -161.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -162.41 173.86 13.52 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 119.727 1.149 . . . . 0.0 108.201 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.9 m -1.77 116.81 0.01 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 131.398 3.879 . . . . 0.0 117.126 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -108.91 141.52 23.53 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -164.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -73.87 -11.57 23.75 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 122.801 2.334 . . . . 0.0 113.498 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.5 -130.71 1.19 Allowed Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 30.9 m -81.37 143.38 32.21 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.84 131.24 36.05 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 110.484 -160.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -94.15 -152.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.755 2.97 . . . . 0.0 109.248 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -148.38 135.21 19.97 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 119.156 0.889 . . . . 0.0 108.611 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -115.18 -13.22 11.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.387 1.075 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -100.77 87.62 3.37 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 118.208 0.458 . . . . 0.0 112.204 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.32 97.11 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 163.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.14 -38.69 15.15 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.31 -173.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.7 tp -165.88 126.63 1.81 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 100.869 -3.752 . . . . 0.0 100.869 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 176.86 60.93 0.0 OUTLIER 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.196 1.362 . . . . 0.0 108.515 -163.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.46 -43.77 93.11 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -166.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.27 -29.68 10.99 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.889 0.768 . . . . 0.0 112.335 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.86 -59.54 0.35 Allowed Glycine 0 C--N 1.352 1.457 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 62.83 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.905 2.482 . . . . 0.0 114.408 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -96.07 119.59 34.84 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.924 1.29 . . . . 0.0 108.67 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.46 117.42 68.39 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 2.47 2.46 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 CA-C-N 125.077 2.849 . . . . 0.0 109.518 -166.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.04 -43.88 21.1 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 30.4 p -105.54 -14.29 15.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.443 1.097 . . . . 0.0 108.171 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 25.56 41.35 Favored Glycine 0 C--N 1.36 1.888 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 163.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.48 102.84 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 101.867 -3.382 . . . . 0.0 101.867 -163.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.89 113.24 25.29 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.837 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 70.6 m -99.61 109.31 21.82 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.12 111.03 42.55 Favored Pre-proline 0 C--N 1.356 0.882 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.91 173.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.36 -4.24 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-N 123.133 2.155 . . . . 0.0 109.192 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 21.6 mt -53.52 -49.46 67.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.184 2.193 . . . . 0.0 114.334 -167.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.56 50.61 12.55 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.627 1.571 . . . . 0.0 114.183 171.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -164.26 -165.87 22.21 Favored Glycine 0 N--CA 1.411 -3.008 1 N-CA-C 101.517 -4.633 . . . . 0.0 101.517 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -92.74 121.68 34.37 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.985 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 2.6 p90 -116.47 160.68 20.25 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 119.023 0.829 . . . . 0.0 109.269 176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.6 tp -104.72 116.0 31.28 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.26 135.7 50.61 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 126.332 1.853 . . . . 0.0 107.801 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.3 m -144.92 118.97 9.39 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.57 153.91 22.18 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 97.5 t -109.98 120.76 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.17 122.6 46.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.986 0.914 . . . . 0.0 108.812 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 32.5 m -79.29 133.35 36.64 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.258 1.423 . . . . 0.0 108.0 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.16 -57.2 21.09 Favored Glycine 0 C--N 1.365 2.167 0 C-N-CA 125.216 1.388 . . . . 0.0 114.267 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 61.3 m170 34.99 72.96 0.09 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.451 2.3 . . . . 0.0 115.186 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.66 -8.15 54.85 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.291 1.436 . . . . 0.0 111.674 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -73.18 -14.53 61.37 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.425 1.49 . . . . 0.0 112.631 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.7 pt-20 118.59 179.45 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 128.587 2.755 . . . . 0.0 108.77 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 102.08 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.057 2.543 . . . . 0.0 106.467 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.22 128.4 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -110.63 122.87 48.84 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.881 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.35 115.41 15.56 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.053 2.541 . . . . 0.0 109.932 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.47 114.18 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 O-C-N 120.216 -1.553 . . . . 0.0 106.863 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.28 144.9 56.54 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.454 1.902 . . . . 0.0 111.358 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -115.61 145.95 42.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 127.196 2.198 . . . . 0.0 109.038 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.13 138.96 35.88 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 126.828 2.051 . . . . 0.0 109.231 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.6 t 100.85 -10.82 0.03 OUTLIER 'General case' 0 C--N 1.35 0.591 0 C-N-CA 129.589 3.155 . . . . 0.0 113.383 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.44 -24.38 0.72 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 119.493 1.042 . . . . 0.0 111.293 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 60.19 168.41 0.08 Allowed 'General case' 0 C--N 1.362 1.115 0 C-N-CA 124.898 1.279 . . . . 0.0 111.541 -163.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -132.37 51.64 Favored Glycine 0 C--N 1.368 2.34 0 O-C-N 119.763 -1.836 . . . . 0.0 109.702 -164.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 48.7 t 54.74 76.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.169 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.03 115.17 27.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -103.87 -35.22 8.24 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.368 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.1 t -99.89 75.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.89 129.66 44.3 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.516 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -141.34 115.42 9.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 125.319 1.448 . . . . 0.0 107.306 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.91 84.76 0.73 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.098 -3.601 . . . . 0.0 104.098 164.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.812 0 C-N-CA 124.916 1.246 . . . . 0.0 112.808 175.484 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 56.3 mt -115.65 133.98 55.5 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -168.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.2 162.77 26.8 Favored Glycine 0 CA--C 1.494 -1.219 0 C-N-CA 124.731 1.158 . . . . 0.0 110.215 -173.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 28.5 m -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -139.55 150.05 44.62 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.7 m -123.0 -30.77 3.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.723 0.692 . . . . 0.0 112.448 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.6 tp -85.88 -51.15 6.58 Favored 'General case' 0 C--N 1.358 0.94 0 CA-C-N 119.648 1.113 . . . . 0.0 112.115 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 38.6 pt -84.8 -175.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.39 1.476 . . . . 0.0 110.133 -176.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.06 80.9 3.04 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -170.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.24 92.32 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.271 1.98 . . . . 0.0 109.932 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 9.6 mp -121.59 144.73 48.57 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -89.91 159.23 17.04 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.334 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.45 123.48 23.19 Favored 'General case' 0 C--N 1.377 1.773 0 CA-C-N 119.769 1.168 . . . . 0.0 108.379 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.64 70.8 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 125.635 1.588 . . . . 0.0 110.92 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.36 175.31 5.53 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 121.631 0.729 . . . . 0.0 111.324 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 96.1 m -141.35 128.59 21.0 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.513 0.725 . . . . 0.0 109.095 -153.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.9 149.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-O 121.466 0.65 . . . . 0.0 109.476 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -143.99 136.67 27.08 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.724 1.209 . . . . 0.0 111.135 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.0 t -93.51 130.51 42.41 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 127.593 2.357 . . . . 0.0 107.401 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -107.25 132.12 53.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 19.7 tp -129.65 75.33 1.64 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.471 -1.695 . . . . 0.0 106.805 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.8 t -159.22 103.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.8 mmm -152.37 70.03 0.9 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 124.24 148.02 7.33 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -116.04 -27.96 6.77 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.52 86.68 5.29 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.36 -164.2 1.56 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -124.56 159.23 31.12 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.9 t -92.31 132.05 37.02 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -158.47 150.7 21.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.54 113.2 25.37 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -98.31 173.04 0.56 Allowed 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 121.853 1.702 . . . . 0.0 108.283 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.62 140.16 49.71 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.54 141.67 39.29 Favored 'General case' 0 C--N 1.374 1.647 0 CA-C-N 119.616 1.098 . . . . 0.0 108.663 -171.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 130.45 72.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -127.37 105.54 8.6 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 982' ' ' SER . . . . . 0.415 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 52.2 p -102.65 162.77 12.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.687 171.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.66 112.56 0.34 Allowed Glycine 0 C--N 1.359 1.825 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -121.61 145.98 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.8 tp -72.58 123.79 23.92 Favored 'General case' 0 C--N 1.381 1.971 0 C-N-CA 124.422 1.089 . . . . 0.0 109.763 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.82 -56.95 2.35 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -131.14 127.31 37.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.32 129.54 9.94 Favored Glycine 0 CA--C 1.487 -1.66 0 N-CA-C 103.379 -3.888 . . . . 0.0 103.379 163.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.41 128.84 90.9 Favored Pre-proline 0 C--N 1.349 0.555 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.122 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -107.0 81.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.782 1.672 . . . . 0.0 109.462 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 78.04 -71.73 0.1 Allowed 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 129.818 3.247 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 56.7 mt 49.16 40.49 17.81 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 128.668 2.787 . . . . 0.0 114.02 -175.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -114.13 131.48 56.41 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.16 109.19 10.95 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.074 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 179.062 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.05 112.85 31.59 Favored Pre-proline 0 N--CA 1.443 -0.801 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -88.35 -21.6 1.48 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.617 1.613 . . . . 0.0 110.161 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 35.93 70.86 0.14 Allowed 'General case' 0 C--N 1.357 0.901 0 C-N-CA 129.161 2.984 . . . . 0.0 115.679 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.29 134.81 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.51 161.93 33.67 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -148.75 146.76 28.21 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 166.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 853' ' ' SER . . . . . 0.457 ' HG ' HG12 ' A' ' 953' ' ' ILE . 16.3 t -166.83 119.25 0.97 Allowed 'General case' 0 C--N 1.35 0.588 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.53 172.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.07 154.87 40.69 Favored 'General case' 0 C--N 1.371 1.531 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -143.11 155.58 44.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 122.201 1.0 . . . . 0.0 109.537 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -131.62 127.6 37.38 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.436 -166.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.2 m -158.8 12.78 0.16 Allowed 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -164.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 2.3 pp -27.71 146.18 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 160.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.78 -44.82 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 122.245 1.837 . . . . 0.0 113.332 -161.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.0 ptt85 -164.28 173.75 11.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -173.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.7 m -4.38 112.56 0.01 OUTLIER 'General case' 0 C--N 1.365 1.242 0 C-N-CA 130.826 3.651 . . . . 0.0 116.436 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.93 162.54 25.14 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -167.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.34 -14.99 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.378 2.052 . . . . 0.0 111.163 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.33 -144.2 4.05 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 28.1 m -64.96 136.14 56.46 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.986 1.715 . . . . 0.0 110.492 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 16.6 m -64.89 143.66 98.87 Favored Pre-proline 0 C--N 1.354 0.78 0 C-N-CA 125.444 1.497 . . . . 0.0 113.2 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -98.7 -151.75 0.03 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.572 0 C-N-CA 123.296 2.664 . . . . 0.0 107.478 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -146.05 130.11 17.4 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -115.93 -15.67 11.19 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.159 0.584 . . . . 0.0 111.08 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -103.23 79.71 1.76 Allowed 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.937 0.495 . . . . 0.0 111.669 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.08 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 127.063 2.145 . . . . 0.0 106.973 165.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 3.3 mt -90.75 -37.16 13.86 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.327 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 60.5 tp -164.64 128.2 2.45 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 172.34 61.96 0.0 OUTLIER 'General case' 0 C--N 1.356 0.854 0 CA-C-N 120.653 1.57 . . . . 0.0 106.973 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.32 98.02 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 116.085 1.884 . . . . 0.0 116.085 -165.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.77 -32.91 8.73 Favored Glycine 0 C--N 1.357 1.728 0 CA-C-N 119.028 0.831 . . . . 0.0 112.076 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.51 -65.01 0.26 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 64.24 -79.13 0.03 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.931 2.492 . . . . 0.0 114.517 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.59 121.87 36.59 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.804 1.642 . . . . 0.0 109.283 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -80.57 118.4 72.25 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 115.611 -2.137 . . . . 0.0 105.884 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -92.42 0.88 4.0 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 CA-C-N 125.514 3.005 . . . . 0.0 109.517 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.6 -45.66 18.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.244 1.018 . . . . 0.0 108.9 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.3 p -106.41 -13.4 15.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.702 1.601 . . . . 0.0 108.17 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 86.24 25.23 37.48 Favored Glycine 0 C--N 1.361 1.949 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.728 162.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.54 101.29 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 -165.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.409 ' HB3' HG23 ' C' ' 962' ' ' VAL . 0.4 OUTLIER -97.29 112.82 24.47 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 112.45 -2.159 . . . . 0.0 108.387 179.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 67.6 m -101.11 107.83 19.36 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . 0.477 ' HB2' HH22 ' C' ' 914' ' ' ARG . . . -90.95 111.79 50.16 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.247 -1.358 . . . . 0.0 111.602 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.05 2.69 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.094 2.141 . . . . 0.0 109.067 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.01 -54.21 45.95 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.545 -167.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.8 68.5 0.83 Allowed 'General case' 0 C--N 1.366 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 111.825 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.77 36.78 Favored Glycine 0 N--CA 1.406 -3.318 1 N-CA-C 102.089 -4.404 . . . . 0.0 102.089 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . 0.424 ' HE ' HG22 ' C' ' 953' ' ' ILE . 71.3 ttt-85 -92.72 119.19 31.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.797 -1.202 . . . . 0.0 108.26 173.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.561 ' HH ' HD12 ' C' ' 896' ' ' LEU . 8.8 t80 -118.19 146.52 44.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.41 116.23 30.59 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 124.222 1.009 . . . . 0.0 109.086 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . 0.561 HD12 ' HH ' ' C' ' 894' ' ' TYR . 7.3 tt -114.42 139.77 49.23 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.016 1.326 . . . . 0.0 109.365 -178.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.1 119.15 10.04 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.484 0.714 . . . . 0.0 109.903 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.38 154.57 21.65 Favored 'General case' 0 C--N 1.365 1.249 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.67 122.36 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.05 123.73 42.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.251 1.02 . . . . 0.0 109.617 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.0 m -83.16 131.36 35.13 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.68 -56.42 20.34 Favored Glycine 0 C--N 1.364 2.109 0 C-N-CA 125.611 1.577 . . . . 0.0 114.762 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 63.6 m170 32.04 72.34 0.07 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 127.946 2.498 . . . . 0.0 115.609 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -74.27 -9.5 58.66 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.967 1.307 . . . . 0.0 111.371 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.96 -18.33 62.01 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.297 1.439 . . . . 0.0 112.568 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.294 12.1 pt-20 124.63 -175.34 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 128.528 2.731 . . . . 0.0 107.783 174.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 100.88 131.32 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 127.696 2.398 . . . . 0.0 106.554 170.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 71.2 t -99.21 123.49 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -105.15 122.72 46.5 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.509 167.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -131.07 117.15 18.72 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.371 2.668 . . . . 0.0 109.607 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 87.1 t -90.1 113.01 25.53 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 144.6 53.58 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.796 1.639 . . . . 0.0 111.58 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.285 1.0 OUTLIER -115.31 147.24 40.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.721 2.008 . . . . 0.0 108.893 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.477 HH22 ' HB2' ' C' ' 888' ' ' ALA . 0.6 OUTLIER -80.34 138.83 36.76 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 127.301 2.241 . . . . 0.0 110.123 -177.327 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 94.19 -2.64 0.1 Allowed 'General case' 0 C--N 1.348 0.537 0 C-N-CA 129.21 3.004 . . . . 0.0 112.701 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -144.17 -26.41 0.53 Allowed 'General case' 0 C--N 1.358 0.95 0 O-C-N 120.904 -1.122 . . . . 0.0 111.819 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 58.89 168.31 0.06 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.197 1.399 . . . . 0.0 111.583 -162.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.72 51.4 Favored Glycine 0 C--N 1.375 2.697 0 O-C-N 119.576 -1.953 . . . . 0.0 109.855 -165.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 51.66 76.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.214 0 C-N-CA 126.197 1.799 . . . . 0.0 111.322 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.39 114.71 26.89 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -170.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -99.12 -38.69 8.83 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.413 -170.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 86.6 t -100.28 82.68 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.72 132.02 39.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.11 0.481 . . . . 0.0 110.49 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 20.7 t -142.75 115.29 8.56 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 108.631 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.25 84.54 0.7 Allowed Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 104.823 -3.311 . . . . 0.0 104.823 166.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.597 0 C-N-CA 125.89 1.709 . . . . 0.0 111.453 174.378 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -121.02 134.02 55.28 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.92 163.45 26.97 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.69 130.94 73.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.39 148.72 49.45 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -116.36 -39.77 3.33 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.415 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 31.4 tp -93.04 -55.15 3.45 Favored 'General case' 0 C--N 1.356 0.863 0 O-C-N 121.57 -0.706 . . . . 0.0 111.747 -166.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.424 HG22 ' HE ' ' C' ' 893' ' ' ARG . 2.3 pp -85.3 -161.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 C-N-CA 125.117 1.367 . . . . 0.0 109.737 -173.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.434 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -170.72 91.55 0.47 Allowed Pre-proline 0 C--N 1.358 0.948 0 O-C-N 121.794 -0.566 . . . . 0.0 110.033 -166.586 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.33 90.61 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 123.247 2.195 . . . . 0.0 109.569 158.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 89.1 mt -123.36 145.83 48.43 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -95.15 159.7 14.89 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-N 118.858 0.753 . . . . 0.0 109.33 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.61 122.67 20.94 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 120.104 1.32 . . . . 0.0 109.411 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 88.79 -8.39 79.59 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 125.896 1.713 . . . . 0.0 111.923 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.14 173.75 8.1 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.946 0.898 . . . . 0.0 109.709 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 81.9 m -142.33 126.21 17.16 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -156.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.432 HG13 HH11 ' C' ' 914' ' ' ARG . 34.8 m -94.99 150.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 123.722 0.809 . . . . 0.0 109.197 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.0 t -140.13 139.46 35.79 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 125.9 1.68 . . . . 0.0 112.195 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.03 128.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.588 0 C-N-CA 126.42 1.888 . . . . 0.0 106.727 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.6 131.36 54.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 25.0 tp -131.92 76.89 1.73 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.284 -1.78 . . . . 0.0 107.617 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 58.3 t -159.03 100.0 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -149.34 83.81 1.43 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.78 149.3 16.14 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -117.4 -17.67 10.04 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.651 0.781 . . . . 0.0 110.374 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.0 tp -99.74 85.4 3.1 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.82 1.66 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -171.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -121.37 157.58 30.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.54 131.5 36.93 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.74 152.8 23.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -125.73 113.97 24.86 Favored Pre-proline 0 C--N 1.356 0.858 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -96.45 170.48 1.04 Allowed 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 121.839 1.693 . . . . 0.0 107.861 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.56 138.38 50.72 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -135.62 138.32 42.78 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 119.488 1.04 . . . . 0.0 108.299 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.62 130.59 69.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -128.9 101.18 5.97 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 982' ' ' SER . . . . . 0.413 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 24.4 p -100.68 163.83 12.15 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.6 1.56 . . . . 0.0 109.115 176.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.8 113.44 0.37 Allowed Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.0 42.62 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 66.3 tp -78.53 125.27 29.13 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.481 1.513 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 12.5 tp -97.49 -56.8 2.42 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 121.993 0.117 . . . . 0.0 110.713 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -131.09 128.36 40.03 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -175.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.41 129.34 9.86 Favored Glycine 0 CA--C 1.486 -1.725 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 163.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.47 132.11 89.65 Favored Pre-proline 0 C--N 1.349 0.563 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.478 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -106.38 79.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 121.305 1.502 . . . . 0.0 109.171 -170.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.98 -72.04 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.019 3.328 . . . . 0.0 109.056 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.9 mt 49.77 39.48 18.03 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 128.678 2.791 . . . . 0.0 113.761 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -112.32 131.42 55.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -128.34 108.97 11.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 179.206 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.455 -0.776 0 N-CA-C 110.021 -0.8 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.87 120.05 24.15 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.69 -21.0 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 122.146 1.802 . . . . 0.0 109.566 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 36.86 70.03 0.19 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 129.103 2.961 . . . . 0.0 115.631 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 87.3 t -118.78 136.5 55.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 158.81 43.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 162.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -149.44 138.56 21.32 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 28.8 t -169.1 117.15 0.65 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.5 152.36 36.09 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.67 157.58 46.53 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.537 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -131.59 131.52 43.34 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -166.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 41.7 p -160.32 16.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -165.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . . . . . . . . . 3.4 pp -21.73 144.1 0.02 OUTLIER Pre-proline 0 C--N 1.37 1.464 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 159.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.8 -43.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 122.093 1.783 . . . . 0.0 111.995 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -164.28 176.67 8.94 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 17.1 m -19.22 120.21 0.02 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.651 3.18 . . . . 0.0 115.656 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -127.67 144.22 50.35 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 -163.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.66 -10.34 17.12 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 122.685 1.995 . . . . 0.0 113.586 -159.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -158.07 -142.05 3.3 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 20.3 m -63.31 145.38 55.68 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 110.47 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.1 128.79 50.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.857 1.263 . . . . 0.0 110.307 -165.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -94.45 -152.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.28 3.32 . . . . 0.0 108.489 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -149.28 135.13 18.81 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -118.33 -13.65 9.81 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 122.753 0.421 . . . . 0.0 111.608 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -100.17 86.73 3.28 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 118.609 0.641 . . . . 0.0 112.545 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . 0.434 HG13 ' HB3' ' A' ' 874' ' ' ASN . 54.0 t -71.92 97.65 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.831 1.652 . . . . 0.0 107.013 168.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.36 -37.21 17.3 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.946 -172.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 29.2 tp -165.4 127.64 2.09 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 101.959 -3.349 . . . . 0.0 101.959 160.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.434 ' HB3' HG13 ' A' ' 871' ' ' VAL . 26.9 t-20 -174.8 60.84 0.02 OUTLIER 'General case' 0 C--N 1.356 0.877 0 CA-C-N 120.553 1.524 . . . . 0.0 110.336 -166.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -58.87 -43.99 90.97 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -166.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.35 -27.23 12.19 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 118.928 0.785 . . . . 0.0 112.747 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -57.76 0.41 Allowed Glycine 0 C--N 1.352 1.465 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.07 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.354 0.804 0 C-N-CA 128.098 2.559 . . . . 0.0 114.746 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -96.78 119.14 34.7 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.21 116.05 62.28 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -95.95 4.88 2.03 Favored 'Trans proline' 0 CA--C 1.505 -0.93 0 CA-C-N 124.405 2.609 . . . . 0.0 109.407 -160.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -79.93 -45.81 17.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.1 p -106.01 -10.43 16.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.348 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.41 28.06 37.48 Favored Glycine 0 C--N 1.366 2.201 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 161.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 22.9 t -101.6 103.05 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 -162.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -102.03 111.13 23.28 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 112.434 -2.166 . . . . 0.0 109.464 -173.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 83.9 m -99.99 107.53 19.5 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.12 111.41 46.64 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 117.106 -1.426 . . . . 0.0 112.2 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.0 -1.24 5.62 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.781 2.321 . . . . 0.0 109.126 166.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -49.13 -54.82 14.49 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 128.856 2.862 . . . . 0.0 115.127 -167.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.47 48.69 14.11 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.63 -161.77 10.74 Favored Glycine 0 N--CA 1.417 -2.578 1 N-CA-C 102.636 -4.185 . . . . 0.0 102.636 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . 0.494 ' HE ' HG22 ' A' ' 953' ' ' ILE . 67.7 ttt-85 -89.92 120.89 31.53 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . 0.464 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.3 t80 -115.58 144.87 43.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -174.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -109.78 116.81 32.35 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.704 0.801 . . . . 0.0 109.871 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.1 140.02 48.83 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.091 1.756 . . . . 0.0 109.049 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -143.98 119.74 10.52 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.526 0.73 . . . . 0.0 109.812 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.47 153.95 22.07 Favored 'General case' 0 C--N 1.367 1.344 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.31 121.07 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.36 123.59 43.77 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.209 -172.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 41.8 m -83.38 131.33 35.06 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.39 -58.07 16.47 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 125.124 1.345 . . . . 0.0 114.107 -169.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 38.25 69.81 0.23 Allowed 'General case' 0 C--N 1.36 1.065 0 C-N-CA 127.085 2.154 . . . . 0.0 114.708 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -73.23 -8.97 58.12 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.161 1.384 . . . . 0.0 111.284 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.33 -19.44 61.65 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.814 1.246 . . . . 0.0 112.486 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.301 13.9 pt-20 127.56 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.161 2.584 . . . . 0.0 108.424 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.7 tttt 102.05 131.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.885 2.474 . . . . 0.0 107.386 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.7 t -99.51 125.38 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 123.306 1.527 . . . . 0.0 106.932 -172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -112.41 122.17 46.94 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.134 -1.848 . . . . 0.0 113.004 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.9 116.81 16.93 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 128.346 2.658 . . . . 0.0 108.538 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.78 112.77 23.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.08 145.67 52.57 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.647 1.579 . . . . 0.0 111.901 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.306 0.8 OUTLIER -114.81 148.87 37.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 126.588 1.955 . . . . 0.0 110.732 177.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 138.75 38.72 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.948 2.099 . . . . 0.0 109.744 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 96.85 -1.22 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 128.816 2.846 . . . . 0.0 112.319 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -147.89 -26.05 0.35 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.108 -0.995 . . . . 0.0 110.634 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 57.92 171.36 0.05 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.194 1.397 . . . . 0.0 111.521 -162.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.44 -133.6 52.63 Favored Glycine 0 C--N 1.373 2.592 0 O-C-N 119.376 -2.078 . . . . 0.0 110.104 -163.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.477 HG23 ' H ' ' A' ' 948' ' ' GLY . 58.5 t 56.32 77.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 126.036 1.735 . . . . 0.0 111.485 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.2 115.17 27.84 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -102.6 -34.09 9.22 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.601 -172.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 95.4 t -99.34 87.24 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 103.252 -2.869 . . . . 0.0 103.252 166.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -94.84 131.18 41.01 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 116.31 9.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.343 1.457 . . . . 0.0 107.714 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.41 85.03 0.71 Allowed Glycine 0 CA--C 1.485 -1.814 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 162.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.62 0 C-N-CA 124.812 1.196 . . . . 0.0 110.987 172.663 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.69 134.34 52.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . 0.477 ' H ' HG23 ' A' ' 919' ' ' VAL . . . -139.7 163.81 26.12 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -174.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.29 132.96 70.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.05 147.46 46.19 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 55.1 m -117.62 -40.98 2.97 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.457 ' HB2' ' HG ' ' C' ' 982' ' ' SER . 36.4 tp -89.27 -54.21 4.21 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.666 0.666 . . . . 0.0 112.082 -165.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.494 HG22 ' HE ' ' A' ' 893' ' ' ARG . 16.3 pt -85.41 -155.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.883 0 C-N-CA 124.724 1.21 . . . . 0.0 110.278 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.464 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -170.07 85.71 0.57 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 C-N-CA 122.981 0.513 . . . . 0.0 109.934 -165.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.14 89.99 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 122.656 1.984 . . . . 0.0 109.538 159.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.78 145.83 48.07 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.568 2.347 . . . . 0.0 105.022 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -92.62 157.16 16.64 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-N 119.444 1.02 . . . . 0.0 108.705 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.27 123.83 23.15 Favored 'General case' 0 C--N 1.37 1.495 0 CA-C-N 119.749 1.159 . . . . 0.0 108.949 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.46 -13.17 67.78 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 125.884 1.707 . . . . 0.0 111.019 170.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.16 176.19 5.38 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.052 0.541 . . . . 0.0 111.697 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 77.7 m -141.74 127.17 18.82 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -157.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . . . . . . . . . 10.5 m -94.9 149.72 4.37 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 121.642 0.734 . . . . 0.0 109.909 173.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.6 m -139.38 137.17 35.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.139 1.775 . . . . 0.0 111.011 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 89.5 t -92.82 129.19 43.73 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 C-N-CA 126.61 1.964 . . . . 0.0 106.666 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -108.35 131.07 55.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.98 77.82 1.81 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 53.0 t -161.21 101.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.848 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -152.3 72.42 0.99 Allowed 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.04 149.42 8.55 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -117.01 -28.75 6.17 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.805 0.842 . . . . 0.0 108.748 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.2 tp -92.6 86.51 5.62 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.37 -164.13 1.54 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -125.29 160.21 29.83 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -93.22 132.07 37.72 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.57 150.01 22.75 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.23 113.58 23.71 Favored Pre-proline 0 C--N 1.355 0.844 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -97.95 172.34 0.64 Allowed 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 108.369 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.17 140.43 49.53 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -140.45 142.25 35.39 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 119.51 1.05 . . . . 0.0 108.757 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.81 129.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -125.81 106.85 9.98 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 52.1 p -99.29 160.74 14.06 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.057 0.943 . . . . 0.0 109.547 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.13 108.35 0.25 Allowed Glycine 0 C--N 1.359 1.836 0 C-N-CA 119.293 -1.432 . . . . 0.0 109.951 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.99 148.78 43.13 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 52.0 tp -72.7 123.39 23.18 Favored 'General case' 0 C--N 1.372 1.568 0 C-N-CA 125.849 1.66 . . . . 0.0 109.456 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.1 tp -99.95 -57.84 2.05 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.82 128.64 39.15 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.911 2.084 . . . . 0.0 106.466 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 130.58 10.32 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 103.979 -3.649 . . . . 0.0 103.979 161.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -69.48 133.56 89.0 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-N 118.662 1.231 . . . . 0.0 110.794 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -106.14 83.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.473 0 CA-C-N 121.469 1.56 . . . . 0.0 109.832 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.44 -72.74 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.398 3.479 . . . . 0.0 109.484 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.3 mt 49.52 40.23 18.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.27 3.028 . . . . 0.0 114.023 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.08 130.51 55.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -127.32 110.1 12.48 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.058 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.454 -0.823 0 N-CA-C 110.004 -0.806 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.2 120.67 25.15 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -92.7 -21.01 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.098 1.785 . . . . 0.0 109.83 -172.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 38.48 69.83 0.24 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 129.08 2.952 . . . . 0.0 115.315 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 78.9 t -118.7 136.42 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.24 158.34 44.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.3 p90 -149.52 139.21 21.74 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.3 t -169.2 117.84 0.66 Allowed 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.66 153.06 34.94 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -138.8 157.67 45.65 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.886 174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.09 130.22 40.95 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -166.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 32.4 p -160.8 14.18 0.11 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.557 -163.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.2 pp -21.58 143.58 0.02 OUTLIER Pre-proline 0 C--N 1.373 1.587 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 158.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.34 -43.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 122.009 1.753 . . . . 0.0 111.936 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -164.15 176.78 8.93 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m -19.36 120.44 0.02 OUTLIER 'General case' 0 C--N 1.363 1.175 0 C-N-CA 129.706 3.203 . . . . 0.0 115.645 171.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -127.92 144.19 50.51 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -163.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.77 -10.6 16.96 Favored 'Trans proline' 0 CA--C 1.512 -0.603 0 CA-C-N 122.698 1.999 . . . . 0.0 113.645 -158.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.62 -141.81 3.25 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -63.25 144.92 56.52 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.984 1.714 . . . . 0.0 110.282 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.13 128.27 54.27 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 124.912 1.285 . . . . 0.0 110.119 -165.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -95.34 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.196 3.264 . . . . 0.0 108.382 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -147.92 133.79 19.07 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -116.48 -13.02 10.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.977 0.911 . . . . 0.0 110.696 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.26 85.7 2.86 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 121.198 0.523 . . . . 0.0 111.281 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . 0.423 HG13 ' HB3' ' B' ' 874' ' ' ASN . 60.7 t -69.77 97.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 163.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 18.5 mt -87.21 -39.32 15.56 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.414 -172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 40.7 tp -165.23 127.25 2.09 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 101.064 -3.68 . . . . 0.0 101.064 165.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . 0.423 ' HB3' HG13 ' B' ' 871' ' ' VAL . 27.3 t-20 178.69 61.02 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 120.157 1.344 . . . . 0.0 109.146 -161.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.52 -43.56 93.38 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.59 -27.6 12.7 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 118.779 0.718 . . . . 0.0 112.669 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.92 -55.73 0.5 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 60.46 -84.11 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 C-N-CA 128.11 2.564 . . . . 0.0 114.866 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.3 118.87 34.71 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.75 116.39 63.72 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.01 5.21 2.37 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 CA-C-N 124.403 2.608 . . . . 0.0 109.73 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.95 -44.38 20.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.5 p -108.2 -10.64 15.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.957 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.79 30.13 30.16 Favored Glycine 0 C--N 1.359 1.819 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 162.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 32.3 t -101.34 102.36 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 -162.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.53 111.79 24.14 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 112.856 -1.974 . . . . 0.0 108.994 -174.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.3 m -100.14 107.67 19.61 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.13 111.53 47.32 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 117.291 -1.338 . . . . 0.0 111.93 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -89.48 0.35 5.89 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.762 2.308 . . . . 0.0 108.759 164.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -48.38 -56.44 8.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 128.914 2.886 . . . . 0.0 115.032 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.85 63.93 1.67 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 170.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.98 -166.68 31.83 Favored Glycine 0 N--CA 1.409 -3.141 0 N-CA-C 103.621 -3.791 . . . . 0.0 103.621 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -90.81 121.16 32.43 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . 0.476 ' H ' HD11 ' B' ' 954' ' ' LEU . 2.0 t80 -117.27 146.04 43.57 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -172.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.34 115.51 28.86 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.2 tt -112.08 139.83 47.27 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 126.275 1.83 . . . . 0.0 108.503 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -143.26 119.19 10.62 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 123.312 0.645 . . . . 0.0 109.43 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.65 154.46 21.42 Favored 'General case' 0 C--N 1.365 1.271 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.69 121.96 61.33 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.38 122.02 43.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.152 0.981 . . . . 0.0 109.123 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 36.4 m -81.41 132.05 35.31 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 107.781 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.01 16.7 Favored Glycine 0 C--N 1.364 2.125 0 C-N-CA 125.14 1.352 . . . . 0.0 114.405 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.5 m170 37.2 70.4 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.204 2.202 . . . . 0.0 114.976 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -73.29 -8.74 57.15 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.28 1.432 . . . . 0.0 111.442 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -73.17 -15.79 61.45 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.083 1.353 . . . . 0.0 112.564 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.314 12.2 pt-20 122.94 -179.29 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 128.568 2.747 . . . . 0.0 108.606 176.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.0 tttt 102.5 131.11 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 127.897 2.479 . . . . 0.0 107.184 170.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.08 126.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -112.52 123.13 49.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.87 174.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.56 115.67 15.75 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 128.223 2.609 . . . . 0.0 109.476 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.4 t -87.89 113.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.21 149.37 41.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.662 1.985 . . . . 0.0 112.369 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.309 0.9 OUTLIER -115.08 149.53 37.37 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 126.598 1.959 . . . . 0.0 110.524 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.71 138.71 36.35 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.593 1.957 . . . . 0.0 109.36 174.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 97.1 -5.76 0.06 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 128.92 2.888 . . . . 0.0 112.569 172.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -146.19 -25.84 0.44 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-N 119.47 1.032 . . . . 0.0 111.349 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 57.9 169.66 0.05 OUTLIER 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.32 1.448 . . . . 0.0 111.571 -162.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.03 -132.89 50.95 Favored Glycine 0 C--N 1.368 2.317 0 O-C-N 119.508 -1.995 . . . . 0.0 109.727 -165.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 53.71 78.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 126.408 1.883 . . . . 0.0 111.631 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.42 28.03 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -103.02 -35.27 8.61 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.632 -172.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 89.6 t -99.35 86.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 166.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.9 130.53 42.83 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -172.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -141.59 117.34 10.4 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.327 1.451 . . . . 0.0 107.235 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.21 85.18 0.73 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.889 -3.684 . . . . 0.0 103.889 164.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.661 0 C-N-CA 124.639 1.114 . . . . 0.0 110.927 174.309 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 CA--C 1.506 -0.747 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.54 134.07 55.42 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.67 164.68 26.0 Favored Glycine 0 CA--C 1.489 -1.545 0 C-N-CA 125.56 1.552 . . . . 0.0 109.281 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.06 133.01 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -135.66 148.51 48.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 52.6 m -122.14 -34.61 3.29 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.367 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 25.8 tp -91.31 -52.34 4.85 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.128 -168.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -86.63 -169.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 124.816 1.246 . . . . 0.0 109.353 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.476 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.62 86.42 2.1 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -168.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.31 90.88 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 117.627 -1.828 . . . . 0.0 109.982 161.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.53 145.58 48.19 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 127.083 2.153 . . . . 0.0 105.412 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -92.16 158.89 15.93 Favored 'General case' 0 C--N 1.363 1.155 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.701 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.55 123.1 22.49 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-N 120.304 1.411 . . . . 0.0 108.602 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.77 -12.02 70.1 Favored Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 125.283 1.421 . . . . 0.0 110.863 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.55 175.7 5.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.905 0.859 . . . . 0.0 110.659 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 83.2 m -142.27 127.51 18.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -154.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . . . . . . . . . 7.5 m -96.28 150.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 CA-C-O 121.464 0.649 . . . . 0.0 110.989 174.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.2 m -138.49 137.39 37.09 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 126.359 1.863 . . . . 0.0 111.035 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.04 129.44 42.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 C-N-CA 127.459 2.303 . . . . 0.0 106.564 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -107.98 130.98 55.02 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 100.886 -3.746 . . . . 0.0 100.886 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.97 77.33 1.78 Allowed 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 54.0 t -159.84 103.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -151.12 72.37 1.06 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.83 148.23 8.35 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -115.38 -27.66 7.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 35.8 tp -93.64 86.43 5.17 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.19 -163.98 1.51 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -125.2 159.29 31.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -91.38 131.13 37.06 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.58 149.99 22.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.826 -2.286 . . . . 0.0 104.826 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.06 113.29 24.12 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -97.06 172.33 0.78 Allowed 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.003 1.802 . . . . 0.0 108.173 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.4 mp -115.92 138.04 51.55 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.3 p -138.79 140.29 38.53 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 119.791 1.178 . . . . 0.0 108.261 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.8 mm -116.31 130.35 71.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -126.53 106.59 9.54 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 982' ' ' SER . . . . . 0.423 ' HG ' ' HB2' ' C' ' 952' ' ' LEU . 35.6 p -101.05 162.89 12.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.489 1.116 . . . . 0.0 110.231 171.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.75 110.31 0.29 Allowed Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.83 147.28 43.2 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.1 122.96 21.85 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 125.135 1.374 . . . . 0.0 109.091 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.1 tp -99.48 -58.09 2.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -131.37 128.39 39.54 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.897 1.679 . . . . 0.0 106.566 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.16 130.42 10.26 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 104.161 -3.575 . . . . 0.0 104.161 161.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.53 133.43 88.94 Favored Pre-proline 0 C--N 1.351 0.657 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.39 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -105.99 82.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.546 1.588 . . . . 0.0 109.195 -170.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.88 -72.28 0.09 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 130.286 3.435 . . . . 0.0 109.444 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 48.69 43.91 21.07 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 129.087 2.955 . . . . 0.0 113.671 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.0 130.23 56.72 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.08 110.2 12.25 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 179.551 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.86 0 N-CA-C 109.962 -0.822 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 34.8 t -125.4 116.52 25.22 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -90.01 -20.71 1.08 Allowed 'Trans proline' 0 CA--C 1.511 -0.638 0 CA-C-N 121.903 1.715 . . . . 0.0 109.662 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 39.16 69.8 0.26 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 128.811 2.844 . . . . 0.0 115.471 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.15 133.73 65.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -137.13 153.96 50.38 Favored 'General case' 0 C--N 1.363 1.158 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 167.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -149.71 141.7 23.87 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.916 0.78 . . . . 0.0 109.725 177.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.8 t -168.68 118.69 0.74 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.159 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.34 153.67 39.98 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -142.52 156.13 45.1 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.274 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -130.21 127.56 39.89 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.699 -164.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 33.3 p -162.35 11.88 0.07 Allowed 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -161.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . . . . . . . . . 3.2 pp -27.62 146.86 0.04 OUTLIER Pre-proline 0 C--N 1.368 1.393 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 157.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.83 -45.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.101 1.786 . . . . 0.0 112.156 -164.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -162.17 172.64 15.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -0.43 107.17 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 130.652 3.581 . . . . 0.0 117.526 167.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -107.46 163.5 16.82 Favored Pre-proline 0 C--N 1.353 0.757 0 C-N-CA 124.249 1.02 . . . . 0.0 110.209 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.05 -13.19 14.19 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.083 2.522 . . . . 0.0 111.318 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.03 -144.39 4.28 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.1 m -64.39 136.6 57.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.364 1.866 . . . . 0.0 111.035 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.38 144.77 98.84 Favored Pre-proline 0 C--N 1.354 0.787 0 C-N-CA 125.392 1.477 . . . . 0.0 113.453 -174.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -100.96 -147.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.435 2.757 . . . . 0.0 106.67 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -147.33 134.25 20.22 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -117.59 -15.54 10.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 122.811 0.444 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . 0.41 HH21 HD21 ' C' ' 872' ' ' LEU . 11.1 mmm180 -102.33 81.52 2.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.402 0.62 . . . . 0.0 111.399 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' C' ' 874' ' ' ASN . 43.6 t -67.99 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 126.265 1.826 . . . . 0.0 107.464 162.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . 0.41 HD21 HH21 ' C' ' 870' ' ' ARG . 6.9 mt -88.47 -37.85 15.46 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 121.601 -0.687 . . . . 0.0 110.68 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.8 tp -165.86 129.77 2.21 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 168.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.417 ' HB3' HG13 ' C' ' 871' ' ' VAL . 33.2 t-20 176.42 61.69 0.0 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.828 1.649 . . . . 0.0 108.034 -165.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.32 -43.68 92.67 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -165.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.01 -28.08 11.47 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 118.896 0.771 . . . . 0.0 112.568 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.36 -57.78 0.42 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 62.38 -82.51 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.214 2.606 . . . . 0.0 114.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.0 120.05 36.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.139 1.376 . . . . 0.0 108.085 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.49 115.95 62.0 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -96.02 5.97 1.91 Allowed 'Trans proline' 0 CA--C 1.506 -0.913 0 CA-C-N 124.659 2.7 . . . . 0.0 109.702 -161.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -79.55 -45.25 19.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 29.3 p -106.72 -11.14 15.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.868 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.93 31.07 30.03 Favored Glycine 0 C--N 1.362 1.987 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 162.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 36.2 t -101.25 101.93 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 100.965 -3.716 . . . . 0.0 100.965 -164.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.26 112.09 24.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 112.127 -2.306 . . . . 0.0 108.548 -175.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 66.4 m -99.39 109.42 22.02 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.34 109.6 34.79 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 117.367 -1.302 . . . . 0.0 111.724 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.35 -4.11 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.434 2.089 . . . . 0.0 108.104 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 55.0 mt -54.54 -52.89 60.62 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 127.937 2.495 . . . . 0.0 114.009 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.56 67.62 0.92 Allowed 'General case' 0 C--N 1.366 1.32 0 CA-C-O 122.262 1.03 . . . . 0.0 111.418 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.54 -169.62 36.78 Favored Glycine 0 N--CA 1.406 -3.334 1 N-CA-C 102.156 -4.377 . . . . 0.0 102.156 -170.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -93.69 120.85 34.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.53 -1.335 . . . . 0.0 108.076 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.461 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.5 t80 -116.73 145.38 43.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -170.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 53.1 tp -109.94 114.88 28.79 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.061 0.945 . . . . 0.0 108.58 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -113.21 137.9 50.78 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.379 1.472 . . . . 0.0 108.814 -173.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -144.3 118.71 9.64 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.82 22.2 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.81 121.76 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.46 124.15 39.34 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.373 1.069 . . . . 0.0 109.837 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 55.5 m -81.47 130.62 35.11 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -50.62 -54.81 19.69 Favored Glycine 0 C--N 1.361 1.956 0 C-N-CA 126.141 1.829 . . . . 0.0 115.776 -170.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 28.7 m170 28.16 78.69 0.02 OUTLIER 'General case' 0 C--N 1.36 1.06 0 C-N-CA 128.162 2.585 . . . . 0.0 116.254 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -72.37 -13.5 61.49 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.9 1.68 . . . . 0.0 111.29 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.04 -17.43 61.43 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.661 1.584 . . . . 0.0 112.617 -168.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.2 pt-20 116.23 -179.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 128.093 2.557 . . . . 0.0 108.769 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 105.51 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 128.554 2.742 . . . . 0.0 105.136 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.8 t -97.23 125.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -101.15 130.87 47.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.086 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.75 113.54 2.8 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 125.252 1.421 . . . . 0.0 110.625 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 6.2 p -85.18 117.73 30.86 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 108.722 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.62 137.78 58.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.646 1.178 . . . . 0.0 109.81 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -117.17 144.39 44.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.609 1.564 . . . . 0.0 107.853 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.45 142.55 37.44 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 128.344 2.657 . . . . 0.0 109.591 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.33 24.1 p 88.6 3.44 0.26 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 129.902 3.281 . . . . 0.0 113.879 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -150.67 -24.26 0.23 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-N 119.453 1.024 . . . . 0.0 111.31 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 58.84 168.37 0.06 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.435 1.494 . . . . 0.0 112.116 -163.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -130.16 49.82 Favored Glycine 0 C--N 1.375 2.744 0 O-C-N 119.384 -2.072 . . . . 0.0 110.135 -163.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 49.2 t 53.48 72.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.175 0 C-N-CA 125.946 1.698 . . . . 0.0 111.974 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.66 116.37 28.95 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -174.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -99.31 -31.31 11.76 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.762 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.88 80.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -95.29 130.76 41.93 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.744 0.307 . . . . 0.0 111.197 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 117.81 9.02 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.287 1.435 . . . . 0.0 107.872 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.15 85.05 0.79 Allowed Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.713 0 C-N-CA 125.311 1.434 . . . . 0.0 110.732 172.965 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.51 134.69 55.24 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.73 162.59 26.24 Favored Glycine 0 CA--C 1.491 -1.421 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.88 132.98 69.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.86 148.71 45.64 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.436 -0.79 . . . . 0.0 108.957 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 63.7 m -108.31 -75.79 0.62 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.423 ' HB2' ' HG ' ' B' ' 982' ' ' SER . 21.9 tp -66.96 -50.74 61.35 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -163.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.89 -176.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 125.94 1.696 . . . . 0.0 109.656 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.461 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -163.14 94.42 1.13 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.1 93.63 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.631 2.221 . . . . 0.0 110.015 162.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.9 mp -120.65 144.49 48.14 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -98.35 160.42 14.29 Favored 'General case' 0 C--N 1.363 1.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.43 123.41 22.31 Favored 'General case' 0 C--N 1.381 1.978 0 CA-C-N 120.329 1.422 . . . . 0.0 109.038 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -9.49 71.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 125.233 1.397 . . . . 0.0 111.794 168.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.65 171.83 4.78 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.438 0.695 . . . . 0.0 112.445 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.5 m -142.73 127.76 18.47 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -159.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.07 149.76 4.38 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 123.627 0.771 . . . . 0.0 109.295 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.2 t -142.29 136.59 29.91 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.495 1.118 . . . . 0.0 111.89 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.47 129.63 43.63 Favored 'Isoleucine or valine' 0 C--N 1.374 1.665 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.11 134.16 48.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.83 73.6 1.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.902 -1.954 . . . . 0.0 107.041 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 48.9 t -162.03 99.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.954 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -152.37 72.69 1.0 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.68 146.94 8.11 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.65 -21.56 10.17 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.413 0.685 . . . . 0.0 109.952 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -99.08 85.94 3.34 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.89 -167.88 2.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -170.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.69 156.73 33.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 15.4 t -91.12 135.53 33.7 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -160.23 154.45 23.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -127.72 115.01 20.85 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -97.57 172.96 0.67 Allowed 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 121.921 1.747 . . . . 0.0 107.894 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.8 mp -115.29 139.17 50.2 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 22.1 p -137.16 138.97 40.81 Favored 'General case' 0 C--N 1.375 1.688 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 31.5 mm -115.54 131.13 68.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -124.98 105.76 9.45 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 982' ' ' SER . . . . . 0.457 ' HG ' ' HB2' ' A' ' 952' ' ' LEU . 26.4 p -100.86 162.65 12.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 109.587 172.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 111.03 0.31 Allowed Glycine 0 C--N 1.358 1.785 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.71 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.75 142.71 47.44 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.1 tp -75.17 125.39 28.85 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.684 1.594 . . . . 0.0 108.569 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.1 -56.03 2.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -130.62 127.53 39.15 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -173.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 128.62 9.59 Favored Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 103.615 -3.794 . . . . 0.0 103.615 164.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.58 130.01 89.42 Favored Pre-proline 0 C--N 1.351 0.641 0 CA-C-O 117.461 -1.257 . . . . 0.0 111.215 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -107.03 80.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 122.519 1.935 . . . . 0.0 109.777 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 77.98 -71.99 0.1 Allowed 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 130.048 3.339 . . . . 0.0 109.414 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 64.9 mt 48.77 41.62 18.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 129.314 3.046 . . . . 0.0 113.596 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -110.0 129.55 55.66 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.94 107.0 9.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.307 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 110.015 -0.802 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.11 120.12 22.37 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.54 -20.24 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.122 1.794 . . . . 0.0 109.827 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 36.6 70.56 0.16 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.933 2.893 . . . . 0.0 115.792 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 77.2 t -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.3 44.7 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 165.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -149.46 139.04 21.65 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.4 t -168.96 117.19 0.66 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.21 36.0 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -136.44 158.49 44.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.425 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.555 HD21 HD23 ' A' ' 858' ' ' LEU . 2.5 tm? -135.07 130.46 35.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -166.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 72.2 m -161.41 8.81 0.08 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -162.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.555 HD23 HD21 ' A' ' 856' ' ' LEU . 2.7 pp -29.59 147.58 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.457 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 162.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.0 -43.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 122.128 1.796 . . . . 0.0 113.487 -161.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -163.44 174.05 12.4 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.0 m -9.3 118.97 0.01 OUTLIER 'General case' 0 C--N 1.361 1.097 0 C-N-CA 130.958 3.703 . . . . 0.0 117.004 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -97.95 160.42 28.48 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 124.691 1.196 . . . . 0.0 109.478 -170.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.09 -16.67 9.73 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.815 2.343 . . . . 0.0 110.098 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.57 -137.82 2.41 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 16.5 m -64.22 145.79 55.39 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.204 1.801 . . . . 0.0 110.652 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.66 130.43 36.96 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 125.514 1.525 . . . . 0.0 110.416 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -96.18 -150.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.927 3.084 . . . . 0.0 108.954 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.58 135.52 19.99 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -117.49 -14.78 10.3 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.985 0.514 . . . . 0.0 111.828 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.29 86.82 3.28 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 118.504 0.593 . . . . 0.0 111.839 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.67 97.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.201 1.801 . . . . 0.0 106.574 168.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.445 ' HB3' HD11 ' B' ' 953' ' ' ILE . 50.0 mt -87.24 -37.36 17.3 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.523 -173.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.16 126.86 1.75 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 101.591 -3.485 . . . . 0.0 101.591 162.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -175.31 60.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.494 1.497 . . . . 0.0 109.652 -168.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.72 -44.35 93.78 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -164.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.53 -28.51 11.29 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 118.99 0.814 . . . . 0.0 112.397 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -60.83 0.31 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 63.12 -80.86 0.03 OUTLIER 'General case' 0 C--N 1.356 0.869 0 C-N-CA 128.008 2.523 . . . . 0.0 114.049 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.68 119.46 32.71 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.794 1.238 . . . . 0.0 108.361 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.95 117.63 68.91 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -96.47 0.9 1.97 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 CA-C-N 125.113 2.862 . . . . 0.0 109.368 -165.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -80.31 -45.66 17.47 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -103.27 -12.61 17.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.347 1.059 . . . . 0.0 109.004 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 22.87 52.67 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 162.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 37.7 t -98.94 103.92 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.43 111.98 24.37 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.357 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 62.1 m -100.87 108.32 20.07 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 888' ' ' ALA . . . . . 0.409 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.37 111.09 45.26 Favored Pre-proline 0 C--N 1.358 0.956 0 CA-C-O 117.153 -1.404 . . . . 0.0 112.016 170.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.6 1.89 3.28 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 CA-C-N 123.001 2.107 . . . . 0.0 108.946 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 39.3 mt -52.8 -51.53 60.44 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 127.9 2.48 . . . . 0.0 114.09 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 44.79 18.3 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.069 1.348 . . . . 0.0 114.023 170.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.49 -163.24 11.79 Favored Glycine 0 N--CA 1.415 -2.737 1 N-CA-C 101.212 -4.755 . . . . 0.0 101.212 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -91.98 121.35 33.48 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.287 0.2 OUTLIER -114.58 159.19 20.72 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 119.32 0.963 . . . . 0.0 108.539 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -105.53 115.41 30.2 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.555 0.742 . . . . 0.0 109.085 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.81 136.34 50.0 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 126.079 1.751 . . . . 0.0 109.178 -168.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.5 m -145.99 118.91 8.72 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 123.469 0.708 . . . . 0.0 109.608 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.3 153.66 22.41 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.99 120.64 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.3 123.17 43.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.898 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 38.5 m -79.73 131.91 36.05 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.29 1.436 . . . . 0.0 107.394 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.36 -57.26 19.39 Favored Glycine 0 C--N 1.363 2.074 0 C-N-CA 125.653 1.597 . . . . 0.0 114.713 -169.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.3 m170 34.04 73.96 0.07 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 127.696 2.399 . . . . 0.0 115.606 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -74.14 -8.3 55.68 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.227 1.411 . . . . 0.0 111.55 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -72.12 -15.58 61.99 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 125.741 1.616 . . . . 0.0 112.225 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.339 7.2 pt-20 116.15 -177.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 128.26 2.624 . . . . 0.0 108.603 173.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 104.53 134.59 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 128.244 2.618 . . . . 0.0 106.41 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 69.0 t -98.19 125.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -111.08 122.36 47.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.015 -1.902 . . . . 0.0 113.446 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.21 117.12 17.04 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.12 2.568 . . . . 0.0 108.766 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 94.5 t -87.04 113.79 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 20.3 mt -62.29 140.78 58.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.908 1.683 . . . . 0.0 110.29 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -116.06 146.78 41.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.214 1.805 . . . . 0.0 109.218 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.571 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.07 139.78 40.11 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.155 2.582 . . . . 0.0 110.13 -174.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.17 -13.62 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 129.603 3.161 . . . . 0.0 112.649 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -139.33 -26.0 0.83 Allowed 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 119.327 0.967 . . . . 0.0 111.095 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 60.54 167.01 0.08 Allowed 'General case' 0 C--N 1.361 1.105 0 C-N-CA 125.226 1.411 . . . . 0.0 111.36 -164.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -134.63 50.49 Favored Glycine 0 C--N 1.37 2.449 0 O-C-N 119.521 -1.987 . . . . 0.0 109.208 -161.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 47.4 t 57.93 75.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.235 0 C-N-CA 125.297 1.439 . . . . 0.0 110.516 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.75 114.77 27.39 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -103.01 -36.17 8.28 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.454 -171.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.28 78.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -95.32 131.55 41.3 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.145 -172.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -143.96 114.69 7.7 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.024 1.33 . . . . 0.0 107.885 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.2 84.69 0.71 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 104.529 -3.428 . . . . 0.0 104.529 167.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 110.96 174.955 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.2 mt -118.26 134.1 55.32 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.82 161.41 25.46 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.91 127.96 73.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -137.58 148.47 45.92 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.4 m -114.73 -44.32 3.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 26.9 tp -84.33 -50.11 8.13 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.431 1.014 . . . . 0.0 112.785 -166.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 12.6 pt -87.88 -169.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 124.688 1.195 . . . . 0.0 109.941 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.23 82.71 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -165.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.55 91.36 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 122.308 1.86 . . . . 0.0 109.592 160.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.1 142.31 49.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -94.51 156.56 16.4 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.17 123.02 21.22 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 119.533 1.06 . . . . 0.0 108.929 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.41 -11.85 71.12 Favored Glycine 0 C--N 1.345 1.082 0 C-N-CA 125.893 1.711 . . . . 0.0 111.246 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.7 175.32 5.77 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.158 0.583 . . . . 0.0 111.467 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 83.7 m -142.54 125.47 16.16 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -159.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.571 HG13 HH11 ' A' ' 914' ' ' ARG . 34.0 m -95.79 150.26 4.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.686 0.755 . . . . 0.0 109.9 171.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.7 138.91 34.59 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.684 1.994 . . . . 0.0 111.382 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.29 129.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 126.301 1.84 . . . . 0.0 106.786 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.43 131.0 54.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.168 -3.271 . . . . 0.0 102.168 170.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.04 77.55 1.77 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.3 t -160.93 99.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.4 mmm -152.4 73.89 1.05 Allowed 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 107.5 141.92 10.16 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.96 -5.88 13.17 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.256 0.623 . . . . 0.0 111.257 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.28 82.86 2.97 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.94 -175.19 3.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -122.0 159.5 26.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 16.8 t -89.01 131.19 35.3 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.69 150.03 22.55 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.41 113.36 23.29 Favored Pre-proline 0 C--N 1.356 0.869 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -98.13 174.29 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 108.54 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.75 140.91 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.46 140.58 37.33 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 119.583 1.083 . . . . 0.0 108.919 -171.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.0 mm -118.85 129.77 74.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -127.3 105.92 8.86 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 33.8 p -100.19 160.99 13.9 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.008 1.323 . . . . 0.0 110.068 170.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -179.2 109.84 0.27 Allowed Glycine 0 C--N 1.358 1.787 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.8 144.96 46.0 Favored 'General case' 0 C--N 1.346 0.439 0 O-C-N 121.416 -1.049 . . . . 0.0 113.713 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.75 123.65 24.53 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 124.591 1.156 . . . . 0.0 109.671 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 23.9 tp -98.72 -57.38 2.2 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.65 128.02 38.19 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.82 10.04 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 103.231 -3.947 . . . . 0.0 103.231 163.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -69.04 130.04 91.71 Favored Pre-proline 0 C--N 1.352 0.703 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.015 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -106.76 82.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 CA-C-N 121.885 1.709 . . . . 0.0 109.89 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 78.29 -72.28 0.09 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 130.265 3.426 . . . . 0.0 109.195 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 76.4 mt 49.93 39.0 17.55 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 129.073 2.949 . . . . 0.0 114.244 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.7 131.95 54.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -129.24 109.46 11.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.134 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 179.656 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.454 -0.801 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.69 120.41 23.01 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.5 -20.47 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.176 1.813 . . . . 0.0 110.081 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 37.95 70.37 0.2 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.926 2.89 . . . . 0.0 115.482 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 82.5 t -118.14 136.03 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.08 157.66 46.35 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -149.5 139.46 21.98 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -169.57 118.23 0.63 Allowed 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.97 153.56 34.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -138.37 158.59 43.98 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.908 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.58 HD21 HD23 ' B' ' 858' ' ' LEU . 2.4 tm? -136.06 128.1 29.65 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -167.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 73.3 m -160.33 13.0 0.12 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -167.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.58 HD23 HD21 ' B' ' 856' ' ' LEU . 2.6 pp -29.03 148.24 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 160.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.63 -43.76 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.104 1.787 . . . . 0.0 113.553 -161.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -163.41 173.83 12.7 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -8.73 118.94 0.01 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 130.952 3.701 . . . . 0.0 117.075 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -97.87 160.42 28.54 Favored Pre-proline 0 N--CA 1.44 -0.926 0 C-N-CA 124.661 1.184 . . . . 0.0 109.606 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.14 -16.69 9.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.776 2.317 . . . . 0.0 110.176 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.43 -137.71 2.37 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -64.05 145.41 55.95 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.13 1.772 . . . . 0.0 110.498 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.89 129.84 40.63 Favored Pre-proline 0 N--CA 1.438 -1.028 0 C-N-CA 125.366 1.466 . . . . 0.0 110.208 -164.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -96.82 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.797 2.998 . . . . 0.0 108.726 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.21 135.54 20.46 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -115.87 -14.05 11.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.019 0.928 . . . . 0.0 110.705 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.17 86.65 3.07 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 118.233 0.469 . . . . 0.0 112.159 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.06 97.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.247 1.819 . . . . 0.0 106.639 164.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' B' ' 855' ' ' ALA . 13.5 mt -87.75 -38.83 15.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.278 -173.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 53.3 tp -166.25 127.49 1.79 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 166.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 178.25 61.0 0.01 OUTLIER 'General case' 0 C--N 1.355 0.825 0 CA-C-N 120.331 1.423 . . . . 0.0 108.807 -164.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.13 -43.96 95.28 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.22 -29.15 10.57 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 118.741 0.7 . . . . 0.0 112.355 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.53 -60.04 0.34 Allowed Glycine 0 C--N 1.353 1.487 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 63.14 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.103 2.561 . . . . 0.0 114.148 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -95.33 119.24 33.5 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 125.007 1.323 . . . . 0.0 108.231 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -80.64 117.83 69.65 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -95.29 0.99 2.5 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 125.144 2.873 . . . . 0.0 109.589 -165.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -80.3 -44.36 19.71 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 33.2 p -105.38 -13.05 15.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.729 1.211 . . . . 0.0 108.581 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.24 47.22 Favored Glycine 0 C--N 1.362 2.009 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 163.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.7 103.44 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 -162.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.57 112.1 24.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 112.515 -2.129 . . . . 0.0 109.475 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 61.3 m -101.08 108.45 20.15 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 888' ' ' ALA . . . . . 0.408 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.43 111.12 45.55 Favored Pre-proline 0 C--N 1.359 0.99 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.844 170.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -93.26 2.08 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 123.101 2.143 . . . . 0.0 108.949 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.32 -49.37 69.85 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.025 2.13 . . . . 0.0 113.888 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.32 48.18 15.38 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.747 1.619 . . . . 0.0 114.431 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.91 -164.92 20.2 Favored Glycine 0 N--CA 1.412 -2.951 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -90.79 121.38 32.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -116.42 159.54 21.85 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 119.36 0.982 . . . . 0.0 108.824 178.195 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -106.19 114.3 28.35 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.55 136.17 49.36 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 126.09 1.756 . . . . 0.0 108.529 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -145.02 119.31 9.54 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.167 0.587 . . . . 0.0 109.566 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.85 22.15 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.33 121.44 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.29 121.97 43.31 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.44 1.096 . . . . 0.0 108.665 -172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.3 m -79.12 132.26 36.51 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 107.749 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.15 -57.25 19.28 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.784 1.659 . . . . 0.0 114.63 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.5 m170 33.92 73.84 0.07 Allowed 'General case' 0 C--N 1.359 1.013 0 C-N-CA 127.746 2.418 . . . . 0.0 115.528 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.0 -8.48 56.28 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.283 1.433 . . . . 0.0 111.493 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -72.22 -14.51 61.81 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 125.807 1.643 . . . . 0.0 112.255 -170.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.341 7.0 pt-20 115.92 -178.27 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 128.641 2.776 . . . . 0.0 108.633 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 104.32 134.18 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 128.081 2.552 . . . . 0.0 106.635 172.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 87.8 t -98.0 126.5 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -172.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -111.98 122.8 48.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.942 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.24 116.88 16.73 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.539 2.336 . . . . 0.0 109.564 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 97.0 t -88.07 113.88 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.62 142.93 57.82 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.337 1.855 . . . . 0.0 110.249 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.7 t -116.47 147.24 41.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.298 1.839 . . . . 0.0 109.424 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.604 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.16 139.39 38.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.664 2.386 . . . . 0.0 109.826 -175.106 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.54 -16.94 0.03 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 129.643 3.177 . . . . 0.0 112.798 173.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -137.37 -25.5 1.03 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 119.384 0.993 . . . . 0.0 111.57 -169.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 60.44 167.35 0.08 Allowed 'General case' 0 C--N 1.36 1.062 0 C-N-CA 125.449 1.499 . . . . 0.0 111.078 -163.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.93 -133.55 49.36 Favored Glycine 0 C--N 1.367 2.259 0 O-C-N 119.664 -1.898 . . . . 0.0 109.066 -163.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 47.7 t 56.04 76.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.18 0 C-N-CA 125.64 1.576 . . . . 0.0 110.794 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.32 115.2 27.83 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -103.35 -36.83 7.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.392 -171.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.65 77.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.14 131.29 42.74 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -142.87 115.26 8.49 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.1 1.36 . . . . 0.0 107.832 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 84.63 0.73 Allowed Glycine 0 CA--C 1.486 -1.777 0 N-CA-C 104.625 -3.39 . . . . 0.0 104.625 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.644 0 C-N-CA 125.615 1.579 . . . . 0.0 111.003 175.397 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.506 -0.712 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.0 mt -116.88 134.23 55.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -142.44 162.67 27.27 Favored Glycine 0 CA--C 1.492 -1.403 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.83 130.73 73.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -137.61 150.09 47.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 54.6 m -119.19 -39.97 2.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.003 0.365 . . . . 0.0 111.91 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.56 -50.2 8.48 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-N 119.142 0.883 . . . . 0.0 112.299 -168.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 872' ' ' LEU . 38.4 pt -84.74 -175.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 125.686 1.595 . . . . 0.0 110.14 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.38 81.92 2.81 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 -169.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.78 92.62 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.294 1.996 . . . . 0.0 110.107 162.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.85 141.85 50.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -93.5 157.19 16.33 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.162 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.92 122.8 21.43 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.808 1.186 . . . . 0.0 108.718 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.04 -11.31 72.46 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 125.667 1.603 . . . . 0.0 111.165 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.8 175.01 6.1 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.624 0.726 . . . . 0.0 110.619 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 91.1 m -142.55 125.61 16.29 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -158.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.604 HG13 HH11 ' B' ' 914' ' ' ARG . 27.2 m -96.78 151.1 4.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 121.637 0.732 . . . . 0.0 110.909 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -140.85 138.94 34.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.864 2.066 . . . . 0.0 111.454 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.71 129.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.466 0 C-N-CA 127.142 2.177 . . . . 0.0 106.964 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -107.29 130.77 54.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.633 -3.469 . . . . 0.0 101.633 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.8 77.11 1.75 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 59.5 t -160.12 100.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -151.59 71.76 1.0 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.25 141.78 9.09 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.44 -5.11 13.51 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.233 0.613 . . . . 0.0 110.994 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 37.8 tp -99.44 82.11 2.62 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.56 -174.5 3.72 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -121.97 159.76 26.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -88.62 130.52 35.26 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.81 150.11 22.4 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 113.3 23.24 Favored Pre-proline 0 C--N 1.356 0.88 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -97.75 173.88 0.61 Allowed 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 121.957 1.772 . . . . 0.0 108.492 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.95 139.53 50.54 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.42 139.63 38.99 Favored 'General case' 0 C--N 1.374 1.646 0 CA-C-N 119.728 1.149 . . . . 0.0 108.572 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.2 mm -116.82 130.4 71.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -127.78 106.03 8.85 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 34.3 p -101.22 163.02 12.48 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.086 1.354 . . . . 0.0 110.538 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.75 111.41 0.31 Allowed Glycine 0 C--N 1.36 1.868 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.85 145.12 45.93 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.25 123.23 23.3 Favored 'General case' 0 C--N 1.376 1.744 0 C-N-CA 124.223 1.009 . . . . 0.0 109.354 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 53.6 tp -98.3 -57.48 2.2 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.4 127.3 37.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.72 128.95 9.72 Favored Glycine 0 CA--C 1.493 -1.329 1 N-CA-C 103.053 -4.019 . . . . 0.0 103.053 163.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.76 128.91 91.65 Favored Pre-proline 0 C--N 1.349 0.567 0 CA-C-O 117.693 -1.146 . . . . 0.0 110.345 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -106.27 82.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 CA-C-N 122.08 1.779 . . . . 0.0 109.593 -168.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.0 -72.04 0.09 Allowed 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 130.201 3.4 . . . . 0.0 109.136 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 76.5 mt 49.47 40.6 19.39 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 128.984 2.914 . . . . 0.0 113.828 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -113.35 131.79 55.83 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -130.02 109.17 10.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.578 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.88 114.43 31.07 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -86.09 -23.92 1.84 Allowed 'Trans proline' 0 CA--C 1.512 -0.584 0 CA-C-N 121.697 1.642 . . . . 0.0 110.285 -171.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 38.8 67.03 0.46 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 128.602 2.761 . . . . 0.0 115.553 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.09 136.95 57.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.93 156.09 49.59 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 8.6 p90 -148.47 137.83 21.96 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.3 t -171.37 119.37 0.47 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.426 -0.796 . . . . 0.0 109.734 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.41 153.61 37.61 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.17 158.46 44.01 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.663 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.486 HD21 HD23 ' C' ' 858' ' ' LEU . 3.0 tm? -140.83 130.21 23.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 74.5 m -158.54 15.99 0.2 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.486 HD23 HD21 ' C' ' 856' ' ' LEU . 2.0 pp -27.25 144.33 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.517 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 160.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -79.75 -45.49 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 122.056 1.77 . . . . 0.0 113.54 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.07 174.42 12.28 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.1 m -5.02 114.83 0.01 OUTLIER 'General case' 0 C--N 1.363 1.185 0 C-N-CA 130.78 3.632 . . . . 0.0 116.901 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.87 156.55 43.67 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.01 -15.63 10.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.346 2.03 . . . . 0.0 111.259 -172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.1 -140.48 2.96 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.0 m -65.8 144.66 56.72 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.621 1.568 . . . . 0.0 110.036 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 74.1 t -98.09 134.39 22.16 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 124.596 1.159 . . . . 0.0 110.521 -158.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -95.77 -152.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.063 3.175 . . . . 0.0 109.832 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -145.4 132.83 20.73 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -113.24 -17.03 12.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.457 0.703 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -102.9 83.42 2.23 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.194 0.521 . . . . 0.0 111.458 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.66 97.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.534 1.934 . . . . 0.0 106.649 165.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.79 -37.87 14.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.889 -173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 34.4 tp -165.02 127.22 2.16 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 31.5 t-20 174.97 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.183 1.356 . . . . 0.0 107.703 -163.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.84 -42.78 94.35 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.79 -28.32 16.4 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.744 0.702 . . . . 0.0 112.284 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.26 -58.44 0.46 Allowed Glycine 0 C--N 1.354 1.53 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 62.45 -81.28 0.02 OUTLIER 'General case' 0 C--N 1.353 0.751 0 C-N-CA 128.119 2.568 . . . . 0.0 114.654 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -95.5 120.3 35.51 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.424 1.49 . . . . 0.0 108.501 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.41 117.38 68.64 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.56 6.59 2.02 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.918 2.792 . . . . 0.0 109.768 -171.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -79.65 -45.33 19.24 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -105.26 -15.83 14.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.894 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.23 24.22 52.3 Favored Glycine 0 C--N 1.363 2.037 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 164.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.67 103.08 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 N-CA-C 101.335 -3.58 . . . . 0.0 101.335 -168.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -94.67 112.14 23.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.929 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 50.7 m -102.86 109.07 20.52 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 888' ' ' ALA . . . . . 0.507 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.25 110.38 42.16 Favored Pre-proline 0 C--N 1.356 0.889 0 CA-C-O 117.221 -1.371 . . . . 0.0 111.774 169.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -92.83 1.33 3.72 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.539 2.159 . . . . 0.0 108.289 164.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 36.4 mt -54.73 -52.68 61.74 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 128.098 2.559 . . . . 0.0 113.794 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.41 67.35 0.95 Allowed 'General case' 0 C--N 1.366 1.29 0 CA-C-O 121.971 0.891 . . . . 0.0 111.177 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.97 171.22 44.11 Favored Glycine 0 N--CA 1.406 -3.307 1 N-CA-C 100.272 -5.131 . . . . 0.0 100.272 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -91.45 116.34 28.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -116.28 160.03 21.03 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-O 121.576 0.703 . . . . 0.0 110.248 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.67 112.77 25.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.39 139.36 50.98 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.142 1.377 . . . . 0.0 109.017 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.5 m -144.15 120.53 10.95 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 110.197 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.53 154.48 19.86 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.52 123.07 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.52 123.63 40.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.256 1.022 . . . . 0.0 109.341 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 49.9 m -79.63 132.7 36.32 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.66 -56.78 16.38 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 125.774 1.654 . . . . 0.0 114.432 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 32.3 71.83 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.979 2.512 . . . . 0.0 114.987 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -72.98 -9.24 58.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.554 1.541 . . . . 0.0 111.803 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -71.92 -16.5 62.11 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.98 1.712 . . . . 0.0 112.274 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 122.13 -173.1 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.571 2.748 . . . . 0.0 107.745 173.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 103.49 134.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 127.949 2.499 . . . . 0.0 106.655 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.03 123.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -104.03 130.0 51.68 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.154 1.781 . . . . 0.0 110.278 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -152.5 114.2 4.34 Favored 'General case' 0 C--N 1.358 0.965 0 C-N-CA 124.97 1.308 . . . . 0.0 110.103 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.53 114.21 27.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 125.238 1.415 . . . . 0.0 107.694 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -61.59 139.92 58.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.112 1.765 . . . . 0.0 111.421 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.1 t -117.53 144.89 44.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.059 2.144 . . . . 0.0 108.842 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.507 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.31 141.91 38.13 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 127.205 2.202 . . . . 0.0 111.003 -174.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.6 t 99.79 -10.78 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.955 3.302 . . . . 0.0 112.179 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -141.8 -25.94 0.68 Allowed 'General case' 0 C--N 1.358 0.944 0 CA-C-N 119.275 0.943 . . . . 0.0 111.672 -172.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 59.72 167.62 0.07 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.229 1.412 . . . . 0.0 111.671 -163.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.06 -131.94 52.2 Favored Glycine 0 C--N 1.373 2.595 0 O-C-N 119.498 -2.001 . . . . 0.0 109.363 -162.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 44.8 t 54.8 74.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 125.567 1.547 . . . . 0.0 111.032 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.12 114.85 27.49 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 27.7 ptt85 -97.96 -38.0 9.57 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.752 -171.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.19 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.012 -2.959 . . . . 0.0 103.012 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -97.53 131.12 44.43 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.183 0.516 . . . . 0.0 111.111 -173.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -144.05 117.06 8.86 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.475 1.51 . . . . 0.0 108.35 171.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 85.01 0.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 105.158 -3.177 . . . . 0.0 105.158 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.605 0 C-N-CA 125.168 1.366 . . . . 0.0 110.798 174.385 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 73.7 mt -122.34 134.24 54.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.96 161.63 26.75 Favored Glycine 0 CA--C 1.491 -1.467 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -174.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 28.4 m -120.8 129.64 75.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.55 150.16 48.47 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.265 -0.897 . . . . 0.0 108.775 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -115.78 -41.03 3.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 16.6 tp -90.05 -52.92 4.72 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 119.069 0.849 . . . . 0.0 111.837 -168.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.51 -177.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 125.709 1.604 . . . . 0.0 109.844 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.99 85.51 1.6 Allowed Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 87.78 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 122.543 1.944 . . . . 0.0 109.49 163.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.18 145.82 48.3 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -92.8 161.37 14.54 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 118.917 0.78 . . . . 0.0 109.721 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.51 122.67 20.87 Favored 'General case' 0 C--N 1.379 1.872 0 CA-C-N 119.907 1.231 . . . . 0.0 109.051 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.73 -12.49 69.72 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.112 1.815 . . . . 0.0 111.372 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.26 175.37 5.41 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-O 121.571 0.701 . . . . 0.0 111.45 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 93.6 m -142.68 126.65 17.28 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.965 0.906 . . . . 0.0 110.569 -159.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.44 147.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.915 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.9 t -142.04 138.88 32.1 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.984 1.714 . . . . 0.0 111.577 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 89.3 t -90.33 129.07 41.78 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 C-N-CA 126.352 1.861 . . . . 0.0 106.701 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.69 132.97 51.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 101.345 -3.576 . . . . 0.0 101.345 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.92 72.16 1.49 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.844 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.2 t -160.97 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -151.78 70.04 0.93 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.2 145.88 7.96 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -117.27 -15.8 10.38 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.044 0.938 . . . . 0.0 110.287 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -101.59 81.98 2.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.79 -161.92 1.22 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -119.61 154.15 34.41 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.6 t -89.58 132.74 34.95 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -156.5 154.41 30.3 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -128.74 120.74 20.71 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -102.49 170.96 0.25 Allowed 'Trans proline' 0 CA--C 1.506 -0.892 0 N-CA-C 107.691 -1.696 . . . . 0.0 107.691 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 8.1 mp -112.53 139.83 47.79 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.5 p -136.56 139.27 42.05 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 119.574 1.079 . . . . 0.0 108.199 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.0 131.11 68.22 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -124.91 104.87 8.83 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 31.1 p -101.88 163.45 12.24 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.357 1.463 . . . . 0.0 110.556 171.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.76 112.14 0.34 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.77 45.78 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.921 -1.341 . . . . 0.0 114.452 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.05 124.45 27.81 Favored 'General case' 0 C--N 1.379 1.875 0 C-N-CA 124.892 1.277 . . . . 0.0 109.724 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 17.1 tp -97.49 -57.09 2.33 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.809 0.338 . . . . 0.0 110.237 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -131.49 127.65 37.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.82 130.72 10.41 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 165.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -70.51 129.5 90.08 Favored Pre-proline 0 C--N 1.35 0.594 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.696 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -106.76 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.014 1.755 . . . . 0.0 109.46 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 78.45 -73.16 0.08 Allowed 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 130.034 3.334 . . . . 0.0 109.048 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.8 mt 49.79 39.66 18.52 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.911 2.884 . . . . 0.0 113.792 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -112.12 131.72 55.29 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.36 109.05 10.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.095 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 110.166 -0.744 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.03 117.89 28.28 Favored Pre-proline 0 C--N 1.353 0.748 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -89.02 -21.0 1.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 CA-C-N 121.998 1.749 . . . . 0.0 110.021 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 37.29 70.57 0.17 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 129.056 2.942 . . . . 0.0 115.493 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 81.7 t -118.23 136.12 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.19 158.11 45.2 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 164.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -150.57 143.49 24.69 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 118.924 0.784 . . . . 0.0 110.117 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.57 118.42 0.85 Allowed 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.444 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.74 154.26 37.15 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.81 157.18 45.76 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.229 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.493 HD21 HD23 ' A' ' 858' ' ' LEU . 2.4 tm? -134.45 130.17 36.35 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -166.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 39.5 p -162.99 13.38 0.07 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -161.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.493 HD23 HD21 ' A' ' 856' ' ' LEU . 3.5 pp -25.18 147.99 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.426 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 159.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.28 -45.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.111 1.79 . . . . 0.0 113.252 -164.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.95 176.1 10.5 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -173.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.55 119.57 0.02 OUTLIER 'General case' 0 C--N 1.364 1.209 0 C-N-CA 130.549 3.54 . . . . 0.0 116.148 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.96 163.7 18.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 123.98 0.912 . . . . 0.0 108.737 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.06 -13.58 13.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.886 2.391 . . . . 0.0 111.189 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.81 -144.74 4.39 Favored Glycine 0 C--N 1.354 1.563 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.5 m -64.67 137.66 57.94 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.375 1.87 . . . . 0.0 110.938 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 14.8 m -69.38 145.59 95.77 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.365 1.466 . . . . 0.0 113.292 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -101.8 -145.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.037 2.492 . . . . 0.0 107.281 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -148.11 134.07 19.16 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -117.4 -14.2 10.37 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.428 0.691 . . . . 0.0 110.42 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.514 HH21 HD23 ' A' ' 872' ' ' LEU . 16.4 mmm180 -100.37 85.92 3.08 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-O 121.335 0.588 . . . . 0.0 111.427 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 74.2 t -69.2 95.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.935 2.494 . . . . 0.0 105.472 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.514 HD23 HH21 ' A' ' 870' ' ' ARG . 4.3 mt -90.79 -38.08 13.23 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.875 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 55.3 tp -166.8 130.62 1.95 Allowed 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.4 p-10 172.15 62.51 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 121.012 1.733 . . . . 0.0 108.537 -172.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.34 -44.19 92.66 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -163.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.39 -31.73 9.36 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.35 -68.76 0.23 Allowed Glycine 0 CA--C 1.489 -1.557 0 N-CA-C 105.592 -3.003 . . . . 0.0 105.592 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 77.29 -67.78 0.19 Allowed 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 128.295 2.638 . . . . 0.0 112.21 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -98.35 122.12 41.13 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.31 1.444 . . . . 0.0 108.101 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.68 118.0 70.45 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 116.115 -1.898 . . . . 0.0 106.113 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.32 -0.46 4.71 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 124.637 2.692 . . . . 0.0 108.768 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.65 -41.39 27.02 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.835 1.254 . . . . 0.0 108.612 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 37.1 p -104.31 -15.34 15.48 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.57 16.81 69.96 Favored Glycine 0 C--N 1.365 2.163 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 167.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 55.7 t -101.87 105.81 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 112.37 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.236 -175.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.29 109.33 20.97 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 888' ' ' ALA . . . . . 0.492 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.76 110.9 44.81 Favored Pre-proline 0 C--N 1.357 0.913 0 CA-C-O 117.172 -1.394 . . . . 0.0 111.678 169.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -93.75 0.44 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 CA-C-N 123.082 2.136 . . . . 0.0 108.602 166.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 61.5 mt -51.73 -54.39 28.96 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 127.988 2.515 . . . . 0.0 114.563 -168.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.13 66.34 1.12 Allowed 'General case' 0 C--N 1.364 1.231 0 CA-C-O 121.926 0.87 . . . . 0.0 112.166 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.27 -169.02 36.57 Favored Glycine 0 N--CA 1.408 -3.17 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -92.99 122.28 35.19 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.018 -1.091 . . . . 0.0 108.214 171.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.422 ' H ' HD11 ' A' ' 954' ' ' LEU . 0.0 OUTLIER -116.56 151.68 35.69 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.94 115.83 30.87 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.867 0.867 . . . . 0.0 108.844 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -112.58 137.11 51.3 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.957 1.703 . . . . 0.0 109.758 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -145.42 119.06 9.14 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 123.634 0.773 . . . . 0.0 109.317 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.59 154.31 21.6 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.43 120.98 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.12 123.21 42.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.349 1.059 . . . . 0.0 109.22 -171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 48.5 m -83.68 132.32 34.88 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.362 1.465 . . . . 0.0 107.272 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.83 17.78 Favored Glycine 0 C--N 1.362 2.026 0 C-N-CA 125.089 1.328 . . . . 0.0 114.309 -170.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 59.1 m170 33.14 73.18 0.07 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 127.86 2.464 . . . . 0.0 115.342 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -73.91 -8.4 55.94 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.288 1.435 . . . . 0.0 111.959 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -71.17 -18.51 62.49 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.567 1.547 . . . . 0.0 112.577 -170.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.309 9.4 pt-20 123.01 -174.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 129.149 2.98 . . . . 0.0 107.915 175.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 102.32 130.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 128.162 2.585 . . . . 0.0 106.509 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 91.2 t -98.31 124.48 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -107.97 130.47 55.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.121 1.769 . . . . 0.0 110.719 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -153.97 115.1 4.09 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 125.217 1.407 . . . . 0.0 110.125 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.85 117.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.532 1.533 . . . . 0.0 107.886 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.9 mt -62.79 137.37 58.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.07 1.348 . . . . 0.0 109.145 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.2 t -116.22 147.89 41.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 126.053 1.741 . . . . 0.0 108.192 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.492 HH22 ' HB3' ' A' ' 888' ' ' ALA . 0.0 OUTLIER -76.03 138.55 40.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 128.418 2.687 . . . . 0.0 110.38 -173.777 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 88.34 3.44 0.28 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.961 2.904 . . . . 0.0 113.012 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -149.73 -24.81 0.27 Allowed 'General case' 0 C--N 1.359 1.019 0 CA-C-N 119.45 1.023 . . . . 0.0 111.61 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 57.76 172.9 0.05 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.947 1.299 . . . . 0.0 112.117 -162.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.02 52.83 Favored Glycine 0 C--N 1.377 2.824 0 O-C-N 119.513 -1.992 . . . . 0.0 110.292 -163.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 54.5 t 55.34 75.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.266 0 C-N-CA 125.651 1.58 . . . . 0.0 111.267 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.58 116.51 28.93 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -102.27 -32.87 9.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.67 -1.605 . . . . 0.0 108.165 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.89 83.3 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.74 131.65 38.89 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.136 0.493 . . . . 0.0 110.636 -172.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.0 t -143.3 115.41 8.37 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.505 1.522 . . . . 0.0 107.569 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.38 84.57 0.76 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 104.937 -3.265 . . . . 0.0 104.937 167.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.582 0 C-N-CA 124.884 1.23 . . . . 0.0 111.193 175.763 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.512 -0.504 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 56.1 mt -121.66 133.6 54.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.97 161.42 27.83 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.48 130.17 74.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -138.82 151.18 46.81 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.4 m -115.35 -43.24 3.08 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.48 -50.84 6.95 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 119.324 0.965 . . . . 0.0 112.714 -166.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.9 -172.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.799 1.64 . . . . 0.0 110.462 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.422 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -160.01 84.18 2.15 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -166.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.68 90.7 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.985 1.745 . . . . 0.0 109.089 159.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.68 142.58 50.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.8 158.72 15.3 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.06 123.09 21.31 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.745 1.157 . . . . 0.0 109.031 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.39 -11.09 72.96 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 125.886 1.708 . . . . 0.0 111.258 170.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.44 174.28 6.79 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 111.552 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.51 127.08 16.04 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -159.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.411 HG13 HH11 ' A' ' 914' ' ' ARG . 15.3 m -98.23 147.3 6.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.401 0.62 . . . . 0.0 110.865 171.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 23.4 t -142.32 137.73 30.79 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.318 1.847 . . . . 0.0 110.888 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 30.3 t -91.57 129.04 42.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 C-N-CA 125.995 1.718 . . . . 0.0 107.315 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.8 131.94 53.34 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 101.437 -3.542 . . . . 0.0 101.437 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.4 72.82 1.51 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.287 -1.779 . . . . 0.0 106.45 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 52.4 t -162.22 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 83.1 mmm -152.88 72.86 0.98 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 117.48 147.08 8.43 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.82 -28.46 7.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.1 tp -92.71 86.36 5.52 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -154.92 0.57 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -124.68 166.96 15.21 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 23.0 t -103.7 131.6 50.72 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 155.89 30.9 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.29 115.05 21.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 173.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -99.78 172.94 0.4 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 121.998 1.799 . . . . 0.0 108.05 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.64 140.97 48.69 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -138.3 140.34 39.52 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.585 1.084 . . . . 0.0 108.479 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.2 mm -116.64 130.88 70.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -126.31 106.16 9.32 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 26.9 p -100.36 160.3 14.45 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.529 1.132 . . . . 0.0 109.253 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.72 109.82 0.28 Allowed Glycine 0 C--N 1.356 1.665 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.888 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.39 143.68 47.32 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -73.35 125.96 29.05 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.955 1.302 . . . . 0.0 109.904 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.82 -57.38 2.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -131.13 127.75 38.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.9 129.98 10.1 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -69.88 128.72 91.63 Favored Pre-proline 0 C--N 1.349 0.573 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.583 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -106.94 80.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.165 1.809 . . . . 0.0 109.233 -169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 79.47 -70.51 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.936 3.295 . . . . 0.0 109.008 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 18.2 mt 50.37 38.21 17.38 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 128.729 2.812 . . . . 0.0 114.202 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -114.98 133.94 55.61 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -129.2 109.98 11.6 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.112 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.226 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.807 0 N-CA-C 110.134 -0.756 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.22 118.36 27.89 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -89.42 -21.61 1.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 122.029 1.76 . . . . 0.0 110.144 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 38.29 69.72 0.24 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 128.964 2.906 . . . . 0.0 115.455 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 79.2 t -117.89 136.21 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.05 158.3 44.7 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.5 143.58 24.81 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 118.821 0.737 . . . . 0.0 110.201 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.64 118.37 0.84 Allowed 'General case' 0 C--N 1.354 0.788 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.203 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.16 154.2 36.52 Favored 'General case' 0 C--N 1.369 1.435 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.37 157.14 46.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.405 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.494 HD21 HD23 ' B' ' 858' ' ' LEU . 2.4 tm? -133.99 130.21 37.29 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -166.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 39.9 p -163.07 13.1 0.06 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -161.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.494 HD23 HD21 ' B' ' 856' ' ' LEU . 3.5 pp -25.06 148.01 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.387 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 159.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.13 -45.66 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 122.14 1.8 . . . . 0.0 113.329 -164.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.83 176.03 10.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.64 119.63 0.02 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.507 3.523 . . . . 0.0 116.138 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -113.82 163.69 18.02 Favored Pre-proline 0 N--CA 1.443 -0.784 0 C-N-CA 124.037 0.935 . . . . 0.0 108.799 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.02 -13.55 14.04 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.875 2.383 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.79 -144.79 4.41 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -64.72 137.73 57.98 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 126.38 1.872 . . . . 0.0 110.901 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.54 145.63 95.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 113.342 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -102.21 -145.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.068 2.512 . . . . 0.0 107.285 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -148.46 134.18 18.88 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -117.0 -13.82 10.61 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.749 0.819 . . . . 0.0 110.21 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.521 HH21 HD23 ' B' ' 872' ' ' LEU . 15.8 mmm180 -99.97 86.47 3.27 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-O 121.11 0.481 . . . . 0.0 111.918 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.85 95.48 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 127.763 2.425 . . . . 0.0 105.402 163.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.521 HD23 HH21 ' B' ' 870' ' ' ARG . 4.5 mt -90.74 -38.14 13.22 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.726 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.5 tp -166.59 130.64 2.04 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.5 p-10 172.48 62.62 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 120.906 1.684 . . . . 0.0 108.903 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.16 -44.06 92.12 Favored 'General case' 0 C--N 1.364 1.216 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.31 -32.01 9.17 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.05 -68.39 0.24 Allowed Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 77.15 -68.18 0.18 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 128.245 2.618 . . . . 0.0 112.288 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -98.38 121.85 40.83 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.331 1.452 . . . . 0.0 108.1 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.03 118.08 70.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-O 116.149 -1.881 . . . . 0.0 106.266 167.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -90.79 -0.22 5.05 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 CA-C-N 124.6 2.679 . . . . 0.0 108.772 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.68 -41.01 27.72 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 124.921 1.288 . . . . 0.0 108.651 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 37.8 p -104.66 -15.53 15.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.67 16.98 69.24 Favored Glycine 0 C--N 1.364 2.111 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.94 105.9 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 -168.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.64 112.43 24.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.366 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.23 109.26 20.89 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 888' ' ' ALA . . . . . 0.485 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.82 111.07 46.02 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.837 169.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.52 1.52 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 123.078 2.135 . . . . 0.0 108.767 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.27 -49.46 72.02 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.819 2.048 . . . . 0.0 114.26 -167.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.69 47.76 17.66 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.302 1.441 . . . . 0.0 114.704 171.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -159.63 -164.18 14.48 Favored Glycine 0 N--CA 1.413 -2.888 1 N-CA-C 101.345 -4.702 . . . . 0.0 101.345 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -89.95 121.35 31.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.432 ' H ' HD11 ' B' ' 954' ' ' LEU 0.25 0.0 OUTLIER -117.17 151.94 35.82 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.901 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.9 tp -106.42 115.64 30.56 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -113.21 136.5 52.67 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.794 1.638 . . . . 0.0 109.063 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.1 m -145.93 119.23 8.95 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 123.542 0.737 . . . . 0.0 109.247 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.18 154.68 20.85 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 96.9 t -105.2 122.11 58.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.45 121.92 41.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.106 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 46.9 m -82.17 131.92 35.24 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 125.353 1.461 . . . . 0.0 107.509 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.67 18.61 Favored Glycine 0 C--N 1.363 2.062 0 C-N-CA 125.165 1.364 . . . . 0.0 114.376 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.9 m170 33.04 73.24 0.07 Allowed 'General case' 0 C--N 1.361 1.072 0 C-N-CA 127.845 2.458 . . . . 0.0 115.357 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -74.02 -8.1 54.9 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.366 1.466 . . . . 0.0 111.901 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -72.03 -15.72 62.04 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.845 1.658 . . . . 0.0 112.619 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.318 8.5 pt-20 119.36 -176.13 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 129.152 2.981 . . . . 0.0 108.192 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 103.24 129.98 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 128.158 2.583 . . . . 0.0 106.561 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.25 125.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -109.02 130.42 55.48 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.024 1.73 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.13 115.07 4.04 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.928 1.291 . . . . 0.0 110.2 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 5.0 p -84.04 117.82 30.29 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 125.494 1.518 . . . . 0.0 107.932 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 28.4 mt -62.96 137.9 58.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.453 1.501 . . . . 0.0 109.083 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.0 t -116.02 148.62 39.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.959 1.704 . . . . 0.0 108.715 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.485 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -77.06 138.19 39.41 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 127.989 2.516 . . . . 0.0 110.169 -173.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 87.6 4.67 0.31 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.863 2.865 . . . . 0.0 113.019 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -150.03 -24.67 0.26 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.438 1.017 . . . . 0.0 111.515 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 57.56 173.79 0.05 OUTLIER 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.881 1.272 . . . . 0.0 111.983 -161.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.38 -133.05 52.83 Favored Glycine 0 C--N 1.374 2.68 0 O-C-N 119.622 -1.924 . . . . 0.0 110.337 -164.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 62.0 t 55.54 75.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.22 0 C-N-CA 125.729 1.612 . . . . 0.0 111.26 172.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.56 116.59 28.99 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -173.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -102.38 -33.14 9.67 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 113.536 -1.666 . . . . 0.0 108.268 -172.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.83 83.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 164.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.35 130.77 40.53 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 121.226 0.536 . . . . 0.0 110.363 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.8 t -142.89 115.43 8.58 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.502 1.521 . . . . 0.0 107.438 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.2 84.67 0.78 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.961 -3.256 . . . . 0.0 104.961 167.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.616 0 C-N-CA 124.888 1.232 . . . . 0.0 111.285 176.184 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.19 133.76 55.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.62 161.74 27.72 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.22 130.91 73.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -138.95 151.15 46.65 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.5 m -113.85 -46.03 3.05 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.02 -49.98 8.42 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 119.221 0.919 . . . . 0.0 112.919 -166.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.63 -173.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.628 1.571 . . . . 0.0 110.455 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.432 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.77 83.86 2.23 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -166.363 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.7 90.69 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 109.099 159.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.65 141.12 51.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -95.49 158.45 15.45 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.19 123.08 21.38 Favored 'General case' 0 C--N 1.376 1.745 0 CA-C-N 119.805 1.184 . . . . 0.0 108.938 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.24 -10.79 73.62 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 125.867 1.699 . . . . 0.0 111.334 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.71 174.3 6.99 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-O 121.464 0.65 . . . . 0.0 111.241 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.4 m -144.43 127.03 16.06 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -159.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.417 HG13 HH11 ' B' ' 914' ' ' ARG . 15.6 m -98.35 147.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 CA-C-O 121.303 0.573 . . . . 0.0 111.397 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 23.1 t -142.76 137.86 30.05 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 126.422 1.889 . . . . 0.0 110.9 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 26.6 t -91.7 129.4 42.43 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 107.536 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.85 132.08 53.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 72.71 1.51 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 49.6 t -161.99 102.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 83.5 mmm -153.18 71.17 0.89 Allowed 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.67 146.47 7.78 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 107.571 -2.212 . . . . 0.0 107.571 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.2 -28.21 7.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 45.5 tp -92.84 86.31 5.45 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.65 -155.63 0.62 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -124.07 167.41 14.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 23.3 t -104.49 131.34 51.99 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.58 155.86 30.91 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.14 114.91 21.76 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -99.41 172.6 0.44 Allowed 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.025 1.817 . . . . 0.0 108.021 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.71 140.74 48.91 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.1 p -138.28 140.4 39.59 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 119.5 1.045 . . . . 0.0 108.49 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.66 131.21 69.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.42 106.1 9.24 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 24.9 p -99.97 160.18 14.52 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.521 1.128 . . . . 0.0 108.858 170.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.94 109.45 0.26 Allowed Glycine 0 C--N 1.356 1.643 0 C-N-CA 118.899 -1.62 . . . . 0.0 109.356 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -122.56 145.23 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 57.3 tp -72.74 126.57 30.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 124.948 1.299 . . . . 0.0 110.449 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 31.4 tp -97.45 -57.18 2.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.317 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -131.2 127.78 38.63 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -173.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 129.71 10.0 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 103.536 -3.826 . . . . 0.0 103.536 163.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.55 128.42 91.11 Favored Pre-proline 0 C--N 1.351 0.668 0 CA-C-O 117.791 -1.099 . . . . 0.0 110.342 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -106.72 82.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 122.12 1.793 . . . . 0.0 109.28 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 79.14 -70.5 0.1 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.911 3.284 . . . . 0.0 109.091 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 19.8 mt 50.08 38.91 17.98 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 128.729 2.812 . . . . 0.0 114.245 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.14 110.13 11.75 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.115 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.336 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.793 0 N-CA-C 110.175 -0.741 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.64 119.28 25.89 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.89 -19.76 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 CA-C-N 122.096 1.784 . . . . 0.0 110.102 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 36.78 71.79 0.13 Allowed 'General case' 0 C--N 1.359 1.014 0 C-N-CA 129.174 2.99 . . . . 0.0 115.388 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 75.0 t -116.85 135.32 57.58 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.43 154.37 50.81 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 163.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 7.2 p90 -150.13 141.83 23.62 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 118.536 0.607 . . . . 0.0 109.93 171.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 23.0 t -168.07 118.58 0.8 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.45 155.36 40.6 Favored 'General case' 0 C--N 1.368 1.405 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.1 156.13 46.02 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.743 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.541 HD21 HD23 ' C' ' 858' ' ' LEU . 2.4 tm? -133.34 128.33 35.44 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.467 -167.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 73.1 m -161.05 10.08 0.09 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -161.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.541 HD23 HD21 ' C' ' 856' ' ' LEU . 2.4 pp -27.63 146.44 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.495 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 161.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.85 -46.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 CA-C-N 122.099 1.786 . . . . 0.0 113.454 -162.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -162.28 171.16 17.73 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m 0.46 106.78 0.01 OUTLIER 'General case' 0 C--N 1.361 1.109 0 C-N-CA 131.116 3.767 . . . . 0.0 116.77 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -103.93 163.33 17.57 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 123.562 0.745 . . . . 0.0 109.316 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.7 -13.54 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.754 2.302 . . . . 0.0 111.069 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -145.35 4.47 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.9 m -65.36 139.39 58.56 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.283 1.833 . . . . 0.0 110.475 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.08 147.59 83.54 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 112.771 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -100.92 -145.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.291 2.661 . . . . 0.0 107.035 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.28 133.85 18.74 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -116.49 -16.28 10.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.501 0.72 . . . . 0.0 110.864 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.414 HH21 HD23 ' C' ' 872' ' ' LEU . 11.3 mmm180 -101.86 82.47 2.26 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.11 96.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 126.706 2.002 . . . . 0.0 106.511 164.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.414 HD23 HH21 ' C' ' 870' ' ' ARG . 1.7 mt -89.64 -36.88 15.01 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.902 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 54.0 tp -164.06 130.3 3.08 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 100.913 -3.736 . . . . 0.0 100.913 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 41.7 t-20 175.01 60.38 0.0 OUTLIER 'General case' 0 C--N 1.356 0.865 0 CA-C-N 120.621 1.555 . . . . 0.0 107.399 -166.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.89 -44.55 95.8 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -165.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.65 -33.09 7.67 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.617 0.644 . . . . 0.0 112.212 -174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 115.86 -65.91 0.31 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 106.193 -2.763 . . . . 0.0 106.193 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 63.66 -80.52 0.03 OUTLIER 'General case' 0 C--N 1.355 0.808 0 C-N-CA 127.983 2.513 . . . . 0.0 113.598 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -94.36 120.74 35.05 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.856 1.263 . . . . 0.0 107.703 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.93 118.24 70.88 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-O 115.989 -1.958 . . . . 0.0 106.03 167.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -90.8 -4.02 4.72 Favored 'Trans proline' 0 CA--C 1.509 -0.731 0 CA-C-N 124.786 2.745 . . . . 0.0 108.795 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -79.92 -40.55 27.94 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 125.17 1.388 . . . . 0.0 108.784 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -103.8 -15.15 15.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.12 16.39 69.7 Favored Glycine 0 C--N 1.363 2.053 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 167.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.83 105.8 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 -167.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.42 ' CB ' HG22 ' C' ' 962' ' ' VAL . 1.3 t80 -97.28 111.67 23.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.204 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 56.3 m -101.32 109.25 21.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 170.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.69 110.51 41.98 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.491 -1.242 . . . . 0.0 111.463 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.08 -0.64 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 122.946 2.088 . . . . 0.0 108.245 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 0.443 HD12 ' H ' ' C' ' 892' ' ' GLY . 3.7 pp -58.18 -43.55 87.57 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.333 1.453 . . . . 0.0 114.69 -166.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.72 46.71 16.84 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 892' ' ' GLY . . . . . 0.443 ' H ' HD12 ' C' ' 890' ' ' LEU . . . -159.03 -163.76 13.51 Favored Glycine 0 N--CA 1.417 -2.571 1 N-CA-C 101.581 -4.608 . . . . 0.0 101.581 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 46.7 ttt-85 -91.32 120.53 32.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.476 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -116.41 156.29 27.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.452 1.101 . . . . 0.0 108.798 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.9 115.52 29.96 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.581 0.752 . . . . 0.0 110.083 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 5.0 tt -116.07 136.06 53.37 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 -174.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.85 119.5 9.78 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 123.633 0.773 . . . . 0.0 109.999 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 154.75 20.94 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.2 t -105.78 122.14 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.55 122.24 41.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.28 1.032 . . . . 0.0 109.142 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 54.3 m -80.44 132.46 35.73 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 125.256 1.423 . . . . 0.0 107.997 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.06 -57.29 20.0 Favored Glycine 0 C--N 1.367 2.268 0 C-N-CA 124.819 1.199 . . . . 0.0 113.343 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 45.06 68.57 0.54 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 127.08 2.152 . . . . 0.0 114.254 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -73.14 -11.84 60.68 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.749 1.22 . . . . 0.0 112.227 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -73.13 -13.94 61.28 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.075 1.75 . . . . 0.0 112.88 -166.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.345 0.3 OUTLIER 118.26 -173.6 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 129.217 3.007 . . . . 0.0 108.398 175.2 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 97.24 133.44 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 128.061 2.545 . . . . 0.0 106.749 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.79 122.56 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -104.4 123.0 46.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.913 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.27 116.72 17.27 Favored 'General case' 0 C--N 1.369 1.441 0 C-N-CA 128.452 2.701 . . . . 0.0 109.434 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 97.3 t -84.0 113.95 23.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.77 148.2 43.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.021 2.129 . . . . 0.0 112.061 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.27 1.0 OUTLIER -116.34 147.07 41.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.257 1.823 . . . . 0.0 110.993 175.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 139.34 38.14 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 127.133 2.173 . . . . 0.0 108.815 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.7 t 94.74 -10.99 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.717 2.807 . . . . 0.0 112.596 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -141.44 -28.35 0.66 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.585 1.084 . . . . 0.0 111.751 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 58.38 170.7 0.06 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 124.855 1.262 . . . . 0.0 112.191 -162.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -135.52 50.16 Favored Glycine 0 C--N 1.372 2.576 0 O-C-N 119.447 -2.033 . . . . 0.0 109.997 -162.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t 56.27 76.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.248 0 C-N-CA 125.551 1.54 . . . . 0.0 111.358 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.2 115.54 28.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 37.8 ptt85 -102.38 -35.15 8.91 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.318 -172.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 93.9 t -99.56 86.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 162.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -93.93 133.54 37.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.657 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.2 t -142.21 115.47 8.91 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.675 1.59 . . . . 0.0 107.633 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.55 84.48 0.68 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 104.628 -3.389 . . . . 0.0 104.628 165.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 111.028 175.456 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 60.8 mt -120.21 133.68 55.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.22 162.38 27.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.61 130.6 74.34 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -138.07 146.44 42.94 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.4 m -107.55 -58.29 1.98 Allowed 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.028 0.377 . . . . 0.0 112.015 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 41.1 tp -77.62 -49.03 15.42 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -165.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 8.0 pt -84.84 -172.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 125.552 1.541 . . . . 0.0 110.274 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.476 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -159.61 92.04 1.81 Allowed Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -167.124 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.59 91.41 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 O-C-N 117.384 -1.956 . . . . 0.0 108.403 155.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.32 145.43 47.12 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -90.86 162.23 14.9 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.46 126.61 30.26 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 120.257 -1.527 . . . . 0.0 107.116 163.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.37 -1.13 64.14 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -54.65 167.93 0.32 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.574 1.549 . . . . 0.0 114.972 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.7 121.75 11.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.42 HG22 ' CB ' ' C' ' 886' ' ' PHE . 2.7 m -100.44 147.73 7.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -143.99 137.79 27.96 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.714 1.206 . . . . 0.0 112.059 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.14 129.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 126.929 2.092 . . . . 0.0 107.96 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.59 133.39 52.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.54 77.5 1.79 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 112.953 -1.93 . . . . 0.0 107.587 172.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 61.2 t -159.59 100.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -153.12 66.24 0.78 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 132.08 147.07 5.82 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -116.75 -16.68 10.64 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.312 0.645 . . . . 0.0 110.059 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -104.61 82.79 1.95 Allowed 'General case' 0 C--N 1.356 0.858 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.6 -167.19 2.02 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -171.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -119.94 155.06 33.51 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.6 t -93.29 132.13 37.78 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.27 151.6 23.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.91 113.7 29.94 Favored Pre-proline 0 C--N 1.355 0.814 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 172.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.0 174.81 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 122.26 1.973 . . . . 0.0 107.804 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.49 141.15 48.45 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.4 p -135.02 140.95 46.04 Favored 'General case' 0 C--N 1.374 1.67 0 CA-C-N 119.206 0.912 . . . . 0.0 108.893 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.3 mm -115.69 131.13 69.0 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -127.1 105.52 8.63 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 29.3 p -100.09 160.12 14.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.499 1.12 . . . . 0.0 109.125 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.86 108.61 0.25 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.23 145.28 45.12 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.42 126.65 30.37 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 125.015 1.326 . . . . 0.0 110.684 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 36.4 tp -98.23 -58.26 2.02 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.651 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -133.13 128.52 36.28 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.407 1.883 . . . . 0.0 106.783 -172.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.77 129.38 9.88 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 103.988 -3.645 . . . . 0.0 103.988 160.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.05 130.05 90.18 Favored Pre-proline 0 C--N 1.35 0.606 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.343 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -106.83 84.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 121.874 1.705 . . . . 0.0 109.518 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.86 -70.84 0.1 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 130.131 3.372 . . . . 0.0 109.494 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 54.0 mt 49.71 40.1 19.22 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 128.867 2.867 . . . . 0.0 113.983 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -115.14 132.48 56.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -130.49 110.53 11.52 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.219 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.758 0 N-CA-C 110.073 -0.78 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.38 120.67 24.9 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -91.11 -21.44 0.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.201 1.822 . . . . 0.0 109.585 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 34.91 71.75 0.11 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 129.258 3.023 . . . . 0.0 115.506 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.03 136.84 53.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.743 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.56 155.74 49.99 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 164.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 8.4 p90 -149.13 138.62 21.69 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.0 t -169.12 117.18 0.64 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.08 153.84 39.37 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.66 155.4 49.18 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.988 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 858' ' ' LEU . 2.0 tm? -130.13 128.82 42.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -165.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 50.8 p -161.05 14.15 0.1 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -161.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 856' ' ' LEU . 3.6 pp -20.95 143.26 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.382 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 159.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.05 -40.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 121.971 1.74 . . . . 0.0 112.481 -162.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 38.6 ptt85 -164.19 176.29 9.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 21.7 m -16.97 119.3 0.02 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 130.129 3.372 . . . . 0.0 115.481 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -119.12 147.18 42.2 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -162.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.13 -10.0 19.31 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.523 2.149 . . . . 0.0 112.695 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.5 -143.3 3.62 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 120.338 1.427 . . . . 0.0 111.265 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 32.9 m -82.68 146.82 28.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.206 1.802 . . . . 0.0 108.3 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.11 138.74 97.41 Favored Pre-proline 0 C--N 1.356 0.854 0 C-N-CA 125.491 1.517 . . . . 0.0 113.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -98.9 -149.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.805 3.003 . . . . 0.0 106.233 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -151.49 131.33 13.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -118.08 -15.02 9.92 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.947 -0.47 . . . . 0.0 111.149 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.81 85.4 2.88 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.911 -0.493 . . . . 0.0 112.005 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.52 98.64 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 126.505 1.922 . . . . 0.0 106.916 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 27.8 mt -87.64 -37.38 16.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.008 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.13 129.45 2.06 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 101.398 -3.556 . . . . 0.0 101.398 162.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 28.8 t-20 -175.8 61.8 0.02 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 120.809 1.64 . . . . 0.0 109.814 -167.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -58.84 -44.78 91.03 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -166.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.08 -31.84 8.26 Favored Glycine 0 C--N 1.354 1.579 0 CA-C-N 118.949 0.795 . . . . 0.0 112.334 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.34 -58.87 0.39 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 63.58 -81.7 0.03 OUTLIER 'General case' 0 C--N 1.355 0.828 0 C-N-CA 128.204 2.602 . . . . 0.0 114.053 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -97.05 119.99 36.56 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.775 1.23 . . . . 0.0 108.35 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -78.84 117.54 67.28 Favored Pre-proline 0 N--CA 1.444 -0.756 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -92.84 2.58 3.63 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.411 2.968 . . . . 0.0 109.451 -166.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -80.74 -45.68 16.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 28.2 p -106.3 -12.89 15.55 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 109.055 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.63 38.46 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.02 103.57 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 -165.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.62 112.24 24.74 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.922 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 87.5 m -100.66 107.97 19.73 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.78 109.92 38.02 Favored Pre-proline 0 C--N 1.355 0.837 0 CA-C-O 117.23 -1.366 . . . . 0.0 110.916 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.12 -2.44 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.845 2.364 . . . . 0.0 108.86 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.47 -57.58 4.0 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 130.329 3.452 . . . . 0.0 114.771 -169.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.99 64.83 1.32 Allowed 'General case' 0 C--N 1.364 1.215 0 CA-C-O 121.759 0.79 . . . . 0.0 112.819 171.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.06 -166.75 32.66 Favored Glycine 0 N--CA 1.41 -3.046 1 N-CA-C 101.467 -4.653 . . . . 0.0 101.467 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -91.75 122.56 34.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.279 -0.96 . . . . 0.0 108.785 172.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.493 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.2 t80 -115.3 145.73 42.19 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.14 115.69 30.19 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.391 0.676 . . . . 0.0 109.315 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.78 139.48 49.09 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.075 1.75 . . . . 0.0 108.843 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 70.1 m -144.12 119.58 10.32 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 123.363 0.665 . . . . 0.0 109.716 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.22 21.55 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.3 t -104.92 121.26 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.76 123.25 43.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.292 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 43.4 m -84.07 131.76 34.77 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 125.657 1.583 . . . . 0.0 106.936 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.56 17.85 Favored Glycine 0 C--N 1.363 2.057 0 C-N-CA 124.595 1.093 . . . . 0.0 113.53 -168.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 56.4 m170 39.39 71.44 0.17 Allowed 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.12 2.168 . . . . 0.0 114.626 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -70.87 -10.54 59.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.936 1.694 . . . . 0.0 111.957 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -73.33 -17.92 61.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.578 1.551 . . . . 0.0 112.746 -168.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.326 12.2 pt-20 124.52 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.603 2.361 . . . . 0.0 108.223 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.4 tttt 100.64 132.34 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 128.129 2.571 . . . . 0.0 107.163 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.32 124.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -108.02 123.62 48.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.163 1.785 . . . . 0.0 112.11 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.57 115.09 14.29 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.121 2.569 . . . . 0.0 109.553 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 90.8 t -87.66 113.77 25.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.578 1.951 . . . . 0.0 111.452 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER -114.44 147.28 39.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 126.671 1.988 . . . . 0.0 109.787 178.421 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.489 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -79.79 140.79 36.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 125.728 1.611 . . . . 0.0 110.0 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.329 24.2 p 92.61 3.86 0.07 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 129.856 3.262 . . . . 0.0 114.227 173.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -148.24 -26.18 0.34 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 119.309 0.959 . . . . 0.0 111.065 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.51 168.17 0.05 Allowed 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.729 1.612 . . . . 0.0 111.835 -162.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.86 -135.0 49.31 Favored Glycine 0 C--N 1.369 2.396 0 O-C-N 119.615 -1.928 . . . . 0.0 109.233 -161.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 41.2 t 55.96 79.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 125.952 1.701 . . . . 0.0 110.992 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.52 113.99 26.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 24.1 ptt85 -103.73 -37.1 7.62 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.014 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -99.27 87.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 166.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.06 130.43 41.74 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.688 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -143.56 115.08 8.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.353 1.461 . . . . 0.0 108.129 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.3 84.7 0.7 Allowed Glycine 0 CA--C 1.484 -1.865 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 165.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 C-N-CA 124.925 1.25 . . . . 0.0 111.302 173.741 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 61.1 mt -116.47 133.84 55.55 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -135.37 161.32 24.67 Favored Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.31 126.77 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -138.84 149.56 45.05 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 71.2 m -106.65 -54.36 2.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.456 0.302 . . . . 0.0 110.908 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.02 -49.9 9.08 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -162.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.52 -175.97 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.381 1.472 . . . . 0.0 110.687 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.504 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -159.33 93.04 1.82 Allowed Pre-proline 0 N--CA 1.44 -0.949 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -164.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.3 92.31 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 O-C-N 116.869 -2.227 . . . . 0.0 110.152 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.504 HD13 ' HB2' ' A' ' 954' ' ' LEU . 6.8 mp -120.85 138.93 53.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -93.21 158.03 15.97 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.843 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.98 123.11 21.28 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 119.896 1.225 . . . . 0.0 108.997 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.13 73.02 Favored Glycine 0 C--N 1.345 1.071 0 C-N-CA 126.541 2.019 . . . . 0.0 111.851 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -73.17 174.96 7.23 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.359 1.064 . . . . 0.0 110.521 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 89.7 m -142.84 125.12 15.49 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 108.821 -160.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.489 HG13 HH11 ' A' ' 914' ' ' ARG . 30.7 m -95.43 149.83 4.43 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-O 121.445 0.64 . . . . 0.0 109.627 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -141.39 138.93 33.34 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.234 1.814 . . . . 0.0 111.414 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 98.6 t -92.05 129.18 43.09 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 C-N-CA 126.484 1.914 . . . . 0.0 106.268 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.05 132.34 53.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.89 78.09 1.83 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 51.3 t -160.98 100.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.973 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -154.32 66.59 0.7 Allowed 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.16 146.89 6.91 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -114.08 -31.89 6.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -90.58 86.97 6.55 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.89 -167.18 2.1 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -122.98 157.62 32.26 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 15.7 t -91.6 133.9 35.14 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.66 151.58 22.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.52 111.16 19.24 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -98.58 173.23 0.51 Allowed 'Trans proline' 0 CA--C 1.507 -0.874 0 C-N-CA 121.742 1.628 . . . . 0.0 108.317 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.58 141.03 48.72 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 24.3 p -138.78 139.71 38.36 Favored 'General case' 0 C--N 1.374 1.66 0 CA-C-N 119.302 0.956 . . . . 0.0 108.513 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.0 mm -118.17 130.25 73.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.21 106.48 9.58 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 37.4 p -99.96 160.81 14.03 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 124.465 1.106 . . . . 0.0 109.678 171.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.97 109.49 0.27 Allowed Glycine 0 C--N 1.358 1.754 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.379 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.94 147.75 43.69 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 54.3 tp -72.43 123.29 22.79 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 126.092 1.757 . . . . 0.0 109.146 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.02 -58.0 2.01 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -133.23 127.44 33.72 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 127.053 2.141 . . . . 0.0 106.383 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.79 129.73 10.0 Favored Glycine 0 CA--C 1.496 -1.144 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 161.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -69.03 131.35 90.83 Favored Pre-proline 0 C--N 1.353 0.744 0 CA-C-N 118.435 1.118 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -105.76 82.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.68 1.636 . . . . 0.0 109.468 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.91 -72.73 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.205 3.402 . . . . 0.0 109.19 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 81.2 mt 50.87 37.68 17.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.377 3.071 . . . . 0.0 114.098 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.54 134.1 52.69 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.96 107.95 8.61 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -178.633 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 110.055 -0.787 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.03 121.01 25.38 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.63 -21.73 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 122.139 1.8 . . . . 0.0 109.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 35.46 71.97 0.11 Allowed 'General case' 0 C--N 1.361 1.079 0 C-N-CA 129.611 3.164 . . . . 0.0 115.127 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.72 136.3 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.6 155.5 50.36 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 9.5 p90 -149.54 139.79 22.23 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 26.6 t -169.11 117.8 0.66 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.51 154.28 36.85 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.29 155.4 47.76 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.905 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.59 127.72 39.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -165.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 51.3 p -160.9 13.8 0.1 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.233 -161.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.6 pp -20.82 143.45 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.456 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 158.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.35 -40.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.98 1.743 . . . . 0.0 112.48 -163.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -164.29 176.31 9.26 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 21.2 m -16.98 119.33 0.02 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.156 3.382 . . . . 0.0 115.451 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.2 147.37 42.77 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -162.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -76.27 -9.87 19.08 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.533 2.155 . . . . 0.0 112.695 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.59 -143.58 3.7 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 120.287 1.403 . . . . 0.0 111.262 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 33.0 m -81.92 147.04 29.48 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.234 1.814 . . . . 0.0 108.326 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 17.4 m -63.08 138.46 97.33 Favored Pre-proline 0 C--N 1.355 0.841 0 C-N-CA 125.413 1.485 . . . . 0.0 113.192 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -99.62 -150.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.723 2.949 . . . . 0.0 106.121 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -150.88 130.71 13.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -116.47 -14.49 10.94 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.427 0.691 . . . . 0.0 110.363 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -101.31 84.07 2.57 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 122.038 -0.414 . . . . 0.0 111.842 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.83 97.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 126.438 1.895 . . . . 0.0 106.461 166.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 12.6 mt -87.98 -38.03 15.87 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.714 -173.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.3 tp -165.3 129.3 2.34 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 101.266 -3.605 . . . . 0.0 101.266 165.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' B' ' 852' ' ' PHE . 32.1 t-20 179.03 62.2 0.01 OUTLIER 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.447 1.476 . . . . 0.0 109.214 -164.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -59.08 -44.54 91.9 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -167.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.88 -32.06 8.22 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 118.768 0.713 . . . . 0.0 112.242 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.16 -58.67 0.39 Allowed Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 63.8 -82.08 0.03 OUTLIER 'General case' 0 C--N 1.356 0.862 0 C-N-CA 128.13 2.572 . . . . 0.0 114.062 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.61 119.82 36.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 125.173 1.389 . . . . 0.0 108.308 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.27 117.92 69.09 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-O 115.459 -2.21 . . . . 0.0 105.309 171.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -91.79 2.31 4.24 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 125.507 3.002 . . . . 0.0 109.671 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -80.41 -44.53 19.19 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.606 1.163 . . . . 0.0 108.704 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 26.8 p -108.59 -13.19 14.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.085 1.354 . . . . 0.0 108.651 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.02 36.15 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 163.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 26.2 t -100.24 103.83 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.605 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 -164.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.402 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.4 OUTLIER -101.23 112.46 24.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.586 -2.097 . . . . 0.0 108.973 -176.014 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 88.7 m -100.79 108.13 19.86 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.96 110.13 39.87 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.138 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.95 -1.04 5.66 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.767 2.311 . . . . 0.0 108.843 165.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 129.832 3.253 . . . . 0.0 114.87 -169.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.45 58.93 2.78 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -170.23 -165.08 27.03 Favored Glycine 0 N--CA 1.412 -2.933 1 N-CA-C 102.461 -4.255 . . . . 0.0 102.461 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -92.08 121.87 34.04 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.777 -1.211 . . . . 0.0 107.868 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.441 ' H ' HD11 ' B' ' 954' ' ' LEU . 1.7 t80 -116.79 146.43 42.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -173.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.8 tp -111.51 114.86 28.24 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -113.35 139.37 48.92 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.28 1.832 . . . . 0.0 108.539 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -143.79 119.74 10.65 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.194 0.598 . . . . 0.0 109.703 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.58 21.01 Favored 'General case' 0 C--N 1.364 1.224 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.49 122.02 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.4 121.81 43.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.145 0.978 . . . . 0.0 109.19 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 40.1 m -82.66 132.0 35.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.646 1.578 . . . . 0.0 107.541 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.29 -57.72 17.68 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 124.758 1.171 . . . . 0.0 113.793 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 38.63 71.74 0.15 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 127.234 2.214 . . . . 0.0 114.774 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -71.0 -10.67 60.16 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.046 1.738 . . . . 0.0 112.043 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -73.82 -15.59 61.17 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.86 1.664 . . . . 0.0 112.908 -167.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.2 pt-20 122.1 179.4 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.856 2.462 . . . . 0.0 108.107 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 101.34 131.87 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 128.074 2.55 . . . . 0.0 107.088 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.26 126.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -110.69 122.85 48.82 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.966 -1.47 . . . . 0.0 113.093 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.81 115.74 15.67 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.842 2.457 . . . . 0.0 109.596 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 76.9 t -88.48 113.88 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 148.53 43.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.093 2.157 . . . . 0.0 111.493 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.275 0.8 OUTLIER -114.6 147.9 38.85 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 126.955 2.102 . . . . 0.0 109.715 178.5 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.512 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.73 140.13 35.73 Favored 'General case' 0 N--CA 1.424 -1.775 0 C-N-CA 125.652 1.581 . . . . 0.0 109.718 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.327 24.0 p 92.81 1.64 0.09 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 129.85 3.26 . . . . 0.0 114.363 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -147.28 -25.98 0.39 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-N 119.527 1.058 . . . . 0.0 111.408 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.55 168.01 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 125.678 1.591 . . . . 0.0 111.692 -162.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.61 -134.54 47.39 Favored Glycine 0 C--N 1.367 2.266 0 O-C-N 119.757 -1.839 . . . . 0.0 109.142 -163.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 44.6 t 54.49 80.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 126.314 1.846 . . . . 0.0 111.008 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.28 114.2 26.67 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -103.97 -38.22 7.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 113.298 -1.774 . . . . 0.0 108.757 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.55 87.01 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.615 -3.105 . . . . 0.0 102.615 166.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.4 130.48 42.19 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.0 t -142.43 115.77 8.99 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.038 1.335 . . . . 0.0 107.813 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.19 84.58 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 103.921 -3.672 . . . . 0.0 103.921 165.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 C-N-CA 125.172 1.367 . . . . 0.0 111.289 174.209 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 62.9 mt -116.95 134.27 54.96 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.62 26.98 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.01 128.83 75.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -138.1 151.51 47.86 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 68.7 m -117.24 -38.04 3.43 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.126 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.35 -53.61 4.27 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.071 0.85 . . . . 0.0 111.947 -168.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.22 177.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.85 1.26 . . . . 0.0 109.858 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -161.08 95.13 1.41 Allowed Pre-proline 0 C--N 1.358 0.954 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -163.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.88 95.74 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.945 2.43 . . . . 0.0 111.181 161.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' B' ' 954' ' ' LEU . 9.5 mp -119.77 139.85 51.67 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -93.92 159.15 15.31 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.841 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.82 122.95 21.61 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 120.058 1.299 . . . . 0.0 108.983 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.1 -11.51 71.94 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.413 1.959 . . . . 0.0 111.681 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -73.44 174.56 8.01 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.321 1.048 . . . . 0.0 109.993 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 94.0 m -143.09 125.06 15.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -158.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.512 HG13 HH11 ' B' ' 914' ' ' ARG . 27.9 m -96.37 150.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 121.567 0.698 . . . . 0.0 110.244 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -140.95 139.02 34.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.518 1.927 . . . . 0.0 111.44 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.2 t -91.63 129.53 42.18 Favored 'Isoleucine or valine' 0 C--N 1.367 1.354 0 C-N-CA 127.261 2.224 . . . . 0.0 106.516 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.79 132.36 52.85 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.59 77.63 1.8 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 50.2 t -160.2 101.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -153.48 66.38 0.76 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.63 145.66 6.52 Favored Glycine 0 CA--C 1.492 -1.383 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -112.87 -30.92 6.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.5 86.76 6.15 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.64 -165.76 1.83 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -123.51 157.84 32.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 16.4 t -91.43 133.22 35.66 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.64 151.66 22.48 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.43 110.78 19.37 Favored Pre-proline 0 C--N 1.353 0.753 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -98.13 173.09 0.58 Allowed 'Trans proline' 0 CA--C 1.507 -0.836 0 C-N-CA 121.812 1.675 . . . . 0.0 108.172 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.51 139.28 50.21 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.8 p -138.02 138.13 38.54 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.5 mm -117.24 130.71 71.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -127.05 106.32 9.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 32.7 p -100.63 160.94 13.94 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.494 1.117 . . . . 0.0 109.771 171.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.21 109.55 0.27 Allowed Glycine 0 C--N 1.358 1.781 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.82 149.62 41.77 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.85 124.14 24.19 Favored 'General case' 0 C--N 1.378 1.836 0 C-N-CA 125.841 1.656 . . . . 0.0 109.718 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.33 -59.06 1.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -133.33 127.22 33.07 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 125.916 1.686 . . . . 0.0 106.489 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.81 130.05 10.11 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 104.311 -3.516 . . . . 0.0 104.311 161.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.12 131.27 90.71 Favored Pre-proline 0 C--N 1.351 0.652 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.205 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -105.48 81.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 121.695 1.641 . . . . 0.0 109.054 -170.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.31 -72.23 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 130.191 3.396 . . . . 0.0 109.139 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 80.1 mt 49.95 40.89 22.09 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 129.126 2.97 . . . . 0.0 113.785 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.96 133.54 55.41 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -133.34 107.78 8.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.13 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.767 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.76 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.51 114.92 29.99 Favored Pre-proline 0 N--CA 1.44 -0.943 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.24 -24.97 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 121.689 1.639 . . . . 0.0 109.826 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 41.55 66.5 0.68 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 128.192 2.597 . . . . 0.0 114.868 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.86 133.74 66.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.01 50.85 Favored 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 166.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 10.3 p90 -149.83 139.55 21.73 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 118.886 0.766 . . . . 0.0 109.82 175.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 22.7 t -169.44 120.2 0.69 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.25 -0.906 . . . . 0.0 108.8 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.51 153.05 34.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.507 ' HB2' HD11 ' C' ' 872' ' ' LEU . . . -139.08 158.08 44.82 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 121.685 0.755 . . . . 0.0 110.493 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.525 HD21 HD23 ' C' ' 858' ' ' LEU . 2.9 tm? -139.89 130.55 25.79 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -164.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 60.1 m -159.02 15.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.525 HD23 HD21 ' C' ' 856' ' ' LEU . 2.0 pp -25.8 142.79 0.04 OUTLIER Pre-proline 0 C--N 1.372 1.546 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 161.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.84 -44.05 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 CA-C-N 122.222 1.829 . . . . 0.0 113.529 -161.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -162.47 175.72 11.2 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 13.1 m -4.63 113.06 0.01 OUTLIER 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.673 3.589 . . . . 0.0 116.774 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 160.91 24.37 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.4 -17.75 7.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.418 2.079 . . . . 0.0 110.533 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -141.29 3.12 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 11.8 m -65.53 143.31 57.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.029 1.732 . . . . 0.0 110.061 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.75 132.65 25.71 Favored Pre-proline 0 N--CA 1.437 -1.098 0 C-N-CA 124.37 1.068 . . . . 0.0 110.447 -159.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.37 -151.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 124.135 3.223 . . . . 0.0 109.334 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -147.1 136.12 22.37 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -114.76 -17.78 11.52 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.669 0.788 . . . . 0.0 110.9 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 26.1 mmm180 -102.48 84.43 2.44 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.166 0.508 . . . . 0.0 111.125 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.68 98.22 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 126.699 1.999 . . . . 0.0 106.868 167.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' C' ' 855' ' ' ALA . 8.8 mt -85.81 -39.43 17.09 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.967 -173.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.9 tp -166.96 128.98 1.7 Allowed 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 100.598 -3.853 . . . . 0.0 100.598 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.1 t-20 178.71 61.91 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 108.333 -164.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.1 -44.42 94.84 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.26 -29.67 11.02 Favored Glycine 0 C--N 1.356 1.661 0 CA-C-N 118.716 0.689 . . . . 0.0 112.165 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.17 -57.76 0.42 Allowed Glycine 0 C--N 1.353 1.521 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 62.91 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.245 2.618 . . . . 0.0 113.982 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -97.53 120.64 38.28 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 125.861 1.665 . . . . 0.0 108.677 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.97 117.87 69.93 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -93.36 5.96 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 124.91 2.789 . . . . 0.0 109.887 -167.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 -46.07 17.8 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -105.67 -13.14 15.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.877 1.271 . . . . 0.0 108.327 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.98 43.63 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 162.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 70.0 t -99.53 104.22 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 102.05 -3.315 . . . . 0.0 102.05 -164.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -98.53 112.37 24.43 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 111.921 -2.4 . . . . 0.0 109.233 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 90.7 m -100.32 109.24 21.43 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.82 108.86 30.7 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.262 -1.352 . . . . 0.0 110.968 171.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -90.11 -3.86 5.28 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.528 2.152 . . . . 0.0 108.43 166.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 68.4 mt -54.51 -52.29 62.44 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 127.736 2.414 . . . . 0.0 114.418 -165.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.58 68.15 0.82 Allowed 'General case' 0 C--N 1.367 1.328 0 CA-C-O 122.076 0.941 . . . . 0.0 111.61 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.88 -167.55 34.95 Favored Glycine 0 N--CA 1.405 -3.433 1 N-CA-C 102.498 -4.241 . . . . 0.0 102.498 -171.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 893' ' ' ARG . . . . . 0.443 ' HE ' HG22 ' C' ' 953' ' ' ILE . 70.4 ttt-85 -92.03 121.21 33.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.275 -1.463 . . . . 0.0 108.643 172.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.591 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -117.78 145.61 44.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 51.6 tp -110.14 113.84 26.86 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.8 tt -112.0 137.61 49.77 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.318 1.447 . . . . 0.0 108.925 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.8 m -144.29 119.27 10.0 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.398 0.679 . . . . 0.0 109.919 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.15 153.74 22.73 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 91.1 t -101.7 122.64 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.59 121.87 40.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.026 0.93 . . . . 0.0 109.355 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.9 130.56 35.39 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -54.82 -56.84 20.71 Favored Glycine 0 C--N 1.366 2.247 0 C-N-CA 125.356 1.455 . . . . 0.0 113.354 -172.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 42.3 65.67 0.86 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.633 2.373 . . . . 0.0 114.181 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.39 -7.24 50.83 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 125.076 1.35 . . . . 0.0 112.178 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -71.38 -14.09 62.06 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.235 1.814 . . . . 0.0 112.187 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.338 6.1 pt-20 113.73 179.53 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.108 2.563 . . . . 0.0 108.051 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 109.42 137.46 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 128.56 2.744 . . . . 0.0 105.856 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 97.8 t -98.4 123.64 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -103.67 131.68 50.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.361 172.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.05 114.22 3.64 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.095 1.358 . . . . 0.0 110.519 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.27 117.74 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 125.867 1.667 . . . . 0.0 108.999 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.6 mt -62.53 143.5 57.12 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.74 1.616 . . . . 0.0 110.519 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 1.4 p -113.78 147.79 37.68 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.627 1.971 . . . . 0.0 107.795 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.528 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -78.73 137.35 37.73 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.891 173.285 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 2.9 t 97.93 -11.48 0.06 Allowed 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 128.797 2.839 . . . . 0.0 112.341 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.86 -27.63 0.58 Allowed 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 119.256 0.934 . . . . 0.0 111.501 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 59.04 169.09 0.06 Allowed 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.933 1.293 . . . . 0.0 112.254 -164.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.84 -130.74 51.46 Favored Glycine 0 C--N 1.376 2.79 0 O-C-N 119.702 -1.874 . . . . 0.0 110.12 -164.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 51.97 73.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.329 0 C-N-CA 126.191 1.797 . . . . 0.0 111.37 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.82 28.37 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -101.18 -30.89 11.3 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.518 -173.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.18 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 165.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -95.22 131.23 41.51 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 120.903 0.382 . . . . 0.0 111.184 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.2 t -143.88 115.07 7.93 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 125.283 1.433 . . . . 0.0 107.812 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.17 85.02 0.72 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 104.281 -3.528 . . . . 0.0 104.281 169.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.602 0 C-N-CA 125.183 1.373 . . . . 0.0 110.892 173.557 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.6 mt -122.46 134.56 54.58 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.93 163.31 27.0 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.76 132.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.46 149.81 47.12 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -121.33 -36.99 2.98 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 118.398 0.544 . . . . 0.0 111.802 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 29.0 tp -89.47 -53.77 4.39 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.533 0.606 . . . . 0.0 112.045 -165.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.443 HG22 ' HE ' ' C' ' 893' ' ' ARG . 25.4 pt -89.83 -162.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.846 0 C-N-CA 125.079 1.352 . . . . 0.0 108.871 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.591 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -165.26 88.15 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -166.543 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.94 88.18 1.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 122.422 1.901 . . . . 0.0 109.133 159.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.8 146.18 48.53 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.479 2.312 . . . . 0.0 105.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -92.71 159.98 15.18 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 119.213 0.915 . . . . 0.0 109.381 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.72 122.66 21.86 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 120.335 1.425 . . . . 0.0 108.954 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.75 71.34 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 125.95 1.738 . . . . 0.0 111.042 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.99 175.44 5.14 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.088 0.555 . . . . 0.0 111.075 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 17.1 p -141.83 127.96 19.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -157.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.528 HG13 HH11 ' C' ' 914' ' ' ARG . 17.1 m -93.41 150.19 4.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.8 t -139.72 136.5 34.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.882 1.273 . . . . 0.0 112.089 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.95 129.08 44.8 Favored 'Isoleucine or valine' 0 C--N 1.373 1.603 0 C-N-CA 126.486 1.914 . . . . 0.0 106.753 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.61 132.37 53.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 171.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.41 78.52 1.83 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.04 -1.891 . . . . 0.0 106.185 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -160.8 100.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.887 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 89.3 mmm -152.16 66.23 0.84 Allowed 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.79 143.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -112.8 -22.37 10.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.462 0.705 . . . . 0.0 109.982 -172.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 6.5 tt -98.6 86.23 3.53 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.74 -164.62 1.64 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -121.66 153.18 38.48 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 20.1 t -89.96 132.2 35.46 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -157.93 151.28 23.36 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.45 115.34 19.74 Favored Pre-proline 0 C--N 1.355 0.823 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.32 171.67 0.38 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.98 138.87 49.2 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.9 p -137.33 137.55 39.04 Favored 'General case' 0 C--N 1.376 1.746 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.0 mm -115.43 131.04 68.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.26 106.38 9.83 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 32.7 p -100.91 163.94 12.06 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.16 1.384 . . . . 0.0 110.222 172.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.91 111.19 0.32 Allowed Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.08 47.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 58.0 tp -78.18 124.42 28.05 Favored 'General case' 0 C--N 1.379 1.88 0 C-N-CA 124.516 1.126 . . . . 0.0 108.135 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 35.1 tp -97.1 -57.2 2.33 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.056 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -131.18 128.49 40.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 -174.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 131.05 10.51 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 103.412 -3.875 . . . . 0.0 103.412 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.41 131.93 88.03 Favored Pre-proline 0 C--N 1.351 0.645 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -105.84 81.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.427 0 CA-C-N 121.903 1.715 . . . . 0.0 109.847 -171.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 78.79 -72.12 0.09 Allowed 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 130.231 3.413 . . . . 0.0 109.171 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.7 mt 51.19 39.88 24.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 129.209 3.004 . . . . 0.0 113.787 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -112.62 133.49 54.64 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.86 107.86 8.59 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.453 -0.9 0 N-CA-C 110.232 -0.719 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 43.8 t -127.85 120.87 21.76 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.12 -22.23 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 122.032 1.762 . . . . 0.0 109.496 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 36.81 69.9 0.19 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.045 2.938 . . . . 0.0 115.607 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.63 136.21 56.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 160.63 37.71 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 12.2 p90 -149.23 139.76 22.51 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.6 t -169.27 116.56 0.61 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.61 153.02 36.11 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.02 158.54 44.22 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.21 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.482 HD21 HD23 ' A' ' 858' ' ' LEU . 2.5 tm? -134.81 134.72 41.14 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -167.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.438 ' H ' ' H ' ' A' ' 858' ' ' LEU . 40.6 p -164.25 10.1 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -163.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.482 HD23 HD21 ' A' ' 856' ' ' LEU . 2.1 pp -28.62 144.76 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.51 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 160.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -79.07 -47.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 122.324 1.866 . . . . 0.0 112.875 -162.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -162.2 170.55 18.86 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.6 m 4.03 104.05 0.0 OUTLIER 'General case' 0 C--N 1.36 1.058 0 C-N-CA 130.848 3.659 . . . . 0.0 117.463 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -96.46 163.57 20.25 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 123.174 0.59 . . . . 0.0 110.25 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.54 -14.61 12.8 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.662 2.241 . . . . 0.0 110.768 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -168.25 -142.5 3.51 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -63.83 144.46 57.03 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.714 2.006 . . . . 0.0 110.864 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 55.2 t -95.12 131.51 29.92 Favored Pre-proline 0 N--CA 1.439 -0.989 0 C-N-CA 124.841 1.256 . . . . 0.0 110.705 -162.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -95.84 -148.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.199 3.266 . . . . 0.0 108.464 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -149.65 136.86 19.79 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 41.6 p-10 -117.24 -15.61 10.41 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.909 0.484 . . . . 0.0 111.98 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -100.78 86.73 3.15 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 118.665 0.666 . . . . 0.0 112.723 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 871' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 874' ' ' ASN . 62.1 t -70.56 97.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.059 1.743 . . . . 0.0 107.123 167.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 48.0 mt -87.92 -36.46 17.12 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.969 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.6 tp -165.16 126.87 2.07 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 160.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.431 ' HB3' HG13 ' A' ' 871' ' ' VAL . 35.3 t-20 -174.88 61.86 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 120.528 1.513 . . . . 0.0 109.387 -168.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.8 -44.43 86.31 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -164.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.22 -30.6 8.61 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.946 0.793 . . . . 0.0 112.38 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.29 -60.76 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.86 -79.18 0.03 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.084 2.554 . . . . 0.0 114.111 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -95.8 120.1 35.48 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.154 1.382 . . . . 0.0 108.296 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.68 116.41 62.9 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -94.59 5.05 2.56 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 CA-C-N 125.204 2.894 . . . . 0.0 108.961 -165.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -79.82 -46.13 17.48 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 27.3 p -106.11 -12.15 15.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.902 172.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.34 25.88 41.91 Favored Glycine 0 C--N 1.362 2.015 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 163.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 44.9 t -101.36 102.83 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 100.481 -3.896 . . . . 0.0 100.481 -163.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 114.48 27.55 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 110.924 -2.853 . . . . 0.0 108.941 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 81.5 m -99.1 109.8 22.47 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.75 110.02 36.52 Favored Pre-proline 0 C--N 1.356 0.851 0 C-N-CA 125.591 1.556 . . . . 0.0 112.875 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -98.29 -8.38 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 CA-C-N 123.195 2.177 . . . . 0.0 108.653 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 26.3 mt -44.51 -58.99 2.66 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 129.963 3.305 . . . . 0.0 114.546 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.09 64.12 1.59 Allowed 'General case' 0 C--N 1.364 1.214 0 CA-C-O 121.839 0.828 . . . . 0.0 111.912 172.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.66 -174.35 39.84 Favored Glycine 0 N--CA 1.409 -3.113 1 N-CA-C 101.364 -4.694 . . . . 0.0 101.364 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.409 HH21 HG22 ' A' ' 953' ' ' ILE . 75.3 ttt-85 -93.34 121.84 35.14 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.253 2.6 p90 -114.04 159.92 19.45 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-N 119.0 0.818 . . . . 0.0 108.936 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.82 117.8 34.95 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.759 0.824 . . . . 0.0 110.061 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.4 tt -111.17 136.54 50.09 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 126.659 1.984 . . . . 0.0 108.997 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 73.1 m -147.01 118.93 8.13 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 153.84 22.05 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.4 t -109.44 118.86 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.28 124.87 44.72 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.41 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 39.5 m -81.38 131.68 35.3 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 125.251 1.42 . . . . 0.0 107.337 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.88 -57.44 19.87 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.161 1.363 . . . . 0.0 114.066 -169.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 66.5 m170 38.15 73.01 0.11 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.13 2.172 . . . . 0.0 115.153 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -71.16 -12.84 61.71 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.784 1.634 . . . . 0.0 111.719 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -73.55 -19.99 60.75 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.299 1.439 . . . . 0.0 112.375 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.324 13.2 pt-20 125.98 -178.21 0.0 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 127.458 2.303 . . . . 0.0 108.261 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 100.72 131.19 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.074 2.549 . . . . 0.0 106.799 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.38 126.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -108.25 123.37 48.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.16 172.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.47 116.92 15.68 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 128.996 2.918 . . . . 0.0 109.892 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 99.4 t -87.91 113.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.0 141.6 57.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 126.142 1.777 . . . . 0.0 110.563 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.4 t -116.98 145.87 43.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 125.218 1.407 . . . . 0.0 111.734 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.494 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -79.68 142.71 35.27 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 129.19 2.996 . . . . 0.0 111.052 -175.505 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 83.86 12.28 0.38 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 128.714 2.806 . . . . 0.0 112.336 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -151.79 -26.72 0.19 Allowed 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.281 -0.887 . . . . 0.0 110.628 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 57.9 167.05 0.04 OUTLIER 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.753 1.621 . . . . 0.0 112.174 -163.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.65 -134.03 49.78 Favored Glycine 0 C--N 1.372 2.556 0 O-C-N 119.217 -2.177 . . . . 0.0 109.742 -161.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 52.8 t 57.79 75.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.313 0 C-N-CA 125.79 1.636 . . . . 0.0 110.651 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.49 114.31 26.83 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -102.33 -35.17 8.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.448 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.6 83.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.728 -3.064 . . . . 0.0 102.728 167.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.59 129.36 43.99 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 121.201 0.524 . . . . 0.0 109.763 -171.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 29.7 t -143.27 115.92 8.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.506 1.523 . . . . 0.0 107.906 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.83 84.68 0.73 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 103.632 -3.787 . . . . 0.0 103.632 163.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.689 0 C-N-CA 126.24 1.876 . . . . 0.0 111.524 172.71 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.49 133.33 55.95 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.64 163.23 25.83 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -172.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 14.5 m -124.62 131.07 73.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -136.86 142.53 42.82 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.2 m -116.72 -44.49 2.83 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 33.2 tp -87.48 -53.65 4.7 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-N 119.442 1.019 . . . . 0.0 111.739 -168.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.409 HG22 HH21 ' A' ' 893' ' ' ARG . 11.2 pt -83.73 -176.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 124.262 1.025 . . . . 0.0 108.313 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.567 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -158.46 83.0 2.67 Favored Pre-proline 0 N--CA 1.433 -1.284 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -163.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.82 91.95 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.535 2.156 . . . . 0.0 109.697 167.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 954' ' ' LEU . 8.9 mp -121.78 145.89 47.6 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 126.558 1.943 . . . . 0.0 106.566 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -95.88 157.91 15.68 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.898 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.55 124.73 24.94 Favored 'General case' 0 C--N 1.375 1.705 0 CA-C-N 119.702 1.137 . . . . 0.0 109.222 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.21 69.55 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 126.306 1.908 . . . . 0.0 112.128 171.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 960' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 914' ' ' ARG . 0.9 OUTLIER -72.49 171.96 11.37 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.839 0.819 . . . . 0.0 112.116 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 85.4 m -142.28 127.81 19.02 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -157.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.494 HG13 HH11 ' A' ' 914' ' ' ARG . 20.2 m -94.83 149.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-O 121.314 0.578 . . . . 0.0 110.114 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.4 m -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 60.9 t -94.07 130.03 43.56 Favored 'Isoleucine or valine' 0 C--N 1.371 1.51 0 C-N-CA 126.623 1.969 . . . . 0.0 106.868 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -106.02 132.84 51.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 73.26 1.47 Allowed 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -163.9 103.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 86.8 mmm -153.27 74.17 1.01 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.75 151.34 9.0 Favored Glycine 0 CA--C 1.495 -1.213 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 123.726 0.811 . . . . 0.0 108.855 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.92 87.34 6.18 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.71 -166.44 1.95 Allowed 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -125.24 160.39 29.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.0 t -92.53 132.08 37.13 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.64 150.2 22.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 113.33 24.31 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -98.35 173.33 0.54 Allowed 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 121.985 1.79 . . . . 0.0 108.447 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.57 140.75 49.21 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -139.86 141.75 36.62 Favored 'General case' 0 C--N 1.375 1.68 0 CA-C-N 119.538 1.063 . . . . 0.0 108.747 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.61 129.35 75.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -125.38 105.43 9.07 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 46.0 p -101.06 161.01 13.9 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.562 1.145 . . . . 0.0 110.281 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.46 0.28 Allowed Glycine 0 C--N 1.356 1.644 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.59 144.32 47.17 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -173.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.9 124.28 26.61 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 124.906 1.282 . . . . 0.0 109.789 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.1 -57.39 2.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.36 128.01 38.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.095 1.758 . . . . 0.0 106.537 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.7 130.73 10.44 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 103.545 -3.822 . . . . 0.0 103.545 163.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.59 130.95 90.08 Favored Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.406 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -107.06 80.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 121.984 1.744 . . . . 0.0 110.293 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 77.14 -72.87 0.09 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 130.602 3.561 . . . . 0.0 109.405 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.5 mt 49.74 40.07 19.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.523 3.129 . . . . 0.0 113.94 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -110.88 130.0 55.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -128.06 109.86 11.94 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.072 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.172 -0.741 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.33 121.41 22.52 Favored Pre-proline 0 C--N 1.354 0.762 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -92.69 -22.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 122.064 1.773 . . . . 0.0 109.879 -174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 38.78 69.58 0.26 Allowed 'General case' 0 C--N 1.36 1.039 0 C-N-CA 129.189 2.996 . . . . 0.0 115.204 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.86 136.24 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.58 160.39 38.21 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -149.41 139.94 22.5 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.3 t -169.31 117.32 0.63 Allowed 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.09 153.82 34.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -139.47 157.72 45.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.808 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.52 HD21 HD23 ' B' ' 858' ' ' LEU . 2.3 tm? -133.09 133.39 42.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -168.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.447 ' H ' ' H ' ' B' ' 858' ' ' LEU . 29.7 p -163.95 8.1 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -163.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.52 HD23 HD21 ' B' ' 856' ' ' LEU . 2.0 pp -28.74 144.91 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.513 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 160.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.43 -47.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 122.242 1.836 . . . . 0.0 112.877 -163.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -162.18 170.4 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.4 m 4.06 104.3 0.0 OUTLIER 'General case' 0 C--N 1.36 1.05 0 C-N-CA 130.877 3.671 . . . . 0.0 117.563 169.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -97.07 163.65 19.54 Favored Pre-proline 0 C--N 1.353 0.731 0 C-N-CA 123.229 0.612 . . . . 0.0 110.412 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.65 -14.83 12.54 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.645 2.23 . . . . 0.0 110.94 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.92 -142.41 3.47 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.2 m -63.63 143.95 57.41 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.611 1.964 . . . . 0.0 110.703 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.45 130.99 32.01 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 124.734 1.214 . . . . 0.0 110.463 -162.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -97.03 -148.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 124.047 3.164 . . . . 0.0 108.212 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.41 136.84 20.07 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -115.17 -13.96 11.76 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.397 1.079 . . . . 0.0 110.567 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.31 87.11 3.14 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 871' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' B' ' 874' ' ' ASN . 58.7 t -70.58 97.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' B' ' 855' ' ' ALA . 18.3 mt -87.58 -38.67 15.76 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.083 -172.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 56.6 tp -165.11 127.08 2.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 100.749 -3.797 . . . . 0.0 100.749 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.432 ' HB3' HG13 ' B' ' 871' ' ' VAL . 33.3 t-20 177.25 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 120.265 1.393 . . . . 0.0 108.648 -163.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -58.18 -43.66 87.6 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -166.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.15 -31.4 8.5 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 118.931 0.787 . . . . 0.0 112.479 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.22 -58.69 0.38 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 65.26 -80.36 0.03 OUTLIER 'General case' 0 C--N 1.355 0.831 0 C-N-CA 128.044 2.538 . . . . 0.0 114.406 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -97.1 119.88 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.335 1.454 . . . . 0.0 108.538 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.55 116.99 65.74 Favored Pre-proline 0 CA--C 1.503 -0.854 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -93.46 5.65 2.94 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.19 2.889 . . . . 0.0 108.986 -166.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -79.79 -44.94 19.71 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.407 1.083 . . . . 0.0 108.6 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 25.4 p -108.99 -12.48 14.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.909 1.284 . . . . 0.0 108.363 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.86 25.86 39.92 Favored Glycine 0 C--N 1.361 1.931 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 163.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 54.8 t -100.82 102.81 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 101.089 -3.671 . . . . 0.0 101.089 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.59 114.82 26.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 111.468 -2.605 . . . . 0.0 108.459 -174.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.0 m -99.17 109.78 22.42 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.15 110.45 38.39 Favored Pre-proline 0 C--N 1.357 0.922 0 C-N-CA 125.477 1.511 . . . . 0.0 113.307 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -99.42 -7.28 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 123.321 2.222 . . . . 0.0 108.931 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 16.0 mt -50.42 -51.95 41.92 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 128.618 2.767 . . . . 0.0 114.339 -168.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.8 49.09 14.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.214 1.406 . . . . 0.0 113.815 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -162.74 -166.68 21.94 Favored Glycine 0 N--CA 1.412 -2.943 1 N-CA-C 101.894 -4.482 . . . . 0.0 101.894 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -92.64 120.94 33.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 1.9 p90 -116.19 160.05 20.95 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-N 118.965 0.802 . . . . 0.0 108.841 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 54.6 tp -105.56 116.37 31.84 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.06 135.64 50.57 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 126.193 1.797 . . . . 0.0 107.827 -166.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 72.9 m -145.26 119.22 9.34 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.9 153.9 21.84 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.06 120.84 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.86 122.89 46.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.275 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.1 m -79.77 131.49 35.93 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.264 1.425 . . . . 0.0 107.936 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.73 -57.45 19.76 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.322 1.439 . . . . 0.0 114.25 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 66.4 m170 37.72 73.46 0.1 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 127.178 2.191 . . . . 0.0 115.093 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -71.48 -12.69 61.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.93 1.692 . . . . 0.0 111.544 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -74.62 -15.62 60.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.664 1.586 . . . . 0.0 112.628 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.0 pt-20 120.57 178.62 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 C-N-CA 127.911 2.485 . . . . 0.0 108.485 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 102.06 131.45 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 128.268 2.627 . . . . 0.0 106.581 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.92 131.57 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -112.02 123.42 50.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.18 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.23 115.04 13.69 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 128.426 2.69 . . . . 0.0 109.878 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.05 113.31 25.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.87 147.23 47.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.868 2.067 . . . . 0.0 111.294 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 1.9 t -117.03 147.3 42.46 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.454 1.502 . . . . 0.0 111.414 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.526 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.56 141.45 35.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 128.914 2.886 . . . . 0.0 110.004 -179.145 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 82.97 9.68 0.62 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.31 2.644 . . . . 0.0 112.82 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -150.17 -26.23 0.25 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.81 168.02 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.476 1.51 . . . . 0.0 112.077 -163.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.29 -133.08 48.42 Favored Glycine 0 C--N 1.366 2.213 0 O-C-N 119.5 -2.0 . . . . 0.0 109.775 -164.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 60.9 t 56.04 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.215 0 C-N-CA 126.23 1.812 . . . . 0.0 111.189 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.6 114.79 27.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -103.15 -35.44 8.48 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.484 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.17 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.04 128.76 44.77 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 33.3 t -141.48 117.43 10.52 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 171.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.82 84.8 0.74 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 165.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.709 0 C-N-CA 125.356 1.455 . . . . 0.0 111.273 175.18 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.4 m . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 59.2 mt -115.3 134.29 55.25 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -168.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.55 163.94 25.73 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 124.999 1.285 . . . . 0.0 109.95 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.97 131.51 72.8 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -137.33 146.52 44.69 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 50.5 m -128.23 -27.37 2.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.364 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 33.8 tp -92.54 -55.55 3.35 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 120.071 1.305 . . . . 0.0 111.425 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.78 -177.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 C-N-CA 125.162 1.385 . . . . 0.0 108.31 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -158.03 82.94 2.81 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.264 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.07 93.63 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.717 2.278 . . . . 0.0 110.223 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.566 HD13 ' HB2' ' B' ' 954' ' ' LEU . 10.5 mp -121.39 145.34 48.01 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 125.824 1.65 . . . . 0.0 107.106 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -95.09 158.19 15.57 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.241 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.88 124.42 24.81 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 119.844 1.202 . . . . 0.0 108.713 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.81 71.04 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 125.997 1.76 . . . . 0.0 111.994 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.73 170.62 14.19 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 117.957 0.878 . . . . 0.0 110.999 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 90.0 m -143.05 127.95 18.36 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.507 -155.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.526 HG13 HH11 ' B' ' 914' ' ' ARG . 16.5 m -96.03 150.31 4.36 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-O 121.172 0.51 . . . . 0.0 111.626 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.7 m -141.05 137.75 33.13 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 126.794 2.038 . . . . 0.0 111.338 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.59 131.05 41.63 Favored 'Isoleucine or valine' 0 C--N 1.368 1.39 0 C-N-CA 127.947 2.499 . . . . 0.0 107.43 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -105.89 132.97 51.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 100.677 -3.823 . . . . 0.0 100.677 171.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.72 72.5 1.4 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 56.8 t -161.83 104.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.3 mmm -152.28 72.68 1.0 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 173.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.26 150.06 8.44 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -115.64 -29.38 6.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 38.3 tp -93.01 86.78 5.53 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.42 -165.95 1.85 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -125.24 159.51 31.46 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.5 t -90.97 131.93 36.28 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.87 150.33 22.5 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.94 113.1 24.43 Favored Pre-proline 0 C--N 1.356 0.889 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -97.86 172.64 0.64 Allowed 'Trans proline' 0 CA--C 1.508 -0.801 0 C-N-CA 121.93 1.754 . . . . 0.0 108.297 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.54 139.18 50.77 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.8 p -139.02 140.56 38.18 Favored 'General case' 0 C--N 1.374 1.65 0 CA-C-N 119.51 1.05 . . . . 0.0 108.499 -170.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.93 130.79 72.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -126.64 105.15 8.5 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 33.3 p -101.72 162.23 13.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.768 1.227 . . . . 0.0 110.494 170.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.14 112.09 0.32 Allowed Glycine 0 C--N 1.357 1.71 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.68 145.32 46.6 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.3 tp -73.14 124.09 24.89 Favored 'General case' 0 C--N 1.379 1.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.423 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.84 -57.52 2.21 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -131.42 127.62 37.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -173.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.81 130.61 10.39 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 103.32 -3.912 . . . . 0.0 103.32 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.11 130.64 89.49 Favored Pre-proline 0 C--N 1.351 0.66 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.569 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -106.26 81.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 122.008 1.753 . . . . 0.0 109.784 -168.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 77.3 -72.38 0.1 Allowed 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 130.311 3.444 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 75.2 mt 49.06 43.33 22.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.326 3.05 . . . . 0.0 113.569 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.52 129.6 56.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -129.0 109.41 11.2 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 N-CA-C 110.328 -0.682 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 31.1 t -122.09 114.73 30.64 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -87.95 -23.65 1.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 CA-C-N 121.649 1.624 . . . . 0.0 110.074 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 37.93 67.95 0.35 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 129.11 2.964 . . . . 0.0 115.755 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.8 136.91 58.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.09 156.84 48.33 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 165.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 8.5 p90 -148.13 138.55 22.84 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 118.767 0.712 . . . . 0.0 109.105 178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 14.0 t -170.74 120.03 0.55 Allowed 'General case' 0 C--N 1.36 1.052 0 O-C-N 121.664 -0.648 . . . . 0.0 110.097 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.8 153.3 35.94 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.36 157.67 45.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.96 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.564 HD11 HD23 ' C' ' 858' ' ' LEU . 2.9 tm? -140.8 130.51 24.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -163.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 72.8 m -157.56 17.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.564 HD23 HD11 ' C' ' 856' ' ' LEU . 2.5 pp -22.44 140.13 0.04 OUTLIER Pre-proline 0 C--N 1.374 1.632 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 159.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.31 -44.76 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 122.243 1.837 . . . . 0.0 111.685 -166.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 30.9 ptt85 -163.89 170.91 16.11 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -1.03 108.73 0.01 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 130.564 3.546 . . . . 0.0 117.22 167.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.52 161.59 23.5 Favored Pre-proline 0 N--CA 1.443 -0.797 0 C-N-CA 123.708 0.803 . . . . 0.0 108.922 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.79 -12.62 14.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.848 2.366 . . . . 0.0 110.776 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.25 3.11 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.7 m -65.48 146.25 55.11 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.906 1.682 . . . . 0.0 111.037 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.21 132.63 31.78 Favored Pre-proline 0 N--CA 1.44 -0.963 0 C-N-CA 125.383 1.473 . . . . 0.0 110.281 -164.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -99.52 -148.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 124.164 3.243 . . . . 0.0 108.556 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -147.28 135.46 21.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -116.21 -18.69 10.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.264 0.626 . . . . 0.0 111.405 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -103.57 80.69 1.82 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 122.888 0.475 . . . . 0.0 111.55 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.27 99.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 126.421 1.889 . . . . 0.0 107.189 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.82 -38.32 14.71 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.856 -172.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 36.9 tp -165.3 127.54 2.11 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 30.1 t-20 176.41 61.92 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 120.234 1.379 . . . . 0.0 107.957 -163.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.84 -42.78 90.09 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -165.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.04 -29.07 13.33 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.844 0.747 . . . . 0.0 112.515 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.31 -57.73 0.49 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 62.66 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.348 2.659 . . . . 0.0 114.891 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -94.13 121.01 35.19 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 125.139 1.376 . . . . 0.0 108.885 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.69 116.92 67.04 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -94.69 7.58 2.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 124.455 2.627 . . . . 0.0 109.332 -169.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -79.34 -46.62 17.3 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 37.5 p -108.02 -10.52 15.46 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.793 1.237 . . . . 0.0 108.411 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 28.0 33.89 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 161.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.84 101.66 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 101.088 -3.671 . . . . 0.0 101.088 -166.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -95.93 112.19 23.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 112.212 -2.267 . . . . 0.0 108.941 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 58.1 m -102.12 109.15 20.78 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 888' ' ' ALA . . . . . 0.494 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.02 110.87 45.15 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.583 170.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.65 1.45 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.569 2.179 . . . . 0.0 108.271 164.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 42.4 mt -53.6 -54.65 34.55 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 128.471 2.709 . . . . 0.0 113.45 -169.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.01 68.43 0.82 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.132 0.968 . . . . 0.0 111.037 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -177.16 174.13 46.79 Favored Glycine 0 N--CA 1.406 -3.348 1 N-CA-C 101.066 -4.813 . . . . 0.0 101.066 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -93.82 117.67 30.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.552 -1.324 . . . . 0.0 107.897 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -115.64 160.12 20.44 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 119.217 0.917 . . . . 0.0 110.159 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.1 tp -108.38 112.78 25.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.4 tt -116.82 140.13 49.8 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.062 1.345 . . . . 0.0 108.861 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 69.0 m -143.42 120.06 11.12 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.461 0.704 . . . . 0.0 109.571 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.26 154.4 19.83 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 95.1 t -100.84 122.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 55.5 mt -94.55 122.52 37.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.584 1.154 . . . . 0.0 109.156 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 12.2 m -81.8 132.55 35.28 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -49.77 -57.01 10.21 Favored Glycine 0 C--N 1.36 1.879 0 C-N-CA 126.159 1.837 . . . . 0.0 115.954 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.3 m80 40.22 69.95 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 127.241 2.216 . . . . 0.0 114.765 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -73.7 -8.86 57.66 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.833 1.253 . . . . 0.0 111.855 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -75.5 -4.9 42.39 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 126.338 1.855 . . . . 0.0 111.543 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.292 47.3 mt-10 96.63 -149.72 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 128.4 2.68 . . . . 0.0 107.804 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 84.12 135.27 0.05 Allowed 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.269 2.227 . . . . 0.0 108.819 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.71 128.22 51.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-O 122.499 1.143 . . . . 0.0 108.025 -171.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -111.08 131.34 55.15 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 127.315 2.246 . . . . 0.0 110.164 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -158.05 113.83 2.75 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.646 1.178 . . . . 0.0 110.716 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.07 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.084 1.754 . . . . 0.0 109.111 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 32.2 mt -62.37 143.32 57.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.261 1.824 . . . . 0.0 111.111 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.265 1.3 p -114.52 148.83 37.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 126.513 1.925 . . . . 0.0 108.598 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.494 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.77 137.74 37.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 125.321 1.449 . . . . 0.0 109.431 176.463 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.0 t 90.24 0.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.689 2.796 . . . . 0.0 112.694 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -145.76 -26.52 0.45 Allowed 'General case' 0 C--N 1.36 1.025 0 CA-C-N 119.495 1.043 . . . . 0.0 111.99 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 58.77 169.57 0.06 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 125.167 1.387 . . . . 0.0 111.954 -163.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.08 -127.93 46.09 Favored Glycine 0 C--N 1.374 2.667 0 O-C-N 119.741 -1.849 . . . . 0.0 110.152 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 53.4 t 49.38 72.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 126.601 1.96 . . . . 0.0 111.912 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 116.55 28.94 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -169.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -95.8 -35.7 11.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.067 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 56.3 t -99.38 81.21 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.84 131.42 40.75 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 121.091 0.472 . . . . 0.0 111.136 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -144.09 116.17 8.39 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 125.351 1.46 . . . . 0.0 108.126 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.09 84.77 0.65 Allowed Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.643 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 173.023 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.07 134.56 55.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.0 163.41 26.65 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -117.91 129.57 74.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.91 146.47 50.94 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.328 -0.858 . . . . 0.0 110.23 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.1 m -103.97 -84.06 0.48 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.716 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.32 -46.96 88.11 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.084 1.754 . . . . 0.0 114.627 -163.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.34 -179.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 124.72 1.208 . . . . 0.0 110.141 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.48 ' HB2' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -163.22 82.24 1.51 Allowed Pre-proline 0 C--N 1.355 0.836 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -168.441 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.92 88.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.278 1.985 . . . . 0.0 110.734 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' C' ' 954' ' ' LEU . 11.2 mp -123.59 147.46 47.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -91.33 162.53 14.57 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.358 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.71 122.74 21.15 Favored 'General case' 0 C--N 1.38 1.934 0 CA-C-N 120.954 1.706 . . . . 0.0 108.957 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.87 73.45 Favored Glycine 0 CA--C 1.496 -1.134 0 C-N-CA 125.49 1.519 . . . . 0.0 111.62 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -68.47 176.44 2.87 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.855 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 90.6 m -143.71 127.28 16.99 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.433 1.093 . . . . 0.0 110.922 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.401 HG13 ' HD3' ' C' ' 914' ' ' ARG . 16.8 m -98.21 147.82 6.42 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 124.802 1.241 . . . . 0.0 108.84 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 16.9 t -141.94 137.95 31.63 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.825 1.65 . . . . 0.0 111.737 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 23.8 t -90.89 129.24 42.0 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 C-N-CA 126.233 1.813 . . . . 0.0 106.169 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.68 133.5 49.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.137 -3.653 . . . . 0.0 101.137 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.53 72.64 1.45 Allowed 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.064 -1.88 . . . . 0.0 106.391 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.5 t -160.39 97.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.4 mmm -150.6 78.27 1.31 Allowed 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.98 147.53 14.1 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -113.96 -22.51 10.06 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.435 0.694 . . . . 0.0 110.135 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -98.7 85.62 3.36 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.03 -166.72 1.96 Allowed 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -119.73 150.02 41.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -88.69 130.32 35.34 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -154.95 147.93 24.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.01 115.27 26.27 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -103.73 177.22 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.7 0 C-N-CA 121.553 1.502 . . . . 0.0 108.283 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.48 138.18 51.58 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -137.81 139.95 40.26 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 119.98 1.264 . . . . 0.0 108.192 -171.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.38 131.48 67.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.47 104.92 8.69 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 35.1 p -101.83 162.89 12.57 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.942 1.297 . . . . 0.0 110.225 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.88 112.18 0.35 Allowed Glycine 0 C--N 1.359 1.818 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.28 141.95 47.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 55.8 tp -76.57 124.32 27.43 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.139 1.376 . . . . 0.0 109.439 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 16.2 tp -97.14 -56.57 2.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -131.21 127.24 37.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.51 9.09 Favored Glycine 0 CA--C 1.494 -1.27 0 N-CA-C 103.485 -3.846 . . . . 0.0 103.485 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -69.91 131.17 89.38 Favored Pre-proline 0 C--N 1.354 0.764 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.929 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -106.27 77.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 CA-C-N 122.219 1.828 . . . . 0.0 109.875 -166.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.02 -73.23 0.08 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 130.21 3.404 . . . . 0.0 108.893 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.3 mt 48.93 42.47 20.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 129.171 2.988 . . . . 0.0 113.479 -173.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -113.61 129.64 56.53 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.42 109.61 11.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.452 -0.917 0 N-CA-C 109.998 -0.808 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 118.73 24.16 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.98 -21.61 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.064 1.773 . . . . 0.0 109.875 -172.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 35.9 69.85 0.17 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.032 2.933 . . . . 0.0 115.773 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.63 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.1 155.72 49.77 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 166.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 11.4 p90 -149.62 138.77 21.27 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.0 t -169.04 117.53 0.66 Allowed 'General case' 0 C--N 1.352 0.702 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.29 152.73 36.21 Favored 'General case' 0 C--N 1.37 1.479 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.48 158.44 44.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.488 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.433 HD11 HD23 ' A' ' 858' ' ' LEU . 2.6 tm? -130.68 130.88 44.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -167.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.0 p -159.22 16.66 0.17 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -167.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.433 HD23 HD11 ' A' ' 856' ' ' LEU . 3.2 pp -21.92 145.55 0.01 OUTLIER Pre-proline 0 C--N 1.368 1.41 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 158.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.36 -48.0 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.927 1.751 . . . . 0.0 112.681 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -163.11 178.52 8.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.3 m -19.43 121.84 0.02 OUTLIER 'General case' 0 C--N 1.363 1.188 0 C-N-CA 129.615 3.166 . . . . 0.0 115.679 172.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -126.63 146.08 55.6 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -163.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -76.86 -10.25 18.24 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 CA-C-N 122.75 2.018 . . . . 0.0 112.937 -161.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.98 -141.12 3.04 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -63.45 145.8 54.89 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.31 1.844 . . . . 0.0 110.48 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 91.9 t -88.93 129.27 48.97 Favored Pre-proline 0 N--CA 1.436 -1.147 0 C-N-CA 125.059 1.344 . . . . 0.0 110.363 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -94.62 -153.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.056 3.171 . . . . 0.0 108.656 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -148.01 132.59 17.76 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -117.59 -11.97 10.38 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 122.707 0.403 . . . . 0.0 111.354 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -99.64 86.68 3.38 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 121.835 -0.541 . . . . 0.0 111.49 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.69 96.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' B' ' 953' ' ' ILE . 60.9 mt -87.18 -37.52 17.22 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.634 -173.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.0 tp -166.32 127.04 1.71 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.009 -3.7 . . . . 0.0 101.009 164.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 29.4 t-20 -177.0 61.13 0.01 OUTLIER 'General case' 0 C--N 1.357 0.93 0 CA-C-N 120.756 1.616 . . . . 0.0 109.618 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -61.01 -44.12 97.89 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -165.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.18 -27.77 12.95 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-N 118.927 0.785 . . . . 0.0 112.614 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.25 -61.74 0.3 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 61.74 -81.79 0.02 OUTLIER 'General case' 0 C--N 1.353 0.749 0 C-N-CA 128.067 2.547 . . . . 0.0 114.125 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -94.36 119.23 32.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.358 1.063 . . . . 0.0 108.47 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.03 117.64 69.1 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -94.91 2.36 2.62 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 CA-C-N 125.12 2.864 . . . . 0.0 109.473 -166.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.46 -45.74 17.07 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.5 p -103.69 -13.97 16.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.438 1.095 . . . . 0.0 108.834 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.76 23.5 49.64 Favored Glycine 0 C--N 1.362 2.012 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 162.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.68 103.7 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.583 -3.488 . . . . 0.0 101.583 -164.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.56 111.46 23.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 112.502 -2.135 . . . . 0.0 109.496 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 57.4 m -100.43 107.89 19.74 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 888' ' ' ALA . . . . . 0.471 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -91.33 110.91 45.94 Favored Pre-proline 0 C--N 1.356 0.87 0 CA-C-O 116.992 -1.48 . . . . 0.0 111.818 171.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.59 2.72 3.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 123.252 2.197 . . . . 0.0 108.91 168.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 40.8 mt -50.39 -53.44 29.26 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 128.03 2.532 . . . . 0.0 114.801 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.14 59.11 3.56 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.43 -166.7 26.95 Favored Glycine 0 N--CA 1.411 -2.978 1 N-CA-C 101.58 -4.608 . . . . 0.0 101.58 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -93.27 119.84 32.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.94 147.21 41.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.9 tp -107.63 114.9 29.19 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -112.68 139.16 48.52 Favored 'General case' 0 C--N 1.361 1.09 0 C-N-CA 126.034 1.733 . . . . 0.0 108.824 -170.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 67.4 m -143.97 118.98 10.01 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 123.422 0.689 . . . . 0.0 109.28 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.28 153.07 23.26 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.12 121.33 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 122.16 42.67 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.529 1.131 . . . . 0.0 108.682 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 10.8 m -80.6 132.35 35.62 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.83 -57.6 13.93 Favored Glycine 0 C--N 1.362 2.027 0 C-N-CA 125.852 1.691 . . . . 0.0 115.36 -167.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 2.4 m80 38.29 72.11 0.14 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 127.568 2.347 . . . . 0.0 114.855 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -72.96 -11.3 60.52 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.915 1.686 . . . . 0.0 111.341 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -72.63 -14.8 61.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.305 1.842 . . . . 0.0 112.215 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.334 7.0 pt-20 116.27 -175.66 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 C-N-CA 127.926 2.491 . . . . 0.0 108.367 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 74.9 tttt 101.59 135.93 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 127.67 2.388 . . . . 0.0 106.461 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.59 125.23 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -106.91 128.53 54.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 110.066 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.3 114.55 4.8 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.114 1.366 . . . . 0.0 109.382 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 97.2 t -88.33 115.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 139.43 58.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.121 1.768 . . . . 0.0 110.152 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.1 t -115.66 146.58 41.71 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.147 1.779 . . . . 0.0 109.339 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.617 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.99 139.26 39.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.315 2.646 . . . . 0.0 110.667 -172.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 95.9 -9.06 0.09 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.339 3.056 . . . . 0.0 112.831 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -138.46 -27.33 0.87 Allowed 'General case' 0 C--N 1.356 0.891 0 CA-C-N 119.448 1.022 . . . . 0.0 111.392 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 60.77 163.56 0.07 Allowed 'General case' 0 C--N 1.361 1.077 0 C-N-CA 125.619 1.567 . . . . 0.0 111.487 -165.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.3 -134.95 48.25 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 119.394 -2.067 . . . . 0.0 109.143 -160.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 58.05 75.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 125.284 1.434 . . . . 0.0 110.515 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.86 114.32 26.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -103.88 -33.05 9.0 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.781 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.76 77.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 166.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.35 130.32 43.49 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.418 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.9 t -144.61 114.77 7.47 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.084 1.353 . . . . 0.0 108.062 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.36 84.9 0.7 Allowed Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 104.731 -3.347 . . . . 0.0 104.731 167.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.631 0 C-N-CA 125.35 1.452 . . . . 0.0 111.212 175.052 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.42 133.76 55.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.25 161.51 25.25 Favored Glycine 0 CA--C 1.493 -1.305 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.96 127.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -138.89 149.43 44.83 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -114.57 -43.05 3.2 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.07 -52.9 5.93 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 119.733 1.151 . . . . 0.0 112.147 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 8.3 pt -87.79 -170.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 124.601 1.161 . . . . 0.0 110.172 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 85.18 1.49 Allowed Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -162.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -73.85 92.34 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 122.565 1.952 . . . . 0.0 109.781 160.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.9 142.8 49.35 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -93.89 158.24 15.74 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.092 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.16 123.88 23.18 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 119.192 0.905 . . . . 0.0 108.832 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.95 73.26 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 125.742 1.639 . . . . 0.0 111.238 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.09 175.02 5.55 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.622 0.769 . . . . 0.0 111.677 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 98.6 m -143.06 125.75 15.96 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.617 HG13 HH11 ' A' ' 914' ' ' ARG . 28.0 m -95.26 150.51 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-O 121.593 0.711 . . . . 0.0 109.544 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -142.07 138.83 32.02 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.156 1.783 . . . . 0.0 111.112 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.71 129.43 42.4 Favored 'Isoleucine or valine' 0 C--N 1.369 1.415 0 C-N-CA 126.021 1.729 . . . . 0.0 106.475 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.49 131.37 52.98 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.45 71.22 1.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.4 t -163.1 100.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.31 71.42 0.89 Allowed 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.46 143.48 7.27 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -111.02 -29.76 7.77 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.573 0.749 . . . . 0.0 108.997 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.8 tp -91.7 87.16 6.2 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.68 -164.51 1.62 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -123.93 159.26 30.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.66 133.83 35.61 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -158.91 152.2 22.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 112.39 22.35 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 172.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -98.86 174.09 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.006 1.804 . . . . 0.0 108.461 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.08 139.69 50.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.567 1.147 . . . . 0.0 108.042 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -140.12 141.4 36.12 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.984 1.266 . . . . 0.0 108.566 -170.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 30.6 mm -118.19 130.11 73.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -126.39 105.87 9.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.1 p -99.96 161.35 13.66 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.598 1.159 . . . . 0.0 109.531 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.44 109.01 0.26 Allowed Glycine 0 C--N 1.359 1.852 0 C-N-CA 119.044 -1.551 . . . . 0.0 110.675 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.95 143.41 47.05 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -74.33 124.68 26.93 Favored 'General case' 0 C--N 1.378 1.845 0 C-N-CA 125.263 1.425 . . . . 0.0 109.058 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.97 -57.94 2.06 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -132.27 128.92 38.85 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 131.85 10.82 Favored Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 103.792 -3.723 . . . . 0.0 103.792 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -69.11 129.12 92.33 Favored Pre-proline 0 C--N 1.352 0.674 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.101 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -106.57 80.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 121.873 1.704 . . . . 0.0 109.733 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 77.95 -72.86 0.08 Allowed 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 130.041 3.336 . . . . 0.0 109.2 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.0 mt 49.51 38.66 15.05 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 128.93 2.892 . . . . 0.0 114.295 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.49 132.1 54.48 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.76 107.99 10.11 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.963 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 N-CA-C 109.931 -0.834 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 119.29 24.96 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -90.24 -21.74 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 122.131 1.797 . . . . 0.0 110.085 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 37.25 69.62 0.21 Allowed 'General case' 0 C--N 1.358 0.971 0 C-N-CA 129.114 2.965 . . . . 0.0 115.587 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.6 135.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.11 155.07 50.73 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 9.4 p90 -149.33 139.61 22.29 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.26 118.25 0.56 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.89 153.1 36.35 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.458 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -137.16 158.4 44.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.093 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.44 129.78 43.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -168.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.5 p -158.85 15.98 0.18 Allowed 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 124.514 1.126 . . . . 0.0 108.119 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.0 pp -21.89 145.64 0.01 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 158.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.54 -48.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.789 1.659 . . . . 0.0 112.684 -169.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.09 178.46 8.26 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.5 m -19.37 121.92 0.02 OUTLIER 'General case' 0 C--N 1.364 1.218 0 C-N-CA 129.634 3.174 . . . . 0.0 115.68 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -126.71 146.17 56.11 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.01 -10.2 18.0 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 122.788 2.031 . . . . 0.0 112.978 -161.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.92 -141.03 3.02 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.3 m -63.39 145.77 54.92 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.19 1.796 . . . . 0.0 110.428 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.65 128.74 51.5 Favored Pre-proline 0 N--CA 1.437 -1.11 0 C-N-CA 125.052 1.341 . . . . 0.0 110.344 -164.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -95.29 -153.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.054 3.169 . . . . 0.0 108.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.44 132.05 17.8 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -115.5 -12.44 11.66 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.841 0.856 . . . . 0.0 110.698 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -100.56 86.42 3.14 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.215 0.531 . . . . 0.0 111.507 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.4 t -70.95 97.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 126.373 1.869 . . . . 0.0 106.29 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' B' ' 855' ' ' ALA . 20.3 mt -87.67 -38.56 15.76 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.181 -174.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.0 tp -166.34 127.52 1.76 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.656 -3.831 . . . . 0.0 100.656 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' B' ' 852' ' ' PHE . 27.5 t-20 178.08 61.32 0.01 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.779 1.627 . . . . 0.0 109.286 -164.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.86 -43.77 97.92 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -167.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.93 -28.61 11.72 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 118.976 0.807 . . . . 0.0 112.734 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.29 -61.32 0.3 Allowed Glycine 0 C--N 1.353 1.489 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 62.12 -81.81 0.02 OUTLIER 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.018 2.527 . . . . 0.0 114.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -95.66 119.08 33.53 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 124.55 1.14 . . . . 0.0 108.283 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.7 117.9 70.07 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -93.68 2.6 3.21 Favored 'Trans proline' 0 CA--C 1.509 -0.76 0 CA-C-N 125.11 2.861 . . . . 0.0 109.728 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -80.46 -44.51 19.1 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.9 p -106.19 -13.87 15.3 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.515 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.94 24.79 43.54 Favored Glycine 0 C--N 1.362 2.018 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 162.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.5 t -100.42 103.51 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 101.711 -3.441 . . . . 0.0 101.711 -162.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.15 111.62 23.88 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.573 -175.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 57.3 m -100.73 107.78 19.46 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 888' ' ' ALA . . . . . 0.464 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -91.5 111.16 47.7 Favored Pre-proline 0 C--N 1.357 0.922 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.88 171.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -93.43 3.3 3.27 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.267 2.202 . . . . 0.0 109.032 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -53.51 -49.6 67.2 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 126.67 1.988 . . . . 0.0 114.611 -169.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.61 48.72 13.73 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.451 1.501 . . . . 0.0 114.587 170.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.61 -165.31 18.24 Favored Glycine 0 N--CA 1.411 -2.972 1 N-CA-C 101.61 -4.596 . . . . 0.0 101.61 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -88.66 119.71 29.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.64 147.71 42.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 48.8 tp -108.7 114.22 27.83 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.57 138.45 49.33 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.965 1.706 . . . . 0.0 108.106 -171.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 73.9 m -143.46 119.13 10.44 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.21 153.33 22.85 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 90.4 t -109.13 122.28 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.13 120.65 41.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 124.557 1.143 . . . . 0.0 108.458 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 10.5 m -79.61 132.85 36.37 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.974 1.31 . . . . 0.0 107.567 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.71 13.26 Favored Glycine 0 C--N 1.364 2.111 0 C-N-CA 125.975 1.75 . . . . 0.0 115.233 -167.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.8 m80 37.96 71.92 0.14 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.558 2.343 . . . . 0.0 114.887 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -72.84 -11.54 60.64 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 126.005 1.722 . . . . 0.0 111.262 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -72.5 -13.64 61.47 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.378 1.871 . . . . 0.0 112.406 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.337 6.9 pt-20 115.69 -176.77 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.267 2.627 . . . . 0.0 108.267 174.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 101.36 135.85 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 127.568 2.347 . . . . 0.0 106.588 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.75 127.29 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -171.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -108.95 128.76 55.21 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.914 1.686 . . . . 0.0 109.969 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.49 114.39 4.7 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.817 1.247 . . . . 0.0 109.649 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.0 t -88.75 115.75 29.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 C-N-CA 125.316 1.446 . . . . 0.0 107.371 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.7 mt -62.27 141.79 58.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.744 2.018 . . . . 0.0 110.021 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.4 t -116.05 147.35 41.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 126.067 1.747 . . . . 0.0 109.506 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.643 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.02 138.81 38.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 127.82 2.448 . . . . 0.0 110.301 -173.299 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 96.35 -12.04 0.08 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 129.385 3.074 . . . . 0.0 112.931 173.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -136.52 -26.91 1.07 Allowed 'General case' 0 C--N 1.357 0.933 0 CA-C-N 119.453 1.024 . . . . 0.0 111.682 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 60.64 163.27 0.06 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.77 1.628 . . . . 0.0 111.317 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.48 -133.52 44.86 Favored Glycine 0 C--N 1.364 2.102 0 O-C-N 119.516 -1.99 . . . . 0.0 108.893 -162.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.3 t 55.86 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.159 0 C-N-CA 125.604 1.562 . . . . 0.0 110.813 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.45 114.72 27.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -104.16 -34.0 8.53 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.788 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 88.4 t -100.92 77.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 166.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -97.97 129.95 44.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.899 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.5 t -143.51 115.53 8.34 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.173 1.389 . . . . 0.0 107.916 169.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.93 84.71 0.73 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 168.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.691 0 C-N-CA 125.435 1.493 . . . . 0.0 111.266 175.614 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 44.3 m . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 65.0 mt -116.4 133.69 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.36 162.97 27.57 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.32 131.08 73.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -138.42 150.23 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.8 m -118.77 -39.78 2.94 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 45.7 tp -82.74 -51.64 7.5 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 119.474 1.034 . . . . 0.0 112.122 -169.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 872' ' ' LEU . 30.2 pt -84.53 -176.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 125.663 1.585 . . . . 0.0 110.307 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.21 84.9 2.04 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -167.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.25 93.54 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.051 1.834 . . . . 0.0 110.389 163.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.56 142.23 49.54 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -93.16 158.85 15.55 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.953 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.05 123.57 23.1 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 119.46 1.027 . . . . 0.0 108.665 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.97 -10.19 74.98 Favored Glycine 0 C--N 1.344 0.984 0 C-N-CA 125.351 1.453 . . . . 0.0 111.207 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.17 174.65 6.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.869 0.867 . . . . 0.0 110.684 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 97.9 m -143.11 125.93 16.1 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -159.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.643 HG13 HH11 ' B' ' 914' ' ' ARG . 20.7 m -96.39 151.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 121.337 0.589 . . . . 0.0 110.625 172.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.2 138.95 31.85 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.236 1.814 . . . . 0.0 111.194 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.2 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 126.971 2.109 . . . . 0.0 106.892 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -105.7 131.26 53.28 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 100.835 -3.765 . . . . 0.0 100.835 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.25 70.62 1.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 58.5 t -161.52 101.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -152.39 69.61 0.88 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.7 142.9 6.63 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 107.39 -2.284 . . . . 0.0 107.39 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -110.14 -29.36 8.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -92.29 86.92 5.86 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.23 -163.17 1.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -124.62 159.22 31.23 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.02 133.33 35.82 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -159.03 152.27 22.48 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 112.39 22.52 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -98.4 173.7 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.071 1.847 . . . . 0.0 108.384 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.41 138.13 52.02 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.3 p -138.99 140.69 38.27 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.892 1.223 . . . . 0.0 108.393 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 33.6 mm -116.02 130.53 70.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -127.17 106.0 8.95 Favored 'General case' 0 C--N 1.363 1.161 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 33.3 p -101.27 162.36 12.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.738 1.215 . . . . 0.0 110.07 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 109.83 0.28 Allowed Glycine 0 C--N 1.359 1.825 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.131 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.41 144.17 47.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 67.7 tp -72.16 124.62 25.4 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 124.9 1.28 . . . . 0.0 109.706 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.46 -58.54 1.94 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.29 128.51 37.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.71 129.93 10.09 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 103.72 -3.752 . . . . 0.0 103.72 164.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.86 129.02 92.65 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.292 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -106.74 80.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.595 1.605 . . . . 0.0 109.103 -169.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 78.01 -72.03 0.09 Allowed 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 129.91 3.284 . . . . 0.0 109.222 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.8 mt 48.74 40.26 15.63 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 128.884 2.874 . . . . 0.0 113.936 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.51 132.14 55.24 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.88 107.63 9.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 178.717 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 N--CA 1.453 -0.885 0 N-CA-C 109.982 -0.814 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.17 114.29 27.77 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.23 -22.24 1.39 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.666 1.631 . . . . 0.0 110.296 -172.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 36.59 70.28 0.17 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.862 2.865 . . . . 0.0 115.893 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.47 137.13 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.8 155.98 49.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 164.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 6.6 p90 -148.44 137.2 21.58 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 18.2 t -171.67 119.8 0.46 Allowed 'General case' 0 C--N 1.362 1.147 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.629 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.54 153.36 35.51 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.81 158.71 43.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.831 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.554 HD21 HD23 ' C' ' 858' ' ' LEU . 2.4 tm? -138.14 130.53 29.1 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -166.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 65.1 m -158.28 16.26 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -171.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.554 HD23 HD21 ' C' ' 856' ' ' LEU . 2.5 pp -30.61 149.54 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.453 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 160.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -80.32 -45.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 122.212 1.826 . . . . 0.0 113.929 -161.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -162.11 178.01 9.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -171.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -15.97 125.36 0.01 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 130.39 3.476 . . . . 0.0 116.57 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.98 149.18 42.87 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -160.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.55 -16.26 19.12 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 112.111 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -138.96 2.56 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.4 m -67.47 144.98 55.43 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 109.98 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.93 133.08 28.25 Favored Pre-proline 0 N--CA 1.439 -0.987 0 C-N-CA 124.797 1.239 . . . . 0.0 110.343 -162.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -97.24 -151.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.806 3.004 . . . . 0.0 109.45 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -144.96 132.52 20.88 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -114.24 -16.53 12.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.492 0.717 . . . . 0.0 111.225 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -102.79 82.79 2.16 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.253 0.549 . . . . 0.0 111.241 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.6 97.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.61 1.964 . . . . 0.0 106.707 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.6 -37.34 13.88 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.561 -173.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.4 tp -164.99 126.61 2.09 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 101.165 -3.643 . . . . 0.0 101.165 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 28.5 t-20 174.03 61.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.139 1.336 . . . . 0.0 107.784 -163.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.28 -42.43 95.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.75 -28.49 18.64 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.802 0.728 . . . . 0.0 112.303 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.88 -58.52 0.47 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 62.53 -81.18 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 128.069 2.547 . . . . 0.0 114.525 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.44 120.1 36.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.332 1.453 . . . . 0.0 108.683 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -85.53 117.31 68.49 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.2 8.03 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 CA-C-N 125.101 2.857 . . . . 0.0 109.643 -169.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.45 -45.4 19.49 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 36.4 p -106.09 -16.45 14.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 125.456 1.502 . . . . 0.0 108.003 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.11 24.54 47.9 Favored Glycine 0 C--N 1.361 1.967 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.6 103.12 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 -166.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.61 111.48 23.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.734 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 52.3 m -102.02 107.89 19.16 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 888' ' ' ALA . . . . . 0.578 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.83 110.83 46.3 Favored Pre-proline 0 C--N 1.357 0.9 0 CA-C-O 117.262 -1.351 . . . . 0.0 111.777 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -93.06 1.43 3.57 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.557 2.171 . . . . 0.0 108.472 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 50.3 mt -53.68 -54.51 36.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.86 2.464 . . . . 0.0 114.179 -169.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.42 69.14 0.74 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 122.185 0.993 . . . . 0.0 111.166 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.82 173.4 46.23 Favored Glycine 0 N--CA 1.405 -3.379 1 N-CA-C 100.791 -4.924 . . . . 0.0 100.791 -170.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -93.32 115.72 28.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.7 -1.25 . . . . 0.0 107.741 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -117.8 160.57 21.16 Favored 'General case' 0 C--N 1.365 1.264 0 CA-C-N 119.161 0.891 . . . . 0.0 110.845 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.5 tp -108.16 113.99 27.53 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 108.131 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.7 141.68 47.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 124.795 1.238 . . . . 0.0 108.898 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.1 m -143.26 120.66 11.64 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.625 0.77 . . . . 0.0 110.241 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 154.6 20.92 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.71 123.62 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 67.6 mt -99.29 120.09 38.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.264 1.025 . . . . 0.0 109.155 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -84.87 132.78 34.35 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.67 -59.16 11.02 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 125.022 1.296 . . . . 0.0 114.095 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.2 m80 39.91 65.02 0.78 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.126 2.171 . . . . 0.0 113.899 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -71.62 -9.43 58.23 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.24 1.416 . . . . 0.0 112.12 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.07 -17.43 61.42 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.244 1.418 . . . . 0.0 112.649 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.32 9.6 pt-20 126.23 -175.61 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 128.108 2.563 . . . . 0.0 107.909 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 40.0 tttp 101.0 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 127.766 2.426 . . . . 0.0 106.741 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.4 t -99.38 123.17 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -109.3 121.65 45.64 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.366 171.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.43 116.92 17.41 Favored 'General case' 0 C--N 1.372 1.551 0 C-N-CA 128.581 2.752 . . . . 0.0 109.885 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.12 114.39 26.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.62 147.11 46.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.835 2.054 . . . . 0.0 111.688 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.269 1.2 p -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.106 2.162 . . . . 0.0 109.685 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.578 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.15 138.95 38.97 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.146 1.778 . . . . 0.0 109.283 174.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 5.8 t 98.0 -16.6 0.05 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 129.23 3.012 . . . . 0.0 112.409 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -136.39 -26.88 1.09 Allowed 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.105 0.866 . . . . 0.0 111.574 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 60.01 169.68 0.08 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.141 1.377 . . . . 0.0 111.308 -164.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.25 -130.98 50.31 Favored Glycine 0 C--N 1.374 2.681 0 O-C-N 119.599 -1.938 . . . . 0.0 110.117 -164.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 60.2 t 53.21 77.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.257 0 C-N-CA 125.961 1.704 . . . . 0.0 111.551 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.7 115.0 27.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -171.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -102.54 -35.7 8.65 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.626 -171.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 86.47 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.33 130.28 42.16 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.102 0.477 . . . . 0.0 110.233 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 21.0 t -142.0 115.45 8.99 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.764 1.626 . . . . 0.0 108.28 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.96 85.48 0.63 Allowed Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 104.51 -3.436 . . . . 0.0 104.51 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.723 0 C-N-CA 124.726 1.155 . . . . 0.0 110.947 170.185 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 65.5 mt -122.08 133.62 54.77 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.71 28.08 Favored Glycine 0 CA--C 1.493 -1.289 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -119.07 131.85 70.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -134.2 150.5 51.07 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 121.369 -0.832 . . . . 0.0 108.955 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 48.8 m -117.47 -42.81 2.85 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 16.8 tp -90.01 -52.62 4.87 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 121.453 -0.779 . . . . 0.0 111.913 -166.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.17 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 126.23 1.812 . . . . 0.0 109.321 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.27 85.93 1.52 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -167.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.12 89.54 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.328 2.019 . . . . 0.0 109.964 164.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.7 145.89 47.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -92.77 161.16 14.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.342 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.53 122.73 20.98 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-N 120.067 1.303 . . . . 0.0 108.877 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.33 -11.19 72.72 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 125.517 1.532 . . . . 0.0 111.377 168.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 175.56 4.04 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.67 0.788 . . . . 0.0 111.608 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.4 m -143.29 126.56 16.6 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.898 0.879 . . . . 0.0 110.412 -160.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.99 148.52 5.46 Favored 'Isoleucine or valine' 0 C--N 1.362 1.129 0 C-N-CA 123.842 0.857 . . . . 0.0 109.191 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.7 t -141.49 139.66 33.35 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 126.079 1.752 . . . . 0.0 111.451 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.44 129.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.369 1.428 0 C-N-CA 126.271 1.828 . . . . 0.0 107.574 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.02 131.53 54.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 168.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.56 77.99 1.78 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.105 -1.862 . . . . 0.0 107.032 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.9 t -159.25 99.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 N-CA-C 104.441 -2.429 . . . . 0.0 104.441 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -150.71 81.07 1.34 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.07 148.64 16.51 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -115.29 -28.56 6.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 109.274 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.4 tp -91.33 87.14 6.35 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.86 -162.56 1.31 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -123.84 157.97 32.91 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.5 133.25 35.66 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.82 150.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.64 112.61 22.75 Favored Pre-proline 0 C--N 1.355 0.817 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -101.45 -178.21 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 121.766 1.644 . . . . 0.0 108.294 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.17 137.32 53.06 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.253 1.021 . . . . 0.0 109.294 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.9 p -138.27 137.26 37.3 Favored 'General case' 0 C--N 1.376 1.719 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.24 131.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -125.14 104.45 8.53 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 30.2 p -102.51 163.72 12.07 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.313 1.445 . . . . 0.0 110.016 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.59 112.29 0.36 Allowed Glycine 0 C--N 1.356 1.679 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.29 143.04 46.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.68 125.18 27.47 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 125.556 1.543 . . . . 0.0 110.054 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 15.5 tp -98.74 -57.35 2.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 122.376 0.27 . . . . 0.0 110.362 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -131.13 128.07 39.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 131.08 10.53 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 104.174 -3.57 . . . . 0.0 104.174 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.28 128.73 91.15 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 117.768 -1.11 . . . . 0.0 111.214 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -106.71 78.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 122.029 1.76 . . . . 0.0 109.667 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 78.61 -72.74 0.08 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.852 3.261 . . . . 0.0 109.083 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.1 mt 49.19 39.46 15.58 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 128.789 2.836 . . . . 0.0 113.828 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.4 132.04 54.74 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.53 107.37 9.42 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.067 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.677 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.455 -0.777 0 N-CA-C 110.031 -0.796 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 45.0 t -126.87 119.55 22.55 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -89.84 -22.21 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.106 1.788 . . . . 0.0 109.797 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 36.92 70.01 0.19 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 129.025 2.93 . . . . 0.0 115.498 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.64 137.23 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.78 160.73 37.28 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 165.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -149.31 140.16 22.79 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.1 t -169.43 116.52 0.6 Allowed 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -122.95 153.18 40.07 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -138.64 157.83 45.38 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.24 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.572 HD21 HD23 ' A' ' 858' ' ' LEU . 2.7 tm? -131.8 130.97 42.49 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -168.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 67.5 m -160.99 8.69 0.08 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -162.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.572 HD23 HD21 ' A' ' 856' ' ' LEU . 2.9 pp -28.93 149.4 0.03 OUTLIER Pre-proline 0 C--N 1.367 1.361 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 162.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.48 -45.15 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.966 1.738 . . . . 0.0 113.672 -163.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -162.56 173.98 13.24 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.89 118.84 0.01 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 130.647 3.579 . . . . 0.0 116.759 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.7 164.44 15.19 Favored Pre-proline 0 N--CA 1.442 -0.846 0 C-N-CA 124.279 1.031 . . . . 0.0 110.271 -171.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.71 -15.5 13.53 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.751 2.301 . . . . 0.0 111.337 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.78 -140.59 3.12 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 120.176 1.353 . . . . 0.0 111.189 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.7 m -63.09 145.38 55.59 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.616 2.366 . . . . 0.0 111.454 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.7 127.1 76.4 Favored Pre-proline 0 N--CA 1.441 -0.879 0 C-N-CA 125.308 1.443 . . . . 0.0 111.59 -166.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -98.52 -150.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.429 2.752 . . . . 0.0 107.779 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -149.25 134.3 18.11 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.52 -13.4 10.3 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.029 0.532 . . . . 0.0 110.524 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -100.09 86.79 3.31 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.78 97.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.145 1.778 . . . . 0.0 106.96 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.24 -37.15 16.31 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.376 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 39.8 tp -166.38 128.3 1.83 Allowed 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 162.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -178.34 61.54 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.84 1.655 . . . . 0.0 109.386 -167.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.28 -44.37 92.47 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -165.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.51 -31.27 8.98 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.827 0.739 . . . . 0.0 112.388 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.59 -62.36 0.29 Allowed Glycine 0 C--N 1.353 1.474 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 66.9 -78.19 0.04 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.108 2.563 . . . . 0.0 113.478 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -96.36 120.53 36.82 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.309 1.444 . . . . 0.0 108.792 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.04 117.19 66.25 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -94.24 5.6 2.64 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 CA-C-N 125.43 2.975 . . . . 0.0 108.991 -168.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -80.29 -45.59 17.62 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 -13.36 15.42 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.107 1.363 . . . . 0.0 108.544 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.79 37.96 Favored Glycine 0 C--N 1.364 2.125 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 161.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 23.7 t -101.05 103.94 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 100.419 -3.919 . . . . 0.0 100.419 -163.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.49 112.44 24.98 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.298 -2.228 . . . . 0.0 108.529 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 68.1 m -100.47 108.42 20.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 167.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 888' ' ' ALA . . . . . 0.434 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.41 111.18 45.88 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.85 171.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -94.35 1.51 2.93 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 CA-C-N 123.107 2.145 . . . . 0.0 109.196 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.49 -49.94 71.21 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.148 2.179 . . . . 0.0 114.076 -168.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 52.63 7.26 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.637 1.175 . . . . 0.0 113.749 169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -166.75 -167.3 27.22 Favored Glycine 0 N--CA 1.414 -2.771 1 N-CA-C 100.496 -5.042 . . . . 0.0 100.496 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.99 121.44 35.47 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.27 3.5 p90 -115.26 161.31 18.65 Favored 'General case' 0 C--N 1.366 1.291 0 CA-C-N 119.099 0.863 . . . . 0.0 109.127 174.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -104.7 116.94 32.9 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.62 0.768 . . . . 0.0 109.538 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -109.45 137.35 47.43 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.806 2.042 . . . . 0.0 109.136 -166.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.5 m -146.37 118.89 8.49 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 123.399 0.68 . . . . 0.0 109.218 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.06 153.55 22.45 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.28 118.86 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.44 123.56 45.7 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.497 -173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 45.8 m -79.17 131.23 36.14 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.414 1.486 . . . . 0.0 107.512 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.77 -56.47 20.33 Favored Glycine 0 C--N 1.362 2.01 0 C-N-CA 126.064 1.792 . . . . 0.0 114.897 -168.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.3 m170 33.52 74.54 0.06 Allowed 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.964 2.506 . . . . 0.0 115.897 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -72.77 -10.72 60.12 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.437 1.495 . . . . 0.0 111.355 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -73.09 -14.74 61.45 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.369 1.468 . . . . 0.0 112.228 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.363 8.3 pt-20 123.4 -168.68 0.0 OUTLIER 'General case' 0 C--N 1.363 1.155 0 C-N-CA 128.26 2.624 . . . . 0.0 108.166 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 64.9 mttt 98.29 135.54 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 128.258 2.623 . . . . 0.0 107.261 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.24 125.26 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.53 128.79 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 127.121 2.168 . . . . 0.0 109.699 176.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.68 114.64 4.7 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.865 1.266 . . . . 0.0 110.06 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.7 114.68 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.51 141.67 58.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.156 1.782 . . . . 0.0 110.297 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 4.8 t -114.92 146.83 40.73 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 126.202 1.801 . . . . 0.0 109.129 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.629 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.17 138.05 38.49 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.91 2.484 . . . . 0.0 110.022 -174.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.27 -3.85 0.07 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.142 2.977 . . . . 0.0 112.809 172.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -144.25 -25.99 0.53 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 119.56 1.073 . . . . 0.0 111.245 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 58.46 166.71 0.05 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.4 1.48 . . . . 0.0 112.1 -164.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.22 -134.87 48.46 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 119.359 -2.088 . . . . 0.0 109.303 -161.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 43.8 t 57.29 73.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 125.467 1.507 . . . . 0.0 110.277 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.68 113.95 26.35 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -103.13 -35.55 8.45 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.404 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.37 78.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 168.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.32 129.09 44.63 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.5 -173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.9 t -143.43 114.56 7.84 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.57 84.51 0.75 Allowed Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.168 -3.573 . . . . 0.0 104.168 165.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.836 0 C-N-CA 124.747 1.165 . . . . 0.0 113.786 178.99 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.0 mt -117.89 133.8 55.57 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.44 26.99 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.01 129.46 75.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -137.75 147.51 44.78 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.7 m -115.6 -44.89 2.93 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 44.7 tp -82.27 -49.95 9.5 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 119.237 0.926 . . . . 0.0 113.038 -166.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.96 -171.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 125.955 1.702 . . . . 0.0 109.973 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.92 81.92 2.07 Favored Pre-proline 0 N--CA 1.437 -1.097 0 C-N-CA 123.442 0.697 . . . . 0.0 109.185 -165.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.75 91.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 122.509 1.932 . . . . 0.0 109.644 162.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.42 142.53 49.92 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -94.78 155.03 17.0 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.579 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.64 123.28 21.49 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 119.518 1.054 . . . . 0.0 108.93 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.75 -10.39 74.71 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 125.706 1.622 . . . . 0.0 111.297 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 175.65 5.14 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.575 0.75 . . . . 0.0 111.332 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 88.5 m -142.6 125.34 15.96 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -160.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.629 HG13 HH11 ' A' ' 914' ' ' ARG . 24.4 m -94.82 151.27 3.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 121.666 0.746 . . . . 0.0 109.692 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.05 138.3 31.69 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.446 1.898 . . . . 0.0 111.269 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.43 129.96 42.24 Favored 'Isoleucine or valine' 0 C--N 1.37 1.484 0 C-N-CA 126.589 1.955 . . . . 0.0 106.322 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -105.92 131.95 52.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.03 71.9 1.49 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 59.1 t -162.75 101.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.8 mmm -153.1 70.67 0.88 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.75 147.07 7.52 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -113.31 -30.33 6.95 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.17 87.65 6.62 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.66 -177.14 4.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -166.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -116.99 156.29 27.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -90.67 134.16 34.61 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.76 150.55 21.03 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.25 112.96 21.46 Favored Pre-proline 0 C--N 1.355 0.832 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -99.58 173.82 0.4 Allowed 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 108.586 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.78 140.1 50.16 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -139.94 141.56 36.46 Favored 'General case' 0 C--N 1.375 1.678 0 CA-C-N 119.748 1.158 . . . . 0.0 108.797 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.5 mm -119.67 130.23 74.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -125.63 104.85 8.6 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 54.8 p -101.6 162.03 13.2 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.831 1.253 . . . . 0.0 110.161 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.99 112.28 0.32 Allowed Glycine 0 C--N 1.358 1.769 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.15 144.43 46.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.1 tp -74.25 124.12 25.81 Favored 'General case' 0 C--N 1.379 1.882 0 C-N-CA 124.59 1.156 . . . . 0.0 109.675 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.61 -57.62 2.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -131.72 127.57 37.09 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.43 129.08 9.77 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 103.498 -3.841 . . . . 0.0 103.498 166.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -69.21 129.04 92.26 Favored Pre-proline 0 C--N 1.352 0.681 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.16 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -106.82 80.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 CA-C-N 122.111 1.79 . . . . 0.0 109.873 -168.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 77.98 -72.79 0.08 Allowed 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 130.149 3.379 . . . . 0.0 109.161 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 78.8 mt 49.54 39.16 16.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 129.279 3.032 . . . . 0.0 114.133 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.7 131.79 55.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.56 108.34 10.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.771 0 N-CA-C 110.006 -0.806 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.55 119.75 23.08 Favored Pre-proline 0 C--N 1.354 0.77 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -90.64 -22.24 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 122.136 1.799 . . . . 0.0 109.986 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 37.69 70.45 0.19 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 129.192 2.997 . . . . 0.0 115.196 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.26 137.46 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.64 160.02 39.4 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 165.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -148.83 139.97 23.11 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.4 t -169.28 117.52 0.64 Allowed 'General case' 0 C--N 1.354 0.765 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -124.37 153.9 41.16 Favored 'General case' 0 C--N 1.368 1.403 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.56 157.85 44.59 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.145 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.582 HD21 HD23 ' B' ' 858' ' ' LEU . 2.7 tm? -133.4 128.44 35.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -168.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.2 m -159.84 12.21 0.13 Allowed 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 124.717 1.207 . . . . 0.0 107.747 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.582 HD23 HD21 ' B' ' 856' ' ' LEU . 2.9 pp -28.68 149.87 0.03 OUTLIER Pre-proline 0 C--N 1.369 1.422 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 160.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.45 -45.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.046 1.766 . . . . 0.0 113.777 -164.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 33.6 ptt85 -162.52 173.93 13.35 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.81 118.94 0.01 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 130.692 3.597 . . . . 0.0 116.771 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.08 164.44 15.12 Favored Pre-proline 0 N--CA 1.442 -0.87 0 C-N-CA 124.325 1.05 . . . . 0.0 110.294 -171.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.77 -15.54 13.4 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.782 2.321 . . . . 0.0 111.35 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.53 -140.85 3.17 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 120.222 1.374 . . . . 0.0 111.193 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.0 m -62.93 144.62 56.59 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.473 2.309 . . . . 0.0 111.388 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.93 126.36 82.32 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.394 1.477 . . . . 0.0 111.565 -167.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -98.98 -150.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.364 2.709 . . . . 0.0 107.566 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -148.79 133.3 17.66 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -114.97 -13.96 11.89 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.333 1.053 . . . . 0.0 109.508 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.994 0.426 . . . . 0.0 111.312 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.78 97.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 126.39 1.876 . . . . 0.0 106.253 163.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.27 -38.91 14.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.659 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 54.5 tp -166.03 127.38 1.85 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 165.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 177.0 61.39 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.509 1.504 . . . . 0.0 108.524 -163.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.79 -43.75 94.26 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -165.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.11 -31.27 9.26 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 118.759 0.709 . . . . 0.0 112.366 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 110.62 -60.74 0.32 Allowed Glycine 0 C--N 1.353 1.476 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 66.23 -79.08 0.03 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.185 2.594 . . . . 0.0 113.644 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -97.01 120.75 37.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.5 1.52 . . . . 0.0 109.033 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.44 117.44 67.11 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 171.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -93.25 5.91 3.0 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-N 125.485 2.995 . . . . 0.0 109.11 -169.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -80.1 -44.17 20.44 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 108.656 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -109.16 -13.82 14.61 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.374 1.47 . . . . 0.0 108.306 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.11 27.82 32.72 Favored Glycine 0 C--N 1.362 2.027 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 162.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.44 103.58 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 -161.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -99.79 112.45 24.7 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.691 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.5 m -101.16 108.23 19.85 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 167.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 888' ' ' ALA . . . . . 0.434 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.66 111.26 46.74 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 117.06 -1.447 . . . . 0.0 111.959 170.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -93.37 1.4 3.42 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 123.186 2.174 . . . . 0.0 109.183 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 31.0 mt -55.43 -49.5 72.25 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.055 2.142 . . . . 0.0 114.36 -168.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.75 52.08 7.02 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.762 1.225 . . . . 0.0 114.263 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.11 -166.41 26.15 Favored Glycine 0 N--CA 1.413 -2.871 1 N-CA-C 101.12 -4.792 . . . . 0.0 101.12 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -93.2 121.33 34.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.308 2.2 p90 -116.92 161.84 18.71 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 119.218 0.917 . . . . 0.0 109.394 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 59.4 tp -105.18 115.76 30.81 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -108.84 136.74 47.89 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 126.335 1.854 . . . . 0.0 108.194 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -145.24 118.65 9.02 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.14 153.58 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.73 120.12 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 122.82 46.26 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 41.6 m -78.58 131.75 36.87 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 125.383 1.473 . . . . 0.0 107.893 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.63 -56.47 20.05 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 126.136 1.827 . . . . 0.0 114.917 -168.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.6 m170 33.16 74.55 0.06 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.058 2.543 . . . . 0.0 115.818 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -72.73 -10.85 60.27 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.542 1.537 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.02 -13.79 61.29 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.495 1.518 . . . . 0.0 112.326 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.361 8.3 pt-20 122.98 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 C-N-CA 128.623 2.769 . . . . 0.0 108.109 172.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 62.7 mttt 97.71 135.19 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 128.211 2.604 . . . . 0.0 107.499 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.15 126.0 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.57 129.27 55.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.352 1.861 . . . . 0.0 109.819 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.8 114.64 4.66 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.566 1.146 . . . . 0.0 110.315 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 96.3 t -89.18 115.14 28.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 C-N-CA 125.569 1.548 . . . . 0.0 107.814 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.8 143.63 57.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 126.694 1.997 . . . . 0.0 110.303 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -115.32 147.43 40.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.318 1.847 . . . . 0.0 109.275 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.609 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.3 137.89 37.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.548 2.339 . . . . 0.0 109.756 -175.446 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.68 -6.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.196 2.998 . . . . 0.0 113.011 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -142.84 -25.68 0.61 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.716 1.144 . . . . 0.0 111.823 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 58.47 165.89 0.04 OUTLIER 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.561 1.544 . . . . 0.0 111.939 -164.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.42 -133.64 45.03 Favored Glycine 0 C--N 1.367 2.289 0 O-C-N 119.455 -2.028 . . . . 0.0 109.05 -163.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 43.0 t 55.29 74.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 110.511 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.33 114.33 26.83 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -172.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -103.84 -36.51 7.79 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.485 -1.688 . . . . 0.0 108.311 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.68 76.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.34 129.2 44.63 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.184 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -142.56 115.21 8.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.963 1.305 . . . . 0.0 107.77 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.56 84.44 0.75 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 166.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.764 0 C-N-CA 124.755 1.169 . . . . 0.0 113.893 178.909 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 40.1 m . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 64.4 mt -115.87 133.84 55.62 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -169.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.16 162.74 26.41 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -172.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.09 129.34 75.59 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.17 150.16 46.52 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 57.9 m -125.12 -30.28 3.22 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 119.159 -0.448 . . . . 0.0 111.751 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 29.3 tp -88.35 -51.94 5.47 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 119.411 1.005 . . . . 0.0 111.803 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.9 pt -84.94 -176.8 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 125.585 1.554 . . . . 0.0 110.011 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.417 ' O ' HD22 ' B' ' 954' ' ' LEU . 0.0 OUTLIER -157.32 81.15 3.26 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -167.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.02 92.22 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.328 2.019 . . . . 0.0 110.09 164.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.5 mp -120.94 142.23 49.94 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -94.62 155.96 16.64 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.342 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.56 122.67 20.9 Favored 'General case' 0 C--N 1.377 1.761 0 CA-C-N 119.874 1.215 . . . . 0.0 108.737 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.16 -9.47 77.56 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 125.51 1.528 . . . . 0.0 111.131 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.22 175.34 5.4 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.79 0.836 . . . . 0.0 110.679 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.3 m -142.83 125.5 15.91 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -158.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.609 HG13 HH11 ' B' ' 914' ' ' ARG . 18.9 m -96.13 151.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 121.5 0.666 . . . . 0.0 110.448 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.0 t -141.65 138.43 32.51 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 126.626 1.97 . . . . 0.0 111.432 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.1 t -91.72 130.01 41.53 Favored 'Isoleucine or valine' 0 C--N 1.369 1.44 0 C-N-CA 127.355 2.262 . . . . 0.0 106.531 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.94 131.98 52.59 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.795 -3.78 . . . . 0.0 100.795 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.99 71.55 1.48 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 57.3 t -161.28 102.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 91.6 mmm -152.13 69.64 0.9 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.93 146.46 7.15 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -112.53 -29.96 7.3 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -174.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.48 87.57 6.46 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.87 4.49 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -167.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -116.88 156.0 28.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.2 t -89.74 133.61 34.6 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.92 150.65 20.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.41 113.06 21.21 Favored Pre-proline 0 C--N 1.356 0.864 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -99.33 173.5 0.42 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 122.047 1.832 . . . . 0.0 108.443 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.02 138.9 51.28 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -138.43 141.19 39.54 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 119.723 1.147 . . . . 0.0 108.539 -171.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 23.6 mm -117.11 130.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -126.19 104.44 8.23 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 61.2 p -103.12 162.91 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.959 1.303 . . . . 0.0 110.722 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.45 113.76 0.37 Allowed Glycine 0 C--N 1.359 1.86 0 N-CA-C 106.684 -2.567 . . . . 0.0 106.684 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.33 145.31 46.27 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.56 124.06 24.45 Favored 'General case' 0 C--N 1.381 1.965 0 C-N-CA 124.486 1.114 . . . . 0.0 109.692 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.26 -57.52 2.19 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -131.41 127.13 36.86 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.68 128.99 9.74 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.69 -3.764 . . . . 0.0 103.69 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.15 128.63 92.51 Favored Pre-proline 0 C--N 1.352 0.687 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.771 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -106.47 79.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 122.079 1.778 . . . . 0.0 109.378 -167.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.47 -72.21 0.09 Allowed 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 130.036 3.335 . . . . 0.0 109.117 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 74.6 mt 49.09 40.62 17.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 129.162 2.985 . . . . 0.0 113.868 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -113.52 131.88 55.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -130.41 108.0 9.66 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 179.309 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.1 114.09 26.3 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.56 -21.89 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 CA-C-N 121.643 1.622 . . . . 0.0 109.859 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 39.16 70.13 0.24 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.633 2.773 . . . . 0.0 115.307 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.31 131.77 72.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -138.71 149.27 44.92 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 5.5 p90 -149.53 139.72 22.19 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.289 0.95 . . . . 0.0 110.117 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 20.4 t -169.16 119.22 0.7 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-O 118.23 -0.89 . . . . 0.0 109.519 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.27 153.96 42.42 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -174.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.23 156.23 47.22 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 122.053 0.93 . . . . 0.0 109.747 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.569 HD21 HD23 ' C' ' 858' ' ' LEU . 1.8 tm? -129.21 127.19 40.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.701 -1.59 . . . . 0.0 106.815 -165.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 47.8 p -159.82 13.0 0.13 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.017 -164.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.569 HD23 HD21 ' C' ' 856' ' ' LEU . 3.0 pp -25.93 146.24 0.03 OUTLIER Pre-proline 0 C--N 1.368 1.413 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 157.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.94 -45.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.111 1.79 . . . . 0.0 113.319 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -163.39 177.95 8.5 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 -172.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 18.4 m -13.47 119.51 0.01 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 130.101 3.36 . . . . 0.0 116.079 172.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.85 161.27 38.98 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -166.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.52 -15.23 8.76 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.408 2.072 . . . . 0.0 110.999 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.26 -144.2 4.04 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -65.49 135.55 55.32 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.86 1.664 . . . . 0.0 110.515 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 17.1 m -65.74 144.02 98.74 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 125.628 1.571 . . . . 0.0 113.184 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -99.71 -151.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 123.303 2.669 . . . . 0.0 107.295 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -146.39 129.94 16.91 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -116.23 -16.17 10.97 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 122.969 0.508 . . . . 0.0 110.705 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -102.39 81.12 2.02 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.089 0.471 . . . . 0.0 111.372 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.15 97.68 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 127.231 2.213 . . . . 0.0 106.652 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 4.9 mt -89.03 -37.3 15.26 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.465 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 45.4 tp -165.31 129.48 2.37 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 100.401 -3.926 . . . . 0.0 100.401 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.1 t-20 175.68 61.56 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 121.218 1.826 . . . . 0.0 108.226 -166.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.55 97.73 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -165.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.02 -28.81 12.65 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.58 0.627 . . . . 0.0 112.663 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.15 -58.71 0.4 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.79 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.588 2.755 . . . . 0.0 114.085 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -97.25 120.8 38.28 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.811 1.644 . . . . 0.0 108.203 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -83.97 116.82 66.66 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -94.22 6.06 2.58 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 CA-C-N 124.955 2.805 . . . . 0.0 109.942 -165.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -79.95 -45.43 18.53 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.7 p -106.4 -12.08 15.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.937 1.295 . . . . 0.0 108.482 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.74 21.22 54.18 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.452 161.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.42 102.44 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -162.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.45 112.06 23.84 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 111.736 -2.484 . . . . 0.0 108.997 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 80.9 m -100.57 108.05 19.88 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.17 111.41 48.43 Favored Pre-proline 0 C--N 1.354 0.798 0 CA-C-O 117.284 -1.341 . . . . 0.0 110.248 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -91.03 0.07 4.88 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.444 2.096 . . . . 0.0 108.621 166.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 87.9 mt -58.21 -50.51 73.28 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.987 1.715 . . . . 0.0 114.59 -164.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.44 68.99 0.75 Allowed 'General case' 0 C--N 1.366 1.305 0 CA-C-O 122.051 0.929 . . . . 0.0 111.738 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.8 -167.75 35.8 Favored Glycine 0 N--CA 1.406 -3.309 1 N-CA-C 102.272 -4.331 . . . . 0.0 102.272 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -92.65 121.49 34.12 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.422 -1.389 . . . . 0.0 108.493 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.525 ' H ' HD11 ' C' ' 954' ' ' LEU . 3.6 t80 -116.9 145.73 43.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -112.18 115.33 28.67 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.035 0.934 . . . . 0.0 108.648 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.2 tt -112.62 140.97 46.93 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.517 1.527 . . . . 0.0 108.505 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -143.01 118.81 10.53 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.86 154.03 22.16 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.58 122.63 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 78.7 mt -97.92 122.57 41.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.309 1.044 . . . . 0.0 108.974 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.66 131.43 35.97 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.21 -56.28 24.06 Favored Glycine 0 C--N 1.367 2.261 0 C-N-CA 125.336 1.446 . . . . 0.0 112.992 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 43.72 63.08 1.69 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.772 2.429 . . . . 0.0 113.981 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -72.68 -7.48 50.63 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 112.594 -168.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 125.381 1.472 . . . . 0.0 112.294 -171.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.336 8.5 pt-20 120.89 -173.37 0.0 OUTLIER 'General case' 0 C--N 1.362 1.148 0 C-N-CA 128.253 2.621 . . . . 0.0 107.956 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.3 tttt 102.62 135.31 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 127.997 2.519 . . . . 0.0 106.524 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 93.2 t -98.39 123.29 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -104.77 129.72 52.97 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.566 1.946 . . . . 0.0 110.171 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.67 114.23 3.74 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.127 1.371 . . . . 0.0 109.943 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.27 117.2 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.818 1.647 . . . . 0.0 108.854 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.45 142.23 57.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.052 1.741 . . . . 0.0 110.204 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.26 1.3 p -113.81 148.73 36.07 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 126.427 1.891 . . . . 0.0 108.368 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.581 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -78.72 137.42 37.77 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.797 1.639 . . . . 0.0 108.364 178.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 101.65 -18.1 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 129.255 3.022 . . . . 0.0 112.281 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -137.5 -26.74 0.97 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 119.277 0.944 . . . . 0.0 111.3 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 59.93 167.17 0.07 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.31 1.444 . . . . 0.0 111.861 -164.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.5 -130.72 51.43 Favored Glycine 0 C--N 1.376 2.764 0 O-C-N 119.554 -1.966 . . . . 0.0 110.197 -163.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 43.2 t 51.8 74.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 126.317 1.847 . . . . 0.0 111.712 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.49 116.62 29.0 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -99.56 -36.66 9.46 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.782 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.85 78.12 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -94.05 132.56 38.41 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -143.55 114.56 7.79 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 125.39 1.476 . . . . 0.0 108.295 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.45 84.97 0.64 Allowed Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 104.765 -3.334 . . . . 0.0 104.765 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.727 0 C-N-CA 125.096 1.332 . . . . 0.0 110.909 172.743 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.511 -0.536 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.6 mt -121.28 134.59 55.17 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.85 162.51 26.29 Favored Glycine 0 CA--C 1.493 -1.344 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.1 130.75 73.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -137.07 150.62 48.15 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 53.3 m -117.71 -36.7 3.6 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.157 -0.34 . . . . 0.0 111.414 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.78 -54.6 3.56 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 118.525 0.602 . . . . 0.0 111.928 -166.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.6 pp -84.76 -173.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 126.463 1.905 . . . . 0.0 110.158 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.525 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -162.12 92.86 1.32 Allowed Pre-proline 0 C--N 1.358 0.942 0 O-C-N 122.02 -0.425 . . . . 0.0 109.947 -168.595 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.33 91.15 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 122.944 2.087 . . . . 0.0 109.797 160.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' C' ' 954' ' ' LEU . 5.9 mp -121.42 142.88 49.58 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -92.43 160.23 15.18 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.75 122.05 19.97 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 120.226 1.375 . . . . 0.0 108.502 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.61 71.45 Favored Glycine 0 C--N 1.347 1.158 0 C-N-CA 125.389 1.471 . . . . 0.0 111.419 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.89 174.99 3.91 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.488 0.715 . . . . 0.0 111.471 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 19.4 p -142.96 127.98 18.48 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.435 0.635 . . . . 0.0 109.416 -161.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.581 HG13 HH11 ' C' ' 914' ' ' ARG . 19.6 m -94.69 150.28 4.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.66 137.72 33.78 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 125.047 1.339 . . . . 0.0 111.916 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.79 129.42 42.49 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 C-N-CA 125.912 1.685 . . . . 0.0 106.805 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -106.82 132.6 52.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 11.4 tp -132.28 75.26 1.62 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.196 -1.82 . . . . 0.0 107.972 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.7 t -158.59 100.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.62 75.15 1.15 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 112.89 145.6 9.51 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -113.0 -30.51 6.99 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.2 tp -92.24 87.06 5.94 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.8 -160.62 1.08 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -123.17 155.13 37.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -91.48 134.02 35.0 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -158.27 151.19 22.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -127.29 116.67 21.58 Favored Pre-proline 0 C--N 1.355 0.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -102.99 173.76 0.19 Allowed 'Trans proline' 0 CA--C 1.508 -0.817 0 N-CA-C 107.925 -1.606 . . . . 0.0 107.925 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -114.55 139.52 49.51 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -137.79 139.44 40.03 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 119.665 1.12 . . . . 0.0 108.001 -169.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.41 131.24 69.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -124.92 105.53 9.3 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 28.6 p -101.76 164.67 11.61 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.61 1.564 . . . . 0.0 109.911 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.15 111.81 0.35 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.06 141.53 48.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -76.7 124.45 27.68 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.386 1.474 . . . . 0.0 108.586 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 18.6 tp -98.1 -57.46 2.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.753 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.91 128.26 38.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.71 131.7 10.83 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.684 -3.766 . . . . 0.0 103.684 162.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.34 132.38 89.75 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.595 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -106.09 78.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.54 1.586 . . . . 0.0 108.954 -171.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 79.56 -71.75 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.207 3.403 . . . . 0.0 109.007 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 68.6 mt 49.87 38.87 17.01 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 129.183 2.993 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.14 131.86 54.76 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.94 107.14 9.14 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 179.544 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 109.854 -0.864 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.94 119.0 21.01 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -89.96 -20.89 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.079 1.778 . . . . 0.0 109.689 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 37.74 69.23 0.25 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.727 2.811 . . . . 0.0 115.618 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.09 137.1 54.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.2 158.84 43.32 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -149.38 138.07 21.02 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 22.9 t -170.28 117.5 0.54 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.73 153.36 34.52 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.01 157.89 45.76 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.68 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.404 HD21 HD23 ' A' ' 858' ' ' LEU . 2.3 tm? -130.75 129.32 42.33 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -166.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.2 p -162.01 14.36 0.09 Allowed 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -163.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.404 HD23 HD21 ' A' ' 856' ' ' LEU . 3.8 pp -24.86 147.44 0.02 OUTLIER Pre-proline 0 C--N 1.366 1.318 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 159.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.51 -45.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 121.918 1.721 . . . . 0.0 112.891 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -163.45 179.34 7.37 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -172.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -24.05 126.76 0.03 OUTLIER 'General case' 0 C--N 1.364 1.225 0 C-N-CA 129.364 3.066 . . . . 0.0 115.22 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -122.77 147.15 50.08 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -158.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.46 -10.35 20.45 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.505 2.137 . . . . 0.0 113.042 -172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.25 -142.01 3.33 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 120.426 1.466 . . . . 0.0 110.558 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.4 m -62.82 144.72 56.28 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 127.213 2.205 . . . . 0.0 110.813 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.11 122.77 84.75 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 125.504 1.522 . . . . 0.0 111.089 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -96.39 -153.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.96 3.107 . . . . 0.0 107.472 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -151.49 135.66 16.71 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -120.12 -11.88 9.18 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 122.146 -0.346 . . . . 0.0 111.905 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.09 87.14 3.39 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.591 0.632 . . . . 0.0 112.264 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.87 97.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 126.213 1.805 . . . . 0.0 106.882 168.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' B' ' 953' ' ' ILE . 67.0 mt -87.48 -37.82 16.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.238 -173.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 32.4 tp -166.65 127.51 1.66 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 101.106 -3.665 . . . . 0.0 101.106 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 179.98 61.04 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 120.839 1.654 . . . . 0.0 108.988 -166.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 -44.03 95.84 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -166.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.72 -27.13 15.13 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 118.863 0.756 . . . . 0.0 112.456 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.77 -58.73 0.39 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 62.68 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 127.933 2.493 . . . . 0.0 114.094 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -95.97 119.54 34.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.785 1.234 . . . . 0.0 108.068 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.05 117.29 67.8 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.53 4.84 2.61 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 124.656 2.699 . . . . 0.0 109.399 -165.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.16 -45.72 17.64 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -104.31 -14.29 15.84 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 124.517 1.127 . . . . 0.0 108.746 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.26 47.65 Favored Glycine 0 C--N 1.363 2.068 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 162.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 52.5 t -100.18 103.89 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 -163.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.71 111.92 24.23 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 112.167 -2.288 . . . . 0.0 109.358 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 64.9 m -100.33 108.18 20.15 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 888' ' ' ALA . . . . . 0.414 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.93 110.75 44.1 Favored Pre-proline 0 C--N 1.357 0.912 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.707 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.22 1.29 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 123.285 2.209 . . . . 0.0 108.94 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 29.9 mt -51.68 -53.84 34.61 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 128.489 2.716 . . . . 0.0 114.151 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.17 65.3 1.31 Allowed 'General case' 0 C--N 1.365 1.277 0 CA-C-O 121.901 0.858 . . . . 0.0 112.057 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.08 -177.93 45.48 Favored Glycine 0 N--CA 1.411 -3.012 1 N-CA-C 101.033 -4.827 . . . . 0.0 101.033 -173.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -93.18 121.27 34.37 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.284 1.3 p90 -114.95 161.68 17.98 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.158 0.89 . . . . 0.0 109.573 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 63.0 tp -104.17 116.45 32.22 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.421 0.688 . . . . 0.0 109.662 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.03 136.72 49.63 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 126.386 1.874 . . . . 0.0 108.916 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.8 m -147.41 119.57 8.29 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 123.318 0.647 . . . . 0.0 109.557 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.42 153.92 21.56 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.5 t -107.97 120.82 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.95 123.96 45.94 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.177 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 42.4 m -81.11 132.97 35.39 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 125.581 1.552 . . . . 0.0 107.389 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.4 -57.22 20.8 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 124.931 1.253 . . . . 0.0 113.765 -170.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.6 m170 36.1 71.48 0.13 Allowed 'General case' 0 C--N 1.36 1.043 0 C-N-CA 127.556 2.342 . . . . 0.0 115.143 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -73.03 -8.02 53.85 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 125.253 1.421 . . . . 0.0 112.028 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.82 -18.76 62.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.18 1.392 . . . . 0.0 112.605 -171.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.305 11.3 pt-20 125.13 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 127.954 2.502 . . . . 0.0 108.16 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 99.16 131.69 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.423 2.289 . . . . 0.0 107.277 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.76 123.81 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -107.97 121.71 45.35 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.015 1.726 . . . . 0.0 112.864 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -130.5 116.13 17.76 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.6 2.76 . . . . 0.0 108.615 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.3 t -84.98 114.74 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.67 141.26 58.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.841 1.656 . . . . 0.0 110.497 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.3 t -115.96 147.18 41.44 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.537 1.935 . . . . 0.0 109.373 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.6 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.68 139.49 39.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.821 2.848 . . . . 0.0 110.634 -173.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 7.2 t 97.55 -12.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 129.269 3.028 . . . . 0.0 112.909 173.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -136.9 -26.51 1.04 Allowed 'General case' 0 C--N 1.356 0.887 0 CA-C-N 119.601 1.091 . . . . 0.0 111.204 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 61.58 163.35 0.08 Allowed 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.473 1.509 . . . . 0.0 111.388 -166.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.77 -135.07 49.43 Favored Glycine 0 C--N 1.37 2.456 0 O-C-N 119.443 -2.036 . . . . 0.0 109.442 -160.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 44.0 t 57.52 78.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.169 0 C-N-CA 125.56 1.544 . . . . 0.0 110.714 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.69 114.42 26.96 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -173.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -102.86 -35.75 8.49 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.479 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -100.22 82.43 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 167.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -94.93 130.21 41.65 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.796 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -142.96 114.88 8.23 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.654 1.582 . . . . 0.0 108.631 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.3 85.12 0.65 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 103.701 -3.76 . . . . 0.0 103.701 162.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.842 0 C-N-CA 124.369 0.985 . . . . 0.0 112.133 172.206 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.52 133.28 55.99 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.13 161.58 27.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -172.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 26.5 m -122.59 127.85 75.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.7 149.32 46.42 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.0 m -115.0 -43.74 3.08 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 22.9 tp -83.71 -50.07 8.51 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 119.491 1.041 . . . . 0.0 112.775 -166.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 7.8 pt -85.01 -174.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 110.438 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.69 81.64 2.74 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 123.154 0.582 . . . . 0.0 109.663 -166.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.24 92.24 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.593 2.195 . . . . 0.0 109.911 162.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.8 143.8 48.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -94.33 156.59 16.44 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.605 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.29 123.47 22.35 Favored 'General case' 0 C--N 1.372 1.547 0 CA-C-N 119.292 0.951 . . . . 0.0 108.861 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.11 72.92 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 125.936 1.731 . . . . 0.0 111.096 171.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.92 175.25 5.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.385 0.674 . . . . 0.0 111.528 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 13.1 t -144.4 128.68 17.8 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.825 0.821 . . . . 0.0 110.191 -164.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.6 HG13 HH11 ' A' ' 914' ' ' ARG . 23.4 m -94.53 151.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.957 172.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.54 138.5 32.76 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 126.197 1.799 . . . . 0.0 111.275 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.69 129.51 42.26 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 C-N-CA 126.102 1.761 . . . . 0.0 107.04 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -107.8 131.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 169.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -131.39 76.44 1.72 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.401 -1.727 . . . . 0.0 107.303 172.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.1 t -160.46 100.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.0 mmm -153.58 70.12 0.83 Allowed 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.05 145.8 7.33 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -113.1 -29.35 7.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.8 tp -91.37 87.42 6.44 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.62 -165.28 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -124.46 161.02 26.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -93.47 133.15 37.05 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.61 151.38 22.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.22 113.39 21.54 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -99.21 173.93 0.42 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 121.875 1.716 . . . . 0.0 108.751 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.43 139.34 51.54 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.707 1.203 . . . . 0.0 108.247 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -140.76 141.9 34.78 Favored 'General case' 0 C--N 1.376 1.727 0 CA-C-N 120.001 1.273 . . . . 0.0 108.599 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 24.3 mm -118.12 129.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -125.14 105.62 9.29 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 32.1 p -101.04 161.97 13.22 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.019 1.328 . . . . 0.0 110.379 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.54 0.28 Allowed Glycine 0 C--N 1.359 1.835 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.17 145.27 46.14 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.37 -1.077 . . . . 0.0 113.809 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.8 tp -75.19 123.09 24.66 Favored 'General case' 0 C--N 1.379 1.857 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 27.7 tp -98.61 -57.33 2.22 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -131.7 128.05 38.17 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 130.95 10.47 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 103.883 -3.687 . . . . 0.0 103.883 165.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -69.09 128.91 92.48 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-O 117.825 -1.083 . . . . 0.0 111.046 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -107.14 80.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.048 1.767 . . . . 0.0 109.814 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.89 -72.75 0.09 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 130.241 3.416 . . . . 0.0 109.315 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 73.2 mt 49.62 39.24 16.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.158 2.983 . . . . 0.0 114.169 -176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -112.1 131.43 55.44 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -128.93 108.7 10.63 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 179.318 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.55 119.19 21.57 Favored Pre-proline 0 C--N 1.354 0.771 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.25 -20.93 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 122.193 1.819 . . . . 0.0 109.905 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 39.31 69.19 0.3 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 128.783 2.833 . . . . 0.0 115.351 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 88.6 t -118.88 136.76 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.21 157.81 45.96 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 165.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.31 138.49 21.41 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -170.68 118.07 0.51 Allowed 'General case' 0 C--N 1.357 0.893 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.67 153.55 34.16 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.508 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -136.13 157.97 45.55 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.433 174.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.434 HD21 HD23 ' B' ' 858' ' ' LEU . 2.2 tm? -130.45 128.04 40.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -167.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.8 p -161.65 13.36 0.09 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.341 -163.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.434 HD23 HD21 ' B' ' 856' ' ' LEU . 3.7 pp -24.56 147.49 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.375 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 158.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.69 -45.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 CA-C-N 121.943 1.729 . . . . 0.0 112.839 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 -163.32 179.22 7.52 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -172.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.8 m -23.82 126.6 0.03 OUTLIER 'General case' 0 C--N 1.365 1.248 0 C-N-CA 129.361 3.064 . . . . 0.0 115.356 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -122.79 147.17 50.17 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -158.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.5 -10.29 20.36 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.517 2.145 . . . . 0.0 113.107 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.99 3.32 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 120.496 1.498 . . . . 0.0 110.516 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 24.3 m -62.83 144.59 56.44 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 127.086 2.154 . . . . 0.0 110.7 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 11.5 t -78.88 122.58 84.78 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 125.521 1.528 . . . . 0.0 111.004 -169.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -97.65 -153.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.932 3.088 . . . . 0.0 107.361 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -150.82 135.09 16.95 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -117.77 -10.95 10.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.604 0.761 . . . . 0.0 110.553 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -100.77 87.52 3.35 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.95 -0.469 . . . . 0.0 112.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.13 97.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.172 1.789 . . . . 0.0 106.507 164.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' B' ' 855' ' ' ALA . 19.2 mt -88.05 -39.17 14.85 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.238 -174.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 44.7 tp -166.1 126.57 1.73 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 100.6 -3.852 . . . . 0.0 100.6 165.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 177.35 60.88 0.01 OUTLIER 'General case' 0 C--N 1.354 0.79 0 CA-C-N 120.464 1.484 . . . . 0.0 108.921 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.24 -43.56 95.99 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -166.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.38 -27.82 14.46 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 118.749 0.704 . . . . 0.0 112.553 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.53 -57.89 0.43 Allowed Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 62.65 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 127.998 2.519 . . . . 0.0 114.221 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -96.86 119.13 34.76 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.926 1.29 . . . . 0.0 108.117 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.89 117.52 68.62 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.66 5.09 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 124.609 2.682 . . . . 0.0 109.529 -164.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.18 -44.6 19.55 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -106.2 -14.64 15.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.872 1.269 . . . . 0.0 108.393 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.87 25.17 42.3 Favored Glycine 0 C--N 1.361 1.917 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.54 103.89 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 -162.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -100.74 111.91 24.22 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 112.609 -2.087 . . . . 0.0 109.144 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.3 m -100.37 108.22 20.19 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 168.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 888' ' ' ALA . . . . . 0.411 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.65 111.0 45.3 Favored Pre-proline 0 C--N 1.357 0.933 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.755 171.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -93.36 1.95 3.4 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.318 2.221 . . . . 0.0 108.929 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.14 -48.57 73.5 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 127.047 2.139 . . . . 0.0 113.951 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.29 48.89 14.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.547 1.539 . . . . 0.0 113.929 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.95 -166.1 20.08 Favored Glycine 0 N--CA 1.412 -2.902 1 N-CA-C 101.569 -4.612 . . . . 0.0 101.569 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -93.31 121.43 34.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.318 0.8 OUTLIER -117.03 161.41 19.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-N 119.26 0.936 . . . . 0.0 109.639 177.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.0 tp -105.38 115.52 30.4 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -109.72 136.46 49.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.313 1.845 . . . . 0.0 108.254 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.8 m -145.25 119.42 9.48 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.82 153.51 22.37 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 95.5 t -108.56 121.81 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.4 122.23 45.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.988 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 38.4 m -79.67 132.99 36.36 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.49 1.516 . . . . 0.0 107.853 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.02 -57.2 21.14 Favored Glycine 0 C--N 1.364 2.129 0 C-N-CA 125.057 1.313 . . . . 0.0 113.896 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.8 m170 35.84 71.79 0.12 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 127.491 2.316 . . . . 0.0 115.173 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -73.18 -7.89 53.38 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.27 1.428 . . . . 0.0 111.976 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -72.55 -15.39 61.77 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 125.46 1.504 . . . . 0.0 112.656 -169.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.317 10.2 pt-20 121.05 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.361 1.067 0 C-N-CA 128.182 2.593 . . . . 0.0 108.224 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 79.7 tttt 100.49 131.82 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 127.537 2.335 . . . . 0.0 107.46 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.76 126.23 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -111.25 122.87 48.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.498 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.58 117.34 17.82 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 128.087 2.555 . . . . 0.0 108.907 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.48 113.86 25.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.2 mt -62.59 143.29 57.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.664 1.986 . . . . 0.0 110.294 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -116.03 147.88 40.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 110.011 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.617 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.75 139.34 38.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 128.044 2.538 . . . . 0.0 110.19 -174.55 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 7.4 t 97.82 -16.35 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.322 3.049 . . . . 0.0 113.078 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -134.49 -26.0 1.45 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 119.599 1.091 . . . . 0.0 111.423 -170.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 61.34 162.88 0.07 Allowed 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.593 1.557 . . . . 0.0 111.176 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.35 -133.92 45.25 Favored Glycine 0 C--N 1.365 2.173 0 O-C-N 119.615 -1.928 . . . . 0.0 109.163 -162.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.13 79.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.149 0 C-N-CA 125.828 1.651 . . . . 0.0 110.823 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 114.91 27.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -103.31 -36.98 7.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.385 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.3 t -100.72 81.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.875 -3.009 . . . . 0.0 102.875 167.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -95.69 129.48 42.89 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.7 t -141.57 115.53 9.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.483 1.513 . . . . 0.0 107.714 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.64 85.0 0.69 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 104.199 -3.56 . . . . 0.0 104.199 163.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.814 0 C-N-CA 124.904 1.24 . . . . 0.0 112.029 173.204 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.4 mt -116.91 133.95 55.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 -171.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.31 162.57 27.58 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.26 130.67 73.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.28 150.6 46.82 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 55.0 m -118.89 -40.49 2.85 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 118.165 0.439 . . . . 0.0 111.918 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.44 -48.9 10.55 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 119.169 0.895 . . . . 0.0 112.646 -167.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 872' ' ' LEU . 40.8 pt -84.29 -177.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.864 1.666 . . . . 0.0 110.389 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.28 81.35 2.91 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -169.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.35 93.41 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.602 2.201 . . . . 0.0 110.321 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.2 mp -120.5 142.52 49.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -93.21 156.97 16.51 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.616 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.02 123.27 22.42 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 119.508 1.049 . . . . 0.0 108.672 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.79 -10.46 74.52 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 125.555 1.55 . . . . 0.0 111.052 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.27 174.82 5.94 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.732 0.813 . . . . 0.0 110.458 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 14.5 t -144.42 128.76 17.86 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.745 0.783 . . . . 0.0 110.42 -161.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.617 HG13 HH11 ' B' ' 914' ' ' ARG . 17.7 m -96.15 151.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.19 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.82 138.51 32.24 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 126.281 1.832 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 90.1 t -91.21 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.331 0 C-N-CA 127.087 2.155 . . . . 0.0 107.275 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -107.41 131.54 54.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 100.77 -3.789 . . . . 0.0 100.77 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.77 75.92 1.69 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.565 -1.652 . . . . 0.0 106.948 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 61.9 t -159.21 102.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -152.8 68.86 0.84 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.76 144.98 6.82 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -111.96 -28.67 7.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -92.3 87.14 5.94 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.97 1.68 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -124.49 160.13 28.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.3 t -91.89 132.88 36.15 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.7 151.49 22.16 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.05 113.29 21.8 Favored Pre-proline 0 C--N 1.356 0.867 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -98.9 173.46 0.46 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.948 1.765 . . . . 0.0 108.693 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.71 137.71 52.5 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -139.76 140.77 36.8 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.91 1.232 . . . . 0.0 108.316 -170.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.48 129.8 72.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -125.83 105.44 8.95 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 34.4 p -102.11 163.14 12.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.104 1.361 . . . . 0.0 110.866 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.02 112.09 0.33 Allowed Glycine 0 C--N 1.36 1.9 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.23 145.15 46.3 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.6 tp -72.75 122.52 21.64 Favored 'General case' 0 C--N 1.381 1.975 0 C-N-CA 124.143 0.977 . . . . 0.0 109.155 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.3 tp -98.39 -57.38 2.21 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -131.46 127.43 37.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 130.25 10.21 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 103.819 -3.712 . . . . 0.0 103.819 165.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.62 128.99 91.77 Favored Pre-proline 0 C--N 1.352 0.702 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.446 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -106.62 80.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 122.029 1.76 . . . . 0.0 109.426 -168.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.16 -72.17 0.09 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 129.98 3.312 . . . . 0.0 109.199 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 68.9 mt 48.79 41.51 18.32 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 129.039 2.936 . . . . 0.0 113.696 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -114.41 131.35 56.62 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.83 108.34 10.07 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 179.096 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.454 -0.821 0 N-CA-C 109.849 -0.866 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.11 114.53 27.8 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -88.86 -21.42 1.32 Allowed 'Trans proline' 0 CA--C 1.512 -0.614 0 CA-C-N 121.723 1.651 . . . . 0.0 110.173 -172.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 35.77 71.39 0.12 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 129.039 2.936 . . . . 0.0 115.84 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.3 t -122.06 136.55 58.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 156.41 49.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 165.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 6.8 p90 -148.8 136.84 20.84 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 118.811 0.732 . . . . 0.0 109.03 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 15.1 t -170.86 119.93 0.53 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.321 -0.862 . . . . 0.0 109.512 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.13 153.11 36.65 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' C' ' 870' ' ' ARG . . . -141.11 157.72 44.9 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.976 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.565 HD11 HD23 ' C' ' 858' ' ' LEU . 2.8 tm? -140.23 129.44 23.74 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -163.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 69.8 m -157.06 19.52 0.3 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.565 HD23 HD11 ' C' ' 856' ' ' LEU . 1.8 pp -25.36 145.59 0.03 OUTLIER Pre-proline 0 C--N 1.373 1.596 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 160.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.6 -49.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.236 1.957 . . . . 0.0 113.463 -164.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.1 ptt85 -162.47 172.39 15.59 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -2.69 112.46 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 130.893 3.677 . . . . 0.0 117.165 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -96.1 161.46 27.14 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.702 1.201 . . . . 0.0 109.651 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.92 -15.8 11.68 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.84 2.36 . . . . 0.0 110.429 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.99 -138.74 2.58 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 10.1 m -65.17 146.76 54.56 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.85 1.66 . . . . 0.0 110.69 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.89 133.31 26.67 Favored Pre-proline 0 N--CA 1.438 -1.044 0 C-N-CA 125.447 1.499 . . . . 0.0 110.554 -162.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -96.54 -152.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.823 3.015 . . . . 0.0 109.443 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.09 134.57 23.17 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -114.44 -17.23 11.81 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.161 0.584 . . . . 0.0 111.766 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 11.4 mmm180 -102.92 83.21 2.2 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.519 0.6 . . . . 0.0 110.958 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.76 97.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.651 1.98 . . . . 0.0 106.51 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 6.5 mt -89.83 -37.99 14.07 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.288 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 33.8 tp -165.52 126.74 1.94 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 29.0 t-20 175.06 61.47 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 120.25 1.387 . . . . 0.0 107.72 -163.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.88 -42.51 93.91 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -165.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.95 -29.11 16.25 Favored Glycine 0 C--N 1.357 1.705 0 CA-C-N 118.736 0.698 . . . . 0.0 112.335 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.14 -58.22 0.51 Allowed Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 63.47 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.087 2.555 . . . . 0.0 114.458 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -96.16 120.69 36.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 125.329 1.452 . . . . 0.0 108.496 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -85.99 116.96 67.8 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.26 8.65 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 124.951 2.804 . . . . 0.0 109.015 -170.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -79.29 -44.39 21.78 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.3 p -107.28 -15.01 14.75 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.832 1.253 . . . . 0.0 107.932 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.62 24.74 49.13 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 164.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.08 103.66 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.95 111.83 23.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.976 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 47.5 m -102.51 108.66 20.04 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 888' ' ' ALA . . . . . 0.541 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.56 110.37 42.7 Favored Pre-proline 0 C--N 1.356 0.85 0 CA-C-O 117.261 -1.352 . . . . 0.0 111.775 170.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -93.56 3.18 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.572 2.181 . . . . 0.0 108.359 164.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.02 -51.55 67.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 127.718 2.407 . . . . 0.0 113.458 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.52 66.09 1.14 Allowed 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.128 0.966 . . . . 0.0 111.66 169.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.08 -179.36 45.59 Favored Glycine 0 N--CA 1.404 -3.442 1 N-CA-C 101.293 -4.723 . . . . 0.0 101.293 -173.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -95.64 116.71 29.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.752 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.83 160.82 20.25 Favored 'General case' 0 C--N 1.366 1.31 0 CA-C-N 119.2 0.909 . . . . 0.0 110.654 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -108.0 110.66 22.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.06 138.99 51.25 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 108.414 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 61.5 m -143.22 120.59 11.62 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.54 0.736 . . . . 0.0 110.25 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -103.65 154.87 19.04 Favored 'General case' 0 C--N 1.364 1.226 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.71 123.47 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 68.9 mt -94.92 124.32 38.9 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.631 1.172 . . . . 0.0 109.403 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.4 m -79.66 132.39 36.21 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.74 22.54 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 125.952 1.739 . . . . 0.0 114.843 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 61.2 m170 31.39 74.33 0.05 OUTLIER 'General case' 0 C--N 1.361 1.076 0 C-N-CA 128.168 2.587 . . . . 0.0 115.615 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -71.0 -11.55 61.04 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.127 1.771 . . . . 0.0 112.457 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -73.89 -5.41 40.9 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.799 2.04 . . . . 0.0 111.796 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.299 47.1 mt-10 100.09 -144.09 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.809 2.844 . . . . 0.0 107.05 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 75.3 tttt 79.12 141.39 0.07 Allowed 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.616 1.966 . . . . 0.0 109.389 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.86 126.23 59.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -110.03 129.92 55.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.908 2.083 . . . . 0.0 110.164 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.51 114.13 2.94 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.692 1.197 . . . . 0.0 110.422 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.406 ' CG1' ' H ' ' C' ' 922' ' ' VAL . 7.2 p -85.54 117.69 30.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 C-N-CA 126.36 1.864 . . . . 0.0 109.04 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.73 137.24 58.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.129 1.372 . . . . 0.0 110.375 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.5 t -117.72 145.39 44.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.797 2.039 . . . . 0.0 107.989 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.541 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.33 140.37 38.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.215 2.206 . . . . 0.0 110.878 -174.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 92.25 0.86 0.12 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 128.982 2.913 . . . . 0.0 112.129 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -147.12 -25.66 0.4 Allowed 'General case' 0 C--N 1.361 1.078 0 CA-C-N 119.499 1.045 . . . . 0.0 112.101 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.5 166.99 0.06 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.422 1.489 . . . . 0.0 111.671 -164.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.7 -130.36 50.93 Favored Glycine 0 C--N 1.375 2.702 0 O-C-N 119.434 -2.041 . . . . 0.0 110.08 -164.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 47.6 t 53.6 73.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.226 0 C-N-CA 125.734 1.614 . . . . 0.0 111.586 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.89 116.1 28.62 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 25.0 ptt85 -98.93 -33.26 10.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.706 -173.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.406 ' H ' ' CG1' ' C' ' 911' ' ' VAL . 61.1 t -100.03 79.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 166.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.88 131.71 40.48 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 120.895 0.378 . . . . 0.0 111.299 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 24.6 t -144.18 115.23 7.88 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 125.324 1.45 . . . . 0.0 108.367 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.54 85.51 0.66 Allowed Glycine 0 CA--C 1.481 -2.035 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 172.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.632 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.675 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 70.0 mt -122.31 134.1 54.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.76 162.24 27.74 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 25.5 m -118.82 130.9 73.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -136.14 150.06 48.91 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.7 t -105.12 -76.35 0.61 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 13.7 tp -61.48 -49.53 76.39 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.25 -177.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.081 1.352 . . . . 0.0 110.477 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.85 84.14 1.31 Allowed Pre-proline 0 C--N 1.356 0.848 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.59 88.14 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 122.478 1.921 . . . . 0.0 109.952 164.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.8 146.22 47.72 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.14 161.37 15.79 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.397 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.65 122.15 20.07 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.408 1.458 . . . . 0.0 108.633 172.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.2 72.71 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 125.504 1.526 . . . . 0.0 111.261 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.99 175.59 3.63 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.739 0.781 . . . . 0.0 111.673 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.9 m -142.81 127.0 17.52 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.774 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.31 147.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 C-N-CA 124.276 1.03 . . . . 0.0 109.155 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 19.6 t -142.43 137.89 30.69 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.849 1.659 . . . . 0.0 111.193 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.7 129.71 41.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -104.05 132.98 49.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.84 71.53 1.45 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.515 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.75 99.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.76 74.43 1.11 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 113.72 145.09 9.05 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -114.1 -21.13 10.68 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.595 0.758 . . . . 0.0 110.007 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -98.71 85.81 3.4 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.82 -158.66 0.88 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -172.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -120.54 169.47 10.32 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 23.2 t -108.38 130.66 55.21 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.72 154.53 30.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.0 115.41 20.44 Favored Pre-proline 0 C--N 1.355 0.813 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 172.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -103.39 176.89 0.15 Allowed 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 121.807 1.671 . . . . 0.0 108.075 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.33 138.97 50.89 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -137.54 139.2 40.33 Favored 'General case' 0 C--N 1.376 1.757 0 CA-C-N 119.931 1.241 . . . . 0.0 108.489 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 34.8 mm -115.14 131.51 67.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -125.34 104.47 8.48 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 26.6 p -102.17 163.92 11.98 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.475 1.51 . . . . 0.0 110.42 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.1 113.19 0.37 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.71 46.69 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.5 124.63 26.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 125.495 1.518 . . . . 0.0 109.598 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.34 -57.61 2.16 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -131.93 127.54 36.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.6 129.32 9.85 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 103.739 -3.744 . . . . 0.0 103.739 165.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.56 127.8 91.66 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.285 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -106.95 78.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.534 0 CA-C-N 121.735 1.655 . . . . 0.0 109.449 -168.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 78.86 -72.77 0.08 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 130.039 3.336 . . . . 0.0 109.063 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 66.0 mt 48.88 40.53 16.78 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 128.975 2.91 . . . . 0.0 113.576 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -112.45 131.1 55.74 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -128.85 108.3 10.34 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.265 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.509 -0.76 0 N-CA-C 109.989 -0.812 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.93 119.36 21.14 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -90.07 -22.02 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.222 1.829 . . . . 0.0 109.666 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 38.14 69.16 0.26 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 128.757 2.823 . . . . 0.0 115.408 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.79 137.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.92 159.29 41.91 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 166.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.27 117.67 0.54 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.3 153.91 33.18 Favored 'General case' 0 C--N 1.372 1.575 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -134.39 158.52 43.63 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.411 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.24 127.71 30.54 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 858' ' ' LEU . 71.5 m -163.12 9.42 0.05 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -159.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 857' ' ' SER . 0.6 OUTLIER -28.5 152.28 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.378 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 160.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -78.38 -42.26 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 121.943 1.73 . . . . 0.0 113.382 -164.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -166.23 -159.16 0.37 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.2 m -31.54 139.04 0.04 OUTLIER 'General case' 0 C--N 1.361 1.104 0 C-N-CA 129.478 3.111 . . . . 0.0 115.29 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.89 164.54 43.14 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.93 -14.15 12.53 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.591 2.194 . . . . 0.0 111.147 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.9 -139.02 2.62 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.2 m -62.93 145.4 55.33 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 126.87 2.068 . . . . 0.0 111.011 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.44 128.12 54.24 Favored Pre-proline 0 N--CA 1.437 -1.093 0 C-N-CA 125.39 1.476 . . . . 0.0 110.315 -165.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -96.26 -149.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.943 3.096 . . . . 0.0 108.361 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.96 134.17 18.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -116.81 -14.45 10.73 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 122.62 0.368 . . . . 0.0 111.719 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.55 87.8 3.46 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.658 0.663 . . . . 0.0 112.47 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.69 97.83 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.014 1.726 . . . . 0.0 106.781 168.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 78.4 mt -87.71 -37.84 16.33 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.865 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 31.7 tp -166.31 127.55 1.77 Allowed 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 163.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 179.53 60.82 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.806 1.639 . . . . 0.0 109.16 -166.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.46 -43.94 93.1 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -165.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.36 -28.04 14.0 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.733 0.697 . . . . 0.0 112.49 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.57 -58.57 0.39 Allowed Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.516 -2.234 . . . . 0.0 107.516 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 63.16 -80.58 0.03 OUTLIER 'General case' 0 C--N 1.355 0.823 0 C-N-CA 128.065 2.546 . . . . 0.0 114.286 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -96.46 119.82 35.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.678 1.191 . . . . 0.0 108.416 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -80.0 117.22 66.39 Favored Pre-proline 0 CA--C 1.503 -0.834 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -93.81 6.25 2.73 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 CA-C-N 125.45 2.982 . . . . 0.0 109.031 -167.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -80.1 -46.66 16.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 21.5 p -108.18 -10.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 108.667 173.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 27.42 38.05 Favored Glycine 0 C--N 1.363 2.028 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 162.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.13 103.26 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.578 0 N-CA-C 100.816 -3.772 . . . . 0.0 100.816 -164.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.36 112.83 25.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.19 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 61.0 m -100.58 108.48 20.4 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 888' ' ' ALA . . . . . 0.44 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.83 110.69 43.53 Favored Pre-proline 0 C--N 1.358 0.966 0 CA-C-O 117.033 -1.461 . . . . 0.0 112.459 172.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -96.46 -1.21 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 123.109 2.146 . . . . 0.0 109.142 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.82 -50.18 66.74 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.65 2.38 . . . . 0.0 114.188 -168.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.18 47.9 13.65 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.29 1.436 . . . . 0.0 114.486 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -160.42 -165.41 17.2 Favored Glycine 0 N--CA 1.415 -2.746 1 N-CA-C 101.291 -4.724 . . . . 0.0 101.291 175.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.444 HH21 HG22 ' A' ' 953' ' ' ILE . 75.9 ttt-85 -93.83 120.9 34.7 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.273 3.7 p90 -115.33 161.33 18.66 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 118.939 0.791 . . . . 0.0 109.479 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.8 tp -104.61 117.08 33.22 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.434 0.694 . . . . 0.0 109.47 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -111.26 137.38 49.06 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 126.446 1.898 . . . . 0.0 108.941 -167.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.7 m -145.58 119.14 9.1 Favored 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.63 153.35 22.5 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.38 120.43 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.62 123.87 47.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.843 -173.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 49.0 m -79.12 131.45 36.24 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 125.396 1.478 . . . . 0.0 107.37 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.19 -55.77 25.97 Favored Glycine 0 C--N 1.365 2.194 0 C-N-CA 124.571 1.081 . . . . 0.0 112.268 -169.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.41 64.91 1.56 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 126.486 1.914 . . . . 0.0 113.466 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -70.84 -9.01 56.74 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.976 1.71 . . . . 0.0 112.731 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.7 -16.8 61.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.509 1.524 . . . . 0.0 112.558 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.321 9.6 pt-20 124.2 -176.18 0.0 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.204 2.602 . . . . 0.0 107.729 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 77.3 tttt 101.49 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 127.743 2.417 . . . . 0.0 106.914 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.33 128.7 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -170.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -110.76 121.16 44.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.042 1.737 . . . . 0.0 113.316 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.37 115.68 15.16 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 128.474 2.71 . . . . 0.0 109.239 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.6 t -88.59 114.08 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.32 141.41 58.3 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.188 1.795 . . . . 0.0 110.713 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 3.9 t -116.29 146.34 42.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 126.089 1.756 . . . . 0.0 109.847 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.453 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.24 141.21 38.74 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 127.201 2.201 . . . . 0.0 110.583 -176.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.313 31.4 p 86.89 10.35 0.17 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 130.268 3.427 . . . . 0.0 114.581 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.83 -25.02 0.27 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-N 119.076 0.853 . . . . 0.0 110.751 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 58.95 166.57 0.05 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.655 1.582 . . . . 0.0 111.703 -164.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.51 51.27 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 119.387 -2.07 . . . . 0.0 109.878 -161.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 48.4 t 57.82 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 125.785 1.634 . . . . 0.0 110.646 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.84 114.14 26.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.12 -36.79 8.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.618 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 92.1 t -100.02 80.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -97.2 128.58 44.21 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.199 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -143.71 116.5 8.76 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.555 1.542 . . . . 0.0 107.369 172.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.54 84.85 0.76 Allowed Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 103.863 -3.695 . . . . 0.0 103.863 163.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.925 0 C-N-CA 124.572 1.082 . . . . 0.0 113.103 176.41 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 73.1 mt -123.49 134.2 53.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.1 161.96 26.39 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 21.1 m -124.51 127.78 73.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.18 146.57 42.86 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -114.52 -46.27 2.97 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 27.3 tp -82.17 -49.87 9.65 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.426 1.012 . . . . 0.0 112.73 -166.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.444 HG22 HH21 ' A' ' 893' ' ' ARG . 13.5 pt -84.7 -174.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.88 1.672 . . . . 0.0 110.044 -178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.7 81.72 2.73 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -167.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 91.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.294 1.996 . . . . 0.0 109.64 163.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -121.9 144.69 48.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -92.8 157.12 16.57 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.119 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.37 123.31 21.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 119.852 1.206 . . . . 0.0 109.056 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.58 -12.03 70.73 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.184 1.849 . . . . 0.0 111.223 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.65 175.57 5.53 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.717 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.8 m -142.31 125.83 16.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -160.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.453 HG13 HH11 ' A' ' 914' ' ' ARG . 4.0 m -96.8 148.5 5.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.249 0.62 . . . . 0.0 109.331 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.5 t -143.82 138.65 28.84 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.051 1.74 . . . . 0.0 111.19 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 71.4 t -91.84 130.28 41.22 Favored 'Isoleucine or valine' 0 C--N 1.367 1.364 0 C-N-CA 126.767 2.027 . . . . 0.0 107.069 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -105.52 133.11 50.81 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 101.071 -3.677 . . . . 0.0 101.071 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 1.5 tp -129.22 72.11 1.46 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.041 -1.89 . . . . 0.0 105.975 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 58.2 t -162.83 100.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.898 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 89.6 mmm -153.59 70.01 0.83 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.77 145.21 7.24 Favored Glycine 0 CA--C 1.493 -1.304 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -112.3 -29.28 7.6 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.3 tp -92.17 87.32 6.06 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.55 -165.32 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -171.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -124.19 159.67 29.59 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -91.64 131.22 37.19 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.1 149.27 22.88 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.91 112.15 22.06 Favored Pre-proline 0 C--N 1.356 0.852 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -99.59 172.33 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.117 1.878 . . . . 0.0 108.269 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.1 mp -116.85 141.17 48.57 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.72 142.33 36.85 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 119.337 0.971 . . . . 0.0 108.562 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.95 129.5 74.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.85 105.63 9.09 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.4 p -101.02 160.55 14.28 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.914 1.286 . . . . 0.0 110.212 171.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.47 110.22 0.29 Allowed Glycine 0 C--N 1.359 1.816 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.96 144.05 46.69 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 67.6 tp -74.15 123.13 23.87 Favored 'General case' 0 C--N 1.379 1.87 0 C-N-CA 124.692 1.197 . . . . 0.0 109.402 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 33.6 tp -99.0 -57.76 2.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.4 127.47 35.49 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.85 131.01 10.53 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.183 -3.567 . . . . 0.0 104.183 164.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.94 129.5 90.87 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.663 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -107.0 80.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.783 1.672 . . . . 0.0 109.823 -168.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 77.69 -72.91 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 130.303 3.441 . . . . 0.0 109.238 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.9 mt 49.6 38.76 15.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 129.288 3.035 . . . . 0.0 114.085 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.31 131.78 54.75 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.42 107.31 9.4 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 179.462 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 N-CA-C 109.99 -0.812 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.65 119.53 21.55 Favored Pre-proline 0 C--N 1.352 0.71 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -90.78 -21.97 0.7 Allowed 'Trans proline' 0 CA--C 1.513 -0.572 0 CA-C-N 122.105 1.787 . . . . 0.0 109.758 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 38.77 69.77 0.25 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.969 2.908 . . . . 0.0 115.065 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.6 136.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.9 158.1 45.14 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -149.02 138.37 21.64 Favored 'General case' 0 C--N 1.361 1.076 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.2 t -170.42 118.61 0.55 Allowed 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.88 153.81 33.94 Favored 'General case' 0 C--N 1.371 1.51 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -135.9 158.55 44.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.157 174.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -136.11 125.08 24.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -166.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.3 m -162.45 13.43 0.07 Allowed 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.959 1.304 . . . . 0.0 107.933 -164.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -27.89 152.8 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.38 0 N-CA-C 118.219 2.674 . . . . 0.0 118.219 158.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -78.04 -42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 CA-C-N 122.01 1.754 . . . . 0.0 113.438 -164.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 16.7 ptt85 -166.65 -159.01 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.0 m -31.35 139.12 0.03 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 129.392 3.077 . . . . 0.0 115.355 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -133.12 164.4 44.23 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.94 -14.1 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.618 2.212 . . . . 0.0 111.202 -175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.0 -138.99 2.62 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -62.83 145.26 55.42 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.81 2.044 . . . . 0.0 110.944 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 91.8 t -88.33 127.78 55.69 Favored Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 125.325 1.45 . . . . 0.0 110.161 -165.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.09 -149.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.952 3.101 . . . . 0.0 108.276 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.35 133.75 18.56 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -115.08 -14.35 11.8 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.747 0.819 . . . . 0.0 110.59 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.01 87.53 3.3 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.075 0.464 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.79 97.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 164.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' B' ' 855' ' ' ALA . 32.6 mt -87.92 -39.41 14.78 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.373 -173.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 46.5 tp -165.72 126.18 1.81 Allowed 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 100.492 -3.892 . . . . 0.0 100.492 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 176.25 60.58 0.0 OUTLIER 'General case' 0 C--N 1.356 0.859 0 CA-C-N 120.405 1.457 . . . . 0.0 108.514 -162.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.9 -43.53 94.78 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -165.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.07 -28.39 13.68 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 118.723 0.692 . . . . 0.0 112.518 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.09 -57.45 0.43 Allowed Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.96 -81.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.827 0 C-N-CA 128.095 2.558 . . . . 0.0 114.325 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -97.01 119.7 35.98 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 124.854 1.261 . . . . 0.0 108.495 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -79.36 117.58 67.84 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 115.481 -2.2 . . . . 0.0 105.322 171.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.92 6.03 3.11 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 CA-C-N 125.51 3.004 . . . . 0.0 109.28 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.88 -45.6 18.33 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.027 0.931 . . . . 0.0 108.888 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 20.7 p -110.05 -11.4 14.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.658 1.183 . . . . 0.0 108.435 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.63 33.22 Favored Glycine 0 C--N 1.363 2.069 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.66 102.79 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.73 113.13 25.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.014 -174.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -100.83 108.48 20.29 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 888' ' ' ALA . . . . . 0.46 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.57 110.92 44.61 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 117.062 -1.447 . . . . 0.0 112.825 172.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -95.92 -1.34 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 CA-C-N 123.301 2.215 . . . . 0.0 109.278 169.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 14.5 mt -53.67 -49.83 67.12 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 127.587 2.355 . . . . 0.0 114.358 -167.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.6 48.59 11.57 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.123 1.369 . . . . 0.0 114.676 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.18 -165.62 20.6 Favored Glycine 0 N--CA 1.412 -2.922 1 N-CA-C 101.534 -4.626 . . . . 0.0 101.534 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -93.44 120.38 33.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.298 2.4 p90 -116.92 161.29 19.57 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.132 0.878 . . . . 0.0 109.624 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -105.82 116.04 31.27 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.37 137.32 47.41 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.444 1.898 . . . . 0.0 108.251 -170.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.5 m -144.46 118.74 9.56 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 153.29 22.92 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.21 121.09 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.15 123.34 47.65 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.127 0.971 . . . . 0.0 108.522 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 43.9 m -78.61 131.41 36.71 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.204 1.402 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -56.76 22.03 Favored Glycine 0 C--N 1.367 2.271 0 C-N-CA 124.73 1.157 . . . . 0.0 112.601 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.5 65.17 1.48 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.552 1.941 . . . . 0.0 113.627 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -70.72 -9.14 56.59 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.017 1.727 . . . . 0.0 112.835 -168.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.88 -15.2 61.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.852 1.661 . . . . 0.0 112.763 -168.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.0 pt-20 122.52 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 128.575 2.75 . . . . 0.0 107.754 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 101.05 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 127.763 2.425 . . . . 0.0 107.126 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 81.2 t -99.82 128.05 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -170.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -108.57 121.18 44.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.202 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.24 115.1 13.76 Favored 'General case' 0 C--N 1.385 2.117 0 C-N-CA 128.21 2.604 . . . . 0.0 109.568 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.48 114.83 27.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 119.695 1.134 . . . . 0.0 108.273 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.24 142.77 57.52 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.84 2.056 . . . . 0.0 110.607 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 3.5 t -116.94 146.71 42.82 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.282 1.833 . . . . 0.0 109.656 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.46 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -79.13 140.8 37.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.936 2.094 . . . . 0.0 110.22 -177.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.31 28.5 p 87.0 8.37 0.21 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.275 3.43 . . . . 0.0 114.731 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.36 -24.93 0.29 Allowed 'General case' 0 C--N 1.356 0.865 0 CA-C-N 119.426 1.012 . . . . 0.0 111.346 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 58.87 165.12 0.04 OUTLIER 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.721 1.609 . . . . 0.0 111.767 -164.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.52 -132.71 47.61 Favored Glycine 0 C--N 1.366 2.196 0 O-C-N 119.438 -2.039 . . . . 0.0 109.599 -162.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.0 77.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.234 0 C-N-CA 126.09 1.756 . . . . 0.0 110.878 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.47 114.62 27.19 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -174.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.69 -36.84 7.74 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.8 -1.545 . . . . 0.0 108.571 -171.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.76 79.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.71 128.42 44.37 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.808 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 28.3 t -142.65 117.67 10.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.607 1.563 . . . . 0.0 107.205 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.59 84.96 0.76 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 104.312 -3.515 . . . . 0.0 104.312 165.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.898 0 C-N-CA 124.734 1.159 . . . . 0.0 113.127 176.405 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.6 m . . . . . 0 CA--C 1.508 -0.666 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.6 mt -115.75 134.2 55.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.13 26.94 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.9 129.86 74.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.86 148.91 45.83 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.1 m -120.88 -38.99 2.76 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.5 0.591 . . . . 0.0 111.995 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.1 tp -82.48 -49.09 10.3 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.351 0.978 . . . . 0.0 112.612 -168.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 42.4 pt -85.15 -175.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.699 1.599 . . . . 0.0 109.829 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 80.91 2.59 Favored Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -169.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.14 92.13 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.479 2.119 . . . . 0.0 110.026 164.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -121.44 144.46 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.95 158.36 15.85 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.828 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.84 122.78 21.33 Favored 'General case' 0 C--N 1.381 1.947 0 CA-C-N 120.147 1.339 . . . . 0.0 108.791 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.26 -11.57 71.78 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 125.868 1.699 . . . . 0.0 111.009 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.43 175.34 5.56 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.608 0.763 . . . . 0.0 110.964 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.1 m -142.56 125.71 16.39 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -159.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.451 HG13 HH11 ' B' ' 914' ' ' ARG . 4.5 m -97.5 148.62 5.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.509 0.724 . . . . 0.0 109.734 173.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -143.33 138.82 29.76 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 126.325 1.85 . . . . 0.0 111.229 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 83.3 t -91.16 130.59 40.1 Favored 'Isoleucine or valine' 0 C--N 1.368 1.413 0 C-N-CA 127.398 2.279 . . . . 0.0 107.312 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.6 133.23 50.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 100.56 -3.867 . . . . 0.0 100.56 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 1.8 tp -129.02 71.53 1.43 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.4 t -161.25 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.0 mmm -152.46 69.83 0.89 Allowed 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.58 144.51 7.09 Favored Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -111.13 -28.69 8.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.78 87.32 5.81 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.34 -164.32 1.57 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -124.55 159.42 30.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 19.0 t -90.79 130.6 36.75 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.13 149.22 22.77 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.81 112.1 22.31 Favored Pre-proline 0 C--N 1.355 0.835 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -99.32 172.36 0.45 Allowed 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 122.099 1.866 . . . . 0.0 108.139 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.1 139.3 50.44 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -138.39 140.78 39.53 Favored 'General case' 0 C--N 1.373 1.63 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.94 129.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -126.55 105.74 8.95 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 55.5 p -102.4 162.42 12.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.467 1.107 . . . . 0.0 110.989 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.53 111.35 0.32 Allowed Glycine 0 C--N 1.358 1.789 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.14 47.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -72.57 122.83 22.01 Favored 'General case' 0 C--N 1.382 2.004 0 C-N-CA 124.583 1.153 . . . . 0.0 109.387 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.9 tp -98.74 -57.84 2.09 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -131.83 127.27 36.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.65 130.67 10.37 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 165.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.87 129.0 91.45 Favored Pre-proline 0 C--N 1.351 0.674 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.532 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -106.77 78.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.016 1.756 . . . . 0.0 109.325 -167.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 77.93 -72.66 0.09 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 130.131 3.372 . . . . 0.0 109.061 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 73.6 mt 49.08 40.63 17.76 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 129.064 2.946 . . . . 0.0 113.719 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.57 131.88 55.39 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.51 106.98 8.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 179.15 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.456 -0.718 0 N-CA-C 110.038 -0.793 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.55 113.75 27.29 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.91 -22.88 1.36 Allowed 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 121.648 1.624 . . . . 0.0 110.151 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 36.8 70.19 0.18 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 128.873 2.869 . . . . 0.0 115.659 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.18 137.03 57.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.66 156.75 48.21 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 9.3 p90 -149.0 137.39 20.99 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-N 118.871 0.759 . . . . 0.0 109.23 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.9 t -171.08 118.86 0.49 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.53 153.06 37.23 Favored 'General case' 0 C--N 1.368 1.378 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.15 159.55 41.94 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.972 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.523 HD21 HD23 ' C' ' 858' ' ' LEU . 2.7 tm? -141.66 130.73 23.28 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -165.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.5 m -160.49 14.16 0.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.523 HD23 HD21 ' C' ' 856' ' ' LEU . 2.2 pp -27.5 145.9 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.532 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 161.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.64 -46.5 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 122.052 1.768 . . . . 0.0 113.634 -162.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -162.75 172.22 15.59 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.8 m -3.57 111.92 0.01 OUTLIER 'General case' 0 C--N 1.363 1.178 0 C-N-CA 130.907 3.683 . . . . 0.0 116.942 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -99.49 163.18 19.05 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 123.646 0.778 . . . . 0.0 110.56 -172.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.61 -17.2 11.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.869 2.38 . . . . 0.0 110.841 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.66 -141.45 3.25 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.3 m -66.52 146.66 54.28 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.268 1.827 . . . . 0.0 110.715 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 96.0 t -94.73 131.27 30.98 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 124.822 1.249 . . . . 0.0 111.164 -159.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -97.6 -151.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 124.087 3.192 . . . . 0.0 109.278 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -147.04 134.37 20.68 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -113.98 -16.0 12.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.353 0.661 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -102.22 84.66 2.52 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.326 0.584 . . . . 0.0 111.7 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.86 97.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.385 1.874 . . . . 0.0 106.697 163.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 8.6 mt -90.1 -38.78 13.31 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.324 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.6 tp -165.54 126.49 1.9 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 29.8 t-20 174.76 60.81 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 120.188 1.358 . . . . 0.0 107.704 -162.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.87 -42.7 94.29 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -164.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.37 -28.82 15.88 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 118.665 0.666 . . . . 0.0 112.306 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.59 -57.58 0.48 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 62.92 -81.22 0.02 OUTLIER 'General case' 0 C--N 1.354 0.782 0 C-N-CA 128.289 2.636 . . . . 0.0 114.641 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -96.02 121.02 37.32 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.534 1.534 . . . . 0.0 108.463 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.41 116.63 65.94 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -94.28 7.61 2.34 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 CA-C-N 125.167 2.881 . . . . 0.0 109.648 -166.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -79.23 -47.37 16.06 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.2 p -108.05 -9.55 15.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.932 1.293 . . . . 0.0 108.285 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.3 25.23 44.51 Favored Glycine 0 C--N 1.361 1.959 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 161.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.62 102.82 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 -163.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -94.83 111.77 23.53 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.494 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -101.8 108.21 19.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 888' ' ' ALA . . . . . 0.556 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.71 110.35 42.84 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.321 169.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -92.21 0.59 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.53 2.154 . . . . 0.0 108.21 165.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 51.6 mt -54.21 -53.23 56.41 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 127.837 2.455 . . . . 0.0 113.672 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.59 66.42 1.08 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 122.16 0.981 . . . . 0.0 110.84 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.44 170.29 43.06 Favored Glycine 0 N--CA 1.404 -3.485 1 N-CA-C 100.568 -5.013 . . . . 0.0 100.568 -167.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -93.85 115.86 28.29 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.375 -1.413 . . . . 0.0 107.968 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -116.5 160.59 20.38 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 119.088 0.858 . . . . 0.0 110.946 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 56.1 tp -107.49 113.35 26.63 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 124.685 1.194 . . . . 0.0 108.05 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.471 HD13 HH12 ' C' ' 921' ' ' ARG . 7.1 tt -118.53 140.81 49.29 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.756 1.223 . . . . 0.0 109.574 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -144.14 120.28 10.79 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.923 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.0 154.22 19.93 Favored 'General case' 0 C--N 1.364 1.208 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 80.1 t -99.57 122.96 51.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.76 122.93 39.06 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.375 1.07 . . . . 0.0 109.39 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 33.8 m -80.4 131.2 35.57 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.72 20.06 Favored Glycine 0 C--N 1.362 2.018 0 C-N-CA 125.872 1.701 . . . . 0.0 114.975 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 32.44 72.65 0.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 128.18 2.592 . . . . 0.0 115.528 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -71.69 -12.72 61.47 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 126.224 1.81 . . . . 0.0 111.552 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -73.07 -17.63 61.4 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.778 1.631 . . . . 0.0 112.502 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.2 pt-20 123.44 -172.21 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 128.498 2.719 . . . . 0.0 107.917 173.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 102.19 133.26 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 128.045 2.538 . . . . 0.0 106.706 171.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 82.3 t -98.32 123.8 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -104.27 129.8 52.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.528 1.931 . . . . 0.0 109.764 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.79 114.14 3.15 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.769 1.228 . . . . 0.0 110.427 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.7 117.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 126.136 1.774 . . . . 0.0 108.809 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.1 mt -63.3 135.9 57.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.294 1.037 . . . . 0.0 109.857 172.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 8.6 t -117.49 143.94 45.55 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 126.636 1.974 . . . . 0.0 107.145 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.556 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.1 OUTLIER -79.88 140.86 36.59 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.159 2.184 . . . . 0.0 110.593 -170.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.315 25.0 p 89.49 6.52 0.13 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 130.205 3.402 . . . . 0.0 113.93 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -149.45 -25.04 0.28 Allowed 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.234 0.924 . . . . 0.0 111.622 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.39 166.92 0.06 Allowed 'General case' 0 C--N 1.364 1.237 0 C-N-CA 125.474 1.51 . . . . 0.0 111.848 -164.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.41 -131.21 51.93 Favored Glycine 0 C--N 1.375 2.737 0 O-C-N 119.441 -2.037 . . . . 0.0 110.047 -163.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . 0.252 47.6 t 54.87 73.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.244 0 C-N-CA 125.404 1.482 . . . . 0.0 111.741 173.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.09 115.9 28.47 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -172.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.471 HH12 HD13 ' C' ' 896' ' ' LEU . 11.7 ptt180 -98.83 -33.59 10.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.744 -173.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.14 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -95.35 131.32 41.59 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.922 0.391 . . . . 0.0 111.14 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -144.26 116.02 8.23 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 125.284 1.434 . . . . 0.0 108.198 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.35 85.23 0.72 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 104.566 -3.413 . . . . 0.0 104.566 169.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.671 0 C-N-CA 125.117 1.341 . . . . 0.0 111.18 172.994 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.4 mt -120.91 134.32 55.29 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.05 162.77 26.37 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.58 130.17 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.28 148.85 52.73 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.299 -0.875 . . . . 0.0 109.737 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.4 m -107.48 -79.85 0.57 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.566 0.746 . . . . 0.0 109.132 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.9 tp -64.1 -49.19 73.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.322 1.849 . . . . 0.0 115.008 -163.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.39 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 126.148 1.779 . . . . 0.0 110.242 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.19 88.35 0.99 Allowed Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -168.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.51 89.86 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.724 2.283 . . . . 0.0 110.121 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 86.0 mt -124.31 147.08 48.41 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.734 1.213 . . . . 0.0 108.014 -176.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.93 158.99 15.24 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.065 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.05 122.86 20.21 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 120.29 1.405 . . . . 0.0 109.516 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.56 77.15 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 126.259 1.885 . . . . 0.0 111.822 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.47 173.85 7.38 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.888 0.875 . . . . 0.0 110.057 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 12.9 t -144.15 129.13 18.51 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.271 -0.893 . . . . 0.0 111.08 -160.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.402 HG13 ' HD3' ' C' ' 914' ' ' ARG . 27.1 m -95.38 149.18 4.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.251 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.46 137.13 33.67 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 126.181 1.793 . . . . 0.0 111.851 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.15 129.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.376 1.739 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -105.04 133.76 49.28 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 9.2 mp -126.89 81.06 1.99 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 112.794 -2.003 . . . . 0.0 107.433 168.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.0 t -158.96 98.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.2 mmm -151.87 73.38 1.06 Allowed 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.43 145.48 10.54 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 108.139 -1.985 . . . . 0.0 108.139 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -112.52 -30.95 6.95 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -91.9 87.05 6.07 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -160.84 1.1 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -172.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -122.54 156.1 34.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.5 t -92.54 133.64 35.74 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -157.34 150.07 23.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 112.11 20.35 Favored Pre-proline 0 C--N 1.357 0.913 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -101.5 175.52 0.24 Allowed 'Trans proline' 0 CA--C 1.509 -0.766 0 C-N-CA 121.877 1.718 . . . . 0.0 108.303 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -115.84 140.58 49.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 24.0 p -137.0 140.17 41.94 Favored 'General case' 0 C--N 1.376 1.749 0 CA-C-N 119.503 1.047 . . . . 0.0 108.466 -172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.2 mm -115.94 131.26 68.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -125.56 104.78 8.59 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 33.1 p -101.62 164.07 11.94 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 125.473 1.509 . . . . 0.0 110.427 172.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.83 112.81 0.35 Allowed Glycine 0 C--N 1.359 1.824 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.76 45.71 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -77.01 124.47 27.82 Favored 'General case' 0 C--N 1.378 1.847 0 C-N-CA 125.046 1.338 . . . . 0.0 109.096 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.97 -57.51 2.21 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -132.19 127.41 35.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.71 129.83 10.06 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 104.051 -3.62 . . . . 0.0 104.051 166.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.1 129.33 90.82 Favored Pre-proline 0 C--N 1.351 0.637 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.937 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -106.74 76.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 121.948 1.731 . . . . 0.0 109.593 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.53 -72.81 0.08 Allowed 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 130.192 3.397 . . . . 0.0 108.989 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 49.56 38.7 15.34 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 129.151 2.981 . . . . 0.0 113.768 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -109.86 131.7 54.82 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -129.92 106.65 8.8 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.071 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.352 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 N-CA-C 109.678 -0.932 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.33 120.44 21.06 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.86 -20.31 0.86 Allowed 'Trans proline' 0 CA--C 1.51 -0.718 0 CA-C-N 122.204 1.823 . . . . 0.0 109.699 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 36.41 69.9 0.18 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 128.987 2.915 . . . . 0.0 115.898 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.19 137.05 54.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.94 160.25 38.88 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -149.2 138.92 21.84 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.0 t -169.37 117.27 0.62 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.9 152.88 36.69 Favored 'General case' 0 C--N 1.37 1.497 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.12 158.73 43.79 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.643 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.531 HD21 HD23 ' A' ' 858' ' ' LEU . 2.3 tm? -132.82 133.53 43.48 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 858' ' ' LEU . 40.5 p -163.21 9.51 0.05 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -164.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.531 HD23 HD21 ' A' ' 856' ' ' LEU . 2.7 pp -31.42 149.21 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.483 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 160.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.39 -43.22 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 CA-C-N 122.34 1.871 . . . . 0.0 113.527 -161.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -162.52 174.13 13.08 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.679 1.127 . . . . 0.0 108.097 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.1 m -2.34 117.01 0.01 OUTLIER 'General case' 0 C--N 1.364 1.214 0 C-N-CA 131.383 3.873 . . . . 0.0 117.103 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.06 141.57 23.68 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -164.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -73.9 -11.48 23.66 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.845 2.364 . . . . 0.0 113.44 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.83 -130.37 1.17 Allowed Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 30.6 m -82.35 143.8 31.0 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.56 131.68 33.53 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 124.594 1.157 . . . . 0.0 110.631 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -93.11 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.863 3.042 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.35 135.23 20.02 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 119.248 0.931 . . . . 0.0 108.532 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -117.83 -13.52 10.12 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 122.895 0.478 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.34 87.3 3.38 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 118.574 0.624 . . . . 0.0 112.183 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.86 97.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.144 1.777 . . . . 0.0 106.894 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.458 ' HB3' HD11 ' B' ' 953' ' ' ILE . 49.4 mt -88.22 -37.09 16.37 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.577 -0.702 . . . . 0.0 110.709 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.6 tp -165.58 125.53 1.78 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 101.138 -3.653 . . . . 0.0 101.138 161.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -174.13 61.14 0.02 OUTLIER 'General case' 0 C--N 1.356 0.886 0 CA-C-N 120.38 1.446 . . . . 0.0 109.321 -168.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.36 -44.2 92.72 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -163.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.68 -28.38 12.6 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 118.863 0.756 . . . . 0.0 112.307 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.83 -60.55 0.32 Allowed Glycine 0 C--N 1.354 1.531 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 62.47 -80.9 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.978 2.511 . . . . 0.0 114.19 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.33 119.75 32.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 124.883 1.273 . . . . 0.0 108.919 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.72 117.43 68.51 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -96.69 1.87 1.86 Allowed 'Trans proline' 0 CA--C 1.506 -0.884 0 CA-C-N 124.986 2.817 . . . . 0.0 109.3 -165.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -79.9 -45.45 18.58 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.6 p -102.84 -13.99 16.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.103 0.961 . . . . 0.0 108.72 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 24.01 47.47 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.94 102.61 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -164.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 112.75 24.94 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 112.181 -2.281 . . . . 0.0 108.656 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 82.5 m -98.97 108.94 21.75 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 888' ' ' ALA . . . . . 0.435 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -89.62 110.76 41.62 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.745 173.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.56 -4.88 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.08 2.136 . . . . 0.0 108.98 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 33.1 mt -49.06 -55.2 12.84 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 128.664 2.786 . . . . 0.0 114.612 -168.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.9 65.25 1.35 Allowed 'General case' 0 C--N 1.364 1.223 0 CA-C-O 121.926 0.869 . . . . 0.0 112.085 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.09 -175.53 42.63 Favored Glycine 0 N--CA 1.408 -3.21 1 N-CA-C 101.034 -4.826 . . . . 0.0 101.034 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.22 121.9 35.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.45 160.43 19.19 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 118.918 0.781 . . . . 0.0 108.965 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 59.7 tp -103.84 117.11 33.56 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.429 0.691 . . . . 0.0 109.698 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.87 136.3 50.11 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 126.762 2.025 . . . . 0.0 108.88 -165.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.2 m -147.17 119.17 8.18 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.597 0.759 . . . . 0.0 109.501 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 154.22 21.56 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 79.0 t -109.3 119.18 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.78 124.33 46.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.992 -173.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 33.7 m -80.48 133.27 35.81 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.34 1.456 . . . . 0.0 107.547 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.9 -57.11 21.58 Favored Glycine 0 C--N 1.364 2.137 0 C-N-CA 125.003 1.287 . . . . 0.0 114.214 -169.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 61.9 m170 35.37 72.73 0.09 Allowed 'General case' 0 C--N 1.361 1.087 0 C-N-CA 127.387 2.275 . . . . 0.0 115.266 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -73.74 -8.38 55.77 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.17 1.388 . . . . 0.0 111.72 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -71.92 -19.93 61.85 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.043 1.337 . . . . 0.0 112.49 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.319 9.3 pt-20 125.03 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.137 0 C-N-CA 128.232 2.613 . . . . 0.0 108.333 174.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 101.01 131.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.846 2.459 . . . . 0.0 106.753 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.31 124.91 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 123.512 1.625 . . . . 0.0 106.839 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -105.68 122.44 46.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.207 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.05 116.46 17.1 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 128.307 2.643 . . . . 0.0 108.769 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.62 113.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.09 142.17 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.538 1.535 . . . . 0.0 111.194 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -115.0 145.09 42.62 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 127.007 2.123 . . . . 0.0 109.086 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.435 HH22 ' HB3' ' A' ' 888' ' ' ALA . 0.0 OUTLIER -79.52 139.22 37.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 127.791 2.436 . . . . 0.0 109.429 -178.173 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.4 t 100.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.35 0.595 0 C-N-CA 129.463 3.105 . . . . 0.0 113.229 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -144.53 -24.41 0.52 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 119.486 1.039 . . . . 0.0 110.958 -175.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 60.18 167.43 0.08 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 124.886 1.274 . . . . 0.0 111.833 -164.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.6 -133.62 52.66 Favored Glycine 0 C--N 1.375 2.729 0 O-C-N 119.279 -2.138 . . . . 0.0 109.891 -161.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 46.7 t 56.6 75.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.295 0 C-N-CA 125.523 1.529 . . . . 0.0 110.99 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.57 115.22 27.71 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -103.05 -35.11 8.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.309 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 88.6 t -99.57 75.77 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.95 130.3 41.65 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.129 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.6 t -143.08 114.49 7.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.379 1.472 . . . . 0.0 108.411 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.54 84.82 0.69 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.882 -3.687 . . . . 0.0 103.882 163.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.859 0 C-N-CA 124.965 1.269 . . . . 0.0 112.708 174.42 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.443 -0.796 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 59.8 mt -117.71 133.54 55.84 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.33 161.33 26.05 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.5 m -125.25 126.3 70.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.77 149.44 43.55 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -115.02 -41.97 3.27 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.59 -50.17 9.07 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 119.373 0.988 . . . . 0.0 113.133 -166.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 8.2 pt -85.09 -171.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 125.371 1.469 . . . . 0.0 110.74 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.482 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -159.25 81.52 2.57 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -168.233 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.18 90.84 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 CA-C-N 122.06 1.772 . . . . 0.0 109.536 160.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 954' ' ' LEU . 8.3 mp -122.01 145.06 48.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -90.98 158.03 16.95 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.464 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.25 123.62 22.65 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-N 119.689 1.131 . . . . 0.0 108.715 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.01 69.9 Favored Glycine 0 CA--C 1.495 -1.2 0 C-N-CA 125.85 1.69 . . . . 0.0 110.999 170.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.11 175.64 5.08 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.025 0.44 . . . . 0.0 112.102 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 94.9 m -140.67 128.32 21.57 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -155.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 962' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.83 149.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -144.24 136.75 26.76 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.247 1.019 . . . . 0.0 111.65 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.21 129.75 44.06 Favored 'Isoleucine or valine' 0 C--N 1.369 1.453 0 C-N-CA 126.868 2.067 . . . . 0.0 107.245 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -107.92 132.29 53.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 168.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 21.0 tp -130.29 75.88 1.68 Allowed 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.212 -1.813 . . . . 0.0 107.045 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.8 t -160.81 101.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.06 71.79 0.92 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.71 150.57 8.3 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -119.06 -29.01 5.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.1 tp -92.25 87.07 5.94 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.5 -163.85 1.5 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -125.08 160.71 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.1 t -94.33 132.06 39.33 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -158.09 150.52 22.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.59 113.33 25.24 Favored Pre-proline 0 C--N 1.356 0.86 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -98.77 173.65 0.47 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.842 1.694 . . . . 0.0 108.365 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.43 141.49 48.27 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.6 p -139.59 142.06 37.13 Favored 'General case' 0 C--N 1.376 1.736 0 CA-C-N 119.592 1.087 . . . . 0.0 108.909 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.7 mm -119.61 129.81 74.88 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -126.15 105.77 9.09 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 44.6 p -101.25 161.92 13.26 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.816 1.246 . . . . 0.0 110.39 171.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.88 111.1 0.29 Allowed Glycine 0 C--N 1.358 1.764 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.1 144.93 46.34 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.01 123.4 25.69 Favored 'General case' 0 C--N 1.378 1.825 0 C-N-CA 124.763 1.225 . . . . 0.0 109.507 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 30.4 tp -98.23 -57.06 2.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -130.92 128.01 39.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.35 129.96 10.09 Favored Glycine 0 CA--C 1.487 -1.706 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 164.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 129.0 91.84 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -107.64 81.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 CA-C-N 121.835 1.691 . . . . 0.0 110.071 -169.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 77.76 -72.48 0.09 Allowed 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.12 3.368 . . . . 0.0 109.313 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 67.9 mt 49.41 38.81 14.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 128.841 2.856 . . . . 0.0 114.411 -176.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.86 131.09 55.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -128.09 109.41 11.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.099 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 179.321 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.961 0 N-CA-C 109.615 -0.956 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.62 121.17 22.11 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -92.45 -20.53 0.55 Allowed 'Trans proline' 0 CA--C 1.512 -0.581 0 CA-C-N 122.238 1.835 . . . . 0.0 110.037 -173.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 37.8 70.22 0.2 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 129.155 2.982 . . . . 0.0 115.532 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.94 136.82 54.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.6 40.69 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 165.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -149.22 139.19 22.03 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -169.17 117.87 0.66 Allowed 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.15 153.55 34.69 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -139.13 158.14 44.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.196 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.564 HD21 HD23 ' B' ' 858' ' ' LEU . 2.1 tm? -132.07 132.11 43.03 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -169.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.428 ' H ' ' H ' ' B' ' 858' ' ' LEU . 30.1 p -162.65 8.26 0.06 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -164.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.564 HD23 HD21 ' B' ' 856' ' ' LEU . 2.6 pp -31.44 149.94 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.441 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 161.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -81.75 -43.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.223 1.83 . . . . 0.0 113.494 -161.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -162.41 173.86 13.52 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 119.727 1.149 . . . . 0.0 108.201 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.9 m -1.77 116.81 0.01 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 131.398 3.879 . . . . 0.0 117.126 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -108.91 141.52 23.53 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -164.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -73.87 -11.57 23.75 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 122.801 2.334 . . . . 0.0 113.498 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.5 -130.71 1.19 Allowed Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 30.9 m -81.37 143.38 32.21 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.84 131.24 36.05 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 110.484 -160.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -94.15 -152.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.755 2.97 . . . . 0.0 109.248 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -148.38 135.21 19.97 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 119.156 0.889 . . . . 0.0 108.611 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -115.18 -13.22 11.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.387 1.075 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -100.77 87.62 3.37 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 118.208 0.458 . . . . 0.0 112.204 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.32 97.11 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 163.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' B' ' 855' ' ' ALA . 19.6 mt -88.14 -38.69 15.15 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.31 -173.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.7 tp -165.88 126.63 1.81 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 100.869 -3.752 . . . . 0.0 100.869 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 176.86 60.93 0.0 OUTLIER 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.196 1.362 . . . . 0.0 108.515 -163.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.46 -43.77 93.11 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -166.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.27 -29.68 10.99 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.889 0.768 . . . . 0.0 112.335 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.86 -59.54 0.35 Allowed Glycine 0 C--N 1.352 1.457 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 62.83 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.905 2.482 . . . . 0.0 114.408 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -96.07 119.59 34.84 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.924 1.29 . . . . 0.0 108.67 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.46 117.42 68.39 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 2.47 2.46 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 CA-C-N 125.077 2.849 . . . . 0.0 109.518 -166.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.04 -43.88 21.1 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 30.4 p -105.54 -14.29 15.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.443 1.097 . . . . 0.0 108.171 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 25.56 41.35 Favored Glycine 0 C--N 1.36 1.888 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 163.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.48 102.84 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 101.867 -3.382 . . . . 0.0 101.867 -163.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.89 113.24 25.29 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.837 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 70.6 m -99.61 109.31 21.82 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 888' ' ' ALA . . . . . 0.447 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -89.12 111.03 42.55 Favored Pre-proline 0 C--N 1.356 0.882 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.91 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.36 -4.24 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-N 123.133 2.155 . . . . 0.0 109.192 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 21.6 mt -53.52 -49.46 67.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.184 2.193 . . . . 0.0 114.334 -167.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.56 50.61 12.55 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.627 1.571 . . . . 0.0 114.183 171.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -164.26 -165.87 22.21 Favored Glycine 0 N--CA 1.411 -3.008 1 N-CA-C 101.517 -4.633 . . . . 0.0 101.517 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -92.74 121.68 34.37 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.985 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 2.6 p90 -116.47 160.68 20.25 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 119.023 0.829 . . . . 0.0 109.269 176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.6 tp -104.72 116.0 31.28 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.26 135.7 50.61 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 126.332 1.853 . . . . 0.0 107.801 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.3 m -144.92 118.97 9.39 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.57 153.91 22.18 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 97.5 t -109.98 120.76 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.17 122.6 46.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.986 0.914 . . . . 0.0 108.812 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 32.5 m -79.29 133.35 36.64 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.258 1.423 . . . . 0.0 108.0 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.16 -57.2 21.09 Favored Glycine 0 C--N 1.365 2.167 0 C-N-CA 125.216 1.388 . . . . 0.0 114.267 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 61.3 m170 34.99 72.96 0.09 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.451 2.3 . . . . 0.0 115.186 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.66 -8.15 54.85 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.291 1.436 . . . . 0.0 111.674 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -73.18 -14.53 61.37 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.425 1.49 . . . . 0.0 112.631 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.7 pt-20 118.59 179.45 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 128.587 2.755 . . . . 0.0 108.77 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 102.08 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.057 2.543 . . . . 0.0 106.467 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.22 128.4 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -110.63 122.87 48.84 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.881 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.35 115.41 15.56 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.053 2.541 . . . . 0.0 109.932 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.47 114.18 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 O-C-N 120.216 -1.553 . . . . 0.0 106.863 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.28 144.9 56.54 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.454 1.902 . . . . 0.0 111.358 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -115.61 145.95 42.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 127.196 2.198 . . . . 0.0 109.038 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.447 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -81.13 138.96 35.88 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 126.828 2.051 . . . . 0.0 109.231 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.6 t 100.85 -10.82 0.03 OUTLIER 'General case' 0 C--N 1.35 0.591 0 C-N-CA 129.589 3.155 . . . . 0.0 113.383 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.44 -24.38 0.72 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 119.493 1.042 . . . . 0.0 111.293 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 60.19 168.41 0.08 Allowed 'General case' 0 C--N 1.362 1.115 0 C-N-CA 124.898 1.279 . . . . 0.0 111.541 -163.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -132.37 51.64 Favored Glycine 0 C--N 1.368 2.34 0 O-C-N 119.763 -1.836 . . . . 0.0 109.702 -164.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 48.7 t 54.74 76.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.169 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.03 115.17 27.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -103.87 -35.22 8.24 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.368 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.1 t -99.89 75.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.89 129.66 44.3 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.516 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -141.34 115.42 9.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 125.319 1.448 . . . . 0.0 107.306 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.91 84.76 0.73 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.098 -3.601 . . . . 0.0 104.098 164.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.812 0 C-N-CA 124.916 1.246 . . . . 0.0 112.808 175.484 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 56.3 mt -115.65 133.98 55.5 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -168.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.2 162.77 26.8 Favored Glycine 0 CA--C 1.494 -1.219 0 C-N-CA 124.731 1.158 . . . . 0.0 110.215 -173.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 28.5 m -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -139.55 150.05 44.62 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.7 m -123.0 -30.77 3.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.723 0.692 . . . . 0.0 112.448 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.6 tp -85.88 -51.15 6.58 Favored 'General case' 0 C--N 1.358 0.94 0 CA-C-N 119.648 1.113 . . . . 0.0 112.115 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 872' ' ' LEU . 38.6 pt -84.8 -175.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.39 1.476 . . . . 0.0 110.133 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.492 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -158.06 80.9 3.04 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -170.372 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.24 92.32 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.271 1.98 . . . . 0.0 109.932 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' B' ' 954' ' ' LEU . 9.6 mp -121.59 144.73 48.57 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -89.91 159.23 17.04 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.334 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.45 123.48 23.19 Favored 'General case' 0 C--N 1.377 1.773 0 CA-C-N 119.769 1.168 . . . . 0.0 108.379 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.64 70.8 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 125.635 1.588 . . . . 0.0 110.92 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.36 175.31 5.53 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 121.631 0.729 . . . . 0.0 111.324 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 96.1 m -141.35 128.59 21.0 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.513 0.725 . . . . 0.0 109.095 -153.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 962' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.9 149.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-O 121.466 0.65 . . . . 0.0 109.476 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -143.99 136.67 27.08 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.724 1.209 . . . . 0.0 111.135 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.0 t -93.51 130.51 42.41 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 127.593 2.357 . . . . 0.0 107.401 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -107.25 132.12 53.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 19.7 tp -129.65 75.33 1.64 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.471 -1.695 . . . . 0.0 106.805 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.8 t -159.22 103.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.8 mmm -152.37 70.03 0.9 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 124.24 148.02 7.33 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -116.04 -27.96 6.77 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.52 86.68 5.29 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.36 -164.2 1.56 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -124.56 159.23 31.12 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.9 t -92.31 132.05 37.02 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -158.47 150.7 21.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.54 113.2 25.37 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -98.31 173.04 0.56 Allowed 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 121.853 1.702 . . . . 0.0 108.283 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.62 140.16 49.71 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.54 141.67 39.29 Favored 'General case' 0 C--N 1.374 1.647 0 CA-C-N 119.616 1.098 . . . . 0.0 108.663 -171.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 130.45 72.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -127.37 105.54 8.6 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 52.2 p -102.65 162.77 12.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.687 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.66 112.56 0.34 Allowed Glycine 0 C--N 1.359 1.825 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -121.61 145.98 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.8 tp -72.58 123.79 23.92 Favored 'General case' 0 C--N 1.381 1.971 0 C-N-CA 124.422 1.089 . . . . 0.0 109.763 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.82 -56.95 2.35 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -131.14 127.31 37.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.32 129.54 9.94 Favored Glycine 0 CA--C 1.487 -1.66 0 N-CA-C 103.379 -3.888 . . . . 0.0 103.379 163.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.41 128.84 90.9 Favored Pre-proline 0 C--N 1.349 0.555 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.122 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -107.0 81.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.782 1.672 . . . . 0.0 109.462 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 78.04 -71.73 0.1 Allowed 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 129.818 3.247 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 56.7 mt 49.16 40.49 17.81 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 128.668 2.787 . . . . 0.0 114.02 -175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -114.13 131.48 56.41 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.16 109.19 10.95 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.074 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 179.062 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.05 112.85 31.59 Favored Pre-proline 0 N--CA 1.443 -0.801 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -88.35 -21.6 1.48 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.617 1.613 . . . . 0.0 110.161 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 35.93 70.86 0.14 Allowed 'General case' 0 C--N 1.357 0.901 0 C-N-CA 129.161 2.984 . . . . 0.0 115.679 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.29 134.81 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.51 161.93 33.67 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -148.75 146.76 28.21 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 166.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.3 t -166.83 119.25 0.97 Allowed 'General case' 0 C--N 1.35 0.588 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.53 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.07 154.87 40.69 Favored 'General case' 0 C--N 1.371 1.531 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -143.11 155.58 44.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 122.201 1.0 . . . . 0.0 109.537 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.553 HD21 HD23 ' C' ' 858' ' ' LEU . 2.2 tm? -131.62 127.6 37.38 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.436 -166.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.2 m -158.8 12.78 0.16 Allowed 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -164.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.553 HD23 HD21 ' C' ' 856' ' ' LEU . 2.3 pp -27.71 146.18 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 160.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.78 -44.82 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 122.245 1.837 . . . . 0.0 113.332 -161.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.0 ptt85 -164.28 173.75 11.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -173.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.7 m -4.38 112.56 0.01 OUTLIER 'General case' 0 C--N 1.365 1.242 0 C-N-CA 130.826 3.651 . . . . 0.0 116.436 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.93 162.54 25.14 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -167.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.34 -14.99 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.378 2.052 . . . . 0.0 111.163 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.33 -144.2 4.05 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 28.1 m -64.96 136.14 56.46 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.986 1.715 . . . . 0.0 110.492 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 16.6 m -64.89 143.66 98.87 Favored Pre-proline 0 C--N 1.354 0.78 0 C-N-CA 125.444 1.497 . . . . 0.0 113.2 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -98.7 -151.75 0.03 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.572 0 C-N-CA 123.296 2.664 . . . . 0.0 107.478 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -146.05 130.11 17.4 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -115.93 -15.67 11.19 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.159 0.584 . . . . 0.0 111.08 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -103.23 79.71 1.76 Allowed 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.937 0.495 . . . . 0.0 111.669 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.08 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 127.063 2.145 . . . . 0.0 106.973 165.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 3.3 mt -90.75 -37.16 13.86 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.327 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 60.5 tp -164.64 128.2 2.45 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 172.34 61.96 0.0 OUTLIER 'General case' 0 C--N 1.356 0.854 0 CA-C-N 120.653 1.57 . . . . 0.0 106.973 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.32 98.02 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 116.085 1.884 . . . . 0.0 116.085 -165.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.77 -32.91 8.73 Favored Glycine 0 C--N 1.357 1.728 0 CA-C-N 119.028 0.831 . . . . 0.0 112.076 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.51 -65.01 0.26 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 64.24 -79.13 0.03 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.931 2.492 . . . . 0.0 114.517 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.59 121.87 36.59 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.804 1.642 . . . . 0.0 109.283 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -80.57 118.4 72.25 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 115.611 -2.137 . . . . 0.0 105.884 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -92.42 0.88 4.0 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 CA-C-N 125.514 3.005 . . . . 0.0 109.517 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.6 -45.66 18.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.244 1.018 . . . . 0.0 108.9 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.3 p -106.41 -13.4 15.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.702 1.601 . . . . 0.0 108.17 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 86.24 25.23 37.48 Favored Glycine 0 C--N 1.361 1.949 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.728 162.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.54 101.29 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 -165.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.29 112.82 24.47 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 112.45 -2.159 . . . . 0.0 108.387 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 67.6 m -101.11 107.83 19.36 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 888' ' ' ALA . . . . . 0.617 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -90.95 111.79 50.16 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.247 -1.358 . . . . 0.0 111.602 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.05 2.69 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.094 2.141 . . . . 0.0 109.067 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.01 -54.21 45.95 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.545 -167.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.8 68.5 0.83 Allowed 'General case' 0 C--N 1.366 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 111.825 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.77 36.78 Favored Glycine 0 N--CA 1.406 -3.318 1 N-CA-C 102.089 -4.404 . . . . 0.0 102.089 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -92.72 119.19 31.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.797 -1.202 . . . . 0.0 108.26 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.452 ' H ' HD11 ' C' ' 954' ' ' LEU . 8.8 t80 -118.19 146.52 44.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.41 116.23 30.59 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 124.222 1.009 . . . . 0.0 109.086 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 7.3 tt -114.42 139.77 49.23 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.016 1.326 . . . . 0.0 109.365 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.1 119.15 10.04 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.484 0.714 . . . . 0.0 109.903 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.38 154.57 21.65 Favored 'General case' 0 C--N 1.365 1.249 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.67 122.36 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.05 123.73 42.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.251 1.02 . . . . 0.0 109.617 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.0 m -83.16 131.36 35.13 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.68 -56.42 20.34 Favored Glycine 0 C--N 1.364 2.109 0 C-N-CA 125.611 1.577 . . . . 0.0 114.762 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 63.6 m170 32.04 72.34 0.07 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 127.946 2.498 . . . . 0.0 115.609 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -74.27 -9.5 58.66 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.967 1.307 . . . . 0.0 111.371 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.96 -18.33 62.01 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.297 1.439 . . . . 0.0 112.568 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.294 12.1 pt-20 124.63 -175.34 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 128.528 2.731 . . . . 0.0 107.783 174.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 100.88 131.32 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 127.696 2.398 . . . . 0.0 106.554 170.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 71.2 t -99.21 123.49 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -105.15 122.72 46.5 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.509 167.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -131.07 117.15 18.72 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.371 2.668 . . . . 0.0 109.607 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.415 HG11 HH21 ' C' ' 921' ' ' ARG . 87.1 t -90.1 113.01 25.53 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 144.6 53.58 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.796 1.639 . . . . 0.0 111.58 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.285 1.0 OUTLIER -115.31 147.24 40.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.721 2.008 . . . . 0.0 108.893 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.617 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.6 OUTLIER -80.34 138.83 36.76 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 127.301 2.241 . . . . 0.0 110.123 -177.327 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 94.19 -2.64 0.1 Allowed 'General case' 0 C--N 1.348 0.537 0 C-N-CA 129.21 3.004 . . . . 0.0 112.701 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -144.17 -26.41 0.53 Allowed 'General case' 0 C--N 1.358 0.95 0 O-C-N 120.904 -1.122 . . . . 0.0 111.819 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 58.89 168.31 0.06 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.197 1.399 . . . . 0.0 111.583 -162.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.72 51.4 Favored Glycine 0 C--N 1.375 2.697 0 O-C-N 119.576 -1.953 . . . . 0.0 109.855 -165.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 51.66 76.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.214 0 C-N-CA 126.197 1.799 . . . . 0.0 111.322 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.39 114.71 26.89 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -170.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.415 HH21 HG11 ' C' ' 911' ' ' VAL . 12.6 ptt180 -99.12 -38.69 8.83 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.413 -170.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 86.6 t -100.28 82.68 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.72 132.02 39.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.11 0.481 . . . . 0.0 110.49 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 20.7 t -142.75 115.29 8.56 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 108.631 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.25 84.54 0.7 Allowed Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 104.823 -3.311 . . . . 0.0 104.823 166.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.597 0 C-N-CA 125.89 1.709 . . . . 0.0 111.453 174.378 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -121.02 134.02 55.28 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.92 163.45 26.97 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.69 130.94 73.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.39 148.72 49.45 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -116.36 -39.77 3.33 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 31.4 tp -93.04 -55.15 3.45 Favored 'General case' 0 C--N 1.356 0.863 0 O-C-N 121.57 -0.706 . . . . 0.0 111.747 -166.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.3 -161.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 C-N-CA 125.117 1.367 . . . . 0.0 109.737 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.452 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -170.72 91.55 0.47 Allowed Pre-proline 0 C--N 1.358 0.948 0 O-C-N 121.794 -0.566 . . . . 0.0 110.033 -166.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.33 90.61 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 123.247 2.195 . . . . 0.0 109.569 158.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 89.1 mt -123.36 145.83 48.43 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -95.15 159.7 14.89 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-N 118.858 0.753 . . . . 0.0 109.33 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.61 122.67 20.94 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 120.104 1.32 . . . . 0.0 109.411 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 88.79 -8.39 79.59 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 125.896 1.713 . . . . 0.0 111.923 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.14 173.75 8.1 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.946 0.898 . . . . 0.0 109.709 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 81.9 m -142.33 126.21 17.16 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -156.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.464 HG13 HH11 ' C' ' 914' ' ' ARG . 34.8 m -94.99 150.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 123.722 0.809 . . . . 0.0 109.197 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.0 t -140.13 139.46 35.79 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 125.9 1.68 . . . . 0.0 112.195 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.03 128.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.588 0 C-N-CA 126.42 1.888 . . . . 0.0 106.727 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.6 131.36 54.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 25.0 tp -131.92 76.89 1.73 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.284 -1.78 . . . . 0.0 107.617 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 58.3 t -159.03 100.0 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -149.34 83.81 1.43 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.78 149.3 16.14 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -117.4 -17.67 10.04 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.651 0.781 . . . . 0.0 110.374 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.0 tp -99.74 85.4 3.1 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.82 1.66 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -171.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -121.37 157.58 30.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.54 131.5 36.93 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.74 152.8 23.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -125.73 113.97 24.86 Favored Pre-proline 0 C--N 1.356 0.858 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -96.45 170.48 1.04 Allowed 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 121.839 1.693 . . . . 0.0 107.861 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.56 138.38 50.72 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -135.62 138.32 42.78 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 119.488 1.04 . . . . 0.0 108.299 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.62 130.59 69.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -128.9 101.18 5.97 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 24.4 p -100.68 163.83 12.15 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.6 1.56 . . . . 0.0 109.115 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.8 113.44 0.37 Allowed Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.0 42.62 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 66.3 tp -78.53 125.27 29.13 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.481 1.513 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 12.5 tp -97.49 -56.8 2.42 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 121.993 0.117 . . . . 0.0 110.713 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -131.09 128.36 40.03 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -175.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.41 129.34 9.86 Favored Glycine 0 CA--C 1.486 -1.725 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 163.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.47 132.11 89.65 Favored Pre-proline 0 C--N 1.349 0.563 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.478 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -106.38 79.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 121.305 1.502 . . . . 0.0 109.171 -170.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.98 -72.04 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.019 3.328 . . . . 0.0 109.056 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.9 mt 49.77 39.48 18.03 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 128.678 2.791 . . . . 0.0 113.761 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -112.32 131.42 55.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -128.34 108.97 11.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 179.206 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.455 -0.776 0 N-CA-C 110.021 -0.8 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.87 120.05 24.15 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.69 -21.0 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 122.146 1.802 . . . . 0.0 109.566 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 36.86 70.03 0.19 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 129.103 2.961 . . . . 0.0 115.631 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 87.3 t -118.78 136.5 55.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 158.81 43.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 162.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 8.1 p90 -149.44 138.56 21.32 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 28.8 t -169.1 117.15 0.65 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.5 152.36 36.09 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.67 157.58 46.53 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.537 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 858' ' ' LEU . 2.6 tm? -131.59 131.52 43.34 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -166.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 41.7 p -160.32 16.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -165.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 856' ' ' LEU . 3.4 pp -21.73 144.1 0.02 OUTLIER Pre-proline 0 C--N 1.37 1.464 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 159.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.8 -43.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 122.093 1.783 . . . . 0.0 111.995 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -164.28 176.67 8.94 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 17.1 m -19.22 120.21 0.02 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.651 3.18 . . . . 0.0 115.656 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -127.67 144.22 50.35 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 -163.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.66 -10.34 17.12 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 122.685 1.995 . . . . 0.0 113.586 -159.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -158.07 -142.05 3.3 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 20.3 m -63.31 145.38 55.68 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 110.47 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.1 128.79 50.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.857 1.263 . . . . 0.0 110.307 -165.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -94.45 -152.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.28 3.32 . . . . 0.0 108.489 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -149.28 135.13 18.81 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -118.33 -13.65 9.81 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 122.753 0.421 . . . . 0.0 111.608 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -100.17 86.73 3.28 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 118.609 0.641 . . . . 0.0 112.545 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 871' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 874' ' ' ASN . 54.0 t -71.92 97.65 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.831 1.652 . . . . 0.0 107.013 168.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.36 -37.21 17.3 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.946 -172.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 29.2 tp -165.4 127.64 2.09 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 101.959 -3.349 . . . . 0.0 101.959 160.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 26.9 t-20 -174.8 60.84 0.02 OUTLIER 'General case' 0 C--N 1.356 0.877 0 CA-C-N 120.553 1.524 . . . . 0.0 110.336 -166.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -58.87 -43.99 90.97 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -166.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.35 -27.23 12.19 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 118.928 0.785 . . . . 0.0 112.747 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -57.76 0.41 Allowed Glycine 0 C--N 1.352 1.465 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.07 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.354 0.804 0 C-N-CA 128.098 2.559 . . . . 0.0 114.746 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -96.78 119.14 34.7 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.21 116.05 62.28 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -95.95 4.88 2.03 Favored 'Trans proline' 0 CA--C 1.505 -0.93 0 CA-C-N 124.405 2.609 . . . . 0.0 109.407 -160.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -79.93 -45.81 17.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.1 p -106.01 -10.43 16.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.348 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.41 28.06 37.48 Favored Glycine 0 C--N 1.366 2.201 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 161.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 22.9 t -101.6 103.05 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 -162.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.468 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.4 OUTLIER -102.03 111.13 23.28 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 112.434 -2.166 . . . . 0.0 109.464 -173.045 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 83.9 m -99.99 107.53 19.5 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 888' ' ' ALA . . . . . 0.461 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.12 111.41 46.64 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 117.106 -1.426 . . . . 0.0 112.2 169.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.0 -1.24 5.62 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.781 2.321 . . . . 0.0 109.126 166.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -49.13 -54.82 14.49 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 128.856 2.862 . . . . 0.0 115.127 -167.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.47 48.69 14.11 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.63 -161.77 10.74 Favored Glycine 0 N--CA 1.417 -2.578 1 N-CA-C 102.636 -4.185 . . . . 0.0 102.636 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.557 ' HE ' HG22 ' A' ' 953' ' ' ILE . 67.7 ttt-85 -89.92 120.89 31.53 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.472 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.3 t80 -115.58 144.87 43.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -174.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -109.78 116.81 32.35 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.704 0.801 . . . . 0.0 109.871 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.1 140.02 48.83 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.091 1.756 . . . . 0.0 109.049 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -143.98 119.74 10.52 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.526 0.73 . . . . 0.0 109.812 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.47 153.95 22.07 Favored 'General case' 0 C--N 1.367 1.344 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.31 121.07 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.36 123.59 43.77 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.209 -172.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 41.8 m -83.38 131.33 35.06 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.39 -58.07 16.47 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 125.124 1.345 . . . . 0.0 114.107 -169.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 38.25 69.81 0.23 Allowed 'General case' 0 C--N 1.36 1.065 0 C-N-CA 127.085 2.154 . . . . 0.0 114.708 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -73.23 -8.97 58.12 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.161 1.384 . . . . 0.0 111.284 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.33 -19.44 61.65 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.814 1.246 . . . . 0.0 112.486 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.301 13.9 pt-20 127.56 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.161 2.584 . . . . 0.0 108.424 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.7 tttt 102.05 131.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.885 2.474 . . . . 0.0 107.386 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.7 t -99.51 125.38 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 123.306 1.527 . . . . 0.0 106.932 -172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -112.41 122.17 46.94 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.134 -1.848 . . . . 0.0 113.004 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.9 116.81 16.93 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 128.346 2.658 . . . . 0.0 108.538 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.78 112.77 23.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.08 145.67 52.57 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.647 1.579 . . . . 0.0 111.901 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.306 0.8 OUTLIER -114.81 148.87 37.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 126.588 1.955 . . . . 0.0 110.732 177.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.587 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.33 138.75 38.72 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.948 2.099 . . . . 0.0 109.744 176.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 96.85 -1.22 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 128.816 2.846 . . . . 0.0 112.319 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -147.89 -26.05 0.35 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.108 -0.995 . . . . 0.0 110.634 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 57.92 171.36 0.05 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.194 1.397 . . . . 0.0 111.521 -162.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.44 -133.6 52.63 Favored Glycine 0 C--N 1.373 2.592 0 O-C-N 119.376 -2.078 . . . . 0.0 110.104 -163.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 948' ' ' GLY . 58.5 t 56.32 77.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 126.036 1.735 . . . . 0.0 111.485 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.2 115.17 27.84 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -102.6 -34.09 9.22 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.601 -172.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 95.4 t -99.34 87.24 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 103.252 -2.869 . . . . 0.0 103.252 166.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -94.84 131.18 41.01 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 116.31 9.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.343 1.457 . . . . 0.0 107.714 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.41 85.03 0.71 Allowed Glycine 0 CA--C 1.485 -1.814 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 162.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.62 0 C-N-CA 124.812 1.196 . . . . 0.0 110.987 172.663 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.69 134.34 52.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 948' ' ' GLY . . . . . 0.465 ' H ' HG22 ' A' ' 919' ' ' VAL . . . -139.7 163.81 26.12 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -174.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.29 132.96 70.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.05 147.46 46.19 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 55.1 m -117.62 -40.98 2.97 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 36.4 tp -89.27 -54.21 4.21 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.666 0.666 . . . . 0.0 112.082 -165.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.557 HG22 ' HE ' ' A' ' 893' ' ' ARG . 16.3 pt -85.41 -155.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.883 0 C-N-CA 124.724 1.21 . . . . 0.0 110.278 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.472 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -170.07 85.71 0.57 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 C-N-CA 122.981 0.513 . . . . 0.0 109.934 -165.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.14 89.99 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 122.656 1.984 . . . . 0.0 109.538 159.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.78 145.83 48.07 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.568 2.347 . . . . 0.0 105.022 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -92.62 157.16 16.64 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-N 119.444 1.02 . . . . 0.0 108.705 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.27 123.83 23.15 Favored 'General case' 0 C--N 1.37 1.495 0 CA-C-N 119.749 1.159 . . . . 0.0 108.949 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.46 -13.17 67.78 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 125.884 1.707 . . . . 0.0 111.019 170.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.16 176.19 5.38 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.052 0.541 . . . . 0.0 111.697 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 77.7 m -141.74 127.17 18.82 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -157.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.587 HG13 HH11 ' A' ' 914' ' ' ARG . 10.5 m -94.9 149.72 4.37 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 121.642 0.734 . . . . 0.0 109.909 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.6 m -139.38 137.17 35.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.139 1.775 . . . . 0.0 111.011 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 89.5 t -92.82 129.19 43.73 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 C-N-CA 126.61 1.964 . . . . 0.0 106.666 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -108.35 131.07 55.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.98 77.82 1.81 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 53.0 t -161.21 101.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.848 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -152.3 72.42 0.99 Allowed 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.04 149.42 8.55 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -117.01 -28.75 6.17 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.805 0.842 . . . . 0.0 108.748 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.2 tp -92.6 86.51 5.62 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.37 -164.13 1.54 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -125.29 160.21 29.83 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -93.22 132.07 37.72 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.57 150.01 22.75 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.23 113.58 23.71 Favored Pre-proline 0 C--N 1.355 0.844 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -97.95 172.34 0.64 Allowed 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 108.369 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.17 140.43 49.53 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -140.45 142.25 35.39 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 119.51 1.05 . . . . 0.0 108.757 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.81 129.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -125.81 106.85 9.98 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 52.1 p -99.29 160.74 14.06 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.057 0.943 . . . . 0.0 109.547 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.13 108.35 0.25 Allowed Glycine 0 C--N 1.359 1.836 0 C-N-CA 119.293 -1.432 . . . . 0.0 109.951 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.99 148.78 43.13 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 52.0 tp -72.7 123.39 23.18 Favored 'General case' 0 C--N 1.372 1.568 0 C-N-CA 125.849 1.66 . . . . 0.0 109.456 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.1 tp -99.95 -57.84 2.05 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.82 128.64 39.15 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.911 2.084 . . . . 0.0 106.466 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 130.58 10.32 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 103.979 -3.649 . . . . 0.0 103.979 161.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -69.48 133.56 89.0 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-N 118.662 1.231 . . . . 0.0 110.794 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -106.14 83.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.473 0 CA-C-N 121.469 1.56 . . . . 0.0 109.832 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.44 -72.74 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.398 3.479 . . . . 0.0 109.484 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.3 mt 49.52 40.23 18.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.27 3.028 . . . . 0.0 114.023 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.08 130.51 55.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -127.32 110.1 12.48 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.058 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.454 -0.823 0 N-CA-C 110.004 -0.806 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.2 120.67 25.15 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -92.7 -21.01 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.098 1.785 . . . . 0.0 109.83 -172.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 38.48 69.83 0.24 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 129.08 2.952 . . . . 0.0 115.315 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 78.9 t -118.7 136.42 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.24 158.34 44.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.416 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 8.3 p90 -149.52 139.21 21.74 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.3 t -169.2 117.84 0.66 Allowed 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.66 153.06 34.94 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -138.8 157.67 45.65 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.886 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.09 130.22 40.95 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -166.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 32.4 p -160.8 14.18 0.11 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.557 -163.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.2 pp -21.58 143.58 0.02 OUTLIER Pre-proline 0 C--N 1.373 1.587 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 158.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.34 -43.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 122.009 1.753 . . . . 0.0 111.936 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -164.15 176.78 8.93 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m -19.36 120.44 0.02 OUTLIER 'General case' 0 C--N 1.363 1.175 0 C-N-CA 129.706 3.203 . . . . 0.0 115.645 171.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -127.92 144.19 50.51 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -163.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.77 -10.6 16.96 Favored 'Trans proline' 0 CA--C 1.512 -0.603 0 CA-C-N 122.698 1.999 . . . . 0.0 113.645 -158.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.62 -141.81 3.25 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -63.25 144.92 56.52 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.984 1.714 . . . . 0.0 110.282 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.13 128.27 54.27 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 124.912 1.285 . . . . 0.0 110.119 -165.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -95.34 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.196 3.264 . . . . 0.0 108.382 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -147.92 133.79 19.07 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -116.48 -13.02 10.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.977 0.911 . . . . 0.0 110.696 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.26 85.7 2.86 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 121.198 0.523 . . . . 0.0 111.281 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 871' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' B' ' 874' ' ' ASN . 60.7 t -69.77 97.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 163.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' B' ' 855' ' ' ALA . 18.5 mt -87.21 -39.32 15.56 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.414 -172.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 40.7 tp -165.23 127.25 2.09 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 101.064 -3.68 . . . . 0.0 101.064 165.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.417 ' HB3' HG13 ' B' ' 871' ' ' VAL . 27.3 t-20 178.69 61.02 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 120.157 1.344 . . . . 0.0 109.146 -161.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.52 -43.56 93.38 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.59 -27.6 12.7 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 118.779 0.718 . . . . 0.0 112.669 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.92 -55.73 0.5 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 60.46 -84.11 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 C-N-CA 128.11 2.564 . . . . 0.0 114.866 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.3 118.87 34.71 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.75 116.39 63.72 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.01 5.21 2.37 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 CA-C-N 124.403 2.608 . . . . 0.0 109.73 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.95 -44.38 20.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.5 p -108.2 -10.64 15.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.957 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.79 30.13 30.16 Favored Glycine 0 C--N 1.359 1.819 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 162.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 32.3 t -101.34 102.36 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 -162.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.448 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.3 OUTLIER -101.53 111.79 24.14 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 112.856 -1.974 . . . . 0.0 108.994 -174.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.3 m -100.14 107.67 19.61 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 888' ' ' ALA . . . . . 0.454 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.13 111.53 47.32 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 117.291 -1.338 . . . . 0.0 111.93 169.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -89.48 0.35 5.89 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.762 2.308 . . . . 0.0 108.759 164.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -48.38 -56.44 8.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 128.914 2.886 . . . . 0.0 115.032 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.85 63.93 1.67 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 170.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.98 -166.68 31.83 Favored Glycine 0 N--CA 1.409 -3.141 0 N-CA-C 103.621 -3.791 . . . . 0.0 103.621 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -90.81 121.16 32.43 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.482 ' H ' HD11 ' B' ' 954' ' ' LEU . 2.0 t80 -117.27 146.04 43.57 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -172.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.34 115.51 28.86 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.2 tt -112.08 139.83 47.27 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 126.275 1.83 . . . . 0.0 108.503 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -143.26 119.19 10.62 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 123.312 0.645 . . . . 0.0 109.43 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.65 154.46 21.42 Favored 'General case' 0 C--N 1.365 1.271 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.69 121.96 61.33 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.38 122.02 43.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.152 0.981 . . . . 0.0 109.123 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 36.4 m -81.41 132.05 35.31 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 107.781 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.01 16.7 Favored Glycine 0 C--N 1.364 2.125 0 C-N-CA 125.14 1.352 . . . . 0.0 114.405 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.5 m170 37.2 70.4 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.204 2.202 . . . . 0.0 114.976 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -73.29 -8.74 57.15 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.28 1.432 . . . . 0.0 111.442 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -73.17 -15.79 61.45 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.083 1.353 . . . . 0.0 112.564 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.314 12.2 pt-20 122.94 -179.29 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 128.568 2.747 . . . . 0.0 108.606 176.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.0 tttt 102.5 131.11 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 127.897 2.479 . . . . 0.0 107.184 170.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.08 126.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -112.52 123.13 49.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.87 174.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.56 115.67 15.75 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 128.223 2.609 . . . . 0.0 109.476 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.4 t -87.89 113.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.21 149.37 41.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.662 1.985 . . . . 0.0 112.369 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.309 0.9 OUTLIER -115.08 149.53 37.37 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 126.598 1.959 . . . . 0.0 110.524 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.599 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.71 138.71 36.35 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.593 1.957 . . . . 0.0 109.36 174.165 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 97.1 -5.76 0.06 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 128.92 2.888 . . . . 0.0 112.569 172.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -146.19 -25.84 0.44 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-N 119.47 1.032 . . . . 0.0 111.349 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 57.9 169.66 0.05 OUTLIER 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.32 1.448 . . . . 0.0 111.571 -162.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.03 -132.89 50.95 Favored Glycine 0 C--N 1.368 2.317 0 O-C-N 119.508 -1.995 . . . . 0.0 109.727 -165.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 53.71 78.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 126.408 1.883 . . . . 0.0 111.631 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.42 28.03 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -103.02 -35.27 8.61 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.632 -172.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 89.6 t -99.35 86.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 166.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.9 130.53 42.83 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -172.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -141.59 117.34 10.4 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.327 1.451 . . . . 0.0 107.235 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.21 85.18 0.73 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.889 -3.684 . . . . 0.0 103.889 164.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.661 0 C-N-CA 124.639 1.114 . . . . 0.0 110.927 174.309 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 CA--C 1.506 -0.747 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.54 134.07 55.42 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.67 164.68 26.0 Favored Glycine 0 CA--C 1.489 -1.545 0 C-N-CA 125.56 1.552 . . . . 0.0 109.281 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.06 133.01 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -135.66 148.51 48.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 52.6 m -122.14 -34.61 3.29 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.367 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 25.8 tp -91.31 -52.34 4.85 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.128 -168.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -86.63 -169.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 124.816 1.246 . . . . 0.0 109.353 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.482 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.62 86.42 2.1 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -168.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.31 90.88 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 117.627 -1.828 . . . . 0.0 109.982 161.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.53 145.58 48.19 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 127.083 2.153 . . . . 0.0 105.412 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -92.16 158.89 15.93 Favored 'General case' 0 C--N 1.363 1.155 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.701 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.55 123.1 22.49 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-N 120.304 1.411 . . . . 0.0 108.602 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.77 -12.02 70.1 Favored Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 125.283 1.421 . . . . 0.0 110.863 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.55 175.7 5.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.905 0.859 . . . . 0.0 110.659 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 83.2 m -142.27 127.51 18.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -154.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.599 HG13 HH11 ' B' ' 914' ' ' ARG . 7.5 m -96.28 150.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 CA-C-O 121.464 0.649 . . . . 0.0 110.989 174.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.2 m -138.49 137.39 37.09 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 126.359 1.863 . . . . 0.0 111.035 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.04 129.44 42.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 C-N-CA 127.459 2.303 . . . . 0.0 106.564 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -107.98 130.98 55.02 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 100.886 -3.746 . . . . 0.0 100.886 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.97 77.33 1.78 Allowed 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 54.0 t -159.84 103.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -151.12 72.37 1.06 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.83 148.23 8.35 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -115.38 -27.66 7.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 35.8 tp -93.64 86.43 5.17 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.19 -163.98 1.51 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -125.2 159.29 31.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -91.38 131.13 37.06 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.58 149.99 22.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.826 -2.286 . . . . 0.0 104.826 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.06 113.29 24.12 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -97.06 172.33 0.78 Allowed 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.003 1.802 . . . . 0.0 108.173 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.4 mp -115.92 138.04 51.55 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.3 p -138.79 140.29 38.53 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 119.791 1.178 . . . . 0.0 108.261 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.8 mm -116.31 130.35 71.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -126.53 106.59 9.54 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 35.6 p -101.05 162.89 12.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.489 1.116 . . . . 0.0 110.231 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.75 110.31 0.29 Allowed Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.83 147.28 43.2 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.1 122.96 21.85 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 125.135 1.374 . . . . 0.0 109.091 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.1 tp -99.48 -58.09 2.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -131.37 128.39 39.54 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.897 1.679 . . . . 0.0 106.566 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.16 130.42 10.26 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 104.161 -3.575 . . . . 0.0 104.161 161.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.53 133.43 88.94 Favored Pre-proline 0 C--N 1.351 0.657 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.39 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -105.99 82.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.546 1.588 . . . . 0.0 109.195 -170.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.88 -72.28 0.09 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 130.286 3.435 . . . . 0.0 109.444 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 48.69 43.91 21.07 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 129.087 2.955 . . . . 0.0 113.671 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.0 130.23 56.72 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.08 110.2 12.25 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 179.551 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.86 0 N-CA-C 109.962 -0.822 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 34.8 t -125.4 116.52 25.22 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -90.01 -20.71 1.08 Allowed 'Trans proline' 0 CA--C 1.511 -0.638 0 CA-C-N 121.903 1.715 . . . . 0.0 109.662 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 39.16 69.8 0.26 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 128.811 2.844 . . . . 0.0 115.471 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.15 133.73 65.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -137.13 153.96 50.38 Favored 'General case' 0 C--N 1.363 1.158 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 167.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 7.0 p90 -149.71 141.7 23.87 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.916 0.78 . . . . 0.0 109.725 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.8 t -168.68 118.69 0.74 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.159 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.34 153.67 39.98 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -142.52 156.13 45.1 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.274 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.542 HD21 HD23 ' C' ' 858' ' ' LEU . 1.9 tm? -130.21 127.56 39.89 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.699 -164.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 33.3 p -162.35 11.88 0.07 Allowed 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -161.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.542 HD23 HD21 ' C' ' 856' ' ' LEU . 3.2 pp -27.62 146.86 0.04 OUTLIER Pre-proline 0 C--N 1.368 1.393 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 157.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.83 -45.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.101 1.786 . . . . 0.0 112.156 -164.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -162.17 172.64 15.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -0.43 107.17 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 130.652 3.581 . . . . 0.0 117.526 167.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -107.46 163.5 16.82 Favored Pre-proline 0 C--N 1.353 0.757 0 C-N-CA 124.249 1.02 . . . . 0.0 110.209 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.05 -13.19 14.19 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.083 2.522 . . . . 0.0 111.318 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.03 -144.39 4.28 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.1 m -64.39 136.6 57.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.364 1.866 . . . . 0.0 111.035 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.38 144.77 98.84 Favored Pre-proline 0 C--N 1.354 0.787 0 C-N-CA 125.392 1.477 . . . . 0.0 113.453 -174.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -100.96 -147.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.435 2.757 . . . . 0.0 106.67 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -147.33 134.25 20.22 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -117.59 -15.54 10.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 122.811 0.444 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.463 HH21 HD23 ' C' ' 872' ' ' LEU . 11.1 mmm180 -102.33 81.52 2.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.402 0.62 . . . . 0.0 111.399 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 871' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' C' ' 874' ' ' ASN . 43.6 t -67.99 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 126.265 1.826 . . . . 0.0 107.464 162.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.463 HD23 HH21 ' C' ' 870' ' ' ARG . 6.9 mt -88.47 -37.85 15.46 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 121.601 -0.687 . . . . 0.0 110.68 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.8 tp -165.86 129.77 2.21 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 168.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.2 t-20 176.42 61.69 0.0 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.828 1.649 . . . . 0.0 108.034 -165.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.32 -43.68 92.67 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -165.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.01 -28.08 11.47 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 118.896 0.771 . . . . 0.0 112.568 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.36 -57.78 0.42 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 62.38 -82.51 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.214 2.606 . . . . 0.0 114.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.0 120.05 36.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.139 1.376 . . . . 0.0 108.085 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.49 115.95 62.0 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -96.02 5.97 1.91 Allowed 'Trans proline' 0 CA--C 1.506 -0.913 0 CA-C-N 124.659 2.7 . . . . 0.0 109.702 -161.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -79.55 -45.25 19.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 29.3 p -106.72 -11.14 15.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.868 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.93 31.07 30.03 Favored Glycine 0 C--N 1.362 1.987 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 162.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 36.2 t -101.25 101.93 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 100.965 -3.716 . . . . 0.0 100.965 -164.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.26 112.09 24.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 112.127 -2.306 . . . . 0.0 108.548 -175.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 66.4 m -99.39 109.42 22.02 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.34 109.6 34.79 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 117.367 -1.302 . . . . 0.0 111.724 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.35 -4.11 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.434 2.089 . . . . 0.0 108.104 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 55.0 mt -54.54 -52.89 60.62 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 127.937 2.495 . . . . 0.0 114.009 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.56 67.62 0.92 Allowed 'General case' 0 C--N 1.366 1.32 0 CA-C-O 122.262 1.03 . . . . 0.0 111.418 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.54 -169.62 36.78 Favored Glycine 0 N--CA 1.406 -3.334 1 N-CA-C 102.156 -4.377 . . . . 0.0 102.156 -170.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -93.69 120.85 34.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.53 -1.335 . . . . 0.0 108.076 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.429 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.5 t80 -116.73 145.38 43.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -170.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 53.1 tp -109.94 114.88 28.79 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.061 0.945 . . . . 0.0 108.58 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -113.21 137.9 50.78 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.379 1.472 . . . . 0.0 108.814 -173.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -144.3 118.71 9.64 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.82 22.2 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.81 121.76 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.46 124.15 39.34 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.373 1.069 . . . . 0.0 109.837 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 55.5 m -81.47 130.62 35.11 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -50.62 -54.81 19.69 Favored Glycine 0 C--N 1.361 1.956 0 C-N-CA 126.141 1.829 . . . . 0.0 115.776 -170.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 28.7 m170 28.16 78.69 0.02 OUTLIER 'General case' 0 C--N 1.36 1.06 0 C-N-CA 128.162 2.585 . . . . 0.0 116.254 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -72.37 -13.5 61.49 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.9 1.68 . . . . 0.0 111.29 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.04 -17.43 61.43 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.661 1.584 . . . . 0.0 112.617 -168.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.2 pt-20 116.23 -179.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 128.093 2.557 . . . . 0.0 108.769 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 105.51 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 128.554 2.742 . . . . 0.0 105.136 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.8 t -97.23 125.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -101.15 130.87 47.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.086 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.75 113.54 2.8 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 125.252 1.421 . . . . 0.0 110.625 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 6.2 p -85.18 117.73 30.86 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 108.722 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.62 137.78 58.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.646 1.178 . . . . 0.0 109.81 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -117.17 144.39 44.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.609 1.564 . . . . 0.0 107.853 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.45 142.55 37.44 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 128.344 2.657 . . . . 0.0 109.591 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.33 24.1 p 88.6 3.44 0.26 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 129.902 3.281 . . . . 0.0 113.879 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -150.67 -24.26 0.23 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-N 119.453 1.024 . . . . 0.0 111.31 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 58.84 168.37 0.06 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.435 1.494 . . . . 0.0 112.116 -163.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -130.16 49.82 Favored Glycine 0 C--N 1.375 2.744 0 O-C-N 119.384 -2.072 . . . . 0.0 110.135 -163.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 49.2 t 53.48 72.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.175 0 C-N-CA 125.946 1.698 . . . . 0.0 111.974 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.66 116.37 28.95 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -99.31 -31.31 11.76 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.762 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.88 80.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -95.29 130.76 41.93 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.744 0.307 . . . . 0.0 111.197 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 117.81 9.02 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.287 1.435 . . . . 0.0 107.872 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.15 85.05 0.79 Allowed Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.713 0 C-N-CA 125.311 1.434 . . . . 0.0 110.732 172.965 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.51 134.69 55.24 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.73 162.59 26.24 Favored Glycine 0 CA--C 1.491 -1.421 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.88 132.98 69.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.86 148.71 45.64 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.436 -0.79 . . . . 0.0 108.957 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 63.7 m -108.31 -75.79 0.62 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 21.9 tp -66.96 -50.74 61.35 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -163.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.89 -176.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 125.94 1.696 . . . . 0.0 109.656 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.64 ' HB2' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -163.14 94.42 1.13 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.25 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.1 93.63 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.631 2.221 . . . . 0.0 110.015 162.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.64 HD13 ' HB2' ' C' ' 954' ' ' LEU . 7.9 mp -120.65 144.49 48.14 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -98.35 160.42 14.29 Favored 'General case' 0 C--N 1.363 1.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.43 123.41 22.31 Favored 'General case' 0 C--N 1.381 1.978 0 CA-C-N 120.329 1.422 . . . . 0.0 109.038 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -9.49 71.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 125.233 1.397 . . . . 0.0 111.794 168.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.65 171.83 4.78 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.438 0.695 . . . . 0.0 112.445 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.5 m -142.73 127.76 18.47 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -159.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.07 149.76 4.38 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 123.627 0.771 . . . . 0.0 109.295 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.2 t -142.29 136.59 29.91 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.495 1.118 . . . . 0.0 111.89 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.47 129.63 43.63 Favored 'Isoleucine or valine' 0 C--N 1.374 1.665 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.11 134.16 48.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.83 73.6 1.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.902 -1.954 . . . . 0.0 107.041 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 48.9 t -162.03 99.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.954 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -152.37 72.69 1.0 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.68 146.94 8.11 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.65 -21.56 10.17 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.413 0.685 . . . . 0.0 109.952 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -99.08 85.94 3.34 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.89 -167.88 2.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -170.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.69 156.73 33.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 15.4 t -91.12 135.53 33.7 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -160.23 154.45 23.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -127.72 115.01 20.85 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -97.57 172.96 0.67 Allowed 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 121.921 1.747 . . . . 0.0 107.894 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.8 mp -115.29 139.17 50.2 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 22.1 p -137.16 138.97 40.81 Favored 'General case' 0 C--N 1.375 1.688 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 31.5 mm -115.54 131.13 68.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -124.98 105.76 9.45 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 26.4 p -100.86 162.65 12.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 109.587 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 111.03 0.31 Allowed Glycine 0 C--N 1.358 1.785 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.71 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.75 142.71 47.44 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.1 tp -75.17 125.39 28.85 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.684 1.594 . . . . 0.0 108.569 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.1 -56.03 2.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -130.62 127.53 39.15 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -173.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 128.62 9.59 Favored Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 103.615 -3.794 . . . . 0.0 103.615 164.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.58 130.01 89.42 Favored Pre-proline 0 C--N 1.351 0.641 0 CA-C-O 117.461 -1.257 . . . . 0.0 111.215 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -107.03 80.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 122.519 1.935 . . . . 0.0 109.777 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 77.98 -71.99 0.1 Allowed 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 130.048 3.339 . . . . 0.0 109.414 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 64.9 mt 48.77 41.62 18.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 129.314 3.046 . . . . 0.0 113.596 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -110.0 129.55 55.66 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.94 107.0 9.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.307 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 110.015 -0.802 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.11 120.12 22.37 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.54 -20.24 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.122 1.794 . . . . 0.0 109.827 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 36.6 70.56 0.16 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.933 2.893 . . . . 0.0 115.792 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 77.2 t -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.3 44.7 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 165.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -149.46 139.04 21.65 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.4 t -168.96 117.19 0.66 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.21 36.0 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -136.44 158.49 44.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.425 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.555 HD21 HD23 ' A' ' 858' ' ' LEU . 2.5 tm? -135.07 130.46 35.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -166.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 72.2 m -161.41 8.81 0.08 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -162.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.555 HD23 HD21 ' A' ' 856' ' ' LEU . 2.7 pp -29.59 147.58 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.457 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 162.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.0 -43.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 122.128 1.796 . . . . 0.0 113.487 -161.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -163.44 174.05 12.4 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.0 m -9.3 118.97 0.01 OUTLIER 'General case' 0 C--N 1.361 1.097 0 C-N-CA 130.958 3.703 . . . . 0.0 117.004 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -97.95 160.42 28.48 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 124.691 1.196 . . . . 0.0 109.478 -170.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.09 -16.67 9.73 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.815 2.343 . . . . 0.0 110.098 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.57 -137.82 2.41 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 16.5 m -64.22 145.79 55.39 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.204 1.801 . . . . 0.0 110.652 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.66 130.43 36.96 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 125.514 1.525 . . . . 0.0 110.416 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -96.18 -150.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.927 3.084 . . . . 0.0 108.954 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.58 135.52 19.99 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -117.49 -14.78 10.3 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.985 0.514 . . . . 0.0 111.828 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.29 86.82 3.28 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 118.504 0.593 . . . . 0.0 111.839 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.67 97.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.201 1.801 . . . . 0.0 106.574 168.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.445 ' HB3' HD11 ' B' ' 953' ' ' ILE . 50.0 mt -87.24 -37.36 17.3 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.523 -173.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.16 126.86 1.75 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 101.591 -3.485 . . . . 0.0 101.591 162.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -175.31 60.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.494 1.497 . . . . 0.0 109.652 -168.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.72 -44.35 93.78 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -164.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.53 -28.51 11.29 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 118.99 0.814 . . . . 0.0 112.397 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -60.83 0.31 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 63.12 -80.86 0.03 OUTLIER 'General case' 0 C--N 1.356 0.869 0 C-N-CA 128.008 2.523 . . . . 0.0 114.049 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.68 119.46 32.71 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.794 1.238 . . . . 0.0 108.361 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.95 117.63 68.91 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -96.47 0.9 1.97 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 CA-C-N 125.113 2.862 . . . . 0.0 109.368 -165.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -80.31 -45.66 17.47 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -103.27 -12.61 17.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.347 1.059 . . . . 0.0 109.004 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 22.87 52.67 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 162.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 37.7 t -98.94 103.92 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.43 111.98 24.37 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.357 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 62.1 m -100.87 108.32 20.07 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 888' ' ' ALA . . . . . 0.409 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.37 111.09 45.26 Favored Pre-proline 0 C--N 1.358 0.956 0 CA-C-O 117.153 -1.404 . . . . 0.0 112.016 170.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.6 1.89 3.28 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 CA-C-N 123.001 2.107 . . . . 0.0 108.946 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 39.3 mt -52.8 -51.53 60.44 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 127.9 2.48 . . . . 0.0 114.09 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 44.79 18.3 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.069 1.348 . . . . 0.0 114.023 170.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.49 -163.24 11.79 Favored Glycine 0 N--CA 1.415 -2.737 1 N-CA-C 101.212 -4.755 . . . . 0.0 101.212 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -91.98 121.35 33.48 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.287 0.2 OUTLIER -114.58 159.19 20.72 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 119.32 0.963 . . . . 0.0 108.539 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -105.53 115.41 30.2 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.555 0.742 . . . . 0.0 109.085 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.81 136.34 50.0 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 126.079 1.751 . . . . 0.0 109.178 -168.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.5 m -145.99 118.91 8.72 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 123.469 0.708 . . . . 0.0 109.608 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.3 153.66 22.41 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.99 120.64 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.3 123.17 43.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.898 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 38.5 m -79.73 131.91 36.05 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.29 1.436 . . . . 0.0 107.394 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.36 -57.26 19.39 Favored Glycine 0 C--N 1.363 2.074 0 C-N-CA 125.653 1.597 . . . . 0.0 114.713 -169.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.3 m170 34.04 73.96 0.07 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 127.696 2.399 . . . . 0.0 115.606 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -74.14 -8.3 55.68 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.227 1.411 . . . . 0.0 111.55 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -72.12 -15.58 61.99 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 125.741 1.616 . . . . 0.0 112.225 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.339 7.2 pt-20 116.15 -177.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 128.26 2.624 . . . . 0.0 108.603 173.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 104.53 134.59 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 128.244 2.618 . . . . 0.0 106.41 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 69.0 t -98.19 125.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -111.08 122.36 47.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.015 -1.902 . . . . 0.0 113.446 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.21 117.12 17.04 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.12 2.568 . . . . 0.0 108.766 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 94.5 t -87.04 113.79 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 20.3 mt -62.29 140.78 58.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.908 1.683 . . . . 0.0 110.29 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -116.06 146.78 41.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.214 1.805 . . . . 0.0 109.218 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.571 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.07 139.78 40.11 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.155 2.582 . . . . 0.0 110.13 -174.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.17 -13.62 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 129.603 3.161 . . . . 0.0 112.649 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -139.33 -26.0 0.83 Allowed 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 119.327 0.967 . . . . 0.0 111.095 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 60.54 167.01 0.08 Allowed 'General case' 0 C--N 1.361 1.105 0 C-N-CA 125.226 1.411 . . . . 0.0 111.36 -164.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -134.63 50.49 Favored Glycine 0 C--N 1.37 2.449 0 O-C-N 119.521 -1.987 . . . . 0.0 109.208 -161.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 47.4 t 57.93 75.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.235 0 C-N-CA 125.297 1.439 . . . . 0.0 110.516 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.75 114.77 27.39 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -103.01 -36.17 8.28 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.454 -171.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.28 78.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -95.32 131.55 41.3 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.145 -172.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -143.96 114.69 7.7 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.024 1.33 . . . . 0.0 107.885 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.2 84.69 0.71 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 104.529 -3.428 . . . . 0.0 104.529 167.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 110.96 174.955 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.2 mt -118.26 134.1 55.32 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.82 161.41 25.46 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.91 127.96 73.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -137.58 148.47 45.92 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.4 m -114.73 -44.32 3.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 26.9 tp -84.33 -50.11 8.13 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.431 1.014 . . . . 0.0 112.785 -166.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 12.6 pt -87.88 -169.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 124.688 1.195 . . . . 0.0 109.941 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.23 82.71 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -165.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.55 91.36 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 122.308 1.86 . . . . 0.0 109.592 160.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.1 142.31 49.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -94.51 156.56 16.4 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.17 123.02 21.22 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 119.533 1.06 . . . . 0.0 108.929 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.41 -11.85 71.12 Favored Glycine 0 C--N 1.345 1.082 0 C-N-CA 125.893 1.711 . . . . 0.0 111.246 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.7 175.32 5.77 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.158 0.583 . . . . 0.0 111.467 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 83.7 m -142.54 125.47 16.16 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -159.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.571 HG13 HH11 ' A' ' 914' ' ' ARG . 34.0 m -95.79 150.26 4.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.686 0.755 . . . . 0.0 109.9 171.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.7 138.91 34.59 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.684 1.994 . . . . 0.0 111.382 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.29 129.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 126.301 1.84 . . . . 0.0 106.786 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.43 131.0 54.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.168 -3.271 . . . . 0.0 102.168 170.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.04 77.55 1.77 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.3 t -160.93 99.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.4 mmm -152.4 73.89 1.05 Allowed 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 107.5 141.92 10.16 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.96 -5.88 13.17 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.256 0.623 . . . . 0.0 111.257 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.28 82.86 2.97 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.94 -175.19 3.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -122.0 159.5 26.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 16.8 t -89.01 131.19 35.3 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.69 150.03 22.55 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.41 113.36 23.29 Favored Pre-proline 0 C--N 1.356 0.869 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -98.13 174.29 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 108.54 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.75 140.91 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.46 140.58 37.33 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 119.583 1.083 . . . . 0.0 108.919 -171.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.0 mm -118.85 129.77 74.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -127.3 105.92 8.86 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 33.8 p -100.19 160.99 13.9 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.008 1.323 . . . . 0.0 110.068 170.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -179.2 109.84 0.27 Allowed Glycine 0 C--N 1.358 1.787 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.8 144.96 46.0 Favored 'General case' 0 C--N 1.346 0.439 0 O-C-N 121.416 -1.049 . . . . 0.0 113.713 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.75 123.65 24.53 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 124.591 1.156 . . . . 0.0 109.671 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 23.9 tp -98.72 -57.38 2.2 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.65 128.02 38.19 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.82 10.04 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 103.231 -3.947 . . . . 0.0 103.231 163.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -69.04 130.04 91.71 Favored Pre-proline 0 C--N 1.352 0.703 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.015 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -106.76 82.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 CA-C-N 121.885 1.709 . . . . 0.0 109.89 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 78.29 -72.28 0.09 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 130.265 3.426 . . . . 0.0 109.195 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 76.4 mt 49.93 39.0 17.55 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 129.073 2.949 . . . . 0.0 114.244 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.7 131.95 54.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -129.24 109.46 11.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.134 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 179.656 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.454 -0.801 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.69 120.41 23.01 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.5 -20.47 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.176 1.813 . . . . 0.0 110.081 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 37.95 70.37 0.2 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.926 2.89 . . . . 0.0 115.482 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 82.5 t -118.14 136.03 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.08 157.66 46.35 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -149.5 139.46 21.98 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -169.57 118.23 0.63 Allowed 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.97 153.56 34.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -138.37 158.59 43.98 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.908 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.58 HD21 HD23 ' B' ' 858' ' ' LEU . 2.4 tm? -136.06 128.1 29.65 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -167.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 73.3 m -160.33 13.0 0.12 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -167.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.58 HD23 HD21 ' B' ' 856' ' ' LEU . 2.6 pp -29.03 148.24 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 160.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.63 -43.76 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.104 1.787 . . . . 0.0 113.553 -161.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -163.41 173.83 12.7 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -8.73 118.94 0.01 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 130.952 3.701 . . . . 0.0 117.075 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -97.87 160.42 28.54 Favored Pre-proline 0 N--CA 1.44 -0.926 0 C-N-CA 124.661 1.184 . . . . 0.0 109.606 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.14 -16.69 9.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.776 2.317 . . . . 0.0 110.176 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.43 -137.71 2.37 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -64.05 145.41 55.95 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.13 1.772 . . . . 0.0 110.498 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.89 129.84 40.63 Favored Pre-proline 0 N--CA 1.438 -1.028 0 C-N-CA 125.366 1.466 . . . . 0.0 110.208 -164.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -96.82 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.797 2.998 . . . . 0.0 108.726 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.21 135.54 20.46 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -115.87 -14.05 11.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.019 0.928 . . . . 0.0 110.705 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.17 86.65 3.07 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 118.233 0.469 . . . . 0.0 112.159 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.06 97.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.247 1.819 . . . . 0.0 106.639 164.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' B' ' 855' ' ' ALA . 13.5 mt -87.75 -38.83 15.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.278 -173.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 53.3 tp -166.25 127.49 1.79 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 166.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 178.25 61.0 0.01 OUTLIER 'General case' 0 C--N 1.355 0.825 0 CA-C-N 120.331 1.423 . . . . 0.0 108.807 -164.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.13 -43.96 95.28 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.22 -29.15 10.57 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 118.741 0.7 . . . . 0.0 112.355 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.53 -60.04 0.34 Allowed Glycine 0 C--N 1.353 1.487 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 63.14 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.103 2.561 . . . . 0.0 114.148 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -95.33 119.24 33.5 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 125.007 1.323 . . . . 0.0 108.231 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -80.64 117.83 69.65 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -95.29 0.99 2.5 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 125.144 2.873 . . . . 0.0 109.589 -165.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -80.3 -44.36 19.71 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 33.2 p -105.38 -13.05 15.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.729 1.211 . . . . 0.0 108.581 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.24 47.22 Favored Glycine 0 C--N 1.362 2.009 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 163.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.7 103.44 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 -162.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.57 112.1 24.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 112.515 -2.129 . . . . 0.0 109.475 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 61.3 m -101.08 108.45 20.15 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 888' ' ' ALA . . . . . 0.408 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.43 111.12 45.55 Favored Pre-proline 0 C--N 1.359 0.99 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.844 170.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -93.26 2.08 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 123.101 2.143 . . . . 0.0 108.949 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.32 -49.37 69.85 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.025 2.13 . . . . 0.0 113.888 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.32 48.18 15.38 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.747 1.619 . . . . 0.0 114.431 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.91 -164.92 20.2 Favored Glycine 0 N--CA 1.412 -2.951 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -90.79 121.38 32.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -116.42 159.54 21.85 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 119.36 0.982 . . . . 0.0 108.824 178.195 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -106.19 114.3 28.35 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.55 136.17 49.36 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 126.09 1.756 . . . . 0.0 108.529 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -145.02 119.31 9.54 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.167 0.587 . . . . 0.0 109.566 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.85 22.15 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.33 121.44 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.29 121.97 43.31 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.44 1.096 . . . . 0.0 108.665 -172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.3 m -79.12 132.26 36.51 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 107.749 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.15 -57.25 19.28 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.784 1.659 . . . . 0.0 114.63 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.5 m170 33.92 73.84 0.07 Allowed 'General case' 0 C--N 1.359 1.013 0 C-N-CA 127.746 2.418 . . . . 0.0 115.528 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.0 -8.48 56.28 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.283 1.433 . . . . 0.0 111.493 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -72.22 -14.51 61.81 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 125.807 1.643 . . . . 0.0 112.255 -170.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.341 7.0 pt-20 115.92 -178.27 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 128.641 2.776 . . . . 0.0 108.633 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 104.32 134.18 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 128.081 2.552 . . . . 0.0 106.635 172.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 87.8 t -98.0 126.5 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -172.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -111.98 122.8 48.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.942 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.24 116.88 16.73 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.539 2.336 . . . . 0.0 109.564 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 97.0 t -88.07 113.88 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.62 142.93 57.82 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.337 1.855 . . . . 0.0 110.249 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.7 t -116.47 147.24 41.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.298 1.839 . . . . 0.0 109.424 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.604 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.16 139.39 38.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.664 2.386 . . . . 0.0 109.826 -175.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.54 -16.94 0.03 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 129.643 3.177 . . . . 0.0 112.798 173.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -137.37 -25.5 1.03 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 119.384 0.993 . . . . 0.0 111.57 -169.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 60.44 167.35 0.08 Allowed 'General case' 0 C--N 1.36 1.062 0 C-N-CA 125.449 1.499 . . . . 0.0 111.078 -163.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.93 -133.55 49.36 Favored Glycine 0 C--N 1.367 2.259 0 O-C-N 119.664 -1.898 . . . . 0.0 109.066 -163.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 47.7 t 56.04 76.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.18 0 C-N-CA 125.64 1.576 . . . . 0.0 110.794 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.32 115.2 27.83 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -103.35 -36.83 7.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.392 -171.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.65 77.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.14 131.29 42.74 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -142.87 115.26 8.49 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.1 1.36 . . . . 0.0 107.832 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 84.63 0.73 Allowed Glycine 0 CA--C 1.486 -1.777 0 N-CA-C 104.625 -3.39 . . . . 0.0 104.625 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.644 0 C-N-CA 125.615 1.579 . . . . 0.0 111.003 175.397 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.506 -0.712 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.0 mt -116.88 134.23 55.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -142.44 162.67 27.27 Favored Glycine 0 CA--C 1.492 -1.403 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.83 130.73 73.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -137.61 150.09 47.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 54.6 m -119.19 -39.97 2.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.003 0.365 . . . . 0.0 111.91 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.56 -50.2 8.48 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-N 119.142 0.883 . . . . 0.0 112.299 -168.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 872' ' ' LEU . 38.4 pt -84.74 -175.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 125.686 1.595 . . . . 0.0 110.14 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.38 81.92 2.81 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 -169.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.78 92.62 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.294 1.996 . . . . 0.0 110.107 162.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.85 141.85 50.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -93.5 157.19 16.33 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.162 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.92 122.8 21.43 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.808 1.186 . . . . 0.0 108.718 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.04 -11.31 72.46 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 125.667 1.603 . . . . 0.0 111.165 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.8 175.01 6.1 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.624 0.726 . . . . 0.0 110.619 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 91.1 m -142.55 125.61 16.29 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -158.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.604 HG13 HH11 ' B' ' 914' ' ' ARG . 27.2 m -96.78 151.1 4.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 121.637 0.732 . . . . 0.0 110.909 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -140.85 138.94 34.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.864 2.066 . . . . 0.0 111.454 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.71 129.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.466 0 C-N-CA 127.142 2.177 . . . . 0.0 106.964 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -107.29 130.77 54.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.633 -3.469 . . . . 0.0 101.633 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.8 77.11 1.75 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 59.5 t -160.12 100.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -151.59 71.76 1.0 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.25 141.78 9.09 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.44 -5.11 13.51 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.233 0.613 . . . . 0.0 110.994 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 37.8 tp -99.44 82.11 2.62 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.56 -174.5 3.72 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -121.97 159.76 26.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -88.62 130.52 35.26 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.81 150.11 22.4 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 113.3 23.24 Favored Pre-proline 0 C--N 1.356 0.88 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -97.75 173.88 0.61 Allowed 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 121.957 1.772 . . . . 0.0 108.492 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.95 139.53 50.54 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.42 139.63 38.99 Favored 'General case' 0 C--N 1.374 1.646 0 CA-C-N 119.728 1.149 . . . . 0.0 108.572 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.2 mm -116.82 130.4 71.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -127.78 106.03 8.85 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 34.3 p -101.22 163.02 12.48 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.086 1.354 . . . . 0.0 110.538 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.75 111.41 0.31 Allowed Glycine 0 C--N 1.36 1.868 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.85 145.12 45.93 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.25 123.23 23.3 Favored 'General case' 0 C--N 1.376 1.744 0 C-N-CA 124.223 1.009 . . . . 0.0 109.354 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 53.6 tp -98.3 -57.48 2.2 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.4 127.3 37.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.72 128.95 9.72 Favored Glycine 0 CA--C 1.493 -1.329 1 N-CA-C 103.053 -4.019 . . . . 0.0 103.053 163.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.76 128.91 91.65 Favored Pre-proline 0 C--N 1.349 0.567 0 CA-C-O 117.693 -1.146 . . . . 0.0 110.345 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -106.27 82.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 CA-C-N 122.08 1.779 . . . . 0.0 109.593 -168.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.0 -72.04 0.09 Allowed 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 130.201 3.4 . . . . 0.0 109.136 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 76.5 mt 49.47 40.6 19.39 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 128.984 2.914 . . . . 0.0 113.828 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -113.35 131.79 55.83 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -130.02 109.17 10.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.578 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.88 114.43 31.07 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -86.09 -23.92 1.84 Allowed 'Trans proline' 0 CA--C 1.512 -0.584 0 CA-C-N 121.697 1.642 . . . . 0.0 110.285 -171.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 38.8 67.03 0.46 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 128.602 2.761 . . . . 0.0 115.553 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.09 136.95 57.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.93 156.09 49.59 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 8.6 p90 -148.47 137.83 21.96 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.3 t -171.37 119.37 0.47 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.426 -0.796 . . . . 0.0 109.734 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.41 153.61 37.61 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.17 158.46 44.01 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.663 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.486 HD21 HD23 ' C' ' 858' ' ' LEU . 3.0 tm? -140.83 130.21 23.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 74.5 m -158.54 15.99 0.2 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.486 HD23 HD21 ' C' ' 856' ' ' LEU . 2.0 pp -27.25 144.33 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.517 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 160.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -79.75 -45.49 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 122.056 1.77 . . . . 0.0 113.54 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.07 174.42 12.28 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.1 m -5.02 114.83 0.01 OUTLIER 'General case' 0 C--N 1.363 1.185 0 C-N-CA 130.78 3.632 . . . . 0.0 116.901 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.87 156.55 43.67 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.01 -15.63 10.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.346 2.03 . . . . 0.0 111.259 -172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.1 -140.48 2.96 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.0 m -65.8 144.66 56.72 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.621 1.568 . . . . 0.0 110.036 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 74.1 t -98.09 134.39 22.16 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 124.596 1.159 . . . . 0.0 110.521 -158.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -95.77 -152.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.063 3.175 . . . . 0.0 109.832 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -145.4 132.83 20.73 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -113.24 -17.03 12.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.457 0.703 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -102.9 83.42 2.23 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.194 0.521 . . . . 0.0 111.458 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.66 97.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.534 1.934 . . . . 0.0 106.649 165.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.79 -37.87 14.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.889 -173.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 34.4 tp -165.02 127.22 2.16 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 31.5 t-20 174.97 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.183 1.356 . . . . 0.0 107.703 -163.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.84 -42.78 94.35 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.79 -28.32 16.4 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.744 0.702 . . . . 0.0 112.284 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.26 -58.44 0.46 Allowed Glycine 0 C--N 1.354 1.53 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 62.45 -81.28 0.02 OUTLIER 'General case' 0 C--N 1.353 0.751 0 C-N-CA 128.119 2.568 . . . . 0.0 114.654 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -95.5 120.3 35.51 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.424 1.49 . . . . 0.0 108.501 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.41 117.38 68.64 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.56 6.59 2.02 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.918 2.792 . . . . 0.0 109.768 -171.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -79.65 -45.33 19.24 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -105.26 -15.83 14.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.894 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.23 24.22 52.3 Favored Glycine 0 C--N 1.363 2.037 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 164.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.67 103.08 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 N-CA-C 101.335 -3.58 . . . . 0.0 101.335 -168.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -94.67 112.14 23.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.929 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 50.7 m -102.86 109.07 20.52 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 888' ' ' ALA . . . . . 0.507 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.25 110.38 42.16 Favored Pre-proline 0 C--N 1.356 0.889 0 CA-C-O 117.221 -1.371 . . . . 0.0 111.774 169.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -92.83 1.33 3.72 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.539 2.159 . . . . 0.0 108.289 164.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 36.4 mt -54.73 -52.68 61.74 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 128.098 2.559 . . . . 0.0 113.794 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.41 67.35 0.95 Allowed 'General case' 0 C--N 1.366 1.29 0 CA-C-O 121.971 0.891 . . . . 0.0 111.177 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.97 171.22 44.11 Favored Glycine 0 N--CA 1.406 -3.307 1 N-CA-C 100.272 -5.131 . . . . 0.0 100.272 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -91.45 116.34 28.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -116.28 160.03 21.03 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-O 121.576 0.703 . . . . 0.0 110.248 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.67 112.77 25.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.39 139.36 50.98 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.142 1.377 . . . . 0.0 109.017 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.5 m -144.15 120.53 10.95 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 110.197 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.53 154.48 19.86 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.52 123.07 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.52 123.63 40.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.256 1.022 . . . . 0.0 109.341 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 49.9 m -79.63 132.7 36.32 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.66 -56.78 16.38 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 125.774 1.654 . . . . 0.0 114.432 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 32.3 71.83 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.979 2.512 . . . . 0.0 114.987 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -72.98 -9.24 58.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.554 1.541 . . . . 0.0 111.803 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -71.92 -16.5 62.11 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.98 1.712 . . . . 0.0 112.274 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 122.13 -173.1 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.571 2.748 . . . . 0.0 107.745 173.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 103.49 134.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 127.949 2.499 . . . . 0.0 106.655 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.03 123.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -104.03 130.0 51.68 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.154 1.781 . . . . 0.0 110.278 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -152.5 114.2 4.34 Favored 'General case' 0 C--N 1.358 0.965 0 C-N-CA 124.97 1.308 . . . . 0.0 110.103 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.53 114.21 27.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 125.238 1.415 . . . . 0.0 107.694 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -61.59 139.92 58.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.112 1.765 . . . . 0.0 111.421 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.1 t -117.53 144.89 44.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.059 2.144 . . . . 0.0 108.842 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.507 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.31 141.91 38.13 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 127.205 2.202 . . . . 0.0 111.003 -174.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.6 t 99.79 -10.78 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.955 3.302 . . . . 0.0 112.179 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -141.8 -25.94 0.68 Allowed 'General case' 0 C--N 1.358 0.944 0 CA-C-N 119.275 0.943 . . . . 0.0 111.672 -172.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 59.72 167.62 0.07 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.229 1.412 . . . . 0.0 111.671 -163.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.06 -131.94 52.2 Favored Glycine 0 C--N 1.373 2.595 0 O-C-N 119.498 -2.001 . . . . 0.0 109.363 -162.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 44.8 t 54.8 74.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 125.567 1.547 . . . . 0.0 111.032 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.12 114.85 27.49 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 27.7 ptt85 -97.96 -38.0 9.57 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.752 -171.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.19 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.012 -2.959 . . . . 0.0 103.012 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -97.53 131.12 44.43 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.183 0.516 . . . . 0.0 111.111 -173.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -144.05 117.06 8.86 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.475 1.51 . . . . 0.0 108.35 171.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 85.01 0.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 105.158 -3.177 . . . . 0.0 105.158 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.605 0 C-N-CA 125.168 1.366 . . . . 0.0 110.798 174.385 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 73.7 mt -122.34 134.24 54.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.96 161.63 26.75 Favored Glycine 0 CA--C 1.491 -1.467 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -174.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 28.4 m -120.8 129.64 75.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.55 150.16 48.47 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.265 -0.897 . . . . 0.0 108.775 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -115.78 -41.03 3.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 16.6 tp -90.05 -52.92 4.72 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 119.069 0.849 . . . . 0.0 111.837 -168.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.51 -177.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 125.709 1.604 . . . . 0.0 109.844 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.99 85.51 1.6 Allowed Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 87.78 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 122.543 1.944 . . . . 0.0 109.49 163.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.18 145.82 48.3 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -92.8 161.37 14.54 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 118.917 0.78 . . . . 0.0 109.721 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.51 122.67 20.87 Favored 'General case' 0 C--N 1.379 1.872 0 CA-C-N 119.907 1.231 . . . . 0.0 109.051 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.73 -12.49 69.72 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.112 1.815 . . . . 0.0 111.372 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.26 175.37 5.41 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-O 121.571 0.701 . . . . 0.0 111.45 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 93.6 m -142.68 126.65 17.28 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.965 0.906 . . . . 0.0 110.569 -159.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.44 147.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.915 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.9 t -142.04 138.88 32.1 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.984 1.714 . . . . 0.0 111.577 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 89.3 t -90.33 129.07 41.78 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 C-N-CA 126.352 1.861 . . . . 0.0 106.701 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.69 132.97 51.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 101.345 -3.576 . . . . 0.0 101.345 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.92 72.16 1.49 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.844 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.2 t -160.97 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -151.78 70.04 0.93 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.2 145.88 7.96 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -117.27 -15.8 10.38 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.044 0.938 . . . . 0.0 110.287 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -101.59 81.98 2.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.79 -161.92 1.22 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -119.61 154.15 34.41 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.6 t -89.58 132.74 34.95 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -156.5 154.41 30.3 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -128.74 120.74 20.71 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -102.49 170.96 0.25 Allowed 'Trans proline' 0 CA--C 1.506 -0.892 0 N-CA-C 107.691 -1.696 . . . . 0.0 107.691 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 8.1 mp -112.53 139.83 47.79 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.5 p -136.56 139.27 42.05 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 119.574 1.079 . . . . 0.0 108.199 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.0 131.11 68.22 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -124.91 104.87 8.83 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 31.1 p -101.88 163.45 12.24 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.357 1.463 . . . . 0.0 110.556 171.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.76 112.14 0.34 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.77 45.78 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.921 -1.341 . . . . 0.0 114.452 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.05 124.45 27.81 Favored 'General case' 0 C--N 1.379 1.875 0 C-N-CA 124.892 1.277 . . . . 0.0 109.724 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 17.1 tp -97.49 -57.09 2.33 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.809 0.338 . . . . 0.0 110.237 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -131.49 127.65 37.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.82 130.72 10.41 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 165.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -70.51 129.5 90.08 Favored Pre-proline 0 C--N 1.35 0.594 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.696 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -106.76 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.014 1.755 . . . . 0.0 109.46 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 78.45 -73.16 0.08 Allowed 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 130.034 3.334 . . . . 0.0 109.048 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.8 mt 49.79 39.66 18.52 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.911 2.884 . . . . 0.0 113.792 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -112.12 131.72 55.29 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.36 109.05 10.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.095 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 110.166 -0.744 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.03 117.89 28.28 Favored Pre-proline 0 C--N 1.353 0.748 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -89.02 -21.0 1.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 CA-C-N 121.998 1.749 . . . . 0.0 110.021 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 37.29 70.57 0.17 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 129.056 2.942 . . . . 0.0 115.493 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 81.7 t -118.23 136.12 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.19 158.11 45.2 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 164.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -150.57 143.49 24.69 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 118.924 0.784 . . . . 0.0 110.117 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.57 118.42 0.85 Allowed 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.444 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.74 154.26 37.15 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.81 157.18 45.76 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.229 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.493 HD21 HD23 ' A' ' 858' ' ' LEU . 2.4 tm? -134.45 130.17 36.35 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -166.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 39.5 p -162.99 13.38 0.07 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -161.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.493 HD23 HD21 ' A' ' 856' ' ' LEU . 3.5 pp -25.18 147.99 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.426 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 159.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.28 -45.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.111 1.79 . . . . 0.0 113.252 -164.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.95 176.1 10.5 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -173.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.55 119.57 0.02 OUTLIER 'General case' 0 C--N 1.364 1.209 0 C-N-CA 130.549 3.54 . . . . 0.0 116.148 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.96 163.7 18.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 123.98 0.912 . . . . 0.0 108.737 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.06 -13.58 13.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.886 2.391 . . . . 0.0 111.189 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.81 -144.74 4.39 Favored Glycine 0 C--N 1.354 1.563 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.5 m -64.67 137.66 57.94 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.375 1.87 . . . . 0.0 110.938 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 14.8 m -69.38 145.59 95.77 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.365 1.466 . . . . 0.0 113.292 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -101.8 -145.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.037 2.492 . . . . 0.0 107.281 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -148.11 134.07 19.16 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -117.4 -14.2 10.37 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.428 0.691 . . . . 0.0 110.42 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.514 HH21 HD23 ' A' ' 872' ' ' LEU . 16.4 mmm180 -100.37 85.92 3.08 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-O 121.335 0.588 . . . . 0.0 111.427 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 74.2 t -69.2 95.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.935 2.494 . . . . 0.0 105.472 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.514 HD23 HH21 ' A' ' 870' ' ' ARG . 4.3 mt -90.79 -38.08 13.23 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.875 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 55.3 tp -166.8 130.62 1.95 Allowed 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.4 p-10 172.15 62.51 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 121.012 1.733 . . . . 0.0 108.537 -172.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.34 -44.19 92.66 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -163.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.39 -31.73 9.36 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.35 -68.76 0.23 Allowed Glycine 0 CA--C 1.489 -1.557 0 N-CA-C 105.592 -3.003 . . . . 0.0 105.592 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 77.29 -67.78 0.19 Allowed 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 128.295 2.638 . . . . 0.0 112.21 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -98.35 122.12 41.13 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.31 1.444 . . . . 0.0 108.101 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.68 118.0 70.45 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 116.115 -1.898 . . . . 0.0 106.113 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.32 -0.46 4.71 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 124.637 2.692 . . . . 0.0 108.768 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.65 -41.39 27.02 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.835 1.254 . . . . 0.0 108.612 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 37.1 p -104.31 -15.34 15.48 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.57 16.81 69.96 Favored Glycine 0 C--N 1.365 2.163 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 167.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 55.7 t -101.87 105.81 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 112.37 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.236 -175.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.29 109.33 20.97 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 888' ' ' ALA . . . . . 0.492 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.76 110.9 44.81 Favored Pre-proline 0 C--N 1.357 0.913 0 CA-C-O 117.172 -1.394 . . . . 0.0 111.678 169.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -93.75 0.44 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 CA-C-N 123.082 2.136 . . . . 0.0 108.602 166.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 61.5 mt -51.73 -54.39 28.96 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 127.988 2.515 . . . . 0.0 114.563 -168.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.13 66.34 1.12 Allowed 'General case' 0 C--N 1.364 1.231 0 CA-C-O 121.926 0.87 . . . . 0.0 112.166 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.27 -169.02 36.57 Favored Glycine 0 N--CA 1.408 -3.17 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -92.99 122.28 35.19 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.018 -1.091 . . . . 0.0 108.214 171.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.422 ' H ' HD11 ' A' ' 954' ' ' LEU . 0.0 OUTLIER -116.56 151.68 35.69 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.94 115.83 30.87 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.867 0.867 . . . . 0.0 108.844 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -112.58 137.11 51.3 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.957 1.703 . . . . 0.0 109.758 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -145.42 119.06 9.14 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 123.634 0.773 . . . . 0.0 109.317 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.59 154.31 21.6 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.43 120.98 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.12 123.21 42.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.349 1.059 . . . . 0.0 109.22 -171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 48.5 m -83.68 132.32 34.88 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.362 1.465 . . . . 0.0 107.272 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.83 17.78 Favored Glycine 0 C--N 1.362 2.026 0 C-N-CA 125.089 1.328 . . . . 0.0 114.309 -170.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 59.1 m170 33.14 73.18 0.07 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 127.86 2.464 . . . . 0.0 115.342 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -73.91 -8.4 55.94 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.288 1.435 . . . . 0.0 111.959 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -71.17 -18.51 62.49 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.567 1.547 . . . . 0.0 112.577 -170.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.309 9.4 pt-20 123.01 -174.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 129.149 2.98 . . . . 0.0 107.915 175.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 102.32 130.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 128.162 2.585 . . . . 0.0 106.509 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 91.2 t -98.31 124.48 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -107.97 130.47 55.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.121 1.769 . . . . 0.0 110.719 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -153.97 115.1 4.09 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 125.217 1.407 . . . . 0.0 110.125 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.85 117.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.532 1.533 . . . . 0.0 107.886 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.9 mt -62.79 137.37 58.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.07 1.348 . . . . 0.0 109.145 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.2 t -116.22 147.89 41.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 126.053 1.741 . . . . 0.0 108.192 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.492 HH22 ' HB3' ' A' ' 888' ' ' ALA . 0.0 OUTLIER -76.03 138.55 40.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 128.418 2.687 . . . . 0.0 110.38 -173.777 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 88.34 3.44 0.28 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.961 2.904 . . . . 0.0 113.012 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -149.73 -24.81 0.27 Allowed 'General case' 0 C--N 1.359 1.019 0 CA-C-N 119.45 1.023 . . . . 0.0 111.61 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 57.76 172.9 0.05 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.947 1.299 . . . . 0.0 112.117 -162.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.02 52.83 Favored Glycine 0 C--N 1.377 2.824 0 O-C-N 119.513 -1.992 . . . . 0.0 110.292 -163.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 54.5 t 55.34 75.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.266 0 C-N-CA 125.651 1.58 . . . . 0.0 111.267 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.58 116.51 28.93 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -102.27 -32.87 9.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.67 -1.605 . . . . 0.0 108.165 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.89 83.3 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.74 131.65 38.89 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.136 0.493 . . . . 0.0 110.636 -172.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.0 t -143.3 115.41 8.37 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.505 1.522 . . . . 0.0 107.569 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.38 84.57 0.76 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 104.937 -3.265 . . . . 0.0 104.937 167.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.582 0 C-N-CA 124.884 1.23 . . . . 0.0 111.193 175.763 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.512 -0.504 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 56.1 mt -121.66 133.6 54.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.97 161.42 27.83 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.48 130.17 74.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -138.82 151.18 46.81 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.4 m -115.35 -43.24 3.08 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.48 -50.84 6.95 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 119.324 0.965 . . . . 0.0 112.714 -166.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.9 -172.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.799 1.64 . . . . 0.0 110.462 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.422 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -160.01 84.18 2.15 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -166.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.68 90.7 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.985 1.745 . . . . 0.0 109.089 159.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.68 142.58 50.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.8 158.72 15.3 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.06 123.09 21.31 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.745 1.157 . . . . 0.0 109.031 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.39 -11.09 72.96 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 125.886 1.708 . . . . 0.0 111.258 170.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.44 174.28 6.79 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 111.552 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.51 127.08 16.04 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -159.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.411 HG13 HH11 ' A' ' 914' ' ' ARG . 15.3 m -98.23 147.3 6.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.401 0.62 . . . . 0.0 110.865 171.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 23.4 t -142.32 137.73 30.79 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.318 1.847 . . . . 0.0 110.888 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 30.3 t -91.57 129.04 42.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 C-N-CA 125.995 1.718 . . . . 0.0 107.315 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.8 131.94 53.34 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 101.437 -3.542 . . . . 0.0 101.437 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.4 72.82 1.51 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.287 -1.779 . . . . 0.0 106.45 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 52.4 t -162.22 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 83.1 mmm -152.88 72.86 0.98 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 117.48 147.08 8.43 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.82 -28.46 7.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.1 tp -92.71 86.36 5.52 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -154.92 0.57 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -124.68 166.96 15.21 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 23.0 t -103.7 131.6 50.72 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 155.89 30.9 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.29 115.05 21.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 173.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -99.78 172.94 0.4 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 121.998 1.799 . . . . 0.0 108.05 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.64 140.97 48.69 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -138.3 140.34 39.52 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.585 1.084 . . . . 0.0 108.479 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.2 mm -116.64 130.88 70.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -126.31 106.16 9.32 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 26.9 p -100.36 160.3 14.45 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.529 1.132 . . . . 0.0 109.253 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.72 109.82 0.28 Allowed Glycine 0 C--N 1.356 1.665 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.888 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.39 143.68 47.32 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -73.35 125.96 29.05 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.955 1.302 . . . . 0.0 109.904 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.82 -57.38 2.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -131.13 127.75 38.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.9 129.98 10.1 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -69.88 128.72 91.63 Favored Pre-proline 0 C--N 1.349 0.573 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.583 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -106.94 80.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.165 1.809 . . . . 0.0 109.233 -169.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 79.47 -70.51 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.936 3.295 . . . . 0.0 109.008 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 18.2 mt 50.37 38.21 17.38 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 128.729 2.812 . . . . 0.0 114.202 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -114.98 133.94 55.61 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -129.2 109.98 11.6 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.112 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.226 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.807 0 N-CA-C 110.134 -0.756 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.22 118.36 27.89 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -89.42 -21.61 1.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 122.029 1.76 . . . . 0.0 110.144 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 38.29 69.72 0.24 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 128.964 2.906 . . . . 0.0 115.455 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 79.2 t -117.89 136.21 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.05 158.3 44.7 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.5 143.58 24.81 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 118.821 0.737 . . . . 0.0 110.201 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.64 118.37 0.84 Allowed 'General case' 0 C--N 1.354 0.788 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.203 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.16 154.2 36.52 Favored 'General case' 0 C--N 1.369 1.435 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.37 157.14 46.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.405 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.494 HD21 HD23 ' B' ' 858' ' ' LEU . 2.4 tm? -133.99 130.21 37.29 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -166.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 39.9 p -163.07 13.1 0.06 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -161.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.494 HD23 HD21 ' B' ' 856' ' ' LEU . 3.5 pp -25.06 148.01 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.387 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 159.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.13 -45.66 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 122.14 1.8 . . . . 0.0 113.329 -164.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.83 176.03 10.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.64 119.63 0.02 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.507 3.523 . . . . 0.0 116.138 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -113.82 163.69 18.02 Favored Pre-proline 0 N--CA 1.443 -0.784 0 C-N-CA 124.037 0.935 . . . . 0.0 108.799 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.02 -13.55 14.04 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.875 2.383 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.79 -144.79 4.41 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -64.72 137.73 57.98 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 126.38 1.872 . . . . 0.0 110.901 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.54 145.63 95.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 113.342 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -102.21 -145.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.068 2.512 . . . . 0.0 107.285 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -148.46 134.18 18.88 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -117.0 -13.82 10.61 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.749 0.819 . . . . 0.0 110.21 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.521 HH21 HD23 ' B' ' 872' ' ' LEU . 15.8 mmm180 -99.97 86.47 3.27 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-O 121.11 0.481 . . . . 0.0 111.918 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.85 95.48 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 127.763 2.425 . . . . 0.0 105.402 163.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.521 HD23 HH21 ' B' ' 870' ' ' ARG . 4.5 mt -90.74 -38.14 13.22 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.726 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.5 tp -166.59 130.64 2.04 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.5 p-10 172.48 62.62 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 120.906 1.684 . . . . 0.0 108.903 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.16 -44.06 92.12 Favored 'General case' 0 C--N 1.364 1.216 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.31 -32.01 9.17 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.05 -68.39 0.24 Allowed Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 77.15 -68.18 0.18 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 128.245 2.618 . . . . 0.0 112.288 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -98.38 121.85 40.83 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.331 1.452 . . . . 0.0 108.1 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.03 118.08 70.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-O 116.149 -1.881 . . . . 0.0 106.266 167.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -90.79 -0.22 5.05 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 CA-C-N 124.6 2.679 . . . . 0.0 108.772 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.68 -41.01 27.72 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 124.921 1.288 . . . . 0.0 108.651 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 37.8 p -104.66 -15.53 15.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.67 16.98 69.24 Favored Glycine 0 C--N 1.364 2.111 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.94 105.9 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 -168.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.64 112.43 24.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.366 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.23 109.26 20.89 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 888' ' ' ALA . . . . . 0.485 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.82 111.07 46.02 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.837 169.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.52 1.52 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 123.078 2.135 . . . . 0.0 108.767 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.27 -49.46 72.02 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.819 2.048 . . . . 0.0 114.26 -167.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.69 47.76 17.66 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.302 1.441 . . . . 0.0 114.704 171.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -159.63 -164.18 14.48 Favored Glycine 0 N--CA 1.413 -2.888 1 N-CA-C 101.345 -4.702 . . . . 0.0 101.345 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -89.95 121.35 31.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.432 ' H ' HD11 ' B' ' 954' ' ' LEU 0.25 0.0 OUTLIER -117.17 151.94 35.82 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.901 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.9 tp -106.42 115.64 30.56 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -113.21 136.5 52.67 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.794 1.638 . . . . 0.0 109.063 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.1 m -145.93 119.23 8.95 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 123.542 0.737 . . . . 0.0 109.247 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.18 154.68 20.85 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 96.9 t -105.2 122.11 58.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.45 121.92 41.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.106 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 46.9 m -82.17 131.92 35.24 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 125.353 1.461 . . . . 0.0 107.509 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.67 18.61 Favored Glycine 0 C--N 1.363 2.062 0 C-N-CA 125.165 1.364 . . . . 0.0 114.376 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.9 m170 33.04 73.24 0.07 Allowed 'General case' 0 C--N 1.361 1.072 0 C-N-CA 127.845 2.458 . . . . 0.0 115.357 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -74.02 -8.1 54.9 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.366 1.466 . . . . 0.0 111.901 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -72.03 -15.72 62.04 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.845 1.658 . . . . 0.0 112.619 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.318 8.5 pt-20 119.36 -176.13 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 129.152 2.981 . . . . 0.0 108.192 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 103.24 129.98 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 128.158 2.583 . . . . 0.0 106.561 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.25 125.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -109.02 130.42 55.48 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.024 1.73 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.13 115.07 4.04 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.928 1.291 . . . . 0.0 110.2 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 5.0 p -84.04 117.82 30.29 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 125.494 1.518 . . . . 0.0 107.932 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 28.4 mt -62.96 137.9 58.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.453 1.501 . . . . 0.0 109.083 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.0 t -116.02 148.62 39.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.959 1.704 . . . . 0.0 108.715 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.485 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -77.06 138.19 39.41 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 127.989 2.516 . . . . 0.0 110.169 -173.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 87.6 4.67 0.31 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.863 2.865 . . . . 0.0 113.019 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -150.03 -24.67 0.26 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.438 1.017 . . . . 0.0 111.515 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 57.56 173.79 0.05 OUTLIER 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.881 1.272 . . . . 0.0 111.983 -161.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.38 -133.05 52.83 Favored Glycine 0 C--N 1.374 2.68 0 O-C-N 119.622 -1.924 . . . . 0.0 110.337 -164.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 62.0 t 55.54 75.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.22 0 C-N-CA 125.729 1.612 . . . . 0.0 111.26 172.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.56 116.59 28.99 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -173.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -102.38 -33.14 9.67 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 113.536 -1.666 . . . . 0.0 108.268 -172.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.83 83.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 164.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.35 130.77 40.53 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 121.226 0.536 . . . . 0.0 110.363 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.8 t -142.89 115.43 8.58 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.502 1.521 . . . . 0.0 107.438 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.2 84.67 0.78 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.961 -3.256 . . . . 0.0 104.961 167.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.616 0 C-N-CA 124.888 1.232 . . . . 0.0 111.285 176.184 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.19 133.76 55.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.62 161.74 27.72 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.22 130.91 73.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -138.95 151.15 46.65 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.5 m -113.85 -46.03 3.05 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.02 -49.98 8.42 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 119.221 0.919 . . . . 0.0 112.919 -166.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.63 -173.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.628 1.571 . . . . 0.0 110.455 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.432 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.77 83.86 2.23 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -166.363 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.7 90.69 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 109.099 159.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.65 141.12 51.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -95.49 158.45 15.45 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.19 123.08 21.38 Favored 'General case' 0 C--N 1.376 1.745 0 CA-C-N 119.805 1.184 . . . . 0.0 108.938 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.24 -10.79 73.62 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 125.867 1.699 . . . . 0.0 111.334 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.71 174.3 6.99 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-O 121.464 0.65 . . . . 0.0 111.241 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.4 m -144.43 127.03 16.06 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -159.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.417 HG13 HH11 ' B' ' 914' ' ' ARG . 15.6 m -98.35 147.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 CA-C-O 121.303 0.573 . . . . 0.0 111.397 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 23.1 t -142.76 137.86 30.05 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 126.422 1.889 . . . . 0.0 110.9 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 26.6 t -91.7 129.4 42.43 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 107.536 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.85 132.08 53.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 72.71 1.51 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 49.6 t -161.99 102.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 83.5 mmm -153.18 71.17 0.89 Allowed 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.67 146.47 7.78 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 107.571 -2.212 . . . . 0.0 107.571 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.2 -28.21 7.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 45.5 tp -92.84 86.31 5.45 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.65 -155.63 0.62 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -124.07 167.41 14.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 23.3 t -104.49 131.34 51.99 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.58 155.86 30.91 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.14 114.91 21.76 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -99.41 172.6 0.44 Allowed 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.025 1.817 . . . . 0.0 108.021 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.71 140.74 48.91 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.1 p -138.28 140.4 39.59 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 119.5 1.045 . . . . 0.0 108.49 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.66 131.21 69.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.42 106.1 9.24 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 24.9 p -99.97 160.18 14.52 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.521 1.128 . . . . 0.0 108.858 170.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.94 109.45 0.26 Allowed Glycine 0 C--N 1.356 1.643 0 C-N-CA 118.899 -1.62 . . . . 0.0 109.356 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -122.56 145.23 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 57.3 tp -72.74 126.57 30.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 124.948 1.299 . . . . 0.0 110.449 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 31.4 tp -97.45 -57.18 2.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.317 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -131.2 127.78 38.63 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -173.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 129.71 10.0 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 103.536 -3.826 . . . . 0.0 103.536 163.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.55 128.42 91.11 Favored Pre-proline 0 C--N 1.351 0.668 0 CA-C-O 117.791 -1.099 . . . . 0.0 110.342 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -106.72 82.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 122.12 1.793 . . . . 0.0 109.28 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 79.14 -70.5 0.1 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.911 3.284 . . . . 0.0 109.091 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 19.8 mt 50.08 38.91 17.98 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 128.729 2.812 . . . . 0.0 114.245 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.14 110.13 11.75 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.115 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.336 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.793 0 N-CA-C 110.175 -0.741 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.64 119.28 25.89 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.89 -19.76 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 CA-C-N 122.096 1.784 . . . . 0.0 110.102 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 36.78 71.79 0.13 Allowed 'General case' 0 C--N 1.359 1.014 0 C-N-CA 129.174 2.99 . . . . 0.0 115.388 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 75.0 t -116.85 135.32 57.58 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.43 154.37 50.81 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 163.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 7.2 p90 -150.13 141.83 23.62 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 118.536 0.607 . . . . 0.0 109.93 171.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 23.0 t -168.07 118.58 0.8 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.45 155.36 40.6 Favored 'General case' 0 C--N 1.368 1.405 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.1 156.13 46.02 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.743 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.541 HD21 HD23 ' C' ' 858' ' ' LEU . 2.4 tm? -133.34 128.33 35.44 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.467 -167.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 73.1 m -161.05 10.08 0.09 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -161.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.541 HD23 HD21 ' C' ' 856' ' ' LEU . 2.4 pp -27.63 146.44 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.495 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 161.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.85 -46.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 CA-C-N 122.099 1.786 . . . . 0.0 113.454 -162.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -162.28 171.16 17.73 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m 0.46 106.78 0.01 OUTLIER 'General case' 0 C--N 1.361 1.109 0 C-N-CA 131.116 3.767 . . . . 0.0 116.77 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -103.93 163.33 17.57 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 123.562 0.745 . . . . 0.0 109.316 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.7 -13.54 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.754 2.302 . . . . 0.0 111.069 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -145.35 4.47 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.9 m -65.36 139.39 58.56 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.283 1.833 . . . . 0.0 110.475 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.08 147.59 83.54 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 112.771 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -100.92 -145.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.291 2.661 . . . . 0.0 107.035 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.28 133.85 18.74 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -116.49 -16.28 10.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.501 0.72 . . . . 0.0 110.864 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.414 HH21 HD23 ' C' ' 872' ' ' LEU . 11.3 mmm180 -101.86 82.47 2.26 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.11 96.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 126.706 2.002 . . . . 0.0 106.511 164.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.414 HD23 HH21 ' C' ' 870' ' ' ARG . 1.7 mt -89.64 -36.88 15.01 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.902 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 54.0 tp -164.06 130.3 3.08 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 100.913 -3.736 . . . . 0.0 100.913 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 41.7 t-20 175.01 60.38 0.0 OUTLIER 'General case' 0 C--N 1.356 0.865 0 CA-C-N 120.621 1.555 . . . . 0.0 107.399 -166.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.89 -44.55 95.8 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -165.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.65 -33.09 7.67 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.617 0.644 . . . . 0.0 112.212 -174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 115.86 -65.91 0.31 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 106.193 -2.763 . . . . 0.0 106.193 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 63.66 -80.52 0.03 OUTLIER 'General case' 0 C--N 1.355 0.808 0 C-N-CA 127.983 2.513 . . . . 0.0 113.598 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -94.36 120.74 35.05 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.856 1.263 . . . . 0.0 107.703 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.93 118.24 70.88 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-O 115.989 -1.958 . . . . 0.0 106.03 167.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -90.8 -4.02 4.72 Favored 'Trans proline' 0 CA--C 1.509 -0.731 0 CA-C-N 124.786 2.745 . . . . 0.0 108.795 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -79.92 -40.55 27.94 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 125.17 1.388 . . . . 0.0 108.784 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -103.8 -15.15 15.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.12 16.39 69.7 Favored Glycine 0 C--N 1.363 2.053 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 167.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.83 105.8 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 -167.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.42 ' CB ' HG22 ' C' ' 962' ' ' VAL . 1.3 t80 -97.28 111.67 23.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.204 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 56.3 m -101.32 109.25 21.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 170.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.69 110.51 41.98 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.491 -1.242 . . . . 0.0 111.463 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.08 -0.64 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 122.946 2.088 . . . . 0.0 108.245 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 0.443 HD12 ' H ' ' C' ' 892' ' ' GLY . 3.7 pp -58.18 -43.55 87.57 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.333 1.453 . . . . 0.0 114.69 -166.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.72 46.71 16.84 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 892' ' ' GLY . . . . . 0.443 ' H ' HD12 ' C' ' 890' ' ' LEU . . . -159.03 -163.76 13.51 Favored Glycine 0 N--CA 1.417 -2.571 1 N-CA-C 101.581 -4.608 . . . . 0.0 101.581 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 46.7 ttt-85 -91.32 120.53 32.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.476 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -116.41 156.29 27.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.452 1.101 . . . . 0.0 108.798 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.9 115.52 29.96 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.581 0.752 . . . . 0.0 110.083 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 5.0 tt -116.07 136.06 53.37 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 -174.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.85 119.5 9.78 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 123.633 0.773 . . . . 0.0 109.999 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 154.75 20.94 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.2 t -105.78 122.14 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.55 122.24 41.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.28 1.032 . . . . 0.0 109.142 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 54.3 m -80.44 132.46 35.73 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 125.256 1.423 . . . . 0.0 107.997 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.06 -57.29 20.0 Favored Glycine 0 C--N 1.367 2.268 0 C-N-CA 124.819 1.199 . . . . 0.0 113.343 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 45.06 68.57 0.54 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 127.08 2.152 . . . . 0.0 114.254 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -73.14 -11.84 60.68 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.749 1.22 . . . . 0.0 112.227 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -73.13 -13.94 61.28 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.075 1.75 . . . . 0.0 112.88 -166.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.345 0.3 OUTLIER 118.26 -173.6 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 129.217 3.007 . . . . 0.0 108.398 175.2 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 97.24 133.44 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 128.061 2.545 . . . . 0.0 106.749 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.79 122.56 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -104.4 123.0 46.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.913 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.27 116.72 17.27 Favored 'General case' 0 C--N 1.369 1.441 0 C-N-CA 128.452 2.701 . . . . 0.0 109.434 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 97.3 t -84.0 113.95 23.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.77 148.2 43.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.021 2.129 . . . . 0.0 112.061 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.27 1.0 OUTLIER -116.34 147.07 41.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.257 1.823 . . . . 0.0 110.993 175.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 139.34 38.14 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 127.133 2.173 . . . . 0.0 108.815 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.7 t 94.74 -10.99 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.717 2.807 . . . . 0.0 112.596 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -141.44 -28.35 0.66 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.585 1.084 . . . . 0.0 111.751 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 58.38 170.7 0.06 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 124.855 1.262 . . . . 0.0 112.191 -162.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -135.52 50.16 Favored Glycine 0 C--N 1.372 2.576 0 O-C-N 119.447 -2.033 . . . . 0.0 109.997 -162.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t 56.27 76.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.248 0 C-N-CA 125.551 1.54 . . . . 0.0 111.358 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.2 115.54 28.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -174.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 37.8 ptt85 -102.38 -35.15 8.91 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.318 -172.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 93.9 t -99.56 86.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 162.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -93.93 133.54 37.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.657 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.2 t -142.21 115.47 8.91 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.675 1.59 . . . . 0.0 107.633 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.55 84.48 0.68 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 104.628 -3.389 . . . . 0.0 104.628 165.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 111.028 175.456 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 60.8 mt -120.21 133.68 55.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.22 162.38 27.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.61 130.6 74.34 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -138.07 146.44 42.94 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.4 m -107.55 -58.29 1.98 Allowed 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.028 0.377 . . . . 0.0 112.015 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 41.1 tp -77.62 -49.03 15.42 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -165.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 8.0 pt -84.84 -172.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 125.552 1.541 . . . . 0.0 110.274 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.476 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -159.61 92.04 1.81 Allowed Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -167.124 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.59 91.41 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 O-C-N 117.384 -1.956 . . . . 0.0 108.403 155.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.32 145.43 47.12 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -90.86 162.23 14.9 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.46 126.61 30.26 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 120.257 -1.527 . . . . 0.0 107.116 163.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.37 -1.13 64.14 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -54.65 167.93 0.32 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.574 1.549 . . . . 0.0 114.972 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.7 121.75 11.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.42 HG22 ' CB ' ' C' ' 886' ' ' PHE . 2.7 m -100.44 147.73 7.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -143.99 137.79 27.96 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.714 1.206 . . . . 0.0 112.059 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.14 129.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 126.929 2.092 . . . . 0.0 107.96 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.59 133.39 52.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.54 77.5 1.79 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 112.953 -1.93 . . . . 0.0 107.587 172.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 61.2 t -159.59 100.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -153.12 66.24 0.78 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 132.08 147.07 5.82 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -116.75 -16.68 10.64 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.312 0.645 . . . . 0.0 110.059 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -104.61 82.79 1.95 Allowed 'General case' 0 C--N 1.356 0.858 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.6 -167.19 2.02 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -171.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -119.94 155.06 33.51 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.6 t -93.29 132.13 37.78 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.27 151.6 23.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.91 113.7 29.94 Favored Pre-proline 0 C--N 1.355 0.814 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 172.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.0 174.81 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 122.26 1.973 . . . . 0.0 107.804 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.49 141.15 48.45 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.4 p -135.02 140.95 46.04 Favored 'General case' 0 C--N 1.374 1.67 0 CA-C-N 119.206 0.912 . . . . 0.0 108.893 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.3 mm -115.69 131.13 69.0 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -127.1 105.52 8.63 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 29.3 p -100.09 160.12 14.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.499 1.12 . . . . 0.0 109.125 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.86 108.61 0.25 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.23 145.28 45.12 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.42 126.65 30.37 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 125.015 1.326 . . . . 0.0 110.684 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 36.4 tp -98.23 -58.26 2.02 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.651 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -133.13 128.52 36.28 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.407 1.883 . . . . 0.0 106.783 -172.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.77 129.38 9.88 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 103.988 -3.645 . . . . 0.0 103.988 160.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.05 130.05 90.18 Favored Pre-proline 0 C--N 1.35 0.606 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.343 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -106.83 84.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 121.874 1.705 . . . . 0.0 109.518 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.86 -70.84 0.1 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 130.131 3.372 . . . . 0.0 109.494 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 54.0 mt 49.71 40.1 19.22 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 128.867 2.867 . . . . 0.0 113.983 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -115.14 132.48 56.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -130.49 110.53 11.52 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.219 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.758 0 N-CA-C 110.073 -0.78 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.38 120.67 24.9 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -91.11 -21.44 0.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.201 1.822 . . . . 0.0 109.585 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 34.91 71.75 0.11 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 129.258 3.023 . . . . 0.0 115.506 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.03 136.84 53.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.743 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.56 155.74 49.99 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 164.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 8.4 p90 -149.13 138.62 21.69 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.0 t -169.12 117.18 0.64 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.08 153.84 39.37 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.66 155.4 49.18 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.988 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 858' ' ' LEU . 2.0 tm? -130.13 128.82 42.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -165.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 50.8 p -161.05 14.15 0.1 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -161.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 856' ' ' LEU . 3.6 pp -20.95 143.26 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.382 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 159.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.05 -40.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 121.971 1.74 . . . . 0.0 112.481 -162.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 38.6 ptt85 -164.19 176.29 9.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 21.7 m -16.97 119.3 0.02 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 130.129 3.372 . . . . 0.0 115.481 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -119.12 147.18 42.2 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -162.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.13 -10.0 19.31 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.523 2.149 . . . . 0.0 112.695 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.5 -143.3 3.62 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 120.338 1.427 . . . . 0.0 111.265 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 32.9 m -82.68 146.82 28.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.206 1.802 . . . . 0.0 108.3 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.11 138.74 97.41 Favored Pre-proline 0 C--N 1.356 0.854 0 C-N-CA 125.491 1.517 . . . . 0.0 113.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -98.9 -149.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.805 3.003 . . . . 0.0 106.233 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -151.49 131.33 13.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -118.08 -15.02 9.92 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.947 -0.47 . . . . 0.0 111.149 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.81 85.4 2.88 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.911 -0.493 . . . . 0.0 112.005 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.52 98.64 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 126.505 1.922 . . . . 0.0 106.916 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 27.8 mt -87.64 -37.38 16.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.008 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.13 129.45 2.06 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 101.398 -3.556 . . . . 0.0 101.398 162.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 28.8 t-20 -175.8 61.8 0.02 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 120.809 1.64 . . . . 0.0 109.814 -167.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -58.84 -44.78 91.03 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -166.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.08 -31.84 8.26 Favored Glycine 0 C--N 1.354 1.579 0 CA-C-N 118.949 0.795 . . . . 0.0 112.334 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.34 -58.87 0.39 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 63.58 -81.7 0.03 OUTLIER 'General case' 0 C--N 1.355 0.828 0 C-N-CA 128.204 2.602 . . . . 0.0 114.053 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -97.05 119.99 36.56 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.775 1.23 . . . . 0.0 108.35 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -78.84 117.54 67.28 Favored Pre-proline 0 N--CA 1.444 -0.756 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -92.84 2.58 3.63 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.411 2.968 . . . . 0.0 109.451 -166.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -80.74 -45.68 16.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 28.2 p -106.3 -12.89 15.55 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 109.055 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.63 38.46 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.02 103.57 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 -165.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.62 112.24 24.74 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.922 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 87.5 m -100.66 107.97 19.73 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.78 109.92 38.02 Favored Pre-proline 0 C--N 1.355 0.837 0 CA-C-O 117.23 -1.366 . . . . 0.0 110.916 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.12 -2.44 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.845 2.364 . . . . 0.0 108.86 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.47 -57.58 4.0 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 130.329 3.452 . . . . 0.0 114.771 -169.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.99 64.83 1.32 Allowed 'General case' 0 C--N 1.364 1.215 0 CA-C-O 121.759 0.79 . . . . 0.0 112.819 171.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.06 -166.75 32.66 Favored Glycine 0 N--CA 1.41 -3.046 1 N-CA-C 101.467 -4.653 . . . . 0.0 101.467 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -91.75 122.56 34.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.279 -0.96 . . . . 0.0 108.785 172.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.493 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.2 t80 -115.3 145.73 42.19 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.14 115.69 30.19 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.391 0.676 . . . . 0.0 109.315 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.78 139.48 49.09 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.075 1.75 . . . . 0.0 108.843 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 70.1 m -144.12 119.58 10.32 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 123.363 0.665 . . . . 0.0 109.716 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.22 21.55 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.3 t -104.92 121.26 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.76 123.25 43.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.292 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 43.4 m -84.07 131.76 34.77 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 125.657 1.583 . . . . 0.0 106.936 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.56 17.85 Favored Glycine 0 C--N 1.363 2.057 0 C-N-CA 124.595 1.093 . . . . 0.0 113.53 -168.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 56.4 m170 39.39 71.44 0.17 Allowed 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.12 2.168 . . . . 0.0 114.626 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -70.87 -10.54 59.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.936 1.694 . . . . 0.0 111.957 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -73.33 -17.92 61.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.578 1.551 . . . . 0.0 112.746 -168.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.326 12.2 pt-20 124.52 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.603 2.361 . . . . 0.0 108.223 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.4 tttt 100.64 132.34 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 128.129 2.571 . . . . 0.0 107.163 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.32 124.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -108.02 123.62 48.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.163 1.785 . . . . 0.0 112.11 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.57 115.09 14.29 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.121 2.569 . . . . 0.0 109.553 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 90.8 t -87.66 113.77 25.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.578 1.951 . . . . 0.0 111.452 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER -114.44 147.28 39.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 126.671 1.988 . . . . 0.0 109.787 178.421 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.489 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -79.79 140.79 36.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 125.728 1.611 . . . . 0.0 110.0 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.329 24.2 p 92.61 3.86 0.07 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 129.856 3.262 . . . . 0.0 114.227 173.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -148.24 -26.18 0.34 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 119.309 0.959 . . . . 0.0 111.065 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.51 168.17 0.05 Allowed 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.729 1.612 . . . . 0.0 111.835 -162.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.86 -135.0 49.31 Favored Glycine 0 C--N 1.369 2.396 0 O-C-N 119.615 -1.928 . . . . 0.0 109.233 -161.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 41.2 t 55.96 79.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 125.952 1.701 . . . . 0.0 110.992 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.52 113.99 26.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 24.1 ptt85 -103.73 -37.1 7.62 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.014 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -99.27 87.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 166.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.06 130.43 41.74 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.688 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -143.56 115.08 8.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.353 1.461 . . . . 0.0 108.129 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.3 84.7 0.7 Allowed Glycine 0 CA--C 1.484 -1.865 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 165.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 C-N-CA 124.925 1.25 . . . . 0.0 111.302 173.741 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 61.1 mt -116.47 133.84 55.55 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -135.37 161.32 24.67 Favored Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.31 126.77 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -138.84 149.56 45.05 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 71.2 m -106.65 -54.36 2.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.456 0.302 . . . . 0.0 110.908 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.02 -49.9 9.08 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -162.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.52 -175.97 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.381 1.472 . . . . 0.0 110.687 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.504 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -159.33 93.04 1.82 Allowed Pre-proline 0 N--CA 1.44 -0.949 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -164.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.3 92.31 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 O-C-N 116.869 -2.227 . . . . 0.0 110.152 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.504 HD13 ' HB2' ' A' ' 954' ' ' LEU . 6.8 mp -120.85 138.93 53.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -93.21 158.03 15.97 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.843 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.98 123.11 21.28 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 119.896 1.225 . . . . 0.0 108.997 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.13 73.02 Favored Glycine 0 C--N 1.345 1.071 0 C-N-CA 126.541 2.019 . . . . 0.0 111.851 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -73.17 174.96 7.23 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.359 1.064 . . . . 0.0 110.521 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 89.7 m -142.84 125.12 15.49 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 108.821 -160.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.489 HG13 HH11 ' A' ' 914' ' ' ARG . 30.7 m -95.43 149.83 4.43 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-O 121.445 0.64 . . . . 0.0 109.627 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -141.39 138.93 33.34 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.234 1.814 . . . . 0.0 111.414 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 98.6 t -92.05 129.18 43.09 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 C-N-CA 126.484 1.914 . . . . 0.0 106.268 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.05 132.34 53.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.89 78.09 1.83 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 51.3 t -160.98 100.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.973 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -154.32 66.59 0.7 Allowed 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.16 146.89 6.91 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -114.08 -31.89 6.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -90.58 86.97 6.55 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.89 -167.18 2.1 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -122.98 157.62 32.26 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 15.7 t -91.6 133.9 35.14 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.66 151.58 22.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.52 111.16 19.24 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -98.58 173.23 0.51 Allowed 'Trans proline' 0 CA--C 1.507 -0.874 0 C-N-CA 121.742 1.628 . . . . 0.0 108.317 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.58 141.03 48.72 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 24.3 p -138.78 139.71 38.36 Favored 'General case' 0 C--N 1.374 1.66 0 CA-C-N 119.302 0.956 . . . . 0.0 108.513 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.0 mm -118.17 130.25 73.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.21 106.48 9.58 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 37.4 p -99.96 160.81 14.03 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 124.465 1.106 . . . . 0.0 109.678 171.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.97 109.49 0.27 Allowed Glycine 0 C--N 1.358 1.754 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.379 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.94 147.75 43.69 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 54.3 tp -72.43 123.29 22.79 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 126.092 1.757 . . . . 0.0 109.146 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.02 -58.0 2.01 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -133.23 127.44 33.72 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 127.053 2.141 . . . . 0.0 106.383 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.79 129.73 10.0 Favored Glycine 0 CA--C 1.496 -1.144 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 161.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -69.03 131.35 90.83 Favored Pre-proline 0 C--N 1.353 0.744 0 CA-C-N 118.435 1.118 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -105.76 82.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.68 1.636 . . . . 0.0 109.468 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.91 -72.73 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.205 3.402 . . . . 0.0 109.19 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 81.2 mt 50.87 37.68 17.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.377 3.071 . . . . 0.0 114.098 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.54 134.1 52.69 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.96 107.95 8.61 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -178.633 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 110.055 -0.787 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.03 121.01 25.38 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.63 -21.73 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 122.139 1.8 . . . . 0.0 109.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 35.46 71.97 0.11 Allowed 'General case' 0 C--N 1.361 1.079 0 C-N-CA 129.611 3.164 . . . . 0.0 115.127 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.72 136.3 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.6 155.5 50.36 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 9.5 p90 -149.54 139.79 22.23 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 26.6 t -169.11 117.8 0.66 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.51 154.28 36.85 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.29 155.4 47.76 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.905 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.59 127.72 39.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -165.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 51.3 p -160.9 13.8 0.1 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.233 -161.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.6 pp -20.82 143.45 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.456 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 158.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.35 -40.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.98 1.743 . . . . 0.0 112.48 -163.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -164.29 176.31 9.26 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 21.2 m -16.98 119.33 0.02 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.156 3.382 . . . . 0.0 115.451 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.2 147.37 42.77 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -162.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -76.27 -9.87 19.08 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.533 2.155 . . . . 0.0 112.695 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.59 -143.58 3.7 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 120.287 1.403 . . . . 0.0 111.262 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 33.0 m -81.92 147.04 29.48 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.234 1.814 . . . . 0.0 108.326 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 17.4 m -63.08 138.46 97.33 Favored Pre-proline 0 C--N 1.355 0.841 0 C-N-CA 125.413 1.485 . . . . 0.0 113.192 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -99.62 -150.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.723 2.949 . . . . 0.0 106.121 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -150.88 130.71 13.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -116.47 -14.49 10.94 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.427 0.691 . . . . 0.0 110.363 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -101.31 84.07 2.57 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 122.038 -0.414 . . . . 0.0 111.842 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.83 97.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 126.438 1.895 . . . . 0.0 106.461 166.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 12.6 mt -87.98 -38.03 15.87 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.714 -173.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.3 tp -165.3 129.3 2.34 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 101.266 -3.605 . . . . 0.0 101.266 165.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' B' ' 852' ' ' PHE . 32.1 t-20 179.03 62.2 0.01 OUTLIER 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.447 1.476 . . . . 0.0 109.214 -164.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -59.08 -44.54 91.9 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -167.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.88 -32.06 8.22 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 118.768 0.713 . . . . 0.0 112.242 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.16 -58.67 0.39 Allowed Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 63.8 -82.08 0.03 OUTLIER 'General case' 0 C--N 1.356 0.862 0 C-N-CA 128.13 2.572 . . . . 0.0 114.062 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.61 119.82 36.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 125.173 1.389 . . . . 0.0 108.308 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.27 117.92 69.09 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-O 115.459 -2.21 . . . . 0.0 105.309 171.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -91.79 2.31 4.24 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 125.507 3.002 . . . . 0.0 109.671 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -80.41 -44.53 19.19 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.606 1.163 . . . . 0.0 108.704 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 26.8 p -108.59 -13.19 14.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.085 1.354 . . . . 0.0 108.651 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.02 36.15 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 163.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 26.2 t -100.24 103.83 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.605 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 -164.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.402 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.4 OUTLIER -101.23 112.46 24.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.586 -2.097 . . . . 0.0 108.973 -176.014 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 88.7 m -100.79 108.13 19.86 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.96 110.13 39.87 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.138 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.95 -1.04 5.66 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.767 2.311 . . . . 0.0 108.843 165.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 129.832 3.253 . . . . 0.0 114.87 -169.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.45 58.93 2.78 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -170.23 -165.08 27.03 Favored Glycine 0 N--CA 1.412 -2.933 1 N-CA-C 102.461 -4.255 . . . . 0.0 102.461 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -92.08 121.87 34.04 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.777 -1.211 . . . . 0.0 107.868 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.441 ' H ' HD11 ' B' ' 954' ' ' LEU . 1.7 t80 -116.79 146.43 42.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -173.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.8 tp -111.51 114.86 28.24 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -113.35 139.37 48.92 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.28 1.832 . . . . 0.0 108.539 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -143.79 119.74 10.65 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.194 0.598 . . . . 0.0 109.703 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.58 21.01 Favored 'General case' 0 C--N 1.364 1.224 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.49 122.02 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.4 121.81 43.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.145 0.978 . . . . 0.0 109.19 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 40.1 m -82.66 132.0 35.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.646 1.578 . . . . 0.0 107.541 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.29 -57.72 17.68 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 124.758 1.171 . . . . 0.0 113.793 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 38.63 71.74 0.15 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 127.234 2.214 . . . . 0.0 114.774 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -71.0 -10.67 60.16 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.046 1.738 . . . . 0.0 112.043 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -73.82 -15.59 61.17 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.86 1.664 . . . . 0.0 112.908 -167.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.2 pt-20 122.1 179.4 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.856 2.462 . . . . 0.0 108.107 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 101.34 131.87 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 128.074 2.55 . . . . 0.0 107.088 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.26 126.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -110.69 122.85 48.82 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.966 -1.47 . . . . 0.0 113.093 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.81 115.74 15.67 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.842 2.457 . . . . 0.0 109.596 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 76.9 t -88.48 113.88 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 148.53 43.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.093 2.157 . . . . 0.0 111.493 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.275 0.8 OUTLIER -114.6 147.9 38.85 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 126.955 2.102 . . . . 0.0 109.715 178.5 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.512 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.73 140.13 35.73 Favored 'General case' 0 N--CA 1.424 -1.775 0 C-N-CA 125.652 1.581 . . . . 0.0 109.718 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.327 24.0 p 92.81 1.64 0.09 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 129.85 3.26 . . . . 0.0 114.363 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -147.28 -25.98 0.39 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-N 119.527 1.058 . . . . 0.0 111.408 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.55 168.01 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 125.678 1.591 . . . . 0.0 111.692 -162.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.61 -134.54 47.39 Favored Glycine 0 C--N 1.367 2.266 0 O-C-N 119.757 -1.839 . . . . 0.0 109.142 -163.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 44.6 t 54.49 80.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 126.314 1.846 . . . . 0.0 111.008 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.28 114.2 26.67 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -103.97 -38.22 7.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 113.298 -1.774 . . . . 0.0 108.757 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.55 87.01 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.615 -3.105 . . . . 0.0 102.615 166.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.4 130.48 42.19 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.0 t -142.43 115.77 8.99 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.038 1.335 . . . . 0.0 107.813 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.19 84.58 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 103.921 -3.672 . . . . 0.0 103.921 165.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 C-N-CA 125.172 1.367 . . . . 0.0 111.289 174.209 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 62.9 mt -116.95 134.27 54.96 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.62 26.98 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.01 128.83 75.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -138.1 151.51 47.86 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 68.7 m -117.24 -38.04 3.43 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.126 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.35 -53.61 4.27 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.071 0.85 . . . . 0.0 111.947 -168.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.22 177.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.85 1.26 . . . . 0.0 109.858 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -161.08 95.13 1.41 Allowed Pre-proline 0 C--N 1.358 0.954 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -163.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.88 95.74 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.945 2.43 . . . . 0.0 111.181 161.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' B' ' 954' ' ' LEU . 9.5 mp -119.77 139.85 51.67 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -93.92 159.15 15.31 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.841 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.82 122.95 21.61 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 120.058 1.299 . . . . 0.0 108.983 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.1 -11.51 71.94 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.413 1.959 . . . . 0.0 111.681 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -73.44 174.56 8.01 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.321 1.048 . . . . 0.0 109.993 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 94.0 m -143.09 125.06 15.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -158.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.512 HG13 HH11 ' B' ' 914' ' ' ARG . 27.9 m -96.37 150.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 121.567 0.698 . . . . 0.0 110.244 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -140.95 139.02 34.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.518 1.927 . . . . 0.0 111.44 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.2 t -91.63 129.53 42.18 Favored 'Isoleucine or valine' 0 C--N 1.367 1.354 0 C-N-CA 127.261 2.224 . . . . 0.0 106.516 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.79 132.36 52.85 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.59 77.63 1.8 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 50.2 t -160.2 101.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -153.48 66.38 0.76 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.63 145.66 6.52 Favored Glycine 0 CA--C 1.492 -1.383 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -112.87 -30.92 6.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.5 86.76 6.15 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.64 -165.76 1.83 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -123.51 157.84 32.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 16.4 t -91.43 133.22 35.66 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.64 151.66 22.48 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.43 110.78 19.37 Favored Pre-proline 0 C--N 1.353 0.753 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -98.13 173.09 0.58 Allowed 'Trans proline' 0 CA--C 1.507 -0.836 0 C-N-CA 121.812 1.675 . . . . 0.0 108.172 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.51 139.28 50.21 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.8 p -138.02 138.13 38.54 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.5 mm -117.24 130.71 71.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -127.05 106.32 9.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 32.7 p -100.63 160.94 13.94 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.494 1.117 . . . . 0.0 109.771 171.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.21 109.55 0.27 Allowed Glycine 0 C--N 1.358 1.781 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.82 149.62 41.77 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.85 124.14 24.19 Favored 'General case' 0 C--N 1.378 1.836 0 C-N-CA 125.841 1.656 . . . . 0.0 109.718 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.33 -59.06 1.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -133.33 127.22 33.07 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 125.916 1.686 . . . . 0.0 106.489 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.81 130.05 10.11 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 104.311 -3.516 . . . . 0.0 104.311 161.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.12 131.27 90.71 Favored Pre-proline 0 C--N 1.351 0.652 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.205 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -105.48 81.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 121.695 1.641 . . . . 0.0 109.054 -170.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.31 -72.23 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 130.191 3.396 . . . . 0.0 109.139 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 80.1 mt 49.95 40.89 22.09 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 129.126 2.97 . . . . 0.0 113.785 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.96 133.54 55.41 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -133.34 107.78 8.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.13 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.767 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.76 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.51 114.92 29.99 Favored Pre-proline 0 N--CA 1.44 -0.943 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.24 -24.97 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 121.689 1.639 . . . . 0.0 109.826 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 41.55 66.5 0.68 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 128.192 2.597 . . . . 0.0 114.868 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.86 133.74 66.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.01 50.85 Favored 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 166.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 10.3 p90 -149.83 139.55 21.73 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 118.886 0.766 . . . . 0.0 109.82 175.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 22.7 t -169.44 120.2 0.69 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.25 -0.906 . . . . 0.0 108.8 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.51 153.05 34.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.507 ' HB2' HD11 ' C' ' 872' ' ' LEU . . . -139.08 158.08 44.82 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 121.685 0.755 . . . . 0.0 110.493 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.525 HD21 HD23 ' C' ' 858' ' ' LEU . 2.9 tm? -139.89 130.55 25.79 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -164.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 60.1 m -159.02 15.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.525 HD23 HD21 ' C' ' 856' ' ' LEU . 2.0 pp -25.8 142.79 0.04 OUTLIER Pre-proline 0 C--N 1.372 1.546 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 161.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.84 -44.05 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 CA-C-N 122.222 1.829 . . . . 0.0 113.529 -161.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -162.47 175.72 11.2 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 13.1 m -4.63 113.06 0.01 OUTLIER 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.673 3.589 . . . . 0.0 116.774 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 160.91 24.37 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.4 -17.75 7.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.418 2.079 . . . . 0.0 110.533 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -141.29 3.12 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 11.8 m -65.53 143.31 57.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.029 1.732 . . . . 0.0 110.061 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.75 132.65 25.71 Favored Pre-proline 0 N--CA 1.437 -1.098 0 C-N-CA 124.37 1.068 . . . . 0.0 110.447 -159.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.37 -151.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 124.135 3.223 . . . . 0.0 109.334 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -147.1 136.12 22.37 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -114.76 -17.78 11.52 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.669 0.788 . . . . 0.0 110.9 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 26.1 mmm180 -102.48 84.43 2.44 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.166 0.508 . . . . 0.0 111.125 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.68 98.22 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 126.699 1.999 . . . . 0.0 106.868 167.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' C' ' 855' ' ' ALA . 8.8 mt -85.81 -39.43 17.09 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.967 -173.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.9 tp -166.96 128.98 1.7 Allowed 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 100.598 -3.853 . . . . 0.0 100.598 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.1 t-20 178.71 61.91 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 108.333 -164.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.1 -44.42 94.84 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.26 -29.67 11.02 Favored Glycine 0 C--N 1.356 1.661 0 CA-C-N 118.716 0.689 . . . . 0.0 112.165 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.17 -57.76 0.42 Allowed Glycine 0 C--N 1.353 1.521 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 62.91 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.245 2.618 . . . . 0.0 113.982 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -97.53 120.64 38.28 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 125.861 1.665 . . . . 0.0 108.677 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.97 117.87 69.93 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -93.36 5.96 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 124.91 2.789 . . . . 0.0 109.887 -167.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 -46.07 17.8 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -105.67 -13.14 15.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.877 1.271 . . . . 0.0 108.327 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.98 43.63 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 162.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 70.0 t -99.53 104.22 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 102.05 -3.315 . . . . 0.0 102.05 -164.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -98.53 112.37 24.43 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 111.921 -2.4 . . . . 0.0 109.233 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 90.7 m -100.32 109.24 21.43 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.82 108.86 30.7 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.262 -1.352 . . . . 0.0 110.968 171.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -90.11 -3.86 5.28 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.528 2.152 . . . . 0.0 108.43 166.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 68.4 mt -54.51 -52.29 62.44 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 127.736 2.414 . . . . 0.0 114.418 -165.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.58 68.15 0.82 Allowed 'General case' 0 C--N 1.367 1.328 0 CA-C-O 122.076 0.941 . . . . 0.0 111.61 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.88 -167.55 34.95 Favored Glycine 0 N--CA 1.405 -3.433 1 N-CA-C 102.498 -4.241 . . . . 0.0 102.498 -171.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 893' ' ' ARG . . . . . 0.443 ' HE ' HG22 ' C' ' 953' ' ' ILE . 70.4 ttt-85 -92.03 121.21 33.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.275 -1.463 . . . . 0.0 108.643 172.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.591 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -117.78 145.61 44.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 51.6 tp -110.14 113.84 26.86 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.8 tt -112.0 137.61 49.77 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.318 1.447 . . . . 0.0 108.925 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.8 m -144.29 119.27 10.0 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.398 0.679 . . . . 0.0 109.919 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.15 153.74 22.73 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 91.1 t -101.7 122.64 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.59 121.87 40.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.026 0.93 . . . . 0.0 109.355 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.9 130.56 35.39 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -54.82 -56.84 20.71 Favored Glycine 0 C--N 1.366 2.247 0 C-N-CA 125.356 1.455 . . . . 0.0 113.354 -172.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 42.3 65.67 0.86 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.633 2.373 . . . . 0.0 114.181 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.39 -7.24 50.83 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 125.076 1.35 . . . . 0.0 112.178 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -71.38 -14.09 62.06 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.235 1.814 . . . . 0.0 112.187 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.338 6.1 pt-20 113.73 179.53 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.108 2.563 . . . . 0.0 108.051 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 109.42 137.46 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 128.56 2.744 . . . . 0.0 105.856 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 97.8 t -98.4 123.64 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -103.67 131.68 50.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.361 172.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.05 114.22 3.64 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.095 1.358 . . . . 0.0 110.519 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.27 117.74 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 125.867 1.667 . . . . 0.0 108.999 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.6 mt -62.53 143.5 57.12 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.74 1.616 . . . . 0.0 110.519 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 1.4 p -113.78 147.79 37.68 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.627 1.971 . . . . 0.0 107.795 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.528 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -78.73 137.35 37.73 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.891 173.285 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 2.9 t 97.93 -11.48 0.06 Allowed 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 128.797 2.839 . . . . 0.0 112.341 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.86 -27.63 0.58 Allowed 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 119.256 0.934 . . . . 0.0 111.501 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 59.04 169.09 0.06 Allowed 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.933 1.293 . . . . 0.0 112.254 -164.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.84 -130.74 51.46 Favored Glycine 0 C--N 1.376 2.79 0 O-C-N 119.702 -1.874 . . . . 0.0 110.12 -164.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 51.97 73.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.329 0 C-N-CA 126.191 1.797 . . . . 0.0 111.37 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.82 28.37 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -101.18 -30.89 11.3 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.518 -173.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.18 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 165.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -95.22 131.23 41.51 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 120.903 0.382 . . . . 0.0 111.184 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.2 t -143.88 115.07 7.93 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 125.283 1.433 . . . . 0.0 107.812 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.17 85.02 0.72 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 104.281 -3.528 . . . . 0.0 104.281 169.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.602 0 C-N-CA 125.183 1.373 . . . . 0.0 110.892 173.557 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.6 mt -122.46 134.56 54.58 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.93 163.31 27.0 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.76 132.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.46 149.81 47.12 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -121.33 -36.99 2.98 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 118.398 0.544 . . . . 0.0 111.802 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 29.0 tp -89.47 -53.77 4.39 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.533 0.606 . . . . 0.0 112.045 -165.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.443 HG22 ' HE ' ' C' ' 893' ' ' ARG . 25.4 pt -89.83 -162.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.846 0 C-N-CA 125.079 1.352 . . . . 0.0 108.871 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.591 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -165.26 88.15 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -166.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.94 88.18 1.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 122.422 1.901 . . . . 0.0 109.133 159.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.8 146.18 48.53 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.479 2.312 . . . . 0.0 105.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -92.71 159.98 15.18 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 119.213 0.915 . . . . 0.0 109.381 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.72 122.66 21.86 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 120.335 1.425 . . . . 0.0 108.954 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.75 71.34 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 125.95 1.738 . . . . 0.0 111.042 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.99 175.44 5.14 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.088 0.555 . . . . 0.0 111.075 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 17.1 p -141.83 127.96 19.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -157.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.528 HG13 HH11 ' C' ' 914' ' ' ARG . 17.1 m -93.41 150.19 4.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.8 t -139.72 136.5 34.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.882 1.273 . . . . 0.0 112.089 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.95 129.08 44.8 Favored 'Isoleucine or valine' 0 C--N 1.373 1.603 0 C-N-CA 126.486 1.914 . . . . 0.0 106.753 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.61 132.37 53.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 171.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.41 78.52 1.83 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.04 -1.891 . . . . 0.0 106.185 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -160.8 100.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.887 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 89.3 mmm -152.16 66.23 0.84 Allowed 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.79 143.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -112.8 -22.37 10.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.462 0.705 . . . . 0.0 109.982 -172.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 6.5 tt -98.6 86.23 3.53 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.74 -164.62 1.64 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -121.66 153.18 38.48 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 20.1 t -89.96 132.2 35.46 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -157.93 151.28 23.36 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.45 115.34 19.74 Favored Pre-proline 0 C--N 1.355 0.823 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.32 171.67 0.38 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.98 138.87 49.2 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.9 p -137.33 137.55 39.04 Favored 'General case' 0 C--N 1.376 1.746 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.0 mm -115.43 131.04 68.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.26 106.38 9.83 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 32.7 p -100.91 163.94 12.06 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.16 1.384 . . . . 0.0 110.222 172.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.91 111.19 0.32 Allowed Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.08 47.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 58.0 tp -78.18 124.42 28.05 Favored 'General case' 0 C--N 1.379 1.88 0 C-N-CA 124.516 1.126 . . . . 0.0 108.135 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 35.1 tp -97.1 -57.2 2.33 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.056 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -131.18 128.49 40.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 -174.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 131.05 10.51 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 103.412 -3.875 . . . . 0.0 103.412 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.41 131.93 88.03 Favored Pre-proline 0 C--N 1.351 0.645 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -105.84 81.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.427 0 CA-C-N 121.903 1.715 . . . . 0.0 109.847 -171.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 78.79 -72.12 0.09 Allowed 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 130.231 3.413 . . . . 0.0 109.171 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.7 mt 51.19 39.88 24.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 129.209 3.004 . . . . 0.0 113.787 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -112.62 133.49 54.64 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.86 107.86 8.59 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.919 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.453 -0.9 0 N-CA-C 110.232 -0.719 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 43.8 t -127.85 120.87 21.76 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.12 -22.23 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 122.032 1.762 . . . . 0.0 109.496 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 36.81 69.9 0.19 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.045 2.938 . . . . 0.0 115.607 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.63 136.21 56.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 160.63 37.71 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 12.2 p90 -149.23 139.76 22.51 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.6 t -169.27 116.56 0.61 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.61 153.02 36.11 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.02 158.54 44.22 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.21 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.482 HD21 HD23 ' A' ' 858' ' ' LEU . 2.5 tm? -134.81 134.72 41.14 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -167.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.438 ' H ' ' H ' ' A' ' 858' ' ' LEU . 40.6 p -164.25 10.1 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -163.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.482 HD23 HD21 ' A' ' 856' ' ' LEU . 2.1 pp -28.62 144.76 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.51 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 160.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -79.07 -47.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 122.324 1.866 . . . . 0.0 112.875 -162.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -162.2 170.55 18.86 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.6 m 4.03 104.05 0.0 OUTLIER 'General case' 0 C--N 1.36 1.058 0 C-N-CA 130.848 3.659 . . . . 0.0 117.463 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -96.46 163.57 20.25 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 123.174 0.59 . . . . 0.0 110.25 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.54 -14.61 12.8 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.662 2.241 . . . . 0.0 110.768 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -168.25 -142.5 3.51 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -63.83 144.46 57.03 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.714 2.006 . . . . 0.0 110.864 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 55.2 t -95.12 131.51 29.92 Favored Pre-proline 0 N--CA 1.439 -0.989 0 C-N-CA 124.841 1.256 . . . . 0.0 110.705 -162.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -95.84 -148.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.199 3.266 . . . . 0.0 108.464 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -149.65 136.86 19.79 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 41.6 p-10 -117.24 -15.61 10.41 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.909 0.484 . . . . 0.0 111.98 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -100.78 86.73 3.15 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 118.665 0.666 . . . . 0.0 112.723 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 871' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 874' ' ' ASN . 62.1 t -70.56 97.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.059 1.743 . . . . 0.0 107.123 167.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 48.0 mt -87.92 -36.46 17.12 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.969 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.6 tp -165.16 126.87 2.07 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 160.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.431 ' HB3' HG13 ' A' ' 871' ' ' VAL . 35.3 t-20 -174.88 61.86 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 120.528 1.513 . . . . 0.0 109.387 -168.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.8 -44.43 86.31 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -164.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.22 -30.6 8.61 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.946 0.793 . . . . 0.0 112.38 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.29 -60.76 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.86 -79.18 0.03 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.084 2.554 . . . . 0.0 114.111 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -95.8 120.1 35.48 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.154 1.382 . . . . 0.0 108.296 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.68 116.41 62.9 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -94.59 5.05 2.56 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 CA-C-N 125.204 2.894 . . . . 0.0 108.961 -165.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -79.82 -46.13 17.48 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 27.3 p -106.11 -12.15 15.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.902 172.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.34 25.88 41.91 Favored Glycine 0 C--N 1.362 2.015 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 163.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 44.9 t -101.36 102.83 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 100.481 -3.896 . . . . 0.0 100.481 -163.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 114.48 27.55 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 110.924 -2.853 . . . . 0.0 108.941 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 81.5 m -99.1 109.8 22.47 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.75 110.02 36.52 Favored Pre-proline 0 C--N 1.356 0.851 0 C-N-CA 125.591 1.556 . . . . 0.0 112.875 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -98.29 -8.38 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 CA-C-N 123.195 2.177 . . . . 0.0 108.653 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 26.3 mt -44.51 -58.99 2.66 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 129.963 3.305 . . . . 0.0 114.546 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.09 64.12 1.59 Allowed 'General case' 0 C--N 1.364 1.214 0 CA-C-O 121.839 0.828 . . . . 0.0 111.912 172.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.66 -174.35 39.84 Favored Glycine 0 N--CA 1.409 -3.113 1 N-CA-C 101.364 -4.694 . . . . 0.0 101.364 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.409 HH21 HG22 ' A' ' 953' ' ' ILE . 75.3 ttt-85 -93.34 121.84 35.14 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.253 2.6 p90 -114.04 159.92 19.45 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-N 119.0 0.818 . . . . 0.0 108.936 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.82 117.8 34.95 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.759 0.824 . . . . 0.0 110.061 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.4 tt -111.17 136.54 50.09 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 126.659 1.984 . . . . 0.0 108.997 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 73.1 m -147.01 118.93 8.13 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 153.84 22.05 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.4 t -109.44 118.86 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.28 124.87 44.72 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.41 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 39.5 m -81.38 131.68 35.3 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 125.251 1.42 . . . . 0.0 107.337 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.88 -57.44 19.87 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.161 1.363 . . . . 0.0 114.066 -169.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 66.5 m170 38.15 73.01 0.11 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.13 2.172 . . . . 0.0 115.153 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -71.16 -12.84 61.71 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.784 1.634 . . . . 0.0 111.719 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -73.55 -19.99 60.75 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.299 1.439 . . . . 0.0 112.375 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.324 13.2 pt-20 125.98 -178.21 0.0 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 127.458 2.303 . . . . 0.0 108.261 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 100.72 131.19 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.074 2.549 . . . . 0.0 106.799 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.38 126.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -108.25 123.37 48.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.16 172.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.47 116.92 15.68 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 128.996 2.918 . . . . 0.0 109.892 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 99.4 t -87.91 113.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.0 141.6 57.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 126.142 1.777 . . . . 0.0 110.563 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.4 t -116.98 145.87 43.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 125.218 1.407 . . . . 0.0 111.734 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.494 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -79.68 142.71 35.27 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 129.19 2.996 . . . . 0.0 111.052 -175.505 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 83.86 12.28 0.38 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 128.714 2.806 . . . . 0.0 112.336 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -151.79 -26.72 0.19 Allowed 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.281 -0.887 . . . . 0.0 110.628 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 57.9 167.05 0.04 OUTLIER 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.753 1.621 . . . . 0.0 112.174 -163.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.65 -134.03 49.78 Favored Glycine 0 C--N 1.372 2.556 0 O-C-N 119.217 -2.177 . . . . 0.0 109.742 -161.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 52.8 t 57.79 75.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.313 0 C-N-CA 125.79 1.636 . . . . 0.0 110.651 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.49 114.31 26.83 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -102.33 -35.17 8.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.448 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.6 83.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.728 -3.064 . . . . 0.0 102.728 167.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.59 129.36 43.99 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 121.201 0.524 . . . . 0.0 109.763 -171.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 29.7 t -143.27 115.92 8.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.506 1.523 . . . . 0.0 107.906 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.83 84.68 0.73 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 103.632 -3.787 . . . . 0.0 103.632 163.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.689 0 C-N-CA 126.24 1.876 . . . . 0.0 111.524 172.71 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.49 133.33 55.95 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.64 163.23 25.83 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -172.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 14.5 m -124.62 131.07 73.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -136.86 142.53 42.82 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.2 m -116.72 -44.49 2.83 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 33.2 tp -87.48 -53.65 4.7 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-N 119.442 1.019 . . . . 0.0 111.739 -168.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.409 HG22 HH21 ' A' ' 893' ' ' ARG . 11.2 pt -83.73 -176.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 124.262 1.025 . . . . 0.0 108.313 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.567 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -158.46 83.0 2.67 Favored Pre-proline 0 N--CA 1.433 -1.284 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -163.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.82 91.95 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.535 2.156 . . . . 0.0 109.697 167.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 954' ' ' LEU . 8.9 mp -121.78 145.89 47.6 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 126.558 1.943 . . . . 0.0 106.566 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -95.88 157.91 15.68 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.898 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.55 124.73 24.94 Favored 'General case' 0 C--N 1.375 1.705 0 CA-C-N 119.702 1.137 . . . . 0.0 109.222 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.21 69.55 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 126.306 1.908 . . . . 0.0 112.128 171.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 960' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 914' ' ' ARG . 0.9 OUTLIER -72.49 171.96 11.37 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.839 0.819 . . . . 0.0 112.116 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 85.4 m -142.28 127.81 19.02 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -157.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.494 HG13 HH11 ' A' ' 914' ' ' ARG . 20.2 m -94.83 149.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-O 121.314 0.578 . . . . 0.0 110.114 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.4 m -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 60.9 t -94.07 130.03 43.56 Favored 'Isoleucine or valine' 0 C--N 1.371 1.51 0 C-N-CA 126.623 1.969 . . . . 0.0 106.868 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -106.02 132.84 51.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 73.26 1.47 Allowed 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -163.9 103.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 86.8 mmm -153.27 74.17 1.01 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.75 151.34 9.0 Favored Glycine 0 CA--C 1.495 -1.213 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 123.726 0.811 . . . . 0.0 108.855 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.92 87.34 6.18 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.71 -166.44 1.95 Allowed 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -125.24 160.39 29.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.0 t -92.53 132.08 37.13 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.64 150.2 22.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 113.33 24.31 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -98.35 173.33 0.54 Allowed 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 121.985 1.79 . . . . 0.0 108.447 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.57 140.75 49.21 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -139.86 141.75 36.62 Favored 'General case' 0 C--N 1.375 1.68 0 CA-C-N 119.538 1.063 . . . . 0.0 108.747 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.61 129.35 75.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -125.38 105.43 9.07 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 46.0 p -101.06 161.01 13.9 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.562 1.145 . . . . 0.0 110.281 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.46 0.28 Allowed Glycine 0 C--N 1.356 1.644 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.59 144.32 47.17 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -173.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.9 124.28 26.61 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 124.906 1.282 . . . . 0.0 109.789 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.1 -57.39 2.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.36 128.01 38.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.095 1.758 . . . . 0.0 106.537 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.7 130.73 10.44 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 103.545 -3.822 . . . . 0.0 103.545 163.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.59 130.95 90.08 Favored Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.406 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -107.06 80.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 121.984 1.744 . . . . 0.0 110.293 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 77.14 -72.87 0.09 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 130.602 3.561 . . . . 0.0 109.405 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.5 mt 49.74 40.07 19.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.523 3.129 . . . . 0.0 113.94 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -110.88 130.0 55.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -128.06 109.86 11.94 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.072 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.172 -0.741 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.33 121.41 22.52 Favored Pre-proline 0 C--N 1.354 0.762 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -92.69 -22.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 122.064 1.773 . . . . 0.0 109.879 -174.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 38.78 69.58 0.26 Allowed 'General case' 0 C--N 1.36 1.039 0 C-N-CA 129.189 2.996 . . . . 0.0 115.204 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.86 136.24 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.58 160.39 38.21 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -149.41 139.94 22.5 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.3 t -169.31 117.32 0.63 Allowed 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.09 153.82 34.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -139.47 157.72 45.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.808 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.52 HD21 HD23 ' B' ' 858' ' ' LEU . 2.3 tm? -133.09 133.39 42.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -168.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.447 ' H ' ' H ' ' B' ' 858' ' ' LEU . 29.7 p -163.95 8.1 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -163.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.52 HD23 HD21 ' B' ' 856' ' ' LEU . 2.0 pp -28.74 144.91 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.513 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 160.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.43 -47.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 122.242 1.836 . . . . 0.0 112.877 -163.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -162.18 170.4 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.4 m 4.06 104.3 0.0 OUTLIER 'General case' 0 C--N 1.36 1.05 0 C-N-CA 130.877 3.671 . . . . 0.0 117.563 169.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -97.07 163.65 19.54 Favored Pre-proline 0 C--N 1.353 0.731 0 C-N-CA 123.229 0.612 . . . . 0.0 110.412 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.65 -14.83 12.54 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.645 2.23 . . . . 0.0 110.94 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.92 -142.41 3.47 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.2 m -63.63 143.95 57.41 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.611 1.964 . . . . 0.0 110.703 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.45 130.99 32.01 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 124.734 1.214 . . . . 0.0 110.463 -162.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -97.03 -148.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 124.047 3.164 . . . . 0.0 108.212 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.41 136.84 20.07 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -115.17 -13.96 11.76 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.397 1.079 . . . . 0.0 110.567 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.31 87.11 3.14 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 871' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' B' ' 874' ' ' ASN . 58.7 t -70.58 97.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' B' ' 855' ' ' ALA . 18.3 mt -87.58 -38.67 15.76 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.083 -172.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 56.6 tp -165.11 127.08 2.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 100.749 -3.797 . . . . 0.0 100.749 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.432 ' HB3' HG13 ' B' ' 871' ' ' VAL . 33.3 t-20 177.25 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 120.265 1.393 . . . . 0.0 108.648 -163.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -58.18 -43.66 87.6 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -166.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.15 -31.4 8.5 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 118.931 0.787 . . . . 0.0 112.479 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.22 -58.69 0.38 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 65.26 -80.36 0.03 OUTLIER 'General case' 0 C--N 1.355 0.831 0 C-N-CA 128.044 2.538 . . . . 0.0 114.406 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -97.1 119.88 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.335 1.454 . . . . 0.0 108.538 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.55 116.99 65.74 Favored Pre-proline 0 CA--C 1.503 -0.854 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -93.46 5.65 2.94 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.19 2.889 . . . . 0.0 108.986 -166.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -79.79 -44.94 19.71 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.407 1.083 . . . . 0.0 108.6 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 25.4 p -108.99 -12.48 14.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.909 1.284 . . . . 0.0 108.363 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.86 25.86 39.92 Favored Glycine 0 C--N 1.361 1.931 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 163.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 54.8 t -100.82 102.81 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 101.089 -3.671 . . . . 0.0 101.089 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.59 114.82 26.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 111.468 -2.605 . . . . 0.0 108.459 -174.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.0 m -99.17 109.78 22.42 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.15 110.45 38.39 Favored Pre-proline 0 C--N 1.357 0.922 0 C-N-CA 125.477 1.511 . . . . 0.0 113.307 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -99.42 -7.28 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 123.321 2.222 . . . . 0.0 108.931 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 16.0 mt -50.42 -51.95 41.92 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 128.618 2.767 . . . . 0.0 114.339 -168.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.8 49.09 14.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.214 1.406 . . . . 0.0 113.815 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -162.74 -166.68 21.94 Favored Glycine 0 N--CA 1.412 -2.943 1 N-CA-C 101.894 -4.482 . . . . 0.0 101.894 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -92.64 120.94 33.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 1.9 p90 -116.19 160.05 20.95 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-N 118.965 0.802 . . . . 0.0 108.841 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 54.6 tp -105.56 116.37 31.84 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.06 135.64 50.57 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 126.193 1.797 . . . . 0.0 107.827 -166.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 72.9 m -145.26 119.22 9.34 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.9 153.9 21.84 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.06 120.84 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.86 122.89 46.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.275 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.1 m -79.77 131.49 35.93 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.264 1.425 . . . . 0.0 107.936 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.73 -57.45 19.76 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.322 1.439 . . . . 0.0 114.25 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 66.4 m170 37.72 73.46 0.1 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 127.178 2.191 . . . . 0.0 115.093 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -71.48 -12.69 61.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.93 1.692 . . . . 0.0 111.544 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -74.62 -15.62 60.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.664 1.586 . . . . 0.0 112.628 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.0 pt-20 120.57 178.62 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 C-N-CA 127.911 2.485 . . . . 0.0 108.485 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 102.06 131.45 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 128.268 2.627 . . . . 0.0 106.581 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.92 131.57 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -112.02 123.42 50.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.18 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.23 115.04 13.69 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 128.426 2.69 . . . . 0.0 109.878 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.05 113.31 25.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.87 147.23 47.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.868 2.067 . . . . 0.0 111.294 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 1.9 t -117.03 147.3 42.46 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.454 1.502 . . . . 0.0 111.414 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.526 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.56 141.45 35.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 128.914 2.886 . . . . 0.0 110.004 -179.145 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 82.97 9.68 0.62 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.31 2.644 . . . . 0.0 112.82 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -150.17 -26.23 0.25 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.81 168.02 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.476 1.51 . . . . 0.0 112.077 -163.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.29 -133.08 48.42 Favored Glycine 0 C--N 1.366 2.213 0 O-C-N 119.5 -2.0 . . . . 0.0 109.775 -164.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 60.9 t 56.04 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.215 0 C-N-CA 126.23 1.812 . . . . 0.0 111.189 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.6 114.79 27.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -103.15 -35.44 8.48 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.484 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.17 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.04 128.76 44.77 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 33.3 t -141.48 117.43 10.52 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 171.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.82 84.8 0.74 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 165.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.709 0 C-N-CA 125.356 1.455 . . . . 0.0 111.273 175.18 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.4 m . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 59.2 mt -115.3 134.29 55.25 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -168.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.55 163.94 25.73 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 124.999 1.285 . . . . 0.0 109.95 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.97 131.51 72.8 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -137.33 146.52 44.69 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 50.5 m -128.23 -27.37 2.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.364 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 33.8 tp -92.54 -55.55 3.35 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 120.071 1.305 . . . . 0.0 111.425 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.78 -177.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 C-N-CA 125.162 1.385 . . . . 0.0 108.31 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -158.03 82.94 2.81 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.264 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.07 93.63 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.717 2.278 . . . . 0.0 110.223 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.566 HD13 ' HB2' ' B' ' 954' ' ' LEU . 10.5 mp -121.39 145.34 48.01 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 125.824 1.65 . . . . 0.0 107.106 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -95.09 158.19 15.57 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.241 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.88 124.42 24.81 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 119.844 1.202 . . . . 0.0 108.713 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.81 71.04 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 125.997 1.76 . . . . 0.0 111.994 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.73 170.62 14.19 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 117.957 0.878 . . . . 0.0 110.999 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 90.0 m -143.05 127.95 18.36 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.507 -155.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.526 HG13 HH11 ' B' ' 914' ' ' ARG . 16.5 m -96.03 150.31 4.36 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-O 121.172 0.51 . . . . 0.0 111.626 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.7 m -141.05 137.75 33.13 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 126.794 2.038 . . . . 0.0 111.338 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.59 131.05 41.63 Favored 'Isoleucine or valine' 0 C--N 1.368 1.39 0 C-N-CA 127.947 2.499 . . . . 0.0 107.43 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -105.89 132.97 51.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 100.677 -3.823 . . . . 0.0 100.677 171.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.72 72.5 1.4 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 56.8 t -161.83 104.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.3 mmm -152.28 72.68 1.0 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 173.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.26 150.06 8.44 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -115.64 -29.38 6.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 38.3 tp -93.01 86.78 5.53 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.42 -165.95 1.85 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -125.24 159.51 31.46 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.5 t -90.97 131.93 36.28 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.87 150.33 22.5 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.94 113.1 24.43 Favored Pre-proline 0 C--N 1.356 0.889 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -97.86 172.64 0.64 Allowed 'Trans proline' 0 CA--C 1.508 -0.801 0 C-N-CA 121.93 1.754 . . . . 0.0 108.297 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.54 139.18 50.77 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.8 p -139.02 140.56 38.18 Favored 'General case' 0 C--N 1.374 1.65 0 CA-C-N 119.51 1.05 . . . . 0.0 108.499 -170.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.93 130.79 72.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -126.64 105.15 8.5 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 33.3 p -101.72 162.23 13.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.768 1.227 . . . . 0.0 110.494 170.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.14 112.09 0.32 Allowed Glycine 0 C--N 1.357 1.71 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.68 145.32 46.6 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.3 tp -73.14 124.09 24.89 Favored 'General case' 0 C--N 1.379 1.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.423 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.84 -57.52 2.21 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -131.42 127.62 37.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -173.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.81 130.61 10.39 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 103.32 -3.912 . . . . 0.0 103.32 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.11 130.64 89.49 Favored Pre-proline 0 C--N 1.351 0.66 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.569 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -106.26 81.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 122.008 1.753 . . . . 0.0 109.784 -168.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 77.3 -72.38 0.1 Allowed 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 130.311 3.444 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 75.2 mt 49.06 43.33 22.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.326 3.05 . . . . 0.0 113.569 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.52 129.6 56.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -129.0 109.41 11.2 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 N-CA-C 110.328 -0.682 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 31.1 t -122.09 114.73 30.64 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -87.95 -23.65 1.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 CA-C-N 121.649 1.624 . . . . 0.0 110.074 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 37.93 67.95 0.35 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 129.11 2.964 . . . . 0.0 115.755 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.8 136.91 58.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.09 156.84 48.33 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 165.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 8.5 p90 -148.13 138.55 22.84 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 118.767 0.712 . . . . 0.0 109.105 178.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 14.0 t -170.74 120.03 0.55 Allowed 'General case' 0 C--N 1.36 1.052 0 O-C-N 121.664 -0.648 . . . . 0.0 110.097 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.8 153.3 35.94 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.36 157.67 45.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.96 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.564 HD11 HD23 ' C' ' 858' ' ' LEU . 2.9 tm? -140.8 130.51 24.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -163.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 72.8 m -157.56 17.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.564 HD23 HD11 ' C' ' 856' ' ' LEU . 2.5 pp -22.44 140.13 0.04 OUTLIER Pre-proline 0 C--N 1.374 1.632 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 159.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.31 -44.76 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 122.243 1.837 . . . . 0.0 111.685 -166.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 30.9 ptt85 -163.89 170.91 16.11 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -1.03 108.73 0.01 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 130.564 3.546 . . . . 0.0 117.22 167.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.52 161.59 23.5 Favored Pre-proline 0 N--CA 1.443 -0.797 0 C-N-CA 123.708 0.803 . . . . 0.0 108.922 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.79 -12.62 14.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.848 2.366 . . . . 0.0 110.776 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.25 3.11 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.7 m -65.48 146.25 55.11 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.906 1.682 . . . . 0.0 111.037 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.21 132.63 31.78 Favored Pre-proline 0 N--CA 1.44 -0.963 0 C-N-CA 125.383 1.473 . . . . 0.0 110.281 -164.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -99.52 -148.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 124.164 3.243 . . . . 0.0 108.556 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -147.28 135.46 21.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -116.21 -18.69 10.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.264 0.626 . . . . 0.0 111.405 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -103.57 80.69 1.82 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 122.888 0.475 . . . . 0.0 111.55 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.27 99.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 126.421 1.889 . . . . 0.0 107.189 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.82 -38.32 14.71 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.856 -172.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 36.9 tp -165.3 127.54 2.11 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 30.1 t-20 176.41 61.92 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 120.234 1.379 . . . . 0.0 107.957 -163.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.84 -42.78 90.09 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -165.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.04 -29.07 13.33 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.844 0.747 . . . . 0.0 112.515 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.31 -57.73 0.49 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 62.66 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.348 2.659 . . . . 0.0 114.891 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -94.13 121.01 35.19 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 125.139 1.376 . . . . 0.0 108.885 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.69 116.92 67.04 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -94.69 7.58 2.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 124.455 2.627 . . . . 0.0 109.332 -169.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -79.34 -46.62 17.3 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 37.5 p -108.02 -10.52 15.46 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.793 1.237 . . . . 0.0 108.411 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 28.0 33.89 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 161.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.84 101.66 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 101.088 -3.671 . . . . 0.0 101.088 -166.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -95.93 112.19 23.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 112.212 -2.267 . . . . 0.0 108.941 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 58.1 m -102.12 109.15 20.78 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 888' ' ' ALA . . . . . 0.494 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.02 110.87 45.15 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.583 170.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.65 1.45 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.569 2.179 . . . . 0.0 108.271 164.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 42.4 mt -53.6 -54.65 34.55 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 128.471 2.709 . . . . 0.0 113.45 -169.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.01 68.43 0.82 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.132 0.968 . . . . 0.0 111.037 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -177.16 174.13 46.79 Favored Glycine 0 N--CA 1.406 -3.348 1 N-CA-C 101.066 -4.813 . . . . 0.0 101.066 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -93.82 117.67 30.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.552 -1.324 . . . . 0.0 107.897 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -115.64 160.12 20.44 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 119.217 0.917 . . . . 0.0 110.159 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.1 tp -108.38 112.78 25.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.4 tt -116.82 140.13 49.8 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.062 1.345 . . . . 0.0 108.861 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 69.0 m -143.42 120.06 11.12 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.461 0.704 . . . . 0.0 109.571 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.26 154.4 19.83 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 95.1 t -100.84 122.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 55.5 mt -94.55 122.52 37.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.584 1.154 . . . . 0.0 109.156 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 12.2 m -81.8 132.55 35.28 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -49.77 -57.01 10.21 Favored Glycine 0 C--N 1.36 1.879 0 C-N-CA 126.159 1.837 . . . . 0.0 115.954 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.3 m80 40.22 69.95 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 127.241 2.216 . . . . 0.0 114.765 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -73.7 -8.86 57.66 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.833 1.253 . . . . 0.0 111.855 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -75.5 -4.9 42.39 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 126.338 1.855 . . . . 0.0 111.543 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.292 47.3 mt-10 96.63 -149.72 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 128.4 2.68 . . . . 0.0 107.804 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 84.12 135.27 0.05 Allowed 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.269 2.227 . . . . 0.0 108.819 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.71 128.22 51.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-O 122.499 1.143 . . . . 0.0 108.025 -171.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -111.08 131.34 55.15 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 127.315 2.246 . . . . 0.0 110.164 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -158.05 113.83 2.75 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.646 1.178 . . . . 0.0 110.716 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.07 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.084 1.754 . . . . 0.0 109.111 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 32.2 mt -62.37 143.32 57.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.261 1.824 . . . . 0.0 111.111 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.265 1.3 p -114.52 148.83 37.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 126.513 1.925 . . . . 0.0 108.598 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.494 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.77 137.74 37.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 125.321 1.449 . . . . 0.0 109.431 176.463 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.0 t 90.24 0.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.689 2.796 . . . . 0.0 112.694 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -145.76 -26.52 0.45 Allowed 'General case' 0 C--N 1.36 1.025 0 CA-C-N 119.495 1.043 . . . . 0.0 111.99 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 58.77 169.57 0.06 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 125.167 1.387 . . . . 0.0 111.954 -163.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.08 -127.93 46.09 Favored Glycine 0 C--N 1.374 2.667 0 O-C-N 119.741 -1.849 . . . . 0.0 110.152 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 53.4 t 49.38 72.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 126.601 1.96 . . . . 0.0 111.912 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 116.55 28.94 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -169.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -95.8 -35.7 11.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.067 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 56.3 t -99.38 81.21 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.84 131.42 40.75 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 121.091 0.472 . . . . 0.0 111.136 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -144.09 116.17 8.39 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 125.351 1.46 . . . . 0.0 108.126 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.09 84.77 0.65 Allowed Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.643 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 173.023 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.07 134.56 55.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.0 163.41 26.65 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -117.91 129.57 74.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.91 146.47 50.94 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.328 -0.858 . . . . 0.0 110.23 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.1 m -103.97 -84.06 0.48 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.716 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.32 -46.96 88.11 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.084 1.754 . . . . 0.0 114.627 -163.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.34 -179.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 124.72 1.208 . . . . 0.0 110.141 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.48 ' HB2' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -163.22 82.24 1.51 Allowed Pre-proline 0 C--N 1.355 0.836 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -168.441 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.92 88.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.278 1.985 . . . . 0.0 110.734 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' C' ' 954' ' ' LEU . 11.2 mp -123.59 147.46 47.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -91.33 162.53 14.57 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.358 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.71 122.74 21.15 Favored 'General case' 0 C--N 1.38 1.934 0 CA-C-N 120.954 1.706 . . . . 0.0 108.957 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.87 73.45 Favored Glycine 0 CA--C 1.496 -1.134 0 C-N-CA 125.49 1.519 . . . . 0.0 111.62 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -68.47 176.44 2.87 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.855 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 90.6 m -143.71 127.28 16.99 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.433 1.093 . . . . 0.0 110.922 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.401 HG13 ' HD3' ' C' ' 914' ' ' ARG . 16.8 m -98.21 147.82 6.42 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 124.802 1.241 . . . . 0.0 108.84 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 16.9 t -141.94 137.95 31.63 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.825 1.65 . . . . 0.0 111.737 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 23.8 t -90.89 129.24 42.0 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 C-N-CA 126.233 1.813 . . . . 0.0 106.169 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.68 133.5 49.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.137 -3.653 . . . . 0.0 101.137 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.53 72.64 1.45 Allowed 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.064 -1.88 . . . . 0.0 106.391 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.5 t -160.39 97.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.4 mmm -150.6 78.27 1.31 Allowed 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.98 147.53 14.1 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -113.96 -22.51 10.06 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.435 0.694 . . . . 0.0 110.135 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -98.7 85.62 3.36 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.03 -166.72 1.96 Allowed 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -119.73 150.02 41.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -88.69 130.32 35.34 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -154.95 147.93 24.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.01 115.27 26.27 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -103.73 177.22 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.7 0 C-N-CA 121.553 1.502 . . . . 0.0 108.283 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.48 138.18 51.58 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -137.81 139.95 40.26 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 119.98 1.264 . . . . 0.0 108.192 -171.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.38 131.48 67.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.47 104.92 8.69 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 35.1 p -101.83 162.89 12.57 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.942 1.297 . . . . 0.0 110.225 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.88 112.18 0.35 Allowed Glycine 0 C--N 1.359 1.818 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.28 141.95 47.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 55.8 tp -76.57 124.32 27.43 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.139 1.376 . . . . 0.0 109.439 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 16.2 tp -97.14 -56.57 2.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -131.21 127.24 37.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.51 9.09 Favored Glycine 0 CA--C 1.494 -1.27 0 N-CA-C 103.485 -3.846 . . . . 0.0 103.485 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -69.91 131.17 89.38 Favored Pre-proline 0 C--N 1.354 0.764 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.929 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -106.27 77.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 CA-C-N 122.219 1.828 . . . . 0.0 109.875 -166.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.02 -73.23 0.08 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 130.21 3.404 . . . . 0.0 108.893 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.3 mt 48.93 42.47 20.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 129.171 2.988 . . . . 0.0 113.479 -173.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -113.61 129.64 56.53 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.42 109.61 11.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.452 -0.917 0 N-CA-C 109.998 -0.808 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 118.73 24.16 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.98 -21.61 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.064 1.773 . . . . 0.0 109.875 -172.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 35.9 69.85 0.17 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.032 2.933 . . . . 0.0 115.773 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.63 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.1 155.72 49.77 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 166.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 11.4 p90 -149.62 138.77 21.27 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.0 t -169.04 117.53 0.66 Allowed 'General case' 0 C--N 1.352 0.702 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.29 152.73 36.21 Favored 'General case' 0 C--N 1.37 1.479 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.48 158.44 44.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.488 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.433 HD11 HD23 ' A' ' 858' ' ' LEU . 2.6 tm? -130.68 130.88 44.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -167.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.0 p -159.22 16.66 0.17 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -167.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.433 HD23 HD11 ' A' ' 856' ' ' LEU . 3.2 pp -21.92 145.55 0.01 OUTLIER Pre-proline 0 C--N 1.368 1.41 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 158.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.36 -48.0 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.927 1.751 . . . . 0.0 112.681 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -163.11 178.52 8.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.3 m -19.43 121.84 0.02 OUTLIER 'General case' 0 C--N 1.363 1.188 0 C-N-CA 129.615 3.166 . . . . 0.0 115.679 172.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -126.63 146.08 55.6 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -163.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -76.86 -10.25 18.24 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 CA-C-N 122.75 2.018 . . . . 0.0 112.937 -161.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.98 -141.12 3.04 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -63.45 145.8 54.89 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.31 1.844 . . . . 0.0 110.48 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 91.9 t -88.93 129.27 48.97 Favored Pre-proline 0 N--CA 1.436 -1.147 0 C-N-CA 125.059 1.344 . . . . 0.0 110.363 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -94.62 -153.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.056 3.171 . . . . 0.0 108.656 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -148.01 132.59 17.76 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -117.59 -11.97 10.38 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 122.707 0.403 . . . . 0.0 111.354 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -99.64 86.68 3.38 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 121.835 -0.541 . . . . 0.0 111.49 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.69 96.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' B' ' 953' ' ' ILE . 60.9 mt -87.18 -37.52 17.22 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.634 -173.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.0 tp -166.32 127.04 1.71 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.009 -3.7 . . . . 0.0 101.009 164.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 29.4 t-20 -177.0 61.13 0.01 OUTLIER 'General case' 0 C--N 1.357 0.93 0 CA-C-N 120.756 1.616 . . . . 0.0 109.618 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -61.01 -44.12 97.89 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -165.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.18 -27.77 12.95 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-N 118.927 0.785 . . . . 0.0 112.614 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.25 -61.74 0.3 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 61.74 -81.79 0.02 OUTLIER 'General case' 0 C--N 1.353 0.749 0 C-N-CA 128.067 2.547 . . . . 0.0 114.125 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -94.36 119.23 32.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.358 1.063 . . . . 0.0 108.47 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.03 117.64 69.1 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -94.91 2.36 2.62 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 CA-C-N 125.12 2.864 . . . . 0.0 109.473 -166.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.46 -45.74 17.07 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.5 p -103.69 -13.97 16.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.438 1.095 . . . . 0.0 108.834 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.76 23.5 49.64 Favored Glycine 0 C--N 1.362 2.012 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 162.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.68 103.7 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.583 -3.488 . . . . 0.0 101.583 -164.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.56 111.46 23.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 112.502 -2.135 . . . . 0.0 109.496 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 57.4 m -100.43 107.89 19.74 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 888' ' ' ALA . . . . . 0.471 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -91.33 110.91 45.94 Favored Pre-proline 0 C--N 1.356 0.87 0 CA-C-O 116.992 -1.48 . . . . 0.0 111.818 171.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.59 2.72 3.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 123.252 2.197 . . . . 0.0 108.91 168.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 40.8 mt -50.39 -53.44 29.26 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 128.03 2.532 . . . . 0.0 114.801 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.14 59.11 3.56 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.43 -166.7 26.95 Favored Glycine 0 N--CA 1.411 -2.978 1 N-CA-C 101.58 -4.608 . . . . 0.0 101.58 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -93.27 119.84 32.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.94 147.21 41.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.9 tp -107.63 114.9 29.19 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -112.68 139.16 48.52 Favored 'General case' 0 C--N 1.361 1.09 0 C-N-CA 126.034 1.733 . . . . 0.0 108.824 -170.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 67.4 m -143.97 118.98 10.01 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 123.422 0.689 . . . . 0.0 109.28 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.28 153.07 23.26 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.12 121.33 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 122.16 42.67 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.529 1.131 . . . . 0.0 108.682 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 10.8 m -80.6 132.35 35.62 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.83 -57.6 13.93 Favored Glycine 0 C--N 1.362 2.027 0 C-N-CA 125.852 1.691 . . . . 0.0 115.36 -167.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 2.4 m80 38.29 72.11 0.14 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 127.568 2.347 . . . . 0.0 114.855 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -72.96 -11.3 60.52 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.915 1.686 . . . . 0.0 111.341 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -72.63 -14.8 61.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.305 1.842 . . . . 0.0 112.215 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.334 7.0 pt-20 116.27 -175.66 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 C-N-CA 127.926 2.491 . . . . 0.0 108.367 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 74.9 tttt 101.59 135.93 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 127.67 2.388 . . . . 0.0 106.461 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.59 125.23 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -106.91 128.53 54.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 110.066 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.3 114.55 4.8 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.114 1.366 . . . . 0.0 109.382 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 97.2 t -88.33 115.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 139.43 58.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.121 1.768 . . . . 0.0 110.152 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.1 t -115.66 146.58 41.71 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.147 1.779 . . . . 0.0 109.339 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.617 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.99 139.26 39.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.315 2.646 . . . . 0.0 110.667 -172.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 95.9 -9.06 0.09 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.339 3.056 . . . . 0.0 112.831 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -138.46 -27.33 0.87 Allowed 'General case' 0 C--N 1.356 0.891 0 CA-C-N 119.448 1.022 . . . . 0.0 111.392 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 60.77 163.56 0.07 Allowed 'General case' 0 C--N 1.361 1.077 0 C-N-CA 125.619 1.567 . . . . 0.0 111.487 -165.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.3 -134.95 48.25 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 119.394 -2.067 . . . . 0.0 109.143 -160.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 58.05 75.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 125.284 1.434 . . . . 0.0 110.515 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.86 114.32 26.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -103.88 -33.05 9.0 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.781 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.76 77.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 166.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.35 130.32 43.49 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.418 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.9 t -144.61 114.77 7.47 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.084 1.353 . . . . 0.0 108.062 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.36 84.9 0.7 Allowed Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 104.731 -3.347 . . . . 0.0 104.731 167.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.631 0 C-N-CA 125.35 1.452 . . . . 0.0 111.212 175.052 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.42 133.76 55.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.25 161.51 25.25 Favored Glycine 0 CA--C 1.493 -1.305 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.96 127.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -138.89 149.43 44.83 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -114.57 -43.05 3.2 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.07 -52.9 5.93 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 119.733 1.151 . . . . 0.0 112.147 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 8.3 pt -87.79 -170.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 124.601 1.161 . . . . 0.0 110.172 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 85.18 1.49 Allowed Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -162.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -73.85 92.34 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 122.565 1.952 . . . . 0.0 109.781 160.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.9 142.8 49.35 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -93.89 158.24 15.74 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.092 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.16 123.88 23.18 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 119.192 0.905 . . . . 0.0 108.832 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.95 73.26 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 125.742 1.639 . . . . 0.0 111.238 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.09 175.02 5.55 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.622 0.769 . . . . 0.0 111.677 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 98.6 m -143.06 125.75 15.96 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.617 HG13 HH11 ' A' ' 914' ' ' ARG . 28.0 m -95.26 150.51 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-O 121.593 0.711 . . . . 0.0 109.544 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -142.07 138.83 32.02 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.156 1.783 . . . . 0.0 111.112 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.71 129.43 42.4 Favored 'Isoleucine or valine' 0 C--N 1.369 1.415 0 C-N-CA 126.021 1.729 . . . . 0.0 106.475 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.49 131.37 52.98 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.45 71.22 1.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.4 t -163.1 100.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.31 71.42 0.89 Allowed 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.46 143.48 7.27 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -111.02 -29.76 7.77 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.573 0.749 . . . . 0.0 108.997 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.8 tp -91.7 87.16 6.2 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.68 -164.51 1.62 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -123.93 159.26 30.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.66 133.83 35.61 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -158.91 152.2 22.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 112.39 22.35 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 172.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -98.86 174.09 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.006 1.804 . . . . 0.0 108.461 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.08 139.69 50.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.567 1.147 . . . . 0.0 108.042 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -140.12 141.4 36.12 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.984 1.266 . . . . 0.0 108.566 -170.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 30.6 mm -118.19 130.11 73.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -126.39 105.87 9.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.1 p -99.96 161.35 13.66 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.598 1.159 . . . . 0.0 109.531 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.44 109.01 0.26 Allowed Glycine 0 C--N 1.359 1.852 0 C-N-CA 119.044 -1.551 . . . . 0.0 110.675 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.95 143.41 47.05 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -74.33 124.68 26.93 Favored 'General case' 0 C--N 1.378 1.845 0 C-N-CA 125.263 1.425 . . . . 0.0 109.058 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.97 -57.94 2.06 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -132.27 128.92 38.85 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 131.85 10.82 Favored Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 103.792 -3.723 . . . . 0.0 103.792 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -69.11 129.12 92.33 Favored Pre-proline 0 C--N 1.352 0.674 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.101 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -106.57 80.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 121.873 1.704 . . . . 0.0 109.733 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 77.95 -72.86 0.08 Allowed 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 130.041 3.336 . . . . 0.0 109.2 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.0 mt 49.51 38.66 15.05 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 128.93 2.892 . . . . 0.0 114.295 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.49 132.1 54.48 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.76 107.99 10.11 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.963 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 N-CA-C 109.931 -0.834 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 119.29 24.96 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -90.24 -21.74 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 122.131 1.797 . . . . 0.0 110.085 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 37.25 69.62 0.21 Allowed 'General case' 0 C--N 1.358 0.971 0 C-N-CA 129.114 2.965 . . . . 0.0 115.587 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.6 135.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.11 155.07 50.73 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 9.4 p90 -149.33 139.61 22.29 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.26 118.25 0.56 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.89 153.1 36.35 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.458 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -137.16 158.4 44.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.093 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.44 129.78 43.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -168.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.5 p -158.85 15.98 0.18 Allowed 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 124.514 1.126 . . . . 0.0 108.119 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.0 pp -21.89 145.64 0.01 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 158.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.54 -48.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.789 1.659 . . . . 0.0 112.684 -169.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.09 178.46 8.26 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.5 m -19.37 121.92 0.02 OUTLIER 'General case' 0 C--N 1.364 1.218 0 C-N-CA 129.634 3.174 . . . . 0.0 115.68 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -126.71 146.17 56.11 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.01 -10.2 18.0 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 122.788 2.031 . . . . 0.0 112.978 -161.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.92 -141.03 3.02 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.3 m -63.39 145.77 54.92 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.19 1.796 . . . . 0.0 110.428 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.65 128.74 51.5 Favored Pre-proline 0 N--CA 1.437 -1.11 0 C-N-CA 125.052 1.341 . . . . 0.0 110.344 -164.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -95.29 -153.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.054 3.169 . . . . 0.0 108.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.44 132.05 17.8 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -115.5 -12.44 11.66 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.841 0.856 . . . . 0.0 110.698 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -100.56 86.42 3.14 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.215 0.531 . . . . 0.0 111.507 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.4 t -70.95 97.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 126.373 1.869 . . . . 0.0 106.29 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' B' ' 855' ' ' ALA . 20.3 mt -87.67 -38.56 15.76 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.181 -174.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.0 tp -166.34 127.52 1.76 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.656 -3.831 . . . . 0.0 100.656 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' B' ' 852' ' ' PHE . 27.5 t-20 178.08 61.32 0.01 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.779 1.627 . . . . 0.0 109.286 -164.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.86 -43.77 97.92 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -167.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.93 -28.61 11.72 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 118.976 0.807 . . . . 0.0 112.734 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.29 -61.32 0.3 Allowed Glycine 0 C--N 1.353 1.489 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 62.12 -81.81 0.02 OUTLIER 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.018 2.527 . . . . 0.0 114.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -95.66 119.08 33.53 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 124.55 1.14 . . . . 0.0 108.283 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.7 117.9 70.07 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -93.68 2.6 3.21 Favored 'Trans proline' 0 CA--C 1.509 -0.76 0 CA-C-N 125.11 2.861 . . . . 0.0 109.728 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -80.46 -44.51 19.1 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.9 p -106.19 -13.87 15.3 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.515 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.94 24.79 43.54 Favored Glycine 0 C--N 1.362 2.018 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 162.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.5 t -100.42 103.51 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 101.711 -3.441 . . . . 0.0 101.711 -162.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.15 111.62 23.88 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.573 -175.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 57.3 m -100.73 107.78 19.46 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 888' ' ' ALA . . . . . 0.464 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -91.5 111.16 47.7 Favored Pre-proline 0 C--N 1.357 0.922 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.88 171.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -93.43 3.3 3.27 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.267 2.202 . . . . 0.0 109.032 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -53.51 -49.6 67.2 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 126.67 1.988 . . . . 0.0 114.611 -169.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.61 48.72 13.73 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.451 1.501 . . . . 0.0 114.587 170.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.61 -165.31 18.24 Favored Glycine 0 N--CA 1.411 -2.972 1 N-CA-C 101.61 -4.596 . . . . 0.0 101.61 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -88.66 119.71 29.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.64 147.71 42.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 48.8 tp -108.7 114.22 27.83 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.57 138.45 49.33 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.965 1.706 . . . . 0.0 108.106 -171.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 73.9 m -143.46 119.13 10.44 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.21 153.33 22.85 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 90.4 t -109.13 122.28 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.13 120.65 41.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 124.557 1.143 . . . . 0.0 108.458 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 10.5 m -79.61 132.85 36.37 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.974 1.31 . . . . 0.0 107.567 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.71 13.26 Favored Glycine 0 C--N 1.364 2.111 0 C-N-CA 125.975 1.75 . . . . 0.0 115.233 -167.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.8 m80 37.96 71.92 0.14 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.558 2.343 . . . . 0.0 114.887 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -72.84 -11.54 60.64 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 126.005 1.722 . . . . 0.0 111.262 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -72.5 -13.64 61.47 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.378 1.871 . . . . 0.0 112.406 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.337 6.9 pt-20 115.69 -176.77 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.267 2.627 . . . . 0.0 108.267 174.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 101.36 135.85 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 127.568 2.347 . . . . 0.0 106.588 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.75 127.29 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -171.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -108.95 128.76 55.21 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.914 1.686 . . . . 0.0 109.969 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.49 114.39 4.7 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.817 1.247 . . . . 0.0 109.649 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.0 t -88.75 115.75 29.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 C-N-CA 125.316 1.446 . . . . 0.0 107.371 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.7 mt -62.27 141.79 58.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.744 2.018 . . . . 0.0 110.021 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.4 t -116.05 147.35 41.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 126.067 1.747 . . . . 0.0 109.506 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.643 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.02 138.81 38.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 127.82 2.448 . . . . 0.0 110.301 -173.299 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 96.35 -12.04 0.08 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 129.385 3.074 . . . . 0.0 112.931 173.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -136.52 -26.91 1.07 Allowed 'General case' 0 C--N 1.357 0.933 0 CA-C-N 119.453 1.024 . . . . 0.0 111.682 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 60.64 163.27 0.06 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.77 1.628 . . . . 0.0 111.317 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.48 -133.52 44.86 Favored Glycine 0 C--N 1.364 2.102 0 O-C-N 119.516 -1.99 . . . . 0.0 108.893 -162.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.3 t 55.86 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.159 0 C-N-CA 125.604 1.562 . . . . 0.0 110.813 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.45 114.72 27.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -104.16 -34.0 8.53 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.788 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 88.4 t -100.92 77.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 166.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -97.97 129.95 44.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.899 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.5 t -143.51 115.53 8.34 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.173 1.389 . . . . 0.0 107.916 169.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.93 84.71 0.73 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 168.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.691 0 C-N-CA 125.435 1.493 . . . . 0.0 111.266 175.614 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 44.3 m . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 65.0 mt -116.4 133.69 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.36 162.97 27.57 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.32 131.08 73.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -138.42 150.23 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.8 m -118.77 -39.78 2.94 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 45.7 tp -82.74 -51.64 7.5 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 119.474 1.034 . . . . 0.0 112.122 -169.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 872' ' ' LEU . 30.2 pt -84.53 -176.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 125.663 1.585 . . . . 0.0 110.307 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.21 84.9 2.04 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -167.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.25 93.54 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.051 1.834 . . . . 0.0 110.389 163.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.56 142.23 49.54 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -93.16 158.85 15.55 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.953 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.05 123.57 23.1 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 119.46 1.027 . . . . 0.0 108.665 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.97 -10.19 74.98 Favored Glycine 0 C--N 1.344 0.984 0 C-N-CA 125.351 1.453 . . . . 0.0 111.207 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.17 174.65 6.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.869 0.867 . . . . 0.0 110.684 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 97.9 m -143.11 125.93 16.1 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -159.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.643 HG13 HH11 ' B' ' 914' ' ' ARG . 20.7 m -96.39 151.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 121.337 0.589 . . . . 0.0 110.625 172.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.2 138.95 31.85 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.236 1.814 . . . . 0.0 111.194 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.2 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 126.971 2.109 . . . . 0.0 106.892 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -105.7 131.26 53.28 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 100.835 -3.765 . . . . 0.0 100.835 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.25 70.62 1.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 58.5 t -161.52 101.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -152.39 69.61 0.88 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.7 142.9 6.63 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 107.39 -2.284 . . . . 0.0 107.39 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -110.14 -29.36 8.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -92.29 86.92 5.86 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.23 -163.17 1.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -124.62 159.22 31.23 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.02 133.33 35.82 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -159.03 152.27 22.48 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 112.39 22.52 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -98.4 173.7 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.071 1.847 . . . . 0.0 108.384 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.41 138.13 52.02 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.3 p -138.99 140.69 38.27 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.892 1.223 . . . . 0.0 108.393 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 33.6 mm -116.02 130.53 70.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -127.17 106.0 8.95 Favored 'General case' 0 C--N 1.363 1.161 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 33.3 p -101.27 162.36 12.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.738 1.215 . . . . 0.0 110.07 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 109.83 0.28 Allowed Glycine 0 C--N 1.359 1.825 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.131 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.41 144.17 47.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 67.7 tp -72.16 124.62 25.4 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 124.9 1.28 . . . . 0.0 109.706 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.46 -58.54 1.94 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.29 128.51 37.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.71 129.93 10.09 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 103.72 -3.752 . . . . 0.0 103.72 164.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.86 129.02 92.65 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.292 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -106.74 80.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.595 1.605 . . . . 0.0 109.103 -169.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 78.01 -72.03 0.09 Allowed 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 129.91 3.284 . . . . 0.0 109.222 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.8 mt 48.74 40.26 15.63 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 128.884 2.874 . . . . 0.0 113.936 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.51 132.14 55.24 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.88 107.63 9.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 178.717 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 N--CA 1.453 -0.885 0 N-CA-C 109.982 -0.814 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.17 114.29 27.77 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.23 -22.24 1.39 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.666 1.631 . . . . 0.0 110.296 -172.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 36.59 70.28 0.17 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.862 2.865 . . . . 0.0 115.893 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.47 137.13 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.8 155.98 49.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 164.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 6.6 p90 -148.44 137.2 21.58 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 18.2 t -171.67 119.8 0.46 Allowed 'General case' 0 C--N 1.362 1.147 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.629 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.54 153.36 35.51 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.81 158.71 43.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.831 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.554 HD21 HD23 ' C' ' 858' ' ' LEU . 2.4 tm? -138.14 130.53 29.1 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -166.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 65.1 m -158.28 16.26 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -171.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.554 HD23 HD21 ' C' ' 856' ' ' LEU . 2.5 pp -30.61 149.54 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.453 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 160.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -80.32 -45.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 122.212 1.826 . . . . 0.0 113.929 -161.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -162.11 178.01 9.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -171.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -15.97 125.36 0.01 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 130.39 3.476 . . . . 0.0 116.57 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.98 149.18 42.87 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -160.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.55 -16.26 19.12 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 112.111 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -138.96 2.56 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.4 m -67.47 144.98 55.43 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 109.98 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.93 133.08 28.25 Favored Pre-proline 0 N--CA 1.439 -0.987 0 C-N-CA 124.797 1.239 . . . . 0.0 110.343 -162.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -97.24 -151.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.806 3.004 . . . . 0.0 109.45 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -144.96 132.52 20.88 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -114.24 -16.53 12.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.492 0.717 . . . . 0.0 111.225 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -102.79 82.79 2.16 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.253 0.549 . . . . 0.0 111.241 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.6 97.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.61 1.964 . . . . 0.0 106.707 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.6 -37.34 13.88 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.561 -173.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.4 tp -164.99 126.61 2.09 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 101.165 -3.643 . . . . 0.0 101.165 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 28.5 t-20 174.03 61.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.139 1.336 . . . . 0.0 107.784 -163.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.28 -42.43 95.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.75 -28.49 18.64 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.802 0.728 . . . . 0.0 112.303 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.88 -58.52 0.47 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 62.53 -81.18 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 128.069 2.547 . . . . 0.0 114.525 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.44 120.1 36.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.332 1.453 . . . . 0.0 108.683 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -85.53 117.31 68.49 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.2 8.03 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 CA-C-N 125.101 2.857 . . . . 0.0 109.643 -169.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.45 -45.4 19.49 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 36.4 p -106.09 -16.45 14.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 125.456 1.502 . . . . 0.0 108.003 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.11 24.54 47.9 Favored Glycine 0 C--N 1.361 1.967 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.6 103.12 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 -166.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.61 111.48 23.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.734 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 52.3 m -102.02 107.89 19.16 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 888' ' ' ALA . . . . . 0.578 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.83 110.83 46.3 Favored Pre-proline 0 C--N 1.357 0.9 0 CA-C-O 117.262 -1.351 . . . . 0.0 111.777 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -93.06 1.43 3.57 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.557 2.171 . . . . 0.0 108.472 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 50.3 mt -53.68 -54.51 36.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.86 2.464 . . . . 0.0 114.179 -169.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.42 69.14 0.74 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 122.185 0.993 . . . . 0.0 111.166 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.82 173.4 46.23 Favored Glycine 0 N--CA 1.405 -3.379 1 N-CA-C 100.791 -4.924 . . . . 0.0 100.791 -170.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -93.32 115.72 28.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.7 -1.25 . . . . 0.0 107.741 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -117.8 160.57 21.16 Favored 'General case' 0 C--N 1.365 1.264 0 CA-C-N 119.161 0.891 . . . . 0.0 110.845 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.5 tp -108.16 113.99 27.53 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 108.131 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.7 141.68 47.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 124.795 1.238 . . . . 0.0 108.898 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.1 m -143.26 120.66 11.64 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.625 0.77 . . . . 0.0 110.241 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 154.6 20.92 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.71 123.62 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 67.6 mt -99.29 120.09 38.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.264 1.025 . . . . 0.0 109.155 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -84.87 132.78 34.35 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.67 -59.16 11.02 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 125.022 1.296 . . . . 0.0 114.095 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.2 m80 39.91 65.02 0.78 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.126 2.171 . . . . 0.0 113.899 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -71.62 -9.43 58.23 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.24 1.416 . . . . 0.0 112.12 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.07 -17.43 61.42 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.244 1.418 . . . . 0.0 112.649 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.32 9.6 pt-20 126.23 -175.61 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 128.108 2.563 . . . . 0.0 107.909 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 40.0 tttp 101.0 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 127.766 2.426 . . . . 0.0 106.741 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.4 t -99.38 123.17 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -109.3 121.65 45.64 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.366 171.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.43 116.92 17.41 Favored 'General case' 0 C--N 1.372 1.551 0 C-N-CA 128.581 2.752 . . . . 0.0 109.885 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.12 114.39 26.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.62 147.11 46.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.835 2.054 . . . . 0.0 111.688 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.269 1.2 p -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.106 2.162 . . . . 0.0 109.685 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.578 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.15 138.95 38.97 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.146 1.778 . . . . 0.0 109.283 174.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 5.8 t 98.0 -16.6 0.05 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 129.23 3.012 . . . . 0.0 112.409 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -136.39 -26.88 1.09 Allowed 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.105 0.866 . . . . 0.0 111.574 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 60.01 169.68 0.08 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.141 1.377 . . . . 0.0 111.308 -164.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.25 -130.98 50.31 Favored Glycine 0 C--N 1.374 2.681 0 O-C-N 119.599 -1.938 . . . . 0.0 110.117 -164.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 60.2 t 53.21 77.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.257 0 C-N-CA 125.961 1.704 . . . . 0.0 111.551 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.7 115.0 27.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -171.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -102.54 -35.7 8.65 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.626 -171.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 86.47 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.33 130.28 42.16 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.102 0.477 . . . . 0.0 110.233 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 21.0 t -142.0 115.45 8.99 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.764 1.626 . . . . 0.0 108.28 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.96 85.48 0.63 Allowed Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 104.51 -3.436 . . . . 0.0 104.51 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.723 0 C-N-CA 124.726 1.155 . . . . 0.0 110.947 170.185 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 65.5 mt -122.08 133.62 54.77 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.71 28.08 Favored Glycine 0 CA--C 1.493 -1.289 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -119.07 131.85 70.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -134.2 150.5 51.07 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 121.369 -0.832 . . . . 0.0 108.955 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 48.8 m -117.47 -42.81 2.85 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 16.8 tp -90.01 -52.62 4.87 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 121.453 -0.779 . . . . 0.0 111.913 -166.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.17 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 126.23 1.812 . . . . 0.0 109.321 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.27 85.93 1.52 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -167.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.12 89.54 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.328 2.019 . . . . 0.0 109.964 164.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.7 145.89 47.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -92.77 161.16 14.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.342 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.53 122.73 20.98 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-N 120.067 1.303 . . . . 0.0 108.877 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.33 -11.19 72.72 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 125.517 1.532 . . . . 0.0 111.377 168.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 175.56 4.04 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.67 0.788 . . . . 0.0 111.608 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.4 m -143.29 126.56 16.6 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.898 0.879 . . . . 0.0 110.412 -160.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.99 148.52 5.46 Favored 'Isoleucine or valine' 0 C--N 1.362 1.129 0 C-N-CA 123.842 0.857 . . . . 0.0 109.191 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.7 t -141.49 139.66 33.35 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 126.079 1.752 . . . . 0.0 111.451 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.44 129.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.369 1.428 0 C-N-CA 126.271 1.828 . . . . 0.0 107.574 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.02 131.53 54.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 168.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.56 77.99 1.78 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.105 -1.862 . . . . 0.0 107.032 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.9 t -159.25 99.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 N-CA-C 104.441 -2.429 . . . . 0.0 104.441 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -150.71 81.07 1.34 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.07 148.64 16.51 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -115.29 -28.56 6.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 109.274 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.4 tp -91.33 87.14 6.35 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.86 -162.56 1.31 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -123.84 157.97 32.91 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.5 133.25 35.66 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.82 150.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.64 112.61 22.75 Favored Pre-proline 0 C--N 1.355 0.817 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -101.45 -178.21 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 121.766 1.644 . . . . 0.0 108.294 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.17 137.32 53.06 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.253 1.021 . . . . 0.0 109.294 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.9 p -138.27 137.26 37.3 Favored 'General case' 0 C--N 1.376 1.719 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.24 131.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -125.14 104.45 8.53 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 30.2 p -102.51 163.72 12.07 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.313 1.445 . . . . 0.0 110.016 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.59 112.29 0.36 Allowed Glycine 0 C--N 1.356 1.679 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.29 143.04 46.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.68 125.18 27.47 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 125.556 1.543 . . . . 0.0 110.054 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 15.5 tp -98.74 -57.35 2.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 122.376 0.27 . . . . 0.0 110.362 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -131.13 128.07 39.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 131.08 10.53 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 104.174 -3.57 . . . . 0.0 104.174 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.28 128.73 91.15 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 117.768 -1.11 . . . . 0.0 111.214 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -106.71 78.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 122.029 1.76 . . . . 0.0 109.667 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 78.61 -72.74 0.08 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.852 3.261 . . . . 0.0 109.083 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.1 mt 49.19 39.46 15.58 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 128.789 2.836 . . . . 0.0 113.828 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.4 132.04 54.74 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.53 107.37 9.42 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.067 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.677 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.455 -0.777 0 N-CA-C 110.031 -0.796 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 45.0 t -126.87 119.55 22.55 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -89.84 -22.21 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.106 1.788 . . . . 0.0 109.797 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 36.92 70.01 0.19 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 129.025 2.93 . . . . 0.0 115.498 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.64 137.23 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.78 160.73 37.28 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 165.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -149.31 140.16 22.79 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.1 t -169.43 116.52 0.6 Allowed 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -122.95 153.18 40.07 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -138.64 157.83 45.38 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.24 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.572 HD21 HD23 ' A' ' 858' ' ' LEU . 2.7 tm? -131.8 130.97 42.49 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -168.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 67.5 m -160.99 8.69 0.08 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -162.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.572 HD23 HD21 ' A' ' 856' ' ' LEU . 2.9 pp -28.93 149.4 0.03 OUTLIER Pre-proline 0 C--N 1.367 1.361 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 162.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.48 -45.15 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.966 1.738 . . . . 0.0 113.672 -163.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -162.56 173.98 13.24 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.89 118.84 0.01 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 130.647 3.579 . . . . 0.0 116.759 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.7 164.44 15.19 Favored Pre-proline 0 N--CA 1.442 -0.846 0 C-N-CA 124.279 1.031 . . . . 0.0 110.271 -171.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.71 -15.5 13.53 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.751 2.301 . . . . 0.0 111.337 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.78 -140.59 3.12 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 120.176 1.353 . . . . 0.0 111.189 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.7 m -63.09 145.38 55.59 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.616 2.366 . . . . 0.0 111.454 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.7 127.1 76.4 Favored Pre-proline 0 N--CA 1.441 -0.879 0 C-N-CA 125.308 1.443 . . . . 0.0 111.59 -166.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -98.52 -150.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.429 2.752 . . . . 0.0 107.779 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -149.25 134.3 18.11 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.52 -13.4 10.3 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.029 0.532 . . . . 0.0 110.524 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -100.09 86.79 3.31 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.78 97.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.145 1.778 . . . . 0.0 106.96 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.24 -37.15 16.31 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.376 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 39.8 tp -166.38 128.3 1.83 Allowed 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 162.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -178.34 61.54 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.84 1.655 . . . . 0.0 109.386 -167.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.28 -44.37 92.47 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -165.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.51 -31.27 8.98 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.827 0.739 . . . . 0.0 112.388 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.59 -62.36 0.29 Allowed Glycine 0 C--N 1.353 1.474 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 66.9 -78.19 0.04 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.108 2.563 . . . . 0.0 113.478 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -96.36 120.53 36.82 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.309 1.444 . . . . 0.0 108.792 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.04 117.19 66.25 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -94.24 5.6 2.64 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 CA-C-N 125.43 2.975 . . . . 0.0 108.991 -168.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -80.29 -45.59 17.62 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 -13.36 15.42 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.107 1.363 . . . . 0.0 108.544 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.79 37.96 Favored Glycine 0 C--N 1.364 2.125 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 161.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 23.7 t -101.05 103.94 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 100.419 -3.919 . . . . 0.0 100.419 -163.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.49 112.44 24.98 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.298 -2.228 . . . . 0.0 108.529 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 68.1 m -100.47 108.42 20.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 167.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 888' ' ' ALA . . . . . 0.434 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.41 111.18 45.88 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.85 171.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -94.35 1.51 2.93 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 CA-C-N 123.107 2.145 . . . . 0.0 109.196 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.49 -49.94 71.21 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.148 2.179 . . . . 0.0 114.076 -168.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 52.63 7.26 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.637 1.175 . . . . 0.0 113.749 169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -166.75 -167.3 27.22 Favored Glycine 0 N--CA 1.414 -2.771 1 N-CA-C 100.496 -5.042 . . . . 0.0 100.496 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.99 121.44 35.47 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.27 3.5 p90 -115.26 161.31 18.65 Favored 'General case' 0 C--N 1.366 1.291 0 CA-C-N 119.099 0.863 . . . . 0.0 109.127 174.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -104.7 116.94 32.9 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.62 0.768 . . . . 0.0 109.538 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -109.45 137.35 47.43 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.806 2.042 . . . . 0.0 109.136 -166.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.5 m -146.37 118.89 8.49 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 123.399 0.68 . . . . 0.0 109.218 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.06 153.55 22.45 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.28 118.86 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.44 123.56 45.7 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.497 -173.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 45.8 m -79.17 131.23 36.14 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.414 1.486 . . . . 0.0 107.512 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.77 -56.47 20.33 Favored Glycine 0 C--N 1.362 2.01 0 C-N-CA 126.064 1.792 . . . . 0.0 114.897 -168.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.3 m170 33.52 74.54 0.06 Allowed 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.964 2.506 . . . . 0.0 115.897 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -72.77 -10.72 60.12 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.437 1.495 . . . . 0.0 111.355 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -73.09 -14.74 61.45 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.369 1.468 . . . . 0.0 112.228 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.363 8.3 pt-20 123.4 -168.68 0.0 OUTLIER 'General case' 0 C--N 1.363 1.155 0 C-N-CA 128.26 2.624 . . . . 0.0 108.166 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 64.9 mttt 98.29 135.54 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 128.258 2.623 . . . . 0.0 107.261 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.24 125.26 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.53 128.79 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 127.121 2.168 . . . . 0.0 109.699 176.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.68 114.64 4.7 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.865 1.266 . . . . 0.0 110.06 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.7 114.68 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.51 141.67 58.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.156 1.782 . . . . 0.0 110.297 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 4.8 t -114.92 146.83 40.73 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 126.202 1.801 . . . . 0.0 109.129 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.629 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.17 138.05 38.49 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.91 2.484 . . . . 0.0 110.022 -174.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.27 -3.85 0.07 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.142 2.977 . . . . 0.0 112.809 172.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -144.25 -25.99 0.53 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 119.56 1.073 . . . . 0.0 111.245 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 58.46 166.71 0.05 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.4 1.48 . . . . 0.0 112.1 -164.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.22 -134.87 48.46 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 119.359 -2.088 . . . . 0.0 109.303 -161.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 43.8 t 57.29 73.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 125.467 1.507 . . . . 0.0 110.277 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.68 113.95 26.35 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -103.13 -35.55 8.45 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.404 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.37 78.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 168.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.32 129.09 44.63 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.5 -173.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.9 t -143.43 114.56 7.84 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.57 84.51 0.75 Allowed Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.168 -3.573 . . . . 0.0 104.168 165.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.836 0 C-N-CA 124.747 1.165 . . . . 0.0 113.786 178.99 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.0 mt -117.89 133.8 55.57 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -172.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.44 26.99 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.01 129.46 75.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -137.75 147.51 44.78 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.7 m -115.6 -44.89 2.93 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 44.7 tp -82.27 -49.95 9.5 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 119.237 0.926 . . . . 0.0 113.038 -166.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.96 -171.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 125.955 1.702 . . . . 0.0 109.973 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.92 81.92 2.07 Favored Pre-proline 0 N--CA 1.437 -1.097 0 C-N-CA 123.442 0.697 . . . . 0.0 109.185 -165.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.75 91.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 122.509 1.932 . . . . 0.0 109.644 162.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.42 142.53 49.92 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -94.78 155.03 17.0 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.579 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.64 123.28 21.49 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 119.518 1.054 . . . . 0.0 108.93 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.75 -10.39 74.71 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 125.706 1.622 . . . . 0.0 111.297 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 175.65 5.14 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.575 0.75 . . . . 0.0 111.332 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 88.5 m -142.6 125.34 15.96 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -160.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.629 HG13 HH11 ' A' ' 914' ' ' ARG . 24.4 m -94.82 151.27 3.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 121.666 0.746 . . . . 0.0 109.692 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.05 138.3 31.69 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.446 1.898 . . . . 0.0 111.269 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.43 129.96 42.24 Favored 'Isoleucine or valine' 0 C--N 1.37 1.484 0 C-N-CA 126.589 1.955 . . . . 0.0 106.322 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -105.92 131.95 52.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.03 71.9 1.49 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 59.1 t -162.75 101.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.8 mmm -153.1 70.67 0.88 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.75 147.07 7.52 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -113.31 -30.33 6.95 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.17 87.65 6.62 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.66 -177.14 4.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -166.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -116.99 156.29 27.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -90.67 134.16 34.61 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.76 150.55 21.03 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.25 112.96 21.46 Favored Pre-proline 0 C--N 1.355 0.832 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -99.58 173.82 0.4 Allowed 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 108.586 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.78 140.1 50.16 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -139.94 141.56 36.46 Favored 'General case' 0 C--N 1.375 1.678 0 CA-C-N 119.748 1.158 . . . . 0.0 108.797 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.5 mm -119.67 130.23 74.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -125.63 104.85 8.6 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 54.8 p -101.6 162.03 13.2 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.831 1.253 . . . . 0.0 110.161 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.99 112.28 0.32 Allowed Glycine 0 C--N 1.358 1.769 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.15 144.43 46.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.1 tp -74.25 124.12 25.81 Favored 'General case' 0 C--N 1.379 1.882 0 C-N-CA 124.59 1.156 . . . . 0.0 109.675 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.61 -57.62 2.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -131.72 127.57 37.09 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.43 129.08 9.77 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 103.498 -3.841 . . . . 0.0 103.498 166.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -69.21 129.04 92.26 Favored Pre-proline 0 C--N 1.352 0.681 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.16 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -106.82 80.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 CA-C-N 122.111 1.79 . . . . 0.0 109.873 -168.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 77.98 -72.79 0.08 Allowed 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 130.149 3.379 . . . . 0.0 109.161 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 78.8 mt 49.54 39.16 16.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 129.279 3.032 . . . . 0.0 114.133 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.7 131.79 55.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.56 108.34 10.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.771 0 N-CA-C 110.006 -0.806 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.55 119.75 23.08 Favored Pre-proline 0 C--N 1.354 0.77 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -90.64 -22.24 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 122.136 1.799 . . . . 0.0 109.986 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 37.69 70.45 0.19 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 129.192 2.997 . . . . 0.0 115.196 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.26 137.46 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.64 160.02 39.4 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 165.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -148.83 139.97 23.11 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.4 t -169.28 117.52 0.64 Allowed 'General case' 0 C--N 1.354 0.765 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -124.37 153.9 41.16 Favored 'General case' 0 C--N 1.368 1.403 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.56 157.85 44.59 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.145 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.582 HD21 HD23 ' B' ' 858' ' ' LEU . 2.7 tm? -133.4 128.44 35.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -168.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.2 m -159.84 12.21 0.13 Allowed 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 124.717 1.207 . . . . 0.0 107.747 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.582 HD23 HD21 ' B' ' 856' ' ' LEU . 2.9 pp -28.68 149.87 0.03 OUTLIER Pre-proline 0 C--N 1.369 1.422 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 160.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.45 -45.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.046 1.766 . . . . 0.0 113.777 -164.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 33.6 ptt85 -162.52 173.93 13.35 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.81 118.94 0.01 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 130.692 3.597 . . . . 0.0 116.771 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.08 164.44 15.12 Favored Pre-proline 0 N--CA 1.442 -0.87 0 C-N-CA 124.325 1.05 . . . . 0.0 110.294 -171.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.77 -15.54 13.4 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.782 2.321 . . . . 0.0 111.35 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.53 -140.85 3.17 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 120.222 1.374 . . . . 0.0 111.193 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.0 m -62.93 144.62 56.59 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.473 2.309 . . . . 0.0 111.388 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.93 126.36 82.32 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.394 1.477 . . . . 0.0 111.565 -167.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -98.98 -150.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.364 2.709 . . . . 0.0 107.566 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -148.79 133.3 17.66 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -114.97 -13.96 11.89 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.333 1.053 . . . . 0.0 109.508 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.994 0.426 . . . . 0.0 111.312 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.78 97.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 126.39 1.876 . . . . 0.0 106.253 163.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.27 -38.91 14.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.659 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 54.5 tp -166.03 127.38 1.85 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 165.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 177.0 61.39 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.509 1.504 . . . . 0.0 108.524 -163.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.79 -43.75 94.26 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -165.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.11 -31.27 9.26 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 118.759 0.709 . . . . 0.0 112.366 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 110.62 -60.74 0.32 Allowed Glycine 0 C--N 1.353 1.476 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 66.23 -79.08 0.03 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.185 2.594 . . . . 0.0 113.644 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -97.01 120.75 37.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.5 1.52 . . . . 0.0 109.033 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.44 117.44 67.11 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 171.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -93.25 5.91 3.0 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-N 125.485 2.995 . . . . 0.0 109.11 -169.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -80.1 -44.17 20.44 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 108.656 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -109.16 -13.82 14.61 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.374 1.47 . . . . 0.0 108.306 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.11 27.82 32.72 Favored Glycine 0 C--N 1.362 2.027 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 162.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.44 103.58 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 -161.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -99.79 112.45 24.7 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.691 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.5 m -101.16 108.23 19.85 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 167.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 888' ' ' ALA . . . . . 0.434 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.66 111.26 46.74 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 117.06 -1.447 . . . . 0.0 111.959 170.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -93.37 1.4 3.42 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 123.186 2.174 . . . . 0.0 109.183 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 31.0 mt -55.43 -49.5 72.25 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.055 2.142 . . . . 0.0 114.36 -168.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.75 52.08 7.02 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.762 1.225 . . . . 0.0 114.263 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.11 -166.41 26.15 Favored Glycine 0 N--CA 1.413 -2.871 1 N-CA-C 101.12 -4.792 . . . . 0.0 101.12 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -93.2 121.33 34.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.308 2.2 p90 -116.92 161.84 18.71 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 119.218 0.917 . . . . 0.0 109.394 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 59.4 tp -105.18 115.76 30.81 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -108.84 136.74 47.89 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 126.335 1.854 . . . . 0.0 108.194 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -145.24 118.65 9.02 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.14 153.58 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.73 120.12 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 122.82 46.26 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 41.6 m -78.58 131.75 36.87 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 125.383 1.473 . . . . 0.0 107.893 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.63 -56.47 20.05 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 126.136 1.827 . . . . 0.0 114.917 -168.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.6 m170 33.16 74.55 0.06 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.058 2.543 . . . . 0.0 115.818 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -72.73 -10.85 60.27 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.542 1.537 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.02 -13.79 61.29 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.495 1.518 . . . . 0.0 112.326 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.361 8.3 pt-20 122.98 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 C-N-CA 128.623 2.769 . . . . 0.0 108.109 172.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 62.7 mttt 97.71 135.19 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 128.211 2.604 . . . . 0.0 107.499 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.15 126.0 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.57 129.27 55.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.352 1.861 . . . . 0.0 109.819 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.8 114.64 4.66 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.566 1.146 . . . . 0.0 110.315 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 96.3 t -89.18 115.14 28.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 C-N-CA 125.569 1.548 . . . . 0.0 107.814 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.8 143.63 57.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 126.694 1.997 . . . . 0.0 110.303 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -115.32 147.43 40.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.318 1.847 . . . . 0.0 109.275 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.609 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.3 137.89 37.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.548 2.339 . . . . 0.0 109.756 -175.446 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.68 -6.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.196 2.998 . . . . 0.0 113.011 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -142.84 -25.68 0.61 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.716 1.144 . . . . 0.0 111.823 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 58.47 165.89 0.04 OUTLIER 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.561 1.544 . . . . 0.0 111.939 -164.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.42 -133.64 45.03 Favored Glycine 0 C--N 1.367 2.289 0 O-C-N 119.455 -2.028 . . . . 0.0 109.05 -163.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 43.0 t 55.29 74.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 110.511 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.33 114.33 26.83 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -172.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -103.84 -36.51 7.79 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.485 -1.688 . . . . 0.0 108.311 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.68 76.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.34 129.2 44.63 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.184 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -142.56 115.21 8.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.963 1.305 . . . . 0.0 107.77 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.56 84.44 0.75 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 166.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.764 0 C-N-CA 124.755 1.169 . . . . 0.0 113.893 178.909 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 40.1 m . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 64.4 mt -115.87 133.84 55.62 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -169.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.16 162.74 26.41 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -172.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.09 129.34 75.59 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.17 150.16 46.52 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 57.9 m -125.12 -30.28 3.22 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 119.159 -0.448 . . . . 0.0 111.751 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 29.3 tp -88.35 -51.94 5.47 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 119.411 1.005 . . . . 0.0 111.803 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.9 pt -84.94 -176.8 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 125.585 1.554 . . . . 0.0 110.011 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.417 ' O ' HD22 ' B' ' 954' ' ' LEU . 0.0 OUTLIER -157.32 81.15 3.26 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -167.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.02 92.22 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.328 2.019 . . . . 0.0 110.09 164.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.5 mp -120.94 142.23 49.94 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -94.62 155.96 16.64 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.342 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.56 122.67 20.9 Favored 'General case' 0 C--N 1.377 1.761 0 CA-C-N 119.874 1.215 . . . . 0.0 108.737 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.16 -9.47 77.56 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 125.51 1.528 . . . . 0.0 111.131 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.22 175.34 5.4 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.79 0.836 . . . . 0.0 110.679 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.3 m -142.83 125.5 15.91 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -158.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.609 HG13 HH11 ' B' ' 914' ' ' ARG . 18.9 m -96.13 151.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 121.5 0.666 . . . . 0.0 110.448 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.0 t -141.65 138.43 32.51 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 126.626 1.97 . . . . 0.0 111.432 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.1 t -91.72 130.01 41.53 Favored 'Isoleucine or valine' 0 C--N 1.369 1.44 0 C-N-CA 127.355 2.262 . . . . 0.0 106.531 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.94 131.98 52.59 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.795 -3.78 . . . . 0.0 100.795 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.99 71.55 1.48 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 57.3 t -161.28 102.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 91.6 mmm -152.13 69.64 0.9 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.93 146.46 7.15 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -112.53 -29.96 7.3 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -174.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.48 87.57 6.46 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.87 4.49 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -167.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -116.88 156.0 28.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.2 t -89.74 133.61 34.6 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.92 150.65 20.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.41 113.06 21.21 Favored Pre-proline 0 C--N 1.356 0.864 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -99.33 173.5 0.42 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 122.047 1.832 . . . . 0.0 108.443 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.02 138.9 51.28 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -138.43 141.19 39.54 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 119.723 1.147 . . . . 0.0 108.539 -171.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 23.6 mm -117.11 130.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -126.19 104.44 8.23 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 61.2 p -103.12 162.91 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.959 1.303 . . . . 0.0 110.722 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.45 113.76 0.37 Allowed Glycine 0 C--N 1.359 1.86 0 N-CA-C 106.684 -2.567 . . . . 0.0 106.684 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.33 145.31 46.27 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.56 124.06 24.45 Favored 'General case' 0 C--N 1.381 1.965 0 C-N-CA 124.486 1.114 . . . . 0.0 109.692 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.26 -57.52 2.19 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -131.41 127.13 36.86 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.68 128.99 9.74 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.69 -3.764 . . . . 0.0 103.69 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.15 128.63 92.51 Favored Pre-proline 0 C--N 1.352 0.687 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.771 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -106.47 79.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 122.079 1.778 . . . . 0.0 109.378 -167.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.47 -72.21 0.09 Allowed 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 130.036 3.335 . . . . 0.0 109.117 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 74.6 mt 49.09 40.62 17.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 129.162 2.985 . . . . 0.0 113.868 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -113.52 131.88 55.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -130.41 108.0 9.66 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 179.309 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.1 114.09 26.3 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.56 -21.89 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 CA-C-N 121.643 1.622 . . . . 0.0 109.859 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 39.16 70.13 0.24 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.633 2.773 . . . . 0.0 115.307 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.31 131.77 72.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -138.71 149.27 44.92 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 5.5 p90 -149.53 139.72 22.19 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.289 0.95 . . . . 0.0 110.117 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 20.4 t -169.16 119.22 0.7 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-O 118.23 -0.89 . . . . 0.0 109.519 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.27 153.96 42.42 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -174.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.23 156.23 47.22 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 122.053 0.93 . . . . 0.0 109.747 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.569 HD21 HD23 ' C' ' 858' ' ' LEU . 1.8 tm? -129.21 127.19 40.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.701 -1.59 . . . . 0.0 106.815 -165.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 47.8 p -159.82 13.0 0.13 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.017 -164.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.569 HD23 HD21 ' C' ' 856' ' ' LEU . 3.0 pp -25.93 146.24 0.03 OUTLIER Pre-proline 0 C--N 1.368 1.413 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 157.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.94 -45.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.111 1.79 . . . . 0.0 113.319 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -163.39 177.95 8.5 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 -172.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 18.4 m -13.47 119.51 0.01 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 130.101 3.36 . . . . 0.0 116.079 172.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.85 161.27 38.98 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -166.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.52 -15.23 8.76 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.408 2.072 . . . . 0.0 110.999 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.26 -144.2 4.04 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -65.49 135.55 55.32 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.86 1.664 . . . . 0.0 110.515 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 17.1 m -65.74 144.02 98.74 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 125.628 1.571 . . . . 0.0 113.184 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -99.71 -151.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 123.303 2.669 . . . . 0.0 107.295 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -146.39 129.94 16.91 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -116.23 -16.17 10.97 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 122.969 0.508 . . . . 0.0 110.705 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -102.39 81.12 2.02 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.089 0.471 . . . . 0.0 111.372 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.15 97.68 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 127.231 2.213 . . . . 0.0 106.652 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 4.9 mt -89.03 -37.3 15.26 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.465 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 45.4 tp -165.31 129.48 2.37 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 100.401 -3.926 . . . . 0.0 100.401 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.1 t-20 175.68 61.56 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 121.218 1.826 . . . . 0.0 108.226 -166.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.55 97.73 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -165.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.02 -28.81 12.65 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.58 0.627 . . . . 0.0 112.663 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.15 -58.71 0.4 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.79 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.588 2.755 . . . . 0.0 114.085 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -97.25 120.8 38.28 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.811 1.644 . . . . 0.0 108.203 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -83.97 116.82 66.66 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -94.22 6.06 2.58 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 CA-C-N 124.955 2.805 . . . . 0.0 109.942 -165.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -79.95 -45.43 18.53 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.7 p -106.4 -12.08 15.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.937 1.295 . . . . 0.0 108.482 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.74 21.22 54.18 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.452 161.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.42 102.44 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -162.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.45 112.06 23.84 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 111.736 -2.484 . . . . 0.0 108.997 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 80.9 m -100.57 108.05 19.88 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.17 111.41 48.43 Favored Pre-proline 0 C--N 1.354 0.798 0 CA-C-O 117.284 -1.341 . . . . 0.0 110.248 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -91.03 0.07 4.88 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.444 2.096 . . . . 0.0 108.621 166.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 87.9 mt -58.21 -50.51 73.28 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.987 1.715 . . . . 0.0 114.59 -164.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.44 68.99 0.75 Allowed 'General case' 0 C--N 1.366 1.305 0 CA-C-O 122.051 0.929 . . . . 0.0 111.738 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.8 -167.75 35.8 Favored Glycine 0 N--CA 1.406 -3.309 1 N-CA-C 102.272 -4.331 . . . . 0.0 102.272 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -92.65 121.49 34.12 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.422 -1.389 . . . . 0.0 108.493 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.525 ' H ' HD11 ' C' ' 954' ' ' LEU . 3.6 t80 -116.9 145.73 43.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -112.18 115.33 28.67 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.035 0.934 . . . . 0.0 108.648 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.2 tt -112.62 140.97 46.93 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.517 1.527 . . . . 0.0 108.505 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -143.01 118.81 10.53 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.86 154.03 22.16 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.58 122.63 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 78.7 mt -97.92 122.57 41.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.309 1.044 . . . . 0.0 108.974 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.66 131.43 35.97 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.21 -56.28 24.06 Favored Glycine 0 C--N 1.367 2.261 0 C-N-CA 125.336 1.446 . . . . 0.0 112.992 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 43.72 63.08 1.69 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.772 2.429 . . . . 0.0 113.981 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -72.68 -7.48 50.63 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 112.594 -168.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 125.381 1.472 . . . . 0.0 112.294 -171.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.336 8.5 pt-20 120.89 -173.37 0.0 OUTLIER 'General case' 0 C--N 1.362 1.148 0 C-N-CA 128.253 2.621 . . . . 0.0 107.956 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.3 tttt 102.62 135.31 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 127.997 2.519 . . . . 0.0 106.524 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 93.2 t -98.39 123.29 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -104.77 129.72 52.97 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.566 1.946 . . . . 0.0 110.171 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.67 114.23 3.74 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.127 1.371 . . . . 0.0 109.943 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.27 117.2 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.818 1.647 . . . . 0.0 108.854 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.45 142.23 57.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.052 1.741 . . . . 0.0 110.204 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.26 1.3 p -113.81 148.73 36.07 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 126.427 1.891 . . . . 0.0 108.368 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.581 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -78.72 137.42 37.77 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.797 1.639 . . . . 0.0 108.364 178.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 101.65 -18.1 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 129.255 3.022 . . . . 0.0 112.281 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -137.5 -26.74 0.97 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 119.277 0.944 . . . . 0.0 111.3 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 59.93 167.17 0.07 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.31 1.444 . . . . 0.0 111.861 -164.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.5 -130.72 51.43 Favored Glycine 0 C--N 1.376 2.764 0 O-C-N 119.554 -1.966 . . . . 0.0 110.197 -163.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 43.2 t 51.8 74.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 126.317 1.847 . . . . 0.0 111.712 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.49 116.62 29.0 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -99.56 -36.66 9.46 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.782 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.85 78.12 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -94.05 132.56 38.41 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -143.55 114.56 7.79 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 125.39 1.476 . . . . 0.0 108.295 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.45 84.97 0.64 Allowed Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 104.765 -3.334 . . . . 0.0 104.765 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.727 0 C-N-CA 125.096 1.332 . . . . 0.0 110.909 172.743 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.511 -0.536 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.6 mt -121.28 134.59 55.17 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.85 162.51 26.29 Favored Glycine 0 CA--C 1.493 -1.344 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.1 130.75 73.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -137.07 150.62 48.15 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 53.3 m -117.71 -36.7 3.6 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.157 -0.34 . . . . 0.0 111.414 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.78 -54.6 3.56 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 118.525 0.602 . . . . 0.0 111.928 -166.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.6 pp -84.76 -173.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 126.463 1.905 . . . . 0.0 110.158 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.525 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -162.12 92.86 1.32 Allowed Pre-proline 0 C--N 1.358 0.942 0 O-C-N 122.02 -0.425 . . . . 0.0 109.947 -168.595 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.33 91.15 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 122.944 2.087 . . . . 0.0 109.797 160.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' C' ' 954' ' ' LEU . 5.9 mp -121.42 142.88 49.58 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -92.43 160.23 15.18 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.75 122.05 19.97 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 120.226 1.375 . . . . 0.0 108.502 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.61 71.45 Favored Glycine 0 C--N 1.347 1.158 0 C-N-CA 125.389 1.471 . . . . 0.0 111.419 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.89 174.99 3.91 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.488 0.715 . . . . 0.0 111.471 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 19.4 p -142.96 127.98 18.48 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.435 0.635 . . . . 0.0 109.416 -161.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.581 HG13 HH11 ' C' ' 914' ' ' ARG . 19.6 m -94.69 150.28 4.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.66 137.72 33.78 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 125.047 1.339 . . . . 0.0 111.916 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.79 129.42 42.49 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 C-N-CA 125.912 1.685 . . . . 0.0 106.805 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -106.82 132.6 52.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 11.4 tp -132.28 75.26 1.62 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.196 -1.82 . . . . 0.0 107.972 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.7 t -158.59 100.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.62 75.15 1.15 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 112.89 145.6 9.51 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -113.0 -30.51 6.99 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.2 tp -92.24 87.06 5.94 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.8 -160.62 1.08 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -123.17 155.13 37.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -91.48 134.02 35.0 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -158.27 151.19 22.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -127.29 116.67 21.58 Favored Pre-proline 0 C--N 1.355 0.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -102.99 173.76 0.19 Allowed 'Trans proline' 0 CA--C 1.508 -0.817 0 N-CA-C 107.925 -1.606 . . . . 0.0 107.925 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -114.55 139.52 49.51 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -137.79 139.44 40.03 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 119.665 1.12 . . . . 0.0 108.001 -169.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.41 131.24 69.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -124.92 105.53 9.3 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 28.6 p -101.76 164.67 11.61 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.61 1.564 . . . . 0.0 109.911 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.15 111.81 0.35 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.06 141.53 48.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -76.7 124.45 27.68 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.386 1.474 . . . . 0.0 108.586 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 18.6 tp -98.1 -57.46 2.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.753 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.91 128.26 38.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.71 131.7 10.83 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.684 -3.766 . . . . 0.0 103.684 162.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.34 132.38 89.75 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.595 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -106.09 78.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.54 1.586 . . . . 0.0 108.954 -171.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 79.56 -71.75 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.207 3.403 . . . . 0.0 109.007 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 68.6 mt 49.87 38.87 17.01 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 129.183 2.993 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.14 131.86 54.76 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.94 107.14 9.14 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 179.544 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 109.854 -0.864 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.94 119.0 21.01 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -89.96 -20.89 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.079 1.778 . . . . 0.0 109.689 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 37.74 69.23 0.25 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.727 2.811 . . . . 0.0 115.618 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.09 137.1 54.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.2 158.84 43.32 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -149.38 138.07 21.02 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 22.9 t -170.28 117.5 0.54 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.73 153.36 34.52 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.01 157.89 45.76 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.68 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.404 HD21 HD23 ' A' ' 858' ' ' LEU . 2.3 tm? -130.75 129.32 42.33 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -166.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.2 p -162.01 14.36 0.09 Allowed 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -163.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.404 HD23 HD21 ' A' ' 856' ' ' LEU . 3.8 pp -24.86 147.44 0.02 OUTLIER Pre-proline 0 C--N 1.366 1.318 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 159.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.51 -45.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 121.918 1.721 . . . . 0.0 112.891 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -163.45 179.34 7.37 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -172.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -24.05 126.76 0.03 OUTLIER 'General case' 0 C--N 1.364 1.225 0 C-N-CA 129.364 3.066 . . . . 0.0 115.22 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -122.77 147.15 50.08 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -158.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.46 -10.35 20.45 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.505 2.137 . . . . 0.0 113.042 -172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.25 -142.01 3.33 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 120.426 1.466 . . . . 0.0 110.558 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.4 m -62.82 144.72 56.28 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 127.213 2.205 . . . . 0.0 110.813 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.11 122.77 84.75 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 125.504 1.522 . . . . 0.0 111.089 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -96.39 -153.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.96 3.107 . . . . 0.0 107.472 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -151.49 135.66 16.71 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -120.12 -11.88 9.18 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 122.146 -0.346 . . . . 0.0 111.905 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.09 87.14 3.39 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.591 0.632 . . . . 0.0 112.264 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.87 97.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 126.213 1.805 . . . . 0.0 106.882 168.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' B' ' 953' ' ' ILE . 67.0 mt -87.48 -37.82 16.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.238 -173.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 32.4 tp -166.65 127.51 1.66 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 101.106 -3.665 . . . . 0.0 101.106 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 179.98 61.04 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 120.839 1.654 . . . . 0.0 108.988 -166.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 -44.03 95.84 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -166.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.72 -27.13 15.13 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 118.863 0.756 . . . . 0.0 112.456 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.77 -58.73 0.39 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 62.68 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 127.933 2.493 . . . . 0.0 114.094 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -95.97 119.54 34.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.785 1.234 . . . . 0.0 108.068 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.05 117.29 67.8 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.53 4.84 2.61 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 124.656 2.699 . . . . 0.0 109.399 -165.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.16 -45.72 17.64 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -104.31 -14.29 15.84 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 124.517 1.127 . . . . 0.0 108.746 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.26 47.65 Favored Glycine 0 C--N 1.363 2.068 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 162.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 52.5 t -100.18 103.89 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 -163.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.71 111.92 24.23 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 112.167 -2.288 . . . . 0.0 109.358 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 64.9 m -100.33 108.18 20.15 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 888' ' ' ALA . . . . . 0.414 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.93 110.75 44.1 Favored Pre-proline 0 C--N 1.357 0.912 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.707 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.22 1.29 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 123.285 2.209 . . . . 0.0 108.94 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 29.9 mt -51.68 -53.84 34.61 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 128.489 2.716 . . . . 0.0 114.151 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.17 65.3 1.31 Allowed 'General case' 0 C--N 1.365 1.277 0 CA-C-O 121.901 0.858 . . . . 0.0 112.057 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.08 -177.93 45.48 Favored Glycine 0 N--CA 1.411 -3.012 1 N-CA-C 101.033 -4.827 . . . . 0.0 101.033 -173.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -93.18 121.27 34.37 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.284 1.3 p90 -114.95 161.68 17.98 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.158 0.89 . . . . 0.0 109.573 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 63.0 tp -104.17 116.45 32.22 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.421 0.688 . . . . 0.0 109.662 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.03 136.72 49.63 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 126.386 1.874 . . . . 0.0 108.916 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.8 m -147.41 119.57 8.29 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 123.318 0.647 . . . . 0.0 109.557 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.42 153.92 21.56 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.5 t -107.97 120.82 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.95 123.96 45.94 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.177 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 42.4 m -81.11 132.97 35.39 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 125.581 1.552 . . . . 0.0 107.389 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.4 -57.22 20.8 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 124.931 1.253 . . . . 0.0 113.765 -170.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.6 m170 36.1 71.48 0.13 Allowed 'General case' 0 C--N 1.36 1.043 0 C-N-CA 127.556 2.342 . . . . 0.0 115.143 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -73.03 -8.02 53.85 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 125.253 1.421 . . . . 0.0 112.028 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.82 -18.76 62.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.18 1.392 . . . . 0.0 112.605 -171.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.305 11.3 pt-20 125.13 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 127.954 2.502 . . . . 0.0 108.16 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 99.16 131.69 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.423 2.289 . . . . 0.0 107.277 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.76 123.81 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -107.97 121.71 45.35 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.015 1.726 . . . . 0.0 112.864 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -130.5 116.13 17.76 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.6 2.76 . . . . 0.0 108.615 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.3 t -84.98 114.74 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.67 141.26 58.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.841 1.656 . . . . 0.0 110.497 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.3 t -115.96 147.18 41.44 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.537 1.935 . . . . 0.0 109.373 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.6 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.68 139.49 39.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.821 2.848 . . . . 0.0 110.634 -173.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 7.2 t 97.55 -12.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 129.269 3.028 . . . . 0.0 112.909 173.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -136.9 -26.51 1.04 Allowed 'General case' 0 C--N 1.356 0.887 0 CA-C-N 119.601 1.091 . . . . 0.0 111.204 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 61.58 163.35 0.08 Allowed 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.473 1.509 . . . . 0.0 111.388 -166.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.77 -135.07 49.43 Favored Glycine 0 C--N 1.37 2.456 0 O-C-N 119.443 -2.036 . . . . 0.0 109.442 -160.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 44.0 t 57.52 78.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.169 0 C-N-CA 125.56 1.544 . . . . 0.0 110.714 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.69 114.42 26.96 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -173.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -102.86 -35.75 8.49 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.479 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -100.22 82.43 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 167.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -94.93 130.21 41.65 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.796 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -142.96 114.88 8.23 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.654 1.582 . . . . 0.0 108.631 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.3 85.12 0.65 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 103.701 -3.76 . . . . 0.0 103.701 162.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.842 0 C-N-CA 124.369 0.985 . . . . 0.0 112.133 172.206 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.52 133.28 55.99 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.13 161.58 27.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -172.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 26.5 m -122.59 127.85 75.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.7 149.32 46.42 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.0 m -115.0 -43.74 3.08 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 22.9 tp -83.71 -50.07 8.51 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 119.491 1.041 . . . . 0.0 112.775 -166.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 7.8 pt -85.01 -174.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 110.438 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.69 81.64 2.74 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 123.154 0.582 . . . . 0.0 109.663 -166.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.24 92.24 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.593 2.195 . . . . 0.0 109.911 162.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.8 143.8 48.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -94.33 156.59 16.44 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.605 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.29 123.47 22.35 Favored 'General case' 0 C--N 1.372 1.547 0 CA-C-N 119.292 0.951 . . . . 0.0 108.861 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.11 72.92 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 125.936 1.731 . . . . 0.0 111.096 171.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.92 175.25 5.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.385 0.674 . . . . 0.0 111.528 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 13.1 t -144.4 128.68 17.8 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.825 0.821 . . . . 0.0 110.191 -164.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.6 HG13 HH11 ' A' ' 914' ' ' ARG . 23.4 m -94.53 151.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.957 172.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.54 138.5 32.76 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 126.197 1.799 . . . . 0.0 111.275 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.69 129.51 42.26 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 C-N-CA 126.102 1.761 . . . . 0.0 107.04 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -107.8 131.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 169.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -131.39 76.44 1.72 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.401 -1.727 . . . . 0.0 107.303 172.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.1 t -160.46 100.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.0 mmm -153.58 70.12 0.83 Allowed 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.05 145.8 7.33 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -113.1 -29.35 7.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.8 tp -91.37 87.42 6.44 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.62 -165.28 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -124.46 161.02 26.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -93.47 133.15 37.05 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.61 151.38 22.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.22 113.39 21.54 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -99.21 173.93 0.42 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 121.875 1.716 . . . . 0.0 108.751 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.43 139.34 51.54 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.707 1.203 . . . . 0.0 108.247 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -140.76 141.9 34.78 Favored 'General case' 0 C--N 1.376 1.727 0 CA-C-N 120.001 1.273 . . . . 0.0 108.599 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 24.3 mm -118.12 129.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -125.14 105.62 9.29 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 32.1 p -101.04 161.97 13.22 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.019 1.328 . . . . 0.0 110.379 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.54 0.28 Allowed Glycine 0 C--N 1.359 1.835 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.17 145.27 46.14 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.37 -1.077 . . . . 0.0 113.809 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.8 tp -75.19 123.09 24.66 Favored 'General case' 0 C--N 1.379 1.857 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 27.7 tp -98.61 -57.33 2.22 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -131.7 128.05 38.17 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 130.95 10.47 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 103.883 -3.687 . . . . 0.0 103.883 165.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -69.09 128.91 92.48 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-O 117.825 -1.083 . . . . 0.0 111.046 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -107.14 80.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.048 1.767 . . . . 0.0 109.814 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.89 -72.75 0.09 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 130.241 3.416 . . . . 0.0 109.315 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 73.2 mt 49.62 39.24 16.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.158 2.983 . . . . 0.0 114.169 -176.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -112.1 131.43 55.44 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -128.93 108.7 10.63 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 179.318 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.55 119.19 21.57 Favored Pre-proline 0 C--N 1.354 0.771 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.25 -20.93 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 122.193 1.819 . . . . 0.0 109.905 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 39.31 69.19 0.3 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 128.783 2.833 . . . . 0.0 115.351 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 88.6 t -118.88 136.76 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.21 157.81 45.96 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 165.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.31 138.49 21.41 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -170.68 118.07 0.51 Allowed 'General case' 0 C--N 1.357 0.893 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.67 153.55 34.16 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.508 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -136.13 157.97 45.55 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.433 174.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.434 HD21 HD23 ' B' ' 858' ' ' LEU . 2.2 tm? -130.45 128.04 40.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -167.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.8 p -161.65 13.36 0.09 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.341 -163.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.434 HD23 HD21 ' B' ' 856' ' ' LEU . 3.7 pp -24.56 147.49 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.375 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 158.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.69 -45.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 CA-C-N 121.943 1.729 . . . . 0.0 112.839 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 -163.32 179.22 7.52 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -172.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.8 m -23.82 126.6 0.03 OUTLIER 'General case' 0 C--N 1.365 1.248 0 C-N-CA 129.361 3.064 . . . . 0.0 115.356 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -122.79 147.17 50.17 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -158.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.5 -10.29 20.36 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.517 2.145 . . . . 0.0 113.107 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.99 3.32 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 120.496 1.498 . . . . 0.0 110.516 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 24.3 m -62.83 144.59 56.44 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 127.086 2.154 . . . . 0.0 110.7 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 11.5 t -78.88 122.58 84.78 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 125.521 1.528 . . . . 0.0 111.004 -169.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -97.65 -153.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.932 3.088 . . . . 0.0 107.361 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -150.82 135.09 16.95 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -117.77 -10.95 10.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.604 0.761 . . . . 0.0 110.553 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -100.77 87.52 3.35 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.95 -0.469 . . . . 0.0 112.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.13 97.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.172 1.789 . . . . 0.0 106.507 164.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' B' ' 855' ' ' ALA . 19.2 mt -88.05 -39.17 14.85 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.238 -174.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 44.7 tp -166.1 126.57 1.73 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 100.6 -3.852 . . . . 0.0 100.6 165.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 177.35 60.88 0.01 OUTLIER 'General case' 0 C--N 1.354 0.79 0 CA-C-N 120.464 1.484 . . . . 0.0 108.921 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.24 -43.56 95.99 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -166.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.38 -27.82 14.46 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 118.749 0.704 . . . . 0.0 112.553 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.53 -57.89 0.43 Allowed Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 62.65 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 127.998 2.519 . . . . 0.0 114.221 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -96.86 119.13 34.76 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.926 1.29 . . . . 0.0 108.117 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.89 117.52 68.62 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.66 5.09 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 124.609 2.682 . . . . 0.0 109.529 -164.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.18 -44.6 19.55 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -106.2 -14.64 15.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.872 1.269 . . . . 0.0 108.393 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.87 25.17 42.3 Favored Glycine 0 C--N 1.361 1.917 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.54 103.89 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 -162.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -100.74 111.91 24.22 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 112.609 -2.087 . . . . 0.0 109.144 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.3 m -100.37 108.22 20.19 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 168.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 888' ' ' ALA . . . . . 0.411 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.65 111.0 45.3 Favored Pre-proline 0 C--N 1.357 0.933 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.755 171.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -93.36 1.95 3.4 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.318 2.221 . . . . 0.0 108.929 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.14 -48.57 73.5 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 127.047 2.139 . . . . 0.0 113.951 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.29 48.89 14.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.547 1.539 . . . . 0.0 113.929 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.95 -166.1 20.08 Favored Glycine 0 N--CA 1.412 -2.902 1 N-CA-C 101.569 -4.612 . . . . 0.0 101.569 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -93.31 121.43 34.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.318 0.8 OUTLIER -117.03 161.41 19.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-N 119.26 0.936 . . . . 0.0 109.639 177.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.0 tp -105.38 115.52 30.4 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -109.72 136.46 49.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.313 1.845 . . . . 0.0 108.254 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.8 m -145.25 119.42 9.48 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.82 153.51 22.37 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 95.5 t -108.56 121.81 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.4 122.23 45.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.988 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 38.4 m -79.67 132.99 36.36 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.49 1.516 . . . . 0.0 107.853 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.02 -57.2 21.14 Favored Glycine 0 C--N 1.364 2.129 0 C-N-CA 125.057 1.313 . . . . 0.0 113.896 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.8 m170 35.84 71.79 0.12 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 127.491 2.316 . . . . 0.0 115.173 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -73.18 -7.89 53.38 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.27 1.428 . . . . 0.0 111.976 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -72.55 -15.39 61.77 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 125.46 1.504 . . . . 0.0 112.656 -169.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.317 10.2 pt-20 121.05 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.361 1.067 0 C-N-CA 128.182 2.593 . . . . 0.0 108.224 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 79.7 tttt 100.49 131.82 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 127.537 2.335 . . . . 0.0 107.46 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.76 126.23 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -111.25 122.87 48.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.498 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.58 117.34 17.82 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 128.087 2.555 . . . . 0.0 108.907 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.48 113.86 25.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.2 mt -62.59 143.29 57.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.664 1.986 . . . . 0.0 110.294 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -116.03 147.88 40.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 110.011 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.617 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.75 139.34 38.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 128.044 2.538 . . . . 0.0 110.19 -174.55 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 7.4 t 97.82 -16.35 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.322 3.049 . . . . 0.0 113.078 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -134.49 -26.0 1.45 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 119.599 1.091 . . . . 0.0 111.423 -170.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 61.34 162.88 0.07 Allowed 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.593 1.557 . . . . 0.0 111.176 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.35 -133.92 45.25 Favored Glycine 0 C--N 1.365 2.173 0 O-C-N 119.615 -1.928 . . . . 0.0 109.163 -162.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.13 79.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.149 0 C-N-CA 125.828 1.651 . . . . 0.0 110.823 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 114.91 27.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -103.31 -36.98 7.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.385 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.3 t -100.72 81.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.875 -3.009 . . . . 0.0 102.875 167.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -95.69 129.48 42.89 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.7 t -141.57 115.53 9.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.483 1.513 . . . . 0.0 107.714 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.64 85.0 0.69 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 104.199 -3.56 . . . . 0.0 104.199 163.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.814 0 C-N-CA 124.904 1.24 . . . . 0.0 112.029 173.204 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.4 mt -116.91 133.95 55.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 -171.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.31 162.57 27.58 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.26 130.67 73.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.28 150.6 46.82 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 55.0 m -118.89 -40.49 2.85 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 118.165 0.439 . . . . 0.0 111.918 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.44 -48.9 10.55 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 119.169 0.895 . . . . 0.0 112.646 -167.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 872' ' ' LEU . 40.8 pt -84.29 -177.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.864 1.666 . . . . 0.0 110.389 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.28 81.35 2.91 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -169.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.35 93.41 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.602 2.201 . . . . 0.0 110.321 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.2 mp -120.5 142.52 49.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -93.21 156.97 16.51 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.616 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.02 123.27 22.42 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 119.508 1.049 . . . . 0.0 108.672 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.79 -10.46 74.52 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 125.555 1.55 . . . . 0.0 111.052 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.27 174.82 5.94 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.732 0.813 . . . . 0.0 110.458 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 14.5 t -144.42 128.76 17.86 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.745 0.783 . . . . 0.0 110.42 -161.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.617 HG13 HH11 ' B' ' 914' ' ' ARG . 17.7 m -96.15 151.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.19 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.82 138.51 32.24 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 126.281 1.832 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 90.1 t -91.21 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.331 0 C-N-CA 127.087 2.155 . . . . 0.0 107.275 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -107.41 131.54 54.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 100.77 -3.789 . . . . 0.0 100.77 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.77 75.92 1.69 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.565 -1.652 . . . . 0.0 106.948 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 61.9 t -159.21 102.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -152.8 68.86 0.84 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.76 144.98 6.82 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -111.96 -28.67 7.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -92.3 87.14 5.94 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.97 1.68 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -124.49 160.13 28.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.3 t -91.89 132.88 36.15 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.7 151.49 22.16 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.05 113.29 21.8 Favored Pre-proline 0 C--N 1.356 0.867 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -98.9 173.46 0.46 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.948 1.765 . . . . 0.0 108.693 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.71 137.71 52.5 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -139.76 140.77 36.8 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.91 1.232 . . . . 0.0 108.316 -170.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.48 129.8 72.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -125.83 105.44 8.95 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 34.4 p -102.11 163.14 12.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.104 1.361 . . . . 0.0 110.866 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.02 112.09 0.33 Allowed Glycine 0 C--N 1.36 1.9 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.23 145.15 46.3 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.6 tp -72.75 122.52 21.64 Favored 'General case' 0 C--N 1.381 1.975 0 C-N-CA 124.143 0.977 . . . . 0.0 109.155 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.3 tp -98.39 -57.38 2.21 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -131.46 127.43 37.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 130.25 10.21 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 103.819 -3.712 . . . . 0.0 103.819 165.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.62 128.99 91.77 Favored Pre-proline 0 C--N 1.352 0.702 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.446 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -106.62 80.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 122.029 1.76 . . . . 0.0 109.426 -168.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.16 -72.17 0.09 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 129.98 3.312 . . . . 0.0 109.199 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 68.9 mt 48.79 41.51 18.32 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 129.039 2.936 . . . . 0.0 113.696 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -114.41 131.35 56.62 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.83 108.34 10.07 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 179.096 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.454 -0.821 0 N-CA-C 109.849 -0.866 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.11 114.53 27.8 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -88.86 -21.42 1.32 Allowed 'Trans proline' 0 CA--C 1.512 -0.614 0 CA-C-N 121.723 1.651 . . . . 0.0 110.173 -172.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 35.77 71.39 0.12 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 129.039 2.936 . . . . 0.0 115.84 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.3 t -122.06 136.55 58.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 156.41 49.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 165.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 6.8 p90 -148.8 136.84 20.84 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 118.811 0.732 . . . . 0.0 109.03 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 15.1 t -170.86 119.93 0.53 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.321 -0.862 . . . . 0.0 109.512 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.13 153.11 36.65 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' C' ' 870' ' ' ARG . . . -141.11 157.72 44.9 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.976 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.565 HD11 HD23 ' C' ' 858' ' ' LEU . 2.8 tm? -140.23 129.44 23.74 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -163.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 69.8 m -157.06 19.52 0.3 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.565 HD23 HD11 ' C' ' 856' ' ' LEU . 1.8 pp -25.36 145.59 0.03 OUTLIER Pre-proline 0 C--N 1.373 1.596 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 160.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.6 -49.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.236 1.957 . . . . 0.0 113.463 -164.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.1 ptt85 -162.47 172.39 15.59 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -2.69 112.46 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 130.893 3.677 . . . . 0.0 117.165 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -96.1 161.46 27.14 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.702 1.201 . . . . 0.0 109.651 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.92 -15.8 11.68 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.84 2.36 . . . . 0.0 110.429 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.99 -138.74 2.58 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 10.1 m -65.17 146.76 54.56 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.85 1.66 . . . . 0.0 110.69 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.89 133.31 26.67 Favored Pre-proline 0 N--CA 1.438 -1.044 0 C-N-CA 125.447 1.499 . . . . 0.0 110.554 -162.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -96.54 -152.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.823 3.015 . . . . 0.0 109.443 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.09 134.57 23.17 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -114.44 -17.23 11.81 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.161 0.584 . . . . 0.0 111.766 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 11.4 mmm180 -102.92 83.21 2.2 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.519 0.6 . . . . 0.0 110.958 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.76 97.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.651 1.98 . . . . 0.0 106.51 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 6.5 mt -89.83 -37.99 14.07 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.288 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 33.8 tp -165.52 126.74 1.94 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 29.0 t-20 175.06 61.47 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 120.25 1.387 . . . . 0.0 107.72 -163.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.88 -42.51 93.91 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -165.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.95 -29.11 16.25 Favored Glycine 0 C--N 1.357 1.705 0 CA-C-N 118.736 0.698 . . . . 0.0 112.335 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.14 -58.22 0.51 Allowed Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 63.47 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.087 2.555 . . . . 0.0 114.458 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -96.16 120.69 36.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 125.329 1.452 . . . . 0.0 108.496 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -85.99 116.96 67.8 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.26 8.65 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 124.951 2.804 . . . . 0.0 109.015 -170.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -79.29 -44.39 21.78 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.3 p -107.28 -15.01 14.75 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.832 1.253 . . . . 0.0 107.932 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.62 24.74 49.13 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 164.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.08 103.66 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.95 111.83 23.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.976 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 47.5 m -102.51 108.66 20.04 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 888' ' ' ALA . . . . . 0.541 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.56 110.37 42.7 Favored Pre-proline 0 C--N 1.356 0.85 0 CA-C-O 117.261 -1.352 . . . . 0.0 111.775 170.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -93.56 3.18 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.572 2.181 . . . . 0.0 108.359 164.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.02 -51.55 67.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 127.718 2.407 . . . . 0.0 113.458 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.52 66.09 1.14 Allowed 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.128 0.966 . . . . 0.0 111.66 169.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.08 -179.36 45.59 Favored Glycine 0 N--CA 1.404 -3.442 1 N-CA-C 101.293 -4.723 . . . . 0.0 101.293 -173.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -95.64 116.71 29.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.752 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.83 160.82 20.25 Favored 'General case' 0 C--N 1.366 1.31 0 CA-C-N 119.2 0.909 . . . . 0.0 110.654 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -108.0 110.66 22.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.06 138.99 51.25 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 108.414 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 61.5 m -143.22 120.59 11.62 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.54 0.736 . . . . 0.0 110.25 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -103.65 154.87 19.04 Favored 'General case' 0 C--N 1.364 1.226 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.71 123.47 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 68.9 mt -94.92 124.32 38.9 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.631 1.172 . . . . 0.0 109.403 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.4 m -79.66 132.39 36.21 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.74 22.54 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 125.952 1.739 . . . . 0.0 114.843 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 61.2 m170 31.39 74.33 0.05 OUTLIER 'General case' 0 C--N 1.361 1.076 0 C-N-CA 128.168 2.587 . . . . 0.0 115.615 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -71.0 -11.55 61.04 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.127 1.771 . . . . 0.0 112.457 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -73.89 -5.41 40.9 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.799 2.04 . . . . 0.0 111.796 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.299 47.1 mt-10 100.09 -144.09 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.809 2.844 . . . . 0.0 107.05 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 75.3 tttt 79.12 141.39 0.07 Allowed 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.616 1.966 . . . . 0.0 109.389 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.86 126.23 59.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -110.03 129.92 55.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.908 2.083 . . . . 0.0 110.164 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.51 114.13 2.94 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.692 1.197 . . . . 0.0 110.422 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.406 ' CG1' ' H ' ' C' ' 922' ' ' VAL . 7.2 p -85.54 117.69 30.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 C-N-CA 126.36 1.864 . . . . 0.0 109.04 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.73 137.24 58.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.129 1.372 . . . . 0.0 110.375 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.5 t -117.72 145.39 44.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.797 2.039 . . . . 0.0 107.989 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.541 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.33 140.37 38.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.215 2.206 . . . . 0.0 110.878 -174.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 92.25 0.86 0.12 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 128.982 2.913 . . . . 0.0 112.129 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -147.12 -25.66 0.4 Allowed 'General case' 0 C--N 1.361 1.078 0 CA-C-N 119.499 1.045 . . . . 0.0 112.101 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.5 166.99 0.06 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.422 1.489 . . . . 0.0 111.671 -164.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.7 -130.36 50.93 Favored Glycine 0 C--N 1.375 2.702 0 O-C-N 119.434 -2.041 . . . . 0.0 110.08 -164.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 47.6 t 53.6 73.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.226 0 C-N-CA 125.734 1.614 . . . . 0.0 111.586 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.89 116.1 28.62 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 25.0 ptt85 -98.93 -33.26 10.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.706 -173.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.406 ' H ' ' CG1' ' C' ' 911' ' ' VAL . 61.1 t -100.03 79.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 166.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.88 131.71 40.48 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 120.895 0.378 . . . . 0.0 111.299 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 24.6 t -144.18 115.23 7.88 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 125.324 1.45 . . . . 0.0 108.367 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.54 85.51 0.66 Allowed Glycine 0 CA--C 1.481 -2.035 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 172.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.632 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.675 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 70.0 mt -122.31 134.1 54.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.76 162.24 27.74 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 25.5 m -118.82 130.9 73.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -136.14 150.06 48.91 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.7 t -105.12 -76.35 0.61 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 13.7 tp -61.48 -49.53 76.39 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.25 -177.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.081 1.352 . . . . 0.0 110.477 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.85 84.14 1.31 Allowed Pre-proline 0 C--N 1.356 0.848 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.59 88.14 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 122.478 1.921 . . . . 0.0 109.952 164.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.8 146.22 47.72 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.14 161.37 15.79 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.397 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.65 122.15 20.07 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.408 1.458 . . . . 0.0 108.633 172.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.2 72.71 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 125.504 1.526 . . . . 0.0 111.261 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.99 175.59 3.63 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.739 0.781 . . . . 0.0 111.673 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.9 m -142.81 127.0 17.52 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.774 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.31 147.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 C-N-CA 124.276 1.03 . . . . 0.0 109.155 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 19.6 t -142.43 137.89 30.69 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.849 1.659 . . . . 0.0 111.193 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.7 129.71 41.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -104.05 132.98 49.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.84 71.53 1.45 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.515 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.75 99.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.76 74.43 1.11 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 113.72 145.09 9.05 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -114.1 -21.13 10.68 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.595 0.758 . . . . 0.0 110.007 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -98.71 85.81 3.4 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.82 -158.66 0.88 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -172.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -120.54 169.47 10.32 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 23.2 t -108.38 130.66 55.21 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.72 154.53 30.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.0 115.41 20.44 Favored Pre-proline 0 C--N 1.355 0.813 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 172.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -103.39 176.89 0.15 Allowed 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 121.807 1.671 . . . . 0.0 108.075 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.33 138.97 50.89 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -137.54 139.2 40.33 Favored 'General case' 0 C--N 1.376 1.757 0 CA-C-N 119.931 1.241 . . . . 0.0 108.489 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 34.8 mm -115.14 131.51 67.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -125.34 104.47 8.48 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 26.6 p -102.17 163.92 11.98 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.475 1.51 . . . . 0.0 110.42 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.1 113.19 0.37 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.71 46.69 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.5 124.63 26.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 125.495 1.518 . . . . 0.0 109.598 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.34 -57.61 2.16 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -131.93 127.54 36.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.6 129.32 9.85 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 103.739 -3.744 . . . . 0.0 103.739 165.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.56 127.8 91.66 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.285 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -106.95 78.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.534 0 CA-C-N 121.735 1.655 . . . . 0.0 109.449 -168.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 78.86 -72.77 0.08 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 130.039 3.336 . . . . 0.0 109.063 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 66.0 mt 48.88 40.53 16.78 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 128.975 2.91 . . . . 0.0 113.576 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -112.45 131.1 55.74 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -128.85 108.3 10.34 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.265 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.509 -0.76 0 N-CA-C 109.989 -0.812 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.93 119.36 21.14 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -90.07 -22.02 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.222 1.829 . . . . 0.0 109.666 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 38.14 69.16 0.26 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 128.757 2.823 . . . . 0.0 115.408 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.79 137.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.92 159.29 41.91 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 166.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.27 117.67 0.54 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.3 153.91 33.18 Favored 'General case' 0 C--N 1.372 1.575 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -134.39 158.52 43.63 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.411 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.24 127.71 30.54 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 858' ' ' LEU . 71.5 m -163.12 9.42 0.05 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -159.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 857' ' ' SER . 0.6 OUTLIER -28.5 152.28 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.378 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 160.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -78.38 -42.26 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 121.943 1.73 . . . . 0.0 113.382 -164.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -166.23 -159.16 0.37 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.2 m -31.54 139.04 0.04 OUTLIER 'General case' 0 C--N 1.361 1.104 0 C-N-CA 129.478 3.111 . . . . 0.0 115.29 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.89 164.54 43.14 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.93 -14.15 12.53 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.591 2.194 . . . . 0.0 111.147 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.9 -139.02 2.62 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.2 m -62.93 145.4 55.33 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 126.87 2.068 . . . . 0.0 111.011 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.44 128.12 54.24 Favored Pre-proline 0 N--CA 1.437 -1.093 0 C-N-CA 125.39 1.476 . . . . 0.0 110.315 -165.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -96.26 -149.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.943 3.096 . . . . 0.0 108.361 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.96 134.17 18.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -116.81 -14.45 10.73 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 122.62 0.368 . . . . 0.0 111.719 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.55 87.8 3.46 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.658 0.663 . . . . 0.0 112.47 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.69 97.83 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.014 1.726 . . . . 0.0 106.781 168.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 78.4 mt -87.71 -37.84 16.33 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.865 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 31.7 tp -166.31 127.55 1.77 Allowed 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 163.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 179.53 60.82 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.806 1.639 . . . . 0.0 109.16 -166.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.46 -43.94 93.1 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -165.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.36 -28.04 14.0 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.733 0.697 . . . . 0.0 112.49 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.57 -58.57 0.39 Allowed Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.516 -2.234 . . . . 0.0 107.516 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 63.16 -80.58 0.03 OUTLIER 'General case' 0 C--N 1.355 0.823 0 C-N-CA 128.065 2.546 . . . . 0.0 114.286 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -96.46 119.82 35.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.678 1.191 . . . . 0.0 108.416 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -80.0 117.22 66.39 Favored Pre-proline 0 CA--C 1.503 -0.834 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -93.81 6.25 2.73 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 CA-C-N 125.45 2.982 . . . . 0.0 109.031 -167.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -80.1 -46.66 16.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 21.5 p -108.18 -10.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 108.667 173.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 27.42 38.05 Favored Glycine 0 C--N 1.363 2.028 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 162.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.13 103.26 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.578 0 N-CA-C 100.816 -3.772 . . . . 0.0 100.816 -164.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.36 112.83 25.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.19 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 61.0 m -100.58 108.48 20.4 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 888' ' ' ALA . . . . . 0.44 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.83 110.69 43.53 Favored Pre-proline 0 C--N 1.358 0.966 0 CA-C-O 117.033 -1.461 . . . . 0.0 112.459 172.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -96.46 -1.21 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 123.109 2.146 . . . . 0.0 109.142 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.82 -50.18 66.74 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.65 2.38 . . . . 0.0 114.188 -168.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.18 47.9 13.65 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.29 1.436 . . . . 0.0 114.486 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -160.42 -165.41 17.2 Favored Glycine 0 N--CA 1.415 -2.746 1 N-CA-C 101.291 -4.724 . . . . 0.0 101.291 175.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.444 HH21 HG22 ' A' ' 953' ' ' ILE . 75.9 ttt-85 -93.83 120.9 34.7 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.273 3.7 p90 -115.33 161.33 18.66 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 118.939 0.791 . . . . 0.0 109.479 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.8 tp -104.61 117.08 33.22 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.434 0.694 . . . . 0.0 109.47 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -111.26 137.38 49.06 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 126.446 1.898 . . . . 0.0 108.941 -167.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.7 m -145.58 119.14 9.1 Favored 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.63 153.35 22.5 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.38 120.43 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.62 123.87 47.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.843 -173.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 49.0 m -79.12 131.45 36.24 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 125.396 1.478 . . . . 0.0 107.37 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.19 -55.77 25.97 Favored Glycine 0 C--N 1.365 2.194 0 C-N-CA 124.571 1.081 . . . . 0.0 112.268 -169.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.41 64.91 1.56 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 126.486 1.914 . . . . 0.0 113.466 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -70.84 -9.01 56.74 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.976 1.71 . . . . 0.0 112.731 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.7 -16.8 61.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.509 1.524 . . . . 0.0 112.558 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.321 9.6 pt-20 124.2 -176.18 0.0 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.204 2.602 . . . . 0.0 107.729 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 77.3 tttt 101.49 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 127.743 2.417 . . . . 0.0 106.914 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.33 128.7 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -170.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -110.76 121.16 44.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.042 1.737 . . . . 0.0 113.316 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.37 115.68 15.16 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 128.474 2.71 . . . . 0.0 109.239 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.6 t -88.59 114.08 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.32 141.41 58.3 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.188 1.795 . . . . 0.0 110.713 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 3.9 t -116.29 146.34 42.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 126.089 1.756 . . . . 0.0 109.847 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.453 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.24 141.21 38.74 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 127.201 2.201 . . . . 0.0 110.583 -176.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.313 31.4 p 86.89 10.35 0.17 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 130.268 3.427 . . . . 0.0 114.581 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.83 -25.02 0.27 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-N 119.076 0.853 . . . . 0.0 110.751 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 58.95 166.57 0.05 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.655 1.582 . . . . 0.0 111.703 -164.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.51 51.27 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 119.387 -2.07 . . . . 0.0 109.878 -161.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 48.4 t 57.82 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 125.785 1.634 . . . . 0.0 110.646 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.84 114.14 26.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.12 -36.79 8.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.618 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 92.1 t -100.02 80.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -97.2 128.58 44.21 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.199 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -143.71 116.5 8.76 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.555 1.542 . . . . 0.0 107.369 172.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.54 84.85 0.76 Allowed Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 103.863 -3.695 . . . . 0.0 103.863 163.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.925 0 C-N-CA 124.572 1.082 . . . . 0.0 113.103 176.41 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 73.1 mt -123.49 134.2 53.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.1 161.96 26.39 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 21.1 m -124.51 127.78 73.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.18 146.57 42.86 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -114.52 -46.27 2.97 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 27.3 tp -82.17 -49.87 9.65 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.426 1.012 . . . . 0.0 112.73 -166.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.444 HG22 HH21 ' A' ' 893' ' ' ARG . 13.5 pt -84.7 -174.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.88 1.672 . . . . 0.0 110.044 -178.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.7 81.72 2.73 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -167.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 91.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.294 1.996 . . . . 0.0 109.64 163.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -121.9 144.69 48.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -92.8 157.12 16.57 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.119 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.37 123.31 21.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 119.852 1.206 . . . . 0.0 109.056 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.58 -12.03 70.73 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.184 1.849 . . . . 0.0 111.223 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.65 175.57 5.53 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.717 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.8 m -142.31 125.83 16.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -160.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.453 HG13 HH11 ' A' ' 914' ' ' ARG . 4.0 m -96.8 148.5 5.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.249 0.62 . . . . 0.0 109.331 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.5 t -143.82 138.65 28.84 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.051 1.74 . . . . 0.0 111.19 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 71.4 t -91.84 130.28 41.22 Favored 'Isoleucine or valine' 0 C--N 1.367 1.364 0 C-N-CA 126.767 2.027 . . . . 0.0 107.069 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -105.52 133.11 50.81 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 101.071 -3.677 . . . . 0.0 101.071 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 1.5 tp -129.22 72.11 1.46 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.041 -1.89 . . . . 0.0 105.975 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 58.2 t -162.83 100.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.898 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 89.6 mmm -153.59 70.01 0.83 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.77 145.21 7.24 Favored Glycine 0 CA--C 1.493 -1.304 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -112.3 -29.28 7.6 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.3 tp -92.17 87.32 6.06 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.55 -165.32 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -171.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -124.19 159.67 29.59 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -91.64 131.22 37.19 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.1 149.27 22.88 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.91 112.15 22.06 Favored Pre-proline 0 C--N 1.356 0.852 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -99.59 172.33 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.117 1.878 . . . . 0.0 108.269 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.1 mp -116.85 141.17 48.57 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.72 142.33 36.85 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 119.337 0.971 . . . . 0.0 108.562 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.95 129.5 74.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.85 105.63 9.09 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.4 p -101.02 160.55 14.28 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.914 1.286 . . . . 0.0 110.212 171.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.47 110.22 0.29 Allowed Glycine 0 C--N 1.359 1.816 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.96 144.05 46.69 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 67.6 tp -74.15 123.13 23.87 Favored 'General case' 0 C--N 1.379 1.87 0 C-N-CA 124.692 1.197 . . . . 0.0 109.402 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 33.6 tp -99.0 -57.76 2.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.4 127.47 35.49 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.85 131.01 10.53 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.183 -3.567 . . . . 0.0 104.183 164.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.94 129.5 90.87 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.663 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -107.0 80.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.783 1.672 . . . . 0.0 109.823 -168.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 77.69 -72.91 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 130.303 3.441 . . . . 0.0 109.238 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.9 mt 49.6 38.76 15.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 129.288 3.035 . . . . 0.0 114.085 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.31 131.78 54.75 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.42 107.31 9.4 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 179.462 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 N-CA-C 109.99 -0.812 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.65 119.53 21.55 Favored Pre-proline 0 C--N 1.352 0.71 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -90.78 -21.97 0.7 Allowed 'Trans proline' 0 CA--C 1.513 -0.572 0 CA-C-N 122.105 1.787 . . . . 0.0 109.758 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 38.77 69.77 0.25 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.969 2.908 . . . . 0.0 115.065 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.6 136.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.9 158.1 45.14 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -149.02 138.37 21.64 Favored 'General case' 0 C--N 1.361 1.076 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.2 t -170.42 118.61 0.55 Allowed 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.88 153.81 33.94 Favored 'General case' 0 C--N 1.371 1.51 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -135.9 158.55 44.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.157 174.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -136.11 125.08 24.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -166.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.3 m -162.45 13.43 0.07 Allowed 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.959 1.304 . . . . 0.0 107.933 -164.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -27.89 152.8 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.38 0 N-CA-C 118.219 2.674 . . . . 0.0 118.219 158.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -78.04 -42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 CA-C-N 122.01 1.754 . . . . 0.0 113.438 -164.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 16.7 ptt85 -166.65 -159.01 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.0 m -31.35 139.12 0.03 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 129.392 3.077 . . . . 0.0 115.355 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -133.12 164.4 44.23 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.94 -14.1 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.618 2.212 . . . . 0.0 111.202 -175.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.0 -138.99 2.62 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -62.83 145.26 55.42 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.81 2.044 . . . . 0.0 110.944 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 91.8 t -88.33 127.78 55.69 Favored Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 125.325 1.45 . . . . 0.0 110.161 -165.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.09 -149.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.952 3.101 . . . . 0.0 108.276 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.35 133.75 18.56 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -115.08 -14.35 11.8 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.747 0.819 . . . . 0.0 110.59 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.01 87.53 3.3 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.075 0.464 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.79 97.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 164.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' B' ' 855' ' ' ALA . 32.6 mt -87.92 -39.41 14.78 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.373 -173.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 46.5 tp -165.72 126.18 1.81 Allowed 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 100.492 -3.892 . . . . 0.0 100.492 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 176.25 60.58 0.0 OUTLIER 'General case' 0 C--N 1.356 0.859 0 CA-C-N 120.405 1.457 . . . . 0.0 108.514 -162.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.9 -43.53 94.78 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -165.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.07 -28.39 13.68 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 118.723 0.692 . . . . 0.0 112.518 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.09 -57.45 0.43 Allowed Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.96 -81.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.827 0 C-N-CA 128.095 2.558 . . . . 0.0 114.325 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -97.01 119.7 35.98 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 124.854 1.261 . . . . 0.0 108.495 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -79.36 117.58 67.84 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 115.481 -2.2 . . . . 0.0 105.322 171.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.92 6.03 3.11 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 CA-C-N 125.51 3.004 . . . . 0.0 109.28 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.88 -45.6 18.33 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.027 0.931 . . . . 0.0 108.888 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 20.7 p -110.05 -11.4 14.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.658 1.183 . . . . 0.0 108.435 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.63 33.22 Favored Glycine 0 C--N 1.363 2.069 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.66 102.79 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.73 113.13 25.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.014 -174.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -100.83 108.48 20.29 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 888' ' ' ALA . . . . . 0.46 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.57 110.92 44.61 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 117.062 -1.447 . . . . 0.0 112.825 172.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -95.92 -1.34 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 CA-C-N 123.301 2.215 . . . . 0.0 109.278 169.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 14.5 mt -53.67 -49.83 67.12 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 127.587 2.355 . . . . 0.0 114.358 -167.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.6 48.59 11.57 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.123 1.369 . . . . 0.0 114.676 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.18 -165.62 20.6 Favored Glycine 0 N--CA 1.412 -2.922 1 N-CA-C 101.534 -4.626 . . . . 0.0 101.534 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -93.44 120.38 33.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.298 2.4 p90 -116.92 161.29 19.57 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.132 0.878 . . . . 0.0 109.624 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -105.82 116.04 31.27 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.37 137.32 47.41 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.444 1.898 . . . . 0.0 108.251 -170.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.5 m -144.46 118.74 9.56 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 153.29 22.92 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.21 121.09 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.15 123.34 47.65 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.127 0.971 . . . . 0.0 108.522 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 43.9 m -78.61 131.41 36.71 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.204 1.402 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -56.76 22.03 Favored Glycine 0 C--N 1.367 2.271 0 C-N-CA 124.73 1.157 . . . . 0.0 112.601 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.5 65.17 1.48 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.552 1.941 . . . . 0.0 113.627 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -70.72 -9.14 56.59 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.017 1.727 . . . . 0.0 112.835 -168.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.88 -15.2 61.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.852 1.661 . . . . 0.0 112.763 -168.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.0 pt-20 122.52 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 128.575 2.75 . . . . 0.0 107.754 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 101.05 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 127.763 2.425 . . . . 0.0 107.126 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 81.2 t -99.82 128.05 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -170.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -108.57 121.18 44.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.202 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.24 115.1 13.76 Favored 'General case' 0 C--N 1.385 2.117 0 C-N-CA 128.21 2.604 . . . . 0.0 109.568 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.48 114.83 27.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 119.695 1.134 . . . . 0.0 108.273 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.24 142.77 57.52 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.84 2.056 . . . . 0.0 110.607 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 3.5 t -116.94 146.71 42.82 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.282 1.833 . . . . 0.0 109.656 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.46 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -79.13 140.8 37.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.936 2.094 . . . . 0.0 110.22 -177.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.31 28.5 p 87.0 8.37 0.21 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.275 3.43 . . . . 0.0 114.731 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.36 -24.93 0.29 Allowed 'General case' 0 C--N 1.356 0.865 0 CA-C-N 119.426 1.012 . . . . 0.0 111.346 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 58.87 165.12 0.04 OUTLIER 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.721 1.609 . . . . 0.0 111.767 -164.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.52 -132.71 47.61 Favored Glycine 0 C--N 1.366 2.196 0 O-C-N 119.438 -2.039 . . . . 0.0 109.599 -162.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.0 77.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.234 0 C-N-CA 126.09 1.756 . . . . 0.0 110.878 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.47 114.62 27.19 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -174.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.69 -36.84 7.74 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.8 -1.545 . . . . 0.0 108.571 -171.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.76 79.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.71 128.42 44.37 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.808 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 28.3 t -142.65 117.67 10.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.607 1.563 . . . . 0.0 107.205 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.59 84.96 0.76 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 104.312 -3.515 . . . . 0.0 104.312 165.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.898 0 C-N-CA 124.734 1.159 . . . . 0.0 113.127 176.405 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.6 m . . . . . 0 CA--C 1.508 -0.666 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.6 mt -115.75 134.2 55.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.13 26.94 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.9 129.86 74.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.86 148.91 45.83 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.1 m -120.88 -38.99 2.76 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.5 0.591 . . . . 0.0 111.995 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.1 tp -82.48 -49.09 10.3 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.351 0.978 . . . . 0.0 112.612 -168.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 42.4 pt -85.15 -175.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.699 1.599 . . . . 0.0 109.829 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 80.91 2.59 Favored Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -169.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.14 92.13 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.479 2.119 . . . . 0.0 110.026 164.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -121.44 144.46 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.95 158.36 15.85 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.828 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.84 122.78 21.33 Favored 'General case' 0 C--N 1.381 1.947 0 CA-C-N 120.147 1.339 . . . . 0.0 108.791 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.26 -11.57 71.78 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 125.868 1.699 . . . . 0.0 111.009 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.43 175.34 5.56 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.608 0.763 . . . . 0.0 110.964 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.1 m -142.56 125.71 16.39 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -159.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.451 HG13 HH11 ' B' ' 914' ' ' ARG . 4.5 m -97.5 148.62 5.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.509 0.724 . . . . 0.0 109.734 173.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -143.33 138.82 29.76 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 126.325 1.85 . . . . 0.0 111.229 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 83.3 t -91.16 130.59 40.1 Favored 'Isoleucine or valine' 0 C--N 1.368 1.413 0 C-N-CA 127.398 2.279 . . . . 0.0 107.312 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.6 133.23 50.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 100.56 -3.867 . . . . 0.0 100.56 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 1.8 tp -129.02 71.53 1.43 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.4 t -161.25 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.0 mmm -152.46 69.83 0.89 Allowed 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.58 144.51 7.09 Favored Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -111.13 -28.69 8.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.78 87.32 5.81 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.34 -164.32 1.57 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -124.55 159.42 30.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 19.0 t -90.79 130.6 36.75 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.13 149.22 22.77 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.81 112.1 22.31 Favored Pre-proline 0 C--N 1.355 0.835 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -99.32 172.36 0.45 Allowed 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 122.099 1.866 . . . . 0.0 108.139 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.1 139.3 50.44 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -138.39 140.78 39.53 Favored 'General case' 0 C--N 1.373 1.63 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.94 129.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -126.55 105.74 8.95 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 55.5 p -102.4 162.42 12.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.467 1.107 . . . . 0.0 110.989 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.53 111.35 0.32 Allowed Glycine 0 C--N 1.358 1.789 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.14 47.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -72.57 122.83 22.01 Favored 'General case' 0 C--N 1.382 2.004 0 C-N-CA 124.583 1.153 . . . . 0.0 109.387 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.9 tp -98.74 -57.84 2.09 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -131.83 127.27 36.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.65 130.67 10.37 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 165.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.87 129.0 91.45 Favored Pre-proline 0 C--N 1.351 0.674 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.532 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -106.77 78.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.016 1.756 . . . . 0.0 109.325 -167.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 77.93 -72.66 0.09 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 130.131 3.372 . . . . 0.0 109.061 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 73.6 mt 49.08 40.63 17.76 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 129.064 2.946 . . . . 0.0 113.719 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.57 131.88 55.39 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.51 106.98 8.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 179.15 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.456 -0.718 0 N-CA-C 110.038 -0.793 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.55 113.75 27.29 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.91 -22.88 1.36 Allowed 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 121.648 1.624 . . . . 0.0 110.151 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 36.8 70.19 0.18 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 128.873 2.869 . . . . 0.0 115.659 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.18 137.03 57.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.66 156.75 48.21 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 9.3 p90 -149.0 137.39 20.99 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-N 118.871 0.759 . . . . 0.0 109.23 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.9 t -171.08 118.86 0.49 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.53 153.06 37.23 Favored 'General case' 0 C--N 1.368 1.378 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.15 159.55 41.94 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.972 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.523 HD21 HD23 ' C' ' 858' ' ' LEU . 2.7 tm? -141.66 130.73 23.28 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -165.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.5 m -160.49 14.16 0.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.523 HD23 HD21 ' C' ' 856' ' ' LEU . 2.2 pp -27.5 145.9 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.532 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 161.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.64 -46.5 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 122.052 1.768 . . . . 0.0 113.634 -162.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -162.75 172.22 15.59 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.8 m -3.57 111.92 0.01 OUTLIER 'General case' 0 C--N 1.363 1.178 0 C-N-CA 130.907 3.683 . . . . 0.0 116.942 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -99.49 163.18 19.05 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 123.646 0.778 . . . . 0.0 110.56 -172.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.61 -17.2 11.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.869 2.38 . . . . 0.0 110.841 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.66 -141.45 3.25 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.3 m -66.52 146.66 54.28 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.268 1.827 . . . . 0.0 110.715 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 96.0 t -94.73 131.27 30.98 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 124.822 1.249 . . . . 0.0 111.164 -159.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -97.6 -151.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 124.087 3.192 . . . . 0.0 109.278 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -147.04 134.37 20.68 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -113.98 -16.0 12.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.353 0.661 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -102.22 84.66 2.52 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.326 0.584 . . . . 0.0 111.7 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.86 97.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.385 1.874 . . . . 0.0 106.697 163.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 8.6 mt -90.1 -38.78 13.31 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.324 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.6 tp -165.54 126.49 1.9 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 29.8 t-20 174.76 60.81 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 120.188 1.358 . . . . 0.0 107.704 -162.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.87 -42.7 94.29 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -164.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.37 -28.82 15.88 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 118.665 0.666 . . . . 0.0 112.306 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.59 -57.58 0.48 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 62.92 -81.22 0.02 OUTLIER 'General case' 0 C--N 1.354 0.782 0 C-N-CA 128.289 2.636 . . . . 0.0 114.641 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -96.02 121.02 37.32 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.534 1.534 . . . . 0.0 108.463 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.41 116.63 65.94 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -94.28 7.61 2.34 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 CA-C-N 125.167 2.881 . . . . 0.0 109.648 -166.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -79.23 -47.37 16.06 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.2 p -108.05 -9.55 15.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.932 1.293 . . . . 0.0 108.285 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.3 25.23 44.51 Favored Glycine 0 C--N 1.361 1.959 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 161.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.62 102.82 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 -163.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -94.83 111.77 23.53 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.494 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -101.8 108.21 19.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 888' ' ' ALA . . . . . 0.556 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.71 110.35 42.84 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.321 169.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -92.21 0.59 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.53 2.154 . . . . 0.0 108.21 165.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 51.6 mt -54.21 -53.23 56.41 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 127.837 2.455 . . . . 0.0 113.672 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.59 66.42 1.08 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 122.16 0.981 . . . . 0.0 110.84 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.44 170.29 43.06 Favored Glycine 0 N--CA 1.404 -3.485 1 N-CA-C 100.568 -5.013 . . . . 0.0 100.568 -167.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -93.85 115.86 28.29 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.375 -1.413 . . . . 0.0 107.968 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -116.5 160.59 20.38 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 119.088 0.858 . . . . 0.0 110.946 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 56.1 tp -107.49 113.35 26.63 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 124.685 1.194 . . . . 0.0 108.05 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.471 HD13 HH12 ' C' ' 921' ' ' ARG . 7.1 tt -118.53 140.81 49.29 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.756 1.223 . . . . 0.0 109.574 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -144.14 120.28 10.79 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.923 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.0 154.22 19.93 Favored 'General case' 0 C--N 1.364 1.208 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 80.1 t -99.57 122.96 51.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.76 122.93 39.06 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.375 1.07 . . . . 0.0 109.39 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 33.8 m -80.4 131.2 35.57 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.72 20.06 Favored Glycine 0 C--N 1.362 2.018 0 C-N-CA 125.872 1.701 . . . . 0.0 114.975 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 32.44 72.65 0.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 128.18 2.592 . . . . 0.0 115.528 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -71.69 -12.72 61.47 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 126.224 1.81 . . . . 0.0 111.552 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -73.07 -17.63 61.4 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.778 1.631 . . . . 0.0 112.502 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.2 pt-20 123.44 -172.21 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 128.498 2.719 . . . . 0.0 107.917 173.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 102.19 133.26 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 128.045 2.538 . . . . 0.0 106.706 171.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 82.3 t -98.32 123.8 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -104.27 129.8 52.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.528 1.931 . . . . 0.0 109.764 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.79 114.14 3.15 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.769 1.228 . . . . 0.0 110.427 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.7 117.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 126.136 1.774 . . . . 0.0 108.809 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.1 mt -63.3 135.9 57.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.294 1.037 . . . . 0.0 109.857 172.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 8.6 t -117.49 143.94 45.55 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 126.636 1.974 . . . . 0.0 107.145 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.556 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.1 OUTLIER -79.88 140.86 36.59 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.159 2.184 . . . . 0.0 110.593 -170.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.315 25.0 p 89.49 6.52 0.13 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 130.205 3.402 . . . . 0.0 113.93 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -149.45 -25.04 0.28 Allowed 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.234 0.924 . . . . 0.0 111.622 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.39 166.92 0.06 Allowed 'General case' 0 C--N 1.364 1.237 0 C-N-CA 125.474 1.51 . . . . 0.0 111.848 -164.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.41 -131.21 51.93 Favored Glycine 0 C--N 1.375 2.737 0 O-C-N 119.441 -2.037 . . . . 0.0 110.047 -163.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . 0.252 47.6 t 54.87 73.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.244 0 C-N-CA 125.404 1.482 . . . . 0.0 111.741 173.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.09 115.9 28.47 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -172.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.471 HH12 HD13 ' C' ' 896' ' ' LEU . 11.7 ptt180 -98.83 -33.59 10.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.744 -173.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.14 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -95.35 131.32 41.59 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.922 0.391 . . . . 0.0 111.14 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -144.26 116.02 8.23 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 125.284 1.434 . . . . 0.0 108.198 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.35 85.23 0.72 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 104.566 -3.413 . . . . 0.0 104.566 169.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.671 0 C-N-CA 125.117 1.341 . . . . 0.0 111.18 172.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.4 mt -120.91 134.32 55.29 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.05 162.77 26.37 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.58 130.17 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.28 148.85 52.73 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.299 -0.875 . . . . 0.0 109.737 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.4 m -107.48 -79.85 0.57 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.566 0.746 . . . . 0.0 109.132 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.9 tp -64.1 -49.19 73.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.322 1.849 . . . . 0.0 115.008 -163.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.39 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 126.148 1.779 . . . . 0.0 110.242 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.19 88.35 0.99 Allowed Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -168.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.51 89.86 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.724 2.283 . . . . 0.0 110.121 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 86.0 mt -124.31 147.08 48.41 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.734 1.213 . . . . 0.0 108.014 -176.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.93 158.99 15.24 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.065 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.05 122.86 20.21 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 120.29 1.405 . . . . 0.0 109.516 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.56 77.15 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 126.259 1.885 . . . . 0.0 111.822 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.47 173.85 7.38 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.888 0.875 . . . . 0.0 110.057 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 12.9 t -144.15 129.13 18.51 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.271 -0.893 . . . . 0.0 111.08 -160.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.402 HG13 ' HD3' ' C' ' 914' ' ' ARG . 27.1 m -95.38 149.18 4.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.251 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.46 137.13 33.67 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 126.181 1.793 . . . . 0.0 111.851 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.15 129.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.376 1.739 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -105.04 133.76 49.28 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 9.2 mp -126.89 81.06 1.99 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 112.794 -2.003 . . . . 0.0 107.433 168.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.0 t -158.96 98.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.2 mmm -151.87 73.38 1.06 Allowed 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.43 145.48 10.54 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 108.139 -1.985 . . . . 0.0 108.139 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -112.52 -30.95 6.95 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -91.9 87.05 6.07 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -160.84 1.1 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -172.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -122.54 156.1 34.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.5 t -92.54 133.64 35.74 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -157.34 150.07 23.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 112.11 20.35 Favored Pre-proline 0 C--N 1.357 0.913 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -101.5 175.52 0.24 Allowed 'Trans proline' 0 CA--C 1.509 -0.766 0 C-N-CA 121.877 1.718 . . . . 0.0 108.303 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -115.84 140.58 49.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 24.0 p -137.0 140.17 41.94 Favored 'General case' 0 C--N 1.376 1.749 0 CA-C-N 119.503 1.047 . . . . 0.0 108.466 -172.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.2 mm -115.94 131.26 68.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -125.56 104.78 8.59 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 33.1 p -101.62 164.07 11.94 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 125.473 1.509 . . . . 0.0 110.427 172.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.83 112.81 0.35 Allowed Glycine 0 C--N 1.359 1.824 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.76 45.71 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -77.01 124.47 27.82 Favored 'General case' 0 C--N 1.378 1.847 0 C-N-CA 125.046 1.338 . . . . 0.0 109.096 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.97 -57.51 2.21 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -132.19 127.41 35.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.71 129.83 10.06 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 104.051 -3.62 . . . . 0.0 104.051 166.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.1 129.33 90.82 Favored Pre-proline 0 C--N 1.351 0.637 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.937 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -106.74 76.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 121.948 1.731 . . . . 0.0 109.593 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.53 -72.81 0.08 Allowed 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 130.192 3.397 . . . . 0.0 108.989 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 49.56 38.7 15.34 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 129.151 2.981 . . . . 0.0 113.768 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -109.86 131.7 54.82 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -129.92 106.65 8.8 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.071 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.352 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 N-CA-C 109.678 -0.932 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.33 120.44 21.06 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.86 -20.31 0.86 Allowed 'Trans proline' 0 CA--C 1.51 -0.718 0 CA-C-N 122.204 1.823 . . . . 0.0 109.699 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 36.41 69.9 0.18 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 128.987 2.915 . . . . 0.0 115.898 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.19 137.05 54.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.94 160.25 38.88 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -149.2 138.92 21.84 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.0 t -169.37 117.27 0.62 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.9 152.88 36.69 Favored 'General case' 0 C--N 1.37 1.497 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.12 158.73 43.79 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.643 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.531 HD21 HD23 ' A' ' 858' ' ' LEU . 2.3 tm? -132.82 133.53 43.48 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 858' ' ' LEU . 40.5 p -163.21 9.51 0.05 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -164.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.531 HD23 HD21 ' A' ' 856' ' ' LEU . 2.7 pp -31.42 149.21 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.483 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 160.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.39 -43.22 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 CA-C-N 122.34 1.871 . . . . 0.0 113.527 -161.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -162.52 174.13 13.08 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.679 1.127 . . . . 0.0 108.097 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.1 m -2.34 117.01 0.01 OUTLIER 'General case' 0 C--N 1.364 1.214 0 C-N-CA 131.383 3.873 . . . . 0.0 117.103 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.06 141.57 23.68 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -164.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -73.9 -11.48 23.66 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.845 2.364 . . . . 0.0 113.44 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.83 -130.37 1.17 Allowed Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 30.6 m -82.35 143.8 31.0 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.56 131.68 33.53 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 124.594 1.157 . . . . 0.0 110.631 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -93.11 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.863 3.042 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.35 135.23 20.02 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 119.248 0.931 . . . . 0.0 108.532 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -117.83 -13.52 10.12 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 122.895 0.478 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.34 87.3 3.38 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 118.574 0.624 . . . . 0.0 112.183 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.86 97.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.144 1.777 . . . . 0.0 106.894 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.458 ' HB3' HD11 ' B' ' 953' ' ' ILE . 49.4 mt -88.22 -37.09 16.37 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.577 -0.702 . . . . 0.0 110.709 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.6 tp -165.58 125.53 1.78 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 101.138 -3.653 . . . . 0.0 101.138 161.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -174.13 61.14 0.02 OUTLIER 'General case' 0 C--N 1.356 0.886 0 CA-C-N 120.38 1.446 . . . . 0.0 109.321 -168.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.36 -44.2 92.72 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -163.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.68 -28.38 12.6 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 118.863 0.756 . . . . 0.0 112.307 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.83 -60.55 0.32 Allowed Glycine 0 C--N 1.354 1.531 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 62.47 -80.9 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.978 2.511 . . . . 0.0 114.19 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.33 119.75 32.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 124.883 1.273 . . . . 0.0 108.919 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.72 117.43 68.51 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -96.69 1.87 1.86 Allowed 'Trans proline' 0 CA--C 1.506 -0.884 0 CA-C-N 124.986 2.817 . . . . 0.0 109.3 -165.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -79.9 -45.45 18.58 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.6 p -102.84 -13.99 16.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.103 0.961 . . . . 0.0 108.72 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 24.01 47.47 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.94 102.61 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -164.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 112.75 24.94 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 112.181 -2.281 . . . . 0.0 108.656 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 82.5 m -98.97 108.94 21.75 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 888' ' ' ALA . . . . . 0.435 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -89.62 110.76 41.62 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.745 173.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.56 -4.88 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.08 2.136 . . . . 0.0 108.98 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 33.1 mt -49.06 -55.2 12.84 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 128.664 2.786 . . . . 0.0 114.612 -168.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.9 65.25 1.35 Allowed 'General case' 0 C--N 1.364 1.223 0 CA-C-O 121.926 0.869 . . . . 0.0 112.085 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.09 -175.53 42.63 Favored Glycine 0 N--CA 1.408 -3.21 1 N-CA-C 101.034 -4.826 . . . . 0.0 101.034 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.22 121.9 35.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.45 160.43 19.19 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 118.918 0.781 . . . . 0.0 108.965 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 59.7 tp -103.84 117.11 33.56 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.429 0.691 . . . . 0.0 109.698 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.87 136.3 50.11 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 126.762 2.025 . . . . 0.0 108.88 -165.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.2 m -147.17 119.17 8.18 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.597 0.759 . . . . 0.0 109.501 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 154.22 21.56 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 79.0 t -109.3 119.18 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.78 124.33 46.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.992 -173.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 33.7 m -80.48 133.27 35.81 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.34 1.456 . . . . 0.0 107.547 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.9 -57.11 21.58 Favored Glycine 0 C--N 1.364 2.137 0 C-N-CA 125.003 1.287 . . . . 0.0 114.214 -169.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 61.9 m170 35.37 72.73 0.09 Allowed 'General case' 0 C--N 1.361 1.087 0 C-N-CA 127.387 2.275 . . . . 0.0 115.266 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -73.74 -8.38 55.77 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.17 1.388 . . . . 0.0 111.72 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -71.92 -19.93 61.85 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.043 1.337 . . . . 0.0 112.49 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.319 9.3 pt-20 125.03 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.137 0 C-N-CA 128.232 2.613 . . . . 0.0 108.333 174.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 101.01 131.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.846 2.459 . . . . 0.0 106.753 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.31 124.91 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 123.512 1.625 . . . . 0.0 106.839 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -105.68 122.44 46.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.207 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.05 116.46 17.1 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 128.307 2.643 . . . . 0.0 108.769 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.62 113.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.09 142.17 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.538 1.535 . . . . 0.0 111.194 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -115.0 145.09 42.62 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 127.007 2.123 . . . . 0.0 109.086 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.435 HH22 ' HB3' ' A' ' 888' ' ' ALA . 0.0 OUTLIER -79.52 139.22 37.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 127.791 2.436 . . . . 0.0 109.429 -178.173 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.4 t 100.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.35 0.595 0 C-N-CA 129.463 3.105 . . . . 0.0 113.229 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -144.53 -24.41 0.52 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 119.486 1.039 . . . . 0.0 110.958 -175.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 60.18 167.43 0.08 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 124.886 1.274 . . . . 0.0 111.833 -164.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.6 -133.62 52.66 Favored Glycine 0 C--N 1.375 2.729 0 O-C-N 119.279 -2.138 . . . . 0.0 109.891 -161.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 46.7 t 56.6 75.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.295 0 C-N-CA 125.523 1.529 . . . . 0.0 110.99 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.57 115.22 27.71 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -103.05 -35.11 8.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.309 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 88.6 t -99.57 75.77 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.95 130.3 41.65 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.129 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.6 t -143.08 114.49 7.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.379 1.472 . . . . 0.0 108.411 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.54 84.82 0.69 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.882 -3.687 . . . . 0.0 103.882 163.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.859 0 C-N-CA 124.965 1.269 . . . . 0.0 112.708 174.42 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.443 -0.796 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 59.8 mt -117.71 133.54 55.84 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.33 161.33 26.05 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.5 m -125.25 126.3 70.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.77 149.44 43.55 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -115.02 -41.97 3.27 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.59 -50.17 9.07 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 119.373 0.988 . . . . 0.0 113.133 -166.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 8.2 pt -85.09 -171.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 125.371 1.469 . . . . 0.0 110.74 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.482 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -159.25 81.52 2.57 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -168.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.18 90.84 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 CA-C-N 122.06 1.772 . . . . 0.0 109.536 160.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 954' ' ' LEU . 8.3 mp -122.01 145.06 48.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -90.98 158.03 16.95 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.464 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.25 123.62 22.65 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-N 119.689 1.131 . . . . 0.0 108.715 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.01 69.9 Favored Glycine 0 CA--C 1.495 -1.2 0 C-N-CA 125.85 1.69 . . . . 0.0 110.999 170.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.11 175.64 5.08 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.025 0.44 . . . . 0.0 112.102 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 94.9 m -140.67 128.32 21.57 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -155.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 962' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.83 149.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -144.24 136.75 26.76 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.247 1.019 . . . . 0.0 111.65 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.21 129.75 44.06 Favored 'Isoleucine or valine' 0 C--N 1.369 1.453 0 C-N-CA 126.868 2.067 . . . . 0.0 107.245 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -107.92 132.29 53.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 168.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 21.0 tp -130.29 75.88 1.68 Allowed 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.212 -1.813 . . . . 0.0 107.045 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.8 t -160.81 101.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.06 71.79 0.92 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.71 150.57 8.3 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -119.06 -29.01 5.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.1 tp -92.25 87.07 5.94 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.5 -163.85 1.5 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -125.08 160.71 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.1 t -94.33 132.06 39.33 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -158.09 150.52 22.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.59 113.33 25.24 Favored Pre-proline 0 C--N 1.356 0.86 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -98.77 173.65 0.47 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.842 1.694 . . . . 0.0 108.365 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.43 141.49 48.27 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.6 p -139.59 142.06 37.13 Favored 'General case' 0 C--N 1.376 1.736 0 CA-C-N 119.592 1.087 . . . . 0.0 108.909 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.7 mm -119.61 129.81 74.88 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -126.15 105.77 9.09 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 44.6 p -101.25 161.92 13.26 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.816 1.246 . . . . 0.0 110.39 171.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.88 111.1 0.29 Allowed Glycine 0 C--N 1.358 1.764 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.1 144.93 46.34 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.01 123.4 25.69 Favored 'General case' 0 C--N 1.378 1.825 0 C-N-CA 124.763 1.225 . . . . 0.0 109.507 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 30.4 tp -98.23 -57.06 2.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -130.92 128.01 39.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.35 129.96 10.09 Favored Glycine 0 CA--C 1.487 -1.706 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 164.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 129.0 91.84 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -107.64 81.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 CA-C-N 121.835 1.691 . . . . 0.0 110.071 -169.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 77.76 -72.48 0.09 Allowed 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.12 3.368 . . . . 0.0 109.313 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 67.9 mt 49.41 38.81 14.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 128.841 2.856 . . . . 0.0 114.411 -176.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.86 131.09 55.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -128.09 109.41 11.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.099 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 179.321 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.961 0 N-CA-C 109.615 -0.956 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.62 121.17 22.11 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -92.45 -20.53 0.55 Allowed 'Trans proline' 0 CA--C 1.512 -0.581 0 CA-C-N 122.238 1.835 . . . . 0.0 110.037 -173.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 37.8 70.22 0.2 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 129.155 2.982 . . . . 0.0 115.532 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.94 136.82 54.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.6 40.69 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 165.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -149.22 139.19 22.03 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -169.17 117.87 0.66 Allowed 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.15 153.55 34.69 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -139.13 158.14 44.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.196 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.564 HD21 HD23 ' B' ' 858' ' ' LEU . 2.1 tm? -132.07 132.11 43.03 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -169.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.428 ' H ' ' H ' ' B' ' 858' ' ' LEU . 30.1 p -162.65 8.26 0.06 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -164.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.564 HD23 HD21 ' B' ' 856' ' ' LEU . 2.6 pp -31.44 149.94 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.441 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 161.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -81.75 -43.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.223 1.83 . . . . 0.0 113.494 -161.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -162.41 173.86 13.52 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 119.727 1.149 . . . . 0.0 108.201 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.9 m -1.77 116.81 0.01 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 131.398 3.879 . . . . 0.0 117.126 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -108.91 141.52 23.53 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -164.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -73.87 -11.57 23.75 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 122.801 2.334 . . . . 0.0 113.498 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.5 -130.71 1.19 Allowed Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 30.9 m -81.37 143.38 32.21 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.84 131.24 36.05 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 110.484 -160.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -94.15 -152.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.755 2.97 . . . . 0.0 109.248 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -148.38 135.21 19.97 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 119.156 0.889 . . . . 0.0 108.611 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -115.18 -13.22 11.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.387 1.075 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -100.77 87.62 3.37 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 118.208 0.458 . . . . 0.0 112.204 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.32 97.11 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 163.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' B' ' 855' ' ' ALA . 19.6 mt -88.14 -38.69 15.15 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.31 -173.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.7 tp -165.88 126.63 1.81 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 100.869 -3.752 . . . . 0.0 100.869 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 176.86 60.93 0.0 OUTLIER 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.196 1.362 . . . . 0.0 108.515 -163.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.46 -43.77 93.11 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -166.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.27 -29.68 10.99 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.889 0.768 . . . . 0.0 112.335 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.86 -59.54 0.35 Allowed Glycine 0 C--N 1.352 1.457 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 62.83 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.905 2.482 . . . . 0.0 114.408 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -96.07 119.59 34.84 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.924 1.29 . . . . 0.0 108.67 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.46 117.42 68.39 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 2.47 2.46 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 CA-C-N 125.077 2.849 . . . . 0.0 109.518 -166.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.04 -43.88 21.1 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 30.4 p -105.54 -14.29 15.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.443 1.097 . . . . 0.0 108.171 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 25.56 41.35 Favored Glycine 0 C--N 1.36 1.888 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 163.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.48 102.84 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 101.867 -3.382 . . . . 0.0 101.867 -163.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.89 113.24 25.29 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.837 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 70.6 m -99.61 109.31 21.82 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 888' ' ' ALA . . . . . 0.447 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -89.12 111.03 42.55 Favored Pre-proline 0 C--N 1.356 0.882 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.91 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.36 -4.24 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-N 123.133 2.155 . . . . 0.0 109.192 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 21.6 mt -53.52 -49.46 67.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.184 2.193 . . . . 0.0 114.334 -167.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.56 50.61 12.55 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.627 1.571 . . . . 0.0 114.183 171.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -164.26 -165.87 22.21 Favored Glycine 0 N--CA 1.411 -3.008 1 N-CA-C 101.517 -4.633 . . . . 0.0 101.517 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -92.74 121.68 34.37 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.985 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 2.6 p90 -116.47 160.68 20.25 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 119.023 0.829 . . . . 0.0 109.269 176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.6 tp -104.72 116.0 31.28 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.26 135.7 50.61 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 126.332 1.853 . . . . 0.0 107.801 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.3 m -144.92 118.97 9.39 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.57 153.91 22.18 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 97.5 t -109.98 120.76 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.17 122.6 46.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.986 0.914 . . . . 0.0 108.812 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 32.5 m -79.29 133.35 36.64 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.258 1.423 . . . . 0.0 108.0 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.16 -57.2 21.09 Favored Glycine 0 C--N 1.365 2.167 0 C-N-CA 125.216 1.388 . . . . 0.0 114.267 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 61.3 m170 34.99 72.96 0.09 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.451 2.3 . . . . 0.0 115.186 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.66 -8.15 54.85 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.291 1.436 . . . . 0.0 111.674 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -73.18 -14.53 61.37 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.425 1.49 . . . . 0.0 112.631 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.7 pt-20 118.59 179.45 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 128.587 2.755 . . . . 0.0 108.77 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 102.08 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.057 2.543 . . . . 0.0 106.467 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.22 128.4 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -110.63 122.87 48.84 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.881 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.35 115.41 15.56 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.053 2.541 . . . . 0.0 109.932 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.47 114.18 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 O-C-N 120.216 -1.553 . . . . 0.0 106.863 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.28 144.9 56.54 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.454 1.902 . . . . 0.0 111.358 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -115.61 145.95 42.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 127.196 2.198 . . . . 0.0 109.038 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.447 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -81.13 138.96 35.88 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 126.828 2.051 . . . . 0.0 109.231 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.6 t 100.85 -10.82 0.03 OUTLIER 'General case' 0 C--N 1.35 0.591 0 C-N-CA 129.589 3.155 . . . . 0.0 113.383 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.44 -24.38 0.72 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 119.493 1.042 . . . . 0.0 111.293 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 60.19 168.41 0.08 Allowed 'General case' 0 C--N 1.362 1.115 0 C-N-CA 124.898 1.279 . . . . 0.0 111.541 -163.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -132.37 51.64 Favored Glycine 0 C--N 1.368 2.34 0 O-C-N 119.763 -1.836 . . . . 0.0 109.702 -164.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 48.7 t 54.74 76.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.169 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.03 115.17 27.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -103.87 -35.22 8.24 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.368 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.1 t -99.89 75.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.89 129.66 44.3 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.516 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -141.34 115.42 9.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 125.319 1.448 . . . . 0.0 107.306 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.91 84.76 0.73 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.098 -3.601 . . . . 0.0 104.098 164.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.812 0 C-N-CA 124.916 1.246 . . . . 0.0 112.808 175.484 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 56.3 mt -115.65 133.98 55.5 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -168.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.2 162.77 26.8 Favored Glycine 0 CA--C 1.494 -1.219 0 C-N-CA 124.731 1.158 . . . . 0.0 110.215 -173.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 28.5 m -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -139.55 150.05 44.62 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.7 m -123.0 -30.77 3.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.723 0.692 . . . . 0.0 112.448 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.6 tp -85.88 -51.15 6.58 Favored 'General case' 0 C--N 1.358 0.94 0 CA-C-N 119.648 1.113 . . . . 0.0 112.115 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 872' ' ' LEU . 38.6 pt -84.8 -175.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.39 1.476 . . . . 0.0 110.133 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.492 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -158.06 80.9 3.04 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -170.372 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.24 92.32 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.271 1.98 . . . . 0.0 109.932 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' B' ' 954' ' ' LEU . 9.6 mp -121.59 144.73 48.57 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -89.91 159.23 17.04 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.334 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.45 123.48 23.19 Favored 'General case' 0 C--N 1.377 1.773 0 CA-C-N 119.769 1.168 . . . . 0.0 108.379 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.64 70.8 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 125.635 1.588 . . . . 0.0 110.92 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.36 175.31 5.53 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 121.631 0.729 . . . . 0.0 111.324 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 96.1 m -141.35 128.59 21.0 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.513 0.725 . . . . 0.0 109.095 -153.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 962' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.9 149.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-O 121.466 0.65 . . . . 0.0 109.476 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -143.99 136.67 27.08 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.724 1.209 . . . . 0.0 111.135 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.0 t -93.51 130.51 42.41 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 127.593 2.357 . . . . 0.0 107.401 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -107.25 132.12 53.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 19.7 tp -129.65 75.33 1.64 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.471 -1.695 . . . . 0.0 106.805 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.8 t -159.22 103.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.8 mmm -152.37 70.03 0.9 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 124.24 148.02 7.33 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -116.04 -27.96 6.77 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.52 86.68 5.29 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.36 -164.2 1.56 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -124.56 159.23 31.12 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.9 t -92.31 132.05 37.02 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -158.47 150.7 21.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.54 113.2 25.37 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -98.31 173.04 0.56 Allowed 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 121.853 1.702 . . . . 0.0 108.283 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.62 140.16 49.71 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.54 141.67 39.29 Favored 'General case' 0 C--N 1.374 1.647 0 CA-C-N 119.616 1.098 . . . . 0.0 108.663 -171.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 130.45 72.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -127.37 105.54 8.6 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 52.2 p -102.65 162.77 12.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.687 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.66 112.56 0.34 Allowed Glycine 0 C--N 1.359 1.825 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -121.61 145.98 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.8 tp -72.58 123.79 23.92 Favored 'General case' 0 C--N 1.381 1.971 0 C-N-CA 124.422 1.089 . . . . 0.0 109.763 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.82 -56.95 2.35 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -131.14 127.31 37.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.32 129.54 9.94 Favored Glycine 0 CA--C 1.487 -1.66 0 N-CA-C 103.379 -3.888 . . . . 0.0 103.379 163.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.41 128.84 90.9 Favored Pre-proline 0 C--N 1.349 0.555 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.122 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -107.0 81.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.782 1.672 . . . . 0.0 109.462 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 78.04 -71.73 0.1 Allowed 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 129.818 3.247 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 56.7 mt 49.16 40.49 17.81 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 128.668 2.787 . . . . 0.0 114.02 -175.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -114.13 131.48 56.41 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.16 109.19 10.95 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.074 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 179.062 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.05 112.85 31.59 Favored Pre-proline 0 N--CA 1.443 -0.801 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -88.35 -21.6 1.48 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.617 1.613 . . . . 0.0 110.161 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 35.93 70.86 0.14 Allowed 'General case' 0 C--N 1.357 0.901 0 C-N-CA 129.161 2.984 . . . . 0.0 115.679 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.29 134.81 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.51 161.93 33.67 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -148.75 146.76 28.21 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 166.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.3 t -166.83 119.25 0.97 Allowed 'General case' 0 C--N 1.35 0.588 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.53 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.07 154.87 40.69 Favored 'General case' 0 C--N 1.371 1.531 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -143.11 155.58 44.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 122.201 1.0 . . . . 0.0 109.537 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.553 HD21 HD23 ' C' ' 858' ' ' LEU . 2.2 tm? -131.62 127.6 37.38 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.436 -166.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.2 m -158.8 12.78 0.16 Allowed 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -164.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.553 HD23 HD21 ' C' ' 856' ' ' LEU . 2.3 pp -27.71 146.18 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 160.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.78 -44.82 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 122.245 1.837 . . . . 0.0 113.332 -161.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.0 ptt85 -164.28 173.75 11.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -173.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.7 m -4.38 112.56 0.01 OUTLIER 'General case' 0 C--N 1.365 1.242 0 C-N-CA 130.826 3.651 . . . . 0.0 116.436 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.93 162.54 25.14 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -167.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.34 -14.99 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.378 2.052 . . . . 0.0 111.163 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.33 -144.2 4.05 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 28.1 m -64.96 136.14 56.46 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.986 1.715 . . . . 0.0 110.492 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 16.6 m -64.89 143.66 98.87 Favored Pre-proline 0 C--N 1.354 0.78 0 C-N-CA 125.444 1.497 . . . . 0.0 113.2 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -98.7 -151.75 0.03 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.572 0 C-N-CA 123.296 2.664 . . . . 0.0 107.478 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -146.05 130.11 17.4 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -115.93 -15.67 11.19 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.159 0.584 . . . . 0.0 111.08 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -103.23 79.71 1.76 Allowed 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.937 0.495 . . . . 0.0 111.669 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.08 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 127.063 2.145 . . . . 0.0 106.973 165.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 3.3 mt -90.75 -37.16 13.86 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.327 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 60.5 tp -164.64 128.2 2.45 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 172.34 61.96 0.0 OUTLIER 'General case' 0 C--N 1.356 0.854 0 CA-C-N 120.653 1.57 . . . . 0.0 106.973 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.32 98.02 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 116.085 1.884 . . . . 0.0 116.085 -165.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.77 -32.91 8.73 Favored Glycine 0 C--N 1.357 1.728 0 CA-C-N 119.028 0.831 . . . . 0.0 112.076 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.51 -65.01 0.26 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 64.24 -79.13 0.03 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.931 2.492 . . . . 0.0 114.517 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.59 121.87 36.59 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.804 1.642 . . . . 0.0 109.283 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -80.57 118.4 72.25 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 115.611 -2.137 . . . . 0.0 105.884 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -92.42 0.88 4.0 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 CA-C-N 125.514 3.005 . . . . 0.0 109.517 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.6 -45.66 18.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.244 1.018 . . . . 0.0 108.9 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.3 p -106.41 -13.4 15.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.702 1.601 . . . . 0.0 108.17 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 86.24 25.23 37.48 Favored Glycine 0 C--N 1.361 1.949 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.728 162.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.54 101.29 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 -165.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.29 112.82 24.47 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 112.45 -2.159 . . . . 0.0 108.387 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 67.6 m -101.11 107.83 19.36 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 888' ' ' ALA . . . . . 0.617 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -90.95 111.79 50.16 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.247 -1.358 . . . . 0.0 111.602 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.05 2.69 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.094 2.141 . . . . 0.0 109.067 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.01 -54.21 45.95 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.545 -167.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.8 68.5 0.83 Allowed 'General case' 0 C--N 1.366 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 111.825 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.77 36.78 Favored Glycine 0 N--CA 1.406 -3.318 1 N-CA-C 102.089 -4.404 . . . . 0.0 102.089 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -92.72 119.19 31.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.797 -1.202 . . . . 0.0 108.26 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.452 ' H ' HD11 ' C' ' 954' ' ' LEU . 8.8 t80 -118.19 146.52 44.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.41 116.23 30.59 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 124.222 1.009 . . . . 0.0 109.086 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 7.3 tt -114.42 139.77 49.23 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.016 1.326 . . . . 0.0 109.365 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.1 119.15 10.04 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.484 0.714 . . . . 0.0 109.903 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.38 154.57 21.65 Favored 'General case' 0 C--N 1.365 1.249 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.67 122.36 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.05 123.73 42.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.251 1.02 . . . . 0.0 109.617 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.0 m -83.16 131.36 35.13 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.68 -56.42 20.34 Favored Glycine 0 C--N 1.364 2.109 0 C-N-CA 125.611 1.577 . . . . 0.0 114.762 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 63.6 m170 32.04 72.34 0.07 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 127.946 2.498 . . . . 0.0 115.609 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -74.27 -9.5 58.66 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.967 1.307 . . . . 0.0 111.371 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.96 -18.33 62.01 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.297 1.439 . . . . 0.0 112.568 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.294 12.1 pt-20 124.63 -175.34 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 128.528 2.731 . . . . 0.0 107.783 174.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 100.88 131.32 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 127.696 2.398 . . . . 0.0 106.554 170.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 71.2 t -99.21 123.49 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -105.15 122.72 46.5 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.509 167.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -131.07 117.15 18.72 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.371 2.668 . . . . 0.0 109.607 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.415 HG11 HH21 ' C' ' 921' ' ' ARG . 87.1 t -90.1 113.01 25.53 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 144.6 53.58 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.796 1.639 . . . . 0.0 111.58 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.285 1.0 OUTLIER -115.31 147.24 40.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.721 2.008 . . . . 0.0 108.893 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.617 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.6 OUTLIER -80.34 138.83 36.76 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 127.301 2.241 . . . . 0.0 110.123 -177.327 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 94.19 -2.64 0.1 Allowed 'General case' 0 C--N 1.348 0.537 0 C-N-CA 129.21 3.004 . . . . 0.0 112.701 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -144.17 -26.41 0.53 Allowed 'General case' 0 C--N 1.358 0.95 0 O-C-N 120.904 -1.122 . . . . 0.0 111.819 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 58.89 168.31 0.06 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.197 1.399 . . . . 0.0 111.583 -162.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.72 51.4 Favored Glycine 0 C--N 1.375 2.697 0 O-C-N 119.576 -1.953 . . . . 0.0 109.855 -165.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 51.66 76.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.214 0 C-N-CA 126.197 1.799 . . . . 0.0 111.322 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.39 114.71 26.89 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -170.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.415 HH21 HG11 ' C' ' 911' ' ' VAL . 12.6 ptt180 -99.12 -38.69 8.83 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.413 -170.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 86.6 t -100.28 82.68 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.72 132.02 39.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.11 0.481 . . . . 0.0 110.49 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 20.7 t -142.75 115.29 8.56 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 108.631 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.25 84.54 0.7 Allowed Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 104.823 -3.311 . . . . 0.0 104.823 166.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.597 0 C-N-CA 125.89 1.709 . . . . 0.0 111.453 174.378 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -121.02 134.02 55.28 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.92 163.45 26.97 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.69 130.94 73.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.39 148.72 49.45 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -116.36 -39.77 3.33 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 31.4 tp -93.04 -55.15 3.45 Favored 'General case' 0 C--N 1.356 0.863 0 O-C-N 121.57 -0.706 . . . . 0.0 111.747 -166.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.3 -161.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 C-N-CA 125.117 1.367 . . . . 0.0 109.737 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.452 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -170.72 91.55 0.47 Allowed Pre-proline 0 C--N 1.358 0.948 0 O-C-N 121.794 -0.566 . . . . 0.0 110.033 -166.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.33 90.61 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 123.247 2.195 . . . . 0.0 109.569 158.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 89.1 mt -123.36 145.83 48.43 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -95.15 159.7 14.89 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-N 118.858 0.753 . . . . 0.0 109.33 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.61 122.67 20.94 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 120.104 1.32 . . . . 0.0 109.411 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 88.79 -8.39 79.59 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 125.896 1.713 . . . . 0.0 111.923 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.14 173.75 8.1 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.946 0.898 . . . . 0.0 109.709 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 81.9 m -142.33 126.21 17.16 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -156.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.464 HG13 HH11 ' C' ' 914' ' ' ARG . 34.8 m -94.99 150.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 123.722 0.809 . . . . 0.0 109.197 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.0 t -140.13 139.46 35.79 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 125.9 1.68 . . . . 0.0 112.195 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.03 128.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.588 0 C-N-CA 126.42 1.888 . . . . 0.0 106.727 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.6 131.36 54.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 25.0 tp -131.92 76.89 1.73 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.284 -1.78 . . . . 0.0 107.617 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 58.3 t -159.03 100.0 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -149.34 83.81 1.43 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.78 149.3 16.14 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -117.4 -17.67 10.04 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.651 0.781 . . . . 0.0 110.374 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.0 tp -99.74 85.4 3.1 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.82 1.66 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -171.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -121.37 157.58 30.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.54 131.5 36.93 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.74 152.8 23.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -125.73 113.97 24.86 Favored Pre-proline 0 C--N 1.356 0.858 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -96.45 170.48 1.04 Allowed 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 121.839 1.693 . . . . 0.0 107.861 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.56 138.38 50.72 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -135.62 138.32 42.78 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 119.488 1.04 . . . . 0.0 108.299 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.62 130.59 69.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -128.9 101.18 5.97 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 24.4 p -100.68 163.83 12.15 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.6 1.56 . . . . 0.0 109.115 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.8 113.44 0.37 Allowed Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.0 42.62 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 66.3 tp -78.53 125.27 29.13 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.481 1.513 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 12.5 tp -97.49 -56.8 2.42 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 121.993 0.117 . . . . 0.0 110.713 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -131.09 128.36 40.03 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -175.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.41 129.34 9.86 Favored Glycine 0 CA--C 1.486 -1.725 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 163.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.47 132.11 89.65 Favored Pre-proline 0 C--N 1.349 0.563 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.478 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -106.38 79.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 121.305 1.502 . . . . 0.0 109.171 -170.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.98 -72.04 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.019 3.328 . . . . 0.0 109.056 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.9 mt 49.77 39.48 18.03 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 128.678 2.791 . . . . 0.0 113.761 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -112.32 131.42 55.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -128.34 108.97 11.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 179.206 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.455 -0.776 0 N-CA-C 110.021 -0.8 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.87 120.05 24.15 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.69 -21.0 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 122.146 1.802 . . . . 0.0 109.566 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 36.86 70.03 0.19 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 129.103 2.961 . . . . 0.0 115.631 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 87.3 t -118.78 136.5 55.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 158.81 43.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 162.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 8.1 p90 -149.44 138.56 21.32 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 28.8 t -169.1 117.15 0.65 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.5 152.36 36.09 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.67 157.58 46.53 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.537 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 858' ' ' LEU . 2.6 tm? -131.59 131.52 43.34 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -166.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 41.7 p -160.32 16.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -165.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 856' ' ' LEU . 3.4 pp -21.73 144.1 0.02 OUTLIER Pre-proline 0 C--N 1.37 1.464 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 159.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.8 -43.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 122.093 1.783 . . . . 0.0 111.995 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -164.28 176.67 8.94 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 17.1 m -19.22 120.21 0.02 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.651 3.18 . . . . 0.0 115.656 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -127.67 144.22 50.35 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 -163.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.66 -10.34 17.12 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 122.685 1.995 . . . . 0.0 113.586 -159.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -158.07 -142.05 3.3 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 20.3 m -63.31 145.38 55.68 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 110.47 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.1 128.79 50.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.857 1.263 . . . . 0.0 110.307 -165.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -94.45 -152.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.28 3.32 . . . . 0.0 108.489 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -149.28 135.13 18.81 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -118.33 -13.65 9.81 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 122.753 0.421 . . . . 0.0 111.608 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -100.17 86.73 3.28 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 118.609 0.641 . . . . 0.0 112.545 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 871' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 874' ' ' ASN . 54.0 t -71.92 97.65 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.831 1.652 . . . . 0.0 107.013 168.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.36 -37.21 17.3 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.946 -172.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 29.2 tp -165.4 127.64 2.09 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 101.959 -3.349 . . . . 0.0 101.959 160.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 26.9 t-20 -174.8 60.84 0.02 OUTLIER 'General case' 0 C--N 1.356 0.877 0 CA-C-N 120.553 1.524 . . . . 0.0 110.336 -166.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -58.87 -43.99 90.97 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -166.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.35 -27.23 12.19 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 118.928 0.785 . . . . 0.0 112.747 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -57.76 0.41 Allowed Glycine 0 C--N 1.352 1.465 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.07 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.354 0.804 0 C-N-CA 128.098 2.559 . . . . 0.0 114.746 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -96.78 119.14 34.7 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.21 116.05 62.28 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -95.95 4.88 2.03 Favored 'Trans proline' 0 CA--C 1.505 -0.93 0 CA-C-N 124.405 2.609 . . . . 0.0 109.407 -160.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -79.93 -45.81 17.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.1 p -106.01 -10.43 16.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.348 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.41 28.06 37.48 Favored Glycine 0 C--N 1.366 2.201 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 161.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 22.9 t -101.6 103.05 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 -162.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.468 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.4 OUTLIER -102.03 111.13 23.28 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 112.434 -2.166 . . . . 0.0 109.464 -173.045 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 83.9 m -99.99 107.53 19.5 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 888' ' ' ALA . . . . . 0.461 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.12 111.41 46.64 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 117.106 -1.426 . . . . 0.0 112.2 169.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.0 -1.24 5.62 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.781 2.321 . . . . 0.0 109.126 166.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -49.13 -54.82 14.49 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 128.856 2.862 . . . . 0.0 115.127 -167.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.47 48.69 14.11 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.63 -161.77 10.74 Favored Glycine 0 N--CA 1.417 -2.578 1 N-CA-C 102.636 -4.185 . . . . 0.0 102.636 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.557 ' HE ' HG22 ' A' ' 953' ' ' ILE . 67.7 ttt-85 -89.92 120.89 31.53 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.472 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.3 t80 -115.58 144.87 43.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -174.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -109.78 116.81 32.35 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.704 0.801 . . . . 0.0 109.871 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.1 140.02 48.83 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.091 1.756 . . . . 0.0 109.049 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -143.98 119.74 10.52 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.526 0.73 . . . . 0.0 109.812 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.47 153.95 22.07 Favored 'General case' 0 C--N 1.367 1.344 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.31 121.07 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.36 123.59 43.77 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.209 -172.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 41.8 m -83.38 131.33 35.06 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.39 -58.07 16.47 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 125.124 1.345 . . . . 0.0 114.107 -169.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 38.25 69.81 0.23 Allowed 'General case' 0 C--N 1.36 1.065 0 C-N-CA 127.085 2.154 . . . . 0.0 114.708 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -73.23 -8.97 58.12 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.161 1.384 . . . . 0.0 111.284 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.33 -19.44 61.65 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.814 1.246 . . . . 0.0 112.486 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.301 13.9 pt-20 127.56 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.161 2.584 . . . . 0.0 108.424 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.7 tttt 102.05 131.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.885 2.474 . . . . 0.0 107.386 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.7 t -99.51 125.38 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 123.306 1.527 . . . . 0.0 106.932 -172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -112.41 122.17 46.94 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.134 -1.848 . . . . 0.0 113.004 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.9 116.81 16.93 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 128.346 2.658 . . . . 0.0 108.538 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.78 112.77 23.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.08 145.67 52.57 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.647 1.579 . . . . 0.0 111.901 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.306 0.8 OUTLIER -114.81 148.87 37.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 126.588 1.955 . . . . 0.0 110.732 177.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.587 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.33 138.75 38.72 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.948 2.099 . . . . 0.0 109.744 176.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 96.85 -1.22 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 128.816 2.846 . . . . 0.0 112.319 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -147.89 -26.05 0.35 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.108 -0.995 . . . . 0.0 110.634 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 57.92 171.36 0.05 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.194 1.397 . . . . 0.0 111.521 -162.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.44 -133.6 52.63 Favored Glycine 0 C--N 1.373 2.592 0 O-C-N 119.376 -2.078 . . . . 0.0 110.104 -163.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 948' ' ' GLY . 58.5 t 56.32 77.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 126.036 1.735 . . . . 0.0 111.485 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.2 115.17 27.84 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -102.6 -34.09 9.22 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.601 -172.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 95.4 t -99.34 87.24 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 103.252 -2.869 . . . . 0.0 103.252 166.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -94.84 131.18 41.01 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 116.31 9.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.343 1.457 . . . . 0.0 107.714 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.41 85.03 0.71 Allowed Glycine 0 CA--C 1.485 -1.814 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 162.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.62 0 C-N-CA 124.812 1.196 . . . . 0.0 110.987 172.663 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.69 134.34 52.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 948' ' ' GLY . . . . . 0.465 ' H ' HG22 ' A' ' 919' ' ' VAL . . . -139.7 163.81 26.12 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -174.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.29 132.96 70.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.05 147.46 46.19 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 55.1 m -117.62 -40.98 2.97 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 36.4 tp -89.27 -54.21 4.21 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.666 0.666 . . . . 0.0 112.082 -165.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.557 HG22 ' HE ' ' A' ' 893' ' ' ARG . 16.3 pt -85.41 -155.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.883 0 C-N-CA 124.724 1.21 . . . . 0.0 110.278 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.472 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -170.07 85.71 0.57 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 C-N-CA 122.981 0.513 . . . . 0.0 109.934 -165.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.14 89.99 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 122.656 1.984 . . . . 0.0 109.538 159.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.78 145.83 48.07 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.568 2.347 . . . . 0.0 105.022 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -92.62 157.16 16.64 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-N 119.444 1.02 . . . . 0.0 108.705 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.27 123.83 23.15 Favored 'General case' 0 C--N 1.37 1.495 0 CA-C-N 119.749 1.159 . . . . 0.0 108.949 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.46 -13.17 67.78 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 125.884 1.707 . . . . 0.0 111.019 170.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.16 176.19 5.38 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.052 0.541 . . . . 0.0 111.697 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 77.7 m -141.74 127.17 18.82 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -157.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.587 HG13 HH11 ' A' ' 914' ' ' ARG . 10.5 m -94.9 149.72 4.37 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 121.642 0.734 . . . . 0.0 109.909 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.6 m -139.38 137.17 35.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.139 1.775 . . . . 0.0 111.011 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 89.5 t -92.82 129.19 43.73 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 C-N-CA 126.61 1.964 . . . . 0.0 106.666 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -108.35 131.07 55.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.98 77.82 1.81 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 53.0 t -161.21 101.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.848 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -152.3 72.42 0.99 Allowed 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.04 149.42 8.55 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -117.01 -28.75 6.17 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.805 0.842 . . . . 0.0 108.748 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.2 tp -92.6 86.51 5.62 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.37 -164.13 1.54 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -125.29 160.21 29.83 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -93.22 132.07 37.72 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.57 150.01 22.75 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.23 113.58 23.71 Favored Pre-proline 0 C--N 1.355 0.844 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -97.95 172.34 0.64 Allowed 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 108.369 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.17 140.43 49.53 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -140.45 142.25 35.39 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 119.51 1.05 . . . . 0.0 108.757 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.81 129.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -125.81 106.85 9.98 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 52.1 p -99.29 160.74 14.06 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.057 0.943 . . . . 0.0 109.547 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.13 108.35 0.25 Allowed Glycine 0 C--N 1.359 1.836 0 C-N-CA 119.293 -1.432 . . . . 0.0 109.951 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.99 148.78 43.13 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 52.0 tp -72.7 123.39 23.18 Favored 'General case' 0 C--N 1.372 1.568 0 C-N-CA 125.849 1.66 . . . . 0.0 109.456 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.1 tp -99.95 -57.84 2.05 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.82 128.64 39.15 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.911 2.084 . . . . 0.0 106.466 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 130.58 10.32 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 103.979 -3.649 . . . . 0.0 103.979 161.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -69.48 133.56 89.0 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-N 118.662 1.231 . . . . 0.0 110.794 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -106.14 83.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.473 0 CA-C-N 121.469 1.56 . . . . 0.0 109.832 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.44 -72.74 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.398 3.479 . . . . 0.0 109.484 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.3 mt 49.52 40.23 18.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.27 3.028 . . . . 0.0 114.023 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.08 130.51 55.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -127.32 110.1 12.48 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.058 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.454 -0.823 0 N-CA-C 110.004 -0.806 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.2 120.67 25.15 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -92.7 -21.01 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.098 1.785 . . . . 0.0 109.83 -172.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 38.48 69.83 0.24 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 129.08 2.952 . . . . 0.0 115.315 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 78.9 t -118.7 136.42 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.24 158.34 44.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.416 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 8.3 p90 -149.52 139.21 21.74 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.3 t -169.2 117.84 0.66 Allowed 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.66 153.06 34.94 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -138.8 157.67 45.65 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.886 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.09 130.22 40.95 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -166.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 32.4 p -160.8 14.18 0.11 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.557 -163.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.2 pp -21.58 143.58 0.02 OUTLIER Pre-proline 0 C--N 1.373 1.587 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 158.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.34 -43.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 122.009 1.753 . . . . 0.0 111.936 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -164.15 176.78 8.93 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m -19.36 120.44 0.02 OUTLIER 'General case' 0 C--N 1.363 1.175 0 C-N-CA 129.706 3.203 . . . . 0.0 115.645 171.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -127.92 144.19 50.51 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -163.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.77 -10.6 16.96 Favored 'Trans proline' 0 CA--C 1.512 -0.603 0 CA-C-N 122.698 1.999 . . . . 0.0 113.645 -158.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.62 -141.81 3.25 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -63.25 144.92 56.52 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.984 1.714 . . . . 0.0 110.282 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.13 128.27 54.27 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 124.912 1.285 . . . . 0.0 110.119 -165.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -95.34 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.196 3.264 . . . . 0.0 108.382 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -147.92 133.79 19.07 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -116.48 -13.02 10.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.977 0.911 . . . . 0.0 110.696 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.26 85.7 2.86 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 121.198 0.523 . . . . 0.0 111.281 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 871' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' B' ' 874' ' ' ASN . 60.7 t -69.77 97.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 163.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' B' ' 855' ' ' ALA . 18.5 mt -87.21 -39.32 15.56 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.414 -172.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 40.7 tp -165.23 127.25 2.09 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 101.064 -3.68 . . . . 0.0 101.064 165.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.417 ' HB3' HG13 ' B' ' 871' ' ' VAL . 27.3 t-20 178.69 61.02 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 120.157 1.344 . . . . 0.0 109.146 -161.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.52 -43.56 93.38 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.59 -27.6 12.7 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 118.779 0.718 . . . . 0.0 112.669 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.92 -55.73 0.5 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 60.46 -84.11 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 C-N-CA 128.11 2.564 . . . . 0.0 114.866 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.3 118.87 34.71 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.75 116.39 63.72 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.01 5.21 2.37 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 CA-C-N 124.403 2.608 . . . . 0.0 109.73 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.95 -44.38 20.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.5 p -108.2 -10.64 15.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.957 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.79 30.13 30.16 Favored Glycine 0 C--N 1.359 1.819 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 162.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 32.3 t -101.34 102.36 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 -162.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.448 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.3 OUTLIER -101.53 111.79 24.14 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 112.856 -1.974 . . . . 0.0 108.994 -174.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.3 m -100.14 107.67 19.61 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 888' ' ' ALA . . . . . 0.454 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.13 111.53 47.32 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 117.291 -1.338 . . . . 0.0 111.93 169.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -89.48 0.35 5.89 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.762 2.308 . . . . 0.0 108.759 164.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -48.38 -56.44 8.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 128.914 2.886 . . . . 0.0 115.032 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.85 63.93 1.67 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 170.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.98 -166.68 31.83 Favored Glycine 0 N--CA 1.409 -3.141 0 N-CA-C 103.621 -3.791 . . . . 0.0 103.621 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -90.81 121.16 32.43 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.482 ' H ' HD11 ' B' ' 954' ' ' LEU . 2.0 t80 -117.27 146.04 43.57 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -172.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.34 115.51 28.86 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.2 tt -112.08 139.83 47.27 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 126.275 1.83 . . . . 0.0 108.503 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -143.26 119.19 10.62 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 123.312 0.645 . . . . 0.0 109.43 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.65 154.46 21.42 Favored 'General case' 0 C--N 1.365 1.271 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.69 121.96 61.33 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.38 122.02 43.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.152 0.981 . . . . 0.0 109.123 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 36.4 m -81.41 132.05 35.31 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 107.781 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.01 16.7 Favored Glycine 0 C--N 1.364 2.125 0 C-N-CA 125.14 1.352 . . . . 0.0 114.405 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.5 m170 37.2 70.4 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.204 2.202 . . . . 0.0 114.976 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -73.29 -8.74 57.15 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.28 1.432 . . . . 0.0 111.442 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -73.17 -15.79 61.45 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.083 1.353 . . . . 0.0 112.564 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.314 12.2 pt-20 122.94 -179.29 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 128.568 2.747 . . . . 0.0 108.606 176.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.0 tttt 102.5 131.11 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 127.897 2.479 . . . . 0.0 107.184 170.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.08 126.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -112.52 123.13 49.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.87 174.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.56 115.67 15.75 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 128.223 2.609 . . . . 0.0 109.476 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.4 t -87.89 113.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.21 149.37 41.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.662 1.985 . . . . 0.0 112.369 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.309 0.9 OUTLIER -115.08 149.53 37.37 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 126.598 1.959 . . . . 0.0 110.524 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.599 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.71 138.71 36.35 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.593 1.957 . . . . 0.0 109.36 174.165 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 97.1 -5.76 0.06 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 128.92 2.888 . . . . 0.0 112.569 172.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -146.19 -25.84 0.44 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-N 119.47 1.032 . . . . 0.0 111.349 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 57.9 169.66 0.05 OUTLIER 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.32 1.448 . . . . 0.0 111.571 -162.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.03 -132.89 50.95 Favored Glycine 0 C--N 1.368 2.317 0 O-C-N 119.508 -1.995 . . . . 0.0 109.727 -165.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 53.71 78.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 126.408 1.883 . . . . 0.0 111.631 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.42 28.03 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -103.02 -35.27 8.61 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.632 -172.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 89.6 t -99.35 86.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 166.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.9 130.53 42.83 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -172.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -141.59 117.34 10.4 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.327 1.451 . . . . 0.0 107.235 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.21 85.18 0.73 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.889 -3.684 . . . . 0.0 103.889 164.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.661 0 C-N-CA 124.639 1.114 . . . . 0.0 110.927 174.309 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 CA--C 1.506 -0.747 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.54 134.07 55.42 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.67 164.68 26.0 Favored Glycine 0 CA--C 1.489 -1.545 0 C-N-CA 125.56 1.552 . . . . 0.0 109.281 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.06 133.01 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -135.66 148.51 48.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 52.6 m -122.14 -34.61 3.29 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.367 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 25.8 tp -91.31 -52.34 4.85 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.128 -168.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -86.63 -169.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 124.816 1.246 . . . . 0.0 109.353 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.482 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.62 86.42 2.1 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -168.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.31 90.88 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 117.627 -1.828 . . . . 0.0 109.982 161.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.53 145.58 48.19 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 127.083 2.153 . . . . 0.0 105.412 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -92.16 158.89 15.93 Favored 'General case' 0 C--N 1.363 1.155 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.701 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.55 123.1 22.49 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-N 120.304 1.411 . . . . 0.0 108.602 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.77 -12.02 70.1 Favored Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 125.283 1.421 . . . . 0.0 110.863 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.55 175.7 5.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.905 0.859 . . . . 0.0 110.659 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 83.2 m -142.27 127.51 18.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -154.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.599 HG13 HH11 ' B' ' 914' ' ' ARG . 7.5 m -96.28 150.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 CA-C-O 121.464 0.649 . . . . 0.0 110.989 174.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.2 m -138.49 137.39 37.09 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 126.359 1.863 . . . . 0.0 111.035 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.04 129.44 42.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 C-N-CA 127.459 2.303 . . . . 0.0 106.564 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -107.98 130.98 55.02 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 100.886 -3.746 . . . . 0.0 100.886 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.97 77.33 1.78 Allowed 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 54.0 t -159.84 103.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -151.12 72.37 1.06 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.83 148.23 8.35 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -115.38 -27.66 7.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 35.8 tp -93.64 86.43 5.17 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.19 -163.98 1.51 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -125.2 159.29 31.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -91.38 131.13 37.06 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.58 149.99 22.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.826 -2.286 . . . . 0.0 104.826 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.06 113.29 24.12 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -97.06 172.33 0.78 Allowed 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.003 1.802 . . . . 0.0 108.173 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.4 mp -115.92 138.04 51.55 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.3 p -138.79 140.29 38.53 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 119.791 1.178 . . . . 0.0 108.261 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.8 mm -116.31 130.35 71.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -126.53 106.59 9.54 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 35.6 p -101.05 162.89 12.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.489 1.116 . . . . 0.0 110.231 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.75 110.31 0.29 Allowed Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.83 147.28 43.2 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.1 122.96 21.85 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 125.135 1.374 . . . . 0.0 109.091 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.1 tp -99.48 -58.09 2.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -131.37 128.39 39.54 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.897 1.679 . . . . 0.0 106.566 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.16 130.42 10.26 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 104.161 -3.575 . . . . 0.0 104.161 161.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.53 133.43 88.94 Favored Pre-proline 0 C--N 1.351 0.657 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.39 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -105.99 82.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.546 1.588 . . . . 0.0 109.195 -170.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.88 -72.28 0.09 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 130.286 3.435 . . . . 0.0 109.444 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 48.69 43.91 21.07 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 129.087 2.955 . . . . 0.0 113.671 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.0 130.23 56.72 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.08 110.2 12.25 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 179.551 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.86 0 N-CA-C 109.962 -0.822 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 34.8 t -125.4 116.52 25.22 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -90.01 -20.71 1.08 Allowed 'Trans proline' 0 CA--C 1.511 -0.638 0 CA-C-N 121.903 1.715 . . . . 0.0 109.662 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 39.16 69.8 0.26 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 128.811 2.844 . . . . 0.0 115.471 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.15 133.73 65.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -137.13 153.96 50.38 Favored 'General case' 0 C--N 1.363 1.158 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 167.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 7.0 p90 -149.71 141.7 23.87 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.916 0.78 . . . . 0.0 109.725 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.8 t -168.68 118.69 0.74 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.159 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.34 153.67 39.98 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -142.52 156.13 45.1 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.274 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.542 HD21 HD23 ' C' ' 858' ' ' LEU . 1.9 tm? -130.21 127.56 39.89 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.699 -164.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 33.3 p -162.35 11.88 0.07 Allowed 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -161.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.542 HD23 HD21 ' C' ' 856' ' ' LEU . 3.2 pp -27.62 146.86 0.04 OUTLIER Pre-proline 0 C--N 1.368 1.393 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 157.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.83 -45.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.101 1.786 . . . . 0.0 112.156 -164.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -162.17 172.64 15.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -0.43 107.17 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 130.652 3.581 . . . . 0.0 117.526 167.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -107.46 163.5 16.82 Favored Pre-proline 0 C--N 1.353 0.757 0 C-N-CA 124.249 1.02 . . . . 0.0 110.209 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.05 -13.19 14.19 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.083 2.522 . . . . 0.0 111.318 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.03 -144.39 4.28 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.1 m -64.39 136.6 57.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.364 1.866 . . . . 0.0 111.035 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.38 144.77 98.84 Favored Pre-proline 0 C--N 1.354 0.787 0 C-N-CA 125.392 1.477 . . . . 0.0 113.453 -174.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -100.96 -147.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.435 2.757 . . . . 0.0 106.67 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -147.33 134.25 20.22 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -117.59 -15.54 10.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 122.811 0.444 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.463 HH21 HD23 ' C' ' 872' ' ' LEU . 11.1 mmm180 -102.33 81.52 2.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.402 0.62 . . . . 0.0 111.399 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 871' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' C' ' 874' ' ' ASN . 43.6 t -67.99 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 126.265 1.826 . . . . 0.0 107.464 162.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.463 HD23 HH21 ' C' ' 870' ' ' ARG . 6.9 mt -88.47 -37.85 15.46 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 121.601 -0.687 . . . . 0.0 110.68 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.8 tp -165.86 129.77 2.21 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 168.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.2 t-20 176.42 61.69 0.0 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.828 1.649 . . . . 0.0 108.034 -165.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.32 -43.68 92.67 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -165.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.01 -28.08 11.47 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 118.896 0.771 . . . . 0.0 112.568 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.36 -57.78 0.42 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 62.38 -82.51 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.214 2.606 . . . . 0.0 114.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.0 120.05 36.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.139 1.376 . . . . 0.0 108.085 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.49 115.95 62.0 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -96.02 5.97 1.91 Allowed 'Trans proline' 0 CA--C 1.506 -0.913 0 CA-C-N 124.659 2.7 . . . . 0.0 109.702 -161.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -79.55 -45.25 19.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 29.3 p -106.72 -11.14 15.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.868 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.93 31.07 30.03 Favored Glycine 0 C--N 1.362 1.987 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 162.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 36.2 t -101.25 101.93 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 100.965 -3.716 . . . . 0.0 100.965 -164.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.26 112.09 24.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 112.127 -2.306 . . . . 0.0 108.548 -175.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 66.4 m -99.39 109.42 22.02 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.34 109.6 34.79 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 117.367 -1.302 . . . . 0.0 111.724 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.35 -4.11 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.434 2.089 . . . . 0.0 108.104 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 55.0 mt -54.54 -52.89 60.62 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 127.937 2.495 . . . . 0.0 114.009 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.56 67.62 0.92 Allowed 'General case' 0 C--N 1.366 1.32 0 CA-C-O 122.262 1.03 . . . . 0.0 111.418 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.54 -169.62 36.78 Favored Glycine 0 N--CA 1.406 -3.334 1 N-CA-C 102.156 -4.377 . . . . 0.0 102.156 -170.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -93.69 120.85 34.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.53 -1.335 . . . . 0.0 108.076 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.429 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.5 t80 -116.73 145.38 43.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -170.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 53.1 tp -109.94 114.88 28.79 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.061 0.945 . . . . 0.0 108.58 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -113.21 137.9 50.78 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.379 1.472 . . . . 0.0 108.814 -173.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -144.3 118.71 9.64 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.82 22.2 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.81 121.76 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.46 124.15 39.34 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.373 1.069 . . . . 0.0 109.837 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 55.5 m -81.47 130.62 35.11 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -50.62 -54.81 19.69 Favored Glycine 0 C--N 1.361 1.956 0 C-N-CA 126.141 1.829 . . . . 0.0 115.776 -170.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 28.7 m170 28.16 78.69 0.02 OUTLIER 'General case' 0 C--N 1.36 1.06 0 C-N-CA 128.162 2.585 . . . . 0.0 116.254 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -72.37 -13.5 61.49 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.9 1.68 . . . . 0.0 111.29 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.04 -17.43 61.43 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.661 1.584 . . . . 0.0 112.617 -168.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.2 pt-20 116.23 -179.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 128.093 2.557 . . . . 0.0 108.769 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 105.51 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 128.554 2.742 . . . . 0.0 105.136 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.8 t -97.23 125.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -101.15 130.87 47.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.086 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.75 113.54 2.8 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 125.252 1.421 . . . . 0.0 110.625 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 6.2 p -85.18 117.73 30.86 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 108.722 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.62 137.78 58.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.646 1.178 . . . . 0.0 109.81 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -117.17 144.39 44.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.609 1.564 . . . . 0.0 107.853 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.45 142.55 37.44 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 128.344 2.657 . . . . 0.0 109.591 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.33 24.1 p 88.6 3.44 0.26 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 129.902 3.281 . . . . 0.0 113.879 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -150.67 -24.26 0.23 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-N 119.453 1.024 . . . . 0.0 111.31 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 58.84 168.37 0.06 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.435 1.494 . . . . 0.0 112.116 -163.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -130.16 49.82 Favored Glycine 0 C--N 1.375 2.744 0 O-C-N 119.384 -2.072 . . . . 0.0 110.135 -163.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 49.2 t 53.48 72.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.175 0 C-N-CA 125.946 1.698 . . . . 0.0 111.974 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.66 116.37 28.95 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -174.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -99.31 -31.31 11.76 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.762 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.88 80.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -95.29 130.76 41.93 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.744 0.307 . . . . 0.0 111.197 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 117.81 9.02 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.287 1.435 . . . . 0.0 107.872 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.15 85.05 0.79 Allowed Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.713 0 C-N-CA 125.311 1.434 . . . . 0.0 110.732 172.965 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.51 134.69 55.24 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.73 162.59 26.24 Favored Glycine 0 CA--C 1.491 -1.421 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.88 132.98 69.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.86 148.71 45.64 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.436 -0.79 . . . . 0.0 108.957 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 63.7 m -108.31 -75.79 0.62 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 21.9 tp -66.96 -50.74 61.35 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -163.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.89 -176.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 125.94 1.696 . . . . 0.0 109.656 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.64 ' HB2' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -163.14 94.42 1.13 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.25 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.1 93.63 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.631 2.221 . . . . 0.0 110.015 162.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.64 HD13 ' HB2' ' C' ' 954' ' ' LEU . 7.9 mp -120.65 144.49 48.14 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -98.35 160.42 14.29 Favored 'General case' 0 C--N 1.363 1.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.43 123.41 22.31 Favored 'General case' 0 C--N 1.381 1.978 0 CA-C-N 120.329 1.422 . . . . 0.0 109.038 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -9.49 71.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 125.233 1.397 . . . . 0.0 111.794 168.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.65 171.83 4.78 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.438 0.695 . . . . 0.0 112.445 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.5 m -142.73 127.76 18.47 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -159.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.07 149.76 4.38 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 123.627 0.771 . . . . 0.0 109.295 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.2 t -142.29 136.59 29.91 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.495 1.118 . . . . 0.0 111.89 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.47 129.63 43.63 Favored 'Isoleucine or valine' 0 C--N 1.374 1.665 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.11 134.16 48.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.83 73.6 1.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.902 -1.954 . . . . 0.0 107.041 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 48.9 t -162.03 99.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.954 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -152.37 72.69 1.0 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.68 146.94 8.11 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.65 -21.56 10.17 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.413 0.685 . . . . 0.0 109.952 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -99.08 85.94 3.34 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.89 -167.88 2.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -170.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.69 156.73 33.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 15.4 t -91.12 135.53 33.7 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -160.23 154.45 23.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -127.72 115.01 20.85 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -97.57 172.96 0.67 Allowed 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 121.921 1.747 . . . . 0.0 107.894 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.8 mp -115.29 139.17 50.2 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 22.1 p -137.16 138.97 40.81 Favored 'General case' 0 C--N 1.375 1.688 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 31.5 mm -115.54 131.13 68.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -124.98 105.76 9.45 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 26.4 p -100.86 162.65 12.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 109.587 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 111.03 0.31 Allowed Glycine 0 C--N 1.358 1.785 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.71 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.75 142.71 47.44 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.1 tp -75.17 125.39 28.85 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.684 1.594 . . . . 0.0 108.569 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.1 -56.03 2.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -130.62 127.53 39.15 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -173.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 128.62 9.59 Favored Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 103.615 -3.794 . . . . 0.0 103.615 164.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.58 130.01 89.42 Favored Pre-proline 0 C--N 1.351 0.641 0 CA-C-O 117.461 -1.257 . . . . 0.0 111.215 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -107.03 80.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 122.519 1.935 . . . . 0.0 109.777 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 77.98 -71.99 0.1 Allowed 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 130.048 3.339 . . . . 0.0 109.414 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 64.9 mt 48.77 41.62 18.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 129.314 3.046 . . . . 0.0 113.596 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -110.0 129.55 55.66 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.94 107.0 9.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.307 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 110.015 -0.802 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.11 120.12 22.37 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.54 -20.24 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.122 1.794 . . . . 0.0 109.827 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 36.6 70.56 0.16 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.933 2.893 . . . . 0.0 115.792 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 77.2 t -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.3 44.7 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 165.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -149.46 139.04 21.65 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.4 t -168.96 117.19 0.66 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.21 36.0 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -136.44 158.49 44.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.425 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.555 HD21 HD23 ' A' ' 858' ' ' LEU . 2.5 tm? -135.07 130.46 35.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -166.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 72.2 m -161.41 8.81 0.08 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -162.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.555 HD23 HD21 ' A' ' 856' ' ' LEU . 2.7 pp -29.59 147.58 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.457 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 162.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.0 -43.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 122.128 1.796 . . . . 0.0 113.487 -161.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -163.44 174.05 12.4 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.0 m -9.3 118.97 0.01 OUTLIER 'General case' 0 C--N 1.361 1.097 0 C-N-CA 130.958 3.703 . . . . 0.0 117.004 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -97.95 160.42 28.48 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 124.691 1.196 . . . . 0.0 109.478 -170.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.09 -16.67 9.73 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.815 2.343 . . . . 0.0 110.098 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.57 -137.82 2.41 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 16.5 m -64.22 145.79 55.39 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.204 1.801 . . . . 0.0 110.652 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.66 130.43 36.96 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 125.514 1.525 . . . . 0.0 110.416 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -96.18 -150.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.927 3.084 . . . . 0.0 108.954 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.58 135.52 19.99 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -117.49 -14.78 10.3 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.985 0.514 . . . . 0.0 111.828 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.29 86.82 3.28 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 118.504 0.593 . . . . 0.0 111.839 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.67 97.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.201 1.801 . . . . 0.0 106.574 168.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.445 ' HB3' HD11 ' B' ' 953' ' ' ILE . 50.0 mt -87.24 -37.36 17.3 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.523 -173.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.16 126.86 1.75 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 101.591 -3.485 . . . . 0.0 101.591 162.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -175.31 60.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.494 1.497 . . . . 0.0 109.652 -168.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.72 -44.35 93.78 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -164.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.53 -28.51 11.29 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 118.99 0.814 . . . . 0.0 112.397 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -60.83 0.31 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 63.12 -80.86 0.03 OUTLIER 'General case' 0 C--N 1.356 0.869 0 C-N-CA 128.008 2.523 . . . . 0.0 114.049 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.68 119.46 32.71 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.794 1.238 . . . . 0.0 108.361 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.95 117.63 68.91 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -96.47 0.9 1.97 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 CA-C-N 125.113 2.862 . . . . 0.0 109.368 -165.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -80.31 -45.66 17.47 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -103.27 -12.61 17.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.347 1.059 . . . . 0.0 109.004 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 22.87 52.67 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 162.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 37.7 t -98.94 103.92 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.43 111.98 24.37 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.357 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 62.1 m -100.87 108.32 20.07 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . 0.409 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.37 111.09 45.26 Favored Pre-proline 0 C--N 1.358 0.956 0 CA-C-O 117.153 -1.404 . . . . 0.0 112.016 170.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.6 1.89 3.28 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 CA-C-N 123.001 2.107 . . . . 0.0 108.946 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 39.3 mt -52.8 -51.53 60.44 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 127.9 2.48 . . . . 0.0 114.09 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 44.79 18.3 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.069 1.348 . . . . 0.0 114.023 170.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.49 -163.24 11.79 Favored Glycine 0 N--CA 1.415 -2.737 1 N-CA-C 101.212 -4.755 . . . . 0.0 101.212 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -91.98 121.35 33.48 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.287 0.2 OUTLIER -114.58 159.19 20.72 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 119.32 0.963 . . . . 0.0 108.539 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -105.53 115.41 30.2 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.555 0.742 . . . . 0.0 109.085 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.81 136.34 50.0 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 126.079 1.751 . . . . 0.0 109.178 -168.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.5 m -145.99 118.91 8.72 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 123.469 0.708 . . . . 0.0 109.608 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.3 153.66 22.41 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.99 120.64 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.3 123.17 43.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.898 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 38.5 m -79.73 131.91 36.05 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.29 1.436 . . . . 0.0 107.394 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.36 -57.26 19.39 Favored Glycine 0 C--N 1.363 2.074 0 C-N-CA 125.653 1.597 . . . . 0.0 114.713 -169.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.3 m170 34.04 73.96 0.07 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 127.696 2.399 . . . . 0.0 115.606 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -74.14 -8.3 55.68 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.227 1.411 . . . . 0.0 111.55 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -72.12 -15.58 61.99 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 125.741 1.616 . . . . 0.0 112.225 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.339 7.2 pt-20 116.15 -177.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 128.26 2.624 . . . . 0.0 108.603 173.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 104.53 134.59 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 128.244 2.618 . . . . 0.0 106.41 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 69.0 t -98.19 125.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -111.08 122.36 47.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.015 -1.902 . . . . 0.0 113.446 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.21 117.12 17.04 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.12 2.568 . . . . 0.0 108.766 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 94.5 t -87.04 113.79 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 20.3 mt -62.29 140.78 58.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.908 1.683 . . . . 0.0 110.29 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -116.06 146.78 41.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.214 1.805 . . . . 0.0 109.218 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.571 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.07 139.78 40.11 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.155 2.582 . . . . 0.0 110.13 -174.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.17 -13.62 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 129.603 3.161 . . . . 0.0 112.649 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -139.33 -26.0 0.83 Allowed 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 119.327 0.967 . . . . 0.0 111.095 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 60.54 167.01 0.08 Allowed 'General case' 0 C--N 1.361 1.105 0 C-N-CA 125.226 1.411 . . . . 0.0 111.36 -164.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -134.63 50.49 Favored Glycine 0 C--N 1.37 2.449 0 O-C-N 119.521 -1.987 . . . . 0.0 109.208 -161.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 47.4 t 57.93 75.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.235 0 C-N-CA 125.297 1.439 . . . . 0.0 110.516 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.75 114.77 27.39 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -103.01 -36.17 8.28 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.454 -171.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.28 78.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -95.32 131.55 41.3 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.145 -172.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -143.96 114.69 7.7 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.024 1.33 . . . . 0.0 107.885 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.2 84.69 0.71 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 104.529 -3.428 . . . . 0.0 104.529 167.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 110.96 174.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.2 mt -118.26 134.1 55.32 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.82 161.41 25.46 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.91 127.96 73.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -137.58 148.47 45.92 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.4 m -114.73 -44.32 3.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 26.9 tp -84.33 -50.11 8.13 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.431 1.014 . . . . 0.0 112.785 -166.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 12.6 pt -87.88 -169.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 124.688 1.195 . . . . 0.0 109.941 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.23 82.71 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -165.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.55 91.36 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 122.308 1.86 . . . . 0.0 109.592 160.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.1 142.31 49.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -94.51 156.56 16.4 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.17 123.02 21.22 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 119.533 1.06 . . . . 0.0 108.929 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.41 -11.85 71.12 Favored Glycine 0 C--N 1.345 1.082 0 C-N-CA 125.893 1.711 . . . . 0.0 111.246 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.7 175.32 5.77 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.158 0.583 . . . . 0.0 111.467 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 83.7 m -142.54 125.47 16.16 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -159.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.571 HG13 HH11 ' A' ' 914' ' ' ARG . 34.0 m -95.79 150.26 4.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.686 0.755 . . . . 0.0 109.9 171.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.7 138.91 34.59 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.684 1.994 . . . . 0.0 111.382 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.29 129.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 126.301 1.84 . . . . 0.0 106.786 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.43 131.0 54.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.168 -3.271 . . . . 0.0 102.168 170.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.04 77.55 1.77 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.3 t -160.93 99.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.4 mmm -152.4 73.89 1.05 Allowed 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 107.5 141.92 10.16 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.96 -5.88 13.17 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.256 0.623 . . . . 0.0 111.257 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.28 82.86 2.97 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.94 -175.19 3.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -122.0 159.5 26.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 16.8 t -89.01 131.19 35.3 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.69 150.03 22.55 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.41 113.36 23.29 Favored Pre-proline 0 C--N 1.356 0.869 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -98.13 174.29 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 108.54 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.75 140.91 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.46 140.58 37.33 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 119.583 1.083 . . . . 0.0 108.919 -171.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.0 mm -118.85 129.77 74.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -127.3 105.92 8.86 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 33.8 p -100.19 160.99 13.9 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.008 1.323 . . . . 0.0 110.068 170.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -179.2 109.84 0.27 Allowed Glycine 0 C--N 1.358 1.787 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.8 144.96 46.0 Favored 'General case' 0 C--N 1.346 0.439 0 O-C-N 121.416 -1.049 . . . . 0.0 113.713 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.75 123.65 24.53 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 124.591 1.156 . . . . 0.0 109.671 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 23.9 tp -98.72 -57.38 2.2 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.65 128.02 38.19 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.82 10.04 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 103.231 -3.947 . . . . 0.0 103.231 163.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -69.04 130.04 91.71 Favored Pre-proline 0 C--N 1.352 0.703 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.015 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -106.76 82.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 CA-C-N 121.885 1.709 . . . . 0.0 109.89 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 78.29 -72.28 0.09 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 130.265 3.426 . . . . 0.0 109.195 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 76.4 mt 49.93 39.0 17.55 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 129.073 2.949 . . . . 0.0 114.244 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.7 131.95 54.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -129.24 109.46 11.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.134 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 179.656 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.454 -0.801 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.69 120.41 23.01 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.5 -20.47 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.176 1.813 . . . . 0.0 110.081 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 37.95 70.37 0.2 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.926 2.89 . . . . 0.0 115.482 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 82.5 t -118.14 136.03 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.08 157.66 46.35 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -149.5 139.46 21.98 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -169.57 118.23 0.63 Allowed 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.97 153.56 34.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -138.37 158.59 43.98 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.908 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.58 HD21 HD23 ' B' ' 858' ' ' LEU . 2.4 tm? -136.06 128.1 29.65 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -167.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 73.3 m -160.33 13.0 0.12 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -167.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.58 HD23 HD21 ' B' ' 856' ' ' LEU . 2.6 pp -29.03 148.24 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 160.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.63 -43.76 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.104 1.787 . . . . 0.0 113.553 -161.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -163.41 173.83 12.7 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -8.73 118.94 0.01 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 130.952 3.701 . . . . 0.0 117.075 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -97.87 160.42 28.54 Favored Pre-proline 0 N--CA 1.44 -0.926 0 C-N-CA 124.661 1.184 . . . . 0.0 109.606 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.14 -16.69 9.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.776 2.317 . . . . 0.0 110.176 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.43 -137.71 2.37 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -64.05 145.41 55.95 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.13 1.772 . . . . 0.0 110.498 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.89 129.84 40.63 Favored Pre-proline 0 N--CA 1.438 -1.028 0 C-N-CA 125.366 1.466 . . . . 0.0 110.208 -164.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -96.82 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.797 2.998 . . . . 0.0 108.726 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.21 135.54 20.46 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -115.87 -14.05 11.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.019 0.928 . . . . 0.0 110.705 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.17 86.65 3.07 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 118.233 0.469 . . . . 0.0 112.159 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.06 97.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.247 1.819 . . . . 0.0 106.639 164.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' B' ' 855' ' ' ALA . 13.5 mt -87.75 -38.83 15.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.278 -173.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 53.3 tp -166.25 127.49 1.79 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 166.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 178.25 61.0 0.01 OUTLIER 'General case' 0 C--N 1.355 0.825 0 CA-C-N 120.331 1.423 . . . . 0.0 108.807 -164.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.13 -43.96 95.28 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.22 -29.15 10.57 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 118.741 0.7 . . . . 0.0 112.355 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.53 -60.04 0.34 Allowed Glycine 0 C--N 1.353 1.487 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 63.14 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.103 2.561 . . . . 0.0 114.148 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -95.33 119.24 33.5 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 125.007 1.323 . . . . 0.0 108.231 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -80.64 117.83 69.65 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -95.29 0.99 2.5 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 125.144 2.873 . . . . 0.0 109.589 -165.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -80.3 -44.36 19.71 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 33.2 p -105.38 -13.05 15.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.729 1.211 . . . . 0.0 108.581 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.24 47.22 Favored Glycine 0 C--N 1.362 2.009 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 163.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.7 103.44 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 -162.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.57 112.1 24.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 112.515 -2.129 . . . . 0.0 109.475 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 61.3 m -101.08 108.45 20.15 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . 0.408 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.43 111.12 45.55 Favored Pre-proline 0 C--N 1.359 0.99 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.844 170.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -93.26 2.08 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 123.101 2.143 . . . . 0.0 108.949 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.32 -49.37 69.85 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.025 2.13 . . . . 0.0 113.888 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.32 48.18 15.38 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.747 1.619 . . . . 0.0 114.431 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.91 -164.92 20.2 Favored Glycine 0 N--CA 1.412 -2.951 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -90.79 121.38 32.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -116.42 159.54 21.85 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 119.36 0.982 . . . . 0.0 108.824 178.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -106.19 114.3 28.35 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.55 136.17 49.36 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 126.09 1.756 . . . . 0.0 108.529 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -145.02 119.31 9.54 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.167 0.587 . . . . 0.0 109.566 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.85 22.15 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.33 121.44 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.29 121.97 43.31 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.44 1.096 . . . . 0.0 108.665 -172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.3 m -79.12 132.26 36.51 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 107.749 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.15 -57.25 19.28 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.784 1.659 . . . . 0.0 114.63 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.5 m170 33.92 73.84 0.07 Allowed 'General case' 0 C--N 1.359 1.013 0 C-N-CA 127.746 2.418 . . . . 0.0 115.528 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.0 -8.48 56.28 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.283 1.433 . . . . 0.0 111.493 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -72.22 -14.51 61.81 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 125.807 1.643 . . . . 0.0 112.255 -170.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.341 7.0 pt-20 115.92 -178.27 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 128.641 2.776 . . . . 0.0 108.633 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 104.32 134.18 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 128.081 2.552 . . . . 0.0 106.635 172.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 87.8 t -98.0 126.5 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -172.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -111.98 122.8 48.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.942 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.24 116.88 16.73 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.539 2.336 . . . . 0.0 109.564 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 97.0 t -88.07 113.88 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.62 142.93 57.82 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.337 1.855 . . . . 0.0 110.249 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.7 t -116.47 147.24 41.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.298 1.839 . . . . 0.0 109.424 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.604 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.16 139.39 38.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.664 2.386 . . . . 0.0 109.826 -175.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.54 -16.94 0.03 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 129.643 3.177 . . . . 0.0 112.798 173.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -137.37 -25.5 1.03 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 119.384 0.993 . . . . 0.0 111.57 -169.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 60.44 167.35 0.08 Allowed 'General case' 0 C--N 1.36 1.062 0 C-N-CA 125.449 1.499 . . . . 0.0 111.078 -163.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.93 -133.55 49.36 Favored Glycine 0 C--N 1.367 2.259 0 O-C-N 119.664 -1.898 . . . . 0.0 109.066 -163.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 47.7 t 56.04 76.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.18 0 C-N-CA 125.64 1.576 . . . . 0.0 110.794 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.32 115.2 27.83 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -103.35 -36.83 7.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.392 -171.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.65 77.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.14 131.29 42.74 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -142.87 115.26 8.49 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.1 1.36 . . . . 0.0 107.832 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 84.63 0.73 Allowed Glycine 0 CA--C 1.486 -1.777 0 N-CA-C 104.625 -3.39 . . . . 0.0 104.625 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.644 0 C-N-CA 125.615 1.579 . . . . 0.0 111.003 175.397 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.506 -0.712 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.0 mt -116.88 134.23 55.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -142.44 162.67 27.27 Favored Glycine 0 CA--C 1.492 -1.403 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.83 130.73 73.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -137.61 150.09 47.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 54.6 m -119.19 -39.97 2.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.003 0.365 . . . . 0.0 111.91 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.56 -50.2 8.48 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-N 119.142 0.883 . . . . 0.0 112.299 -168.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 872' ' ' LEU . 38.4 pt -84.74 -175.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 125.686 1.595 . . . . 0.0 110.14 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.38 81.92 2.81 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 -169.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.78 92.62 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.294 1.996 . . . . 0.0 110.107 162.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.85 141.85 50.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -93.5 157.19 16.33 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.162 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.92 122.8 21.43 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.808 1.186 . . . . 0.0 108.718 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.04 -11.31 72.46 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 125.667 1.603 . . . . 0.0 111.165 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.8 175.01 6.1 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.624 0.726 . . . . 0.0 110.619 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 91.1 m -142.55 125.61 16.29 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -158.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.604 HG13 HH11 ' B' ' 914' ' ' ARG . 27.2 m -96.78 151.1 4.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 121.637 0.732 . . . . 0.0 110.909 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -140.85 138.94 34.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.864 2.066 . . . . 0.0 111.454 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.71 129.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.466 0 C-N-CA 127.142 2.177 . . . . 0.0 106.964 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -107.29 130.77 54.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.633 -3.469 . . . . 0.0 101.633 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.8 77.11 1.75 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 59.5 t -160.12 100.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -151.59 71.76 1.0 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.25 141.78 9.09 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.44 -5.11 13.51 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.233 0.613 . . . . 0.0 110.994 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 37.8 tp -99.44 82.11 2.62 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.56 -174.5 3.72 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -121.97 159.76 26.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -88.62 130.52 35.26 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.81 150.11 22.4 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 113.3 23.24 Favored Pre-proline 0 C--N 1.356 0.88 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -97.75 173.88 0.61 Allowed 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 121.957 1.772 . . . . 0.0 108.492 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.95 139.53 50.54 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.42 139.63 38.99 Favored 'General case' 0 C--N 1.374 1.646 0 CA-C-N 119.728 1.149 . . . . 0.0 108.572 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.2 mm -116.82 130.4 71.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -127.78 106.03 8.85 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 34.3 p -101.22 163.02 12.48 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.086 1.354 . . . . 0.0 110.538 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.75 111.41 0.31 Allowed Glycine 0 C--N 1.36 1.868 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.85 145.12 45.93 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.25 123.23 23.3 Favored 'General case' 0 C--N 1.376 1.744 0 C-N-CA 124.223 1.009 . . . . 0.0 109.354 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 53.6 tp -98.3 -57.48 2.2 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.4 127.3 37.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.72 128.95 9.72 Favored Glycine 0 CA--C 1.493 -1.329 1 N-CA-C 103.053 -4.019 . . . . 0.0 103.053 163.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.76 128.91 91.65 Favored Pre-proline 0 C--N 1.349 0.567 0 CA-C-O 117.693 -1.146 . . . . 0.0 110.345 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -106.27 82.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 CA-C-N 122.08 1.779 . . . . 0.0 109.593 -168.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.0 -72.04 0.09 Allowed 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 130.201 3.4 . . . . 0.0 109.136 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 76.5 mt 49.47 40.6 19.39 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 128.984 2.914 . . . . 0.0 113.828 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -113.35 131.79 55.83 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -130.02 109.17 10.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.578 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.88 114.43 31.07 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -86.09 -23.92 1.84 Allowed 'Trans proline' 0 CA--C 1.512 -0.584 0 CA-C-N 121.697 1.642 . . . . 0.0 110.285 -171.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 38.8 67.03 0.46 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 128.602 2.761 . . . . 0.0 115.553 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.09 136.95 57.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.93 156.09 49.59 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 8.6 p90 -148.47 137.83 21.96 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.3 t -171.37 119.37 0.47 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.426 -0.796 . . . . 0.0 109.734 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.41 153.61 37.61 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.17 158.46 44.01 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.663 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.486 HD21 HD23 ' C' ' 858' ' ' LEU . 3.0 tm? -140.83 130.21 23.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 74.5 m -158.54 15.99 0.2 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.486 HD23 HD21 ' C' ' 856' ' ' LEU . 2.0 pp -27.25 144.33 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.517 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 160.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -79.75 -45.49 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 122.056 1.77 . . . . 0.0 113.54 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.07 174.42 12.28 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.1 m -5.02 114.83 0.01 OUTLIER 'General case' 0 C--N 1.363 1.185 0 C-N-CA 130.78 3.632 . . . . 0.0 116.901 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.87 156.55 43.67 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.01 -15.63 10.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.346 2.03 . . . . 0.0 111.259 -172.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.1 -140.48 2.96 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.0 m -65.8 144.66 56.72 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.621 1.568 . . . . 0.0 110.036 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 74.1 t -98.09 134.39 22.16 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 124.596 1.159 . . . . 0.0 110.521 -158.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -95.77 -152.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.063 3.175 . . . . 0.0 109.832 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -145.4 132.83 20.73 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -113.24 -17.03 12.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.457 0.703 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -102.9 83.42 2.23 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.194 0.521 . . . . 0.0 111.458 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.66 97.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.534 1.934 . . . . 0.0 106.649 165.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.79 -37.87 14.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.889 -173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 34.4 tp -165.02 127.22 2.16 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 31.5 t-20 174.97 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.183 1.356 . . . . 0.0 107.703 -163.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.84 -42.78 94.35 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.79 -28.32 16.4 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.744 0.702 . . . . 0.0 112.284 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.26 -58.44 0.46 Allowed Glycine 0 C--N 1.354 1.53 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 62.45 -81.28 0.02 OUTLIER 'General case' 0 C--N 1.353 0.751 0 C-N-CA 128.119 2.568 . . . . 0.0 114.654 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -95.5 120.3 35.51 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.424 1.49 . . . . 0.0 108.501 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.41 117.38 68.64 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.56 6.59 2.02 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.918 2.792 . . . . 0.0 109.768 -171.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -79.65 -45.33 19.24 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -105.26 -15.83 14.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.894 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.23 24.22 52.3 Favored Glycine 0 C--N 1.363 2.037 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 164.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.67 103.08 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 N-CA-C 101.335 -3.58 . . . . 0.0 101.335 -168.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -94.67 112.14 23.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.929 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 50.7 m -102.86 109.07 20.52 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . 0.507 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.25 110.38 42.16 Favored Pre-proline 0 C--N 1.356 0.889 0 CA-C-O 117.221 -1.371 . . . . 0.0 111.774 169.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -92.83 1.33 3.72 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.539 2.159 . . . . 0.0 108.289 164.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 36.4 mt -54.73 -52.68 61.74 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 128.098 2.559 . . . . 0.0 113.794 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.41 67.35 0.95 Allowed 'General case' 0 C--N 1.366 1.29 0 CA-C-O 121.971 0.891 . . . . 0.0 111.177 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.97 171.22 44.11 Favored Glycine 0 N--CA 1.406 -3.307 1 N-CA-C 100.272 -5.131 . . . . 0.0 100.272 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -91.45 116.34 28.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -116.28 160.03 21.03 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-O 121.576 0.703 . . . . 0.0 110.248 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.67 112.77 25.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.39 139.36 50.98 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.142 1.377 . . . . 0.0 109.017 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.5 m -144.15 120.53 10.95 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 110.197 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.53 154.48 19.86 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.52 123.07 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.52 123.63 40.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.256 1.022 . . . . 0.0 109.341 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 49.9 m -79.63 132.7 36.32 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.66 -56.78 16.38 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 125.774 1.654 . . . . 0.0 114.432 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 32.3 71.83 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.979 2.512 . . . . 0.0 114.987 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -72.98 -9.24 58.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.554 1.541 . . . . 0.0 111.803 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -71.92 -16.5 62.11 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.98 1.712 . . . . 0.0 112.274 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 122.13 -173.1 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.571 2.748 . . . . 0.0 107.745 173.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 103.49 134.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 127.949 2.499 . . . . 0.0 106.655 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.03 123.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -104.03 130.0 51.68 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.154 1.781 . . . . 0.0 110.278 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -152.5 114.2 4.34 Favored 'General case' 0 C--N 1.358 0.965 0 C-N-CA 124.97 1.308 . . . . 0.0 110.103 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.53 114.21 27.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 125.238 1.415 . . . . 0.0 107.694 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -61.59 139.92 58.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.112 1.765 . . . . 0.0 111.421 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.1 t -117.53 144.89 44.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.059 2.144 . . . . 0.0 108.842 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.507 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.31 141.91 38.13 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 127.205 2.202 . . . . 0.0 111.003 -174.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.6 t 99.79 -10.78 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.955 3.302 . . . . 0.0 112.179 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -141.8 -25.94 0.68 Allowed 'General case' 0 C--N 1.358 0.944 0 CA-C-N 119.275 0.943 . . . . 0.0 111.672 -172.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 59.72 167.62 0.07 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.229 1.412 . . . . 0.0 111.671 -163.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.06 -131.94 52.2 Favored Glycine 0 C--N 1.373 2.595 0 O-C-N 119.498 -2.001 . . . . 0.0 109.363 -162.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 44.8 t 54.8 74.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 125.567 1.547 . . . . 0.0 111.032 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.12 114.85 27.49 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 27.7 ptt85 -97.96 -38.0 9.57 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.752 -171.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.19 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.012 -2.959 . . . . 0.0 103.012 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -97.53 131.12 44.43 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.183 0.516 . . . . 0.0 111.111 -173.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -144.05 117.06 8.86 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.475 1.51 . . . . 0.0 108.35 171.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 85.01 0.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 105.158 -3.177 . . . . 0.0 105.158 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.605 0 C-N-CA 125.168 1.366 . . . . 0.0 110.798 174.385 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 73.7 mt -122.34 134.24 54.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.96 161.63 26.75 Favored Glycine 0 CA--C 1.491 -1.467 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -174.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 28.4 m -120.8 129.64 75.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.55 150.16 48.47 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.265 -0.897 . . . . 0.0 108.775 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -115.78 -41.03 3.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 16.6 tp -90.05 -52.92 4.72 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 119.069 0.849 . . . . 0.0 111.837 -168.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.51 -177.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 125.709 1.604 . . . . 0.0 109.844 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.99 85.51 1.6 Allowed Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 87.78 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 122.543 1.944 . . . . 0.0 109.49 163.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.18 145.82 48.3 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -92.8 161.37 14.54 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 118.917 0.78 . . . . 0.0 109.721 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.51 122.67 20.87 Favored 'General case' 0 C--N 1.379 1.872 0 CA-C-N 119.907 1.231 . . . . 0.0 109.051 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.73 -12.49 69.72 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.112 1.815 . . . . 0.0 111.372 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.26 175.37 5.41 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-O 121.571 0.701 . . . . 0.0 111.45 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 93.6 m -142.68 126.65 17.28 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.965 0.906 . . . . 0.0 110.569 -159.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.44 147.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.915 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.9 t -142.04 138.88 32.1 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.984 1.714 . . . . 0.0 111.577 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 89.3 t -90.33 129.07 41.78 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 C-N-CA 126.352 1.861 . . . . 0.0 106.701 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.69 132.97 51.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 101.345 -3.576 . . . . 0.0 101.345 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.92 72.16 1.49 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.844 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.2 t -160.97 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -151.78 70.04 0.93 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.2 145.88 7.96 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -117.27 -15.8 10.38 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.044 0.938 . . . . 0.0 110.287 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -101.59 81.98 2.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.79 -161.92 1.22 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -119.61 154.15 34.41 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.6 t -89.58 132.74 34.95 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -156.5 154.41 30.3 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -128.74 120.74 20.71 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -102.49 170.96 0.25 Allowed 'Trans proline' 0 CA--C 1.506 -0.892 0 N-CA-C 107.691 -1.696 . . . . 0.0 107.691 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 8.1 mp -112.53 139.83 47.79 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.5 p -136.56 139.27 42.05 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 119.574 1.079 . . . . 0.0 108.199 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.0 131.11 68.22 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -124.91 104.87 8.83 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 31.1 p -101.88 163.45 12.24 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.357 1.463 . . . . 0.0 110.556 171.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.76 112.14 0.34 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.77 45.78 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.921 -1.341 . . . . 0.0 114.452 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.05 124.45 27.81 Favored 'General case' 0 C--N 1.379 1.875 0 C-N-CA 124.892 1.277 . . . . 0.0 109.724 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 17.1 tp -97.49 -57.09 2.33 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.809 0.338 . . . . 0.0 110.237 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -131.49 127.65 37.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.82 130.72 10.41 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 165.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -70.51 129.5 90.08 Favored Pre-proline 0 C--N 1.35 0.594 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.696 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -106.76 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.014 1.755 . . . . 0.0 109.46 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 78.45 -73.16 0.08 Allowed 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 130.034 3.334 . . . . 0.0 109.048 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.8 mt 49.79 39.66 18.52 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.911 2.884 . . . . 0.0 113.792 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -112.12 131.72 55.29 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.36 109.05 10.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.095 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 110.166 -0.744 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.03 117.89 28.28 Favored Pre-proline 0 C--N 1.353 0.748 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -89.02 -21.0 1.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 CA-C-N 121.998 1.749 . . . . 0.0 110.021 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 37.29 70.57 0.17 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 129.056 2.942 . . . . 0.0 115.493 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 81.7 t -118.23 136.12 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.19 158.11 45.2 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 164.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -150.57 143.49 24.69 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 118.924 0.784 . . . . 0.0 110.117 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.57 118.42 0.85 Allowed 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.444 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.74 154.26 37.15 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.81 157.18 45.76 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.229 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.493 HD21 HD23 ' A' ' 858' ' ' LEU . 2.4 tm? -134.45 130.17 36.35 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -166.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 39.5 p -162.99 13.38 0.07 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -161.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.493 HD23 HD21 ' A' ' 856' ' ' LEU . 3.5 pp -25.18 147.99 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.426 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 159.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.28 -45.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.111 1.79 . . . . 0.0 113.252 -164.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.95 176.1 10.5 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -173.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.55 119.57 0.02 OUTLIER 'General case' 0 C--N 1.364 1.209 0 C-N-CA 130.549 3.54 . . . . 0.0 116.148 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.96 163.7 18.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 123.98 0.912 . . . . 0.0 108.737 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.06 -13.58 13.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.886 2.391 . . . . 0.0 111.189 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.81 -144.74 4.39 Favored Glycine 0 C--N 1.354 1.563 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.5 m -64.67 137.66 57.94 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.375 1.87 . . . . 0.0 110.938 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 14.8 m -69.38 145.59 95.77 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.365 1.466 . . . . 0.0 113.292 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -101.8 -145.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.037 2.492 . . . . 0.0 107.281 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -148.11 134.07 19.16 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -117.4 -14.2 10.37 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.428 0.691 . . . . 0.0 110.42 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.514 HH21 HD23 ' A' ' 872' ' ' LEU . 16.4 mmm180 -100.37 85.92 3.08 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-O 121.335 0.588 . . . . 0.0 111.427 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 74.2 t -69.2 95.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.935 2.494 . . . . 0.0 105.472 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.514 HD23 HH21 ' A' ' 870' ' ' ARG . 4.3 mt -90.79 -38.08 13.23 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.875 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 55.3 tp -166.8 130.62 1.95 Allowed 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.4 p-10 172.15 62.51 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 121.012 1.733 . . . . 0.0 108.537 -172.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.34 -44.19 92.66 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -163.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.39 -31.73 9.36 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.35 -68.76 0.23 Allowed Glycine 0 CA--C 1.489 -1.557 0 N-CA-C 105.592 -3.003 . . . . 0.0 105.592 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 77.29 -67.78 0.19 Allowed 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 128.295 2.638 . . . . 0.0 112.21 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -98.35 122.12 41.13 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.31 1.444 . . . . 0.0 108.101 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.68 118.0 70.45 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 116.115 -1.898 . . . . 0.0 106.113 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.32 -0.46 4.71 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 124.637 2.692 . . . . 0.0 108.768 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.65 -41.39 27.02 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.835 1.254 . . . . 0.0 108.612 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 37.1 p -104.31 -15.34 15.48 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.57 16.81 69.96 Favored Glycine 0 C--N 1.365 2.163 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 167.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 55.7 t -101.87 105.81 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 112.37 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.236 -175.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.29 109.33 20.97 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . 0.492 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.76 110.9 44.81 Favored Pre-proline 0 C--N 1.357 0.913 0 CA-C-O 117.172 -1.394 . . . . 0.0 111.678 169.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -93.75 0.44 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 CA-C-N 123.082 2.136 . . . . 0.0 108.602 166.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 61.5 mt -51.73 -54.39 28.96 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 127.988 2.515 . . . . 0.0 114.563 -168.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.13 66.34 1.12 Allowed 'General case' 0 C--N 1.364 1.231 0 CA-C-O 121.926 0.87 . . . . 0.0 112.166 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.27 -169.02 36.57 Favored Glycine 0 N--CA 1.408 -3.17 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -92.99 122.28 35.19 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.018 -1.091 . . . . 0.0 108.214 171.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.422 ' H ' HD11 ' A' ' 954' ' ' LEU . 0.0 OUTLIER -116.56 151.68 35.69 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.94 115.83 30.87 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.867 0.867 . . . . 0.0 108.844 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -112.58 137.11 51.3 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.957 1.703 . . . . 0.0 109.758 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -145.42 119.06 9.14 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 123.634 0.773 . . . . 0.0 109.317 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.59 154.31 21.6 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.43 120.98 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.12 123.21 42.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.349 1.059 . . . . 0.0 109.22 -171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 48.5 m -83.68 132.32 34.88 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.362 1.465 . . . . 0.0 107.272 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.83 17.78 Favored Glycine 0 C--N 1.362 2.026 0 C-N-CA 125.089 1.328 . . . . 0.0 114.309 -170.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 59.1 m170 33.14 73.18 0.07 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 127.86 2.464 . . . . 0.0 115.342 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -73.91 -8.4 55.94 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.288 1.435 . . . . 0.0 111.959 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -71.17 -18.51 62.49 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.567 1.547 . . . . 0.0 112.577 -170.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.309 9.4 pt-20 123.01 -174.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 129.149 2.98 . . . . 0.0 107.915 175.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 102.32 130.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 128.162 2.585 . . . . 0.0 106.509 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 91.2 t -98.31 124.48 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -107.97 130.47 55.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.121 1.769 . . . . 0.0 110.719 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -153.97 115.1 4.09 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 125.217 1.407 . . . . 0.0 110.125 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.85 117.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.532 1.533 . . . . 0.0 107.886 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.9 mt -62.79 137.37 58.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.07 1.348 . . . . 0.0 109.145 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.2 t -116.22 147.89 41.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 126.053 1.741 . . . . 0.0 108.192 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.492 HH22 ' HB3' ' A' ' 888' ' ' ALA . 0.0 OUTLIER -76.03 138.55 40.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 128.418 2.687 . . . . 0.0 110.38 -173.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 88.34 3.44 0.28 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.961 2.904 . . . . 0.0 113.012 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -149.73 -24.81 0.27 Allowed 'General case' 0 C--N 1.359 1.019 0 CA-C-N 119.45 1.023 . . . . 0.0 111.61 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 57.76 172.9 0.05 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.947 1.299 . . . . 0.0 112.117 -162.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.02 52.83 Favored Glycine 0 C--N 1.377 2.824 0 O-C-N 119.513 -1.992 . . . . 0.0 110.292 -163.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 54.5 t 55.34 75.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.266 0 C-N-CA 125.651 1.58 . . . . 0.0 111.267 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.58 116.51 28.93 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -102.27 -32.87 9.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.67 -1.605 . . . . 0.0 108.165 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.89 83.3 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.74 131.65 38.89 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.136 0.493 . . . . 0.0 110.636 -172.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.0 t -143.3 115.41 8.37 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.505 1.522 . . . . 0.0 107.569 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.38 84.57 0.76 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 104.937 -3.265 . . . . 0.0 104.937 167.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.582 0 C-N-CA 124.884 1.23 . . . . 0.0 111.193 175.763 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.512 -0.504 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 56.1 mt -121.66 133.6 54.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.97 161.42 27.83 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.48 130.17 74.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -138.82 151.18 46.81 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.4 m -115.35 -43.24 3.08 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.48 -50.84 6.95 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 119.324 0.965 . . . . 0.0 112.714 -166.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.9 -172.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.799 1.64 . . . . 0.0 110.462 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.422 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -160.01 84.18 2.15 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -166.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.68 90.7 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.985 1.745 . . . . 0.0 109.089 159.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.68 142.58 50.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.8 158.72 15.3 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.06 123.09 21.31 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.745 1.157 . . . . 0.0 109.031 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.39 -11.09 72.96 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 125.886 1.708 . . . . 0.0 111.258 170.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.44 174.28 6.79 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 111.552 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.51 127.08 16.04 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -159.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.411 HG13 HH11 ' A' ' 914' ' ' ARG . 15.3 m -98.23 147.3 6.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.401 0.62 . . . . 0.0 110.865 171.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 23.4 t -142.32 137.73 30.79 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.318 1.847 . . . . 0.0 110.888 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 30.3 t -91.57 129.04 42.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 C-N-CA 125.995 1.718 . . . . 0.0 107.315 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.8 131.94 53.34 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 101.437 -3.542 . . . . 0.0 101.437 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.4 72.82 1.51 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.287 -1.779 . . . . 0.0 106.45 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 52.4 t -162.22 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 83.1 mmm -152.88 72.86 0.98 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 117.48 147.08 8.43 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.82 -28.46 7.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.1 tp -92.71 86.36 5.52 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -154.92 0.57 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -124.68 166.96 15.21 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 23.0 t -103.7 131.6 50.72 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 155.89 30.9 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.29 115.05 21.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 173.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -99.78 172.94 0.4 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 121.998 1.799 . . . . 0.0 108.05 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.64 140.97 48.69 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -138.3 140.34 39.52 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.585 1.084 . . . . 0.0 108.479 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.2 mm -116.64 130.88 70.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -126.31 106.16 9.32 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 26.9 p -100.36 160.3 14.45 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.529 1.132 . . . . 0.0 109.253 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.72 109.82 0.28 Allowed Glycine 0 C--N 1.356 1.665 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.888 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.39 143.68 47.32 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -73.35 125.96 29.05 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.955 1.302 . . . . 0.0 109.904 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.82 -57.38 2.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -131.13 127.75 38.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.9 129.98 10.1 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -69.88 128.72 91.63 Favored Pre-proline 0 C--N 1.349 0.573 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.583 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -106.94 80.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.165 1.809 . . . . 0.0 109.233 -169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 79.47 -70.51 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.936 3.295 . . . . 0.0 109.008 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 18.2 mt 50.37 38.21 17.38 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 128.729 2.812 . . . . 0.0 114.202 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -114.98 133.94 55.61 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -129.2 109.98 11.6 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.112 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.226 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.807 0 N-CA-C 110.134 -0.756 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.22 118.36 27.89 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -89.42 -21.61 1.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 122.029 1.76 . . . . 0.0 110.144 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 38.29 69.72 0.24 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 128.964 2.906 . . . . 0.0 115.455 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 79.2 t -117.89 136.21 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.05 158.3 44.7 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.5 143.58 24.81 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 118.821 0.737 . . . . 0.0 110.201 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.64 118.37 0.84 Allowed 'General case' 0 C--N 1.354 0.788 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.203 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.16 154.2 36.52 Favored 'General case' 0 C--N 1.369 1.435 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.37 157.14 46.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.405 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.494 HD21 HD23 ' B' ' 858' ' ' LEU . 2.4 tm? -133.99 130.21 37.29 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -166.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 39.9 p -163.07 13.1 0.06 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -161.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.494 HD23 HD21 ' B' ' 856' ' ' LEU . 3.5 pp -25.06 148.01 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.387 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 159.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.13 -45.66 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 122.14 1.8 . . . . 0.0 113.329 -164.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.83 176.03 10.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.64 119.63 0.02 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.507 3.523 . . . . 0.0 116.138 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -113.82 163.69 18.02 Favored Pre-proline 0 N--CA 1.443 -0.784 0 C-N-CA 124.037 0.935 . . . . 0.0 108.799 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.02 -13.55 14.04 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.875 2.383 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.79 -144.79 4.41 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -64.72 137.73 57.98 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 126.38 1.872 . . . . 0.0 110.901 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.54 145.63 95.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 113.342 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -102.21 -145.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.068 2.512 . . . . 0.0 107.285 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -148.46 134.18 18.88 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -117.0 -13.82 10.61 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.749 0.819 . . . . 0.0 110.21 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.521 HH21 HD23 ' B' ' 872' ' ' LEU . 15.8 mmm180 -99.97 86.47 3.27 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-O 121.11 0.481 . . . . 0.0 111.918 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.85 95.48 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 127.763 2.425 . . . . 0.0 105.402 163.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.521 HD23 HH21 ' B' ' 870' ' ' ARG . 4.5 mt -90.74 -38.14 13.22 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.726 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.5 tp -166.59 130.64 2.04 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.5 p-10 172.48 62.62 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 120.906 1.684 . . . . 0.0 108.903 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.16 -44.06 92.12 Favored 'General case' 0 C--N 1.364 1.216 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.31 -32.01 9.17 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.05 -68.39 0.24 Allowed Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 77.15 -68.18 0.18 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 128.245 2.618 . . . . 0.0 112.288 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -98.38 121.85 40.83 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.331 1.452 . . . . 0.0 108.1 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.03 118.08 70.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-O 116.149 -1.881 . . . . 0.0 106.266 167.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -90.79 -0.22 5.05 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 CA-C-N 124.6 2.679 . . . . 0.0 108.772 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.68 -41.01 27.72 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 124.921 1.288 . . . . 0.0 108.651 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 37.8 p -104.66 -15.53 15.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.67 16.98 69.24 Favored Glycine 0 C--N 1.364 2.111 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.94 105.9 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 -168.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.64 112.43 24.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.366 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.23 109.26 20.89 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . 0.485 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.82 111.07 46.02 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.837 169.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.52 1.52 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 123.078 2.135 . . . . 0.0 108.767 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.27 -49.46 72.02 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.819 2.048 . . . . 0.0 114.26 -167.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.69 47.76 17.66 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.302 1.441 . . . . 0.0 114.704 171.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -159.63 -164.18 14.48 Favored Glycine 0 N--CA 1.413 -2.888 1 N-CA-C 101.345 -4.702 . . . . 0.0 101.345 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -89.95 121.35 31.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.432 ' H ' HD11 ' B' ' 954' ' ' LEU 0.25 0.0 OUTLIER -117.17 151.94 35.82 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.901 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.9 tp -106.42 115.64 30.56 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -113.21 136.5 52.67 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.794 1.638 . . . . 0.0 109.063 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.1 m -145.93 119.23 8.95 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 123.542 0.737 . . . . 0.0 109.247 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.18 154.68 20.85 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 96.9 t -105.2 122.11 58.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.45 121.92 41.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.106 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 46.9 m -82.17 131.92 35.24 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 125.353 1.461 . . . . 0.0 107.509 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.67 18.61 Favored Glycine 0 C--N 1.363 2.062 0 C-N-CA 125.165 1.364 . . . . 0.0 114.376 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.9 m170 33.04 73.24 0.07 Allowed 'General case' 0 C--N 1.361 1.072 0 C-N-CA 127.845 2.458 . . . . 0.0 115.357 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -74.02 -8.1 54.9 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.366 1.466 . . . . 0.0 111.901 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -72.03 -15.72 62.04 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.845 1.658 . . . . 0.0 112.619 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.318 8.5 pt-20 119.36 -176.13 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 129.152 2.981 . . . . 0.0 108.192 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 103.24 129.98 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 128.158 2.583 . . . . 0.0 106.561 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.25 125.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -109.02 130.42 55.48 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.024 1.73 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.13 115.07 4.04 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.928 1.291 . . . . 0.0 110.2 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 5.0 p -84.04 117.82 30.29 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 125.494 1.518 . . . . 0.0 107.932 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 28.4 mt -62.96 137.9 58.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.453 1.501 . . . . 0.0 109.083 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.0 t -116.02 148.62 39.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.959 1.704 . . . . 0.0 108.715 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.485 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -77.06 138.19 39.41 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 127.989 2.516 . . . . 0.0 110.169 -173.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 87.6 4.67 0.31 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.863 2.865 . . . . 0.0 113.019 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -150.03 -24.67 0.26 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.438 1.017 . . . . 0.0 111.515 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 57.56 173.79 0.05 OUTLIER 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.881 1.272 . . . . 0.0 111.983 -161.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.38 -133.05 52.83 Favored Glycine 0 C--N 1.374 2.68 0 O-C-N 119.622 -1.924 . . . . 0.0 110.337 -164.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 62.0 t 55.54 75.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.22 0 C-N-CA 125.729 1.612 . . . . 0.0 111.26 172.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.56 116.59 28.99 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -173.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -102.38 -33.14 9.67 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 113.536 -1.666 . . . . 0.0 108.268 -172.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.83 83.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 164.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.35 130.77 40.53 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 121.226 0.536 . . . . 0.0 110.363 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.8 t -142.89 115.43 8.58 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.502 1.521 . . . . 0.0 107.438 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.2 84.67 0.78 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.961 -3.256 . . . . 0.0 104.961 167.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.616 0 C-N-CA 124.888 1.232 . . . . 0.0 111.285 176.184 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.19 133.76 55.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.62 161.74 27.72 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.22 130.91 73.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -138.95 151.15 46.65 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.5 m -113.85 -46.03 3.05 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.02 -49.98 8.42 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 119.221 0.919 . . . . 0.0 112.919 -166.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.63 -173.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.628 1.571 . . . . 0.0 110.455 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.432 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.77 83.86 2.23 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -166.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.7 90.69 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 109.099 159.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.65 141.12 51.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -95.49 158.45 15.45 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.19 123.08 21.38 Favored 'General case' 0 C--N 1.376 1.745 0 CA-C-N 119.805 1.184 . . . . 0.0 108.938 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.24 -10.79 73.62 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 125.867 1.699 . . . . 0.0 111.334 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.71 174.3 6.99 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-O 121.464 0.65 . . . . 0.0 111.241 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.4 m -144.43 127.03 16.06 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -159.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.417 HG13 HH11 ' B' ' 914' ' ' ARG . 15.6 m -98.35 147.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 CA-C-O 121.303 0.573 . . . . 0.0 111.397 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 23.1 t -142.76 137.86 30.05 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 126.422 1.889 . . . . 0.0 110.9 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 26.6 t -91.7 129.4 42.43 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 107.536 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.85 132.08 53.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 72.71 1.51 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 49.6 t -161.99 102.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 83.5 mmm -153.18 71.17 0.89 Allowed 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.67 146.47 7.78 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 107.571 -2.212 . . . . 0.0 107.571 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.2 -28.21 7.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 45.5 tp -92.84 86.31 5.45 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.65 -155.63 0.62 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -124.07 167.41 14.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 23.3 t -104.49 131.34 51.99 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.58 155.86 30.91 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.14 114.91 21.76 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -99.41 172.6 0.44 Allowed 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.025 1.817 . . . . 0.0 108.021 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.71 140.74 48.91 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.1 p -138.28 140.4 39.59 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 119.5 1.045 . . . . 0.0 108.49 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.66 131.21 69.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.42 106.1 9.24 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 24.9 p -99.97 160.18 14.52 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.521 1.128 . . . . 0.0 108.858 170.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.94 109.45 0.26 Allowed Glycine 0 C--N 1.356 1.643 0 C-N-CA 118.899 -1.62 . . . . 0.0 109.356 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -122.56 145.23 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 57.3 tp -72.74 126.57 30.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 124.948 1.299 . . . . 0.0 110.449 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 31.4 tp -97.45 -57.18 2.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.317 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -131.2 127.78 38.63 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -173.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 129.71 10.0 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 103.536 -3.826 . . . . 0.0 103.536 163.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.55 128.42 91.11 Favored Pre-proline 0 C--N 1.351 0.668 0 CA-C-O 117.791 -1.099 . . . . 0.0 110.342 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -106.72 82.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 122.12 1.793 . . . . 0.0 109.28 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 79.14 -70.5 0.1 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.911 3.284 . . . . 0.0 109.091 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 19.8 mt 50.08 38.91 17.98 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 128.729 2.812 . . . . 0.0 114.245 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.14 110.13 11.75 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.115 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.336 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.793 0 N-CA-C 110.175 -0.741 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.64 119.28 25.89 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.89 -19.76 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 CA-C-N 122.096 1.784 . . . . 0.0 110.102 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 36.78 71.79 0.13 Allowed 'General case' 0 C--N 1.359 1.014 0 C-N-CA 129.174 2.99 . . . . 0.0 115.388 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 75.0 t -116.85 135.32 57.58 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.43 154.37 50.81 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 163.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 7.2 p90 -150.13 141.83 23.62 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 118.536 0.607 . . . . 0.0 109.93 171.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 23.0 t -168.07 118.58 0.8 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.45 155.36 40.6 Favored 'General case' 0 C--N 1.368 1.405 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.1 156.13 46.02 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.743 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.541 HD21 HD23 ' C' ' 858' ' ' LEU . 2.4 tm? -133.34 128.33 35.44 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.467 -167.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 73.1 m -161.05 10.08 0.09 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -161.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.541 HD23 HD21 ' C' ' 856' ' ' LEU . 2.4 pp -27.63 146.44 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.495 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 161.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.85 -46.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 CA-C-N 122.099 1.786 . . . . 0.0 113.454 -162.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -162.28 171.16 17.73 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m 0.46 106.78 0.01 OUTLIER 'General case' 0 C--N 1.361 1.109 0 C-N-CA 131.116 3.767 . . . . 0.0 116.77 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -103.93 163.33 17.57 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 123.562 0.745 . . . . 0.0 109.316 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.7 -13.54 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.754 2.302 . . . . 0.0 111.069 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -145.35 4.47 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.9 m -65.36 139.39 58.56 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.283 1.833 . . . . 0.0 110.475 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.08 147.59 83.54 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 112.771 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -100.92 -145.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.291 2.661 . . . . 0.0 107.035 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.28 133.85 18.74 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -116.49 -16.28 10.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.501 0.72 . . . . 0.0 110.864 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.414 HH21 HD23 ' C' ' 872' ' ' LEU . 11.3 mmm180 -101.86 82.47 2.26 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.11 96.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 126.706 2.002 . . . . 0.0 106.511 164.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.414 HD23 HH21 ' C' ' 870' ' ' ARG . 1.7 mt -89.64 -36.88 15.01 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.902 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 54.0 tp -164.06 130.3 3.08 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 100.913 -3.736 . . . . 0.0 100.913 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 41.7 t-20 175.01 60.38 0.0 OUTLIER 'General case' 0 C--N 1.356 0.865 0 CA-C-N 120.621 1.555 . . . . 0.0 107.399 -166.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.89 -44.55 95.8 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -165.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.65 -33.09 7.67 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.617 0.644 . . . . 0.0 112.212 -174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 115.86 -65.91 0.31 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 106.193 -2.763 . . . . 0.0 106.193 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 63.66 -80.52 0.03 OUTLIER 'General case' 0 C--N 1.355 0.808 0 C-N-CA 127.983 2.513 . . . . 0.0 113.598 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -94.36 120.74 35.05 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.856 1.263 . . . . 0.0 107.703 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.93 118.24 70.88 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-O 115.989 -1.958 . . . . 0.0 106.03 167.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -90.8 -4.02 4.72 Favored 'Trans proline' 0 CA--C 1.509 -0.731 0 CA-C-N 124.786 2.745 . . . . 0.0 108.795 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -79.92 -40.55 27.94 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 125.17 1.388 . . . . 0.0 108.784 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -103.8 -15.15 15.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.12 16.39 69.7 Favored Glycine 0 C--N 1.363 2.053 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 167.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.83 105.8 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 -167.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.42 ' CB ' HG22 ' C' ' 962' ' ' VAL . 1.3 t80 -97.28 111.67 23.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.204 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 56.3 m -101.32 109.25 21.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 170.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.69 110.51 41.98 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.491 -1.242 . . . . 0.0 111.463 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.08 -0.64 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 122.946 2.088 . . . . 0.0 108.245 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 0.443 HD12 ' H ' ' C' ' 892' ' ' GLY . 3.7 pp -58.18 -43.55 87.57 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.333 1.453 . . . . 0.0 114.69 -166.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.72 46.71 16.84 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . 0.443 ' H ' HD12 ' C' ' 890' ' ' LEU . . . -159.03 -163.76 13.51 Favored Glycine 0 N--CA 1.417 -2.571 1 N-CA-C 101.581 -4.608 . . . . 0.0 101.581 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 46.7 ttt-85 -91.32 120.53 32.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.476 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -116.41 156.29 27.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.452 1.101 . . . . 0.0 108.798 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.9 115.52 29.96 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.581 0.752 . . . . 0.0 110.083 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 5.0 tt -116.07 136.06 53.37 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 -174.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.85 119.5 9.78 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 123.633 0.773 . . . . 0.0 109.999 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 154.75 20.94 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.2 t -105.78 122.14 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.55 122.24 41.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.28 1.032 . . . . 0.0 109.142 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 54.3 m -80.44 132.46 35.73 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 125.256 1.423 . . . . 0.0 107.997 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.06 -57.29 20.0 Favored Glycine 0 C--N 1.367 2.268 0 C-N-CA 124.819 1.199 . . . . 0.0 113.343 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 45.06 68.57 0.54 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 127.08 2.152 . . . . 0.0 114.254 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -73.14 -11.84 60.68 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.749 1.22 . . . . 0.0 112.227 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -73.13 -13.94 61.28 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.075 1.75 . . . . 0.0 112.88 -166.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.345 0.3 OUTLIER 118.26 -173.6 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 129.217 3.007 . . . . 0.0 108.398 175.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 97.24 133.44 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 128.061 2.545 . . . . 0.0 106.749 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.79 122.56 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -104.4 123.0 46.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.913 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.27 116.72 17.27 Favored 'General case' 0 C--N 1.369 1.441 0 C-N-CA 128.452 2.701 . . . . 0.0 109.434 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 97.3 t -84.0 113.95 23.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.77 148.2 43.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.021 2.129 . . . . 0.0 112.061 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.27 1.0 OUTLIER -116.34 147.07 41.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.257 1.823 . . . . 0.0 110.993 175.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 139.34 38.14 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 127.133 2.173 . . . . 0.0 108.815 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.7 t 94.74 -10.99 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.717 2.807 . . . . 0.0 112.596 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -141.44 -28.35 0.66 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.585 1.084 . . . . 0.0 111.751 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 58.38 170.7 0.06 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 124.855 1.262 . . . . 0.0 112.191 -162.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -135.52 50.16 Favored Glycine 0 C--N 1.372 2.576 0 O-C-N 119.447 -2.033 . . . . 0.0 109.997 -162.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t 56.27 76.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.248 0 C-N-CA 125.551 1.54 . . . . 0.0 111.358 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.2 115.54 28.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 37.8 ptt85 -102.38 -35.15 8.91 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.318 -172.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 93.9 t -99.56 86.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 162.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -93.93 133.54 37.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.657 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.2 t -142.21 115.47 8.91 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.675 1.59 . . . . 0.0 107.633 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.55 84.48 0.68 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 104.628 -3.389 . . . . 0.0 104.628 165.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 111.028 175.456 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 60.8 mt -120.21 133.68 55.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.22 162.38 27.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.61 130.6 74.34 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -138.07 146.44 42.94 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.4 m -107.55 -58.29 1.98 Allowed 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.028 0.377 . . . . 0.0 112.015 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 41.1 tp -77.62 -49.03 15.42 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -165.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 8.0 pt -84.84 -172.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 125.552 1.541 . . . . 0.0 110.274 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.476 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -159.61 92.04 1.81 Allowed Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -167.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.59 91.41 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 O-C-N 117.384 -1.956 . . . . 0.0 108.403 155.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.32 145.43 47.12 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -90.86 162.23 14.9 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.46 126.61 30.26 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 120.257 -1.527 . . . . 0.0 107.116 163.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.37 -1.13 64.14 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -54.65 167.93 0.32 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.574 1.549 . . . . 0.0 114.972 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.7 121.75 11.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.42 HG22 ' CB ' ' C' ' 886' ' ' PHE . 2.7 m -100.44 147.73 7.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -143.99 137.79 27.96 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.714 1.206 . . . . 0.0 112.059 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.14 129.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 126.929 2.092 . . . . 0.0 107.96 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.59 133.39 52.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.54 77.5 1.79 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 112.953 -1.93 . . . . 0.0 107.587 172.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 61.2 t -159.59 100.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -153.12 66.24 0.78 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 132.08 147.07 5.82 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -116.75 -16.68 10.64 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.312 0.645 . . . . 0.0 110.059 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -104.61 82.79 1.95 Allowed 'General case' 0 C--N 1.356 0.858 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.6 -167.19 2.02 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -171.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -119.94 155.06 33.51 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.6 t -93.29 132.13 37.78 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.27 151.6 23.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.91 113.7 29.94 Favored Pre-proline 0 C--N 1.355 0.814 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 172.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.0 174.81 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 122.26 1.973 . . . . 0.0 107.804 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.49 141.15 48.45 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.4 p -135.02 140.95 46.04 Favored 'General case' 0 C--N 1.374 1.67 0 CA-C-N 119.206 0.912 . . . . 0.0 108.893 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.3 mm -115.69 131.13 69.0 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -127.1 105.52 8.63 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 29.3 p -100.09 160.12 14.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.499 1.12 . . . . 0.0 109.125 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.86 108.61 0.25 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.23 145.28 45.12 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.42 126.65 30.37 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 125.015 1.326 . . . . 0.0 110.684 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 36.4 tp -98.23 -58.26 2.02 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.651 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -133.13 128.52 36.28 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.407 1.883 . . . . 0.0 106.783 -172.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.77 129.38 9.88 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 103.988 -3.645 . . . . 0.0 103.988 160.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.05 130.05 90.18 Favored Pre-proline 0 C--N 1.35 0.606 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.343 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -106.83 84.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 121.874 1.705 . . . . 0.0 109.518 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.86 -70.84 0.1 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 130.131 3.372 . . . . 0.0 109.494 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 54.0 mt 49.71 40.1 19.22 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 128.867 2.867 . . . . 0.0 113.983 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -115.14 132.48 56.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -130.49 110.53 11.52 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.219 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.758 0 N-CA-C 110.073 -0.78 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.38 120.67 24.9 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -91.11 -21.44 0.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.201 1.822 . . . . 0.0 109.585 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 34.91 71.75 0.11 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 129.258 3.023 . . . . 0.0 115.506 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.03 136.84 53.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.743 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.56 155.74 49.99 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 164.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 8.4 p90 -149.13 138.62 21.69 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.0 t -169.12 117.18 0.64 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.08 153.84 39.37 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.66 155.4 49.18 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.988 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 858' ' ' LEU . 2.0 tm? -130.13 128.82 42.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -165.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 50.8 p -161.05 14.15 0.1 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -161.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 856' ' ' LEU . 3.6 pp -20.95 143.26 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.382 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 159.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.05 -40.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 121.971 1.74 . . . . 0.0 112.481 -162.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 38.6 ptt85 -164.19 176.29 9.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 21.7 m -16.97 119.3 0.02 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 130.129 3.372 . . . . 0.0 115.481 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -119.12 147.18 42.2 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -162.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.13 -10.0 19.31 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.523 2.149 . . . . 0.0 112.695 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.5 -143.3 3.62 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 120.338 1.427 . . . . 0.0 111.265 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 32.9 m -82.68 146.82 28.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.206 1.802 . . . . 0.0 108.3 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.11 138.74 97.41 Favored Pre-proline 0 C--N 1.356 0.854 0 C-N-CA 125.491 1.517 . . . . 0.0 113.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -98.9 -149.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.805 3.003 . . . . 0.0 106.233 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -151.49 131.33 13.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -118.08 -15.02 9.92 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.947 -0.47 . . . . 0.0 111.149 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.81 85.4 2.88 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.911 -0.493 . . . . 0.0 112.005 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.52 98.64 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 126.505 1.922 . . . . 0.0 106.916 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 27.8 mt -87.64 -37.38 16.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.008 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.13 129.45 2.06 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 101.398 -3.556 . . . . 0.0 101.398 162.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 28.8 t-20 -175.8 61.8 0.02 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 120.809 1.64 . . . . 0.0 109.814 -167.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -58.84 -44.78 91.03 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -166.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.08 -31.84 8.26 Favored Glycine 0 C--N 1.354 1.579 0 CA-C-N 118.949 0.795 . . . . 0.0 112.334 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.34 -58.87 0.39 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 63.58 -81.7 0.03 OUTLIER 'General case' 0 C--N 1.355 0.828 0 C-N-CA 128.204 2.602 . . . . 0.0 114.053 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -97.05 119.99 36.56 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.775 1.23 . . . . 0.0 108.35 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -78.84 117.54 67.28 Favored Pre-proline 0 N--CA 1.444 -0.756 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -92.84 2.58 3.63 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.411 2.968 . . . . 0.0 109.451 -166.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -80.74 -45.68 16.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 28.2 p -106.3 -12.89 15.55 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 109.055 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.63 38.46 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.02 103.57 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 -165.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.62 112.24 24.74 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.922 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 87.5 m -100.66 107.97 19.73 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.78 109.92 38.02 Favored Pre-proline 0 C--N 1.355 0.837 0 CA-C-O 117.23 -1.366 . . . . 0.0 110.916 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.12 -2.44 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.845 2.364 . . . . 0.0 108.86 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.47 -57.58 4.0 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 130.329 3.452 . . . . 0.0 114.771 -169.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.99 64.83 1.32 Allowed 'General case' 0 C--N 1.364 1.215 0 CA-C-O 121.759 0.79 . . . . 0.0 112.819 171.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.06 -166.75 32.66 Favored Glycine 0 N--CA 1.41 -3.046 1 N-CA-C 101.467 -4.653 . . . . 0.0 101.467 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -91.75 122.56 34.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.279 -0.96 . . . . 0.0 108.785 172.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.493 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.2 t80 -115.3 145.73 42.19 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.14 115.69 30.19 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.391 0.676 . . . . 0.0 109.315 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.78 139.48 49.09 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.075 1.75 . . . . 0.0 108.843 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 70.1 m -144.12 119.58 10.32 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 123.363 0.665 . . . . 0.0 109.716 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.22 21.55 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.3 t -104.92 121.26 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.76 123.25 43.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.292 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 43.4 m -84.07 131.76 34.77 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 125.657 1.583 . . . . 0.0 106.936 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.56 17.85 Favored Glycine 0 C--N 1.363 2.057 0 C-N-CA 124.595 1.093 . . . . 0.0 113.53 -168.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 56.4 m170 39.39 71.44 0.17 Allowed 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.12 2.168 . . . . 0.0 114.626 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -70.87 -10.54 59.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.936 1.694 . . . . 0.0 111.957 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -73.33 -17.92 61.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.578 1.551 . . . . 0.0 112.746 -168.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.326 12.2 pt-20 124.52 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.603 2.361 . . . . 0.0 108.223 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.4 tttt 100.64 132.34 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 128.129 2.571 . . . . 0.0 107.163 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.32 124.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -108.02 123.62 48.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.163 1.785 . . . . 0.0 112.11 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.57 115.09 14.29 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.121 2.569 . . . . 0.0 109.553 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 90.8 t -87.66 113.77 25.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.578 1.951 . . . . 0.0 111.452 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER -114.44 147.28 39.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 126.671 1.988 . . . . 0.0 109.787 178.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.489 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -79.79 140.79 36.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 125.728 1.611 . . . . 0.0 110.0 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.329 24.2 p 92.61 3.86 0.07 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 129.856 3.262 . . . . 0.0 114.227 173.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -148.24 -26.18 0.34 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 119.309 0.959 . . . . 0.0 111.065 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.51 168.17 0.05 Allowed 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.729 1.612 . . . . 0.0 111.835 -162.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.86 -135.0 49.31 Favored Glycine 0 C--N 1.369 2.396 0 O-C-N 119.615 -1.928 . . . . 0.0 109.233 -161.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 41.2 t 55.96 79.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 125.952 1.701 . . . . 0.0 110.992 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.52 113.99 26.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 24.1 ptt85 -103.73 -37.1 7.62 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.014 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -99.27 87.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 166.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.06 130.43 41.74 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.688 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -143.56 115.08 8.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.353 1.461 . . . . 0.0 108.129 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.3 84.7 0.7 Allowed Glycine 0 CA--C 1.484 -1.865 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 165.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 C-N-CA 124.925 1.25 . . . . 0.0 111.302 173.741 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 61.1 mt -116.47 133.84 55.55 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -135.37 161.32 24.67 Favored Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.31 126.77 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -138.84 149.56 45.05 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 71.2 m -106.65 -54.36 2.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.456 0.302 . . . . 0.0 110.908 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.02 -49.9 9.08 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -162.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.52 -175.97 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.381 1.472 . . . . 0.0 110.687 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.504 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -159.33 93.04 1.82 Allowed Pre-proline 0 N--CA 1.44 -0.949 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -164.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.3 92.31 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 O-C-N 116.869 -2.227 . . . . 0.0 110.152 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.504 HD13 ' HB2' ' A' ' 954' ' ' LEU . 6.8 mp -120.85 138.93 53.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -93.21 158.03 15.97 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.843 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.98 123.11 21.28 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 119.896 1.225 . . . . 0.0 108.997 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.13 73.02 Favored Glycine 0 C--N 1.345 1.071 0 C-N-CA 126.541 2.019 . . . . 0.0 111.851 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -73.17 174.96 7.23 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.359 1.064 . . . . 0.0 110.521 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 89.7 m -142.84 125.12 15.49 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 108.821 -160.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.489 HG13 HH11 ' A' ' 914' ' ' ARG . 30.7 m -95.43 149.83 4.43 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-O 121.445 0.64 . . . . 0.0 109.627 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -141.39 138.93 33.34 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.234 1.814 . . . . 0.0 111.414 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 98.6 t -92.05 129.18 43.09 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 C-N-CA 126.484 1.914 . . . . 0.0 106.268 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.05 132.34 53.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.89 78.09 1.83 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 51.3 t -160.98 100.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.973 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -154.32 66.59 0.7 Allowed 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.16 146.89 6.91 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -114.08 -31.89 6.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -90.58 86.97 6.55 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.89 -167.18 2.1 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -122.98 157.62 32.26 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 15.7 t -91.6 133.9 35.14 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.66 151.58 22.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.52 111.16 19.24 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -98.58 173.23 0.51 Allowed 'Trans proline' 0 CA--C 1.507 -0.874 0 C-N-CA 121.742 1.628 . . . . 0.0 108.317 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.58 141.03 48.72 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 24.3 p -138.78 139.71 38.36 Favored 'General case' 0 C--N 1.374 1.66 0 CA-C-N 119.302 0.956 . . . . 0.0 108.513 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.0 mm -118.17 130.25 73.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.21 106.48 9.58 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 37.4 p -99.96 160.81 14.03 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 124.465 1.106 . . . . 0.0 109.678 171.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.97 109.49 0.27 Allowed Glycine 0 C--N 1.358 1.754 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.379 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.94 147.75 43.69 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 54.3 tp -72.43 123.29 22.79 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 126.092 1.757 . . . . 0.0 109.146 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.02 -58.0 2.01 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -133.23 127.44 33.72 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 127.053 2.141 . . . . 0.0 106.383 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.79 129.73 10.0 Favored Glycine 0 CA--C 1.496 -1.144 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 161.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -69.03 131.35 90.83 Favored Pre-proline 0 C--N 1.353 0.744 0 CA-C-N 118.435 1.118 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -105.76 82.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.68 1.636 . . . . 0.0 109.468 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.91 -72.73 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.205 3.402 . . . . 0.0 109.19 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 81.2 mt 50.87 37.68 17.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.377 3.071 . . . . 0.0 114.098 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.54 134.1 52.69 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.96 107.95 8.61 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -178.633 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 110.055 -0.787 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.03 121.01 25.38 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.63 -21.73 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 122.139 1.8 . . . . 0.0 109.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 35.46 71.97 0.11 Allowed 'General case' 0 C--N 1.361 1.079 0 C-N-CA 129.611 3.164 . . . . 0.0 115.127 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.72 136.3 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.6 155.5 50.36 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 9.5 p90 -149.54 139.79 22.23 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 26.6 t -169.11 117.8 0.66 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.51 154.28 36.85 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.29 155.4 47.76 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.905 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.59 127.72 39.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -165.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 51.3 p -160.9 13.8 0.1 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.233 -161.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.6 pp -20.82 143.45 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.456 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 158.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.35 -40.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.98 1.743 . . . . 0.0 112.48 -163.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -164.29 176.31 9.26 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 21.2 m -16.98 119.33 0.02 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.156 3.382 . . . . 0.0 115.451 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.2 147.37 42.77 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -162.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -76.27 -9.87 19.08 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.533 2.155 . . . . 0.0 112.695 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.59 -143.58 3.7 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 120.287 1.403 . . . . 0.0 111.262 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 33.0 m -81.92 147.04 29.48 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.234 1.814 . . . . 0.0 108.326 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 17.4 m -63.08 138.46 97.33 Favored Pre-proline 0 C--N 1.355 0.841 0 C-N-CA 125.413 1.485 . . . . 0.0 113.192 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -99.62 -150.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.723 2.949 . . . . 0.0 106.121 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -150.88 130.71 13.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -116.47 -14.49 10.94 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.427 0.691 . . . . 0.0 110.363 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -101.31 84.07 2.57 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 122.038 -0.414 . . . . 0.0 111.842 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.83 97.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 126.438 1.895 . . . . 0.0 106.461 166.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 12.6 mt -87.98 -38.03 15.87 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.714 -173.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.3 tp -165.3 129.3 2.34 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 101.266 -3.605 . . . . 0.0 101.266 165.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' B' ' 852' ' ' PHE . 32.1 t-20 179.03 62.2 0.01 OUTLIER 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.447 1.476 . . . . 0.0 109.214 -164.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -59.08 -44.54 91.9 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -167.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.88 -32.06 8.22 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 118.768 0.713 . . . . 0.0 112.242 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.16 -58.67 0.39 Allowed Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 63.8 -82.08 0.03 OUTLIER 'General case' 0 C--N 1.356 0.862 0 C-N-CA 128.13 2.572 . . . . 0.0 114.062 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.61 119.82 36.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 125.173 1.389 . . . . 0.0 108.308 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.27 117.92 69.09 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-O 115.459 -2.21 . . . . 0.0 105.309 171.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -91.79 2.31 4.24 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 125.507 3.002 . . . . 0.0 109.671 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -80.41 -44.53 19.19 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.606 1.163 . . . . 0.0 108.704 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 26.8 p -108.59 -13.19 14.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.085 1.354 . . . . 0.0 108.651 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.02 36.15 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 163.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 26.2 t -100.24 103.83 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.605 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 -164.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.402 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.4 OUTLIER -101.23 112.46 24.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.586 -2.097 . . . . 0.0 108.973 -176.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 88.7 m -100.79 108.13 19.86 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.96 110.13 39.87 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.138 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.95 -1.04 5.66 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.767 2.311 . . . . 0.0 108.843 165.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 129.832 3.253 . . . . 0.0 114.87 -169.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.45 58.93 2.78 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -170.23 -165.08 27.03 Favored Glycine 0 N--CA 1.412 -2.933 1 N-CA-C 102.461 -4.255 . . . . 0.0 102.461 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -92.08 121.87 34.04 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.777 -1.211 . . . . 0.0 107.868 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.441 ' H ' HD11 ' B' ' 954' ' ' LEU . 1.7 t80 -116.79 146.43 42.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -173.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.8 tp -111.51 114.86 28.24 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -113.35 139.37 48.92 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.28 1.832 . . . . 0.0 108.539 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -143.79 119.74 10.65 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.194 0.598 . . . . 0.0 109.703 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.58 21.01 Favored 'General case' 0 C--N 1.364 1.224 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.49 122.02 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.4 121.81 43.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.145 0.978 . . . . 0.0 109.19 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 40.1 m -82.66 132.0 35.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.646 1.578 . . . . 0.0 107.541 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.29 -57.72 17.68 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 124.758 1.171 . . . . 0.0 113.793 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 38.63 71.74 0.15 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 127.234 2.214 . . . . 0.0 114.774 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -71.0 -10.67 60.16 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.046 1.738 . . . . 0.0 112.043 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -73.82 -15.59 61.17 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.86 1.664 . . . . 0.0 112.908 -167.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.2 pt-20 122.1 179.4 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.856 2.462 . . . . 0.0 108.107 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 101.34 131.87 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 128.074 2.55 . . . . 0.0 107.088 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.26 126.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -110.69 122.85 48.82 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.966 -1.47 . . . . 0.0 113.093 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.81 115.74 15.67 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.842 2.457 . . . . 0.0 109.596 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 76.9 t -88.48 113.88 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 148.53 43.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.093 2.157 . . . . 0.0 111.493 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.275 0.8 OUTLIER -114.6 147.9 38.85 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 126.955 2.102 . . . . 0.0 109.715 178.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.512 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.73 140.13 35.73 Favored 'General case' 0 N--CA 1.424 -1.775 0 C-N-CA 125.652 1.581 . . . . 0.0 109.718 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.327 24.0 p 92.81 1.64 0.09 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 129.85 3.26 . . . . 0.0 114.363 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -147.28 -25.98 0.39 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-N 119.527 1.058 . . . . 0.0 111.408 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.55 168.01 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 125.678 1.591 . . . . 0.0 111.692 -162.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.61 -134.54 47.39 Favored Glycine 0 C--N 1.367 2.266 0 O-C-N 119.757 -1.839 . . . . 0.0 109.142 -163.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 44.6 t 54.49 80.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 126.314 1.846 . . . . 0.0 111.008 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.28 114.2 26.67 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -103.97 -38.22 7.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 113.298 -1.774 . . . . 0.0 108.757 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.55 87.01 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.615 -3.105 . . . . 0.0 102.615 166.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.4 130.48 42.19 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.0 t -142.43 115.77 8.99 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.038 1.335 . . . . 0.0 107.813 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.19 84.58 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 103.921 -3.672 . . . . 0.0 103.921 165.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 C-N-CA 125.172 1.367 . . . . 0.0 111.289 174.209 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 62.9 mt -116.95 134.27 54.96 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.62 26.98 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.01 128.83 75.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -138.1 151.51 47.86 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 68.7 m -117.24 -38.04 3.43 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.126 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.35 -53.61 4.27 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.071 0.85 . . . . 0.0 111.947 -168.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.22 177.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.85 1.26 . . . . 0.0 109.858 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -161.08 95.13 1.41 Allowed Pre-proline 0 C--N 1.358 0.954 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -163.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.88 95.74 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.945 2.43 . . . . 0.0 111.181 161.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' B' ' 954' ' ' LEU . 9.5 mp -119.77 139.85 51.67 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -93.92 159.15 15.31 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.841 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.82 122.95 21.61 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 120.058 1.299 . . . . 0.0 108.983 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.1 -11.51 71.94 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.413 1.959 . . . . 0.0 111.681 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -73.44 174.56 8.01 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.321 1.048 . . . . 0.0 109.993 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 94.0 m -143.09 125.06 15.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -158.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.512 HG13 HH11 ' B' ' 914' ' ' ARG . 27.9 m -96.37 150.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 121.567 0.698 . . . . 0.0 110.244 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -140.95 139.02 34.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.518 1.927 . . . . 0.0 111.44 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.2 t -91.63 129.53 42.18 Favored 'Isoleucine or valine' 0 C--N 1.367 1.354 0 C-N-CA 127.261 2.224 . . . . 0.0 106.516 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.79 132.36 52.85 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.59 77.63 1.8 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 50.2 t -160.2 101.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -153.48 66.38 0.76 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.63 145.66 6.52 Favored Glycine 0 CA--C 1.492 -1.383 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -112.87 -30.92 6.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.5 86.76 6.15 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.64 -165.76 1.83 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -123.51 157.84 32.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 16.4 t -91.43 133.22 35.66 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.64 151.66 22.48 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.43 110.78 19.37 Favored Pre-proline 0 C--N 1.353 0.753 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -98.13 173.09 0.58 Allowed 'Trans proline' 0 CA--C 1.507 -0.836 0 C-N-CA 121.812 1.675 . . . . 0.0 108.172 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.51 139.28 50.21 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.8 p -138.02 138.13 38.54 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.5 mm -117.24 130.71 71.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -127.05 106.32 9.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 32.7 p -100.63 160.94 13.94 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.494 1.117 . . . . 0.0 109.771 171.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.21 109.55 0.27 Allowed Glycine 0 C--N 1.358 1.781 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.82 149.62 41.77 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.85 124.14 24.19 Favored 'General case' 0 C--N 1.378 1.836 0 C-N-CA 125.841 1.656 . . . . 0.0 109.718 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.33 -59.06 1.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -133.33 127.22 33.07 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 125.916 1.686 . . . . 0.0 106.489 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.81 130.05 10.11 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 104.311 -3.516 . . . . 0.0 104.311 161.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.12 131.27 90.71 Favored Pre-proline 0 C--N 1.351 0.652 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.205 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -105.48 81.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 121.695 1.641 . . . . 0.0 109.054 -170.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.31 -72.23 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 130.191 3.396 . . . . 0.0 109.139 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 80.1 mt 49.95 40.89 22.09 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 129.126 2.97 . . . . 0.0 113.785 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.96 133.54 55.41 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -133.34 107.78 8.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.13 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.767 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.76 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.51 114.92 29.99 Favored Pre-proline 0 N--CA 1.44 -0.943 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.24 -24.97 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 121.689 1.639 . . . . 0.0 109.826 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 41.55 66.5 0.68 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 128.192 2.597 . . . . 0.0 114.868 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.86 133.74 66.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.01 50.85 Favored 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 166.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 10.3 p90 -149.83 139.55 21.73 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 118.886 0.766 . . . . 0.0 109.82 175.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 22.7 t -169.44 120.2 0.69 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.25 -0.906 . . . . 0.0 108.8 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.51 153.05 34.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.507 ' HB2' HD11 ' C' ' 872' ' ' LEU . . . -139.08 158.08 44.82 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 121.685 0.755 . . . . 0.0 110.493 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.525 HD21 HD23 ' C' ' 858' ' ' LEU . 2.9 tm? -139.89 130.55 25.79 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -164.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 60.1 m -159.02 15.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.525 HD23 HD21 ' C' ' 856' ' ' LEU . 2.0 pp -25.8 142.79 0.04 OUTLIER Pre-proline 0 C--N 1.372 1.546 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 161.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.84 -44.05 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 CA-C-N 122.222 1.829 . . . . 0.0 113.529 -161.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -162.47 175.72 11.2 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 13.1 m -4.63 113.06 0.01 OUTLIER 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.673 3.589 . . . . 0.0 116.774 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 160.91 24.37 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.4 -17.75 7.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.418 2.079 . . . . 0.0 110.533 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -141.29 3.12 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 11.8 m -65.53 143.31 57.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.029 1.732 . . . . 0.0 110.061 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.75 132.65 25.71 Favored Pre-proline 0 N--CA 1.437 -1.098 0 C-N-CA 124.37 1.068 . . . . 0.0 110.447 -159.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.37 -151.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 124.135 3.223 . . . . 0.0 109.334 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -147.1 136.12 22.37 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -114.76 -17.78 11.52 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.669 0.788 . . . . 0.0 110.9 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 26.1 mmm180 -102.48 84.43 2.44 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.166 0.508 . . . . 0.0 111.125 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.68 98.22 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 126.699 1.999 . . . . 0.0 106.868 167.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' C' ' 855' ' ' ALA . 8.8 mt -85.81 -39.43 17.09 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.967 -173.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.9 tp -166.96 128.98 1.7 Allowed 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 100.598 -3.853 . . . . 0.0 100.598 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.1 t-20 178.71 61.91 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 108.333 -164.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.1 -44.42 94.84 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.26 -29.67 11.02 Favored Glycine 0 C--N 1.356 1.661 0 CA-C-N 118.716 0.689 . . . . 0.0 112.165 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.17 -57.76 0.42 Allowed Glycine 0 C--N 1.353 1.521 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 62.91 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.245 2.618 . . . . 0.0 113.982 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -97.53 120.64 38.28 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 125.861 1.665 . . . . 0.0 108.677 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.97 117.87 69.93 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -93.36 5.96 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 124.91 2.789 . . . . 0.0 109.887 -167.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 -46.07 17.8 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -105.67 -13.14 15.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.877 1.271 . . . . 0.0 108.327 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.98 43.63 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 162.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 70.0 t -99.53 104.22 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 102.05 -3.315 . . . . 0.0 102.05 -164.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -98.53 112.37 24.43 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 111.921 -2.4 . . . . 0.0 109.233 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 90.7 m -100.32 109.24 21.43 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.82 108.86 30.7 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.262 -1.352 . . . . 0.0 110.968 171.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -90.11 -3.86 5.28 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.528 2.152 . . . . 0.0 108.43 166.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 68.4 mt -54.51 -52.29 62.44 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 127.736 2.414 . . . . 0.0 114.418 -165.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.58 68.15 0.82 Allowed 'General case' 0 C--N 1.367 1.328 0 CA-C-O 122.076 0.941 . . . . 0.0 111.61 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.88 -167.55 34.95 Favored Glycine 0 N--CA 1.405 -3.433 1 N-CA-C 102.498 -4.241 . . . . 0.0 102.498 -171.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . 0.443 ' HE ' HG22 ' C' ' 953' ' ' ILE . 70.4 ttt-85 -92.03 121.21 33.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.275 -1.463 . . . . 0.0 108.643 172.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.591 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -117.78 145.61 44.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 51.6 tp -110.14 113.84 26.86 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.8 tt -112.0 137.61 49.77 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.318 1.447 . . . . 0.0 108.925 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.8 m -144.29 119.27 10.0 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.398 0.679 . . . . 0.0 109.919 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.15 153.74 22.73 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 91.1 t -101.7 122.64 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.59 121.87 40.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.026 0.93 . . . . 0.0 109.355 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.9 130.56 35.39 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -54.82 -56.84 20.71 Favored Glycine 0 C--N 1.366 2.247 0 C-N-CA 125.356 1.455 . . . . 0.0 113.354 -172.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 42.3 65.67 0.86 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.633 2.373 . . . . 0.0 114.181 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.39 -7.24 50.83 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 125.076 1.35 . . . . 0.0 112.178 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -71.38 -14.09 62.06 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.235 1.814 . . . . 0.0 112.187 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.338 6.1 pt-20 113.73 179.53 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.108 2.563 . . . . 0.0 108.051 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 109.42 137.46 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 128.56 2.744 . . . . 0.0 105.856 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 97.8 t -98.4 123.64 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -103.67 131.68 50.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.361 172.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.05 114.22 3.64 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.095 1.358 . . . . 0.0 110.519 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.27 117.74 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 125.867 1.667 . . . . 0.0 108.999 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.6 mt -62.53 143.5 57.12 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.74 1.616 . . . . 0.0 110.519 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 1.4 p -113.78 147.79 37.68 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.627 1.971 . . . . 0.0 107.795 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.528 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -78.73 137.35 37.73 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.891 173.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 2.9 t 97.93 -11.48 0.06 Allowed 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 128.797 2.839 . . . . 0.0 112.341 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.86 -27.63 0.58 Allowed 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 119.256 0.934 . . . . 0.0 111.501 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 59.04 169.09 0.06 Allowed 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.933 1.293 . . . . 0.0 112.254 -164.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.84 -130.74 51.46 Favored Glycine 0 C--N 1.376 2.79 0 O-C-N 119.702 -1.874 . . . . 0.0 110.12 -164.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 51.97 73.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.329 0 C-N-CA 126.191 1.797 . . . . 0.0 111.37 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.82 28.37 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -101.18 -30.89 11.3 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.518 -173.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.18 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 165.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -95.22 131.23 41.51 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 120.903 0.382 . . . . 0.0 111.184 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.2 t -143.88 115.07 7.93 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 125.283 1.433 . . . . 0.0 107.812 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.17 85.02 0.72 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 104.281 -3.528 . . . . 0.0 104.281 169.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.602 0 C-N-CA 125.183 1.373 . . . . 0.0 110.892 173.557 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.6 mt -122.46 134.56 54.58 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.93 163.31 27.0 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.76 132.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.46 149.81 47.12 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -121.33 -36.99 2.98 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 118.398 0.544 . . . . 0.0 111.802 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 29.0 tp -89.47 -53.77 4.39 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.533 0.606 . . . . 0.0 112.045 -165.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.443 HG22 ' HE ' ' C' ' 893' ' ' ARG . 25.4 pt -89.83 -162.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.846 0 C-N-CA 125.079 1.352 . . . . 0.0 108.871 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.591 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -165.26 88.15 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -166.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.94 88.18 1.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 122.422 1.901 . . . . 0.0 109.133 159.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.8 146.18 48.53 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.479 2.312 . . . . 0.0 105.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -92.71 159.98 15.18 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 119.213 0.915 . . . . 0.0 109.381 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.72 122.66 21.86 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 120.335 1.425 . . . . 0.0 108.954 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.75 71.34 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 125.95 1.738 . . . . 0.0 111.042 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.99 175.44 5.14 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.088 0.555 . . . . 0.0 111.075 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 17.1 p -141.83 127.96 19.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -157.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.528 HG13 HH11 ' C' ' 914' ' ' ARG . 17.1 m -93.41 150.19 4.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.8 t -139.72 136.5 34.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.882 1.273 . . . . 0.0 112.089 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.95 129.08 44.8 Favored 'Isoleucine or valine' 0 C--N 1.373 1.603 0 C-N-CA 126.486 1.914 . . . . 0.0 106.753 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.61 132.37 53.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 171.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.41 78.52 1.83 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.04 -1.891 . . . . 0.0 106.185 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -160.8 100.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.887 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 89.3 mmm -152.16 66.23 0.84 Allowed 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.79 143.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -112.8 -22.37 10.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.462 0.705 . . . . 0.0 109.982 -172.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 6.5 tt -98.6 86.23 3.53 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.74 -164.62 1.64 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -121.66 153.18 38.48 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 20.1 t -89.96 132.2 35.46 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -157.93 151.28 23.36 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.45 115.34 19.74 Favored Pre-proline 0 C--N 1.355 0.823 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.32 171.67 0.38 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.98 138.87 49.2 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.9 p -137.33 137.55 39.04 Favored 'General case' 0 C--N 1.376 1.746 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.0 mm -115.43 131.04 68.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.26 106.38 9.83 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 32.7 p -100.91 163.94 12.06 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.16 1.384 . . . . 0.0 110.222 172.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.91 111.19 0.32 Allowed Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.08 47.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 58.0 tp -78.18 124.42 28.05 Favored 'General case' 0 C--N 1.379 1.88 0 C-N-CA 124.516 1.126 . . . . 0.0 108.135 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 35.1 tp -97.1 -57.2 2.33 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.056 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -131.18 128.49 40.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 -174.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 131.05 10.51 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 103.412 -3.875 . . . . 0.0 103.412 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.41 131.93 88.03 Favored Pre-proline 0 C--N 1.351 0.645 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -105.84 81.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.427 0 CA-C-N 121.903 1.715 . . . . 0.0 109.847 -171.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 78.79 -72.12 0.09 Allowed 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 130.231 3.413 . . . . 0.0 109.171 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.7 mt 51.19 39.88 24.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 129.209 3.004 . . . . 0.0 113.787 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -112.62 133.49 54.64 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.86 107.86 8.59 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.453 -0.9 0 N-CA-C 110.232 -0.719 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 43.8 t -127.85 120.87 21.76 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.12 -22.23 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 122.032 1.762 . . . . 0.0 109.496 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 36.81 69.9 0.19 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.045 2.938 . . . . 0.0 115.607 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.63 136.21 56.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 160.63 37.71 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 12.2 p90 -149.23 139.76 22.51 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.6 t -169.27 116.56 0.61 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.61 153.02 36.11 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.02 158.54 44.22 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.21 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.482 HD21 HD23 ' A' ' 858' ' ' LEU . 2.5 tm? -134.81 134.72 41.14 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -167.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.438 ' H ' ' H ' ' A' ' 858' ' ' LEU . 40.6 p -164.25 10.1 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -163.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.482 HD23 HD21 ' A' ' 856' ' ' LEU . 2.1 pp -28.62 144.76 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.51 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 160.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -79.07 -47.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 122.324 1.866 . . . . 0.0 112.875 -162.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -162.2 170.55 18.86 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.6 m 4.03 104.05 0.0 OUTLIER 'General case' 0 C--N 1.36 1.058 0 C-N-CA 130.848 3.659 . . . . 0.0 117.463 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -96.46 163.57 20.25 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 123.174 0.59 . . . . 0.0 110.25 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.54 -14.61 12.8 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.662 2.241 . . . . 0.0 110.768 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -168.25 -142.5 3.51 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -63.83 144.46 57.03 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.714 2.006 . . . . 0.0 110.864 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 55.2 t -95.12 131.51 29.92 Favored Pre-proline 0 N--CA 1.439 -0.989 0 C-N-CA 124.841 1.256 . . . . 0.0 110.705 -162.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -95.84 -148.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.199 3.266 . . . . 0.0 108.464 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -149.65 136.86 19.79 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 41.6 p-10 -117.24 -15.61 10.41 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.909 0.484 . . . . 0.0 111.98 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -100.78 86.73 3.15 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 118.665 0.666 . . . . 0.0 112.723 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 874' ' ' ASN . 62.1 t -70.56 97.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.059 1.743 . . . . 0.0 107.123 167.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 48.0 mt -87.92 -36.46 17.12 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.969 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.6 tp -165.16 126.87 2.07 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 160.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.431 ' HB3' HG13 ' A' ' 871' ' ' VAL . 35.3 t-20 -174.88 61.86 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 120.528 1.513 . . . . 0.0 109.387 -168.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.8 -44.43 86.31 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -164.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.22 -30.6 8.61 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.946 0.793 . . . . 0.0 112.38 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.29 -60.76 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.86 -79.18 0.03 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.084 2.554 . . . . 0.0 114.111 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -95.8 120.1 35.48 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.154 1.382 . . . . 0.0 108.296 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.68 116.41 62.9 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -94.59 5.05 2.56 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 CA-C-N 125.204 2.894 . . . . 0.0 108.961 -165.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -79.82 -46.13 17.48 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 27.3 p -106.11 -12.15 15.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.902 172.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.34 25.88 41.91 Favored Glycine 0 C--N 1.362 2.015 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 163.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 44.9 t -101.36 102.83 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 100.481 -3.896 . . . . 0.0 100.481 -163.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 114.48 27.55 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 110.924 -2.853 . . . . 0.0 108.941 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 81.5 m -99.1 109.8 22.47 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.75 110.02 36.52 Favored Pre-proline 0 C--N 1.356 0.851 0 C-N-CA 125.591 1.556 . . . . 0.0 112.875 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -98.29 -8.38 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 CA-C-N 123.195 2.177 . . . . 0.0 108.653 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 26.3 mt -44.51 -58.99 2.66 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 129.963 3.305 . . . . 0.0 114.546 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.09 64.12 1.59 Allowed 'General case' 0 C--N 1.364 1.214 0 CA-C-O 121.839 0.828 . . . . 0.0 111.912 172.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.66 -174.35 39.84 Favored Glycine 0 N--CA 1.409 -3.113 1 N-CA-C 101.364 -4.694 . . . . 0.0 101.364 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.409 HH21 HG22 ' A' ' 953' ' ' ILE . 75.3 ttt-85 -93.34 121.84 35.14 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.253 2.6 p90 -114.04 159.92 19.45 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-N 119.0 0.818 . . . . 0.0 108.936 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.82 117.8 34.95 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.759 0.824 . . . . 0.0 110.061 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.4 tt -111.17 136.54 50.09 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 126.659 1.984 . . . . 0.0 108.997 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 73.1 m -147.01 118.93 8.13 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 153.84 22.05 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.4 t -109.44 118.86 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.28 124.87 44.72 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.41 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 39.5 m -81.38 131.68 35.3 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 125.251 1.42 . . . . 0.0 107.337 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.88 -57.44 19.87 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.161 1.363 . . . . 0.0 114.066 -169.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 66.5 m170 38.15 73.01 0.11 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.13 2.172 . . . . 0.0 115.153 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -71.16 -12.84 61.71 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.784 1.634 . . . . 0.0 111.719 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -73.55 -19.99 60.75 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.299 1.439 . . . . 0.0 112.375 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.324 13.2 pt-20 125.98 -178.21 0.0 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 127.458 2.303 . . . . 0.0 108.261 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 100.72 131.19 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.074 2.549 . . . . 0.0 106.799 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.38 126.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -108.25 123.37 48.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.16 172.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.47 116.92 15.68 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 128.996 2.918 . . . . 0.0 109.892 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 99.4 t -87.91 113.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.0 141.6 57.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 126.142 1.777 . . . . 0.0 110.563 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.4 t -116.98 145.87 43.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 125.218 1.407 . . . . 0.0 111.734 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.494 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -79.68 142.71 35.27 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 129.19 2.996 . . . . 0.0 111.052 -175.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 83.86 12.28 0.38 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 128.714 2.806 . . . . 0.0 112.336 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -151.79 -26.72 0.19 Allowed 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.281 -0.887 . . . . 0.0 110.628 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 57.9 167.05 0.04 OUTLIER 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.753 1.621 . . . . 0.0 112.174 -163.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.65 -134.03 49.78 Favored Glycine 0 C--N 1.372 2.556 0 O-C-N 119.217 -2.177 . . . . 0.0 109.742 -161.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 52.8 t 57.79 75.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.313 0 C-N-CA 125.79 1.636 . . . . 0.0 110.651 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.49 114.31 26.83 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -102.33 -35.17 8.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.448 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.6 83.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.728 -3.064 . . . . 0.0 102.728 167.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.59 129.36 43.99 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 121.201 0.524 . . . . 0.0 109.763 -171.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 29.7 t -143.27 115.92 8.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.506 1.523 . . . . 0.0 107.906 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.83 84.68 0.73 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 103.632 -3.787 . . . . 0.0 103.632 163.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.689 0 C-N-CA 126.24 1.876 . . . . 0.0 111.524 172.71 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.49 133.33 55.95 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.64 163.23 25.83 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -172.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 14.5 m -124.62 131.07 73.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -136.86 142.53 42.82 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.2 m -116.72 -44.49 2.83 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 33.2 tp -87.48 -53.65 4.7 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-N 119.442 1.019 . . . . 0.0 111.739 -168.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.409 HG22 HH21 ' A' ' 893' ' ' ARG . 11.2 pt -83.73 -176.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 124.262 1.025 . . . . 0.0 108.313 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.567 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -158.46 83.0 2.67 Favored Pre-proline 0 N--CA 1.433 -1.284 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -163.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.82 91.95 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.535 2.156 . . . . 0.0 109.697 167.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 954' ' ' LEU . 8.9 mp -121.78 145.89 47.6 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 126.558 1.943 . . . . 0.0 106.566 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -95.88 157.91 15.68 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.898 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.55 124.73 24.94 Favored 'General case' 0 C--N 1.375 1.705 0 CA-C-N 119.702 1.137 . . . . 0.0 109.222 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.21 69.55 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 126.306 1.908 . . . . 0.0 112.128 171.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 914' ' ' ARG . 0.9 OUTLIER -72.49 171.96 11.37 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.839 0.819 . . . . 0.0 112.116 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 85.4 m -142.28 127.81 19.02 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -157.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.494 HG13 HH11 ' A' ' 914' ' ' ARG . 20.2 m -94.83 149.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-O 121.314 0.578 . . . . 0.0 110.114 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.4 m -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 60.9 t -94.07 130.03 43.56 Favored 'Isoleucine or valine' 0 C--N 1.371 1.51 0 C-N-CA 126.623 1.969 . . . . 0.0 106.868 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -106.02 132.84 51.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 73.26 1.47 Allowed 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -163.9 103.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 86.8 mmm -153.27 74.17 1.01 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.75 151.34 9.0 Favored Glycine 0 CA--C 1.495 -1.213 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 123.726 0.811 . . . . 0.0 108.855 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.92 87.34 6.18 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.71 -166.44 1.95 Allowed 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -125.24 160.39 29.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.0 t -92.53 132.08 37.13 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.64 150.2 22.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 113.33 24.31 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -98.35 173.33 0.54 Allowed 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 121.985 1.79 . . . . 0.0 108.447 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.57 140.75 49.21 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -139.86 141.75 36.62 Favored 'General case' 0 C--N 1.375 1.68 0 CA-C-N 119.538 1.063 . . . . 0.0 108.747 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.61 129.35 75.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -125.38 105.43 9.07 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 46.0 p -101.06 161.01 13.9 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.562 1.145 . . . . 0.0 110.281 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.46 0.28 Allowed Glycine 0 C--N 1.356 1.644 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.59 144.32 47.17 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -173.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.9 124.28 26.61 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 124.906 1.282 . . . . 0.0 109.789 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.1 -57.39 2.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.36 128.01 38.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.095 1.758 . . . . 0.0 106.537 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.7 130.73 10.44 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 103.545 -3.822 . . . . 0.0 103.545 163.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.59 130.95 90.08 Favored Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.406 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -107.06 80.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 121.984 1.744 . . . . 0.0 110.293 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 77.14 -72.87 0.09 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 130.602 3.561 . . . . 0.0 109.405 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.5 mt 49.74 40.07 19.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.523 3.129 . . . . 0.0 113.94 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -110.88 130.0 55.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -128.06 109.86 11.94 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.072 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.172 -0.741 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.33 121.41 22.52 Favored Pre-proline 0 C--N 1.354 0.762 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -92.69 -22.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 122.064 1.773 . . . . 0.0 109.879 -174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 38.78 69.58 0.26 Allowed 'General case' 0 C--N 1.36 1.039 0 C-N-CA 129.189 2.996 . . . . 0.0 115.204 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.86 136.24 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.58 160.39 38.21 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -149.41 139.94 22.5 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.3 t -169.31 117.32 0.63 Allowed 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.09 153.82 34.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -139.47 157.72 45.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.808 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.52 HD21 HD23 ' B' ' 858' ' ' LEU . 2.3 tm? -133.09 133.39 42.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -168.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.447 ' H ' ' H ' ' B' ' 858' ' ' LEU . 29.7 p -163.95 8.1 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -163.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.52 HD23 HD21 ' B' ' 856' ' ' LEU . 2.0 pp -28.74 144.91 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.513 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 160.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.43 -47.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 122.242 1.836 . . . . 0.0 112.877 -163.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -162.18 170.4 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.4 m 4.06 104.3 0.0 OUTLIER 'General case' 0 C--N 1.36 1.05 0 C-N-CA 130.877 3.671 . . . . 0.0 117.563 169.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -97.07 163.65 19.54 Favored Pre-proline 0 C--N 1.353 0.731 0 C-N-CA 123.229 0.612 . . . . 0.0 110.412 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.65 -14.83 12.54 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.645 2.23 . . . . 0.0 110.94 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.92 -142.41 3.47 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.2 m -63.63 143.95 57.41 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.611 1.964 . . . . 0.0 110.703 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.45 130.99 32.01 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 124.734 1.214 . . . . 0.0 110.463 -162.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -97.03 -148.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 124.047 3.164 . . . . 0.0 108.212 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.41 136.84 20.07 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -115.17 -13.96 11.76 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.397 1.079 . . . . 0.0 110.567 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.31 87.11 3.14 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' B' ' 874' ' ' ASN . 58.7 t -70.58 97.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' B' ' 855' ' ' ALA . 18.3 mt -87.58 -38.67 15.76 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.083 -172.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 56.6 tp -165.11 127.08 2.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 100.749 -3.797 . . . . 0.0 100.749 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.432 ' HB3' HG13 ' B' ' 871' ' ' VAL . 33.3 t-20 177.25 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 120.265 1.393 . . . . 0.0 108.648 -163.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -58.18 -43.66 87.6 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -166.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.15 -31.4 8.5 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 118.931 0.787 . . . . 0.0 112.479 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.22 -58.69 0.38 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 65.26 -80.36 0.03 OUTLIER 'General case' 0 C--N 1.355 0.831 0 C-N-CA 128.044 2.538 . . . . 0.0 114.406 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -97.1 119.88 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.335 1.454 . . . . 0.0 108.538 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.55 116.99 65.74 Favored Pre-proline 0 CA--C 1.503 -0.854 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -93.46 5.65 2.94 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.19 2.889 . . . . 0.0 108.986 -166.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -79.79 -44.94 19.71 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.407 1.083 . . . . 0.0 108.6 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 25.4 p -108.99 -12.48 14.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.909 1.284 . . . . 0.0 108.363 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.86 25.86 39.92 Favored Glycine 0 C--N 1.361 1.931 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 163.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 54.8 t -100.82 102.81 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 101.089 -3.671 . . . . 0.0 101.089 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.59 114.82 26.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 111.468 -2.605 . . . . 0.0 108.459 -174.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.0 m -99.17 109.78 22.42 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.15 110.45 38.39 Favored Pre-proline 0 C--N 1.357 0.922 0 C-N-CA 125.477 1.511 . . . . 0.0 113.307 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -99.42 -7.28 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 123.321 2.222 . . . . 0.0 108.931 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 16.0 mt -50.42 -51.95 41.92 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 128.618 2.767 . . . . 0.0 114.339 -168.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.8 49.09 14.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.214 1.406 . . . . 0.0 113.815 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -162.74 -166.68 21.94 Favored Glycine 0 N--CA 1.412 -2.943 1 N-CA-C 101.894 -4.482 . . . . 0.0 101.894 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -92.64 120.94 33.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 1.9 p90 -116.19 160.05 20.95 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-N 118.965 0.802 . . . . 0.0 108.841 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 54.6 tp -105.56 116.37 31.84 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.06 135.64 50.57 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 126.193 1.797 . . . . 0.0 107.827 -166.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 72.9 m -145.26 119.22 9.34 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.9 153.9 21.84 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.06 120.84 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.86 122.89 46.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.275 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.1 m -79.77 131.49 35.93 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.264 1.425 . . . . 0.0 107.936 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.73 -57.45 19.76 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.322 1.439 . . . . 0.0 114.25 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 66.4 m170 37.72 73.46 0.1 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 127.178 2.191 . . . . 0.0 115.093 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -71.48 -12.69 61.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.93 1.692 . . . . 0.0 111.544 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -74.62 -15.62 60.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.664 1.586 . . . . 0.0 112.628 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.0 pt-20 120.57 178.62 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 C-N-CA 127.911 2.485 . . . . 0.0 108.485 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 102.06 131.45 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 128.268 2.627 . . . . 0.0 106.581 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.92 131.57 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -112.02 123.42 50.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.18 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.23 115.04 13.69 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 128.426 2.69 . . . . 0.0 109.878 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.05 113.31 25.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.87 147.23 47.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.868 2.067 . . . . 0.0 111.294 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 1.9 t -117.03 147.3 42.46 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.454 1.502 . . . . 0.0 111.414 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.526 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.56 141.45 35.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 128.914 2.886 . . . . 0.0 110.004 -179.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 82.97 9.68 0.62 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.31 2.644 . . . . 0.0 112.82 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -150.17 -26.23 0.25 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.81 168.02 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.476 1.51 . . . . 0.0 112.077 -163.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.29 -133.08 48.42 Favored Glycine 0 C--N 1.366 2.213 0 O-C-N 119.5 -2.0 . . . . 0.0 109.775 -164.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 60.9 t 56.04 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.215 0 C-N-CA 126.23 1.812 . . . . 0.0 111.189 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.6 114.79 27.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -103.15 -35.44 8.48 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.484 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.17 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.04 128.76 44.77 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 33.3 t -141.48 117.43 10.52 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 171.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.82 84.8 0.74 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 165.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.709 0 C-N-CA 125.356 1.455 . . . . 0.0 111.273 175.18 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.4 m . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 59.2 mt -115.3 134.29 55.25 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -168.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.55 163.94 25.73 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 124.999 1.285 . . . . 0.0 109.95 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.97 131.51 72.8 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -137.33 146.52 44.69 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 50.5 m -128.23 -27.37 2.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.364 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 33.8 tp -92.54 -55.55 3.35 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 120.071 1.305 . . . . 0.0 111.425 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.78 -177.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 C-N-CA 125.162 1.385 . . . . 0.0 108.31 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -158.03 82.94 2.81 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.07 93.63 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.717 2.278 . . . . 0.0 110.223 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.566 HD13 ' HB2' ' B' ' 954' ' ' LEU . 10.5 mp -121.39 145.34 48.01 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 125.824 1.65 . . . . 0.0 107.106 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -95.09 158.19 15.57 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.241 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.88 124.42 24.81 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 119.844 1.202 . . . . 0.0 108.713 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.81 71.04 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 125.997 1.76 . . . . 0.0 111.994 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.73 170.62 14.19 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 117.957 0.878 . . . . 0.0 110.999 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 90.0 m -143.05 127.95 18.36 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.507 -155.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.526 HG13 HH11 ' B' ' 914' ' ' ARG . 16.5 m -96.03 150.31 4.36 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-O 121.172 0.51 . . . . 0.0 111.626 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.7 m -141.05 137.75 33.13 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 126.794 2.038 . . . . 0.0 111.338 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.59 131.05 41.63 Favored 'Isoleucine or valine' 0 C--N 1.368 1.39 0 C-N-CA 127.947 2.499 . . . . 0.0 107.43 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -105.89 132.97 51.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 100.677 -3.823 . . . . 0.0 100.677 171.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.72 72.5 1.4 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 56.8 t -161.83 104.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.3 mmm -152.28 72.68 1.0 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 173.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.26 150.06 8.44 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -115.64 -29.38 6.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 38.3 tp -93.01 86.78 5.53 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.42 -165.95 1.85 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -125.24 159.51 31.46 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.5 t -90.97 131.93 36.28 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.87 150.33 22.5 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.94 113.1 24.43 Favored Pre-proline 0 C--N 1.356 0.889 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -97.86 172.64 0.64 Allowed 'Trans proline' 0 CA--C 1.508 -0.801 0 C-N-CA 121.93 1.754 . . . . 0.0 108.297 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.54 139.18 50.77 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.8 p -139.02 140.56 38.18 Favored 'General case' 0 C--N 1.374 1.65 0 CA-C-N 119.51 1.05 . . . . 0.0 108.499 -170.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.93 130.79 72.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -126.64 105.15 8.5 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 33.3 p -101.72 162.23 13.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.768 1.227 . . . . 0.0 110.494 170.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.14 112.09 0.32 Allowed Glycine 0 C--N 1.357 1.71 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.68 145.32 46.6 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.3 tp -73.14 124.09 24.89 Favored 'General case' 0 C--N 1.379 1.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.423 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.84 -57.52 2.21 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -131.42 127.62 37.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -173.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.81 130.61 10.39 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 103.32 -3.912 . . . . 0.0 103.32 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.11 130.64 89.49 Favored Pre-proline 0 C--N 1.351 0.66 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.569 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -106.26 81.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 122.008 1.753 . . . . 0.0 109.784 -168.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 77.3 -72.38 0.1 Allowed 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 130.311 3.444 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 75.2 mt 49.06 43.33 22.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.326 3.05 . . . . 0.0 113.569 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.52 129.6 56.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -129.0 109.41 11.2 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 N-CA-C 110.328 -0.682 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 31.1 t -122.09 114.73 30.64 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -87.95 -23.65 1.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 CA-C-N 121.649 1.624 . . . . 0.0 110.074 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 37.93 67.95 0.35 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 129.11 2.964 . . . . 0.0 115.755 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.8 136.91 58.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.09 156.84 48.33 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 165.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 8.5 p90 -148.13 138.55 22.84 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 118.767 0.712 . . . . 0.0 109.105 178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 14.0 t -170.74 120.03 0.55 Allowed 'General case' 0 C--N 1.36 1.052 0 O-C-N 121.664 -0.648 . . . . 0.0 110.097 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.8 153.3 35.94 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.36 157.67 45.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.96 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.564 HD11 HD23 ' C' ' 858' ' ' LEU . 2.9 tm? -140.8 130.51 24.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -163.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 72.8 m -157.56 17.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.564 HD23 HD11 ' C' ' 856' ' ' LEU . 2.5 pp -22.44 140.13 0.04 OUTLIER Pre-proline 0 C--N 1.374 1.632 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 159.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.31 -44.76 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 122.243 1.837 . . . . 0.0 111.685 -166.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 30.9 ptt85 -163.89 170.91 16.11 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -1.03 108.73 0.01 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 130.564 3.546 . . . . 0.0 117.22 167.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.52 161.59 23.5 Favored Pre-proline 0 N--CA 1.443 -0.797 0 C-N-CA 123.708 0.803 . . . . 0.0 108.922 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.79 -12.62 14.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.848 2.366 . . . . 0.0 110.776 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.25 3.11 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.7 m -65.48 146.25 55.11 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.906 1.682 . . . . 0.0 111.037 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.21 132.63 31.78 Favored Pre-proline 0 N--CA 1.44 -0.963 0 C-N-CA 125.383 1.473 . . . . 0.0 110.281 -164.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -99.52 -148.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 124.164 3.243 . . . . 0.0 108.556 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -147.28 135.46 21.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -116.21 -18.69 10.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.264 0.626 . . . . 0.0 111.405 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -103.57 80.69 1.82 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 122.888 0.475 . . . . 0.0 111.55 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.27 99.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 126.421 1.889 . . . . 0.0 107.189 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.82 -38.32 14.71 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.856 -172.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 36.9 tp -165.3 127.54 2.11 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 30.1 t-20 176.41 61.92 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 120.234 1.379 . . . . 0.0 107.957 -163.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.84 -42.78 90.09 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -165.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.04 -29.07 13.33 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.844 0.747 . . . . 0.0 112.515 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.31 -57.73 0.49 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 62.66 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.348 2.659 . . . . 0.0 114.891 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -94.13 121.01 35.19 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 125.139 1.376 . . . . 0.0 108.885 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.69 116.92 67.04 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -94.69 7.58 2.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 124.455 2.627 . . . . 0.0 109.332 -169.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -79.34 -46.62 17.3 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 37.5 p -108.02 -10.52 15.46 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.793 1.237 . . . . 0.0 108.411 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 28.0 33.89 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 161.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.84 101.66 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 101.088 -3.671 . . . . 0.0 101.088 -166.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -95.93 112.19 23.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 112.212 -2.267 . . . . 0.0 108.941 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 58.1 m -102.12 109.15 20.78 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . 0.494 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.02 110.87 45.15 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.583 170.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.65 1.45 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.569 2.179 . . . . 0.0 108.271 164.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 42.4 mt -53.6 -54.65 34.55 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 128.471 2.709 . . . . 0.0 113.45 -169.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.01 68.43 0.82 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.132 0.968 . . . . 0.0 111.037 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -177.16 174.13 46.79 Favored Glycine 0 N--CA 1.406 -3.348 1 N-CA-C 101.066 -4.813 . . . . 0.0 101.066 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -93.82 117.67 30.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.552 -1.324 . . . . 0.0 107.897 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -115.64 160.12 20.44 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 119.217 0.917 . . . . 0.0 110.159 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.1 tp -108.38 112.78 25.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.4 tt -116.82 140.13 49.8 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.062 1.345 . . . . 0.0 108.861 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 69.0 m -143.42 120.06 11.12 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.461 0.704 . . . . 0.0 109.571 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.26 154.4 19.83 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 95.1 t -100.84 122.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 55.5 mt -94.55 122.52 37.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.584 1.154 . . . . 0.0 109.156 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 12.2 m -81.8 132.55 35.28 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -49.77 -57.01 10.21 Favored Glycine 0 C--N 1.36 1.879 0 C-N-CA 126.159 1.837 . . . . 0.0 115.954 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.3 m80 40.22 69.95 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 127.241 2.216 . . . . 0.0 114.765 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -73.7 -8.86 57.66 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.833 1.253 . . . . 0.0 111.855 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -75.5 -4.9 42.39 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 126.338 1.855 . . . . 0.0 111.543 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.292 47.3 mt-10 96.63 -149.72 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 128.4 2.68 . . . . 0.0 107.804 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 84.12 135.27 0.05 Allowed 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.269 2.227 . . . . 0.0 108.819 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.71 128.22 51.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-O 122.499 1.143 . . . . 0.0 108.025 -171.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -111.08 131.34 55.15 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 127.315 2.246 . . . . 0.0 110.164 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -158.05 113.83 2.75 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.646 1.178 . . . . 0.0 110.716 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.07 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.084 1.754 . . . . 0.0 109.111 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 32.2 mt -62.37 143.32 57.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.261 1.824 . . . . 0.0 111.111 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.265 1.3 p -114.52 148.83 37.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 126.513 1.925 . . . . 0.0 108.598 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.494 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.77 137.74 37.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 125.321 1.449 . . . . 0.0 109.431 176.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.0 t 90.24 0.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.689 2.796 . . . . 0.0 112.694 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -145.76 -26.52 0.45 Allowed 'General case' 0 C--N 1.36 1.025 0 CA-C-N 119.495 1.043 . . . . 0.0 111.99 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 58.77 169.57 0.06 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 125.167 1.387 . . . . 0.0 111.954 -163.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.08 -127.93 46.09 Favored Glycine 0 C--N 1.374 2.667 0 O-C-N 119.741 -1.849 . . . . 0.0 110.152 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 53.4 t 49.38 72.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 126.601 1.96 . . . . 0.0 111.912 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 116.55 28.94 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -169.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -95.8 -35.7 11.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.067 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 56.3 t -99.38 81.21 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.84 131.42 40.75 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 121.091 0.472 . . . . 0.0 111.136 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -144.09 116.17 8.39 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 125.351 1.46 . . . . 0.0 108.126 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.09 84.77 0.65 Allowed Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.643 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 173.023 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.07 134.56 55.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.0 163.41 26.65 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -117.91 129.57 74.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.91 146.47 50.94 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.328 -0.858 . . . . 0.0 110.23 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.1 m -103.97 -84.06 0.48 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.716 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.32 -46.96 88.11 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.084 1.754 . . . . 0.0 114.627 -163.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.34 -179.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 124.72 1.208 . . . . 0.0 110.141 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.48 ' HB2' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -163.22 82.24 1.51 Allowed Pre-proline 0 C--N 1.355 0.836 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -168.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.92 88.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.278 1.985 . . . . 0.0 110.734 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' C' ' 954' ' ' LEU . 11.2 mp -123.59 147.46 47.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -91.33 162.53 14.57 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.358 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.71 122.74 21.15 Favored 'General case' 0 C--N 1.38 1.934 0 CA-C-N 120.954 1.706 . . . . 0.0 108.957 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.87 73.45 Favored Glycine 0 CA--C 1.496 -1.134 0 C-N-CA 125.49 1.519 . . . . 0.0 111.62 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -68.47 176.44 2.87 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.855 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 90.6 m -143.71 127.28 16.99 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.433 1.093 . . . . 0.0 110.922 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.401 HG13 ' HD3' ' C' ' 914' ' ' ARG . 16.8 m -98.21 147.82 6.42 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 124.802 1.241 . . . . 0.0 108.84 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 16.9 t -141.94 137.95 31.63 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.825 1.65 . . . . 0.0 111.737 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 23.8 t -90.89 129.24 42.0 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 C-N-CA 126.233 1.813 . . . . 0.0 106.169 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.68 133.5 49.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.137 -3.653 . . . . 0.0 101.137 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.53 72.64 1.45 Allowed 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.064 -1.88 . . . . 0.0 106.391 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.5 t -160.39 97.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.4 mmm -150.6 78.27 1.31 Allowed 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.98 147.53 14.1 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -113.96 -22.51 10.06 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.435 0.694 . . . . 0.0 110.135 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -98.7 85.62 3.36 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.03 -166.72 1.96 Allowed 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -119.73 150.02 41.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -88.69 130.32 35.34 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -154.95 147.93 24.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.01 115.27 26.27 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -103.73 177.22 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.7 0 C-N-CA 121.553 1.502 . . . . 0.0 108.283 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.48 138.18 51.58 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -137.81 139.95 40.26 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 119.98 1.264 . . . . 0.0 108.192 -171.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.38 131.48 67.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.47 104.92 8.69 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 35.1 p -101.83 162.89 12.57 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.942 1.297 . . . . 0.0 110.225 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.88 112.18 0.35 Allowed Glycine 0 C--N 1.359 1.818 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.28 141.95 47.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 55.8 tp -76.57 124.32 27.43 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.139 1.376 . . . . 0.0 109.439 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 16.2 tp -97.14 -56.57 2.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -131.21 127.24 37.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.51 9.09 Favored Glycine 0 CA--C 1.494 -1.27 0 N-CA-C 103.485 -3.846 . . . . 0.0 103.485 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -69.91 131.17 89.38 Favored Pre-proline 0 C--N 1.354 0.764 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.929 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -106.27 77.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 CA-C-N 122.219 1.828 . . . . 0.0 109.875 -166.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.02 -73.23 0.08 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 130.21 3.404 . . . . 0.0 108.893 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.3 mt 48.93 42.47 20.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 129.171 2.988 . . . . 0.0 113.479 -173.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -113.61 129.64 56.53 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.42 109.61 11.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.452 -0.917 0 N-CA-C 109.998 -0.808 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 118.73 24.16 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.98 -21.61 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.064 1.773 . . . . 0.0 109.875 -172.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 35.9 69.85 0.17 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.032 2.933 . . . . 0.0 115.773 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.63 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.1 155.72 49.77 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 166.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 11.4 p90 -149.62 138.77 21.27 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.0 t -169.04 117.53 0.66 Allowed 'General case' 0 C--N 1.352 0.702 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.29 152.73 36.21 Favored 'General case' 0 C--N 1.37 1.479 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.48 158.44 44.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.488 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.433 HD11 HD23 ' A' ' 858' ' ' LEU . 2.6 tm? -130.68 130.88 44.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -167.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.0 p -159.22 16.66 0.17 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -167.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.433 HD23 HD11 ' A' ' 856' ' ' LEU . 3.2 pp -21.92 145.55 0.01 OUTLIER Pre-proline 0 C--N 1.368 1.41 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 158.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.36 -48.0 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.927 1.751 . . . . 0.0 112.681 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -163.11 178.52 8.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.3 m -19.43 121.84 0.02 OUTLIER 'General case' 0 C--N 1.363 1.188 0 C-N-CA 129.615 3.166 . . . . 0.0 115.679 172.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -126.63 146.08 55.6 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -163.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -76.86 -10.25 18.24 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 CA-C-N 122.75 2.018 . . . . 0.0 112.937 -161.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.98 -141.12 3.04 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -63.45 145.8 54.89 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.31 1.844 . . . . 0.0 110.48 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 91.9 t -88.93 129.27 48.97 Favored Pre-proline 0 N--CA 1.436 -1.147 0 C-N-CA 125.059 1.344 . . . . 0.0 110.363 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -94.62 -153.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.056 3.171 . . . . 0.0 108.656 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -148.01 132.59 17.76 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -117.59 -11.97 10.38 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 122.707 0.403 . . . . 0.0 111.354 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -99.64 86.68 3.38 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 121.835 -0.541 . . . . 0.0 111.49 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.69 96.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' B' ' 953' ' ' ILE . 60.9 mt -87.18 -37.52 17.22 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.634 -173.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.0 tp -166.32 127.04 1.71 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.009 -3.7 . . . . 0.0 101.009 164.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 29.4 t-20 -177.0 61.13 0.01 OUTLIER 'General case' 0 C--N 1.357 0.93 0 CA-C-N 120.756 1.616 . . . . 0.0 109.618 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -61.01 -44.12 97.89 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -165.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.18 -27.77 12.95 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-N 118.927 0.785 . . . . 0.0 112.614 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.25 -61.74 0.3 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 61.74 -81.79 0.02 OUTLIER 'General case' 0 C--N 1.353 0.749 0 C-N-CA 128.067 2.547 . . . . 0.0 114.125 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -94.36 119.23 32.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.358 1.063 . . . . 0.0 108.47 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.03 117.64 69.1 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -94.91 2.36 2.62 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 CA-C-N 125.12 2.864 . . . . 0.0 109.473 -166.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.46 -45.74 17.07 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.5 p -103.69 -13.97 16.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.438 1.095 . . . . 0.0 108.834 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.76 23.5 49.64 Favored Glycine 0 C--N 1.362 2.012 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 162.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.68 103.7 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.583 -3.488 . . . . 0.0 101.583 -164.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.56 111.46 23.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 112.502 -2.135 . . . . 0.0 109.496 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 57.4 m -100.43 107.89 19.74 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . 0.471 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -91.33 110.91 45.94 Favored Pre-proline 0 C--N 1.356 0.87 0 CA-C-O 116.992 -1.48 . . . . 0.0 111.818 171.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.59 2.72 3.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 123.252 2.197 . . . . 0.0 108.91 168.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 40.8 mt -50.39 -53.44 29.26 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 128.03 2.532 . . . . 0.0 114.801 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.14 59.11 3.56 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.43 -166.7 26.95 Favored Glycine 0 N--CA 1.411 -2.978 1 N-CA-C 101.58 -4.608 . . . . 0.0 101.58 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -93.27 119.84 32.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.94 147.21 41.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.9 tp -107.63 114.9 29.19 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -112.68 139.16 48.52 Favored 'General case' 0 C--N 1.361 1.09 0 C-N-CA 126.034 1.733 . . . . 0.0 108.824 -170.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 67.4 m -143.97 118.98 10.01 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 123.422 0.689 . . . . 0.0 109.28 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.28 153.07 23.26 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.12 121.33 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 122.16 42.67 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.529 1.131 . . . . 0.0 108.682 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 10.8 m -80.6 132.35 35.62 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.83 -57.6 13.93 Favored Glycine 0 C--N 1.362 2.027 0 C-N-CA 125.852 1.691 . . . . 0.0 115.36 -167.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 2.4 m80 38.29 72.11 0.14 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 127.568 2.347 . . . . 0.0 114.855 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -72.96 -11.3 60.52 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.915 1.686 . . . . 0.0 111.341 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -72.63 -14.8 61.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.305 1.842 . . . . 0.0 112.215 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.334 7.0 pt-20 116.27 -175.66 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 C-N-CA 127.926 2.491 . . . . 0.0 108.367 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 74.9 tttt 101.59 135.93 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 127.67 2.388 . . . . 0.0 106.461 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.59 125.23 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -106.91 128.53 54.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 110.066 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.3 114.55 4.8 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.114 1.366 . . . . 0.0 109.382 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 97.2 t -88.33 115.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 139.43 58.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.121 1.768 . . . . 0.0 110.152 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.1 t -115.66 146.58 41.71 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.147 1.779 . . . . 0.0 109.339 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.617 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.99 139.26 39.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.315 2.646 . . . . 0.0 110.667 -172.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 95.9 -9.06 0.09 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.339 3.056 . . . . 0.0 112.831 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -138.46 -27.33 0.87 Allowed 'General case' 0 C--N 1.356 0.891 0 CA-C-N 119.448 1.022 . . . . 0.0 111.392 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 60.77 163.56 0.07 Allowed 'General case' 0 C--N 1.361 1.077 0 C-N-CA 125.619 1.567 . . . . 0.0 111.487 -165.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.3 -134.95 48.25 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 119.394 -2.067 . . . . 0.0 109.143 -160.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 58.05 75.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 125.284 1.434 . . . . 0.0 110.515 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.86 114.32 26.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -103.88 -33.05 9.0 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.781 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.76 77.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 166.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.35 130.32 43.49 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.418 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.9 t -144.61 114.77 7.47 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.084 1.353 . . . . 0.0 108.062 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.36 84.9 0.7 Allowed Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 104.731 -3.347 . . . . 0.0 104.731 167.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.631 0 C-N-CA 125.35 1.452 . . . . 0.0 111.212 175.052 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.42 133.76 55.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.25 161.51 25.25 Favored Glycine 0 CA--C 1.493 -1.305 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.96 127.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -138.89 149.43 44.83 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -114.57 -43.05 3.2 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.07 -52.9 5.93 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 119.733 1.151 . . . . 0.0 112.147 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 8.3 pt -87.79 -170.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 124.601 1.161 . . . . 0.0 110.172 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 85.18 1.49 Allowed Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -162.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -73.85 92.34 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 122.565 1.952 . . . . 0.0 109.781 160.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.9 142.8 49.35 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -93.89 158.24 15.74 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.092 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.16 123.88 23.18 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 119.192 0.905 . . . . 0.0 108.832 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.95 73.26 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 125.742 1.639 . . . . 0.0 111.238 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.09 175.02 5.55 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.622 0.769 . . . . 0.0 111.677 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 98.6 m -143.06 125.75 15.96 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.617 HG13 HH11 ' A' ' 914' ' ' ARG . 28.0 m -95.26 150.51 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-O 121.593 0.711 . . . . 0.0 109.544 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -142.07 138.83 32.02 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.156 1.783 . . . . 0.0 111.112 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.71 129.43 42.4 Favored 'Isoleucine or valine' 0 C--N 1.369 1.415 0 C-N-CA 126.021 1.729 . . . . 0.0 106.475 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.49 131.37 52.98 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.45 71.22 1.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.4 t -163.1 100.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.31 71.42 0.89 Allowed 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.46 143.48 7.27 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -111.02 -29.76 7.77 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.573 0.749 . . . . 0.0 108.997 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.8 tp -91.7 87.16 6.2 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.68 -164.51 1.62 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -123.93 159.26 30.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.66 133.83 35.61 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -158.91 152.2 22.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 112.39 22.35 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 172.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -98.86 174.09 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.006 1.804 . . . . 0.0 108.461 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.08 139.69 50.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.567 1.147 . . . . 0.0 108.042 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -140.12 141.4 36.12 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.984 1.266 . . . . 0.0 108.566 -170.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 30.6 mm -118.19 130.11 73.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -126.39 105.87 9.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.1 p -99.96 161.35 13.66 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.598 1.159 . . . . 0.0 109.531 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.44 109.01 0.26 Allowed Glycine 0 C--N 1.359 1.852 0 C-N-CA 119.044 -1.551 . . . . 0.0 110.675 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.95 143.41 47.05 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -74.33 124.68 26.93 Favored 'General case' 0 C--N 1.378 1.845 0 C-N-CA 125.263 1.425 . . . . 0.0 109.058 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.97 -57.94 2.06 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -132.27 128.92 38.85 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 131.85 10.82 Favored Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 103.792 -3.723 . . . . 0.0 103.792 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -69.11 129.12 92.33 Favored Pre-proline 0 C--N 1.352 0.674 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.101 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -106.57 80.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 121.873 1.704 . . . . 0.0 109.733 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 77.95 -72.86 0.08 Allowed 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 130.041 3.336 . . . . 0.0 109.2 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.0 mt 49.51 38.66 15.05 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 128.93 2.892 . . . . 0.0 114.295 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.49 132.1 54.48 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.76 107.99 10.11 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.963 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 N-CA-C 109.931 -0.834 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 119.29 24.96 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -90.24 -21.74 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 122.131 1.797 . . . . 0.0 110.085 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 37.25 69.62 0.21 Allowed 'General case' 0 C--N 1.358 0.971 0 C-N-CA 129.114 2.965 . . . . 0.0 115.587 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.6 135.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.11 155.07 50.73 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 9.4 p90 -149.33 139.61 22.29 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.26 118.25 0.56 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.89 153.1 36.35 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.458 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -137.16 158.4 44.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.093 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.44 129.78 43.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -168.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.5 p -158.85 15.98 0.18 Allowed 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 124.514 1.126 . . . . 0.0 108.119 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.0 pp -21.89 145.64 0.01 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 158.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.54 -48.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.789 1.659 . . . . 0.0 112.684 -169.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.09 178.46 8.26 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.5 m -19.37 121.92 0.02 OUTLIER 'General case' 0 C--N 1.364 1.218 0 C-N-CA 129.634 3.174 . . . . 0.0 115.68 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -126.71 146.17 56.11 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.01 -10.2 18.0 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 122.788 2.031 . . . . 0.0 112.978 -161.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.92 -141.03 3.02 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.3 m -63.39 145.77 54.92 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.19 1.796 . . . . 0.0 110.428 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.65 128.74 51.5 Favored Pre-proline 0 N--CA 1.437 -1.11 0 C-N-CA 125.052 1.341 . . . . 0.0 110.344 -164.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -95.29 -153.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.054 3.169 . . . . 0.0 108.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.44 132.05 17.8 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -115.5 -12.44 11.66 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.841 0.856 . . . . 0.0 110.698 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -100.56 86.42 3.14 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.215 0.531 . . . . 0.0 111.507 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.4 t -70.95 97.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 126.373 1.869 . . . . 0.0 106.29 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' B' ' 855' ' ' ALA . 20.3 mt -87.67 -38.56 15.76 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.181 -174.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.0 tp -166.34 127.52 1.76 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.656 -3.831 . . . . 0.0 100.656 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' B' ' 852' ' ' PHE . 27.5 t-20 178.08 61.32 0.01 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.779 1.627 . . . . 0.0 109.286 -164.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.86 -43.77 97.92 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -167.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.93 -28.61 11.72 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 118.976 0.807 . . . . 0.0 112.734 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.29 -61.32 0.3 Allowed Glycine 0 C--N 1.353 1.489 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 62.12 -81.81 0.02 OUTLIER 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.018 2.527 . . . . 0.0 114.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -95.66 119.08 33.53 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 124.55 1.14 . . . . 0.0 108.283 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.7 117.9 70.07 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -93.68 2.6 3.21 Favored 'Trans proline' 0 CA--C 1.509 -0.76 0 CA-C-N 125.11 2.861 . . . . 0.0 109.728 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -80.46 -44.51 19.1 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.9 p -106.19 -13.87 15.3 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.515 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.94 24.79 43.54 Favored Glycine 0 C--N 1.362 2.018 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 162.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.5 t -100.42 103.51 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 101.711 -3.441 . . . . 0.0 101.711 -162.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.15 111.62 23.88 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.573 -175.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 57.3 m -100.73 107.78 19.46 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . 0.464 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -91.5 111.16 47.7 Favored Pre-proline 0 C--N 1.357 0.922 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.88 171.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -93.43 3.3 3.27 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.267 2.202 . . . . 0.0 109.032 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -53.51 -49.6 67.2 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 126.67 1.988 . . . . 0.0 114.611 -169.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.61 48.72 13.73 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.451 1.501 . . . . 0.0 114.587 170.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.61 -165.31 18.24 Favored Glycine 0 N--CA 1.411 -2.972 1 N-CA-C 101.61 -4.596 . . . . 0.0 101.61 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -88.66 119.71 29.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.64 147.71 42.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 48.8 tp -108.7 114.22 27.83 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.57 138.45 49.33 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.965 1.706 . . . . 0.0 108.106 -171.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 73.9 m -143.46 119.13 10.44 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.21 153.33 22.85 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 90.4 t -109.13 122.28 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.13 120.65 41.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 124.557 1.143 . . . . 0.0 108.458 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 10.5 m -79.61 132.85 36.37 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.974 1.31 . . . . 0.0 107.567 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.71 13.26 Favored Glycine 0 C--N 1.364 2.111 0 C-N-CA 125.975 1.75 . . . . 0.0 115.233 -167.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.8 m80 37.96 71.92 0.14 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.558 2.343 . . . . 0.0 114.887 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -72.84 -11.54 60.64 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 126.005 1.722 . . . . 0.0 111.262 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -72.5 -13.64 61.47 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.378 1.871 . . . . 0.0 112.406 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.337 6.9 pt-20 115.69 -176.77 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.267 2.627 . . . . 0.0 108.267 174.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 101.36 135.85 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 127.568 2.347 . . . . 0.0 106.588 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.75 127.29 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -171.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -108.95 128.76 55.21 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.914 1.686 . . . . 0.0 109.969 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.49 114.39 4.7 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.817 1.247 . . . . 0.0 109.649 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.0 t -88.75 115.75 29.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 C-N-CA 125.316 1.446 . . . . 0.0 107.371 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.7 mt -62.27 141.79 58.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.744 2.018 . . . . 0.0 110.021 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.4 t -116.05 147.35 41.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 126.067 1.747 . . . . 0.0 109.506 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.643 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.02 138.81 38.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 127.82 2.448 . . . . 0.0 110.301 -173.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 96.35 -12.04 0.08 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 129.385 3.074 . . . . 0.0 112.931 173.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -136.52 -26.91 1.07 Allowed 'General case' 0 C--N 1.357 0.933 0 CA-C-N 119.453 1.024 . . . . 0.0 111.682 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 60.64 163.27 0.06 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.77 1.628 . . . . 0.0 111.317 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.48 -133.52 44.86 Favored Glycine 0 C--N 1.364 2.102 0 O-C-N 119.516 -1.99 . . . . 0.0 108.893 -162.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.3 t 55.86 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.159 0 C-N-CA 125.604 1.562 . . . . 0.0 110.813 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.45 114.72 27.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -104.16 -34.0 8.53 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.788 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 88.4 t -100.92 77.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 166.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -97.97 129.95 44.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.899 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.5 t -143.51 115.53 8.34 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.173 1.389 . . . . 0.0 107.916 169.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.93 84.71 0.73 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 168.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.691 0 C-N-CA 125.435 1.493 . . . . 0.0 111.266 175.614 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 44.3 m . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 65.0 mt -116.4 133.69 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.36 162.97 27.57 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.32 131.08 73.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -138.42 150.23 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.8 m -118.77 -39.78 2.94 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 45.7 tp -82.74 -51.64 7.5 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 119.474 1.034 . . . . 0.0 112.122 -169.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 872' ' ' LEU . 30.2 pt -84.53 -176.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 125.663 1.585 . . . . 0.0 110.307 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.21 84.9 2.04 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -167.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.25 93.54 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.051 1.834 . . . . 0.0 110.389 163.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.56 142.23 49.54 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -93.16 158.85 15.55 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.953 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.05 123.57 23.1 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 119.46 1.027 . . . . 0.0 108.665 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.97 -10.19 74.98 Favored Glycine 0 C--N 1.344 0.984 0 C-N-CA 125.351 1.453 . . . . 0.0 111.207 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.17 174.65 6.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.869 0.867 . . . . 0.0 110.684 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 97.9 m -143.11 125.93 16.1 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -159.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.643 HG13 HH11 ' B' ' 914' ' ' ARG . 20.7 m -96.39 151.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 121.337 0.589 . . . . 0.0 110.625 172.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.2 138.95 31.85 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.236 1.814 . . . . 0.0 111.194 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.2 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 126.971 2.109 . . . . 0.0 106.892 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -105.7 131.26 53.28 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 100.835 -3.765 . . . . 0.0 100.835 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.25 70.62 1.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 58.5 t -161.52 101.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -152.39 69.61 0.88 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.7 142.9 6.63 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 107.39 -2.284 . . . . 0.0 107.39 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -110.14 -29.36 8.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -92.29 86.92 5.86 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.23 -163.17 1.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -124.62 159.22 31.23 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.02 133.33 35.82 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -159.03 152.27 22.48 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 112.39 22.52 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -98.4 173.7 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.071 1.847 . . . . 0.0 108.384 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.41 138.13 52.02 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.3 p -138.99 140.69 38.27 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.892 1.223 . . . . 0.0 108.393 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 33.6 mm -116.02 130.53 70.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -127.17 106.0 8.95 Favored 'General case' 0 C--N 1.363 1.161 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 33.3 p -101.27 162.36 12.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.738 1.215 . . . . 0.0 110.07 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 109.83 0.28 Allowed Glycine 0 C--N 1.359 1.825 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.131 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.41 144.17 47.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 67.7 tp -72.16 124.62 25.4 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 124.9 1.28 . . . . 0.0 109.706 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.46 -58.54 1.94 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.29 128.51 37.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.71 129.93 10.09 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 103.72 -3.752 . . . . 0.0 103.72 164.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.86 129.02 92.65 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.292 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -106.74 80.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.595 1.605 . . . . 0.0 109.103 -169.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 78.01 -72.03 0.09 Allowed 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 129.91 3.284 . . . . 0.0 109.222 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.8 mt 48.74 40.26 15.63 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 128.884 2.874 . . . . 0.0 113.936 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.51 132.14 55.24 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.88 107.63 9.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 178.717 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 N--CA 1.453 -0.885 0 N-CA-C 109.982 -0.814 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.17 114.29 27.77 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.23 -22.24 1.39 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.666 1.631 . . . . 0.0 110.296 -172.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 36.59 70.28 0.17 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.862 2.865 . . . . 0.0 115.893 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.47 137.13 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.8 155.98 49.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 164.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 6.6 p90 -148.44 137.2 21.58 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 18.2 t -171.67 119.8 0.46 Allowed 'General case' 0 C--N 1.362 1.147 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.629 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.54 153.36 35.51 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.81 158.71 43.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.831 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.554 HD21 HD23 ' C' ' 858' ' ' LEU . 2.4 tm? -138.14 130.53 29.1 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -166.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 65.1 m -158.28 16.26 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -171.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.554 HD23 HD21 ' C' ' 856' ' ' LEU . 2.5 pp -30.61 149.54 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.453 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 160.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -80.32 -45.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 122.212 1.826 . . . . 0.0 113.929 -161.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -162.11 178.01 9.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -171.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -15.97 125.36 0.01 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 130.39 3.476 . . . . 0.0 116.57 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.98 149.18 42.87 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -160.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.55 -16.26 19.12 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 112.111 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -138.96 2.56 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.4 m -67.47 144.98 55.43 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 109.98 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.93 133.08 28.25 Favored Pre-proline 0 N--CA 1.439 -0.987 0 C-N-CA 124.797 1.239 . . . . 0.0 110.343 -162.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -97.24 -151.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.806 3.004 . . . . 0.0 109.45 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -144.96 132.52 20.88 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -114.24 -16.53 12.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.492 0.717 . . . . 0.0 111.225 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -102.79 82.79 2.16 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.253 0.549 . . . . 0.0 111.241 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.6 97.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.61 1.964 . . . . 0.0 106.707 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.6 -37.34 13.88 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.561 -173.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.4 tp -164.99 126.61 2.09 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 101.165 -3.643 . . . . 0.0 101.165 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 28.5 t-20 174.03 61.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.139 1.336 . . . . 0.0 107.784 -163.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.28 -42.43 95.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.75 -28.49 18.64 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.802 0.728 . . . . 0.0 112.303 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.88 -58.52 0.47 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 62.53 -81.18 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 128.069 2.547 . . . . 0.0 114.525 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.44 120.1 36.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.332 1.453 . . . . 0.0 108.683 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -85.53 117.31 68.49 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.2 8.03 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 CA-C-N 125.101 2.857 . . . . 0.0 109.643 -169.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.45 -45.4 19.49 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 36.4 p -106.09 -16.45 14.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 125.456 1.502 . . . . 0.0 108.003 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.11 24.54 47.9 Favored Glycine 0 C--N 1.361 1.967 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.6 103.12 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 -166.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.61 111.48 23.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.734 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 52.3 m -102.02 107.89 19.16 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . 0.578 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.83 110.83 46.3 Favored Pre-proline 0 C--N 1.357 0.9 0 CA-C-O 117.262 -1.351 . . . . 0.0 111.777 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -93.06 1.43 3.57 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.557 2.171 . . . . 0.0 108.472 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 50.3 mt -53.68 -54.51 36.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.86 2.464 . . . . 0.0 114.179 -169.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.42 69.14 0.74 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 122.185 0.993 . . . . 0.0 111.166 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.82 173.4 46.23 Favored Glycine 0 N--CA 1.405 -3.379 1 N-CA-C 100.791 -4.924 . . . . 0.0 100.791 -170.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -93.32 115.72 28.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.7 -1.25 . . . . 0.0 107.741 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -117.8 160.57 21.16 Favored 'General case' 0 C--N 1.365 1.264 0 CA-C-N 119.161 0.891 . . . . 0.0 110.845 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.5 tp -108.16 113.99 27.53 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 108.131 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.7 141.68 47.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 124.795 1.238 . . . . 0.0 108.898 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.1 m -143.26 120.66 11.64 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.625 0.77 . . . . 0.0 110.241 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 154.6 20.92 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.71 123.62 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 67.6 mt -99.29 120.09 38.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.264 1.025 . . . . 0.0 109.155 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -84.87 132.78 34.35 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.67 -59.16 11.02 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 125.022 1.296 . . . . 0.0 114.095 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.2 m80 39.91 65.02 0.78 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.126 2.171 . . . . 0.0 113.899 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -71.62 -9.43 58.23 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.24 1.416 . . . . 0.0 112.12 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.07 -17.43 61.42 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.244 1.418 . . . . 0.0 112.649 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.32 9.6 pt-20 126.23 -175.61 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 128.108 2.563 . . . . 0.0 107.909 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 40.0 tttp 101.0 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 127.766 2.426 . . . . 0.0 106.741 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.4 t -99.38 123.17 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -109.3 121.65 45.64 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.366 171.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.43 116.92 17.41 Favored 'General case' 0 C--N 1.372 1.551 0 C-N-CA 128.581 2.752 . . . . 0.0 109.885 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.12 114.39 26.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.62 147.11 46.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.835 2.054 . . . . 0.0 111.688 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.269 1.2 p -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.106 2.162 . . . . 0.0 109.685 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.578 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.15 138.95 38.97 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.146 1.778 . . . . 0.0 109.283 174.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 5.8 t 98.0 -16.6 0.05 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 129.23 3.012 . . . . 0.0 112.409 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -136.39 -26.88 1.09 Allowed 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.105 0.866 . . . . 0.0 111.574 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 60.01 169.68 0.08 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.141 1.377 . . . . 0.0 111.308 -164.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.25 -130.98 50.31 Favored Glycine 0 C--N 1.374 2.681 0 O-C-N 119.599 -1.938 . . . . 0.0 110.117 -164.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 60.2 t 53.21 77.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.257 0 C-N-CA 125.961 1.704 . . . . 0.0 111.551 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.7 115.0 27.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -171.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -102.54 -35.7 8.65 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.626 -171.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 86.47 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.33 130.28 42.16 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.102 0.477 . . . . 0.0 110.233 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 21.0 t -142.0 115.45 8.99 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.764 1.626 . . . . 0.0 108.28 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.96 85.48 0.63 Allowed Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 104.51 -3.436 . . . . 0.0 104.51 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.723 0 C-N-CA 124.726 1.155 . . . . 0.0 110.947 170.185 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 65.5 mt -122.08 133.62 54.77 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.71 28.08 Favored Glycine 0 CA--C 1.493 -1.289 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -119.07 131.85 70.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -134.2 150.5 51.07 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 121.369 -0.832 . . . . 0.0 108.955 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 48.8 m -117.47 -42.81 2.85 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 16.8 tp -90.01 -52.62 4.87 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 121.453 -0.779 . . . . 0.0 111.913 -166.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.17 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 126.23 1.812 . . . . 0.0 109.321 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.27 85.93 1.52 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -167.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.12 89.54 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.328 2.019 . . . . 0.0 109.964 164.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.7 145.89 47.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -92.77 161.16 14.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.342 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.53 122.73 20.98 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-N 120.067 1.303 . . . . 0.0 108.877 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.33 -11.19 72.72 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 125.517 1.532 . . . . 0.0 111.377 168.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 175.56 4.04 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.67 0.788 . . . . 0.0 111.608 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.4 m -143.29 126.56 16.6 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.898 0.879 . . . . 0.0 110.412 -160.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.99 148.52 5.46 Favored 'Isoleucine or valine' 0 C--N 1.362 1.129 0 C-N-CA 123.842 0.857 . . . . 0.0 109.191 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.7 t -141.49 139.66 33.35 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 126.079 1.752 . . . . 0.0 111.451 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.44 129.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.369 1.428 0 C-N-CA 126.271 1.828 . . . . 0.0 107.574 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.02 131.53 54.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 168.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.56 77.99 1.78 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.105 -1.862 . . . . 0.0 107.032 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.9 t -159.25 99.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 N-CA-C 104.441 -2.429 . . . . 0.0 104.441 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -150.71 81.07 1.34 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.07 148.64 16.51 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -115.29 -28.56 6.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 109.274 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.4 tp -91.33 87.14 6.35 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.86 -162.56 1.31 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -123.84 157.97 32.91 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.5 133.25 35.66 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.82 150.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.64 112.61 22.75 Favored Pre-proline 0 C--N 1.355 0.817 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -101.45 -178.21 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 121.766 1.644 . . . . 0.0 108.294 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.17 137.32 53.06 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.253 1.021 . . . . 0.0 109.294 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.9 p -138.27 137.26 37.3 Favored 'General case' 0 C--N 1.376 1.719 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.24 131.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -125.14 104.45 8.53 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 30.2 p -102.51 163.72 12.07 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.313 1.445 . . . . 0.0 110.016 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.59 112.29 0.36 Allowed Glycine 0 C--N 1.356 1.679 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.29 143.04 46.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.68 125.18 27.47 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 125.556 1.543 . . . . 0.0 110.054 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 15.5 tp -98.74 -57.35 2.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 122.376 0.27 . . . . 0.0 110.362 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -131.13 128.07 39.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 131.08 10.53 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 104.174 -3.57 . . . . 0.0 104.174 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.28 128.73 91.15 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 117.768 -1.11 . . . . 0.0 111.214 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -106.71 78.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 122.029 1.76 . . . . 0.0 109.667 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 78.61 -72.74 0.08 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.852 3.261 . . . . 0.0 109.083 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.1 mt 49.19 39.46 15.58 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 128.789 2.836 . . . . 0.0 113.828 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.4 132.04 54.74 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.53 107.37 9.42 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.067 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.677 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.455 -0.777 0 N-CA-C 110.031 -0.796 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 45.0 t -126.87 119.55 22.55 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -89.84 -22.21 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.106 1.788 . . . . 0.0 109.797 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 36.92 70.01 0.19 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 129.025 2.93 . . . . 0.0 115.498 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.64 137.23 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.78 160.73 37.28 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 165.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -149.31 140.16 22.79 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.1 t -169.43 116.52 0.6 Allowed 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -122.95 153.18 40.07 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -138.64 157.83 45.38 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.24 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.572 HD21 HD23 ' A' ' 858' ' ' LEU . 2.7 tm? -131.8 130.97 42.49 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -168.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 67.5 m -160.99 8.69 0.08 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -162.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.572 HD23 HD21 ' A' ' 856' ' ' LEU . 2.9 pp -28.93 149.4 0.03 OUTLIER Pre-proline 0 C--N 1.367 1.361 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 162.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.48 -45.15 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.966 1.738 . . . . 0.0 113.672 -163.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -162.56 173.98 13.24 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.89 118.84 0.01 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 130.647 3.579 . . . . 0.0 116.759 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.7 164.44 15.19 Favored Pre-proline 0 N--CA 1.442 -0.846 0 C-N-CA 124.279 1.031 . . . . 0.0 110.271 -171.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.71 -15.5 13.53 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.751 2.301 . . . . 0.0 111.337 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.78 -140.59 3.12 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 120.176 1.353 . . . . 0.0 111.189 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.7 m -63.09 145.38 55.59 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.616 2.366 . . . . 0.0 111.454 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.7 127.1 76.4 Favored Pre-proline 0 N--CA 1.441 -0.879 0 C-N-CA 125.308 1.443 . . . . 0.0 111.59 -166.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -98.52 -150.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.429 2.752 . . . . 0.0 107.779 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -149.25 134.3 18.11 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.52 -13.4 10.3 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.029 0.532 . . . . 0.0 110.524 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -100.09 86.79 3.31 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.78 97.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.145 1.778 . . . . 0.0 106.96 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.24 -37.15 16.31 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.376 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 39.8 tp -166.38 128.3 1.83 Allowed 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 162.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -178.34 61.54 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.84 1.655 . . . . 0.0 109.386 -167.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.28 -44.37 92.47 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -165.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.51 -31.27 8.98 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.827 0.739 . . . . 0.0 112.388 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.59 -62.36 0.29 Allowed Glycine 0 C--N 1.353 1.474 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 66.9 -78.19 0.04 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.108 2.563 . . . . 0.0 113.478 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -96.36 120.53 36.82 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.309 1.444 . . . . 0.0 108.792 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.04 117.19 66.25 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -94.24 5.6 2.64 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 CA-C-N 125.43 2.975 . . . . 0.0 108.991 -168.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -80.29 -45.59 17.62 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 -13.36 15.42 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.107 1.363 . . . . 0.0 108.544 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.79 37.96 Favored Glycine 0 C--N 1.364 2.125 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 161.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 23.7 t -101.05 103.94 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 100.419 -3.919 . . . . 0.0 100.419 -163.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.49 112.44 24.98 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.298 -2.228 . . . . 0.0 108.529 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 68.1 m -100.47 108.42 20.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 167.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . 0.434 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.41 111.18 45.88 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.85 171.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -94.35 1.51 2.93 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 CA-C-N 123.107 2.145 . . . . 0.0 109.196 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.49 -49.94 71.21 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.148 2.179 . . . . 0.0 114.076 -168.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 52.63 7.26 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.637 1.175 . . . . 0.0 113.749 169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -166.75 -167.3 27.22 Favored Glycine 0 N--CA 1.414 -2.771 1 N-CA-C 100.496 -5.042 . . . . 0.0 100.496 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.99 121.44 35.47 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.27 3.5 p90 -115.26 161.31 18.65 Favored 'General case' 0 C--N 1.366 1.291 0 CA-C-N 119.099 0.863 . . . . 0.0 109.127 174.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -104.7 116.94 32.9 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.62 0.768 . . . . 0.0 109.538 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -109.45 137.35 47.43 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.806 2.042 . . . . 0.0 109.136 -166.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.5 m -146.37 118.89 8.49 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 123.399 0.68 . . . . 0.0 109.218 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.06 153.55 22.45 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.28 118.86 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.44 123.56 45.7 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.497 -173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 45.8 m -79.17 131.23 36.14 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.414 1.486 . . . . 0.0 107.512 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.77 -56.47 20.33 Favored Glycine 0 C--N 1.362 2.01 0 C-N-CA 126.064 1.792 . . . . 0.0 114.897 -168.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.3 m170 33.52 74.54 0.06 Allowed 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.964 2.506 . . . . 0.0 115.897 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -72.77 -10.72 60.12 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.437 1.495 . . . . 0.0 111.355 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -73.09 -14.74 61.45 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.369 1.468 . . . . 0.0 112.228 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.363 8.3 pt-20 123.4 -168.68 0.0 OUTLIER 'General case' 0 C--N 1.363 1.155 0 C-N-CA 128.26 2.624 . . . . 0.0 108.166 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 64.9 mttt 98.29 135.54 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 128.258 2.623 . . . . 0.0 107.261 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.24 125.26 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.53 128.79 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 127.121 2.168 . . . . 0.0 109.699 176.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.68 114.64 4.7 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.865 1.266 . . . . 0.0 110.06 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.7 114.68 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.51 141.67 58.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.156 1.782 . . . . 0.0 110.297 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 4.8 t -114.92 146.83 40.73 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 126.202 1.801 . . . . 0.0 109.129 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.629 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.17 138.05 38.49 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.91 2.484 . . . . 0.0 110.022 -174.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.27 -3.85 0.07 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.142 2.977 . . . . 0.0 112.809 172.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -144.25 -25.99 0.53 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 119.56 1.073 . . . . 0.0 111.245 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 58.46 166.71 0.05 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.4 1.48 . . . . 0.0 112.1 -164.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.22 -134.87 48.46 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 119.359 -2.088 . . . . 0.0 109.303 -161.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 43.8 t 57.29 73.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 125.467 1.507 . . . . 0.0 110.277 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.68 113.95 26.35 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -103.13 -35.55 8.45 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.404 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.37 78.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 168.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.32 129.09 44.63 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.5 -173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.9 t -143.43 114.56 7.84 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.57 84.51 0.75 Allowed Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.168 -3.573 . . . . 0.0 104.168 165.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.836 0 C-N-CA 124.747 1.165 . . . . 0.0 113.786 178.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.0 mt -117.89 133.8 55.57 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.44 26.99 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.01 129.46 75.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -137.75 147.51 44.78 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.7 m -115.6 -44.89 2.93 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 44.7 tp -82.27 -49.95 9.5 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 119.237 0.926 . . . . 0.0 113.038 -166.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.96 -171.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 125.955 1.702 . . . . 0.0 109.973 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.92 81.92 2.07 Favored Pre-proline 0 N--CA 1.437 -1.097 0 C-N-CA 123.442 0.697 . . . . 0.0 109.185 -165.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.75 91.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 122.509 1.932 . . . . 0.0 109.644 162.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.42 142.53 49.92 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -94.78 155.03 17.0 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.579 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.64 123.28 21.49 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 119.518 1.054 . . . . 0.0 108.93 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.75 -10.39 74.71 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 125.706 1.622 . . . . 0.0 111.297 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 175.65 5.14 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.575 0.75 . . . . 0.0 111.332 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 88.5 m -142.6 125.34 15.96 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -160.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.629 HG13 HH11 ' A' ' 914' ' ' ARG . 24.4 m -94.82 151.27 3.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 121.666 0.746 . . . . 0.0 109.692 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.05 138.3 31.69 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.446 1.898 . . . . 0.0 111.269 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.43 129.96 42.24 Favored 'Isoleucine or valine' 0 C--N 1.37 1.484 0 C-N-CA 126.589 1.955 . . . . 0.0 106.322 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -105.92 131.95 52.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.03 71.9 1.49 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 59.1 t -162.75 101.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.8 mmm -153.1 70.67 0.88 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.75 147.07 7.52 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -113.31 -30.33 6.95 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.17 87.65 6.62 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.66 -177.14 4.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -166.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -116.99 156.29 27.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -90.67 134.16 34.61 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.76 150.55 21.03 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.25 112.96 21.46 Favored Pre-proline 0 C--N 1.355 0.832 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -99.58 173.82 0.4 Allowed 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 108.586 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.78 140.1 50.16 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -139.94 141.56 36.46 Favored 'General case' 0 C--N 1.375 1.678 0 CA-C-N 119.748 1.158 . . . . 0.0 108.797 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.5 mm -119.67 130.23 74.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -125.63 104.85 8.6 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 54.8 p -101.6 162.03 13.2 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.831 1.253 . . . . 0.0 110.161 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.99 112.28 0.32 Allowed Glycine 0 C--N 1.358 1.769 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.15 144.43 46.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.1 tp -74.25 124.12 25.81 Favored 'General case' 0 C--N 1.379 1.882 0 C-N-CA 124.59 1.156 . . . . 0.0 109.675 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.61 -57.62 2.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -131.72 127.57 37.09 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.43 129.08 9.77 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 103.498 -3.841 . . . . 0.0 103.498 166.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -69.21 129.04 92.26 Favored Pre-proline 0 C--N 1.352 0.681 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.16 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -106.82 80.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 CA-C-N 122.111 1.79 . . . . 0.0 109.873 -168.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 77.98 -72.79 0.08 Allowed 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 130.149 3.379 . . . . 0.0 109.161 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 78.8 mt 49.54 39.16 16.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 129.279 3.032 . . . . 0.0 114.133 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.7 131.79 55.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.56 108.34 10.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.771 0 N-CA-C 110.006 -0.806 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.55 119.75 23.08 Favored Pre-proline 0 C--N 1.354 0.77 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -90.64 -22.24 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 122.136 1.799 . . . . 0.0 109.986 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 37.69 70.45 0.19 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 129.192 2.997 . . . . 0.0 115.196 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.26 137.46 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.64 160.02 39.4 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 165.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -148.83 139.97 23.11 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.4 t -169.28 117.52 0.64 Allowed 'General case' 0 C--N 1.354 0.765 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -124.37 153.9 41.16 Favored 'General case' 0 C--N 1.368 1.403 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.56 157.85 44.59 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.145 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.582 HD21 HD23 ' B' ' 858' ' ' LEU . 2.7 tm? -133.4 128.44 35.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -168.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.2 m -159.84 12.21 0.13 Allowed 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 124.717 1.207 . . . . 0.0 107.747 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.582 HD23 HD21 ' B' ' 856' ' ' LEU . 2.9 pp -28.68 149.87 0.03 OUTLIER Pre-proline 0 C--N 1.369 1.422 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 160.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.45 -45.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.046 1.766 . . . . 0.0 113.777 -164.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 33.6 ptt85 -162.52 173.93 13.35 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.81 118.94 0.01 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 130.692 3.597 . . . . 0.0 116.771 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.08 164.44 15.12 Favored Pre-proline 0 N--CA 1.442 -0.87 0 C-N-CA 124.325 1.05 . . . . 0.0 110.294 -171.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.77 -15.54 13.4 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.782 2.321 . . . . 0.0 111.35 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.53 -140.85 3.17 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 120.222 1.374 . . . . 0.0 111.193 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.0 m -62.93 144.62 56.59 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.473 2.309 . . . . 0.0 111.388 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.93 126.36 82.32 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.394 1.477 . . . . 0.0 111.565 -167.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -98.98 -150.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.364 2.709 . . . . 0.0 107.566 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -148.79 133.3 17.66 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -114.97 -13.96 11.89 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.333 1.053 . . . . 0.0 109.508 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.994 0.426 . . . . 0.0 111.312 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.78 97.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 126.39 1.876 . . . . 0.0 106.253 163.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.27 -38.91 14.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.659 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 54.5 tp -166.03 127.38 1.85 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 165.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 177.0 61.39 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.509 1.504 . . . . 0.0 108.524 -163.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.79 -43.75 94.26 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -165.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.11 -31.27 9.26 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 118.759 0.709 . . . . 0.0 112.366 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 110.62 -60.74 0.32 Allowed Glycine 0 C--N 1.353 1.476 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 66.23 -79.08 0.03 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.185 2.594 . . . . 0.0 113.644 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -97.01 120.75 37.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.5 1.52 . . . . 0.0 109.033 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.44 117.44 67.11 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 171.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -93.25 5.91 3.0 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-N 125.485 2.995 . . . . 0.0 109.11 -169.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -80.1 -44.17 20.44 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 108.656 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -109.16 -13.82 14.61 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.374 1.47 . . . . 0.0 108.306 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.11 27.82 32.72 Favored Glycine 0 C--N 1.362 2.027 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 162.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.44 103.58 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 -161.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -99.79 112.45 24.7 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.691 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.5 m -101.16 108.23 19.85 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 167.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . 0.434 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.66 111.26 46.74 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 117.06 -1.447 . . . . 0.0 111.959 170.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -93.37 1.4 3.42 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 123.186 2.174 . . . . 0.0 109.183 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 31.0 mt -55.43 -49.5 72.25 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.055 2.142 . . . . 0.0 114.36 -168.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.75 52.08 7.02 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.762 1.225 . . . . 0.0 114.263 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.11 -166.41 26.15 Favored Glycine 0 N--CA 1.413 -2.871 1 N-CA-C 101.12 -4.792 . . . . 0.0 101.12 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -93.2 121.33 34.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.308 2.2 p90 -116.92 161.84 18.71 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 119.218 0.917 . . . . 0.0 109.394 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 59.4 tp -105.18 115.76 30.81 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -108.84 136.74 47.89 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 126.335 1.854 . . . . 0.0 108.194 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -145.24 118.65 9.02 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.14 153.58 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.73 120.12 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 122.82 46.26 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 41.6 m -78.58 131.75 36.87 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 125.383 1.473 . . . . 0.0 107.893 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.63 -56.47 20.05 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 126.136 1.827 . . . . 0.0 114.917 -168.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.6 m170 33.16 74.55 0.06 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.058 2.543 . . . . 0.0 115.818 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -72.73 -10.85 60.27 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.542 1.537 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.02 -13.79 61.29 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.495 1.518 . . . . 0.0 112.326 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.361 8.3 pt-20 122.98 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 C-N-CA 128.623 2.769 . . . . 0.0 108.109 172.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 62.7 mttt 97.71 135.19 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 128.211 2.604 . . . . 0.0 107.499 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.15 126.0 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.57 129.27 55.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.352 1.861 . . . . 0.0 109.819 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.8 114.64 4.66 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.566 1.146 . . . . 0.0 110.315 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 96.3 t -89.18 115.14 28.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 C-N-CA 125.569 1.548 . . . . 0.0 107.814 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.8 143.63 57.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 126.694 1.997 . . . . 0.0 110.303 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -115.32 147.43 40.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.318 1.847 . . . . 0.0 109.275 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.609 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.3 137.89 37.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.548 2.339 . . . . 0.0 109.756 -175.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.68 -6.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.196 2.998 . . . . 0.0 113.011 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -142.84 -25.68 0.61 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.716 1.144 . . . . 0.0 111.823 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 58.47 165.89 0.04 OUTLIER 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.561 1.544 . . . . 0.0 111.939 -164.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.42 -133.64 45.03 Favored Glycine 0 C--N 1.367 2.289 0 O-C-N 119.455 -2.028 . . . . 0.0 109.05 -163.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 43.0 t 55.29 74.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 110.511 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.33 114.33 26.83 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -172.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -103.84 -36.51 7.79 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.485 -1.688 . . . . 0.0 108.311 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.68 76.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.34 129.2 44.63 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.184 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -142.56 115.21 8.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.963 1.305 . . . . 0.0 107.77 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.56 84.44 0.75 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 166.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.764 0 C-N-CA 124.755 1.169 . . . . 0.0 113.893 178.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 40.1 m . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 64.4 mt -115.87 133.84 55.62 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -169.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.16 162.74 26.41 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -172.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.09 129.34 75.59 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.17 150.16 46.52 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 57.9 m -125.12 -30.28 3.22 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 119.159 -0.448 . . . . 0.0 111.751 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 29.3 tp -88.35 -51.94 5.47 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 119.411 1.005 . . . . 0.0 111.803 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.9 pt -84.94 -176.8 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 125.585 1.554 . . . . 0.0 110.011 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.417 ' O ' HD22 ' B' ' 954' ' ' LEU . 0.0 OUTLIER -157.32 81.15 3.26 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -167.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.02 92.22 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.328 2.019 . . . . 0.0 110.09 164.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.5 mp -120.94 142.23 49.94 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -94.62 155.96 16.64 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.342 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.56 122.67 20.9 Favored 'General case' 0 C--N 1.377 1.761 0 CA-C-N 119.874 1.215 . . . . 0.0 108.737 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.16 -9.47 77.56 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 125.51 1.528 . . . . 0.0 111.131 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.22 175.34 5.4 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.79 0.836 . . . . 0.0 110.679 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.3 m -142.83 125.5 15.91 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -158.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.609 HG13 HH11 ' B' ' 914' ' ' ARG . 18.9 m -96.13 151.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 121.5 0.666 . . . . 0.0 110.448 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.0 t -141.65 138.43 32.51 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 126.626 1.97 . . . . 0.0 111.432 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.1 t -91.72 130.01 41.53 Favored 'Isoleucine or valine' 0 C--N 1.369 1.44 0 C-N-CA 127.355 2.262 . . . . 0.0 106.531 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.94 131.98 52.59 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.795 -3.78 . . . . 0.0 100.795 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.99 71.55 1.48 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 57.3 t -161.28 102.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 91.6 mmm -152.13 69.64 0.9 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.93 146.46 7.15 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -112.53 -29.96 7.3 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -174.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.48 87.57 6.46 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.87 4.49 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -167.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -116.88 156.0 28.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.2 t -89.74 133.61 34.6 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.92 150.65 20.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.41 113.06 21.21 Favored Pre-proline 0 C--N 1.356 0.864 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -99.33 173.5 0.42 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 122.047 1.832 . . . . 0.0 108.443 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.02 138.9 51.28 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -138.43 141.19 39.54 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 119.723 1.147 . . . . 0.0 108.539 -171.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 23.6 mm -117.11 130.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -126.19 104.44 8.23 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 61.2 p -103.12 162.91 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.959 1.303 . . . . 0.0 110.722 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.45 113.76 0.37 Allowed Glycine 0 C--N 1.359 1.86 0 N-CA-C 106.684 -2.567 . . . . 0.0 106.684 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.33 145.31 46.27 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.56 124.06 24.45 Favored 'General case' 0 C--N 1.381 1.965 0 C-N-CA 124.486 1.114 . . . . 0.0 109.692 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.26 -57.52 2.19 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -131.41 127.13 36.86 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.68 128.99 9.74 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.69 -3.764 . . . . 0.0 103.69 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.15 128.63 92.51 Favored Pre-proline 0 C--N 1.352 0.687 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.771 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -106.47 79.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 122.079 1.778 . . . . 0.0 109.378 -167.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.47 -72.21 0.09 Allowed 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 130.036 3.335 . . . . 0.0 109.117 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 74.6 mt 49.09 40.62 17.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 129.162 2.985 . . . . 0.0 113.868 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -113.52 131.88 55.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -130.41 108.0 9.66 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 179.309 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.1 114.09 26.3 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.56 -21.89 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 CA-C-N 121.643 1.622 . . . . 0.0 109.859 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 39.16 70.13 0.24 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.633 2.773 . . . . 0.0 115.307 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.31 131.77 72.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -138.71 149.27 44.92 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 5.5 p90 -149.53 139.72 22.19 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.289 0.95 . . . . 0.0 110.117 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 20.4 t -169.16 119.22 0.7 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-O 118.23 -0.89 . . . . 0.0 109.519 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.27 153.96 42.42 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -174.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.23 156.23 47.22 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 122.053 0.93 . . . . 0.0 109.747 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.569 HD21 HD23 ' C' ' 858' ' ' LEU . 1.8 tm? -129.21 127.19 40.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.701 -1.59 . . . . 0.0 106.815 -165.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 47.8 p -159.82 13.0 0.13 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.017 -164.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.569 HD23 HD21 ' C' ' 856' ' ' LEU . 3.0 pp -25.93 146.24 0.03 OUTLIER Pre-proline 0 C--N 1.368 1.413 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 157.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.94 -45.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.111 1.79 . . . . 0.0 113.319 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -163.39 177.95 8.5 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 -172.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 18.4 m -13.47 119.51 0.01 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 130.101 3.36 . . . . 0.0 116.079 172.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.85 161.27 38.98 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -166.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.52 -15.23 8.76 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.408 2.072 . . . . 0.0 110.999 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.26 -144.2 4.04 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -65.49 135.55 55.32 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.86 1.664 . . . . 0.0 110.515 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 17.1 m -65.74 144.02 98.74 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 125.628 1.571 . . . . 0.0 113.184 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -99.71 -151.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 123.303 2.669 . . . . 0.0 107.295 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -146.39 129.94 16.91 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -116.23 -16.17 10.97 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 122.969 0.508 . . . . 0.0 110.705 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -102.39 81.12 2.02 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.089 0.471 . . . . 0.0 111.372 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.15 97.68 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 127.231 2.213 . . . . 0.0 106.652 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 4.9 mt -89.03 -37.3 15.26 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.465 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 45.4 tp -165.31 129.48 2.37 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 100.401 -3.926 . . . . 0.0 100.401 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.1 t-20 175.68 61.56 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 121.218 1.826 . . . . 0.0 108.226 -166.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.55 97.73 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -165.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.02 -28.81 12.65 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.58 0.627 . . . . 0.0 112.663 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.15 -58.71 0.4 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.79 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.588 2.755 . . . . 0.0 114.085 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -97.25 120.8 38.28 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.811 1.644 . . . . 0.0 108.203 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -83.97 116.82 66.66 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -94.22 6.06 2.58 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 CA-C-N 124.955 2.805 . . . . 0.0 109.942 -165.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -79.95 -45.43 18.53 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.7 p -106.4 -12.08 15.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.937 1.295 . . . . 0.0 108.482 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.74 21.22 54.18 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.452 161.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.42 102.44 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -162.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.45 112.06 23.84 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 111.736 -2.484 . . . . 0.0 108.997 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 80.9 m -100.57 108.05 19.88 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.17 111.41 48.43 Favored Pre-proline 0 C--N 1.354 0.798 0 CA-C-O 117.284 -1.341 . . . . 0.0 110.248 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -91.03 0.07 4.88 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.444 2.096 . . . . 0.0 108.621 166.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 87.9 mt -58.21 -50.51 73.28 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.987 1.715 . . . . 0.0 114.59 -164.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.44 68.99 0.75 Allowed 'General case' 0 C--N 1.366 1.305 0 CA-C-O 122.051 0.929 . . . . 0.0 111.738 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.8 -167.75 35.8 Favored Glycine 0 N--CA 1.406 -3.309 1 N-CA-C 102.272 -4.331 . . . . 0.0 102.272 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -92.65 121.49 34.12 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.422 -1.389 . . . . 0.0 108.493 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.525 ' H ' HD11 ' C' ' 954' ' ' LEU . 3.6 t80 -116.9 145.73 43.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -112.18 115.33 28.67 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.035 0.934 . . . . 0.0 108.648 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.2 tt -112.62 140.97 46.93 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.517 1.527 . . . . 0.0 108.505 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -143.01 118.81 10.53 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.86 154.03 22.16 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.58 122.63 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 78.7 mt -97.92 122.57 41.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.309 1.044 . . . . 0.0 108.974 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.66 131.43 35.97 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.21 -56.28 24.06 Favored Glycine 0 C--N 1.367 2.261 0 C-N-CA 125.336 1.446 . . . . 0.0 112.992 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 43.72 63.08 1.69 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.772 2.429 . . . . 0.0 113.981 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -72.68 -7.48 50.63 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 112.594 -168.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 125.381 1.472 . . . . 0.0 112.294 -171.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.336 8.5 pt-20 120.89 -173.37 0.0 OUTLIER 'General case' 0 C--N 1.362 1.148 0 C-N-CA 128.253 2.621 . . . . 0.0 107.956 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.3 tttt 102.62 135.31 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 127.997 2.519 . . . . 0.0 106.524 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 93.2 t -98.39 123.29 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -104.77 129.72 52.97 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.566 1.946 . . . . 0.0 110.171 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.67 114.23 3.74 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.127 1.371 . . . . 0.0 109.943 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.27 117.2 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.818 1.647 . . . . 0.0 108.854 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.45 142.23 57.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.052 1.741 . . . . 0.0 110.204 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.26 1.3 p -113.81 148.73 36.07 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 126.427 1.891 . . . . 0.0 108.368 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.581 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -78.72 137.42 37.77 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.797 1.639 . . . . 0.0 108.364 178.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 101.65 -18.1 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 129.255 3.022 . . . . 0.0 112.281 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -137.5 -26.74 0.97 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 119.277 0.944 . . . . 0.0 111.3 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 59.93 167.17 0.07 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.31 1.444 . . . . 0.0 111.861 -164.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.5 -130.72 51.43 Favored Glycine 0 C--N 1.376 2.764 0 O-C-N 119.554 -1.966 . . . . 0.0 110.197 -163.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 43.2 t 51.8 74.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 126.317 1.847 . . . . 0.0 111.712 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.49 116.62 29.0 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -99.56 -36.66 9.46 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.782 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.85 78.12 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -94.05 132.56 38.41 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -143.55 114.56 7.79 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 125.39 1.476 . . . . 0.0 108.295 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.45 84.97 0.64 Allowed Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 104.765 -3.334 . . . . 0.0 104.765 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.727 0 C-N-CA 125.096 1.332 . . . . 0.0 110.909 172.743 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.511 -0.536 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.6 mt -121.28 134.59 55.17 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.85 162.51 26.29 Favored Glycine 0 CA--C 1.493 -1.344 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.1 130.75 73.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -137.07 150.62 48.15 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 53.3 m -117.71 -36.7 3.6 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.157 -0.34 . . . . 0.0 111.414 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.78 -54.6 3.56 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 118.525 0.602 . . . . 0.0 111.928 -166.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.6 pp -84.76 -173.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 126.463 1.905 . . . . 0.0 110.158 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.525 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -162.12 92.86 1.32 Allowed Pre-proline 0 C--N 1.358 0.942 0 O-C-N 122.02 -0.425 . . . . 0.0 109.947 -168.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.33 91.15 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 122.944 2.087 . . . . 0.0 109.797 160.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' C' ' 954' ' ' LEU . 5.9 mp -121.42 142.88 49.58 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -92.43 160.23 15.18 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.75 122.05 19.97 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 120.226 1.375 . . . . 0.0 108.502 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.61 71.45 Favored Glycine 0 C--N 1.347 1.158 0 C-N-CA 125.389 1.471 . . . . 0.0 111.419 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.89 174.99 3.91 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.488 0.715 . . . . 0.0 111.471 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 19.4 p -142.96 127.98 18.48 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.435 0.635 . . . . 0.0 109.416 -161.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.581 HG13 HH11 ' C' ' 914' ' ' ARG . 19.6 m -94.69 150.28 4.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.66 137.72 33.78 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 125.047 1.339 . . . . 0.0 111.916 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.79 129.42 42.49 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 C-N-CA 125.912 1.685 . . . . 0.0 106.805 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -106.82 132.6 52.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 11.4 tp -132.28 75.26 1.62 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.196 -1.82 . . . . 0.0 107.972 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.7 t -158.59 100.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.62 75.15 1.15 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 112.89 145.6 9.51 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -113.0 -30.51 6.99 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.2 tp -92.24 87.06 5.94 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.8 -160.62 1.08 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -123.17 155.13 37.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -91.48 134.02 35.0 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -158.27 151.19 22.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -127.29 116.67 21.58 Favored Pre-proline 0 C--N 1.355 0.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -102.99 173.76 0.19 Allowed 'Trans proline' 0 CA--C 1.508 -0.817 0 N-CA-C 107.925 -1.606 . . . . 0.0 107.925 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -114.55 139.52 49.51 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -137.79 139.44 40.03 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 119.665 1.12 . . . . 0.0 108.001 -169.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.41 131.24 69.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -124.92 105.53 9.3 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 28.6 p -101.76 164.67 11.61 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.61 1.564 . . . . 0.0 109.911 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.15 111.81 0.35 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.06 141.53 48.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -76.7 124.45 27.68 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.386 1.474 . . . . 0.0 108.586 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 18.6 tp -98.1 -57.46 2.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.753 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.91 128.26 38.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.71 131.7 10.83 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.684 -3.766 . . . . 0.0 103.684 162.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.34 132.38 89.75 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.595 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -106.09 78.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.54 1.586 . . . . 0.0 108.954 -171.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 79.56 -71.75 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.207 3.403 . . . . 0.0 109.007 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 68.6 mt 49.87 38.87 17.01 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 129.183 2.993 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.14 131.86 54.76 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.94 107.14 9.14 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 179.544 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 109.854 -0.864 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.94 119.0 21.01 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -89.96 -20.89 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.079 1.778 . . . . 0.0 109.689 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 37.74 69.23 0.25 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.727 2.811 . . . . 0.0 115.618 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.09 137.1 54.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.2 158.84 43.32 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -149.38 138.07 21.02 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 22.9 t -170.28 117.5 0.54 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.73 153.36 34.52 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.01 157.89 45.76 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.68 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.404 HD21 HD23 ' A' ' 858' ' ' LEU . 2.3 tm? -130.75 129.32 42.33 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -166.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.2 p -162.01 14.36 0.09 Allowed 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -163.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.404 HD23 HD21 ' A' ' 856' ' ' LEU . 3.8 pp -24.86 147.44 0.02 OUTLIER Pre-proline 0 C--N 1.366 1.318 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 159.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.51 -45.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 121.918 1.721 . . . . 0.0 112.891 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -163.45 179.34 7.37 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -172.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -24.05 126.76 0.03 OUTLIER 'General case' 0 C--N 1.364 1.225 0 C-N-CA 129.364 3.066 . . . . 0.0 115.22 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -122.77 147.15 50.08 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -158.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.46 -10.35 20.45 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.505 2.137 . . . . 0.0 113.042 -172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.25 -142.01 3.33 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 120.426 1.466 . . . . 0.0 110.558 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.4 m -62.82 144.72 56.28 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 127.213 2.205 . . . . 0.0 110.813 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.11 122.77 84.75 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 125.504 1.522 . . . . 0.0 111.089 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -96.39 -153.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.96 3.107 . . . . 0.0 107.472 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -151.49 135.66 16.71 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -120.12 -11.88 9.18 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 122.146 -0.346 . . . . 0.0 111.905 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.09 87.14 3.39 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.591 0.632 . . . . 0.0 112.264 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.87 97.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 126.213 1.805 . . . . 0.0 106.882 168.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' B' ' 953' ' ' ILE . 67.0 mt -87.48 -37.82 16.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.238 -173.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 32.4 tp -166.65 127.51 1.66 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 101.106 -3.665 . . . . 0.0 101.106 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 179.98 61.04 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 120.839 1.654 . . . . 0.0 108.988 -166.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 -44.03 95.84 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -166.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.72 -27.13 15.13 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 118.863 0.756 . . . . 0.0 112.456 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.77 -58.73 0.39 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 62.68 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 127.933 2.493 . . . . 0.0 114.094 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -95.97 119.54 34.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.785 1.234 . . . . 0.0 108.068 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.05 117.29 67.8 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.53 4.84 2.61 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 124.656 2.699 . . . . 0.0 109.399 -165.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.16 -45.72 17.64 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -104.31 -14.29 15.84 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 124.517 1.127 . . . . 0.0 108.746 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.26 47.65 Favored Glycine 0 C--N 1.363 2.068 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 162.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 52.5 t -100.18 103.89 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 -163.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.71 111.92 24.23 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 112.167 -2.288 . . . . 0.0 109.358 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 64.9 m -100.33 108.18 20.15 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . 0.414 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.93 110.75 44.1 Favored Pre-proline 0 C--N 1.357 0.912 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.707 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.22 1.29 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 123.285 2.209 . . . . 0.0 108.94 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 29.9 mt -51.68 -53.84 34.61 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 128.489 2.716 . . . . 0.0 114.151 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.17 65.3 1.31 Allowed 'General case' 0 C--N 1.365 1.277 0 CA-C-O 121.901 0.858 . . . . 0.0 112.057 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.08 -177.93 45.48 Favored Glycine 0 N--CA 1.411 -3.012 1 N-CA-C 101.033 -4.827 . . . . 0.0 101.033 -173.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -93.18 121.27 34.37 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.284 1.3 p90 -114.95 161.68 17.98 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.158 0.89 . . . . 0.0 109.573 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 63.0 tp -104.17 116.45 32.22 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.421 0.688 . . . . 0.0 109.662 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.03 136.72 49.63 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 126.386 1.874 . . . . 0.0 108.916 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.8 m -147.41 119.57 8.29 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 123.318 0.647 . . . . 0.0 109.557 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.42 153.92 21.56 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.5 t -107.97 120.82 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.95 123.96 45.94 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.177 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 42.4 m -81.11 132.97 35.39 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 125.581 1.552 . . . . 0.0 107.389 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.4 -57.22 20.8 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 124.931 1.253 . . . . 0.0 113.765 -170.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.6 m170 36.1 71.48 0.13 Allowed 'General case' 0 C--N 1.36 1.043 0 C-N-CA 127.556 2.342 . . . . 0.0 115.143 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -73.03 -8.02 53.85 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 125.253 1.421 . . . . 0.0 112.028 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.82 -18.76 62.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.18 1.392 . . . . 0.0 112.605 -171.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.305 11.3 pt-20 125.13 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 127.954 2.502 . . . . 0.0 108.16 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 99.16 131.69 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.423 2.289 . . . . 0.0 107.277 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.76 123.81 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -107.97 121.71 45.35 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.015 1.726 . . . . 0.0 112.864 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -130.5 116.13 17.76 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.6 2.76 . . . . 0.0 108.615 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.3 t -84.98 114.74 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.67 141.26 58.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.841 1.656 . . . . 0.0 110.497 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.3 t -115.96 147.18 41.44 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.537 1.935 . . . . 0.0 109.373 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.6 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.68 139.49 39.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.821 2.848 . . . . 0.0 110.634 -173.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 7.2 t 97.55 -12.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 129.269 3.028 . . . . 0.0 112.909 173.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -136.9 -26.51 1.04 Allowed 'General case' 0 C--N 1.356 0.887 0 CA-C-N 119.601 1.091 . . . . 0.0 111.204 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 61.58 163.35 0.08 Allowed 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.473 1.509 . . . . 0.0 111.388 -166.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.77 -135.07 49.43 Favored Glycine 0 C--N 1.37 2.456 0 O-C-N 119.443 -2.036 . . . . 0.0 109.442 -160.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 44.0 t 57.52 78.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.169 0 C-N-CA 125.56 1.544 . . . . 0.0 110.714 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.69 114.42 26.96 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -173.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -102.86 -35.75 8.49 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.479 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -100.22 82.43 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 167.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -94.93 130.21 41.65 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.796 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -142.96 114.88 8.23 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.654 1.582 . . . . 0.0 108.631 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.3 85.12 0.65 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 103.701 -3.76 . . . . 0.0 103.701 162.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.842 0 C-N-CA 124.369 0.985 . . . . 0.0 112.133 172.206 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.52 133.28 55.99 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.13 161.58 27.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -172.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 26.5 m -122.59 127.85 75.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.7 149.32 46.42 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.0 m -115.0 -43.74 3.08 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 22.9 tp -83.71 -50.07 8.51 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 119.491 1.041 . . . . 0.0 112.775 -166.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 7.8 pt -85.01 -174.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 110.438 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.69 81.64 2.74 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 123.154 0.582 . . . . 0.0 109.663 -166.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.24 92.24 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.593 2.195 . . . . 0.0 109.911 162.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.8 143.8 48.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -94.33 156.59 16.44 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.605 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.29 123.47 22.35 Favored 'General case' 0 C--N 1.372 1.547 0 CA-C-N 119.292 0.951 . . . . 0.0 108.861 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.11 72.92 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 125.936 1.731 . . . . 0.0 111.096 171.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.92 175.25 5.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.385 0.674 . . . . 0.0 111.528 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 13.1 t -144.4 128.68 17.8 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.825 0.821 . . . . 0.0 110.191 -164.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.6 HG13 HH11 ' A' ' 914' ' ' ARG . 23.4 m -94.53 151.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.957 172.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.54 138.5 32.76 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 126.197 1.799 . . . . 0.0 111.275 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.69 129.51 42.26 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 C-N-CA 126.102 1.761 . . . . 0.0 107.04 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -107.8 131.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 169.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -131.39 76.44 1.72 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.401 -1.727 . . . . 0.0 107.303 172.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.1 t -160.46 100.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.0 mmm -153.58 70.12 0.83 Allowed 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.05 145.8 7.33 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -113.1 -29.35 7.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.8 tp -91.37 87.42 6.44 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.62 -165.28 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -124.46 161.02 26.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -93.47 133.15 37.05 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.61 151.38 22.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.22 113.39 21.54 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -99.21 173.93 0.42 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 121.875 1.716 . . . . 0.0 108.751 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.43 139.34 51.54 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.707 1.203 . . . . 0.0 108.247 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -140.76 141.9 34.78 Favored 'General case' 0 C--N 1.376 1.727 0 CA-C-N 120.001 1.273 . . . . 0.0 108.599 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 24.3 mm -118.12 129.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -125.14 105.62 9.29 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 32.1 p -101.04 161.97 13.22 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.019 1.328 . . . . 0.0 110.379 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.54 0.28 Allowed Glycine 0 C--N 1.359 1.835 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.17 145.27 46.14 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.37 -1.077 . . . . 0.0 113.809 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.8 tp -75.19 123.09 24.66 Favored 'General case' 0 C--N 1.379 1.857 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 27.7 tp -98.61 -57.33 2.22 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -131.7 128.05 38.17 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 130.95 10.47 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 103.883 -3.687 . . . . 0.0 103.883 165.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -69.09 128.91 92.48 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-O 117.825 -1.083 . . . . 0.0 111.046 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -107.14 80.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.048 1.767 . . . . 0.0 109.814 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.89 -72.75 0.09 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 130.241 3.416 . . . . 0.0 109.315 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 73.2 mt 49.62 39.24 16.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.158 2.983 . . . . 0.0 114.169 -176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -112.1 131.43 55.44 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -128.93 108.7 10.63 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 179.318 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.55 119.19 21.57 Favored Pre-proline 0 C--N 1.354 0.771 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.25 -20.93 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 122.193 1.819 . . . . 0.0 109.905 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 39.31 69.19 0.3 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 128.783 2.833 . . . . 0.0 115.351 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 88.6 t -118.88 136.76 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.21 157.81 45.96 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 165.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.31 138.49 21.41 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -170.68 118.07 0.51 Allowed 'General case' 0 C--N 1.357 0.893 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.67 153.55 34.16 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.508 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -136.13 157.97 45.55 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.433 174.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.434 HD21 HD23 ' B' ' 858' ' ' LEU . 2.2 tm? -130.45 128.04 40.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -167.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.8 p -161.65 13.36 0.09 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.341 -163.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.434 HD23 HD21 ' B' ' 856' ' ' LEU . 3.7 pp -24.56 147.49 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.375 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 158.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.69 -45.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 CA-C-N 121.943 1.729 . . . . 0.0 112.839 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 -163.32 179.22 7.52 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -172.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.8 m -23.82 126.6 0.03 OUTLIER 'General case' 0 C--N 1.365 1.248 0 C-N-CA 129.361 3.064 . . . . 0.0 115.356 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -122.79 147.17 50.17 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -158.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.5 -10.29 20.36 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.517 2.145 . . . . 0.0 113.107 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.99 3.32 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 120.496 1.498 . . . . 0.0 110.516 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 24.3 m -62.83 144.59 56.44 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 127.086 2.154 . . . . 0.0 110.7 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 11.5 t -78.88 122.58 84.78 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 125.521 1.528 . . . . 0.0 111.004 -169.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -97.65 -153.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.932 3.088 . . . . 0.0 107.361 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -150.82 135.09 16.95 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -117.77 -10.95 10.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.604 0.761 . . . . 0.0 110.553 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -100.77 87.52 3.35 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.95 -0.469 . . . . 0.0 112.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.13 97.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.172 1.789 . . . . 0.0 106.507 164.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' B' ' 855' ' ' ALA . 19.2 mt -88.05 -39.17 14.85 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.238 -174.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 44.7 tp -166.1 126.57 1.73 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 100.6 -3.852 . . . . 0.0 100.6 165.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 177.35 60.88 0.01 OUTLIER 'General case' 0 C--N 1.354 0.79 0 CA-C-N 120.464 1.484 . . . . 0.0 108.921 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.24 -43.56 95.99 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -166.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.38 -27.82 14.46 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 118.749 0.704 . . . . 0.0 112.553 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.53 -57.89 0.43 Allowed Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 62.65 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 127.998 2.519 . . . . 0.0 114.221 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -96.86 119.13 34.76 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.926 1.29 . . . . 0.0 108.117 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.89 117.52 68.62 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.66 5.09 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 124.609 2.682 . . . . 0.0 109.529 -164.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.18 -44.6 19.55 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -106.2 -14.64 15.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.872 1.269 . . . . 0.0 108.393 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.87 25.17 42.3 Favored Glycine 0 C--N 1.361 1.917 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.54 103.89 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 -162.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -100.74 111.91 24.22 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 112.609 -2.087 . . . . 0.0 109.144 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.3 m -100.37 108.22 20.19 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 168.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . 0.411 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.65 111.0 45.3 Favored Pre-proline 0 C--N 1.357 0.933 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.755 171.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -93.36 1.95 3.4 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.318 2.221 . . . . 0.0 108.929 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.14 -48.57 73.5 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 127.047 2.139 . . . . 0.0 113.951 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.29 48.89 14.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.547 1.539 . . . . 0.0 113.929 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.95 -166.1 20.08 Favored Glycine 0 N--CA 1.412 -2.902 1 N-CA-C 101.569 -4.612 . . . . 0.0 101.569 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -93.31 121.43 34.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.318 0.8 OUTLIER -117.03 161.41 19.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-N 119.26 0.936 . . . . 0.0 109.639 177.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.0 tp -105.38 115.52 30.4 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -109.72 136.46 49.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.313 1.845 . . . . 0.0 108.254 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.8 m -145.25 119.42 9.48 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.82 153.51 22.37 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 95.5 t -108.56 121.81 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.4 122.23 45.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.988 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 38.4 m -79.67 132.99 36.36 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.49 1.516 . . . . 0.0 107.853 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.02 -57.2 21.14 Favored Glycine 0 C--N 1.364 2.129 0 C-N-CA 125.057 1.313 . . . . 0.0 113.896 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.8 m170 35.84 71.79 0.12 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 127.491 2.316 . . . . 0.0 115.173 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -73.18 -7.89 53.38 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.27 1.428 . . . . 0.0 111.976 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -72.55 -15.39 61.77 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 125.46 1.504 . . . . 0.0 112.656 -169.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.317 10.2 pt-20 121.05 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.361 1.067 0 C-N-CA 128.182 2.593 . . . . 0.0 108.224 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 79.7 tttt 100.49 131.82 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 127.537 2.335 . . . . 0.0 107.46 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.76 126.23 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -111.25 122.87 48.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.498 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.58 117.34 17.82 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 128.087 2.555 . . . . 0.0 108.907 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.48 113.86 25.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.2 mt -62.59 143.29 57.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.664 1.986 . . . . 0.0 110.294 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -116.03 147.88 40.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 110.011 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.617 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.75 139.34 38.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 128.044 2.538 . . . . 0.0 110.19 -174.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 7.4 t 97.82 -16.35 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.322 3.049 . . . . 0.0 113.078 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -134.49 -26.0 1.45 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 119.599 1.091 . . . . 0.0 111.423 -170.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 61.34 162.88 0.07 Allowed 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.593 1.557 . . . . 0.0 111.176 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.35 -133.92 45.25 Favored Glycine 0 C--N 1.365 2.173 0 O-C-N 119.615 -1.928 . . . . 0.0 109.163 -162.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.13 79.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.149 0 C-N-CA 125.828 1.651 . . . . 0.0 110.823 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 114.91 27.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -103.31 -36.98 7.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.385 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.3 t -100.72 81.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.875 -3.009 . . . . 0.0 102.875 167.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -95.69 129.48 42.89 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.7 t -141.57 115.53 9.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.483 1.513 . . . . 0.0 107.714 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.64 85.0 0.69 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 104.199 -3.56 . . . . 0.0 104.199 163.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.814 0 C-N-CA 124.904 1.24 . . . . 0.0 112.029 173.204 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.4 mt -116.91 133.95 55.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 -171.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.31 162.57 27.58 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.26 130.67 73.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.28 150.6 46.82 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 55.0 m -118.89 -40.49 2.85 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 118.165 0.439 . . . . 0.0 111.918 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.44 -48.9 10.55 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 119.169 0.895 . . . . 0.0 112.646 -167.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 872' ' ' LEU . 40.8 pt -84.29 -177.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.864 1.666 . . . . 0.0 110.389 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.28 81.35 2.91 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -169.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.35 93.41 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.602 2.201 . . . . 0.0 110.321 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.2 mp -120.5 142.52 49.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -93.21 156.97 16.51 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.616 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.02 123.27 22.42 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 119.508 1.049 . . . . 0.0 108.672 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.79 -10.46 74.52 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 125.555 1.55 . . . . 0.0 111.052 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.27 174.82 5.94 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.732 0.813 . . . . 0.0 110.458 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 14.5 t -144.42 128.76 17.86 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.745 0.783 . . . . 0.0 110.42 -161.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.617 HG13 HH11 ' B' ' 914' ' ' ARG . 17.7 m -96.15 151.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.19 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.82 138.51 32.24 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 126.281 1.832 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 90.1 t -91.21 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.331 0 C-N-CA 127.087 2.155 . . . . 0.0 107.275 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -107.41 131.54 54.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 100.77 -3.789 . . . . 0.0 100.77 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.77 75.92 1.69 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.565 -1.652 . . . . 0.0 106.948 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 61.9 t -159.21 102.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -152.8 68.86 0.84 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.76 144.98 6.82 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -111.96 -28.67 7.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -92.3 87.14 5.94 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.97 1.68 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -124.49 160.13 28.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.3 t -91.89 132.88 36.15 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.7 151.49 22.16 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.05 113.29 21.8 Favored Pre-proline 0 C--N 1.356 0.867 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -98.9 173.46 0.46 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.948 1.765 . . . . 0.0 108.693 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.71 137.71 52.5 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -139.76 140.77 36.8 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.91 1.232 . . . . 0.0 108.316 -170.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.48 129.8 72.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -125.83 105.44 8.95 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 34.4 p -102.11 163.14 12.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.104 1.361 . . . . 0.0 110.866 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.02 112.09 0.33 Allowed Glycine 0 C--N 1.36 1.9 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.23 145.15 46.3 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.6 tp -72.75 122.52 21.64 Favored 'General case' 0 C--N 1.381 1.975 0 C-N-CA 124.143 0.977 . . . . 0.0 109.155 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.3 tp -98.39 -57.38 2.21 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -131.46 127.43 37.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 130.25 10.21 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 103.819 -3.712 . . . . 0.0 103.819 165.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.62 128.99 91.77 Favored Pre-proline 0 C--N 1.352 0.702 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.446 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -106.62 80.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 122.029 1.76 . . . . 0.0 109.426 -168.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.16 -72.17 0.09 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 129.98 3.312 . . . . 0.0 109.199 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 68.9 mt 48.79 41.51 18.32 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 129.039 2.936 . . . . 0.0 113.696 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -114.41 131.35 56.62 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.83 108.34 10.07 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 179.096 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.454 -0.821 0 N-CA-C 109.849 -0.866 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.11 114.53 27.8 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -88.86 -21.42 1.32 Allowed 'Trans proline' 0 CA--C 1.512 -0.614 0 CA-C-N 121.723 1.651 . . . . 0.0 110.173 -172.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 35.77 71.39 0.12 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 129.039 2.936 . . . . 0.0 115.84 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.3 t -122.06 136.55 58.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 156.41 49.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 165.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 6.8 p90 -148.8 136.84 20.84 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 118.811 0.732 . . . . 0.0 109.03 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 15.1 t -170.86 119.93 0.53 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.321 -0.862 . . . . 0.0 109.512 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.13 153.11 36.65 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' C' ' 870' ' ' ARG . . . -141.11 157.72 44.9 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.976 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.565 HD11 HD23 ' C' ' 858' ' ' LEU . 2.8 tm? -140.23 129.44 23.74 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -163.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 69.8 m -157.06 19.52 0.3 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.565 HD23 HD11 ' C' ' 856' ' ' LEU . 1.8 pp -25.36 145.59 0.03 OUTLIER Pre-proline 0 C--N 1.373 1.596 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 160.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.6 -49.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.236 1.957 . . . . 0.0 113.463 -164.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.1 ptt85 -162.47 172.39 15.59 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -2.69 112.46 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 130.893 3.677 . . . . 0.0 117.165 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -96.1 161.46 27.14 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.702 1.201 . . . . 0.0 109.651 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.92 -15.8 11.68 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.84 2.36 . . . . 0.0 110.429 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.99 -138.74 2.58 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 10.1 m -65.17 146.76 54.56 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.85 1.66 . . . . 0.0 110.69 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.89 133.31 26.67 Favored Pre-proline 0 N--CA 1.438 -1.044 0 C-N-CA 125.447 1.499 . . . . 0.0 110.554 -162.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -96.54 -152.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.823 3.015 . . . . 0.0 109.443 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.09 134.57 23.17 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -114.44 -17.23 11.81 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.161 0.584 . . . . 0.0 111.766 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 11.4 mmm180 -102.92 83.21 2.2 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.519 0.6 . . . . 0.0 110.958 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.76 97.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.651 1.98 . . . . 0.0 106.51 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 6.5 mt -89.83 -37.99 14.07 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.288 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 33.8 tp -165.52 126.74 1.94 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 29.0 t-20 175.06 61.47 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 120.25 1.387 . . . . 0.0 107.72 -163.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.88 -42.51 93.91 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -165.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.95 -29.11 16.25 Favored Glycine 0 C--N 1.357 1.705 0 CA-C-N 118.736 0.698 . . . . 0.0 112.335 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.14 -58.22 0.51 Allowed Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 63.47 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.087 2.555 . . . . 0.0 114.458 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -96.16 120.69 36.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 125.329 1.452 . . . . 0.0 108.496 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -85.99 116.96 67.8 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.26 8.65 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 124.951 2.804 . . . . 0.0 109.015 -170.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -79.29 -44.39 21.78 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.3 p -107.28 -15.01 14.75 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.832 1.253 . . . . 0.0 107.932 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.62 24.74 49.13 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 164.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.08 103.66 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.95 111.83 23.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.976 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 47.5 m -102.51 108.66 20.04 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . 0.541 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.56 110.37 42.7 Favored Pre-proline 0 C--N 1.356 0.85 0 CA-C-O 117.261 -1.352 . . . . 0.0 111.775 170.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -93.56 3.18 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.572 2.181 . . . . 0.0 108.359 164.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.02 -51.55 67.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 127.718 2.407 . . . . 0.0 113.458 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.52 66.09 1.14 Allowed 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.128 0.966 . . . . 0.0 111.66 169.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.08 -179.36 45.59 Favored Glycine 0 N--CA 1.404 -3.442 1 N-CA-C 101.293 -4.723 . . . . 0.0 101.293 -173.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -95.64 116.71 29.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.752 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.83 160.82 20.25 Favored 'General case' 0 C--N 1.366 1.31 0 CA-C-N 119.2 0.909 . . . . 0.0 110.654 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -108.0 110.66 22.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.06 138.99 51.25 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 108.414 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 61.5 m -143.22 120.59 11.62 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.54 0.736 . . . . 0.0 110.25 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -103.65 154.87 19.04 Favored 'General case' 0 C--N 1.364 1.226 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.71 123.47 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 68.9 mt -94.92 124.32 38.9 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.631 1.172 . . . . 0.0 109.403 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.4 m -79.66 132.39 36.21 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.74 22.54 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 125.952 1.739 . . . . 0.0 114.843 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 61.2 m170 31.39 74.33 0.05 OUTLIER 'General case' 0 C--N 1.361 1.076 0 C-N-CA 128.168 2.587 . . . . 0.0 115.615 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -71.0 -11.55 61.04 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.127 1.771 . . . . 0.0 112.457 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -73.89 -5.41 40.9 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.799 2.04 . . . . 0.0 111.796 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.299 47.1 mt-10 100.09 -144.09 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.809 2.844 . . . . 0.0 107.05 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 75.3 tttt 79.12 141.39 0.07 Allowed 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.616 1.966 . . . . 0.0 109.389 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.86 126.23 59.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -110.03 129.92 55.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.908 2.083 . . . . 0.0 110.164 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.51 114.13 2.94 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.692 1.197 . . . . 0.0 110.422 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.406 ' CG1' ' H ' ' C' ' 922' ' ' VAL . 7.2 p -85.54 117.69 30.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 C-N-CA 126.36 1.864 . . . . 0.0 109.04 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.73 137.24 58.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.129 1.372 . . . . 0.0 110.375 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.5 t -117.72 145.39 44.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.797 2.039 . . . . 0.0 107.989 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.541 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.33 140.37 38.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.215 2.206 . . . . 0.0 110.878 -174.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 92.25 0.86 0.12 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 128.982 2.913 . . . . 0.0 112.129 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -147.12 -25.66 0.4 Allowed 'General case' 0 C--N 1.361 1.078 0 CA-C-N 119.499 1.045 . . . . 0.0 112.101 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.5 166.99 0.06 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.422 1.489 . . . . 0.0 111.671 -164.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.7 -130.36 50.93 Favored Glycine 0 C--N 1.375 2.702 0 O-C-N 119.434 -2.041 . . . . 0.0 110.08 -164.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 47.6 t 53.6 73.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.226 0 C-N-CA 125.734 1.614 . . . . 0.0 111.586 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.89 116.1 28.62 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 25.0 ptt85 -98.93 -33.26 10.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.706 -173.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.406 ' H ' ' CG1' ' C' ' 911' ' ' VAL . 61.1 t -100.03 79.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 166.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.88 131.71 40.48 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 120.895 0.378 . . . . 0.0 111.299 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 24.6 t -144.18 115.23 7.88 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 125.324 1.45 . . . . 0.0 108.367 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.54 85.51 0.66 Allowed Glycine 0 CA--C 1.481 -2.035 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 172.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.632 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.675 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 70.0 mt -122.31 134.1 54.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.76 162.24 27.74 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 25.5 m -118.82 130.9 73.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -136.14 150.06 48.91 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.7 t -105.12 -76.35 0.61 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 13.7 tp -61.48 -49.53 76.39 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.25 -177.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.081 1.352 . . . . 0.0 110.477 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.85 84.14 1.31 Allowed Pre-proline 0 C--N 1.356 0.848 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.59 88.14 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 122.478 1.921 . . . . 0.0 109.952 164.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.8 146.22 47.72 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.14 161.37 15.79 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.397 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.65 122.15 20.07 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.408 1.458 . . . . 0.0 108.633 172.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.2 72.71 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 125.504 1.526 . . . . 0.0 111.261 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.99 175.59 3.63 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.739 0.781 . . . . 0.0 111.673 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.9 m -142.81 127.0 17.52 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.774 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.31 147.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 C-N-CA 124.276 1.03 . . . . 0.0 109.155 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 19.6 t -142.43 137.89 30.69 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.849 1.659 . . . . 0.0 111.193 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.7 129.71 41.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -104.05 132.98 49.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.84 71.53 1.45 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.515 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.75 99.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.76 74.43 1.11 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 113.72 145.09 9.05 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -114.1 -21.13 10.68 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.595 0.758 . . . . 0.0 110.007 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -98.71 85.81 3.4 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.82 -158.66 0.88 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -172.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -120.54 169.47 10.32 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 23.2 t -108.38 130.66 55.21 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.72 154.53 30.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.0 115.41 20.44 Favored Pre-proline 0 C--N 1.355 0.813 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 172.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -103.39 176.89 0.15 Allowed 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 121.807 1.671 . . . . 0.0 108.075 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.33 138.97 50.89 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -137.54 139.2 40.33 Favored 'General case' 0 C--N 1.376 1.757 0 CA-C-N 119.931 1.241 . . . . 0.0 108.489 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 34.8 mm -115.14 131.51 67.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -125.34 104.47 8.48 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 26.6 p -102.17 163.92 11.98 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.475 1.51 . . . . 0.0 110.42 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.1 113.19 0.37 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.71 46.69 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.5 124.63 26.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 125.495 1.518 . . . . 0.0 109.598 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.34 -57.61 2.16 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -131.93 127.54 36.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.6 129.32 9.85 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 103.739 -3.744 . . . . 0.0 103.739 165.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.56 127.8 91.66 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.285 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -106.95 78.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.534 0 CA-C-N 121.735 1.655 . . . . 0.0 109.449 -168.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 78.86 -72.77 0.08 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 130.039 3.336 . . . . 0.0 109.063 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 66.0 mt 48.88 40.53 16.78 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 128.975 2.91 . . . . 0.0 113.576 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -112.45 131.1 55.74 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -128.85 108.3 10.34 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.265 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.509 -0.76 0 N-CA-C 109.989 -0.812 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.93 119.36 21.14 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -90.07 -22.02 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.222 1.829 . . . . 0.0 109.666 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 38.14 69.16 0.26 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 128.757 2.823 . . . . 0.0 115.408 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.79 137.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.92 159.29 41.91 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 166.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.27 117.67 0.54 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.3 153.91 33.18 Favored 'General case' 0 C--N 1.372 1.575 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -134.39 158.52 43.63 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.411 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.24 127.71 30.54 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 858' ' ' LEU . 71.5 m -163.12 9.42 0.05 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -159.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 857' ' ' SER . 0.6 OUTLIER -28.5 152.28 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.378 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 160.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -78.38 -42.26 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 121.943 1.73 . . . . 0.0 113.382 -164.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -166.23 -159.16 0.37 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.2 m -31.54 139.04 0.04 OUTLIER 'General case' 0 C--N 1.361 1.104 0 C-N-CA 129.478 3.111 . . . . 0.0 115.29 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.89 164.54 43.14 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.93 -14.15 12.53 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.591 2.194 . . . . 0.0 111.147 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.9 -139.02 2.62 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.2 m -62.93 145.4 55.33 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 126.87 2.068 . . . . 0.0 111.011 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.44 128.12 54.24 Favored Pre-proline 0 N--CA 1.437 -1.093 0 C-N-CA 125.39 1.476 . . . . 0.0 110.315 -165.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -96.26 -149.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.943 3.096 . . . . 0.0 108.361 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.96 134.17 18.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -116.81 -14.45 10.73 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 122.62 0.368 . . . . 0.0 111.719 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.55 87.8 3.46 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.658 0.663 . . . . 0.0 112.47 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.69 97.83 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.014 1.726 . . . . 0.0 106.781 168.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 78.4 mt -87.71 -37.84 16.33 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.865 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 31.7 tp -166.31 127.55 1.77 Allowed 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 163.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 179.53 60.82 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.806 1.639 . . . . 0.0 109.16 -166.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.46 -43.94 93.1 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -165.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.36 -28.04 14.0 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.733 0.697 . . . . 0.0 112.49 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.57 -58.57 0.39 Allowed Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.516 -2.234 . . . . 0.0 107.516 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 63.16 -80.58 0.03 OUTLIER 'General case' 0 C--N 1.355 0.823 0 C-N-CA 128.065 2.546 . . . . 0.0 114.286 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -96.46 119.82 35.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.678 1.191 . . . . 0.0 108.416 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -80.0 117.22 66.39 Favored Pre-proline 0 CA--C 1.503 -0.834 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -93.81 6.25 2.73 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 CA-C-N 125.45 2.982 . . . . 0.0 109.031 -167.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -80.1 -46.66 16.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 21.5 p -108.18 -10.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 108.667 173.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 27.42 38.05 Favored Glycine 0 C--N 1.363 2.028 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 162.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.13 103.26 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.578 0 N-CA-C 100.816 -3.772 . . . . 0.0 100.816 -164.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.36 112.83 25.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.19 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 61.0 m -100.58 108.48 20.4 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . 0.44 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.83 110.69 43.53 Favored Pre-proline 0 C--N 1.358 0.966 0 CA-C-O 117.033 -1.461 . . . . 0.0 112.459 172.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -96.46 -1.21 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 123.109 2.146 . . . . 0.0 109.142 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.82 -50.18 66.74 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.65 2.38 . . . . 0.0 114.188 -168.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.18 47.9 13.65 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.29 1.436 . . . . 0.0 114.486 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -160.42 -165.41 17.2 Favored Glycine 0 N--CA 1.415 -2.746 1 N-CA-C 101.291 -4.724 . . . . 0.0 101.291 175.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.444 HH21 HG22 ' A' ' 953' ' ' ILE . 75.9 ttt-85 -93.83 120.9 34.7 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.273 3.7 p90 -115.33 161.33 18.66 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 118.939 0.791 . . . . 0.0 109.479 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.8 tp -104.61 117.08 33.22 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.434 0.694 . . . . 0.0 109.47 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -111.26 137.38 49.06 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 126.446 1.898 . . . . 0.0 108.941 -167.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.7 m -145.58 119.14 9.1 Favored 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.63 153.35 22.5 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.38 120.43 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.62 123.87 47.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.843 -173.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 49.0 m -79.12 131.45 36.24 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 125.396 1.478 . . . . 0.0 107.37 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.19 -55.77 25.97 Favored Glycine 0 C--N 1.365 2.194 0 C-N-CA 124.571 1.081 . . . . 0.0 112.268 -169.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.41 64.91 1.56 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 126.486 1.914 . . . . 0.0 113.466 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -70.84 -9.01 56.74 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.976 1.71 . . . . 0.0 112.731 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.7 -16.8 61.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.509 1.524 . . . . 0.0 112.558 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.321 9.6 pt-20 124.2 -176.18 0.0 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.204 2.602 . . . . 0.0 107.729 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 77.3 tttt 101.49 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 127.743 2.417 . . . . 0.0 106.914 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.33 128.7 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -170.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -110.76 121.16 44.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.042 1.737 . . . . 0.0 113.316 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.37 115.68 15.16 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 128.474 2.71 . . . . 0.0 109.239 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.6 t -88.59 114.08 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.32 141.41 58.3 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.188 1.795 . . . . 0.0 110.713 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 3.9 t -116.29 146.34 42.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 126.089 1.756 . . . . 0.0 109.847 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.453 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.24 141.21 38.74 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 127.201 2.201 . . . . 0.0 110.583 -176.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.313 31.4 p 86.89 10.35 0.17 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 130.268 3.427 . . . . 0.0 114.581 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.83 -25.02 0.27 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-N 119.076 0.853 . . . . 0.0 110.751 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 58.95 166.57 0.05 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.655 1.582 . . . . 0.0 111.703 -164.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.51 51.27 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 119.387 -2.07 . . . . 0.0 109.878 -161.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 48.4 t 57.82 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 125.785 1.634 . . . . 0.0 110.646 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.84 114.14 26.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.12 -36.79 8.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.618 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 92.1 t -100.02 80.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -97.2 128.58 44.21 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.199 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -143.71 116.5 8.76 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.555 1.542 . . . . 0.0 107.369 172.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.54 84.85 0.76 Allowed Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 103.863 -3.695 . . . . 0.0 103.863 163.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.925 0 C-N-CA 124.572 1.082 . . . . 0.0 113.103 176.41 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 73.1 mt -123.49 134.2 53.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.1 161.96 26.39 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 21.1 m -124.51 127.78 73.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.18 146.57 42.86 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -114.52 -46.27 2.97 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 27.3 tp -82.17 -49.87 9.65 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.426 1.012 . . . . 0.0 112.73 -166.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.444 HG22 HH21 ' A' ' 893' ' ' ARG . 13.5 pt -84.7 -174.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.88 1.672 . . . . 0.0 110.044 -178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.7 81.72 2.73 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -167.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 91.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.294 1.996 . . . . 0.0 109.64 163.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -121.9 144.69 48.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -92.8 157.12 16.57 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.119 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.37 123.31 21.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 119.852 1.206 . . . . 0.0 109.056 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.58 -12.03 70.73 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.184 1.849 . . . . 0.0 111.223 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.65 175.57 5.53 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.717 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.8 m -142.31 125.83 16.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -160.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.453 HG13 HH11 ' A' ' 914' ' ' ARG . 4.0 m -96.8 148.5 5.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.249 0.62 . . . . 0.0 109.331 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.5 t -143.82 138.65 28.84 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.051 1.74 . . . . 0.0 111.19 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 71.4 t -91.84 130.28 41.22 Favored 'Isoleucine or valine' 0 C--N 1.367 1.364 0 C-N-CA 126.767 2.027 . . . . 0.0 107.069 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -105.52 133.11 50.81 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 101.071 -3.677 . . . . 0.0 101.071 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 1.5 tp -129.22 72.11 1.46 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.041 -1.89 . . . . 0.0 105.975 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 58.2 t -162.83 100.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.898 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 89.6 mmm -153.59 70.01 0.83 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.77 145.21 7.24 Favored Glycine 0 CA--C 1.493 -1.304 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -112.3 -29.28 7.6 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.3 tp -92.17 87.32 6.06 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.55 -165.32 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -171.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -124.19 159.67 29.59 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -91.64 131.22 37.19 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.1 149.27 22.88 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.91 112.15 22.06 Favored Pre-proline 0 C--N 1.356 0.852 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -99.59 172.33 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.117 1.878 . . . . 0.0 108.269 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.1 mp -116.85 141.17 48.57 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.72 142.33 36.85 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 119.337 0.971 . . . . 0.0 108.562 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.95 129.5 74.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.85 105.63 9.09 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.4 p -101.02 160.55 14.28 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.914 1.286 . . . . 0.0 110.212 171.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.47 110.22 0.29 Allowed Glycine 0 C--N 1.359 1.816 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.96 144.05 46.69 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 67.6 tp -74.15 123.13 23.87 Favored 'General case' 0 C--N 1.379 1.87 0 C-N-CA 124.692 1.197 . . . . 0.0 109.402 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 33.6 tp -99.0 -57.76 2.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.4 127.47 35.49 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.85 131.01 10.53 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.183 -3.567 . . . . 0.0 104.183 164.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.94 129.5 90.87 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.663 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -107.0 80.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.783 1.672 . . . . 0.0 109.823 -168.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 77.69 -72.91 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 130.303 3.441 . . . . 0.0 109.238 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.9 mt 49.6 38.76 15.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 129.288 3.035 . . . . 0.0 114.085 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.31 131.78 54.75 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.42 107.31 9.4 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 179.462 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 N-CA-C 109.99 -0.812 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.65 119.53 21.55 Favored Pre-proline 0 C--N 1.352 0.71 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -90.78 -21.97 0.7 Allowed 'Trans proline' 0 CA--C 1.513 -0.572 0 CA-C-N 122.105 1.787 . . . . 0.0 109.758 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 38.77 69.77 0.25 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.969 2.908 . . . . 0.0 115.065 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.6 136.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.9 158.1 45.14 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -149.02 138.37 21.64 Favored 'General case' 0 C--N 1.361 1.076 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.2 t -170.42 118.61 0.55 Allowed 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.88 153.81 33.94 Favored 'General case' 0 C--N 1.371 1.51 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -135.9 158.55 44.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.157 174.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -136.11 125.08 24.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -166.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.3 m -162.45 13.43 0.07 Allowed 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.959 1.304 . . . . 0.0 107.933 -164.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -27.89 152.8 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.38 0 N-CA-C 118.219 2.674 . . . . 0.0 118.219 158.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -78.04 -42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 CA-C-N 122.01 1.754 . . . . 0.0 113.438 -164.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 16.7 ptt85 -166.65 -159.01 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.0 m -31.35 139.12 0.03 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 129.392 3.077 . . . . 0.0 115.355 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -133.12 164.4 44.23 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.94 -14.1 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.618 2.212 . . . . 0.0 111.202 -175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.0 -138.99 2.62 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -62.83 145.26 55.42 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.81 2.044 . . . . 0.0 110.944 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 91.8 t -88.33 127.78 55.69 Favored Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 125.325 1.45 . . . . 0.0 110.161 -165.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.09 -149.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.952 3.101 . . . . 0.0 108.276 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.35 133.75 18.56 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -115.08 -14.35 11.8 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.747 0.819 . . . . 0.0 110.59 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.01 87.53 3.3 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.075 0.464 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.79 97.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 164.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' B' ' 855' ' ' ALA . 32.6 mt -87.92 -39.41 14.78 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.373 -173.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 46.5 tp -165.72 126.18 1.81 Allowed 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 100.492 -3.892 . . . . 0.0 100.492 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 176.25 60.58 0.0 OUTLIER 'General case' 0 C--N 1.356 0.859 0 CA-C-N 120.405 1.457 . . . . 0.0 108.514 -162.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.9 -43.53 94.78 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -165.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.07 -28.39 13.68 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 118.723 0.692 . . . . 0.0 112.518 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.09 -57.45 0.43 Allowed Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.96 -81.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.827 0 C-N-CA 128.095 2.558 . . . . 0.0 114.325 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -97.01 119.7 35.98 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 124.854 1.261 . . . . 0.0 108.495 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -79.36 117.58 67.84 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 115.481 -2.2 . . . . 0.0 105.322 171.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.92 6.03 3.11 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 CA-C-N 125.51 3.004 . . . . 0.0 109.28 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.88 -45.6 18.33 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.027 0.931 . . . . 0.0 108.888 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 20.7 p -110.05 -11.4 14.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.658 1.183 . . . . 0.0 108.435 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.63 33.22 Favored Glycine 0 C--N 1.363 2.069 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.66 102.79 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.73 113.13 25.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.014 -174.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -100.83 108.48 20.29 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . 0.46 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.57 110.92 44.61 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 117.062 -1.447 . . . . 0.0 112.825 172.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -95.92 -1.34 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 CA-C-N 123.301 2.215 . . . . 0.0 109.278 169.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 14.5 mt -53.67 -49.83 67.12 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 127.587 2.355 . . . . 0.0 114.358 -167.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.6 48.59 11.57 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.123 1.369 . . . . 0.0 114.676 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.18 -165.62 20.6 Favored Glycine 0 N--CA 1.412 -2.922 1 N-CA-C 101.534 -4.626 . . . . 0.0 101.534 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -93.44 120.38 33.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.298 2.4 p90 -116.92 161.29 19.57 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.132 0.878 . . . . 0.0 109.624 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -105.82 116.04 31.27 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.37 137.32 47.41 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.444 1.898 . . . . 0.0 108.251 -170.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.5 m -144.46 118.74 9.56 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 153.29 22.92 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.21 121.09 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.15 123.34 47.65 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.127 0.971 . . . . 0.0 108.522 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 43.9 m -78.61 131.41 36.71 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.204 1.402 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -56.76 22.03 Favored Glycine 0 C--N 1.367 2.271 0 C-N-CA 124.73 1.157 . . . . 0.0 112.601 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.5 65.17 1.48 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.552 1.941 . . . . 0.0 113.627 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -70.72 -9.14 56.59 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.017 1.727 . . . . 0.0 112.835 -168.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.88 -15.2 61.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.852 1.661 . . . . 0.0 112.763 -168.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.0 pt-20 122.52 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 128.575 2.75 . . . . 0.0 107.754 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 101.05 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 127.763 2.425 . . . . 0.0 107.126 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 81.2 t -99.82 128.05 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -170.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -108.57 121.18 44.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.202 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.24 115.1 13.76 Favored 'General case' 0 C--N 1.385 2.117 0 C-N-CA 128.21 2.604 . . . . 0.0 109.568 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.48 114.83 27.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 119.695 1.134 . . . . 0.0 108.273 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.24 142.77 57.52 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.84 2.056 . . . . 0.0 110.607 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 3.5 t -116.94 146.71 42.82 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.282 1.833 . . . . 0.0 109.656 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.46 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -79.13 140.8 37.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.936 2.094 . . . . 0.0 110.22 -177.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.31 28.5 p 87.0 8.37 0.21 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.275 3.43 . . . . 0.0 114.731 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.36 -24.93 0.29 Allowed 'General case' 0 C--N 1.356 0.865 0 CA-C-N 119.426 1.012 . . . . 0.0 111.346 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 58.87 165.12 0.04 OUTLIER 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.721 1.609 . . . . 0.0 111.767 -164.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.52 -132.71 47.61 Favored Glycine 0 C--N 1.366 2.196 0 O-C-N 119.438 -2.039 . . . . 0.0 109.599 -162.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.0 77.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.234 0 C-N-CA 126.09 1.756 . . . . 0.0 110.878 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.47 114.62 27.19 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -174.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.69 -36.84 7.74 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.8 -1.545 . . . . 0.0 108.571 -171.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.76 79.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.71 128.42 44.37 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.808 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 28.3 t -142.65 117.67 10.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.607 1.563 . . . . 0.0 107.205 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.59 84.96 0.76 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 104.312 -3.515 . . . . 0.0 104.312 165.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.898 0 C-N-CA 124.734 1.159 . . . . 0.0 113.127 176.405 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.6 m . . . . . 0 CA--C 1.508 -0.666 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.6 mt -115.75 134.2 55.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.13 26.94 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.9 129.86 74.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.86 148.91 45.83 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.1 m -120.88 -38.99 2.76 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.5 0.591 . . . . 0.0 111.995 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.1 tp -82.48 -49.09 10.3 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.351 0.978 . . . . 0.0 112.612 -168.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 42.4 pt -85.15 -175.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.699 1.599 . . . . 0.0 109.829 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 80.91 2.59 Favored Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -169.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.14 92.13 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.479 2.119 . . . . 0.0 110.026 164.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -121.44 144.46 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.95 158.36 15.85 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.828 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.84 122.78 21.33 Favored 'General case' 0 C--N 1.381 1.947 0 CA-C-N 120.147 1.339 . . . . 0.0 108.791 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.26 -11.57 71.78 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 125.868 1.699 . . . . 0.0 111.009 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.43 175.34 5.56 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.608 0.763 . . . . 0.0 110.964 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.1 m -142.56 125.71 16.39 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -159.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.451 HG13 HH11 ' B' ' 914' ' ' ARG . 4.5 m -97.5 148.62 5.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.509 0.724 . . . . 0.0 109.734 173.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -143.33 138.82 29.76 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 126.325 1.85 . . . . 0.0 111.229 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 83.3 t -91.16 130.59 40.1 Favored 'Isoleucine or valine' 0 C--N 1.368 1.413 0 C-N-CA 127.398 2.279 . . . . 0.0 107.312 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.6 133.23 50.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 100.56 -3.867 . . . . 0.0 100.56 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 1.8 tp -129.02 71.53 1.43 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.4 t -161.25 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.0 mmm -152.46 69.83 0.89 Allowed 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.58 144.51 7.09 Favored Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -111.13 -28.69 8.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.78 87.32 5.81 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.34 -164.32 1.57 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -124.55 159.42 30.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 19.0 t -90.79 130.6 36.75 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.13 149.22 22.77 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.81 112.1 22.31 Favored Pre-proline 0 C--N 1.355 0.835 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -99.32 172.36 0.45 Allowed 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 122.099 1.866 . . . . 0.0 108.139 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.1 139.3 50.44 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -138.39 140.78 39.53 Favored 'General case' 0 C--N 1.373 1.63 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.94 129.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -126.55 105.74 8.95 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 55.5 p -102.4 162.42 12.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.467 1.107 . . . . 0.0 110.989 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.53 111.35 0.32 Allowed Glycine 0 C--N 1.358 1.789 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.14 47.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -72.57 122.83 22.01 Favored 'General case' 0 C--N 1.382 2.004 0 C-N-CA 124.583 1.153 . . . . 0.0 109.387 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.9 tp -98.74 -57.84 2.09 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -131.83 127.27 36.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.65 130.67 10.37 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 165.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.87 129.0 91.45 Favored Pre-proline 0 C--N 1.351 0.674 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.532 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -106.77 78.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.016 1.756 . . . . 0.0 109.325 -167.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 77.93 -72.66 0.09 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 130.131 3.372 . . . . 0.0 109.061 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 73.6 mt 49.08 40.63 17.76 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 129.064 2.946 . . . . 0.0 113.719 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.57 131.88 55.39 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.51 106.98 8.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 179.15 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.456 -0.718 0 N-CA-C 110.038 -0.793 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.55 113.75 27.29 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.91 -22.88 1.36 Allowed 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 121.648 1.624 . . . . 0.0 110.151 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 36.8 70.19 0.18 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 128.873 2.869 . . . . 0.0 115.659 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.18 137.03 57.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.66 156.75 48.21 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 9.3 p90 -149.0 137.39 20.99 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-N 118.871 0.759 . . . . 0.0 109.23 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.9 t -171.08 118.86 0.49 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.53 153.06 37.23 Favored 'General case' 0 C--N 1.368 1.378 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.15 159.55 41.94 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.972 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.523 HD21 HD23 ' C' ' 858' ' ' LEU . 2.7 tm? -141.66 130.73 23.28 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -165.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.5 m -160.49 14.16 0.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.523 HD23 HD21 ' C' ' 856' ' ' LEU . 2.2 pp -27.5 145.9 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.532 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 161.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.64 -46.5 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 122.052 1.768 . . . . 0.0 113.634 -162.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -162.75 172.22 15.59 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.8 m -3.57 111.92 0.01 OUTLIER 'General case' 0 C--N 1.363 1.178 0 C-N-CA 130.907 3.683 . . . . 0.0 116.942 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -99.49 163.18 19.05 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 123.646 0.778 . . . . 0.0 110.56 -172.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.61 -17.2 11.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.869 2.38 . . . . 0.0 110.841 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.66 -141.45 3.25 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.3 m -66.52 146.66 54.28 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.268 1.827 . . . . 0.0 110.715 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 96.0 t -94.73 131.27 30.98 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 124.822 1.249 . . . . 0.0 111.164 -159.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -97.6 -151.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 124.087 3.192 . . . . 0.0 109.278 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -147.04 134.37 20.68 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -113.98 -16.0 12.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.353 0.661 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -102.22 84.66 2.52 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.326 0.584 . . . . 0.0 111.7 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.86 97.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.385 1.874 . . . . 0.0 106.697 163.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 8.6 mt -90.1 -38.78 13.31 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.324 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.6 tp -165.54 126.49 1.9 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 29.8 t-20 174.76 60.81 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 120.188 1.358 . . . . 0.0 107.704 -162.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.87 -42.7 94.29 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -164.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.37 -28.82 15.88 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 118.665 0.666 . . . . 0.0 112.306 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.59 -57.58 0.48 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 62.92 -81.22 0.02 OUTLIER 'General case' 0 C--N 1.354 0.782 0 C-N-CA 128.289 2.636 . . . . 0.0 114.641 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -96.02 121.02 37.32 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.534 1.534 . . . . 0.0 108.463 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.41 116.63 65.94 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -94.28 7.61 2.34 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 CA-C-N 125.167 2.881 . . . . 0.0 109.648 -166.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -79.23 -47.37 16.06 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.2 p -108.05 -9.55 15.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.932 1.293 . . . . 0.0 108.285 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.3 25.23 44.51 Favored Glycine 0 C--N 1.361 1.959 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 161.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.62 102.82 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 -163.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -94.83 111.77 23.53 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.494 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -101.8 108.21 19.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . 0.556 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.71 110.35 42.84 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.321 169.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -92.21 0.59 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.53 2.154 . . . . 0.0 108.21 165.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 51.6 mt -54.21 -53.23 56.41 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 127.837 2.455 . . . . 0.0 113.672 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.59 66.42 1.08 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 122.16 0.981 . . . . 0.0 110.84 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.44 170.29 43.06 Favored Glycine 0 N--CA 1.404 -3.485 1 N-CA-C 100.568 -5.013 . . . . 0.0 100.568 -167.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -93.85 115.86 28.29 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.375 -1.413 . . . . 0.0 107.968 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -116.5 160.59 20.38 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 119.088 0.858 . . . . 0.0 110.946 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 56.1 tp -107.49 113.35 26.63 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 124.685 1.194 . . . . 0.0 108.05 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.471 HD13 HH12 ' C' ' 921' ' ' ARG . 7.1 tt -118.53 140.81 49.29 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.756 1.223 . . . . 0.0 109.574 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -144.14 120.28 10.79 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.923 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.0 154.22 19.93 Favored 'General case' 0 C--N 1.364 1.208 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 80.1 t -99.57 122.96 51.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.76 122.93 39.06 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.375 1.07 . . . . 0.0 109.39 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 33.8 m -80.4 131.2 35.57 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.72 20.06 Favored Glycine 0 C--N 1.362 2.018 0 C-N-CA 125.872 1.701 . . . . 0.0 114.975 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 32.44 72.65 0.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 128.18 2.592 . . . . 0.0 115.528 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -71.69 -12.72 61.47 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 126.224 1.81 . . . . 0.0 111.552 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -73.07 -17.63 61.4 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.778 1.631 . . . . 0.0 112.502 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.2 pt-20 123.44 -172.21 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 128.498 2.719 . . . . 0.0 107.917 173.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 102.19 133.26 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 128.045 2.538 . . . . 0.0 106.706 171.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 82.3 t -98.32 123.8 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -104.27 129.8 52.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.528 1.931 . . . . 0.0 109.764 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.79 114.14 3.15 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.769 1.228 . . . . 0.0 110.427 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.7 117.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 126.136 1.774 . . . . 0.0 108.809 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.1 mt -63.3 135.9 57.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.294 1.037 . . . . 0.0 109.857 172.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 8.6 t -117.49 143.94 45.55 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 126.636 1.974 . . . . 0.0 107.145 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.556 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.1 OUTLIER -79.88 140.86 36.59 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.159 2.184 . . . . 0.0 110.593 -170.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.315 25.0 p 89.49 6.52 0.13 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 130.205 3.402 . . . . 0.0 113.93 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -149.45 -25.04 0.28 Allowed 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.234 0.924 . . . . 0.0 111.622 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.39 166.92 0.06 Allowed 'General case' 0 C--N 1.364 1.237 0 C-N-CA 125.474 1.51 . . . . 0.0 111.848 -164.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.41 -131.21 51.93 Favored Glycine 0 C--N 1.375 2.737 0 O-C-N 119.441 -2.037 . . . . 0.0 110.047 -163.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . 0.252 47.6 t 54.87 73.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.244 0 C-N-CA 125.404 1.482 . . . . 0.0 111.741 173.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.09 115.9 28.47 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -172.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.471 HH12 HD13 ' C' ' 896' ' ' LEU . 11.7 ptt180 -98.83 -33.59 10.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.744 -173.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.14 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -95.35 131.32 41.59 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.922 0.391 . . . . 0.0 111.14 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -144.26 116.02 8.23 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 125.284 1.434 . . . . 0.0 108.198 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.35 85.23 0.72 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 104.566 -3.413 . . . . 0.0 104.566 169.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.671 0 C-N-CA 125.117 1.341 . . . . 0.0 111.18 172.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.4 mt -120.91 134.32 55.29 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.05 162.77 26.37 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.58 130.17 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.28 148.85 52.73 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.299 -0.875 . . . . 0.0 109.737 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.4 m -107.48 -79.85 0.57 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.566 0.746 . . . . 0.0 109.132 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.9 tp -64.1 -49.19 73.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.322 1.849 . . . . 0.0 115.008 -163.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.39 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 126.148 1.779 . . . . 0.0 110.242 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.19 88.35 0.99 Allowed Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -168.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.51 89.86 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.724 2.283 . . . . 0.0 110.121 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 86.0 mt -124.31 147.08 48.41 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.734 1.213 . . . . 0.0 108.014 -176.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.93 158.99 15.24 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.065 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.05 122.86 20.21 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 120.29 1.405 . . . . 0.0 109.516 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.56 77.15 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 126.259 1.885 . . . . 0.0 111.822 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.47 173.85 7.38 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.888 0.875 . . . . 0.0 110.057 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 12.9 t -144.15 129.13 18.51 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.271 -0.893 . . . . 0.0 111.08 -160.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.402 HG13 ' HD3' ' C' ' 914' ' ' ARG . 27.1 m -95.38 149.18 4.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.251 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.46 137.13 33.67 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 126.181 1.793 . . . . 0.0 111.851 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.15 129.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.376 1.739 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -105.04 133.76 49.28 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 9.2 mp -126.89 81.06 1.99 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 112.794 -2.003 . . . . 0.0 107.433 168.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.0 t -158.96 98.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.2 mmm -151.87 73.38 1.06 Allowed 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.43 145.48 10.54 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 108.139 -1.985 . . . . 0.0 108.139 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -112.52 -30.95 6.95 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -91.9 87.05 6.07 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -160.84 1.1 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -172.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -122.54 156.1 34.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.5 t -92.54 133.64 35.74 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -157.34 150.07 23.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 112.11 20.35 Favored Pre-proline 0 C--N 1.357 0.913 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -101.5 175.52 0.24 Allowed 'Trans proline' 0 CA--C 1.509 -0.766 0 C-N-CA 121.877 1.718 . . . . 0.0 108.303 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -115.84 140.58 49.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 24.0 p -137.0 140.17 41.94 Favored 'General case' 0 C--N 1.376 1.749 0 CA-C-N 119.503 1.047 . . . . 0.0 108.466 -172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.2 mm -115.94 131.26 68.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -125.56 104.78 8.59 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 33.1 p -101.62 164.07 11.94 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 125.473 1.509 . . . . 0.0 110.427 172.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.83 112.81 0.35 Allowed Glycine 0 C--N 1.359 1.824 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.76 45.71 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -77.01 124.47 27.82 Favored 'General case' 0 C--N 1.378 1.847 0 C-N-CA 125.046 1.338 . . . . 0.0 109.096 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.97 -57.51 2.21 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -132.19 127.41 35.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.71 129.83 10.06 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 104.051 -3.62 . . . . 0.0 104.051 166.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.1 129.33 90.82 Favored Pre-proline 0 C--N 1.351 0.637 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.937 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -106.74 76.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 121.948 1.731 . . . . 0.0 109.593 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.53 -72.81 0.08 Allowed 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 130.192 3.397 . . . . 0.0 108.989 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 49.56 38.7 15.34 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 129.151 2.981 . . . . 0.0 113.768 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -109.86 131.7 54.82 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -129.92 106.65 8.8 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.071 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.352 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 N-CA-C 109.678 -0.932 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.33 120.44 21.06 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.86 -20.31 0.86 Allowed 'Trans proline' 0 CA--C 1.51 -0.718 0 CA-C-N 122.204 1.823 . . . . 0.0 109.699 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 36.41 69.9 0.18 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 128.987 2.915 . . . . 0.0 115.898 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.19 137.05 54.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.94 160.25 38.88 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -149.2 138.92 21.84 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.0 t -169.37 117.27 0.62 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.9 152.88 36.69 Favored 'General case' 0 C--N 1.37 1.497 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.12 158.73 43.79 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.643 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.531 HD21 HD23 ' A' ' 858' ' ' LEU . 2.3 tm? -132.82 133.53 43.48 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 858' ' ' LEU . 40.5 p -163.21 9.51 0.05 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -164.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.531 HD23 HD21 ' A' ' 856' ' ' LEU . 2.7 pp -31.42 149.21 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.483 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 160.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.39 -43.22 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 CA-C-N 122.34 1.871 . . . . 0.0 113.527 -161.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -162.52 174.13 13.08 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.679 1.127 . . . . 0.0 108.097 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.1 m -2.34 117.01 0.01 OUTLIER 'General case' 0 C--N 1.364 1.214 0 C-N-CA 131.383 3.873 . . . . 0.0 117.103 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.06 141.57 23.68 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -164.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -73.9 -11.48 23.66 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.845 2.364 . . . . 0.0 113.44 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.83 -130.37 1.17 Allowed Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 30.6 m -82.35 143.8 31.0 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.56 131.68 33.53 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 124.594 1.157 . . . . 0.0 110.631 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -93.11 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.863 3.042 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.35 135.23 20.02 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 119.248 0.931 . . . . 0.0 108.532 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -117.83 -13.52 10.12 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 122.895 0.478 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.34 87.3 3.38 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 118.574 0.624 . . . . 0.0 112.183 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.86 97.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.144 1.777 . . . . 0.0 106.894 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.458 ' HB3' HD11 ' B' ' 953' ' ' ILE . 49.4 mt -88.22 -37.09 16.37 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.577 -0.702 . . . . 0.0 110.709 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.6 tp -165.58 125.53 1.78 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 101.138 -3.653 . . . . 0.0 101.138 161.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -174.13 61.14 0.02 OUTLIER 'General case' 0 C--N 1.356 0.886 0 CA-C-N 120.38 1.446 . . . . 0.0 109.321 -168.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.36 -44.2 92.72 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -163.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.68 -28.38 12.6 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 118.863 0.756 . . . . 0.0 112.307 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.83 -60.55 0.32 Allowed Glycine 0 C--N 1.354 1.531 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 62.47 -80.9 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.978 2.511 . . . . 0.0 114.19 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.33 119.75 32.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 124.883 1.273 . . . . 0.0 108.919 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.72 117.43 68.51 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -96.69 1.87 1.86 Allowed 'Trans proline' 0 CA--C 1.506 -0.884 0 CA-C-N 124.986 2.817 . . . . 0.0 109.3 -165.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -79.9 -45.45 18.58 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.6 p -102.84 -13.99 16.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.103 0.961 . . . . 0.0 108.72 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 24.01 47.47 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.94 102.61 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -164.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 112.75 24.94 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 112.181 -2.281 . . . . 0.0 108.656 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 82.5 m -98.97 108.94 21.75 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . 0.435 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -89.62 110.76 41.62 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.745 173.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.56 -4.88 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.08 2.136 . . . . 0.0 108.98 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 33.1 mt -49.06 -55.2 12.84 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 128.664 2.786 . . . . 0.0 114.612 -168.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.9 65.25 1.35 Allowed 'General case' 0 C--N 1.364 1.223 0 CA-C-O 121.926 0.869 . . . . 0.0 112.085 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.09 -175.53 42.63 Favored Glycine 0 N--CA 1.408 -3.21 1 N-CA-C 101.034 -4.826 . . . . 0.0 101.034 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.22 121.9 35.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.45 160.43 19.19 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 118.918 0.781 . . . . 0.0 108.965 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 59.7 tp -103.84 117.11 33.56 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.429 0.691 . . . . 0.0 109.698 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.87 136.3 50.11 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 126.762 2.025 . . . . 0.0 108.88 -165.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.2 m -147.17 119.17 8.18 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.597 0.759 . . . . 0.0 109.501 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 154.22 21.56 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 79.0 t -109.3 119.18 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.78 124.33 46.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.992 -173.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 33.7 m -80.48 133.27 35.81 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.34 1.456 . . . . 0.0 107.547 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.9 -57.11 21.58 Favored Glycine 0 C--N 1.364 2.137 0 C-N-CA 125.003 1.287 . . . . 0.0 114.214 -169.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 61.9 m170 35.37 72.73 0.09 Allowed 'General case' 0 C--N 1.361 1.087 0 C-N-CA 127.387 2.275 . . . . 0.0 115.266 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -73.74 -8.38 55.77 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.17 1.388 . . . . 0.0 111.72 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -71.92 -19.93 61.85 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.043 1.337 . . . . 0.0 112.49 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.319 9.3 pt-20 125.03 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.137 0 C-N-CA 128.232 2.613 . . . . 0.0 108.333 174.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 101.01 131.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.846 2.459 . . . . 0.0 106.753 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.31 124.91 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 123.512 1.625 . . . . 0.0 106.839 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -105.68 122.44 46.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.207 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.05 116.46 17.1 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 128.307 2.643 . . . . 0.0 108.769 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.62 113.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.09 142.17 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.538 1.535 . . . . 0.0 111.194 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -115.0 145.09 42.62 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 127.007 2.123 . . . . 0.0 109.086 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.435 HH22 ' HB3' ' A' ' 888' ' ' ALA . 0.0 OUTLIER -79.52 139.22 37.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 127.791 2.436 . . . . 0.0 109.429 -178.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.4 t 100.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.35 0.595 0 C-N-CA 129.463 3.105 . . . . 0.0 113.229 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -144.53 -24.41 0.52 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 119.486 1.039 . . . . 0.0 110.958 -175.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 60.18 167.43 0.08 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 124.886 1.274 . . . . 0.0 111.833 -164.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.6 -133.62 52.66 Favored Glycine 0 C--N 1.375 2.729 0 O-C-N 119.279 -2.138 . . . . 0.0 109.891 -161.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 46.7 t 56.6 75.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.295 0 C-N-CA 125.523 1.529 . . . . 0.0 110.99 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.57 115.22 27.71 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -103.05 -35.11 8.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.309 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 88.6 t -99.57 75.77 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.95 130.3 41.65 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.129 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.6 t -143.08 114.49 7.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.379 1.472 . . . . 0.0 108.411 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.54 84.82 0.69 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.882 -3.687 . . . . 0.0 103.882 163.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.859 0 C-N-CA 124.965 1.269 . . . . 0.0 112.708 174.42 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.443 -0.796 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 59.8 mt -117.71 133.54 55.84 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.33 161.33 26.05 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.5 m -125.25 126.3 70.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.77 149.44 43.55 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -115.02 -41.97 3.27 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.59 -50.17 9.07 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 119.373 0.988 . . . . 0.0 113.133 -166.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 8.2 pt -85.09 -171.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 125.371 1.469 . . . . 0.0 110.74 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.482 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -159.25 81.52 2.57 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -168.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.18 90.84 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 CA-C-N 122.06 1.772 . . . . 0.0 109.536 160.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 954' ' ' LEU . 8.3 mp -122.01 145.06 48.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -90.98 158.03 16.95 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.464 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.25 123.62 22.65 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-N 119.689 1.131 . . . . 0.0 108.715 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.01 69.9 Favored Glycine 0 CA--C 1.495 -1.2 0 C-N-CA 125.85 1.69 . . . . 0.0 110.999 170.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.11 175.64 5.08 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.025 0.44 . . . . 0.0 112.102 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 94.9 m -140.67 128.32 21.57 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -155.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.83 149.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -144.24 136.75 26.76 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.247 1.019 . . . . 0.0 111.65 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.21 129.75 44.06 Favored 'Isoleucine or valine' 0 C--N 1.369 1.453 0 C-N-CA 126.868 2.067 . . . . 0.0 107.245 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -107.92 132.29 53.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 168.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 21.0 tp -130.29 75.88 1.68 Allowed 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.212 -1.813 . . . . 0.0 107.045 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.8 t -160.81 101.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.06 71.79 0.92 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.71 150.57 8.3 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -119.06 -29.01 5.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.1 tp -92.25 87.07 5.94 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.5 -163.85 1.5 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -125.08 160.71 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.1 t -94.33 132.06 39.33 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -158.09 150.52 22.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.59 113.33 25.24 Favored Pre-proline 0 C--N 1.356 0.86 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -98.77 173.65 0.47 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.842 1.694 . . . . 0.0 108.365 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.43 141.49 48.27 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.6 p -139.59 142.06 37.13 Favored 'General case' 0 C--N 1.376 1.736 0 CA-C-N 119.592 1.087 . . . . 0.0 108.909 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.7 mm -119.61 129.81 74.88 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -126.15 105.77 9.09 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 44.6 p -101.25 161.92 13.26 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.816 1.246 . . . . 0.0 110.39 171.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.88 111.1 0.29 Allowed Glycine 0 C--N 1.358 1.764 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.1 144.93 46.34 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.01 123.4 25.69 Favored 'General case' 0 C--N 1.378 1.825 0 C-N-CA 124.763 1.225 . . . . 0.0 109.507 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 30.4 tp -98.23 -57.06 2.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -130.92 128.01 39.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.35 129.96 10.09 Favored Glycine 0 CA--C 1.487 -1.706 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 164.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 129.0 91.84 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -107.64 81.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 CA-C-N 121.835 1.691 . . . . 0.0 110.071 -169.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 77.76 -72.48 0.09 Allowed 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.12 3.368 . . . . 0.0 109.313 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 67.9 mt 49.41 38.81 14.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 128.841 2.856 . . . . 0.0 114.411 -176.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.86 131.09 55.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -128.09 109.41 11.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.099 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 179.321 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.961 0 N-CA-C 109.615 -0.956 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.62 121.17 22.11 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -92.45 -20.53 0.55 Allowed 'Trans proline' 0 CA--C 1.512 -0.581 0 CA-C-N 122.238 1.835 . . . . 0.0 110.037 -173.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 37.8 70.22 0.2 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 129.155 2.982 . . . . 0.0 115.532 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.94 136.82 54.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.6 40.69 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 165.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -149.22 139.19 22.03 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -169.17 117.87 0.66 Allowed 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.15 153.55 34.69 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -139.13 158.14 44.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.196 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.564 HD21 HD23 ' B' ' 858' ' ' LEU . 2.1 tm? -132.07 132.11 43.03 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -169.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.428 ' H ' ' H ' ' B' ' 858' ' ' LEU . 30.1 p -162.65 8.26 0.06 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -164.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.564 HD23 HD21 ' B' ' 856' ' ' LEU . 2.6 pp -31.44 149.94 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.441 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 161.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -81.75 -43.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.223 1.83 . . . . 0.0 113.494 -161.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -162.41 173.86 13.52 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 119.727 1.149 . . . . 0.0 108.201 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.9 m -1.77 116.81 0.01 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 131.398 3.879 . . . . 0.0 117.126 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -108.91 141.52 23.53 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -164.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -73.87 -11.57 23.75 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 122.801 2.334 . . . . 0.0 113.498 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.5 -130.71 1.19 Allowed Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 30.9 m -81.37 143.38 32.21 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.84 131.24 36.05 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 110.484 -160.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -94.15 -152.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.755 2.97 . . . . 0.0 109.248 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -148.38 135.21 19.97 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 119.156 0.889 . . . . 0.0 108.611 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -115.18 -13.22 11.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.387 1.075 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -100.77 87.62 3.37 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 118.208 0.458 . . . . 0.0 112.204 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.32 97.11 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 163.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' B' ' 855' ' ' ALA . 19.6 mt -88.14 -38.69 15.15 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.31 -173.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.7 tp -165.88 126.63 1.81 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 100.869 -3.752 . . . . 0.0 100.869 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 176.86 60.93 0.0 OUTLIER 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.196 1.362 . . . . 0.0 108.515 -163.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.46 -43.77 93.11 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -166.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.27 -29.68 10.99 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.889 0.768 . . . . 0.0 112.335 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.86 -59.54 0.35 Allowed Glycine 0 C--N 1.352 1.457 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 62.83 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.905 2.482 . . . . 0.0 114.408 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -96.07 119.59 34.84 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.924 1.29 . . . . 0.0 108.67 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.46 117.42 68.39 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 2.47 2.46 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 CA-C-N 125.077 2.849 . . . . 0.0 109.518 -166.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.04 -43.88 21.1 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 30.4 p -105.54 -14.29 15.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.443 1.097 . . . . 0.0 108.171 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 25.56 41.35 Favored Glycine 0 C--N 1.36 1.888 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 163.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.48 102.84 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 101.867 -3.382 . . . . 0.0 101.867 -163.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.89 113.24 25.29 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.837 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 70.6 m -99.61 109.31 21.82 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . 0.447 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -89.12 111.03 42.55 Favored Pre-proline 0 C--N 1.356 0.882 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.91 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.36 -4.24 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-N 123.133 2.155 . . . . 0.0 109.192 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 21.6 mt -53.52 -49.46 67.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.184 2.193 . . . . 0.0 114.334 -167.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.56 50.61 12.55 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.627 1.571 . . . . 0.0 114.183 171.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -164.26 -165.87 22.21 Favored Glycine 0 N--CA 1.411 -3.008 1 N-CA-C 101.517 -4.633 . . . . 0.0 101.517 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -92.74 121.68 34.37 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.985 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 2.6 p90 -116.47 160.68 20.25 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 119.023 0.829 . . . . 0.0 109.269 176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.6 tp -104.72 116.0 31.28 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.26 135.7 50.61 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 126.332 1.853 . . . . 0.0 107.801 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.3 m -144.92 118.97 9.39 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.57 153.91 22.18 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 97.5 t -109.98 120.76 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.17 122.6 46.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.986 0.914 . . . . 0.0 108.812 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 32.5 m -79.29 133.35 36.64 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.258 1.423 . . . . 0.0 108.0 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.16 -57.2 21.09 Favored Glycine 0 C--N 1.365 2.167 0 C-N-CA 125.216 1.388 . . . . 0.0 114.267 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 61.3 m170 34.99 72.96 0.09 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.451 2.3 . . . . 0.0 115.186 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.66 -8.15 54.85 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.291 1.436 . . . . 0.0 111.674 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -73.18 -14.53 61.37 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.425 1.49 . . . . 0.0 112.631 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.7 pt-20 118.59 179.45 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 128.587 2.755 . . . . 0.0 108.77 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 102.08 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.057 2.543 . . . . 0.0 106.467 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.22 128.4 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -110.63 122.87 48.84 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.881 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.35 115.41 15.56 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.053 2.541 . . . . 0.0 109.932 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.47 114.18 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 O-C-N 120.216 -1.553 . . . . 0.0 106.863 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.28 144.9 56.54 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.454 1.902 . . . . 0.0 111.358 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -115.61 145.95 42.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 127.196 2.198 . . . . 0.0 109.038 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.447 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -81.13 138.96 35.88 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 126.828 2.051 . . . . 0.0 109.231 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.6 t 100.85 -10.82 0.03 OUTLIER 'General case' 0 C--N 1.35 0.591 0 C-N-CA 129.589 3.155 . . . . 0.0 113.383 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.44 -24.38 0.72 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 119.493 1.042 . . . . 0.0 111.293 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 60.19 168.41 0.08 Allowed 'General case' 0 C--N 1.362 1.115 0 C-N-CA 124.898 1.279 . . . . 0.0 111.541 -163.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -132.37 51.64 Favored Glycine 0 C--N 1.368 2.34 0 O-C-N 119.763 -1.836 . . . . 0.0 109.702 -164.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 48.7 t 54.74 76.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.169 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.03 115.17 27.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -103.87 -35.22 8.24 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.368 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.1 t -99.89 75.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.89 129.66 44.3 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.516 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -141.34 115.42 9.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 125.319 1.448 . . . . 0.0 107.306 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.91 84.76 0.73 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.098 -3.601 . . . . 0.0 104.098 164.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.812 0 C-N-CA 124.916 1.246 . . . . 0.0 112.808 175.484 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 56.3 mt -115.65 133.98 55.5 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -168.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.2 162.77 26.8 Favored Glycine 0 CA--C 1.494 -1.219 0 C-N-CA 124.731 1.158 . . . . 0.0 110.215 -173.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 28.5 m -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -139.55 150.05 44.62 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.7 m -123.0 -30.77 3.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.723 0.692 . . . . 0.0 112.448 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.6 tp -85.88 -51.15 6.58 Favored 'General case' 0 C--N 1.358 0.94 0 CA-C-N 119.648 1.113 . . . . 0.0 112.115 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 872' ' ' LEU . 38.6 pt -84.8 -175.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.39 1.476 . . . . 0.0 110.133 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.492 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -158.06 80.9 3.04 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -170.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.24 92.32 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.271 1.98 . . . . 0.0 109.932 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' B' ' 954' ' ' LEU . 9.6 mp -121.59 144.73 48.57 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -89.91 159.23 17.04 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.334 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.45 123.48 23.19 Favored 'General case' 0 C--N 1.377 1.773 0 CA-C-N 119.769 1.168 . . . . 0.0 108.379 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.64 70.8 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 125.635 1.588 . . . . 0.0 110.92 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.36 175.31 5.53 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 121.631 0.729 . . . . 0.0 111.324 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 96.1 m -141.35 128.59 21.0 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.513 0.725 . . . . 0.0 109.095 -153.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.9 149.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-O 121.466 0.65 . . . . 0.0 109.476 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -143.99 136.67 27.08 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.724 1.209 . . . . 0.0 111.135 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.0 t -93.51 130.51 42.41 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 127.593 2.357 . . . . 0.0 107.401 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -107.25 132.12 53.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 19.7 tp -129.65 75.33 1.64 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.471 -1.695 . . . . 0.0 106.805 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.8 t -159.22 103.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.8 mmm -152.37 70.03 0.9 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 124.24 148.02 7.33 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -116.04 -27.96 6.77 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.52 86.68 5.29 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.36 -164.2 1.56 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -124.56 159.23 31.12 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.9 t -92.31 132.05 37.02 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -158.47 150.7 21.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.54 113.2 25.37 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -98.31 173.04 0.56 Allowed 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 121.853 1.702 . . . . 0.0 108.283 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.62 140.16 49.71 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.54 141.67 39.29 Favored 'General case' 0 C--N 1.374 1.647 0 CA-C-N 119.616 1.098 . . . . 0.0 108.663 -171.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 130.45 72.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -127.37 105.54 8.6 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 52.2 p -102.65 162.77 12.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.687 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.66 112.56 0.34 Allowed Glycine 0 C--N 1.359 1.825 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -121.61 145.98 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.8 tp -72.58 123.79 23.92 Favored 'General case' 0 C--N 1.381 1.971 0 C-N-CA 124.422 1.089 . . . . 0.0 109.763 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.82 -56.95 2.35 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -131.14 127.31 37.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.32 129.54 9.94 Favored Glycine 0 CA--C 1.487 -1.66 0 N-CA-C 103.379 -3.888 . . . . 0.0 103.379 163.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.41 128.84 90.9 Favored Pre-proline 0 C--N 1.349 0.555 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.122 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -107.0 81.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.782 1.672 . . . . 0.0 109.462 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 78.04 -71.73 0.1 Allowed 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 129.818 3.247 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 56.7 mt 49.16 40.49 17.81 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 128.668 2.787 . . . . 0.0 114.02 -175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -114.13 131.48 56.41 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.16 109.19 10.95 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.074 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 179.062 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.05 112.85 31.59 Favored Pre-proline 0 N--CA 1.443 -0.801 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -88.35 -21.6 1.48 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.617 1.613 . . . . 0.0 110.161 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 35.93 70.86 0.14 Allowed 'General case' 0 C--N 1.357 0.901 0 C-N-CA 129.161 2.984 . . . . 0.0 115.679 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.29 134.81 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.51 161.93 33.67 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -148.75 146.76 28.21 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 166.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.3 t -166.83 119.25 0.97 Allowed 'General case' 0 C--N 1.35 0.588 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.53 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.07 154.87 40.69 Favored 'General case' 0 C--N 1.371 1.531 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -143.11 155.58 44.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 122.201 1.0 . . . . 0.0 109.537 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.553 HD21 HD23 ' C' ' 858' ' ' LEU . 2.2 tm? -131.62 127.6 37.38 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.436 -166.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.2 m -158.8 12.78 0.16 Allowed 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -164.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.553 HD23 HD21 ' C' ' 856' ' ' LEU . 2.3 pp -27.71 146.18 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 160.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.78 -44.82 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 122.245 1.837 . . . . 0.0 113.332 -161.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.0 ptt85 -164.28 173.75 11.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -173.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.7 m -4.38 112.56 0.01 OUTLIER 'General case' 0 C--N 1.365 1.242 0 C-N-CA 130.826 3.651 . . . . 0.0 116.436 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.93 162.54 25.14 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -167.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.34 -14.99 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.378 2.052 . . . . 0.0 111.163 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.33 -144.2 4.05 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 28.1 m -64.96 136.14 56.46 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.986 1.715 . . . . 0.0 110.492 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 16.6 m -64.89 143.66 98.87 Favored Pre-proline 0 C--N 1.354 0.78 0 C-N-CA 125.444 1.497 . . . . 0.0 113.2 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -98.7 -151.75 0.03 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.572 0 C-N-CA 123.296 2.664 . . . . 0.0 107.478 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -146.05 130.11 17.4 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -115.93 -15.67 11.19 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.159 0.584 . . . . 0.0 111.08 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -103.23 79.71 1.76 Allowed 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.937 0.495 . . . . 0.0 111.669 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.08 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 127.063 2.145 . . . . 0.0 106.973 165.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 3.3 mt -90.75 -37.16 13.86 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.327 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 60.5 tp -164.64 128.2 2.45 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 172.34 61.96 0.0 OUTLIER 'General case' 0 C--N 1.356 0.854 0 CA-C-N 120.653 1.57 . . . . 0.0 106.973 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.32 98.02 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 116.085 1.884 . . . . 0.0 116.085 -165.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.77 -32.91 8.73 Favored Glycine 0 C--N 1.357 1.728 0 CA-C-N 119.028 0.831 . . . . 0.0 112.076 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.51 -65.01 0.26 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 64.24 -79.13 0.03 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.931 2.492 . . . . 0.0 114.517 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.59 121.87 36.59 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.804 1.642 . . . . 0.0 109.283 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -80.57 118.4 72.25 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 115.611 -2.137 . . . . 0.0 105.884 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -92.42 0.88 4.0 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 CA-C-N 125.514 3.005 . . . . 0.0 109.517 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.6 -45.66 18.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.244 1.018 . . . . 0.0 108.9 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.3 p -106.41 -13.4 15.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.702 1.601 . . . . 0.0 108.17 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 86.24 25.23 37.48 Favored Glycine 0 C--N 1.361 1.949 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.728 162.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.54 101.29 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 -165.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.29 112.82 24.47 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 112.45 -2.159 . . . . 0.0 108.387 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 67.6 m -101.11 107.83 19.36 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . 0.617 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -90.95 111.79 50.16 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.247 -1.358 . . . . 0.0 111.602 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.05 2.69 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.094 2.141 . . . . 0.0 109.067 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.01 -54.21 45.95 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.545 -167.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.8 68.5 0.83 Allowed 'General case' 0 C--N 1.366 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 111.825 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.77 36.78 Favored Glycine 0 N--CA 1.406 -3.318 1 N-CA-C 102.089 -4.404 . . . . 0.0 102.089 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -92.72 119.19 31.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.797 -1.202 . . . . 0.0 108.26 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.452 ' H ' HD11 ' C' ' 954' ' ' LEU . 8.8 t80 -118.19 146.52 44.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.41 116.23 30.59 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 124.222 1.009 . . . . 0.0 109.086 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 7.3 tt -114.42 139.77 49.23 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.016 1.326 . . . . 0.0 109.365 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.1 119.15 10.04 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.484 0.714 . . . . 0.0 109.903 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.38 154.57 21.65 Favored 'General case' 0 C--N 1.365 1.249 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.67 122.36 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.05 123.73 42.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.251 1.02 . . . . 0.0 109.617 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.0 m -83.16 131.36 35.13 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.68 -56.42 20.34 Favored Glycine 0 C--N 1.364 2.109 0 C-N-CA 125.611 1.577 . . . . 0.0 114.762 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 63.6 m170 32.04 72.34 0.07 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 127.946 2.498 . . . . 0.0 115.609 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -74.27 -9.5 58.66 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.967 1.307 . . . . 0.0 111.371 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.96 -18.33 62.01 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.297 1.439 . . . . 0.0 112.568 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.294 12.1 pt-20 124.63 -175.34 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 128.528 2.731 . . . . 0.0 107.783 174.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 100.88 131.32 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 127.696 2.398 . . . . 0.0 106.554 170.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 71.2 t -99.21 123.49 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -105.15 122.72 46.5 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.509 167.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -131.07 117.15 18.72 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.371 2.668 . . . . 0.0 109.607 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.415 HG11 HH21 ' C' ' 921' ' ' ARG . 87.1 t -90.1 113.01 25.53 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 144.6 53.58 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.796 1.639 . . . . 0.0 111.58 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.285 1.0 OUTLIER -115.31 147.24 40.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.721 2.008 . . . . 0.0 108.893 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.617 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.6 OUTLIER -80.34 138.83 36.76 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 127.301 2.241 . . . . 0.0 110.123 -177.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 94.19 -2.64 0.1 Allowed 'General case' 0 C--N 1.348 0.537 0 C-N-CA 129.21 3.004 . . . . 0.0 112.701 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -144.17 -26.41 0.53 Allowed 'General case' 0 C--N 1.358 0.95 0 O-C-N 120.904 -1.122 . . . . 0.0 111.819 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 58.89 168.31 0.06 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.197 1.399 . . . . 0.0 111.583 -162.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.72 51.4 Favored Glycine 0 C--N 1.375 2.697 0 O-C-N 119.576 -1.953 . . . . 0.0 109.855 -165.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 51.66 76.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.214 0 C-N-CA 126.197 1.799 . . . . 0.0 111.322 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.39 114.71 26.89 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -170.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.415 HH21 HG11 ' C' ' 911' ' ' VAL . 12.6 ptt180 -99.12 -38.69 8.83 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.413 -170.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 86.6 t -100.28 82.68 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.72 132.02 39.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.11 0.481 . . . . 0.0 110.49 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 20.7 t -142.75 115.29 8.56 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 108.631 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.25 84.54 0.7 Allowed Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 104.823 -3.311 . . . . 0.0 104.823 166.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.597 0 C-N-CA 125.89 1.709 . . . . 0.0 111.453 174.378 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -121.02 134.02 55.28 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.92 163.45 26.97 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.69 130.94 73.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.39 148.72 49.45 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -116.36 -39.77 3.33 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 31.4 tp -93.04 -55.15 3.45 Favored 'General case' 0 C--N 1.356 0.863 0 O-C-N 121.57 -0.706 . . . . 0.0 111.747 -166.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.3 -161.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 C-N-CA 125.117 1.367 . . . . 0.0 109.737 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.452 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -170.72 91.55 0.47 Allowed Pre-proline 0 C--N 1.358 0.948 0 O-C-N 121.794 -0.566 . . . . 0.0 110.033 -166.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.33 90.61 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 123.247 2.195 . . . . 0.0 109.569 158.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 89.1 mt -123.36 145.83 48.43 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -95.15 159.7 14.89 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-N 118.858 0.753 . . . . 0.0 109.33 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.61 122.67 20.94 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 120.104 1.32 . . . . 0.0 109.411 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 88.79 -8.39 79.59 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 125.896 1.713 . . . . 0.0 111.923 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.14 173.75 8.1 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.946 0.898 . . . . 0.0 109.709 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 81.9 m -142.33 126.21 17.16 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -156.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.464 HG13 HH11 ' C' ' 914' ' ' ARG . 34.8 m -94.99 150.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 123.722 0.809 . . . . 0.0 109.197 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.0 t -140.13 139.46 35.79 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 125.9 1.68 . . . . 0.0 112.195 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.03 128.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.588 0 C-N-CA 126.42 1.888 . . . . 0.0 106.727 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.6 131.36 54.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 25.0 tp -131.92 76.89 1.73 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.284 -1.78 . . . . 0.0 107.617 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 58.3 t -159.03 100.0 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -149.34 83.81 1.43 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.78 149.3 16.14 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -117.4 -17.67 10.04 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.651 0.781 . . . . 0.0 110.374 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.0 tp -99.74 85.4 3.1 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.82 1.66 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -171.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -121.37 157.58 30.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.54 131.5 36.93 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.74 152.8 23.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -125.73 113.97 24.86 Favored Pre-proline 0 C--N 1.356 0.858 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -96.45 170.48 1.04 Allowed 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 121.839 1.693 . . . . 0.0 107.861 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.56 138.38 50.72 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -135.62 138.32 42.78 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 119.488 1.04 . . . . 0.0 108.299 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.62 130.59 69.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -128.9 101.18 5.97 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 24.4 p -100.68 163.83 12.15 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.6 1.56 . . . . 0.0 109.115 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.8 113.44 0.37 Allowed Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.0 42.62 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 66.3 tp -78.53 125.27 29.13 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.481 1.513 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 12.5 tp -97.49 -56.8 2.42 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 121.993 0.117 . . . . 0.0 110.713 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -131.09 128.36 40.03 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -175.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.41 129.34 9.86 Favored Glycine 0 CA--C 1.486 -1.725 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 163.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.47 132.11 89.65 Favored Pre-proline 0 C--N 1.349 0.563 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.478 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -106.38 79.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 121.305 1.502 . . . . 0.0 109.171 -170.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.98 -72.04 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.019 3.328 . . . . 0.0 109.056 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.9 mt 49.77 39.48 18.03 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 128.678 2.791 . . . . 0.0 113.761 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -112.32 131.42 55.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -128.34 108.97 11.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 179.206 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.455 -0.776 0 N-CA-C 110.021 -0.8 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.87 120.05 24.15 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.69 -21.0 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 122.146 1.802 . . . . 0.0 109.566 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 36.86 70.03 0.19 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 129.103 2.961 . . . . 0.0 115.631 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 87.3 t -118.78 136.5 55.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 158.81 43.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 162.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 8.1 p90 -149.44 138.56 21.32 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 28.8 t -169.1 117.15 0.65 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.5 152.36 36.09 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.67 157.58 46.53 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.537 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 858' ' ' LEU . 2.6 tm? -131.59 131.52 43.34 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -166.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 41.7 p -160.32 16.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -165.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 856' ' ' LEU . 3.4 pp -21.73 144.1 0.02 OUTLIER Pre-proline 0 C--N 1.37 1.464 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 159.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.8 -43.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 122.093 1.783 . . . . 0.0 111.995 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -164.28 176.67 8.94 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 17.1 m -19.22 120.21 0.02 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.651 3.18 . . . . 0.0 115.656 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -127.67 144.22 50.35 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 -163.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.66 -10.34 17.12 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 122.685 1.995 . . . . 0.0 113.586 -159.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -158.07 -142.05 3.3 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 20.3 m -63.31 145.38 55.68 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 110.47 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.1 128.79 50.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.857 1.263 . . . . 0.0 110.307 -165.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -94.45 -152.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.28 3.32 . . . . 0.0 108.489 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -149.28 135.13 18.81 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -118.33 -13.65 9.81 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 122.753 0.421 . . . . 0.0 111.608 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -100.17 86.73 3.28 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 118.609 0.641 . . . . 0.0 112.545 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 874' ' ' ASN . 54.0 t -71.92 97.65 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.831 1.652 . . . . 0.0 107.013 168.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.36 -37.21 17.3 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.946 -172.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 29.2 tp -165.4 127.64 2.09 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 101.959 -3.349 . . . . 0.0 101.959 160.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 26.9 t-20 -174.8 60.84 0.02 OUTLIER 'General case' 0 C--N 1.356 0.877 0 CA-C-N 120.553 1.524 . . . . 0.0 110.336 -166.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -58.87 -43.99 90.97 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -166.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.35 -27.23 12.19 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 118.928 0.785 . . . . 0.0 112.747 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -57.76 0.41 Allowed Glycine 0 C--N 1.352 1.465 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.07 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.354 0.804 0 C-N-CA 128.098 2.559 . . . . 0.0 114.746 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -96.78 119.14 34.7 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.21 116.05 62.28 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -95.95 4.88 2.03 Favored 'Trans proline' 0 CA--C 1.505 -0.93 0 CA-C-N 124.405 2.609 . . . . 0.0 109.407 -160.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -79.93 -45.81 17.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.1 p -106.01 -10.43 16.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.348 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.41 28.06 37.48 Favored Glycine 0 C--N 1.366 2.201 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 161.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 22.9 t -101.6 103.05 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 -162.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.468 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.4 OUTLIER -102.03 111.13 23.28 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 112.434 -2.166 . . . . 0.0 109.464 -173.045 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 83.9 m -99.99 107.53 19.5 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . 0.461 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.12 111.41 46.64 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 117.106 -1.426 . . . . 0.0 112.2 169.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.0 -1.24 5.62 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.781 2.321 . . . . 0.0 109.126 166.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -49.13 -54.82 14.49 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 128.856 2.862 . . . . 0.0 115.127 -167.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.47 48.69 14.11 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.63 -161.77 10.74 Favored Glycine 0 N--CA 1.417 -2.578 1 N-CA-C 102.636 -4.185 . . . . 0.0 102.636 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.557 ' HE ' HG22 ' A' ' 953' ' ' ILE . 67.7 ttt-85 -89.92 120.89 31.53 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.472 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.3 t80 -115.58 144.87 43.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -174.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -109.78 116.81 32.35 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.704 0.801 . . . . 0.0 109.871 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.1 140.02 48.83 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.091 1.756 . . . . 0.0 109.049 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -143.98 119.74 10.52 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.526 0.73 . . . . 0.0 109.812 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.47 153.95 22.07 Favored 'General case' 0 C--N 1.367 1.344 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.31 121.07 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.36 123.59 43.77 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.209 -172.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 41.8 m -83.38 131.33 35.06 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.39 -58.07 16.47 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 125.124 1.345 . . . . 0.0 114.107 -169.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 38.25 69.81 0.23 Allowed 'General case' 0 C--N 1.36 1.065 0 C-N-CA 127.085 2.154 . . . . 0.0 114.708 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -73.23 -8.97 58.12 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.161 1.384 . . . . 0.0 111.284 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.33 -19.44 61.65 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.814 1.246 . . . . 0.0 112.486 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.301 13.9 pt-20 127.56 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.161 2.584 . . . . 0.0 108.424 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.7 tttt 102.05 131.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.885 2.474 . . . . 0.0 107.386 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.7 t -99.51 125.38 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 123.306 1.527 . . . . 0.0 106.932 -172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -112.41 122.17 46.94 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.134 -1.848 . . . . 0.0 113.004 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.9 116.81 16.93 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 128.346 2.658 . . . . 0.0 108.538 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.78 112.77 23.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.08 145.67 52.57 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.647 1.579 . . . . 0.0 111.901 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.306 0.8 OUTLIER -114.81 148.87 37.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 126.588 1.955 . . . . 0.0 110.732 177.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.587 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.33 138.75 38.72 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.948 2.099 . . . . 0.0 109.744 176.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 96.85 -1.22 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 128.816 2.846 . . . . 0.0 112.319 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -147.89 -26.05 0.35 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.108 -0.995 . . . . 0.0 110.634 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 57.92 171.36 0.05 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.194 1.397 . . . . 0.0 111.521 -162.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.44 -133.6 52.63 Favored Glycine 0 C--N 1.373 2.592 0 O-C-N 119.376 -2.078 . . . . 0.0 110.104 -163.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 948' ' ' GLY . 58.5 t 56.32 77.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 126.036 1.735 . . . . 0.0 111.485 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.2 115.17 27.84 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -102.6 -34.09 9.22 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.601 -172.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 95.4 t -99.34 87.24 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 103.252 -2.869 . . . . 0.0 103.252 166.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -94.84 131.18 41.01 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 116.31 9.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.343 1.457 . . . . 0.0 107.714 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.41 85.03 0.71 Allowed Glycine 0 CA--C 1.485 -1.814 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 162.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.62 0 C-N-CA 124.812 1.196 . . . . 0.0 110.987 172.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.69 134.34 52.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . 0.465 ' H ' HG22 ' A' ' 919' ' ' VAL . . . -139.7 163.81 26.12 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -174.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.29 132.96 70.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.05 147.46 46.19 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 55.1 m -117.62 -40.98 2.97 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 36.4 tp -89.27 -54.21 4.21 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.666 0.666 . . . . 0.0 112.082 -165.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.557 HG22 ' HE ' ' A' ' 893' ' ' ARG . 16.3 pt -85.41 -155.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.883 0 C-N-CA 124.724 1.21 . . . . 0.0 110.278 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.472 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -170.07 85.71 0.57 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 C-N-CA 122.981 0.513 . . . . 0.0 109.934 -165.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.14 89.99 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 122.656 1.984 . . . . 0.0 109.538 159.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.78 145.83 48.07 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.568 2.347 . . . . 0.0 105.022 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -92.62 157.16 16.64 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-N 119.444 1.02 . . . . 0.0 108.705 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.27 123.83 23.15 Favored 'General case' 0 C--N 1.37 1.495 0 CA-C-N 119.749 1.159 . . . . 0.0 108.949 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.46 -13.17 67.78 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 125.884 1.707 . . . . 0.0 111.019 170.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.16 176.19 5.38 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.052 0.541 . . . . 0.0 111.697 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 77.7 m -141.74 127.17 18.82 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -157.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.587 HG13 HH11 ' A' ' 914' ' ' ARG . 10.5 m -94.9 149.72 4.37 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 121.642 0.734 . . . . 0.0 109.909 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.6 m -139.38 137.17 35.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.139 1.775 . . . . 0.0 111.011 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 89.5 t -92.82 129.19 43.73 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 C-N-CA 126.61 1.964 . . . . 0.0 106.666 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -108.35 131.07 55.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.98 77.82 1.81 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 53.0 t -161.21 101.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.848 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -152.3 72.42 0.99 Allowed 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.04 149.42 8.55 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -117.01 -28.75 6.17 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.805 0.842 . . . . 0.0 108.748 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.2 tp -92.6 86.51 5.62 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.37 -164.13 1.54 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -125.29 160.21 29.83 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -93.22 132.07 37.72 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.57 150.01 22.75 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.23 113.58 23.71 Favored Pre-proline 0 C--N 1.355 0.844 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -97.95 172.34 0.64 Allowed 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 108.369 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.17 140.43 49.53 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -140.45 142.25 35.39 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 119.51 1.05 . . . . 0.0 108.757 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.81 129.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -125.81 106.85 9.98 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 52.1 p -99.29 160.74 14.06 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.057 0.943 . . . . 0.0 109.547 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.13 108.35 0.25 Allowed Glycine 0 C--N 1.359 1.836 0 C-N-CA 119.293 -1.432 . . . . 0.0 109.951 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.99 148.78 43.13 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 52.0 tp -72.7 123.39 23.18 Favored 'General case' 0 C--N 1.372 1.568 0 C-N-CA 125.849 1.66 . . . . 0.0 109.456 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.1 tp -99.95 -57.84 2.05 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.82 128.64 39.15 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.911 2.084 . . . . 0.0 106.466 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 130.58 10.32 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 103.979 -3.649 . . . . 0.0 103.979 161.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -69.48 133.56 89.0 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-N 118.662 1.231 . . . . 0.0 110.794 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -106.14 83.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.473 0 CA-C-N 121.469 1.56 . . . . 0.0 109.832 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.44 -72.74 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.398 3.479 . . . . 0.0 109.484 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.3 mt 49.52 40.23 18.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.27 3.028 . . . . 0.0 114.023 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.08 130.51 55.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -127.32 110.1 12.48 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.058 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.454 -0.823 0 N-CA-C 110.004 -0.806 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.2 120.67 25.15 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -92.7 -21.01 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.098 1.785 . . . . 0.0 109.83 -172.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 38.48 69.83 0.24 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 129.08 2.952 . . . . 0.0 115.315 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 78.9 t -118.7 136.42 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.24 158.34 44.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.416 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 8.3 p90 -149.52 139.21 21.74 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.3 t -169.2 117.84 0.66 Allowed 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.66 153.06 34.94 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -138.8 157.67 45.65 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.886 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.09 130.22 40.95 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -166.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 32.4 p -160.8 14.18 0.11 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.557 -163.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.2 pp -21.58 143.58 0.02 OUTLIER Pre-proline 0 C--N 1.373 1.587 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 158.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.34 -43.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 122.009 1.753 . . . . 0.0 111.936 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -164.15 176.78 8.93 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m -19.36 120.44 0.02 OUTLIER 'General case' 0 C--N 1.363 1.175 0 C-N-CA 129.706 3.203 . . . . 0.0 115.645 171.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -127.92 144.19 50.51 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -163.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.77 -10.6 16.96 Favored 'Trans proline' 0 CA--C 1.512 -0.603 0 CA-C-N 122.698 1.999 . . . . 0.0 113.645 -158.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.62 -141.81 3.25 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -63.25 144.92 56.52 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.984 1.714 . . . . 0.0 110.282 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.13 128.27 54.27 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 124.912 1.285 . . . . 0.0 110.119 -165.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -95.34 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.196 3.264 . . . . 0.0 108.382 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -147.92 133.79 19.07 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -116.48 -13.02 10.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.977 0.911 . . . . 0.0 110.696 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.26 85.7 2.86 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 121.198 0.523 . . . . 0.0 111.281 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' B' ' 874' ' ' ASN . 60.7 t -69.77 97.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 163.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' B' ' 855' ' ' ALA . 18.5 mt -87.21 -39.32 15.56 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.414 -172.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 40.7 tp -165.23 127.25 2.09 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 101.064 -3.68 . . . . 0.0 101.064 165.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.417 ' HB3' HG13 ' B' ' 871' ' ' VAL . 27.3 t-20 178.69 61.02 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 120.157 1.344 . . . . 0.0 109.146 -161.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.52 -43.56 93.38 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.59 -27.6 12.7 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 118.779 0.718 . . . . 0.0 112.669 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.92 -55.73 0.5 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 60.46 -84.11 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 C-N-CA 128.11 2.564 . . . . 0.0 114.866 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.3 118.87 34.71 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.75 116.39 63.72 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.01 5.21 2.37 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 CA-C-N 124.403 2.608 . . . . 0.0 109.73 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.95 -44.38 20.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.5 p -108.2 -10.64 15.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.957 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.79 30.13 30.16 Favored Glycine 0 C--N 1.359 1.819 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 162.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 32.3 t -101.34 102.36 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 -162.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.448 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.3 OUTLIER -101.53 111.79 24.14 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 112.856 -1.974 . . . . 0.0 108.994 -174.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.3 m -100.14 107.67 19.61 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . 0.454 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.13 111.53 47.32 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 117.291 -1.338 . . . . 0.0 111.93 169.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -89.48 0.35 5.89 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.762 2.308 . . . . 0.0 108.759 164.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -48.38 -56.44 8.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 128.914 2.886 . . . . 0.0 115.032 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.85 63.93 1.67 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 170.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.98 -166.68 31.83 Favored Glycine 0 N--CA 1.409 -3.141 0 N-CA-C 103.621 -3.791 . . . . 0.0 103.621 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -90.81 121.16 32.43 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.482 ' H ' HD11 ' B' ' 954' ' ' LEU . 2.0 t80 -117.27 146.04 43.57 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -172.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.34 115.51 28.86 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.2 tt -112.08 139.83 47.27 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 126.275 1.83 . . . . 0.0 108.503 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -143.26 119.19 10.62 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 123.312 0.645 . . . . 0.0 109.43 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.65 154.46 21.42 Favored 'General case' 0 C--N 1.365 1.271 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.69 121.96 61.33 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.38 122.02 43.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.152 0.981 . . . . 0.0 109.123 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 36.4 m -81.41 132.05 35.31 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 107.781 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.01 16.7 Favored Glycine 0 C--N 1.364 2.125 0 C-N-CA 125.14 1.352 . . . . 0.0 114.405 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.5 m170 37.2 70.4 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.204 2.202 . . . . 0.0 114.976 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -73.29 -8.74 57.15 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.28 1.432 . . . . 0.0 111.442 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -73.17 -15.79 61.45 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.083 1.353 . . . . 0.0 112.564 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.314 12.2 pt-20 122.94 -179.29 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 128.568 2.747 . . . . 0.0 108.606 176.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.0 tttt 102.5 131.11 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 127.897 2.479 . . . . 0.0 107.184 170.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.08 126.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -112.52 123.13 49.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.87 174.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.56 115.67 15.75 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 128.223 2.609 . . . . 0.0 109.476 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.4 t -87.89 113.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.21 149.37 41.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.662 1.985 . . . . 0.0 112.369 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.309 0.9 OUTLIER -115.08 149.53 37.37 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 126.598 1.959 . . . . 0.0 110.524 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.599 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.71 138.71 36.35 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.593 1.957 . . . . 0.0 109.36 174.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 97.1 -5.76 0.06 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 128.92 2.888 . . . . 0.0 112.569 172.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -146.19 -25.84 0.44 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-N 119.47 1.032 . . . . 0.0 111.349 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 57.9 169.66 0.05 OUTLIER 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.32 1.448 . . . . 0.0 111.571 -162.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.03 -132.89 50.95 Favored Glycine 0 C--N 1.368 2.317 0 O-C-N 119.508 -1.995 . . . . 0.0 109.727 -165.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 53.71 78.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 126.408 1.883 . . . . 0.0 111.631 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.42 28.03 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -103.02 -35.27 8.61 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.632 -172.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 89.6 t -99.35 86.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 166.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.9 130.53 42.83 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -172.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -141.59 117.34 10.4 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.327 1.451 . . . . 0.0 107.235 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.21 85.18 0.73 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.889 -3.684 . . . . 0.0 103.889 164.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.661 0 C-N-CA 124.639 1.114 . . . . 0.0 110.927 174.309 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 CA--C 1.506 -0.747 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.54 134.07 55.42 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.67 164.68 26.0 Favored Glycine 0 CA--C 1.489 -1.545 0 C-N-CA 125.56 1.552 . . . . 0.0 109.281 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.06 133.01 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -135.66 148.51 48.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 52.6 m -122.14 -34.61 3.29 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.367 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 25.8 tp -91.31 -52.34 4.85 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.128 -168.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -86.63 -169.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 124.816 1.246 . . . . 0.0 109.353 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.482 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.62 86.42 2.1 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -168.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.31 90.88 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 117.627 -1.828 . . . . 0.0 109.982 161.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.53 145.58 48.19 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 127.083 2.153 . . . . 0.0 105.412 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -92.16 158.89 15.93 Favored 'General case' 0 C--N 1.363 1.155 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.701 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.55 123.1 22.49 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-N 120.304 1.411 . . . . 0.0 108.602 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.77 -12.02 70.1 Favored Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 125.283 1.421 . . . . 0.0 110.863 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.55 175.7 5.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.905 0.859 . . . . 0.0 110.659 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 83.2 m -142.27 127.51 18.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -154.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.599 HG13 HH11 ' B' ' 914' ' ' ARG . 7.5 m -96.28 150.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 CA-C-O 121.464 0.649 . . . . 0.0 110.989 174.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.2 m -138.49 137.39 37.09 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 126.359 1.863 . . . . 0.0 111.035 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.04 129.44 42.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 C-N-CA 127.459 2.303 . . . . 0.0 106.564 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -107.98 130.98 55.02 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 100.886 -3.746 . . . . 0.0 100.886 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.97 77.33 1.78 Allowed 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 54.0 t -159.84 103.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -151.12 72.37 1.06 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.83 148.23 8.35 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -115.38 -27.66 7.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 35.8 tp -93.64 86.43 5.17 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.19 -163.98 1.51 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -125.2 159.29 31.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -91.38 131.13 37.06 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.58 149.99 22.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.826 -2.286 . . . . 0.0 104.826 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.06 113.29 24.12 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -97.06 172.33 0.78 Allowed 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.003 1.802 . . . . 0.0 108.173 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.4 mp -115.92 138.04 51.55 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.3 p -138.79 140.29 38.53 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 119.791 1.178 . . . . 0.0 108.261 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.8 mm -116.31 130.35 71.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -126.53 106.59 9.54 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 35.6 p -101.05 162.89 12.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.489 1.116 . . . . 0.0 110.231 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.75 110.31 0.29 Allowed Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.83 147.28 43.2 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.1 122.96 21.85 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 125.135 1.374 . . . . 0.0 109.091 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.1 tp -99.48 -58.09 2.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -131.37 128.39 39.54 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.897 1.679 . . . . 0.0 106.566 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.16 130.42 10.26 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 104.161 -3.575 . . . . 0.0 104.161 161.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.53 133.43 88.94 Favored Pre-proline 0 C--N 1.351 0.657 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.39 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -105.99 82.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.546 1.588 . . . . 0.0 109.195 -170.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.88 -72.28 0.09 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 130.286 3.435 . . . . 0.0 109.444 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 48.69 43.91 21.07 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 129.087 2.955 . . . . 0.0 113.671 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.0 130.23 56.72 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.08 110.2 12.25 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 179.551 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.86 0 N-CA-C 109.962 -0.822 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 34.8 t -125.4 116.52 25.22 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -90.01 -20.71 1.08 Allowed 'Trans proline' 0 CA--C 1.511 -0.638 0 CA-C-N 121.903 1.715 . . . . 0.0 109.662 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 39.16 69.8 0.26 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 128.811 2.844 . . . . 0.0 115.471 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.15 133.73 65.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -137.13 153.96 50.38 Favored 'General case' 0 C--N 1.363 1.158 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 167.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 7.0 p90 -149.71 141.7 23.87 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.916 0.78 . . . . 0.0 109.725 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.8 t -168.68 118.69 0.74 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.159 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.34 153.67 39.98 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -142.52 156.13 45.1 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.274 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.542 HD21 HD23 ' C' ' 858' ' ' LEU . 1.9 tm? -130.21 127.56 39.89 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.699 -164.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 33.3 p -162.35 11.88 0.07 Allowed 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -161.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.542 HD23 HD21 ' C' ' 856' ' ' LEU . 3.2 pp -27.62 146.86 0.04 OUTLIER Pre-proline 0 C--N 1.368 1.393 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 157.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.83 -45.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.101 1.786 . . . . 0.0 112.156 -164.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -162.17 172.64 15.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -0.43 107.17 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 130.652 3.581 . . . . 0.0 117.526 167.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -107.46 163.5 16.82 Favored Pre-proline 0 C--N 1.353 0.757 0 C-N-CA 124.249 1.02 . . . . 0.0 110.209 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.05 -13.19 14.19 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.083 2.522 . . . . 0.0 111.318 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.03 -144.39 4.28 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.1 m -64.39 136.6 57.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.364 1.866 . . . . 0.0 111.035 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.38 144.77 98.84 Favored Pre-proline 0 C--N 1.354 0.787 0 C-N-CA 125.392 1.477 . . . . 0.0 113.453 -174.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -100.96 -147.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.435 2.757 . . . . 0.0 106.67 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -147.33 134.25 20.22 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -117.59 -15.54 10.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 122.811 0.444 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.463 HH21 HD23 ' C' ' 872' ' ' LEU . 11.1 mmm180 -102.33 81.52 2.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.402 0.62 . . . . 0.0 111.399 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' C' ' 874' ' ' ASN . 43.6 t -67.99 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 126.265 1.826 . . . . 0.0 107.464 162.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.463 HD23 HH21 ' C' ' 870' ' ' ARG . 6.9 mt -88.47 -37.85 15.46 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 121.601 -0.687 . . . . 0.0 110.68 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.8 tp -165.86 129.77 2.21 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 168.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.2 t-20 176.42 61.69 0.0 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.828 1.649 . . . . 0.0 108.034 -165.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.32 -43.68 92.67 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -165.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.01 -28.08 11.47 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 118.896 0.771 . . . . 0.0 112.568 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.36 -57.78 0.42 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 62.38 -82.51 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.214 2.606 . . . . 0.0 114.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.0 120.05 36.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.139 1.376 . . . . 0.0 108.085 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.49 115.95 62.0 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -96.02 5.97 1.91 Allowed 'Trans proline' 0 CA--C 1.506 -0.913 0 CA-C-N 124.659 2.7 . . . . 0.0 109.702 -161.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -79.55 -45.25 19.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 29.3 p -106.72 -11.14 15.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.868 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.93 31.07 30.03 Favored Glycine 0 C--N 1.362 1.987 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 162.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 36.2 t -101.25 101.93 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 100.965 -3.716 . . . . 0.0 100.965 -164.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.26 112.09 24.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 112.127 -2.306 . . . . 0.0 108.548 -175.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 66.4 m -99.39 109.42 22.02 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.34 109.6 34.79 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 117.367 -1.302 . . . . 0.0 111.724 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.35 -4.11 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.434 2.089 . . . . 0.0 108.104 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 55.0 mt -54.54 -52.89 60.62 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 127.937 2.495 . . . . 0.0 114.009 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.56 67.62 0.92 Allowed 'General case' 0 C--N 1.366 1.32 0 CA-C-O 122.262 1.03 . . . . 0.0 111.418 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.54 -169.62 36.78 Favored Glycine 0 N--CA 1.406 -3.334 1 N-CA-C 102.156 -4.377 . . . . 0.0 102.156 -170.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -93.69 120.85 34.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.53 -1.335 . . . . 0.0 108.076 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.429 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.5 t80 -116.73 145.38 43.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -170.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 53.1 tp -109.94 114.88 28.79 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.061 0.945 . . . . 0.0 108.58 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -113.21 137.9 50.78 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.379 1.472 . . . . 0.0 108.814 -173.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -144.3 118.71 9.64 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.82 22.2 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.81 121.76 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.46 124.15 39.34 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.373 1.069 . . . . 0.0 109.837 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 55.5 m -81.47 130.62 35.11 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -50.62 -54.81 19.69 Favored Glycine 0 C--N 1.361 1.956 0 C-N-CA 126.141 1.829 . . . . 0.0 115.776 -170.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 28.7 m170 28.16 78.69 0.02 OUTLIER 'General case' 0 C--N 1.36 1.06 0 C-N-CA 128.162 2.585 . . . . 0.0 116.254 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -72.37 -13.5 61.49 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.9 1.68 . . . . 0.0 111.29 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.04 -17.43 61.43 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.661 1.584 . . . . 0.0 112.617 -168.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.2 pt-20 116.23 -179.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 128.093 2.557 . . . . 0.0 108.769 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 105.51 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 128.554 2.742 . . . . 0.0 105.136 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.8 t -97.23 125.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -101.15 130.87 47.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.086 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.75 113.54 2.8 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 125.252 1.421 . . . . 0.0 110.625 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 6.2 p -85.18 117.73 30.86 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 108.722 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.62 137.78 58.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.646 1.178 . . . . 0.0 109.81 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -117.17 144.39 44.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.609 1.564 . . . . 0.0 107.853 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.45 142.55 37.44 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 128.344 2.657 . . . . 0.0 109.591 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.33 24.1 p 88.6 3.44 0.26 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 129.902 3.281 . . . . 0.0 113.879 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -150.67 -24.26 0.23 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-N 119.453 1.024 . . . . 0.0 111.31 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 58.84 168.37 0.06 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.435 1.494 . . . . 0.0 112.116 -163.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -130.16 49.82 Favored Glycine 0 C--N 1.375 2.744 0 O-C-N 119.384 -2.072 . . . . 0.0 110.135 -163.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 49.2 t 53.48 72.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.175 0 C-N-CA 125.946 1.698 . . . . 0.0 111.974 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.66 116.37 28.95 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -99.31 -31.31 11.76 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.762 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.88 80.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -95.29 130.76 41.93 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.744 0.307 . . . . 0.0 111.197 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 117.81 9.02 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.287 1.435 . . . . 0.0 107.872 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.15 85.05 0.79 Allowed Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.713 0 C-N-CA 125.311 1.434 . . . . 0.0 110.732 172.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.51 134.69 55.24 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.73 162.59 26.24 Favored Glycine 0 CA--C 1.491 -1.421 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.88 132.98 69.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.86 148.71 45.64 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.436 -0.79 . . . . 0.0 108.957 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 63.7 m -108.31 -75.79 0.62 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 21.9 tp -66.96 -50.74 61.35 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -163.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.89 -176.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 125.94 1.696 . . . . 0.0 109.656 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.64 ' HB2' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -163.14 94.42 1.13 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.1 93.63 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.631 2.221 . . . . 0.0 110.015 162.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.64 HD13 ' HB2' ' C' ' 954' ' ' LEU . 7.9 mp -120.65 144.49 48.14 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -98.35 160.42 14.29 Favored 'General case' 0 C--N 1.363 1.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.43 123.41 22.31 Favored 'General case' 0 C--N 1.381 1.978 0 CA-C-N 120.329 1.422 . . . . 0.0 109.038 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -9.49 71.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 125.233 1.397 . . . . 0.0 111.794 168.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.65 171.83 4.78 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.438 0.695 . . . . 0.0 112.445 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.5 m -142.73 127.76 18.47 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -159.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.07 149.76 4.38 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 123.627 0.771 . . . . 0.0 109.295 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.2 t -142.29 136.59 29.91 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.495 1.118 . . . . 0.0 111.89 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.47 129.63 43.63 Favored 'Isoleucine or valine' 0 C--N 1.374 1.665 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.11 134.16 48.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.83 73.6 1.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.902 -1.954 . . . . 0.0 107.041 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 48.9 t -162.03 99.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.954 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -152.37 72.69 1.0 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.68 146.94 8.11 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.65 -21.56 10.17 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.413 0.685 . . . . 0.0 109.952 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -99.08 85.94 3.34 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.89 -167.88 2.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -170.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.69 156.73 33.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 15.4 t -91.12 135.53 33.7 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -160.23 154.45 23.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -127.72 115.01 20.85 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -97.57 172.96 0.67 Allowed 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 121.921 1.747 . . . . 0.0 107.894 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.8 mp -115.29 139.17 50.2 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 22.1 p -137.16 138.97 40.81 Favored 'General case' 0 C--N 1.375 1.688 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 31.5 mm -115.54 131.13 68.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -124.98 105.76 9.45 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 26.4 p -100.86 162.65 12.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 109.587 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 111.03 0.31 Allowed Glycine 0 C--N 1.358 1.785 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.71 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.75 142.71 47.44 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.1 tp -75.17 125.39 28.85 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.684 1.594 . . . . 0.0 108.569 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.1 -56.03 2.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -130.62 127.53 39.15 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -173.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 128.62 9.59 Favored Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 103.615 -3.794 . . . . 0.0 103.615 164.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.58 130.01 89.42 Favored Pre-proline 0 C--N 1.351 0.641 0 CA-C-O 117.461 -1.257 . . . . 0.0 111.215 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -107.03 80.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 122.519 1.935 . . . . 0.0 109.777 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 77.98 -71.99 0.1 Allowed 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 130.048 3.339 . . . . 0.0 109.414 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 64.9 mt 48.77 41.62 18.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 129.314 3.046 . . . . 0.0 113.596 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -110.0 129.55 55.66 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.94 107.0 9.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.307 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.455 -0.773 0 N-CA-C 110.015 -0.802 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.11 120.12 22.37 Favored Pre-proline 0 N--CA 1.443 -0.816 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -90.54 -20.24 0.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.122 1.794 . . . . 0.0 109.827 -173.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 36.6 70.56 0.16 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 128.933 2.893 . . . . 0.0 115.792 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 77.2 t -118.3 136.17 56.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.3 44.7 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 165.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -149.46 139.04 21.65 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.4 t -168.96 117.19 0.66 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.74 153.21 36.0 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 -177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -136.44 158.49 44.3 Favored 'General case' 0 CA--C 1.507 -0.677 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.425 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.555 HD21 HD23 ' A' ' 858' ' ' LEU . 2.5 tm? -135.07 130.46 35.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 -166.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 72.2 m -161.41 8.81 0.08 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 -162.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.555 HD23 HD21 ' A' ' 856' ' ' LEU . 2.7 pp -29.59 147.58 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.457 0 N-CA-C 117.132 2.271 . . . . 0.0 117.132 162.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -82.0 -43.23 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 CA-C-N 122.128 1.796 . . . . 0.0 113.487 -161.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -163.44 174.05 12.4 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 -174.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.0 m -9.3 118.97 0.01 OUTLIER 'General case' 0 C--N 1.361 1.097 0 C-N-CA 130.958 3.703 . . . . 0.0 117.004 174.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -97.95 160.42 28.48 Favored Pre-proline 0 N--CA 1.44 -0.943 0 C-N-CA 124.691 1.196 . . . . 0.0 109.478 -170.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.09 -16.67 9.73 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.815 2.343 . . . . 0.0 110.098 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.57 -137.82 2.41 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 16.5 m -64.22 145.79 55.39 Favored 'General case' 0 C--N 1.357 0.933 0 C-N-CA 126.204 1.801 . . . . 0.0 110.652 -179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 77.8 t -92.66 130.43 36.96 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 125.514 1.525 . . . . 0.0 110.416 -164.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -96.18 -150.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.927 3.084 . . . . 0.0 108.954 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.58 135.52 19.99 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -117.49 -14.78 10.3 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.985 0.514 . . . . 0.0 111.828 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.29 86.82 3.28 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 118.504 0.593 . . . . 0.0 111.839 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -71.67 97.3 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 C-N-CA 126.201 1.801 . . . . 0.0 106.574 168.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.445 ' HB3' HD11 ' B' ' 953' ' ' ILE . 50.0 mt -87.24 -37.36 17.3 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.523 -173.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.16 126.86 1.75 Allowed 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 101.591 -3.485 . . . . 0.0 101.591 162.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -175.31 60.93 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 CA-C-N 120.494 1.497 . . . . 0.0 109.652 -168.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.72 -44.35 93.78 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 116.549 2.055 . . . . 0.0 116.549 -164.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.53 -28.51 11.29 Favored Glycine 0 C--N 1.355 1.584 0 CA-C-N 118.99 0.814 . . . . 0.0 112.397 -175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -60.83 0.31 Allowed Glycine 0 C--N 1.353 1.495 0 N-CA-C 107.305 -2.318 . . . . 0.0 107.305 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 63.12 -80.86 0.03 OUTLIER 'General case' 0 C--N 1.356 0.869 0 C-N-CA 128.008 2.523 . . . . 0.0 114.049 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.68 119.46 32.71 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.794 1.238 . . . . 0.0 108.361 -177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -80.95 117.63 68.91 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 103.845 -2.65 . . . . 0.0 103.845 174.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -96.47 0.9 1.97 Allowed 'Trans proline' 0 CA--C 1.508 -0.816 0 CA-C-N 125.113 2.862 . . . . 0.0 109.368 -165.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -80.31 -45.66 17.47 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -103.27 -12.61 17.16 Favored 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 124.347 1.059 . . . . 0.0 109.004 173.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 22.87 52.67 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 162.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 37.7 t -98.94 103.92 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 101.578 -3.49 . . . . 0.0 101.578 -163.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -101.43 111.98 24.37 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 112.014 -2.357 . . . . 0.0 109.357 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 62.1 m -100.87 108.32 20.07 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 168.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . 0.409 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.37 111.09 45.26 Favored Pre-proline 0 C--N 1.358 0.956 0 CA-C-O 117.153 -1.404 . . . . 0.0 112.016 170.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.6 1.89 3.28 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 CA-C-N 123.001 2.107 . . . . 0.0 108.946 169.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 39.3 mt -52.8 -51.53 60.44 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 127.9 2.48 . . . . 0.0 114.09 -169.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 44.79 18.3 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 125.069 1.348 . . . . 0.0 114.023 170.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.49 -163.24 11.79 Favored Glycine 0 N--CA 1.415 -2.737 1 N-CA-C 101.212 -4.755 . . . . 0.0 101.212 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -91.98 121.35 33.48 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.287 0.2 OUTLIER -114.58 159.19 20.72 Favored 'General case' 0 C--N 1.366 1.322 0 CA-C-N 119.32 0.963 . . . . 0.0 108.539 175.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -105.53 115.41 30.2 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 123.555 0.742 . . . . 0.0 109.085 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.81 136.34 50.0 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 126.079 1.751 . . . . 0.0 109.178 -168.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.5 m -145.99 118.91 8.72 Favored 'General case' 0 C--N 1.362 1.123 0 C-N-CA 123.469 0.708 . . . . 0.0 109.608 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.3 153.66 22.41 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 94.8 t -108.99 120.64 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -99.3 123.17 43.37 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.898 -173.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 38.5 m -79.73 131.91 36.05 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 125.29 1.436 . . . . 0.0 107.394 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.36 -57.26 19.39 Favored Glycine 0 C--N 1.363 2.074 0 C-N-CA 125.653 1.597 . . . . 0.0 114.713 -169.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.3 m170 34.04 73.96 0.07 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 127.696 2.399 . . . . 0.0 115.606 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -74.14 -8.3 55.68 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 125.227 1.411 . . . . 0.0 111.55 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -72.12 -15.58 61.99 Favored 'General case' 0 C--N 1.357 0.929 0 C-N-CA 125.741 1.616 . . . . 0.0 112.225 -171.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.339 7.2 pt-20 116.15 -177.47 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 128.26 2.624 . . . . 0.0 108.603 173.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 79.4 tttt 104.53 134.59 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.243 0 C-N-CA 128.244 2.618 . . . . 0.0 106.41 171.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 69.0 t -98.19 125.46 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 -172.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -111.08 122.36 47.68 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 113.015 -1.902 . . . . 0.0 113.446 173.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.21 117.12 17.04 Favored 'General case' 0 C--N 1.364 1.221 0 C-N-CA 128.12 2.568 . . . . 0.0 108.766 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 94.5 t -87.04 113.79 25.16 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 171.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 20.3 mt -62.29 140.78 58.49 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.908 1.683 . . . . 0.0 110.29 176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -116.06 146.78 41.92 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 126.214 1.805 . . . . 0.0 109.218 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.571 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.07 139.78 40.11 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 128.155 2.582 . . . . 0.0 110.13 -174.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.17 -13.62 0.03 OUTLIER 'General case' 0 CA--C 1.511 -0.551 0 C-N-CA 129.603 3.161 . . . . 0.0 112.649 172.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -139.33 -26.0 0.83 Allowed 'General case' 0 CA--C 1.501 -0.927 0 CA-C-N 119.327 0.967 . . . . 0.0 111.095 -171.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 60.54 167.01 0.08 Allowed 'General case' 0 C--N 1.361 1.105 0 C-N-CA 125.226 1.411 . . . . 0.0 111.36 -164.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -134.63 50.49 Favored Glycine 0 C--N 1.37 2.449 0 O-C-N 119.521 -1.987 . . . . 0.0 109.208 -161.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 47.4 t 57.93 75.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.235 0 C-N-CA 125.297 1.439 . . . . 0.0 110.516 173.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.75 114.77 27.39 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -172.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.2 ptt180 -103.01 -36.17 8.28 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.143 -1.39 . . . . 0.0 108.454 -171.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.5 t -101.28 78.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 102.744 -3.058 . . . . 0.0 102.744 168.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -95.32 131.55 41.3 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.145 -172.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -143.96 114.69 7.7 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 125.024 1.33 . . . . 0.0 107.885 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.2 84.69 0.71 Allowed Glycine 0 CA--C 1.485 -1.813 0 N-CA-C 104.529 -3.428 . . . . 0.0 104.529 167.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.66 0 C-N-CA 125.452 1.501 . . . . 0.0 110.96 174.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 41.5 m . . . . . 0 N--CA 1.447 -0.619 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.2 mt -118.26 134.1 55.32 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 105.788 -1.931 . . . . 0.0 105.788 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.82 161.41 25.46 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -175.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 33.0 m -123.91 127.96 73.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -137.58 148.47 45.92 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.4 m -114.73 -44.32 3.07 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 26.9 tp -84.33 -50.11 8.13 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.431 1.014 . . . . 0.0 112.785 -166.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 12.6 pt -87.88 -169.6 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.865 0 C-N-CA 124.688 1.195 . . . . 0.0 109.941 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.23 82.71 2.2 Favored Pre-proline 0 N--CA 1.438 -1.029 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -165.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.55 91.36 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 CA-C-N 122.308 1.86 . . . . 0.0 109.592 160.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.7 mp -121.1 142.31 49.97 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -94.51 156.56 16.4 Favored 'General case' 0 C--N 1.361 1.075 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.17 123.02 21.22 Favored 'General case' 0 C--N 1.372 1.565 0 CA-C-N 119.533 1.06 . . . . 0.0 108.929 177.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.41 -11.85 71.12 Favored Glycine 0 C--N 1.345 1.082 0 C-N-CA 125.893 1.711 . . . . 0.0 111.246 170.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.7 175.32 5.77 Favored 'General case' 0 C--N 1.357 0.913 0 C-N-CA 123.158 0.583 . . . . 0.0 111.467 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 83.7 m -142.54 125.47 16.16 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 -159.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.571 HG13 HH11 ' A' ' 914' ' ' ARG . 34.0 m -95.79 150.26 4.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.686 0.755 . . . . 0.0 109.9 171.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.7 138.91 34.59 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 126.684 1.994 . . . . 0.0 111.382 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.29 129.27 43.15 Favored 'Isoleucine or valine' 0 C--N 1.37 1.487 0 C-N-CA 126.301 1.84 . . . . 0.0 106.786 -177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -107.43 131.0 54.76 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 102.168 -3.271 . . . . 0.0 102.168 170.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.1 tt -132.04 77.55 1.77 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.3 t -160.93 99.69 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.842 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.4 mmm -152.4 73.89 1.05 Allowed 'General case' 0 CA--C 1.495 -1.172 0 N-CA-C 104.821 -2.289 . . . . 0.0 104.821 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 107.5 141.92 10.16 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.96 -5.88 13.17 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.256 0.623 . . . . 0.0 111.257 -171.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.9 tp -98.28 82.86 2.97 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.94 -175.19 3.95 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -168.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 24.4 t60 -122.0 159.5 26.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 16.8 t -89.01 131.19 35.3 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -176.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.69 150.03 22.55 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.41 113.36 23.29 Favored Pre-proline 0 C--N 1.356 0.869 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 174.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -98.13 174.29 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.806 0 C-N-CA 121.895 1.73 . . . . 0.0 108.54 -177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.6 mp -117.75 140.91 49.03 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.46 140.58 37.33 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 119.583 1.083 . . . . 0.0 108.919 -171.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.0 mm -118.85 129.77 74.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -127.3 105.92 8.86 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 33.8 p -100.19 160.99 13.9 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 125.008 1.323 . . . . 0.0 110.068 170.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -179.2 109.84 0.27 Allowed Glycine 0 C--N 1.358 1.787 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.8 144.96 46.0 Favored 'General case' 0 C--N 1.346 0.439 0 O-C-N 121.416 -1.049 . . . . 0.0 113.713 -173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -73.75 123.65 24.53 Favored 'General case' 0 C--N 1.375 1.676 0 C-N-CA 124.591 1.156 . . . . 0.0 109.671 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 23.9 tp -98.72 -57.38 2.2 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.65 128.02 38.19 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.99 129.82 10.04 Favored Glycine 0 CA--C 1.494 -1.263 0 N-CA-C 103.231 -3.947 . . . . 0.0 103.231 163.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 79.1 m-20 -69.04 130.04 91.71 Favored Pre-proline 0 C--N 1.352 0.703 0 CA-C-O 117.779 -1.105 . . . . 0.0 111.015 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -106.76 82.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 CA-C-N 121.885 1.709 . . . . 0.0 109.89 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 78.29 -72.28 0.09 Allowed 'General case' 0 CA--C 1.499 -0.983 0 C-N-CA 130.265 3.426 . . . . 0.0 109.195 177.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 76.4 mt 49.93 39.0 17.55 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 129.073 2.949 . . . . 0.0 114.244 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.7 131.95 54.95 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -129.24 109.46 11.15 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 105.104 -2.184 . . . . 0.0 105.104 176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.134 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 179.656 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 N--CA 1.454 -0.801 0 N-CA-C 109.988 -0.812 . . . . 0.0 109.988 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.2 t -126.69 120.41 23.01 Favored Pre-proline 0 N--CA 1.445 -0.704 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.5 -20.47 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 CA-C-N 122.176 1.813 . . . . 0.0 110.081 -173.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 37.95 70.37 0.2 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 128.926 2.89 . . . . 0.0 115.482 178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 82.5 t -118.14 136.03 56.65 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.08 157.66 46.35 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 165.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -149.5 139.46 21.98 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -169.57 118.23 0.63 Allowed 'General case' 0 C--N 1.354 0.781 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -177.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.97 153.56 34.45 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -138.37 158.59 43.98 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 119.319 -0.952 . . . . 0.0 111.908 176.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.58 HD21 HD23 ' B' ' 858' ' ' LEU . 2.4 tm? -136.06 128.1 29.65 Favored 'General case' 0 N--CA 1.428 -1.57 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -167.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 73.3 m -160.33 13.0 0.12 Allowed 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -167.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.58 HD23 HD21 ' B' ' 856' ' ' LEU . 2.6 pp -29.03 148.24 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 160.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -81.63 -43.76 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.104 1.787 . . . . 0.0 113.553 -161.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -163.41 173.83 12.7 Favored 'General case' 0 CA--C 1.503 -0.851 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 -174.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -8.73 118.94 0.01 OUTLIER 'General case' 0 C--N 1.364 1.207 0 C-N-CA 130.952 3.701 . . . . 0.0 117.075 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -97.87 160.42 28.54 Favored Pre-proline 0 N--CA 1.44 -0.926 0 C-N-CA 124.661 1.184 . . . . 0.0 109.606 -170.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.14 -16.69 9.64 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.776 2.317 . . . . 0.0 110.176 176.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.43 -137.71 2.37 Favored Glycine 0 C--N 1.353 1.499 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -64.05 145.41 55.95 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.13 1.772 . . . . 0.0 110.498 -179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 89.2 t -91.89 129.84 40.63 Favored Pre-proline 0 N--CA 1.438 -1.028 0 C-N-CA 125.366 1.466 . . . . 0.0 110.208 -164.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -96.82 -150.95 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.797 2.998 . . . . 0.0 108.726 178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -148.21 135.54 20.46 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.8 p30 -115.87 -14.05 11.32 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 124.019 0.928 . . . . 0.0 110.705 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.17 86.65 3.07 Favored 'General case' 0 C--N 1.354 0.79 0 CA-C-N 118.233 0.469 . . . . 0.0 112.159 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.8 t -70.06 97.6 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 126.247 1.819 . . . . 0.0 106.639 164.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.467 HD11 ' HB2' ' B' ' 855' ' ' ALA . 13.5 mt -87.75 -38.83 15.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.077 -1.049 . . . . 0.0 111.278 -173.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 53.3 tp -166.25 127.49 1.79 Allowed 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 166.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 178.25 61.0 0.01 OUTLIER 'General case' 0 C--N 1.355 0.825 0 CA-C-N 120.331 1.423 . . . . 0.0 108.807 -164.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -60.13 -43.96 95.28 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -166.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.22 -29.15 10.57 Favored Glycine 0 C--N 1.356 1.654 0 CA-C-N 118.741 0.7 . . . . 0.0 112.355 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.53 -60.04 0.34 Allowed Glycine 0 C--N 1.353 1.487 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 63.14 -81.06 0.03 OUTLIER 'General case' 0 C--N 1.355 0.834 0 C-N-CA 128.103 2.561 . . . . 0.0 114.148 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -95.33 119.24 33.5 Favored 'General case' 0 N--CA 1.434 -1.261 0 C-N-CA 125.007 1.323 . . . . 0.0 108.231 -176.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -80.64 117.83 69.65 Favored Pre-proline 0 N--CA 1.44 -0.968 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 174.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -95.29 0.99 2.5 Favored 'Trans proline' 0 CA--C 1.508 -0.811 0 CA-C-N 125.144 2.873 . . . . 0.0 109.589 -165.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -80.3 -44.36 19.71 Favored 'General case' 0 CA--C 1.501 -0.916 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 33.2 p -105.38 -13.05 15.78 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 124.729 1.211 . . . . 0.0 108.581 174.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 24.24 47.22 Favored Glycine 0 C--N 1.362 2.009 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 163.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 38.5 t -99.7 103.44 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.385 0 N-CA-C 101.614 -3.476 . . . . 0.0 101.614 -162.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.57 112.1 24.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 112.515 -2.129 . . . . 0.0 109.475 -174.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 61.3 m -101.08 108.45 20.15 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . 0.408 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.43 111.12 45.55 Favored Pre-proline 0 C--N 1.359 0.99 0 CA-C-O 117.152 -1.404 . . . . 0.0 111.844 170.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -93.26 2.08 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.698 0 CA-C-N 123.101 2.143 . . . . 0.0 108.949 168.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 27.8 mt -54.32 -49.37 69.85 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.025 2.13 . . . . 0.0 113.888 -169.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.32 48.18 15.38 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 125.747 1.619 . . . . 0.0 114.431 170.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.91 -164.92 20.2 Favored Glycine 0 N--CA 1.412 -2.951 1 N-CA-C 100.611 -4.995 . . . . 0.0 100.611 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -90.79 121.38 32.61 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -116.42 159.54 21.85 Favored 'General case' 0 C--N 1.368 1.399 0 CA-C-N 119.36 0.982 . . . . 0.0 108.824 178.195 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.5 tp -106.19 114.3 28.35 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -109.55 136.17 49.36 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 126.09 1.756 . . . . 0.0 108.529 -170.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -145.02 119.31 9.54 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 123.167 0.587 . . . . 0.0 109.566 175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.85 22.15 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 89.2 t -109.33 121.44 62.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -102.29 121.97 43.31 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 124.44 1.096 . . . . 0.0 108.665 -172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.3 m -79.12 132.26 36.51 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 107.749 175.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.15 -57.25 19.28 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.784 1.659 . . . . 0.0 114.63 -168.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.5 m170 33.92 73.84 0.07 Allowed 'General case' 0 C--N 1.359 1.013 0 C-N-CA 127.746 2.418 . . . . 0.0 115.528 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.0 -8.48 56.28 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.283 1.433 . . . . 0.0 111.493 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -72.22 -14.51 61.81 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 125.807 1.643 . . . . 0.0 112.255 -170.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.341 7.0 pt-20 115.92 -178.27 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.137 0 C-N-CA 128.641 2.776 . . . . 0.0 108.633 174.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 104.32 134.18 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 128.081 2.552 . . . . 0.0 106.635 172.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 87.8 t -98.0 126.5 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -172.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -111.98 122.8 48.78 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.942 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.24 116.88 16.73 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 127.539 2.336 . . . . 0.0 109.564 -177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 97.0 t -88.07 113.88 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.805 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.62 142.93 57.82 Favored 'General case' 0 CA--C 1.503 -0.837 0 C-N-CA 126.337 1.855 . . . . 0.0 110.249 176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.7 t -116.47 147.24 41.91 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 126.298 1.839 . . . . 0.0 109.424 -179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.604 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.16 139.39 38.98 Favored 'General case' 0 N--CA 1.431 -1.402 0 C-N-CA 127.664 2.386 . . . . 0.0 109.826 -175.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 101.54 -16.94 0.03 OUTLIER 'General case' 0 C--N 1.349 0.586 0 C-N-CA 129.643 3.177 . . . . 0.0 112.798 173.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -137.37 -25.5 1.03 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 119.384 0.993 . . . . 0.0 111.57 -169.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 60.44 167.35 0.08 Allowed 'General case' 0 C--N 1.36 1.062 0 C-N-CA 125.449 1.499 . . . . 0.0 111.078 -163.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.93 -133.55 49.36 Favored Glycine 0 C--N 1.367 2.259 0 O-C-N 119.664 -1.898 . . . . 0.0 109.066 -163.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 47.7 t 56.04 76.4 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.18 0 C-N-CA 125.64 1.576 . . . . 0.0 110.794 174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.32 115.2 27.83 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.7 ptt180 -103.35 -36.83 7.89 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.771 -1.559 . . . . 0.0 108.392 -171.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 98.5 t -101.65 77.8 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 168.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -96.14 131.29 42.74 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.825 -172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -142.87 115.26 8.49 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 125.1 1.36 . . . . 0.0 107.832 169.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 84.63 0.73 Allowed Glycine 0 CA--C 1.486 -1.777 0 N-CA-C 104.625 -3.39 . . . . 0.0 104.625 168.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.644 0 C-N-CA 125.615 1.579 . . . . 0.0 111.003 175.397 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 CA--C 1.506 -0.712 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.0 mt -116.88 134.23 55.03 Favored 'General case' 0 N--CA 1.434 -1.265 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -142.44 162.67 27.27 Favored Glycine 0 CA--C 1.492 -1.403 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -119.83 130.73 73.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.775 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 172.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.0 p90 -137.61 150.09 47.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 54.6 m -119.19 -39.97 2.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 118.003 0.365 . . . . 0.0 111.91 176.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 26.4 tp -83.56 -50.2 8.48 Favored 'General case' 0 C--N 1.359 1.014 0 CA-C-N 119.142 0.883 . . . . 0.0 112.299 -168.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.445 HD11 ' HB3' ' A' ' 872' ' ' LEU . 38.4 pt -84.74 -175.47 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 125.686 1.595 . . . . 0.0 110.14 -176.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.38 81.92 2.81 Favored Pre-proline 0 N--CA 1.44 -0.95 0 N-CA-C 109.497 -0.556 . . . . 0.0 109.497 -169.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.78 92.62 0.87 Allowed 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.294 1.996 . . . . 0.0 110.107 162.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.85 141.85 50.19 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 104.724 -2.324 . . . . 0.0 104.724 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -93.5 157.19 16.33 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.162 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.92 122.8 21.43 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.808 1.186 . . . . 0.0 108.718 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.04 -11.31 72.46 Favored Glycine 0 CA--C 1.497 -1.062 0 C-N-CA 125.667 1.603 . . . . 0.0 111.165 170.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.8 175.01 6.1 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 121.624 0.726 . . . . 0.0 110.619 178.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 91.1 m -142.55 125.61 16.29 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -158.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.604 HG13 HH11 ' B' ' 914' ' ' ARG . 27.2 m -96.78 151.1 4.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 121.637 0.732 . . . . 0.0 110.909 171.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -140.85 138.94 34.35 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 126.864 2.066 . . . . 0.0 111.454 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 94.8 t -91.71 129.64 42.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.466 0 C-N-CA 127.142 2.177 . . . . 0.0 106.964 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -107.29 130.77 54.72 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.633 -3.469 . . . . 0.0 101.633 172.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.7 tt -131.8 77.11 1.75 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 59.5 t -160.12 100.99 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.839 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -151.59 71.76 1.0 Allowed 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.25 141.78 9.09 Favored Glycine 0 C--N 1.349 1.295 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -113.44 -5.11 13.51 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 123.233 0.613 . . . . 0.0 110.994 -172.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 37.8 tp -99.44 82.11 2.62 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 177.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.56 -174.5 3.72 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -168.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -121.97 159.76 26.27 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -88.62 130.52 35.26 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -176.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.81 150.11 22.4 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 104.995 -2.224 . . . . 0.0 104.995 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.43 113.3 23.24 Favored Pre-proline 0 C--N 1.356 0.88 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 174.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -97.75 173.88 0.61 Allowed 'Trans proline' 0 CA--C 1.507 -0.859 0 C-N-CA 121.957 1.772 . . . . 0.0 108.492 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -116.95 139.53 50.54 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.42 139.63 38.99 Favored 'General case' 0 C--N 1.374 1.646 0 CA-C-N 119.728 1.149 . . . . 0.0 108.572 -171.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.2 mm -116.82 130.4 71.77 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 107.321 -1.362 . . . . 0.0 107.321 178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -127.78 106.03 8.85 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -176.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 34.3 p -101.22 163.02 12.48 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.086 1.354 . . . . 0.0 110.538 171.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.75 111.41 0.31 Allowed Glycine 0 C--N 1.36 1.868 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 174.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.85 145.12 45.93 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.25 123.23 23.3 Favored 'General case' 0 C--N 1.376 1.744 0 C-N-CA 124.223 1.009 . . . . 0.0 109.354 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 53.6 tp -98.3 -57.48 2.2 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -131.4 127.3 37.24 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -173.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.72 128.95 9.72 Favored Glycine 0 CA--C 1.493 -1.329 1 N-CA-C 103.053 -4.019 . . . . 0.0 103.053 163.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -69.76 128.91 91.65 Favored Pre-proline 0 C--N 1.349 0.567 0 CA-C-O 117.693 -1.146 . . . . 0.0 110.345 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -106.27 82.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 CA-C-N 122.08 1.779 . . . . 0.0 109.593 -168.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.0 -72.04 0.09 Allowed 'General case' 0 CA--C 1.5 -0.97 0 C-N-CA 130.201 3.4 . . . . 0.0 109.136 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 76.5 mt 49.47 40.6 19.39 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 128.984 2.914 . . . . 0.0 113.828 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -113.35 131.79 55.83 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -130.02 109.17 10.65 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 176.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.091 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.578 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.059 -0.785 . . . . 0.0 110.059 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.88 114.43 31.07 Favored Pre-proline 0 N--CA 1.442 -0.862 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -86.09 -23.92 1.84 Allowed 'Trans proline' 0 CA--C 1.512 -0.584 0 CA-C-N 121.697 1.642 . . . . 0.0 110.285 -171.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 38.8 67.03 0.46 Allowed 'General case' 0 C--N 1.357 0.934 0 C-N-CA 128.602 2.761 . . . . 0.0 115.553 175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 22.8 t -122.09 136.95 57.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.93 156.09 49.59 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 165.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 8.6 p90 -148.47 137.83 21.96 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.3 t -171.37 119.37 0.47 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.426 -0.796 . . . . 0.0 109.734 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.41 153.61 37.61 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 -176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.17 158.46 44.01 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 120.149 -0.62 . . . . 0.0 110.663 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.486 HD21 HD23 ' C' ' 858' ' ' LEU . 3.0 tm? -140.83 130.21 23.79 Favored 'General case' 0 N--CA 1.425 -1.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -163.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 74.5 m -158.54 15.99 0.2 Allowed 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 -168.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.486 HD23 HD21 ' C' ' 856' ' ' LEU . 2.0 pp -27.25 144.33 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.517 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 160.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -79.75 -45.49 0.1 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 CA-C-N 122.056 1.77 . . . . 0.0 113.54 -162.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.07 174.42 12.28 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 107.143 -1.428 . . . . 0.0 107.143 -174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.1 m -5.02 114.83 0.01 OUTLIER 'General case' 0 C--N 1.363 1.185 0 C-N-CA 130.78 3.632 . . . . 0.0 116.901 170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.87 156.55 43.67 Favored Pre-proline 0 N--CA 1.44 -0.935 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 -167.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.01 -15.63 10.36 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.346 2.03 . . . . 0.0 111.259 -172.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.1 -140.48 2.96 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.0 m -65.8 144.66 56.72 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.621 1.568 . . . . 0.0 110.036 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 74.1 t -98.09 134.39 22.16 Favored Pre-proline 0 N--CA 1.437 -1.096 0 C-N-CA 124.596 1.159 . . . . 0.0 110.521 -158.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -95.77 -152.96 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 124.063 3.175 . . . . 0.0 109.832 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -145.4 132.83 20.73 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -113.24 -17.03 12.43 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 123.457 0.703 . . . . 0.0 111.124 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -102.9 83.42 2.23 Favored 'General case' 0 C--N 1.353 0.753 0 CA-C-O 121.194 0.521 . . . . 0.0 111.458 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.66 97.46 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 C-N-CA 126.534 1.934 . . . . 0.0 106.649 165.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 14.2 mt -89.79 -37.87 14.2 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 118.855 -1.138 . . . . 0.0 110.889 -173.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 34.4 tp -165.02 127.22 2.16 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 101.36 -3.57 . . . . 0.0 101.36 167.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 31.5 t-20 174.97 61.29 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 120.183 1.356 . . . . 0.0 107.703 -163.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -59.84 -42.78 94.35 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.79 -28.32 16.4 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.744 0.702 . . . . 0.0 112.284 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.26 -58.44 0.46 Allowed Glycine 0 C--N 1.354 1.53 0 N-CA-C 107.838 -2.105 . . . . 0.0 107.838 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 62.45 -81.28 0.02 OUTLIER 'General case' 0 C--N 1.353 0.751 0 C-N-CA 128.119 2.568 . . . . 0.0 114.654 174.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -95.5 120.3 35.51 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 125.424 1.49 . . . . 0.0 108.501 -175.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -85.41 117.38 68.64 Favored Pre-proline 0 N--CA 1.437 -1.122 0 N-CA-C 105.003 -2.221 . . . . 0.0 105.003 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.56 6.59 2.02 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 CA-C-N 124.918 2.792 . . . . 0.0 109.768 -171.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -79.65 -45.33 19.24 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -105.26 -15.83 14.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.894 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.23 24.22 52.3 Favored Glycine 0 C--N 1.363 2.037 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 164.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.67 103.08 14.41 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.429 0 N-CA-C 101.335 -3.58 . . . . 0.0 101.335 -168.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -94.67 112.14 23.89 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 112.547 -2.115 . . . . 0.0 108.929 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 50.7 m -102.86 109.07 20.52 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 169.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . 0.507 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.25 110.38 42.16 Favored Pre-proline 0 C--N 1.356 0.889 0 CA-C-O 117.221 -1.371 . . . . 0.0 111.774 169.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -92.83 1.33 3.72 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.539 2.159 . . . . 0.0 108.289 164.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 36.4 mt -54.73 -52.68 61.74 Favored 'General case' 0 CA--C 1.498 -1.032 0 C-N-CA 128.098 2.559 . . . . 0.0 113.794 -168.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.41 67.35 0.95 Allowed 'General case' 0 C--N 1.366 1.29 0 CA-C-O 121.971 0.891 . . . . 0.0 111.177 169.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.97 171.22 44.11 Favored Glycine 0 N--CA 1.406 -3.307 1 N-CA-C 100.272 -5.131 . . . . 0.0 100.272 -169.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -91.45 116.34 28.77 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -116.28 160.03 21.03 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-O 121.576 0.703 . . . . 0.0 110.248 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.67 112.77 25.64 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.8 tt -117.39 139.36 50.98 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.142 1.377 . . . . 0.0 109.017 -175.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.5 m -144.15 120.53 10.95 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 123.563 0.745 . . . . 0.0 110.197 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.53 154.48 19.86 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.52 123.07 53.22 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 106.608 -1.627 . . . . 0.0 106.608 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -96.52 123.63 40.25 Favored 'General case' 0 N--CA 1.44 -0.936 0 C-N-CA 124.256 1.022 . . . . 0.0 109.341 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 49.9 m -79.63 132.7 36.32 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.66 -56.78 16.38 Favored Glycine 0 C--N 1.363 2.053 0 C-N-CA 125.774 1.654 . . . . 0.0 114.432 -172.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 32.3 71.83 0.08 Allowed 'General case' 0 C--N 1.36 1.061 0 C-N-CA 127.979 2.512 . . . . 0.0 114.987 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -72.98 -9.24 58.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.554 1.541 . . . . 0.0 111.803 -176.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -71.92 -16.5 62.11 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 125.98 1.712 . . . . 0.0 112.274 -170.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.327 8.9 pt-20 122.13 -173.1 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.187 0 C-N-CA 128.571 2.748 . . . . 0.0 107.745 173.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt 103.49 134.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.347 0 C-N-CA 127.949 2.499 . . . . 0.0 106.655 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.03 123.93 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.172 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -104.03 130.0 51.68 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 126.154 1.781 . . . . 0.0 110.278 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -152.5 114.2 4.34 Favored 'General case' 0 C--N 1.358 0.965 0 C-N-CA 124.97 1.308 . . . . 0.0 110.103 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.53 114.21 27.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 C-N-CA 125.238 1.415 . . . . 0.0 107.694 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -61.59 139.92 58.2 Favored 'General case' 0 N--CA 1.443 -0.802 0 C-N-CA 126.112 1.765 . . . . 0.0 111.421 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.1 t -117.53 144.89 44.65 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 127.059 2.144 . . . . 0.0 108.842 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.507 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.31 141.91 38.13 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 127.205 2.202 . . . . 0.0 111.003 -174.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.6 t 99.79 -10.78 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 129.955 3.302 . . . . 0.0 112.179 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -141.8 -25.94 0.68 Allowed 'General case' 0 C--N 1.358 0.944 0 CA-C-N 119.275 0.943 . . . . 0.0 111.672 -172.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 59.72 167.62 0.07 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.229 1.412 . . . . 0.0 111.671 -163.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.06 -131.94 52.2 Favored Glycine 0 C--N 1.373 2.595 0 O-C-N 119.498 -2.001 . . . . 0.0 109.363 -162.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 44.8 t 54.8 74.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 125.567 1.547 . . . . 0.0 111.032 174.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.12 114.85 27.49 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 -169.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 27.7 ptt85 -97.96 -38.0 9.57 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.752 -171.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.5 t -100.19 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 103.012 -2.959 . . . . 0.0 103.012 169.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -97.53 131.12 44.43 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.183 0.516 . . . . 0.0 111.111 -173.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -144.05 117.06 8.86 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.475 1.51 . . . . 0.0 108.35 171.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.89 85.01 0.74 Allowed Glycine 0 CA--C 1.485 -1.79 0 N-CA-C 105.158 -3.177 . . . . 0.0 105.158 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.605 0 C-N-CA 125.168 1.366 . . . . 0.0 110.798 174.385 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 73.7 mt -122.34 134.24 54.65 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 105.415 -2.068 . . . . 0.0 105.415 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.96 161.63 26.75 Favored Glycine 0 CA--C 1.491 -1.467 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -174.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 28.4 m -120.8 129.64 75.44 Favored 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -136.55 150.16 48.47 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.265 -0.897 . . . . 0.0 108.775 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -115.78 -41.03 3.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 16.6 tp -90.05 -52.92 4.72 Favored 'General case' 0 C--N 1.358 0.966 0 CA-C-N 119.069 0.849 . . . . 0.0 111.837 -168.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.51 -177.21 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.859 0 C-N-CA 125.709 1.604 . . . . 0.0 109.844 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.99 85.51 1.6 Allowed Pre-proline 0 N--CA 1.44 -0.96 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -169.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -75.78 87.78 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 CA-C-N 122.543 1.944 . . . . 0.0 109.49 163.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.6 mp -123.18 145.82 48.3 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 -174.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -92.8 161.37 14.54 Favored 'General case' 0 C--N 1.362 1.124 0 CA-C-N 118.917 0.78 . . . . 0.0 109.721 -174.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.51 122.67 20.87 Favored 'General case' 0 C--N 1.379 1.872 0 CA-C-N 119.907 1.231 . . . . 0.0 109.051 173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.73 -12.49 69.72 Favored Glycine 0 C--N 1.347 1.145 0 C-N-CA 126.112 1.815 . . . . 0.0 111.372 168.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.26 175.37 5.41 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-O 121.571 0.701 . . . . 0.0 111.45 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 93.6 m -142.68 126.65 17.28 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.965 0.906 . . . . 0.0 110.569 -159.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 16.0 m -98.44 147.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.362 1.132 0 C-N-CA 124.447 1.099 . . . . 0.0 108.915 173.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.9 t -142.04 138.88 32.1 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 125.984 1.714 . . . . 0.0 111.577 -172.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 89.3 t -90.33 129.07 41.78 Favored 'Isoleucine or valine' 0 C--N 1.369 1.439 0 C-N-CA 126.352 1.861 . . . . 0.0 106.701 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.69 132.97 51.17 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 101.345 -3.576 . . . . 0.0 101.345 172.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.92 72.16 1.49 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 113.282 -1.781 . . . . 0.0 106.844 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.2 t -160.97 100.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -151.78 70.04 0.93 Allowed 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.2 145.88 7.96 Favored Glycine 0 C--N 1.352 1.466 0 N-CA-C 108.557 -1.817 . . . . 0.0 108.557 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 60.0 mm-40 -117.27 -15.8 10.38 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 124.044 0.938 . . . . 0.0 110.287 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -101.59 81.98 2.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.79 -161.92 1.22 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -172.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -119.61 154.15 34.41 Favored 'General case' 0 CA--C 1.496 -1.116 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.6 t -89.58 132.74 34.95 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -156.5 154.41 30.3 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 106.11 -1.811 . . . . 0.0 106.11 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -128.74 120.74 20.71 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 170.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -102.49 170.96 0.25 Allowed 'Trans proline' 0 CA--C 1.506 -0.892 0 N-CA-C 107.691 -1.696 . . . . 0.0 107.691 174.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 8.1 mp -112.53 139.83 47.79 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.5 p -136.56 139.27 42.05 Favored 'General case' 0 C--N 1.376 1.758 0 CA-C-N 119.574 1.079 . . . . 0.0 108.199 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.6 mm -115.0 131.11 68.22 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -124.91 104.87 8.83 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 -174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 31.1 p -101.88 163.45 12.24 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.357 1.463 . . . . 0.0 110.556 171.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.76 112.14 0.34 Allowed Glycine 0 C--N 1.358 1.768 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 173.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.56 143.77 45.78 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.921 -1.341 . . . . 0.0 114.452 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 54.1 tp -77.05 124.45 27.81 Favored 'General case' 0 C--N 1.379 1.875 0 C-N-CA 124.892 1.277 . . . . 0.0 109.724 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 17.1 tp -97.49 -57.09 2.33 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-O 120.809 0.338 . . . . 0.0 110.237 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -131.49 127.65 37.75 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -175.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.82 130.72 10.41 Favored Glycine 0 N--CA 1.434 -1.438 0 N-CA-C 103.888 -3.685 . . . . 0.0 103.888 165.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -70.51 129.5 90.08 Favored Pre-proline 0 C--N 1.35 0.594 0 CA-C-O 118.019 -0.991 . . . . 0.0 110.696 -177.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -106.76 78.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.014 1.755 . . . . 0.0 109.46 -169.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 78.45 -73.16 0.08 Allowed 'General case' 0 CA--C 1.5 -0.961 0 C-N-CA 130.034 3.334 . . . . 0.0 109.048 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.8 mt 49.79 39.66 18.52 Favored 'General case' 0 C--N 1.344 0.345 0 C-N-CA 128.911 2.884 . . . . 0.0 113.792 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -112.12 131.72 55.29 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.36 109.05 10.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.095 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 179.736 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo . . . . . 0 N--CA 1.454 -0.844 0 N-CA-C 110.166 -0.744 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.03 117.89 28.28 Favored Pre-proline 0 C--N 1.353 0.748 0 N-CA-C 104.57 -2.381 . . . . 0.0 104.57 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -89.02 -21.0 1.34 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 CA-C-N 121.998 1.749 . . . . 0.0 110.021 -172.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 37.29 70.57 0.17 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 129.056 2.942 . . . . 0.0 115.493 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 81.7 t -118.23 136.12 56.42 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -175.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.19 158.11 45.2 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 164.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 10.7 p90 -150.57 143.49 24.69 Favored 'General case' 0 C--N 1.361 1.087 0 CA-C-N 118.924 0.784 . . . . 0.0 110.117 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.57 118.42 0.85 Allowed 'General case' 0 C--N 1.353 0.756 0 CA-C-O 118.504 -0.76 . . . . 0.0 109.444 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.74 154.26 37.15 Favored 'General case' 0 C--N 1.37 1.466 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.81 157.18 45.76 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 119.306 -0.958 . . . . 0.0 111.229 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.493 HD21 HD23 ' A' ' 858' ' ' LEU . 2.4 tm? -134.45 130.17 36.35 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -166.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 39.5 p -162.99 13.38 0.07 Allowed 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 -161.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.493 HD23 HD21 ' A' ' 856' ' ' LEU . 3.5 pp -25.18 147.99 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.426 0 N-CA-C 117.174 2.287 . . . . 0.0 117.174 159.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -81.28 -45.51 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.111 1.79 . . . . 0.0 113.252 -164.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.95 176.1 10.5 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -173.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.55 119.57 0.02 OUTLIER 'General case' 0 C--N 1.364 1.209 0 C-N-CA 130.549 3.54 . . . . 0.0 116.148 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -113.96 163.7 18.12 Favored Pre-proline 0 N--CA 1.443 -0.782 0 C-N-CA 123.98 0.912 . . . . 0.0 108.737 -171.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.06 -13.58 13.96 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 122.886 2.391 . . . . 0.0 111.189 -178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.81 -144.74 4.39 Favored Glycine 0 C--N 1.354 1.563 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.5 m -64.67 137.66 57.94 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 126.375 1.87 . . . . 0.0 110.938 -176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 14.8 m -69.38 145.59 95.77 Favored Pre-proline 0 N--CA 1.443 -0.792 0 C-N-CA 125.365 1.466 . . . . 0.0 113.292 -173.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -101.8 -145.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.037 2.492 . . . . 0.0 107.281 177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -148.11 134.07 19.16 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 174.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -117.4 -14.2 10.37 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 123.428 0.691 . . . . 0.0 110.42 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.514 HH21 HD23 ' A' ' 872' ' ' LEU . 16.4 mmm180 -100.37 85.92 3.08 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-O 121.335 0.588 . . . . 0.0 111.427 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 74.2 t -69.2 95.51 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 C-N-CA 127.935 2.494 . . . . 0.0 105.472 163.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.514 HD23 HH21 ' A' ' 870' ' ' ARG . 4.3 mt -90.79 -38.08 13.23 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 118.554 -1.258 . . . . 0.0 110.875 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 55.3 tp -166.8 130.62 1.95 Allowed 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 100.645 -3.835 . . . . 0.0 100.645 172.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.4 p-10 172.15 62.51 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.162 0 CA-C-N 121.012 1.733 . . . . 0.0 108.537 -172.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.34 -44.19 92.66 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -163.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.39 -31.73 9.36 Favored Glycine 0 C--N 1.355 1.606 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.35 -68.76 0.23 Allowed Glycine 0 CA--C 1.489 -1.557 0 N-CA-C 105.592 -3.003 . . . . 0.0 105.592 -179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 77.29 -67.78 0.19 Allowed 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 128.295 2.638 . . . . 0.0 112.21 174.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -98.35 122.12 41.13 Favored 'General case' 0 N--CA 1.434 -1.266 0 C-N-CA 125.31 1.444 . . . . 0.0 108.101 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -80.68 118.0 70.45 Favored Pre-proline 0 N--CA 1.444 -0.741 0 CA-C-O 116.115 -1.898 . . . . 0.0 106.113 167.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -91.32 -0.46 4.71 Favored 'Trans proline' 0 CA--C 1.51 -0.723 0 CA-C-N 124.637 2.692 . . . . 0.0 108.768 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.65 -41.39 27.02 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.835 1.254 . . . . 0.0 108.612 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 37.1 p -104.31 -15.34 15.48 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.57 16.81 69.96 Favored Glycine 0 C--N 1.365 2.163 0 N-CA-C 110.204 -1.158 . . . . 0.0 110.204 167.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 55.7 t -101.87 105.81 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.352 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 -168.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.39 112.37 24.4 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 112.871 -1.968 . . . . 0.0 109.236 -175.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.29 109.33 20.97 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 168.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . 0.492 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.76 110.9 44.81 Favored Pre-proline 0 C--N 1.357 0.913 0 CA-C-O 117.172 -1.394 . . . . 0.0 111.678 169.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -93.75 0.44 3.25 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 CA-C-N 123.082 2.136 . . . . 0.0 108.602 166.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 61.5 mt -51.73 -54.39 28.96 Favored 'General case' 0 CA--C 1.501 -0.922 0 C-N-CA 127.988 2.515 . . . . 0.0 114.563 -168.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.13 66.34 1.12 Allowed 'General case' 0 C--N 1.364 1.231 0 CA-C-O 121.926 0.87 . . . . 0.0 112.166 171.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.27 -169.02 36.57 Favored Glycine 0 N--CA 1.408 -3.17 1 N-CA-C 101.837 -4.505 . . . . 0.0 101.837 -174.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -92.99 122.28 35.19 Favored 'General case' 0 CA--C 1.512 -0.498 0 CA-C-N 114.018 -1.091 . . . . 0.0 108.214 171.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.422 ' H ' HD11 ' A' ' 954' ' ' LEU . 0.0 OUTLIER -116.56 151.68 35.69 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -178.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -106.94 115.83 30.87 Favored 'General case' 0 C--N 1.354 0.777 0 C-N-CA 123.867 0.867 . . . . 0.0 108.844 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -112.58 137.11 51.3 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.957 1.703 . . . . 0.0 109.758 -169.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -145.42 119.06 9.14 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 123.634 0.773 . . . . 0.0 109.317 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.59 154.31 21.6 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 95.3 t -105.43 120.98 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.93 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -98.12 123.21 42.06 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 124.349 1.059 . . . . 0.0 109.22 -171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 48.5 m -83.68 132.32 34.88 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 125.362 1.465 . . . . 0.0 107.272 176.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.37 -57.83 17.78 Favored Glycine 0 C--N 1.362 2.026 0 C-N-CA 125.089 1.328 . . . . 0.0 114.309 -170.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 59.1 m170 33.14 73.18 0.07 Allowed 'General case' 0 C--N 1.361 1.082 0 C-N-CA 127.86 2.464 . . . . 0.0 115.342 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -73.91 -8.4 55.94 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 125.288 1.435 . . . . 0.0 111.959 -176.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -71.17 -18.51 62.49 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 125.567 1.547 . . . . 0.0 112.577 -170.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.309 9.4 pt-20 123.01 -174.16 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.041 0 C-N-CA 129.149 2.98 . . . . 0.0 107.915 175.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt 102.32 130.1 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.291 0 C-N-CA 128.162 2.585 . . . . 0.0 106.509 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 91.2 t -98.31 124.48 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -172.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -107.97 130.47 55.04 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.121 1.769 . . . . 0.0 110.719 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -153.97 115.1 4.09 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 125.217 1.407 . . . . 0.0 110.125 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 4.6 p -83.85 117.73 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 C-N-CA 125.532 1.533 . . . . 0.0 107.886 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.9 mt -62.79 137.37 58.25 Favored 'General case' 0 N--CA 1.439 -0.988 0 C-N-CA 125.07 1.348 . . . . 0.0 109.145 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.2 t -116.22 147.89 41.0 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 126.053 1.741 . . . . 0.0 108.192 -179.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.492 HH22 ' HB3' ' A' ' 888' ' ' ALA . 0.0 OUTLIER -76.03 138.55 40.94 Favored 'General case' 0 N--CA 1.429 -1.524 0 C-N-CA 128.418 2.687 . . . . 0.0 110.38 -173.777 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 88.34 3.44 0.28 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.961 2.904 . . . . 0.0 113.012 173.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -149.73 -24.81 0.27 Allowed 'General case' 0 C--N 1.359 1.019 0 CA-C-N 119.45 1.023 . . . . 0.0 111.61 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 65.0 mt-30 57.76 172.9 0.05 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 124.947 1.299 . . . . 0.0 112.117 -162.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.55 -133.02 52.83 Favored Glycine 0 C--N 1.377 2.824 0 O-C-N 119.513 -1.992 . . . . 0.0 110.292 -163.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 54.5 t 55.34 75.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.266 0 C-N-CA 125.651 1.58 . . . . 0.0 111.267 172.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.58 116.51 28.93 Favored 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 11.4 ptt180 -102.27 -32.87 9.84 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 113.67 -1.605 . . . . 0.0 108.165 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.89 83.3 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 102.502 -3.147 . . . . 0.0 102.502 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -93.74 131.65 38.89 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.136 0.493 . . . . 0.0 110.636 -172.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.0 t -143.3 115.41 8.37 Favored 'General case' 0 N--CA 1.437 -1.099 0 C-N-CA 125.505 1.522 . . . . 0.0 107.569 176.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.38 84.57 0.76 Allowed Glycine 0 CA--C 1.487 -1.694 0 N-CA-C 104.937 -3.265 . . . . 0.0 104.937 167.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.582 0 C-N-CA 124.884 1.23 . . . . 0.0 111.193 175.763 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.6 m . . . . . 0 CA--C 1.512 -0.504 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 56.1 mt -121.66 133.6 54.97 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 105.35 -2.093 . . . . 0.0 105.35 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.97 161.42 27.83 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.8 m -120.48 130.17 74.76 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 176.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -138.82 151.18 46.81 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.4 m -115.35 -43.24 3.08 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 112.886 0.699 . . . . 0.0 112.886 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 45.5 tp -85.48 -50.84 6.95 Favored 'General case' 0 C--N 1.358 0.974 0 CA-C-N 119.324 0.965 . . . . 0.0 112.714 -166.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.9 -172.63 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.799 1.64 . . . . 0.0 110.462 -174.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.422 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -160.01 84.18 2.15 Favored Pre-proline 0 N--CA 1.436 -1.142 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -166.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -73.68 90.7 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.985 1.745 . . . . 0.0 109.089 159.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.0 mp -121.68 142.58 50.01 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -96.8 158.72 15.3 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 -178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.06 123.09 21.31 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.745 1.157 . . . . 0.0 109.031 177.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.39 -11.09 72.96 Favored Glycine 0 C--N 1.346 1.086 0 C-N-CA 125.886 1.708 . . . . 0.0 111.258 170.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.44 174.28 6.79 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 111.552 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.51 127.08 16.04 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 -159.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.411 HG13 HH11 ' A' ' 914' ' ' ARG . 15.3 m -98.23 147.3 6.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.913 0 CA-C-O 121.401 0.62 . . . . 0.0 110.865 171.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 23.4 t -142.32 137.73 30.79 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.318 1.847 . . . . 0.0 110.888 -175.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 30.3 t -91.57 129.04 42.89 Favored 'Isoleucine or valine' 0 C--N 1.37 1.467 0 C-N-CA 125.995 1.718 . . . . 0.0 107.315 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -106.8 131.94 53.34 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 101.437 -3.542 . . . . 0.0 101.437 173.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.4 72.82 1.51 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 113.287 -1.779 . . . . 0.0 106.45 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 52.4 t -162.22 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 83.1 mmm -152.88 72.86 0.98 Allowed 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 104.89 -2.263 . . . . 0.0 104.89 176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 117.48 147.08 8.43 Favored Glycine 0 C--N 1.349 1.289 0 N-CA-C 107.696 -2.162 . . . . 0.0 107.696 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.82 -28.46 7.06 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -174.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.1 tp -92.71 86.36 5.52 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -154.92 0.57 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -124.68 166.96 15.21 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 23.0 t -103.7 131.6 50.72 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 155.89 30.9 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.29 115.05 21.53 Favored Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 173.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -99.78 172.94 0.4 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 121.998 1.799 . . . . 0.0 108.05 178.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.64 140.97 48.69 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -138.3 140.34 39.52 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.585 1.084 . . . . 0.0 108.479 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.2 mm -116.64 130.88 70.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -126.31 106.16 9.32 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 -177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 26.9 p -100.36 160.3 14.45 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.529 1.132 . . . . 0.0 109.253 171.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.72 109.82 0.28 Allowed Glycine 0 C--N 1.356 1.665 0 C-N-CA 119.27 -1.443 . . . . 0.0 109.888 175.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.39 143.68 47.32 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -73.35 125.96 29.05 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 124.955 1.302 . . . . 0.0 109.904 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 55.7 tp -96.82 -57.38 2.3 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 20.5 t80 -131.13 127.75 38.7 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 -173.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.9 129.98 10.1 Favored Glycine 0 N--CA 1.436 -1.311 0 N-CA-C 103.419 -3.872 . . . . 0.0 103.419 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -69.88 128.72 91.63 Favored Pre-proline 0 C--N 1.349 0.573 0 CA-C-O 117.7 -1.143 . . . . 0.0 110.583 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -106.94 80.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 122.165 1.809 . . . . 0.0 109.233 -169.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 79.47 -70.51 0.1 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.936 3.295 . . . . 0.0 109.008 178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 18.2 mt 50.37 38.21 17.38 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 128.729 2.812 . . . . 0.0 114.202 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -114.98 133.94 55.61 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -129.2 109.98 11.6 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.938 -2.245 . . . . 0.0 104.938 175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.112 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.226 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 N--CA 1.454 -0.807 0 N-CA-C 110.134 -0.756 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 39.2 t -123.22 118.36 27.89 Favored Pre-proline 0 N--CA 1.443 -0.786 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 -179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -89.42 -21.61 1.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 CA-C-N 122.029 1.76 . . . . 0.0 110.144 -172.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 38.29 69.72 0.24 Allowed 'General case' 0 C--N 1.359 0.997 0 C-N-CA 128.964 2.906 . . . . 0.0 115.455 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 79.2 t -117.89 136.21 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.694 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.05 158.3 44.7 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 163.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -150.5 143.58 24.81 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 118.821 0.737 . . . . 0.0 110.201 172.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.1 t -167.64 118.37 0.84 Allowed 'General case' 0 C--N 1.354 0.788 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.203 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.16 154.2 36.52 Favored 'General case' 0 C--N 1.369 1.435 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 -175.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.37 157.14 46.0 Favored 'General case' 0 CA--C 1.501 -0.924 0 C-N-CA 119.137 -1.025 . . . . 0.0 111.405 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.494 HD21 HD23 ' B' ' 858' ' ' LEU . 2.4 tm? -133.99 130.21 37.29 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -166.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 39.9 p -163.07 13.1 0.06 Allowed 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -161.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.494 HD23 HD21 ' B' ' 856' ' ' LEU . 3.5 pp -25.06 148.01 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.387 0 N-CA-C 117.262 2.319 . . . . 0.0 117.262 159.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.13 -45.66 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 CA-C-N 122.14 1.8 . . . . 0.0 113.329 -164.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -162.83 176.03 10.65 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -173.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.9 m -14.64 119.63 0.02 OUTLIER 'General case' 0 C--N 1.363 1.187 0 C-N-CA 130.507 3.523 . . . . 0.0 116.138 175.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -113.82 163.69 18.02 Favored Pre-proline 0 N--CA 1.443 -0.784 0 C-N-CA 124.037 0.935 . . . . 0.0 108.799 -171.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -79.02 -13.55 14.04 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.875 2.383 . . . . 0.0 111.218 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.79 -144.79 4.41 Favored Glycine 0 C--N 1.354 1.55 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -64.72 137.73 57.98 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 126.38 1.872 . . . . 0.0 110.901 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 15.2 m -69.54 145.63 95.41 Favored Pre-proline 0 N--CA 1.442 -0.849 0 C-N-CA 125.403 1.481 . . . . 0.0 113.342 -172.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -102.21 -145.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 123.068 2.512 . . . . 0.0 107.285 177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -148.46 134.18 18.88 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 174.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -117.0 -13.82 10.61 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.749 0.819 . . . . 0.0 110.21 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.521 HH21 HD23 ' B' ' 872' ' ' LEU . 15.8 mmm180 -99.97 86.47 3.27 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-O 121.11 0.481 . . . . 0.0 111.918 177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 72.5 t -69.85 95.48 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 127.763 2.425 . . . . 0.0 105.402 163.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.521 HD23 HH21 ' B' ' 870' ' ' ARG . 4.5 mt -90.74 -38.14 13.22 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 118.524 -1.271 . . . . 0.0 110.726 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.5 tp -166.59 130.64 2.04 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.794 -3.78 . . . . 0.0 100.794 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . 0.338 5.5 p-10 172.48 62.62 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 120.906 1.684 . . . . 0.0 108.903 -172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -59.16 -44.06 92.12 Favored 'General case' 0 C--N 1.364 1.216 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -163.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.31 -32.01 9.17 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 110.351 -1.1 . . . . 0.0 110.351 176.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 106.05 -68.39 0.24 Allowed Glycine 0 CA--C 1.49 -1.505 0 N-CA-C 105.711 -2.956 . . . . 0.0 105.711 -179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 77.15 -68.18 0.18 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 128.245 2.618 . . . . 0.0 112.288 174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -98.38 121.85 40.83 Favored 'General case' 0 N--CA 1.434 -1.244 0 C-N-CA 125.331 1.452 . . . . 0.0 108.1 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -80.03 118.08 70.66 Favored Pre-proline 0 N--CA 1.444 -0.737 0 CA-C-O 116.149 -1.881 . . . . 0.0 106.266 167.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -90.79 -0.22 5.05 Favored 'Trans proline' 0 CA--C 1.509 -0.742 0 CA-C-N 124.6 2.679 . . . . 0.0 108.772 178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -79.68 -41.01 27.72 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 124.921 1.288 . . . . 0.0 108.651 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 37.8 p -104.66 -15.53 15.25 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.67 16.98 69.24 Favored Glycine 0 C--N 1.364 2.111 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 167.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.94 105.9 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.357 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 -168.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -98.64 112.43 24.49 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 113.019 -1.9 . . . . 0.0 109.366 -175.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 51.1 m -102.23 109.26 20.89 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 168.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . 0.485 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.82 111.07 46.02 Favored Pre-proline 0 C--N 1.357 0.916 0 CA-C-O 117.157 -1.401 . . . . 0.0 111.837 169.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -94.52 1.52 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 CA-C-N 123.078 2.135 . . . . 0.0 108.767 167.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 44.3 mt -55.27 -49.46 72.02 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 126.819 2.048 . . . . 0.0 114.26 -167.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.69 47.76 17.66 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 125.302 1.441 . . . . 0.0 114.704 171.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -159.63 -164.18 14.48 Favored Glycine 0 N--CA 1.413 -2.888 1 N-CA-C 101.345 -4.702 . . . . 0.0 101.345 176.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 74.1 ttt-85 -89.95 121.35 31.97 Favored 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.432 ' H ' HD11 ' B' ' 954' ' ' LEU 0.25 0.0 OUTLIER -117.17 151.94 35.82 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 -175.901 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.9 tp -106.42 115.64 30.56 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -113.21 136.5 52.67 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.794 1.638 . . . . 0.0 109.063 -169.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.1 m -145.93 119.23 8.95 Favored 'General case' 0 C--N 1.361 1.099 0 C-N-CA 123.542 0.737 . . . . 0.0 109.247 174.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.18 154.68 20.85 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 176.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 96.9 t -105.2 122.11 58.05 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.891 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -99.45 121.92 41.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.106 -171.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 46.9 m -82.17 131.92 35.24 Favored 'General case' 0 C--N 1.353 0.749 0 C-N-CA 125.353 1.461 . . . . 0.0 107.509 175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.72 -57.67 18.61 Favored Glycine 0 C--N 1.363 2.062 0 C-N-CA 125.165 1.364 . . . . 0.0 114.376 -170.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.9 m170 33.04 73.24 0.07 Allowed 'General case' 0 C--N 1.361 1.072 0 C-N-CA 127.845 2.458 . . . . 0.0 115.357 -178.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.5 ptt85 -74.02 -8.1 54.9 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.366 1.466 . . . . 0.0 111.901 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -72.03 -15.72 62.04 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.845 1.658 . . . . 0.0 112.619 -170.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.318 8.5 pt-20 119.36 -176.13 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 C-N-CA 129.152 2.981 . . . . 0.0 108.192 176.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt 103.24 129.98 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 128.158 2.583 . . . . 0.0 106.561 172.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.25 125.14 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 -172.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -109.02 130.42 55.48 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 126.024 1.73 . . . . 0.0 110.608 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.13 115.07 4.04 Favored 'General case' 0 C--N 1.357 0.92 0 C-N-CA 124.928 1.291 . . . . 0.0 110.2 -174.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 5.0 p -84.04 117.82 30.29 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 C-N-CA 125.494 1.518 . . . . 0.0 107.932 176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 28.4 mt -62.96 137.9 58.4 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.453 1.501 . . . . 0.0 109.083 174.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.0 t -116.02 148.62 39.97 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 125.959 1.704 . . . . 0.0 108.715 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.485 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -77.06 138.19 39.41 Favored 'General case' 0 N--CA 1.428 -1.533 0 C-N-CA 127.989 2.516 . . . . 0.0 110.169 -173.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.7 t 87.6 4.67 0.31 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 128.863 2.865 . . . . 0.0 113.019 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -150.03 -24.67 0.26 Allowed 'General case' 0 C--N 1.358 0.975 0 CA-C-N 119.438 1.017 . . . . 0.0 111.515 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 57.56 173.79 0.05 OUTLIER 'General case' 0 C--N 1.361 1.09 0 C-N-CA 124.881 1.272 . . . . 0.0 111.983 -161.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.38 -133.05 52.83 Favored Glycine 0 C--N 1.374 2.68 0 O-C-N 119.622 -1.924 . . . . 0.0 110.337 -164.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 62.0 t 55.54 75.88 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.22 0 C-N-CA 125.729 1.612 . . . . 0.0 111.26 172.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.56 116.59 28.99 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 -173.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 11.3 ptt180 -102.38 -33.14 9.67 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 113.536 -1.666 . . . . 0.0 108.268 -172.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.83 83.28 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 164.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -94.35 130.77 40.53 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-O 121.226 0.536 . . . . 0.0 110.363 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.8 t -142.89 115.43 8.58 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 125.502 1.521 . . . . 0.0 107.438 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.2 84.67 0.78 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.961 -3.256 . . . . 0.0 104.961 167.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.616 0 C-N-CA 124.888 1.232 . . . . 0.0 111.285 176.184 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 54.1 mt -121.19 133.76 55.19 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.62 161.74 27.72 Favored Glycine 0 C--N 1.348 1.222 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -177.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -120.22 130.91 73.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 176.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -138.95 151.15 46.65 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.5 m -113.85 -46.03 3.05 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 49.0 tp -84.02 -49.98 8.42 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 119.221 0.919 . . . . 0.0 112.919 -166.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -84.63 -173.37 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 C-N-CA 125.628 1.571 . . . . 0.0 110.455 -174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.432 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.77 83.86 2.23 Favored Pre-proline 0 N--CA 1.435 -1.19 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 -166.363 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -73.7 90.69 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 CA-C-N 121.897 1.713 . . . . 0.0 109.099 159.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.65 141.12 51.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -95.49 158.45 15.45 Favored 'General case' 0 C--N 1.36 1.055 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.19 123.08 21.38 Favored 'General case' 0 C--N 1.376 1.745 0 CA-C-N 119.805 1.184 . . . . 0.0 108.938 177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.24 -10.79 73.62 Favored Glycine 0 C--N 1.345 1.054 0 C-N-CA 125.867 1.699 . . . . 0.0 111.334 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.71 174.3 6.99 Favored 'General case' 0 C--N 1.357 0.895 0 CA-C-O 121.464 0.65 . . . . 0.0 111.241 177.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.4 m -144.43 127.03 16.06 Favored 'General case' 0 CA--C 1.501 -0.933 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -159.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.417 HG13 HH11 ' B' ' 914' ' ' ARG . 15.6 m -98.35 147.64 6.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 CA-C-O 121.303 0.573 . . . . 0.0 111.397 171.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 23.1 t -142.76 137.86 30.05 Favored 'General case' 0 C--N 1.361 1.094 0 C-N-CA 126.422 1.889 . . . . 0.0 110.9 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 26.6 t -91.7 129.4 42.43 Favored 'Isoleucine or valine' 0 C--N 1.37 1.471 0 C-N-CA 126.37 1.868 . . . . 0.0 107.536 -175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -106.85 132.08 53.22 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 101.223 -3.621 . . . . 0.0 101.223 173.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -131.2 72.71 1.51 Allowed 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.214 -1.773 . . . . 0.0 106.214 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 49.6 t -161.99 102.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 105.955 -1.869 . . . . 0.0 105.955 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 83.5 mmm -153.18 71.17 0.89 Allowed 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.67 146.47 7.78 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 107.571 -2.212 . . . . 0.0 107.571 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -114.2 -28.21 7.37 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -174.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 45.5 tp -92.84 86.31 5.45 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.65 -155.63 0.62 Allowed 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -124.07 167.41 14.23 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 23.3 t -104.49 131.34 51.99 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.97 -1.492 . . . . 0.0 106.97 -176.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -157.58 155.86 30.91 Favored 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 -178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.14 114.91 21.76 Favored Pre-proline 0 N--CA 1.443 -0.808 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -99.41 172.6 0.44 Allowed 'Trans proline' 0 CA--C 1.508 -0.818 0 C-N-CA 122.025 1.817 . . . . 0.0 108.021 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -115.71 140.74 48.91 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.1 p -138.28 140.4 39.59 Favored 'General case' 0 C--N 1.374 1.632 0 CA-C-N 119.5 1.045 . . . . 0.0 108.49 -170.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.3 mm -116.66 131.21 69.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.42 106.1 9.24 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 -177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 24.9 p -99.97 160.18 14.52 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.521 1.128 . . . . 0.0 108.858 170.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.94 109.45 0.26 Allowed Glycine 0 C--N 1.356 1.643 0 C-N-CA 118.899 -1.62 . . . . 0.0 109.356 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -122.56 145.23 48.53 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.213 1.56 . . . . 0.0 115.213 -174.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 57.3 tp -72.74 126.57 30.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 124.948 1.299 . . . . 0.0 110.449 -175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 31.4 tp -97.45 -57.18 2.31 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.317 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -131.2 127.78 38.63 Favored 'General case' 0 N--CA 1.431 -1.402 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -173.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 129.71 10.0 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 103.536 -3.826 . . . . 0.0 103.536 163.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -70.55 128.42 91.11 Favored Pre-proline 0 C--N 1.351 0.668 0 CA-C-O 117.791 -1.099 . . . . 0.0 110.342 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -106.72 82.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 CA-C-N 122.12 1.793 . . . . 0.0 109.28 -169.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 79.14 -70.5 0.1 Allowed 'General case' 0 CA--C 1.501 -0.921 0 C-N-CA 129.911 3.284 . . . . 0.0 109.091 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 19.8 mt 50.08 38.91 17.98 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 128.729 2.812 . . . . 0.0 114.245 -176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.14 110.13 11.75 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.115 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 179.336 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.793 0 N-CA-C 110.175 -0.741 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.64 119.28 25.89 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -90.89 -19.76 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 CA-C-N 122.096 1.784 . . . . 0.0 110.102 -172.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 36.78 71.79 0.13 Allowed 'General case' 0 C--N 1.359 1.014 0 C-N-CA 129.174 2.99 . . . . 0.0 115.388 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 75.0 t -116.85 135.32 57.58 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.698 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -173.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.43 154.37 50.81 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.473 -1.676 . . . . 0.0 106.473 163.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 7.2 p90 -150.13 141.83 23.62 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 118.536 0.607 . . . . 0.0 109.93 171.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 23.0 t -168.07 118.58 0.8 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.45 155.36 40.6 Favored 'General case' 0 C--N 1.368 1.405 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -173.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.1 156.13 46.02 Favored 'General case' 0 CA--C 1.497 -1.08 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.743 -178.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.541 HD21 HD23 ' C' ' 858' ' ' LEU . 2.4 tm? -133.34 128.33 35.44 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 114.255 -1.339 . . . . 0.0 107.467 -167.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 73.1 m -161.05 10.08 0.09 Allowed 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -161.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.541 HD23 HD21 ' C' ' 856' ' ' LEU . 2.4 pp -27.63 146.44 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.495 0 N-CA-C 117.005 2.224 . . . . 0.0 117.005 161.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -79.85 -46.35 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 CA-C-N 122.099 1.786 . . . . 0.0 113.454 -162.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 47.2 ptt85 -162.28 171.16 17.73 Favored 'General case' 0 CA--C 1.501 -0.942 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -175.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m 0.46 106.78 0.01 OUTLIER 'General case' 0 C--N 1.361 1.109 0 C-N-CA 131.116 3.767 . . . . 0.0 116.77 170.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -103.93 163.33 17.57 Favored Pre-proline 0 N--CA 1.443 -0.79 0 C-N-CA 123.562 0.745 . . . . 0.0 109.316 -175.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.7 -13.54 13.14 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.754 2.302 . . . . 0.0 111.069 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -145.35 4.47 Favored Glycine 0 C--N 1.354 1.573 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.9 m -65.36 139.39 58.56 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.283 1.833 . . . . 0.0 110.475 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.08 147.59 83.54 Favored Pre-proline 0 N--CA 1.442 -0.872 0 C-N-CA 124.882 1.273 . . . . 0.0 112.771 -170.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -100.92 -145.67 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.291 2.661 . . . . 0.0 107.035 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.28 133.85 18.74 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 175.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 41.3 p-10 -116.49 -16.28 10.82 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 123.501 0.72 . . . . 0.0 110.864 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.414 HH21 HD23 ' C' ' 872' ' ' LEU . 11.3 mmm180 -101.86 82.47 2.26 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 112.253 0.464 . . . . 0.0 112.253 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 56.6 t -69.11 96.89 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 C-N-CA 126.706 2.002 . . . . 0.0 106.511 164.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.414 HD23 HH21 ' C' ' 870' ' ' ARG . 1.7 mt -89.64 -36.88 15.01 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 119.159 -1.017 . . . . 0.0 110.902 -175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 54.0 tp -164.06 130.3 3.08 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 100.913 -3.736 . . . . 0.0 100.913 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 41.7 t-20 175.01 60.38 0.0 OUTLIER 'General case' 0 C--N 1.356 0.865 0 CA-C-N 120.621 1.555 . . . . 0.0 107.399 -166.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -62.89 -44.55 95.8 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 -165.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.65 -33.09 7.67 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 118.617 0.644 . . . . 0.0 112.212 -174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 115.86 -65.91 0.31 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 106.193 -2.763 . . . . 0.0 106.193 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 63.66 -80.52 0.03 OUTLIER 'General case' 0 C--N 1.355 0.808 0 C-N-CA 127.983 2.513 . . . . 0.0 113.598 176.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -94.36 120.74 35.05 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 124.856 1.263 . . . . 0.0 107.703 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.93 118.24 70.88 Favored Pre-proline 0 N--CA 1.444 -0.73 0 CA-C-O 115.989 -1.958 . . . . 0.0 106.03 167.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -90.8 -4.02 4.72 Favored 'Trans proline' 0 CA--C 1.509 -0.731 0 CA-C-N 124.786 2.745 . . . . 0.0 108.795 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -79.92 -40.55 27.94 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 125.17 1.388 . . . . 0.0 108.784 -175.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 38.4 p -103.8 -15.15 15.79 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 174.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.12 16.39 69.7 Favored Glycine 0 C--N 1.363 2.053 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 167.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.83 105.8 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.272 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 -167.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.42 ' CB ' HG22 ' C' ' 962' ' ' VAL . 1.3 t80 -97.28 111.67 23.82 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 113.294 -1.775 . . . . 0.0 109.204 -177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 56.3 m -101.32 109.25 21.07 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 170.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.69 110.51 41.98 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.491 -1.242 . . . . 0.0 111.463 171.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.08 -0.64 2.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 CA-C-N 122.946 2.088 . . . . 0.0 108.245 169.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 0.443 HD12 ' H ' ' C' ' 892' ' ' GLY . 3.7 pp -58.18 -43.55 87.57 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 125.333 1.453 . . . . 0.0 114.69 -166.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.72 46.71 16.84 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . 0.443 ' H ' HD12 ' C' ' 890' ' ' LEU . . . -159.03 -163.76 13.51 Favored Glycine 0 N--CA 1.417 -2.571 1 N-CA-C 101.581 -4.608 . . . . 0.0 101.581 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 46.7 ttt-85 -91.32 120.53 32.28 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.476 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -116.41 156.29 27.04 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 124.452 1.101 . . . . 0.0 108.798 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.2 tp -109.9 115.52 29.96 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 123.581 0.752 . . . . 0.0 110.083 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 5.0 tt -116.07 136.06 53.37 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 125.412 1.485 . . . . 0.0 108.226 -174.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.85 119.5 9.78 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 123.633 0.773 . . . . 0.0 109.999 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 154.75 20.94 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.2 t -105.78 122.14 58.93 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.798 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.55 122.24 41.51 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 124.28 1.032 . . . . 0.0 109.142 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 54.3 m -80.44 132.46 35.73 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 125.256 1.423 . . . . 0.0 107.997 173.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.06 -57.29 20.0 Favored Glycine 0 C--N 1.367 2.268 0 C-N-CA 124.819 1.199 . . . . 0.0 113.343 -171.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 45.06 68.57 0.54 Allowed 'General case' 0 C--N 1.358 0.935 0 C-N-CA 127.08 2.152 . . . . 0.0 114.254 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 34.3 ptt85 -73.14 -11.84 60.68 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 124.749 1.22 . . . . 0.0 112.227 -171.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -73.13 -13.94 61.28 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.075 1.75 . . . . 0.0 112.88 -166.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.345 0.3 OUTLIER 118.26 -173.6 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 129.217 3.007 . . . . 0.0 108.398 175.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt 97.24 133.44 0.02 OUTLIER 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 128.061 2.545 . . . . 0.0 106.749 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.79 122.56 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 -176.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -104.4 123.0 46.65 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.913 169.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.27 116.72 17.27 Favored 'General case' 0 C--N 1.369 1.441 0 C-N-CA 128.452 2.701 . . . . 0.0 109.434 -176.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 97.3 t -84.0 113.95 23.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 175.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.6 mt -61.77 148.2 43.78 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 127.021 2.129 . . . . 0.0 112.061 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.27 1.0 OUTLIER -116.34 147.07 41.95 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 126.257 1.823 . . . . 0.0 110.993 175.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.07 139.34 38.14 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 127.133 2.173 . . . . 0.0 108.815 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.7 t 94.74 -10.99 0.11 Allowed 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 128.717 2.807 . . . . 0.0 112.596 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -141.44 -28.35 0.66 Allowed 'General case' 0 C--N 1.36 1.024 0 CA-C-N 119.585 1.084 . . . . 0.0 111.751 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 58.38 170.7 0.06 Allowed 'General case' 0 C--N 1.361 1.07 0 C-N-CA 124.855 1.262 . . . . 0.0 112.191 -162.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.17 -135.52 50.16 Favored Glycine 0 C--N 1.372 2.576 0 O-C-N 119.447 -2.033 . . . . 0.0 109.997 -162.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 39.3 t 56.27 76.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.248 0 C-N-CA 125.551 1.54 . . . . 0.0 111.358 174.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.2 115.54 28.11 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 105.879 -1.897 . . . . 0.0 105.879 -174.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 37.8 ptt85 -102.38 -35.15 8.91 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 113.699 -1.591 . . . . 0.0 108.318 -172.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 93.9 t -99.56 86.37 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 N-CA-C 102.277 -3.231 . . . . 0.0 102.277 162.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -93.93 133.54 37.25 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.657 -173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.2 t -142.21 115.47 8.91 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.675 1.59 . . . . 0.0 107.633 176.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.55 84.48 0.68 Allowed Glycine 0 CA--C 1.487 -1.71 0 N-CA-C 104.628 -3.389 . . . . 0.0 104.628 165.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.574 0 C-N-CA 124.495 1.045 . . . . 0.0 111.028 175.456 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 60.8 mt -120.21 133.68 55.43 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 105.675 -1.972 . . . . 0.0 105.675 -177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.22 162.38 27.56 Favored Glycine 0 C--N 1.347 1.187 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.61 130.6 74.34 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -138.07 146.44 42.94 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.4 m -107.55 -58.29 1.98 Allowed 'General case' 0 C--N 1.356 0.862 0 CA-C-N 118.028 0.377 . . . . 0.0 112.015 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 41.1 tp -77.62 -49.03 15.42 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -165.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 8.0 pt -84.84 -172.76 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 C-N-CA 125.552 1.541 . . . . 0.0 110.274 -173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.476 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -159.61 92.04 1.81 Allowed Pre-proline 0 N--CA 1.431 -1.385 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -167.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.59 91.41 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 O-C-N 117.384 -1.956 . . . . 0.0 108.403 155.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 93.4 mt -120.32 145.43 47.12 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 106.595 -1.632 . . . . 0.0 106.595 175.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -90.86 162.23 14.9 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.46 126.61 30.26 Favored 'General case' 0 C--N 1.374 1.631 0 O-C-N 120.257 -1.527 . . . . 0.0 107.116 163.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.37 -1.13 64.14 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 173.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -54.65 167.93 0.32 Allowed 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 125.574 1.549 . . . . 0.0 114.972 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.3 m -144.7 121.75 11.41 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.42 HG22 ' CB ' ' C' ' 886' ' ' PHE . 2.7 m -100.44 147.73 7.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.815 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 173.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -143.99 137.79 27.96 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.714 1.206 . . . . 0.0 112.059 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 57.4 t -93.14 129.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.371 1.504 0 C-N-CA 126.929 2.092 . . . . 0.0 107.96 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -108.59 133.39 52.78 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 101.98 -3.341 . . . . 0.0 101.98 166.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -130.54 77.5 1.79 Allowed 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 112.953 -1.93 . . . . 0.0 107.587 172.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 61.2 t -159.59 100.34 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.921 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -153.12 66.24 0.78 Allowed 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 132.08 147.07 5.82 Favored Glycine 0 C--N 1.349 1.299 0 N-CA-C 107.486 -2.246 . . . . 0.0 107.486 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -116.75 -16.68 10.64 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.312 0.645 . . . . 0.0 110.059 -175.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -104.61 82.79 1.95 Allowed 'General case' 0 C--N 1.356 0.858 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.6 -167.19 2.02 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -171.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.0 m80 -119.94 155.06 33.51 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -177.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.6 t -93.29 132.13 37.78 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -158.27 151.6 23.12 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.91 113.7 29.94 Favored Pre-proline 0 C--N 1.355 0.814 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 172.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -98.0 174.81 0.55 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 122.26 1.973 . . . . 0.0 107.804 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.49 141.15 48.45 Favored 'General case' 0 C--N 1.353 0.741 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.4 p -135.02 140.95 46.04 Favored 'General case' 0 C--N 1.374 1.67 0 CA-C-N 119.206 0.912 . . . . 0.0 108.893 -172.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.3 mm -115.69 131.13 69.0 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -127.1 105.52 8.63 Favored 'General case' 0 C--N 1.364 1.237 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 29.3 p -100.09 160.12 14.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 124.499 1.12 . . . . 0.0 109.125 171.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.86 108.61 0.25 Allowed Glycine 0 CA--C 1.488 -1.642 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 172.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.23 145.28 45.12 Favored 'General case' 0 C--N 1.348 0.533 0 N-CA-C 114.025 1.121 . . . . 0.0 114.025 -176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 52.3 tp -72.42 126.65 30.37 Favored 'General case' 0 C--N 1.376 1.754 0 C-N-CA 125.015 1.326 . . . . 0.0 110.684 -176.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 36.4 tp -98.23 -58.26 2.02 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.651 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -133.13 128.52 36.28 Favored 'General case' 0 N--CA 1.431 -1.405 0 C-N-CA 126.407 1.883 . . . . 0.0 106.783 -172.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.77 129.38 9.88 Favored Glycine 0 N--CA 1.436 -1.346 0 N-CA-C 103.988 -3.645 . . . . 0.0 103.988 160.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -70.05 130.05 90.18 Favored Pre-proline 0 C--N 1.35 0.606 0 CA-C-O 117.895 -1.05 . . . . 0.0 110.343 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -106.83 84.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.637 0 CA-C-N 121.874 1.705 . . . . 0.0 109.518 -172.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.86 -70.84 0.1 Allowed 'General case' 0 CA--C 1.501 -0.919 0 C-N-CA 130.131 3.372 . . . . 0.0 109.494 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 54.0 mt 49.71 40.1 19.22 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 128.867 2.867 . . . . 0.0 113.983 -175.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -115.14 132.48 56.59 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -130.49 110.53 11.52 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 105.073 -2.195 . . . . 0.0 105.073 176.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.109 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 179.219 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.758 0 N-CA-C 110.073 -0.78 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.38 120.67 24.9 Favored Pre-proline 0 N--CA 1.442 -0.825 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -91.11 -21.44 0.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.201 1.822 . . . . 0.0 109.585 -172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 34.91 71.75 0.11 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 129.258 3.023 . . . . 0.0 115.506 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.1 t -118.03 136.84 53.91 Favored 'Isoleucine or valine' 0 C--N 1.353 0.743 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -172.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.56 155.74 49.99 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 164.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 8.4 p90 -149.13 138.62 21.69 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 174.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.0 t -169.12 117.18 0.64 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.08 153.84 39.37 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.66 155.4 49.18 Favored 'General case' 0 CA--C 1.506 -0.737 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.988 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.414 HD11 HD23 ' A' ' 858' ' ' LEU . 2.0 tm? -130.13 128.82 42.58 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -165.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 50.8 p -161.05 14.15 0.1 Allowed 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -161.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.414 HD23 HD11 ' A' ' 856' ' ' LEU . 3.6 pp -20.95 143.26 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.382 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 159.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.05 -40.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.71 0 CA-C-N 121.971 1.74 . . . . 0.0 112.481 -162.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 38.6 ptt85 -164.19 176.29 9.36 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 21.7 m -16.97 119.3 0.02 OUTLIER 'General case' 0 C--N 1.363 1.183 0 C-N-CA 130.129 3.372 . . . . 0.0 115.481 172.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -119.12 147.18 42.2 Favored Pre-proline 0 N--CA 1.44 -0.946 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -162.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -76.13 -10.0 19.31 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.523 2.149 . . . . 0.0 112.695 -177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.5 -143.3 3.62 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-N 120.338 1.427 . . . . 0.0 111.265 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 32.9 m -82.68 146.82 28.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.206 1.802 . . . . 0.0 108.3 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 17.0 m -63.11 138.74 97.41 Favored Pre-proline 0 C--N 1.356 0.854 0 C-N-CA 125.491 1.517 . . . . 0.0 113.335 -174.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -98.9 -149.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.805 3.003 . . . . 0.0 106.233 171.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -151.49 131.33 13.27 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.3 p-10 -118.08 -15.02 9.92 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.947 -0.47 . . . . 0.0 111.149 -178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -100.81 85.4 2.88 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 121.911 -0.493 . . . . 0.0 112.005 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.52 98.64 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 C-N-CA 126.505 1.922 . . . . 0.0 106.916 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 27.8 mt -87.64 -37.38 16.81 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.008 -173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.0 tp -166.13 129.45 2.06 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 101.398 -3.556 . . . . 0.0 101.398 162.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 28.8 t-20 -175.8 61.8 0.02 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 120.809 1.64 . . . . 0.0 109.814 -167.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -58.84 -44.78 91.03 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 116.738 2.125 . . . . 0.0 116.738 -166.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.08 -31.84 8.26 Favored Glycine 0 C--N 1.354 1.579 0 CA-C-N 118.949 0.795 . . . . 0.0 112.334 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.34 -58.87 0.39 Allowed Glycine 0 C--N 1.352 1.429 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 63.58 -81.7 0.03 OUTLIER 'General case' 0 C--N 1.355 0.828 0 C-N-CA 128.204 2.602 . . . . 0.0 114.053 174.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -97.05 119.99 36.56 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 124.775 1.23 . . . . 0.0 108.35 -177.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -78.84 117.54 67.28 Favored Pre-proline 0 N--CA 1.444 -0.756 0 N-CA-C 104.765 -2.309 . . . . 0.0 104.765 171.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -92.84 2.58 3.63 Favored 'Trans proline' 0 CA--C 1.509 -0.77 0 CA-C-N 125.411 2.968 . . . . 0.0 109.451 -166.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -80.74 -45.68 16.68 Favored 'General case' 0 CA--C 1.5 -0.953 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -174.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 28.2 p -106.3 -12.89 15.55 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.782 1.233 . . . . 0.0 109.055 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.55 27.63 38.46 Favored Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 163.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 24.8 t -100.02 103.57 14.95 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.594 0 N-CA-C 101.007 -3.701 . . . . 0.0 101.007 -165.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.62 112.24 24.74 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 112.408 -2.178 . . . . 0.0 108.922 -175.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 87.5 m -100.66 107.97 19.73 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 169.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.78 109.92 38.02 Favored Pre-proline 0 C--N 1.355 0.837 0 CA-C-O 117.23 -1.366 . . . . 0.0 110.916 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.12 -2.44 5.46 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.845 2.364 . . . . 0.0 108.86 166.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -45.47 -57.58 4.0 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 130.329 3.452 . . . . 0.0 114.771 -169.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.99 64.83 1.32 Allowed 'General case' 0 C--N 1.364 1.215 0 CA-C-O 121.759 0.79 . . . . 0.0 112.819 171.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.06 -166.75 32.66 Favored Glycine 0 N--CA 1.41 -3.046 1 N-CA-C 101.467 -4.653 . . . . 0.0 101.467 -176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 73.0 ttt-85 -91.75 122.56 34.42 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 114.279 -0.96 . . . . 0.0 108.785 172.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.493 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.2 t80 -115.3 145.73 42.19 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 36.8 tp -110.14 115.69 30.19 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 123.391 0.676 . . . . 0.0 109.315 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -113.78 139.48 49.09 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 126.075 1.75 . . . . 0.0 108.843 -172.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 70.1 m -144.12 119.58 10.32 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 123.363 0.665 . . . . 0.0 109.716 175.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.22 21.55 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.3 t -104.92 121.26 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.76 123.25 43.83 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.292 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 43.4 m -84.07 131.76 34.77 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 125.657 1.583 . . . . 0.0 106.936 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.17 -57.56 17.85 Favored Glycine 0 C--N 1.363 2.057 0 C-N-CA 124.595 1.093 . . . . 0.0 113.53 -168.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 56.4 m170 39.39 71.44 0.17 Allowed 'General case' 0 C--N 1.358 0.976 0 C-N-CA 127.12 2.168 . . . . 0.0 114.626 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -70.87 -10.54 59.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.936 1.694 . . . . 0.0 111.957 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -73.33 -17.92 61.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 125.578 1.551 . . . . 0.0 112.746 -168.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.326 12.2 pt-20 124.52 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 127.603 2.361 . . . . 0.0 108.223 175.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.4 tttt 100.64 132.34 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.263 0 C-N-CA 128.129 2.571 . . . . 0.0 107.163 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.32 124.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -173.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -108.02 123.62 48.94 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.163 1.785 . . . . 0.0 112.11 173.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.57 115.09 14.29 Favored 'General case' 0 C--N 1.364 1.208 0 C-N-CA 128.121 2.569 . . . . 0.0 109.553 -178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 90.8 t -87.66 113.77 25.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.891 0 N-CA-C 106.079 -1.823 . . . . 0.0 106.079 173.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.5 mt -62.01 146.3 50.57 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 126.578 1.951 . . . . 0.0 111.452 175.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.272 0.7 OUTLIER -114.44 147.28 39.51 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 126.671 1.988 . . . . 0.0 109.787 178.421 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.489 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -79.79 140.79 36.74 Favored 'General case' 0 N--CA 1.425 -1.706 0 C-N-CA 125.728 1.611 . . . . 0.0 110.0 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.329 24.2 p 92.61 3.86 0.07 Allowed 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 129.856 3.262 . . . . 0.0 114.227 173.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -148.24 -26.18 0.34 Allowed 'General case' 0 C--N 1.357 0.906 0 CA-C-N 119.309 0.959 . . . . 0.0 111.065 179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.51 168.17 0.05 Allowed 'General case' 0 C--N 1.362 1.123 0 C-N-CA 125.729 1.612 . . . . 0.0 111.835 -162.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.86 -135.0 49.31 Favored Glycine 0 C--N 1.369 2.396 0 O-C-N 119.615 -1.928 . . . . 0.0 109.233 -161.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 41.2 t 55.96 79.16 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.222 0 C-N-CA 125.952 1.701 . . . . 0.0 110.992 175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.52 113.99 26.41 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 24.1 ptt85 -103.73 -37.1 7.62 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.014 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -99.27 87.3 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 102.689 -3.078 . . . . 0.0 102.689 166.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -95.06 130.43 41.74 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.688 -171.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -143.56 115.08 8.08 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 125.353 1.461 . . . . 0.0 108.129 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.3 84.7 0.7 Allowed Glycine 0 CA--C 1.484 -1.865 0 N-CA-C 103.642 -3.783 . . . . 0.0 103.642 165.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.626 0 C-N-CA 124.925 1.25 . . . . 0.0 111.302 173.741 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 32.0 m . . . . . 0 CA--C 1.512 -0.5 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 61.1 mt -116.47 133.84 55.55 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 -169.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -135.37 161.32 24.67 Favored Glycine 0 CA--C 1.49 -1.527 0 N-CA-C 108.541 -1.824 . . . . 0.0 108.541 -175.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -122.31 126.77 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 172.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 29.8 p90 -138.84 149.56 45.05 Favored 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 71.2 m -106.65 -54.36 2.48 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.456 0.302 . . . . 0.0 110.908 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.02 -49.9 9.08 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -162.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.52 -175.97 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.381 1.472 . . . . 0.0 110.687 -174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.504 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -159.33 93.04 1.82 Allowed Pre-proline 0 N--CA 1.44 -0.949 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -164.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -76.3 92.31 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.842 0 O-C-N 116.869 -2.227 . . . . 0.0 110.152 158.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.504 HD13 ' HB2' ' A' ' 954' ' ' LEU . 6.8 mp -120.85 138.93 53.82 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 -93.21 158.03 15.97 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 119.362 -0.935 . . . . 0.0 108.843 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.98 123.11 21.28 Favored 'General case' 0 C--N 1.373 1.597 0 CA-C-N 119.896 1.225 . . . . 0.0 108.997 176.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.13 73.02 Favored Glycine 0 C--N 1.345 1.071 0 C-N-CA 126.541 2.019 . . . . 0.0 111.851 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -73.17 174.96 7.23 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.359 1.064 . . . . 0.0 110.521 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 89.7 m -142.84 125.12 15.49 Favored 'General case' 0 CA--C 1.502 -0.89 0 O-C-N 121.334 -0.854 . . . . 0.0 108.821 -160.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.489 HG13 HH11 ' A' ' 914' ' ' ARG . 30.7 m -95.43 149.83 4.43 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-O 121.445 0.64 . . . . 0.0 109.627 171.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -141.39 138.93 33.34 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 126.234 1.814 . . . . 0.0 111.414 -173.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 98.6 t -92.05 129.18 43.09 Favored 'Isoleucine or valine' 0 C--N 1.368 1.381 0 C-N-CA 126.484 1.914 . . . . 0.0 106.268 -177.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -107.05 132.34 53.08 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 6.5 tt -129.89 78.09 1.83 Allowed 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 51.3 t -160.98 100.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.973 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -154.32 66.59 0.7 Allowed 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 105.2 -2.148 . . . . 0.0 105.2 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.16 146.89 6.91 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 107.567 -2.213 . . . . 0.0 107.567 177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -114.08 -31.89 6.21 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -173.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -90.58 86.97 6.55 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.89 -167.18 2.1 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -122.98 157.62 32.26 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 15.7 t -91.6 133.9 35.14 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.66 151.58 22.34 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 105.331 -2.1 . . . . 0.0 105.331 -176.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.52 111.16 19.24 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 174.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -98.58 173.23 0.51 Allowed 'Trans proline' 0 CA--C 1.507 -0.874 0 C-N-CA 121.742 1.628 . . . . 0.0 108.317 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.9 mp -116.58 141.03 48.72 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 24.3 p -138.78 139.71 38.36 Favored 'General case' 0 C--N 1.374 1.66 0 CA-C-N 119.302 0.956 . . . . 0.0 108.513 -170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.0 mm -118.17 130.25 73.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 N-CA-C 106.044 -1.835 . . . . 0.0 106.044 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -126.21 106.48 9.58 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 -175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 37.4 p -99.96 160.81 14.03 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 124.465 1.106 . . . . 0.0 109.678 171.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.97 109.49 0.27 Allowed Glycine 0 C--N 1.358 1.754 0 C-N-CA 119.385 -1.388 . . . . 0.0 110.379 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.94 147.75 43.69 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 54.3 tp -72.43 123.29 22.79 Favored 'General case' 0 C--N 1.376 1.755 0 C-N-CA 126.092 1.757 . . . . 0.0 109.146 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.6 tp -100.02 -58.0 2.01 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -133.23 127.44 33.72 Favored 'General case' 0 N--CA 1.424 -1.726 0 C-N-CA 127.053 2.141 . . . . 0.0 106.383 -174.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.79 129.73 10.0 Favored Glycine 0 CA--C 1.496 -1.144 0 N-CA-C 104.213 -3.555 . . . . 0.0 104.213 161.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.5 m-20 -69.03 131.35 90.83 Favored Pre-proline 0 C--N 1.353 0.744 0 CA-C-N 118.435 1.118 . . . . 0.0 110.469 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -105.76 82.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 CA-C-N 121.68 1.636 . . . . 0.0 109.468 -169.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.91 -72.73 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.205 3.402 . . . . 0.0 109.19 177.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 81.2 mt 50.87 37.68 17.91 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 129.377 3.071 . . . . 0.0 114.098 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -110.54 134.1 52.69 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.96 107.95 8.61 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.129 0 N-CA-C 114.914 1.449 . . . . 0.0 114.914 -178.633 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 110.055 -0.787 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 46.5 t -125.03 121.01 25.38 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -91.63 -21.73 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 CA-C-N 122.139 1.8 . . . . 0.0 109.674 -172.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 35.46 71.97 0.11 Allowed 'General case' 0 C--N 1.361 1.079 0 C-N-CA 129.611 3.164 . . . . 0.0 115.127 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 86.1 t -117.72 136.3 55.32 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.6 155.5 50.36 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 165.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 9.5 p90 -149.54 139.79 22.23 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 174.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 26.6 t -169.11 117.8 0.66 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -176.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -121.51 154.28 36.85 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.29 155.4 47.76 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.905 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -130.59 127.72 39.58 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -165.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 51.3 p -160.9 13.8 0.1 Allowed 'General case' 0 N--CA 1.431 -1.381 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.233 -161.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.6 pp -20.82 143.45 0.02 OUTLIER Pre-proline 0 C--N 1.369 1.456 0 N-CA-C 117.456 2.391 . . . . 0.0 117.456 158.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -84.35 -40.94 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 121.98 1.743 . . . . 0.0 112.48 -163.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -164.29 176.31 9.26 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -174.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 21.2 m -16.98 119.33 0.02 OUTLIER 'General case' 0 C--N 1.364 1.211 0 C-N-CA 130.156 3.382 . . . . 0.0 115.451 171.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -119.2 147.37 42.77 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -162.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -76.27 -9.87 19.08 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.533 2.155 . . . . 0.0 112.695 -177.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.59 -143.58 3.7 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 120.287 1.403 . . . . 0.0 111.262 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 33.0 m -81.92 147.04 29.48 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 126.234 1.814 . . . . 0.0 108.326 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 17.4 m -63.08 138.46 97.33 Favored Pre-proline 0 C--N 1.355 0.841 0 C-N-CA 125.413 1.485 . . . . 0.0 113.192 -174.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -99.62 -150.07 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 123.723 2.949 . . . . 0.0 106.121 171.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -150.88 130.71 13.24 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.7 p-10 -116.47 -14.49 10.94 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.427 0.691 . . . . 0.0 110.363 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -101.31 84.07 2.57 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 122.038 -0.414 . . . . 0.0 111.842 178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.83 97.64 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 126.438 1.895 . . . . 0.0 106.461 166.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 12.6 mt -87.98 -38.03 15.87 Favored 'General case' 0 C--N 1.357 0.901 0 C-N-CA 119.651 -0.82 . . . . 0.0 110.714 -173.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.3 tp -165.3 129.3 2.34 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 101.266 -3.605 . . . . 0.0 101.266 165.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' B' ' 852' ' ' PHE . 32.1 t-20 179.03 62.2 0.01 OUTLIER 'General case' 0 C--N 1.356 0.885 0 CA-C-N 120.447 1.476 . . . . 0.0 109.214 -164.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -59.08 -44.54 91.9 Favored 'General case' 0 C--N 1.362 1.122 0 N-CA-C 116.573 2.064 . . . . 0.0 116.573 -167.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.88 -32.06 8.22 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 118.768 0.713 . . . . 0.0 112.242 -174.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.16 -58.67 0.39 Allowed Glycine 0 C--N 1.353 1.515 0 N-CA-C 107.051 -2.42 . . . . 0.0 107.051 -178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 63.8 -82.08 0.03 OUTLIER 'General case' 0 C--N 1.356 0.862 0 C-N-CA 128.13 2.572 . . . . 0.0 114.062 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -97.61 119.82 36.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 C-N-CA 125.173 1.389 . . . . 0.0 108.308 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -78.27 117.92 69.09 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-O 115.459 -2.21 . . . . 0.0 105.309 171.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -91.79 2.31 4.24 Favored 'Trans proline' 0 CA--C 1.51 -0.703 0 CA-C-N 125.507 3.002 . . . . 0.0 109.671 -168.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -80.41 -44.53 19.19 Favored 'General case' 0 CA--C 1.5 -0.952 0 C-N-CA 124.606 1.163 . . . . 0.0 108.704 -174.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 26.8 p -108.59 -13.19 14.87 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 125.085 1.354 . . . . 0.0 108.651 174.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 28.02 36.15 Favored Glycine 0 C--N 1.361 1.922 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 163.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 26.2 t -100.24 103.83 15.32 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.605 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 -164.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.402 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.4 OUTLIER -101.23 112.46 24.97 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 112.586 -2.097 . . . . 0.0 108.973 -176.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 88.7 m -100.79 108.13 19.86 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 169.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.96 110.13 39.87 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.288 -1.339 . . . . 0.0 111.138 169.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -89.95 -1.04 5.66 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.767 2.311 . . . . 0.0 108.843 165.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -46.87 -55.46 7.96 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 129.832 3.253 . . . . 0.0 114.87 -169.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.45 58.93 2.78 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -170.23 -165.08 27.03 Favored Glycine 0 N--CA 1.412 -2.933 1 N-CA-C 102.461 -4.255 . . . . 0.0 102.461 -176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 -92.08 121.87 34.04 Favored 'General case' 0 CA--C 1.507 -0.678 0 CA-C-N 113.777 -1.211 . . . . 0.0 107.868 175.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.441 ' H ' HD11 ' B' ' 954' ' ' LEU . 1.7 t80 -116.79 146.43 42.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -173.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.8 tp -111.51 114.86 28.24 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -113.35 139.37 48.92 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 126.28 1.832 . . . . 0.0 108.539 -174.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -143.79 119.74 10.65 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.194 0.598 . . . . 0.0 109.703 176.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 154.58 21.01 Favored 'General case' 0 C--N 1.364 1.224 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.49 122.02 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -102.4 121.81 43.05 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.145 0.978 . . . . 0.0 109.19 -171.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 40.1 m -82.66 132.0 35.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 125.646 1.578 . . . . 0.0 107.541 175.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.29 -57.72 17.68 Favored Glycine 0 C--N 1.364 2.13 0 C-N-CA 124.758 1.171 . . . . 0.0 113.793 -169.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.1 m170 38.63 71.74 0.15 Allowed 'General case' 0 C--N 1.36 1.045 0 C-N-CA 127.234 2.214 . . . . 0.0 114.774 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -71.0 -10.67 60.16 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.046 1.738 . . . . 0.0 112.043 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -73.82 -15.59 61.17 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 125.86 1.664 . . . . 0.0 112.908 -167.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.2 pt-20 122.1 179.4 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 127.856 2.462 . . . . 0.0 108.107 176.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.3 tttt 101.34 131.87 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 128.074 2.55 . . . . 0.0 107.088 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 99.8 t -100.26 126.42 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -110.69 122.85 48.82 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 113.966 -1.47 . . . . 0.0 113.093 175.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.81 115.74 15.67 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.842 2.457 . . . . 0.0 109.596 -176.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 76.9 t -88.48 113.88 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 172.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 148.53 43.39 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.093 2.157 . . . . 0.0 111.493 176.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.275 0.8 OUTLIER -114.6 147.9 38.85 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 126.955 2.102 . . . . 0.0 109.715 178.5 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.512 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.73 140.13 35.73 Favored 'General case' 0 N--CA 1.424 -1.775 0 C-N-CA 125.652 1.581 . . . . 0.0 109.718 178.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.327 24.0 p 92.81 1.64 0.09 Allowed 'General case' 0 CA--C 1.508 -0.661 0 C-N-CA 129.85 3.26 . . . . 0.0 114.363 174.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -147.28 -25.98 0.39 Allowed 'General case' 0 C--N 1.357 0.92 0 CA-C-N 119.527 1.058 . . . . 0.0 111.408 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 58.55 168.01 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 125.678 1.591 . . . . 0.0 111.692 -162.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.61 -134.54 47.39 Favored Glycine 0 C--N 1.367 2.266 0 O-C-N 119.757 -1.839 . . . . 0.0 109.142 -163.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 44.6 t 54.49 80.48 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 126.314 1.846 . . . . 0.0 111.008 176.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.28 114.2 26.67 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 22.6 ptt85 -103.97 -38.22 7.07 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 113.298 -1.774 . . . . 0.0 108.757 -170.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.6 t -99.55 87.01 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.615 -3.105 . . . . 0.0 102.615 166.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -95.4 130.48 42.19 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -172.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.0 t -142.43 115.77 8.99 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.038 1.335 . . . . 0.0 107.813 173.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.19 84.58 0.71 Allowed Glycine 0 N--CA 1.429 -1.796 0 N-CA-C 103.921 -3.672 . . . . 0.0 103.921 165.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 C-N-CA 125.172 1.367 . . . . 0.0 111.289 174.209 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 49.8 m . . . . . 0 CA--C 1.508 -0.648 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 62.9 mt -116.95 134.27 54.96 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -170.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.62 26.98 Favored Glycine 0 CA--C 1.491 -1.417 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.01 128.83 75.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -138.1 151.51 47.86 Favored 'General case' 0 CA--C 1.504 -0.814 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 68.7 m -117.24 -38.04 3.43 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 119.343 -0.361 . . . . 0.0 111.126 177.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 21.5 tp -91.35 -53.61 4.27 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 119.071 0.85 . . . . 0.0 111.947 -168.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.22 177.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.85 1.26 . . . . 0.0 109.858 -177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.47 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -161.08 95.13 1.41 Allowed Pre-proline 0 C--N 1.358 0.954 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 -163.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.88 95.74 1.08 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.945 2.43 . . . . 0.0 111.181 161.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' B' ' 954' ' ' LEU . 9.5 mp -119.77 139.85 51.67 Favored 'General case' 0 C--N 1.355 0.82 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 175.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -93.92 159.15 15.31 Favored 'General case' 0 C--N 1.364 1.196 0 C-N-CA 119.443 -0.903 . . . . 0.0 109.841 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.82 122.95 21.61 Favored 'General case' 0 C--N 1.375 1.695 0 CA-C-N 120.058 1.299 . . . . 0.0 108.983 176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.1 -11.51 71.94 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.413 1.959 . . . . 0.0 111.681 170.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -73.44 174.56 8.01 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 124.321 1.048 . . . . 0.0 109.993 -178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 94.0 m -143.09 125.06 15.2 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -158.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.512 HG13 HH11 ' B' ' 914' ' ' ARG . 27.9 m -96.37 150.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 CA-C-O 121.567 0.698 . . . . 0.0 110.244 172.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 14.0 t -140.95 139.02 34.2 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 126.518 1.927 . . . . 0.0 111.44 -176.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.2 t -91.63 129.53 42.18 Favored 'Isoleucine or valine' 0 C--N 1.367 1.354 0 C-N-CA 127.261 2.224 . . . . 0.0 106.516 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -106.79 132.36 52.85 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 100.707 -3.812 . . . . 0.0 100.707 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.2 tt -129.59 77.63 1.8 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 105.723 -1.955 . . . . 0.0 105.723 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 50.2 t -160.2 101.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.961 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 176.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -153.48 66.38 0.76 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 125.63 145.66 6.52 Favored Glycine 0 CA--C 1.492 -1.383 0 N-CA-C 107.463 -2.255 . . . . 0.0 107.463 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -112.87 -30.92 6.88 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.5 86.76 6.15 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.64 -165.76 1.83 Allowed 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -172.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -123.51 157.84 32.68 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 16.4 t -91.43 133.22 35.66 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -158.64 151.66 22.48 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.43 110.78 19.37 Favored Pre-proline 0 C--N 1.353 0.753 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -98.13 173.09 0.58 Allowed 'Trans proline' 0 CA--C 1.507 -0.836 0 C-N-CA 121.812 1.675 . . . . 0.0 108.172 -179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.51 139.28 50.21 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.8 p -138.02 138.13 38.54 Favored 'General case' 0 C--N 1.374 1.67 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.5 mm -117.24 130.71 71.71 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -127.05 106.32 9.19 Favored 'General case' 0 C--N 1.36 1.024 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -174.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 32.7 p -100.63 160.94 13.94 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.494 1.117 . . . . 0.0 109.771 171.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.21 109.55 0.27 Allowed Glycine 0 C--N 1.358 1.781 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 174.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.82 149.62 41.77 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -175.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 58.7 tp -71.85 124.14 24.19 Favored 'General case' 0 C--N 1.378 1.836 0 C-N-CA 125.841 1.656 . . . . 0.0 109.718 -179.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 57.8 tp -99.33 -59.06 1.79 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 175.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -133.33 127.22 33.07 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 125.916 1.686 . . . . 0.0 106.489 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.81 130.05 10.11 Favored Glycine 0 CA--C 1.495 -1.158 0 N-CA-C 104.311 -3.516 . . . . 0.0 104.311 161.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -69.12 131.27 90.71 Favored Pre-proline 0 C--N 1.351 0.652 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.205 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -105.48 81.71 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 121.695 1.641 . . . . 0.0 109.054 -170.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.31 -72.23 0.09 Allowed 'General case' 0 CA--C 1.5 -0.951 0 C-N-CA 130.191 3.396 . . . . 0.0 109.139 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 80.1 mt 49.95 40.89 22.09 Favored 'General case' 0 C--N 1.346 0.45 0 C-N-CA 129.126 2.97 . . . . 0.0 113.785 -175.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -113.96 133.54 55.41 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -133.34 107.78 8.31 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 178.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.13 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 -178.767 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.455 -0.76 0 N-CA-C 110.053 -0.787 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 42.5 t -122.51 114.92 29.99 Favored Pre-proline 0 N--CA 1.44 -0.943 0 N-CA-C 103.958 -2.608 . . . . 0.0 103.958 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -87.24 -24.97 1.15 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 CA-C-N 121.689 1.639 . . . . 0.0 109.826 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 41.55 66.5 0.68 Allowed 'General case' 0 C--N 1.359 0.988 0 C-N-CA 128.192 2.597 . . . . 0.0 114.868 175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 87.6 t -120.86 133.74 66.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -175.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.91 153.01 50.85 Favored 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 166.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.464 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 10.3 p90 -149.83 139.55 21.73 Favored 'General case' 0 C--N 1.362 1.145 0 CA-C-N 118.886 0.766 . . . . 0.0 109.82 175.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 22.7 t -169.44 120.2 0.69 Allowed 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.25 -0.906 . . . . 0.0 108.8 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.51 153.05 34.82 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 105.357 -2.09 . . . . 0.0 105.357 -174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.507 ' HB2' HD11 ' C' ' 872' ' ' LEU . . . -139.08 158.08 44.82 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 121.685 0.755 . . . . 0.0 110.493 177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.525 HD21 HD23 ' C' ' 858' ' ' LEU . 2.9 tm? -139.89 130.55 25.79 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -164.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 60.1 m -159.02 15.62 0.17 Allowed 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 -170.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.525 HD23 HD21 ' C' ' 856' ' ' LEU . 2.0 pp -25.8 142.79 0.04 OUTLIER Pre-proline 0 C--N 1.372 1.546 0 N-CA-C 117.059 2.244 . . . . 0.0 117.059 161.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -79.84 -44.05 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 CA-C-N 122.222 1.829 . . . . 0.0 113.529 -161.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 41.3 ptt85 -162.47 175.72 11.2 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 -176.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 13.1 m -4.63 113.06 0.01 OUTLIER 'General case' 0 C--N 1.365 1.272 0 C-N-CA 130.673 3.589 . . . . 0.0 116.774 171.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 160.91 24.37 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -173.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -82.4 -17.75 7.44 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.418 2.079 . . . . 0.0 110.533 -177.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.4 -141.29 3.12 Favored Glycine 0 C--N 1.353 1.508 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 11.8 m -65.53 143.31 57.73 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 126.029 1.732 . . . . 0.0 110.061 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 60.0 t -96.75 132.65 25.71 Favored Pre-proline 0 N--CA 1.437 -1.098 0 C-N-CA 124.37 1.068 . . . . 0.0 110.447 -159.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -95.37 -151.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 124.135 3.223 . . . . 0.0 109.334 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -147.1 136.12 22.37 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -114.76 -17.78 11.52 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 123.669 0.788 . . . . 0.0 110.9 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.419 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 26.1 mmm180 -102.48 84.43 2.44 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.166 0.508 . . . . 0.0 111.125 -178.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.68 98.22 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 C-N-CA 126.699 1.999 . . . . 0.0 106.868 167.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' C' ' 855' ' ' ALA . 8.8 mt -85.81 -39.43 17.09 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.967 -173.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.9 tp -166.96 128.98 1.7 Allowed 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 100.598 -3.853 . . . . 0.0 100.598 167.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.1 t-20 178.71 61.91 0.01 OUTLIER 'General case' 0 CA--C 1.5 -0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 108.333 -164.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -60.1 -44.42 94.84 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 116.215 1.931 . . . . 0.0 116.215 -166.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.26 -29.67 11.02 Favored Glycine 0 C--N 1.356 1.661 0 CA-C-N 118.716 0.689 . . . . 0.0 112.165 -175.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.17 -57.76 0.42 Allowed Glycine 0 C--N 1.353 1.521 0 N-CA-C 107.308 -2.317 . . . . 0.0 107.308 -178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 62.91 -82.63 0.02 OUTLIER 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.245 2.618 . . . . 0.0 113.982 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -97.53 120.64 38.28 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 125.861 1.665 . . . . 0.0 108.677 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -81.97 117.87 69.93 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -93.36 5.96 2.95 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 CA-C-N 124.91 2.789 . . . . 0.0 109.887 -167.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -79.69 -46.07 17.8 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -176.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -105.67 -13.14 15.66 Favored 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.877 1.271 . . . . 0.0 108.327 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.8 25.98 43.63 Favored Glycine 0 C--N 1.362 2.019 0 N-CA-C 110.614 -0.994 . . . . 0.0 110.614 162.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 70.0 t -99.53 104.22 15.77 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.431 0 N-CA-C 102.05 -3.315 . . . . 0.0 102.05 -164.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -98.53 112.37 24.43 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 111.921 -2.4 . . . . 0.0 109.233 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 90.7 m -100.32 109.24 21.43 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 171.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.82 108.86 30.7 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.262 -1.352 . . . . 0.0 110.968 171.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -90.11 -3.86 5.28 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 122.528 2.152 . . . . 0.0 108.43 166.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 68.4 mt -54.51 -52.29 62.44 Favored 'General case' 0 CA--C 1.499 -1.019 0 C-N-CA 127.736 2.414 . . . . 0.0 114.418 -165.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.58 68.15 0.82 Allowed 'General case' 0 C--N 1.367 1.328 0 CA-C-O 122.076 0.941 . . . . 0.0 111.61 169.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.88 -167.55 34.95 Favored Glycine 0 N--CA 1.405 -3.433 1 N-CA-C 102.498 -4.241 . . . . 0.0 102.498 -171.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . 0.443 ' HE ' HG22 ' C' ' 953' ' ' ILE . 70.4 ttt-85 -92.03 121.21 33.38 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 113.275 -1.463 . . . . 0.0 108.643 172.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.591 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.8 t80 -117.78 145.61 44.39 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -173.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 51.6 tp -110.14 113.84 26.86 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.8 tt -112.0 137.61 49.77 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 125.318 1.447 . . . . 0.0 108.925 -175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.8 m -144.29 119.27 10.0 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.398 0.679 . . . . 0.0 109.919 175.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.15 153.74 22.73 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 91.1 t -101.7 122.64 54.12 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 -179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.6 mt -97.59 121.87 40.0 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.026 0.93 . . . . 0.0 109.355 -175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.9 130.56 35.39 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -54.82 -56.84 20.71 Favored Glycine 0 C--N 1.366 2.247 0 C-N-CA 125.356 1.455 . . . . 0.0 113.354 -172.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 42.3 65.67 0.86 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.633 2.373 . . . . 0.0 114.181 174.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.39 -7.24 50.83 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 125.076 1.35 . . . . 0.0 112.178 -170.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -71.38 -14.09 62.06 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 126.235 1.814 . . . . 0.0 112.187 -171.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.338 6.1 pt-20 113.73 179.53 0.0 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.108 2.563 . . . . 0.0 108.051 174.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.9 tttt 109.42 137.46 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 128.56 2.744 . . . . 0.0 105.856 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 97.8 t -98.4 123.64 51.06 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 105.116 -2.179 . . . . 0.0 105.116 -175.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -103.67 131.68 50.62 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-N 113.44 -1.709 . . . . 0.0 110.361 172.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.05 114.22 3.64 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.095 1.358 . . . . 0.0 110.519 -173.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.27 117.74 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 125.867 1.667 . . . . 0.0 108.999 178.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.6 mt -62.53 143.5 57.12 Favored 'General case' 0 N--CA 1.439 -1.002 0 C-N-CA 125.74 1.616 . . . . 0.0 110.519 173.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 1.4 p -113.78 147.79 37.68 Favored 'General case' 0 CA--C 1.495 -1.152 0 C-N-CA 126.627 1.971 . . . . 0.0 107.795 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.528 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -78.73 137.35 37.73 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 114.095 -1.412 . . . . 0.0 107.891 173.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 2.9 t 97.93 -11.48 0.06 Allowed 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 128.797 2.839 . . . . 0.0 112.341 172.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -142.86 -27.63 0.58 Allowed 'General case' 0 CA--C 1.5 -0.96 0 CA-C-N 119.256 0.934 . . . . 0.0 111.501 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 59.04 169.09 0.06 Allowed 'General case' 0 C--N 1.361 1.094 0 C-N-CA 124.933 1.293 . . . . 0.0 112.254 -164.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.84 -130.74 51.46 Favored Glycine 0 C--N 1.376 2.79 0 O-C-N 119.702 -1.874 . . . . 0.0 110.12 -164.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 51.97 73.15 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.367 1.329 0 C-N-CA 126.191 1.797 . . . . 0.0 111.37 173.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.82 28.37 Favored 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -101.18 -30.89 11.3 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.114 -1.403 . . . . 0.0 108.518 -173.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.4 t -100.18 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 103.055 -2.942 . . . . 0.0 103.055 165.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -95.22 131.23 41.51 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 120.903 0.382 . . . . 0.0 111.184 -175.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.2 t -143.88 115.07 7.93 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 125.283 1.433 . . . . 0.0 107.812 172.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.17 85.02 0.72 Allowed Glycine 0 CA--C 1.482 -2.022 0 N-CA-C 104.281 -3.528 . . . . 0.0 104.281 169.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.602 0 C-N-CA 125.183 1.373 . . . . 0.0 110.892 173.557 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.448 -0.542 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.6 mt -122.46 134.56 54.58 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.93 163.31 27.0 Favored Glycine 0 CA--C 1.491 -1.459 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.76 132.24 70.79 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -137.46 149.81 47.12 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 49.7 m -121.33 -36.99 2.98 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 118.398 0.544 . . . . 0.0 111.802 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 29.0 tp -89.47 -53.77 4.39 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.533 0.606 . . . . 0.0 112.045 -165.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.443 HG22 ' HE ' ' C' ' 893' ' ' ARG . 25.4 pt -89.83 -162.44 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.846 0 C-N-CA 125.079 1.352 . . . . 0.0 108.871 -178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.591 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -165.26 88.15 0.98 Allowed Pre-proline 0 N--CA 1.437 -1.08 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 -166.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -73.94 88.18 1.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 CA-C-N 122.422 1.901 . . . . 0.0 109.133 159.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.2 mp -123.8 146.18 48.53 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.479 2.312 . . . . 0.0 105.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -92.71 159.98 15.18 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 119.213 0.915 . . . . 0.0 109.381 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.72 122.66 21.86 Favored 'General case' 0 C--N 1.374 1.645 0 CA-C-N 120.335 1.425 . . . . 0.0 108.954 174.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.16 -11.75 71.34 Favored Glycine 0 C--N 1.346 1.134 0 C-N-CA 125.95 1.738 . . . . 0.0 111.042 167.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.99 175.44 5.14 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 123.088 0.555 . . . . 0.0 111.075 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 17.1 p -141.83 127.96 19.69 Favored 'General case' 0 CA--C 1.502 -0.902 0 C-N-CA 123.58 0.752 . . . . 0.0 109.325 -157.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.528 HG13 HH11 ' C' ' 914' ' ' ARG . 17.1 m -93.41 150.19 4.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.8 t -139.72 136.5 34.26 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.882 1.273 . . . . 0.0 112.089 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.95 129.08 44.8 Favored 'Isoleucine or valine' 0 C--N 1.373 1.603 0 C-N-CA 126.486 1.914 . . . . 0.0 106.753 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -107.61 132.37 53.37 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 171.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 7.2 tt -131.41 78.52 1.83 Allowed 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 113.04 -1.891 . . . . 0.0 106.185 174.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -160.8 100.38 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.887 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 177.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 89.3 mmm -152.16 66.23 0.84 Allowed 'General case' 0 CA--C 1.498 -1.056 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.79 143.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -112.8 -22.37 10.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 123.462 0.705 . . . . 0.0 109.982 -172.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 6.5 tt -98.6 86.23 3.53 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.74 -164.62 1.64 Allowed 'General case' 0 CA--C 1.503 -0.841 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -173.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -121.66 153.18 38.48 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 20.1 t -89.96 132.2 35.46 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 -176.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -157.93 151.28 23.36 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 105.318 -2.105 . . . . 0.0 105.318 -176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.45 115.34 19.74 Favored Pre-proline 0 C--N 1.355 0.823 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -100.32 171.67 0.38 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 N-CA-C 108.279 -1.47 . . . . 0.0 108.279 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.98 138.87 49.2 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.9 p -137.33 137.55 39.04 Favored 'General case' 0 C--N 1.376 1.746 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -168.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 36.0 mm -115.43 131.04 68.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -125.26 106.38 9.83 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 32.7 p -100.91 163.94 12.06 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.16 1.384 . . . . 0.0 110.222 172.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.91 111.19 0.32 Allowed Glycine 0 C--N 1.36 1.865 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 174.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.08 47.47 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 58.0 tp -78.18 124.42 28.05 Favored 'General case' 0 C--N 1.379 1.88 0 C-N-CA 124.516 1.126 . . . . 0.0 108.135 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 35.1 tp -97.1 -57.2 2.33 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.056 -176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -131.18 128.49 40.11 Favored 'General case' 0 N--CA 1.43 -1.464 0 N-CA-C 105.527 -2.027 . . . . 0.0 105.527 -174.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 131.05 10.51 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 103.412 -3.875 . . . . 0.0 103.412 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -70.41 131.93 88.03 Favored Pre-proline 0 C--N 1.351 0.645 0 CA-C-O 117.713 -1.137 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -105.84 81.91 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.427 0 CA-C-N 121.903 1.715 . . . . 0.0 109.847 -171.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 78.79 -72.12 0.09 Allowed 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 130.231 3.413 . . . . 0.0 109.171 176.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 73.7 mt 51.19 39.88 24.68 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 129.209 3.004 . . . . 0.0 113.787 -176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -112.62 133.49 54.64 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 80.3 m80 -132.86 107.86 8.59 Favored 'General case' 0 CA--C 1.497 -1.079 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.1 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 -178.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.453 -0.9 0 N-CA-C 110.232 -0.719 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 43.8 t -127.85 120.87 21.76 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -91.12 -22.23 0.6 Allowed 'Trans proline' 0 N--CA 1.455 -0.741 0 CA-C-N 122.032 1.762 . . . . 0.0 109.496 -173.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 36.81 69.9 0.19 Allowed 'General case' 0 C--N 1.359 0.994 0 C-N-CA 129.045 2.938 . . . . 0.0 115.607 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 70.3 t -118.63 136.21 56.55 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 -174.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 160.63 37.71 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 166.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 12.2 p90 -149.23 139.76 22.51 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.6 t -169.27 116.56 0.61 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.61 153.02 36.11 Favored 'General case' 0 CA--C 1.487 -1.458 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.02 158.54 44.22 Favored 'General case' 0 C--N 1.351 0.646 0 C-N-CA 119.55 -0.86 . . . . 0.0 111.21 174.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.482 HD21 HD23 ' A' ' 858' ' ' LEU . 2.5 tm? -134.81 134.72 41.14 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -167.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.438 ' H ' ' H ' ' A' ' 858' ' ' LEU . 40.6 p -164.25 10.1 0.04 OUTLIER 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -163.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.482 HD23 HD21 ' A' ' 856' ' ' LEU . 2.1 pp -28.62 144.76 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.51 0 N-CA-C 116.524 2.046 . . . . 0.0 116.524 160.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -79.07 -47.92 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.66 0 CA-C-N 122.324 1.866 . . . . 0.0 112.875 -162.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -162.2 170.55 18.86 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.6 m 4.03 104.05 0.0 OUTLIER 'General case' 0 C--N 1.36 1.058 0 C-N-CA 130.848 3.659 . . . . 0.0 117.463 168.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -96.46 163.57 20.25 Favored Pre-proline 0 C--N 1.353 0.734 0 C-N-CA 123.174 0.59 . . . . 0.0 110.25 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.54 -14.61 12.8 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 122.662 2.241 . . . . 0.0 110.768 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -168.25 -142.5 3.51 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -63.83 144.46 57.03 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.714 2.006 . . . . 0.0 110.864 -176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 55.2 t -95.12 131.51 29.92 Favored Pre-proline 0 N--CA 1.439 -0.989 0 C-N-CA 124.841 1.256 . . . . 0.0 110.705 -162.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -95.84 -148.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 124.199 3.266 . . . . 0.0 108.464 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 16.1 p90 -149.65 136.86 19.79 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 41.6 p-10 -117.24 -15.61 10.41 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.909 0.484 . . . . 0.0 111.98 -179.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -100.78 86.73 3.15 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 118.665 0.666 . . . . 0.0 112.723 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . 0.431 HG13 ' HB3' ' A' ' 874' ' ' ASN . 62.1 t -70.56 97.99 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.92 0 C-N-CA 126.059 1.743 . . . . 0.0 107.123 167.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 48.0 mt -87.92 -36.46 17.12 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.969 -174.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.6 tp -165.16 126.87 2.07 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 160.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.431 ' HB3' HG13 ' A' ' 871' ' ' VAL . 35.3 t-20 -174.88 61.86 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.841 0 CA-C-N 120.528 1.513 . . . . 0.0 109.387 -168.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.8 -44.43 86.31 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 -164.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.22 -30.6 8.61 Favored Glycine 0 C--N 1.356 1.673 0 CA-C-N 118.946 0.793 . . . . 0.0 112.38 -175.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 112.29 -60.76 0.33 Allowed Glycine 0 C--N 1.352 1.466 0 N-CA-C 107.026 -2.43 . . . . 0.0 107.026 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 65.86 -79.18 0.03 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.084 2.554 . . . . 0.0 114.111 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -95.8 120.1 35.48 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.154 1.382 . . . . 0.0 108.296 -175.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -81.68 116.41 62.9 Favored Pre-proline 0 CA--C 1.502 -0.876 0 N-CA-C 104.066 -2.568 . . . . 0.0 104.066 172.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -94.59 5.05 2.56 Favored 'Trans proline' 0 CA--C 1.505 -0.942 0 CA-C-N 125.204 2.894 . . . . 0.0 108.961 -165.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -79.82 -46.13 17.48 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 27.3 p -106.11 -12.15 15.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.902 172.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.34 25.88 41.91 Favored Glycine 0 C--N 1.362 2.015 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 163.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 44.9 t -101.36 102.83 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.603 0 N-CA-C 100.481 -3.896 . . . . 0.0 100.481 -163.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 114.48 27.55 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 110.924 -2.853 . . . . 0.0 108.941 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 81.5 m -99.1 109.8 22.47 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.75 110.02 36.52 Favored Pre-proline 0 C--N 1.356 0.851 0 C-N-CA 125.591 1.556 . . . . 0.0 112.875 175.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -98.29 -8.38 0.62 Allowed 'Trans proline' 0 N--CA 1.46 -0.462 0 CA-C-N 123.195 2.177 . . . . 0.0 108.653 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 26.3 mt -44.51 -58.99 2.66 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 129.963 3.305 . . . . 0.0 114.546 -170.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.09 64.12 1.59 Allowed 'General case' 0 C--N 1.364 1.214 0 CA-C-O 121.839 0.828 . . . . 0.0 111.912 172.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.66 -174.35 39.84 Favored Glycine 0 N--CA 1.409 -3.113 1 N-CA-C 101.364 -4.694 . . . . 0.0 101.364 -174.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.409 HH21 HG22 ' A' ' 953' ' ' ILE . 75.3 ttt-85 -93.34 121.84 35.14 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 171.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.253 2.6 p90 -114.04 159.92 19.45 Favored 'General case' 0 C--N 1.363 1.195 0 CA-C-N 119.0 0.818 . . . . 0.0 108.936 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.4 tp -104.82 117.8 34.95 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 123.759 0.824 . . . . 0.0 110.061 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.4 tt -111.17 136.54 50.09 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 126.659 1.984 . . . . 0.0 108.997 -164.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 73.1 m -147.01 118.93 8.13 Favored 'General case' 0 C--N 1.361 1.108 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 153.84 22.05 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 81.4 t -109.44 118.86 57.65 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.28 124.87 44.72 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.841 -1.072 . . . . 0.0 109.41 -173.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 39.5 m -81.38 131.68 35.3 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 125.251 1.42 . . . . 0.0 107.337 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.88 -57.44 19.87 Favored Glycine 0 C--N 1.362 2.001 0 C-N-CA 125.161 1.363 . . . . 0.0 114.066 -169.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 66.5 m170 38.15 73.01 0.11 Allowed 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.13 2.172 . . . . 0.0 115.153 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.8 ptt85 -71.16 -12.84 61.71 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.784 1.634 . . . . 0.0 111.719 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -73.55 -19.99 60.75 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.299 1.439 . . . . 0.0 112.375 -168.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.324 13.2 pt-20 125.98 -178.21 0.0 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 127.458 2.303 . . . . 0.0 108.261 175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 100.72 131.19 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 128.074 2.549 . . . . 0.0 106.799 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 100.0 t -99.38 126.94 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -171.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -108.25 123.37 48.68 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.16 172.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.47 116.92 15.68 Favored 'General case' 0 C--N 1.363 1.156 0 C-N-CA 128.996 2.918 . . . . 0.0 109.892 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 99.4 t -87.91 113.09 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 171.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 29.7 mt -62.0 141.6 57.97 Favored 'General case' 0 CA--C 1.501 -0.911 0 C-N-CA 126.142 1.777 . . . . 0.0 110.563 177.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 2.4 t -116.98 145.87 43.38 Favored 'General case' 0 CA--C 1.512 -0.51 0 C-N-CA 125.218 1.407 . . . . 0.0 111.734 175.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.494 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -79.68 142.71 35.27 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 129.19 2.996 . . . . 0.0 111.052 -175.505 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 83.86 12.28 0.38 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 128.714 2.806 . . . . 0.0 112.336 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 64.5 m-80 -151.79 -26.72 0.19 Allowed 'General case' 0 C--N 1.357 0.916 0 O-C-N 121.281 -0.887 . . . . 0.0 110.628 177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 57.9 167.05 0.04 OUTLIER 'General case' 0 C--N 1.362 1.121 0 C-N-CA 125.753 1.621 . . . . 0.0 112.174 -163.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.65 -134.03 49.78 Favored Glycine 0 C--N 1.372 2.556 0 O-C-N 119.217 -2.177 . . . . 0.0 109.742 -161.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 52.8 t 57.79 75.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.313 0 C-N-CA 125.79 1.636 . . . . 0.0 110.651 173.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.49 114.31 26.83 Favored 'General case' 0 CA--C 1.491 -1.3 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 -177.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -102.33 -35.17 8.93 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.448 -170.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.6 83.25 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 102.728 -3.064 . . . . 0.0 102.728 167.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -96.59 129.36 43.99 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-O 121.201 0.524 . . . . 0.0 109.763 -171.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 29.7 t -143.27 115.92 8.67 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 125.506 1.523 . . . . 0.0 107.906 172.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.83 84.68 0.73 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 103.632 -3.787 . . . . 0.0 103.632 163.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.689 0 C-N-CA 126.24 1.876 . . . . 0.0 111.524 172.71 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.509 -0.619 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.1 mt -118.49 133.33 55.95 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 -172.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.64 163.23 25.83 Favored Glycine 0 CA--C 1.491 -1.465 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 -172.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 14.5 m -124.62 131.07 73.21 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 172.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -136.86 142.53 42.82 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 52.2 m -116.72 -44.49 2.83 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 33.2 tp -87.48 -53.65 4.7 Favored 'General case' 0 C--N 1.361 1.105 0 CA-C-N 119.442 1.019 . . . . 0.0 111.739 -168.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.409 HG22 HH21 ' A' ' 893' ' ' ARG . 11.2 pt -83.73 -176.21 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 124.262 1.025 . . . . 0.0 108.313 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.567 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -158.46 83.0 2.67 Favored Pre-proline 0 N--CA 1.433 -1.284 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 -163.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.82 91.95 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.535 2.156 . . . . 0.0 109.697 167.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.567 HD13 ' HB2' ' A' ' 954' ' ' LEU . 8.9 mp -121.78 145.89 47.6 Favored 'General case' 0 CA--C 1.505 -0.787 0 C-N-CA 126.558 1.943 . . . . 0.0 106.566 -175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -95.88 157.91 15.68 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.431 -0.907 . . . . 0.0 108.898 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.55 124.73 24.94 Favored 'General case' 0 C--N 1.375 1.705 0 CA-C-N 119.702 1.137 . . . . 0.0 109.222 173.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.03 -12.21 69.55 Favored Glycine 0 CA--C 1.498 -0.994 0 C-N-CA 126.306 1.908 . . . . 0.0 112.128 171.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 914' ' ' ARG . 0.9 OUTLIER -72.49 171.96 11.37 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 117.839 0.819 . . . . 0.0 112.116 179.433 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 85.4 m -142.28 127.81 19.02 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -157.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.494 HG13 HH11 ' A' ' 914' ' ' ARG . 20.2 m -94.83 149.55 4.42 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 CA-C-O 121.314 0.578 . . . . 0.0 110.114 174.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.4 m -141.32 137.5 32.45 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 126.348 1.859 . . . . 0.0 111.637 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 60.9 t -94.07 130.03 43.56 Favored 'Isoleucine or valine' 0 C--N 1.371 1.51 0 C-N-CA 126.623 1.969 . . . . 0.0 106.868 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -106.02 132.84 51.62 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 101.83 -3.396 . . . . 0.0 101.83 168.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 73.26 1.47 Allowed 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.7 t -163.9 103.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 86.8 mmm -153.27 74.17 1.01 Allowed 'General case' 0 CA--C 1.493 -1.212 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.75 151.34 9.0 Favored Glycine 0 CA--C 1.495 -1.213 0 N-CA-C 108.301 -1.92 . . . . 0.0 108.301 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -117.18 -30.26 5.68 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 123.726 0.811 . . . . 0.0 108.855 -173.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.92 87.34 6.18 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.71 -166.44 1.95 Allowed 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -171.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 39.6 t60 -125.24 160.39 29.35 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.0 t -92.53 132.08 37.13 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -176.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -157.64 150.2 22.8 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 104.737 -2.319 . . . . 0.0 104.737 -176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.98 113.33 24.31 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 174.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -98.35 173.33 0.54 Allowed 'Trans proline' 0 CA--C 1.508 -0.824 0 C-N-CA 121.985 1.79 . . . . 0.0 108.447 -177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.57 140.75 49.21 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -139.86 141.75 36.62 Favored 'General case' 0 C--N 1.375 1.68 0 CA-C-N 119.538 1.063 . . . . 0.0 108.747 -171.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.4 mm -119.61 129.35 75.45 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 N-CA-C 105.944 -1.872 . . . . 0.0 105.944 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -125.38 105.43 9.07 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 46.0 p -101.06 161.01 13.9 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 124.562 1.145 . . . . 0.0 110.281 170.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.46 0.28 Allowed Glycine 0 C--N 1.356 1.644 0 N-CA-C 108.181 -1.968 . . . . 0.0 108.181 175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.59 144.32 47.17 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -173.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 58.6 tp -74.9 124.28 26.61 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 124.906 1.282 . . . . 0.0 109.789 -176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.1 -57.39 2.23 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -177.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -131.36 128.01 38.77 Favored 'General case' 0 N--CA 1.43 -1.45 0 C-N-CA 126.095 1.758 . . . . 0.0 106.537 -176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.7 130.73 10.44 Favored Glycine 0 CA--C 1.493 -1.337 0 N-CA-C 103.545 -3.822 . . . . 0.0 103.545 163.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -69.59 130.95 90.08 Favored Pre-proline 0 C--N 1.354 0.785 0 CA-C-O 117.835 -1.079 . . . . 0.0 111.406 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -107.06 80.96 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.425 0 CA-C-N 121.984 1.744 . . . . 0.0 110.293 -169.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 77.14 -72.87 0.09 Allowed 'General case' 0 CA--C 1.5 -0.948 0 C-N-CA 130.602 3.561 . . . . 0.0 109.405 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.5 mt 49.74 40.07 19.25 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 129.523 3.129 . . . . 0.0 113.94 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -110.88 130.0 55.71 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 177.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -128.06 109.86 11.94 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 176.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.072 0 N-CA-C 115.526 1.676 . . . . 0.0 115.526 179.956 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.172 -0.741 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.0 t -127.33 121.41 22.52 Favored Pre-proline 0 C--N 1.354 0.762 0 N-CA-C 105.235 -2.135 . . . . 0.0 105.235 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -92.69 -22.79 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 CA-C-N 122.064 1.773 . . . . 0.0 109.879 -174.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 38.78 69.58 0.26 Allowed 'General case' 0 C--N 1.36 1.039 0 C-N-CA 129.189 2.996 . . . . 0.0 115.204 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 69.7 t -117.86 136.24 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -173.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.58 160.39 38.21 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 165.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -149.41 139.94 22.5 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.3 t -169.31 117.32 0.63 Allowed 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.09 153.82 34.17 Favored 'General case' 0 CA--C 1.489 -1.384 0 N-CA-C 105.747 -1.945 . . . . 0.0 105.747 -177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -139.47 157.72 45.36 Favored 'General case' 0 CA--C 1.498 -1.051 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.808 176.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.52 HD21 HD23 ' B' ' 858' ' ' LEU . 2.3 tm? -133.09 133.39 42.89 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -168.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.447 ' H ' ' H ' ' B' ' 858' ' ' LEU . 29.7 p -163.95 8.1 0.04 OUTLIER 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -163.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.52 HD23 HD21 ' B' ' 856' ' ' LEU . 2.0 pp -28.74 144.91 0.05 OUTLIER Pre-proline 0 C--N 1.371 1.513 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 160.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -79.43 -47.79 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.705 0 CA-C-N 122.242 1.836 . . . . 0.0 112.877 -163.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -162.18 170.4 19.13 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.4 m 4.06 104.3 0.0 OUTLIER 'General case' 0 C--N 1.36 1.05 0 C-N-CA 130.877 3.671 . . . . 0.0 117.563 169.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -97.07 163.65 19.54 Favored Pre-proline 0 C--N 1.353 0.731 0 C-N-CA 123.229 0.612 . . . . 0.0 110.412 -177.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.65 -14.83 12.54 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.645 2.23 . . . . 0.0 110.94 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.92 -142.41 3.47 Favored Glycine 0 C--N 1.354 1.561 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.2 m -63.63 143.95 57.41 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 126.611 1.964 . . . . 0.0 110.703 -177.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 54.7 t -94.45 130.99 32.01 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 124.734 1.214 . . . . 0.0 110.463 -162.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -97.03 -148.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 124.047 3.164 . . . . 0.0 108.212 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -149.41 136.84 20.07 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -115.17 -13.96 11.76 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.397 1.079 . . . . 0.0 110.567 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 23.1 mmm180 -101.31 87.11 3.14 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' B' ' 874' ' ' ASN . 58.7 t -70.58 97.18 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 164.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' B' ' 855' ' ' ALA . 18.3 mt -87.58 -38.67 15.76 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 119.09 -1.044 . . . . 0.0 111.083 -172.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 56.6 tp -165.11 127.08 2.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 N-CA-C 100.749 -3.797 . . . . 0.0 100.749 165.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.432 ' HB3' HG13 ' B' ' 871' ' ' VAL . 33.3 t-20 177.25 61.42 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 120.265 1.393 . . . . 0.0 108.648 -163.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -58.18 -43.66 87.6 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 116.58 2.067 . . . . 0.0 116.58 -166.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.15 -31.4 8.5 Favored Glycine 0 C--N 1.355 1.627 0 CA-C-N 118.931 0.787 . . . . 0.0 112.479 -176.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.22 -58.69 0.38 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.389 -2.284 . . . . 0.0 107.389 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 65.26 -80.36 0.03 OUTLIER 'General case' 0 C--N 1.355 0.831 0 C-N-CA 128.044 2.538 . . . . 0.0 114.406 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -97.1 119.88 36.4 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 125.335 1.454 . . . . 0.0 108.538 -174.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -80.55 116.99 65.74 Favored Pre-proline 0 CA--C 1.503 -0.854 0 N-CA-C 104.632 -2.359 . . . . 0.0 104.632 171.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -93.46 5.65 2.94 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 CA-C-N 125.19 2.889 . . . . 0.0 108.986 -166.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -79.79 -44.94 19.71 Favored 'General case' 0 CA--C 1.499 -0.991 0 C-N-CA 124.407 1.083 . . . . 0.0 108.6 -176.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 25.4 p -108.99 -12.48 14.86 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.909 1.284 . . . . 0.0 108.363 173.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.86 25.86 39.92 Favored Glycine 0 C--N 1.361 1.931 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 163.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 54.8 t -100.82 102.81 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.543 0 N-CA-C 101.089 -3.671 . . . . 0.0 101.089 -162.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -97.59 114.82 26.82 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 111.468 -2.605 . . . . 0.0 108.459 -174.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.0 m -99.17 109.78 22.42 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -89.15 110.45 38.39 Favored Pre-proline 0 C--N 1.357 0.922 0 C-N-CA 125.477 1.511 . . . . 0.0 113.307 175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -99.42 -7.28 0.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 CA-C-N 123.321 2.222 . . . . 0.0 108.931 172.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 16.0 mt -50.42 -51.95 41.92 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 128.618 2.767 . . . . 0.0 114.339 -168.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.8 49.09 14.88 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.214 1.406 . . . . 0.0 113.815 172.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -162.74 -166.68 21.94 Favored Glycine 0 N--CA 1.412 -2.943 1 N-CA-C 101.894 -4.482 . . . . 0.0 101.894 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 60.7 ttt-85 -92.64 120.94 33.57 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 1.9 p90 -116.19 160.05 20.95 Favored 'General case' 0 C--N 1.365 1.275 0 CA-C-N 118.965 0.802 . . . . 0.0 108.841 177.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 54.6 tp -105.56 116.37 31.84 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.06 135.64 50.57 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 126.193 1.797 . . . . 0.0 107.827 -166.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 72.9 m -145.26 119.22 9.34 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 176.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.9 153.9 21.84 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -110.06 120.84 61.88 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -103.86 122.89 46.09 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.275 -172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 37.1 m -79.77 131.49 35.93 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 125.264 1.425 . . . . 0.0 107.936 174.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.73 -57.45 19.76 Favored Glycine 0 C--N 1.365 2.154 0 C-N-CA 125.322 1.439 . . . . 0.0 114.25 -168.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 66.4 m170 37.72 73.46 0.1 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 127.178 2.191 . . . . 0.0 115.093 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -71.48 -12.69 61.52 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.93 1.692 . . . . 0.0 111.544 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -74.62 -15.62 60.82 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.664 1.586 . . . . 0.0 112.628 -166.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.334 11.0 pt-20 120.57 178.62 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 C-N-CA 127.911 2.485 . . . . 0.0 108.485 176.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 102.06 131.45 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.104 0 C-N-CA 128.268 2.627 . . . . 0.0 106.581 172.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.5 t -98.92 131.57 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -112.02 123.42 50.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 113.83 -1.532 . . . . 0.0 113.18 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.23 115.04 13.69 Favored 'General case' 0 C--N 1.369 1.421 0 C-N-CA 128.426 2.69 . . . . 0.0 109.878 -175.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 99.0 t -89.05 113.31 25.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.87 147.23 47.32 Favored 'General case' 0 CA--C 1.502 -0.898 0 C-N-CA 126.868 2.067 . . . . 0.0 111.294 178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 1.9 t -117.03 147.3 42.46 Favored 'General case' 0 CA--C 1.511 -0.537 0 C-N-CA 125.454 1.502 . . . . 0.0 111.414 176.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.526 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.56 141.45 35.07 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 128.914 2.886 . . . . 0.0 110.004 -179.145 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 4.2 t 82.97 9.68 0.62 Allowed 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 128.31 2.644 . . . . 0.0 112.82 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -150.17 -26.23 0.25 Allowed 'General case' 0 C--N 1.358 0.935 0 O-C-N 121.137 -0.977 . . . . 0.0 110.934 178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 57.81 168.02 0.04 OUTLIER 'General case' 0 C--N 1.362 1.14 0 C-N-CA 125.476 1.51 . . . . 0.0 112.077 -163.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.29 -133.08 48.42 Favored Glycine 0 C--N 1.366 2.213 0 O-C-N 119.5 -2.0 . . . . 0.0 109.775 -164.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 60.9 t 56.04 77.81 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.215 0 C-N-CA 126.23 1.812 . . . . 0.0 111.189 173.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.6 114.79 27.44 Favored 'General case' 0 CA--C 1.494 -1.174 0 N-CA-C 105.198 -2.149 . . . . 0.0 105.198 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 15.2 ptt180 -103.15 -35.44 8.48 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.103 -1.408 . . . . 0.0 108.484 -172.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 97.0 t -100.17 81.47 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 167.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -98.04 128.76 44.77 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -172.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 33.3 t -141.48 117.43 10.52 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 171.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.82 84.8 0.74 Allowed Glycine 0 N--CA 1.429 -1.809 0 N-CA-C 103.583 -3.807 . . . . 0.0 103.583 165.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.709 0 C-N-CA 125.356 1.455 . . . . 0.0 111.273 175.18 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 48.4 m . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 59.2 mt -115.3 134.29 55.25 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -168.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -138.55 163.94 25.73 Favored Glycine 0 CA--C 1.493 -1.319 0 C-N-CA 124.999 1.285 . . . . 0.0 109.95 -171.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 24.7 m -120.97 131.51 72.8 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 169.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -137.33 146.52 44.69 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 175.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 50.5 m -128.23 -27.37 2.71 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-O 118.748 -0.644 . . . . 0.0 112.364 176.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 33.8 tp -92.54 -55.55 3.35 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 120.071 1.305 . . . . 0.0 111.425 -172.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -83.78 -177.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.911 0 C-N-CA 125.162 1.385 . . . . 0.0 108.31 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.566 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -158.03 82.94 2.81 Favored Pre-proline 0 N--CA 1.437 -1.093 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.264 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -74.07 93.63 0.89 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.717 2.278 . . . . 0.0 110.223 169.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.566 HD13 ' HB2' ' B' ' 954' ' ' LEU . 10.5 mp -121.39 145.34 48.01 Favored 'General case' 0 CA--C 1.502 -0.881 0 C-N-CA 125.824 1.65 . . . . 0.0 107.106 -177.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -95.09 158.19 15.57 Favored 'General case' 0 C--N 1.363 1.186 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.241 174.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.88 124.42 24.81 Favored 'General case' 0 C--N 1.38 1.928 0 CA-C-N 119.844 1.202 . . . . 0.0 108.713 174.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.81 71.04 Favored Glycine 0 CA--C 1.498 -0.993 0 C-N-CA 125.997 1.76 . . . . 0.0 111.994 172.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -72.73 170.62 14.19 Favored 'General case' 0 C--N 1.359 0.999 0 CA-C-N 117.957 0.878 . . . . 0.0 110.999 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 90.0 m -143.05 127.95 18.36 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.507 -155.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.526 HG13 HH11 ' B' ' 914' ' ' ARG . 16.5 m -96.03 150.31 4.36 Favored 'Isoleucine or valine' 0 C--N 1.363 1.172 0 CA-C-O 121.172 0.51 . . . . 0.0 111.626 175.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.7 m -141.05 137.75 33.13 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 126.794 2.038 . . . . 0.0 111.338 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 57.7 t -93.59 131.05 41.63 Favored 'Isoleucine or valine' 0 C--N 1.368 1.39 0 C-N-CA 127.947 2.499 . . . . 0.0 107.43 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -105.89 132.97 51.35 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 100.677 -3.823 . . . . 0.0 100.677 171.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.72 72.5 1.4 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 178.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 56.8 t -161.83 104.69 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.3 mmm -152.28 72.68 1.0 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 173.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.26 150.06 8.44 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 107.957 -2.057 . . . . 0.0 107.957 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -115.64 -29.38 6.48 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 38.3 tp -93.01 86.78 5.53 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.42 -165.95 1.85 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -125.24 159.51 31.46 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.5 t -90.97 131.93 36.28 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -157.87 150.33 22.5 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 -176.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.94 113.1 24.43 Favored Pre-proline 0 C--N 1.356 0.889 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -97.86 172.64 0.64 Allowed 'Trans proline' 0 CA--C 1.508 -0.801 0 C-N-CA 121.93 1.754 . . . . 0.0 108.297 -178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -116.54 139.18 50.77 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.8 p -139.02 140.56 38.18 Favored 'General case' 0 C--N 1.374 1.65 0 CA-C-N 119.51 1.05 . . . . 0.0 108.499 -170.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.93 130.79 72.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -126.64 105.15 8.5 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 33.3 p -101.72 162.23 13.06 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 124.768 1.227 . . . . 0.0 110.494 170.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.14 112.09 0.32 Allowed Glycine 0 C--N 1.357 1.71 0 N-CA-C 107.33 -2.308 . . . . 0.0 107.33 174.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.68 145.32 46.6 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.3 tp -73.14 124.09 24.89 Favored 'General case' 0 C--N 1.379 1.873 0 C-N-CA 124.177 0.991 . . . . 0.0 109.423 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.84 -57.52 2.21 Favored 'General case' 0 N--CA 1.438 -1.044 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -131.42 127.62 37.85 Favored 'General case' 0 N--CA 1.43 -1.432 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -173.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.81 130.61 10.39 Favored Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 103.32 -3.912 . . . . 0.0 103.32 163.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -70.11 130.64 89.49 Favored Pre-proline 0 C--N 1.351 0.66 0 CA-C-O 117.744 -1.122 . . . . 0.0 110.569 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -106.26 81.92 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.466 0 CA-C-N 122.008 1.753 . . . . 0.0 109.784 -168.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 77.3 -72.38 0.1 Allowed 'General case' 0 CA--C 1.5 -0.965 0 C-N-CA 130.311 3.444 . . . . 0.0 109.283 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 75.2 mt 49.06 43.33 22.13 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 129.326 3.05 . . . . 0.0 113.569 -174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -114.52 129.6 56.68 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -129.0 109.41 11.2 Favored 'General case' 0 CA--C 1.496 -1.122 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.04 0 N-CA-C 115.607 1.706 . . . . 0.0 115.607 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 N--CA 1.452 -0.935 0 N-CA-C 110.328 -0.682 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 31.1 t -122.09 114.73 30.64 Favored Pre-proline 0 N--CA 1.442 -0.861 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -87.95 -23.65 1.2 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 CA-C-N 121.649 1.624 . . . . 0.0 110.074 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 37.93 67.95 0.35 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 129.11 2.964 . . . . 0.0 115.755 175.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.6 t -122.8 136.91 58.05 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.09 156.84 48.33 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 165.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 8.5 p90 -148.13 138.55 22.84 Favored 'General case' 0 C--N 1.36 1.049 0 CA-C-N 118.767 0.712 . . . . 0.0 109.105 178.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 14.0 t -170.74 120.03 0.55 Allowed 'General case' 0 C--N 1.36 1.052 0 O-C-N 121.664 -0.648 . . . . 0.0 110.097 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.8 153.3 35.94 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.36 157.67 45.19 Favored 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.96 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.564 HD11 HD23 ' C' ' 858' ' ' LEU . 2.9 tm? -140.8 130.51 24.24 Favored 'General case' 0 N--CA 1.427 -1.609 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -163.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 72.8 m -157.56 17.66 0.27 Allowed 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 -167.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.564 HD23 HD11 ' C' ' 856' ' ' LEU . 2.5 pp -22.44 140.13 0.04 OUTLIER Pre-proline 0 C--N 1.374 1.632 0 N-CA-C 116.535 2.05 . . . . 0.0 116.535 159.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -80.31 -44.76 0.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 CA-C-N 122.243 1.837 . . . . 0.0 111.685 -166.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 30.9 ptt85 -163.89 170.91 16.11 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 15.9 m -1.03 108.73 0.01 OUTLIER 'General case' 0 C--N 1.358 0.957 0 C-N-CA 130.564 3.546 . . . . 0.0 117.22 167.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -100.52 161.59 23.5 Favored Pre-proline 0 N--CA 1.443 -0.797 0 C-N-CA 123.708 0.803 . . . . 0.0 108.922 -175.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -78.79 -12.62 14.83 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.848 2.366 . . . . 0.0 110.776 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.25 3.11 Favored Glycine 0 N--CA 1.435 -1.39 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 177.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.7 m -65.48 146.25 55.11 Favored 'General case' 0 C--N 1.355 0.809 0 C-N-CA 125.906 1.682 . . . . 0.0 111.037 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.0 t -92.21 132.63 31.78 Favored Pre-proline 0 N--CA 1.44 -0.963 0 C-N-CA 125.383 1.473 . . . . 0.0 110.281 -164.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -99.52 -148.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 124.164 3.243 . . . . 0.0 108.556 179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -147.28 135.46 21.53 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 -177.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -116.21 -18.69 10.49 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 123.264 0.626 . . . . 0.0 111.405 -178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -103.57 80.69 1.82 Allowed 'General case' 0 C--N 1.354 0.79 0 C-N-CA 122.888 0.475 . . . . 0.0 111.55 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 46.6 t -67.27 99.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 126.421 1.889 . . . . 0.0 107.189 167.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.0 mt -88.82 -38.32 14.71 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.856 -172.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 36.9 tp -165.3 127.54 2.11 Favored 'General case' 0 CA--C 1.492 -1.269 0 N-CA-C 101.4 -3.556 . . . . 0.0 101.4 167.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.455 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 30.1 t-20 176.41 61.92 0.0 OUTLIER 'General case' 0 CA--C 1.501 -0.929 0 CA-C-N 120.234 1.379 . . . . 0.0 107.957 -163.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -58.84 -42.78 90.09 Favored 'General case' 0 C--N 1.36 1.026 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 -165.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -91.04 -29.07 13.33 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.844 0.747 . . . . 0.0 112.515 -177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.31 -57.73 0.49 Allowed Glycine 0 C--N 1.353 1.48 0 N-CA-C 108.04 -2.024 . . . . 0.0 108.04 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 62.66 -81.64 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.348 2.659 . . . . 0.0 114.891 173.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -94.13 121.01 35.19 Favored 'General case' 0 N--CA 1.435 -1.203 0 C-N-CA 125.139 1.376 . . . . 0.0 108.885 -174.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -83.69 116.92 67.04 Favored Pre-proline 0 N--CA 1.441 -0.918 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -94.69 7.58 2.2 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 124.455 2.627 . . . . 0.0 109.332 -169.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 81.2 mt-10 -79.34 -46.62 17.3 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 37.5 p -108.02 -10.52 15.46 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 124.793 1.237 . . . . 0.0 108.411 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.58 28.0 33.89 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 110.611 -0.995 . . . . 0.0 110.611 161.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.84 101.66 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.561 0 N-CA-C 101.088 -3.671 . . . . 0.0 101.088 -166.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -95.93 112.19 23.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 112.212 -2.267 . . . . 0.0 108.941 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 58.1 m -102.12 109.15 20.78 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 168.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . 0.494 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.02 110.87 45.15 Favored Pre-proline 0 C--N 1.356 0.881 0 CA-C-O 117.293 -1.337 . . . . 0.0 111.583 170.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -92.65 1.45 3.82 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 122.569 2.179 . . . . 0.0 108.271 164.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 42.4 mt -53.6 -54.65 34.55 Favored 'General case' 0 CA--C 1.497 -1.061 0 C-N-CA 128.471 2.709 . . . . 0.0 113.45 -169.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.01 68.43 0.82 Allowed 'General case' 0 C--N 1.365 1.278 0 CA-C-O 122.132 0.968 . . . . 0.0 111.037 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -177.16 174.13 46.79 Favored Glycine 0 N--CA 1.406 -3.348 1 N-CA-C 101.066 -4.813 . . . . 0.0 101.066 -169.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.7 ttt-85 -93.82 117.67 30.4 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 113.552 -1.324 . . . . 0.0 107.897 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -115.64 160.12 20.44 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 119.217 0.917 . . . . 0.0 110.159 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.1 tp -108.38 112.78 25.39 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.4 tt -116.82 140.13 49.8 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 125.062 1.345 . . . . 0.0 108.861 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 69.0 m -143.42 120.06 11.12 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.461 0.704 . . . . 0.0 109.571 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.26 154.4 19.83 Favored 'General case' 0 C--N 1.362 1.136 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 95.1 t -100.84 122.82 53.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.866 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 55.5 mt -94.55 122.52 37.22 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.584 1.154 . . . . 0.0 109.156 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 12.2 m -81.8 132.55 35.28 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 174.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -49.77 -57.01 10.21 Favored Glycine 0 C--N 1.36 1.879 0 C-N-CA 126.159 1.837 . . . . 0.0 115.954 -168.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.3 m80 40.22 69.95 0.28 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 127.241 2.216 . . . . 0.0 114.765 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -73.7 -8.86 57.66 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 124.833 1.253 . . . . 0.0 111.855 -177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 74.5 t60 -75.5 -4.9 42.39 Favored 'General case' 0 C--N 1.357 0.927 0 C-N-CA 126.338 1.855 . . . . 0.0 111.543 -174.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.292 47.3 mt-10 96.63 -149.72 0.0 OUTLIER 'General case' 0 CA--C 1.499 -0.987 0 C-N-CA 128.4 2.68 . . . . 0.0 107.804 175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 84.12 135.27 0.05 Allowed 'General case' 0 C--N 1.36 1.064 0 C-N-CA 127.269 2.227 . . . . 0.0 108.819 -175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 87.2 t -99.71 128.22 51.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-O 122.499 1.143 . . . . 0.0 108.025 -171.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -111.08 131.34 55.15 Favored 'General case' 0 C--N 1.346 0.446 0 C-N-CA 127.315 2.246 . . . . 0.0 110.164 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -158.05 113.83 2.75 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 124.646 1.178 . . . . 0.0 110.716 -175.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.07 116.58 30.27 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.084 1.754 . . . . 0.0 109.111 177.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 32.2 mt -62.37 143.32 57.14 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 126.261 1.824 . . . . 0.0 111.111 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.265 1.3 p -114.52 148.83 37.34 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 126.513 1.925 . . . . 0.0 108.598 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.494 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.77 137.74 37.89 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 125.321 1.449 . . . . 0.0 109.431 176.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.0 t 90.24 0.15 0.23 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 128.689 2.796 . . . . 0.0 112.694 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -145.76 -26.52 0.45 Allowed 'General case' 0 C--N 1.36 1.025 0 CA-C-N 119.495 1.043 . . . . 0.0 111.99 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 58.77 169.57 0.06 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 125.167 1.387 . . . . 0.0 111.954 -163.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.08 -127.93 46.09 Favored Glycine 0 C--N 1.374 2.667 0 O-C-N 119.741 -1.849 . . . . 0.0 110.152 -166.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 53.4 t 49.38 72.53 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.162 0 C-N-CA 126.601 1.96 . . . . 0.0 111.912 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 116.55 28.94 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -169.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 21.5 ptt85 -95.8 -35.7 11.42 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.067 -172.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 56.3 t -99.38 81.21 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 103.281 -2.859 . . . . 0.0 103.281 167.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -94.84 131.42 40.75 Favored 'General case' 0 C--N 1.354 0.793 0 CA-C-O 121.091 0.472 . . . . 0.0 111.136 -174.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 22.8 t -144.09 116.17 8.39 Favored 'General case' 0 C--N 1.36 1.036 0 C-N-CA 125.351 1.46 . . . . 0.0 108.126 171.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.09 84.77 0.65 Allowed Glycine 0 CA--C 1.484 -1.899 0 N-CA-C 105.228 -3.149 . . . . 0.0 105.228 173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.643 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 173.023 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.51 -0.57 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.4 mt -120.07 134.56 55.22 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.572 -2.381 . . . . 0.0 104.572 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.0 163.41 26.65 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -117.91 129.57 74.1 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -128.91 146.47 50.94 Favored 'General case' 0 C--N 1.357 0.928 0 O-C-N 121.328 -0.858 . . . . 0.0 110.23 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.1 m -103.97 -84.06 0.48 Allowed 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.655 0.782 . . . . 0.0 109.716 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 11.3 tp -61.32 -46.96 88.11 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 126.084 1.754 . . . . 0.0 114.627 -163.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.34 -179.01 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 124.72 1.208 . . . . 0.0 110.141 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.48 ' HB2' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -163.22 82.24 1.51 Allowed Pre-proline 0 C--N 1.355 0.836 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -168.441 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -75.92 88.98 1.27 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.278 1.985 . . . . 0.0 110.734 168.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.48 HD13 ' HB2' ' C' ' 954' ' ' LEU . 11.2 mp -123.59 147.46 47.3 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -176.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -91.33 162.53 14.57 Favored 'General case' 0 C--N 1.365 1.255 0 CA-C-O 118.295 -0.86 . . . . 0.0 109.358 -172.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.71 122.74 21.15 Favored 'General case' 0 C--N 1.38 1.934 0 CA-C-N 120.954 1.706 . . . . 0.0 108.957 172.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.23 -10.87 73.45 Favored Glycine 0 CA--C 1.496 -1.134 0 C-N-CA 125.49 1.519 . . . . 0.0 111.62 167.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -68.47 176.44 2.87 Favored 'General case' 0 C--N 1.357 0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.855 176.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 90.6 m -143.71 127.28 16.99 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 124.433 1.093 . . . . 0.0 110.922 -164.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.401 HG13 ' HD3' ' C' ' 914' ' ' ARG . 16.8 m -98.21 147.82 6.42 Favored 'Isoleucine or valine' 0 C--N 1.364 1.202 0 C-N-CA 124.802 1.241 . . . . 0.0 108.84 172.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 16.9 t -141.94 137.95 31.63 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 125.825 1.65 . . . . 0.0 111.737 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 23.8 t -90.89 129.24 42.0 Favored 'Isoleucine or valine' 0 C--N 1.374 1.65 0 C-N-CA 126.233 1.813 . . . . 0.0 106.169 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -104.68 133.5 49.42 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.137 -3.653 . . . . 0.0 101.137 175.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.53 72.64 1.45 Allowed 'General case' 0 N--CA 1.438 -1.041 0 CA-C-N 113.064 -1.88 . . . . 0.0 106.391 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 49.5 t -160.39 97.9 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.888 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.4 mmm -150.6 78.27 1.31 Allowed 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 104.48 -2.415 . . . . 0.0 104.48 177.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.98 147.53 14.1 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -113.96 -22.51 10.06 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.435 0.694 . . . . 0.0 110.135 -175.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -98.7 85.62 3.36 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.03 -166.72 1.96 Allowed 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.8 t60 -119.73 150.02 41.05 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -88.69 130.32 35.34 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -176.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -154.95 147.93 24.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -125.01 115.27 26.27 Favored Pre-proline 0 C--N 1.356 0.849 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 174.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -103.73 177.22 0.14 Allowed 'Trans proline' 0 CA--C 1.51 -0.7 0 C-N-CA 121.553 1.502 . . . . 0.0 108.283 -176.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.2 mp -116.48 138.18 51.58 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.0 p -137.81 139.95 40.26 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 119.98 1.264 . . . . 0.0 108.192 -171.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.4 mm -115.38 131.48 67.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -125.47 104.92 8.69 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 -173.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 35.1 p -101.83 162.89 12.57 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.942 1.297 . . . . 0.0 110.225 171.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.88 112.18 0.35 Allowed Glycine 0 C--N 1.359 1.818 0 N-CA-C 108.418 -1.873 . . . . 0.0 108.418 174.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.28 141.95 47.68 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 55.8 tp -76.57 124.32 27.43 Favored 'General case' 0 C--N 1.38 1.926 0 C-N-CA 125.139 1.376 . . . . 0.0 109.439 -176.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 16.2 tp -97.14 -56.57 2.51 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -131.21 127.24 37.5 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.06 127.51 9.09 Favored Glycine 0 CA--C 1.494 -1.27 0 N-CA-C 103.485 -3.846 . . . . 0.0 103.485 166.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -69.91 131.17 89.38 Favored Pre-proline 0 C--N 1.354 0.764 0 CA-C-O 117.756 -1.116 . . . . 0.0 110.929 -174.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -106.27 77.74 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.512 0 CA-C-N 122.219 1.828 . . . . 0.0 109.875 -166.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.02 -73.23 0.08 Allowed 'General case' 0 CA--C 1.5 -0.96 0 C-N-CA 130.21 3.404 . . . . 0.0 108.893 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.3 mt 48.93 42.47 20.56 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 129.171 2.988 . . . . 0.0 113.479 -173.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -113.61 129.64 56.53 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.42 109.61 11.57 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 104.891 -2.263 . . . . 0.0 104.891 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.02 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 179.999 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo . . . . . 0 N--CA 1.452 -0.917 0 N-CA-C 109.998 -0.808 . . . . 0.0 109.998 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.3 t -125.81 118.73 24.16 Favored Pre-proline 0 N--CA 1.442 -0.874 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -88.98 -21.61 1.24 Allowed 'Trans proline' 0 N--CA 1.455 -0.783 0 CA-C-N 122.064 1.773 . . . . 0.0 109.875 -172.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 35.9 69.85 0.17 Allowed 'General case' 0 C--N 1.357 0.925 0 C-N-CA 129.032 2.933 . . . . 0.0 115.773 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 91.9 t -118.63 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -173.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.1 155.72 49.77 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 166.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 11.4 p90 -149.62 138.77 21.27 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.0 t -169.04 117.53 0.66 Allowed 'General case' 0 C--N 1.352 0.702 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -174.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.29 152.73 36.21 Favored 'General case' 0 C--N 1.37 1.479 0 N-CA-C 105.026 -2.213 . . . . 0.0 105.026 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.48 158.44 44.38 Favored 'General case' 0 C--N 1.351 0.647 0 C-N-CA 119.412 -0.915 . . . . 0.0 111.488 174.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.433 HD11 HD23 ' A' ' 858' ' ' LEU . 2.6 tm? -130.68 130.88 44.45 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -167.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.0 p -159.22 16.66 0.17 Allowed 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -167.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.433 HD23 HD11 ' A' ' 856' ' ' LEU . 3.2 pp -21.92 145.55 0.01 OUTLIER Pre-proline 0 C--N 1.368 1.41 0 N-CA-C 117.641 2.46 . . . . 0.0 117.641 158.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -81.36 -48.0 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 121.927 1.751 . . . . 0.0 112.681 -169.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.0 ptt85 -163.11 178.52 8.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.3 m -19.43 121.84 0.02 OUTLIER 'General case' 0 C--N 1.363 1.188 0 C-N-CA 129.615 3.166 . . . . 0.0 115.679 172.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -126.63 146.08 55.6 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 -163.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -76.86 -10.25 18.24 Favored 'Trans proline' 0 CA--C 1.511 -0.662 0 CA-C-N 122.75 2.018 . . . . 0.0 112.937 -161.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.98 -141.12 3.04 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 108.966 -1.654 . . . . 0.0 108.966 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.1 m -63.45 145.8 54.89 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 126.31 1.844 . . . . 0.0 110.48 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 91.9 t -88.93 129.27 48.97 Favored Pre-proline 0 N--CA 1.436 -1.147 0 C-N-CA 125.059 1.344 . . . . 0.0 110.363 -164.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -94.62 -153.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 124.056 3.171 . . . . 0.0 108.656 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -148.01 132.59 17.76 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -117.59 -11.97 10.38 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 122.707 0.403 . . . . 0.0 111.354 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.2 mmm180 -99.64 86.68 3.38 Favored 'General case' 0 C--N 1.354 0.776 0 O-C-N 121.835 -0.541 . . . . 0.0 111.49 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.69 96.94 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 169.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' B' ' 953' ' ' ILE . 60.9 mt -87.18 -37.52 17.22 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 119.413 -0.915 . . . . 0.0 110.634 -173.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.0 tp -166.32 127.04 1.71 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 101.009 -3.7 . . . . 0.0 101.009 164.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 29.4 t-20 -177.0 61.13 0.01 OUTLIER 'General case' 0 C--N 1.357 0.93 0 CA-C-N 120.756 1.616 . . . . 0.0 109.618 -167.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -61.01 -44.12 97.89 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 116.377 1.992 . . . . 0.0 116.377 -165.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.18 -27.77 12.95 Favored Glycine 0 C--N 1.357 1.718 0 CA-C-N 118.927 0.785 . . . . 0.0 112.614 -174.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.25 -61.74 0.3 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 107.434 -2.267 . . . . 0.0 107.434 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 61.74 -81.79 0.02 OUTLIER 'General case' 0 C--N 1.353 0.749 0 C-N-CA 128.067 2.547 . . . . 0.0 114.125 176.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -94.36 119.23 32.8 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 124.358 1.063 . . . . 0.0 108.47 -177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -82.03 117.64 69.1 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 103.746 -2.687 . . . . 0.0 103.746 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -94.91 2.36 2.62 Favored 'Trans proline' 0 CA--C 1.509 -0.771 0 CA-C-N 125.12 2.864 . . . . 0.0 109.473 -166.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -80.46 -45.74 17.07 Favored 'General case' 0 CA--C 1.5 -0.967 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 34.5 p -103.69 -13.97 16.29 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.438 1.095 . . . . 0.0 108.834 174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.76 23.5 49.64 Favored Glycine 0 C--N 1.362 2.012 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 162.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 42.2 t -99.68 103.7 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.471 0 N-CA-C 101.583 -3.488 . . . . 0.0 101.583 -164.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -101.56 111.46 23.7 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 112.502 -2.135 . . . . 0.0 109.496 -174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 57.4 m -100.43 107.89 19.74 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 168.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . 0.471 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -91.33 110.91 45.94 Favored Pre-proline 0 C--N 1.356 0.87 0 CA-C-O 116.992 -1.48 . . . . 0.0 111.818 171.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -93.59 2.72 3.25 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 123.252 2.197 . . . . 0.0 108.91 168.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 40.8 mt -50.39 -53.44 29.26 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 128.03 2.532 . . . . 0.0 114.801 -170.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.14 59.11 3.56 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 113.471 0.915 . . . . 0.0 113.471 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.43 -166.7 26.95 Favored Glycine 0 N--CA 1.411 -2.978 1 N-CA-C 101.58 -4.608 . . . . 0.0 101.58 -175.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -93.27 119.84 32.88 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.94 147.21 41.39 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 -174.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 52.9 tp -107.63 114.9 29.19 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -112.68 139.16 48.52 Favored 'General case' 0 C--N 1.361 1.09 0 C-N-CA 126.034 1.733 . . . . 0.0 108.824 -170.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 67.4 m -143.97 118.98 10.01 Favored 'General case' 0 C--N 1.361 1.103 0 C-N-CA 123.422 0.689 . . . . 0.0 109.28 176.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.28 153.07 23.26 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 96.0 t -109.12 121.33 62.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.906 0 N-CA-C 106.026 -1.842 . . . . 0.0 106.026 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.34 122.16 42.67 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 124.529 1.131 . . . . 0.0 108.682 -174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 10.8 m -80.6 132.35 35.62 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.83 -57.6 13.93 Favored Glycine 0 C--N 1.362 2.027 0 C-N-CA 125.852 1.691 . . . . 0.0 115.36 -167.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 2.4 m80 38.29 72.11 0.14 Allowed 'General case' 0 C--N 1.359 0.996 0 C-N-CA 127.568 2.347 . . . . 0.0 114.855 178.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 51.3 ptt85 -72.96 -11.3 60.52 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.915 1.686 . . . . 0.0 111.341 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -72.63 -14.8 61.69 Favored 'General case' 0 N--CA 1.44 -0.955 0 C-N-CA 126.305 1.842 . . . . 0.0 112.215 -169.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.334 7.0 pt-20 116.27 -175.66 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 C-N-CA 127.926 2.491 . . . . 0.0 108.367 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 74.9 tttt 101.59 135.93 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.255 0 C-N-CA 127.67 2.388 . . . . 0.0 106.461 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 67.9 t -98.59 125.23 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.058 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 -171.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -106.91 128.53 54.39 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 126.563 1.945 . . . . 0.0 110.066 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.3 114.55 4.8 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.114 1.366 . . . . 0.0 109.382 -176.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 97.2 t -88.33 115.38 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 18.7 mt -61.94 139.43 58.39 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 126.121 1.768 . . . . 0.0 110.152 176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.1 t -115.66 146.58 41.71 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 126.147 1.779 . . . . 0.0 109.339 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.617 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.99 139.26 39.14 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 128.315 2.646 . . . . 0.0 110.667 -172.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 95.9 -9.06 0.09 Allowed 'General case' 0 N--CA 1.447 -0.582 0 C-N-CA 129.339 3.056 . . . . 0.0 112.831 173.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -138.46 -27.33 0.87 Allowed 'General case' 0 C--N 1.356 0.891 0 CA-C-N 119.448 1.022 . . . . 0.0 111.392 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 60.77 163.56 0.07 Allowed 'General case' 0 C--N 1.361 1.077 0 C-N-CA 125.619 1.567 . . . . 0.0 111.487 -165.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.3 -134.95 48.25 Favored Glycine 0 C--N 1.368 2.349 0 O-C-N 119.394 -2.067 . . . . 0.0 109.143 -160.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 58.05 75.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.137 0 C-N-CA 125.284 1.434 . . . . 0.0 110.515 174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.86 114.32 26.82 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -103.88 -33.05 9.0 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.781 -173.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.76 77.11 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 102.747 -3.057 . . . . 0.0 102.747 166.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -96.35 130.32 43.49 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.418 -173.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 24.9 t -144.61 114.77 7.47 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 125.084 1.353 . . . . 0.0 108.062 168.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.36 84.9 0.7 Allowed Glycine 0 CA--C 1.484 -1.851 0 N-CA-C 104.731 -3.347 . . . . 0.0 104.731 167.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.631 0 C-N-CA 125.35 1.452 . . . . 0.0 111.212 175.052 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 48.9 m . . . . . 0 N--CA 1.445 -0.69 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 65.8 mt -119.42 133.76 55.54 Favored 'General case' 0 N--CA 1.434 -1.27 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 -172.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -137.25 161.51 25.25 Favored Glycine 0 CA--C 1.493 -1.305 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -173.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 30.1 m -123.96 127.3 73.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -138.89 149.43 44.83 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -114.57 -43.05 3.2 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 44.2 tp -84.07 -52.9 5.93 Favored 'General case' 0 C--N 1.361 1.079 0 CA-C-N 119.733 1.151 . . . . 0.0 112.147 -168.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 8.3 pt -87.79 -170.32 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 C-N-CA 124.601 1.161 . . . . 0.0 110.172 -174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.57 85.18 1.49 Allowed Pre-proline 0 N--CA 1.437 -1.102 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -162.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -73.85 92.34 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 CA-C-N 122.565 1.952 . . . . 0.0 109.781 160.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.9 142.8 49.35 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -93.89 158.24 15.74 Favored 'General case' 0 C--N 1.363 1.184 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.092 177.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.16 123.88 23.18 Favored 'General case' 0 C--N 1.371 1.534 0 CA-C-N 119.192 0.905 . . . . 0.0 108.832 174.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -10.95 73.26 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 125.742 1.639 . . . . 0.0 111.238 171.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.09 175.02 5.55 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 123.622 0.769 . . . . 0.0 111.677 177.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 98.6 m -143.06 125.75 15.96 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -161.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.617 HG13 HH11 ' A' ' 914' ' ' ARG . 28.0 m -95.26 150.51 4.14 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 CA-C-O 121.593 0.711 . . . . 0.0 109.544 171.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.8 t -142.07 138.83 32.02 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 126.156 1.783 . . . . 0.0 111.112 -177.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 97.0 t -91.71 129.43 42.4 Favored 'Isoleucine or valine' 0 C--N 1.369 1.415 0 C-N-CA 126.021 1.729 . . . . 0.0 106.475 -178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -105.49 131.37 52.98 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 101.343 -3.577 . . . . 0.0 101.343 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.45 71.22 1.47 Allowed 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.4 t -163.1 100.17 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.31 71.42 0.89 Allowed 'General case' 0 CA--C 1.496 -1.117 0 N-CA-C 105.039 -2.208 . . . . 0.0 105.039 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.46 143.48 7.27 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 107.775 -2.13 . . . . 0.0 107.775 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -111.02 -29.76 7.77 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 123.573 0.749 . . . . 0.0 108.997 -173.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.8 tp -91.7 87.16 6.2 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.68 -164.51 1.62 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 106.968 -1.493 . . . . 0.0 106.968 -171.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 26.0 t60 -123.93 159.26 30.11 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.66 133.83 35.61 Favored 'General case' 0 C--N 1.356 0.872 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -158.91 152.2 22.63 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 -177.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.8 112.39 22.35 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 172.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -98.86 174.09 0.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.006 1.804 . . . . 0.0 108.461 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -118.08 139.69 50.86 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 124.567 1.147 . . . . 0.0 108.042 -176.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -140.12 141.4 36.12 Favored 'General case' 0 C--N 1.375 1.71 0 CA-C-N 119.984 1.266 . . . . 0.0 108.566 -170.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 30.6 mm -118.19 130.11 73.54 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -126.39 105.87 9.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.1 p -99.96 161.35 13.66 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 124.598 1.159 . . . . 0.0 109.531 171.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.44 109.01 0.26 Allowed Glycine 0 C--N 1.359 1.852 0 C-N-CA 119.044 -1.551 . . . . 0.0 110.675 175.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.95 143.41 47.05 Favored 'General case' 0 C--N 1.349 0.562 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -174.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 61.7 tp -74.33 124.68 26.93 Favored 'General case' 0 C--N 1.378 1.845 0 C-N-CA 125.263 1.425 . . . . 0.0 109.058 -176.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 24.3 tp -98.97 -57.94 2.06 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.352 -178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -132.27 128.92 38.85 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 -175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 131.85 10.82 Favored Glycine 0 CA--C 1.492 -1.378 0 N-CA-C 103.792 -3.723 . . . . 0.0 103.792 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -69.11 129.12 92.33 Favored Pre-proline 0 C--N 1.352 0.674 0 CA-C-O 117.814 -1.089 . . . . 0.0 111.101 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -106.57 80.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 121.873 1.704 . . . . 0.0 109.733 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 77.95 -72.86 0.08 Allowed 'General case' 0 CA--C 1.502 -0.89 0 C-N-CA 130.041 3.336 . . . . 0.0 109.2 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.0 mt 49.51 38.66 15.05 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 128.93 2.892 . . . . 0.0 114.295 -176.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -110.49 132.1 54.48 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.76 107.99 10.11 Favored 'General case' 0 CA--C 1.498 -1.055 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.061 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 178.963 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo . . . . . 0 N--CA 1.453 -0.898 0 N-CA-C 109.931 -0.834 . . . . 0.0 109.931 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.6 t -125.31 119.29 24.96 Favored Pre-proline 0 N--CA 1.445 -0.724 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -90.24 -21.74 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.648 0 CA-C-N 122.131 1.797 . . . . 0.0 110.085 -172.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 37.25 69.62 0.21 Allowed 'General case' 0 C--N 1.358 0.971 0 C-N-CA 129.114 2.965 . . . . 0.0 115.587 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 61.3 t -118.6 135.13 60.0 Favored 'Isoleucine or valine' 0 C--N 1.352 0.694 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 -172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -136.11 155.07 50.73 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 166.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 9.4 p90 -149.33 139.61 22.29 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.26 118.25 0.56 Allowed 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.89 153.1 36.35 Favored 'General case' 0 C--N 1.369 1.424 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.458 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -137.16 158.4 44.53 Favored 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.082 -1.047 . . . . 0.0 112.093 176.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.44 129.78 43.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 -168.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.5 p -158.85 15.98 0.18 Allowed 'General case' 0 N--CA 1.431 -1.388 0 C-N-CA 124.514 1.126 . . . . 0.0 108.119 -167.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.0 pp -21.89 145.64 0.01 OUTLIER Pre-proline 0 C--N 1.37 1.468 0 N-CA-C 117.631 2.456 . . . . 0.0 117.631 158.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -81.54 -48.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 121.789 1.659 . . . . 0.0 112.684 -169.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 39.8 ptt85 -163.09 178.46 8.26 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 -173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.5 m -19.37 121.92 0.02 OUTLIER 'General case' 0 C--N 1.364 1.218 0 C-N-CA 129.634 3.174 . . . . 0.0 115.68 172.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -126.71 146.17 56.11 Favored Pre-proline 0 N--CA 1.44 -0.97 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 -163.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.01 -10.2 18.0 Favored 'Trans proline' 0 CA--C 1.512 -0.623 0 CA-C-N 122.788 2.031 . . . . 0.0 112.978 -161.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -161.92 -141.03 3.02 Favored Glycine 0 CA--C 1.491 -1.428 0 N-CA-C 109.067 -1.613 . . . . 0.0 109.067 176.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.3 m -63.39 145.77 54.92 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 126.19 1.796 . . . . 0.0 110.428 -179.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.65 128.74 51.5 Favored Pre-proline 0 N--CA 1.437 -1.11 0 C-N-CA 125.052 1.341 . . . . 0.0 110.344 -164.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -95.29 -153.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.054 3.169 . . . . 0.0 108.572 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -147.44 132.05 17.8 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -115.5 -12.44 11.66 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 123.841 0.856 . . . . 0.0 110.698 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -100.56 86.42 3.14 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.215 0.531 . . . . 0.0 111.507 177.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.4 t -70.95 97.45 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 126.373 1.869 . . . . 0.0 106.29 165.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.458 HD11 ' HB2' ' B' ' 855' ' ' ALA . 20.3 mt -87.67 -38.56 15.76 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.012 -1.075 . . . . 0.0 111.181 -174.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 51.0 tp -166.34 127.52 1.76 Allowed 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 100.656 -3.831 . . . . 0.0 100.656 166.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.41 ' HA ' ' HA ' ' B' ' 852' ' ' PHE . 27.5 t-20 178.08 61.32 0.01 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.779 1.627 . . . . 0.0 109.286 -164.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.86 -43.77 97.92 Favored 'General case' 0 C--N 1.363 1.166 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 -167.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.93 -28.61 11.72 Favored Glycine 0 C--N 1.355 1.623 0 CA-C-N 118.976 0.807 . . . . 0.0 112.734 -174.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.29 -61.32 0.3 Allowed Glycine 0 C--N 1.353 1.489 0 N-CA-C 107.503 -2.239 . . . . 0.0 107.503 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 62.12 -81.81 0.02 OUTLIER 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.018 2.527 . . . . 0.0 114.237 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -95.66 119.08 33.53 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 124.55 1.14 . . . . 0.0 108.283 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -81.7 117.9 70.07 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 174.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -93.68 2.6 3.21 Favored 'Trans proline' 0 CA--C 1.509 -0.76 0 CA-C-N 125.11 2.861 . . . . 0.0 109.728 -166.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -80.46 -44.51 19.1 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.9 p -106.19 -13.87 15.3 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.515 176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.94 24.79 43.54 Favored Glycine 0 C--N 1.362 2.018 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 162.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.5 t -100.42 103.51 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 101.711 -3.441 . . . . 0.0 101.711 -162.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -101.15 111.62 23.88 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 112.95 -1.932 . . . . 0.0 109.573 -175.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 57.3 m -100.73 107.78 19.46 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 169.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . 0.464 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -91.5 111.16 47.7 Favored Pre-proline 0 C--N 1.357 0.922 0 CA-C-O 117.013 -1.47 . . . . 0.0 111.88 171.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -93.43 3.3 3.27 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.267 2.202 . . . . 0.0 109.032 168.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -53.51 -49.6 67.2 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 126.67 1.988 . . . . 0.0 114.611 -169.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.61 48.72 13.73 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 125.451 1.501 . . . . 0.0 114.587 170.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.61 -165.31 18.24 Favored Glycine 0 N--CA 1.411 -2.972 1 N-CA-C 101.61 -4.596 . . . . 0.0 101.61 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 56.1 ttt-85 -88.66 119.71 29.39 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.64 147.71 42.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 -172.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 48.8 tp -108.7 114.22 27.83 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -112.57 138.45 49.33 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 125.965 1.706 . . . . 0.0 108.106 -171.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 73.9 m -143.46 119.13 10.44 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.21 153.33 22.85 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 90.4 t -109.13 122.28 63.52 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -103.13 120.65 41.08 Favored 'General case' 0 CA--C 1.504 -0.823 0 C-N-CA 124.557 1.143 . . . . 0.0 108.458 -173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 10.5 m -79.61 132.85 36.37 Favored 'General case' 0 C--N 1.353 0.758 0 C-N-CA 124.974 1.31 . . . . 0.0 107.567 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.61 -57.71 13.26 Favored Glycine 0 C--N 1.364 2.111 0 C-N-CA 125.975 1.75 . . . . 0.0 115.233 -167.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.8 m80 37.96 71.92 0.14 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 127.558 2.343 . . . . 0.0 114.887 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 51.2 ptt85 -72.84 -11.54 60.64 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 126.005 1.722 . . . . 0.0 111.262 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -72.5 -13.64 61.47 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 126.378 1.871 . . . . 0.0 112.406 -168.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.337 6.9 pt-20 115.69 -176.77 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.147 0 C-N-CA 128.267 2.627 . . . . 0.0 108.267 174.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 74.1 tttt 101.36 135.85 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 C-N-CA 127.568 2.347 . . . . 0.0 106.588 172.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 78.3 t -98.75 127.29 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 -171.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -108.95 128.76 55.21 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.914 1.686 . . . . 0.0 109.969 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.49 114.39 4.7 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 124.817 1.247 . . . . 0.0 109.649 -176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.0 t -88.75 115.75 29.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 C-N-CA 125.316 1.446 . . . . 0.0 107.371 177.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.7 mt -62.27 141.79 58.06 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 126.744 2.018 . . . . 0.0 110.021 177.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.4 t -116.05 147.35 41.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 126.067 1.747 . . . . 0.0 109.506 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.643 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.02 138.81 38.19 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 127.82 2.448 . . . . 0.0 110.301 -173.299 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 96.35 -12.04 0.08 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 129.385 3.074 . . . . 0.0 112.931 173.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -136.52 -26.91 1.07 Allowed 'General case' 0 C--N 1.357 0.933 0 CA-C-N 119.453 1.024 . . . . 0.0 111.682 -171.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 60.64 163.27 0.06 Allowed 'General case' 0 C--N 1.362 1.152 0 C-N-CA 125.77 1.628 . . . . 0.0 111.317 -165.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.48 -133.52 44.86 Favored Glycine 0 C--N 1.364 2.102 0 O-C-N 119.516 -1.99 . . . . 0.0 108.893 -162.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.3 t 55.86 76.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.159 0 C-N-CA 125.604 1.562 . . . . 0.0 110.813 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.45 114.72 27.32 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 -173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -104.16 -34.0 8.53 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-N 113.794 -1.548 . . . . 0.0 108.788 -173.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 88.4 t -100.92 77.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.919 -2.993 . . . . 0.0 102.919 166.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -97.97 129.95 44.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.899 -174.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.5 t -143.51 115.53 8.34 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 125.173 1.389 . . . . 0.0 107.916 169.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.93 84.71 0.73 Allowed Glycine 0 CA--C 1.488 -1.64 0 N-CA-C 104.918 -3.273 . . . . 0.0 104.918 168.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.691 0 C-N-CA 125.435 1.493 . . . . 0.0 111.266 175.614 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 44.3 m . . . . . 0 N--CA 1.444 -0.772 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 65.0 mt -116.4 133.69 55.73 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 -169.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.36 162.97 27.57 Favored Glycine 0 CA--C 1.492 -1.381 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -173.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 33.4 m -119.32 131.08 73.01 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 173.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -138.42 150.23 46.29 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 178.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.8 m -118.77 -39.78 2.94 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 176.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 45.7 tp -82.74 -51.64 7.5 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-N 119.474 1.034 . . . . 0.0 112.122 -169.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.475 HD11 ' HB3' ' A' ' 872' ' ' LEU . 30.2 pt -84.53 -176.18 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 C-N-CA 125.663 1.585 . . . . 0.0 110.307 -177.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.21 84.9 2.04 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -167.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.25 93.54 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.051 1.834 . . . . 0.0 110.389 163.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.4 mp -120.56 142.23 49.54 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 105.225 -2.139 . . . . 0.0 105.225 179.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -93.16 158.85 15.55 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.953 177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.05 123.57 23.1 Favored 'General case' 0 C--N 1.376 1.747 0 CA-C-N 119.46 1.027 . . . . 0.0 108.665 175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.97 -10.19 74.98 Favored Glycine 0 C--N 1.344 0.984 0 C-N-CA 125.351 1.453 . . . . 0.0 111.207 170.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.17 174.65 6.09 Favored 'General case' 0 N--CA 1.439 -0.993 0 C-N-CA 123.869 0.867 . . . . 0.0 110.684 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 97.9 m -143.11 125.93 16.1 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -159.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.643 HG13 HH11 ' B' ' 914' ' ' ARG . 20.7 m -96.39 151.18 4.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-O 121.337 0.589 . . . . 0.0 110.625 172.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.2 138.95 31.85 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.236 1.814 . . . . 0.0 111.194 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 99.0 t -91.2 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 126.971 2.109 . . . . 0.0 106.892 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -105.7 131.26 53.28 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 100.835 -3.765 . . . . 0.0 100.835 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -131.25 70.62 1.46 Allowed 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 179.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 58.5 t -161.52 101.1 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.0 mmm -152.39 69.61 0.88 Allowed 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 105.31 -2.107 . . . . 0.0 105.31 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.7 142.9 6.63 Favored Glycine 0 C--N 1.35 1.347 0 N-CA-C 107.39 -2.284 . . . . 0.0 107.39 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -110.14 -29.36 8.23 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -174.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -92.29 86.92 5.86 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.801 -1.555 . . . . 0.0 106.801 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.23 -163.17 1.38 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -172.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 25.8 t60 -124.62 159.22 31.23 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.7 t -92.02 133.33 35.82 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -159.03 152.27 22.48 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -177.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 112.39 22.52 Favored Pre-proline 0 C--N 1.355 0.819 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 172.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -98.4 173.7 0.53 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.071 1.847 . . . . 0.0 108.384 -179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -117.41 138.13 52.02 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.3 p -138.99 140.69 38.27 Favored 'General case' 0 C--N 1.374 1.651 0 CA-C-N 119.892 1.223 . . . . 0.0 108.393 -170.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 33.6 mm -116.02 130.53 70.58 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 N-CA-C 107.243 -1.392 . . . . 0.0 107.243 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -127.17 106.0 8.95 Favored 'General case' 0 C--N 1.363 1.161 0 N-CA-C 106.564 -1.643 . . . . 0.0 106.564 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 33.3 p -101.27 162.36 12.95 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 124.738 1.215 . . . . 0.0 110.07 171.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 109.83 0.28 Allowed Glycine 0 C--N 1.359 1.825 0 C-N-CA 119.234 -1.46 . . . . 0.0 110.131 173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.41 144.17 47.07 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.313 1.597 . . . . 0.0 115.313 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 67.7 tp -72.16 124.62 25.4 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 124.9 1.28 . . . . 0.0 109.706 -178.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.46 -58.54 1.94 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -132.29 128.51 37.93 Favored 'General case' 0 N--CA 1.43 -1.452 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -174.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.71 129.93 10.09 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 103.72 -3.752 . . . . 0.0 103.72 164.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -68.86 129.02 92.65 Favored Pre-proline 0 C--N 1.351 0.648 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.292 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -106.74 80.18 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 CA-C-N 121.595 1.605 . . . . 0.0 109.103 -169.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 78.01 -72.03 0.09 Allowed 'General case' 0 CA--C 1.501 -0.92 0 C-N-CA 129.91 3.284 . . . . 0.0 109.222 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.8 mt 48.74 40.26 15.63 Favored 'General case' 0 C--N 1.346 0.42 0 C-N-CA 128.884 2.874 . . . . 0.0 113.936 -175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -112.51 132.14 55.24 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.88 107.63 9.53 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.093 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 178.717 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo . . . . . 0 N--CA 1.453 -0.885 0 N-CA-C 109.982 -0.814 . . . . 0.0 109.982 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.4 t -124.17 114.29 27.77 Favored Pre-proline 0 N--CA 1.442 -0.832 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.23 -22.24 1.39 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.666 1.631 . . . . 0.0 110.296 -172.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 36.59 70.28 0.17 Allowed 'General case' 0 C--N 1.357 0.9 0 C-N-CA 128.862 2.865 . . . . 0.0 115.893 177.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.47 137.13 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.759 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.8 155.98 49.67 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 105.223 -2.14 . . . . 0.0 105.223 164.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.42 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 6.6 p90 -148.44 137.2 21.58 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 18.2 t -171.67 119.8 0.46 Allowed 'General case' 0 C--N 1.362 1.147 0 CA-C-O 118.218 -0.896 . . . . 0.0 109.629 -176.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.54 153.36 35.51 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.81 158.71 43.64 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 120.192 -0.603 . . . . 0.0 110.831 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.554 HD21 HD23 ' C' ' 858' ' ' LEU . 2.4 tm? -138.14 130.53 29.1 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -166.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 65.1 m -158.28 16.26 0.21 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -171.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.554 HD23 HD21 ' C' ' 856' ' ' LEU . 2.5 pp -30.61 149.54 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.453 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 160.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -80.32 -45.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 122.212 1.826 . . . . 0.0 113.929 -161.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -162.11 178.01 9.18 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -171.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -15.97 125.36 0.01 OUTLIER 'General case' 0 C--N 1.364 1.21 0 C-N-CA 130.39 3.476 . . . . 0.0 116.57 174.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.98 149.18 42.87 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 -160.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -75.55 -16.26 19.12 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.687 2.258 . . . . 0.0 112.111 -176.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -138.96 2.56 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 9.4 m -67.47 144.98 55.43 Favored 'General case' 0 C--N 1.356 0.889 0 C-N-CA 125.364 1.466 . . . . 0.0 109.98 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 54.4 t -93.93 133.08 28.25 Favored Pre-proline 0 N--CA 1.439 -0.987 0 C-N-CA 124.797 1.239 . . . . 0.0 110.343 -162.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -97.24 -151.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.806 3.004 . . . . 0.0 109.45 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 6.6 p90 -144.96 132.52 20.88 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 36.3 p-10 -114.24 -16.53 12.02 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 123.492 0.717 . . . . 0.0 111.225 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -102.79 82.79 2.16 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-O 121.253 0.549 . . . . 0.0 111.241 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 48.3 t -68.6 97.32 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.61 1.964 . . . . 0.0 106.707 165.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 16.8 mt -90.6 -37.34 13.88 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.561 -173.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.4 tp -164.99 126.61 2.09 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 101.165 -3.643 . . . . 0.0 101.165 167.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.42 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 28.5 t-20 174.03 61.34 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.88 0 CA-C-N 120.139 1.336 . . . . 0.0 107.784 -163.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -60.28 -42.43 95.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 -165.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.75 -28.49 18.64 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 118.802 0.728 . . . . 0.0 112.303 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.88 -58.52 0.47 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 62.53 -81.18 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 128.069 2.547 . . . . 0.0 114.525 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -96.44 120.1 36.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 125.332 1.453 . . . . 0.0 108.683 -175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -85.53 117.31 68.49 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 173.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -94.2 8.03 2.3 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 CA-C-N 125.101 2.857 . . . . 0.0 109.643 -169.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.45 -45.4 19.49 Favored 'General case' 0 CA--C 1.499 -1.016 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 36.4 p -106.09 -16.45 14.61 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 125.456 1.502 . . . . 0.0 108.003 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.11 24.54 47.9 Favored Glycine 0 C--N 1.361 1.967 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 164.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 48.1 t -101.6 103.12 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.437 0 N-CA-C 101.511 -3.514 . . . . 0.0 101.511 -166.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.61 111.48 23.4 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 112.648 -2.069 . . . . 0.0 108.734 -178.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 52.3 m -102.02 107.89 19.16 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 168.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . 0.578 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.83 110.83 46.3 Favored Pre-proline 0 C--N 1.357 0.9 0 CA-C-O 117.262 -1.351 . . . . 0.0 111.777 171.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -93.06 1.43 3.57 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.557 2.171 . . . . 0.0 108.472 165.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 50.3 mt -53.68 -54.51 36.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 127.86 2.464 . . . . 0.0 114.179 -169.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.42 69.14 0.74 Allowed 'General case' 0 C--N 1.365 1.274 0 CA-C-O 122.185 0.993 . . . . 0.0 111.166 171.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.82 173.4 46.23 Favored Glycine 0 N--CA 1.405 -3.379 1 N-CA-C 100.791 -4.924 . . . . 0.0 100.791 -170.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.5 ttt-85 -93.32 115.72 28.29 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 113.7 -1.25 . . . . 0.0 107.741 174.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -117.8 160.57 21.16 Favored 'General case' 0 C--N 1.365 1.264 0 CA-C-N 119.161 0.891 . . . . 0.0 110.845 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 64.5 tp -108.16 113.99 27.53 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 124.495 1.118 . . . . 0.0 108.131 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.2 tt -116.7 141.68 47.89 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 124.795 1.238 . . . . 0.0 108.898 -176.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 63.1 m -143.26 120.66 11.64 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 123.625 0.77 . . . . 0.0 110.241 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.11 154.6 20.92 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.0 t -99.71 123.62 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 67.6 mt -99.29 120.09 38.99 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 124.264 1.025 . . . . 0.0 109.155 -172.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -84.87 132.78 34.35 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 106.789 -1.559 . . . . 0.0 106.789 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.67 -59.16 11.02 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 125.022 1.296 . . . . 0.0 114.095 -169.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.2 m80 39.91 65.02 0.78 Allowed 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.126 2.171 . . . . 0.0 113.899 176.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -71.62 -9.43 58.23 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 125.24 1.416 . . . . 0.0 112.12 -174.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.07 -17.43 61.42 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.244 1.418 . . . . 0.0 112.649 -170.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.32 9.6 pt-20 126.23 -175.61 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.151 0 C-N-CA 128.108 2.563 . . . . 0.0 107.909 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 40.0 tttp 101.0 130.51 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.252 0 C-N-CA 127.766 2.426 . . . . 0.0 106.741 171.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.4 t -99.38 123.17 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.205 0 N-CA-C 105.566 -2.012 . . . . 0.0 105.566 -174.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -109.3 121.65 45.64 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.366 171.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.43 116.92 17.41 Favored 'General case' 0 C--N 1.372 1.551 0 C-N-CA 128.581 2.752 . . . . 0.0 109.885 -177.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 98.2 t -87.12 114.39 26.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 22.2 mt -61.62 147.11 46.84 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 126.835 2.054 . . . . 0.0 111.688 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.269 1.2 p -114.96 149.14 37.79 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 127.106 2.162 . . . . 0.0 109.685 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.578 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.15 138.95 38.97 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.146 1.778 . . . . 0.0 109.283 174.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 5.8 t 98.0 -16.6 0.05 Allowed 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 129.23 3.012 . . . . 0.0 112.409 173.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -136.39 -26.88 1.09 Allowed 'General case' 0 C--N 1.356 0.863 0 CA-C-N 119.105 0.866 . . . . 0.0 111.574 -170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 60.01 169.68 0.08 Allowed 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.141 1.377 . . . . 0.0 111.308 -164.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.25 -130.98 50.31 Favored Glycine 0 C--N 1.374 2.681 0 O-C-N 119.599 -1.938 . . . . 0.0 110.117 -164.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 60.2 t 53.21 77.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.257 0 C-N-CA 125.961 1.704 . . . . 0.0 111.551 174.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.7 115.0 27.46 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 -171.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -102.54 -35.7 8.65 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 114.069 -1.423 . . . . 0.0 108.626 -171.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 86.47 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 102.897 -3.001 . . . . 0.0 102.897 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -95.33 130.28 42.16 Favored 'General case' 0 C--N 1.351 0.672 0 CA-C-O 121.102 0.477 . . . . 0.0 110.233 -176.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 21.0 t -142.0 115.45 8.99 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 125.764 1.626 . . . . 0.0 108.28 174.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.96 85.48 0.63 Allowed Glycine 0 CA--C 1.48 -2.132 0 N-CA-C 104.51 -3.436 . . . . 0.0 104.51 170.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.723 0 C-N-CA 124.726 1.155 . . . . 0.0 110.947 170.185 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.0 m . . . . . 0 N--CA 1.445 -0.7 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 65.5 mt -122.08 133.62 54.77 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -145.24 163.71 28.08 Favored Glycine 0 CA--C 1.493 -1.289 0 N-CA-C 109.071 -1.611 . . . . 0.0 109.071 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -119.07 131.85 70.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -134.2 150.5 51.07 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 121.369 -0.832 . . . . 0.0 108.955 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 48.8 m -117.47 -42.81 2.85 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 16.8 tp -90.01 -52.62 4.87 Favored 'General case' 0 C--N 1.358 0.977 0 O-C-N 121.453 -0.779 . . . . 0.0 111.913 -166.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.17 -176.91 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.773 0 C-N-CA 126.23 1.812 . . . . 0.0 109.321 -176.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -162.27 85.93 1.52 Allowed Pre-proline 0 N--CA 1.443 -0.824 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -167.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.12 89.54 1.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.328 2.019 . . . . 0.0 109.964 164.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.7 145.89 47.98 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 -176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -92.77 161.16 14.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.342 -179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.53 122.73 20.98 Favored 'General case' 0 C--N 1.382 2.012 0 CA-C-N 120.067 1.303 . . . . 0.0 108.877 174.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.33 -11.19 72.72 Favored Glycine 0 C--N 1.346 1.13 0 C-N-CA 125.517 1.532 . . . . 0.0 111.377 168.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.55 175.56 4.04 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.67 0.788 . . . . 0.0 111.608 177.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 99.4 m -143.29 126.56 16.6 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 123.898 0.879 . . . . 0.0 110.412 -160.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 27.2 m -96.99 148.52 5.46 Favored 'Isoleucine or valine' 0 C--N 1.362 1.129 0 C-N-CA 123.842 0.857 . . . . 0.0 109.191 173.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.7 t -141.49 139.66 33.35 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 126.079 1.752 . . . . 0.0 111.451 -174.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 98.2 t -90.44 129.01 41.97 Favored 'Isoleucine or valine' 0 C--N 1.369 1.428 0 C-N-CA 126.271 1.828 . . . . 0.0 107.574 -177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -108.02 131.53 54.48 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 101.731 -3.433 . . . . 0.0 101.731 168.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 5.1 tt -132.56 77.99 1.78 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 113.105 -1.862 . . . . 0.0 107.032 173.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.9 t -159.25 99.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.974 0 N-CA-C 104.441 -2.429 . . . . 0.0 104.441 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -150.71 81.07 1.34 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 104.018 -2.586 . . . . 0.0 104.018 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.07 148.64 16.51 Favored Glycine 0 C--N 1.348 1.231 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 -177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -115.29 -28.56 6.86 Favored 'General case' 0 N--CA 1.441 -0.875 0 C-N-CA 123.484 0.713 . . . . 0.0 109.274 -173.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.4 tp -91.33 87.14 6.35 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.86 -162.56 1.31 Allowed 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 30.1 m80 -123.84 157.97 32.91 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 -178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.5 133.25 35.66 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.82 150.82 23.06 Favored 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.64 112.61 22.75 Favored Pre-proline 0 C--N 1.355 0.817 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 172.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -101.45 -178.21 0.15 Allowed 'Trans proline' 0 CA--C 1.51 -0.705 0 C-N-CA 121.766 1.644 . . . . 0.0 108.294 -177.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 tt -118.17 137.32 53.06 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 124.253 1.021 . . . . 0.0 109.294 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 21.9 p -138.27 137.26 37.3 Favored 'General case' 0 C--N 1.376 1.719 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 42.0 mm -115.24 131.89 66.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -125.14 104.45 8.53 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 -173.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 30.2 p -102.51 163.72 12.07 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.313 1.445 . . . . 0.0 110.016 171.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.59 112.29 0.36 Allowed Glycine 0 C--N 1.356 1.679 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.29 143.04 46.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 57.6 tp -73.68 125.18 27.47 Favored 'General case' 0 C--N 1.376 1.745 0 C-N-CA 125.556 1.543 . . . . 0.0 110.054 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 15.5 tp -98.74 -57.35 2.2 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 122.376 0.27 . . . . 0.0 110.362 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -131.13 128.07 39.37 Favored 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 -175.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 131.08 10.53 Favored Glycine 0 N--CA 1.433 -1.514 0 N-CA-C 104.174 -3.57 . . . . 0.0 104.174 167.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -70.28 128.73 91.15 Favored Pre-proline 0 C--N 1.348 0.522 0 CA-C-O 117.768 -1.11 . . . . 0.0 111.214 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -106.71 78.06 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.572 0 CA-C-N 122.029 1.76 . . . . 0.0 109.667 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 78.61 -72.74 0.08 Allowed 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 129.852 3.261 . . . . 0.0 109.083 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 67.1 mt 49.19 39.46 15.58 Favored 'General case' 0 C--N 1.346 0.448 0 C-N-CA 128.789 2.836 . . . . 0.0 113.828 -174.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.4 132.04 54.74 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.53 107.37 9.42 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 105.299 -2.112 . . . . 0.0 105.299 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.067 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 178.677 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.455 -0.777 0 N-CA-C 110.031 -0.796 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 45.0 t -126.87 119.55 22.55 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 104.585 -2.376 . . . . 0.0 104.585 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -89.84 -22.21 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.106 1.788 . . . . 0.0 109.797 -173.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 36.92 70.01 0.19 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 129.025 2.93 . . . . 0.0 115.498 -179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 80.5 t -118.64 137.23 53.26 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.705 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -174.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.78 160.73 37.28 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 165.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -149.31 140.16 22.79 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 27.1 t -169.43 116.52 0.6 Allowed 'General case' 0 C--N 1.352 0.705 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 -178.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -122.95 153.18 40.07 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 -176.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -138.64 157.83 45.38 Favored 'General case' 0 C--N 1.353 0.743 0 C-N-CA 119.292 -0.963 . . . . 0.0 111.24 177.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.572 HD21 HD23 ' A' ' 858' ' ' LEU . 2.7 tm? -131.8 130.97 42.49 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 -168.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 67.5 m -160.99 8.69 0.08 Allowed 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -162.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.572 HD23 HD21 ' A' ' 856' ' ' LEU . 2.9 pp -28.93 149.4 0.03 OUTLIER Pre-proline 0 C--N 1.367 1.361 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 162.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -81.48 -45.15 0.08 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.553 0 CA-C-N 121.966 1.738 . . . . 0.0 113.672 -163.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 33.9 ptt85 -162.56 173.98 13.24 Favored 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -174.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.89 118.84 0.01 OUTLIER 'General case' 0 C--N 1.363 1.19 0 C-N-CA 130.647 3.579 . . . . 0.0 116.759 174.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -104.7 164.44 15.19 Favored Pre-proline 0 N--CA 1.442 -0.846 0 C-N-CA 124.279 1.031 . . . . 0.0 110.271 -171.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -78.71 -15.5 13.53 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.751 2.301 . . . . 0.0 111.337 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.78 -140.59 3.12 Favored Glycine 0 C--N 1.356 1.689 0 CA-C-N 120.176 1.353 . . . . 0.0 111.189 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.7 m -63.09 145.38 55.59 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 127.616 2.366 . . . . 0.0 111.454 -174.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -80.7 127.1 76.4 Favored Pre-proline 0 N--CA 1.441 -0.879 0 C-N-CA 125.308 1.443 . . . . 0.0 111.59 -166.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -98.52 -150.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.429 2.752 . . . . 0.0 107.779 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -149.25 134.3 18.11 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 39.7 p-10 -117.52 -13.4 10.3 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 123.029 0.532 . . . . 0.0 110.524 178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -100.09 86.79 3.31 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 54.1 t -71.78 97.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 126.145 1.778 . . . . 0.0 106.96 168.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 42.3 mt -88.24 -37.15 16.31 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.376 -173.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 39.8 tp -166.38 128.3 1.83 Allowed 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 101.438 -3.542 . . . . 0.0 101.438 162.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 -178.34 61.54 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.84 1.655 . . . . 0.0 109.386 -167.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.28 -44.37 92.47 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -165.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.51 -31.27 8.98 Favored Glycine 0 C--N 1.355 1.617 0 CA-C-N 118.827 0.739 . . . . 0.0 112.388 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.59 -62.36 0.29 Allowed Glycine 0 C--N 1.353 1.474 0 N-CA-C 106.791 -2.524 . . . . 0.0 106.791 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 66.9 -78.19 0.04 OUTLIER 'General case' 0 C--N 1.355 0.814 0 C-N-CA 128.108 2.563 . . . . 0.0 113.478 174.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -96.36 120.53 36.82 Favored 'General case' 0 N--CA 1.431 -1.398 0 C-N-CA 125.309 1.444 . . . . 0.0 108.792 -176.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -80.04 117.19 66.25 Favored Pre-proline 0 N--CA 1.441 -0.875 0 N-CA-C 104.311 -2.478 . . . . 0.0 104.311 171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -94.24 5.6 2.64 Favored 'Trans proline' 0 CA--C 1.508 -0.784 0 CA-C-N 125.43 2.975 . . . . 0.0 108.991 -168.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -80.29 -45.59 17.62 Favored 'General case' 0 CA--C 1.501 -0.913 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 25.3 p -106.28 -13.36 15.42 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.107 1.363 . . . . 0.0 108.544 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.48 26.79 37.96 Favored Glycine 0 C--N 1.364 2.125 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 161.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 23.7 t -101.05 103.94 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 N-CA-C 100.419 -3.919 . . . . 0.0 100.419 -163.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -101.49 112.44 24.98 Favored 'General case' 0 CA--C 1.504 -0.806 0 CA-C-N 112.298 -2.228 . . . . 0.0 108.529 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 68.1 m -100.47 108.42 20.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 167.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . 0.434 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.41 111.18 45.88 Favored Pre-proline 0 C--N 1.357 0.896 0 CA-C-O 117.062 -1.447 . . . . 0.0 111.85 171.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -94.35 1.51 2.93 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 CA-C-N 123.107 2.145 . . . . 0.0 109.196 169.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 30.2 mt -55.49 -49.94 71.21 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.148 2.179 . . . . 0.0 114.076 -168.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.22 52.63 7.26 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.637 1.175 . . . . 0.0 113.749 169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -166.75 -167.3 27.22 Favored Glycine 0 N--CA 1.414 -2.771 1 N-CA-C 100.496 -5.042 . . . . 0.0 100.496 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.99 121.44 35.47 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.27 3.5 p90 -115.26 161.31 18.65 Favored 'General case' 0 C--N 1.366 1.291 0 CA-C-N 119.099 0.863 . . . . 0.0 109.127 174.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -104.7 116.94 32.9 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 123.62 0.768 . . . . 0.0 109.538 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -109.45 137.35 47.43 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 126.806 2.042 . . . . 0.0 109.136 -166.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.5 m -146.37 118.89 8.49 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 123.399 0.68 . . . . 0.0 109.218 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.06 153.55 22.45 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.8 t -110.28 118.86 58.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.014 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -101.44 123.56 45.7 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.497 -173.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 45.8 m -79.17 131.23 36.14 Favored 'General case' 0 C--N 1.353 0.736 0 C-N-CA 125.414 1.486 . . . . 0.0 107.512 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.77 -56.47 20.33 Favored Glycine 0 C--N 1.362 2.01 0 C-N-CA 126.064 1.792 . . . . 0.0 114.897 -168.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.3 m170 33.52 74.54 0.06 Allowed 'General case' 0 C--N 1.359 0.987 0 C-N-CA 127.964 2.506 . . . . 0.0 115.897 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -72.77 -10.72 60.12 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.437 1.495 . . . . 0.0 111.355 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -73.09 -14.74 61.45 Favored 'General case' 0 C--N 1.357 0.908 0 C-N-CA 125.369 1.468 . . . . 0.0 112.228 -171.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.363 8.3 pt-20 123.4 -168.68 0.0 OUTLIER 'General case' 0 C--N 1.363 1.155 0 C-N-CA 128.26 2.624 . . . . 0.0 108.166 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 64.9 mttt 98.29 135.54 0.02 OUTLIER 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 128.258 2.623 . . . . 0.0 107.261 170.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.9 t -100.24 125.26 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.53 128.79 54.83 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 127.121 2.168 . . . . 0.0 109.699 176.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.68 114.64 4.7 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 124.865 1.266 . . . . 0.0 110.06 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.7 114.68 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.0 mt -62.51 141.67 58.31 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 126.156 1.782 . . . . 0.0 110.297 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 4.8 t -114.92 146.83 40.73 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 126.202 1.801 . . . . 0.0 109.129 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.629 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.17 138.05 38.49 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 127.91 2.484 . . . . 0.0 110.022 -174.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.27 -3.85 0.07 Allowed 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 129.142 2.977 . . . . 0.0 112.809 172.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 72.1 m-80 -144.25 -25.99 0.53 Allowed 'General case' 0 C--N 1.357 0.931 0 CA-C-N 119.56 1.073 . . . . 0.0 111.245 -175.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 58.46 166.71 0.05 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.4 1.48 . . . . 0.0 112.1 -164.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.22 -134.87 48.46 Favored Glycine 0 C--N 1.37 2.454 0 O-C-N 119.359 -2.088 . . . . 0.0 109.303 -161.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 43.8 t 57.29 73.49 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 125.467 1.507 . . . . 0.0 110.277 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.68 113.95 26.35 Favored 'General case' 0 CA--C 1.492 -1.262 0 N-CA-C 105.409 -2.071 . . . . 0.0 105.409 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -103.13 -35.55 8.45 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 113.943 -1.481 . . . . 0.0 108.404 -170.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 90.8 t -100.37 78.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.338 -3.208 . . . . 0.0 102.338 168.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -97.32 129.09 44.63 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.5 -173.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.9 t -143.43 114.56 7.84 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 169.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.57 84.51 0.75 Allowed Glycine 0 CA--C 1.487 -1.669 0 N-CA-C 104.168 -3.573 . . . . 0.0 104.168 165.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.836 0 C-N-CA 124.747 1.165 . . . . 0.0 113.786 178.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 40.3 m . . . . . 0 CA--C 1.507 -0.68 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 62.0 mt -117.89 133.8 55.57 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 -172.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.66 162.44 26.99 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.3 m -122.01 129.46 75.38 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 176.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -137.75 147.51 44.78 Favored 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -178.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.7 m -115.6 -44.89 2.93 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 178.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 44.7 tp -82.27 -49.95 9.5 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 119.237 0.926 . . . . 0.0 113.038 -166.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 13.7 pt -86.96 -171.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 C-N-CA 125.955 1.702 . . . . 0.0 109.973 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -160.92 81.92 2.07 Favored Pre-proline 0 N--CA 1.437 -1.097 0 C-N-CA 123.442 0.697 . . . . 0.0 109.185 -165.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -73.75 91.27 0.9 Allowed 'Trans proline' 0 N--CA 1.46 -0.498 0 CA-C-N 122.509 1.932 . . . . 0.0 109.644 162.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.5 mp -121.42 142.53 49.92 Favored 'General case' 0 CA--C 1.502 -0.884 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 -179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -94.78 155.03 17.0 Favored 'General case' 0 C--N 1.361 1.108 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.579 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.64 123.28 21.49 Favored 'General case' 0 C--N 1.372 1.566 0 CA-C-N 119.518 1.054 . . . . 0.0 108.93 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.75 -10.39 74.71 Favored Glycine 0 C--N 1.346 1.135 0 C-N-CA 125.706 1.622 . . . . 0.0 111.297 171.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.21 175.65 5.14 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 123.575 0.75 . . . . 0.0 111.332 177.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 88.5 m -142.6 125.34 15.96 Favored 'General case' 0 CA--C 1.494 -1.179 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -160.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.629 HG13 HH11 ' A' ' 914' ' ' ARG . 24.4 m -94.82 151.27 3.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 CA-C-O 121.666 0.746 . . . . 0.0 109.692 171.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -142.05 138.3 31.69 Favored 'General case' 0 C--N 1.352 0.675 0 C-N-CA 126.446 1.898 . . . . 0.0 111.269 -177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 75.6 t -92.43 129.96 42.24 Favored 'Isoleucine or valine' 0 C--N 1.37 1.484 0 C-N-CA 126.589 1.955 . . . . 0.0 106.322 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -105.92 131.95 52.61 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 101.237 -3.616 . . . . 0.0 101.237 173.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -131.03 71.9 1.49 Allowed 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 59.1 t -162.75 101.37 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.811 0 N-CA-C 105.486 -2.042 . . . . 0.0 105.486 -177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.8 mmm -153.1 70.67 0.88 Allowed 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.75 147.07 7.52 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -113.31 -30.33 6.95 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.9 tp -91.17 87.65 6.62 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.66 -177.14 4.6 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -166.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -116.99 156.29 27.71 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 17.1 t -90.67 134.16 34.61 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.76 150.55 21.03 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -177.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.25 112.96 21.46 Favored Pre-proline 0 C--N 1.355 0.832 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -99.58 173.82 0.4 Allowed 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 121.952 1.768 . . . . 0.0 108.586 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.5 mp -117.78 140.1 50.16 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -139.94 141.56 36.46 Favored 'General case' 0 C--N 1.375 1.678 0 CA-C-N 119.748 1.158 . . . . 0.0 108.797 -170.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 21.5 mm -119.67 130.23 74.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -125.63 104.85 8.6 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 54.8 p -101.6 162.03 13.2 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 124.831 1.253 . . . . 0.0 110.161 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.99 112.28 0.32 Allowed Glycine 0 C--N 1.358 1.769 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 174.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.15 144.43 46.67 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -174.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.1 tp -74.25 124.12 25.81 Favored 'General case' 0 C--N 1.379 1.882 0 C-N-CA 124.59 1.156 . . . . 0.0 109.675 -175.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 28.6 tp -98.61 -57.62 2.15 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.847 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -131.72 127.57 37.09 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -174.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.43 129.08 9.77 Favored Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 103.498 -3.841 . . . . 0.0 103.498 166.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -69.21 129.04 92.26 Favored Pre-proline 0 C--N 1.352 0.681 0 CA-C-O 117.743 -1.123 . . . . 0.0 111.16 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -106.82 80.6 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 CA-C-N 122.111 1.79 . . . . 0.0 109.873 -168.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 77.98 -72.79 0.08 Allowed 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 130.149 3.379 . . . . 0.0 109.161 178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 78.8 mt 49.54 39.16 16.34 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 129.279 3.032 . . . . 0.0 114.133 -176.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -111.7 131.79 55.06 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.56 108.34 10.15 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 177.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 179.574 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.771 0 N-CA-C 110.006 -0.806 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.8 t -126.55 119.75 23.08 Favored Pre-proline 0 C--N 1.354 0.77 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 -178.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -90.64 -22.24 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 CA-C-N 122.136 1.799 . . . . 0.0 109.986 -173.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 37.69 70.45 0.19 Allowed 'General case' 0 C--N 1.36 1.047 0 C-N-CA 129.192 2.997 . . . . 0.0 115.196 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.26 137.46 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.64 160.02 39.4 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 165.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -148.83 139.97 23.11 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.4 t -169.28 117.52 0.64 Allowed 'General case' 0 C--N 1.354 0.765 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 -178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -124.37 153.9 41.16 Favored 'General case' 0 C--N 1.368 1.403 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 -175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -141.56 157.85 44.59 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.145 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.582 HD21 HD23 ' B' ' 858' ' ' LEU . 2.7 tm? -133.4 128.44 35.56 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -168.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.2 m -159.84 12.21 0.13 Allowed 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 124.717 1.207 . . . . 0.0 107.747 -166.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.582 HD23 HD21 ' B' ' 856' ' ' LEU . 2.9 pp -28.68 149.87 0.03 OUTLIER Pre-proline 0 C--N 1.369 1.422 0 N-CA-C 117.642 2.46 . . . . 0.0 117.642 160.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.45 -45.5 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.609 0 CA-C-N 122.046 1.766 . . . . 0.0 113.777 -164.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 33.6 ptt85 -162.52 173.93 13.35 Favored 'General case' 0 CA--C 1.504 -0.818 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -173.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 16.5 m -11.81 118.94 0.01 OUTLIER 'General case' 0 C--N 1.363 1.156 0 C-N-CA 130.692 3.597 . . . . 0.0 116.771 174.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -105.08 164.44 15.12 Favored Pre-proline 0 N--CA 1.442 -0.87 0 C-N-CA 124.325 1.05 . . . . 0.0 110.294 -171.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.77 -15.54 13.4 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.782 2.321 . . . . 0.0 111.35 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -171.53 -140.85 3.17 Favored Glycine 0 C--N 1.355 1.6 0 CA-C-N 120.222 1.374 . . . . 0.0 111.193 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 20.0 m -62.93 144.62 56.59 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.473 2.309 . . . . 0.0 111.388 -174.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -78.93 126.36 82.32 Favored Pre-proline 0 N--CA 1.443 -0.81 0 C-N-CA 125.394 1.477 . . . . 0.0 111.565 -167.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -98.98 -150.99 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.506 0 C-N-CA 123.364 2.709 . . . . 0.0 107.566 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -148.79 133.3 17.66 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -114.97 -13.96 11.89 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 124.333 1.053 . . . . 0.0 109.508 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -100.85 86.4 3.07 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.994 0.426 . . . . 0.0 111.312 177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.78 97.49 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 126.39 1.876 . . . . 0.0 106.253 163.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 19.6 mt -88.27 -38.91 14.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 118.574 -1.25 . . . . 0.0 111.659 -173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 54.5 tp -166.03 127.38 1.85 Allowed 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 100.831 -3.766 . . . . 0.0 100.831 165.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 177.0 61.39 0.01 OUTLIER 'General case' 0 C--N 1.356 0.852 0 CA-C-N 120.509 1.504 . . . . 0.0 108.524 -163.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -59.79 -43.75 94.26 Favored 'General case' 0 C--N 1.363 1.177 0 N-CA-C 116.219 1.933 . . . . 0.0 116.219 -165.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.11 -31.27 9.26 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 118.759 0.709 . . . . 0.0 112.366 -175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 110.62 -60.74 0.32 Allowed Glycine 0 C--N 1.353 1.476 0 N-CA-C 107.064 -2.414 . . . . 0.0 107.064 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 66.23 -79.08 0.03 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.185 2.594 . . . . 0.0 113.644 174.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -97.01 120.75 37.95 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.5 1.52 . . . . 0.0 109.033 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -79.44 117.44 67.11 Favored Pre-proline 0 N--CA 1.443 -0.811 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 171.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -93.25 5.91 3.0 Favored 'Trans proline' 0 CA--C 1.509 -0.754 0 CA-C-N 125.485 2.995 . . . . 0.0 109.11 -169.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -80.1 -44.17 20.44 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 124.472 1.109 . . . . 0.0 108.656 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -109.16 -13.82 14.61 Favored 'General case' 0 N--CA 1.438 -1.03 0 C-N-CA 125.374 1.47 . . . . 0.0 108.306 175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.11 27.82 32.72 Favored Glycine 0 C--N 1.362 2.027 0 N-CA-C 110.424 -1.071 . . . . 0.0 110.424 162.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 24.2 t -101.44 103.58 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 -161.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -99.79 112.45 24.7 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 112.928 -1.942 . . . . 0.0 108.691 -175.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.5 m -101.16 108.23 19.85 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 167.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . 0.434 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.66 111.26 46.74 Favored Pre-proline 0 C--N 1.358 0.958 0 CA-C-O 117.06 -1.447 . . . . 0.0 111.959 170.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -93.37 1.4 3.42 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 123.186 2.174 . . . . 0.0 109.183 168.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 31.0 mt -55.43 -49.5 72.25 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.055 2.142 . . . . 0.0 114.36 -168.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.75 52.08 7.02 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.762 1.225 . . . . 0.0 114.263 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -167.11 -166.41 26.15 Favored Glycine 0 N--CA 1.413 -2.871 1 N-CA-C 101.12 -4.792 . . . . 0.0 101.12 178.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 66.1 ttt-85 -93.2 121.33 34.45 Favored 'General case' 0 CA--C 1.512 -0.484 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 -176.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.308 2.2 p90 -116.92 161.84 18.71 Favored 'General case' 0 C--N 1.368 1.405 0 CA-C-N 119.218 0.917 . . . . 0.0 109.394 176.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 59.4 tp -105.18 115.76 30.81 Favored 'General case' 0 C--N 1.351 0.661 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -108.84 136.74 47.89 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 126.335 1.854 . . . . 0.0 108.194 -169.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -145.24 118.65 9.02 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 177.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.14 153.58 22.44 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.7 t -110.73 120.12 60.87 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.35 122.82 46.26 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 41.6 m -78.58 131.75 36.87 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 125.383 1.473 . . . . 0.0 107.893 175.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.63 -56.47 20.05 Favored Glycine 0 C--N 1.364 2.128 0 C-N-CA 126.136 1.827 . . . . 0.0 114.917 -168.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 56.6 m170 33.16 74.55 0.06 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.058 2.543 . . . . 0.0 115.818 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -72.73 -10.85 60.27 Favored 'General case' 0 C--N 1.357 0.904 0 C-N-CA 125.542 1.537 . . . . 0.0 111.33 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -73.02 -13.79 61.29 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 125.495 1.518 . . . . 0.0 112.326 -170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.361 8.3 pt-20 122.98 -169.13 0.0 OUTLIER 'General case' 0 C--N 1.36 1.062 0 C-N-CA 128.623 2.769 . . . . 0.0 108.109 172.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 62.7 mttt 97.71 135.19 0.02 OUTLIER 'General case' 0 CA--C 1.495 -1.169 0 C-N-CA 128.211 2.604 . . . . 0.0 107.499 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.15 126.0 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 106.19 -1.782 . . . . 0.0 106.19 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -107.57 129.27 55.0 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.352 1.861 . . . . 0.0 109.819 176.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -151.8 114.64 4.66 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.566 1.146 . . . . 0.0 110.315 -176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 96.3 t -89.18 115.14 28.42 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 C-N-CA 125.569 1.548 . . . . 0.0 107.814 176.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 17.4 mt -62.8 143.63 57.34 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 126.694 1.997 . . . . 0.0 110.303 175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -115.32 147.43 40.46 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.318 1.847 . . . . 0.0 109.275 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.609 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -79.3 137.89 37.52 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 127.548 2.339 . . . . 0.0 109.756 -175.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 6.1 t 96.68 -6.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 129.196 2.998 . . . . 0.0 113.011 173.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -142.84 -25.68 0.61 Allowed 'General case' 0 C--N 1.357 0.923 0 CA-C-N 119.716 1.144 . . . . 0.0 111.823 -173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 58.47 165.89 0.04 OUTLIER 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.561 1.544 . . . . 0.0 111.939 -164.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.42 -133.64 45.03 Favored Glycine 0 C--N 1.367 2.289 0 O-C-N 119.455 -2.028 . . . . 0.0 109.05 -163.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 43.0 t 55.29 74.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 125.837 1.655 . . . . 0.0 110.511 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.33 114.33 26.83 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 -172.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -103.84 -36.51 7.79 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 113.485 -1.688 . . . . 0.0 108.311 -171.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.1 t -100.68 76.72 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 102.49 -3.152 . . . . 0.0 102.49 168.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.34 129.2 44.63 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.184 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -142.56 115.21 8.59 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 124.963 1.305 . . . . 0.0 107.77 169.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.56 84.44 0.75 Allowed Glycine 0 CA--C 1.488 -1.637 0 N-CA-C 104.492 -3.443 . . . . 0.0 104.492 166.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.764 0 C-N-CA 124.755 1.169 . . . . 0.0 113.893 178.909 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 40.1 m . . . . . 0 CA--C 1.509 -0.621 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 64.4 mt -115.87 133.84 55.62 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -169.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.16 162.74 26.41 Favored Glycine 0 CA--C 1.491 -1.41 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -172.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 27.0 m -120.09 129.34 75.59 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.17 150.16 46.52 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 57.9 m -125.12 -30.28 3.22 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-O 119.159 -0.448 . . . . 0.0 111.751 175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 29.3 tp -88.35 -51.94 5.47 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 119.411 1.005 . . . . 0.0 111.803 -169.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.9 pt -84.94 -176.8 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 C-N-CA 125.585 1.554 . . . . 0.0 110.011 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.417 ' O ' HD22 ' B' ' 954' ' ' LEU . 0.0 OUTLIER -157.32 81.15 3.26 Favored Pre-proline 0 N--CA 1.439 -0.985 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -167.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.02 92.22 0.9 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.328 2.019 . . . . 0.0 110.09 164.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.5 mp -120.94 142.23 49.94 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 104.598 -2.371 . . . . 0.0 104.598 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 93.4 mt-30 -94.62 155.96 16.64 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.342 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.56 122.67 20.9 Favored 'General case' 0 C--N 1.377 1.761 0 CA-C-N 119.874 1.215 . . . . 0.0 108.737 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.16 -9.47 77.56 Favored Glycine 0 CA--C 1.498 -1.005 0 C-N-CA 125.51 1.528 . . . . 0.0 111.131 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.22 175.34 5.4 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 123.79 0.836 . . . . 0.0 110.679 176.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.3 m -142.83 125.5 15.91 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -158.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.609 HG13 HH11 ' B' ' 914' ' ' ARG . 18.9 m -96.13 151.88 3.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 CA-C-O 121.5 0.666 . . . . 0.0 110.448 171.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.0 t -141.65 138.43 32.51 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 126.626 1.97 . . . . 0.0 111.432 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.1 t -91.72 130.01 41.53 Favored 'Isoleucine or valine' 0 C--N 1.369 1.44 0 C-N-CA 127.355 2.262 . . . . 0.0 106.531 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -105.94 131.98 52.59 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 100.795 -3.78 . . . . 0.0 100.795 175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.99 71.55 1.48 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 57.3 t -161.28 102.35 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.828 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 91.6 mmm -152.13 69.64 0.9 Allowed 'General case' 0 CA--C 1.502 -0.888 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.93 146.46 7.15 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -112.53 -29.96 7.3 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -174.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.5 tp -91.48 87.57 6.46 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.61 -176.87 4.49 Favored 'General case' 0 CA--C 1.5 -0.96 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 -167.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -116.88 156.0 28.09 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 178.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.2 t -89.74 133.61 34.6 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 -177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -158.92 150.65 20.82 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 -177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.41 113.06 21.21 Favored Pre-proline 0 C--N 1.356 0.864 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -99.33 173.5 0.42 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 122.047 1.832 . . . . 0.0 108.443 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -117.02 138.9 51.28 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.7 p -138.43 141.19 39.54 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 119.723 1.147 . . . . 0.0 108.539 -171.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 23.6 mm -117.11 130.5 71.91 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -126.19 104.44 8.23 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 61.2 p -103.12 162.91 12.57 Favored 'General case' 0 N--CA 1.445 -0.695 0 C-N-CA 124.959 1.303 . . . . 0.0 110.722 172.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 177.45 113.76 0.37 Allowed Glycine 0 C--N 1.359 1.86 0 N-CA-C 106.684 -2.567 . . . . 0.0 106.684 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.33 145.31 46.27 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 -176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.5 tp -72.56 124.06 24.45 Favored 'General case' 0 C--N 1.381 1.965 0 C-N-CA 124.486 1.114 . . . . 0.0 109.692 -178.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.1 tp -98.26 -57.52 2.19 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -131.41 127.13 36.86 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 -172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.68 128.99 9.74 Favored Glycine 0 N--CA 1.434 -1.437 0 N-CA-C 103.69 -3.764 . . . . 0.0 103.69 166.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -69.15 128.63 92.51 Favored Pre-proline 0 C--N 1.352 0.687 0 CA-C-O 117.856 -1.068 . . . . 0.0 110.771 -179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -106.47 79.59 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 122.079 1.778 . . . . 0.0 109.378 -167.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 78.47 -72.21 0.09 Allowed 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 130.036 3.335 . . . . 0.0 109.117 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 74.6 mt 49.09 40.62 17.83 Favored 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 129.162 2.985 . . . . 0.0 113.868 -175.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -113.52 131.88 55.9 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -130.41 108.0 9.66 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.061 -2.2 . . . . 0.0 105.061 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.61 1.707 . . . . 0.0 115.61 179.309 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 110.044 -0.791 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 46.8 t -125.1 114.09 26.3 Favored Pre-proline 0 N--CA 1.441 -0.884 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -88.56 -21.89 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 CA-C-N 121.643 1.622 . . . . 0.0 109.859 -173.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 39.16 70.13 0.24 Allowed 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.633 2.773 . . . . 0.0 115.307 177.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.5 t -121.31 131.77 72.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -138.71 149.27 44.92 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 168.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 5.5 p90 -149.53 139.72 22.19 Favored 'General case' 0 C--N 1.365 1.257 0 CA-C-N 119.289 0.95 . . . . 0.0 110.117 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 20.4 t -169.16 119.22 0.7 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-O 118.23 -0.89 . . . . 0.0 109.519 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.27 153.96 42.42 Favored 'General case' 0 C--N 1.37 1.458 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -174.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -139.23 156.23 47.22 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-O 122.053 0.93 . . . . 0.0 109.747 -176.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.569 HD21 HD23 ' C' ' 858' ' ' LEU . 1.8 tm? -129.21 127.19 40.78 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-N 113.701 -1.59 . . . . 0.0 106.815 -165.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 47.8 p -159.82 13.0 0.13 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.766 -1.106 . . . . 0.0 108.017 -164.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.569 HD23 HD21 ' C' ' 856' ' ' LEU . 3.0 pp -25.93 146.24 0.03 OUTLIER Pre-proline 0 C--N 1.368 1.413 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 157.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -81.94 -45.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 CA-C-N 122.111 1.79 . . . . 0.0 113.319 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -163.39 177.95 8.5 Favored 'General case' 0 CA--C 1.501 -0.923 0 N-CA-C 106.193 -1.781 . . . . 0.0 106.193 -172.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 18.4 m -13.47 119.51 0.01 OUTLIER 'General case' 0 C--N 1.363 1.195 0 C-N-CA 130.101 3.36 . . . . 0.0 116.079 172.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -119.85 161.27 38.98 Favored Pre-proline 0 N--CA 1.442 -0.849 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 -166.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -82.52 -15.23 8.76 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.408 2.072 . . . . 0.0 110.999 -173.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.26 -144.2 4.04 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -65.49 135.55 55.32 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.86 1.664 . . . . 0.0 110.515 -178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 17.1 m -65.74 144.02 98.74 Favored Pre-proline 0 N--CA 1.443 -0.811 0 C-N-CA 125.628 1.571 . . . . 0.0 113.184 -173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -99.71 -151.06 0.02 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.714 0 C-N-CA 123.303 2.669 . . . . 0.0 107.295 177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -146.39 129.94 16.91 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 175.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -116.23 -16.17 10.97 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 122.969 0.508 . . . . 0.0 110.705 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -102.39 81.12 2.02 Favored 'General case' 0 C--N 1.353 0.749 0 CA-C-O 121.089 0.471 . . . . 0.0 111.372 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -68.15 97.68 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 127.231 2.213 . . . . 0.0 106.652 166.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 4.9 mt -89.03 -37.3 15.26 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.465 -174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 45.4 tp -165.31 129.48 2.37 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 100.401 -3.926 . . . . 0.0 100.401 168.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.1 t-20 175.68 61.56 0.0 OUTLIER 'General case' 0 C--N 1.357 0.925 0 CA-C-N 121.218 1.826 . . . . 0.0 108.226 -166.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.55 97.73 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -165.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.02 -28.81 12.65 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.58 0.627 . . . . 0.0 112.663 -175.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.15 -58.71 0.4 Allowed Glycine 0 C--N 1.353 1.509 0 N-CA-C 107.524 -2.23 . . . . 0.0 107.524 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 62.79 -82.84 0.02 OUTLIER 'General case' 0 C--N 1.354 0.802 0 C-N-CA 128.588 2.755 . . . . 0.0 114.085 175.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 5.3 p90 -97.25 120.8 38.28 Favored 'General case' 0 N--CA 1.434 -1.236 0 C-N-CA 125.811 1.644 . . . . 0.0 108.203 -176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -83.97 116.82 66.66 Favored Pre-proline 0 N--CA 1.439 -0.987 0 N-CA-C 104.114 -2.55 . . . . 0.0 104.114 174.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -94.22 6.06 2.58 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 CA-C-N 124.955 2.805 . . . . 0.0 109.942 -165.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -79.95 -45.43 18.53 Favored 'General case' 0 CA--C 1.498 -1.023 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.7 p -106.4 -12.08 15.76 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 124.937 1.295 . . . . 0.0 108.482 175.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.74 21.22 54.18 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.452 161.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.7 t -97.42 102.44 13.46 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.412 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -162.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -95.45 112.06 23.84 Favored 'General case' 0 CA--C 1.504 -0.801 0 CA-C-N 111.736 -2.484 . . . . 0.0 108.997 -175.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 80.9 m -100.57 108.05 19.88 Favored 'General case' 0 C--N 1.359 1.015 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -91.17 111.41 48.43 Favored Pre-proline 0 C--N 1.354 0.798 0 CA-C-O 117.284 -1.341 . . . . 0.0 110.248 170.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -91.03 0.07 4.88 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 122.444 2.096 . . . . 0.0 108.621 166.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 87.9 mt -58.21 -50.51 73.28 Favored 'General case' 0 CA--C 1.499 -1.004 0 C-N-CA 125.987 1.715 . . . . 0.0 114.59 -164.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 59.44 68.99 0.75 Allowed 'General case' 0 C--N 1.366 1.305 0 CA-C-O 122.051 0.929 . . . . 0.0 111.738 170.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.8 -167.75 35.8 Favored Glycine 0 N--CA 1.406 -3.309 1 N-CA-C 102.272 -4.331 . . . . 0.0 102.272 -172.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -92.65 121.49 34.12 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 113.422 -1.389 . . . . 0.0 108.493 174.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.525 ' H ' HD11 ' C' ' 954' ' ' LEU . 3.6 t80 -116.9 145.73 43.41 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 -172.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -112.18 115.33 28.67 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.035 0.934 . . . . 0.0 108.648 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.2 tt -112.62 140.97 46.93 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.517 1.527 . . . . 0.0 108.505 -176.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 67.3 m -143.01 118.81 10.53 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.86 154.03 22.16 Favored 'General case' 0 C--N 1.363 1.176 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.58 122.63 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.83 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 78.7 mt -97.92 122.57 41.19 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.309 1.044 . . . . 0.0 108.974 -175.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 59.1 m -79.66 131.43 35.97 Favored 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 172.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -55.21 -56.28 24.06 Favored Glycine 0 C--N 1.367 2.261 0 C-N-CA 125.336 1.446 . . . . 0.0 112.992 -172.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 43.72 63.08 1.69 Allowed 'General case' 0 C--N 1.357 0.892 0 C-N-CA 127.772 2.429 . . . . 0.0 113.981 171.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -72.68 -7.48 50.63 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 125.082 1.353 . . . . 0.0 112.594 -168.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -71.11 -17.61 62.56 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 125.381 1.472 . . . . 0.0 112.294 -171.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.336 8.5 pt-20 120.89 -173.37 0.0 OUTLIER 'General case' 0 C--N 1.362 1.148 0 C-N-CA 128.253 2.621 . . . . 0.0 107.956 173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.3 tttt 102.62 135.31 0.01 OUTLIER 'General case' 0 CA--C 1.492 -1.25 0 C-N-CA 127.997 2.519 . . . . 0.0 106.524 172.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 93.2 t -98.39 123.29 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.118 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 -175.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -104.77 129.72 52.97 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 126.566 1.946 . . . . 0.0 110.171 171.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.67 114.23 3.74 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 125.127 1.371 . . . . 0.0 109.943 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 3.9 p -85.27 117.2 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.95 0 C-N-CA 125.818 1.647 . . . . 0.0 108.854 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.45 142.23 57.99 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.052 1.741 . . . . 0.0 110.204 173.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.26 1.3 p -113.81 148.73 36.07 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 126.427 1.891 . . . . 0.0 108.368 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.581 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -78.72 137.42 37.77 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 125.797 1.639 . . . . 0.0 108.364 178.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.5 t 101.65 -18.1 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.613 0 C-N-CA 129.255 3.022 . . . . 0.0 112.281 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -137.5 -26.74 0.97 Allowed 'General case' 0 CA--C 1.502 -0.882 0 CA-C-N 119.277 0.944 . . . . 0.0 111.3 -169.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 59.93 167.17 0.07 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.31 1.444 . . . . 0.0 111.861 -164.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.5 -130.72 51.43 Favored Glycine 0 C--N 1.376 2.764 0 O-C-N 119.554 -1.966 . . . . 0.0 110.197 -163.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 43.2 t 51.8 74.17 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.197 0 C-N-CA 126.317 1.847 . . . . 0.0 111.712 175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.49 116.62 29.0 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -169.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -99.56 -36.66 9.46 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.782 -172.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 50.7 t -100.85 78.12 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 102.92 -2.993 . . . . 0.0 102.92 168.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -94.05 132.56 38.41 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.138 -174.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -143.55 114.56 7.79 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 125.39 1.476 . . . . 0.0 108.295 173.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.45 84.97 0.64 Allowed Glycine 0 CA--C 1.484 -1.873 0 N-CA-C 104.765 -3.334 . . . . 0.0 104.765 169.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.727 0 C-N-CA 125.096 1.332 . . . . 0.0 110.909 172.743 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 26.8 m . . . . . 0 CA--C 1.511 -0.536 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 71.6 mt -121.28 134.59 55.17 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 -178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.85 162.51 26.29 Favored Glycine 0 CA--C 1.493 -1.344 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -173.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.4 m -120.1 130.75 73.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 175.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -137.07 150.62 48.15 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.302 -0.874 . . . . 0.0 108.978 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 53.3 m -117.71 -36.7 3.6 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.157 -0.34 . . . . 0.0 111.414 178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.5 tp -93.78 -54.6 3.56 Favored 'General case' 0 C--N 1.358 0.937 0 CA-C-N 118.525 0.602 . . . . 0.0 111.928 -166.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.6 pp -84.76 -173.63 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.757 0 C-N-CA 126.463 1.905 . . . . 0.0 110.158 -174.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.525 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -162.12 92.86 1.32 Allowed Pre-proline 0 C--N 1.358 0.942 0 O-C-N 122.02 -0.425 . . . . 0.0 109.947 -168.595 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -75.33 91.15 1.06 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 CA-C-N 122.944 2.087 . . . . 0.0 109.797 160.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' C' ' 954' ' ' LEU . 5.9 mp -121.42 142.88 49.58 Favored 'General case' 0 CA--C 1.506 -0.736 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -92.43 160.23 15.18 Favored 'General case' 0 C--N 1.362 1.143 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.75 122.05 19.97 Favored 'General case' 0 C--N 1.375 1.692 0 CA-C-N 120.226 1.375 . . . . 0.0 108.502 174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -11.61 71.45 Favored Glycine 0 C--N 1.347 1.158 0 C-N-CA 125.389 1.471 . . . . 0.0 111.419 168.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.89 174.99 3.91 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.488 0.715 . . . . 0.0 111.471 176.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 19.4 p -142.96 127.98 18.48 Favored 'General case' 0 CA--C 1.501 -0.942 0 CA-C-O 121.435 0.635 . . . . 0.0 109.416 -161.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.581 HG13 HH11 ' C' ' 914' ' ' ARG . 19.6 m -94.69 150.28 4.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -140.66 137.72 33.78 Favored 'General case' 0 C--N 1.348 0.533 0 C-N-CA 125.047 1.339 . . . . 0.0 111.916 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 39.2 t -91.79 129.42 42.49 Favored 'Isoleucine or valine' 0 C--N 1.372 1.572 0 C-N-CA 125.912 1.685 . . . . 0.0 106.805 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -106.82 132.6 52.59 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 170.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 11.4 tp -132.28 75.26 1.62 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 113.196 -1.82 . . . . 0.0 107.972 173.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.7 t -158.59 100.18 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 N-CA-C 104.38 -2.452 . . . . 0.0 104.38 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.62 75.15 1.15 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 112.89 145.6 9.51 Favored Glycine 0 C--N 1.35 1.346 0 N-CA-C 108.023 -2.031 . . . . 0.0 108.023 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 -113.0 -30.51 6.99 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -173.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.2 tp -92.24 87.06 5.94 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.8 -160.62 1.08 Allowed 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -172.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -123.17 155.13 37.68 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -91.48 134.02 35.0 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -158.27 151.19 22.6 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -177.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -127.29 116.67 21.58 Favored Pre-proline 0 C--N 1.355 0.839 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 172.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -102.99 173.76 0.19 Allowed 'Trans proline' 0 CA--C 1.508 -0.817 0 N-CA-C 107.925 -1.606 . . . . 0.0 107.925 177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -114.55 139.52 49.51 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 178.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -137.79 139.44 40.03 Favored 'General case' 0 C--N 1.376 1.741 0 CA-C-N 119.665 1.12 . . . . 0.0 108.001 -169.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 33.4 mm -116.41 131.24 69.57 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -124.92 105.53 9.3 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 28.6 p -101.76 164.67 11.61 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.61 1.564 . . . . 0.0 109.911 172.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.15 111.81 0.35 Allowed Glycine 0 C--N 1.358 1.772 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.06 141.53 48.13 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.715 1.376 . . . . 0.0 114.715 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -76.7 124.45 27.68 Favored 'General case' 0 C--N 1.379 1.871 0 C-N-CA 125.386 1.474 . . . . 0.0 108.586 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 18.6 tp -98.1 -57.46 2.21 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 116.766 -0.197 . . . . 0.0 110.753 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -131.91 128.26 38.16 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 -174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.71 131.7 10.83 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 103.684 -3.766 . . . . 0.0 103.684 162.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -69.34 132.38 89.75 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.595 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -106.09 78.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 121.54 1.586 . . . . 0.0 108.954 -171.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 79.56 -71.75 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.207 3.403 . . . . 0.0 109.007 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 68.6 mt 49.87 38.87 17.01 Favored 'General case' 0 C--N 1.346 0.423 0 C-N-CA 129.183 2.993 . . . . 0.0 113.654 -175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -111.14 131.86 54.76 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -129.94 107.14 9.14 Favored 'General case' 0 CA--C 1.497 -1.069 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.097 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 179.544 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.455 -0.763 0 N-CA-C 109.854 -0.864 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.94 119.0 21.01 Favored Pre-proline 0 N--CA 1.443 -0.776 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -89.96 -20.89 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 CA-C-N 122.079 1.778 . . . . 0.0 109.689 -173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 37.74 69.23 0.25 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 128.727 2.811 . . . . 0.0 115.618 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 99.3 t -119.09 137.1 54.16 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -173.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.2 158.84 43.32 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 165.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -149.38 138.07 21.02 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 22.9 t -170.28 117.5 0.54 Allowed 'General case' 0 C--N 1.354 0.788 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.73 153.36 34.52 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 105.091 -2.188 . . . . 0.0 105.091 -178.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.01 157.89 45.76 Favored 'General case' 0 C--N 1.35 0.601 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.68 173.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.404 HD21 HD23 ' A' ' 858' ' ' LEU . 2.3 tm? -130.75 129.32 42.33 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -166.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 49.2 p -162.01 14.36 0.09 Allowed 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -163.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.404 HD23 HD21 ' A' ' 856' ' ' LEU . 3.8 pp -24.86 147.44 0.02 OUTLIER Pre-proline 0 C--N 1.366 1.318 0 N-CA-C 117.359 2.355 . . . . 0.0 117.359 159.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -81.51 -45.27 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.613 0 CA-C-N 121.918 1.721 . . . . 0.0 112.891 -166.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -163.45 179.34 7.37 Favored 'General case' 0 CA--C 1.501 -0.915 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 -172.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -24.05 126.76 0.03 OUTLIER 'General case' 0 C--N 1.364 1.225 0 C-N-CA 129.364 3.066 . . . . 0.0 115.22 173.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -122.77 147.15 50.08 Favored Pre-proline 0 N--CA 1.44 -0.975 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 -158.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.46 -10.35 20.45 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.505 2.137 . . . . 0.0 113.042 -172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.25 -142.01 3.33 Favored Glycine 0 C--N 1.355 1.592 0 CA-C-N 120.426 1.466 . . . . 0.0 110.558 177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.4 m -62.82 144.72 56.28 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 127.213 2.205 . . . . 0.0 110.813 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 11.2 t -79.11 122.77 84.75 Favored Pre-proline 0 N--CA 1.44 -0.948 0 C-N-CA 125.504 1.522 . . . . 0.0 111.089 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -96.39 -153.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.96 3.107 . . . . 0.0 107.472 176.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -151.49 135.66 16.71 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.3 p-10 -120.12 -11.88 9.18 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 122.146 -0.346 . . . . 0.0 111.905 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -100.09 87.14 3.39 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 118.591 0.632 . . . . 0.0 112.264 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.87 97.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 126.213 1.805 . . . . 0.0 106.882 168.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.408 ' HB3' HD11 ' B' ' 953' ' ' ILE . 67.0 mt -87.48 -37.82 16.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.238 -173.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 32.4 tp -166.65 127.51 1.66 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 101.106 -3.665 . . . . 0.0 101.106 163.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 179.98 61.04 0.01 OUTLIER 'General case' 0 CA--C 1.504 -0.803 0 CA-C-N 120.839 1.654 . . . . 0.0 108.988 -166.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -60.32 -44.03 95.84 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 116.269 1.951 . . . . 0.0 116.269 -166.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.72 -27.13 15.13 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-N 118.863 0.756 . . . . 0.0 112.456 -175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.77 -58.73 0.39 Allowed Glycine 0 C--N 1.353 1.506 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 62.68 -81.35 0.02 OUTLIER 'General case' 0 C--N 1.355 0.813 0 C-N-CA 127.933 2.493 . . . . 0.0 114.094 175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -95.97 119.54 34.65 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.785 1.234 . . . . 0.0 108.068 -177.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -82.05 117.29 67.8 Favored Pre-proline 0 N--CA 1.441 -0.919 0 N-CA-C 103.78 -2.674 . . . . 0.0 103.78 173.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.53 4.84 2.61 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 CA-C-N 124.656 2.699 . . . . 0.0 109.399 -165.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.16 -45.72 17.64 Favored 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 35.8 p -104.31 -14.29 15.84 Favored 'General case' 0 N--CA 1.439 -0.994 0 C-N-CA 124.517 1.127 . . . . 0.0 108.746 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.45 24.26 47.65 Favored Glycine 0 C--N 1.363 2.068 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 162.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 52.5 t -100.18 103.89 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.422 0 N-CA-C 101.738 -3.43 . . . . 0.0 101.738 -163.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.71 111.92 24.23 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-N 112.167 -2.288 . . . . 0.0 109.358 -172.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 64.9 m -100.33 108.18 20.15 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . 0.414 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.93 110.75 44.1 Favored Pre-proline 0 C--N 1.357 0.912 0 CA-C-O 117.121 -1.418 . . . . 0.0 111.707 170.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -93.22 1.29 3.51 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 CA-C-N 123.285 2.209 . . . . 0.0 108.94 168.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 29.9 mt -51.68 -53.84 34.61 Favored 'General case' 0 CA--C 1.501 -0.93 0 C-N-CA 128.489 2.716 . . . . 0.0 114.151 -170.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.17 65.3 1.31 Allowed 'General case' 0 C--N 1.365 1.277 0 CA-C-O 121.901 0.858 . . . . 0.0 112.057 171.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.08 -177.93 45.48 Favored Glycine 0 N--CA 1.411 -3.012 1 N-CA-C 101.033 -4.827 . . . . 0.0 101.033 -173.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -93.18 121.27 34.37 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.284 1.3 p90 -114.95 161.68 17.98 Favored 'General case' 0 C--N 1.365 1.262 0 CA-C-N 119.158 0.89 . . . . 0.0 109.573 175.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 63.0 tp -104.17 116.45 32.22 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 123.421 0.688 . . . . 0.0 109.662 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -111.03 136.72 49.63 Favored 'General case' 0 C--N 1.362 1.152 0 C-N-CA 126.386 1.874 . . . . 0.0 108.916 -167.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.8 m -147.41 119.57 8.29 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 123.318 0.647 . . . . 0.0 109.557 176.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.42 153.92 21.56 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.5 t -107.97 120.82 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.991 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -100.95 123.96 45.94 Favored 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.177 -171.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 42.4 m -81.11 132.97 35.39 Favored 'General case' 0 C--N 1.353 0.761 0 C-N-CA 125.581 1.552 . . . . 0.0 107.389 176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.4 -57.22 20.8 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 124.931 1.253 . . . . 0.0 113.765 -170.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 57.6 m170 36.1 71.48 0.13 Allowed 'General case' 0 C--N 1.36 1.043 0 C-N-CA 127.556 2.342 . . . . 0.0 115.143 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -73.03 -8.02 53.85 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 125.253 1.421 . . . . 0.0 112.028 -175.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.82 -18.76 62.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 125.18 1.392 . . . . 0.0 112.605 -171.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.305 11.3 pt-20 125.13 -176.32 0.0 OUTLIER 'General case' 0 C--N 1.362 1.146 0 C-N-CA 127.954 2.502 . . . . 0.0 108.16 174.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.3 tttt 99.16 131.69 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.197 0 C-N-CA 127.423 2.289 . . . . 0.0 107.277 169.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -99.76 123.81 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 -173.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -107.97 121.71 45.35 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.015 1.726 . . . . 0.0 112.864 169.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -130.5 116.13 17.76 Favored 'General case' 0 C--N 1.362 1.12 0 C-N-CA 128.6 2.76 . . . . 0.0 108.615 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.3 t -84.98 114.74 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 19.2 mt -62.67 141.26 58.61 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.841 1.656 . . . . 0.0 110.497 175.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 5.3 t -115.96 147.18 41.44 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.537 1.935 . . . . 0.0 109.373 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.6 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -77.68 139.49 39.45 Favored 'General case' 0 N--CA 1.43 -1.44 0 C-N-CA 128.821 2.848 . . . . 0.0 110.634 -173.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 7.2 t 97.55 -12.9 0.07 Allowed 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 129.269 3.028 . . . . 0.0 112.909 173.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -136.9 -26.51 1.04 Allowed 'General case' 0 C--N 1.356 0.887 0 CA-C-N 119.601 1.091 . . . . 0.0 111.204 -172.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 61.58 163.35 0.08 Allowed 'General case' 0 C--N 1.36 1.027 0 C-N-CA 125.473 1.509 . . . . 0.0 111.388 -166.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.77 -135.07 49.43 Favored Glycine 0 C--N 1.37 2.456 0 O-C-N 119.443 -2.036 . . . . 0.0 109.442 -160.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 44.0 t 57.52 78.28 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.169 0 C-N-CA 125.56 1.544 . . . . 0.0 110.714 175.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.69 114.42 26.96 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 105.704 -1.962 . . . . 0.0 105.704 -173.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -102.86 -35.75 8.49 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.29 -1.323 . . . . 0.0 108.479 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.6 t -100.22 82.43 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.163 0 N-CA-C 102.587 -3.116 . . . . 0.0 102.587 167.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -94.93 130.21 41.65 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-O 121.219 0.533 . . . . 0.0 109.796 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -142.96 114.88 8.23 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 125.654 1.582 . . . . 0.0 108.631 175.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.3 85.12 0.65 Allowed Glycine 0 N--CA 1.429 -1.783 0 N-CA-C 103.701 -3.76 . . . . 0.0 103.701 162.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.842 0 C-N-CA 124.369 0.985 . . . . 0.0 112.133 172.206 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 38.2 m . . . . . 0 CA--C 1.507 -0.706 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 76.3 mt -118.52 133.28 55.99 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 105.388 -2.078 . . . . 0.0 105.388 -172.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.13 161.58 27.58 Favored Glycine 0 CA--C 1.491 -1.452 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -172.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 26.5 m -122.59 127.85 75.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 173.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -137.7 149.32 46.42 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.0 m -115.0 -43.74 3.08 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 22.9 tp -83.71 -50.07 8.51 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 119.491 1.041 . . . . 0.0 112.775 -166.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 7.8 pt -85.01 -174.0 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 125.483 1.513 . . . . 0.0 110.438 -176.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.69 81.64 2.74 Favored Pre-proline 0 N--CA 1.439 -1.012 0 C-N-CA 123.154 0.582 . . . . 0.0 109.663 -166.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.24 92.24 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.593 2.195 . . . . 0.0 109.911 162.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.4 mp -120.8 143.8 48.65 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 104.31 -2.478 . . . . 0.0 104.31 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -94.33 156.59 16.44 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.605 178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.29 123.47 22.35 Favored 'General case' 0 C--N 1.372 1.547 0 CA-C-N 119.292 0.951 . . . . 0.0 108.861 176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.11 72.92 Favored Glycine 0 C--N 1.345 1.059 0 C-N-CA 125.936 1.731 . . . . 0.0 111.096 171.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.92 175.25 5.25 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 123.385 0.674 . . . . 0.0 111.528 176.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 13.1 t -144.4 128.68 17.8 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.825 0.821 . . . . 0.0 110.191 -164.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.6 HG13 HH11 ' A' ' 914' ' ' ARG . 23.4 m -94.53 151.13 3.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.957 172.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.54 138.5 32.76 Favored 'General case' 0 C--N 1.35 0.6 0 C-N-CA 126.197 1.799 . . . . 0.0 111.275 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 91.0 t -91.69 129.51 42.26 Favored 'Isoleucine or valine' 0 C--N 1.369 1.432 0 C-N-CA 126.102 1.761 . . . . 0.0 107.04 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -107.8 131.87 54.01 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 101.689 -3.449 . . . . 0.0 101.689 169.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 26.6 tp -131.39 76.44 1.72 Allowed 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.401 -1.727 . . . . 0.0 107.303 172.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 60.1 t -160.46 100.53 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.897 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.0 mmm -153.58 70.12 0.83 Allowed 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 104.551 -2.389 . . . . 0.0 104.551 179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.05 145.8 7.33 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -113.1 -29.35 7.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -173.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 41.8 tp -91.37 87.42 6.44 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.62 -165.28 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 -171.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.6 t60 -124.46 161.02 26.95 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.0 t -93.47 133.15 37.05 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 -176.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.61 151.38 22.2 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.22 113.39 21.54 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 173.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -99.21 173.93 0.42 Allowed 'Trans proline' 0 CA--C 1.508 -0.78 0 C-N-CA 121.875 1.716 . . . . 0.0 108.751 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -118.43 139.34 51.54 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.707 1.203 . . . . 0.0 108.247 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -140.76 141.9 34.78 Favored 'General case' 0 C--N 1.376 1.727 0 CA-C-N 120.001 1.273 . . . . 0.0 108.599 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 24.3 mm -118.12 129.33 74.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.777 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -125.14 105.62 9.29 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 32.1 p -101.04 161.97 13.22 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.019 1.328 . . . . 0.0 110.379 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.23 110.54 0.28 Allowed Glycine 0 C--N 1.359 1.835 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 175.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.17 145.27 46.14 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.37 -1.077 . . . . 0.0 113.809 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 62.8 tp -75.19 123.09 24.66 Favored 'General case' 0 C--N 1.379 1.857 0 C-N-CA 124.535 1.134 . . . . 0.0 109.376 -176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 27.7 tp -98.61 -57.33 2.22 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -131.7 128.05 38.17 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.82 130.95 10.47 Favored Glycine 0 CA--C 1.494 -1.271 0 N-CA-C 103.883 -3.687 . . . . 0.0 103.883 165.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -69.09 128.91 92.48 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-O 117.825 -1.083 . . . . 0.0 111.046 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -107.14 80.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.561 0 CA-C-N 122.048 1.767 . . . . 0.0 109.814 -169.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 77.89 -72.75 0.09 Allowed 'General case' 0 CA--C 1.5 -0.944 0 C-N-CA 130.241 3.416 . . . . 0.0 109.315 177.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 73.2 mt 49.62 39.24 16.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 129.158 2.983 . . . . 0.0 114.169 -176.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -112.1 131.43 55.44 Favored 'General case' 0 CA--C 1.496 -1.131 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -128.93 108.7 10.63 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.025 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 179.318 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.455 -0.768 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.55 119.19 21.57 Favored Pre-proline 0 C--N 1.354 0.771 0 N-CA-C 104.835 -2.283 . . . . 0.0 104.835 -179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -91.25 -20.93 0.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.646 0 CA-C-N 122.193 1.819 . . . . 0.0 109.905 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 39.31 69.19 0.3 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 128.783 2.833 . . . . 0.0 115.351 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 88.6 t -118.88 136.76 55.06 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 N-CA-C 107.524 -1.288 . . . . 0.0 107.524 -173.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.21 157.81 45.96 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 165.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -149.31 138.49 21.41 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 21.4 t -170.68 118.07 0.51 Allowed 'General case' 0 C--N 1.357 0.893 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.67 153.55 34.16 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 -177.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.508 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -136.13 157.97 45.55 Favored 'General case' 0 CA--C 1.504 -0.822 0 C-N-CA 118.835 -1.146 . . . . 0.0 112.433 174.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.434 HD21 HD23 ' B' ' 858' ' ' LEU . 2.2 tm? -130.45 128.04 40.47 Favored 'General case' 0 N--CA 1.427 -1.586 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -167.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 36.8 p -161.65 13.36 0.09 Allowed 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.341 -163.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.434 HD23 HD21 ' B' ' 856' ' ' LEU . 3.7 pp -24.56 147.49 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.375 0 N-CA-C 117.438 2.384 . . . . 0.0 117.438 158.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -81.69 -45.35 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.612 0 CA-C-N 121.943 1.729 . . . . 0.0 112.839 -167.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 32.2 ptt85 -163.32 179.22 7.52 Favored 'General case' 0 CA--C 1.501 -0.921 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 -172.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.8 m -23.82 126.6 0.03 OUTLIER 'General case' 0 C--N 1.365 1.248 0 C-N-CA 129.361 3.064 . . . . 0.0 115.356 173.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -122.79 147.17 50.17 Favored Pre-proline 0 N--CA 1.441 -0.898 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 -158.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -75.5 -10.29 20.36 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.517 2.145 . . . . 0.0 113.107 -172.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.31 -141.99 3.32 Favored Glycine 0 C--N 1.354 1.531 0 CA-C-N 120.496 1.498 . . . . 0.0 110.516 177.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 24.3 m -62.83 144.59 56.44 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 127.086 2.154 . . . . 0.0 110.7 -176.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 11.5 t -78.88 122.58 84.78 Favored Pre-proline 0 N--CA 1.439 -1.007 0 C-N-CA 125.521 1.528 . . . . 0.0 111.004 -169.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -97.65 -153.77 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.932 3.088 . . . . 0.0 107.361 177.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -150.82 135.09 16.95 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -117.77 -10.95 10.41 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 123.604 0.761 . . . . 0.0 110.553 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -100.77 87.52 3.35 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.95 -0.469 . . . . 0.0 112.235 177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -70.13 97.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 C-N-CA 126.172 1.789 . . . . 0.0 106.507 164.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.508 HD11 ' HB2' ' B' ' 855' ' ' ALA . 19.2 mt -88.05 -39.17 14.85 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.238 -174.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 44.7 tp -166.1 126.57 1.73 Allowed 'General case' 0 CA--C 1.492 -1.251 0 N-CA-C 100.6 -3.852 . . . . 0.0 100.6 165.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 177.35 60.88 0.01 OUTLIER 'General case' 0 C--N 1.354 0.79 0 CA-C-N 120.464 1.484 . . . . 0.0 108.921 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.24 -43.56 95.99 Favored 'General case' 0 C--N 1.364 1.212 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -166.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.38 -27.82 14.46 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 118.749 0.704 . . . . 0.0 112.553 -175.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 107.53 -57.89 0.43 Allowed Glycine 0 C--N 1.353 1.512 0 N-CA-C 107.904 -2.078 . . . . 0.0 107.904 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 62.65 -81.92 0.02 OUTLIER 'General case' 0 C--N 1.354 0.781 0 C-N-CA 127.998 2.519 . . . . 0.0 114.221 175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -96.86 119.13 34.76 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 124.926 1.29 . . . . 0.0 108.117 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.89 117.52 68.62 Favored Pre-proline 0 N--CA 1.441 -0.91 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 173.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -93.66 5.09 2.94 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 CA-C-N 124.609 2.682 . . . . 0.0 109.529 -164.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.18 -44.6 19.55 Favored 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 34.4 p -106.2 -14.64 15.08 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 124.872 1.269 . . . . 0.0 108.393 174.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.87 25.17 42.3 Favored Glycine 0 C--N 1.361 1.917 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 162.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 53.5 t -100.54 103.89 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.383 0 N-CA-C 101.743 -3.429 . . . . 0.0 101.743 -162.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -100.74 111.91 24.22 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 112.609 -2.087 . . . . 0.0 109.144 -173.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 67.3 m -100.37 108.22 20.19 Favored 'General case' 0 C--N 1.355 0.828 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 168.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . 0.411 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.65 111.0 45.3 Favored Pre-proline 0 C--N 1.357 0.933 0 CA-C-O 116.956 -1.497 . . . . 0.0 111.755 171.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -93.36 1.95 3.4 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.318 2.221 . . . . 0.0 108.929 168.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 22.7 mt -55.14 -48.57 73.5 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 127.047 2.139 . . . . 0.0 113.951 -169.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.29 48.89 14.17 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 125.547 1.539 . . . . 0.0 113.929 170.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -161.95 -166.1 20.08 Favored Glycine 0 N--CA 1.412 -2.902 1 N-CA-C 101.569 -4.612 . . . . 0.0 101.569 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 67.0 ttt-85 -93.31 121.43 34.68 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -176.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.318 0.8 OUTLIER -117.03 161.41 19.44 Favored 'General case' 0 C--N 1.364 1.234 0 CA-C-N 119.26 0.936 . . . . 0.0 109.639 177.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 58.0 tp -105.38 115.52 30.4 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.0 tt -109.72 136.46 49.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.313 1.845 . . . . 0.0 108.254 -168.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 75.8 m -145.25 119.42 9.48 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.82 153.51 22.37 Favored 'General case' 0 C--N 1.361 1.091 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 95.5 t -108.56 121.81 62.16 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 106.247 -1.76 . . . . 0.0 106.247 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -104.4 122.23 45.05 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.012 -0.994 . . . . 0.0 108.988 -170.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 38.4 m -79.67 132.99 36.36 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 125.49 1.516 . . . . 0.0 107.853 175.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -59.02 -57.2 21.14 Favored Glycine 0 C--N 1.364 2.129 0 C-N-CA 125.057 1.313 . . . . 0.0 113.896 -170.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 57.8 m170 35.84 71.79 0.12 Allowed 'General case' 0 C--N 1.361 1.089 0 C-N-CA 127.491 2.316 . . . . 0.0 115.173 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.1 ptt85 -73.18 -7.89 53.38 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 125.27 1.428 . . . . 0.0 111.976 -175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -72.55 -15.39 61.77 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 125.46 1.504 . . . . 0.0 112.656 -169.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.317 10.2 pt-20 121.05 -178.96 0.0 OUTLIER 'General case' 0 C--N 1.361 1.067 0 C-N-CA 128.182 2.593 . . . . 0.0 108.224 175.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 79.7 tttt 100.49 131.82 0.01 OUTLIER 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 127.537 2.335 . . . . 0.0 107.46 170.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 77.6 t -99.76 126.23 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 106.403 -1.703 . . . . 0.0 106.403 -172.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -111.25 122.87 48.98 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.867 -1.515 . . . . 0.0 112.498 173.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.58 117.34 17.82 Favored 'General case' 0 C--N 1.369 1.423 0 C-N-CA 128.087 2.555 . . . . 0.0 108.907 -177.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 91.0 t -87.48 113.86 25.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 18.2 mt -62.59 143.29 57.43 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 126.664 1.986 . . . . 0.0 110.294 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 4.1 t -116.03 147.88 40.76 Favored 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 110.011 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.617 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -78.75 139.34 38.44 Favored 'General case' 0 N--CA 1.428 -1.532 0 C-N-CA 128.044 2.538 . . . . 0.0 110.19 -174.55 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 7.4 t 97.82 -16.35 0.05 Allowed 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 129.322 3.049 . . . . 0.0 113.078 173.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -134.49 -26.0 1.45 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 119.599 1.091 . . . . 0.0 111.423 -170.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 61.34 162.88 0.07 Allowed 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.593 1.557 . . . . 0.0 111.176 -165.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 62.35 -133.92 45.25 Favored Glycine 0 C--N 1.365 2.173 0 O-C-N 119.615 -1.928 . . . . 0.0 109.163 -162.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.13 79.54 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.149 0 C-N-CA 125.828 1.651 . . . . 0.0 110.823 175.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.44 114.91 27.56 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -103.31 -36.98 7.85 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.842 -1.527 . . . . 0.0 108.385 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 99.3 t -100.72 81.44 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 102.875 -3.009 . . . . 0.0 102.875 167.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -95.69 129.48 42.89 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 -173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 23.7 t -141.57 115.53 9.24 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 125.483 1.513 . . . . 0.0 107.714 174.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.64 85.0 0.69 Allowed Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 104.199 -3.56 . . . . 0.0 104.199 163.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.814 0 C-N-CA 124.904 1.24 . . . . 0.0 112.029 173.204 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.4 mt -116.91 133.95 55.37 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 105.318 -2.104 . . . . 0.0 105.318 -171.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.31 162.57 27.58 Favored Glycine 0 CA--C 1.491 -1.437 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -175.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -119.26 130.67 73.63 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.28 150.6 46.82 Favored 'General case' 0 CA--C 1.506 -0.734 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 55.0 m -118.89 -40.49 2.85 Favored 'General case' 0 C--N 1.355 0.847 0 CA-C-N 118.165 0.439 . . . . 0.0 111.918 177.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 20.9 tp -82.44 -48.9 10.55 Favored 'General case' 0 C--N 1.358 0.977 0 CA-C-N 119.169 0.895 . . . . 0.0 112.646 -167.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.408 HD11 ' HB3' ' A' ' 872' ' ' LEU . 40.8 pt -84.29 -177.19 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.825 0 C-N-CA 125.864 1.666 . . . . 0.0 110.389 -176.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.28 81.35 2.91 Favored Pre-proline 0 N--CA 1.441 -0.921 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -169.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -74.35 93.41 0.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.602 2.201 . . . . 0.0 110.321 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 6.2 mp -120.5 142.52 49.21 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -93.21 156.97 16.51 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 118.973 -1.091 . . . . 0.0 109.616 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.02 123.27 22.42 Favored 'General case' 0 C--N 1.377 1.769 0 CA-C-N 119.508 1.049 . . . . 0.0 108.672 177.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.79 -10.46 74.52 Favored Glycine 0 CA--C 1.496 -1.138 0 C-N-CA 125.555 1.55 . . . . 0.0 111.052 170.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.27 174.82 5.94 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.732 0.813 . . . . 0.0 110.458 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 14.5 t -144.42 128.76 17.86 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.745 0.783 . . . . 0.0 110.42 -161.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.617 HG13 HH11 ' B' ' 914' ' ' ARG . 17.7 m -96.15 151.73 3.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.19 174.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 17.2 t -141.82 138.51 32.24 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 126.281 1.832 . . . . 0.0 111.193 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 90.1 t -91.21 129.89 41.24 Favored 'Isoleucine or valine' 0 C--N 1.367 1.331 0 C-N-CA 127.087 2.155 . . . . 0.0 107.275 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -107.41 131.54 54.16 Favored 'General case' 0 N--CA 1.427 -1.614 0 N-CA-C 100.77 -3.789 . . . . 0.0 100.77 171.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 26.0 tp -130.77 75.92 1.69 Allowed 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 113.565 -1.652 . . . . 0.0 106.948 172.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 61.9 t -159.21 102.06 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.84 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 177.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -152.8 68.86 0.84 Allowed 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 122.76 144.98 6.82 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 107.372 -2.291 . . . . 0.0 107.372 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -111.96 -28.67 7.93 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -174.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -92.3 87.14 5.94 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.97 1.68 Allowed 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -172.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -124.49 160.13 28.99 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.3 t -91.89 132.88 36.15 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -158.7 151.49 22.16 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 105.322 -2.103 . . . . 0.0 105.322 -177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.05 113.29 21.8 Favored Pre-proline 0 C--N 1.356 0.867 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 173.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -98.9 173.46 0.46 Allowed 'Trans proline' 0 CA--C 1.507 -0.867 0 C-N-CA 121.948 1.765 . . . . 0.0 108.693 -178.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.71 137.71 52.5 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -139.76 140.77 36.8 Favored 'General case' 0 C--N 1.375 1.709 0 CA-C-N 119.91 1.232 . . . . 0.0 108.316 -170.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.48 129.8 72.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -125.83 105.44 8.95 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 34.4 p -102.11 163.14 12.4 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.104 1.361 . . . . 0.0 110.866 171.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.02 112.09 0.33 Allowed Glycine 0 C--N 1.36 1.9 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 174.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.23 145.15 46.3 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.6 tp -72.75 122.52 21.64 Favored 'General case' 0 C--N 1.381 1.975 0 C-N-CA 124.143 0.977 . . . . 0.0 109.155 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 60.3 tp -98.39 -57.38 2.21 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -131.46 127.43 37.37 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.79 130.25 10.21 Favored Glycine 0 N--CA 1.433 -1.547 0 N-CA-C 103.819 -3.712 . . . . 0.0 103.819 165.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -69.62 128.99 91.77 Favored Pre-proline 0 C--N 1.352 0.702 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.446 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -106.62 80.34 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 CA-C-N 122.029 1.76 . . . . 0.0 109.426 -168.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 78.16 -72.17 0.09 Allowed 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 129.98 3.312 . . . . 0.0 109.199 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 68.9 mt 48.79 41.51 18.32 Favored 'General case' 0 C--N 1.347 0.472 0 C-N-CA 129.039 2.936 . . . . 0.0 113.696 -175.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -114.41 131.35 56.62 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -129.83 108.34 10.07 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 179.096 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo . . . . . 0 N--CA 1.454 -0.821 0 N-CA-C 109.849 -0.866 . . . . 0.0 109.849 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.11 114.53 27.8 Favored Pre-proline 0 N--CA 1.443 -0.82 0 N-CA-C 104.505 -2.406 . . . . 0.0 104.505 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -88.86 -21.42 1.32 Allowed 'Trans proline' 0 CA--C 1.512 -0.614 0 CA-C-N 121.723 1.651 . . . . 0.0 110.173 -172.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 35.77 71.39 0.12 Allowed 'General case' 0 C--N 1.359 1.004 0 C-N-CA 129.039 2.936 . . . . 0.0 115.84 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 20.3 t -122.06 136.55 58.56 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.07 156.41 49.06 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 165.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.417 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 6.8 p90 -148.8 136.84 20.84 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 118.811 0.732 . . . . 0.0 109.03 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 15.1 t -170.86 119.93 0.53 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.321 -0.862 . . . . 0.0 109.512 -175.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.13 153.11 36.65 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 105.982 -1.858 . . . . 0.0 105.982 -176.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' C' ' 870' ' ' ARG . . . -141.11 157.72 44.9 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 119.736 -0.785 . . . . 0.0 110.976 177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.565 HD11 HD23 ' C' ' 858' ' ' LEU . 2.8 tm? -140.23 129.44 23.74 Favored 'General case' 0 N--CA 1.426 -1.656 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -163.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 69.8 m -157.06 19.52 0.3 Allowed 'General case' 0 N--CA 1.431 -1.404 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 -172.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.565 HD23 HD11 ' C' ' 856' ' ' LEU . 1.8 pp -25.36 145.59 0.03 OUTLIER Pre-proline 0 C--N 1.373 1.596 0 N-CA-C 117.201 2.297 . . . . 0.0 117.201 160.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -77.6 -49.54 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.236 1.957 . . . . 0.0 113.463 -164.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.1 ptt85 -162.47 172.39 15.59 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -2.69 112.46 0.01 OUTLIER 'General case' 0 C--N 1.361 1.08 0 C-N-CA 130.893 3.677 . . . . 0.0 117.165 170.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -96.1 161.46 27.14 Favored Pre-proline 0 N--CA 1.442 -0.859 0 C-N-CA 124.702 1.201 . . . . 0.0 109.651 -172.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -79.92 -15.8 11.68 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.84 2.36 . . . . 0.0 110.429 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.99 -138.74 2.58 Favored Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 10.1 m -65.17 146.76 54.56 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 125.85 1.66 . . . . 0.0 110.69 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 87.4 t -94.89 133.31 26.67 Favored Pre-proline 0 N--CA 1.438 -1.044 0 C-N-CA 125.447 1.499 . . . . 0.0 110.554 -162.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -96.54 -152.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.823 3.015 . . . . 0.0 109.443 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -145.09 134.57 23.17 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -114.44 -17.23 11.81 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 123.161 0.584 . . . . 0.0 111.766 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.424 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 11.4 mmm180 -102.92 83.21 2.2 Favored 'General case' 0 C--N 1.354 0.772 0 CA-C-N 118.519 0.6 . . . . 0.0 110.958 -179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.76 97.81 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 126.651 1.98 . . . . 0.0 106.51 166.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 6.5 mt -89.83 -37.99 14.07 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 118.521 -1.272 . . . . 0.0 111.288 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 33.8 tp -165.52 126.74 1.94 Allowed 'General case' 0 CA--C 1.49 -1.327 0 N-CA-C 101.22 -3.622 . . . . 0.0 101.22 167.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.417 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 29.0 t-20 175.06 61.47 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 120.25 1.387 . . . . 0.0 107.72 -163.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -59.88 -42.51 93.91 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 -165.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -89.95 -29.11 16.25 Favored Glycine 0 C--N 1.357 1.705 0 CA-C-N 118.736 0.698 . . . . 0.0 112.335 -177.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 104.14 -58.22 0.51 Allowed Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.918 -2.073 . . . . 0.0 107.918 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 63.47 -81.15 0.03 OUTLIER 'General case' 0 C--N 1.353 0.724 0 C-N-CA 128.087 2.555 . . . . 0.0 114.458 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -96.16 120.69 36.91 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 125.329 1.452 . . . . 0.0 108.496 -175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -85.99 116.96 67.8 Favored Pre-proline 0 N--CA 1.437 -1.098 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 172.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.26 8.65 2.18 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 CA-C-N 124.951 2.804 . . . . 0.0 109.015 -170.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -79.29 -44.39 21.78 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 34.3 p -107.28 -15.01 14.75 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 124.832 1.253 . . . . 0.0 107.932 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.62 24.74 49.13 Favored Glycine 0 C--N 1.362 1.981 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 164.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.08 103.66 15.3 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.399 0 N-CA-C 101.711 -3.44 . . . . 0.0 101.711 -167.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -94.95 111.83 23.59 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 112.881 -1.963 . . . . 0.0 108.976 -178.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 47.5 m -102.51 108.66 20.04 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 168.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . 0.541 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.56 110.37 42.7 Favored Pre-proline 0 C--N 1.356 0.85 0 CA-C-O 117.261 -1.352 . . . . 0.0 111.775 170.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -93.56 3.18 3.22 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.572 2.181 . . . . 0.0 108.359 164.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 44.1 mt -56.02 -51.55 67.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 127.718 2.407 . . . . 0.0 113.458 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.52 66.09 1.14 Allowed 'General case' 0 C--N 1.364 1.234 0 CA-C-O 122.128 0.966 . . . . 0.0 111.66 169.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.08 -179.36 45.59 Favored Glycine 0 N--CA 1.404 -3.442 1 N-CA-C 101.293 -4.723 . . . . 0.0 101.293 -173.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -95.64 116.71 29.25 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.752 175.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 24.7 p90 -116.83 160.82 20.25 Favored 'General case' 0 C--N 1.366 1.31 0 CA-C-N 119.2 0.909 . . . . 0.0 110.654 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 60.2 tp -108.0 110.66 22.43 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 176.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.6 tt -117.06 138.99 51.25 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.845 1.258 . . . . 0.0 108.414 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 61.5 m -143.22 120.59 11.62 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 123.54 0.736 . . . . 0.0 110.25 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -103.65 154.87 19.04 Favored 'General case' 0 C--N 1.364 1.226 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 92.4 t -100.71 123.47 53.68 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 68.9 mt -94.92 124.32 38.9 Favored 'General case' 0 N--CA 1.44 -0.927 0 C-N-CA 124.631 1.172 . . . . 0.0 109.403 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.4 m -79.66 132.39 36.21 Favored 'General case' 0 C--N 1.352 0.701 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 174.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -51.36 -54.74 22.54 Favored Glycine 0 C--N 1.362 2.019 0 C-N-CA 125.952 1.739 . . . . 0.0 114.843 -170.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 61.2 m170 31.39 74.33 0.05 OUTLIER 'General case' 0 C--N 1.361 1.076 0 C-N-CA 128.168 2.587 . . . . 0.0 115.615 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -71.0 -11.55 61.04 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.127 1.771 . . . . 0.0 112.457 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -73.89 -5.41 40.9 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 126.799 2.04 . . . . 0.0 111.796 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.299 47.1 mt-10 100.09 -144.09 0.0 OUTLIER 'General case' 0 CA--C 1.499 -1.013 0 C-N-CA 128.809 2.844 . . . . 0.0 107.05 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 75.3 tttt 79.12 141.39 0.07 Allowed 'General case' 0 C--N 1.36 1.032 0 C-N-CA 126.616 1.966 . . . . 0.0 109.389 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.86 126.23 59.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -110.03 129.92 55.61 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 126.908 2.083 . . . . 0.0 110.164 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.51 114.13 2.94 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.692 1.197 . . . . 0.0 110.422 -175.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.406 ' CG1' ' H ' ' C' ' 922' ' ' VAL . 7.2 p -85.54 117.69 30.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.881 0 C-N-CA 126.36 1.864 . . . . 0.0 109.04 177.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.73 137.24 58.22 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 125.129 1.372 . . . . 0.0 110.375 173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 7.5 t -117.72 145.39 44.49 Favored 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 126.797 2.039 . . . . 0.0 107.989 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.541 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.0 OUTLIER -78.33 140.37 38.79 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 127.215 2.206 . . . . 0.0 110.878 -174.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 4.9 t 92.25 0.86 0.12 Allowed 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 128.982 2.913 . . . . 0.0 112.129 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -147.12 -25.66 0.4 Allowed 'General case' 0 C--N 1.361 1.078 0 CA-C-N 119.499 1.045 . . . . 0.0 112.101 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.5 166.99 0.06 Allowed 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.422 1.489 . . . . 0.0 111.671 -164.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.7 -130.36 50.93 Favored Glycine 0 C--N 1.375 2.702 0 O-C-N 119.434 -2.041 . . . . 0.0 110.08 -164.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 47.6 t 53.6 73.03 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.226 0 C-N-CA 125.734 1.614 . . . . 0.0 111.586 174.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.89 116.1 28.62 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -171.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 25.0 ptt85 -98.93 -33.26 10.92 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.706 -173.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.406 ' H ' ' CG1' ' C' ' 911' ' ' VAL . 61.1 t -100.03 79.44 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 166.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -94.88 131.71 40.48 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 120.895 0.378 . . . . 0.0 111.299 -175.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 24.6 t -144.18 115.23 7.88 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 125.324 1.45 . . . . 0.0 108.367 171.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -99.54 85.51 0.66 Allowed Glycine 0 CA--C 1.481 -2.035 0 N-CA-C 105.226 -3.149 . . . . 0.0 105.226 172.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.632 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 172.675 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.9 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 70.0 mt -122.31 134.1 54.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.852 -2.277 . . . . 0.0 104.852 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -143.76 162.24 27.74 Favored Glycine 0 CA--C 1.49 -1.498 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -175.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 25.5 m -118.82 130.9 73.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -136.14 150.06 48.91 Favored 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.7 t -105.12 -76.35 0.61 Allowed 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 174.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 13.7 tp -61.48 -49.53 76.39 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -164.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -84.25 -177.86 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 125.081 1.352 . . . . 0.0 110.477 -174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -163.85 84.14 1.31 Allowed Pre-proline 0 C--N 1.356 0.848 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -169.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.59 88.14 1.31 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 CA-C-N 122.478 1.921 . . . . 0.0 109.952 164.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -122.8 146.22 47.72 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 -174.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -90.14 161.37 15.79 Favored 'General case' 0 C--N 1.365 1.251 0 CA-C-O 118.474 -0.774 . . . . 0.0 109.397 -173.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.65 122.15 20.07 Favored 'General case' 0 C--N 1.379 1.878 0 CA-C-N 120.408 1.458 . . . . 0.0 108.633 172.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.27 -11.2 72.71 Favored Glycine 0 C--N 1.347 1.149 0 C-N-CA 125.504 1.526 . . . . 0.0 111.261 167.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -68.99 175.59 3.63 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-O 121.739 0.781 . . . . 0.0 111.673 176.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.9 m -142.81 127.0 17.52 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 124.458 1.103 . . . . 0.0 110.774 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 19.7 m -98.31 147.15 7.01 Favored 'Isoleucine or valine' 0 C--N 1.364 1.198 0 C-N-CA 124.276 1.03 . . . . 0.0 109.155 173.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 19.6 t -142.43 137.89 30.69 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 125.849 1.659 . . . . 0.0 111.193 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.7 129.71 41.08 Favored 'Isoleucine or valine' 0 C--N 1.37 1.489 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -176.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -104.05 132.98 49.75 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 100.973 -3.714 . . . . 0.0 100.973 174.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.84 71.53 1.45 Allowed 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 112.978 -1.919 . . . . 0.0 106.515 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 62.0 t -161.75 99.34 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -151.76 74.43 1.11 Allowed 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 113.72 145.09 9.05 Favored Glycine 0 C--N 1.35 1.359 0 N-CA-C 108.361 -1.895 . . . . 0.0 108.361 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -114.1 -21.13 10.68 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 123.595 0.758 . . . . 0.0 110.007 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -98.71 85.81 3.4 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.82 -158.66 0.88 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 -172.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -120.54 169.47 10.32 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 23.2 t -108.38 130.66 55.21 Favored 'General case' 0 CA--C 1.504 -0.817 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -176.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.72 154.53 30.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.0 115.41 20.44 Favored Pre-proline 0 C--N 1.355 0.813 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 172.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -103.39 176.89 0.15 Allowed 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 121.807 1.671 . . . . 0.0 108.075 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -116.33 138.97 50.89 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.2 p -137.54 139.2 40.33 Favored 'General case' 0 C--N 1.376 1.757 0 CA-C-N 119.931 1.241 . . . . 0.0 108.489 -171.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 34.8 mm -115.14 131.51 67.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.761 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -125.34 104.47 8.48 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 26.6 p -102.17 163.92 11.98 Favored 'General case' 0 C--N 1.35 0.622 0 C-N-CA 125.475 1.51 . . . . 0.0 110.42 172.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 179.1 113.19 0.37 Allowed Glycine 0 C--N 1.358 1.8 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 174.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.18 142.71 46.69 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 114.69 1.367 . . . . 0.0 114.69 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 63.7 tp -73.5 124.63 26.22 Favored 'General case' 0 C--N 1.378 1.827 0 C-N-CA 125.495 1.518 . . . . 0.0 109.598 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.7 tp -98.34 -57.61 2.16 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.517 -0.179 . . . . 0.0 110.517 -178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -131.93 127.54 36.61 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 -175.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.6 129.32 9.85 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 103.739 -3.744 . . . . 0.0 103.739 165.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -70.56 127.8 91.66 Favored Pre-proline 0 C--N 1.349 0.55 0 CA-C-O 117.847 -1.073 . . . . 0.0 110.285 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -106.95 78.41 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.534 0 CA-C-N 121.735 1.655 . . . . 0.0 109.449 -168.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 78.86 -72.77 0.08 Allowed 'General case' 0 N--CA 1.44 -0.975 0 C-N-CA 130.039 3.336 . . . . 0.0 109.063 178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 66.0 mt 48.88 40.53 16.78 Favored 'General case' 0 C--N 1.346 0.451 0 C-N-CA 128.975 2.91 . . . . 0.0 113.576 -175.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -112.45 131.1 55.74 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -128.85 108.3 10.34 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.126 0 N-CA-C 115.749 1.759 . . . . 0.0 115.749 179.265 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 CA--C 1.509 -0.76 0 N-CA-C 109.989 -0.812 . . . . 0.0 109.989 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.9 t -127.93 119.36 21.14 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -90.07 -22.02 0.87 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 CA-C-N 122.222 1.829 . . . . 0.0 109.666 -173.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 38.14 69.16 0.26 Allowed 'General case' 0 C--N 1.36 1.03 0 C-N-CA 128.757 2.823 . . . . 0.0 115.408 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 82.9 t -118.79 137.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.92 159.29 41.91 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 166.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -149.13 138.14 21.36 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -170.27 117.67 0.54 Allowed 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 -175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.3 153.91 33.18 Favored 'General case' 0 C--N 1.372 1.575 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -134.39 158.52 43.63 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 119.005 -1.078 . . . . 0.0 111.411 172.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.24 127.71 30.54 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -166.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.434 ' H ' ' H ' ' A' ' 858' ' ' LEU . 71.5 m -163.12 9.42 0.05 Allowed 'General case' 0 N--CA 1.438 -1.06 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -159.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.434 ' H ' ' H ' ' A' ' 857' ' ' SER . 0.6 OUTLIER -28.5 152.28 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.378 0 N-CA-C 118.158 2.651 . . . . 0.0 118.158 160.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -78.38 -42.26 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.597 0 CA-C-N 121.943 1.73 . . . . 0.0 113.382 -164.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 16.6 ptt85 -166.23 -159.16 0.37 Allowed 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 -174.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.2 m -31.54 139.04 0.04 OUTLIER 'General case' 0 C--N 1.361 1.104 0 C-N-CA 129.478 3.111 . . . . 0.0 115.29 170.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -132.89 164.54 43.14 Favored Pre-proline 0 N--CA 1.442 -0.838 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -173.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -79.93 -14.15 12.53 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 122.591 2.194 . . . . 0.0 111.147 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.9 -139.02 2.62 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 110.012 -1.235 . . . . 0.0 110.012 179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 18.2 m -62.93 145.4 55.33 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 126.87 2.068 . . . . 0.0 111.011 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.44 128.12 54.24 Favored Pre-proline 0 N--CA 1.437 -1.093 0 C-N-CA 125.39 1.476 . . . . 0.0 110.315 -165.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -96.26 -149.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 123.943 3.096 . . . . 0.0 108.361 178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.96 134.17 18.32 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 42.8 p-10 -116.81 -14.45 10.73 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 122.62 0.368 . . . . 0.0 111.719 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.55 87.8 3.46 Favored 'General case' 0 C--N 1.354 0.803 0 CA-C-N 118.658 0.663 . . . . 0.0 112.47 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 59.4 t -70.69 97.83 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 C-N-CA 126.014 1.726 . . . . 0.0 106.781 168.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 78.4 mt -87.71 -37.84 16.33 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.865 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 31.7 tp -166.31 127.55 1.77 Allowed 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 101.337 -3.579 . . . . 0.0 101.337 163.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 179.53 60.82 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 120.806 1.639 . . . . 0.0 109.16 -166.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -59.46 -43.94 93.1 Favored 'General case' 0 C--N 1.362 1.114 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 -165.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.36 -28.04 14.0 Favored Glycine 0 C--N 1.357 1.703 0 CA-C-N 118.733 0.697 . . . . 0.0 112.49 -175.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.57 -58.57 0.39 Allowed Glycine 0 C--N 1.354 1.534 0 N-CA-C 107.516 -2.234 . . . . 0.0 107.516 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 63.16 -80.58 0.03 OUTLIER 'General case' 0 C--N 1.355 0.823 0 C-N-CA 128.065 2.546 . . . . 0.0 114.286 174.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -96.46 119.82 35.64 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.678 1.191 . . . . 0.0 108.416 -177.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -80.0 117.22 66.39 Favored Pre-proline 0 CA--C 1.503 -0.834 0 N-CA-C 104.773 -2.306 . . . . 0.0 104.773 171.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -93.81 6.25 2.73 Favored 'Trans proline' 0 CA--C 1.51 -0.714 0 CA-C-N 125.45 2.982 . . . . 0.0 109.031 -167.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -80.1 -46.66 16.08 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 21.5 p -108.18 -10.76 15.36 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 124.352 1.061 . . . . 0.0 108.667 173.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.87 27.42 38.05 Favored Glycine 0 C--N 1.363 2.028 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 162.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 43.3 t -100.13 103.26 14.54 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.578 0 N-CA-C 100.816 -3.772 . . . . 0.0 100.816 -164.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.36 112.83 25.2 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 111.423 -2.626 . . . . 0.0 109.19 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 61.0 m -100.58 108.48 20.4 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 169.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . 0.44 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.83 110.69 43.53 Favored Pre-proline 0 C--N 1.358 0.966 0 CA-C-O 117.033 -1.461 . . . . 0.0 112.459 172.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -96.46 -1.21 1.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.513 0 CA-C-N 123.109 2.146 . . . . 0.0 109.142 170.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 14.3 mt -53.82 -50.18 66.74 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 127.65 2.38 . . . . 0.0 114.188 -168.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.18 47.9 13.65 Favored 'General case' 0 C--N 1.357 0.895 0 C-N-CA 125.29 1.436 . . . . 0.0 114.486 170.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -160.42 -165.41 17.2 Favored Glycine 0 N--CA 1.415 -2.746 1 N-CA-C 101.291 -4.724 . . . . 0.0 101.291 175.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.444 HH21 HG22 ' A' ' 953' ' ' ILE . 75.9 ttt-85 -93.83 120.9 34.7 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . 0.273 3.7 p90 -115.33 161.33 18.66 Favored 'General case' 0 C--N 1.367 1.344 0 CA-C-N 118.939 0.791 . . . . 0.0 109.479 175.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 57.8 tp -104.61 117.08 33.22 Favored 'General case' 0 C--N 1.351 0.657 0 C-N-CA 123.434 0.694 . . . . 0.0 109.47 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 10.4 tt -111.26 137.38 49.06 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 126.446 1.898 . . . . 0.0 108.941 -167.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.7 m -145.58 119.14 9.1 Favored 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.63 153.35 22.5 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.38 120.43 60.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -102.62 123.87 47.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.843 -173.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 49.0 m -79.12 131.45 36.24 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 125.396 1.478 . . . . 0.0 107.37 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.19 -55.77 25.97 Favored Glycine 0 C--N 1.365 2.194 0 C-N-CA 124.571 1.081 . . . . 0.0 112.268 -169.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.41 64.91 1.56 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 126.486 1.914 . . . . 0.0 113.466 170.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -70.84 -9.01 56.74 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.976 1.71 . . . . 0.0 112.731 -167.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.7 -16.8 61.67 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.509 1.524 . . . . 0.0 112.558 -169.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.321 9.6 pt-20 124.2 -176.18 0.0 OUTLIER 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.204 2.602 . . . . 0.0 107.729 175.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 77.3 tttt 101.49 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.493 -1.212 0 C-N-CA 127.743 2.417 . . . . 0.0 106.914 170.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 66.8 t -99.33 128.7 50.77 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -170.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -110.76 121.16 44.66 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.042 1.737 . . . . 0.0 113.316 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -133.37 115.68 15.16 Favored 'General case' 0 C--N 1.37 1.49 0 C-N-CA 128.474 2.71 . . . . 0.0 109.239 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.6 t -88.59 114.08 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.32 141.41 58.3 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 126.188 1.795 . . . . 0.0 110.713 177.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 3.9 t -116.29 146.34 42.47 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 126.089 1.756 . . . . 0.0 109.847 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.453 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.24 141.21 38.74 Favored 'General case' 0 N--CA 1.432 -1.329 0 C-N-CA 127.201 2.201 . . . . 0.0 110.583 -176.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . 0.313 31.4 p 86.89 10.35 0.17 Allowed 'General case' 0 CA--C 1.508 -0.647 0 C-N-CA 130.268 3.427 . . . . 0.0 114.581 173.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -149.83 -25.02 0.27 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-N 119.076 0.853 . . . . 0.0 110.751 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 58.95 166.57 0.05 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.655 1.582 . . . . 0.0 111.703 -164.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.83 -133.51 51.27 Favored Glycine 0 C--N 1.369 2.394 0 O-C-N 119.387 -2.07 . . . . 0.0 109.878 -161.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 48.4 t 57.82 77.13 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.242 0 C-N-CA 125.785 1.634 . . . . 0.0 110.646 174.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.84 114.14 26.59 Favored 'General case' 0 CA--C 1.491 -1.302 0 N-CA-C 105.536 -2.024 . . . . 0.0 105.536 -174.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.12 -36.79 8.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 114.325 -1.307 . . . . 0.0 108.618 -170.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 92.1 t -100.02 80.43 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 102.292 -3.225 . . . . 0.0 102.292 169.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -97.2 128.58 44.21 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.199 -172.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 26.3 t -143.71 116.5 8.76 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 125.555 1.542 . . . . 0.0 107.369 172.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.54 84.85 0.76 Allowed Glycine 0 N--CA 1.43 -1.704 0 N-CA-C 103.863 -3.695 . . . . 0.0 103.863 163.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.925 0 C-N-CA 124.572 1.082 . . . . 0.0 113.103 176.41 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 CA--C 1.512 -0.506 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 73.1 mt -123.49 134.2 53.93 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.1 161.96 26.39 Favored Glycine 0 C--N 1.349 1.29 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 -175.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 21.1 m -124.51 127.78 73.18 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -138.18 146.57 42.86 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.942 -1.132 . . . . 0.0 107.942 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -114.52 -46.27 2.97 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 27.3 tp -82.17 -49.87 9.65 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 119.426 1.012 . . . . 0.0 112.73 -166.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.444 HG22 HH21 ' A' ' 893' ' ' ARG . 13.5 pt -84.7 -174.4 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 C-N-CA 125.88 1.672 . . . . 0.0 110.044 -178.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -158.7 81.72 2.73 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -167.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.09 91.02 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 122.294 1.996 . . . . 0.0 109.64 163.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -121.9 144.69 48.71 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -92.8 157.12 16.57 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.411 -0.915 . . . . 0.0 109.119 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.37 123.31 21.43 Favored 'General case' 0 C--N 1.377 1.771 0 CA-C-N 119.852 1.206 . . . . 0.0 109.056 176.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.58 -12.03 70.73 Favored Glycine 0 C--N 1.345 1.051 0 C-N-CA 126.184 1.849 . . . . 0.0 111.223 170.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -71.65 175.57 5.53 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 123.332 0.653 . . . . 0.0 111.717 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 99.8 m -142.31 125.83 16.76 Favored 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -160.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.453 HG13 HH11 ' A' ' 914' ' ' ARG . 4.0 m -96.8 148.5 5.43 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 123.249 0.62 . . . . 0.0 109.331 172.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 16.5 t -143.82 138.65 28.84 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.051 1.74 . . . . 0.0 111.19 -172.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 71.4 t -91.84 130.28 41.22 Favored 'Isoleucine or valine' 0 C--N 1.367 1.364 0 C-N-CA 126.767 2.027 . . . . 0.0 107.069 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -105.52 133.11 50.81 Favored 'General case' 0 N--CA 1.429 -1.525 0 N-CA-C 101.071 -3.677 . . . . 0.0 101.071 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 1.5 tp -129.22 72.11 1.46 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 113.041 -1.89 . . . . 0.0 105.975 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 58.2 t -162.83 100.47 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.898 0 N-CA-C 105.752 -1.944 . . . . 0.0 105.752 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 89.6 mmm -153.59 70.01 0.83 Allowed 'General case' 0 CA--C 1.496 -1.127 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.77 145.21 7.24 Favored Glycine 0 CA--C 1.493 -1.304 0 N-CA-C 107.722 -2.151 . . . . 0.0 107.722 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -112.3 -29.28 7.6 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -173.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.3 tp -92.17 87.32 6.06 Favored 'General case' 0 C--N 1.356 0.891 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.55 -165.32 1.75 Allowed 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -171.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 27.2 t60 -124.19 159.67 29.59 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 19.3 t -91.64 131.22 37.19 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.1 149.27 22.88 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 -176.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.91 112.15 22.06 Favored Pre-proline 0 C--N 1.356 0.852 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -99.59 172.33 0.43 Allowed 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.117 1.878 . . . . 0.0 108.269 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.1 mp -116.85 141.17 48.57 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.7 p -139.72 142.33 36.85 Favored 'General case' 0 C--N 1.375 1.681 0 CA-C-N 119.337 0.971 . . . . 0.0 108.562 -171.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 27.3 mm -117.95 129.5 74.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -125.85 105.63 9.09 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 -176.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 34.4 p -101.02 160.55 14.28 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 124.914 1.286 . . . . 0.0 110.212 171.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.47 110.22 0.29 Allowed Glycine 0 C--N 1.359 1.816 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.96 144.05 46.69 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -173.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 67.6 tp -74.15 123.13 23.87 Favored 'General case' 0 C--N 1.379 1.87 0 C-N-CA 124.692 1.197 . . . . 0.0 109.402 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 33.6 tp -99.0 -57.76 2.1 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -132.4 127.47 35.49 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -94.85 131.01 10.53 Favored Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 104.183 -3.567 . . . . 0.0 104.183 164.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -69.94 129.5 90.87 Favored Pre-proline 0 C--N 1.353 0.737 0 CA-C-O 117.902 -1.047 . . . . 0.0 110.663 -178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -107.0 80.11 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.402 0 CA-C-N 121.783 1.672 . . . . 0.0 109.823 -168.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 77.69 -72.91 0.09 Allowed 'General case' 0 CA--C 1.501 -0.929 0 C-N-CA 130.303 3.441 . . . . 0.0 109.238 178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 80.9 mt 49.6 38.76 15.63 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 129.288 3.035 . . . . 0.0 114.085 -176.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.31 131.78 54.75 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -129.42 107.31 9.4 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.106 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 179.462 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo . . . . . 0 N--CA 1.455 -0.781 0 N-CA-C 109.99 -0.812 . . . . 0.0 109.99 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 45.8 t -127.65 119.53 21.55 Favored Pre-proline 0 C--N 1.352 0.71 0 N-CA-C 104.818 -2.29 . . . . 0.0 104.818 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -90.78 -21.97 0.7 Allowed 'Trans proline' 0 CA--C 1.513 -0.572 0 CA-C-N 122.105 1.787 . . . . 0.0 109.758 -173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 38.77 69.77 0.25 Allowed 'General case' 0 C--N 1.358 0.974 0 C-N-CA 128.969 2.908 . . . . 0.0 115.065 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.6 136.74 54.84 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -173.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.9 158.1 45.14 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 166.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -149.02 138.37 21.64 Favored 'General case' 0 C--N 1.361 1.076 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.2 t -170.42 118.61 0.55 Allowed 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -175.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.88 153.81 33.94 Favored 'General case' 0 C--N 1.371 1.51 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -135.9 158.55 44.13 Favored 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 119.002 -1.079 . . . . 0.0 112.157 174.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -136.11 125.08 24.23 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -166.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 74.3 m -162.45 13.43 0.07 Allowed 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 124.959 1.304 . . . . 0.0 107.933 -164.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -27.89 152.8 0.02 OUTLIER Pre-proline 0 C--N 1.368 1.38 0 N-CA-C 118.219 2.674 . . . . 0.0 118.219 158.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -78.04 -42.17 0.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 CA-C-N 122.01 1.754 . . . . 0.0 113.438 -164.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 16.7 ptt85 -166.65 -159.01 0.34 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -174.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 18.0 m -31.35 139.12 0.03 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 129.392 3.077 . . . . 0.0 115.355 170.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -133.12 164.4 44.23 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -173.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.94 -14.1 12.53 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.618 2.212 . . . . 0.0 111.202 -175.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.0 -138.99 2.62 Favored Glycine 0 C--N 1.354 1.528 0 N-CA-C 110.024 -1.231 . . . . 0.0 110.024 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 18.8 m -62.83 145.26 55.42 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 126.81 2.044 . . . . 0.0 110.944 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 91.8 t -88.33 127.78 55.69 Favored Pre-proline 0 N--CA 1.438 -1.048 0 C-N-CA 125.325 1.45 . . . . 0.0 110.161 -165.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -97.09 -149.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.952 3.101 . . . . 0.0 108.276 179.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -148.35 133.75 18.56 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -115.08 -14.35 11.8 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 123.747 0.819 . . . . 0.0 110.59 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 20.5 mmm180 -101.01 87.53 3.3 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-O 121.075 0.464 . . . . 0.0 111.423 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -69.79 97.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 164.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' B' ' 855' ' ' ALA . 32.6 mt -87.92 -39.41 14.78 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 118.548 -1.261 . . . . 0.0 111.373 -173.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 46.5 tp -165.72 126.18 1.81 Allowed 'General case' 0 CA--C 1.49 -1.329 0 N-CA-C 100.492 -3.892 . . . . 0.0 100.492 166.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 176.25 60.58 0.0 OUTLIER 'General case' 0 C--N 1.356 0.859 0 CA-C-N 120.405 1.457 . . . . 0.0 108.514 -162.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.9 -43.53 94.78 Favored 'General case' 0 C--N 1.362 1.146 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -165.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.07 -28.39 13.68 Favored Glycine 0 C--N 1.356 1.641 0 CA-C-N 118.723 0.692 . . . . 0.0 112.518 -175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.09 -57.45 0.43 Allowed Glycine 0 C--N 1.353 1.5 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 62.96 -81.3 0.02 OUTLIER 'General case' 0 C--N 1.355 0.827 0 C-N-CA 128.095 2.558 . . . . 0.0 114.325 174.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 4.4 p90 -97.01 119.7 35.98 Favored 'General case' 0 N--CA 1.434 -1.227 0 C-N-CA 124.854 1.261 . . . . 0.0 108.495 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 54.3 m-20 -79.36 117.58 67.84 Favored Pre-proline 0 N--CA 1.443 -0.783 0 CA-C-O 115.481 -2.2 . . . . 0.0 105.322 171.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -92.92 6.03 3.11 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 CA-C-N 125.51 3.004 . . . . 0.0 109.28 -168.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -79.88 -45.6 18.33 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 124.027 0.931 . . . . 0.0 108.888 -176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 20.7 p -110.05 -11.4 14.63 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 124.658 1.183 . . . . 0.0 108.435 174.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.18 28.63 33.22 Favored Glycine 0 C--N 1.363 2.069 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 163.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.66 102.79 13.92 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.555 0 N-CA-C 100.898 -3.742 . . . . 0.0 100.898 -164.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.73 113.13 25.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 111.819 -2.446 . . . . 0.0 109.014 -174.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -100.83 108.48 20.29 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 168.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . 0.46 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.57 110.92 44.61 Favored Pre-proline 0 C--N 1.357 0.919 0 CA-C-O 117.062 -1.447 . . . . 0.0 112.825 172.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -95.92 -1.34 2.12 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 CA-C-N 123.301 2.215 . . . . 0.0 109.278 169.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 14.5 mt -53.67 -49.83 67.12 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 127.587 2.355 . . . . 0.0 114.358 -167.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.6 48.59 11.57 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.123 1.369 . . . . 0.0 114.676 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -163.18 -165.62 20.6 Favored Glycine 0 N--CA 1.412 -2.922 1 N-CA-C 101.534 -4.626 . . . . 0.0 101.534 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -93.44 120.38 33.65 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.298 2.4 p90 -116.92 161.29 19.57 Favored 'General case' 0 C--N 1.367 1.327 0 CA-C-N 119.132 0.878 . . . . 0.0 109.624 177.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 55.4 tp -105.82 116.04 31.27 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.37 137.32 47.41 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 126.444 1.898 . . . . 0.0 108.251 -170.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.5 m -144.46 118.74 9.56 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 153.29 22.92 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 176.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 99.2 t -110.21 121.09 62.46 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.15 123.34 47.65 Favored 'General case' 0 N--CA 1.44 -0.954 0 C-N-CA 124.127 0.971 . . . . 0.0 108.522 -172.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 43.9 m -78.61 131.41 36.71 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.204 1.402 . . . . 0.0 107.935 173.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -56.76 22.03 Favored Glycine 0 C--N 1.367 2.271 0 C-N-CA 124.73 1.157 . . . . 0.0 112.601 -169.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 49.5 65.17 1.48 Allowed 'General case' 0 C--N 1.357 0.907 0 C-N-CA 126.552 1.941 . . . . 0.0 113.627 170.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 53.7 ptt85 -70.72 -9.14 56.59 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.017 1.727 . . . . 0.0 112.835 -168.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -72.88 -15.2 61.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.852 1.661 . . . . 0.0 112.763 -168.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.0 pt-20 122.52 -177.38 0.0 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 C-N-CA 128.575 2.75 . . . . 0.0 107.754 175.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 76.4 tttt 101.05 132.49 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 127.763 2.425 . . . . 0.0 107.126 170.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 81.2 t -99.82 128.05 52.06 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.066 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -170.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -108.57 121.18 44.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 114.127 -1.397 . . . . 0.0 113.202 175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -134.24 115.1 13.76 Favored 'General case' 0 C--N 1.385 2.117 0 C-N-CA 128.21 2.604 . . . . 0.0 109.568 -177.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 92.8 t -88.48 114.83 27.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 119.695 1.134 . . . . 0.0 108.273 172.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.24 142.77 57.52 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 126.84 2.056 . . . . 0.0 110.607 177.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 3.5 t -116.94 146.71 42.82 Favored 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 126.282 1.833 . . . . 0.0 109.656 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.46 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -79.13 140.8 37.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 C-N-CA 126.936 2.094 . . . . 0.0 110.22 -177.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . . . . . . . . 0.31 28.5 p 87.0 8.37 0.21 Allowed 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 130.275 3.43 . . . . 0.0 114.731 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -149.36 -24.93 0.29 Allowed 'General case' 0 C--N 1.356 0.865 0 CA-C-N 119.426 1.012 . . . . 0.0 111.346 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 59.8 mt-30 58.87 165.12 0.04 OUTLIER 'General case' 0 C--N 1.362 1.15 0 C-N-CA 125.721 1.609 . . . . 0.0 111.767 -164.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 61.52 -132.71 47.61 Favored Glycine 0 C--N 1.366 2.196 0 O-C-N 119.438 -2.039 . . . . 0.0 109.599 -162.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 46.9 t 56.0 77.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.234 0 C-N-CA 126.09 1.756 . . . . 0.0 110.878 175.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.47 114.62 27.19 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 105.543 -2.021 . . . . 0.0 105.543 -174.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -103.69 -36.84 7.74 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-N 113.8 -1.545 . . . . 0.0 108.571 -171.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.4 t -100.76 79.25 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.409 -3.182 . . . . 0.0 102.409 168.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -97.71 128.42 44.37 Favored 'General case' 0 C--N 1.353 0.727 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.808 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 28.3 t -142.65 117.67 10.02 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 125.607 1.563 . . . . 0.0 107.205 172.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.59 84.96 0.76 Allowed Glycine 0 CA--C 1.487 -1.675 0 N-CA-C 104.312 -3.515 . . . . 0.0 104.312 165.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.898 0 C-N-CA 124.734 1.159 . . . . 0.0 113.127 176.405 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 51.6 m . . . . . 0 CA--C 1.508 -0.666 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 67.6 mt -115.75 134.2 55.26 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 -170.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.67 163.13 26.94 Favored Glycine 0 CA--C 1.491 -1.453 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 32.6 m -119.9 129.86 74.9 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 171.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -137.86 148.91 45.83 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.1 m -120.88 -38.99 2.76 Favored 'General case' 0 C--N 1.356 0.877 0 CA-C-N 118.5 0.591 . . . . 0.0 111.995 176.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.1 tp -82.48 -49.09 10.3 Favored 'General case' 0 C--N 1.359 1.015 0 CA-C-N 119.351 0.978 . . . . 0.0 112.612 -168.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 42.4 pt -85.15 -175.14 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.86 0 C-N-CA 125.699 1.599 . . . . 0.0 109.829 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -159.41 80.91 2.59 Favored Pre-proline 0 N--CA 1.441 -0.896 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -169.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.14 92.13 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.479 2.119 . . . . 0.0 110.026 164.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 8.0 mp -121.44 144.46 48.67 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 105.361 -2.088 . . . . 0.0 105.361 -179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -92.95 158.36 15.85 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 119.745 -0.782 . . . . 0.0 109.828 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.84 122.78 21.33 Favored 'General case' 0 C--N 1.381 1.947 0 CA-C-N 120.147 1.339 . . . . 0.0 108.791 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.26 -11.57 71.78 Favored Glycine 0 CA--C 1.496 -1.101 0 C-N-CA 125.868 1.699 . . . . 0.0 111.009 169.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -71.43 175.34 5.56 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.608 0.763 . . . . 0.0 110.964 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 98.1 m -142.56 125.71 16.39 Favored 'General case' 0 CA--C 1.499 -1.019 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -159.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.451 HG13 HH11 ' B' ' 914' ' ' ARG . 4.5 m -97.5 148.62 5.55 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 123.509 0.724 . . . . 0.0 109.734 173.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 16.6 t -143.33 138.82 29.76 Favored 'General case' 0 C--N 1.358 0.966 0 C-N-CA 126.325 1.85 . . . . 0.0 111.229 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 83.3 t -91.16 130.59 40.1 Favored 'Isoleucine or valine' 0 C--N 1.368 1.413 0 C-N-CA 127.398 2.279 . . . . 0.0 107.312 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -105.6 133.23 50.68 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 100.56 -3.867 . . . . 0.0 100.56 172.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 1.8 tp -129.02 71.53 1.43 Allowed 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.4 t -161.25 101.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.866 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.0 mmm -152.46 69.83 0.89 Allowed 'General case' 0 CA--C 1.499 -1.003 0 N-CA-C 105.245 -2.132 . . . . 0.0 105.245 176.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 120.58 144.51 7.09 Favored Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.574 -2.21 . . . . 0.0 107.574 179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -111.13 -28.69 8.18 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.7 tp -92.78 87.32 5.81 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.772 -1.566 . . . . 0.0 106.772 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.34 -164.32 1.57 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 -172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -124.55 159.42 30.66 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 19.0 t -90.79 130.6 36.75 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -157.13 149.22 22.77 Favored 'General case' 0 N--CA 1.44 -0.963 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.81 112.1 22.31 Favored Pre-proline 0 C--N 1.355 0.835 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -99.32 172.36 0.45 Allowed 'Trans proline' 0 CA--C 1.509 -0.743 0 C-N-CA 122.099 1.866 . . . . 0.0 108.139 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.1 139.3 50.44 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 23.0 p -138.39 140.78 39.53 Favored 'General case' 0 C--N 1.373 1.63 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -171.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 30.9 mm -115.94 129.74 71.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.724 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -126.55 105.74 8.95 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -175.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 55.5 p -102.4 162.42 12.93 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.467 1.107 . . . . 0.0 110.989 170.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.53 111.35 0.32 Allowed Glycine 0 C--N 1.358 1.789 0 N-CA-C 107.949 -2.06 . . . . 0.0 107.949 174.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.35 144.14 47.02 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 -174.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 63.0 tp -72.57 122.83 22.01 Favored 'General case' 0 C--N 1.382 2.004 0 C-N-CA 124.583 1.153 . . . . 0.0 109.387 -178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.9 tp -98.74 -57.84 2.09 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -131.83 127.27 36.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 -173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.65 130.67 10.37 Favored Glycine 0 N--CA 1.433 -1.503 0 N-CA-C 103.837 -3.705 . . . . 0.0 103.837 165.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -69.87 129.0 91.45 Favored Pre-proline 0 C--N 1.351 0.674 0 CA-C-O 117.963 -1.018 . . . . 0.0 110.532 -179.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -106.77 78.82 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.448 0 CA-C-N 122.016 1.756 . . . . 0.0 109.325 -167.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 77.93 -72.66 0.09 Allowed 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 130.131 3.372 . . . . 0.0 109.061 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 73.6 mt 49.08 40.63 17.76 Favored 'General case' 0 C--N 1.346 0.417 0 C-N-CA 129.064 2.946 . . . . 0.0 113.719 -174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -112.57 131.88 55.39 Favored 'General case' 0 CA--C 1.496 -1.104 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -130.51 106.98 8.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 176.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.08 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 179.15 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 N--CA 1.456 -0.718 0 N-CA-C 110.038 -0.793 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 44.9 t -124.55 113.75 27.29 Favored Pre-proline 0 N--CA 1.441 -0.876 0 N-CA-C 104.3 -2.481 . . . . 0.0 104.3 -178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -87.91 -22.88 1.36 Allowed 'Trans proline' 0 CA--C 1.511 -0.633 0 CA-C-N 121.648 1.624 . . . . 0.0 110.151 -172.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 36.8 70.19 0.18 Allowed 'General case' 0 C--N 1.358 0.96 0 C-N-CA 128.873 2.869 . . . . 0.0 115.659 177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 23.4 t -122.18 137.03 57.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.66 156.75 48.21 Favored 'General case' 0 C--N 1.362 1.133 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 9.3 p90 -149.0 137.39 20.99 Favored 'General case' 0 C--N 1.361 1.08 0 CA-C-N 118.871 0.759 . . . . 0.0 109.23 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.9 t -171.08 118.86 0.49 Allowed 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.328 -0.858 . . . . 0.0 109.719 -175.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -120.53 153.06 37.23 Favored 'General case' 0 C--N 1.368 1.378 0 N-CA-C 105.585 -2.006 . . . . 0.0 105.585 -176.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -140.15 159.55 41.94 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.972 179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.523 HD21 HD23 ' C' ' 858' ' ' LEU . 2.7 tm? -141.66 130.73 23.28 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 -165.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.5 m -160.49 14.16 0.12 Allowed 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -167.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.523 HD23 HD21 ' C' ' 856' ' ' LEU . 2.2 pp -27.5 145.9 0.04 OUTLIER Pre-proline 0 C--N 1.371 1.532 0 N-CA-C 117.202 2.297 . . . . 0.0 117.202 161.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -78.64 -46.5 0.11 Allowed 'Trans proline' 0 N--CA 1.457 -0.639 0 CA-C-N 122.052 1.768 . . . . 0.0 113.634 -162.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 31.5 ptt85 -162.75 172.22 15.59 Favored 'General case' 0 CA--C 1.502 -0.867 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 16.8 m -3.57 111.92 0.01 OUTLIER 'General case' 0 C--N 1.363 1.178 0 C-N-CA 130.907 3.683 . . . . 0.0 116.942 170.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -99.49 163.18 19.05 Favored Pre-proline 0 N--CA 1.443 -0.802 0 C-N-CA 123.646 0.778 . . . . 0.0 110.56 -172.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.61 -17.2 11.35 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.869 2.38 . . . . 0.0 110.841 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -169.66 -141.45 3.25 Favored Glycine 0 C--N 1.354 1.535 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 6.3 m -66.52 146.66 54.28 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 126.268 1.827 . . . . 0.0 110.715 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 96.0 t -94.73 131.27 30.98 Favored Pre-proline 0 N--CA 1.44 -0.936 0 C-N-CA 124.822 1.249 . . . . 0.0 111.164 -159.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -97.6 -151.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 124.087 3.192 . . . . 0.0 109.278 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 7.6 p90 -147.04 134.37 20.68 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 40.0 p-10 -113.98 -16.0 12.23 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.353 0.661 . . . . 0.0 110.786 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 13.0 mmm180 -102.22 84.66 2.52 Favored 'General case' 0 CA--C 1.506 -0.74 0 CA-C-O 121.326 0.584 . . . . 0.0 111.7 179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 47.9 t -68.86 97.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 126.385 1.874 . . . . 0.0 106.697 163.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 8.6 mt -90.1 -38.78 13.31 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.863 -1.135 . . . . 0.0 111.324 -173.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 30.6 tp -165.54 126.49 1.9 Allowed 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 100.99 -3.708 . . . . 0.0 100.99 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 29.8 t-20 174.76 60.81 0.0 OUTLIER 'General case' 0 CA--C 1.502 -0.879 0 CA-C-N 120.188 1.358 . . . . 0.0 107.704 -162.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.87 -42.7 94.29 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 -164.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.37 -28.82 15.88 Favored Glycine 0 C--N 1.356 1.678 0 CA-C-N 118.665 0.666 . . . . 0.0 112.306 -177.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 105.59 -57.58 0.48 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 107.928 -2.069 . . . . 0.0 107.928 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 62.92 -81.22 0.02 OUTLIER 'General case' 0 C--N 1.354 0.782 0 C-N-CA 128.289 2.636 . . . . 0.0 114.641 173.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -96.02 121.02 37.32 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 125.534 1.534 . . . . 0.0 108.463 -174.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -84.41 116.63 65.94 Favored Pre-proline 0 N--CA 1.44 -0.926 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -94.28 7.61 2.34 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 CA-C-N 125.167 2.881 . . . . 0.0 109.648 -166.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -79.23 -47.37 16.06 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.2 p -108.05 -9.55 15.61 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.932 1.293 . . . . 0.0 108.285 175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.3 25.23 44.51 Favored Glycine 0 C--N 1.361 1.959 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 161.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 60.0 t -99.62 102.82 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.589 0 N-CA-C 100.687 -3.82 . . . . 0.0 100.687 -163.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -94.83 111.77 23.53 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 111.957 -2.383 . . . . 0.0 109.494 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 60.7 m -101.8 108.21 19.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 168.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . 0.556 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -91.71 110.35 42.84 Favored Pre-proline 0 C--N 1.355 0.813 0 CA-C-O 117.197 -1.382 . . . . 0.0 111.321 169.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -92.21 0.59 4.13 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.53 2.154 . . . . 0.0 108.21 165.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 51.6 mt -54.21 -53.23 56.41 Favored 'General case' 0 CA--C 1.495 -1.142 0 C-N-CA 127.837 2.455 . . . . 0.0 113.672 -169.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.59 66.42 1.08 Allowed 'General case' 0 C--N 1.366 1.324 0 CA-C-O 122.16 0.981 . . . . 0.0 110.84 171.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -176.44 170.29 43.06 Favored Glycine 0 N--CA 1.404 -3.485 1 N-CA-C 100.568 -5.013 . . . . 0.0 100.568 -167.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 68.6 ttt-85 -93.85 115.86 28.29 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.375 -1.413 . . . . 0.0 107.968 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -116.5 160.59 20.38 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 119.088 0.858 . . . . 0.0 110.946 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 56.1 tp -107.49 113.35 26.63 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 124.685 1.194 . . . . 0.0 108.05 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.471 HD13 HH12 ' C' ' 921' ' ' ARG . 7.1 tt -118.53 140.81 49.29 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 124.756 1.223 . . . . 0.0 109.574 -176.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -144.14 120.28 10.79 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 123.585 0.754 . . . . 0.0 109.923 -178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -104.0 154.22 19.93 Favored 'General case' 0 C--N 1.364 1.208 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 80.1 t -99.57 122.96 51.99 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.924 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 88.9 mt -95.76 122.93 39.06 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 124.375 1.07 . . . . 0.0 109.39 -176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 33.8 m -80.4 131.2 35.57 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 174.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -52.07 -55.72 20.06 Favored Glycine 0 C--N 1.362 2.018 0 C-N-CA 125.872 1.701 . . . . 0.0 114.975 -169.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 32.44 72.65 0.07 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 128.18 2.592 . . . . 0.0 115.528 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -71.69 -12.72 61.47 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 126.224 1.81 . . . . 0.0 111.552 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -73.07 -17.63 61.4 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 125.778 1.631 . . . . 0.0 112.502 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.323 9.2 pt-20 123.44 -172.21 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.122 0 C-N-CA 128.498 2.719 . . . . 0.0 107.917 173.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 78.6 tttt 102.19 133.26 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.293 0 C-N-CA 128.045 2.538 . . . . 0.0 106.706 171.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 82.3 t -98.32 123.8 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 N-CA-C 105.74 -1.948 . . . . 0.0 105.74 -172.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -104.27 129.8 52.08 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 126.528 1.931 . . . . 0.0 109.764 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.79 114.14 3.15 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 124.769 1.228 . . . . 0.0 110.427 -174.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 5.6 p -85.7 117.68 31.01 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 126.136 1.774 . . . . 0.0 108.809 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 23.1 mt -63.3 135.9 57.33 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 124.294 1.037 . . . . 0.0 109.857 172.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 8.6 t -117.49 143.94 45.55 Favored 'General case' 0 CA--C 1.496 -1.115 0 C-N-CA 126.636 1.974 . . . . 0.0 107.145 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.556 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.1 OUTLIER -79.88 140.86 36.59 Favored 'General case' 0 N--CA 1.425 -1.717 0 C-N-CA 127.159 2.184 . . . . 0.0 110.593 -170.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.315 25.0 p 89.49 6.52 0.13 Allowed 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 130.205 3.402 . . . . 0.0 113.93 177.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -149.45 -25.04 0.28 Allowed 'General case' 0 C--N 1.357 0.897 0 CA-C-N 119.234 0.924 . . . . 0.0 111.622 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 59.39 166.92 0.06 Allowed 'General case' 0 C--N 1.364 1.237 0 C-N-CA 125.474 1.51 . . . . 0.0 111.848 -164.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.41 -131.21 51.93 Favored Glycine 0 C--N 1.375 2.737 0 O-C-N 119.441 -2.037 . . . . 0.0 110.047 -163.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . 0.252 47.6 t 54.87 73.31 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.365 1.244 0 C-N-CA 125.404 1.482 . . . . 0.0 111.741 173.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.09 115.9 28.47 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 -172.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.471 HH12 HD13 ' C' ' 896' ' ' LEU . 11.7 ptt180 -98.83 -33.59 10.82 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.744 -173.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.14 80.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.98 0 N-CA-C 103.283 -2.858 . . . . 0.0 103.283 167.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -95.35 131.32 41.59 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-O 120.922 0.391 . . . . 0.0 111.14 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -144.26 116.02 8.23 Favored 'General case' 0 C--N 1.362 1.141 0 C-N-CA 125.284 1.434 . . . . 0.0 108.198 172.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.35 85.23 0.72 Allowed Glycine 0 CA--C 1.484 -1.874 0 N-CA-C 104.566 -3.413 . . . . 0.0 104.566 169.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.671 0 C-N-CA 125.117 1.341 . . . . 0.0 111.18 172.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 CA--C 1.511 -0.556 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 72.4 mt -120.91 134.32 55.29 Favored 'General case' 0 N--CA 1.433 -1.301 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -140.05 162.77 26.37 Favored Glycine 0 CA--C 1.49 -1.513 0 N-CA-C 108.682 -1.767 . . . . 0.0 108.682 -175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 30.3 m -118.58 130.17 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.202 -1.777 . . . . 0.0 106.202 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -131.28 148.85 52.73 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.299 -0.875 . . . . 0.0 109.737 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.4 m -107.48 -79.85 0.57 Allowed 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 123.566 0.746 . . . . 0.0 109.132 174.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 37.9 tp -64.1 -49.19 73.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 126.322 1.849 . . . . 0.0 115.008 -163.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.8 pp -83.39 -177.63 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 126.148 1.779 . . . . 0.0 110.242 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -165.19 88.35 0.99 Allowed Pre-proline 0 C--N 1.359 0.987 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -168.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -75.51 89.86 1.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 122.724 2.283 . . . . 0.0 110.121 166.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 86.0 mt -124.31 147.08 48.41 Favored 'General case' 0 N--CA 1.442 -0.846 0 C-N-CA 124.734 1.213 . . . . 0.0 108.014 -176.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -94.93 158.99 15.24 Favored 'General case' 0 C--N 1.365 1.25 0 C-N-CA 119.478 -0.889 . . . . 0.0 109.065 -176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.05 122.86 20.21 Favored 'General case' 0 C--N 1.381 1.951 0 CA-C-N 120.29 1.405 . . . . 0.0 109.516 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 90.43 -9.56 77.15 Favored Glycine 0 CA--C 1.498 -1.022 0 C-N-CA 126.259 1.885 . . . . 0.0 111.822 169.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -71.47 173.85 7.38 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 123.888 0.875 . . . . 0.0 110.057 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 12.9 t -144.15 129.13 18.51 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.271 -0.893 . . . . 0.0 111.08 -160.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.402 HG13 ' HD3' ' C' ' 914' ' ' ARG . 27.1 m -95.38 149.18 4.66 Favored 'Isoleucine or valine' 0 C--N 1.358 0.961 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.251 175.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -140.46 137.13 33.67 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 126.181 1.793 . . . . 0.0 111.851 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 6.4 t -93.15 129.79 43.14 Favored 'Isoleucine or valine' 0 C--N 1.376 1.739 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -174.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -105.04 133.76 49.28 Favored 'General case' 0 N--CA 1.428 -1.552 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 174.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 9.2 mp -126.89 81.06 1.99 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 112.794 -2.003 . . . . 0.0 107.433 168.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 57.0 t -158.96 98.01 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 N-CA-C 104.385 -2.45 . . . . 0.0 104.385 173.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.2 mmm -151.87 73.38 1.06 Allowed 'General case' 0 CA--C 1.493 -1.246 0 N-CA-C 104.432 -2.433 . . . . 0.0 104.432 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 110.43 145.48 10.54 Favored Glycine 0 C--N 1.35 1.306 0 N-CA-C 108.139 -1.985 . . . . 0.0 108.139 -179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -112.52 -30.95 6.95 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -173.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -91.9 87.05 6.07 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.66 -160.84 1.1 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 -172.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 34.0 t60 -122.54 156.1 34.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 18.5 t -92.54 133.64 35.74 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -157.34 150.07 23.23 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 105.156 -2.165 . . . . 0.0 105.156 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.9 112.11 20.35 Favored Pre-proline 0 C--N 1.357 0.913 0 N-CA-C 106.824 -1.546 . . . . 0.0 106.824 171.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -101.5 175.52 0.24 Allowed 'Trans proline' 0 CA--C 1.509 -0.766 0 C-N-CA 121.877 1.718 . . . . 0.0 108.303 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -115.84 140.58 49.09 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 24.0 p -137.0 140.17 41.94 Favored 'General case' 0 C--N 1.376 1.749 0 CA-C-N 119.503 1.047 . . . . 0.0 108.466 -172.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 32.2 mm -115.94 131.26 68.93 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -125.56 104.78 8.59 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 -173.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 33.1 p -101.62 164.07 11.94 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 125.473 1.509 . . . . 0.0 110.427 172.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.83 112.81 0.35 Allowed Glycine 0 C--N 1.359 1.824 0 N-CA-C 108.918 -1.673 . . . . 0.0 108.918 175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.46 143.76 45.71 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 -177.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.8 tp -77.01 124.47 27.82 Favored 'General case' 0 C--N 1.378 1.847 0 C-N-CA 125.046 1.338 . . . . 0.0 109.096 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 14.0 tp -97.97 -57.51 2.21 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -132.19 127.41 35.78 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 -177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -93.71 129.83 10.06 Favored Glycine 0 CA--C 1.491 -1.462 0 N-CA-C 104.051 -3.62 . . . . 0.0 104.051 166.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -70.1 129.33 90.82 Favored Pre-proline 0 C--N 1.351 0.637 0 CA-C-O 117.872 -1.061 . . . . 0.0 110.937 -175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -106.74 76.87 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 121.948 1.731 . . . . 0.0 109.593 -167.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 78.53 -72.81 0.08 Allowed 'General case' 0 CA--C 1.5 -0.962 0 C-N-CA 130.192 3.397 . . . . 0.0 108.989 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 49.56 38.7 15.34 Favored 'General case' 0 C--N 1.346 0.414 0 C-N-CA 129.151 2.981 . . . . 0.0 113.768 -175.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -109.86 131.7 54.82 Favored 'General case' 0 CA--C 1.496 -1.1 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -129.92 106.65 8.8 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 105.092 -2.188 . . . . 0.0 105.092 176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.071 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 179.352 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 N--CA 1.451 -1.006 0 N-CA-C 109.678 -0.932 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 46.0 t -128.33 120.44 21.06 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -90.86 -20.31 0.86 Allowed 'Trans proline' 0 CA--C 1.51 -0.718 0 CA-C-N 122.204 1.823 . . . . 0.0 109.699 -173.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 36.41 69.9 0.18 Allowed 'General case' 0 C--N 1.358 0.937 0 C-N-CA 128.987 2.915 . . . . 0.0 115.898 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 83.3 t -119.19 137.05 54.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.94 160.25 38.88 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 165.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -149.2 138.92 21.84 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 25.0 t -169.37 117.27 0.62 Allowed 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.516 -1.291 . . . . 0.0 107.516 -177.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.9 152.88 36.69 Favored 'General case' 0 C--N 1.37 1.497 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -137.12 158.73 43.79 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.643 174.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.531 HD21 HD23 ' A' ' 858' ' ' LEU . 2.3 tm? -132.82 133.53 43.48 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -168.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 858' ' ' LEU . 40.5 p -163.21 9.51 0.05 Allowed 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -164.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.531 HD23 HD21 ' A' ' 856' ' ' LEU . 2.7 pp -31.42 149.21 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.483 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 160.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -81.39 -43.22 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.703 0 CA-C-N 122.34 1.871 . . . . 0.0 113.527 -161.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 34.6 ptt85 -162.52 174.13 13.08 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 119.679 1.127 . . . . 0.0 108.097 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 18.1 m -2.34 117.01 0.01 OUTLIER 'General case' 0 C--N 1.364 1.214 0 C-N-CA 131.383 3.873 . . . . 0.0 117.103 173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -109.06 141.57 23.68 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 -164.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -73.9 -11.48 23.66 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.845 2.364 . . . . 0.0 113.44 -175.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.83 -130.37 1.17 Allowed Glycine 0 C--N 1.351 1.405 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 30.6 m -82.35 143.8 31.0 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 85.6 t -92.56 131.68 33.53 Favored Pre-proline 0 N--CA 1.439 -1.022 0 C-N-CA 124.594 1.157 . . . . 0.0 110.631 -160.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -93.11 -152.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.863 3.042 . . . . 0.0 109.38 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 13.5 p90 -148.35 135.23 20.02 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 119.248 0.931 . . . . 0.0 108.532 -177.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 40.4 p-10 -117.83 -13.52 10.12 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 122.895 0.478 . . . . 0.0 111.781 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -100.34 87.3 3.38 Favored 'General case' 0 C--N 1.355 0.822 0 CA-C-N 118.574 0.624 . . . . 0.0 112.183 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.86 97.39 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 126.144 1.777 . . . . 0.0 106.894 167.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.458 ' HB3' HD11 ' B' ' 953' ' ' ILE . 49.4 mt -88.22 -37.09 16.37 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.577 -0.702 . . . . 0.0 110.709 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 44.6 tp -165.58 125.53 1.78 Allowed 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 101.138 -3.653 . . . . 0.0 101.138 161.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -174.13 61.14 0.02 OUTLIER 'General case' 0 C--N 1.356 0.886 0 CA-C-N 120.38 1.446 . . . . 0.0 109.321 -168.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.36 -44.2 92.72 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -163.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.68 -28.38 12.6 Favored Glycine 0 C--N 1.357 1.724 0 CA-C-N 118.863 0.756 . . . . 0.0 112.307 -176.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.83 -60.55 0.32 Allowed Glycine 0 C--N 1.354 1.531 0 N-CA-C 107.639 -2.184 . . . . 0.0 107.639 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 62.47 -80.9 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.978 2.511 . . . . 0.0 114.19 175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -93.33 119.75 32.82 Favored 'General case' 0 N--CA 1.434 -1.271 0 C-N-CA 124.883 1.273 . . . . 0.0 108.919 -175.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -82.72 117.43 68.51 Favored Pre-proline 0 N--CA 1.437 -1.105 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 173.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -96.69 1.87 1.86 Allowed 'Trans proline' 0 CA--C 1.506 -0.884 0 CA-C-N 124.986 2.817 . . . . 0.0 109.3 -165.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -79.9 -45.45 18.58 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 -177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.6 p -102.84 -13.99 16.76 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 124.103 0.961 . . . . 0.0 108.72 174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 24.01 47.47 Favored Glycine 0 C--N 1.363 2.042 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 162.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 40.5 t -100.94 102.61 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 -164.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.61 112.75 24.94 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 112.181 -2.281 . . . . 0.0 108.656 -177.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 82.5 m -98.97 108.94 21.75 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 169.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . 0.435 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -89.62 110.76 41.62 Favored Pre-proline 0 C--N 1.356 0.849 0 CA-C-O 117.294 -1.336 . . . . 0.0 112.745 173.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.56 -4.88 1.92 Allowed 'Trans proline' 0 N--CA 1.458 -0.577 0 CA-C-N 123.08 2.136 . . . . 0.0 108.98 169.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 33.1 mt -49.06 -55.2 12.84 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 128.664 2.786 . . . . 0.0 114.612 -168.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.9 65.25 1.35 Allowed 'General case' 0 C--N 1.364 1.223 0 CA-C-O 121.926 0.869 . . . . 0.0 112.085 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -175.09 -175.53 42.63 Favored Glycine 0 N--CA 1.408 -3.21 1 N-CA-C 101.034 -4.826 . . . . 0.0 101.034 -174.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -93.22 121.9 35.06 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -114.45 160.43 19.19 Favored 'General case' 0 C--N 1.364 1.224 0 CA-C-N 118.918 0.781 . . . . 0.0 108.965 173.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 59.7 tp -103.84 117.11 33.56 Favored 'General case' 0 C--N 1.348 0.535 0 C-N-CA 123.429 0.691 . . . . 0.0 109.698 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.87 136.3 50.11 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 126.762 2.025 . . . . 0.0 108.88 -165.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 74.2 m -147.17 119.17 8.18 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 123.597 0.759 . . . . 0.0 109.501 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.25 154.22 21.56 Favored 'General case' 0 C--N 1.361 1.087 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 79.0 t -109.3 119.18 58.23 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.962 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -100.78 124.33 46.27 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.992 -173.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 33.7 m -80.48 133.27 35.81 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.34 1.456 . . . . 0.0 107.547 176.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.9 -57.11 21.58 Favored Glycine 0 C--N 1.364 2.137 0 C-N-CA 125.003 1.287 . . . . 0.0 114.214 -169.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 61.9 m170 35.37 72.73 0.09 Allowed 'General case' 0 C--N 1.361 1.087 0 C-N-CA 127.387 2.275 . . . . 0.0 115.266 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -73.74 -8.38 55.77 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.17 1.388 . . . . 0.0 111.72 -175.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -71.92 -19.93 61.85 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.043 1.337 . . . . 0.0 112.49 -171.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.319 9.3 pt-20 125.03 -177.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.137 0 C-N-CA 128.232 2.613 . . . . 0.0 108.333 174.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 101.01 131.78 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.345 0 C-N-CA 127.846 2.459 . . . . 0.0 106.753 170.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.31 124.91 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.123 0 CA-C-O 123.512 1.625 . . . . 0.0 106.839 -172.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -105.68 122.44 46.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 113.223 -1.808 . . . . 0.0 113.207 168.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.05 116.46 17.1 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 128.307 2.643 . . . . 0.0 108.769 -177.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 89.5 t -86.62 113.37 24.27 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 174.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 33.7 mt -62.09 142.17 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.538 1.535 . . . . 0.0 111.194 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -115.0 145.09 42.62 Favored 'General case' 0 CA--C 1.502 -0.885 0 C-N-CA 127.007 2.123 . . . . 0.0 109.086 178.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.435 HH22 ' HB3' ' A' ' 888' ' ' ALA . 0.0 OUTLIER -79.52 139.22 37.64 Favored 'General case' 0 N--CA 1.427 -1.612 0 C-N-CA 127.791 2.436 . . . . 0.0 109.429 -178.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.4 t 100.37 -6.34 0.03 OUTLIER 'General case' 0 C--N 1.35 0.595 0 C-N-CA 129.463 3.105 . . . . 0.0 113.229 173.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 75.2 m-80 -144.53 -24.41 0.52 Allowed 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 119.486 1.039 . . . . 0.0 110.958 -175.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 60.18 167.43 0.08 Allowed 'General case' 0 C--N 1.361 1.091 0 C-N-CA 124.886 1.274 . . . . 0.0 111.833 -164.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 58.6 -133.62 52.66 Favored Glycine 0 C--N 1.375 2.729 0 O-C-N 119.279 -2.138 . . . . 0.0 109.891 -161.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 46.7 t 56.6 75.77 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.366 1.295 0 C-N-CA 125.523 1.529 . . . . 0.0 110.99 174.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.57 115.22 27.71 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 -178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -103.05 -35.11 8.65 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.309 -175.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 88.6 t -99.57 75.77 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.222 0 N-CA-C 102.138 -3.282 . . . . 0.0 102.138 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -94.95 130.3 41.65 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.129 -172.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 22.6 t -143.08 114.49 7.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 125.379 1.472 . . . . 0.0 108.411 172.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.54 84.82 0.69 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.882 -3.687 . . . . 0.0 103.882 163.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.859 0 C-N-CA 124.965 1.269 . . . . 0.0 112.708 174.42 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 44.1 m . . . . . 0 N--CA 1.443 -0.796 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 59.8 mt -117.71 133.54 55.84 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -170.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.33 161.33 26.05 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 17.5 m -125.25 126.3 70.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 174.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -139.77 149.44 43.55 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 50.2 m -115.02 -41.97 3.27 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 29.2 tp -82.59 -50.17 9.07 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 119.373 0.988 . . . . 0.0 113.133 -166.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . . . . . . . . . 8.2 pt -85.09 -171.77 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 C-N-CA 125.371 1.469 . . . . 0.0 110.74 -175.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.482 ' HB2' HD13 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -159.25 81.52 2.57 Favored Pre-proline 0 N--CA 1.435 -1.22 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -168.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.18 90.84 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.87 0 CA-C-N 122.06 1.772 . . . . 0.0 109.536 160.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' A' ' 954' ' ' LEU . 8.3 mp -122.01 145.06 48.5 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 -178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -90.98 158.03 16.95 Favored 'General case' 0 C--N 1.362 1.13 0 C-N-CA 118.673 -1.211 . . . . 0.0 109.464 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.25 123.62 22.65 Favored 'General case' 0 C--N 1.369 1.443 0 CA-C-N 119.689 1.131 . . . . 0.0 108.715 172.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.99 -12.01 69.9 Favored Glycine 0 CA--C 1.495 -1.2 0 C-N-CA 125.85 1.69 . . . . 0.0 110.999 170.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.11 175.64 5.08 Favored 'General case' 0 C--N 1.355 0.841 0 CA-C-O 121.025 0.44 . . . . 0.0 112.102 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 94.9 m -140.67 128.32 21.57 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -155.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . . . . . . . . . 3.2 m -91.83 149.44 4.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 17.4 t -144.24 136.75 26.76 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 124.247 1.019 . . . . 0.0 111.65 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.21 129.75 44.06 Favored 'Isoleucine or valine' 0 C--N 1.369 1.453 0 C-N-CA 126.868 2.067 . . . . 0.0 107.245 178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -107.92 132.29 53.63 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 102.34 -3.207 . . . . 0.0 102.34 168.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 21.0 tp -130.29 75.88 1.68 Allowed 'General case' 0 N--CA 1.439 -1.024 0 CA-C-N 113.212 -1.813 . . . . 0.0 107.045 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 61.8 t -160.81 101.58 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.6 mmm -153.06 71.79 0.92 Allowed 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.804 -2.295 . . . . 0.0 104.804 178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 121.71 150.57 8.3 Favored Glycine 0 CA--C 1.493 -1.283 0 N-CA-C 107.893 -2.083 . . . . 0.0 107.893 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -119.06 -29.01 5.37 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 42.1 tp -92.25 87.07 5.94 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.5 -163.85 1.5 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 -171.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 32.4 t60 -125.08 160.71 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.1 t -94.33 132.06 39.33 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -158.09 150.52 22.27 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.59 113.33 25.24 Favored Pre-proline 0 C--N 1.356 0.86 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 174.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -98.77 173.65 0.47 Allowed 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 121.842 1.694 . . . . 0.0 108.365 -177.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.0 mp -117.43 141.49 48.27 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 23.6 p -139.59 142.06 37.13 Favored 'General case' 0 C--N 1.376 1.736 0 CA-C-N 119.592 1.087 . . . . 0.0 108.909 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 23.7 mm -119.61 129.81 74.88 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -126.15 105.77 9.09 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 -177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 44.6 p -101.25 161.92 13.26 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 124.816 1.246 . . . . 0.0 110.39 171.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.88 111.1 0.29 Allowed Glycine 0 C--N 1.358 1.764 0 N-CA-C 108.292 -1.923 . . . . 0.0 108.292 175.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.1 144.93 46.34 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.861 1.059 . . . . 0.0 113.861 -174.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.01 123.4 25.69 Favored 'General case' 0 C--N 1.378 1.825 0 C-N-CA 124.763 1.225 . . . . 0.0 109.507 -175.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 30.4 tp -98.23 -57.06 2.3 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -130.92 128.01 39.64 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 105.966 -1.865 . . . . 0.0 105.966 -175.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.35 129.96 10.09 Favored Glycine 0 CA--C 1.487 -1.706 0 N-CA-C 103.44 -3.864 . . . . 0.0 103.44 164.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -69.56 129.0 91.84 Favored Pre-proline 0 C--N 1.353 0.738 0 CA-C-O 117.869 -1.062 . . . . 0.0 111.153 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -107.64 81.44 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 CA-C-N 121.835 1.691 . . . . 0.0 110.071 -169.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 77.76 -72.48 0.09 Allowed 'General case' 0 CA--C 1.5 -0.954 0 C-N-CA 130.12 3.368 . . . . 0.0 109.313 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 67.9 mt 49.41 38.81 14.99 Favored 'General case' 0 C--N 1.346 0.427 0 C-N-CA 128.841 2.856 . . . . 0.0 114.411 -176.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -111.86 131.09 55.58 Favored 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -128.09 109.41 11.5 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 175.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.099 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 179.321 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 N--CA 1.452 -0.961 0 N-CA-C 109.615 -0.956 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 44.4 t -127.62 121.17 22.11 Favored Pre-proline 0 C--N 1.353 0.726 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -92.45 -20.53 0.55 Allowed 'Trans proline' 0 CA--C 1.512 -0.581 0 CA-C-N 122.238 1.835 . . . . 0.0 110.037 -173.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 37.8 70.22 0.2 Allowed 'General case' 0 C--N 1.358 0.949 0 C-N-CA 129.155 2.982 . . . . 0.0 115.532 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 85.4 t -118.94 136.82 54.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 N-CA-C 107.68 -1.229 . . . . 0.0 107.68 -173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.6 159.6 40.69 Favored 'General case' 0 C--N 1.36 1.041 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 165.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -149.22 139.19 22.03 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 23.2 t -169.17 117.87 0.66 Allowed 'General case' 0 C--N 1.358 0.956 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -119.15 153.55 34.69 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.462 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -139.13 158.14 44.7 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 119.138 -1.025 . . . . 0.0 112.196 175.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.564 HD21 HD23 ' B' ' 858' ' ' LEU . 2.1 tm? -132.07 132.11 43.03 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -169.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.428 ' H ' ' H ' ' B' ' 858' ' ' LEU . 30.1 p -162.65 8.26 0.06 Allowed 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -164.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.564 HD23 HD21 ' B' ' 856' ' ' LEU . 2.6 pp -31.44 149.94 0.04 OUTLIER Pre-proline 0 C--N 1.369 1.441 0 N-CA-C 116.854 2.168 . . . . 0.0 116.854 161.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -81.75 -43.56 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.564 0 CA-C-N 122.223 1.83 . . . . 0.0 113.494 -161.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -162.41 173.86 13.52 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 119.727 1.149 . . . . 0.0 108.201 -173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.9 m -1.77 116.81 0.01 OUTLIER 'General case' 0 C--N 1.364 1.199 0 C-N-CA 131.398 3.879 . . . . 0.0 117.126 173.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -108.91 141.52 23.53 Favored Pre-proline 0 N--CA 1.442 -0.826 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 -164.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -73.87 -11.57 23.75 Favored 'Trans proline' 0 CA--C 1.512 -0.581 0 C-N-CA 122.801 2.334 . . . . 0.0 113.498 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.5 -130.71 1.19 Allowed Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 30.9 m -81.37 143.38 32.21 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 68.6 t -91.84 131.24 36.05 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 124.529 1.132 . . . . 0.0 110.484 -160.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -94.15 -152.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.755 2.97 . . . . 0.0 109.248 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -148.38 135.21 19.97 Favored 'General case' 0 C--N 1.36 1.038 0 CA-C-N 119.156 0.889 . . . . 0.0 108.611 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 36.1 p30 -115.18 -13.22 11.79 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.387 1.075 . . . . 0.0 110.516 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -100.77 87.62 3.37 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 118.208 0.458 . . . . 0.0 112.204 177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.32 97.11 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.875 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 163.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' B' ' 855' ' ' ALA . 19.6 mt -88.14 -38.69 15.15 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 118.903 -1.119 . . . . 0.0 111.31 -173.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 55.7 tp -165.88 126.63 1.81 Allowed 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 100.869 -3.752 . . . . 0.0 100.869 166.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 176.86 60.93 0.0 OUTLIER 'General case' 0 C--N 1.356 0.883 0 CA-C-N 120.196 1.362 . . . . 0.0 108.515 -163.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.46 -43.77 93.11 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 116.417 2.006 . . . . 0.0 116.417 -166.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -92.27 -29.68 10.99 Favored Glycine 0 C--N 1.356 1.674 0 CA-C-N 118.889 0.768 . . . . 0.0 112.335 -176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.86 -59.54 0.35 Allowed Glycine 0 C--N 1.352 1.457 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 -179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 62.83 -81.02 0.02 OUTLIER 'General case' 0 C--N 1.355 0.824 0 C-N-CA 127.905 2.482 . . . . 0.0 114.408 174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -96.07 119.59 34.84 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 124.924 1.29 . . . . 0.0 108.67 -174.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.46 117.42 68.39 Favored Pre-proline 0 N--CA 1.437 -1.103 0 N-CA-C 104.312 -2.477 . . . . 0.0 104.312 174.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -95.28 2.47 2.46 Favored 'Trans proline' 0 CA--C 1.508 -0.777 0 CA-C-N 125.077 2.849 . . . . 0.0 109.518 -166.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -80.04 -43.88 21.1 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -177.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 30.4 p -105.54 -14.29 15.34 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.443 1.097 . . . . 0.0 108.171 175.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.77 25.56 41.35 Favored Glycine 0 C--N 1.36 1.888 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 163.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 42.9 t -101.48 102.84 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.436 0 N-CA-C 101.867 -3.382 . . . . 0.0 101.867 -163.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -98.89 113.24 25.29 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-N 112.51 -2.132 . . . . 0.0 108.837 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 70.6 m -99.61 109.31 21.82 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . 0.447 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -89.12 111.03 42.55 Favored Pre-proline 0 C--N 1.356 0.882 0 CA-C-O 117.221 -1.371 . . . . 0.0 112.91 173.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -95.36 -4.24 2.08 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 CA-C-N 123.133 2.155 . . . . 0.0 109.192 168.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 21.6 mt -53.52 -49.46 67.54 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.184 2.193 . . . . 0.0 114.334 -167.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 56.56 50.61 12.55 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 125.627 1.571 . . . . 0.0 114.183 171.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -164.26 -165.87 22.21 Favored Glycine 0 N--CA 1.411 -3.008 1 N-CA-C 101.517 -4.633 . . . . 0.0 101.517 176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 65.8 ttt-85 -92.74 121.68 34.37 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 114.462 -0.869 . . . . 0.0 108.985 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . 0.283 2.6 p90 -116.47 160.68 20.25 Favored 'General case' 0 C--N 1.367 1.365 0 CA-C-N 119.023 0.829 . . . . 0.0 109.269 176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 57.6 tp -104.72 116.0 31.28 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -110.26 135.7 50.61 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 126.332 1.853 . . . . 0.0 107.801 -167.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.3 m -144.92 118.97 9.39 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.57 153.91 22.18 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 177.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 97.5 t -109.98 120.76 61.66 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -105.17 122.6 46.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 123.986 0.914 . . . . 0.0 108.812 -172.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 32.5 m -79.29 133.35 36.64 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.258 1.423 . . . . 0.0 108.0 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -58.16 -57.2 21.09 Favored Glycine 0 C--N 1.365 2.167 0 C-N-CA 125.216 1.388 . . . . 0.0 114.267 -169.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 61.3 m170 34.99 72.96 0.09 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.451 2.3 . . . . 0.0 115.186 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -73.66 -8.15 54.85 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 125.291 1.436 . . . . 0.0 111.674 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -73.18 -14.53 61.37 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 125.425 1.49 . . . . 0.0 112.631 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.7 pt-20 118.59 179.45 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.089 0 C-N-CA 128.587 2.755 . . . . 0.0 108.77 176.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 80.7 tttt 102.08 132.14 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.173 0 C-N-CA 128.057 2.543 . . . . 0.0 106.467 171.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 96.7 t -99.22 128.4 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.981 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 -171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -110.63 122.87 48.84 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 113.787 -1.551 . . . . 0.0 113.881 173.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.35 115.41 15.56 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.053 2.541 . . . . 0.0 109.932 -175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.47 114.18 25.99 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.884 0 O-C-N 120.216 -1.553 . . . . 0.0 106.863 173.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 27.8 mt -63.28 144.9 56.54 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 126.454 1.902 . . . . 0.0 111.358 176.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . . . . . . . . . 5.4 t -115.61 145.95 42.23 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 127.196 2.198 . . . . 0.0 109.038 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.447 HH22 ' HB3' ' B' ' 888' ' ' ALA . 0.0 OUTLIER -81.13 138.96 35.88 Favored 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 126.828 2.051 . . . . 0.0 109.231 -179.539 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.6 t 100.85 -10.82 0.03 OUTLIER 'General case' 0 C--N 1.35 0.591 0 C-N-CA 129.589 3.155 . . . . 0.0 113.383 173.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -141.44 -24.38 0.72 Allowed 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 119.493 1.042 . . . . 0.0 111.293 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 60.19 168.41 0.08 Allowed 'General case' 0 C--N 1.362 1.115 0 C-N-CA 124.898 1.279 . . . . 0.0 111.541 -163.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -132.37 51.64 Favored Glycine 0 C--N 1.368 2.34 0 O-C-N 119.763 -1.836 . . . . 0.0 109.702 -164.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 48.7 t 54.74 76.61 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.196 0 C-N-CA 125.984 1.714 . . . . 0.0 111.169 174.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.03 115.17 27.86 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -103.87 -35.22 8.24 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.368 -176.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.1 t -99.89 75.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.144 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 169.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -96.89 129.66 44.3 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.516 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 25.9 t -141.34 115.42 9.27 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 125.319 1.448 . . . . 0.0 107.306 170.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.91 84.76 0.73 Allowed Glycine 0 CA--C 1.488 -1.633 0 N-CA-C 104.098 -3.601 . . . . 0.0 104.098 164.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.812 0 C-N-CA 124.916 1.246 . . . . 0.0 112.808 175.484 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 45.6 m . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 56.3 mt -115.65 133.98 55.5 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 -168.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.2 162.77 26.8 Favored Glycine 0 CA--C 1.494 -1.219 0 C-N-CA 124.731 1.158 . . . . 0.0 110.215 -173.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 28.5 m -121.06 128.38 76.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 172.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -139.55 150.05 44.62 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 53.7 m -123.0 -30.77 3.73 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-N 118.723 0.692 . . . . 0.0 112.448 176.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 23.6 tp -85.88 -51.15 6.58 Favored 'General case' 0 C--N 1.358 0.94 0 CA-C-N 119.648 1.113 . . . . 0.0 112.115 -170.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.458 HD11 ' HB3' ' A' ' 872' ' ' LEU . 38.6 pt -84.8 -175.35 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 C-N-CA 125.39 1.476 . . . . 0.0 110.133 -176.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.492 ' HB2' HD13 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -158.06 80.9 3.04 Favored Pre-proline 0 N--CA 1.437 -1.092 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 -170.372 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.24 92.32 0.92 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.271 1.98 . . . . 0.0 109.932 163.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.492 HD13 ' HB2' ' B' ' 954' ' ' LEU . 9.6 mp -121.59 144.73 48.57 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -89.91 159.23 17.04 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 118.922 -1.111 . . . . 0.0 110.334 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.45 123.48 23.19 Favored 'General case' 0 C--N 1.377 1.773 0 CA-C-N 119.769 1.168 . . . . 0.0 108.379 173.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.73 -11.64 70.8 Favored Glycine 0 CA--C 1.495 -1.174 0 C-N-CA 125.635 1.588 . . . . 0.0 110.92 169.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.36 175.31 5.53 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 121.631 0.729 . . . . 0.0 111.324 176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 96.1 m -141.35 128.59 21.0 Favored 'General case' 0 CA--C 1.503 -0.844 0 C-N-CA 123.513 0.725 . . . . 0.0 109.095 -153.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.9 149.76 4.22 Favored 'Isoleucine or valine' 0 C--N 1.362 1.118 0 CA-C-O 121.466 0.65 . . . . 0.0 109.476 178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 18.3 t -143.99 136.67 27.08 Favored 'General case' 0 C--N 1.351 0.643 0 C-N-CA 124.724 1.209 . . . . 0.0 111.135 174.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 87.0 t -93.51 130.51 42.41 Favored 'Isoleucine or valine' 0 C--N 1.367 1.352 0 C-N-CA 127.593 2.357 . . . . 0.0 107.401 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -107.25 132.12 53.44 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 101.13 -3.656 . . . . 0.0 101.13 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 19.7 tp -129.65 75.33 1.64 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 113.471 -1.695 . . . . 0.0 106.805 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 55.8 t -159.22 103.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.876 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 89.8 mmm -152.37 70.03 0.9 Allowed 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 124.24 148.02 7.33 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.559 -2.216 . . . . 0.0 107.559 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -116.04 -27.96 6.77 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -174.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 39.9 tp -93.52 86.68 5.29 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 178.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.36 -164.2 1.56 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 -173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 31.3 t60 -124.56 159.23 31.12 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 17.9 t -92.31 132.05 37.02 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -158.47 150.7 21.71 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.751 -2.314 . . . . 0.0 104.751 -177.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.54 113.2 25.37 Favored Pre-proline 0 C--N 1.357 0.894 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 174.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -98.31 173.04 0.56 Allowed 'Trans proline' 0 CA--C 1.508 -0.794 0 C-N-CA 121.853 1.702 . . . . 0.0 108.283 -178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.2 mp -116.62 140.16 49.71 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 22.6 p -138.54 141.67 39.29 Favored 'General case' 0 C--N 1.374 1.647 0 CA-C-N 119.616 1.098 . . . . 0.0 108.663 -171.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 26.7 mm -117.3 130.45 72.19 Favored 'Isoleucine or valine' 0 C--N 1.354 0.764 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -127.37 105.54 8.6 Favored 'General case' 0 C--N 1.364 1.23 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 52.2 p -102.65 162.77 12.66 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 110.687 171.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.66 112.56 0.34 Allowed Glycine 0 C--N 1.359 1.825 0 N-CA-C 107.235 -2.346 . . . . 0.0 107.235 174.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -121.61 145.98 47.44 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 61.8 tp -72.58 123.79 23.92 Favored 'General case' 0 C--N 1.381 1.971 0 C-N-CA 124.422 1.089 . . . . 0.0 109.763 -177.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.6 tp -97.82 -56.95 2.35 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 15.2 t80 -131.14 127.31 37.79 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 -172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.32 129.54 9.94 Favored Glycine 0 CA--C 1.487 -1.66 0 N-CA-C 103.379 -3.888 . . . . 0.0 103.379 163.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -70.41 128.84 90.9 Favored Pre-proline 0 C--N 1.349 0.555 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.122 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -107.0 81.68 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 CA-C-N 121.782 1.672 . . . . 0.0 109.462 -168.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 78.04 -71.73 0.1 Allowed 'General case' 0 CA--C 1.501 -0.908 0 C-N-CA 129.818 3.247 . . . . 0.0 109.203 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 56.7 mt 49.16 40.49 17.81 Favored 'General case' 0 C--N 1.346 0.413 0 C-N-CA 128.668 2.787 . . . . 0.0 114.02 -175.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -114.13 131.48 56.41 Favored 'General case' 0 CA--C 1.495 -1.168 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -129.16 109.19 10.95 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 105.153 -2.166 . . . . 0.0 105.153 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.074 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 179.062 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 N--CA 1.45 -1.047 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 38.9 t -122.05 112.85 31.59 Favored Pre-proline 0 N--CA 1.443 -0.801 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -88.35 -21.6 1.48 Allowed 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 121.617 1.613 . . . . 0.0 110.161 -171.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 35.93 70.86 0.14 Allowed 'General case' 0 C--N 1.357 0.901 0 C-N-CA 129.161 2.984 . . . . 0.0 115.679 176.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 47.9 t -120.29 134.81 62.58 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -177.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -134.51 161.93 33.67 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 166.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . . . . . . . . . 15.6 p90 -148.75 146.76 28.21 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 166.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.3 t -166.83 119.25 0.97 Allowed 'General case' 0 C--N 1.35 0.588 0 CA-C-O 118.447 -0.787 . . . . 0.0 109.53 172.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -125.07 154.87 40.69 Favored 'General case' 0 C--N 1.371 1.531 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -143.11 155.58 44.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 122.201 1.0 . . . . 0.0 109.537 -176.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.553 HD21 HD23 ' C' ' 858' ' ' LEU . 2.2 tm? -131.62 127.6 37.38 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.436 -166.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 75.2 m -158.8 12.78 0.16 Allowed 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -164.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.553 HD23 HD21 ' C' ' 856' ' ' LEU . 2.3 pp -27.71 146.18 0.04 OUTLIER Pre-proline 0 C--N 1.37 1.463 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 160.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.78 -44.82 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.684 0 CA-C-N 122.245 1.837 . . . . 0.0 113.332 -161.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 34.0 ptt85 -164.28 173.75 11.93 Favored 'General case' 0 CA--C 1.5 -0.974 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -173.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.7 m -4.38 112.56 0.01 OUTLIER 'General case' 0 C--N 1.365 1.242 0 C-N-CA 130.826 3.651 . . . . 0.0 116.436 170.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -115.93 162.54 25.14 Favored Pre-proline 0 N--CA 1.443 -0.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -167.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.34 -14.99 9.11 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.378 2.052 . . . . 0.0 111.163 -175.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -167.33 -144.2 4.05 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 28.1 m -64.96 136.14 56.46 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 125.986 1.715 . . . . 0.0 110.492 -178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 16.6 m -64.89 143.66 98.87 Favored Pre-proline 0 C--N 1.354 0.78 0 C-N-CA 125.444 1.497 . . . . 0.0 113.2 -174.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -98.7 -151.75 0.03 OUTLIER 'Trans proline' 0 CA--C 1.513 -0.572 0 C-N-CA 123.296 2.664 . . . . 0.0 107.478 177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -146.05 130.11 17.4 Favored 'General case' 0 N--CA 1.441 -0.906 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 175.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -115.93 -15.67 11.19 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.159 0.584 . . . . 0.0 111.08 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -103.23 79.71 1.76 Allowed 'General case' 0 C--N 1.352 0.693 0 C-N-CA 122.937 0.495 . . . . 0.0 111.669 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.08 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 127.063 2.145 . . . . 0.0 106.973 165.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 3.3 mt -90.75 -37.16 13.86 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 120.035 -0.666 . . . . 0.0 111.327 -174.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 60.5 tp -164.64 128.2 2.45 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 101.119 -3.66 . . . . 0.0 101.119 169.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 172.34 61.96 0.0 OUTLIER 'General case' 0 C--N 1.356 0.854 0 CA-C-N 120.653 1.57 . . . . 0.0 106.973 -164.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.72 -43.32 98.02 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 116.085 1.884 . . . . 0.0 116.085 -165.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -90.77 -32.91 8.73 Favored Glycine 0 C--N 1.357 1.728 0 CA-C-N 119.028 0.831 . . . . 0.0 112.076 -175.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 111.51 -65.01 0.26 Allowed Glycine 0 C--N 1.351 1.398 0 N-CA-C 107.032 -2.427 . . . . 0.0 107.032 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 64.24 -79.13 0.03 OUTLIER 'General case' 0 C--N 1.353 0.748 0 C-N-CA 127.931 2.492 . . . . 0.0 114.517 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.59 121.87 36.59 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 125.804 1.642 . . . . 0.0 109.283 -173.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 -80.57 118.4 72.25 Favored Pre-proline 0 N--CA 1.445 -0.696 0 CA-C-O 115.611 -2.137 . . . . 0.0 105.884 168.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -92.42 0.88 4.0 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 CA-C-N 125.514 3.005 . . . . 0.0 109.517 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.6 -45.66 18.73 Favored 'General case' 0 CA--C 1.5 -0.973 0 C-N-CA 124.244 1.018 . . . . 0.0 108.9 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 26.3 p -106.41 -13.4 15.37 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 125.702 1.601 . . . . 0.0 108.17 175.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 86.24 25.23 37.48 Favored Glycine 0 C--N 1.361 1.949 0 C-N-CA 120.105 -1.045 . . . . 0.0 110.728 162.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 47.6 t -101.54 101.29 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.419 0 N-CA-C 101.588 -3.486 . . . . 0.0 101.588 -165.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -97.29 112.82 24.47 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-N 112.45 -2.159 . . . . 0.0 108.387 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 67.6 m -101.11 107.83 19.36 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 168.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . 0.617 ' HB3' HH22 ' C' ' 914' ' ' ARG . . . -90.95 111.79 50.16 Favored Pre-proline 0 C--N 1.357 0.901 0 CA-C-O 117.247 -1.358 . . . . 0.0 111.602 171.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -92.05 2.69 4.05 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 CA-C-N 123.094 2.141 . . . . 0.0 109.067 167.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 95.5 mt -55.01 -54.21 45.95 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 127.039 2.136 . . . . 0.0 114.545 -167.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.8 68.5 0.83 Allowed 'General case' 0 C--N 1.366 1.293 0 CA-C-O 121.981 0.896 . . . . 0.0 111.825 171.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.28 -169.77 36.78 Favored Glycine 0 N--CA 1.406 -3.318 1 N-CA-C 102.089 -4.404 . . . . 0.0 102.089 -172.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -92.72 119.19 31.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 113.797 -1.202 . . . . 0.0 108.26 173.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.452 ' H ' HD11 ' C' ' 954' ' ' LEU . 8.8 t80 -118.19 146.52 44.16 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 -168.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 54.0 tp -111.41 116.23 30.59 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 124.222 1.009 . . . . 0.0 109.086 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 7.3 tt -114.42 139.77 49.23 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 125.016 1.326 . . . . 0.0 109.365 -178.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 70.3 m -144.1 119.15 10.04 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.484 0.714 . . . . 0.0 109.903 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.38 154.57 21.65 Favored 'General case' 0 C--N 1.365 1.249 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 98.1 t -100.67 122.36 52.58 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 92.1 mt -98.05 123.73 42.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.251 1.02 . . . . 0.0 109.617 -174.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 39.0 m -83.16 131.36 35.13 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -53.68 -56.42 20.34 Favored Glycine 0 C--N 1.364 2.109 0 C-N-CA 125.611 1.577 . . . . 0.0 114.762 -170.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 63.6 m170 32.04 72.34 0.07 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 127.946 2.498 . . . . 0.0 115.609 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -74.27 -9.5 58.66 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 124.967 1.307 . . . . 0.0 111.371 -177.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.96 -18.33 62.01 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 125.297 1.439 . . . . 0.0 112.568 -169.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.294 12.1 pt-20 124.63 -175.34 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.139 0 C-N-CA 128.528 2.731 . . . . 0.0 107.783 174.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 44.1 tttp 100.88 131.32 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.371 0 C-N-CA 127.696 2.398 . . . . 0.0 106.554 170.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 71.2 t -99.21 123.49 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 -175.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -105.15 122.72 46.5 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.783 -1.553 . . . . 0.0 113.509 167.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -131.07 117.15 18.72 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.371 2.668 . . . . 0.0 109.607 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.415 HG11 HH21 ' C' ' 921' ' ' ARG . 87.1 t -90.1 113.01 25.53 Favored 'Isoleucine or valine' 0 C--N 1.36 1.058 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.28 144.6 53.58 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 125.796 1.639 . . . . 0.0 111.58 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . . . . . . . . 0.285 1.0 OUTLIER -115.31 147.24 40.69 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 126.721 2.008 . . . . 0.0 108.893 177.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.617 HH22 ' HB3' ' C' ' 888' ' ' ALA . 0.6 OUTLIER -80.34 138.83 36.76 Favored 'General case' 0 N--CA 1.426 -1.638 0 C-N-CA 127.301 2.241 . . . . 0.0 110.123 -177.327 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . . . . . . . . . 6.3 t 94.19 -2.64 0.1 Allowed 'General case' 0 C--N 1.348 0.537 0 C-N-CA 129.21 3.004 . . . . 0.0 112.701 176.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -144.17 -26.41 0.53 Allowed 'General case' 0 C--N 1.358 0.95 0 O-C-N 120.904 -1.122 . . . . 0.0 111.819 -175.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 58.89 168.31 0.06 Allowed 'General case' 0 C--N 1.361 1.083 0 C-N-CA 125.197 1.399 . . . . 0.0 111.583 -162.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.11 -130.72 51.4 Favored Glycine 0 C--N 1.375 2.697 0 O-C-N 119.576 -1.953 . . . . 0.0 109.855 -165.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 45.2 t 51.66 76.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.214 0 C-N-CA 126.197 1.799 . . . . 0.0 111.322 176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.39 114.71 26.89 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -170.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.415 HH21 HG11 ' C' ' 911' ' ' VAL . 12.6 ptt180 -99.12 -38.69 8.83 Favored 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 113.57 -1.65 . . . . 0.0 108.413 -170.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 86.6 t -100.28 82.68 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 102.852 -3.018 . . . . 0.0 102.852 167.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -94.72 132.02 39.92 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 121.11 0.481 . . . . 0.0 110.49 -174.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 20.7 t -142.75 115.29 8.56 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.441 1.496 . . . . 0.0 108.631 174.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.25 84.54 0.7 Allowed Glycine 0 CA--C 1.486 -1.76 0 N-CA-C 104.823 -3.311 . . . . 0.0 104.823 166.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.597 0 C-N-CA 125.89 1.709 . . . . 0.0 111.453 174.378 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.446 -0.642 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -121.02 134.02 55.28 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 104.936 -2.246 . . . . 0.0 104.936 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -141.92 163.45 26.97 Favored Glycine 0 CA--C 1.492 -1.391 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 32.9 m -119.69 130.94 73.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 175.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -135.39 148.72 49.45 Favored 'General case' 0 C--N 1.358 0.952 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 -178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 51.9 m -116.36 -39.77 3.33 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 31.4 tp -93.04 -55.15 3.45 Favored 'General case' 0 C--N 1.356 0.863 0 O-C-N 121.57 -0.706 . . . . 0.0 111.747 -166.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.3 -161.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 C-N-CA 125.117 1.367 . . . . 0.0 109.737 -173.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.452 HD11 ' H ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER -170.72 91.55 0.47 Allowed Pre-proline 0 C--N 1.358 0.948 0 O-C-N 121.794 -0.566 . . . . 0.0 110.033 -166.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.33 90.61 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 CA-C-N 123.247 2.195 . . . . 0.0 109.569 158.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 89.1 mt -123.36 145.83 48.43 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -95.15 159.7 14.89 Favored 'General case' 0 C--N 1.363 1.173 0 CA-C-N 118.858 0.753 . . . . 0.0 109.33 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.61 122.67 20.94 Favored 'General case' 0 C--N 1.379 1.879 0 CA-C-N 120.104 1.32 . . . . 0.0 109.411 178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 88.79 -8.39 79.59 Favored Glycine 0 C--N 1.346 1.094 0 C-N-CA 125.896 1.713 . . . . 0.0 111.923 170.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -72.14 173.75 8.1 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 123.946 0.898 . . . . 0.0 109.709 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 81.9 m -142.33 126.21 17.16 Favored 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -156.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.464 HG13 HH11 ' C' ' 914' ' ' ARG . 34.8 m -94.99 150.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.355 0.805 0 C-N-CA 123.722 0.809 . . . . 0.0 109.197 175.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 15.0 t -140.13 139.46 35.79 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 125.9 1.68 . . . . 0.0 112.195 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 90.8 t -90.03 128.79 41.76 Favored 'Isoleucine or valine' 0 C--N 1.373 1.588 0 C-N-CA 126.42 1.888 . . . . 0.0 106.727 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -107.6 131.36 54.45 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 101.545 -3.502 . . . . 0.0 101.545 169.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 25.0 tp -131.92 76.89 1.73 Allowed 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 113.284 -1.78 . . . . 0.0 107.617 173.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 58.3 t -159.03 100.0 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.501 -0.918 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 84.9 mmm -149.34 83.81 1.43 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 103.599 -2.741 . . . . 0.0 103.599 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 106.78 149.3 16.14 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 109.066 -1.614 . . . . 0.0 109.066 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -117.4 -17.67 10.04 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 123.651 0.781 . . . . 0.0 110.374 -174.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 42.0 tp -99.74 85.4 3.1 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.38 -164.82 1.66 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -171.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 12.1 m80 -121.37 157.58 30.14 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 17.8 t -91.54 131.5 36.93 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -158.74 152.8 23.69 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -125.73 113.97 24.86 Favored Pre-proline 0 C--N 1.356 0.858 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -96.45 170.48 1.04 Allowed 'Trans proline' 0 CA--C 1.508 -0.803 0 C-N-CA 121.839 1.693 . . . . 0.0 107.861 177.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.0 mp -114.56 138.38 50.72 Favored 'General case' 0 C--N 1.353 0.723 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 23.1 p -135.62 138.32 42.78 Favored 'General case' 0 C--N 1.374 1.636 0 CA-C-N 119.488 1.04 . . . . 0.0 108.299 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 37.9 mm -115.62 130.59 69.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -128.9 101.18 5.97 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 24.4 p -100.68 163.83 12.15 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 125.6 1.56 . . . . 0.0 109.115 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . 178.8 113.44 0.37 Allowed Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 107.907 -2.077 . . . . 0.0 107.907 178.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -116.15 146.0 42.62 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 66.3 tp -78.53 125.27 29.13 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.481 1.513 . . . . 0.0 109.365 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 12.5 tp -97.49 -56.8 2.42 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 121.993 0.117 . . . . 0.0 110.713 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -131.09 128.36 40.03 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -175.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.41 129.34 9.86 Favored Glycine 0 CA--C 1.486 -1.725 0 N-CA-C 103.441 -3.864 . . . . 0.0 103.441 163.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -69.47 132.11 89.65 Favored Pre-proline 0 C--N 1.349 0.563 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.478 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -106.38 79.49 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.671 0 CA-C-N 121.305 1.502 . . . . 0.0 109.171 -170.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 78.98 -72.04 0.08 Allowed 'General case' 0 CA--C 1.499 -0.998 0 C-N-CA 130.019 3.328 . . . . 0.0 109.056 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 69.9 mt 49.77 39.48 18.03 Favored 'General case' 0 C--N 1.346 0.418 0 C-N-CA 128.678 2.791 . . . . 0.0 113.761 -175.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -112.32 131.42 55.53 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -128.34 108.97 11.02 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.121 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 179.206 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.455 -0.776 0 N-CA-C 110.021 -0.8 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 44.2 t -125.87 120.05 24.15 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 104.408 -2.442 . . . . 0.0 104.408 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -91.69 -21.0 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 CA-C-N 122.146 1.802 . . . . 0.0 109.566 -172.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 36.86 70.03 0.19 Allowed 'General case' 0 C--N 1.359 0.984 0 C-N-CA 129.103 2.961 . . . . 0.0 115.631 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 87.3 t -118.78 136.5 55.78 Favored 'Isoleucine or valine' 0 C--N 1.353 0.721 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 -173.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.02 158.81 43.38 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 106.754 -1.572 . . . . 0.0 106.754 162.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.461 ' HA ' ' HA ' ' A' ' 874' ' ' ASN . 8.1 p90 -149.44 138.56 21.32 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 172.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 28.8 t -169.1 117.15 0.65 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.5 152.36 36.09 Favored 'General case' 0 CA--C 1.487 -1.448 0 N-CA-C 104.916 -2.253 . . . . 0.0 104.916 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -135.67 157.58 46.53 Favored 'General case' 0 CA--C 1.509 -0.597 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.537 171.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.409 HD11 HD23 ' A' ' 858' ' ' LEU . 2.6 tm? -131.59 131.52 43.34 Favored 'General case' 0 N--CA 1.433 -1.322 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -166.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . . . . . . . . . 41.7 p -160.32 16.18 0.13 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 -165.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.409 HD23 HD11 ' A' ' 856' ' ' LEU . 3.4 pp -21.73 144.1 0.02 OUTLIER Pre-proline 0 C--N 1.37 1.464 0 N-CA-C 117.317 2.34 . . . . 0.0 117.317 159.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.8 -43.57 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.695 0 CA-C-N 122.093 1.783 . . . . 0.0 111.995 -167.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 40.3 ptt85 -164.28 176.67 8.94 Favored 'General case' 0 CA--C 1.499 -1.0 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -175.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 17.1 m -19.22 120.21 0.02 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.651 3.18 . . . . 0.0 115.656 171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -127.67 144.22 50.35 Favored Pre-proline 0 N--CA 1.44 -0.953 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 -163.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.66 -10.34 17.12 Favored 'Trans proline' 0 CA--C 1.512 -0.619 0 CA-C-N 122.685 1.995 . . . . 0.0 113.586 -159.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -158.07 -142.05 3.3 Favored Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 178.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 20.3 m -63.31 145.38 55.68 Favored 'General case' 0 C--N 1.357 0.911 0 C-N-CA 126.086 1.754 . . . . 0.0 110.47 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 95.0 t -89.1 128.79 50.41 Favored Pre-proline 0 N--CA 1.439 -1.017 0 C-N-CA 124.857 1.263 . . . . 0.0 110.307 -165.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -94.45 -152.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 124.28 3.32 . . . . 0.0 108.489 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . . . . . . . . . 11.9 p90 -149.28 135.13 18.81 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 -177.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -118.33 -13.65 9.81 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 122.753 0.421 . . . . 0.0 111.608 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -100.17 86.73 3.28 Favored 'General case' 0 C--N 1.355 0.81 0 CA-C-N 118.609 0.641 . . . . 0.0 112.545 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . 0.442 HG13 ' HB3' ' A' ' 874' ' ' ASN . 54.0 t -71.92 97.65 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 125.831 1.652 . . . . 0.0 107.013 168.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 79.7 mt -87.36 -37.21 17.3 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.946 -172.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 29.2 tp -165.4 127.64 2.09 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 101.959 -3.349 . . . . 0.0 101.959 160.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.461 ' HA ' ' HA ' ' A' ' 852' ' ' PHE . 26.9 t-20 -174.8 60.84 0.02 OUTLIER 'General case' 0 C--N 1.356 0.877 0 CA-C-N 120.553 1.524 . . . . 0.0 110.336 -166.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -58.87 -43.99 90.97 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 116.47 2.026 . . . . 0.0 116.47 -166.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.35 -27.23 12.19 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 118.928 0.785 . . . . 0.0 112.747 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 109.72 -57.76 0.41 Allowed Glycine 0 C--N 1.352 1.465 0 N-CA-C 107.894 -2.082 . . . . 0.0 107.894 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 61.07 -83.21 0.02 OUTLIER 'General case' 0 C--N 1.354 0.804 0 C-N-CA 128.098 2.559 . . . . 0.0 114.746 174.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -96.78 119.14 34.7 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -176.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -83.21 116.05 62.28 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 103.583 -2.747 . . . . 0.0 103.583 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -95.95 4.88 2.03 Favored 'Trans proline' 0 CA--C 1.505 -0.93 0 CA-C-N 124.405 2.609 . . . . 0.0 109.407 -160.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -79.93 -45.81 17.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -177.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 32.1 p -106.01 -10.43 16.58 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.348 173.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.41 28.06 37.48 Favored Glycine 0 C--N 1.366 2.201 0 N-CA-C 110.441 -1.063 . . . . 0.0 110.441 161.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 22.9 t -101.6 103.05 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.693 0 N-CA-C 100.305 -3.961 . . . . 0.0 100.305 -162.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.468 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.4 OUTLIER -102.03 111.13 23.28 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 112.434 -2.166 . . . . 0.0 109.464 -173.045 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 83.9 m -99.99 107.53 19.5 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 170.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . 0.461 ' HB3' HH22 ' A' ' 914' ' ' ARG . . . -90.12 111.41 46.64 Favored Pre-proline 0 C--N 1.355 0.805 0 CA-C-O 117.106 -1.426 . . . . 0.0 112.2 169.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -90.0 -1.24 5.62 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.781 2.321 . . . . 0.0 109.126 166.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 6.9 tt -49.13 -54.82 14.49 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 128.856 2.862 . . . . 0.0 115.127 -167.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.47 48.69 14.11 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 171.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . -154.63 -161.77 10.74 Favored Glycine 0 N--CA 1.417 -2.578 1 N-CA-C 102.636 -4.185 . . . . 0.0 102.636 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.557 ' HE ' HG22 ' A' ' 953' ' ' ILE . 67.7 ttt-85 -89.92 120.89 31.53 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.472 ' H ' HD11 ' A' ' 954' ' ' LEU . 1.3 t80 -115.58 144.87 43.26 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 -174.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -109.78 116.81 32.35 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 123.704 0.801 . . . . 0.0 109.871 177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.9 tt -114.1 140.02 48.83 Favored 'General case' 0 C--N 1.361 1.069 0 C-N-CA 126.091 1.756 . . . . 0.0 109.049 -172.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -143.98 119.74 10.52 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 123.526 0.73 . . . . 0.0 109.812 174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.47 153.95 22.07 Favored 'General case' 0 C--N 1.367 1.344 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 77.9 t -106.31 121.07 58.38 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.36 123.59 43.77 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.209 -172.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 41.8 m -83.38 131.33 35.06 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -57.39 -58.07 16.47 Favored Glycine 0 C--N 1.359 1.854 0 C-N-CA 125.124 1.345 . . . . 0.0 114.107 -169.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 58.6 m170 38.25 69.81 0.23 Allowed 'General case' 0 C--N 1.36 1.065 0 C-N-CA 127.085 2.154 . . . . 0.0 114.708 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -73.23 -8.97 58.12 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 125.161 1.384 . . . . 0.0 111.284 -175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -72.33 -19.44 61.65 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 124.814 1.246 . . . . 0.0 112.486 -171.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . . . . . . . . 0.301 13.9 pt-20 127.56 -176.81 0.0 OUTLIER 'General case' 0 C--N 1.361 1.078 0 C-N-CA 128.161 2.584 . . . . 0.0 108.424 174.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . . . . . . . . . 78.7 tttt 102.05 131.74 0.01 OUTLIER 'General case' 0 CA--C 1.491 -1.29 0 C-N-CA 127.885 2.474 . . . . 0.0 107.386 169.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 63.7 t -99.51 125.38 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-O 123.306 1.527 . . . . 0.0 106.932 -172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 39.3 tp10 -112.41 122.17 46.94 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.134 -1.848 . . . . 0.0 113.004 173.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.9 116.81 16.93 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 128.346 2.658 . . . . 0.0 108.538 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . . . . . . . . . 95.7 t -86.78 112.77 23.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 172.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 28.8 mt -62.08 145.67 52.57 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 125.647 1.579 . . . . 0.0 111.901 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . . . . . . . . 0.306 0.8 OUTLIER -114.81 148.87 37.88 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 126.588 1.955 . . . . 0.0 110.732 177.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.587 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -78.33 138.75 38.72 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 126.948 2.099 . . . . 0.0 109.744 176.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 96.85 -1.22 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 128.816 2.846 . . . . 0.0 112.319 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -147.89 -26.05 0.35 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.108 -0.995 . . . . 0.0 110.634 -175.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 57.92 171.36 0.05 Allowed 'General case' 0 C--N 1.361 1.069 0 C-N-CA 125.194 1.397 . . . . 0.0 111.521 -162.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 57.44 -133.6 52.63 Favored Glycine 0 C--N 1.373 2.592 0 O-C-N 119.376 -2.078 . . . . 0.0 110.104 -163.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.465 HG22 ' H ' ' A' ' 948' ' ' GLY . 58.5 t 56.32 77.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.178 0 C-N-CA 126.036 1.735 . . . . 0.0 111.485 173.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.2 115.17 27.84 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 -175.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -102.6 -34.09 9.22 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.601 -172.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 95.4 t -99.34 87.24 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 103.252 -2.869 . . . . 0.0 103.252 166.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -94.84 131.18 41.01 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 23.2 t -142.91 116.31 9.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 C-N-CA 125.343 1.457 . . . . 0.0 107.714 176.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.41 85.03 0.71 Allowed Glycine 0 CA--C 1.485 -1.814 0 N-CA-C 103.689 -3.764 . . . . 0.0 103.689 162.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 1.62 0 C-N-CA 124.812 1.196 . . . . 0.0 110.987 172.663 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 74.8 mt -124.69 134.34 52.89 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . 0.465 ' H ' HG22 ' A' ' 919' ' ' VAL . . . -139.7 163.81 26.12 Favored Glycine 0 CA--C 1.494 -1.268 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -174.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 31.3 m -124.29 132.96 70.57 Favored 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 171.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -137.05 147.46 46.19 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 55.1 m -117.62 -40.98 2.97 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . . . . . . . . . 36.4 tp -89.27 -54.21 4.21 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 118.666 0.666 . . . . 0.0 112.082 -165.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.557 HG22 ' HE ' ' A' ' 893' ' ' ARG . 16.3 pt -85.41 -155.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.883 0 C-N-CA 124.724 1.21 . . . . 0.0 110.278 -179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.472 HD11 ' H ' ' A' ' 894' ' ' TYR . 0.0 OUTLIER -170.07 85.71 0.57 Allowed Pre-proline 0 N--CA 1.44 -0.955 0 C-N-CA 122.981 0.513 . . . . 0.0 109.934 -165.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.14 89.99 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 122.656 1.984 . . . . 0.0 109.538 159.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 6.6 mp -122.78 145.83 48.07 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.568 2.347 . . . . 0.0 105.022 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -92.62 157.16 16.64 Favored 'General case' 0 C--N 1.363 1.185 0 CA-C-N 119.444 1.02 . . . . 0.0 108.705 178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.27 123.83 23.15 Favored 'General case' 0 C--N 1.37 1.495 0 CA-C-N 119.749 1.159 . . . . 0.0 108.949 174.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.46 -13.17 67.78 Favored Glycine 0 CA--C 1.496 -1.126 0 C-N-CA 125.884 1.707 . . . . 0.0 111.019 170.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.16 176.19 5.38 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 123.052 0.541 . . . . 0.0 111.697 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . . . . . . . . . 77.7 m -141.74 127.17 18.82 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -157.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.587 HG13 HH11 ' A' ' 914' ' ' ARG . 10.5 m -94.9 149.72 4.37 Favored 'Isoleucine or valine' 0 C--N 1.36 1.054 0 CA-C-O 121.642 0.734 . . . . 0.0 109.909 173.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 72.6 m -139.38 137.17 35.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.139 1.775 . . . . 0.0 111.011 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . . . . . . . . . 89.5 t -92.82 129.19 43.73 Favored 'Isoleucine or valine' 0 C--N 1.367 1.343 0 C-N-CA 126.61 1.964 . . . . 0.0 106.666 -178.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -108.35 131.07 55.12 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 101.879 -3.378 . . . . 0.0 101.879 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . . . . . . . . . 7.0 tt -130.98 77.82 1.81 Allowed 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 173.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . . . . . . . . . 53.0 t -161.21 101.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.848 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 178.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -152.3 72.42 0.99 Allowed 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 119.04 149.42 8.55 Favored Glycine 0 C--N 1.349 1.266 0 N-CA-C 108.053 -2.019 . . . . 0.0 108.053 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -117.01 -28.75 6.17 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 123.805 0.842 . . . . 0.0 108.748 -173.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 38.2 tp -92.6 86.51 5.62 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.37 -164.13 1.54 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 106.889 -1.522 . . . . 0.0 106.889 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 38.7 t60 -125.29 160.21 29.83 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -93.22 132.07 37.72 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.57 150.01 22.75 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 104.878 -2.268 . . . . 0.0 104.878 -177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.23 113.58 23.71 Favored Pre-proline 0 C--N 1.355 0.844 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 173.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -97.95 172.34 0.64 Allowed 'Trans proline' 0 CA--C 1.507 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 108.369 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 7.3 mp -117.17 140.43 49.53 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 22.4 p -140.45 142.25 35.39 Favored 'General case' 0 C--N 1.376 1.728 0 CA-C-N 119.51 1.05 . . . . 0.0 108.757 -170.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 25.6 mm -118.81 129.46 75.0 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 N-CA-C 105.924 -1.88 . . . . 0.0 105.924 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -125.81 106.85 9.98 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -177.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 52.1 p -99.29 160.74 14.06 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.057 0.943 . . . . 0.0 109.547 170.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.13 108.35 0.25 Allowed Glycine 0 C--N 1.359 1.836 0 C-N-CA 119.293 -1.432 . . . . 0.0 109.951 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -119.99 148.78 43.13 Favored 'General case' 0 C--N 1.348 0.525 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -173.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 52.0 tp -72.7 123.39 23.18 Favored 'General case' 0 C--N 1.372 1.568 0 C-N-CA 125.849 1.66 . . . . 0.0 109.456 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 19.1 tp -99.95 -57.84 2.05 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -131.82 128.64 39.15 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 126.911 2.084 . . . . 0.0 106.466 -174.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.12 130.58 10.32 Favored Glycine 0 N--CA 1.437 -1.282 0 N-CA-C 103.979 -3.649 . . . . 0.0 103.979 161.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -69.48 133.56 89.0 Favored Pre-proline 0 C--N 1.353 0.75 0 CA-C-N 118.662 1.231 . . . . 0.0 110.794 177.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -106.14 83.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.473 0 CA-C-N 121.469 1.56 . . . . 0.0 109.832 -169.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.44 -72.74 0.09 Allowed 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 130.398 3.479 . . . . 0.0 109.484 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 71.3 mt 49.52 40.23 18.75 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 129.27 3.028 . . . . 0.0 114.023 -176.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -112.08 130.51 55.86 Favored 'General case' 0 CA--C 1.497 -1.064 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 78.5 m80 -127.32 110.1 12.48 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 104.949 -2.241 . . . . 0.0 104.949 175.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.058 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 179.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.454 -0.823 0 N-CA-C 110.004 -0.806 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 42.7 t -125.2 120.67 25.15 Favored Pre-proline 0 C--N 1.353 0.74 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -92.7 -21.01 0.47 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 CA-C-N 122.098 1.785 . . . . 0.0 109.83 -172.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 32.1 tt0 38.48 69.83 0.24 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 129.08 2.952 . . . . 0.0 115.315 177.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 78.9 t -118.7 136.42 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.715 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -135.24 158.34 44.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 162.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.416 ' HA ' ' HA ' ' B' ' 874' ' ' ASN . 8.3 p90 -149.52 139.21 21.74 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 172.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 22.3 t -169.2 117.84 0.66 Allowed 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -118.66 153.06 34.94 Favored 'General case' 0 CA--C 1.486 -1.486 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' B' ' 872' ' ' LEU . . . -138.8 157.67 45.65 Favored 'General case' 0 CA--C 1.498 -1.028 0 C-N-CA 118.768 -1.173 . . . . 0.0 111.886 174.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -132.09 130.22 40.95 Favored 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -166.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . . . . . . . . . 32.4 p -160.8 14.18 0.11 Allowed 'General case' 0 N--CA 1.43 -1.454 0 CA-C-N 114.37 -1.286 . . . . 0.0 107.557 -163.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . . . . . . . . . 3.2 pp -21.58 143.58 0.02 OUTLIER Pre-proline 0 C--N 1.373 1.587 0 N-CA-C 117.155 2.28 . . . . 0.0 117.155 158.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -83.34 -43.18 0.08 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.72 0 CA-C-N 122.009 1.753 . . . . 0.0 111.936 -168.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 40.1 ptt85 -164.15 176.78 8.93 Favored 'General case' 0 CA--C 1.499 -0.999 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -175.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 17.2 m -19.36 120.44 0.02 OUTLIER 'General case' 0 C--N 1.363 1.175 0 C-N-CA 129.706 3.203 . . . . 0.0 115.645 171.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -127.92 144.19 50.51 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 -163.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.77 -10.6 16.96 Favored 'Trans proline' 0 CA--C 1.512 -0.603 0 CA-C-N 122.698 1.999 . . . . 0.0 113.645 -158.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -157.62 -141.81 3.25 Favored Glycine 0 C--N 1.351 1.404 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -63.25 144.92 56.52 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 125.984 1.714 . . . . 0.0 110.282 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 98.9 t -88.13 128.27 54.27 Favored Pre-proline 0 N--CA 1.437 -1.079 0 C-N-CA 124.912 1.285 . . . . 0.0 110.119 -165.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -95.34 -153.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 124.196 3.264 . . . . 0.0 108.382 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -147.92 133.79 19.07 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -116.48 -13.02 10.95 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 123.977 0.911 . . . . 0.0 110.696 -179.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -101.26 85.7 2.86 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-O 121.198 0.523 . . . . 0.0 111.281 176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . 0.417 HG13 ' HB3' ' B' ' 874' ' ' ASN . 60.7 t -69.77 97.32 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 106.276 -1.749 . . . . 0.0 106.276 163.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' B' ' 855' ' ' ALA . 18.5 mt -87.21 -39.32 15.56 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.414 -172.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 40.7 tp -165.23 127.25 2.09 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 101.064 -3.68 . . . . 0.0 101.064 165.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.417 ' HB3' HG13 ' B' ' 871' ' ' VAL . 27.3 t-20 178.69 61.02 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 120.157 1.344 . . . . 0.0 109.146 -161.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -59.52 -43.56 93.38 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -167.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -93.59 -27.6 12.7 Favored Glycine 0 C--N 1.356 1.653 0 CA-C-N 118.779 0.718 . . . . 0.0 112.669 -175.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.92 -55.73 0.5 Allowed Glycine 0 C--N 1.352 1.469 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 60.46 -84.11 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 C-N-CA 128.11 2.564 . . . . 0.0 114.866 174.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.3 118.87 34.71 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 -176.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -82.75 116.39 63.72 Favored Pre-proline 0 N--CA 1.441 -0.905 0 N-CA-C 104.265 -2.495 . . . . 0.0 104.265 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -95.01 5.21 2.37 Favored 'Trans proline' 0 CA--C 1.506 -0.881 0 CA-C-N 124.403 2.608 . . . . 0.0 109.73 -161.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -79.95 -44.38 20.42 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 -177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.5 p -108.2 -10.64 15.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.957 174.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.79 30.13 30.16 Favored Glycine 0 C--N 1.359 1.819 0 N-CA-C 111.096 -0.801 . . . . 0.0 111.096 162.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 32.3 t -101.34 102.36 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.353 0 N-CA-C 101.332 -3.581 . . . . 0.0 101.332 -162.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.448 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.3 OUTLIER -101.53 111.79 24.14 Favored 'General case' 0 C--N 1.351 0.666 0 CA-C-N 112.856 -1.974 . . . . 0.0 108.994 -174.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 78.3 m -100.14 107.67 19.61 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 105.375 -2.084 . . . . 0.0 105.375 170.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . 0.454 ' HB3' HH22 ' B' ' 914' ' ' ARG . . . -90.13 111.53 47.32 Favored Pre-proline 0 C--N 1.356 0.857 0 CA-C-O 117.291 -1.338 . . . . 0.0 111.93 169.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -89.48 0.35 5.89 Favored 'Trans proline' 0 N--CA 1.459 -0.541 0 C-N-CA 122.762 2.308 . . . . 0.0 108.759 164.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 7.0 tt -48.38 -56.44 8.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 128.914 2.886 . . . . 0.0 115.032 -167.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 57.85 63.93 1.67 Allowed 'General case' 0 C--N 1.363 1.195 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 170.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . -172.98 -166.68 31.83 Favored Glycine 0 N--CA 1.409 -3.141 0 N-CA-C 103.621 -3.791 . . . . 0.0 103.621 -176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 54.6 ttt-85 -90.81 121.16 32.43 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 173.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.482 ' H ' HD11 ' B' ' 954' ' ' LEU . 2.0 t80 -117.27 146.04 43.57 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 -172.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 38.7 tp -112.34 115.51 28.86 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 10.2 tt -112.08 139.83 47.27 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 126.275 1.83 . . . . 0.0 108.503 -174.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 66.4 m -143.26 119.19 10.62 Favored 'General case' 0 C--N 1.359 1.0 0 C-N-CA 123.312 0.645 . . . . 0.0 109.43 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.65 154.46 21.42 Favored 'General case' 0 C--N 1.365 1.271 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 98.2 t -107.69 121.96 61.33 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -103.38 122.02 43.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 124.152 0.981 . . . . 0.0 109.123 -171.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 36.4 m -81.41 132.05 35.31 Favored 'General case' 0 C--N 1.353 0.732 0 C-N-CA 125.261 1.424 . . . . 0.0 107.781 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -56.81 -58.01 16.7 Favored Glycine 0 C--N 1.364 2.125 0 C-N-CA 125.14 1.352 . . . . 0.0 114.405 -170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 58.5 m170 37.2 70.4 0.18 Allowed 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.204 2.202 . . . . 0.0 114.976 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -73.29 -8.74 57.15 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 125.28 1.432 . . . . 0.0 111.442 -176.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -73.17 -15.79 61.45 Favored 'General case' 0 C--N 1.357 0.906 0 C-N-CA 125.083 1.353 . . . . 0.0 112.564 -169.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . . . . . . . . 0.314 12.2 pt-20 122.94 -179.29 0.0 OUTLIER 'General case' 0 CA--C 1.495 -1.172 0 C-N-CA 128.568 2.747 . . . . 0.0 108.606 176.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . . . . . . . . . 78.0 tttt 102.5 131.11 0.01 OUTLIER 'General case' 0 CA--C 1.495 -1.166 0 C-N-CA 127.897 2.479 . . . . 0.0 107.184 170.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 89.3 t -99.08 126.51 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -172.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -112.52 123.13 49.61 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.23 -1.35 . . . . 0.0 112.87 174.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -132.56 115.67 15.75 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 128.223 2.609 . . . . 0.0 109.476 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . . . . . . . . . 93.4 t -87.89 113.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 107.175 -1.416 . . . . 0.0 107.175 172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.21 149.37 41.89 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 126.662 1.985 . . . . 0.0 112.369 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . . . . . . . . 0.309 0.9 OUTLIER -115.08 149.53 37.37 Favored 'General case' 0 CA--C 1.51 -0.591 0 C-N-CA 126.598 1.959 . . . . 0.0 110.524 178.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.599 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -80.71 138.71 36.35 Favored 'General case' 0 N--CA 1.436 -1.142 0 C-N-CA 126.593 1.957 . . . . 0.0 109.36 174.165 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . . . . . . . . . 3.5 t 97.1 -5.76 0.06 Allowed 'General case' 0 C--N 1.348 0.533 0 C-N-CA 128.92 2.888 . . . . 0.0 112.569 172.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -146.19 -25.84 0.44 Allowed 'General case' 0 C--N 1.358 0.953 0 CA-C-N 119.47 1.032 . . . . 0.0 111.349 -172.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 57.9 169.66 0.05 OUTLIER 'General case' 0 C--N 1.362 1.112 0 C-N-CA 125.32 1.448 . . . . 0.0 111.571 -162.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 60.03 -132.89 50.95 Favored Glycine 0 C--N 1.368 2.317 0 O-C-N 119.508 -1.995 . . . . 0.0 109.727 -165.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . . . . . . . . . 61.0 t 53.71 78.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.181 0 C-N-CA 126.408 1.883 . . . . 0.0 111.631 174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.66 115.42 28.03 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -103.02 -35.27 8.61 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 113.825 -1.534 . . . . 0.0 108.632 -172.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 89.6 t -99.35 86.55 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 N-CA-C 103.121 -2.918 . . . . 0.0 103.121 166.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -95.9 130.53 42.83 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -172.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 22.7 t -141.59 117.34 10.4 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 125.327 1.451 . . . . 0.0 107.235 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -98.21 85.18 0.73 Allowed Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 103.889 -3.684 . . . . 0.0 103.889 164.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.661 0 C-N-CA 124.639 1.114 . . . . 0.0 110.927 174.309 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 42.2 m . . . . . 0 CA--C 1.506 -0.747 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 69.8 mt -115.54 134.07 55.42 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 -169.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.67 164.68 26.0 Favored Glycine 0 CA--C 1.489 -1.545 0 C-N-CA 125.56 1.552 . . . . 0.0 109.281 -172.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -120.06 133.01 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 170.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . . . . . . . . . 48.0 p90 -135.66 148.51 48.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 176.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 52.6 m -122.14 -34.61 3.29 Favored 'General case' 0 C--N 1.355 0.846 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.367 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . . . . . . . . . 25.8 tp -91.31 -52.34 4.85 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 118.943 0.792 . . . . 0.0 112.128 -168.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . . . . . . . . . 44.6 pt -86.63 -169.5 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.963 0 C-N-CA 124.816 1.246 . . . . 0.0 109.353 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.482 HD11 ' H ' ' B' ' 894' ' ' TYR . 0.0 OUTLIER -159.62 86.42 2.1 Favored Pre-proline 0 N--CA 1.442 -0.829 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -168.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.31 90.88 0.98 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 O-C-N 117.627 -1.828 . . . . 0.0 109.982 161.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 7.3 mp -122.53 145.58 48.19 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 127.083 2.153 . . . . 0.0 105.412 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -92.16 158.89 15.93 Favored 'General case' 0 C--N 1.363 1.155 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.701 178.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -72.55 123.1 22.49 Favored 'General case' 0 C--N 1.378 1.829 0 CA-C-N 120.304 1.411 . . . . 0.0 108.602 175.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.77 -12.02 70.1 Favored Glycine 0 CA--C 1.494 -1.231 0 C-N-CA 125.283 1.421 . . . . 0.0 110.863 168.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.55 175.7 5.35 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 121.905 0.859 . . . . 0.0 110.659 177.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . . . . . . . . . 83.2 m -142.27 127.51 18.67 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -154.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.599 HG13 HH11 ' B' ' 914' ' ' ARG . 7.5 m -96.28 150.14 4.47 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 CA-C-O 121.464 0.649 . . . . 0.0 110.989 174.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 71.2 m -138.49 137.39 37.09 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 126.359 1.863 . . . . 0.0 111.035 178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.04 129.44 42.68 Favored 'Isoleucine or valine' 0 C--N 1.366 1.283 0 C-N-CA 127.459 2.303 . . . . 0.0 106.564 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -107.98 130.98 55.02 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 100.886 -3.746 . . . . 0.0 100.886 173.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . . . . . . . . . 6.6 tt -130.97 77.33 1.78 Allowed 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 105.724 -1.954 . . . . 0.0 105.724 173.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . . . . . . . . . 54.0 t -159.84 103.05 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -151.12 72.37 1.06 Allowed 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 175.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.83 148.23 8.35 Favored Glycine 0 C--N 1.349 1.301 0 N-CA-C 107.822 -2.111 . . . . 0.0 107.822 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -115.38 -27.66 7.13 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 35.8 tp -93.64 86.43 5.17 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -137.19 -163.98 1.51 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -125.2 159.29 31.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 18.3 t -91.38 131.13 37.06 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -157.58 149.99 22.71 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 104.826 -2.286 . . . . 0.0 104.826 -177.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.06 113.29 24.12 Favored Pre-proline 0 C--N 1.355 0.842 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 173.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -97.06 172.33 0.78 Allowed 'Trans proline' 0 CA--C 1.505 -0.957 0 C-N-CA 122.003 1.802 . . . . 0.0 108.173 -179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 7.4 mp -115.92 138.04 51.55 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 21.3 p -138.79 140.29 38.53 Favored 'General case' 0 C--N 1.375 1.711 0 CA-C-N 119.791 1.178 . . . . 0.0 108.261 -170.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 28.8 mm -116.31 130.35 71.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.757 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -126.53 106.59 9.54 Favored 'General case' 0 C--N 1.361 1.095 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 -176.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 35.6 p -101.05 162.89 12.57 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 124.489 1.116 . . . . 0.0 110.231 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -177.75 110.31 0.29 Allowed Glycine 0 C--N 1.359 1.852 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -117.83 147.28 43.2 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 49.6 tp -72.1 122.96 21.85 Favored 'General case' 0 C--N 1.378 1.838 0 C-N-CA 125.135 1.374 . . . . 0.0 109.091 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 59.1 tp -99.48 -58.09 2.01 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -131.37 128.39 39.54 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 125.897 1.679 . . . . 0.0 106.566 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -96.16 130.42 10.26 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 104.161 -3.575 . . . . 0.0 104.161 161.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -69.53 133.43 88.94 Favored Pre-proline 0 C--N 1.351 0.657 0 CA-C-O 117.986 -1.006 . . . . 0.0 110.39 176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -105.99 82.33 0.02 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.721 0 CA-C-N 121.546 1.588 . . . . 0.0 109.195 -170.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 77.88 -72.28 0.09 Allowed 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 130.286 3.435 . . . . 0.0 109.444 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 69.6 mt 48.69 43.91 21.07 Favored 'General case' 0 C--N 1.345 0.396 0 C-N-CA 129.087 2.955 . . . . 0.0 113.671 -174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -116.0 130.23 56.72 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 78.8 m80 -128.08 110.2 12.25 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 175.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.034 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 179.551 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo . . . . . 0 N--CA 1.453 -0.86 0 N-CA-C 109.962 -0.822 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 34.8 t -125.4 116.52 25.22 Favored Pre-proline 0 N--CA 1.443 -0.781 0 N-CA-C 104.453 -2.425 . . . . 0.0 104.453 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -90.01 -20.71 1.08 Allowed 'Trans proline' 0 CA--C 1.511 -0.638 0 CA-C-N 121.903 1.715 . . . . 0.0 109.662 -172.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 39.16 69.8 0.26 Allowed 'General case' 0 C--N 1.359 0.981 0 C-N-CA 128.811 2.844 . . . . 0.0 115.471 176.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 40.0 t -120.15 133.73 65.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -137.13 153.96 50.38 Favored 'General case' 0 C--N 1.363 1.158 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 167.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.456 ' HA ' ' HA ' ' C' ' 874' ' ' ASN . 7.0 p90 -149.71 141.7 23.87 Favored 'General case' 0 C--N 1.362 1.123 0 CA-C-N 118.916 0.78 . . . . 0.0 109.725 177.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 16.8 t -168.68 118.69 0.74 Allowed 'General case' 0 C--N 1.349 0.549 0 CA-C-O 118.597 -0.716 . . . . 0.0 109.159 -177.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -123.34 153.67 39.98 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.872 -2.27 . . . . 0.0 104.872 -174.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -142.52 156.13 45.1 Favored 'General case' 0 CA--C 1.494 -1.204 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.274 -178.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.542 HD21 HD23 ' C' ' 858' ' ' LEU . 1.9 tm? -130.21 127.56 39.89 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 113.931 -1.486 . . . . 0.0 107.699 -164.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . . . . . . . . . 33.3 p -162.35 11.88 0.07 Allowed 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 -161.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.542 HD23 HD21 ' C' ' 856' ' ' LEU . 3.2 pp -27.62 146.86 0.04 OUTLIER Pre-proline 0 C--N 1.368 1.393 0 N-CA-C 116.542 2.053 . . . . 0.0 116.542 157.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.83 -45.79 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.101 1.786 . . . . 0.0 112.156 -164.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -162.17 172.64 15.48 Favored 'General case' 0 CA--C 1.5 -0.977 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 -174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 19.2 m -0.43 107.17 0.01 OUTLIER 'General case' 0 C--N 1.359 1.013 0 C-N-CA 130.652 3.581 . . . . 0.0 117.526 167.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -107.46 163.5 16.82 Favored Pre-proline 0 C--N 1.353 0.757 0 C-N-CA 124.249 1.02 . . . . 0.0 110.209 -174.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -79.05 -13.19 14.19 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.083 2.522 . . . . 0.0 111.318 -178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -170.03 -144.39 4.28 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 23.1 m -64.39 136.6 57.27 Favored 'General case' 0 C--N 1.356 0.876 0 C-N-CA 126.364 1.866 . . . . 0.0 111.035 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 15.9 m -66.38 144.77 98.84 Favored Pre-proline 0 C--N 1.354 0.787 0 C-N-CA 125.392 1.477 . . . . 0.0 113.453 -174.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -100.96 -147.69 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.435 2.757 . . . . 0.0 106.67 176.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -147.33 134.25 20.22 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 174.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -117.59 -15.54 10.2 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 122.811 0.444 . . . . 0.0 110.334 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.463 HH21 HD23 ' C' ' 872' ' ' LEU . 11.1 mmm180 -102.33 81.52 2.08 Favored 'General case' 0 CA--C 1.503 -0.857 0 CA-C-O 121.402 0.62 . . . . 0.0 111.399 178.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . 0.418 HG13 ' HB3' ' C' ' 874' ' ' ASN . 43.6 t -67.99 97.75 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 C-N-CA 126.265 1.826 . . . . 0.0 107.464 162.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.463 HD23 HH21 ' C' ' 870' ' ' ARG . 6.9 mt -88.47 -37.85 15.46 Favored 'General case' 0 C--N 1.358 0.938 0 O-C-N 121.601 -0.687 . . . . 0.0 110.68 -174.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . . . . . . . . . 51.8 tp -165.86 129.77 2.21 Favored 'General case' 0 CA--C 1.491 -1.323 1 N-CA-C 100.157 -4.016 . . . . 0.0 100.157 168.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' C' ' 852' ' ' PHE . 33.2 t-20 176.42 61.69 0.0 OUTLIER 'General case' 0 C--N 1.357 0.929 0 CA-C-N 120.828 1.649 . . . . 0.0 108.034 -165.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -59.32 -43.68 92.67 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 116.161 1.912 . . . . 0.0 116.161 -165.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -94.01 -28.08 11.47 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 118.896 0.771 . . . . 0.0 112.568 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 108.36 -57.78 0.42 Allowed Glycine 0 C--N 1.353 1.486 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 62.38 -82.51 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 C-N-CA 128.214 2.606 . . . . 0.0 114.557 174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -97.0 120.05 36.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 C-N-CA 125.139 1.376 . . . . 0.0 108.085 -175.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.49 115.95 62.0 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 174.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -96.02 5.97 1.91 Allowed 'Trans proline' 0 CA--C 1.506 -0.913 0 CA-C-N 124.659 2.7 . . . . 0.0 109.702 -161.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -79.55 -45.25 19.58 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 -178.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 29.3 p -106.72 -11.14 15.88 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 114.929 -1.032 . . . . 0.0 108.868 174.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.93 31.07 30.03 Favored Glycine 0 C--N 1.362 1.987 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 162.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 36.2 t -101.25 101.93 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 N-CA-C 100.965 -3.716 . . . . 0.0 100.965 -164.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -101.26 112.09 24.5 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 112.127 -2.306 . . . . 0.0 108.548 -175.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 66.4 m -99.39 109.42 22.02 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 171.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -90.34 109.6 34.79 Favored Pre-proline 0 C--N 1.355 0.846 0 CA-C-O 117.367 -1.302 . . . . 0.0 111.724 173.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -95.35 -4.11 2.1 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.434 2.089 . . . . 0.0 108.104 168.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 55.0 mt -54.54 -52.89 60.62 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 127.937 2.495 . . . . 0.0 114.009 -165.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 58.56 67.62 0.92 Allowed 'General case' 0 C--N 1.366 1.32 0 CA-C-O 122.262 1.03 . . . . 0.0 111.418 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . -174.54 -169.62 36.78 Favored Glycine 0 N--CA 1.406 -3.334 1 N-CA-C 102.156 -4.377 . . . . 0.0 102.156 -170.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 66.2 ttt-85 -93.69 120.85 34.47 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 113.53 -1.335 . . . . 0.0 108.076 174.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.429 ' H ' HD11 ' C' ' 954' ' ' LEU . 1.5 t80 -116.73 145.38 43.51 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 -170.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 53.1 tp -109.94 114.88 28.79 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.061 0.945 . . . . 0.0 108.58 178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -113.21 137.9 50.78 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 125.379 1.472 . . . . 0.0 108.814 -173.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 75.0 m -144.3 118.71 9.64 Favored 'General case' 0 C--N 1.361 1.092 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 174.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.34 153.82 22.2 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 82.2 t -104.81 121.76 57.07 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 76.5 mt -95.46 124.15 39.34 Favored 'General case' 0 N--CA 1.441 -0.909 0 C-N-CA 124.373 1.069 . . . . 0.0 109.837 -176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 55.5 m -81.47 130.62 35.11 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 172.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -50.62 -54.81 19.69 Favored Glycine 0 C--N 1.361 1.956 0 C-N-CA 126.141 1.829 . . . . 0.0 115.776 -170.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 28.7 m170 28.16 78.69 0.02 OUTLIER 'General case' 0 C--N 1.36 1.06 0 C-N-CA 128.162 2.585 . . . . 0.0 116.254 -174.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 52.0 ptt85 -72.37 -13.5 61.49 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 125.9 1.68 . . . . 0.0 111.29 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -73.04 -17.43 61.43 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 125.661 1.584 . . . . 0.0 112.617 -168.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . . . . . . . . 0.332 7.2 pt-20 116.23 -179.85 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.31 0 C-N-CA 128.093 2.557 . . . . 0.0 108.769 175.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . . . . . . . . . 81.4 tttt 105.51 133.66 0.01 OUTLIER 'General case' 0 CA--C 1.489 -1.367 0 C-N-CA 128.554 2.742 . . . . 0.0 105.136 173.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 86.8 t -97.23 125.06 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.125 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 -172.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -101.15 130.87 47.29 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.086 173.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.75 113.54 2.8 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 125.252 1.421 . . . . 0.0 110.625 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . . . . . . . . . 6.2 p -85.18 117.73 30.86 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 C-N-CA 126.114 1.765 . . . . 0.0 108.722 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 34.9 mt -62.62 137.78 58.34 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 124.646 1.178 . . . . 0.0 109.81 173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 6.9 t -117.17 144.39 44.8 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.609 1.564 . . . . 0.0 107.853 177.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.45 142.55 37.44 Favored 'General case' 0 N--CA 1.425 -1.704 0 C-N-CA 128.344 2.657 . . . . 0.0 109.591 -176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . . . . . . . . 0.33 24.1 p 88.6 3.44 0.26 Allowed 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 129.902 3.281 . . . . 0.0 113.879 177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -150.67 -24.26 0.23 Allowed 'General case' 0 C--N 1.361 1.07 0 CA-C-N 119.453 1.024 . . . . 0.0 111.31 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 58.84 168.37 0.06 Allowed 'General case' 0 C--N 1.362 1.146 0 C-N-CA 125.435 1.494 . . . . 0.0 112.116 -163.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 59.5 -130.16 49.82 Favored Glycine 0 C--N 1.375 2.744 0 O-C-N 119.384 -2.072 . . . . 0.0 110.135 -163.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 49.2 t 53.48 72.39 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.175 0 C-N-CA 125.946 1.698 . . . . 0.0 111.974 173.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.66 116.37 28.95 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -174.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . . . . . . . . . 36.2 ptt85 -99.31 -31.31 11.76 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.762 -174.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 61.6 t -99.88 80.02 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 166.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -95.29 130.76 41.93 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.744 0.307 . . . . 0.0 111.197 -175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 23.1 t -144.5 117.81 9.02 Favored 'General case' 0 C--N 1.362 1.133 0 C-N-CA 125.287 1.435 . . . . 0.0 107.872 171.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -97.15 85.05 0.79 Allowed Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 104.133 -3.587 . . . . 0.0 104.133 168.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.713 0 C-N-CA 125.311 1.434 . . . . 0.0 110.732 172.965 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 75.9 mt -120.51 134.69 55.24 Favored 'General case' 0 N--CA 1.432 -1.356 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -178.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -139.73 162.59 26.24 Favored Glycine 0 CA--C 1.491 -1.421 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -174.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 17.0 m -120.88 132.98 69.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -137.86 148.71 45.64 Favored 'General case' 0 CA--C 1.503 -0.835 0 O-C-N 121.436 -0.79 . . . . 0.0 108.957 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 63.7 m -108.31 -75.79 0.62 Allowed 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 123.634 0.774 . . . . 0.0 109.03 176.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . . . . . . . . . 21.9 tp -66.96 -50.74 61.35 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 -163.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.89 -176.87 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.067 0 C-N-CA 125.94 1.696 . . . . 0.0 109.656 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.64 ' HB2' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -163.14 94.42 1.13 Allowed Pre-proline 0 N--CA 1.438 -1.058 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -164.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.1 93.63 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.631 2.221 . . . . 0.0 110.015 162.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.64 HD13 ' HB2' ' C' ' 954' ' ' LEU . 7.9 mp -120.65 144.49 48.14 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 -178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -98.35 160.42 14.29 Favored 'General case' 0 C--N 1.363 1.187 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -71.43 123.41 22.31 Favored 'General case' 0 C--N 1.381 1.978 0 CA-C-N 120.329 1.422 . . . . 0.0 109.038 173.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -9.49 71.83 Favored Glycine 0 C--N 1.348 1.247 0 C-N-CA 125.233 1.397 . . . . 0.0 111.794 168.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -66.65 171.83 4.78 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 123.438 0.695 . . . . 0.0 112.445 176.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . . . . . . . . . 98.5 m -142.73 127.76 18.47 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -159.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . . . . . . . . . 2.9 m -95.07 149.76 4.38 Favored 'Isoleucine or valine' 0 C--N 1.363 1.158 0 C-N-CA 123.627 0.771 . . . . 0.0 109.295 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 18.2 t -142.29 136.59 29.91 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 124.495 1.118 . . . . 0.0 111.89 176.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . . . . . . . . . 24.2 t -93.47 129.63 43.63 Favored 'Isoleucine or valine' 0 C--N 1.374 1.665 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -105.11 134.16 48.68 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 101.794 -3.41 . . . . 0.0 101.794 172.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.83 73.6 1.47 Allowed 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 112.902 -1.954 . . . . 0.0 107.041 177.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 48.9 t -162.03 99.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.954 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 -175.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -152.37 72.69 1.0 Allowed 'General case' 0 CA--C 1.493 -1.219 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 118.68 146.94 8.11 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 108.085 -2.006 . . . . 0.0 108.085 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 -114.65 -21.56 10.17 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 123.413 0.685 . . . . 0.0 109.952 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -99.08 85.94 3.34 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -136.89 -167.88 2.17 Favored 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 -170.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -122.69 156.73 33.77 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 15.4 t -91.12 135.53 33.7 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -160.23 154.45 23.38 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -127.72 115.01 20.85 Favored Pre-proline 0 N--CA 1.443 -0.815 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 172.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -97.57 172.96 0.67 Allowed 'Trans proline' 0 CA--C 1.506 -0.906 0 C-N-CA 121.921 1.747 . . . . 0.0 107.894 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.8 mp -115.29 139.17 50.2 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 22.1 p -137.16 138.97 40.81 Favored 'General case' 0 C--N 1.375 1.688 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 31.5 mm -115.54 131.13 68.81 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -124.98 105.76 9.45 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 -175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 26.4 p -100.86 162.65 12.75 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.996 1.318 . . . . 0.0 109.587 172.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -178.23 111.03 0.31 Allowed Glycine 0 C--N 1.358 1.785 0 C-N-CA 119.325 -1.417 . . . . 0.0 109.71 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -118.75 142.71 47.44 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 64.1 tp -75.17 125.39 28.85 Favored 'General case' 0 C--N 1.377 1.79 0 C-N-CA 125.684 1.594 . . . . 0.0 108.569 178.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 32.3 tp -97.1 -56.03 2.68 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -130.62 127.53 39.15 Favored 'General case' 0 N--CA 1.432 -1.368 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 -173.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -95.5 128.62 9.59 Favored Glycine 0 CA--C 1.49 -1.514 0 N-CA-C 103.615 -3.794 . . . . 0.0 103.615 164.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -70.58 130.01 89.42 Favored Pre-proline 0 C--N 1.351 0.641 0 CA-C-O 117.461 -1.257 . . . . 0.0 111.215 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -107.03 80.48 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.514 0 CA-C-N 122.519 1.935 . . . . 0.0 109.777 -169.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 77.98 -71.99 0.1 Allowed 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 130.048 3.339 . . . . 0.0 109.414 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 64.9 mt 48.77 41.62 18.43 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 129.314 3.046 . . . . 0.0 113.596 -174.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -110.0 129.55 55.66 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -128.94 107.0 9.27 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.067 -2.197 . . . . 0.0 105.067 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.066 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 179.307 . . . . . . . . 0 0 . 1 stop_ save_